FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Frassanito, P
   D'Onofrio, GF
   Pennisi, G
   Massimi, L
   Tamburrini, G
   Muto, M
   Caldarelli, M
AF Frassanito, Paolo
   D'Onofrio, Ginevra Federica
   Pennisi, Giovanni
   Massimi, Luca
   Tamburrini, Gianpiero
   Muto, Mario
   Caldarelli, Massimo
TI Multimodal Management of Aggressive Recurrent Aneurysmal Bone Cyst of
   Spine: Case Report and Review of Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Aneurysmal bone cyst; Hydroxyapatite; Multimodal management;
   Personalized medicine; Sclerotherapy; Spinal cord compression; Spine
ID COMPRESSION; SUBSTITUTE
AB BACKGROUND: Different treatment options have been proposed for aneurysmal bone cysts (ABCs) with sclerotherapy favored as primary treatment and surgery remaining the mainstay of treatment in case of compression of neural structures. Recurrent spinal ABCs are burdened by increased risk of spinal deformity and instability, further complicating the management of these cases.
   CASE DESCRIPTION: A 15-year-old boy presented with acute symptoms and signs of spinal cord compression due to a large thoracic ABC. Subtotal resection of the lesion achieved optimal decompression of neural structures with good neurologic recovery, but the remnant of the lesion rapidly grew with recurrent spinal cord compression after 40 days. The patient underwent total surgical resection with full neurologic recovery. Unfortunately, recurrence of the lesion was documented at 3-months' follow-up. This was successfully treated with percutaneous injection of hydroxyapatite cement. Two years' follow-up ruled out any further recurrence of the lesion. Furthermore, spinal deformity and instability were also excluded.
   CONCLUSIONS: Percutaneous sclerotherapy with hydroxyapatite cement proved to be highly effective and safe in the treatment of spinal ABC, though surgery remains mandatory in case of spinal cord compression. The main advantage of sclerotherapy with hydroxyapatite cement seems to be the capacity to regenerate bone with normal radiologic features.
C1 [Frassanito, Paolo; D'Onofrio, Ginevra Federica; Pennisi, Giovanni; Massimi, Luca; Tamburrini, Gianpiero; Caldarelli, Massimo] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Neurochirurgia Infantile, Rome, Italy.
   [Muto, Mario] AORN A Cardarelli, Neuroradiol, Naples, Italy.
RP Frassanito, P (reprint author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Neurochirurgia Infantile, Rome, Italy.
EM paolo.frassanito@gmail.com
RI FRASSANITO, Paolo/K-4099-2018
OI FRASSANITO, Paolo/0000-0003-0071-3126
CR [Anonymous], JAMA SURG
   Boubbou M, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.111.2117
   Chan MSM, 2002, PEDIATR RADIOL, V32, P601, DOI 10.1007/s00247-001-0648-5
   DEDIOS AMV, 1992, CANCER, V69, P2921, DOI 10.1002/1097-0142(19920615)69:12<2921::AID-CNCR2820691210>3.0.CO;2-E
   Fahed R, 2016, J NEURO INTERV SURG, V8, pe4, DOI DOI 10.1136/NEU-RINTSURG-2014-011541.REP
   Feigenberg SJ, 2001, INT J RADIAT ONCOL, V49, P1243, DOI 10.1016/S0360-3016(00)01462-0
   Ghanem I, 2017, J CHILD ORTHOP, V11, P448, DOI 10.1302/1863-2548.11.170106
   Guarnieri G, 2013, BMJ CASE REP, V2013
   Harrop JS, 2009, SPINE, V34, pS39, DOI 10.1097/BRS.0b013e3181ba0024
   HOLMES RE, 1988, J ORAL MAXIL SURG, V46, P661, DOI 10.1016/0278-2391(88)90109-7
   MALAWER MM, 1991, CLIN ORTHOP RELAT R, P42
   MARTINEZ V, 1988, CANCER, V61, P2291, DOI 10.1002/1097-0142(19880601)61:11<2291::AID-CNCR2820611125>3.0.CO;2-V
   Masala S, 2012, NEURORADIOLOGY, V54, P589, DOI 10.1007/s00234-011-0940-5
   Mascard E, 2015, ORTHOP TRAUMATOL-SUR, V101, pS119, DOI 10.1016/j.otsr.2014.06.031
   Papagelopoulos PJ, 1998, SPINE, V23, P621, DOI 10.1097/00007632-199803010-00018
   Rai AT, 2005, AM J NEURORADIOL, V26, P30
   Shiels WE, 2013, CLIN ORTHOP RELAT R, V471, P2675, DOI 10.1007/s11999-013-3043-2
   Tsagozis P, 2015, ORTHOP REV, V7, P106, DOI 10.4081/or.2015.6182
   Ulici A, 2018, J INT MED RES, V46, P538, DOI 10.1177/0300060517722244
   WHO, WHO CLASSIFICATION T
   Zileli M, 2013, EUR SPINE J, V22, P593, DOI 10.1007/s00586-012-2510-x
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 423
EP 427
DI 10.1016/j.wneu.2019.02.246
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400272
PM 30904804
DA 2020-05-12
ER

PT J
AU Algoet, M
   Van Dyck-Lippens, PJ
   Casselman, J
   Sirimsi, S
   Fletcher, CDM
   Van den Berghe, I
   Vanopdenbosch, L
   De Muynck, S
   Vantomme, N
AF Algoet, Michiel
   Van Dyck-Lippens, Pieter Jan
   Casselman, Jan
   Sirimsi, Sabriya
   Fletcher, Christophe D. M.
   Van den Berghe, Ivo
   Vanopdenbosch, Ludo
   De Muynck, Stijn
   Vantomme, Nikolaas
TI Intracanal Optic Nerve Cavernous Hemangioma: A Case Report and Review of
   the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cavernous malformations; Optic canal; Optic nerve; Visual field deficit
ID MALFORMATIONS; MANAGEMENT; ANGIOMA; RADIOSURGERY
AB BACKGROUND: Cerebral cavernous malformations of the intracanalicular optic nerve are extremely rare lesions. Only a few case reports and 1 case series have been published. We report an additional case with atypical imaging and review the existing literature with attention to time to surgery and imaging characteristics.
   CASE DESCRIPTION: In a 38-year-old man with progressive visual field deficit, a lesion compressing the left optic nerve in the optic canal was diagnosed. On magnetic resonance imaging, this lesion had a homogeneous signal and was tentatively diagnosed as a meningioma. A left frontolateral craniotomy with extradural skull base approach with neuronavigation was performed for resection and definitive diagnosis of the lesion. Pathologic examination showed a lesion most consistent with a cavernous hemangioma. Follow-up magnetic resonance imaging at 6 months showed no remaining tissue or recurrence. Clinically, there was subjective and objective improvement of sight.
   CONCLUSIONS: A cerebral cavernous malformation should always be in the differential diagnosis of a lesion causing an optic neuropathy with visual acuity loss and visual field defect. Clinical presentation of an optic neuropathy requires medical imaging; magnetic resonance imaging is the modality of choice in the diagnosis of these lesions. The treatment of cerebral cavernous malformation is gross total resection.
C1 [Algoet, Michiel] Univ Leuven, Leuven, Belgium.
   [Van Dyck-Lippens, Pieter Jan] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium.
   [Algoet, Michiel; Van Dyck-Lippens, Pieter Jan; De Muynck, Stijn; Vantomme, Nikolaas] AZ Sint Jan Brugge Oostende, Dept Neurosurg, Brugge, Belgium.
   [Casselman, Jan] AZ Sint Jan Brugge Oostende, Dept Radiol, Brugge, Belgium.
   [Sirimsi, Sabriya; Van den Berghe, Ivo] AZ Sint Jan Brugge Oostende, Dept Pathol, Brugge, Belgium.
   [Vanopdenbosch, Ludo] AZ Sint Jan Brugge Oostende, Dept Neurol, Brugge, Belgium.
   [Fletcher, Christophe D. M.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.
RP Algoet, M (reprint author), Univ Leuven, Leuven, Belgium.; Algoet, M (reprint author), AZ Sint Jan Brugge Oostende, Dept Neurosurg, Brugge, Belgium.
EM michielalgoet@hotmail.com
OI Algoet, Michiel/0000-0002-4763-7426
CR Akers A, 2017, NEUROSURGERY, V80, P665, DOI 10.1093/neuros/nyx091
   Batra S, 2009, NAT REV NEUROL, V5, P659, DOI 10.1038/nrneurol.2009.177
   Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241
   Chen YB, 2017, AM J OPHTHALMOL, V173, P1, DOI 10.1016/j.ajo.2016.09.022
   Chibbaro S, 2018, J CLIN NEUROSCI, V52, P135, DOI 10.1016/j.jocn.2018.03.021
   Deshmukh VR, 2003, NEUROSURGERY, V53, P352, DOI 10.1227/01.NEU.0000073531.84342.C2
   Goncalves Vitor M, 2014, Surg Neurol Int, V5, pS455, DOI 10.4103/2152-7806.143723
   Hamed-Azzam S, 2018, EYE, V32, P333, DOI 10.1038/eye.2017.173
   HASSLER W, 1989, SURG NEUROL, V31, P444, DOI 10.1016/0090-3019(89)90089-X
   Hempelmann RG, 2007, ACTA NEUROCHIR, V149, P699, DOI 10.1007/s00701-007-1163-8
   Liu JK, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10129
   MCCORMICK WF, 1966, J NEUROSURG, V24, P865, DOI 10.3171/jns.1966.24.5.0865
   Meng X, 2017, WORLD NEUROSURG, V106
   Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016
   Pollock BE, 2000, J NEUROSURG, V93, P987, DOI 10.3171/jns.2000.93.6.0987
   Ramina K, 2013, J NEUROL SURG PART A, V74, P265, DOI 10.1055/s-0032-1304806
   Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x
   RIGAMONTI D, 1987, J NEUROSURG, V67, P518, DOI 10.3171/jns.1987.67.4.0518
   Salman RAS, 2012, LANCET NEUROL, V11, P217, DOI 10.1016/S1474-4422(12)70004-2
   SATO K, 1994, J COMPUT ASSIST TOMO, V18, P990, DOI 10.1097/00004728-199411000-00029
   Schick U, 2009, CLIN NEUROL NEUROSUR, V111, P801, DOI 10.1016/j.clineuro.2009.08.004
   SILVA ICE, 1984, J NEUROSURG, V60, P838
   SZE G, 1987, AM J ROENTGENOL, V149, P1223, DOI 10.2214/ajr.149.6.1223
   Xu QS, 2016, ONCOL LETT, V11, P1545, DOI 10.3892/ol.2015.4053
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 428
EP 433
DI 10.1016/j.wneu.2019.02.202
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400273
PM 30876990
DA 2020-05-12
ER

PT J
AU Gassie, K
   Grewal, S
   Chen, SG
AF Gassie, Kelly
   Grewal, Sanjeet
   Chen, Selby G.
TI Atlantooccipital Synovial Cyst with Isolated Hypoglossal Nerve Palsy:
   Case Report of Nonfusion Surgical Approach and Review of Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Atlantooccipital synovial cyst; Hypoglossal nerve palsy
ID INTRANEURAL GANGLION CYST; MICROSURGICAL RESECTION; SECONDARY
AB BACKGROUND: Isolated hypoglossal nerve palsy caused by an atlantooccipital synovial cyst is a rare lesion, with fewer than 5 cases reported in the literature.
   CASE DESCRIPTION: Our patient presented with acute hypoglossal nerve dysfunction. Our differential included neoplasm, trauma, stroke, multiple sclerosis, or other inflammatory/infectious etiology. Imaging revealed a peripherally enhancing, extradural focus in the left premedullary cistern, most likely consistent with a synovial cyst.
   CONCLUSIONS: A left suboccipital craniectomy was performed in the region of the left hypoglossal canal, in which a cystic structure was noted at the occipital condyle and C1 vertebral junction. The nerve was adequately decompressed via aspiration of the cyst. Postoperatively, the patient substantially improved. Although rare, synovial cysts must be included in the differential diagnosis of atlantooccipital lesions.
C1 [Gassie, Kelly; Grewal, Sanjeet; Chen, Selby G.] Mayo Clin Florida, Dept Neurol Surg, Jacksonville, FL 32224 USA.
RP Gassie, K (reprint author), Mayo Clin Florida, Dept Neurol Surg, Jacksonville, FL 32224 USA.
EM gassie.kelly@mayo.edu
OI Grewal, Sanjeet/0000-0002-4307-7062
CR Baldauf J, 2005, J NEUROSURG, V103, P920, DOI 10.3171/jns.2005.103.5.0920
   Bilgin-Freiert A, 2015, J NEUROL SURG REP, V76, P180, DOI 10.1055/s-0035-1555016
   Boviatsis EJ, 2008, EUR SPINE J, V17, P831, DOI 10.1007/s00586-007-0563-z
   CARTWRIGHT MJ, 1991, CLIN NEUROL NEUROSUR, V93, P69, DOI 10.1016/0303-8467(91)90013-F
   Elhammady MS, 2009, J NEUROSURG-SPINE, V10, P234, DOI 10.3171/2008.12.SPINE08158
   Fujii H, 2014, J STROKE CEREBROVASC, V23, pE405, DOI 10.1016/j.jstrokecerebrovasdis.2014.03.004
   Giordano M, 2012, J CLIN NEUROSCI, V19, P472, DOI 10.1016/j.jocn.2011.04.035
   Henaux PL, 2011, NEUROCHIRURGIE, V57, P129, DOI 10.1016/j.neuchi.2011.07.004
   KAO CC, 1974, J NEUROSURG, V41, P372, DOI 10.3171/jns.1974.41.3.0372
   Keane JR, 1996, ARCH NEUROL-CHICAGO, V53, P561, DOI 10.1001/archneur.1996.00550060105023
   Mendes-Araujo L, 2010, BRIT J RADIOL, V83, pE35, DOI 10.1259/bjr/97329463
   Mujic A, 2003, J CLIN NEUROSCI, V10, P492, DOI 10.1016/S0967-5868(03)00083-3
   Nonaka Y, 2010, J NEUROSURG, V113, P380, DOI 10.3171/2010.1.JNS091526
   Patro SN, 2014, NEURORADIOL J, V27, P361, DOI 10.15274/NRJ-2014-10039
   Ryu H, 1999, BRIT J NEUROSURG, V13, P492
   Scholz C, 2017, CLIN NEUROL NEUROSUR, V153, P35, DOI 10.1016/j.clineuro.2016.12.008
   THOMPSON EO, 1994, RADIOGRAPHICS, V14, P939, DOI 10.1148/radiographics.14.5.7991825
   Wen HT, 1997, J NEUROSURG, V87, P555, DOI 10.3171/jns.1997.87.4.0555
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 434
EP 438
DI 10.1016/j.wneu.2019.03.159
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400274
PM 30922910
DA 2020-05-12
ER

PT J
AU Cavallo, LM
   Solari, D
   Somma, T
   Cappabianca, P
AF Cavallo, Luigi M.
   Solari, Domenico
   Somma, Teresa
   Cappabianca, Paolo
TI The 3F (Fat, Flap, and Flash) Technique For Skull Base Reconstruction
   After Endoscopic Endonasal Suprasellar Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE CSF leakage; Endoscopic endonasal surgery; Extended approaches; Skull
   base reconstruction; Transsphenoidal surgery
ID CEREBROSPINAL-FLUID LEAKS; TRANSSPHENOIDAL APPROACH; TUBERCULUM SELLAE;
   RESECTION; CRANIOPHARYNGIOMAS; SURGERY; REPAIR; PREDICTORS; EXPERIENCE;
   MANAGEMENT
AB BACKGROUND: Endoscopic endonasal surgery is a rapidly evolving field that offers the possibility of treating a wide variety of skull base lesions. Reconstruction of the osteodural defect is of utmost importance, as an effective and watertight closure is mandatory. Over the years, various techniques and materials have been adopted in an effort of providing a resilient and reliable method of closure.
   MATERIALS AND METHODS: We retrospectively analyzed data from a series of 25 patients who underwent skull base reconstruction according to a novel paradigm following endoscopic endonasal transtuberculum-transplanum approaches for tumor removal between June 2017 and June 2018. The 3F strategy involves autologous fat grafting, nasoseptal flap coverage, and flash mobilization out of the bed following the operation.
   RESULTS: The 3F technique achieved successful watertight closure in 24 of 25 cases (96%). One case of postoperative cerebrospinal fluid rhinorrhea developed on postoperative day 10, which did not require reoperation. No perioperative complications related to the 3F strategy (e.g., overpacking, infections, or hematomas) occurred. No donor graft site infections or hematomas developed.
   CONCLUSIONS: The 3F skull base reconstruction is a safe and effective method in achieving watertight closure after extended endoscopic endonasal approaches. Despite this study reporting a preliminary experience in a small series of patients, it seems that the 3F technique can be considered as a viable solution among the wide kaleidoscope of available skull base reconstruction methods.
C1 [Cavallo, Luigi M.; Solari, Domenico; Somma, Teresa; Cappabianca, Paolo] Univ Napoli Federico Naples II, Div Neurosurg, Naples, Italy.
RP Solari, D (reprint author), Univ Napoli Federico Naples II, Div Neurosurg, Naples, Italy.
EM d.solari.md@gmail.com
OI SOLARI, Domenico/0000-0003-1535-8737
CR Banu MA, 2014, J NEUROSURG, V121, P961, DOI 10.3171/2014.5.JNS132028
   Caggiano C, 2018, WORLD NEUROSURG, V117, pE575, DOI 10.1016/j.wneu.2018.06.090
   Cappabianca P, 2002, J NEUROSURG, V97, P293, DOI 10.3171/jns.2002.97.2.0293
   Cappabianca P, 2002, NEUROSURGERY, V51, P1365, DOI 10.1227/01.NEU.0000035904.77559.9F
   Cappabianca P, 2008, ADV TECHNICAL STANDA, P152
   Cavallo Luigi M, 2005, Neurosurg Focus, V19, pE2
   Cavallo LM, 2014, WORLD NEUROSURG, V82, pE479, DOI 10.1016/j.wneu.2013.01.017
   Cavallo LM, 2009, J NEUROSURG, V111, P578, DOI 10.3171/2009.2.JNS081026
   Cavallo LM, 2007, J NEUROSURG, V107, P713, DOI 10.3171/JNS-07/10/0713
   Cavallo LM, 2014, J NEUROSURG, V121, P100, DOI 10.3171/2014.3.JNS131521
   Cavallo LM, 2013, NEUROSURG REV, V36, P27, DOI 10.1007/s10143-012-0403-4
   D'Anza B, 2016, AM J RHINOL ALLERGY, V30, P430, DOI 10.2500/ajra.2016.30.4377
   de Divitiis E, 2007, NEUROSURGERY, V61, P229, DOI 10.1227/01.neu.0000303221.63016.f2
   De Divitiis E, 2007, NEUROSURGERY, V61, P219, DOI 10.1227/01.neu.0000303220.55393.73
   de Divitiis E, 2007, NEUROSURGERY, V60, P46, DOI 10.1227/01.NEU.0000249211.89096.25
   de Divitiis O, 2007, NEUROSURGERY, V61, P239, DOI 10.1227/01.neu.0000303222.40145.1a
   de Notaris M, 2012, J NEUROSURG, V116, P622, DOI 10.3171/2011.11.JNS111162
   Dhandapani S, 2017, J NEUROSURG, V126, P418, DOI 10.3171/2016.1.JNS152238
   Di Somma A, 2019, J NEUROSURG, V130, P848, DOI 10.3171/2017.9.JNS171406
   Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66
   Frank G, 2006, NEUROSURGERY, V59, P75, DOI 10.1227/01.NEU.0000219897.98238.A3
   Gardner PA, 2008, NEUROSURGERY, V63, P36, DOI 10.1227/01.NEU.0000335069.30319.1E
   Gardner PA, 2008, J NEUROSURG, V109, P6, DOI 10.3171/JNS/2008/109/7/0006
   Gondim JA, 2014, WORLD NEUROSURG, V82, pE281, DOI 10.1016/j.wneu.2013.08.028
   Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4
   Hutton DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107199
   Jeswani S, 2016, J NEUROSURG, V124, P627, DOI 10.3171/2015.3.JNS142254
   Juraschka K, 2014, J NEUROSURG, V121, P75, DOI 10.3171/2014.3.JNS131679
   Kassam A B, 2008, NEUROSURGERY S1, V63, pONS44
   Kassam Amin, 2005, Neurosurg Focus, V19, pE3
   Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5
   Kassam AB, 2008, J NEUROSURG, V108, P715, DOI 10.3171/JNS/2008/108/4/0715
   Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406
   Kelly DF, 2001, NEUROSURGERY, V49, P885, DOI 10.1097/00006123-200110000-00020
   Kelly DF, 2001, NEUROSURGERY, V49, P889
   Komotar RJ, 2012, BRIT J NEUROSURG, V26, P637, DOI 10.3109/02688697.2012.654837
   Kono Y, 2011, INFECT CONT HOSP EP, V32, P77, DOI 10.1086/657635
   Koutourousiou M, 2014, J NEUROSURG, V120, P1326, DOI 10.3171/2014.2.JNS13767
   Koutourousiou M, 2013, J NEUROSURG, V119, P1194, DOI 10.3171/2013.6.JNS122259
   Laufer I, 2007, J NEUROSURG, V106, P400, DOI 10.3171/jns.2007.106.3.400
   Laws ER, 1982, MANAGEMENT PITUITARY, P329
   Leng LZ, 2008, NEUROSURGERY, V62, P342, DOI [10.1227/01.NEU.0000312720.93685.17, 10.1227/01.neu.0000326017.84315.1f]
   Leng LZ, 2012, NEUROSURGERY, V70, P110, DOI 10.1227/NEU.0b013e31822e8ffc
   Locatelli D, 2006, NEUROSURGERY S2, V58
   Locatelli D, 2006, NEUROSURGERY, V58
   Magill ST, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17753
   Moussazadeh N, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16299
   Otto BA, 2013, LARYNGOSCOPE, V123, P2976, DOI 10.1002/lary.24210
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   Rivera-Serrano CM, 2011, LARYNGOSCOPE, V121, P990, DOI 10.1002/lary.21419
   SPAZIANTE R, 2005, SCHMIDEK SWEET OPERA, V1, P390
   Tabaee APD, 2007, PRACTICAL ENDOSCOPIC, P191
   Watelet JB, 2002, AM J RHINOL, V16, P77, DOI 10.1177/194589240201600202
   Ziu MT, 2013, WORLD NEUROSURG, V80, P554, DOI 10.1016/j.wneu.2012.08.001
NR 54
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 439
EP 446
DI 10.1016/j.wneu.2019.03.125
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400275
PM 30904811
DA 2020-05-12
ER

PT J
AU Cofano, F
   Sciarrone, GJ
   Pecoraro, MF
   Marengo, N
   Ajello, M
   Penner, F
   Petrone, S
   Ducati, A
   Zenga, F
   Musso, C
   Garbossa, D
AF Cofano, Fabio
   Sciarrone, Giuseppe Junior
   Pecoraro, Michele Federico
   Marengo, Nicola
   Ajello, Marco
   Penner, Federica
   Petrone, Salvatore
   Ducati, Alessandro
   Zenga, Francesco
   Musso, Corrado
   Garbossa, Diego
TI Cervical Interfacet Spacers to Promote Indirect Decompression and
   Enhance Fusion in Degenerative Spine: A Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Atlantoaxial instability; Cervical interfacet spacers; Cervical
   radiculopathy; Cervical spine surgery; Indirect decompression; Minimally
   invasive surgery
ID ALLOGRAFT SPACERS; PSEUDOARTHROSIS; DISKECTOMY; RADICULOPATHY;
   MANAGEMENT; FIXATION; STABILIZATION; ARTHRODESIS; REPLACEMENT; REVISION
AB BACKGROUND: Among the posterior techniques, the use of cervical inter-facet spacers (CISs) represents a promising technology whose potentialities are still being studied. The purpose of the present review was to assess the available data on CISs.
   METHODS: A search on PubMed was performed. The search terms were "cervical interfacet spacers," "facet spacers," "DTRAX facet system," "Goel facet spacer," "pseudarthrosis," "cervical lordosis," "iatrogenic kyphosis," "cervical foraminal decompression," "cervical biomechanics," "atlantoaxial instability," and "subaxial instability."
   RESULTS: Mechanical studies have shown that stand-alone CISs promoted stiffness in all directions, except for extension. Foraminal distraction was recorded in 86% of the cases. Clinical studies have shown that the use of CISs could promote successful arthrodesis, given the large surface area affected by fusion and decreasing the need for autografts. The effectiveness for the treatment of radiculopathy has been confirmed by several clinical studies. In a series of 154 levels of implanted CISs, no evidence of significant loss of cervical lordosis was identified. CISs could help in enhancing fusion in C1-C2 fixation.
   CONCLUSIONS: Biomechanical studies on specimens showed a positive trend in increasing stiffness of the cervical spine, despite some controversial results. In clinical studies, facet distraction was shown to be a safe and valid option for clinical indirect decompression, although longer follow-up is required for confirmation. No evidence of the loss of cervical lordosis has been recorded. The long-term effects and CIS use in revision procedures as adjuvant implants to treat pseudarthrosis or atlantoaxial instability are currently under investigation, and further studies are needed.
C1 [Cofano, Fabio; Marengo, Nicola; Ajello, Marco; Penner, Federica; Petrone, Salvatore; Ducati, Alessandro; Zenga, Francesco; Garbossa, Diego] Univ Turin, Dept Neurosci, Div Neurosurg, Turin, Italy.
   [Sciarrone, Giuseppe Junior; Pecoraro, Michele Federico; Musso, Corrado] Humanitas Res Ctr, Spinal Surg, Bergamo, Italy.
RP Cofano, F (reprint author), Univ Turin, Dept Neurosci, Div Neurosurg, Turin, Italy.
EM fabio.cofano@gmail.com
RI Garbossa, Diego/AAC-8888-2019; Ajello, Marco/AAC-9910-2019
OI Penner, Federica/0000-0002-4491-1725
CR Bertagnoli R, 2005, ORTHOP CLIN N AM, V36, P355, DOI 10.1016/j.ocl.2005.02.009
   Carreon Leah, 2006, Spine J, V6, P154, DOI 10.1016/j.spinee.2005.07.003
   Cheng L, J CLIN NEUROSCI, DOI [10.1016/j.jcon.2019.01.018, DOI 10.1016/J.JCON.2019.01.018]
   Coric D, 1997, J NEUROSURG, V86, P969, DOI 10.3171/jns.1997.86.6.0969
   Elder BD, 2016, J CLIN NEUROSCI, V24, P57, DOI 10.1016/j.jocn.2015.07.019
   FAREY ID, 1990, J BONE JOINT SURG AM, V72A, P1171, DOI 10.2106/00004623-199072080-00007
   Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e
   Goel A, 2011, J NEUROSURG-SPINE, V14, P689, DOI 10.3171/2011.2.SPINE10601
   Heary RF, 2005, SPINE SURG TECHNIQUE, P351
   Huang DG, 2015, SPINE J, V15, P2271, DOI 10.1016/j.spinee.2015.07.008
   Joaquim AF, 2018, NEUROL INDIA, V66, P1003, DOI 10.4103/0028-3886.237025
   Kaiser MG, 2009, J NEUROSURG-SPINE, V11, P228, DOI 10.3171/2009.2.SPINE08729
   Kasliwal MK, 2016, NEUROSURGERY, V78, P661, DOI 10.1227/NEU.0000000000001087
   Koerner John D, 2015, HSS J, V11, P2, DOI 10.1007/s11420-014-9394-8
   Kuhns CA, 2005, SPINE, V30, P2424, DOI 10.1097/01.brs.0000184314.26543.7d
   Leasure JM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026363
   Leven D, 2016, ASIAN SPINE J, V10, P776, DOI 10.4184/asj.2016.10.4.776
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Liu H, 2012, J SPINAL DISORD TECH, V25, P138, DOI 10.1097/BSD.0b013e31821532a5
   Matz PG, 2009, J NEUROSURG-SPINE, V11, P170, DOI 10.3171/2009.3.SPINE08724
   Maulucci CM, 2016, J NEUROSURG-SPINE, V24, P69, DOI 10.3171/2015.4.SPINE14845
   McAnany SJ, 2015, GLOB SPINE J, V5, P148, DOI 10.1055/s-0035-1544176
   McCormack BM, 2016, J CLIN NEUROSCI, V34, P299, DOI 10.1016/j.jocn.2016.08.008
   McCormack BM, 2013, J NEUROSURG-SPINE, V18, P245, DOI 10.3171/2012.12.SPINE12477
   Mobbs RJ, 2007, J CLIN NEUROSCI, V14, P639, DOI 10.1016/j.jocn.2006.04.003
   Mummaneni PV, 2009, J NEUROSURG-SPINE, V11, P130, DOI 10.3171/2009.3.SPINE08728
   Phillips FM, 1997, SPINE, V22, P1585, DOI 10.1097/00007632-199707150-00012
   Riley LH, 2010, SPINE, V35, pS76, DOI 10.1097/BRS.0b013e3181d81a96
   Salunke P, 2016, EUR SPINE J, V25, P1098, DOI 10.1007/s00586-015-4370-7
   Siambanes D, 1998, Am J Orthop (Belle Mead NJ), V27, P792
   Siemionow Kris, 2018, J Spine Surg, V4, P281, DOI 10.21037/jss.2018.05.27
   Siemionow K, 2016, J NEUROL SURG PART A, V77, P482, DOI 10.1055/s-0036-1584210
   Siemionow K, 2016, EUR SPINE J, V25, P2279, DOI 10.1007/s00586-016-4430-7
   Siemionow K, 2016, WORLD NEUROSURG, V89, DOI 10.1016/j.wneu.2016.01.053
   Skovrlj B, 2017, J NEUROSURG SCI, V61, P325, DOI 10.23736/S0390-5616.16.03906-0
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Tan LA, 2015, J NEUROSURG-SPINE, V22, P466, DOI 10.3171/2014.10.SPINE14192
   Tan LA, 2014, J NEUROSURG-SPINE, V20, P178, DOI 10.3171/2013.11.SPINE131
   Tuchman A, 2017, GLOB SPINE J, V7, P59, DOI 10.1055/s-0036-1580610
   Turel MK, 2017, J CRANIOVERTEBRAL JU, V8, P332, DOI 10.4103/jcvjs.JCVJS_87_17
   Voronov LI, 2016, MED DEVICES-EVID RES, V9, P285, DOI 10.2147/MDER.S111031
   Voronov LI, 2016, MED DEVICES-EVID RES, V9, P223, DOI 10.2147/MDER.S109588
   Wenger M, 2010, MED DEVICES-EVID RES, V3, P11
   Zdeblick TA, 1997, J BONE JOINT SURG AM, V79A, P523, DOI 10.2106/00004623-199704000-00007
   Zechmeister I, 2011, EUR SPINE J, V20, P177, DOI 10.1007/s00586-010-1583-7
NR 45
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 447
EP 452
DI 10.1016/j.wneu.2019.03.114
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400276
PM 30904796
OA Green Published
DA 2020-05-12
ER

PT J
AU Houston, R
   Gagliardo, C
   Vassallo, S
   Wynne, PJ
   Mazzola, CA
AF Houston, Rebecca
   Gagliardo, Christina
   Vassallo, Sheryl
   Wynne, Peter J.
   Mazzola, Catherine A.
TI Spinal Epidural Abscess in Children: Case Report and Review of the
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Child; Methicillin-susceptible Staphylococcus aureus; MSSA;
   Neurosurgery; Pediatrics; SEA; Spinal epidural abscess
ID BACK-PAIN; MANAGEMENT; FEVER
AB BACKGROUND: Spinal epidural abscess (SEA) is a rare but serious infection in the epidural space along the spinal cord. SEA should be considered in patients with backache, fever, neurological deficits and/or spinal tenderness. Early diagnosis is imperative to prevent permanent neurological sequelae.
   CASE DESCRIPTION: We report a case of lumbar SEA in a 13-year-old girl who was immunocompetent and presented with spinal tenderness, back pain and 4 days of fever. A lumbar magnetic resonance imaging demonstrated an epidural abscess from L3-S1. She had emergent surgical intervention. Cultures grew methicillin-susceptible Staphylococcus aureus. She was also given long-term systemic antibiotics and she made a complete recovery within 2 months.
   CONCLUSIONS: SEA in an immunocompetent pediatric without risk factors is an extremely rare condition. In the English-language literature, there are only 30 reported cases in the past 19 years; our case brings the total to 31. Non-surgical treatment has been successful in both adult and pediatric patients under certain conditions. Still, there exists a risk of deterioration with non-surgical management, even in patients for whom treatment is begun in the absence of neurologic deficits. Tracking neurological deficits in children can be challenging, particularly in young children who are non-verbal and not yet ambulating, and a reliable neurologic examination is a critical component of non-surgical care. In consideration of these facts and the accelerated time frame of deterioration, once neurologic deficits are present, surgery plus systemic antibiotics remains the standard of care for pediatric SEA patients, with each individual case meriting review of the full clinical picture.
C1 [Houston, Rebecca] Rowan Univ, Sch Med UMDNJ, Stratford, NJ 08028 USA.
   [Gagliardo, Christina; Vassallo, Sheryl; Mazzola, Catherine A.] Goryeb Childrens Hosp, Atlantic Hlth Syst, Div Pediat Infect Dis, Morristown, NJ USA.
   [Gagliardo, Christina] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
   [Wynne, Peter J.] Morristown Med Ctr, Dept Radiol, Morristown, NJ USA.
RP Houston, R (reprint author), Rowan Univ, Sch Med UMDNJ, Stratford, NJ 08028 USA.
EM Houstonr5@Rowan.edu
CR Abd-El-Barr MM, 2015, J NEUROSURG-SPINE, V22, P318, DOI 10.3171/2014.11.SPINE131166
   Auletta JJ, 2001, CLIN INFECT DIS, V32, P9, DOI 10.1086/317527
   Aycan A, 2016, CASE REP INFECT DIS, DOI 10.1155/2016/7958291
   BAIRMERRITT MH, PEDIATRICS, V106, pE3
   BAKER AS, 1992, CLIN INFECT DIS, V15, P28, DOI 10.1093/clinids/15.1.28
   Chen WC, 2008, J MICROBIOL IMMUNOL, V41, P215
   CURLING OD, 1990, NEUROSURGERY, V27, P185, DOI 10.1227/00006123-199008000-00002
   Flikweert ER, 2002, EUR J PEDIATR SURG, V12, P141, DOI 10.1055/s-2002-30169
   Fotaki A, 2019, ACTA PAEDIATR, V108, P28, DOI 10.1111/apa.14579
   Ghosh PS, 2009, J CHILD NEUROL, V24, P768, DOI 10.1177/0883073808329524
   Greenberg MS, 2016, HDB NEUROSURGERY
   Harris TJ, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.05.029
   Hawkins M, 2013, PEDIATRICS, V132, pE1680, DOI 10.1542/peds.2012-3805
   Hazelton B, 2012, J PAEDIATR CHILD H, V48, pE132, DOI 10.1111/j.1440-1754.2011.02078.x
   Horner K, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1406
   Karikari IO, 2009, NEUROSURGERY, V65, P919, DOI 10.1227/01.NEU.0000356972.97356.C5
   Kiymaz N, 2005, NEUROL MED-CHIR, V45, P540, DOI 10.2176/nmc.45.540
   Kose Mehmet, 2009, Spine J, V9, pe1, DOI 10.1016/j.spinee.2007.12.003
   Mantadakis E, 2011, EUR J PEDIATR, V170, P945, DOI 10.1007/s00431-011-1437-2
   Mohanty CB, 2018, CHILD NERV SYST, V34, P1947, DOI 10.1007/s00381-018-3885-8
   Nejat F, 2002, PEDIATR INFECT DIS J, V21, P797, DOI 10.1097/00006454-200208000-00024
   NUSSBAUM ES, 1992, SURG NEUROL, V38, P225, DOI 10.1016/0090-3019(92)90173-K
   Parkinson Jonathon F, 2004, Neurosurg Focus, V17, pE12
   Paro-Panjan D, 2006, EUR J PEDIATR, V165, P730, DOI 10.1007/s00431-006-0148-6
   Pathak A, 2013, CASE REPORTS, V2013
   Pradilla Gustavo, 2010, Curr Infect Dis Rep, V12, P484, DOI 10.1007/s11908-010-0140-1
   Prasad M, 2014, PEDIATR NEUROL, V50, P540, DOI 10.1016/j.pediatrneurol.2014.01.034
   Raus Iulian, 2015, Clujul Med, V88, P555, DOI 10.15386/cjmed-460
   Rood CJ, 2014, PEDIATR ANN, V43, P177, DOI 10.3928/00904481-20140417-05
   Rook JL, 2011, PEDIATR EMERG CARE, V27, P530, DOI 10.1097/PEC.0b013e31821d86d5
   Sales Jafar Ganjpour, 2013, Med J Islam Repub Iran, V27, P38
   Shawar R, 2017, PEDIATR REV, V38, P46, DOI 10.1542/pir.2014-0127
   Siddiq F, 2004, ARCH INTERN MED, V164, P2409, DOI 10.1001/archinte.164.22.2409
   Smith GA, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS14136
   Spears J, 2001, PEDIATR NEUROSURG, V35, P337, DOI 10.1159/000050450
   Tang K, 2001, CHILD NERV SYST, V17, P629, DOI 10.1007/s003810100477
   Tsang YP, 2012, HONG KONG J EMERG ME, V19, P411
   Vergori A, 2015, IDCases, V2, P109, DOI 10.1016/j.idcr.2015.09.008
   송경진, 2009, [Journal of the Korean Orthopaedic Association, 대한정형외과학회지], V44, P680
NR 39
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 453
EP 460
DI 10.1016/j.wneu.2019.01.294
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400277
PM 30797918
DA 2020-05-12
ER

PT J
AU Gokcen, HB
   Ozturk, C
AF Gokcen, H. Bahadir
   Ozturk, Cagatay
TI Ossification of the Ligamentum Flavum at the Thoracic and Lumbar Region
   in an Achondroplastic Patient
SO WORLD NEUROSURGERY
LA English
DT Article
DE Achondroplasia; Ossification of ligamentum flavum; Spinal stenosis;
   Thoracolumbar kyphosis
ID THORACOLUMBAR KYPHOSIS; SURGICAL-TREATMENT; STENOSIS
AB BACKGROUND: Achondroplasia, a genetic disorder of bone growth, produces specific clinical features of the extremities and spine. Spinal stenosis, seen in patients with achondroplasia, is a congenital disorder related to premature fusion of the pedicles to the lamina. It can be caused by ossification of the ligamentum flavum, which is rare in patients with achondroplasia.
   CASE DESCRIPTION: We report a rare congenital spinal stenosis with ossification of the ligamentum flavum and thoracolumbar kyphosis deformity in a 24-year-old man with dwarfism and achondroplasia. He was treated with posterior instrumentation and decompression with a wide laminectomy.
   CONCLUSIONS: Treatment of the deformity and the rare condition of ligamentum flavum in a patient with achondroplasia resulted in improved neurologic status and symptoms. To our knowledge, this is the first case report including treatment for both the deformity and thoracic and lumbar ossified ligamentum flavum lesion in a patient with achondroplasia.
C1 [Gokcen, H. Bahadir; Ozturk, Cagatay] Istinye Univ, Med Fac, Dept Orthoped & Traumatol, Istanbul, Turkey.
RP Gokcen, HB (reprint author), Istinye Univ, Med Fac, Dept Orthoped & Traumatol, Istanbul, Turkey.
EM bahadrgokcen@gmail.com
OI OZTURK, CAGATAY/0000-0003-3133-206X
CR Agabegi Steven S, 2008, Orthopedics, V31, P168, DOI 10.3928/01477447-20080201-01
   Ain MC, 2006, SPINE, V31, P197, DOI 10.1097/01.brs.0000194778.60486.a3
   Borkhuu B, 2009, SPINE, V34, P1699, DOI 10.1097/BRS.0b013e3181ac8f9d
   Chakraborty T, 2017, J NEUROL STROKE, V7
   FRANCOMANO CA, 1995, NEW ENGL J MED, V332, P58, DOI 10.1056/NEJM199501053320113
   HALL JG, 1988, J PEDIATR-US, V112, P166, DOI 10.1016/S0022-3476(88)80157-4
   Hunter AGW, 1998, J MED GENET, V35, P705, DOI 10.1136/jmg.35.9.705
   Li Ka-Kin, 2002, Spine (Phila Pa 1976), V27, pE308, DOI 10.1097/00007632-200206150-00026
   Liao JC, 2006, ACTA ORTHOP, V77, P541, DOI 10.1080/17453670610012566
   Lonstein J E, 1988, Basic Life Sci, V48, P283
   Lutte LD, 1997, CLIN ORTHOP RELAT R, V126, P139
   MIYASAKA K, 1982, RADIOLOGY, V143, P463, DOI 10.1148/radiology.143.2.7071348
   Modi HN, 2008, CLIN ORTHOP RELAT R, V466, P907, DOI 10.1007/s11999-008-0142-6
   OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140
   OFIRAM E, 2006, SPINE, V31, pE46
   Pauli RM, 1997, J PEDIATR ORTHOPED, V17, P726, DOI 10.1097/00004694-199711000-00006
   Saito Kimio, 2014, J Med Case Rep, V8, P88, DOI 10.1186/1752-1947-8-88
   Shiokawa K, 2001, J NEUROSURG, V94, P221, DOI 10.3171/spi.2001.94.2.0221
   Shirley ED, 2009, J AM ACAD ORTHOP SUR, V17, P231, DOI 10.5435/00124635-200904000-00004
   Srikumaran U, 2007, SPINE, V32, P2423, DOI 10.1097/BRS.0b013e3181574286
   Suzuki K, 2008, J Orthop Surg (Hong Kong), V16, P392
   Thomeer RTWM, 2002, J NEUROSURG, V96, P292, DOI 10.3171/spi.2002.96.3.0292
   Yoon SH, 2011, EUR SPINE J, V20, P216, DOI 10.1007/s00586-010-1515-6
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 461
EP 465
DI 10.1016/j.wneu.2019.03.028
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400278
PM 30877011
DA 2020-05-12
ER

PT J
AU Shakur, SF
   Brunozzi, D
   Alaraj, A
AF Shakur, Sophia F.
   Brunozzi, Denise
   Alaraj, Ali
TI Glue Embolization with Guide Catheter Dextrose Push of Recurrent Dural
   Arteriovenous Fistula Previously Embolized with Onyx: Neuroendovascular
   Surgical Video
SO WORLD NEUROSURGERY
LA English
DT Article
DE Dural arteriovenous fistula; Embolic agent; Embolization; Glue; Guide
   catheter; Onyx
C1 [Shakur, Sophia F.; Brunozzi, Denise; Alaraj, Ali] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.
RP Alaraj, A (reprint author), Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA.
EM alaraj@uic.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 466
EP 466
DI 10.1016/j.wneu.2019.02.181
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400279
PM 30862592
DA 2020-05-12
ER

PT J
AU Lopez-Gonzalez, MA
   Sharafeddin, F
   Eastin, TM
   Gospodarev, V
   Jaeger, A
AF Lopez-Gonzalez, Miguel Angel
   Sharafeddin, Fransua
   Eastin, Timothy Marc
   Gospodarev, Vadim
   Jaeger, Andrew
TI Microsurgical Technique for Basilar Apex Aneurysm Clipping:
   Two-Dimensional Video
SO WORLD NEUROSURGERY
LA English
DT Article
DE Basilar apex aneurysm; Cranio-orbito-zygomatic craniotomy; Microsurgical
   clipping
C1 [Lopez-Gonzalez, Miguel Angel; Eastin, Timothy Marc] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92354 USA.
   [Sharafeddin, Fransua] Loma Linda Univ, Sch Med, Ctr Neurosci Res, Loma Linda, CA USA.
   [Gospodarev, Vadim; Jaeger, Andrew] Loma Linda Univ, Sch Med, Loma Linda, CA USA.
RP Lopez-Gonzalez, MA (reprint author), Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92354 USA.
EM mlopezgonzalez@llu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 467
EP 467
DI 10.1016/j.wneu.2019.02.189
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400280
PM 30862602
DA 2020-05-12
ER

PT J
AU Kuroda, H
   Mochizuki, T
   Shimizu, S
   Kumabe, T
AF Kuroda, Hiroki
   Mochizuki, Takahiro
   Shimizu, Satoru
   Kumabe, Toshihiro
TI Rupture of Thrombosed Cerebral Aneurysm During Antithrombotic Therapy
   for Ischemic Stroke: Case Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Antithrombotic therapy; Ischemic stroke; Subarachnoid hemorrhage;
   Thrombosed cerebral aneurysm
ID UNRUPTURED INTRACRANIAL ANEURYSMS; NATURAL-HISTORY; MANAGEMENT
AB BACKGROUND: Thrombosed cerebral aneurysm (TCA) can cause cerebral infarction. However, treatment of cerebral infarction due to embolism from TCA is controversial because of the risk of rupture, and no consensus has been established for the treatment of patients with this condition.
   CASE DESCRIPTION: A 75-year-old woman suffered left hemiparesis. Computed tomography (CT) showed a high-density round mass in the right sylvian fissure, which was suspected to be a nonruptured TCA. Magnetic resonance (MR) angiography and CT angiography demonstrated an aneurysm in the distal part of the right middle cerebral artery with poor opacification of most of the aneurysm, suggesting partial thrombosis. Diffusion-weighted MR imaging revealed high intensity in the right frontal lobe, in a distribution distal to the aneurysm. The diagnosis was cerebral infarction due to embolism from a partially thrombosed aneurysm. She was treated with antithrombotic therapy. On day 4, she suddenly became comatose. CT and CT angiography revealed subarachnoid hemorrhage (SAH) and enlarged opacification in the aneurysm, respectively. She underwent neck clipping of the aneurysm, but her neurologic improvement was poor. TCA causing ischemic stroke followed by SAH is extremely rare, with only 4 previous reported cases. All patients had received antithrombotic therapies, and most aneurysms had ruptured within a few days after starting antithrombotic therapy. The outcomes were extremely poor.
   CONCLUSIONS: We suggest that antithrombotic therapy might be avoided for these patients. Early surgical treatment without antithrombotic therapy is recommended to prevent aneurysm rupture and recurrent distal embolism from the TCA.
C1 [Kuroda, Hiroki; Mochizuki, Takahiro; Shimizu, Satoru] Yokohama Brain & Spine Ctr, Dept Neurosurg, Yokohama, Kanagawa, Japan.
   [Kumabe, Toshihiro] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa, Japan.
RP Kuroda, H (reprint author), Yokohama Brain & Spine Ctr, Dept Neurosurg, Yokohama, Kanagawa, Japan.
EM ktre29moon@hotmail.com
CR BROWNLEE RD, 1995, STROKE, V26, P1945, DOI 10.1161/01.STR.26.10.1945
   Guillon B, 2011, AM J NEURORADIOL, V32, P1862, DOI 10.3174/ajnr.A2645
   JUVELA S, 1993, J NEUROSURG, V79, P174, DOI 10.3171/jns.1993.79.2.0174
   Kato M, 2005, NEUROL MED-CHIR, V45, P472, DOI 10.2176/nmc.45.472
   Lonjon M, 2015, NEUROCHIRURGIE, V61, P361, DOI 10.1016/j.neuchi.2015.08.003
   McLaughlin N, 2008, CAN J NEUROL SCI, V35, P588, DOI 10.1017/S0317167100009379
   NAGASHIMA M, 1993, ACTA NEUROCHIR, V124, P71, DOI 10.1007/BF01401125
   Nanda A, 2006, NEUROSURGERY, V58, P831, DOI 10.1227/01.NEU.0000209643.66807.80
   PRZELOMSKI MM, 1986, NEUROLOGY, V36, P584, DOI 10.1212/WNL.36.4.584
   Qureshi AI, 2000, NEUROSURGERY, V46, P282, DOI 10.1097/00006123-200002000-00006
   RAPS EC, 1993, ARCH NEUROL-CHICAGO, V50, P265, DOI 10.1001/archneur.1993.00540030031010
   Ritter MA, 2003, J NEUROL, V250, P1255, DOI 10.1007/s00415-003-0177-2
   SOLOMON RA, 1994, J NEUROSURG, V80, P440, DOI 10.3171/jns.1994.80.3.0440
   SUTHERLAND GR, 1982, J NEUROSURG, V56, P53, DOI 10.3171/jns.1982.56.1.0053
   Ueno T, 2018, CASE REP NEUROL, V10, P66, DOI 10.1159/000487587
   WIEBERS DO, 1987, J NEUROSURG, V66, P23, DOI 10.3171/jns.1987.66.1.0023
   WIRTH FP, 1983, NEUROSURGERY, V12, P507, DOI 10.1227/00006123-198305000-00005
NR 17
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 468
EP 471
DI 10.1016/j.wneu.2019.02.238
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400281
PM 30898732
DA 2020-05-12
ER

PT J
AU Dhaliwal, J
   Calafiore, R
   Bulsara, KR
   Onyiuke, H
AF Dhaliwal, Joravar
   Calafiore, Rebecca
   Bulsara, Ketan R.
   Onyiuke, Hilary
TI Vertebral Metastasis from Primary Parotid Adenocarcinoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Back pain; Lumbar vertebrae; Metastasis; Parotid adenocarcinoma
ID SURVIVAL
AB BACKGROUND: Parotid adenocarcinoma comprises 10% of all parotid cancers and does not frequently produce distant metastases. The most common site for metastases is the lung, and there have only been 2 reported cases of skeletal metastases. The purpose of this study is to report the first vertebral metastasis from a primary parotid adenocarcinoma. Patient records, imaging, and pathology from a case of vertebral metastasis of a primary parotid adenocarcinoma were reviewed. A literature review of parotid adenocarcinoma metastases was also performed and is presented.
   CASE DESCRIPTION: A 53-year-old male with a medical history of parotid adenocarcinoma treated with chemotherapy and radiation presented with back pain. Computed tomography and magnetic resonance imaging of the lumbar region showed a lytic lesion on the left side of the L4 vertebral body, and a biopsy confirmed the lesion was metastatic adenocarcinoma.
   CONCLUSIONS: Distant metastases from a primary parotid adenocarcinoma are rare events, especially metastases to bone. This case represents the first vertebral metastasis from a primary parotid adenocarcinoma.
C1 [Dhaliwal, Joravar; Calafiore, Rebecca] Univ Connecticut, Sch Med, Farmington, CT 06032 USA.
   [Bulsara, Ketan R.; Onyiuke, Hilary] UConn Hlth, Dept Surg, Div Neurosurg, Farmington, CT USA.
RP Dhaliwal, J (reprint author), Univ Connecticut, Sch Med, Farmington, CT 06032 USA.
EM jdhaliw@gmail.com
CR Conibear J, 2009, GRAND ROUNDS, V9, P59
   HABIN DJ, 1995, J SMALL ANIM PRACT, V36, P445, DOI 10.1111/j.1748-5827.1995.tb02776.x
   KOKA VN, 1989, J LARYNGOL OTOL, V103, P675, DOI 10.1017/S0022215100109703
   Renehan AG, 1999, BRIT J CANCER, V80, P1296, DOI 10.1038/sj.bjc.6990501
   Schwentner I, 2006, ACTA OTO-LARYNGOL, V126, P340, DOI 10.1080/00016480500401035
   SPITZ MR, 1984, ARCH OTOLARYNGOL, V110, P45
   Wirkus Jaclyn, 2007, ORL Head Neck Nurs, V25, P10
   Zhan KY, 2016, HEAD NECK-J SCI SPEC, V38, P1208, DOI 10.1002/hed.24382
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 472
EP 474
DI 10.1016/j.wneu.2019.02.229
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400282
PM 30885865
DA 2020-05-12
ER

PT J
AU Ho, MY
   Yang, SH
   Chen, CM
   Huang, APH
AF Ho, Meng-Yin
   Yang, Shih-Hung
   Chen, Chien-Min
   Huang, Abel Po-Hao
TI Hemostatic Thrombin-Gelatin Matrix-Related Intracranial Cyst Formation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cyst formation; FloSeal; Hemostatic agent; Intracerebral hemorrhage
ID FLOSEAL; HEMORRHAGE; EFFICACY; SAFETY
AB BACKGROUND: Local hemostatic agents have been used in the neurosurgical field for many years; it is safe and efficient with no fatal complication reported in the literature. We routinely used a gelatin-thrombin hemostatic agent (FloSeal Hemostatic Matrix) for hemostasis in minimally invasive endoscopic-assisted surgery for more than 500 patients with intracerebral hemorrhage. However, 2 cases with sterile cyst formation were encountered.
   CASE DESCRIPTION: We reported 2 cases with sterile cyst formation after the use of a gelatin-thrombin hemostatic agent. Both of them had intracerebral hemorrhage. One received endoscopic hematoma evacuation, and the other had traditional craniotomy. They all received drainage of the cyst due to progressive enlargement and the mass effect they exert.
   CONCLUSIONS: These sterile cysts were very close to the ventricle wall on images. We hypothesized that cyst wall may be formed not only by hemostatic agent-related fibrosis and inflammation according to the previous literature review but also by the presence of the check valve mechanism between the cyst and the ventricle, which caused further dilation of the cyst.
C1 [Ho, Meng-Yin; Yang, Shih-Hung; Huang, Abel Po-Hao] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.
   [Chen, Chien-Min] Chang Hau Christian Hosp, Dept Neurosurg, Changhua, Changhua, Taiwan.
RP Huang, APH (reprint author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.
EM how.how0622@gmail.com
OI YANG, SHIH-HUNG/0000-0002-8572-4977
CR Agarwal NS, 2015, J ALLER CL IMM-PRACT, V3, P110, DOI 10.1016/j.jaip.2014.05.010
   Bordes Brianne, 2016, J Pediatr Pharmacol Ther, V21, P358
   Caglar M, 2014, ARCH GYNECOL OBSTET, V290, P501, DOI 10.1007/s00404-014-3249-x
   Chakrabarti D, 2016, J NEUROSURG ANESTH, V28, P88, DOI 10.1097/ANA.0000000000000219
   Chapman WC, 2007, J AM COLL SURGEONS, V205, P252, DOI 10.1016/j.jamcollsurg.2007.03.020
   Ereth MH, 2008, NEUROSURGERY, V63, P369, DOI 10.1227/01.NEU.0000327031.98098.DD
   Gazzeri R, 2011, ACTA NEUROCHIR, V153, P148, DOI 10.1007/s00701-010-0762-y
   Kuo LT, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS10313
   Luh HT, 2018, J FORMOS MED ASSOC, V117, P63, DOI 10.1016/j.jfma.2017.02.016
   Reeves A, 2011, MINIM INVAS NEUROSUR, V54, P132, DOI 10.1055/s-0031-1279717
   Shashoua AR, 2009, JSLS-J SOC LAPAROEND, V13, P226
   Thomas PJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.052
   Zeiler FA, 2015, ACTA NEUROCHIR, V157, P513, DOI 10.1007/s00701-015-2346-3
NR 13
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 475
EP 480
DI 10.1016/j.wneu.2019.03.030
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400283
PM 30872190
DA 2020-05-12
ER

PT J
AU Hasegawa, H
   Shin, M
   Kin, T
   Saito, N
AF Hasegawa, Hirotaka
   Shin, Masahiro
   Kin, Taichi
   Saito, Nobuhito
TI Fully Endoscopic Minimally Invasive Tumor Resection for Cystic
   Cerebellar Hemangioblastoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebellar hemangioblastoma; Cystic tumor; Endoscopic surgery;
   Three-dimensional virtual reality simulation; von Hippel-Lindau disease
ID CENTRAL-NERVOUS-SYSTEM; NATURAL-HISTORY
AB BACKGROUND: von Hippel-Lindau disease-related hemangioblastoma is likely to occur in the cerebellum and accompany a cyst. As multiple hemangioblastomas commonly occur in von Hippel-Lindau disease, and multiple surgeries may thus be necessary, a minimally invasive surgical strategy is of great importance.
   METHODS: We present 2 patients with von Hippel-Lindau disease-related hemangioblastomas successfully treated by a fully endoscopic transcranial approach via a short skin incision and a 2 cm x 2 cm small bony window. Before surgery, a three-dimensional virtual reality model was created to determine the ideal trajectory.
   RESULTS: Patient 1 had 2 serial large cystic tumors that equally contributed to obstructive hydrocephalus and were resected sequentially via a single endoscopic trajectory. Patient 2 had a progressive large cystic tumor that was resected endoscopically. Complete resection of the tumors was achieved without any complications in either patient.
   CONCLUSIONS: Small nodular tumors accompanying a large cyst are plausible candidates for endoscopic transcranial surgery. The spatial relationship of nodules, cyst, and cerebellar parenchyma is important to determine the applicability of the present technique. Preoperative three-dimensional virtual reality simulation helps assess the feasibility of this approach.
C1 [Hasegawa, Hirotaka; Shin, Masahiro; Kin, Taichi; Saito, Nobuhito] Univ Tokyo Hosp, Dept Neurosurg, Tokyo, Japan.
RP Hasegawa, H (reprint author), Univ Tokyo Hosp, Dept Neurosurg, Tokyo, Japan.
EM hirohasegawa-tky@umin.ac.jp
RI Hasegawa, Hirotaka/AAJ-2034-2020
OI Hasegawa, Hirotaka/0000-0002-3585-2188
CR Catapano D, 2005, NEUROSURGERY, V56, P1215, DOI 10.1227/01.NEU.0000159646.15026.D6
   Chen YB, 2017, AM J OPHTHALMOL, V173, P1, DOI 10.1016/j.ajo.2016.09.022
   Conway JE, 2001, NEUROSURGERY, V48, P55, DOI 10.1097/00006123-200101000-00009
   Di X, 2007, MINIM INVAS NEUROSUR, V50, P227, DOI 10.1055/s-2007-985861
   Fomichev D, 2016, WORLD NEUROSURG, V94, P181, DOI 10.1016/j.wneu.2016.06.124
   Giannetti AV, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.04.029
   Hanakita S, 2014, NEURO-ONCOLOGY, V16, P429, DOI 10.1093/neuonc/not201
   Hasegawa H, 2018, J NEUROSURG, V128, P1438, DOI 10.3171/2017.1.JNS162000
   Jagannathan J, 2008, J NEUROSURG, V108, P210, DOI 10.3171/JNS/2008/108/2/0210
   Kajiwara K, 2010, MINIM INVAS NEUROSUR, V53, P86, DOI 10.1055/s-0030-1249053
   Kano H, 2015, J NEUROSURG, V122, P1469, DOI 10.3171/2014.10.JNS131602
   Kin T, 2011, NEUROSURGERY S, V69
   Kin T, 2012, J NEUROSURG, V117, P78, DOI 10.3171/2012.3.JNS111541
   Kin T, 2011, NEUROSURGERY, V69, P40, DOI 10.1227/NEU.0b013e318211019a
   Kin T, 2009, NEUROSURGERY, V65, P121, DOI 10.1227/01.NEU.0000347890.19718.0A
   Kong DS, 2019, J NEUROSURG, V130, P838, DOI 10.3171/2017.11.JNS171337
   Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4
   Novak Z, 2004, Bratisl Lek Listy, V105, P8
   Richard S, 1998, J INTERN MED, V243, P547
   Shin M, 2017, J NEUROSURG, V126, P212, DOI 10.3171/2016.1.JNS151979
   Shin M, 2015, J NEUROSURG, V123, P748, DOI 10.3171/2014.11.JNS141921
   Shin M, 2015, NEUROL MED-CHIR, V55, P336, DOI 10.2176/nmc.oa.2014-0280
   Slater A, 2003, AM J NEURORADIOL, V24, P1570
   Taniguchi M, 2016, J NEUROSURG, V124, P1032, DOI 10.3171/2015.1.JNS142526
   Wanebo JE, 2003, J NEUROSURG, V98, P82, DOI 10.3171/jns.2003.98.1.0082
   Wong JHY, 2015, STROKE, V46, P2699, DOI 10.1161/STROKEAHA.115.008221
NR 26
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 484
EP 490
DI 10.1016/j.wneu.2019.03.158
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400285
PM 30922906
DA 2020-05-12
ER

PT J
AU D'Aliberti, GA
   Colistra, D
   Iacopino, G
   Bramerio, MA
   Cenzato, M
   Talamonti, G
AF D'Aliberti, Giuseppe Antonio
   Colistra, Davide
   Iacopino, Giorgia
   Bramerio, Manuela Adele
   Cenzato, Marco
   Talamonti, Giuseppe
TI Hydrocephalus due to a Cavernoma-Like Lesion of an Obliterated Cerebral
   Arteriovenous Malformation Treated by Embolization and Radiosurgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Cavernoma; Gamma knife; Hydrocephalus
ID CYST FORMATION; BRAIN EDEMA
AB BACKGROUND: Gamma-Knife radiosurgery can be the treatment of choice for small cerebral arteriovenous malformations (AVMs) in eloquent brain areas or, in association with endovascular treatment, for large and complex AVMs. Among the possible delayed complications occurring after radiosurgery of AVMs, de novo formation of a cavernoma has only recently been described. The authors report a unique case of communicating hydrocephalus with highly proteinaceous cerebrospinal fluid due to a cavernoma-like lesion of an obliterated cerebral AVM treated by embolization and radiosurgery.
   CASE DESCRIPTION: A 43-year-old female patient with a left parieto-occipital AVM (Spetzler-Martin grade III) underwent a multimodality treatment comprising several endovascular procedures and Gamma-Knife radiosurgery. At the follow-up angiograms, the AVM was completely obliterated. Twelve years later, she came back to our attention for headache and vomit with the radiological evidence of brain edema, severe hydrocephalus, and a chronic encapsulated intracerebral hematoma. At the beginning, the drainage of hydrocephalus proved ineffective to improve symptoms and edema. Therefore, the surgical resection of both the obliterated AVM and the cavernoma-like lesion-histologically confirmed-was necessary. The hydrocephalus resolved as well as the cerebral edema after 3 weeks, without necessity of a ventriculoperitoneal shunt.
   CONCLUSIONS: In previous neurosurgical literature, the association of a caveroma-like lesion in an obliterated AVM and communicating hydrocephalus with highly proteinaceous cerebrospinal fluid has not yet been discussed. We believe that only the surgical resection of both the obliterated AVM and the cavernoma-like lesion can lead to complete clinical recovery of the hydrocephalus.
C1 [D'Aliberti, Giuseppe Antonio; Cenzato, Marco; Talamonti, Giuseppe] Osped Niguarda Ca Granda, Dept Neurosurg, Milan, Italy.
   [Bramerio, Manuela Adele] Osped Niguarda Ca Granda, Dept Pathol, Milan, Italy.
   [Colistra, Davide; Iacopino, Giorgia] Sapienza Univ Rome, Div Neurosurg, Dept Neurol & Psychiat, Rome, Italy.
RP Colistra, D (reprint author), Sapienza Univ Rome, Div Neurosurg, Dept Neurol & Psychiat, Rome, Italy.
EM colistra.davide@gmail.com
RI Talamonti, Giuseppe/AAC-2760-2019
OI Talamonti, Giuseppe/0000-0002-9164-3292
CR Ding DL, 2015, ACTA NEUROCHIR, V157, P775, DOI 10.1007/s00701-015-2380-1
   Foroughi M, 2010, ACTA NEUROCHIR, V152, P803, DOI 10.1007/s00701-009-0581-1
   Huo X, 2015, J NEUROSURG, P1
   Kim JW, 2016, EXP NEUROBIOL, V25, P191, DOI 10.5607/en.2016.25.4.191
   Kurita H, 1996, J NEUROSURG, V84, P874, DOI 10.3171/jns.1996.84.5.0874
   Maeder P, 1998, AM J NEURORADIOL, V19, P1141
   Motegi H, 2008, NEUROL MED-CHIR, V48, P397, DOI 10.2176/nmc.48.397
   Narayanan M, 2017, HAND CLINIC, V143, P85, DOI 10.1016/B978-0-444-63640-9.00008-4
   Pomeraniec IJ, 2018, J NEUROSURG, V129, P937, DOI 10.3171/2017.6.JNS17559
   Radanowicz-Harttmann V, 1998, ACTA NEUROCHIR, V140, P194, DOI 10.1007/s007010050084
   Schaller C, 2005, ACTA NEUROCHIR, V147, P1103, DOI 10.1007/s00701-005-0600-9
   Shuto T, 2012, J NEUROSURG, V117, P135, DOI 10.3171/2012.6.GKS12318
   Takei J, 2016, CASE REP NEUROL MED, DOI 10.1155/2016/5130820
   Takeuchi S, 2009, ACTA NEUROCHIR, V151, P1513, DOI 10.1007/s00701-009-0443-x
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 491
EP 495
DI 10.1016/j.wneu.2019.03.068
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400286
PM 30885872
DA 2020-05-12
ER

PT J
AU Ravina, K
   Kramer, DR
   Strickland, BA
   Wolfswinkel, EM
   Rennert, RC
   Carey, JN
   Russin, JJ
AF Ravina, Kristine
   Kramer, Daniel R.
   Strickland, Ben A.
   Wolfswinkel, Erik M.
   Rennert, Robert C.
   Carey, Joseph N.
   Russin, Jonathan J.
TI Complex Revascularization for Idiopathic Intracranial Occlusive Disease
   with Unruptured, Fusiform Anterior Cerebral Artery and Middle Cerebral
   Artery Aneurysms: 3-Dimensional Operative Video
SO WORLD NEUROSURGERY
LA English
DT Article
DE Combined revascularization; Extracranial-to-intracranial bypass;
   Fusiform aneurysm; Idiopathic intracranial occlusive disease; Radial
   artery flow-through free flap
C1 [Ravina, Kristine; Russin, Jonathan J.] Univ Southern Calif, Neurorestorat Ctr, Los Angeles, CA 90007 USA.
   [Kramer, Daniel R.; Strickland, Ben A.; Russin, Jonathan J.] Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA.
   [Wolfswinkel, Erik M.; Carey, Joseph N.] Univ Southern Calif, Keck Sch Med, Div Plast & Reconstruct Surg, Dept Surg, Los Angeles, CA USA.
   [Rennert, Robert C.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA.
RP Russin, JJ (reprint author), Univ Southern Calif, Neurorestorat Ctr, Los Angeles, CA 90007 USA.; Russin, JJ (reprint author), Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA.
EM jonathan.russin@med.usc.edu
OI Ravina, Kristine/0000-0002-0927-5719
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 496
EP 496
DI 10.1016/j.wneu.2019.03.164
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400287
PM 30922896
DA 2020-05-12
ER

PT J
AU Mastronardi, L
   Corrivetti, F
   Scavo, CG
   Roperto, R
   Cacciotti, G
   Campione, A
AF Mastronardi, Luciano
   Corrivetti, Francesco
   Scavo, Carlo Giacobbo
   Roperto, Raffaelino
   Cacciotti, Guglielmo
   Campione, Alberto
TI Hand-Held Thulium Laser Fiber and Ultrasonic Aspirator for Opening the
   Internal Auditory Canal During Acoustic Neuroma Microneurosurgery:
   Operative Technique
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acoustic neuroma; Endoscopic-assisted surgery; Internal auditory canal;
   Laser fiber; Skull base tumors; Ultrasonic aspirator; Vestibular
   schwannoma
C1 [Mastronardi, Luciano; Corrivetti, Francesco; Scavo, Carlo Giacobbo; Roperto, Raffaelino; Cacciotti, Guglielmo; Campione, Alberto] San Filippo Neri Hosp, Unit Neurosurg, Rome, Italy.
RP Mastronardi, L (reprint author), San Filippo Neri Hosp, Unit Neurosurg, Rome, Italy.
EM mastro@tin.it
OI Corrivetti, Francesco/0000-0002-1023-958X; Campione,
   Alberto/0000-0003-1969-2126
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 497
EP 497
DI 10.1016/j.wneu.2019.03.204
PG 1
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400288
PM 30928583
DA 2020-05-12
ER

PT J
AU Ni, B
   Du, T
   Shu, W
   Lu, G
   Zhu, HW
AF Ni Bing
   Du Tao
   Shu Wei
   Lu Guang
   Zhu Hongwei
TI Percutaneous Endoscopic C2-C3 Medial Branches Neurotomy for Cervicogenic
   Headache
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical medial branch; Cervicogenic headache; Endoscopic; Neurotomy;
   Radiofrequency
ID NERVE
AB BACKGROUND: Cervicogenic headache (CEH) is characterized by unilateral posterior head and neck pain originating from cervical structures and may be improved or resolved by successful treatment of the causative cervical disorder or lesion. Cervical medial branch radiofrequency (RF) lesion therapy is effective in some CEH patients with no significant pathologic abnormalities that can be surgically corrected. However, patients with refractory CEH are often encountered clinically.
   CASE DESCRIPTION: Here we describe the case of a 68-year-old female with an 18-year history of CEH who did not respond to a series of treatments including nonsteroidal antiinflammatory drugs, anticonvulsants, medial branch diagnostic block, medial branch RF lesion, and spinal cord stimulation. After careful examination, we performed percutaneous endoscopic right C2-C3 medial branch neurotomy under local anesthesia and neuroleptanalgesia. The patient's constant pain was ultimately relieved.
   CONCLUSIONS: For patients with refractory CEH who failed medial branch RF lesion, which could be relieved briefly by diagnostic medial branch injection, percutaneous endoscopic C2-C3 medial branches neurotomy may alleviate their pain under the premise of full informed consent, accurate localization, careful intraoperative exploration, and stimulation testing.
C1 [Ni Bing; Du Tao; Shu Wei; Lu Guang; Zhu Hongwei] Capital Med Univ, Xuanwu Hosp, Beijing Inst Funct Neurosurg, Beijing, Peoples R China.
RP Zhu, HW (reprint author), Capital Med Univ, Xuanwu Hosp, Beijing Inst Funct Neurosurg, Beijing, Peoples R China.
EM xwyyzhw@sina.com
OI Du, Tao/0000-0002-9456-0804
CR Bartleson J D, 2014, Neurol Clin Pract, V4, P342, DOI 10.1212/CPJ.0000000000000044
   Dunning JR, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0912-3
   Ebraheim NA, 1998, SPINE, V23, P1968, DOI 10.1097/00007632-199809150-00009
   Elahi F, 2014, NEUROMODULATION, V17, P784, DOI 10.1111/ner.12114
   Fredriksen TA, 2015, J HEADACHE PAIN, V16, P1, DOI 10.1186/1129-2377-16-6
   Nagar VR, 2015, PAIN PHYSICIAN, V18, P109
   Schrot RJ, 2014, J NEUROSURG-SPINE, V21, P217, DOI 10.3171/2014.4.SPINE13669
   van Suijlekom H, 2010, PAIN PRACT, V10, P124, DOI 10.1111/j.1533-2500.2009.00354.x
   Wahezi SE, 2016, PAIN PHYSICIAN, V19, pE1079
   Wang E, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0442-3
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 498
EP 501
DI 10.1016/j.wneu.2019.03.072
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400289
PM 30885858
DA 2020-05-12
ER

PT J
AU Tringali, G
   D'Ammando, A
   Bono, B
   Colombetti, A
   Franzini, A
AF Tringali, Giovanni
   D'Ammando, Antonio
   Bono, Beatrice
   Colombetti, Anna
   Franzini, Angelo
TI Two-Staged Frontal Bone Defect Reconstruction: Perioperative Assessment
   of Scalp Vascularization Using Near-Infrared Indocyanine Green Video
   Angiography (Visionsense Iridium)
SO WORLD NEUROSURGERY
LA English
DT Article
DE Angiography; Cranioplasty; Indocyanine green fluorescence; Skin flap;
   Visionsense iridium
ID LASER-INDUCED FLUORESCENCE; ALGORITHMIC APPROACH; CRANIOPLASTY;
   IMPLANTS; COMPLICATIONS; EXPERIENCE; MANAGEMENT; EXPANSION; PERFUSION;
   SURGERY
AB BACKGROUND: Head trauma and neurosurgical-related osteomyelitis are common causes of cranial bone defect. Even though cranioplasty is considered a safe and well-consolidated procedure, there are still some issues about the flap's vascularization assessment. In this paper we describe a 2-staged cranioplasty procedure, focusing on the perioperative evaluation of the skin flap vascularization. Our goal is to assess if the skin flap's perfusion measurement with indocyanine green fluorescence can be considered a reliable method to predict good outcome in cranioplasties.
   CASE DESCRIPTION: A 50-year-old patient presented with a wide frontal bone defect due to a prior surgery-related osteomyelitis. During the first operation, a tissue expander was placed under the scalp in order to grant an appropriate skin stretching. During the second operation the defect was repaired with a custom-made prosthesis after tissue expander removal. During all procedures, vascular integrity of the skin flap was intraoperatively assessed by means of indocyanine green fluorescence.
   CONCLUSIONS: Surgical procedures were well tolerated; at 1 year of follow-up the cosmetic defect was unremarkable. Indocyanine green fluorescence can be a good aid to predict the probability of the skin flap survival by measuring its perfusion.
C1 [Tringali, Giovanni; D'Ammando, Antonio; Bono, Beatrice; Franzini, Angelo] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neurosurg, Milan, Italy.
   [Colombetti, Anna] Fdn IRCSS Ist Nazl Tumori, Milan, Italy.
RP D'Ammando, A (reprint author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Neurosurg, Milan, Italy.
EM a.dammando89@gmail.com
RI Tringali, Giovanni/AAF-3635-2020; Colombetti, Anna/AAC-3117-2020
OI Tringali, Giovanni/0000-0003-1493-4034; Colombetti,
   Anna/0000-0002-1719-6092
CR Acerbi F, 2016, CLIN NEUROL NEUROSUR, V146, P123, DOI 10.1016/j.clineuro.2016.05.003
   Alves AC, 2018, J CRANIOFAC SURG, V29, P1402, DOI 10.1097/SCS.0000000000004512
   Baumeister S, 2008, PLAST RECONSTR SURG, V122, p195E, DOI 10.1097/PRS.0b013e3181858eee
   Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6
   Burnier P, 2017, J PLAST RECONSTR AES, V70, P814, DOI 10.1016/j.bjps.2017.01.020
   Carloni R, 2015, J CRANIO MAXILL SURG, V43, P1409, DOI 10.1016/j.jcms.2015.06.017
   Cash TF, 2001, CLIN DERMATOL, V19, P161, DOI 10.1016/S0738-081X(00)00127-9
   Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9
   Dammers R, 2015, CRANIOMAXILLOFACIAL, V09, P355
   de Franca Sabrina A, 2018, Surg Neurol Int, V9, P61, DOI 10.4103/sni.sni_388_17
   Desai SC, 2015, JAMA FACIAL PLAST SU, V17, P56, DOI 10.1001/jamafacial.2014.889
   Echalier C, 2016, ANN CHIR PLAST ESTH, V61, P858, DOI 10.1016/j.anplas.2016.07.021
   Eppley BL, 2002, PLAST RECONSTR SURG, V109, P864, DOI 10.1097/00006534-200203000-00005
   Ferroli P, 2011, J NEUROSURG, V115, P18, DOI 10.3171/2011.3.JNS10620
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Holm C, 2002, BRIT J PLAST SURG, V55, P635, DOI 10.1054/bjps.2002.3969
   Ibrahim Z, 2016, J CRANIOFAC SURG, V27, P229, DOI 10.1097/SCS.0000000000002289
   Javer AR, 2010, OTOLARYNG CLIN N AM, V43, P827, DOI 10.1016/j.otc.2010.04.021
   Kasper EM, 2012, NEUROSURGERY, V71, P15, DOI 10.1227/NEU.0b013e318242cea2
   Komorowska-Timek E, 2010, PLAST RECONSTR SURG, V125, P1065, DOI 10.1097/PRS.0b013e3181d17f80
   Leedy JE, 2005, PLAST RECONSTR SURG, V116, P1114, DOI 10.1097/01.prs.0000179188.25019.6c
   Lin Samuel J, 2008, Semin Plast Surg, V22, P281, DOI 10.1055/s-0028-1095887
   Liu DZ, 2011, J RECONSTR MICROSURG, V27, P355, DOI 10.1055/s-0031-1281515
   Lohman RF, 2013, J RECONSTR MICROSURG, V29, P51, DOI 10.1055/s-0032-1326741
   Miller JP, 2018, ANN PLAS SURG, V80, pS356, DOI 10.1097/SAP.0000000000001422
   Miyazawa T, 2007, SURG NEUROL, V67, P291, DOI 10.1016/j.surneu.2006.04.019
   Rathmann P, 2018, INT J COMPUT ASS RAD, V13, P479, DOI 10.1007/s11548-017-1683-5
   Reddy S, 2014, PLAST RECONSTR SURG, V133, P864, DOI 10.1097/PRS.0000000000000013
   Ryu HS, 2008, SKIN RES TECHNOL, V14, P354, DOI 10.1111/j.1600-0846.2008.00302.x
   SOLOMON G A, 1986, Journal of Reconstructive Microsurgery, V3, P39, DOI 10.1055/s-2007-1007037
   Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9
   Stieglitz LH, 2014, ACTA NEUROCHIR, V156, P793, DOI 10.1007/s00701-013-1977-5
   Still J, 1999, ANN PLAS SURG, V42, P266, DOI 10.1097/00000637-199903000-00007
   Sundseth J, 2013, J CENT NERV SYST DIS, V5, P19, DOI 10.4137/JCNSD.S11106
   Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201
   Winkler P A, 2000, Neurosurg Focus, V8, pe9
   Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 502
EP 507
DI 10.1016/j.wneu.2019.02.247
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400290
PM 30904791
DA 2020-05-12
ER

PT J
AU Aggarwal, V
   Maheshwari, C
   Narang, A
   Atwal, J
   Bahadur, R
AF Aggarwal, Varun
   Maheshwari, Chandni
   Narang, Amit
   Atwal, Jagdeep
   Bahadur, Raj
TI Lessons Learned from a Migratory Intradural Extramedullary Schwannoma: A
   Case Report with Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE CSF dynamics; Intraoperative imaging; Migratory intradural
   extramedullary schwannoma; Redundant nerve roots; Subarachnoid space
   dilatation
ID CAUDA-EQUINA; MOBILE NEURINOMA; POSITION; TUMORS
AB BACKGROUND: Migratory tumors of the spinal cord are rare and can present as a missing tumor intraoperatively. This can lead to unnecessary abandonment of surgery or unnecessary laminectomies.
   CASE DESCRIPTION: We present a case of migratory intradural extramedullary tumor of the spine, which was missing intraoperatively. The surgery was abandoned, and on reimaging the tumor was found to have migrated. Here we summarize a review of the literature of such cases and the lessons we learned from our experience, emphasizing the measures to prevent tumor displacement and the importance of intraoperative imaging.
   CONCLUSIONS: Migratory schwannoma should be suspected in case of a missing lesion. Intraoperative ultrasonography and myelography use should be definitely considered where facility for intraoperative magnetic resonance imaging is not available. Preventive measures should be taken to avoid tumor migration in all routine cases of intradural extramedullary lesions.
C1 [Aggarwal, Varun; Narang, Amit] Guru Gobind Singh Med Coll & Hosp, Dept Neurosurg, Faridkot, Punjab, India.
   [Maheshwari, Chandni] Guru Gobind Singh Med Coll & Hosp, Dept Anaesthesia, Faridkot, Punjab, India.
   [Atwal, Jagdeep; Bahadur, Raj] Guru Gobind Singh Med Coll & Hosp, Dept Orthopaed, Faridkot, Punjab, India.
RP Aggarwal, V (reprint author), Guru Gobind Singh Med Coll & Hosp, Dept Neurosurg, Faridkot, Punjab, India.
EM drvarunaggarwal86@gmail.com
CR Bauer DF, 2008, CHILD NERV SYST, V24, P1043, DOI 10.1007/s00381-008-0640-6
   Dennes L, 1987, J NEUROSURG, V66, P131
   Friedman JA, 2003, SPINE, V28, P288, DOI 10.1097/00007632-200302010-00016
   HOLLIN SA, 1978, J NEUROSURG, V48, P135, DOI 10.3171/jns.1978.48.1.0135
   HUSAG L, 1980, SCHWEIZ ARCH NEUROL, V127, P205
   Iizuka H, 1998, SURG NEUROL, V50, P492, DOI 10.1016/S0090-3019(98)00125-6
   ISU T, 1989, NEUROSURGERY, V25, P968, DOI 10.1227/00006123-198912000-00020
   Kasama H, 2017, SURG SCI, V8, P184
   Khan RA, 2013, BMJ CASE REP, V2013
   Kim SB, 2010, J KOREAN NEUROSURG S, V47, P64, DOI 10.3340/jkns.2010.47.1.64
   Kothari Ajay, 2017, J Clin Orthop Trauma, V8, P197, DOI 10.1016/j.jcot.2017.06.008
   Lee DY, 2017, NERVE, V3, P71
   Marin-Sanabria EA, 2007, SINGAP MED J, V48, P53
   Murai H, 1991, SEIKEI GEKA, V42, P1746
   Naik S, 2016, J SPINE, V5, P323
   NAMURA S, 1993, J NEUROSURG, V79, P277, DOI 10.3171/jns.1993.79.2.0277
   PAU A, 1982, ACTA NEUROCHIR, V60, P115, DOI 10.1007/BF01401756
   Ranger MRB, 2008, BRIT J ANAESTH, V101, P804, DOI 10.1093/bja/aen295
   SATOH T, 1991, Neurological Surgery, V19, P891
   TAVY DLJ, 1987, J NEUROSURG, V66, P131, DOI 10.3171/jns.1987.66.1.0131
   Terada Y, 2016, NEUROSURGERY, V78, pE156, DOI 10.1227/NEU.0000000000000975
   Tomimatsu T, 1974, KANTOH SEISAISI, V5, P213
   Toscano DT, 2016, CUREUS, V8, DOI 10.7759/cureus.715
   Varughese G, 1976, Surg Neurol, V5, P161
   Varughese G, 1997, CAN J SURG, V40, P59
   WORTZMAN G, 1963, J NEUROSURG, V20, P164, DOI 10.3171/jns.1963.20.2.0164
NR 26
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 508
EP 512
DI 10.1016/j.wneu.2019.03.117
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400291
PM 30904802
DA 2020-05-12
ER

PT J
AU Li, K
   Barras, CD
   Chandra, RV
   Kok, HK
   Maingard, JT
   Carter, NS
   Russell, JH
   Lai, L
   Brooks, M
   Asadi, H
AF Li, Kenny
   Barras, Christen D.
   Chandra, Ronil, V
   Kok, Hong K.
   Maingard, Julian T.
   Carter, Nicole S.
   Russell, Jeremy H.
   Lai, Leon
   Brooks, Mark
   Asadi, Hamed
TI A Review of the Management of Cerebral Vasospasm After Aneurysmal
   Subarachnoid Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Review
DE Aneurysmal subarachnoid hemorrhage; Delayed cerebral ischemia; Delayed
   ischemic neurologic deficits; Endovascular; Intra-arterial vasodilator;
   Transluminal balloon angioplasty; Vasospasm
ID TRANSLUMINAL BALLOON ANGIOPLASTY; EARLY BRAIN-INJURY; ENDOVASCULAR
   TREATMENT; INTRAARTERIAL PAPAVERINE; TRANSCRANIAL DOPPLER;
   DIAGNOSTIC-ACCURACY; MEDICAL-MANAGEMENT; MAGNESIUM-SULFATE; CT
   PERFUSION; BLOOD-FLOW
AB BACKGROUND: Despite decades of research, cerebral vasospasm (CV) continues to account for high morbidity and mortality in patients who survive their initial aneurysmal subarachnoid hemorrhage.
   OBJECTIVE: To define the scope of the problem and review key treatment strategies that have shaped the way CV is managed in the contemporary era.
   METHODS: A literature search was performed of CV management after aneurysmal subarachnoid hemorrhage.
   RESULTS: Recent advances in neuroimaging have led to improved detection of vasospasm, but established treatment guidelines including hemodynamic augmentation and interventional procedures remain highly variable among neurosurgical centers. Experimental research in subarachnoid hemorrhage continues to identify novel targets for therapy.
   CONCLUSIONS: Proactive and preventive strategies such as oral nimodipine and endovascular rescue therapies can reduce the morbidity and mortality associated with CV.
C1 [Li, Kenny; Maingard, Julian T.; Asadi, Hamed] Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia.
   [Barras, Christen D.] Univ Adelaide, North Terrace Campus, Adelaide, SA, Australia.
   [Barras, Christen D.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Chandra, Ronil, V] Monash Hlth, Intervent Neuroradiol Serv, Clayton, Vic, Australia.
   [Lai, Leon] Monash Hlth, Dept Neurosurg, Clayton, Vic, Australia.
   [Kok, Hong K.] Northern Hlth, Intervent Radiol Serv, Epping, Vic, Australia.
   [Maingard, Julian T.; Brooks, Mark; Asadi, Hamed] Austin Hosp, Intervent Radiol Serv, Dept Radiol, Heidelberg, Vic, Australia.
   [Maingard, Julian T.] Austin Hosp, Intervent Neuroradiol Serv, Dept Radiol, Heidelberg, Vic, Australia.
   [Carter, Nicole S.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia.
   [Russell, Jeremy H.] Austin Hlth, Dept Neurosurg, Heidelberg, Vic, Australia.
   [Brooks, Mark; Asadi, Hamed] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.
RP Li, K (reprint author), Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia.
EM kenny.li@live.com.au
OI Chandra, Ronil/0000-0001-7555-2297
CR Abruzzo T, 2012, J NEUROINTERV SURG, V4, P169, DOI 10.1136/neurintsurg-2011-010248
   Aburto-Murrieta Y, 2012, VASC ENDOVASC SURG, V46, P460, DOI 10.1177/1538574412454585
   Adamczyk P, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/462491
   Akhigbe T, 2017, WORLD NEUROSURG, V101, P476, DOI 10.1016/j.wneu.2017.01.125
   Al-Mufti F, 2017, WORLD NEUROSURG, V107, P148, DOI [10.1016/J.WNEU.2017.07.114, 10.1016/j.wneu.2017.07.114]
   Aladag MA, 2017, BRIT J NEUROSURG, V31, P439, DOI 10.1080/02688697.2017.1297367
   Alamri AS, 2016, STROKE S1, V47
   Andereggen L, 2017, AM J NEURORADIOL, V38, P561, DOI 10.3174/ajnr.A5024
   Aoyama K, 2012, EUR RADIOL, V22, P2382, DOI 10.1007/s00330-012-2511-5
   Atalay B, 2006, NEUROSURGERY, V59, P1102, DOI 10.1227/01.NEU.0000245605.22817.44
   Bauer AM, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00072
   Bell DL, 2015, J NEUROINTERV SURG, V7, P438, DOI 10.1136/neurintsurg-2014-011164
   Bhogal P, 2017, J NEUROINTERV SURG, V9, P52, DOI 10.1136/neurintsurg-2016-012546
   Boulouis G, 2017, EUR RADIOL, V27, P3333, DOI 10.1007/s00330-016-4702-y
   Burrell C, 2016, EXPERT REV NEUROTHER, V16, P1251, DOI 10.1080/14737175.2016.1203257
   Chalouhi N, 2014, CLIN NEUROL NEUROSUR, V118, P26, DOI 10.1016/j.clineuro.2013.12.012
   Cheng MF, 2014, ACTA NEUROCHIR, V156, P2103, DOI 10.1007/s00701-014-2196-4
   Cho WS, 2018, J KOREAN NEUROSURG S, V61, P127, DOI 10.3340/jkns.2017.0404.005
   Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839
   Dankbaar JW, 2009, STROKE, V40, P3493, DOI 10.1161/STROKEAHA.109.559013
   Deshaies EM, 2009, NEUROL RES, V31, P644, DOI 10.1179/174313209X382340
   Dhar R, 2016, NEUROCRIT CARE, V25, P201, DOI 10.1007/s12028-016-0243-0
   Ditz C, 2018, WORLD NEUROSURG, V112, pE791, DOI 10.1016/j.wneu.2018.01.156
   Dolatowski K, 2014, EUR J RADIOL, V83, P1881, DOI 10.1016/j.ejrad.2014.06.020
   Dorhout MSM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006184.pub2
   Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3
   Duman E, 2017, INTERV NEURORADIOL, V23, DOI 10.1177/1591019917732288
   Durrant JC, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0521-1
   ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660
   Egge A, 2001, NEUROSURGERY, V49, P593, DOI 10.1097/00006123-200109000-00012
   Ehlert A, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.047
   Findlay JM, 2016, CAN J NEUROL SCI, V43, P15, DOI 10.1017/cjn.2015.288
   Findlay JM, 2010, WORLD NEUROSURG, V74, P244, DOI 10.1016/j.wneu.2010.03.038
   Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6
   Fujimoto M, 2018, MOL NEUROBIOL, V55, P1951, DOI 10.1007/s12035-017-0466-x
   Gathier CS, 2018, STROKE, V49, P76, DOI 10.1161/STROKEAHA.117.017956
   Ghanem MA, 2014, EGYPT J ANAESTH, V30, P73, DOI 10.1016/j.egja.2013.07.006
   Greenberg ED, 2010, AM J NEURORADIOL, V31, P1853, DOI 10.3174/ajnr.A2246
   Hanggi D, 2009, CENT EUR NEUROSURG, V70, P61, DOI 10.1055/s-0028-1087214
   HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537
   Hoh BL, 2005, NEUROSURG CLIN N AM, V16, P501, DOI 10.1016/j.nec.2005.04.004
   Hollingworth M, 2015, WORLD NEUROSURG, V83, P1120, DOI 10.1016/j.wneu.2015.01.036
   Ishihara Hideyuki, 2016, Nihon Rinsho, V74, P677
   Jabbarli R, 2013, J STROKE CEREBROVASC, V22, P1332, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.006
   Jestaedt L, 2008, NEUROSURGERY, V62, P610, DOI 10.1227/01.NEU.0000311351.32904.8B
   Kieninger M, 2018, NEUROCRIT CARE, V28, P65, DOI 10.1007/s12028-017-0428-1
   Kim JH, 2014, NEUROL SCI, V35, P715, DOI 10.1007/s10072-013-1589-0
   Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5
   KISER TH, 2013, HOSP PHARM S5, V48, pS2, DOI DOI 10.1310/hpj48S5-S2
   Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140
   Koyanagi M, 2018, J NEUROSURG, V128, P717, DOI 10.3171/2016.10.JNS162227
   Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428
   Kwon HJ, 2019, CLIN NEURORADIOL, V29, P751, DOI 10.1007/s00062-018-0711-3
   Laban KG, 2015, J CEREBR BLOOD F MET, V35, P1085, DOI 10.1038/jcbfm.2015.89
   Labriffe M, 2015, J NEURORADIOLOGY, V42, P358, DOI 10.1016/j.neurad.2015.04.001
   Lannes M, 2017, CAN J NEUROL SCI, V44, P152, DOI 10.1017/cjn.2016.316
   Lazaridis C, 2010, NEUROSURG CLIN N AM, V21, P353, DOI 10.1016/j.nec.2009.10.006
   Lennihan L, 2000, STROKE, V31, P383, DOI 10.1161/01.STR.31.2.383
   [李立 Li Li], 2015, [中华急诊医学杂志, Chinese Journal of Emergency Medicine], V24, P1357
   Lilla N, 2018, WORLD NEUROSURG, V116, pE57, DOI 10.1016/j.wneu.2018.03.205
   Lilla N, 2016, J NEUROL SCI, V370, P312, DOI 10.1016/j.jns.2016.09.032
   Lin BF, 2014, NEUROCRIT CARE, V21, P316, DOI 10.1007/s12028-014-0010-z
   Liu GJ, 2012, EUR J CLIN PHARMACOL, V68, P131, DOI 10.1007/s00228-011-1100-x
   Liu JH, 2015, INT J CLIN EXP MED, V8, P7198
   Liu L, 2018, MOL NEUROBIOL, V55, P8346, DOI 10.1007/s12035-018-1006-z
   Liu Y-F, 2016, CHINESE NEUROSURG J, V2, P4, DOI [10.1186/s41016-016-0023-x, DOI 10.1186/S41016-016-0023-X]
   Liu-DeRyke X, 2006, PHARMACOTHERAPY, V26, P182, DOI 10.1592/phco.26.2.182
   Loan JJM, 2018, BRIT J NEUROSURG, V32, P157, DOI 10.1080/02688697.2018.1426720
   Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980
   Manoel ALD, 2015, STROKE, V46, P1826, DOI 10.1161/STROKEAHA.115.008728
   Marshall SA, 2010, NEUROSURG CLIN N AM, V21, P291, DOI 10.1016/j.nec.2009.10.010
   Matsuda N, 2016, CEREBROVASC DIS, V42, P97, DOI 10.1159/000445509
   McGuinness B, 2010, NEUROSURG CLIN N AM, V21, P281, DOI 10.1016/j.nec.2009.10.007
   Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7
   Miley JT, 2011, NEUROSURGERY, V69, P161, DOI 10.1227/NEU.0b013e31822a8976
   Mills JN, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415960
   Mistry AM, 2016, CEREBROVASC DIS, V42, P263, DOI 10.1159/000446251
   Mortimer AM, 2015, J NEUROINTERV SURG, V7, P881, DOI 10.1136/neurintsurg-2014-011403
   Niu PP, 2014, J NEUROL SCI, V336, P146, DOI 10.1016/j.jns.2013.10.027
   Odom MJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/943914
   Onal MB, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0356-2_9
   Ota N, 2017, WORLD NEUROSURG, V107, P630, DOI 10.1016/j.wneu.2017.08.088
   Pandey AS, 2013, NEUROIMAG CLIN N AM, V23, P593, DOI 10.1016/j.nic.2013.03.008
   Panni P, 2017, J NEUROSURG SCI, V61, P665, DOI 10.23736/S0390-5616.16.03151-9
   Patel AS, 2017, WORLD NEUROSURG, V98, P189, DOI 10.1016/j.wneu.2016.10.064
   PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636
   Pierot L, 2010, CURR OPIN CRIT CARE, V16, P110, DOI 10.1097/MCC.0b013e3283372ef2
   de Aguiar PHP, 2013, ACTA NEUROCHIR SUPPL, V115, P91, DOI 10.1007/978-3-7091-1192-5_20
   Rahme R, 2013, ACTA NEUROCHIR SUPPL, V115, P107, DOI 10.1007/978-3-7091-1192-5_23
   Reddy D, 2014, NEUROCRIT CARE, V21, P356, DOI 10.1007/s12028-014-9964-0
   Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264
   Sadahiro H, 2016, J STROKE CEREBROVASC, V25, P2352, DOI 10.1016/j.jstrokecerebrovasdis.2016.05.032
   Sadamasa N, 2014, NEUROCRIT CARE, V21, P470, DOI 10.1007/s12028-014-9996-5
   Senbokuya N, 2013, J NEUROSURG, V118, P121, DOI 10.3171/2012.9.JNS12492
   Shen J, 2017, J NEUROSURG, V127, P291, DOI 10.3171/2016.5.JNS152900
   Siasios I, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/571328
   Siuta M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/972417
   Sokolowski JD, 2018, J NEUROINTERV SURG, V10, P367, DOI 10.1136/neurintsurg-2017-013363
   Solter VV, 2014, ACTA CLIN CROAT, V53, P113
   Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087
   Stiefel MF, 2006, NEUROCRIT CARE, V4, P113, DOI 10.1385/NCC:4:2:113
   Su SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04573
   Sun HG, 2014, TURK NEUROSURG, V24, P757, DOI 10.5137/1019-5149.JTN.9914-13.1
   Suzuki H, 2018, NEURAL REGEN RES, V13, P1175, DOI 10.4103/1673-5374.235022
   Tekiner A, 2014, TURK NEUROSURG, V24, P885, DOI 10.5137/1019-5149.JTN.9785-13.2
   Teramoto A, 2012, NEUROL MED-CHIR, V52, P355
   Thiex R, 2010, AM J NEURORADIOL, V31, P230, DOI 10.3174/ajnr.A1803
   Treggiari MM, 2003, J NEUROSURG, V98, P978, DOI 10.3171/jns.2003.98.5.0978
   Veldeman M, 2016, BRIT J ANAESTH, V117, P17, DOI 10.1093/bja/aew095
   Venkatraman A, 2018, J NEUROINTERV SURG, V10, P380, DOI 10.1136/neurintsurg-2017-013128
   Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275
   Washington CW, 2016, J NEUROSURG, V124, P318, DOI 10.3171/2015.2.JNS142752
   Wong GKC, 2010, STROKE, V41, P921, DOI 10.1161/STROKEAHA.109.571125
   Wu Y, 2013, CHIN J CEREBROVASC D, V10, P588
   Yao Z, 2017, CLIN NEUROL NEUROSUR, V163, P9, DOI 10.1016/j.clineuro.2017.09.016
   Yilmaz C, 2018, TURK NEUROSURG, V28, P667, DOI 10.5137/1019-5149.JTN.14781-15.3
   Yoneda H, 2014, WORLD NEUROSURG, V81, P309, DOI 10.1016/j.wneu.2012.09.020
   Zhao JZ, 2011, NEUROL MED-CHIR, V51, P679, DOI 10.2176/nmc.51.679
   Zwienenberg-Lee M, 2008, STROKE, V39, P1759, DOI 10.1161/STROKEAHA.107.502666
NR 119
TC 5
Z9 6
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 513
EP 527
DI 10.1016/j.wneu.2019.03.083
PG 15
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400292
PM 30898740
DA 2020-05-12
ER

PT J
AU Santander, XA
   Revuelta, JM
   Cotua, C
   Rodriguez, BA
   Moreno, PD
   Mazzei, AS
AF Santander, Xavier A.
   Manuel Revuelta, Juan
   Cotua, Carlos
   Arellano Rodriguez, Beatriz
   de Leyva Moreno, Patricia
   Saab Mazzei, Anwar
TI Occult Transorbital Intracranial Injury by Windshield Wiper Handle: Case
   Report and Review of Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Foreign body; Nonmissile; Occult; Penetrating brain injury; Windshield
   wiper handle
ID PENETRATING INJURY; CASE SERIES; BRAIN; COMPLICATIONS; ANGIOGRAPHY;
   MANAGEMENT
AB BACKGROUND: We present the case of a 51-year-old male with an occult transorbital intracranial injury after a car accident. The identified foreign object was a windshield wiper handle. To our knowledge, this is the first case reported.
   CASE DESCRIPTION: Multidisciplinary treatment with maxillofacial and otorhinolaryngology departments was planned. A bifrontal craniotomy with removal of the foreign object and posterior orbital reconstruction were performed. A review of the literature was done, in order to highlight certain general principles in decision making despite the variability in case presentation.
   CONCLUSIONS: Occult TII is a rare subtype of penetrating brain injury. Diagnosis requires high suspicion as it can be missed during physical examination. Computed tomography (CT) scan, CT angiogram, and magnetic resonance imaging should be performed in order to design the optimal treatment for each patient. Magnetic resonance imaging should be avoided when metallic density on CT is observed. The use of a broad-spectrum antibiotic regimen is critical.
C1 [Santander, Xavier A.; Cotua, Carlos; Saab Mazzei, Anwar] Univ Hosp Puerta Hierro Majadahonda, Dept Neurosurg, Madrid, Spain.
   [Manuel Revuelta, Juan] Clin San Carlos Hosp, Dept Neurosurg, Madrid, Spain.
   [Arellano Rodriguez, Beatriz] Univ Hosp Puerta Hierro Majadahonda, Dept Otorhinolaryngol, Madrid, Spain.
   [de Leyva Moreno, Patricia] Univ Hosp Puerta Hierro Majadahonda, Dept Maxillofacial Surg, Madrid, Spain.
RP Mazzei, AS (reprint author), Univ Hosp Puerta Hierro Majadahonda, Dept Neurosurg, Madrid, Spain.
EM anwarsm@gmail.com
OI Revuelta-Barbero, J. Manuel/0000-0002-6426-2734; Santander,
   Xavier/0000-0002-9990-7758; Saab Mazzei, Anwar/0000-0002-6900-7943
CR Arat YO, 2015, ULUS TRAVMA ACIL CER, V21, P271, DOI 10.5505/tjtes.2015.48839
   Balasubramanian C, 2009, SURG NEUROL, V71, P238, DOI 10.1016/j.surneu.2007.07.050
   Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688
   Borkar SA, 2014, CHILD NERV SYST, V30, P1441, DOI 10.1007/s00381-014-2364-0
   de Holanda LF, 2016, WORLD NEUROSURG, V90, P420, DOI 10.1016/j.wneu.2016.03.015
   DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012
   MILLER CF, 1977, SURG NEUROL, V7, P95
   Mzimbiri JM, 2016, WORLD NEUROSURG, V87, P26, DOI 10.1016/j.wneu.2015.12.063
   Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008
   van Duinen M Th, 2000, TRANSORBITAL INTRACR
   Zyck S, 2016, WORLD NEUROSURG, V91, P297, DOI 10.1016/j.wneu.2016.04.012
NR 11
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 530
EP 532
DI 10.1016/j.wneu.2019.02.154
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400294
PM 30904801
DA 2020-05-12
ER

PT J
AU Kan, I
   Kato, N
   Otani, K
   Abe, Y
   Ishibashi, T
   Murayama, Y
AF Kan, Issei
   Kato, Naoki
   Otani, Katharina
   Abe, Yukiko
   Ishibashi, Toshihiro
   Murayama, Yuichi
TI Intravenous 3-Dimensional Digital Subtraction Angiography During
   Surgical Treatment of Intracranial Aneurysm
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysm clipping; C-arm CT; Hybrid operating room; Intraoperative
   imaging
ID MICROVASCULAR DOPPLER SONOGRAPHY; INTRAOPERATIVE ANGIOGRAPHY;
   ENDOVASCULAR COILING; CEREBRAL ANEURYSMS; CT ANGIOGRAPHY; DETECTOR CT;
   SURGERY
AB BACKGROUND: Although intraarterial 3-dimensional digital subtraction angiography (ia-3DDSA) using an angiographic C-arm system is still the gold standard for postoperative confirmation of surgical clipping of intracranial aneurysms, ia-3DDSA requires catheterization and intraarterial injection of contrast medium, which adds risks to the surgical procedure and takes time. We propose a less invasive acquisition of 3D digital subtraction angiography with intravenous injection (iv-3DDSA) in the hybrid operating room to confirm the results of surgical clipping immediately after surgery.
   CASE DESCRIPTION: A 56-year-old woman was diagnosed with an incidental wide-necked aneurysm located at the distal anterior cerebral artery. We performed surgical clipping. During the surgery, indocyanine green video angiography and Doppler ultrasonography were used for confirmation, and after the surgery iv-3DDSA and ia-3DDSA were performed with the angiography C-arm system in the hybrid operating room while the patient was still under anesthesia. We could confirm that there was no neck remnant left and that the parent vesselswere patent on both iv-3DDSA and ia-3DDSA images. The image quality of iv-3DDSA was sufficient for all treatment evaluations and offered the additional benefits of visualizing the whole angioarchitecture including the contralateral side, being less invasive, and requiring only a few minutes until the availability of images.
   CONCLUSIONS: Iv-3DDSA can be useful for postsurgical confirmation of clipping of aneurysms in the hybrid operating room.
C1 [Kan, Issei; Kato, Naoki; Ishibashi, Toshihiro; Murayama, Yuichi] Jikei Univ Hosp, Dept Neurosurg, Tokyo, Japan.
   [Abe, Yukiko] Jikei Univ Hosp, Dept Radiol, Tokyo, Japan.
   [Otani, Katharina] Siemens Healthcare KK, AT Innovat Dept, Tokyo, Japan.
RP Kan, I (reprint author), Jikei Univ Hosp, Dept Neurosurg, Tokyo, Japan.
EM isseikan@gmail.com
RI Otani, Katharina/D-8259-2019; Kato, Naoki/F-3104-2019
OI Otani, Katharina/0000-0002-2322-3405; Kato, Naoki/0000-0001-5041-6985;
   Ishibashi, Toshihiro/0000-0003-1044-5604; Kan, Issei/0000-0003-4829-4784
CR Akdemir H, 2006, MINIM INVAS NEUROSUR, V49, P312, DOI 10.1055/s-2006-954577
   Ardeshiri A, 2009, J NEUROSURG, V111, P1168, DOI 10.3171/2009.1.JNS08862
   Chalouhi N, 2012, NEUROSURGERY, V71, P1162, DOI 10.1227/NEU.0b013e318271ebfc
   Chiang VL, 2002, J NEUROSURG, V96, P988, DOI 10.3171/jns.2002.96.6.0988
   Fong YW, 2018, WORLD NEUROSURG, V114, pE573, DOI 10.1016/j.wneu.2018.03.035
   Jeon JS, 2013, AM J NEURORADIOL, V34, P129, DOI 10.3174/ajnr.A3301
   Kang HS, 2004, AM J NEURORADIOL, V25, P1463
   Kumar R, 2009, NEUROCRIT CARE, V11, P299, DOI 10.1007/s12028-009-9229-5
   Malinova V, 2015, CLIN NEUROL NEUROSUR, V137, P79, DOI 10.1016/j.clineuro.2015.06.021
   Marbacher S, 2019, J NEUROSURG, V131, P64, DOI 10.3171/2018.1.JNS172253
   MARTIN NA, 1990, J NEUROSURG, V73, P526, DOI 10.3171/jns.1990.73.4.0526
   Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5
   Molyneux AJ, 2015, LANCET, V385, P691, DOI 10.1016/S0140-6736(14)60975-2
   Murayama Y, 2013, J NEUROINTERV SURG, V5, P489, DOI 10.1136/neurintsurg-2012-010382
   Pjontek R, 2016, J NEUROINTERV SURG, V8, P824, DOI 10.1136/neurintsurg-2015-011787
   Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982
   Saake M, 2012, NEURORADIOLOGY, V54, P727, DOI 10.1007/s00234-011-0965-9
   Spetzler RF, 2015, J NEUROSURG, V123, P609, DOI 10.3171/2014.9.JNS141749
   Stendel R, 2000, J NEUROL NEUROSUR PS, V68, P29, DOI 10.1136/jnnp.68.1.29
   Struffert T, 2010, AM J NEURORADIOL, V31, P1462, DOI 10.3174/ajnr.A2083
   Struffert T, 2011, EUR RADIOL, V21, P1797, DOI 10.1007/s00330-011-2113-7
   Tang G, 2002, J NEUROSURG, V96, P993, DOI 10.3171/jns.2002.96.6.0993
   Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
   Wong SC, 2012, ACAD RADIOL, V19, P701, DOI 10.1016/j.acra.2012.02.012
NR 24
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 533
EP 536
DI 10.1016/j.wneu.2019.02.160
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400295
PM 30862577
DA 2020-05-12
ER

PT J
AU Wang, CW
   Zhang, YL
   Wang, JG
   Ni, SL
AF Wang, Chuanwei
   Zhang, Yulin
   Wang, Jiangang
   Ni, Shilei
TI Anterior Cerebral Artery Rupture During Extended Endoscopic Endonasal
   Transsphenoidal Approach for Severely Calcified Craniopharyngioma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Artery rupture; Calcified; Craniopharyngioma; Transsphenoidal approach
ID INTERNAL CAROTID-ARTERY; ENDOVASCULAR MANAGEMENT; SURGERY; LIMITATIONS
AB BACKGROUND: This report discusses the risks and complications of using the extended endoscopic endonasal transsphenoidal approach (EEETA) in a special craniopharyngioma case to caution neurosurgeons. CASE
   DESCRIPTION: A 38-year-old woman with craniopharyngioma underwent EEETA surgery. Her anterior cerebral artery was punctured intraoperatively and clipped using an aneurysm clip through the nose in an emergency procedure.
   CONCLUSIONS: The coexistence of severe calcified craniopharyngiomas, especially with sharp calcified spurs, a narrow distance between the anterior communicating artery and the planum sphenoidale, and a narrow distance between the bilateral internal carotid arteries is a significant warning signal during EEETA for craniopharyngiomas. In this circumstance, it may be preferable to use open microsurgical approaches. If the anterior communicating artery or anterior cerebral artery is punctured during EEETA, another method is available to fix the problem using an aneurysm clip through the nose, and not only endovascular embolization.
C1 [Wang, Chuanwei; Zhang, Yulin; Wang, Jiangang; Ni, Shilei] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China.
   [Wang, Chuanwei; Zhang, Yulin; Wang, Jiangang; Ni, Shilei] Shandong Univ, Inst Brain & Brain Inspired Sci, Jinan, Shandong, Peoples R China.
   [Wang, Chuanwei; Zhang, Yulin; Wang, Jiangang; Ni, Shilei] Shandong Key Lab Brain Funct Remodeling, Jinan, Shandong, Peoples R China.
RP Ni, SL (reprint author), Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China.; Ni, SL (reprint author), Shandong Univ, Inst Brain & Brain Inspired Sci, Jinan, Shandong, Peoples R China.; Ni, SL (reprint author), Shandong Key Lab Brain Funct Remodeling, Jinan, Shandong, Peoples R China.
EM nslqlyy@hotmail.com
OI Wang, Chuanwei/0000-0003-3431-6508
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81502148, 81874082]
FX This work was supported by the National Natural Science Foundation of
   China (81502148, Chuanwei Wang; 81874082, Shilei Ni).
CR Bal E, 2016, WORLD NEUROSURG, V94, P375, DOI 10.1016/j.wneu.2016.07.004
   Elliott RE, 2011, NEUROSURGERY, V69, P630, DOI 10.1227/NEU.0b013e31821a872d
   Fahlbusch R, 1999, J NEUROSURG, V90, P237, DOI 10.3171/jns.1999.90.2.0237
   Ghatge SB, 2010, INTERV NEURORADIOL, V16, P31, DOI 10.1177/159101991001600104
   Griauzde J, 2015, J NEUROINTERV SURG, V7, P67, DOI 10.1136/neurintsurg-2013-010878
   Kasemsiri P, 2014, WORLD NEUROSURG, V82, pS12, DOI 10.1016/j.wneu.2014.07.022
   Kim BM, 2015, J NEUROSURG, V122, P1223, DOI 10.3171/2014.10.JNS14328
   Liu JK, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16284
   Matsuo T, 2014, NEUROL MED-CHIR, V54, P974, DOI 10.2176/nmc.oa.2014-0038
   Park HR, 2017, WORLD NEUROSURG, V103, P465, DOI 10.1016/j.wneu.2017.04.047
   Sylvester PT, 2016, J NEUROSURG, V125, P1256, DOI 10.3171/2015.6.JNS142483
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 537
EP 540
DI 10.1016/j.wneu.2019.02.128
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400296
PM 30844531
DA 2020-05-12
ER

PT J
AU Liu, XW
   Li, TF
   Shi, L
   Wu, ZF
   Chen, DY
   Xu, B
   Chen, Y
AF Liu, Xiaowei
   Li, Tiefeng
   Shi, Lei
   Wu, Zhenfang
   Chen, Deyu
   Xu, Bin
   Chen, Yu
TI Application of Piezosurgery in En Bloc Laminectomy for the Treatment of
   Multilevel Thoracic Ossification of Ligamentum Flavum
SO WORLD NEUROSURGERY
LA English
DT Article
DE En bloc laminectomy; Piezosurgery; Thoracic ossification of ligamentum
   flavum
ID DURAL OSSIFICATION; MYELOPATHY; SURGERY; DECOMPRESSION; PREVALENCE;
   PREDICTORS; MORPHOLOGY; OUTCOMES
AB OBJECTIVE: To evaluate safety and effectiveness of the application of piezosurgery in en bloc laminectomy for the treatment of multilevel thoracic ossification of ligamentum flavum (MTOLF).
   METHODS: Forty-one cases who had MTOLF and underwent en bloc laminectomy from January 2012 to January 2017 were reviewed and divided into Group A (high-speed drill, n = 23) and Group B (piezosurgery, n = 18). Comparisons in clinical outcome and perioperative complications were carried out between the 2 groups.
   RESULTS: Mean follow-up period was comparable between Group A (12.6 months) and Group B (11.4 months). Both operation time and intraoperative blood loss in Group A were significantly more than those in Group B (P < 0). Although final Japanese Orthopaedic Association (JOA) score in both groups significantly increased, differences in preoperative JOA, final JOA, and neurologic recovery rate between the 2 groups weren't significant. Perioperative complications included early neurologic deterioration (1 in Group A), wound infection (2 in Group A and 1 in Group B), and leakage of cerebrospinal fluid (5 in Group A and 1 in Group B); incidences of these complications between the 2 groups weren't significant (P > 0.05). A relationship analysis showed that cases with preoperative tram track sign, tuberous OLF, or larger compression ratio were at greater risk of developing an intraoperative dura defect.
   CONCLUSIONS: The application of piezosurgery in en bloc laminectomy is a safe and effective method in the treatment of MTOLF, and it was advantageous for reducing both operation time and intraoperative blood loss compared with the high-speed drill.
C1 [Liu, Xiaowei; Wu, Zhenfang; Xu, Bin] Nanjing Univ, Jinling Hosp, Dept Orthoped, Nanjing, Jiangsu, Peoples R China.
   [Li, Tiefeng; Shi, Lei; Chen, Deyu; Chen, Yu] Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthopaed, Shanghai, Peoples R China.
RP Chen, Y (reprint author), Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthopaed, Shanghai, Peoples R China.
EM cyspine@smmu.edu.cn
CR Ando K, 2013, SPINE, V38, pE748, DOI 10.1097/BRS.0b013e31828ff736
   Augustin G, 2012, CLIN BIOMECH, V27, P313, DOI 10.1016/j.clinbiomech.2011.10.010
   Baba S, 2016, EUR SPINE J, V25, P1912, DOI 10.1007/s00586-015-4158-9
   Dellepiane M, 2008, ENT-EAR NOSE THROAT, V87, P212, DOI 10.1177/014556130808700412
   Gao R, 2013, SPINE J, V13, P1032, DOI 10.1016/j.spinee.2013.02.034
   Grauvogel J, 2014, SPINE J, V14, P628, DOI 10.1016/j.spinee.2013.06.085
   Guo JJ, 2010, SPINE, V35, P51, DOI 10.1097/BRS.0b013e3181b3f779
   Jia LS, 2010, NEUROSURGERY, V66, P1181, DOI 10.1227/01.NEU.0000369516.17394.B0
   Li KP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004913
   Miyakoshi N, 2003, J NEUROSURG, V99, P251, DOI 10.3171/spi.2003.99.3.0251
   Miyashita T, 2013, SPINE J, V13, pE7, DOI 10.1016/j.spinee.2013.02.013
   Mori K, 2013, SPINE, V38, pE1216, DOI 10.1097/BRS.0b013e31829e018b
   Muthukumar N, 2009, SPINE, V34, P2654, DOI 10.1097/BRS.0b013e3181b541c9
   Nakagawa H, 2005, J NEUROSURG-SPINE, V2, P431, DOI 10.3171/spi.2005.2.4.0431
   OKADA K, 1991, SPINE, V16, P280, DOI 10.1097/00007632-199103000-00005
   Pan SF, 2016, ORTHOP SURG, V8, P257, DOI 10.1111/os.12244
   Pandey Rupesh Kumar, 2013, J Clin Orthop Trauma, V4, P15, DOI 10.1016/j.jcot.2013.01.002
   Pascal-Moussellard H, 2005, SPINE, V30, pE400, DOI 10.1097/01.brs.0000169450.49181.91
   Sanghvi AV, 2011, EUR SPINE J, V20, P205, DOI 10.1007/s00586-010-1423-9
   Schaller BJ, 2005, NEUROSURGERY, V57, DOI 10.1227/01.NEU.0000176700.77461.C9
   Sun XZ, 2011, J NEUROSURG-SPINE, V15, P386, DOI 10.3171/2011.5.SPINE10748
   Vercellotti T, 2007, ACTA OTO-LARYNGOL, V127, P932, DOI 10.1080/00016480601110154
   Wang H, 2017, J CLIN NEUROSCI, V45, P83, DOI 10.1016/j.jocn.2017.07.008
   Young WF, 2001, J CLIN NEUROSCI, V8, P129, DOI 10.1054/jocn.1998.0785
   Yu SZ, 2013, ACTA NEUROCHIR, V155, P1169, DOI 10.1007/s00701-013-1694-0
   Zhang JT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23019
   Zhong ZM, 2016, J CLIN NEUROSCI, V28, P77, DOI 10.1016/j.jocn.2015.09.023
NR 27
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 541
EP 546
DI 10.1016/j.wneu.2019.03.200
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400297
PM 30928600
DA 2020-05-12
ER

PT J
AU Wang, T
   Richard, SA
   Zhang, CW
   Wang, CH
   Xie, XD
AF Wang, Ting
   Richard, Seidu A.
   Zhang, Chang Wei
   Wang Chaohua
   Xie, Xiao Dong
TI Dural Arteriovenous Fistulas with Perimedullary Venous Drainage
   Successfully Managed Via Endovascular Electrocoagulation
SO WORLD NEUROSURGERY
LA English
DT Article
DE DAVF; Electrocoagulation; Endovascular; Transarterial; Transvenous
ID IMAGING FINDINGS; CLASSIFICATION; LESION; ONYX
AB BACKGROUND: Dural arteriovenous fistulas (DAVFs) with perimedullary venous drainage are very rare intracranial DAVFs. Treating DAVF via an endovascular electrocoagulation technique, to the best of our knowledge, has not been reported in the literature. We therefore report the first successful case.
   CASE DESCRIPTION: We report a rare case of Cognard type V DAVF. The feeding arteries were the middle meningeal artery, the recurrent meningeal branch of ophthalmic artery, and the meningohypophyseal trunk. The patient presented with paresthesia and weakness in the lower limbs. T2-weighted magnetic resonance imaging revealed a high signal in the medulla oblongata and upper cervical spinal cord. Our first procedure via the middle meningeal artery with Onyx 18 (ev3 Neurovascular) as the embolization agent failed to occlude the fistula. We finally occluded the fistula with the endovascular electro-coagulation technique. Two-year follow-up revealed total disappearance of the fistula and relieve of patient's symptoms.
   CONCLUSIONS: The endovascular electrocoagulation technique is very effective in the management of complex DAVFs with perimedullary venous drainage.
C1 [Wang, Ting; Richard, Seidu A.; Zhang, Chang Wei; Wang Chaohua; Xie, Xiao Dong] Sichuan Univ, Dept Neurosurg, West China Hosp, Chengdu, Sichuan, Peoples R China.
   [Richard, Seidu A.] Princefield Univ, Dept Med, Accra, Ho Volta Region, Ghana.
RP Wang, CH (reprint author), Sichuan Univ, Dept Neurosurg, West China Hosp, Chengdu, Sichuan, Peoples R China.
EM 56472685@qq.com
RI Richard, Seidu A./H-7590-2017
OI Richard, Seidu A./0000-0003-3475-0363
CR Abud LG, 2016, ARQ NEURO-PSIQUIAT, V74, P178, DOI 10.1590/0004-282X20150171
   Abud TG, 2011, AM J NEURORADIOL, V32, P2185, DOI 10.3174/ajnr.A2702
   Lorenzo SA, 2011, INTERV NEURORADIOL, V17, P108, DOI 10.1177/159101991101700117
   Brunereau L, 1996, AM J NEURORADIOL, V17, P1549
   COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961
   Cruz R, 1998, INTERV NEURORADIOL, V4, P241, DOI 10.1177/159101999800400308
   Gandhi D, 2012, AM J NEURORADIOL, V33, P1007, DOI 10.3174/ajnr.A2798
   Hacein-Bey L, 2014, CLIN NEUROL NEUROSUR, V121, P64, DOI 10.1016/j.clineuro.2014.01.018
   Ji C, 1997, AM J NEURORADIOL, V18, P1669
   Jiang YH, 2016, INT J STROKE, V11, pNP60, DOI 10.1177/1747493016641953
   Kwon BJ, 2005, AM J NEURORADIOL, V26, P2500
   Luo CB, 2014, J CHIN MED ASSOC, V77, P610, DOI 10.1016/j.jcma.2014.08.011
   Lv XL, 2011, NEUROL INDIA, V59, P899, DOI 10.4103/0028-3886.91374
   Maimon S, 2011, AM J NEURORADIOL, V32, P2180, DOI 10.3174/ajnr.A2728
   Mathon B, 2013, NEUROCHIRURGIE, V59, P133, DOI 10.1016/j.neuchi.2013.04.009
   Pannu Y, 2004, SURG NEUROL, V62, P463, DOI 10.1016/j.surneu.2004.01.017
   Patsalides A, 2010, J NEUROINTERV SURG, V2, P390, DOI 10.1136/jnis.2009.001750
   Ricolfi F, 1999, NEURORADIOLOGY, V41, P803, DOI 10.1007/s002340050846
   Roelz R, 2015, J NEUROSURG, V123, P1534, DOI 10.3171/2014.11.JNS142278
   Sato K, 2013, J NEUROSURG, V118, P451, DOI 10.3171/2012.10.JNS121028
   Sheehan J, 2006, J NEUROSURG, V104, P864, DOI 10.3171/jns.2006.104.6.864
   SIGEL B, 1965, SURG GYNECOL OBSTETR, V121, P823
   Signorelli F, 2015, CLIN NEUROL NEUROSUR, V128, P123, DOI 10.1016/j.clineuro.2014.11.011
   Wiesmann M, 2000, EUR RADIOL, V10, P1606, DOI 10.1007/s003300000382
   WOIMANT F, 1982, REV NEUROL, V138, P559
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 547
EP 551
DI 10.1016/j.wneu.2019.03.223
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400298
PM 30930314
DA 2020-05-12
ER

PT J
AU Rennert, RC
   Steinberg, JA
   Strickland, B
   Rayina, K
   Bakhsheshian, J
   Fredrickson, V
   Pannell, JS
   Khalessi, AA
   Russin, JJ
AF Rennert, Robert C.
   Steinberg, Jeffrey A.
   Strickland, Ben A.
   Rayina, Kristine
   Bakhsheshian, Joshua
   Fredrickson, Vance
   Pannell, J. Scott
   Khalessi, Alexander A.
   Russin, Jonathan J.
TI Extracranial-to-Intracranial Bypass for Refractory Vertebrobasilar
   Insufficiency
SO WORLD NEUROSURGERY
LA English
DT Article
DE Basilar ischemia; Cerebral bypass; Stroke
ID ARTERY BYPASS; REVASCULARIZATION; SUPERIOR; STROKE; FLOW
AB BACKGROUND: Vertebrobasilar insufficiency (VBI) is associated with high rates of morbidity and mortality, especially after failure of first-line medical and/or endovascular therapies. Although the optimal therapeutic strategy for refractory VBI remains unclear, surgical bypass represents a potentially life-saving treatment in this patient subset.
   METHODS: A multi-institution retrospective database review was performed to identify patients with symptomatic refractory VBI over a 4-year period (July 2014 to July 2018). Surgical treatments, as well as clinical and neurologic outcomes were recorded.
   RESULTS: Five patients were identified with refractory VBI (average age 55 +/- 11.0 years). All 5 patients had clinically significant posterior circulation strokes on presentation. Three patients underwent superficial temporal artery-to-superior cerebellar artery bypass based on significant acute perfusion mismatches or progressive strokes despite maximal medical therapy; 1 surgical patient (33%) experienced punctate perioperative strokes and there were no significant bypass related complications. Functional outcomes in the 3 surgical patients were correlated with preoperative stroke burden. The remaining 2 patients experienced rapid neurologic declines after presentation that precluded bypass, and died shortly thereafter.
   CONCLUSIONS: Refractory VBI has high morbidity, with cerebral bypass representing a safe and potentially efficacious treatment for selected patients. Long-term postbypass outcomes are dependent on the level of irreversible preoperative neurologic injuries.
C1 [Rennert, Robert C.; Steinberg, Jeffrey A.; Pannell, J. Scott; Khalessi, Alexander A.] Univ Calif San Diego, Dept Neurol Surg, San Diego, CA 92103 USA.
   [Strickland, Ben A.; Bakhsheshian, Joshua; Fredrickson, Vance] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA USA.
   [Rayina, Kristine; Russin, Jonathan J.] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Neurorestorat Ctr, Los Angeles, CA 90007 USA.
RP Russin, JJ (reprint author), Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Neurorestorat Ctr, Los Angeles, CA 90007 USA.
EM jonathan.russin@med.usc.edu
OI Ravina, Kristine/0000-0002-0927-5719; Bakhsheshian,
   Joshua/0000-0003-2983-6082
CR Ausman James I, 2018, Surg Neurol Int, V9, P106, DOI 10.4103/sni.sni_373_17
   AUSMAN JI, 1990, J NEUROSURG, V72, P554, DOI 10.3171/jns.1990.72.4.0554
   Britz GW, 2016, WORLD NEUROSURG, V85, P106, DOI [10.1016/J.WNEU.2015.08.004, 10.1016/j.wneu.2015.08.004]
   Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335
   Coert BA, 2005, SKULL BASE-INTERD AP, V15, P43, DOI 10.1055/s-2005-868162
   Corliss BM, 2018, J NEUROSURG, V129, P1160, DOI 10.3171/2017.6.JNS17535
   Demel SL, 2015, NEUROHOSPITALIST, V5, P142, DOI 10.1177/1941874415583847
   Esposito G, 2016, STROKE, V47, P282, DOI 10.1161/STROKEAHA.115.008220
   Gory B, 2018, J NEUROSURG, V129, P1482, DOI 10.3171/2017.7.JNS171043
   HOPKINS LN, 1987, J NEUROSURG, V66, P662, DOI 10.3171/jns.1987.66.5.0662
   Inoue T, 2012, ACTA NEUROCHIR, V154, P1455, DOI 10.1007/s00701-012-1398-x
   Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024
   OGAWA A, 1992, J NEUROSURG, V76, P955, DOI 10.3171/jns.1992.76.6.0955
   Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610
   Rangel-Castilla L, 2015, J NEUROSURG, V122, P671, DOI 10.3171/2014.9.JNS14194
   Rennert RC, 2019, OPER NEUROSURG, V16, P583, DOI 10.1093/ons/opy154
   Rennert RC, 2018, WORLD NEUROSURG, V114, P352, DOI [10.1016/J.WNEU.2018.03.189, 10.1016/j.wneu.2018.03.189]
   Russin J, 2018, OPER NEUROSURG, V14, P139, DOI 10.1093/ons/opx094
   Strickland B, 2018, WORLD NEUROSURG, V117, pE417, DOI 10.1016/j.wneu.2018.06.046
   Takeuchi Satoru, 2015, Surg Neurol Int, V6, P95, DOI 10.4103/2152-7806.157949
   van Houwelingen RC, 2016, JAMA NEUROL, V73, P1225, DOI 10.1001/jamaneurol.2016.1408
   White TG, 2016, WORLD NEUROSURG, V91, P285, DOI 10.1016/j.wneu.2016.03.090
   Yonekawa Y, 2001, J NEUROSURG, V94, P339, DOI 10.3171/jns.2001.94.2.0339
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 552
EP 559
DI 10.1016/j.wneu.2019.03.184
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400299
PM 30926554
DA 2020-05-12
ER

PT J
AU Horan, J
   Tromp, S
   Mankahla, N
AF Horan, Jack
   Tromp, Sean
   Mankahla, Ncedile
TI Transient Incomplete Locked-In Syndrome Secondary to Supratentorial
   Gunshot Wound
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral gunshot injury; Locked in syndrome; Neurotrauma
AB BACKGROUND: Locked-in syndrome (LIS) is a rare neurologic disorder characterized as quadriplegia with anarthria. The diagnosis of LIS is challenging and requires a high index of suspicion. The syndrome is typically caused by an infratentorial lesion to the ventral pons, regardless of etiology. LIS secondary to supratentorial injury is extremely rare, and to our knowledge, this is the first reported case.
   CASE DESCRIPTION: We report the case of a 26-year-old woman who sustained a gunshot to the left suboccipital area, with supratentorial extension. A diagnosis of incomplete LIS was made on the day of admission, with eye movement preservation. Imaging studies confirmed bilateral injury of the motor homunculus. The clinical course was that of progressive improvement, aided by intensive care unit (ICU) supportive care and early physiotherapy rehabilitation. Her condition improved, and she was discharged to a rehabilitation facility at the end of week 7 postadmission.
   CONCLUSIONS: This is a unique case of incomplete LIS after supratentorial injury. Initial ICU care and early rehabilitation likely played a major role in the full recovery of this patient. The influence of etiology and site of injury on outcome prognosis is also suggested. Although severe diffuse brain injury may occur in the face of an unremarkable computed tomography (CT) scan, the emerging role of magnetic resonance imaging in optimally evaluating traumatic brain injury with discordant clinical and CT information is highlighted and is useful in cases of LIS where prognosis prediction is important.
C1 [Horan, Jack] Groote Schuur Hosp, Dept Neurosurg, Cape Town, South Africa.
   Univ Cape Town, Cape Town, South Africa.
RP Horan, J (reprint author), Groote Schuur Hosp, Dept Neurosurg, Cape Town, South Africa.
EM jackhoran27@gmail.com
CR BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105
   Carrai R, 2009, NEUROPHYSIOL CLIN, V39, P95, DOI 10.1016/j.neucli.2008.11.003
   Casanova E, 2003, ARCH PHYS MED REHAB, V84, P862, DOI 10.1016/S0003-9993(03)00008-X
   CHANG B, 1979, EUR NEUROL, V18, P391, DOI 10.1159/000115110
   Fitzgerald LF, 1997, J TRAUMA, V42, P147, DOI 10.1097/00005373-199701000-00028
   HAIG AJ, 1987, ARCH PHYS MED REHAB, V68, P24
   Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781
   MARTIVILALTA JL, 1977, LANCET, V2, P1351
   Ozer AB, 2014, SAUDI J ANAESTH, V8, pS109, DOI 10.4103/1658-354X.144089
   PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758
   Plum F, 1972, Contemp Neurol Ser, V10, P1
   RAEGRANT AD, 1989, J NEUROL NEUROSUR PS, V52, P1191, DOI 10.1136/jnnp.52.10.1191
   Semple PL, 2001, S AFR MED J, V91, P141
   Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 560
EP 563
DI 10.1016/j.wneu.2019.03.163
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400300
PM 30922899
DA 2020-05-12
ER

PT J
AU Norager, NH
   Lilja-Cyron, A
   Hansen, TS
   Juhler, M
AF Norager, Nicolas Hernandez
   Lilja-Cyron, Alexander
   Hansen, Torben Skovbo
   Juhler, Marianne
TI Deciding on Appropriate Telemetric Intracranial Pressure Monitoring
   System
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hydrocephalus; ICP; Intracranial hypertension; Intracranial pressure;
   Telemetric; Telemetry
ID ICP; IDENTIFICATION; BRAIN
AB BACKGROUND: The clinical advantage of telemetric intracranial pressure (ICP) monitoring has previously been limited by issues with inaccuracy and zero-drift. Today, 2 comparable telemetric ICP monitoring systems are available performing adequately in these parameters. The objective of this study is to identify appropriate uses of each system.
   METHODS: The 2 telemetric ICP monitoring systems from Raumedic (implant: Neurovent-P-tel) and Miethke (implant: Sensor Reservoir) are compared in terms of fundamental differences, sensor survival, monitoring possibilities, complications, and cost/benefit. Two illustrative cases are presented highlighting clinical advantages and disadvantages of each system.
   RESULTS: Both systems provide transdermal (telemetric) ICP measurements through external application of a reader unit cabled to a portable data sampler. Thereby, they allow several ICP monitoring sessions without multiple surgical insertions of a cabled ICP sensor. The Miethke implant has a high sampling frequency (40 Hz) and a long CE (Conformite Europeenne) approval (3 years) but cannot be used for long-duration monitoring sessions. In comparison, the Raumedic implant has a lower sampling frequency (5 Hz) and shorter CE approval (90 days) but can be used for long-duration monitoring sessions. The standard 3-year cost for a patient with a Neurovent-P-tel is 17,380 (sic), and for the Sensor Reservoir it is 15,790 (sic).
   CONCLUSIONS: The Miethke system is useful in outpatient clinics where patients have sequential point measurements of ICP performed, whereas the Raumedic system is ideal for long-duration ICP monitoring outside the hospital. When choosing between the 2 systems, it must primarily be decided if the clinical situation requires longduration monitoring sessions or continuous repeated ambulatory follow-up sessions.
C1 [Norager, Nicolas Hernandez; Lilja-Cyron, Alexander; Juhler, Marianne] Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark.
   [Hansen, Torben Skovbo; Juhler, Marianne] Aarhus Univ Hosp, Aarhus, Denmark.
RP Norager, NH (reprint author), Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark.
EM nicolas.norager@gmail.com
RI Lilja-Cyron, Alexander/AAF-3780-2020
OI Lilja-Cyron, Alexander/0000-0003-2915-249X; Norager,
   Nicolas/0000-0003-1896-7749
FU LundbeckfondenLundbeckfonden
FX This study was funded by Lundbeckfonden. The sponsor had no role in the
   design or conduct of this research.
CR Antes S, 2018, WORLD NEUROSURG, V109, pE642, DOI 10.1016/j.wneu.2017.10.044
   Antes S, 2016, WORLD NEUROSURG, V91, P133, DOI 10.1016/j.wneu.2016.03.096
   Arroyo-Palacios J, 2016, NEUROCRIT CARE, V25, P424, DOI 10.1007/s12028-016-0268-4
   ATKINSON JR, 1967, J NEUROSURG, V27, P428, DOI 10.3171/jns.1967.27.5.0428
   Barber JM, 2017, BRIT J NEUROSURG, V31, P300, DOI 10.1080/02688697.2016.1229752
   Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS37, DOI [DOI 10.1089/NEU.2007.9989, 10.1089/neu.2007.9989]
   Cosman BJ., 1977, J NEUROSURG, P899
   CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874
   Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114
   Czosnyka M, 2017, HAND CLINIC, V140, P67, DOI 10.1016/B978-0-444-63600-3.00005-2
   GUCER G, 1988, NEUROSURGERY, V22, P892
   Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607
   Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146
   Kiefer Michael, 2012, Acta Neurochir Suppl, V114, P111, DOI 10.1007/978-3-7091-0956-4_20
   Kolokathi A, 2013, STUD HEALTH TECHNOL, V190, P157, DOI 10.3233/978-1-61499-276-9-157
   Korinek AM, 2011, NEUROSURGERY, V68, P985, DOI 10.1227/NEU.0b013e318208f360
   Lilja A, 2014, CLIN NEUROL NEUROSUR, V120, P36, DOI 10.1016/j.clineuro.2014.02.010
   LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1
   Mansson PK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013389
   Norager NH, 2018, ACTA NEUROCHIR, V160, P2137, DOI 10.1007/s00701-018-3691-9
   Raboel PH, 2012, CRIT CARE RES PRACT, V2012, P3
   Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003
   Reddy GK, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.10.034
   Schuhmann MU, 2008, PEDIATR NEUROSURG, V44, P269, DOI 10.1159/000131675
   Stanne TM, 2009, BIOCHEM J, V417, P257, DOI 10.1042/BJ20081146
   Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110
   Thompson S, 2016, FLUIDS BARRIERS C S1, V14, pA63
   Tirado-Caballero J, 2018, J NEUROSURG, P2
   Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5
   Welschehold S, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822dda12
   Yang CH, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL III, PROCEEDINGS, P131, DOI 10.1109/IITA.2008.582
NR 31
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 564
EP 569
DI 10.1016/j.wneu.2019.03.077
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400301
PM 30898734
DA 2020-05-12
ER

PT J
AU Morinaga, Y
   Nii, K
   Sakamoto, K
   Inoue, R
   Mitsutake, T
   Hanada, H
AF Morinaga, Yusuke
   Nii, Kouhei
   Sakamoto, Kimiya
   Inoue, Ritsurou
   Mitsutake, Takafumi
   Hanada, Hayatsura
TI Case of Acromegaly Caused by Rathke Cleft Cyst Mimicking Plurihormonal
   Pituitary Adenoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acromegaly; GH; Plurihormonal pituitary adenoma; Rathke cleft cyst
ID TUMORS
AB BACKGROUND: Acromegaly caused by Rathke cleft cyst (RCC) mimicking a plurihormonal pituitary adenoma (PA) is rare.
   CASE DESCRIPTION: We report a 71-year-old woman who presented with hyperhidrosis in 2013. Magnetic resonance imaging performed in April 2018 revealed that the patient had a pituitary tumor, and she was referred to our hospital. She presented with an acromegaly-like appearance with mild hypertrophy at her limb extremities. Preoperative blood tests, magnetic resonance imaging, and an endocrine tolerance test indicated that the patient's symptoms satisfied the diagnostic criteria for acromegaly, with a suspected diagnosis of an RCC and growth hormone (GH)-producing PA. Endoscopic transsphenoidal surgery (eTSS) was performed. Permanent pathologic diagnosis showed an RCC mimicking a plurihormonal PA, which was confirmed via immunohistochemistry. Blood sampling 2 months post surgery showed reduced GH (0.41 ng/mL) and increased insulin-like growth factor-1 (IGF-1) (356 ng/mL) levels. In addition, a postoperative endocrine tolerance test revealed a parasitic reaction of GH and secondary adrenocortical hypofunction. No RCC recurrence was found, and the GH (0.32 ng/mL) and previously increased IGF-1 (169 ng/mL) levels were normalized 12 months after eTSS.
   CONCLUSIONS: We reported a rare case of acromegaly caused by RCC mimicking a plurihormonal PA. This case suggests that inflammation associated with RCC might be involved in the development of adenomatous cells. Postoperative clinical symptoms and elevated fibrinogen and IGF-1 levels later improved. This outcome suggested that the transient increase in IGF-1 2 months after surgery might reflect RCC-induced inflammation.
C1 [Morinaga, Yusuke; Nii, Kouhei; Sakamoto, Kimiya; Inoue, Ritsurou; Mitsutake, Takafumi; Hanada, Hayatsura] Fukuoka Univ, Chikushi Hosp, Dept Neurosurg, Chikushino City, Japan.
RP Morinaga, Y (reprint author), Fukuoka Univ, Chikushi Hosp, Dept Neurosurg, Chikushino City, Japan.
EM yu_the_morio@yahoo.co.jp
CR ANNEGERS JF, 1978, MAYO CLIN PROC, V53, P641
   Gittleman H, 2014, J NEUROSURG, V121, P527, DOI 10.3171/2014.5.JNS131819
   Hojo Masato, 2017, Asian J Neurosurg, V12, P283, DOI 10.4103/1793-5482.146390
   Laws ER, 2019, J ENDOCRINOL INVEST, V42, P129, DOI 10.1007/s40618-018-0901-5
   Noh SJ, 2007, ACTA NEUROCHIR, V149, P1223, DOI 10.1007/s00701-007-1295-x
   Sumida M, 2001, NEURORADIOLOGY, V43, P755, DOI 10.1007/s002340100559
   Tang C, 2018, J CRANIOFAC SURG, V29, P1887, DOI 10.1097/SCS.0000000000004811
   Villwock JA, 2014, INT FORUM ALLERGY RH, V4, P767, DOI 10.1002/alr.21356
   Zada G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09318
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 570
EP 575
DI 10.1016/j.wneu.2019.02.163
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400302
PM 30862574
DA 2020-05-12
ER

PT J
AU Karekezi, C
   El Khamlichi, A
AF Karekezi, Claire
   El Khamlichi, Abdeslam
TI Takeoff of African Neurosurgery and the World Federation of
   Neurosurgical Societies Rabat Training Center Alumni
SO WORLD NEUROSURGERY
LA English
DT Article
DE African neurosurgery; Neurosurgical education; Rabat Training Center
AB The World Federation of Neurosurgical Societies (WFNS) Rabat Training Center was established in 2002 following the efforts of Dr. Abdeslam El Khamlichi. This institution has paved the way to guide tremendous change and to improve neurosurgery training in Africa, especially Sub-Saharan Africa (SSA). The center has enabled so far the training of more than 58 neurosurgical candidates, from approximately 18 countries in SSA, including 30 neurosurgeons who are already back in their respective countries, establishing and improving neurosurgical care. It is clear that this is the first successful example of the WFNS in increasing the neurosurgical workforce in SSA by well-trained and competent neurosurgeons. Consequently, this experience is worth depicting. We reviewed the profile of the neurosurgeons trained in this center and shortly summarized their reestablishment in their respective countries and their challenges to provide neurosurgical care in such source-limited countries.
C1 [Karekezi, Claire] Rwanda Mil Hosp, Dept Neurosurg, Kigali, Rwanda.
   [El Khamlichi, Abdeslam] Hop Specialites Rabat, Natl Ctr Rehabil & Neurosci, Rabat, Morocco.
RP Karekezi, C (reprint author), Rwanda Mil Hosp, Dept Neurosurg, Kigali, Rwanda.
EM clairekarekezi@gmail.com
CR Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042
   Corley JA, 2016, NEUROSURGERY, V79, pE544, DOI 10.1227/NEU.0000000000001351
   Dempsey KE, 2017, WORLD NEUROSURG, V101, P196, DOI 10.1016/j.wneu.2017.01.104
   Dewan MC, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18249
   Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500
   El Khamlichi A, 2001, NEUROSURGERY, V48, P1344, DOI 10.1097/00006123-200106000-00034
   El Khamlichi A, 1998, SURG NEUROL, V49, P342
   El Khamlichi Abdeslam, 2014, World Neurosurg, V81, P234, DOI 10.1016/j.wneu.2013.10.051
   Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X
   Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048
   Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5
   Venturini S, 2018, WORLD NEUROSURG, V109, P98, DOI 10.1016/j.wneu.2017.09.117
NR 12
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 576
EP 580
DI 10.1016/j.wneu.2019.03.141
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400303
PM 30910756
DA 2020-05-12
ER

PT J
AU Paterakis, K
   Brotis, A
   Bakopoulou, M
   Rountas, C
   Dardiotis, E
   Hadjigeorgiou, GM
   Fountas, KN
   Karantanas, A
AF Paterakis, Konstantinos
   Brotis, Alexandros
   Bakopoulou, Maria
   Rountas, Christos
   Dardiotis, Efthymios
   Hadjigeorgiou, Georgios M.
   Fountas, Kostas N.
   Karantanas, Apostolos
TI A Giant Tarlov Cyst Presenting with Hydronephrosis in a Patient with
   Marfan Syndrome: A Case Report and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Giant; Nerve root cyst; Perineural cyst; Tarlov cyst
ID FIBRIN GLUE THERAPY; MICROSURGICAL TREATMENT; MENINGEAL CYSTS;
   SURGICAL-TREATMENT; PERINEURIAL CYSTS; CLASSIFICATION; FENESTRATION;
   ASPIRATION; DRAINAGE; SPINE
AB BACKGROUND: Giant Tarlov cysts are always symptomatic and mimic many serious pathologic entities. We present the largest, to our knowledge, reported Tarlov cyst.
   CASE DESCRIPTION: A 33-year-old woman with Marfan syndrome suffered from right kidney hydronephrosis because of ureter obstruction, for which she was treated with nephrostomy. Her neurologic examination was unremarkable. The role of magnetic resonance imaging in the management of this case is described. Absence of intractranial hypotension symptoms after cerebrospinal fluid (CSF) overdrainage suggested the presence of a valve-like mechanism. The patient was planned for surgical cyst remodeling by the application of titanium clips. The cyst's neck was exposed through an L5-S2 laminectomy. L5 and S1 laminae were severely eroded. CSF leaked out of the underlying, bulging, and thinned dura at each attempt for clip application. Intraoperatively, multiple responses from the S1, S2, and S3 roots were simultaneously recorded at each stimulation. Therefore, we decided to abandon this technique and performed a nonwatertight duroplasty followed by a layered wound closure instead. A week later, the patient received a lumbar-peritoneal shunt. The patient remained neurologically intact, the cyst shrunk, and the nephrostomy was removed.
   CONCLUSIONS: Indirect evidence was helpful to assess for the presence of a valve-like mechanism. Intraoperatively, the surgeon must keep on high alert for sacral erosion to avoid inadvertent dural tear and rootlet injury. Finally, lumboperitoneal diversion remains a valid alternative in the management of our giant Tarlov cyst because it reduced the intracystic pressure that resulted in cyst regression.
C1 [Paterakis, Konstantinos; Fountas, Kostas N.] Univ Thessaly, Med Sch, Thessaly, Greece.
   [Paterakis, Konstantinos; Brotis, Alexandros; Fountas, Kostas N.] Univ Hosp Larissa, Dept Neurosurg, Thessaly, Greece.
   [Bakopoulou, Maria] Animus Kyanous Stavros Private Clin, Larisa, Thessaly, Greece.
   [Rountas, Christos] Univ Thessaly, Univ Hosp Larissa, Med Sch, Dept Radiol, Thessaly, Greece.
   [Dardiotis, Efthymios; Hadjigeorgiou, Georgios M.] Univ Thessaly, Univ Hosp Larissa, Med Sch, Dept Neurol, Thessaly, Greece.
   [Karantanas, Apostolos] Univ Crete, Univ Hosp Heraklion, Med Sch, Dept Diagnost Radiol, Iraklion, Greece.
RP Paterakis, K (reprint author), Univ Thessaly, Med Sch, Thessaly, Greece.; Paterakis, K (reprint author), Univ Hosp Larissa, Dept Neurosurg, Thessaly, Greece.
EM kpaterakis@yahoo.com
RI Karantanas, Apostolos/AAE-6820-2020; Paterakis,
   Konstantinos/AAH-4554-2019
OI Karantanas, Apostolos/0000-0002-0927-2403; paterakis,
   konstantinos/0000-0002-9107-8422; Dardiotis,
   Efthimios/0000-0003-2957-641X; Brotis, Alexandros/0000-0001-6031-4528
CR Acosta Jr FL, 2003, NEUROSURG FOCUS, V15, P15
   Ahn NU, 2000, SPINE, V25, P1562, DOI 10.1097/00007632-200006150-00017
   Andrieux C, 2017, INT J SURG CASE REP, V39, P25, DOI 10.1016/j.ijscr.2017.07.045
   Arnold PM, 2013, J SPINAL CORD MED, V36, P499, DOI 10.1179/2045772312Y.0000000079
   Asamoto S, 2013, ACTA NEUROCHIR, V155, P309, DOI 10.1007/s00701-012-1550-7
   Bartels RHMA, 1997, NEUROSURGERY, V40, P861, DOI 10.1097/00006123-199704000-00044
   Burke JF, 2016, J NEUROSURG-SPINE, V24, P700, DOI 10.3171/2015.9.SPINE153
   Canadas V, 2010, NAT REV CARDIOL, V7, P256, DOI 10.1038/nrcardio.2010.30
   Cantore G, 2013, WORLD NEUROSURG, V79, P381, DOI 10.1016/j.wneu.2012.06.015
   Caspar W, 2003, SURG NEUROL, V59, P101, DOI 10.1016/S0090-3019(02)00981-3
   GOYAL RN, 1987, SPINE, V12, P209, DOI 10.1097/00007632-198704000-00003
   Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78
   H'ng MWC, 2009, ULTRASOUND OBST GYN, V34, P230, DOI 10.1002/uog.6448
   Hefti M, 2006, ACTA NEUROCHIR, V148, P479, DOI 10.1007/s00701-005-0684-2
   Hirst JE, 2009, J MINIM INVAS GYN, V16, P78, DOI 10.1016/j.jmig.2008.09.580
   Ishii K, 2007, J NEUROSURG-SPINE, V7, P259, DOI 10.3171/SPI-07/08/259
   Langdown AJ, 2005, J SPINAL DISORD TECH, V18, P29, DOI 10.1097/01.bsd.0000133495.78245.71
   Lee ETC, 2015, J CLIN CASE REP, V5, P476
   Lee JY, 2004, ACTA NEUROCHIR, V146, P667, DOI 10.1007/s00701-004-0274-8
   Lucantoni C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11221
   Mummaneni PV, 2000, NEUROSURGERY, V47, P74, DOI 10.1097/00006123-200007000-00016
   NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366
   Neulen A, 2011, ACTA NEUROCHIR, V153, P1427, DOI 10.1007/s00701-011-1043-0
   Ostojic P, 2015, Z RHEUMATOL, V74, P75, DOI 10.1007/s00393-014-1507-8
   Park HJ, 2011, AM J ROENTGENOL, V196, P1151, DOI 10.2214/AJR.10.5457
   Patel MR, 1997, AM J ROENTGENOL, V168, P367, DOI 10.2214/ajr.168.2.9016209
   PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293
   PEH WCG, 1992, CLIN RADIOL, V46, P329, DOI 10.1016/S0009-9260(05)80377-0
   Potts MB, 2016, WORLD NEUROSURG, V86, P233, DOI 10.1016/j.wneu.2015.09.055
   Slipman Curtis W, 2003, Spine J, V3, P317, DOI 10.1016/S1529-9430(03)00027-5
   Smith Z, 2011, SPINE J, V11, p119S
   Tanaka M, 2006, ACTA MED OKAYAMA, V60, P65
   TARLOV IM, 1970, J NEUROL NEUROSUR PS, V33, P833, DOI 10.1136/jnnp.33.6.833
   Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1067, DOI 10.1001/archneurpsyc.1938.02270120017001
   Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025
   Wang B, 2014, J NEUROSURG-SPINE, V21, P833, DOI 10.3171/2014.8.SPINE148
   Zhang T, 2007, J NEUROSURG-SPINE, V7, P145, DOI 10.3171/SPI-07/08/145
   Zheng XS, 2016, WORLD NEUROSURG, V88, P70, DOI 10.1016/j.wneu.2016.01.016
NR 38
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 581
EP 587
DI 10.1016/j.wneu.2019.02.222
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400304
PM 30880195
DA 2020-05-12
ER

PT J
AU Wang, L
   Jiang, YP
   Li, M
   Qi, L
AF Wang, Liang
   Jiang, Yunpeng
   Li, Mu
   Qi, Lei
TI Postoperative Progression of Cervical Ossification of Posterior
   Longitudinal Ligament: A Systematic Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cervical spine; Ossification of posterior longitudinal ligament;
   Postoperative; Progression; Review
ID OPEN-DOOR LAMINOPLASTY; TERM-FOLLOW-UP; INSTRUMENTED FUSION;
   SURGICAL-TREATMENT; ANTERIOR DECOMPRESSION; EXPANSIVE LAMINOPLASTY;
   RISK-FACTORS; SPINE; MYELOPATHY; LAMINECTOMY
AB OBJECTIVE: The purpose of this study was to provide a systematic and comprehensive review of the existing literature regrading postoperative ossification of posterior longitudinal ligament (OPLL) progression.
   METHODS: Using the PRISMA guidelines, we conducted an exhaustive review of electronic databases. Potential articles were screened and related information was extracted and analyzed. Twenty-four articles with low-quality evidence were included in the review. The findings of the literature review were divided into several groups: the relationship of surgery to OPLL progression; incidence and risk factors; timing and process of OPLL progression; the effect of additional instrumentation on progression; and neurologic deterioration related with progression.
   RESULTS: There was no definitive conclusion for whether surgery could accelerate OPLL progression compared with the natural course. The incidence of postoperative OPLL progression was reported from 3.3% to 74.5%. Younger age, involvement of multiple levels and mixed or continuous types are recognized as risk factors. OPLL could progress transversely and longitudinally and progression in length appeared more significant than progression in thickness. Although radiologic OPLL progression was observed significantly more frequently after laminoplasty than after fusion surgery, whether additional instrumented fusion could suppress progression needs further research. Radiographic progression of OPLL did not positively correspond with neurologic deterioration.
   CONCLUSIONS: The lack of high-level evidence makes it difficult to draw definite conclusions and further research and long-term follow-up clinical studies are needed to better understand postoperative OPLL progression.
C1 [Wang, Liang; Jiang, Yunpeng; Li, Mu; Qi, Lei] Shandong Univ, Qilu Hosp, Dept Orthopaed Surg, Jinan, Shandong, Peoples R China.
RP Qi, L (reprint author), Shandong Univ, Qilu Hosp, Dept Orthopaed Surg, Jinan, Shandong, Peoples R China.
EM qilei_spine@hotmail.com
CR Abiola R, 2016, GLOB SPINE J, V6, P195, DOI 10.1055/s-0035-1556580
   An HS, 2014, J AM ACAD ORTHOP SUR, V22, P420, DOI 10.5435/JAAOS-22-07-420
   Chen JA, 2011, MED HYPOTHESES, V76, P73, DOI 10.1016/j.mehy.2010.08.034
   Chen ZH, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS15596
   Chiba K, 2005, J NEUROSURG-SPINE, V3, P17, DOI 10.3171/spi.2005.3.1.0017
   Choi BW, 2015, J NEUROSURG-SPINE, V23, P539, DOI 10.3171/2015.1.SPINE131167
   Fargen KM, 2012, J NEUROSURG-SPINE, V17, P512, DOI 10.3171/2012.9.SPINE12548
   Fujimori T, 2016, SPINE, V41, P1668, DOI 10.1097/BRS.0000000000001643
   Fujimori T, 2015, SPINE, V40, pE394, DOI 10.1097/BRS.0000000000000791
   Fujimori T, 2012, J NEUROSURG-SPINE, V16, P289, DOI 10.3171/2011.11.SPINE11502
   Fujiyoshi T, 2010, J CLIN NEUROSCI, V17, P320, DOI 10.1016/j.jocn.2009.06.023
   Goel A, 2016, J CRANIOVERTEBRAL JU, V7, P20, DOI 10.4103/0974-8237.176613
   Goel A, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.05.017
   HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005
   Hori T, 2007, SPINE, V32, pE551, DOI 10.1097/BRS.0b013e31814614f3
   Hori T, 2006, SPINE, V31, P2807, DOI 10.1097/01.brs.0000245870.97231.65
   Iwasaki M, 2002, J NEUROSURG, V96, P180, DOI 10.3171/spi.2002.96.2.0180
   Izumi T, 2013, EUR SPINE J, V22, P2569, DOI 10.1007/s00586-013-2989-9
   Katsumi K, 2018, INT ORTHOP, V42, P835, DOI 10.1007/s00264-017-3667-z
   Katsumi K, 2016, EUR SPINE J, V25, P1634, DOI 10.1007/s00586-015-4328-9
   Kawaguchi Y, 2001, J BONE JOINT SURG AM, V83A, P1798, DOI 10.2106/00004623-200112000-00005
   Kim B, 2015, SPINE J, V15, P875, DOI 10.1016/j.spinee.2015.01.028
   Koda M, 2015, EUR SPINE J, V24, P2555, DOI 10.1007/s00586-015-3888-z
   Lee CH, 2017, SPINE, V42, P887, DOI 10.1097/BRS.0000000000001933
   Lee CH, 2016, CLIN SPINE SURG, V29, pE9, DOI 10.1097/BSD.0000000000000058
   Lee DH, 2018, SPINE J, V18, P1116, DOI 10.1016/j.spinee.2017.10.069
   Lee JJ, 2018, SPINE J, V18, P1779, DOI 10.1016/j.spinee.2018.03.002
   Lee SE, 2016, WORLD NEUROSURG, V90, P51, DOI 10.1016/j.wneu.2015.11.074
   Lin DS, 2012, INDIAN J ORTHOP, V46, P92, DOI 10.4103/0019-5413.91642
   Liu XW, 2017, EUR SPINE J, V26, P1173, DOI 10.1007/s00586-016-4912-7
   Liu XZ, 2014, EUR SPINE J, V23, P362, DOI 10.1007/s00586-013-3043-7
   Matsunaga S, 2002, J NEUROSURG, V96, P168, DOI 10.3171/spi.2002.96.2.0168
   Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33
   McLeroy KR, 2012, AM J PUBLIC HEALTH, V102, P780, DOI 10.2105/AJPH.2011.300630
   Mehdi SK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS1630
   Murakami M, 2010, J NEUROSURG-SPINE, V12, P577, DOI 10.3171/2010.1.SPINE09452
   Ogawa Y, 2004, J NEUROSURG-SPINE, V1, P168, DOI 10.3171/spi.2004.1.2.0168
   Ota M, 2016, J CLIN NEUROSCI, V34, P162, DOI 10.1016/j.jocn.2016.06.013
   Oxford Centre for Evidence-Based Medicine Work Group, 2011, OXF LEV EV 2
   Rustagi T, 2018, WORLD NEUROSURG, V110, P11, DOI 10.1016/j.wneu.2017.10.105
   Saetia K, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.11.FOCUS10276
   Sakai K, 2012, SPINE, V37, P367, DOI 10.1097/BRS.0b013e31821f4a51
   Sakaura H, 2011, EUR SPINE J, V20, P928, DOI 10.1007/s00586-011-1690-0
   Stapleton CJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10271
   Sugita S, 2014, J NEUROSURG-SPINE, V21, P773, DOI 10.3171/2014.7.SPINE131191
   SUZUKI K, 1991, NEURORADIOLOGY, V33, P427, DOI 10.1007/BF00598618
   Takatsu T, 1999, J SPINAL DISORD, V12, P271
   Wu JC, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10268
   Yoshimura N, 2014, OSTEOPOROSIS INT, V25, P1089, DOI 10.1007/s00198-013-2489-0
NR 49
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 593
EP 600
DI 10.1016/j.wneu.2019.03.229
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400308
PM 30930321
DA 2020-05-12
ER

PT J
AU Yu, YL
   Shi, MT
   Lu, HJ
AF Yu, Yun-Li
   Shi, Meng-Ting
   Lu, Hong-Juan
TI Case of Childhood Absence Epilepsy with Focal Spikes
SO WORLD NEUROSURGERY
LA English
DT Article
DE Childhood absence epilepsy; Coexistence; Electroencephalogram; Epilepsy;
   Rolandic spikes
ID SEIZURES; ABNORMALITIES; FEATURES
AB BACKGROUND: Childhood absence epilepsy is a common generalized epilepsy syndrome characterized by childhood onset of frequent sporadic absence seizures. During onset, the electroencephalogram exhibits bilateral, symmetric, and synchronous discharges of approximately 3 Hz of generalized spike-and-wave complexes. Focal spikes are often found in children with focal epilepsy but are not common in absence epilepsy.
   CASE DESCRIPTION: In the case patient, focal spikes were observed during active onset of absence epilepsy and at 5 years after the first hospital visit, at which time absence epilepsy was controlled and medication was withdrawn without focal seizure attack in the interim.
   CONCLUSIONS: This case demonstrates that focal spikes associated with childhood absence epilepsy do not require specific treatment in the absence of focal seizures.
C1 [Yu, Yun-Li; Shi, Meng-Ting; Lu, Hong-Juan] Guizhou Med Univ, Dept Neurol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China.
RP Yu, YL (reprint author), Guizhou Med Univ, Dept Neurol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China.
EM yuyunli_cn@163.com
CR ALIBERTI V, 1994, EPILEPSIA, V35, P297, DOI 10.1111/j.1528-1157.1994.tb02433.x
   [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x
   Cerminara C, 2012, SEIZURE-EUR J EPILEP, V21, P70, DOI 10.1016/j.seizure.2011.09.005
   Esmail EH, 2016, NEUROL SCI, V37, P1071, DOI 10.1007/s10072-016-2538-5
   Jayalakshmi SS, 2010, ACTA NEUROL SCAND, V122, P115, DOI 10.1111/j.1600-0404.2009.01270.x
   Linane A, 2016, EPILEPSY BEHAV, V54, P20, DOI 10.1016/j.yebeh.2015.10.005
   Matur Z, 2009, SEIZURE-EUR J EPILEP, V18, P352, DOI 10.1016/j.seizure.2009.01.007
   Sadleir LG, 2006, NEUROLOGY, V67, P413, DOI 10.1212/01.wnl.0000228257.60184.82
   Sarkis RA, 2009, PEDIATR NEUROL, V41, P428, DOI 10.1016/j.pediatrneurol.2009.07.004
   Seneviratne U, 2014, EPILEPSIA, V55, P1157, DOI 10.1111/epi.12688
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 601
EP 604
DI 10.1016/j.wneu.2019.02.225
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400309
PM 30880214
DA 2020-05-12
ER

PT J
AU Priola, SM
   Heyn, C
   da Costa, L
AF Priola, Stefano Maria
   Heyn, Chinthaka
   da Costa, Leodante
TI Minimally Invasive Approach for the Removal of a Ruptured
   Radiculomedullary Artery Aneurysm: Case Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Minimally invasive surgery; Neuromonitoring; Radiculomedullary artery
   aneurysm; Spinal subarachnoid hemorrhage
ID SPINAL SUBARACHNOID HEMORRHAGE; ADAMKIEWICZ; DISSECTION; PATIENT
AB BACKGROUND: Radiculomedullary arteries aneurysms are rare, with only few cases so far reported.
   CASE DESCRIPTION: We report the case of a 54-year-old woman with sudden onset of upper thoracic back pain. Magnetic resonance imaging/magnetic resonance angiography of the spine showed a cervico-thoraco-lumbar hematoma, with no evidence of underlying vascular malformations. Using Phantom retractors, a unilateral laminectomy was performed at the level of T3, in proximity of the thickest part of the epidural hematoma. No epidural blood was detected. The dura was opened, and subdural and subarachnoid blood was found. After its removal, a fusiform aneurysm of the right radiculomedullary artery was found. The parental vessel was temporarily clipped and the aneurysm removed after ligation of both proximal and distal vessels. No postoperative complications occurred.
   CONCLUSIONS: Rupture of radiculomedullary artery aneurysm always should be considered as differential diagnosis in patients with sudden onset of isolated back pain, headache, and spinal epidural/subdural bleeding. Among different possible treatments, surgery represents a valid option. The use of microsurgical techniques is crucial to achieve a good clinical outcome. A minimally invasive approach can be used to minimize muscle disruption, with minimal blood loss, and faster recovery.
C1 [Priola, Stefano Maria; da Costa, Leodante] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Div Neurosurg, Toronto, ON, Canada.
   [Heyn, Chinthaka; da Costa, Leodante] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada.
RP Priola, SM (reprint author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Div Neurosurg, Toronto, ON, Canada.
EM stefanopriola@gmail.com
RI Priola, Stefano Maria/O-3077-2019
OI Priola, Stefano Maria/0000-0002-5153-6230
CR BAHAR S, 1993, NEURORADIOLOGY, V35, P352, DOI 10.1007/BF00588368
   BANNA MM, 1973, J NEUROSURG, V39, P761, DOI 10.3171/jns.1973.39.6.0761
   Berlis A, 2005, AM J NEURORADIOL, V26, P405
   FODY EP, 1980, ARCH NEUROL-CHICAGO, V37, P173, DOI 10.1001/archneur.1980.00500520071013
   GARCIA CA, 1979, NEUROLOGY, V29, P394, DOI 10.1212/WNL.29.3.394
   Germano A, 2013, NEUROSURG REV, V36, P123, DOI 10.1007/s10143-012-0408-z
   Gonzalez LF, 2005, NEUROSURGERY, V57, P1127, DOI 10.1227/01.NEU.0000186010.34779.10
   Romero DG, 2014, INTERV NEURORADIOL, V20, P774, DOI 10.15274/INR-2014-10074
   Hino H, 1989, Rinsho Shinkeigaku, V29, P1009
   Iihoshi S, 2011, NEUROL MED-CHIR, V51, P649, DOI 10.2176/nmc.51.649
   Kim HJ, 2012, NEUROSURGERY, V71, pE749, DOI 10.1227/NEU.0b013e31825ea539
   Kim Seung Bin, 2017, J Cerebrovasc Endovasc Neurosurg, V19, P217, DOI 10.7461/jcen.2017.19.3.217
   KINAL ME, 1957, J NEUROSURG, V14, P561, DOI 10.3171/jns.1957.14.5.0561
   KITO K, 1983, J NEUROSURG, V58, P126, DOI 10.3171/jns.1983.58.1.0126
   KORMOS RL, 1980, NEUROSURGERY, V6, P657, DOI 10.1227/00006123-198006000-00009
   Lavoie P, 2007, J NEUROSURG-SPINE, V6, P460, DOI 10.3171/spi.2007.6.5.460
   LEECH PJ, 1976, J NEUROSURG, V45, P331, DOI 10.3171/jns.1976.45.3.0331
   Massand MG, 2005, AM J NEURORADIOL, V26, P2415
   Nakamura A, 2015, REGEN THER, V2, P49, DOI 10.1016/j.reth.2015.11.001
   RENGACHARY SS, 1993, NEUROSURGERY, V33, P125
   SAUNDERS FW, 1987, SURG NEUROL, V27, P269, DOI 10.1016/0090-3019(87)90041-3
   SMITH BS, 1986, NEUROSURGERY, V18, P217, DOI 10.1227/00006123-198602000-00020
   Son S, 2013, J KOREAN NEUROSURG S, V54, P50, DOI 10.3340/jkns.2013.54.1.50
   Vishteh AG, 1997, NEUROSURGERY, V40, P207, DOI 10.1097/00006123-199701000-00047
   Walz DM, 2006, AM J NEURORADIOL, V27, P1576
NR 25
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 605
EP 610
DI 10.1016/j.wneu.2019.03.225
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400310
PM 30930328
DA 2020-05-12
ER

PT J
AU Fang, JC
   Liu, Y
   Jiang, XC
AF Fang, Jincheng
   Liu, Yun
   Jiang, Xiaochun
TI Ossified Chronic Subdural Hematoma in Children: Case Report and Review
   of Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Children; Ossified chronic subdural hematoma
AB BACKGROUND: Chronic subdural hematoma is a frequently clinical common problem encountered in neurosurgery practice. Nevertheless, ossified chronic subdural hematoma is extremely rare, especially in children.
   CASE DESCRIPTION: Here we report a case of ossified chronic subdural hematoma in a 7-year-old female child, with a literature review.
   CONCLUSIONS: Because of its infrequency and variable clinical manifestation, ossified chronic subdural hematoma should be considered and included in the differential diagnosis when we encounter an intracranial placeholder.
C1 [Fang, Jincheng; Jiang, Xiaochun] Yijishan Hosp, Wannan Med Coll, Dept Neurosurg, Wuhu, Anhui, Peoples R China.
   [Liu, Yun] Wannan Med Coll, Wuhu, Anhui, Peoples R China.
RP Jiang, XC (reprint author), Yijishan Hosp, Wannan Med Coll, Dept Neurosurg, Wuhu, Anhui, Peoples R China.
EM jiangxiaochun2001@hotmail.com
CR Cattalani A, 2017, CLIN NEUROL NEUROSUR, V162, P101, DOI 10.1016/j.clineuro.2017.09.015
   Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3
   Dinc C, 2006, TURK NOROSIRURJI DER, V16, P126
   Ide Mitsunobu, 1993, Neurologia Medico-Chirurgica, V33, P559, DOI 10.2176/nmc.33.559
   Kaplan M, 2008, TURK NEUROSURG, V18, P420
   MCKISSOCK W, 1960, LANCET, V1, P1365
   Moon HG, 2003, YONSEI MED J, V44, P915, DOI 10.3349/ymj.2003.44.5.915
   Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371
   Park JS, 2003, J KOREAN NEUROSURG S, V34, P177
   Per H, 2006, BRAIN DEV-JPN, V28, P607, DOI 10.1016/j.braindev.2006.03.012
   Turgut M, 1997, CHILD NERV SYST, V13, P415, DOI 10.1007/s003810050111
NR 11
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 613
EP 615
DI 10.1016/j.wneu.2019.03.144
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400312
PM 30926556
DA 2020-05-12
ER

PT J
AU Wang, JH
   Yang, S
   Yuan, XF
   Guo, FQ
AF Wang, Jianhong
   Yang, Shu
   Yuan, Xiaofan
   Guo, Fuqiang
TI Small Balloon Bridge: Improved Technique for Reaccessing Carotid Artery
   Stent
SO WORLD NEUROSURGERY
LA English
DT Article
DE Angle; Carotid artery stent; Complication; Guiding catheter; Reaccess;
   Small balloon bridge
ID ENDARTERECTOMY
AB BACKGROUND: This is new research about the technology for navigating a catheter that is eccentric or tangentially angled to the long axis of a carotid artery stent. In our clinical practice, we found resistance when the 8-French guiding catheter crossed the balloon, even when it was partially expanded. Therefore we intended to improve the operating procedure by using a smaller balloon with a diameter of 2 mm. The smaller balloon can navigate the guiding catheter to reaccess the angled junction with minimal resistance after it is fully expanded.
   CASE DESCRIPTION: We applied the small balloon bridge technology in 1 case of left internal carotid artery stent implantation. After the stents were released successfully, we found that it was difficult to recapture an umbrella because the guiding catheter had a steep angle to the long axis of carotid artery with released stents. To overcome this obstacle, we sent a 2-mm balloon into the tip of the catheter and then inflated it fully. Therefore the steep angle could be straightened due to the expanded balloon playing a supportive effect. As a result, the guiding catheter reaccessed the previous angled junction smoothly as the small balloon moved forward and recaptured the umbrella successfully.
   CONCLUSIONS: Using the small balloon bridge technique to navigate the guiding catheter is a safer, simpler, and more effective operation for carotid interventional therapy. Furthermore, it might also be applied to other endovascular treatments that require guiding catheters for intervention.
C1 [Wang, Jianhong; Yang, Shu; Yuan, Xiaofan; Guo, Fuqiang] Univ Elect Sci & Technol, Dept Neurol, Affiliated Hosp, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.
RP Guo, FQ (reprint author), Univ Elect Sci & Technol, Dept Neurol, Affiliated Hosp, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.
EM guofuqiang2005@126.com
OI Yuan, Xiaofan/0000-0002-8789-9623
CR Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321
   Featherstone RL, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20200
   Garriboli L, 2019, J ENDOVASC THER, V26, P121, DOI 10.1177/1526602818816656
   Lal BK, 2019, J VASC SURG, V69, P800, DOI 10.1016/j.jvs.2018.06.221
   Santiago-Dieppa DR, 2018, WORLD NEUROSURG, V113, P257, DOI 10.1016/j.wneu.2018.02.091
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 616
EP 618
DI 10.1016/j.wneu.2019.03.018
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400313
PM 30876996
DA 2020-05-12
ER

PT J
AU Kim, M
   Simon, J
   Mirza, K
   Swong, K
   Johans, S
   Riedy, L
   Anderson, D
AF Kim, Miri
   Simon, Joshua
   Mirza, Kamran
   Swong, Kevin
   Johans, Stephen
   Riedy, Loren
   Anderson, Douglas
TI Spinal Intradural Escherichia coli Abscess Masquerading as a Neoplasm in
   a Pediatric Patient with History of Neonatal E. coli Meningitis: A Case
   Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Escherichia coli; Intradural spinal abscess; Meningitis; Spinal cord
   tumor
ID CORD ABSCESS; CHILDREN
AB BACKGROUND: Central nervous system abscesses frequently can be seen in the immunocompromised population and most commonly consist of intracranial collections in the adult patient. Spinal intradural abscesses are less commonly encountered, and there are even fewer numbers in the pediatric population with a concordant absence of documentation in the published literature.
   CASE DESCRIPTION: In this case report, we describe the presentation of a 2-year-old boy with a history of perinatal Escherichia coli meningitis at 2.5 months of age who was found to have an intradural spinal lesion, initially concerning for neoplasm, but later confirmed as an E. coli abscess following biopsy. He was managed with surgical aspiration of the abscess and a long course of intravenous antibiotics. The patient was treated with antibiotics with repeat imaging studies that revealed residual abscess that required re-aspiration at a later date.
   CONCLUSIONS: Here we present an unusual disease process with an unusual disease pathogenesis in a pediatric patient currently residing in a developed country.
C1 [Kim, Miri; Simon, Joshua; Swong, Kevin; Johans, Stephen; Riedy, Loren; Anderson, Douglas] Loyola Univ Med Ctr, Dept Neurol Surg, Maywood, IL 60153 USA.
   [Mirza, Kamran] Loyola Univ Med Ctr, Dept Pathol, Maywood, IL 60153 USA.
RP Anderson, D (reprint author), Loyola Univ Med Ctr, Dept Neurol Surg, Maywood, IL 60153 USA.
EM dander1@lumc.edu
CR Aggarwal M, 2011, INDIAN PEDIATR, V48, P973
   BARTELS RH, 1992, J NEUROSURG, V76, P307, DOI 10.3171/jns.1992.76.2.0307
   CANDON E, 1994, REV NEUROL-FRANCE, V150, P370
   Cartes-Zumelzu FW, 2004, AM J NEURORADIOL, V25, P1310
   Kurita N, 2009, NEUROL MED-CHIR, V49, P262, DOI 10.2176/nmc.49.262
   MENEZES AH, 1977, SURG NEUROL, V8, P461
   Mohanty CB, 2018, CHILD NERV SYST, V34, P1947, DOI 10.1007/s00381-018-3885-8
   Murphy KJ, 1998, AM J NEURORADIOL, V19, P341
   Prasad GL, 2019, EUR J PEDIATR SURG, V29, P229, DOI 10.1055/s-0038-1655736
   Simon JK, 2003, PEDIATR INFECT DIS J, V22, P186
   Tyagi R, 2016, J ORTHOP, V13, P254, DOI 10.1016/j.jor.2016.06.005
   Velissaris Dimitris, 2009, World J Emerg Surg, V4, P31, DOI 10.1186/1749-7922-4-31
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 619
EP 623
DI 10.1016/j.wneu.2019.02.243
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400314
PM 30904800
DA 2020-05-12
ER

PT J
AU Hosono, J
   Nitta, M
   Masui, K
   Maruyama, T
   Komori, T
   Yokoo, H
   Saito, T
   Muragaki, Y
   Kawamata, T
AF Hosono, Junji
   Nitta, Masayuki
   Masui, Kenta
   Maruyama, Takashi
   Komori, Takashi
   Yokoo, Hideaki
   Saito, Taiichi
   Muragaki, Yoshihiro
   Kawamata, Takakazu
TI Role of a Promoter Mutation in TERT in Malignant Transformation of
   Pleomorphic Xanthoastrocytoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Glioma; Malignant transformation; Pleomorphic xanthoastrocytoma (PXA);
   TERT promoter mutation
ID EPITHELIOID GLIOBLASTOMA; LOW-GRADE; TUMORS; FREQUENCY; OUTCOMES; CANCER
AB BACKGROUND: Pleomorphic xanthoastrocytoma (PXA) is categorized as grade II, other astrocytic tumors per the 2016 World Health Organization classification. Despite being a relatively benign type of tumor, PXA often has an aggressive clinical course. The more malignant form of PXA is now known as anaplastic pleomorphic xanthoastrocytoma (A-PXA) and is categorized as a grade III tumor. Clinical and genetic factors associated with malignant transformation remain unclear. In particular, typical genetic expression patterns in PXA and A-PXA remain unidentified.
   CASE DESCRIPTION: We present a case of recurrent PXA in which malignant transformation followed a promoter mutation in TERT. In this case, genetic chronologic changes accompanying malignant transformation of PXA were thoroughly examined. The promoter mutation was detected in the second operative specimen after stereotactic radiosurgery (SRS) at the first tumor recurrence. Subsequently, a malignant transformation to the A-PXA occurred at the time of the second recurrence, and the tumor repeatedly recurred afterward.
   CONCLUSIONS: TERT promotor mutations may contribute to the malignant transformation of PXA; the mechanism of this mutation is unknown, but it may have been caused by SRS. Therefore, improvident use of radiation should be avoided to prevent the malignant transformation of PXA.
C1 [Hosono, Junji; Nitta, Masayuki; Maruyama, Takashi; Saito, Taiichi; Muragaki, Yoshihiro; Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Grad Sch Med, Shinjuku Ku, Tokyo, Japan.
   [Masui, Kenta] Tokyo Womens Med Univ, Dept Pathol, Grad Sch Med, Shinjuku Ku, Tokyo, Japan.
   [Muragaki, Yoshihiro] Tokyo Womens Med Univ, Fac Adv Technosurg, Grad Sch Med, Shinjuku Ku, Tokyo, Japan.
   [Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Lab Med & Pathol Neuropathol, Fuchu, Tokyo, Japan.
   [Yokoo, Hideaki] Gunma Univ, Dept Human Pathol, Grad Sch Med, Maebashi, Gumma, Japan.
RP Nitta, M (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Grad Sch Med, Shinjuku Ku, Tokyo, Japan.
EM nitta.masayuki@twmu.ac.jp
OI Saito, Taiichi/0000-0002-5016-9619
CR Aibaidula A, 2017, NEURO-ONCOLOGY, V19, P1327, DOI 10.1093/neuonc/nox078
   Alexandrescu S, 2016, BRAIN PATHOL, V26, P215, DOI 10.1111/bpa.12295
   Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6
   Chakrabarty A, 1999, BRIT J NEUROSURG, V13, P516, DOI 10.1080/02688699908540631
   Chan AKY, 2015, MODERN PATHOL, V28, P177, DOI 10.1038/modpathol.2014.94
   Goutagny S, 2014, BRAIN PATHOL, V24, P184, DOI 10.1111/bpa.12110
   Heidenreich B, 2014, CURR OPIN GENET DEV, V24, P30, DOI 10.1016/j.gde.2013.11.005
   Vuong HG, 2017, CRIT REV ONCOL HEMAT, V120, P1, DOI 10.1016/j.critrevonc.2017.09.013
   Ida CM, 2015, BRAIN PATHOL, V25, P575, DOI 10.1111/bpa.12217
   Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x
   Juratli TA, 2017, ONCOTARGET, V8, P109228, DOI 10.18632/oncotarget.22650
   Kleinschmidt-DeMasters BK, 2013, AM J SURG PATHOL, V37, P685, DOI 10.1097/PAS.0b013e31827f9c5e
   Koelsche C, 2013, ACTA NEUROPATHOL, V126, P907, DOI 10.1007/s00401-013-1195-5
   Korshunov A, 2018, BRAIN PATHOL, V28, P656, DOI 10.1111/bpa.12566
   Lee Y, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0465-1
   Lim S, 2013, J KOREAN NEUROSURG S, V53, P281, DOI 10.3340/jkns.2013.53.5.281
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Marton E, 2007, J NEUROL SCI, V252, P144, DOI 10.1016/j.jns.2006.11.008
   Masui K, 2018, BIOMED RES INT, DOI 10.1155/2018/7945845
   Matsumura N, 2017, NEUROPATHOLOGY, V37, P58, DOI 10.1111/neup.12318
   Muragaki Y, 2013, J NEUROSURG, V119, P845, DOI 10.3171/2013.7.JNS13415
   Nakajima N, 2018, BRAIN PATHOL, V28, P663, DOI 10.1111/bpa.12572
   Nakajima T, 2006, ACTA NEUROCHIR, V148, P67, DOI 10.1007/s00701-005-0549-8
   Perkins SM, 2012, J NEURO-ONCOL, V110, P99, DOI 10.1007/s11060-012-0939-8
   Rutkowski MJ, 2016, WORLD NEUROSURG, V95, P368, DOI 10.1016/j.wneu.2016.07.068
   Sahm F, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv377
   Schmidt Y, 2013, J NEURO-ONCOL, V111, P59, DOI 10.1007/s11060-012-0991-4
   Tanaka S, 2014, BRAIN TUMOR PATHOL, V31, P172, DOI 10.1007/s10014-014-0192-2
   Tekkok IH, 2004, PEDIATR NEUROSURG, V40, P171, DOI 10.1159/000081935
   Vaubel RA, 2018, BRAIN PATHOL, V28, P172, DOI 10.1111/bpa.12495
   Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185
NR 31
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 624
EP 630
DI 10.1016/j.wneu.2018.12.095
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400315
PM 30599247
DA 2020-05-12
ER

PT J
AU Futch, HS
   Corliss, BM
   Polifka, AJ
   Holt, BL
   Fox, WC
AF Futch, Hunter S.
   Corliss, Brian M.
   Polifka, Adam J.
   Holt, Brian L.
   Fox, W. Christopher
TI Solitaire Stent Retriever Mechanical Thrombectomy in a 6-Month-Old
   Patient with Acute Occlusion of the Internal Carotid Artery Terminus:
   Case Report
SO WORLD NEUROSURGERY
LA English
DT Article
DE Infant; Mechanical thrombectomy; Solitaire; Stent retriever; Stroke
ID ACUTE ISCHEMIC-STROKE; PEDIATRIC STROKE; INTRAARTERIAL THROMBOLYSIS;
   ENDOVASCULAR TREATMENT; CHILD; THROMBOSIS; THERAPY; MANAGEMENT; DEVICES;
   FR
AB BACKGROUND: Endovascular mechanical thrombectomy (MT) performed with stent retriever devices have proven efficacious in the treatment of adult patients with acute cerebral ischemia resulting from large-vessel occlusion. Recently, reports describing the use of MT in pediatric large-vessel occlusion have increased. However, these case reports are generally limited to older children and teenagers.
   CASE DESCRIPTION: We report the use of a Solitaire (Medtronic, Minneapolis, Minnesota, USA) stent retriever for thrombectomy and revascularization of the right middle cerebral artery) in a 6-month-old patient.
   CONCLUSIONS: To our knowledge, this is the youngest patient reported to be treated with MT using a stent retriever. This case adds to the growing literature that supports the use of MT as a stroke intervention in pediatric patients.
C1 [Futch, Hunter S.] Univ Florida, Coll Med, Gainesville, FL USA.
   [Corliss, Brian M.; Polifka, Adam J.; Holt, Brian L.; Fox, W. Christopher] Univ Florida, Dept Neurol Surg, Gainesville, FL 32611 USA.
RP Fox, WC (reprint author), Univ Florida, Dept Neurol Surg, Gainesville, FL 32611 USA.
EM w.chrisfox@neurosurgery.ufl.edu
OI Fox, W Christopher/0000-0002-7762-9902
CR Alnaami I, 2013, ANN THORAC SURG, V96, pE65, DOI 10.1016/j.athoracsur.2013.03.104
   Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Bigi S, 2018, ANN NEUROL, V83, P1125, DOI 10.1002/ana.25242
   Bodey C, 2014, EUR J PAEDIATR NEURO, V18, P730, DOI 10.1016/j.ejpn.2014.07.006
   Buompadre MC, 2017, PEDIATR NEUROL, V66, P21, DOI 10.1016/j.pediatrneurol.2016.09.007
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Dubedout S, 2013, PEDIATR NEUROL, V49, P379, DOI 10.1016/j.pediatrneurol.2013.06.008
   Fink J, 2013, J CHILD NEUROL, V28, P1521, DOI 10.1177/0883073812460334
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Gruber A, 2000, NEUROLOGY, V54, P1684, DOI 10.1212/WNL.54.8.1684
   Grunwald IQ, 2010, J INVASIVE CARDIOL, V22, P63
   Hu YC, 2014, CHILD NERV SYST, V30, P937, DOI 10.1007/s00381-013-2313-3
   Huang MIP, 2017, STROKE, V48, P2026, DOI 10.1161/STROKEAHA.117.016887
   Huded V, 2015, J VASC INTERV NEUROL, V8, P4
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Kim ES, 2018, CASE REP PEDIAT, V2018, P1
   Modrau B, 2011, CASE REP NEUROL, V3, P91, DOI 10.1159/000327554
   Nicosia G, 2017, CHILD NERV SYST, V33, P349, DOI 10.1007/s00381-016-3259-z
   Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158
   Rhee E, 2014, PEDIATR TRANSPLANT, V18, pE88, DOI 10.1111/petr.12241
   Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696
   de la Maza SS, 2014, J CHILD NEUROL, V29, P269, DOI 10.1177/0883073813509889
   Savastano L, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2015-011821.rep
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   See AP, 2016, PEDIATR NEUROSURG, V51, P263, DOI 10.1159/000445902
   Shaikh H, 2015, J NEUROINTERV SURG, V7, DOI 10.1136/neurintsurg-2013-011088.rep
   Stidd David A, 2014, Neurointervention, V9, P94, DOI 10.5469/neuroint.2014.9.2.94
   Stowe RC, 2018, BRAIN DEV-JPN, V40, P81, DOI 10.1016/j.braindev.2017.08.001
   Sun LR, 2018, PEDIATR NEUROL, V82, P53, DOI 10.1016/j.pediatrneurol.2018.02.002
   Tabone L, 2017, STROKE, V48, P2278, DOI 10.1161/STROKEAHA.117.016591
   Taneja SR, 2011, J PAEDIATR CHILD H, V47, P408, DOI 10.1111/j.1440-1754.2010.01974.x
   Tsivgoulis G, 2008, J NEUROL SCI, V275, P151, DOI 10.1016/j.jns.2008.07.018
   van den Wijngaard I, 2014, INTERV NEURORADIOL, V20, P345, DOI 10.15274/NRJ-2014-10026
   Vega RA, 2015, J NEUROSURG-PEDIATR, V15, P301, DOI 10.3171/2014.10.PEDS14292
   Wilson JL, 2017, PEDIATR NEUROL, V69, P87, DOI 10.1016/j.pediatrneurol.2017.01.013
   Zanaty M, 2014, CLIN NEUROL NEUROSUR, V127, P15, DOI 10.1016/j.clineuro.2014.09.022
NR 36
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 631
EP 637
DI 10.1016/j.wneu.2019.03.038
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400316
PM 30877002
DA 2020-05-12
ER

PT J
AU Khan, IS
   D'Agostino, EN
   Calnan, DR
   Lee, JE
   Aronson, JP
AF Khan, Imad S.
   D'Agostino, Erin N.
   Calnan, Daniel R.
   Lee, James E.
   Aronson, Joshua P.
TI Deep Brain Stimulation for Memory Modulation: A New Frontier
SO WORLD NEUROSURGERY
LA English
DT Review
DE Deep brain stimulation; Memory; Modulation; Network; Review
ID MEDIAL TEMPORAL-LOBE; SPATIAL WORKING-MEMORY; LA-TOURETTE-SYNDROME;
   ELECTRICAL-STIMULATION; NUCLEUS BASALIS; THALAMIC-STIMULATION;
   PEDUNCULOPONTINE NUCLEUS; HIPPOCAMPAL INTERACTIONS; DEMENTIA; CORTEX
AB BACKGROUND: In the coming years the number of patients with cognitive disorders, such as Alzheimer disease and traumatic brain injury, is expected to dramatically increase, leading to an ever-increasing societal cost. Unfortunately, few medical and pharmacologic treatments have shown tangible benefit in the treatment of these diseases. Deep brain stimulation (DBS) is an established surgical technique to address multiple conditions, including Parkinson disease and essential tremor. Data from patients being treated with DBS, as well as those being monitored for seizures with depth electrodes, have suggested improvement in memory with electrical neuromodulation.
   METHODS: MEDLINE was searched from inception through March 2018 using the keywords "DBS," "Deep Brain Stimulation," "Memory," "Memory Modulation," and " Cognition." Studies evaluating the effect of DBS on memory and learning were shortlisted and reviewed.
   RESULTS: Efforts to stimulate various nodes within the memory circuitry suggest that the variable effects may result from different mechanisms, including alteration of neural firing patterns, increased activity across several regions, and amplification of neural plasticity. Some of these targets, such as the entorhinal cortex, hippocampus, and nucleus basalis of Meynert, have shown promising results with regards to modulation of memory.
   CONCLUSIONS: Given the aging population and increasing numbers of patients with memory impairment from neurodegenerative diseases, interest in neuromodulation for memory enhancement will likely expand. Further work should employ more sophisticated responsive stimulation parameters and precise spatial targeting that may lead to an effective stimulation strategy for memory enhancement.
C1 [Khan, Imad S.; Calnan, Daniel R.; Lee, James E.; Aronson, Joshua P.] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA.
   [D'Agostino, Erin N.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA.
RP Khan, IS (reprint author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA.
EM Imad.S.Khan@hitchcock.org
CR Alessandro S, 2010, J NEUROL SCI, V289, P44, DOI 10.1016/j.jns.2009.08.017
   Balak N, 2018, WORLD NEUROSURG, V110, P133, DOI 10.1016/j.wneu.2017.10.168
   Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008
   Bick SKB, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS162
   BICKFORD R G, 1958, Res Publ Assoc Res Nerv Ment Dis, V36, P227
   Bickford RG, 1958, RES PUBL ASSOC RES N, V36, P241
   Blasberg F, 2018, NEUROMODULATION, V21, P541, DOI 10.1111/ner.12766
   Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290
   Boex C, 2011, SEIZURE-EUR J EPILEP, V20, P485, DOI 10.1016/j.seizure.2011.03.001
   Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005
   Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133
   CAPARROSLEFEBVRE D, 1992, REV NEUROL, V148, P117
   Ceravolo R, 2011, EUR J NEUROL, V18, P842, DOI 10.1111/j.1468-1331.2010.03254.x
   Chapman L F, 1967, Trans Am Neurol Assoc, V92, P50
   Chen T, 2019, J NEUROSURG, V130, P109, DOI 10.3171/2017.8.JNS17883
   Churchwell JC, 2011, BEHAV BRAIN RES, V225, P389, DOI 10.1016/j.bbr.2011.07.045
   Cohen N, 2015, NEUROSCI BIOBEHAV R, V50, P128, DOI 10.1016/j.neubiorev.2014.11.002
   Coleshill SG, 2004, J NEUROSCI, V24, P1612, DOI 10.1523/JNEUROSCI.4352-03.2004
   Costa A, 2010, PARKINSONISM RELAT D, V16, P64, DOI 10.1016/j.parkreldis.2009.05.009
   De Salles AAF, 2018, NEUROSURGERY, V83, P800, DOI 10.1093/neuros/nyy024
   Denys D, 2009, PROG BRAIN RES, V175, P419, DOI 10.1016/S0079-6123(09)17527-1
   Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561
   Durschmid S, 2020, EUR J NEUROSCI, V51, P1201, DOI 10.1111/ejn.13749
   Ervin F R, 1969, Proc Annu Meet Am Psychopathol Assoc, V58, P54
   Ezzyat Y, 2017, CURR BIOL, V27, P1251, DOI 10.1016/j.cub.2017.03.028
   FEINDEL W, 1954, AMA ARCH NEUROL PSY, V72, P605, DOI 10.1001/archneurpsyc.1954.02330050075012
   Fell J, 2013, BRAIN STIMUL, V6, P270, DOI 10.1016/j.brs.2012.08.001
   Fernandez G, 2002, HIPPOCAMPUS, V12, P514, DOI 10.1002/hipo.10050
   Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x
   Fontaine D, 2013, J ALZHEIMERS DIS, V34, P315, DOI 10.3233/JAD-121579
   Freund HJ, 2009, ARCH NEUROL-CHICAGO, V66, P781, DOI 10.1001/archneurol.2009.102
   Gagnon G, 2010, BRAIN RES, V1344, P148, DOI 10.1016/j.brainres.2010.04.041
   Gratwicke J, 2013, NEUROSCI BIOBEHAV R, V37, P2676, DOI 10.1016/j.neubiorev.2013.09.003
   Grubert C, 2011, WORLD J BIOL PSYCHIA, V12, P516, DOI 10.3109/15622975.2011.583940
   HALGREN E, 1985, BRAIN COGNITION, V4, P287, DOI 10.1016/0278-2626(85)90022-3
   Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295
   Hansen N, 2018, HIPPOCAMPUS, V28, P12, DOI 10.1002/hipo.22808
   Hardenacke K, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.12.005
   Hescham S, 2013, NEUROSCI BIOBEHAV R, V37, P2666, DOI 10.1016/j.neubiorev.2013.09.002
   Hescham S, 2013, BRAIN STIMUL, V6, P72, DOI 10.1016/j.brs.2012.01.008
   Hohne M, 2016, NEUROIMAGE, V139, P127, DOI 10.1016/j.neuroimage.2016.06.021
   Hoge J, 2007, NEUROBIOL LEARN MEM, V88, P225, DOI 10.1016/j.nlm.2007.04.013
   Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010
   Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176
   Innocenti I, 2010, NEUROIMAGE, V53, P325, DOI 10.1016/j.neuroimage.2010.06.011
   Jacobs J, 2016, NEURON, V92, P983, DOI 10.1016/j.neuron.2016.10.062
   Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007
   Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170
   Kim K, 2016, NEUROBIOL LEARN MEM, V134, P162, DOI 10.1016/j.nlm.2016.04.001
   Kubu CS, 2013, STEREOT FUNCT NEUROS, V91, P374, DOI 10.1159/000348321
   Kuhn J, 2015, MOL PSYCHIATR, V20, P353, DOI 10.1038/mp.2014.32
   Lacruz ME, 2010, NEUROSCIENCE, V170, P623, DOI 10.1016/j.neuroscience.2010.06.042
   Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089
   Lee DJ, 2017, EPILEPSY RES, V130, P53, DOI 10.1016/j.eplepsyres.2017.01.005
   Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744
   Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646
   LEE GP, 1988, NEUROPSYCHOLOGIA, V26, P623, DOI 10.1016/0028-3932(88)90118-2
   LEE GP, 1990, CORTEX, V26, P433, DOI 10.1016/S0010-9452(13)80092-5
   Lozano AM, 2016, J ALZHEIMERS DIS, V54, P777, DOI 10.3233/JAD-160017
   Velasco AL, 2007, EPILEPSIA, V48, P1895, DOI 10.1111/j.1528-1167.2007.01181.x
   Mantione M, 2015, J PSYCHIATR NEUROSCI, V40, P378, DOI 10.1503/jpn.140210
   Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492
   Mazzone P, 2005, NEUROREPORT, V16, P1877, DOI 10.1097/01.wnr.0000187629.38010.12
   McLachlan RS, 2010, EPILEPSIA, V51, P304, DOI 10.1111/j.1528-1167.2009.02332.x
   Merkow MB, 2017, BRAIN STIMUL, V10, P645, DOI 10.1016/j.brs.2016.12.011
   Miatton M, 2011, EPILEPSY BEHAV, V22, P759, DOI 10.1016/j.yebeh.2011.09.016
   Miller JP, 2015, BRAIN, V138, P1833, DOI 10.1093/brain/awv095
   Montero-Pastor A, 2004, BEHAV BRAIN RES, V154, P41, DOI 10.1016/j.bbr.2004.01.017
   Montero-Pastor A, 2001, BRAIN RES, V900, P337, DOI 10.1016/S0006-8993(01)02325-3
   Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230
   Oh YS, 2012, SEIZURE-EUR J EPILEP, V21, P183, DOI 10.1016/j.seizure.2011.12.003
   PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103
   Perng CH, 2018, PSYCHOPHARMACOLOGY, V235, P1571, DOI 10.1007/s00213-018-4867-y
   Pisoni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123085
   Ravikumar VK, 2017, MOVEMENT DISORD, V32, P1165, DOI 10.1002/mds.26997
   Rezai AR, 2016, NEUROSURGERY, V79, P204, DOI 10.1227/NEU.0000000000001190
   Sankar T, 2015, BRAIN STIMUL, V8, P645, DOI 10.1016/j.brs.2014.11.020
   Sederberg PB, 2006, NEUROIMAGE, V32, P1422, DOI 10.1016/j.neuroimage.2006.04.223
   Servello D, 2008, J NEUROL NEUROSUR PS, V79, P136, DOI 10.1136/jnnp.2006.104067
   Servello D, 2016, NEUROSURGERY, V78, P91, DOI 10.1227/NEU.0000000000001004
   Shah A, 2012, J CLIN NEUROSCI, V19, P289, DOI 10.1016/j.jocn.2011.04.039
   Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975
   SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849
   Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515
   Stefani A, 2010, CLIN EEG NEUROSCI, V41, P82, DOI 10.1177/155005941004100207
   Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011
   Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125
   Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212
   Thomas AG, 2011, RADIOGRAPHICS, V31, P1107, DOI 10.1148/rg.314105729
   Titiz AS, 2017, ELIFE, V6, DOI [10.7554/eLife.29515.001, 10.7554/eLife.29515]
   Troster AI, 2017, SEIZURE-EUR J EPILEP, V45, P133, DOI 10.1016/j.seizure.2016.12.014
   Troster AI, 1997, NEUROLOGY, V49, P1078, DOI 10.1212/WNL.49.4.1078
   Troster AI, 1999, NEUROLOGY, V53, P1774, DOI 10.1212/WNL.53.8.1774
   TURNBULL IM, 1985, APPL NEUROPHYSIOL, V48, P216
   Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118
   Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004
   Watrous AJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00075
   Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315
   Wharen RE, 2017, PARKINSONISM RELAT D, V40, P18, DOI 10.1016/j.parkreldis.2017.03.017
   Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258
   Zeidman P, 2016, NAT REV NEUROSCI, V17, P173, DOI 10.1038/nrn.2015.24
NR 101
TC 4
Z9 4
U1 3
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 638
EP 646
DI 10.1016/j.wneu.2018.12.184
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400317
PM 30654156
DA 2020-05-12
ER

PT J
AU Li, YW
   Mao, F
   Cheng, FL
   Peng, CH
   Guo, DS
   Wang, BF
AF Li, Youwei
   Mao, Feng
   Cheng, Fangling
   Peng, Chenghao
   Guo, Dongsheng
   Wang, Baofeng
TI A Meta-Analysis of Endoscopic Microvascular Decompression versus
   Microscopic Microvascular Decompression for the Treatment for Cranial
   Nerve Syndrome Caused by Vascular Compression
SO WORLD NEUROSURGERY
LA English
DT Review
DE Endoscopic; Hemifacial spasm; Meta-analysis; Microvascular
   decompression; Trigeminal neuralgia
ID TRIGEMINAL NEURALGIA; HEMIFACIAL SPASM; ADJUNCTIVE USE; SURGERY
AB OBJECTIVE: The aim of this study was to compare the efficacy and safety of endoscopic microvascular decompression (E-MVD) and microscopic microvascular decompression (M-MVD) for the treatment for cranial nerve syndrome caused by vascular compression, including primary trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia.
   METHODS: A systematic search of the online databases, including PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials, China Biology Medicine disc, and China National Knowledge Infrastructure, was performed from January 1966 to March 2018. The language of the included literature was not limited. Relevant outcomes of perioperative safety and postoperative efficacy were considered for meta-analysis. Single-arm and cumulative meta-analyses were also conducted. All the outcomes were calculated as odds ratios (ORs) with 95% confidence intervals using R language.
   RESULTS: A total of 9 studies involving 1093 (E-MVD [543] vs. M-MVD [550]) patients were included for analysis in our study. The recent remission rate (92% vs. 86%; OR, 1.71; P = 0.0089), offending vessel discovery rate (99% vs. 95%; OR 2.76, P = 0.0061), and long-term remission rate (97% vs. 87%; OR 4.59, P = 0.0036) were significantly higher in patients who underwent E-MVD than in those who underwent M-MVD, whereas perioperative complications (23% vs. 35%; OR 0.56, P < 0.0001) were significantly lower in patients who underwent E-MVD.
   CONCLUSIONS: This meta-analysis confirms that E-MVD is superior to M-MVD both in perioperative and postoperative efficacy (short- and long-term), and therefore it should be considered as an appropriate treatment choice for patients with neuralgia and hemifacial spasm.
C1 [Li, Youwei; Mao, Feng; Cheng, Fangling; Peng, Chenghao; Guo, Dongsheng; Wang, Baofeng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Tongji Med Coll, Wuhan, Hubei, Peoples R China.
RP Wang, BF (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Tongji Med Coll, Wuhan, Hubei, Peoples R China.
EM wbf620@163.com
FU Nation National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81874086, 81472364, 81702480]
FX This work was supported by the Nation National Natural Science
   Foundation of China (grant numbers: 81874086, 81472364, and 81702480).
CR Abdeen K, 2000, NEUROL RES, V22, P522
   Antonini G, 2014, PAIN, V155, P1464, DOI 10.1016/j.pain.2014.04.020
   Apra C, 2017, NEUROSURG REV, V40, P577, DOI 10.1007/s10143-017-0812-5
   Ba TLH, 2016, CHIN J PRACT NERVOUS, V19, P51
   Badr-El-Dine M, 2002, OTOL NEUROTOL, V23, P122, DOI 10.1097/00129492-200203000-00002
   Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701
   Bohman LE, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14318
   BURCHIEL KJ, 1988, J NEUROSURG, V69, P35, DOI 10.3171/jns.1988.69.1.0035
   Campos-Benitez M, 2008, J NEUROSURG, V109, P416, DOI 10.3171/JNS/2008/109/9/0416
   Chen MJ, 2008, J CRANIO MAXILL SURG, V36, P456, DOI 10.1016/j.jcms.2008.05.002
   Cheng WY, 2008, SURG NEUROL, V70, P40, DOI 10.1016/j.surneu.2008.02.024
   Dubey A, 2018, WORLD NEUROSURG, V113, pE612, DOI 10.1016/j.wneu.2018.02.108
   Duntze J, 2011, NEUROCHIRURGIE, V57, P68, DOI 10.1016/j.neuchi.2011.03.003
   HAINES SJ, 1980, J NEUROSURG, V52, P381, DOI 10.3171/jns.1980.52.3.0381
   Halpern CH, 2013, MINIM INVASIVE SURG, V2013, DOI 10.1155/2013/739432
   He YJ, 2014, CHIN J MINIM INVASIV, V19, P446
   JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159
   Jiang L, 2012, J CLIN NEUROSURG, V9, P349
   Kabil MS, 2005, MINIM INVAS NEUROSUR, V48, P207, DOI 10.1055/s-2005-870928
   King WA, 2001, NEUROSURGERY, V49, P108, DOI 10.1097/00006123-200107000-00017
   Komatsu F, 2017, J NEUROL SURG PART A, V78, P291, DOI 10.1055/s-0036-1592077
   Lee JYK, 2017, J NEUROSURG, V126, P1676, DOI 10.3171/2016.5.JNS1621
   Miyazaki H, 2005, LARYNGOSCOPE, V115, P1612, DOI 10.1097/01.mlg.0000172038.22929.63
   Moher David, 2009, Open Med, V3, pe123
   Piazza M, 2016, NEUROSURG CLIN N AM, V27, P305, DOI 10.1016/j.nec.2016.02.008
   Pollock BE, 2010, NEUROSURGERY, V67, P8
   Pollock BE, 2010, NEUROSURGERY, V67, P633, DOI 10.1227/01.NEU.0000377861.14650.98
   Shen ZC, 2014, CHINA MED HERALD, V11, P62
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Xiang H, 2018, WORLD NEUROSURG, V111, pE328, DOI 10.1016/j.wneu.2017.12.051
   Xu B., 2016, CHIN J PRACT NERVOUS, V19, P69
   Yadav YR, 2018, WORLD NEUROSURG, V114, P436, DOI 10.1016/j.wneu.2018.03.154
   Zu XW, 2016, SHANXI MED J, V45, P879
NR 34
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 647
EP +
DI 10.1016/j.wneu.2019.01.220
PG 16
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400318
PM 30776512
DA 2020-05-12
ER

PT J
AU Texakalidis, P
   Chaitidis, N
   Giannopoulos, S
   Giannopoulos, S
   Machinis, T
   Jabbour, P
   Rivet, D
   Reavey-Cantwell, J
   Rangel-Castilla, L
AF Texakalidis, Pavlos
   Chaitidis, Nikolaos
   Giannopoulos, Stefanos
   Giannopoulos, Spyridon
   Machinis, Theofilos
   Jabbour, Pascal
   Rivet, Dennis
   Reavey-Cantwell, John
   Rangel-Castilla, Leonardo
TI Carotid Revascularization in Older Adults: A Systematic Review and
   Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Carotid; Embolic protection; Endarterectomy; Octogenarians; Older
   adults; Stenting; Stroke
ID STROKE PREVENTION; FLOW REVERSAL; ENDARTERECTOMY; OCTOGENARIANS;
   STENOSIS; INTERVENTION; ANGIOPLASTY; BENEFITS
AB BACKGROUND: Results from studies comparing carotid artery endarterectomy (CEA) with carotid artery stenting (CAS) in the elderly population are variable in the literature. The objective of this study was to investigate whether CEA or CAS is associated with a better safety profile in older adults (>80 years of age) for treatment of symptomatic and asymptomatic stenosis.
   METHODS: A random-effects meta-analysis was performed, and the I-2 statistic was used to assess heterogeneity according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Subgroup analyses were performed as needed.
   RESULTS: Nine studies comprising 5955 patients were included in this meta-analysis. No differences were identified in terms of 30-day stroke (CEA: 5.8% [n = 257/4415]; CAS: 10.5% [n = 81/767]; odds ratio [OR], 0.57; 95% confidence interval [CI], 0.30-1.08; I-2 [26.1%), myocardial infarction (MI) (CEA: 1.1% [n = 4/357]; CAS: 0.5% [n = 2/355]; OR, 1.67; 95% CI, 0.37-7.46; I-2 = 0%), transient ischemic attack (TIA) (CEA: 0% [n = 0/98]; CAS: 4.2% [n = 7/166]; OR, 0.28; 95% CI, 0.03-2.52; I-2 [0%), death (CEA: 1.5% [n = 8/523]; CAS: 0.9% [n = 4/431]; OR, 1.41; 95% CI, 0.43-4.58; I-2 = 0%), and cranial nerve injury (CEA: 5.8% [n = 3/51]; CAS: 0% [n = 0/51]; OR, 4.74; 95% CI, 0.5-44.98; I-2 = 0%). A subgroup comparing CEA with transfemoral protected CAS showed that patients in the CEA group had a statistically significant lower risk of 30-day stroke (OR, 0.31; 95% CI, 0.17-0.57; I-2 = 30.8%).
   CONCLUSIONS: This study shows that CEA is associated with a statistically significant lower risk of 30-day stroke in the elderly population compared with transfemoral CAS with distal or proximal protection. No differences were noted in the rates of periprocedural TIA, MI, death, and cranial nerve injury between CEA and CAS in the original pooled analysis.
C1 [Texakalidis, Pavlos] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
   [Chaitidis, Nikolaos] 401 Gen Mil Hosp, Athens, Greece.
   [Giannopoulos, Stefanos] 251 HAF & VA Hosp, Dept Vasc Surg, Athens, Greece.
   [Giannopoulos, Spyridon] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece.
   [Machinis, Theofilos; Rivet, Dennis; Reavey-Cantwell, John] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA.
   [Jabbour, Pascal] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA.
   [Rangel-Castilla, Leonardo] Mayo Clin, Dept Neurosurg, Rochester, MN USA.
RP Texakalidis, P (reprint author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
EM pavlostex.med@gmail.com
RI Giannopoulos, Stefanos/W-9294-2019
OI Giannopoulos, Stefanos/0000-0002-1942-911X
CR Alric P, 2002, J ENDOVASC THER, V9, P14, DOI 10.1583/1545-1550(2002)009<0014:CASFSF>2.0.CO;2
   Alvarez B, 2008, J VASC SURG, V47, P96, DOI 10.1016/j.jvs.2007.09.032
   Blackshear JL, 2011, CIRCULATION, V123, P2571, DOI 10.1161/CIRCULATIONAHA.110.008250
   Brown KE, 2008, ANN SURG, V248, P110, DOI 10.1097/SLA.0b013e318176c49d
   De Rango P, 2012, EUR J VASC ENDOVASC, V44, P252, DOI 10.1016/j.ejvs.2012.06.006
   Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079
   Fantozzi C, 2016, ANN VASC SURG, V33, P132, DOI 10.1016/j.avsg.2015.10.039
   Flores A, 2009, J CARDIOVASC SURG, V50, P745
   Giannopoulos S, 2018, CARDIOVASC REVASCULA, V19, P638, DOI 10.1016/j.carrev.2018.01.014
   Halliday A, 2004, LANCET, V363, P1491
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hobson RW, 2004, J VASC SURG, V40, P1106, DOI 10.1016/j.jvs.2004.10.022
   Kakisis JD, 2017, EUR J VASC ENDOVASC, V53, P320, DOI 10.1016/j.ejvs.2016.12.026
   Lal BK, 2009, J VASC SURG, V50, P1224, DOI 10.1016/j.jvs.2009.09.003
   Lam RC, 2007, J VASC SURG, V45, P875, DOI 10.1016/j.jvs.2006.12.059
   Miyawaki S, 2014, NEUROL MED-CHIR, V54, P120, DOI 10.2176/nmc.oa2012-0436
   Naylor AR, 2009, EUR J VASC ENDOVASC, V37, P625, DOI 10.1016/j.ejvs.2009.01.026
   Rockman CB, 2003, ANN VASC SURG, V17, P9, DOI 10.1007/s10016-001-0330-2
   Sardar P, 2017, J AM COLL CARDIOL, V69, P2266, DOI 10.1016/j.jacc.2017.02.053
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.i4086, 10.1136/bmj.g7647]
   Sheffet AJ, 2010, INT J STROKE, V5, P40, DOI 10.1111/j.1747-4949.2009.00405.x
   Texakalidis P, 2018, CARDIOVASC REVASCULA, V19, P545, DOI 10.1016/j.carrev.2017.12.010
   Texakalidis P, 2018, J ENDOVASC THER, V25, P523, DOI 10.1177/1526602818783505
   Texakalidis P, 2018, WORLD NEUROSURG, V116, P444, DOI 10.1016/j.wneu.2018.05.160
   Texakalidis P, 2018, WORLD NEUROSURG, V115, P421, DOI 10.1016/j.wneu.2018.02.196
   Vouyouka AG, 2012, J VASC SURG, V56, P334, DOI 10.1016/j.jvs.2012.01.066
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035
   Yoshida S, 2013, J VASC SURG, V58, P120, DOI 10.1016/j.jvs.2012.12.075
   Zarins CK, 2009, J ENDOVASC THER, V16, P397, DOI 10.1583/08-2685.1
NR 30
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 656
EP +
DI 10.1016/j.wneu.2019.02.030
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400319
PM 30797928
DA 2020-05-12
ER

PT J
AU Perdomo-Pantoja, A
   Ishida, W
   Zygourakis, C
   Holmes, C
   Iyer, RR
   Cottrill, E
   Theodore, N
   Witham, TF
   Lo, SFL
AF Perdomo-Pantoja, Alexander
   Ishida, Wataru
   Zygourakis, Corinna
   Holmes, Christina
   Iyer, Rajiv R.
   Cottrill, Ethan
   Theodore, Nicholas
   Witham, Timothy F.
   Lo, Sheng-fu L.
TI Accuracy of Current Techniques for Placement of Pedicle Screws in the
   Spine: A Comprehensive Systematic Review and Meta-Analysis of 51,161
   Screws
SO WORLD NEUROSURGERY
LA English
DT Review
DE Accuracy; Fluoroscopy; Freehand; Navigation; Pedicle Screw; Robot
ID INTRAOPERATIVE COMPUTED-TOMOGRAPHY; ADOLESCENT IDIOPATHIC SCOLIOSIS;
   FACET JOINT VIOLATION; FREE-HAND PLACEMENT; THORACIC PEDICLE; LUMBAR
   SPINE; THORACOLUMBAR SPINE; IN-VIVO; O-ARM; POSTOPERATIVE ASSESSMENT
AB BACKGROUND: Pedicle screws (PSs) are routinely used for stabilization to enhance fusion in a variety of spinal diseases. Although the accuracy of different PS placement methods has been previously reported, most of these studies have been limited to 1 or 2 techniques. The purpose was to determine the current accuracy of PS placement among 4 modalities of PS insertion (freehand [FH], fluoroscopy-assisted [FA], computed tomography navigation-guided [CTNav], and robot-assisted [RA]) and analyze variables associated with screw misplacement.
   METHODS: A systematic review was performed of peer-reviewed articles reporting PS accuracy of 1 technique from January 1990 to June 2018. Accuracy of PS placement, PS insertion technique, and pedicle breach (PB) data were collected. A meta-analysis was performed to estimate the overall pooled (OP) rates of PS accuracy as a primary outcome, stratified by screw insertion techniques. Potential determinants were analyzed via meta-regression analyses.
   RESULTS: Seventy-eight studies with 7858 patients, 51,161 PSs, and 3614 cortical PBs were included. CTNav showed the highest PS placement accuracy compared with other techniques: OP accuracy rates were 95.5%, 93.1%, 91.5%, and 90.5%, via CTNav, FH, FA, and RA techniques, respectively. RA and CTNav were associated with the highest PS accuracy in the thoracic spine, compared with FH.
   CONCLUSIONS: The OP data show that CTNav has the highest PS accuracy rates. Thoracic PSs were associated with lower accuracy rates; however, RA showed fewer breaches in the thoracic spine compared with FH and FA. Given the heterogeneity among studies, further standardized and comparative investigations are required to confirm our findings.
C1 [Perdomo-Pantoja, Alexander; Ishida, Wataru; Zygourakis, Corinna; Iyer, Rajiv R.; Cottrill, Ethan; Theodore, Nicholas; Witham, Timothy F.; Lo, Sheng-fu L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Holmes, Christina] Florida State Univ, Florida A&M Univ, Coll Engn, Tallahassee, FL 32306 USA.
RP Lo, SFL (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
EM larrylo@jhmi.edu
RI Perdomo-Pantoja, Alexander/N-9161-2019; Holmes, Christina/AAE-6142-2020;
   Ishida, Wataru/J-6566-2019
OI Perdomo-Pantoja, Alexander/0000-0002-4981-8132; Ishida,
   Wataru/0000-0001-7015-3027; Cottrill, Ethan/0000-0001-5991-7962
FU AO North America; Ely Lilly and Company; Gordon & Marylin Macklin
   Foundation; AO Foundation; Chordoma Foundation
FX Disclosure of funding, source of financial support and industry
   affiliations, and personal or institutional financial interest in drugs,
   material, or devices: N.T., royalties from Globus Medical, Depuy
   Synthes; stock ownership in Globus Medical; consulting for Globus
   Medical; scientific advisory board member for Globus Medical; fellowship
   support from AO North America. T.F.W., research support from Ely Lilly
   and Company, Gordon & Marylin Macklin Foundation. S.-f.L.L., research
   support from AO Foundation and Chordoma Foundation.
CR Abul-Kasim K, 2010, EUR SPINE J, V19, P96, DOI 10.1007/s00586-009-1203-6
   Ahmad FU, 2014, J NEUROSURG-SPINE, V21, P826, DOI 10.3171/2014.7.SPINE13846
   Amato V, 2010, J NEUROSURG-SPINE, V12, P306, DOI 10.3171/2009.9.SPINE09261
   Balling H, 2017, EUR SPINE J, V26, P2898, DOI 10.1007/s00586-017-5108-5
   Barsa P, 2013, EUR SPINE J, V22, P1446, DOI 10.1007/s00586-013-2815-4
   Beck M, 2009, EUR SPINE J, V18, P1469, DOI 10.1007/s00586-009-1050-5
   Belmont PJ, 2001, SPINE, V26, P2340, DOI 10.1097/00007632-200111010-00010
   Boachie-Adjei O, 2000, J SPINAL DISORD, V13, P496, DOI 10.1097/00002517-200012000-00005
   BOUCHER HH, 1959, J BONE JOINT SURG BR, V41, P248
   Braga BP, 2010, ARQ NEURO-PSIQUIAT, V68, P390, DOI 10.1590/S0004-282X2010000300012
   Bransford R, 2006, J TRAUMA, V60, P1047, DOI 10.1097/01.ta.0000215949.95089.18
   Bydon M, 2014, J NEUROSURG-SPINE, V21, P320, DOI 10.3171/2014.5.SPINE13567
   Chang KW, 2012, J SPINAL DISORD TECH, V25, pE67, DOI 10.1097/BSD.0b013e31823db498
   Chenin L, 2017, WORLD NEUROSURG, V105, P86, DOI 10.1016/j.wneu.2017.05.118
   Chiu CK, 2015, BONE JOINT J, V97B, P1111, DOI 10.1302/0301-620X.97B8.35330
   CHIU CK, 2017, J ORTHOP SURG-HONG K, V25
   Cho JY, 2012, COMPUT AIDED SURG, V17, P300, DOI 10.3109/10929088.2012.728625
   Cordemans V, 2017, EUR SPINE J, V26, P2906, DOI 10.1007/s00586-017-5139-y
   Dede O, 2014, SPINE, V39, P286, DOI 10.1097/BRS.0000000000000127
   Devito DP, 2010, SPINE, V35, P2109, DOI 10.1097/BRS.0b013e3181d323ab
   Dinesh SK, 2012, BRIT J NEUROSURG, V26, P838, DOI 10.3109/02688697.2012.690917
   Du JP, 2018, WORLD NEUROSURG, V109, P24, DOI 10.1016/j.wneu.2017.07.154
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ebraheim NA, 1997, SPINE, V22, P1553, DOI 10.1097/00007632-199707150-00002
   Etemadifar Mohammadreza, 2017, Adv Biomed Res, V6, P19, DOI 10.4103/2277-9175.201331
   Fan Chiang Chih-Yun, 2012, Chang Gung Med J, V35, P332
   FAN Y, 2018, MEDICINE, V97
   Fennell VS, 2014, J NEUROSURG-SPINE, V21, P778, DOI 10.3171/2014.7.SPINE1489
   Fichtner J, 2018, WORLD NEUROSURG, V109, pE24, DOI 10.1016/j.wneu.2017.09.091
   Fomekong E, 2017, WORLD NEUROSURG, V108, P76, DOI 10.1016/j.wneu.2017.08.149
   Fu TS, 2004, ACTA ORTHOP SCAND, V75, P730, DOI 10.1080/00016470410004102
   Fujimori T, 2017, CLIN SPINE SURG, V30, pE64, DOI 10.1097/BSD.0b013e3182a357ad
   Fuster S, 2010, NEUROCIRUGIA, V21, P306
   Gao ST, 2018, EUR SPINE J, V27, P921, DOI 10.1007/s00586-017-5333-y
   Gautschi OP, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11168
   Gelalis ID, 2012, EUR SPINE J, V21, P247, DOI 10.1007/s00586-011-2011-3
   GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004
   Gokcen HB, 2018, INT J SURG, V51, P83, DOI 10.1016/j.ijsu.2018.01.006
   Guzey FK, 2006, J SPINAL DISORD TECH, V19, P436, DOI 10.1097/00024720-200608000-00011
   Halm H, 2000, EUR SPINE J, V9, P191, DOI 10.1007/s005860000139
   Hamad A, 2017, BRIT J NEUROSURG, V31, P526, DOI 10.1080/02688697.2017.1297374
   Hansen-Algenstaedt N, 2015, SPINE, V40, pE954, DOI 10.1097/BRS.0000000000000958
   HARRINGTON PR, 1969, SOUTH MED J, V62, P1, DOI 10.1097/00007611-196901000-00001
   Hecht N, 2016, EUR SPINE J, V25, P716, DOI 10.1007/s00586-015-3814-4
   Heintel TM, 2013, EUR SPINE J, V22, P495, DOI 10.1007/s00586-012-2476-8
   Hicks JM, 2010, SPINE, V35, pE465, DOI 10.1097/BRS.0b013e3181d1021a
   Karapinar L, 2008, J SPINAL DISORD TECH, V21, P63, DOI 10.1097/BSD.0b013e3181453dc6
   Kim TT, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13531
   Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B
   Knox JB, 2011, SPINE J, V11, P213, DOI 10.1016/j.spinee.2011.01.024
   Koktekir E, 2014, SPINE J, V14, P1702, DOI 10.1016/j.spinee.2014.03.044
   Krieg Sandro M, 2018, Neurosurg Focus, V45, pV3, DOI 10.3171/2018.7.FocusVid.18108
   Kuntz C, 2004, J SPINAL DISORD TECH, V17, P206, DOI 10.1097/00024720-200406000-00007
   Kuo KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153235
   Kwan MK, 2017, J ORTHOP SURG-HONG K, V25, DOI 10.1177/2309499017722438
   Larson AN, 2012, SPINE, V37, pE188, DOI 10.1097/BRS.0b013e31822a2e0a
   Lee CH, 2014, ASIAN SPINE J, V8, P237, DOI 10.4184/asj.2014.8.3.237
   Lee CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000757
   Lee KD, 2014, J KOREAN NEUROSURG S, V56, P16, DOI 10.3340/jkns.2014.56.1.16
   Lee MH, 2013, J SPINAL DISORD TECH, V26, pE183, DOI 10.1097/BSD.0b013e31828054c8
   Li J, 2013, J SPINAL DISORD TECH, V26, pE46, DOI 10.1097/BSD.0b013e31825d5c87
   Liljenqvist UR, 1997, SPINE, V22, P2239, DOI 10.1097/00007632-199710010-00008
   Ling JM, 2014, J CLIN NEUROSCI, V21, P493, DOI 10.1016/j.jocn.2013.02.034
   Liu H, 2016, INT J COMPUT ASS RAD, V11, P2273, DOI 10.1007/s11548-016-1448-6
   Macke JJ, 2016, J ROBOT SURG, V10, P145, DOI 10.1007/s11701-016-0587-7
   Malhotra D, 2014, OPER NEUROSURG, V10, P497, DOI 10.1227/NEU.0000000000000489
   McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021
   Miekisiak G, 2015, J SPINAL DISORD TECH, V28, pE194, DOI 10.1097/BSD.0000000000000243
   Mohanty S P, 2018, Musculoskelet Surg, V102, P47, DOI 10.1007/s12306-017-0498-4
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Molliqaj G, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS179
   Motiei-Langroudi R, 2015, SPINE J, V15, P700, DOI 10.1016/j.spinee.2014.12.012
   Nakanishi K, 2009, ARCH ORTHOP TRAUM SU, V129, P1211, DOI 10.1007/s00402-008-0807-3
   Nevzati E, 2014, WORLD NEUROSURG, V82, P866, DOI 10.1016/j.wneu.2014.06.023
   Odgers CJ, 1996, J SPINAL DISORD, V9, P334
   Oertel MF, 2011, J NEUROSURG-SPINE, V14, P532, DOI 10.3171/2010.10.SPINE091032
   Ohba T, 2016, EUR SPINE J, V25, P1775, DOI 10.1007/s00586-016-4489-1
   Park DK, 2014, J SPINAL DISORD TECH, V27, P154, DOI 10.1097/BSD.0b013e318250ec75
   Parker SL, 2014, SPINE, V39, P683, DOI 10.1097/BRS.0000000000000221
   Parker SL, 2011, NEUROSURGERY, V68, P170, DOI 10.1227/NEU.0b013e3181fdfaf4
   Pechlivanis I, 2009, SPINE, V34, P392, DOI 10.1097/BRS.0b013e318191ed32
   Powers Ciaran J, 2006, Neurosurg Focus, V20, pE3
   Puvanesarajah V, 2014, WORLD J ORTHOP, V5, P112, DOI 10.5312/wjo.v5.i2.112
   Rajasekaran S, 2018, EUR SPINE J, V27, P2339, DOI 10.1007/s00586-017-5453-4
   Rampersaud YR, 2005, SPINE, V30, pE183, DOI 10.1097/01.brs.0000157490.65706.38
   Ravi B, 2011, SPINE, V36, P84, DOI 10.1097/BRS.0b013e3181cbfd09
   Rivkin MA, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13499
   Rodrigues LMR, 2011, J PEDIATR ORTHOP B, V20, P195, DOI 10.1097/BPB.0b013e328344105c
   ROYCAMILLE R, 1976, RECONS SURG, V15, P2
   Sarwahi V, 2016, SPINE, V41, pE548, DOI 10.1097/BRS.0000000000001318
   Schizas C, 2007, EUR SPINE J, V16, P625, DOI 10.1007/s00586-006-0262-1
   Tabaraee E, 2013, SPINE, V38, P1953, DOI 10.1097/BRS.0b013e3182a51d1e
   Tsai TH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004834
   Van de Kelft E, 2012, SPINE, V37, pE1580, DOI 10.1097/BRS.0b013e318271b1fa
   van Dijk JD, 2015, SPINE, V40, pE986, DOI 10.1097/BRS.0000000000000960
   Wang VY, 2010, EUR SPINE J, V19, P821, DOI 10.1007/s00586-010-1293-1
   Winder Mark J, 2017, J Spine Surg, V3, P193, DOI 10.21037/jss.2017.06.05
   Youkilis AS, 2001, NEUROSURGERY, V48, P771, DOI 10.1097/00006123-200104000-00015
   Yu TM, 2017, INT J SURG, V43, P46, DOI 10.1016/j.ijsu.2017.05.041
   Zdichavsky M, 2004, EUR J TRAUMA, V30, P241, DOI DOI 10.1007/S00068-004-1423-8
   Zhu F, 2014, J SPINAL DISORD TECH, V27, P431, DOI 10.1097/BSD.0b013e31828d6a1b
   Zygourakis Corinna C, 2018, Neurosurg Focus, V45, pV6, DOI 10.3171/2018.7.FocusVid.18123
NR 102
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP 664
EP +
DI 10.1016/j.wneu.2019.02.217
PG 18
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400320
PM 30880208
DA 2020-05-12
ER

PT J
AU Akbik, OS
   Starling, RV
   Gahramanov, S
   Zhu, YL
   Lewis, J
AF Akbik, Omar S.
   Starling, Robert, V
   Gahramanov, Seymur
   Zhu, Yiliang
   Lewis, Jeremy
TI Mortality and Functional Outcome in Surgically Evacuated Acute Subdural
   Hematoma in Elderly Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acute subdural hematoma; Elderly traumatic brain injury
ID PREINJURY WARFARIN; INJURY; AGE
AB BACKGROUND: Significant morbidity and mortality is associated with surgical evacuation of acute subdural hematomas (ASDHs) in the elderly population. The literature remains mixed on risk factors associated with poor outcomes, specifically preoperative antithrombotic usage and postoperative seizures.
   METHODS: Between January 1, 2013, and December 31, 2017, we retrospectively identified 62 patients >= 65 years of age who underwent a craniotomy for evacuation of an ASDH, with the primary outcome being Glasgow Outcome Scale (GOS) score at discharge and 3- and 6-month follow-up.
   RESULTS: Of the patients, 52% were women, with a median age of 78 years (range, 65-93 years). The mechanism of injury was because of a fall in 40 patients. Twenty-eight patients (44%) had a poor outcome (GOS score 1-2) at discharge, increasing to 31 patients (50%) at 3-month follow-up. Eight patients (13%) had a good outcome (GOS score 4-5) at discharge, increasing to 17 patients (27%) at 3-month follow-up. Perioperative mortality rate was 39%, increasing to 44% at 3-month follow-up. The strongest associations with mortality in descending order were 24-hour postoperative Glasgow Come Scale (GCS) score, midline shift, preoperative GCS score, and pupillary abnormalities. Although age was not a statistically significant factor for mortality, patients with a favorable outcome (GOS score 4-5) had a median age of 71 years versus 78 years for GOS score 1-3. Preoperative antithrombotic usage and postoperative seizures were not significant predictors of outcome or mortality.
   CONCLUSIONS: A high percentage of morbidity and mortality remains in the management of ASDHs in the elderly population; however, a significant percentage (27%) can still go on to have a favorable outcome.
C1 [Akbik, Omar S.; Starling, Robert, V; Gahramanov, Seymur; Zhu, Yiliang; Lewis, Jeremy] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.
RP Akbik, OS (reprint author), Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.
EM osakbik@salud.unm.edu
CR Benedetto N, 2017, BRIT J NEUROSURG, V31, P244, DOI 10.1080/02688697.2016.1244249
   Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313
   Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542
   He W, 2016, AGING WORLD 2015
   Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023
   Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051
   Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa
   McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041
   Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B
   Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096
   Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311
   Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095
   Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030
   Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763
   Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417
NR 15
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1235
EP E1241
DI 10.1016/j.wneu.2019.02.234
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400155
PM 30885866
DA 2020-05-12
ER

PT J
AU Alunpipatthanachai, B
   Thirapattaraphan, P
   Fried, H
   Vavilala, MS
   Lele, AV
AF Alunpipatthanachai, Bhunyawee
   Thirapattaraphan, Porntip
   Fried, Herbert
   Vavilala, Monica S.
   Lele, Abhijit, V
TI External Ventricular Drain Management Practices in Thailand: Results of
   the EPRACT Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE External ventricular drain; Insertion; Maintenance; Protocols; Quality
   improvement; Thailand
ID INFECTIONS
AB OBJECTIVE: We explored the external ventricular drain (EVD) practices in Thailand.
   METHODS: We performed a survey-based study to describe EVD insertion, maintenance, quality improvement (QI) practices, and incidence of EVD infection.
   RESULTS: The study included 58 of 101 hospitals contacted (57.4% response rate), with >= 600 beds (44.8%) and dedicated neurocritical care units (53%). The reasons for EVD placement included aneurysmal subarachnoid hemorrhage, traumatic brain injury, and ventriculoperitoneal shunt malfunction or infection; 75.9% of the hospitals cared for <= 100 EVDs annually. In Thailand, nonantimicrobial EVD catheters (98.3%) were used most often. Most hospitals (56.9%) did not routinely sample the cerebrospinal fluid. Prophylactic daily antibiotic use was prevalent (62.1%). Most hospitals (77.6%) did not measure the intracranial pressure during intrahospital transport. EVD infection was a commonly (69%) tracked QI measure; however, up to one third of the hospitals did not track any EVD QI measure. Most hospitals (94.8%) had no written EVD insertion and maintenance protocols. Most hospitals (79.3%) reported an EVD infection rate of <= 5% in the previous year. The low EVD infection rate, high cost, and/or the lack of equipment could account for the low usage of antimicrobial catheters and intracranial pressure monitoring.
   CONCLUSIONS: The results of the present study have identified QI opportunities in EVD management in Thailand. The development of an EVD-related QI process, reliable tracking of EVD infection rates, adaptation of U.S. guidelines to create standardized EVD protocols, and examination of the association between EVD practices and clinical outcomes in low-to middle-income countries are urgently needed.
C1 [Alunpipatthanachai, Bhunyawee; Vavilala, Monica S.; Lele, Abhijit, V] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA.
   [Thirapattaraphan, Porntip] Khon Kaen Univ, Fac Med, Dept Surg, Div Neurosurg, Khon Kaen, Thailand.
   [Fried, Herbert] Univ Colorado, Dept Neurol Surg, Aurora, CO USA.
RP Lele, AV (reprint author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA.
EM abhijit2@uw.edu
CR [Anonymous], 2017, STAT IC COMP PROGR
   Chaikittisilpa N, 2017, NEUROCRIT CARE, V26, P196, DOI 10.1007/s12028-016-0308-0
   Champey J, 2019, J NEUROSURG, V130, P2034, DOI 10.3171/2018.1.JNS172486
   CLARK WC, 1989, NEUROSURGERY, V25, P20
   Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8
   Fuangworawong P, 2016, INT J SURG, V33, P88, DOI 10.1016/j.ijsu.2016.07.068
   Hanchaiphiboolkul Suchat, 2011, Journal of the Medical Association of Thailand, V94, P427
   Kammoun B, 2018, WORLD NEUROSURG, V119, P428, DOI 10.1016/j.wneu.2018.07.261
   Kohli G, 2018, WORLD NEUROSURG, V110, pE135, DOI 10.1016/j.wneu.2017.10.129
   Lele AV, 2017, J NEUROSURG ANESTH, V29, P191, DOI 10.1097/ANA.0000000000000407
   Lewis A, 2017, NEUROHOSPITALIST, V7, P15, DOI 10.1177/1941874416663281
   Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]
   Ortiz R, 2006, CURR NEUROL NEUROSCI, V6, P525, DOI 10.1007/s11910-006-0056-1
   Phuenpathom N, 2000, J CLIN NEUROSCI, V7, P223, DOI 10.1054/jocn.1999.0203
   Sekula RF, 2008, BRIT J NEUROSURG, V22, P213, DOI 10.1080/02688690701832084
   Suwanwela NC, 2014, J STROKE, V16, P1, DOI 10.5853/jos.2014.16.1.1
   Veerasarn Kullapat, 2016, Journal of the Medical Association of Thailand, V99, pS62
NR 17
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E743
EP E752
DI 10.1016/j.wneu.2019.02.144
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400092
PM 30851470
DA 2020-05-12
ER

PT J
AU Asencio-Cortes, C
   Salgado-Lopez, L
   Munoz-Hernandez, F
   de Quintana-Schmidt, C
   Rodriguez-Rodriguez, R
   Alvarez-Holzapfel, MJ
   Conesa, G
AF Asencio-Cortes, Carlos
   Salgado-Lopez, Laura
   Munoz-Hernandez, Fernando
   de Quintana-Schmidt, Cristian
   Rodriguez-Rodriguez, Rodrigo
   Jesus Alvarez-Holzapfel, Maria
   Conesa, Gerardo
TI Long-Term Safety and Performance of a Polymeric Clamplike Cranial
   Fixation System
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bone flap; Craniotomy; Cranial fixation devices; Polyetheretherketone
ID BONE FLAP FIXATION; SCREW FIXATION; TITANIUM; RECONSTRUCTION;
   RELIABILITY; IMPLANTS; PLATES; PEEK
AB OBJECTIVE: After a craniotomy procedure to access the brain, neurosurgeons have several options to fix the bone flap to the skull. The aim of this study was to assess if a polymeric clamplike fixation system (Cranial LOOP) is a safe and reliable system that maintains over time an appropriate alignment of the bone flap.
   METHODS: This is an observational, retrospective, case series study of 60 patients who underwent a craniotomy and were subject to cranial bone flap fixation with the Cranial LOOP fixation system. Baseline clinical parameters, surgical variables, medical records, and all postoperative medical images available were reviewed to assess the bone flap alignment and potential adverse events.
   RESULTS: A total of 182 Cranial LOOPs were implanted in the 60 patients (56.01 +/- 20.21 years, 55% women) included in the study. The cranial fixation system maintained a good bone flap alignment in 95% of the patients studied immediately after surgery and in up to 96.7% of them at the end of follow-up. No intraoperative complications were reported. An ulcer potentially related to a device was detected, which was solved without the need for device removal. No artifacts were observed in any of the 219 medical images analyzed.
   CONCLUSIONS: Cranial LOOP is a safe and reliable postoperative long-term cranial bone flap fixation system. This device can fix the bone flap after a wide range of craniotomy procedures, performed in multiple locations, and provides good bone flap alignment. Cranial LOOP does not interfere in patient follow-up through medical imaging.
C1 [Asencio-Cortes, Carlos; Salgado-Lopez, Laura; Munoz-Hernandez, Fernando; de Quintana-Schmidt, Cristian; Rodriguez-Rodriguez, Rodrigo; Jesus Alvarez-Holzapfel, Maria; Conesa, Gerardo] Hosp Santa Creu i St Pau, Neurosurg Dept, Barcelona, Spain.
RP Asencio-Cortes, C (reprint author), Hosp Santa Creu i St Pau, Neurosurg Dept, Barcelona, Spain.
EM casencio@santpan.cat
OI Munoz Hernandez, Fernando/0000-0002-5827-0519
FU NEOS Surgery S. L; Comite Etico de Investigacion con Medicamentos de la
   Fundacio de Gestio Sanitaria del Hospital de la Santa Creu i Sant Pau de
   Barcelona"
FX Carlos Asencio-Cortes receives honoraria and consulting fees from NEOS
   Surgery. This study has been funded by NEOS Surgery S. L. The sponsor
   has participated in the study protocol design but has not had any
   contribution in the collection and interpretation of the data. The terms
   of this sponsorship have been reviewed and approved by the "Comite Etico
   de Investigacion con Medicamentos de la Fundacio de Gestio Sanitaria del
   Hospital de la Santa Creu i Sant Pau de Barcelona" and found to be in
   accordance with its policy on objectivity in research.
CR Broaddus WC, 2002, J NEUROSURG, V96, P244, DOI 10.3171/jns.2002.96.2.0244
   Camarini ET, 2011, J CRANIOFAC SURG, V22, P2205, DOI 10.1097/SCS.0b013e3182326f2c
   Chibbaro S, 2011, MINIM INVAS NEUROSUR, V54, P282, DOI 10.1055/s-0031-1297246
   Estin D, 2000, SURG NEUROL, V53, P391, DOI 10.1016/S0090-3019(00)00186-5
   Frydman GH, 2017, COMPARATIVE MED, V67, P165
   Garcia-Gonzalez D, 2017, J MECH BEHAV BIOMED, V69, P342, DOI 10.1016/j.jmbbm.2017.01.012
   Gupta R, 2016, ACTA NEUROCHIR, V158, P1845, DOI 10.1007/s00701-016-2929-7
   Hanasono MM, 2009, ANN PLAS SURG, V62, P653, DOI 10.1097/SAP.0b013e318184abc7
   Lemcke J, 2009, ACTA NEUROCHIR, V151, P1231, DOI 10.1007/s00701-009-0361-y
   Lerch KD, 1999, NEUROSURGERY, V44, P902, DOI 10.1097/00006123-199904000-00137
   Lethaus B, 2012, J NEUROTRAUM, V29, P1077, DOI 10.1089/neu.2011.1794
   Noda K, 2009, NEUROL MED-CHIR, V49, P559, DOI 10.2176/nmc.49.559
   Persing JA, 1996, J CRANIOFAC SURG, V7, P267
   Shellock FG, 1998, RADIOLOGY, V207, P822, DOI 10.1148/radiology.207.3.9609911
   SMITH SC, 1991, NEUROSURGERY, V29, P417, DOI 10.1227/00006123-199109000-00013
   US Food and Drug Administration, 2017, MAUDE ADV EV REP AES
   Van Loock K, 2011, MINIM INVAS NEUROSUR, V54, P119, DOI 10.1055/s-0031-1283171
   Winston KR, 2003, J NEUROSURG, V99, P484, DOI 10.3171/jns.2003.99.3.0484
   Winston KR, 1999, PEDIATR NEUROSURG, V31, P225, DOI 10.1159/000028867
   YAREMCHUK MJ, 1995, J CRANIOFAC SURG, V6, P525, DOI 10.1097/00001665-199511000-00023
NR 20
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E758
EP E764
DI 10.1016/j.wneu.2019.02.146
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400094
PM 30853518
DA 2020-05-12
ER

PT J
AU Azab, WA
   Nasim, K
   Abdelnabi, EA
   Yousef, W
   Najibullah, M
   Khan, T
   Zaidan, SN
   Bokeris, AA
   Mostafa, KH
   Geng, D
AF Azab, Waleed A.
   Nasim, Khurram
   Abdelnabi, Ehab A.
   Yousef, Waleed
   Najibullah, Mustafa
   Khan, Tufail
   Zaidan, Salem N.
   Bokeris, Abdulaziz A.
   Mostafa, Kamal H.
   Geng, Dangmurenjiafu
TI Endoscopic Endonasal Excision of Large and Giant Pituitary Adenomas:
   Radiological and Intraoperative Correlates of the Extent of Resection
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adenoma; Endoscopic; Endonasal; Pituitary; Sella; Transsphenoidal;
   Volumetric
ID CAVERNOUS SINUS SPACE; SKULL BASE SURGERY; TRANSSPHENOIDAL APPROACH;
   CLASSIFICATION; EXPERIENCE; MANAGEMENT; INVASION; SIZE
AB BACKGROUND: Despite the superb visualization offered by the endoscopic endonasal transsphenoidal approach, the resection rates of large and giant pituitary adenomas have remained much lower than those of smaller macroadenomas. Various tumor characteristics can influence the extent of resection (EOR) and have been variably reported. Additional understanding of these factors is mandatory to improve the results. We analyzed the radiological and intraoperative tumor characteristics influencing the EOR in a cohort of patients with large and giant pituitary macroadenomas undergoing endoscopic endonasal transsphenoidal excision under our care.
   METHODS: Twenty-eight patients were included. Magnetic resonance images were retrospectively analyzed for pre- and postoperative tumor volumetric analysis; preoperative tumor volume calculation using the formula (A x B x C/2); preoperative radioanatomical characteristics, including tumor shape, radiological structure, contrast enhancement, and extension; and the EOR. Intraoperative data were retrieved and included.
   RESULTS: The preoperative calculated tumor volume was 38.14 +/- 23.02 cm(3) and the preoperative measured tumor volume was 50.345 +/- 17.36 cm(3). A statistically significant difference was found between the calculated and measured tumor volumes for the whole cohort and for tumors with a maximum diameter >3.9 cm. A statistically significant difference in the EOR was found at a volume threshold of 26.2 cm(3). Large cysts, heterogeneous enhancement, Knosp grade <= 2, soft tumor consistency, and tumor hemorrhage were significantly associated with gross total resection.
   CONCLUSIONS: Volumetric analysis should replace 2-dimensional methods in determining the size of large and giant pituitary adenomas. Specific tumor characteristics were associated with the EOR and could help in predicting the EOR for these tumors.
C1 [Azab, Waleed A.; Nasim, Khurram; Yousef, Waleed; Khan, Tufail; Zaidan, Salem N.; Bokeris, Abdulaziz A.; Mostafa, Kamal H.] Ibn Sina Hosp, Dept Neurosurg, Kuwait, Kuwait.
   [Abdelnabi, Ehab A.] Ibn Sina Hosp, Dept Radiol, Kuwait, Kuwait.
   [Najibullah, Mustafa; Geng, Dangmurenjiafu] Xinjiang Med Univ, Dept Neurosurg, Affiliated Hosp 1, Urumqi, Peoples R China.
RP Azab, WA (reprint author), Ibn Sina Hosp, Dept Neurosurg, Kuwait, Kuwait.
EM waleedazab@hotmail.com
CR Agrawal A, 2007, CLIN NEUROL NEUROSUR, V109, P645, DOI 10.1016/j.clineuro.2007.06.007
   Cappabianca P, 2002, MINIM INVAS NEUROSUR, V45, P193, DOI 10.1055/s-2002-36197
   Cappabianca P, 2008, ADV TECH STAND NEURO, V33, P151, DOI 10.1007/978-3-211-72283-1_4
   Cappabianca P, 2017, BRAIN SPINE SURG ELD, P141
   Cappabianca P, 2014, WORLD NEUROSURG, V82, pS3, DOI 10.1016/j.wneu.2014.07.019
   Cappabianca P, 2015, J NEUROSURG, V122, P473, DOI 10.3171/2014.8.JNS141716
   Cappabianca P, 2014, ACTA NEUROCHIR, V156, P2217, DOI 10.1007/s00701-014-2213-7
   Cavallo LM, 2008, NEUROSURG REV, V31, P55, DOI 10.1007/s10143-007-0098-0
   Chabot JD, 2015, WORLD NEUROSURG, V84, P978, DOI 10.1016/j.wneu.2015.06.007
   Chohan MO, 2016, PITUITARY, V19, P311, DOI 10.1007/s11102-016-0709-2
   Davies BM, 2016, ACTA NEUROCHIR, V158, P677, DOI 10.1007/s00701-015-2699-7
   Neto MAD, 2010, CLIN ENDOCRINOL, V72, P512, DOI 10.1111/j.1365-2265.2009.03665.x
   Di Maio S, 2011, J NEUROSURG, V114, P345, DOI 10.3171/2010.9.JNS10262
   Goel A, 2004, SURG NEUROL, V61, P436, DOI 10.1016/j.surneu.2003.08.036
   Gondim JA, 2014, WORLD NEUROSURG, V82, pE281, DOI 10.1016/j.wneu.2013.08.028
   Hofstetter CP, 2012, PITUITARY, V15, P450, DOI 10.1007/s11102-011-0350-z
   Juraschka K, 2014, J NEUROSURG, V121, P75, DOI 10.3171/2014.3.JNS131679
   KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008
   Komotar RJ, 2012, PITUITARY, V15, P150, DOI 10.1007/s11102-011-0359-3
   Koutourousiou M, 2013, J NEUROSURG, V118, P621, DOI 10.3171/2012.11.JNS121190
   Kuo CH, 2016, WORLD NEUROSURG, V91, P121, DOI 10.1016/j.wneu.2016.03.092
   KWAK R, 1983, STROKE, V14, P493, DOI 10.1161/01.STR.14.4.493
   Losa M, 2008, J NEUROSURG, V108, P525, DOI 10.3171/JNS/2008/108/3/0525
   Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
   Musluman AM, 2011, WORLD NEUROSURG, V76, P141, DOI 10.1016/j.wneu.2011.02.009
   Prevedello DM, 2007, J NEUROSURG, V107, P206, DOI 10.3171/JNS-07/07/0206
   Yano S, 2017, WORLD NEUROSURG, V99, P533, DOI 10.1016/j.wneu.2016.12.068
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
NR 28
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E793
EP E802
DI 10.1016/j.wneu.2019.02.151
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400099
PM 30857994
DA 2020-05-12
ER

PT J
AU Bae, IS
   Chun, HJ
   Yi, HJ
   Bak, KH
   Choi, KS
   Kim, DW
AF Bae, In-Suk
   Chun, Hyoung-Joon
   Yi, Hyeong-Joong
   Bak, Koang-Hum
   Choi, Kyu-Sun
   Kim, Dong-Won
TI Modified Glasgow Coma Scale Using Serum Factors as a Prognostic Model in
   Traumatic Brain Injury
SO WORLD NEUROSURGERY
LA English
DT Article
DE Decompressive craniectomy; Glasgow Coma Scale; Mortality; Outcome;
   Traumatic brain injury
ID BASE DEFICIT; PREDICTIVE-VALUE; MORTALITY; LACTATE; HYPERGLYCEMIA;
   COAGULOPATHY; SCORE; OUTCOMES; IMPACT
AB BACKGROUND: Traumatic brain injury (TBI) is a major cause of death and disability. This study evaluated a possible relationship between serum factors at admission and the outcome of TBI. We propose a statistically validated scale for patients with TBI that combines serum factors and the Glasgow Coma Scale (GCS).
   METHODS: Between May 2011 and July 2016, 219 patients underwent decompressive craniectomy for TBI. We assessed laboratory data on admission, and correlations with GSC and Glasgow Outcome Scale were investigated. The modified GCS was developed from a multivariable logistic regression model, which was validated with the backward stepwise method.
   RESULTS: Of 219 patients with TBI enrolled in our study, 175 were men (79.9%) and 44 were women (20.1%) with a mean age of 49.1 +/- 11.5 years. Initial serum values of hemoglobin, platelets, prothrombin time, and lactate dehydrogenase were associated with in-hospital mortality. The factor score was derived by adding the following points: hemoglobin (>= 13.0 g/dL [0, < 13.0 g/dL = 1), platelets (>= 150 x 10(3)/mm(3) [0, < 150 x 10(3)/mm(3) = 1), prothrombin time (< 13.2 seconds [0, >= 13.2 seconds = 1), and lactate dehydrogenase (< 271 U/L = 0, >= 271 U/L = 1). The modified GCS score (GCS score [range, 6-15] - FS [range, 0-4]) was calculated.
   CONCLUSIONS: The modified GCS score using serum factors extended the information provided about patient outcomes to be comparable to more complex methods. The modified GCS score may be useful to predict in-hospital mortality in patients with TBI.
C1 [Bae, In-Suk; Chun, Hyoung-Joon; Yi, Hyeong-Joong; Bak, Koang-Hum; Choi, Kyu-Sun] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea.
   [Kim, Dong-Won] Hanyang Univ, Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.
RP Chun, HJ (reprint author), Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea.
EM tdy815@hanyang.ac.kr
OI Bae, In-Suk/0000-0002-0738-9253
CR Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769
   Callaway DW, 2009, J TRAUMA, V66, P1040, DOI 10.1097/TA.0b013e3181895e9e
   Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48
   Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c
   Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291
   Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548
   Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8
   Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8
   Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1
   LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43
   Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019
   MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF
   McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484
   Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68
   Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292
   Namiki J, 2011, CLIN NEUROL NEUROSUR, V113, P393, DOI 10.1016/j.clineuro.2011.01.001
   Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022
   Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018
   RAO CJ, 1978, J NEUROL NEUROSUR PS, V41, P948, DOI 10.1136/jnnp.41.10.948
   Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d
   Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038
   Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015
   Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310
   Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6
   Salim A, 2009, AM SURGEON, V75, P25
   Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58
   Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26
   Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13
   Ting HW, 2010, J CHIN MED ASSOC, V73, P139, DOI 10.1016/S1726-4901(10)70028-9
   Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5
   Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034
   Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014
   Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac
   Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4
NR 34
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E959
EP E964
DI 10.1016/j.wneu.2019.02.197
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400120
PM 30876987
DA 2020-05-12
ER

PT J
AU Balogun, JA
   Adebayo, AM
AF Balogun, James A.
   Adebayo, Ayodeji M.
TI Perception (of) and Willingness to Choose a Neurosurgery Career Among
   Final-Year Medical Students in Ibadan, Nigeria
SO WORLD NEUROSURGERY
LA English
DT Article
DE Medical students; Neurosurgery; Neurosurgery career; Perception
ID GENERAL-SURGERY; RECRUITMENT; ROTATIONS; EXPOSURE; IMPACT
AB BACKGROUND: The deficit in access to neurosurgical care worldwide remains a challenge, particularly in the developing economies such as Nigeria, where the neurosurgeon density is low. The concern that arguably subsists in sub-Saharan Africa is the decline in the number of recruited candidates into surgical specialty training programs, including neurosurgery, despite increasing burden of surgical cases. This study assessed the perception and willingness of medical undergraduates regarding neurosurgery career and determined the factors influencing their choice. This understanding will be critical to advancing ways of motivating them toward a neurosurgery career.
   METHODS: A cross-sectional study was conducted among 256 consenting final-year medical students of the College of Medicine, University of Ibadan, Nigeria. Data on the perception (of) and willingness to choose neurosurgery career were obtained. Data were analyzed with descriptive statistics and chi(2) test at P < 0.05.
   RESULTS: The mean age of respondents was 24.9 +/- 1.9 years. Within the duration of their clinical trainings, almost all (96.1%) the respondents had 1-2 neurosurgical postings. Although surgery was the most preferred specialty, only 7.8% of the respondents reported a willingness to choose neurosurgery as a career. Proffered reasons for dissatisfaction with neurosurgical postings were unfriendly teaching environment (52.6%) and incessant industrial strikes, coupled with stress among trainers and residents (27.7%). More male than female students were willing to choose neurosurgery career (P = 0.027).
   CONCLUSIONS: Our study indicated that the proportion of final-year medical students willing to choose neurosurgery career was low and there was sex disparity in the willingness to pursue a neurosurgical career.
C1 [Balogun, James A.] Univ Ibadan, Coll Med, Dept Surg, Div Neurosurg, Ibadan, Nigeria.
   [Adebayo, Ayodeji M.] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Nigeria.
   [Balogun, James A.] Univ Coll Hosp, Dept Neurosurg, Ibadan, Nigeria.
RP Balogun, JA (reprint author), Univ Ibadan, Coll Med, Dept Surg, Div Neurosurg, Ibadan, Nigeria.; Balogun, JA (reprint author), Univ Coll Hosp, Dept Neurosurg, Ibadan, Nigeria.
EM jamesabalogun@gmail.com
CR Agarwal Nitin, 2013, World Neurosurg, V80, P745, DOI 10.1016/j.wneu.2013.08.027
   Benzil DL, 2008, J NEUROSURG, V109, P378, DOI 10.3171/JNS/2008/109/9/0378
   Burch V C, 2011, Educ Health (Abingdon), V24, P614
   Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500
   Ekenze SO, 2013, WORLD J SURG, V37, P2094, DOI 10.1007/s00268-013-2073-y
   Fox BD, 2011, J NEUROSURG, V114, P27, DOI 10.3171/2010.5.JNS10245
   Goldin SB, 2007, J SURG RES, V143, P151, DOI 10.1016/j.jss.2007.08.021
   Grigg M, 2014, ANZ J SURG, V84, P653, DOI 10.1111/ans.12389
   Hill EJR, 2014, AM J SURG, V208, P860, DOI 10.1016/j.amjsurg.2014.04.016
   Kahn D, 2006, S AFR J SURG, V44, P108
   Kollias C, 2010, MALAWI MED J, V22, P20
   Lobel DA, 2015, TEACH LEARN MED, V27, P201, DOI 10.1080/10401334.2015.1011656
   Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X
   Poenaru D, 1998, AM J SURG, V175, P515, DOI 10.1016/S0002-9610(98)00078-6
   Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029
   Quintana LM, 2013, WORLD NEUROSURG, V80, P789, DOI 10.1016/j.wneu.2013.09.004
   Sandquist MK, 2009, J SURG RES, V153, P152, DOI 10.1016/j.jss.2008.03.028
   Scott IM, 2008, CAN J SURG, V51, P371
   Sutton PA, 2014, J SURG EDUC, V71, P662, DOI 10.1016/j.jsurg.2014.03.005
   Tomasello F, 2015, WORLD NEUROSURG, V83, P37, DOI 10.1016/j.wneu.2013.11.004
   Zuccato JA, 2016, CAN J NEUROL SCI, V43, P410, DOI 10.1017/cjn.2015.332
   Zuckerman SL, 2016, WORLD NEUROSURG, V86, P120, DOI 10.1016/j.wneu.2015.08.081
NR 22
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E998
EP E1004
DI 10.1016/j.wneu.2019.03.020
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400125
PM 30877009
DA 2020-05-12
ER

PT J
AU Barthelemy, EJ
   Spaggiari, R
   Corley, J
   Lepard, JR
   Staffa, SJ
   Iv, V
   Servadei, F
   Park, KB
AF Barthelemy, Ernest J.
   Spaggiari, Riccardo
   Corley, Jacquelyn
   Lepard, Jacob R.
   Staffa, Steven J.
   Iv, Vycheth
   Servadei, Franco
   Park, Kee B.
TI Injury-to-Admission Delay Beyond 4 Hours Is Associated with Worsening
   Outcomes for Traumatic Brain Injury in Cambodia
SO WORLD NEUROSURGERY
LA English
DT Article
DE Global health; Global neurosurgery; Global surgery; LMIC; Prehospital
   care; Sustainable development; TBI
ID HEMATOMA
AB BACKGROUND: In Cambodia, the most common victims of traumatic brain injury (TBI) are men 20-30 years of age involved in motor vehicle collision. Secondary injury sustained by these patients occurs during the time period between initial insult and hospital admission. Strengthening prehospital systems for TBI in low- and middle-income countries (LMICs) such as Cambodia is therefore a key element of the development agenda for universal health equity. We report a retrospective analysis of the relationship between prehospital delays and TBI outcomes among patients from a large government hospital in Cambodia.
   METHODS: Data were collected from 3476 patients with TBI admitted to a major government hospital in Phnom Penh, Cambodia, from June 2013 to June 2018. Patients with missing data or those admitted >8 hours postinjury were excluded. Statistical analyses examined associations between injury-to-admission delay (IAD) and outcomes such as Glasgow Outcome Scale (GOS) score and length of stay (LOS).
   RESULTS: A total of 2125 patients with TBI (76.85% men) were included. The median age was 27 years (interquartile range, 22-37 years). Injury severity at presentation included 1406 mild (66%), 464 moderate (22%), and 240 severe cases (11%). No Glasgow Coma Scale (GCS) data were available for 15 patients (1%). We found an inverse relationship between IAD and GOS score, most evidently for mild and moderate TBI (n = 1870; 88%). Regression analysis revealed a marked decrease in GOS score at the IAD >4-hour threshold. Each 30-minute delay in IAD was correlated with >2-hour increase in LOS for mild (P < 0.001) and moderate TBI (P < 0.001).
   CONCLUSIONS: In a retrospective cohort of >2000 patients with TBI from Cambodia, we found that increasing IAD was associated with worsening outcome, especially beyond the 4-hour threshold. These data should inform development of prehospital guidelines for TBI care in LMICs.
C1 [Barthelemy, Ernest J.; Corley, Jacquelyn; Lepard, Jacob R.; Park, Kee B.] Harvard Med Sch, Global Neurosurg Initiat, Program Global Surg & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA.
   [Barthelemy, Ernest J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.
   [Spaggiari, Riccardo; Servadei, Franco] Humanitas Univ & Res Hosp, Milan, Italy.
   [Corley, Jacquelyn] Duke Dept Neurosurg, Durham, NC USA.
   [Lepard, Jacob R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA.
   [Barthelemy, Ernest J.; Corley, Jacquelyn] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA.
   [Lepard, Jacob R.] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA.
   [Staffa, Steven J.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA.
   [Iv, Vycheth] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia.
RP Barthelemy, EJ (reprint author), Harvard Med Sch, Global Neurosurg Initiat, Program Global Surg & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Barthelemy, EJ (reprint author), Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.; Barthelemy, EJ (reprint author), Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA.
EM globalneurosurgeon@gmail.com
FU UAB Women's Leadership Council
FX This research was conducted while J. R. Lepard was a Wilson Family
   Clinical Scholar supported by the UAB Women's Leadership Council.
CR Barthelemy EJ, 2018, WORLD NEUROSURG, V120, P143, DOI 10.1016/j.wneu.2018.08.070
   Barthelemy EJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.10.012
   Fatigba HO, 2013, WORLD NEUROSURG, V80, P246, DOI 10.1016/j.wneu.2011.09.016
   Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001
   Goldstein LN, 2017, AFR J EMERG MED, V7, P100, DOI 10.1016/j.afjem.2017.04.012
   Griswold D, 2016, WORLD NEUROSURG, V93, P474, DOI 10.1016/j.wneu.2016.06.044
   Gutowski P, 2018, WORLD NEUROSURG, V118, pE166, DOI 10.1016/j.wneu.2018.06.147
   Henry GL, 2010, NEUROLOGIC EMERGENCI
   Hilmer Louise Vera, 2018, Asian J Neurosurg, V13, P23, DOI 10.4103/ajns.AJNS_342_16
   Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9
   Kang Jiin, 2015, Korean J Neurotrauma, V11, P112, DOI 10.13004/kjnt.2015.11.2.112
   Kulkarni AP, 2013, INDIAN J CRIT CARE M, V17, P292, DOI 10.4103/0972-5229.120321
   Mason A, 2005, E ASIAN EC DEV 2 DEM
   Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X
   Mock C, 2014, AFR J TRAUMA, V3, P3, DOI [10.4103/1597-1112.139448, DOI 10.4103/1597-1112.139448]
   Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011
   Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127
   Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035
   SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503
   Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5
   Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056
   United Nations, TRANSF OUR WORLD 203
   Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004
   WHO Ministry of Health of Cambodia, 2012, CAMB HLTH SERV DEL P
   World Health Organization, 2005, PREH TRAUM CAR SYST
NR 25
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E232
EP E240
DI 10.1016/j.wneu.2019.02.019
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400029
PM 30825623
DA 2020-05-12
ER

PT J
AU Baschera, D
   Jager, D
   Preda, R
   Z'Graggen, WJ
   Raabe, A
   Exadaktylos, AK
   Hasler, RM
AF Baschera, Dominik
   Jaeger, Damian
   Preda, Raluca
   Z'Graggen, Werner J.
   Raabe, Andreas
   Exadaktylos, Aristomenis K.
   Hasler, Rebecca M.
TI Comparison of the Incidence and Severity of Traumatic Brain Injury
   Caused by Electrical Bicycle and Bicycle Accidents-A Retrospective
   Cohort Study From a Swiss Level I Trauma Center
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bicycle; E-bike; Head trauma; Helmet; TBI
ID HELMET USE; E-BIKE; CYCLISTS; SAFETY; RIDERS; SPEED; COSTS; CITY
AB BACKGROUND: Electrical bicycles (E-bikes) allow people of all ages to ride at high speeds but have an inherent risk of traumatic brain injury (TBI). Their sales have increased tremendously in recent years.
   METHODS: We performed a retrospective cohort study to compare the incidence and severity of TBI in E-bikers and conventional bicyclists. We included patients at a Swiss level 1 trauma center admitted from 2010 to 2015. The primary outcome was the association between TBI and the bicycle type. The secondary outcome was the association between helmet use and TBI severity.
   RESULTS: Of 557 patients injured riding an E-bike (n = 73) or a bicycle (n = 484), 60% sustained a TBI, most of which were mild (Glasgow coma scale [GCS] score, 13-15; E-bike, 78%; bicycle, 88%). TBI was more often moderate (GCS score, 9-12) or severe (GCS score, 3-8) in E-bikers than in bicyclists (P = 0.04). Intracranial hemorrhage, traumatic subarachnoid hemorrhage, and subdural hematoma occurred significantly more often in E-bikers than in bicyclists (P < 0.05). Neurosurgical intervention was necessary for 5 E-bikers (7%) and 25 (5%) bicyclists (P = 0.15). Wearing a helmet correlated with a lower risk of neurosurgical intervention in bicyclists (odds ratio [OR], 0.21; 95% confidence interval [CI], 0.06-0.73; P = 0.01) and a lower risk of calvarial fractures in both bicyclists (OR, 0.16; 95% CI, 0.06-0.42; P < 0.01) and E-bikers (OR, 0.21; 95% CI, 0.05-0.84; P = 0.03).
   CONCLUSIONS: E-bikers had a significantly greater risk of moderate to severe TBI compared with bicyclists. Helmet use was associated with decreased odds of severe TBI in bicyclists and a tendency toward a more favorable outcome for E-bikers.
C1 [Baschera, Dominik] Kantonsspital Winterthur, Dept Neurosurg, Winterthur, Switzerland.
   [Jaeger, Damian; Exadaktylos, Aristomenis K.; Hasler, Rebecca M.] Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland.
   [Preda, Raluca; Z'Graggen, Werner J.; Raabe, Andreas] Bern Univ Hosp, Inselspital, Dept Neurosurg, Bern, Switzerland.
RP Hasler, RM (reprint author), Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland.
EM rebecca.hasler@insel.ch
OI Baschera, Dominik/0000-0002-9634-9922; Hasler, Rebecca
   Maria/0000-0002-0616-2313
FU "Furstlicher Kommerzienrat Guido Feger" Foundation
FX The present study was supported by the "Furstlicher Kommerzienrat Guido
   Feger" Foundation.
CR Airaksinen Noora, 2010, Ann Adv Automot Med, V54, P267
   Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8
   Buffat M, 2014, DISTRIBUTION EFFECTS
   Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146
   Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016
   Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281
   Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407
   Du W, 2014, INJURY PREV, V20, P128, DOI 10.1136/injuryprev-2012-040618
   Du W, 2013, ACCIDENT ANAL PREV, V59, P319, DOI 10.1016/j.aap.2013.06.011
   EilertPetersson E, 1997, ACCIDENT ANAL PREV, V29, P363, DOI 10.1016/S0001-4575(97)00002-X
   Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1038/sj.ph.1900713
   Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007
   Feng ZY, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.024646
   Hefny AF, 2012, INJURY, V43, P1547, DOI 10.1016/j.injury.2011.05.016
   Howick J, EXPLANATION 2011 OXF
   Hu F, 2014, TRAFFIC INJ PREV, V15, P319, DOI 10.1080/15389588.2013.817669
   Jellinek R, 2013, AUSWIRKUNGEN ENTWICK
   JENNETT B, 1975, LANCET, V1, P480
   Kim YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181362
   Kubitzki J, 2013, NICHTMOTORISIERTE VE
   Lawinger T., 2013, Z VERKEHRSSICHERHEIT, V59, P99
   Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668
   Neumann MV, 2016, EMERG MED AUSTRALAS, V28, P90, DOI 10.1111/1742-6723.12495
   Olds K, 2015, J FORENSIC LEG MED, V34, P99, DOI 10.1016/j.jflm.2015.05.018
   Otte D, 2014, VKU VERKEHRSUNFALL F, V52, P48
   Papoutsi S, 2014, EMERG MED INT, DOI 10.1155/2014/850236
   Petzoldt T, 2017, SAFETY SCI, V92, P283, DOI 10.1016/j.ssci.2015.07.021
   [R-Core-Team Computing R.F. f.S], 2014, R LANG ENV STAT COMP
   Scheiman S, 2010, ACCIDENT ANAL PREV, V42, P758, DOI 10.1016/j.aap.2009.11.005
   Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010
   Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022
   Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568
   Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004
   Swiss Council for Accident Prevention, 2017, SURV HELM WEAR RAT C
   TEASDALE G, 1974, LANCET, V2, P81
   Teschke K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008052
   Thompson D, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001855, 10.1002/14651858.CD001855]
   Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974
   Veisten K, 2007, ACCIDENT ANAL PREV, V39, P1162, DOI 10.1016/j.aap.2007.03.002
   Vlakveld WP, 2015, ACCIDENT ANAL PREV, V74, P97, DOI 10.1016/j.aap.2014.10.018
   Weber T, 2014, ACCIDENT ANAL PREV, V73, P47, DOI 10.1016/j.aap.2014.07.020
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003902
   Zhang X, 2015, ASIA-PAC J PUBLIC HE, V27
   Zhou SA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007395
   Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y
NR 45
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1023
EP E1034
DI 10.1016/j.wneu.2019.03.032
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400129
PM 30857998
DA 2020-05-12
ER

PT J
AU Batista, PD
   Machado, IP
   Roios, P
   Lavrador, J
   Cattoni, MB
   Martins, J
   Carvalho, H
AF Batista, Pedro D.
   Machado, Ines P.
   Roios, Pedro
   Lavrador, Jose
   Cattoni, Maria B.
   Martins, Jorge
   Carvalho, Herculano
TI Position and Orientation Errors in a Neuronavigation Procedure: A
   Stepwise Protocol Using a Cranial Phantom
SO WORLD NEUROSURGERY
LA English
DT Article
DE Accuracy; Error analysis; Image-guided neurosurgery; Neuronavigation;
   Phantom; Precision
ID APPLICATION ACCURACY; GUIDED NEUROSURGERY; REGISTRATION; NAVIGATION;
   PLACEMENT; TRACKING; SYSTEMS; DEVICE
AB OBJECTIVE: Neuronavigation procedures demand high precision and accuracy. Despite this need, there are still few studies analyzing errors in such procedures. The aim of this study was to use a custom- built cranial phantom to measure target position and orientation errors in different phases of a simulated neuronavigation procedure.
   METHODS: A cranial phantom with 10 target sites was designed and imaged with computed tomography and magnetic resonance. A segmentation of a cloud of points of the phantom (ground truth) was obtained using an optical tracking system and compared with the images (imaging phase). Targets and trajectories were then planned with neuronavigation software and compared with the ground truth (planning phase). The same plan was used to identify the points in real space after image-to-phantom registration and calculate the final error of the procedure by comparison with the ground truth (registration and execution phase).
   RESULTS: The mean errors after the imaging phase were 1.11 +/- 0.42 mm and 3.23 degrees +/- 1.69 degrees for position and orientation, respectively. After planning the mean errors were 1.10 +/- 0.39 mm and 5.55 degrees +/- 2.91 degrees. The global errors after the registration and mechanical execution were 3.93 +/- 1.70 mm and 3.65 degrees +/- 1.29 degrees.
   CONCLUSIONS: After a stepwise analysis, registration and mechanical execution were the main contributors to the global position error.
C1 [Batista, Pedro D.; Lavrador, Jose; Cattoni, Maria B.; Carvalho, Herculano] CHLN, Hosp Santa Maria, Dept Neurosurg, Lisbon, Portugal.
   [Machado, Ines P.; Roios, Pedro; Martins, Jorge] Univ Lisbon, Inst Super Tecn, IDMEC LAETA, Lisbon, Portugal.
   [Lavrador, Jose] Kings Coll Hosp London, Fdn Trust, Dept Adult & Paediat Neurosurg, London, England.
RP Batista, PD (reprint author), CHLN, Hosp Santa Maria, Dept Neurosurg, Lisbon, Portugal.
EM pedroduartebatista@gmail.com
RI Batista, Pedro Filipe Duarte Pereira/AAJ-4388-2020; Martins,
   Jorge/J-5018-2012
OI Batista, Pedro Filipe Duarte Pereira/0000-0002-4436-4485; Martins,
   Jorge/0000-0003-3789-6384
CR Ballesteros-Zebadua P, 2016, BRIT J NEUROSURG, V8697, P1
   Cardinale F, 2013, NEUROSURGERY, V72, P353, DOI 10.1227/NEU.0b013e31827d1161
   Dorward NL, 1999, J NEUROSURG, V90, P160, DOI 10.3171/jns.1999.90.1.0160
   Gerard IJ, 2015, INT J COMPUT ASS RAD, V10, P1579, DOI 10.1007/s11548-014-1145-2
   Hernes TAN, 2006, INT J MED ROBOT COMP, V2, P45, DOI 10.1002/rcs.68
   Horsley V, 1908, BRAIN, V31, P45, DOI 10.1093/brain/31.1.45
   Jodicke A, 1998, MINIM INVAS NEUROSUR, V41, P13, DOI 10.1055/s-2008-1052008
   Lefranc M, 2014, STEREOT FUNCT NEUROS, V92, P242, DOI 10.1159/000362936
   Liu YL, 2017, COMPUT ASSIST SURG, V22, P319, DOI 10.1080/24699322.2017.1389411
   Wang MN, 2011, NEUROSURGERY, V68, P1131, DOI 10.1227/NEU.0b013e318209cc45
   Mascott CR, 2006, J NEUROSURG, V105, P561, DOI 10.3171/jns.2006.105.4.561
   Mascott CR, 2006, NEUROSURGERY, V59, P146, DOI 10.1227/01.NEU.0000220089.39533.4E
   Mehta AD, 2005, J NEUROSURG, V102, P1040, DOI 10.3171/jns.2005.102.6.1040
   Moriarty TM, 2000, NEUROSURGERY, V47, P1138, DOI 10.1097/00006123-200011000-00023
   Neumann JO, 2015, STEREOT FUNCT NEUROS, V93, P380, DOI 10.1159/000441233
   Pappas IPI, 2005, MED PHYS, V32, P1796, DOI 10.1118/1.1901363
   Poggi S, 2003, PHYS MED BIOL, V48, P2199, DOI 10.1088/0031-9155/48/14/311
   Spetzger U, 2002, MINIM INVAS NEUROSUR, V45, P6, DOI 10.1055/s-2002-23583
   Stieglitz LH, 2013, NEUROSURGERY, V72, P796, DOI 10.1227/NEU.0b013e318287072d
   Strong EB, 2008, ARCH OTOLARYNGOL, V134, P1080, DOI 10.1001/archotol.134.10.1080
   Walton L, 1996, NEUROSURGERY, V38, P170, DOI 10.1097/00006123-199601000-00038
   Wang MN, 2011, COMPUT AIDED SURG, V16, P161, DOI 10.3109/10929088.2011.579791
   Widmann G, 2008, MINIM INVAS NEUROSUR, V51, P361, DOI 10.1055/s-0028-1085424
   Widmann G, 2012, INT J MED ROBOT COMP, V8, P1, DOI 10.1002/rcs.441
NR 24
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E342
EP E350
DI 10.1016/j.wneu.2019.02.052
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400040
PM 30822590
DA 2020-05-12
ER

PT J
AU Baucher, G
   Troude, L
   Pauly, V
   Bernard, F
   Zieleskiewicz, L
   Roche, PH
AF Baucher, Guillaume
   Troude, Lucas
   Pauly, Vanessa
   Bernard, Florian
   Zieleskiewicz, Laurent
   Roche, Pierre-Hugues
TI Predictive Factors of Poor Prognosis After Surgical Management of
   Traumatic Acute Subdural Hematomas: A Single-Center Series
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acute subdural hematoma; Craniectomy; Polytrauma; Traumatic brain injury
ID SEVERE HEAD-INJURY; BRAIN-INJURY; ELDERLY-PATIENTS; MIDLINE SHIFT;
   CT-SCAN; MORTALITY; CRANIOTOMY; CRANIECTOMY; EVACUATION; SURVIVAL
AB BACKGROUND: Traumatic acute subdural hematomas (ASDHs) showed the highest mortality of intracranial hematomas. The aim of the current study was to identify predictive factors of poor prognosis among patients who were operated on.
   METHODS: This is a single-center retrospective cohort study of 82 patients who underwent surgical evacuation of a traumatic ASDH between January 2009 and December 2016. The epidemiologic, clinical, radiologic, and surgical features were recorded. Postoperative outcome were assessed by the Glasgow Outcome Scale (GOS) score at 6 months. Univariate and multivariate analysis and a classification and regression tree (CART) were performed.
   RESULTS: At 6 months, 76% of patients achieved an unfavorable outcome (GOS score 1-3). The context of polytrauma (P = 0.03) and ASDH thickness >= 20 mm (P = 0.02) were significantly associated with poor outcome in the multivariate analysis. The CART algorithm isolated 3 subgroups of patients with an unfavorable prognosis: polytrauma (91%), isolated head injury (HI) featuring an ASDH thickness >= 20 mm (89%), or isolated HI featuring a thickness < 20 mm in a patient older than 54 years (71%). Isolated patients with HI younger than 54 years harboring an ASDH < 20 mm thick had the most promising results, with 53% with a GOS score of 4 or 5.
   CONCLUSIONS: The context of polytrauma, ASDH thickness, and age were major predictive factors of poor prognosis in patients with surgically evacuated traumatic ASDH. The CART algorithm using these features isolated subgroups with decreasingly unfavorable outcome, providing a relevant statistical tool to apply to future studies of traumatic ASDH.
C1 [Baucher, Guillaume; Troude, Lucas; Roche, Pierre-Hugues] Aix Marseille Univ, Dept Neurosurg, La Timone Med Campus, Marseille, France.
   [Zieleskiewicz, Laurent] Aix Marseille Univ, Dept Anesthesiol & Crit Care, North Univ Hosp, AP HM, La Timone Med Campus, Marseille, France.
   [Pauly, Vanessa] Aix Marseille Univ, La Concept Hosp, Dept Publ Hlth, La Timone Med Campus, Marseille, France.
   [Pauly, Vanessa] Aix Marseille Univ, Qual Life Ctr, CEReSS, La Timone Med Campus, Marseille, France.
   [Pauly, Vanessa] Aix Marseille Univ, Hlth Serv Res, CEReSS, La Timone Med Campus, Marseille, France.
   [Bernard, Florian] Univ Angers, Dept Neurosurg, CHU Angers, Angers, France.
RP Baucher, G (reprint author), Aix Marseille Univ, Dept Neurosurg, La Timone Med Campus, Marseille, France.
EM guillaume.baucner@ap-hm.fr
OI /0000-0003-4023-1463; Bernard, Florian/0000-0002-6110-2567
CR Arifin MZ, 2013, J NEUROSURG SCI, V57, P277
   Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728
   Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x
   Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070
   Bullock AR, 2006, NEUROSURGERY, V58, pVI
   Bullock MR, 2006, NEUROSURGERY, V58, psi
   Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78
   Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c
   DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005
   Evans JA, 2015, INJURY, V46, P76, DOI 10.1016/j.injury.2014.07.009
   Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018
   Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0
   Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061
   HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563
   Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023
   HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858
   Hu C, 2018, J BIOPHARM STAT, V28, P333, DOI 10.1080/10543406.2017.1377730
   JENNETT B, 1975, LANCET, V1, P480
   JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285
   Kakarieka A, 1995, Neurologia, V10, P159
   Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204
   Kato-Negishi M, 2013, PROC IEEE MICR ELECT, P130, DOI 10.1109/MEMSYS.2013.6474194
   Kim J, 2013, J CLIN NEUROSCI, V20, P1697, DOI 10.1016/j.jocn.2013.02.021
   Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143
   Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894
   KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257
   Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318
   Kwon H, 2017, J KOREAN NEUROSURG S, V60, P723, DOI 10.3340/jkns.2017.0506.011
   Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48
   Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832
   Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8
   LONG DM, 1985, NEUROSURGERY, V17, P348, DOI 10.1227/00006123-198508000-00022
   Lucke-Wold B.P., 2016, ARCH EMERG MED CRIT, V1, P1010
   Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033
   MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049
   Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643
   MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285
   MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14
   Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359
   MAY BR, 1974, BRIT J RADIOL, V47, P742, DOI 10.1259/0007-1285-47-563-742
   McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041
   Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008
   Moussa WMM, 2018, NEUROSURG REV, V41, P483, DOI 10.1007/s10143-017-0873-5
   Okten Ali Ihsan, 2006, Ulus Travma Acil Cerrahi Derg, V12, P107
   Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446
   Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25
   Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096
   Pilitsis J, 2013, CLIN NEUROL NEUROSUR, V115, P1429, DOI 10.1016/j.clineuro.2013.01.017
   Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095
   Rapana A, 1997, CLIN NEUROL NEUROSUR, V99, P124, DOI 10.1016/S0303-8467(96)00585-9
   Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111420
   REILLY PL, 1975, LANCET, V2, P375
   Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034
   SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961
   Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004
   Sawauchi S, 2007, NEUROL SURG TOKYO, V35, P43
   SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503
   Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034
   Servadei E, 2000, BRIT J NEUROSURG, V14, P110
   Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006
   SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254
   TEASDALE G, 1974, LANCET, V2, P81
   TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691
   van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332
   Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010
   Vyas NA, 2007, SURG NEUROL, V67, P314, DOI 10.1016/j.surneu.2006.03.039
   WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212
   Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019
   Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025
   Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234
   Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402
   Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011
NR 72
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E944
EP E952
DI 10.1016/j.wneu.2019.02.194
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400118
PM 30876998
DA 2020-05-12
ER

PT J
AU Bhargav, AG
   Rinaldo, L
   Lanzino, G
   Elder, BD
AF Bhargav, Adip G.
   Rinaldo, Lorenzo
   Lanzino, Giuseppe
   Elder, Benjamin D.
TI Comparison of Complication and Revision Rates After Frontal Versus
   Parietal Approach for Ventricular Shunt Placement in Idiopathic Normal
   Pressure Hydrocephalus
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hydrocephalus; Revision surgery; Shunt malfunction; Technique;
   Ventriculoperitoneal shunt
ID CATHETER PLACEMENT
AB BACKGROUND: Ventricular shunts are most commonly placed via a frontal or parietal approach. However, there is a paucity of data comparing complication and revision rates associated with these approaches in the idiopathic normal pressure hydrocephalus (iNPH) population.
   METHODS: Patients with iNPH treated with ventricular shunting between 2001 and 2017 at our institution were included for analysis. Patient characteristics, catheter accuracy, and incidence of revision were determined from the medical record. Catheter accuracy was determined using axial computed tomography imaging and classified as grade 1, 2, or 3 based on location of the catheter tip.
   RESULTS: There were 348 patients included for analysis with 266 (76.4%) and 82 (23.6%) receiving a frontal versus parietal shunt, respectively. Patients undergoing the parietal approach were more likely to receive a programmable valve (37.8% vs. 25.2%; P = 0.026). Neuronavigation was used more frequently for patients undergoing the parietal approach (26.8% vs. 4.1%; P < 0.001); however, a minority of cases used neuronavigation in general (9.5%). There was no difference in catheter accuracy between the 2 approaches and no difference in catheter accuracy with the use of neuronavigation. The overall revision rate was 21.0%, and there were no differences in the incidence of revisions between the frontal and parietal approaches (21.8% vs. 18.3%, respectively; P = 0.495). There were no differences in revision subtypes between the approaches.
   CONCLUSIONS: These results suggest that the type of approach for shunting may not have a significant impact on complication and revision rates in patients with iNPH, and either approach is a reasonable first-line option.
C1 [Bhargav, Adip G.] Mayo Clin, Sch Med, Rochester, MN USA.
   [Rinaldo, Lorenzo; Lanzino, Giuseppe; Elder, Benjamin D.] Mayo Clin, Dept Neurosurg, Rochester, MN 55905 USA.
   [Lanzino, Giuseppe] Mayo Clin, Dept Radiol, Rochester, MN USA.
   [Elder, Benjamin D.] Mayo Clin, Dept Bioengn, Rochester, MN 55905 USA.
   [Elder, Benjamin D.] Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA.
RP Elder, BD (reprint author), Mayo Clin, Dept Neurosurg, Rochester, MN 55905 USA.; Elder, BD (reprint author), Mayo Clin, Dept Bioengn, Rochester, MN 55905 USA.; Elder, BD (reprint author), Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA.
EM Elder.Benjamin@mayo.edu
CR ALBRIGHT AL, 1988, J NEUROSURG, V69, P883, DOI 10.3171/jns.1988.69.6.0883
   Azeem SS, 2007, NEUROSURGERY, V60, P243, DOI 10.1227/01.NEU.0000255387.03088.53
   Dickerman RD, 2005, J CLIN NEUROSCI, V12, P781, DOI 10.1016/j.jocn.2004.12.005
   Gil Z, 2002, CHILD NERV SYST, V18, P26, DOI 10.1007/s00381-001-0550-3
   Hayhurst C, 2010, J NEUROSURG, V113, P1273, DOI 10.3171/2010.3.JNS091237
   Hebb AO, 2001, NEUROSURGERY, V49, P1166, DOI 10.1097/00006123-200111000-00028
   Kestle JRW, 2013, J NEUROSURG, V119, P64, DOI 10.3171/2012.4.JNS12485
   Li M, 2017, INT J SURG, V44, P139, DOI 10.1016/j.ijsu.2017.06.078
   Lind CRP, 2008, J CLIN NEUROSCI, V15, P886, DOI 10.1016/j.jocn.2007.05.013
   Lind CRP, 2009, J CLIN NEUROSCI, V16, P918, DOI 10.1016/j.jocn.2008.09.015
   Meier U, 2004, J NEUROSURG, V100, P1036, DOI 10.3171/jns.2004.100.6.1036
   Pujari S, 2008, J NEUROL NEUROSUR PS, V79, P1282, DOI 10.1136/jnnp.2007.123620
   Relkin Norman, 2005, Neurosurgery, V57, pS4
   Silverberg GD, 2002, J NEUROSURG, V97, P1271, DOI 10.3171/jns.2002.97.6.1271
   Wan KR, 2011, J CLIN NEUROSCI, V18, P485, DOI 10.1016/j.jocn.2010.06.018
   Whitehead WE, 2017, J NEUROSURG-PEDIATR, V19, P157, DOI 10.3171/2016.8.PEDS16229
   Wilson TJ, 2013, J NEUROSURG, V119, P66, DOI 10.3171/2012.11.JNS111384
NR 17
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1017
EP E1022
DI 10.1016/j.wneu.2019.03.027
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400128
PM 30878745
DA 2020-05-12
ER

PT J
AU Bindal, S
   Bindal, SK
   Bindal, M
   Bindal, AK
AF Bindal, Shivani
   Bindal, Shray K.
   Bindal, Mohini
   Bindal, Ajay K.
TI Noninstrumented Lumbar Fusion with Bone Morphogenetic Proteins for
   Spinal Stenosis with Spondylolisthesis in the Elderly
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bone morphogenetic proteins; Elderly; Laminectomy; Spinal fusion; Spinal
   stenosis; Spondylolisthesis
ID DEGENERATIVE SPONDYLOLISTHESIS; RHBMP-2; DECOMPRESSION; SURGERY;
   LAMINECTOMY; TRENDS; COMPLICATIONS; REOPERATION; ARTHRODESIS; AUTOGRAFT
AB OBJECTIVE: This study examined the use of noninstrumented posterolateral lumbar fusion with bone morphogenetic protein (BMP) and compared its effectiveness with that of instrumented fusion for the treatment of lumbar spinal stenosis (LSS) with spondylolisthesis in elderly patients.
   METHODS: This study was a retrospective review of 93 patients treated in a single-surgeon neurosurgical private practice over a 15-year period. Fifty-nine patients over the age of 65 who underwent noninstrumented posterolateral fusion with rhBMP-2 (Infuse) for LSS with spondylolisthesis were compared with 34 patients who underwent instrumented fusion without rhBMP-2. Outcomes in terms of reoperation rate, pain improvement, Oswestry Disability Index (ODI) score, and number of extra follow-up visits due to persistent problems were characterized by the use of t tests and chi(2) tests.
   RESULTS: The reoperation rate in the noninstrumented rhBMP-2 fusion group was significantly lower than in the instrumented fusion group (17.6% vs. 3.4%, P = 0.048). The mean pain improvement was significantly higher in the noninstrumented rhBMP-2 group at 3 months (8.1 vs. 6.0, P < 0.001, 95% confidence interval [CI] 1.2 to 3.0) and at 1 year (7.25 vs. 5.6, P = 0.030, 95% CI 0.3 to 3.1). The ODI score improvement was significantly higher in the noninstrumented rhBMP-2 group (51 vs. 42.8, P < 0.001, 95% CI 4.7 to 11.6). The mean number of additional follow-up visits per patient was significantly lower in the noninstrumented rhBMP-2 group (0.068 vs. 1.23, P < 0.001, 95% CI 0.59 to 1.75).
   CONCLUSION: Noninstrumented posterolateral lumbar fusion with rhBMP-2 in elderly patients with LSS and spondylolisthesis is a viable alternative to instrumented fusion based on clinical outcomes measured in this study.
C1 [Bindal, Shivani; Bindal, Shray K.; Bindal, Mohini; Bindal, Ajay K.] Bindal Neurosurg Clin, Houston, TX 77074 USA.
RP Bindal, S (reprint author), Bindal Neurosurg Clin, Houston, TX 77074 USA.
EM shivbndl@gmail.com
OI Bindal, Shivani/0000-0002-3728-5930
CR Abdu WA, 2009, SPINE, V34, P2351, DOI 10.1097/BRS.0b013e3181b8a829
   Alvin MD, 2016, CLIN SPINE SURG, V29, pE80, DOI 10.1097/BSD.0000000000000103
   Crandall DG, 2013, SPINE, V38, P1137, DOI 10.1097/BRS.0b013e3182880298
   Dagostino PR, 2014, SPINE J, V14, P20, DOI 10.1016/j.spinee.2012.10.035
   Deyo RA, 2012, SPINE, V37, P222, DOI 10.1097/BRS.0b013e31821bfa3a
   Epstein Nancy Ellen, 2016, Surg Neurol Int, V7, pS337, DOI 10.4103/2152-7806.182546
   Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017
   Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003
   Forsth P, 2016, NEW ENGL J MED, V374, P1413, DOI 10.1056/NEJMoa1513721
   Ghogawala Z, 2016, NEW ENGL J MED, V374, P1424, DOI 10.1056/NEJMoa1508788
   Gibson JNA, 1999, SPINE, V24, P1820, DOI 10.1097/00007632-199909010-00012
   Glassman SD, 2008, SPINE, V33, P2843, DOI 10.1097/BRS.0b013e318190705d
   Hamilton DK, 2008, SURG NEUROL, V69, P457, DOI 10.1016/j.surneu.2007.09.008
   HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002
   Hoffmann MF, 2013, SPINE J, V13, P1244, DOI 10.1016/j.spinee.2013.06.022
   Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012
   Kepler CK, 2014, SPINE, V39, P1584, DOI 10.1097/BRS.0000000000000486
   Kuntz KM, 2000, SPINE, V25, P1132, DOI 10.1097/00007632-200005010-00015
   Lad SP, 2013, J BONE JOINT SURG AM, V95, DOI 10.2106/JBJS.L.00730
   Lee KB, 2010, EUR SPINE J, V19, P924, DOI 10.1007/s00586-009-1248-6
   Mahesh B, 2017, INDIAN J ORTHOP, V51, P139, DOI 10.4103/0019-5413.201704
   Martin CR, 2007, SPINE, V32, P1791, DOI 10.1097/BRS.0b013e3180bc219e
   Matz PG, 2016, SPINE J, V16, P439, DOI 10.1016/j.spinee.2015.11.055
   Oliveira Oberdan Ribeiro Gonçalves de, 2017, Rev. bras. ortop., V52, P124, DOI 10.1016/j.rboe.2016.03.005
   Park SB, 2011, J KOREAN NEUROSURG S, V49, P317, DOI 10.3340/jkns.2011.49.6.317
   Sengupta DK, 2005, SPINE, V30, pS71, DOI 10.1097/01.brs.0000155579.88537.8e
   Singh K, 2013, SPINE J, V13, P1118, DOI 10.1016/j.spinee.2013.07.028
   Vorhies JS, 2018, CLIN SPINE SURG, V31, pE74, DOI 10.1097/BSD.0000000000000564
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1427
EP E1435
DI 10.1016/j.wneu.2019.02.251
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400180
PM 30904805
DA 2020-05-12
ER

PT J
AU Bowden, G
   Faramand, A
   Niranjan, A
   Lunsford, LD
   Monaco, E
AF Bowden, Greg
   Faramand, Andrew
   Niranjan, Ajay
   Lunsford, L. Dade
   Monaco, Edward, III
TI Gamma Knife Radiosurgery for the Management of More Than 15 Cerebral
   Metastases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain; Breast cancer; Gamma Knife; Lung cancer; Melanoma; Metastasis;
   Stereotactic radiosurgery
ID WHOLE-BRAIN RADIOTHERAPY; CELL LUNG-CANCER; STEREOTACTIC RADIOSURGERY;
   BREAST-CANCER; SURVIVAL; DIAGNOSIS; INDEXES; VOLUME
AB BACKGROUND: The number of metastases that can be treated safely and effectively with Gamma Knife stereotactic radiosurgery (SRS) remains controversial despite continuing evidence to support its expanded utilization. We endeavored to elucidate the survival outcomes for patients who presented with >= 15 brain metastases at the time of initial SRS.
   METHODS: This retrospective analysis reviewed patients treated for >= 15 brain metastases originating from breast cancer, lung cancer, or melanoma. Ninety-three patients met the inclusion criteria. In this study, 3016 tumors were treated. The median number of tumors at the first SRS procedure was 23 (range, 15-67) for breast cancer, 21 (range, 15-48) for lung cancer, and 21 (range, 15-67) for melanoma. The mean aggregate metastases volume was 8.75 cm(3) for breast, 6.89 cm(3) for lung, and 9.98 cm(3) for melanoma.
   RESULTS: Patients with breast cancer, lung cancer, and melanoma had a median survival after diagnosis of brain metastases of 18.0, 9.4, and 6.3 months, respectively. The survival after SRS was 16 months for breast cancer, 4.6 months for lung cancer, and 3.1 months for melanoma. Patients with breast cancer had significantly longer survival than patients with lung cancer and melanoma after SRS (P = 0.001). A higher Karnofsky Performance Status score was associated with an increase in survival across all tumor types. Repeat SRS for local or distant progression was performed in 56% of patients with breast cancer, 35% of patients with lung cancer, and 24% of patients with melanoma.
   CONCLUSIONS: SRS is an effective means of managing extensive brain metastases, particularly in patients with breast cancer. The primary tumor type, systemic disease, and performance status heavily influence survival outcomes.
C1 [Bowden, Greg; Faramand, Andrew; Niranjan, Ajay; Lunsford, L. Dade; Monaco, Edward, III] Ctr Image Guided Neurosurg, Dept Neurol Surg, Pittsburgh, PA 15213 USA.
RP Bowden, G (reprint author), Ctr Image Guided Neurosurg, Dept Neurol Surg, Pittsburgh, PA 15213 USA.
EM gregbowden@gmail.com
CR Ali A, 2013, CURR ONCOL, V20, pE300, DOI 10.3747/co.20.1481
   Belhocine TZ, 2006, J NUCL MED, V47, P957
   Bowden G, 2015, J NEUROSURG, V122, P766, DOI 10.3171/2014.12.JNS141111
   Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0
   Grandhi R, 2012, J NEUROSURG, V117, P237, DOI 10.3171/2012.4.JNS11870
   Hall MD, 2014, J NEUROSURG, V121, P84, DOI 10.3171/2014.7.GKS14972
   Higuchi Yoshinori, 2018, Cancer Manag Res, V10, P1889, DOI 10.2147/CMAR.S116718
   Hughes RT, 2019, NEUROSURGERY, V85, P257, DOI 10.1093/neuros/nyy276
   Jeene PM, 2018, ACTA ONCOL, V57, P637, DOI 10.1080/0284186X.2017.1418534
   Kano H, 2018, J NEUROSURG, V128, P14, DOI 10.3171/2016.9.JNS161011
   Knoll MA, 2018, AM J CLIN ONCOL-CANC, V41, P425, DOI 10.1097/COC.0000000000000299
   Kondziolka D, 2014, J NEUROSURG, V120, P24, DOI 10.3171/2013.9.JNS13788
   Kondziolka D, 2011, J NEUROSURG, V114, P792, DOI 10.3171/2010.8.JNS10461
   Mainwaring W, 2019, CLIN BREAST CANCER, V19, pE343, DOI 10.1016/j.clbc.2018.11.001
   Marshall DC, 2016, J NEURO-ONCOL, V128, P119, DOI 10.1007/s11060-016-2084-2
   Mastorakos P, 2019, NEUROSURGERY, V84, P868, DOI 10.1093/neuros/nyy203
   Mathieu D, 2007, NEUROSURGERY, V60, P481
   Mathieu D, 2007, NEUROSURGERY, V60, P471, DOI 10.1227/01.NEU.0000255342.10780.52
   Monaco EA, 2013, CANCER-AM CANCER SOC, V119, P226, DOI 10.1002/cncr.27504
   Mulvenna P, 2016, LANCET, V388, P2004, DOI 10.1016/S0140-6736(16)30825-X
   Robin TP, 2018, LUNG CANCER, V120, P88, DOI 10.1016/j.lungcan.2018.03.027
   Rostami R, 2016, J NEURO-ONCOL, V127, P407, DOI 10.1007/s11060-016-2075-3
   Routman DM, 2018, CANCER MED-US, V7, P757, DOI 10.1002/cam4.1352
   Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074
   Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527
   Wegner RE, 2011, INT J RADIAT ONCOL, V81, pE21, DOI 10.1016/j.ijrobp.2011.01.001
   Wolf A, 2018, J NEUROSURG, V128, P23, DOI 10.3171/2016.10.JNS161036
   Wolf A, 2016, J NEURO-ONCOL, V127, P607, DOI 10.1007/s11060-016-2072-6
   Yamamoto M, 2002, INT J RADIAT ONCOL, V53, P1279, DOI 10.1016/S0360-3016(02)02855-9
   Yamamoto M, 2014, J NEUROSURG, V121, P16, DOI 10.3171/2014.8.GKS141421
   Yang CCJ, 1998, STEREOT FUNCT NEUROS, V70, P41, DOI 10.1159/000056405
NR 31
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E989
EP E997
DI 10.1016/j.wneu.2019.03.019
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400124
PM 30876993
DA 2020-05-12
ER

PT J
AU Briggs, RG
   Pryor, DP
   Conner, AK
   Nix, CE
   Milton, CK
   Kuiper, JK
   Palejwala, AH
   Sughrue, ME
AF Briggs, Robert G.
   Pryor, Dillon P.
   Conner, Andrew K.
   Nix, Cameron E.
   Milton, Camille K.
   Kuiper, Joseph K.
   Palejwala, Ali H.
   Sughrue, Michael E.
TI The Artery of Aphasia, A Uniquely Sensitive Posterior Temporal Middle
   Cerebral Artery Branch that Supplies Language Areas in the Brain:
   Anatomy and Report of Four Cases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aphasia; Artery; Audition; Language; Network; Temporal lobe
ID EVENT-RELATED FMRI; AUDITORY-CORTEX ACTIVATION; NEURAL BASIS;
   FUNCTIONAL-ANATOMY; SENTENCE COMPREHENSION; PREFRONTAL CORTEX; LEXICAL
   DECISION; EPISODIC MEMORY; CORTICAL ACTIVATION; FRONTAL ACTIVATION
AB BACKGROUND: Arterial disruption during brain surgery can cause devastating injuries to wide expanses of white and gray matter beyond the tumor resection cavity. Such damage may occur as a result of disrupting blood flow through en passage arteries. Identification of these arteries is critical to prevent unforeseen neurologic sequelae during brain tumor resection. In this study, we discuss one such artery, termed the artery of aphasia (AoA), which when disrupted can lead to receptive and expressive language deficits.
   METHODS: We performed a retrospective review of all patients undergoing an awake craniotomy for resection of a glioma by the senior author from 2012 to 2018. Patients were included if they experienced language deficits secondary to postoperative infarction in the left posterior temporal lobe in the distribution of the AoA. The gross anatomy of the AoA was then compared with activation likelihood estimations of the auditory and semantic language networks using coordinate-based meta-analytic techniques.
   RESULTS: We identified 4 patients with left-sided posterior temporal artery infarctions in the distribution of the AoA on diffusion-weighted magnetic resonance imaging. All 4 patients developed substantial expressive and receptive language deficits after surgery. Functional language improvement occurred in only 2/4 patients. Activation likelihood estimations localized parts of the auditory and semantic language networks in the distribution of the AoA.
   CONCLUSIONS: The AoA is prone to blood flow disruption despite benign manipulation. Patients seem to have limited capacity for speech recovery after intraoperative ischemia in the distribution of this artery, which supplies parts of the auditory and semantic language networks.
C1 [Briggs, Robert G.; Pryor, Dillon P.; Conner, Andrew K.; Nix, Cameron E.; Milton, Camille K.; Kuiper, Joseph K.; Palejwala, Ali H.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurosurg, Oklahoma City, OK USA.
   [Sughrue, Michael E.] Prince Wales Private Hosp, Dept Neurosurg, Sydney, NSW, Australia.
RP Sughrue, ME (reprint author), Prince Wales Private Hosp, Dept Neurosurg, Sydney, NSW, Australia.
EM sughruevs@gmail.com
CR Abutalebi J, 2007, J NEUROSCI, V27, P13762, DOI 10.1523/JNEUROSCI.3294-07.2007
   Ackermann H, 2001, NEUROREPORT, V12, P4087, DOI 10.1097/00001756-200112210-00045
   Addis DR, 2006, NEUROIMAGE, V33, P1194, DOI 10.1016/j.neuroimage.2006.07.039
   ANDREWS RJ, 1993, NEUROSURGERY, V33, P1052
   Aparicio M, 2007, NEUROIMAGE, V35, P1303, DOI 10.1016/j.neuroimage.2006.12.046
   Assaf M, 2006, BIOL PSYCHIAT, V59, P452, DOI 10.1016/j.biopsych.2005.07.039
   Assaf M, 2006, PSYCHIAT RES-NEUROIM, V147, P115, DOI 10.1016/j.pscychresns.2006.01.002
   Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554
   Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044
   Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050
   Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065
   Bedny M, 2006, BRAIN LANG, V98, P127, DOI 10.1016/j.bandl.2006.04.008
   Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078
   Bense S, 2001, J NEUROPHYSIOL, V85, P886
   BERNSTEIN M, 1994, J NEUROSURG, V81, P165, DOI 10.3171/jns.1994.81.2.0165
   Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133
   Binder JR, 1996, BRAIN, V119, P1239, DOI 10.1093/brain/119.4.1239
   Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108
   Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512
   Bonner-Jackson A, 2005, BIOL PSYCHIAT, V58, P47, DOI 10.1016/j.biopsych.2005.05.011
   Bonner-Jackson A, 2007, BIOL PSYCHIAT, V61, P1141, DOI 10.1016/j.biopsych.2006.07.006
   Booth JR, 2002, HUM BRAIN MAPP, V16, P251, DOI 10.1002/hbm.10054
   Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5
   Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008
   Buchsbaum BR, 2005, NEUROIMAGE, V24, P444, DOI 10.1016/j.neuroimage.2004.08.025
   CABANTOG AM, 1994, CAN J NEUROL SCI, V21, P213, DOI 10.1017/S0317167100041184
   Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166
   Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048
   Carreiras M, 2007, J COGNITIVE NEUROSCI, V19, P433, DOI 10.1162/jocn.2007.19.3.433
   Carreiras M, 2006, HUM BRAIN MAPP, V27, P963, DOI 10.1002/hbm.20236
   Carreiras M, 2009, HUM BRAIN MAPP, V30, P3079, DOI 10.1002/hbm.20730
   Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389
   Chan SWY, 2008, NEUROPSYCHOLOGIA, V46, P2896, DOI 10.1016/j.neuropsychologia.2008.05.030
   Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066
   Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.0.CO;2-6
   Chee MWL, 2003, HUM BRAIN MAPP, V18, P186, DOI 10.1002/hbm.10092
   Chee MWL, 2001, NEUROIMAGE, V13, P1155, DOI 10.1006/nimg.2001.0781
   Chen E, 2008, BRAIN LANG, V107, P194, DOI 10.1016/j.bandl.2008.06.007
   Chou TL, 2006, HUM BRAIN MAPP, V27, P915, DOI 10.1002/hbm.20231
   Christodoulou JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100552
   Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315
   CIRIC I, 1987, NEUROSURGERY, V21, P21, DOI 10.1227/00006123-198707000-00005
   Contreras JM, 2012, SOC COGN AFFECT NEUR, V7, P764, DOI 10.1093/scan/nsr053
   Cooke A, 2002, HUM BRAIN MAPP, V15, P80, DOI 10.1002/hbm.10006
   Curtis VA, 1999, SCHIZOPHR RES, V37, P35, DOI 10.1016/S0920-9964(98)00141-8
   Curtis VA, 2001, J AFFECT DISORDERS, V66, P111, DOI 10.1016/S0165-0327(00)00240-8
   Curtis VA, 2007, BIPOLAR DISORD, V9, P358, DOI 10.1111/j.1399-5618.2007.00422.x
   Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7
   Davis MH, 2004, BRAIN LANG, V89, P439, DOI 10.1016/S0093-934X(03)00471-1
   De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003
   de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054
   Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551
   Dennis NA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.004
   Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837
   Diaz MT, 2011, J COGNITIVE NEUROSCI, V23, P3586, DOI 10.1162/jocn_a_00053
   Dick F, 2007, J COGNITIVE NEUROSCI, V19, P799, DOI 10.1162/jocn.2007.19.5.799
   Ding GS, 2003, NEUROREPORT, V14, P1557, DOI 10.1097/00001756-200308260-00003
   Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002
   Eddington KM, 2007, J COGNITIVE NEUROSCI, V19, P1152, DOI 10.1162/jocn.2007.19.7.1152
   Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017
   Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718
   Elliott R, 2004, BIOL PSYCHIAT, V55, P1163, DOI 10.1016/j.biopsych.2004.03.007
   Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059
   Fairhall SL, 2014, CEREB CORTEX, V24, P1687, DOI 10.1093/cercor/bht039
   Ferstl EC, 2001, COGNITIVE BRAIN RES, V11, P325, DOI 10.1016/S0926-6410(01)00007-6
   Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285
   Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070
   FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357
   Finger EC, 2006, NEUROIMAGE, V33, P414, DOI 10.1016/j.neuroimage.2006.06.011
   Forseth KJ, 2018, BRAIN, V141, P2112, DOI 10.1093/brain/awy120
   Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139
   Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789
   Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8
   Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011
   Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878
   Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039
   Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044
   Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526
   Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291
   Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0
   Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893
   Grahn JA, 2009, NEUROIMAGE, V47, P1894, DOI 10.1016/j.neuroimage.2009.04.039
   Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009
   Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276
   Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9
   Grossman M, 2002, HUM BRAIN MAPP, V15, P124, DOI 10.1002/hbm.10117
   Grossman M, 2003, BRAIN, V126, P292, DOI 10.1093/brain/awg027
   Gu XS, 2007, BEHAV BRAIN RES, V181, P218, DOI 10.1016/j.bbr.2007.04.008
   Haist F, 2001, BRAIN LANG, V76, P340, DOI 10.1006/brln.2000.2433
   Haller S, 2007, EUR J NEUROSCI, V26, P2074, DOI 10.1111/j.1460-9568.2007.05816.x
   Han SH, 2010, NEUROPSYCHOLOGIA, V48, P3436, DOI 10.1016/j.neuropsychologia.2010.07.026
   Hargreaves IS, 2012, BRAIN LANG, V120, P73, DOI 10.1016/j.bandl.2011.10.004
   Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9
   Hart HC, 2004, HUM BRAIN MAPP, V21, P178, DOI 10.1002/hbm.10156
   Haupt S, 2009, HUM BRAIN MAPP, V30, P3043, DOI 10.1002/hbm.20731
   Heim S, 2009, HUM BRAIN MAPP, V30, P928, DOI 10.1002/hbm.20556
   Hervey-Jumper SL, 2015, J NEUROSURG, V123, P325, DOI 10.3171/2014.10.JNS141520
   Hesling I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011571
   Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7
   Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011
   Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113
   HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783
   Hofer A, 2003, AM J PSYCHIAT, V160, P1802, DOI 10.1176/appi.ajp.160.10.1802
   Hofer A, 2003, AM J PSYCHIAT, V160, P911, DOI 10.1176/appi.ajp.160.5.911
   Horovitz SG, 2002, MAGN RESON IMAGING, V20, P319, DOI 10.1016/S0730-725X(02)00496-4
   Hu W, 2010, BRAIN, V133, P1694, DOI 10.1093/brain/awq106
   Husain FT, 2006, HUM BRAIN MAPP, V27, P636, DOI 10.1002/hbm.20207
   Husain FT, 2006, NEUROREPORT, V17, P617, DOI 10.1097/00001756-200604240-00012
   Ilg R, 2007, NEUROIMAGE, V38, P228, DOI 10.1016/j.neuroimage.2007.07.014
   Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001
   Ino Tadashi, 2008, Open Neuroimag J, V2, P56, DOI 10.2174/1874440000802010056
   Isenberg AL, 2012, HUM BRAIN MAPP, V33, P2453, DOI 10.1002/hbm.21373
   Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020
   Jackson Christina, 2016, Handb Clin Neurol, V134, P201, DOI 10.1016/B978-0-12-802997-8.00012-8
   Jager G, 2006, PSYCHOPHARMACOLOGY, V185, P358, DOI 10.1007/s00213-005-0298-7
   Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0
   Jardri R, 2007, NEUROIMAGE, V35, P1645, DOI 10.1016/j.neuroimage.2007.02.002
   Jobard G, 2007, NEUROIMAGE, V34, P784, DOI 10.1016/j.neuroimage.2006.06.067
   Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826
   Katzir T, 2005, NEUROIMAGE, V27, P106, DOI 10.1016/j.neuroimage.2005.04.013
   Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672
   Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003
   Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006
   Kiehl KA, 2001, SCHIZOPHR RES, V48, P159, DOI 10.1016/S0920-9964(00)00117-1
   Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441
   Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5
   Knaus TA, 2008, J INT NEUROPSYCH SOC, V14, P967, DOI 10.1017/S1355617708081216
   Koutsarnakis C, 2015, WORLD NEUROSURG, V84, P483, DOI 10.1016/j.wneu.2015.04.018
   Kraut MA, 2006, J COGNITIVE NEUROSCI, V18, P1877, DOI 10.1162/jocn.2006.18.11.1877
   Kubicki M, 2003, NEUROIMAGE, V20, P1923, DOI 10.1016/S1053-8119(03)00383-5
   Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050
   Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138
   Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065
   Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144
   Lattner S, 2005, HUM BRAIN MAPP, V24, P11, DOI 10.1002/hbm.20065
   Le Clec'H G, 2000, NEUROIMAGE, V12, P381, DOI 10.1006/nimg.2000.0627
   Lee SS, 2006, NEUROIMAGE, V29, P536, DOI 10.1016/j.neuroimage.2005.08.003
   Leff AP, 2008, J NEUROSCI, V28, P13209, DOI 10.1523/JNEUROSCI.2903-08.2008
   Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x
   Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65
   Longe O, 2007, CEREB CORTEX, V17, P1812, DOI 10.1093/cercor/bhl099
   Luke KK, 2002, HUM BRAIN MAPP, V16, P133, DOI 10.1002/hbm.10029
   Luo Q, 2003, COGNITIVE BRAIN RES, V17, P527, DOI 10.1016/S0926-6410(03)00167-8
   Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025
   Maguire EA, 2004, NEUROIMAGE, V22, P171, DOI 10.1016/j.neuroimage.2003.12.036
   Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005
   Mashal N, 2009, LATERALITY, V14, P30, DOI 10.1080/13576500802049433
   Mathiak K, 2004, NEUROIMAGE, V21, P154, DOI 10.1016/j.neuroimage.2003.09.036
   Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821
   Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008
   Michael EB, 2001, HUM BRAIN MAPP, V13, P239, DOI 10.1002/hbm.1036
   Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4
   Mitchell RLC, 2004, BRIT J PSYCHIAT, V184, P223, DOI 10.1192/bjp.184.3.223
   Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007
   Nakic M, 2006, NEUROIMAGE, V31, P1752, DOI 10.1016/j.neuroimage.2006.02.022
   Neumann K, 2003, J FLUENCY DISORD, V28, P381, DOI 10.1016/j.jfludis.2003.07.003
   Newman SD, 2011, BRAIN RES, V1410, P77, DOI 10.1016/j.brainres.2011.06.053
   Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010
   Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818
   ORIGITANO TC, 1994, NEUROSURGERY, V35, P351, DOI 10.1227/00006123-199409000-00001
   Peters J, 2007, EUR J NEUROSCI, V26, P1333, DOI 10.1111/j.1460-9568.2007.05752.x
   Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235
   Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67
   Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1
   Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441
   Postle BR, 2007, CEREB CORTEX, V17, P2151, DOI 10.1093/cercor/bhl123
   Preibisch C, 2003, NEUROIMAGE, V20, P1356, DOI 10.1016/S1053-8119(03)00376-8
   Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005
   Quillan MR, 1966, SEMANTIC MEMORY
   Ragland JD, 2005, AM J PSYCHIAT, V162, P1840, DOI 10.1176/appi.ajp.162.10.1840
   Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191
   Rao SM, 1997, J NEUROSCI, V17, P5528
   Rapp AM, 2004, COGNITIVE BRAIN RES, V20, P395, DOI 10.1016/j.cogbrainres.2004.03.017
   Rey-Dios R, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.12.FOCUS12342
   Ries ML, 2006, NEUROIMAGE, V29, P485, DOI 10.1016/j.neuroimage.2005.07.030
   Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123
   Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009
   Rossell SL, 2002, BRAIN LANG, V80, P97, DOI 10.1006/brln.2000.2449
   Rossell SL, 2001, NEUROPSYCHOLOGIA, V39, P1167, DOI 10.1016/S0028-3932(01)00049-5
   Sabsevitz DS, 2005, NEUROIMAGE, V27, P188, DOI 10.1016/j.neuroimage.2005.04.012
   Saito Y, 2006, NEUROREPORT, V17, P1893, DOI 10.1097/WNR.0b013e328011519c
   Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090
   Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048
   Schmidt GL, 2009, BRAIN COGNITION, V71, P375, DOI 10.1016/j.bandc.2009.06.001
   Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018
   Seghier ML, 2008, HUM BRAIN MAPP, V29, P461, DOI 10.1002/hbm.20410
   Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8
   Sevostianov A, 2002, INT J NEUROSCI, V112, P587, DOI 10.1080/00207450290025671
   Sevostianov A, 2002, HUM BRAIN MAPP, V16, P168, DOI 10.1002/hbm.10037
   Sharp DJ, 2010, HUM BRAIN MAPP, V31, P365, DOI 10.1002/hbm.20871
   Smith JS, 2005, J NEUROSURG, V103, P428, DOI 10.3171/jns.2005.103.3.0428
   Smith JS, 2006, J NEURO-ONCOL, V79, P203, DOI 10.1007/s11060-006-9127-z
   Soderlund H, 2007, NEUROIMAGE, V35, P928, DOI 10.1016/j.neuroimage.2006.12.024
   Sonty SP, 2003, ANN NEUROL, V53, P35, DOI 10.1002/ana.10390
   Specht K, 2005, NEUROSCI LETT, V384, P60, DOI 10.1016/j.neulet.2005.04.057
   Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034
   Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4
   Stringaris AK, 2007, BRAIN LANG, V100, P150, DOI 10.1016/j.bandl.2005.08.001
   Stringaris AK, 2006, NEUROIMAGE, V33, P784, DOI 10.1016/j.neuroimage.2006.06.057
   Suh S, 2007, BRAIN RES, V1136, P178, DOI 10.1016/j.brainres.2006.12.043
   Suzuki M, 2002, NEUROSCI RES COMMUN, V30, P197, DOI 10.1002/nrc.10031
   Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195
   Thierry G, 2003, HUM BRAIN MAPP, V19, P37, DOI 10.1002/hbm.10101
   Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028
   Thompson CK, 2007, J COGNITIVE NEUROSCI, V19, P1753, DOI 10.1162/jocn.2007.19.11.1753
   Thompson-Schill SL, 1999, NEUROPSYCHOLOGIA, V37, P671, DOI 10.1016/S0028-3932(98)00126-2
   Tieleman A, 2005, NEUROIMAGE, V26, P565, DOI 10.1016/j.neuroimage.2005.02.017
   Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054
   Toyomura A, 2007, NEUROSCIENCE, V146, P499, DOI 10.1016/j.neuroscience.2007.02.023
   Tulving Endel, 1972, ORG MEMORY, P381, DOI DOI 10.1017/S0140525X00047257
   Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186
   Tyler LK, 2008, J COGNITIVE NEUROSCI, V20, P1381, DOI 10.1162/jocn.2008.20095
   Tyler LK, 2004, NEUROPSYCHOLOGIA, V42, P512, DOI 10.1016/j.neuropsychologia.2003.10.001
   Tyler LK, 2003, NEUROIMAGE, V18, P542, DOI 10.1016/S1053-8119(02)00047-2
   Uchiyama H, 2006, BRAIN RES, V1124, P100, DOI 10.1016/j.brainres.2006.09.088
   Ulmer S, 2006, NEUROLOGY, V67, P1668, DOI 10.1212/01.wnl.0000242894.21705.3c
   Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2
   van Dijk P, 2003, HEARING RES, V181, P8, DOI 10.1016/S0378-5955(03)00130-8
   Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002
   Vorhold V, 2007, NEUROPSYCHOLOGIA, V45, P3242, DOI 10.1016/j.neuropsychologia.2007.06.023
   Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2
   Warnick R, 2011, NEUROLOGICAL SURG, P1285
   Wartenburger I, 2003, NEURON, V37, P159, DOI 10.1016/S0896-6273(02)01150-9
   Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125
   Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998
   Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263
   Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075)
   Wood JN, 2003, J COGNITIVE NEUROSCI, V15, P236, DOI 10.1162/089892903321208178
   Xu B, 2002, NEUROIMAGE, V17, P859, DOI 10.1006/nimg.2002.1215
   Xue G, 2004, NEUROREPORT, V15, P791, DOI 10.1097/00001756-200404090-00010
   Ye Z, 2009, NEUROIMAGE, V48, P280, DOI 10.1016/j.neuroimage.2009.06.032
   Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066
   Yoon HW, 2006, NEUROSCI LETT, V392, P90, DOI 10.1016/j.neulet.2005.09.027
   Yoon HW, 2009, NEUROSCI LETT, V450, P311, DOI 10.1016/j.neulet.2008.12.011
   Yu X, 2011, NEUROIMAGE, V58, P912, DOI 10.1016/j.neuroimage.2011.06.039
   Zahn R, 2004, COGNITIVE BRAIN RES, V18, P322, DOI 10.1016/j.cogbrainres.2003.10.021
NR 236
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E65
EP E76
DI 10.1016/j.wneu.2019.01.159
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400010
PM 30735868
DA 2020-05-12
ER

PT J
AU Cajigas, I
   Kanne, AM
   Ribot, R
   Casabella, AM
   Mahavadi, A
   Jermakowicz, W
   Sur, S
   Millan, C
   Saporta, A
   Lowe, M
   Velez-Ruiz, N
   Rey, G
   Ibrahim, GM
   Ivan, ME
   Jagid, JR
AF Cajigas, Iahn
   Kanne, Andres M.
   Ribot, Ramses
   Casabella, Amanda M.
   Mahavadi, Anil
   Jermakowicz, Walter
   Sur, Samir
   Millan, Carlos
   Saporta, Anita
   Lowe, Merredith
   Velez-Ruiz, Naymee
   Rey, Gustavo
   Ibrahim, George M.
   Ivan, Michael E.
   Jagid, Jonathan R.
TI Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Mesial
   Temporal Epilepsy: A Case Series Analysis of Outcomes and Complications
   at 2-Year Follow-Up
SO WORLD NEUROSURGERY
LA English
DT Article
DE Engel outcome; Laser interstitial thermal therapy; Magnetic
   resonance-guided laser interstitial thermal therapy; Mesial temporal
   epilepsy
ID LOBE EPILEPSY; ABLATION; SURGERY; THERMOTHERAPY
AB BACKGROUND: Laser interstitial thermal therapy (LITT) presents an important new minimally invasive tool in the management of drug-resistant mesial temporal epilepsy (MTE). However, because of its relative novelty, not much is known about long-term seizure freedom rates. The objective of this study was to evaluate the postsurgical seizure outcome following LITT after a minimum follow-up period of 2 years.
   METHODS: Medical records of all patients who underwent LITT for MTE from 2013 to 2018 at our comprehensive epilepsy center under a single surgeon were retrospectively reviewed. Data related to demographics, presurgical evaluations, and seizure outcome were compared between seizure-free (SF) and non-seizure-free (NSF) patients.
   RESULTS: In all, 26 patients were identified with at least 2 years of follow-up. Mean age was 43.8 years +/- 11.6 years, and 46.2% were female. After a mean follow-up time of 42.9 months (range, 24.3-58.8 months), 61.5% (16/26) were free of disabling seizures, and 26.9% (7/26) had only rare disabling seizures. Whereas seizure-freedom rates between patients with and without mesial temporal sclerosis (MTS) were not statistically different (68% vs. 43%, P = 0.23), NSF patients without MTS had a shorter median time to first seizure than did NSF patients with MTS (0.55 month vs. 10 months, log-rank test P = 0.007). Postoperative complications occurred in 2 patients (7.7%), consisting of 1 permanent and 1 transient homonymous hemianopia.
   CONCLUSIONS: LITT appears to be a safe and effective initial surgical option for treatment-resistant MTE. Among patients who have seizures after treatment, those without MTS appear to have seizures earlier than those with MTS.
C1 [Cajigas, Iahn; Casabella, Amanda M.; Mahavadi, Anil; Jermakowicz, Walter; Sur, Samir; Ivan, Michael E.; Jagid, Jonathan R.] Univ Miami, Miller Sch Med, Comprehens Epilepsy Ctr, Dept Neurosurg, Miami, FL 33136 USA.
   [Kanne, Andres M.; Ribot, Ramses; Millan, Carlos; Saporta, Anita; Lowe, Merredith; Velez-Ruiz, Naymee; Rey, Gustavo] Univ Miami, Miller Sch Med, Comprehens Epilepsy Ctr, Dept Neurol, Miami, FL 33136 USA.
   [Ibrahim, George M.] Univ Toronto, Div Neurosurg, Dept Surg, Hosp Sick Children, Toronto, ON, Canada.
RP Jagid, JR (reprint author), Univ Miami, Miller Sch Med, Comprehens Epilepsy Ctr, Dept Neurosurg, Miami, FL 33136 USA.
EM jjagid@med.miami.edu
RI Cajigas, Iahn/O-9260-2018; Jermakowicz, Walter/AAC-5467-2019
OI Cajigas, Iahn/0000-0002-5808-453X; Jermakowicz,
   Walter/0000-0001-6517-208X
CR Agha RA, 2018, INT J SURG, V60, P279, DOI 10.1016/j.ijsu.2018.10.031
   Agha RA, 2016, INT J SURG, V36, P319, DOI 10.1016/j.ijsu.2016.10.025
   Crane J, 2002, NEUROPSYCHOLOGIA, V40, P530, DOI 10.1016/S0028-3932(01)00131-2
   Curry DJ, 2012, EPILEPSY BEHAV, V24, P408, DOI 10.1016/j.yebeh.2012.04.135
   Donos C, 2018, EPILEPSIA, V59, P1421, DOI 10.1111/epi.14443
   Drane DL, 2018, EPILEPSY RES, V142, P170, DOI 10.1016/j.eplepsyres.2017.09.016
   Engel Jr J., 1993, SURG TREATMENT EPILE, P609
   Grewal SS, 2019, J NEUROSURG, V130, P2055, DOI 10.3171/2018.2.JNS171873
   Gross RE, 2018, ANN NEUROL, V83, P575, DOI 10.1002/ana.25180
   Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161
   Hemb M, 2013, J NEUROL NEUROSUR PS, V84, P800, DOI 10.1136/jnnp-2012-304038
   Hoppe C, 2017, SEIZURE-EUR J EPILEP, V48, P45, DOI 10.1016/j.seizure.2017.04.002
   Jermakowicz WJ, 2017, OPER NEUROSURG, V13, P627, DOI 10.1093/ons/opx029
   Jermakowicz WJ, 2017, EPILEPSIA, V58, P801, DOI 10.1111/epi.13715
   Kahn T, 1998, JMRI-J MAGN RESON IM, V8, P160, DOI 10.1002/jmri.1880080128
   Kang JY, 2016, EPILEPSIA, V57, P325, DOI 10.1111/epi.13284
   Kerezoudis P, 2018, J NEUROSURG, V128, P1158, DOI 10.3171/2016.12.JNS162096
   Mathon B, 2017, EPILEPSIA, V58, P1473, DOI 10.1111/epi.13831
   McGonigal A, 2017, EPILEPSY RES, V137, P123, DOI 10.1016/j.eplepsyres.2017.08.016
   NARABAYASHI H, 1963, ARCH NEUROL-CHICAGO, V9, P1
   Patil AA, 1995, STEREOT FUNCT NEUROS, V65, P86, DOI 10.1159/000098902
   Schulze-Bonhage A, 2017, SEIZURE-EUR J EPILEP, V44, P169, DOI 10.1016/j.seizure.2016.10.026
   Tao JX, 2018, J NEUROL NEUROSUR PS, V89, P542, DOI 10.1136/jnnp-2017-316833
   Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007
   Waseem H, 2017, J CLIN NEUROSCI, V38, P1, DOI 10.1016/j.jocn.2016.12.002
   Waseem H, 2015, EPILEPSY BEHAV, V51, P152, DOI 10.1016/j.yebeh.2015.07.022
   Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x
   WIESER HG, 1982, SURG NEUROL, V17, P445, DOI 10.1016/S0090-3019(82)80016-5
   Willie JT, 2014, NEUROSURGERY, V74, P569, DOI 10.1227/NEU.0000000000000343
   Youngerman BE, 2018, EPILEPSIA, V59, P595, DOI 10.1111/epi.14004
NR 30
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1121
EP E1129
DI 10.1016/j.wneu.2019.03.057
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400141
PM 30880205
DA 2020-05-12
ER

PT J
AU Camlar, M
   Turk, C
   Buhur, A
   Oltulu, F
   Oren, M
   Senoglu, M
   Ozer, F
AF Camlar, Mahmut
   Turk, Caglar
   Buhur, Aylin
   Oltulu, Fatih
   Oren, Merve
   Senoglu, Mehmet
   Ozer, Fusun
TI Does Decompressive Duraplasty Have a Neuroprotective Effect on Spinal
   Trauma?: An Experimental Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Duraplasty; Experiment; Rat; Spinal trauma; Surgical technique
ID CEREBROSPINAL-FLUID DRAINAGE; NF-KAPPA-B; CORD-INJURY; CERVICAL
   MYELOPATHY; INFLAMMATION; PARAPLEGIA; MECHANISMS; REPAIR; MODEL
AB BACKGROUND: Spinal cord injury (SCI) may result in neuromotor, sensory, and autonomic function damages. Edema because of spinal cord trauma can reach serious dimensions. The aim of this study was to histologically evaluate the effects of duraplasty on neural tissues.
   METHODS: Twenty-eight Wistar rats were randomly divided into 4 experimental groups: group 1 received laminectomy without SCI (sham); group 2 received laminectomy and SCI with the weight drop method; group 3 received laminectomy, SCI, and duraplasty within the first 6-8 hours of SCI; and group 4 received laminectomy, SCI, and duraplasty after 24 hours of SCI. The neurologic functions of the rats were tested periodically. All animals were euthanized 28 days after the surgery. Histopathologic and immunohistochemical evaluations were performed, and Kruskal-Wallis tests were used for statistical comparison of data between the groups.
   RESULTS: There was no significant difference in the Tarlov examination scores from different time points between the groups. The number of neurons stained with nuclear factor kappa beta was higher in group 3 than groups 1 and 4. The number of neurons stained with terminal deoxynucleotidyl transferase dUTP nick-end labeling was higher in group 2 than group 3.
   CONCLUSIONS: Decompressive laminectomy is a procedure frequently used in spinal trauma surgery. However, it is often unclear whether the decompression is fully adequate. Our results will aid the development of further studies regarding the reliability of duraplasty in the treatment of SCI.
C1 [Camlar, Mahmut; Turk, Caglar; Senoglu, Mehmet; Ozer, Fusun] Univ Hlth Sci, Tepecik Res & Training Hosp, Dept Neurosurg, Izmir, Turkey.
   [Buhur, Aylin; Oltulu, Fatih] Ege Univ, Dept Histol & Embryol, Izmir, Turkey.
   [Oren, Merve] Erzurum Prov Hlth Directorate, Publ Hlth Serv Presidency, Erzurum, Turkey.
RP Camlar, M (reprint author), Univ Hlth Sci, Tepecik Res & Training Hosp, Dept Neurosurg, Izmir, Turkey.
EM drcamlar@gmail.com
RI /AAD-1806-2020; Camlar, Mahmut/AAG-5071-2019
OI /0000-0002-3383-7830; Camlar, Mahmut/0000-0002-6467-0172; BUHUR,
   Aylin/0000-0002-3759-6616
CR ALLEN AR, 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003
   Cemil B, 2012, ULUS TRAVMA ACIL CER, V18, P463, DOI 10.5505/tjtes.2012.84829
   Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x
   Cina CS, 2004, J VASC SURG, V40, P36, DOI 10.1016/j.jvs.2004.03.017
   Coselli JS, 2002, J VASC SURG, V35, P631, DOI 10.1067/mva.2002.122024
   Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490
   Emon Selin Tural, 2017, Turk Neurosurg, V27, P946, DOI 10.5137/1019-5149.JTN.17508-16.1
   Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   HARADA A, 1992, SPINE, V17, P1275, DOI 10.1097/00007632-199211000-00003
   Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853
   Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221
   KOBRINE AI, 1977, ACTA NEUROL SCAND, V56, P54
   Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217
   Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]
   Liang HS, 2012, J BIOMED MATER RES B, V100B, P2131, DOI 10.1002/jbm.b.32778
   Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348
   MATSUYAMA Y, 1995, SPINE, V20, P1657, DOI 10.1097/00007632-199508000-00002
   Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746
   Ozgiray E, 2011, PEDIATR NEUROSURG, V47, P254, DOI 10.1159/000335400
   PERKINS PG, 1988, INJURY, V19, P397, DOI 10.1016/0020-1383(88)90132-5
   Puliyappadamba VT, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.963478
   Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245
   SENTER HJ, 1979, J NEUROSURG, V50, P198, DOI 10.3171/jns.1979.50.2.0198
   Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740
   TARLOV IM, 1972, J NEUROSURG, V36, P10, DOI 10.3171/jns.1972.36.1.0010
   Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64
   Zhang J, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0369-y
   Zhang NW, 2017, PHARMACOL REP, V69, P1001, DOI 10.1016/j.pharep.2017.02.012
NR 31
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E288
EP E294
DI 10.1016/j.wneu.2019.02.043
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400035
PM 30822587
DA 2020-05-12
ER

PT J
AU Chang, CW
   Fu, TS
   Chen, WJ
   Chen, CW
   Lai, PL
   Chen, SH
AF Chang, Chia-Wei
   Fu, Tsai-Sheng
   Chen, Wen-Jer
   Chen, Chien-Wen
   Lai, Po-Liang
   Chen, Shih-Hao
TI Management of Infected Transforaminal Lumbar Interbody Fusion Cage in
   Posterior Degenerative Lumbar Spine Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Debridement and fusion; Interbody fusion cage; Organ/space infection;
   Transforaminal lumbar interbody
ID SURGICAL SITE INFECTION; WOUND-INFECTION; SPONDYLODISCITIS; RATES
AB BACKGROUND: The postoperative infection rates for transforaminal lumbar interbody fusion (TLIF) have ranged from <2% to 4%. However, no consensus has been reached on the treatment strategies. TLIF cage preservation or revision surgery for lumbar spine reconstruction are 2 possible treatments. We aimed to determine the most effective method for organ/space infection control.
   METHODS: The data from 4923 patients who had undergone TLIF with cage and posterior pedicle-screw instrumentation for spondylolysis or degenerative spondylolisthesis from January 2008 to December 2015 were retrospectively analyzed. Of the 4923 patients, 32 (0.65%) had developed organ/space infection of the interbody cage and were divided into 2 groups: those whose interbody cage was removed for revision (group 1) and those who interbody cage was retained (group 2). We compared the initial management of both groups in terms of age, sex, elapsed time to diagnosis, changes in spinal lordotic angle, visual analog scale score, fusion status, and Kirkaldy-Willis functional outcomes.
   RESULTS: The 32 patients with organ/space infection had a mean age of 66.3 years and a follow-up period of 23.8 months. Significant differences were observed in the mean elapsed time to diagnosis (P = 0.004), lordotic angle correction at the disease level (P = 0.03), and Kirkaldy-Wallis functional outcomes (P = 0.01). Of the 17 patients undergoing debridement for implant retention, 9 (52.9%) exhibited poor results.
   CONCLUSIONS: The most important factor contributing to TLIF cage retention failure was epidural fibrosis of the previous transforaminal route and biofilm adhesion on interbody devices affecting infection clearance. Thus, we would recommend a combined anterior and posterior approach or the transforaminal route for radical debridement with cage removal and fusion to achieve better clinical outcomes.
C1 [Chang, Chia-Wei; Fu, Tsai-Sheng] Chang Gung Mem Hosp, Keelung Branch, Dept Orthopaed Surg, Keelung, Taiwan.
   [Chen, Wen-Jer; Chen, Chien-Wen; Lai, Po-Liang] Chang Gung Mem Hosp, Dept Orthopaed Surg, Linkou, Taiwan.
   [Chen, Wen-Jer; Chen, Chien-Wen; Lai, Po-Liang] Chang Gung Univ, Coll Med, Linkou, Taiwan.
   [Chen, Shih-Hao] Buddhist Tzu Chi Gen Hosp, Dept Orthopaed Surg, Taichung Branch, Taichung, Taiwan.
RP Chen, SH (reprint author), Buddhist Tzu Chi Gen Hosp, Dept Orthopaed Surg, Taichung Branch, Taichung, Taiwan.
EM shihhaotzuchi@gmail.com
CR Ahn DK, 2012, J SPINAL DISORD TECH, V25, pE230, DOI 10.1097/BSD.0b013e31825c6f7b
   Brown EM, 2004, SPINE, V29, P938, DOI 10.1097/00007632-200404150-00023
   Carmouche JJ, 2004, SPINE, V29, pE542, DOI 10.1097/01.brs.0000146802.38753.38
   Chen CN, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-89
   Chen SH, 2018, CLIN SPINE SURG, V31, P225, DOI 10.1097/BSD.0000000000000633
   Chen SH, 2015, EUR SPINE J, V24, P561, DOI 10.1007/s00586-014-3636-9
   Goode AP, 2011, SPINE, V36, P752, DOI 10.1097/BRS.0b013e3181e030b3
   Ha KY, 2004, EUR SPINE J, V13, P419, DOI 10.1007/s00586-003-0584-1
   Hegde V, 2012, WORLD J ORTHOP, V3, P182, DOI 10.5312/wjo.v3.i11.182
   Hsieh MK, 2011, SPINE J, V11, P24, DOI 10.1016/j.spinee.2010.10.021
   Kim JI, 2010, J SPINAL DISORD TECH, V23, P258, DOI 10.1097/BSD.0b013e3181a9452c
   Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763
   Kowalski TJ, 2007, CLIN INFECT DIS, V44, P913, DOI 10.1086/512194
   Lee JS, 2015, ASIAN SPINE J, V9, P841, DOI 10.4184/asj.2015.9.6.841
   Lee KH, 2012, EUR SPINE J, V21, P2265, DOI 10.1007/s00586-012-2281-4
   Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087
   Lu ML, 2015, EUR SPINE J, V24, P555, DOI 10.1007/s00586-014-3585-3
   Mirovsky Y, 2007, J SPINAL DISORD TECH, V20, P127, DOI 10.1097/01.bsd.0000211266.66615.e5
   O'Toole JE, 2009, J NEUROSURG-SPINE, V11, P471, DOI 10.3171/2009.5.SPINE08633
   Pappou IP, 2006, CLIN ORTHOP RELAT R, P120, DOI 10.1097/01.blo.0000203446.06028.b5
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Smith JS, 2011, SPINE, V36, P556, DOI 10.1097/BRS.0b013e3181eadd41
   Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5
   Sweet FA, 2011, SPINE, V36, P2084, DOI 10.1097/BRS.0b013e3181ff2cb1
   Thakkar RS, 2012, RADIOL CLIN N AM, V50, P731, DOI 10.1016/j.rcl.2012.04.006
   Tsai TT, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1533-1
   Zaveri GR, 2009, J SPINAL DISORD TECH, V22, P257, DOI 10.1097/BSD.0b013e31818859d0
NR 27
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E330
EP E341
DI 10.1016/j.wneu.2019.02.050
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400039
PM 30822594
DA 2020-05-12
ER

PT J
AU Chang, T
   Li, LH
   Yang, YL
   Li, M
   Qu, Y
   Gao, L
AF Chang, Tao
   Li, Lihong
   Yang, Yanlong
   Li, Min
   Qu, Yan
   Gao, Li
TI Transcranial Doppler Ultrasonography for the Management of Severe
   Traumatic Brain Injury After Decompressive Craniectomy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral hemodynamics; Decompressive craniectomy; Intracranial pressure;
   Transcranial Doppler ultrasonography; Traumatic brain injury
ID CEREBRAL PERFUSION-PRESSURE; SONOGRAPHY; MODERATE
AB BACKGROUND: Cerebral hemodynamic transformation is a relatively common finding in patients with traumatic brain injury (TBI). Knowledge of cerebral hemodynamic disturbance may assist in predicting the management outcome. Transcranial Doppler ultrasonography (TCD) monitoring of patients with TBI can be used to reveal various pathologic hemodynamic changes. The objective of this study was to compare the clinical outcomes of postoperative routine intracranial pressure (ICP) monitoring versus ICP monitoring combined with TCD monitoring in patients with brain trauma after decompressive craniectomy.
   METHODS: This was a retrospective study of 30 patients with TBI who underwent ICP combined with TCD monitoring (after 2015) compared with a historical control group of 30 patients who only underwent routine ICP monitoring (in 2013-2014). ICP, partial pressure of carbon dioxide, hemoglobin, and hematocrit values were monitored and recorded on a daily basis for 7 days after operation. Neuroimaging was also performed at admission. Neurologic outcome was assessed at 2 weeks and 6 months after operation using the Glasgow Outcome Score Extended (GOS-E). Unconditional multivariable logistic regression was conducted to analyze the factors for favorable clinical outcome.
   RESULTS: Two weeks after operation, there were no differences in mortality rate between the 2 groups (P = 0.643). When considering the GOS-E score at 6 months, there were no differences in clinical prognosis between the 2 groups (P = 0.101), but the ICP combined with TCD monitoring group showed a higher frequency of patients with favorable outcome compared with the routine ICP monitoring group (P = 0.043). Unconditional multivariable logistic regression results showed that no factor was independently associated with GOS-E at 6 months.
   CONCLUSIONS: TCD could be helpful for the serial monitoring of cerebral hemodynamic changes after decompressive craniectomy for TBI, which could be beneficial for neurologic outcome improvement.
C1 [Chang, Tao; Li, Lihong; Yang, Yanlong; Li, Min; Qu, Yan; Gao, Li] Air Force Med Univ, Affiliated Hosp 2, Dept Neurosurg, Xian, Shaanxi, Peoples R China.
RP Gao, L (reprint author), Air Force Med Univ, Affiliated Hosp 2, Dept Neurosurg, Xian, Shaanxi, Peoples R China.
EM gaoli089@yeah.net
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81401044]
FX This study was funded by the National Natural Science Foundation of
   China (81401044).
CR Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007
   Bor-Seng-Shu E, 2004, ARQ NEURO-PSIQUIAT, V62, P715, DOI 10.1590/S0004-282X2004000400028
   Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432
   Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363
   Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4
   Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146
   Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150
   Mahdavi Z, 2015, CRIT CARE NURS CLIN, V27, P213, DOI 10.1016/j.cnc.2015.02.002
   Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1
   Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1
   Moreno J A, 2000, Neurosurg Focus, V8, pe8
   Pinto SM, 2018, AM J PHYS MED REHAB, V97, P747, DOI 10.1097/PHM.0000000000000961
   Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812
   Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6
   Sarkar S, 2007, POSTGRAD MED J, V83, P683, DOI 10.1136/pgmj.2007.058602
   Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238
   Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002
   Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x
   Turek Radovan, 2013, Acta Neurochir Suppl, V118, P265, DOI 10.1007/978-3-7091-1434-6_50
   Verim S, 2013, TURK KARDIYOL DERN A, V41, P248, DOI 10.5543/tkda.2013.76429
   Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137
NR 21
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E116
EP E124
DI 10.1016/j.wneu.2019.02.005
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400016
PM 30790743
OA Bronze
DA 2020-05-12
ER

PT J
AU Chen, CHJ
   Nguyen, T
   Udawatta, M
   Duong, C
   Romiyo, P
   Sheppard, JP
   Gopen, Q
   Yang, I
AF Chen, Cheng Hao Jacky
   Nguyen, Thien
   Udawatta, Methma
   Duong, Courtney
   Romiyo, Prasanth
   Sheppard, John P.
   Gopen, Quinton
   Yang, Isaac
TI Clinical Assessment of Patients with Bilateral Superior Semicircular
   Canal Dehiscence
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bilateral; Outcomes; Superior semicircular canal dehiscence;
   Symptomology
ID REPAIR
AB OBJECTIVE: Superior semicircular canal dehiscence (SSCD) is caused by a deformity in the arcuate eminence, leading to various vestibular and auditory symptoms that can manifest unilaterally or bilaterally. The aim of the present study was to distinguish the differences in symptoms, treatment options, and outcomes between patients with unilateral and bilateral SSCD.
   METHODS: A retrospective medical record analysis was conducted to identify patients with SSCD treated at a tertiary care center from March 2011 to May 2017. The patient demographic data, preoperative symptom presentation, and postoperative outcomes were extracted. Statistical analyses were performed using IBM SPSS Statistics. Fisher's exact tests were computed to investigate the relationships between binary variables, with a significance level of P < 0.05.
   RESULTS: A total of 99 patients with SSCD had been treated at our institution from March 2011 to May 2017. Of these 99 patients, 41 (41.4%) had a diagnosis of bilateral SSCD. Of the 41 patients with bilateral SSCD, 27 (65.9%) were women, and the mean age was 53.6 +/- 10.9 years (range, 31.7-73.9). The most common presenting symptom was tinnitus (n = 33; 80.4%) and dizziness (n = 33; 80.4%). Previous trauma to the head correlated with a bilateral SSCD presentation (P = 0.04). Trends were reported between female sex and bilateral SSCD [r(35) = 0.32379; P = 0.0506]. Postoperatively, trends were also found, with greater rates of dizziness in patients with bilateral SSCD compared with those with unilateral SSCD (odds ratio, 3.81; P = 0.0659), and less improvement in dizziness (odds ratio, 0.186; P = 0.0627). No other significant differences were found between the symptoms or clinical outcomes and improvements between the bilateral and unilateral cohorts.
   CONCLUSION: Bilateral SSCD might result in different clinical symptoms that are more prevalent compared with unilateral SSCD. The findings from the present series of patients with bilateral SSCD suggest that patient symptoms and history are important in the diagnosis of bilateral SSCD and deciding whether 1 or both dehiscences requires surgical intervention.
C1 [Chen, Cheng Hao Jacky; Nguyen, Thien; Udawatta, Methma; Duong, Courtney; Romiyo, Prasanth; Sheppard, John P.; Yang, Isaac] Ronald Reagan UCLA Med Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA.
   [Gopen, Quinton; Yang, Isaac] Ronald Reagan UCLA Med Ctr, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.
   [Yang, Isaac] Ronald Reagan UCLA Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90095 USA.
   [Yang, Isaac] Ronald Reagan UCLA Med Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.
   [Yang, Isaac] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Yang, Isaac] Harbor UCLA Med Ctr, Dept Neurosurg, Torrance, CA 90509 USA.
   [Yang, Isaac] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.
RP Yang, I (reprint author), Ronald Reagan UCLA Med Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA.; Yang, I (reprint author), Ronald Reagan UCLA Med Ctr, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.; Yang, I (reprint author), Ronald Reagan UCLA Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90095 USA.; Yang, I (reprint author), Ronald Reagan UCLA Med Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Yang, I (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.; Yang, I (reprint author), Harbor UCLA Med Ctr, Dept Neurosurg, Torrance, CA 90509 USA.; Yang, I (reprint author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.
EM iyang@mednet.ucl.edu
RI Duong, Courtney/AAD-4121-2019
OI Udawatta, Methma/0000-0002-5225-7006
CR Agrawal Y, 2012, OTOL NEUROTOL, V33, P72, DOI 10.1097/MAO.0b013e31823c9182
   Amoodi HA, 2011, LARYNGOSCOPE, V121, P1117, DOI 10.1002/lary.21398
   Carey JP, 2000, ARCH OTOLARYNGOL, V126, P137, DOI 10.1001/archotol.126.2.137
   Deutschlander A, 2004, NEUROLOGY, V62, P784, DOI 10.1212/01.WNL.0000117978.13194.ED
   Friedland DR, 2006, OTOL NEUROTOL, V27, P346, DOI 10.1097/00129492-200604000-00010
   Hamid MA, 2001, OTOL NEUROTOL, V22, P567, DOI 10.1097/00129492-200107000-00026
   Kanaan AA, 2011, INT J PEDIATR OTORHI, V75, P877, DOI 10.1016/j.ijporl.2011.03.019
   Lagman C, 2017, J NEUROSURG-PEDIATR, V20, P196, DOI 10.3171/2017.3.PEDS1734
   Manzari L, 2011, ACTA OTO-LARYNGOL, V131, P107, DOI 10.3109/00016489.2010.507780
   Manzari L, 2009, OTOL NEUROTOL, V30, P423, DOI 10.1097/MAO.0b013e3181684048
   Minor LB, 2003, OTOL NEUROTOL, V24, P270, DOI 10.1097/00129492-200303000-00023
   Minor LB, 2001, ANN NY ACAD SCI, V942, P259
   Minor LB, 1998, ARCH OTOLARYNGOL, V124, P249, DOI 10.1001/archotol.124.3.249
   Niesten MEF, 2013, LARYNGOSCOPE, V123, P226, DOI 10.1002/lary.23550
   Peng KA, 2014, CASE REP OTOLARYNGOL, DOI 10.1155/2014/817291
   Nguyen T, 2018, ACTA NEUROCHIR, V160, P1219, DOI 10.1007/s00701-017-3346-2
   Tilikete C, 2004, ANN NEUROL, V56, P556, DOI 10.1002/ana.20231
   Ung N, 2017, J CLIN NEUROSCI, V43, P103, DOI 10.1016/j.jocn.2017.05.003
   Yew A, 2012, J NEUROL SURG PART B, V73, P365, DOI 10.1055/s-0032-1324397
NR 19
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1549
EP E1552
DI 10.1016/j.wneu.2019.03.205
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400195
PM 30928582
DA 2020-05-12
ER

PT J
AU Chen, CJ
   Shabo, LM
   Ding, D
   Ironside, N
   Kano, H
   Mathieu, D
   Kondziolka, D
   Feliciano, C
   Rodriguez-Mercado, R
   Grills, IS
   Barnett, G
   Lunsford, LD
   Sheehan, JP
AF Chen, Ching-Jen
   Shabo, Leah M.
   Ding, Dale
   Ironside, Natasha
   Kano, Hideyuki
   Mathieu, David
   Kondziolka, Douglas
   Feliciano, Caleb
   Rodriguez-Mercado, Rafael
   Grills, Inga S.
   Barnett, Gene
   Lunsford, L. Dade
   Sheehan, Jason P.
CA Int Radiosurg Res Fdn
TI Seizure Presentation in Patients with Brain Arteriovenous Malformations
   Treated with Stereotactic Radiosurgery: A Multicenter Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Hemorrhage; Radiosurgery; Seizure
ID SECONDARY EPILEPTOGENESIS; VASCULAR MALFORMATIONS; EPILEPTIC SEIZURES;
   NATURAL-HISTORY; GRADING SYSTEM; RISK; HEMORRHAGE; MANAGEMENT; SCALE;
   SIZE
AB BACKGROUND: Seizures are the second most common clinical presentation in patients with brain arteriovenous malformations (AVMs) and the most common presentation of unruptured AVMs. The aim of the present multicenter, retrospective cohort study was to identify the predictors of seizure presentation in patients with AVM who had undergone stereotactic radiosurgery (SRS).
   METHODS: We performed a retrospective review of patients with AVM who had been treated with SRS at 8 participating International Radiosurgery Research Foundation sites. The patient and AVM characteristics were compared between those with and without seizure presentation in univariable and multivariable models. A subgroup analysis of patients with cortical AVMs was performed.
   RESULTS: The study cohort included 2333 patients with AVM, including 419 (18%) with and 1914 (82%) without a seizure presentation. Previous AVM resection (odds ratio [OR], 7.65; P = 0.001), a lack of previous AVM hemorrhage (OR, 0.004; P < 0.001), a cortical AVM location (OR, 1559.42; P < 0.001), a lower Spetzler-Martin grade (OR, 0.51; P = 0.007), and a higher Virginia radiosurgery AVM score (OR, 1.46; P = 0.008) were independent predictors of seizure presentation. The rate of seizure presentation in patients with cortical AVMs was 27%. Previous AVM resection (OR, 8.36; P < 0.001), a lack of previous AVM hemorrhage (OR, 0.004; P < 0.001), and temporal AVM location (OR, 4.15; P < 0.001) were independent predictors of seizure presentation for cortical AVMs.
   CONCLUSION: We identified multiple factors associated with seizure presentation in patients with AVM to undergo SRS. Previous AVM resection, a cortical AVM location, and a lack of previous AVM hemorrhage were the strongest predictors of pre-SRS seizures. The Spetzler-Martin grade and Virginia radiosurgery AVM score might have a role in seizure risk stratification. For cortical AVMs, a temporal lobe location was predictive of seizure presentation.
C1 [Chen, Ching-Jen; Shabo, Leah M.; Sheehan, Jason P.] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA 22908 USA.
   [Ding, Dale] Univ Louisville, Dept Neurosurg, Louisville, KY 40292 USA.
   [Ironside, Natasha] Columbia Univ, Dept Neurol Surg, Med Ctr, New York Presbyterian, New York, NY USA.
   [Kano, Hideyuki; Lunsford, L. Dade] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.
   [Mathieu, David] Univ Sherbrooke, Ctr Rech CHUS, Div Neurosurg, Sherbrooke, PQ, Canada.
   [Kondziolka, Douglas] NYU, Dept Neurosurg, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.
   [Feliciano, Caleb; Rodriguez-Mercado, Rafael] Univ Puerto Rico, Sect Neurol Surg, San Juan, PR 00936 USA.
   [Grills, Inga S.] Beaumont Hlth Syst, Dept Radiat Oncol, Royal Oak, MI USA.
   [Barnett, Gene] Cleveland Clin Fdn, Dept Neurosurg, 9500 Euclid Ave, Cleveland, OH 44195 USA.
RP Sheehan, JP (reprint author), Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA 22908 USA.
EM jsheehan@virginia.edu
RI Ding, Dale/AAN-3583-2020
OI Kondziolka, Douglas/0000-0001-8925-7344; Mathieu,
   David/0000-0003-2029-6315
CR Awad IA, 1990, INTRACRANIAL VASCULA, P49
   Batjer H H, 1989, Neurol Med Chir (Tokyo), V29, P401, DOI 10.2176/nmc.29.401
   Batjer H H, 1989, Neurol Med Chir (Tokyo), V29, P395, DOI 10.2176/nmc.29.395
   BROWN RD, 1988, J NEUROSURG, V68, P352, DOI 10.3171/jns.1988.68.3.0352
   Cascino GD, 2008, EPILEPSIA, V49, P79, DOI 10.1111/j.1528-1167.2008.01930.x
   Chen CJ, 2018, STROKE, V49, P1939, DOI 10.1161/STROKEAHA.118.022052
   Chen CJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS1454
   CRAWFORD PM, 1986, EPILEPSIA, V27, P270, DOI 10.1111/j.1528-1157.1986.tb03539.x
   Darsaut TE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1019-0
   Ding D, 2016, STROKE, V47, P342, DOI 10.1161/STROKEAHA.115.011400
   Ding D, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.02.039
   DODICK DW, 1994, MAYO CLIN PROC, V69, P741, DOI 10.1016/S0025-6196(12)61091-X
   Eisenschenk S, 1998, STEREOT FUNCT NEUROS, V71, P51, DOI 10.1159/000029648
   Engel Jr J, 1986, KINDLING, V3, P37
   Fierstra J, 2011, BRAIN, V134, P100, DOI 10.1093/brain/awq286
   Garcin B, 2012, NEUROLOGY, V78, P626, DOI 10.1212/WNL.0b013e3182494d40
   Ghossoub M, 2001, NEUROCHIRURGIE, V47, P168
   GOLDENSOHN ES, 1984, EPILEPSIA, V25, pS156, DOI 10.1111/j.1528-1157.1984.tb05648.x
   GRAF CJ, 1983, J NEUROSURG, V58, P331, DOI 10.3171/jns.1983.58.3.0331
   Hofmeister C, 2000, STROKE, V31, P1307, DOI 10.1161/01.STR.31.6.1307
   Hoh BL, 2002, NEUROSURGERY, V51, P303, DOI 10.1097/00006123-200208000-00004
   Ironside N, 2018, WORLD NEUROSURG, V120, P550, DOI 10.1016/j.wneu.2018.08.121
   Johnson SA, 2018, J NEUROSURG, V128, P7
   Josephson CB, 2012, NEUROLOGY, V79, P500, DOI 10.1212/WNL.0b013e3182635696
   Kida Y, 2000, J CLIN NEUROSCI, V7, P6, DOI 10.1054/jocn.2000.0701
   Kim H, 2015, NEUROSURGERY, V76, P25, DOI 10.1227/NEU.0000000000000556
   KRAEMER DL, 1994, EPILEPSIA, V35, pS30, DOI 10.1111/j.1528-1157.1994.tb05987.x
   LEBLANC R, 1983, CAN J NEUROL SCI, V10, P91, DOI 10.1017/S031716710004470X
   LUNSFORD LD, 1991, J NEUROSURG, V75, P512, DOI 10.3171/jns.1991.75.4.0512
   Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8
   MORIYA N, 1990, JPN J PSYCHIAT NEUR, V44, P381
   Morrell F, 1987, SURG TREATMENT EPILE, P701
   MURPHY MJ, 1985, ARCH NEUROL-CHICAGO, V42, P477, DOI 10.1001/archneur.1985.04060050079012
   Nagata S, 2006, SURG NEUROL, V66, P50, DOI 10.1016/j.surneu.2005.12.017
   PARKINSON D, 1980, J NEUROSURG, V53, P285, DOI 10.3171/jns.1980.53.3.0285
   PIEPGRAS DG, 1993, J NEUROSURG, V78, P5, DOI 10.3171/jns.1993.78.1.0005
   SPETZLER RF, 1992, J NEUROSURG, V76, P918, DOI 10.3171/jns.1992.76.6.0918
   SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476
   Stapf C, 2003, STROKE, V34, P2664, DOI 10.1161/01.STR.0000094824.03372.9B
   Stapf C, 2000, STROKE, V31, P2365, DOI 10.1161/01.STR.31.10.2365
   Starke RM, 2017, J NEUROSURG, V126, P36, DOI 10.3171/2015.9.JNS151311
   Starke RM, 2013, J NEUROSURG, V119, P981, DOI 10.3171/2013.5.JNS1311
   STEINER L, 1992, J NEUROSURG, V77, P1, DOI 10.3171/jns.1992.77.1.0001
   SVIEN HJ, 1965, J NEUROSURG, V23, P23, DOI 10.3171/jns.1965.23.1.0023
   TURJMAN F, 1995, AM J NEURORADIOL, V16, P345
   WALTIMO O, 1973, J NEUROL SCI, V19, P13, DOI 10.1016/0022-510X(73)90051-8
   Wegner RE, 2011, INT J RADIAT ONCOL, V79, P1147, DOI 10.1016/j.ijrobp.2009.12.056
   Wolf HK, 1996, ACTA NEUROPATHOL, V91, P376, DOI 10.1007/s004010050439
   YEH HS, 1991, ARCH NEUROL-CHICAGO, V48, P1122, DOI 10.1001/archneur.1991.00530230030016
   Zeiler FA, 2011, CAN J NEUROL SCI, V38, P851, DOI 10.1017/S0317167100012427
NR 50
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E634
EP E640
DI 10.1016/j.wneu.2019.02.104
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400077
PM 30831294
DA 2020-05-12
ER

PT J
AU Chen, C
   Feng, F
   Tan, HN
   Li, Z
   Zhang, ZH
   Liang, JQ
   Li, XY
   Shen, JX
AF Chen, Chong
   Feng, Fan
   Tan, Haining
   Li, Zheng
   Zhang, Zhihai
   Liang, Jinqian
   Li, Xingye
   Shen, Jianxiong
TI Preliminary Study of a New Growing Rod System in Immature Swine Model
SO WORLD NEUROSURGERY
LA English
DT Article
DE Early-onset scoliosis (EOS); New growing rod; Nonfusion technique; Swine
   model
ID SPINAL DEFORMITIES; PULMONARY-FUNCTION; YOUNG-CHILDREN; SCOLIOSIS;
   FUSION; CURVATURE
AB BACKGROUND: Growing rod techniques have been demonstrated to be a valuable treatment in early-onset scoliosis; however, repeated surgeries and general anesthesia cannot be avoided.
   METHODS: This study included 12 immature swine that were randomly assigned to receive either a novel growing rod system (experimental group) or a traditional growing rod system (control group). Lengthening was undertaken at 4-week intervals, for a total observation period of 12 weeks. Radiography, computed tomography, and motion analysis of the spine were conducted to evaluate rod extension, growth and nonfusion of the spine, and fixation.
   RESULTS: One swine (control group) was excluded from the analysis because of a deep wound infection at 1 week after the initial operation. No complications were observed in the remaining 11 swine. In the experimental group, the average lengthening operation lasted 12.1 +/- 3.1 minutes, and average incision length was 1.1 +/- 0.2 cm; both values were significantly less compared with the control group (P < 0.001). No significant between-group differences in mean trunk length, body mass, or thickness of cephalad-instrumented or caudad-instrumented vertebrae and intervertebral disks were present before the initial operation or at the final assessment (12 weeks after operation; P > 0.05). Spinal growth and motion of instrumented spinal segments were conserved.
   CONCLUSIONS: The novel growing rod system is safe and effective in immature swine, preserving spine growth potential and involving less surgical trauma.
C1 [Chen, Chong; Feng, Fan; Tan, Haining; Li, Zheng; Liang, Jinqian; Li, Xingye; Shen, Jianxiong] Peking Union Med Coll, Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthoped Surg, Beijing, Peoples R China.
   [Zhang, Zhihai] China Med Univ, Dept Spinal Surg, Aviat Gen Hosp, Beijing, Peoples R China.
RP Shen, JX (reprint author), Peking Union Med Coll, Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthoped Surg, Beijing, Peoples R China.
EM sjxpumch@163.com
RI Shen, Jianxiong/AAH-6200-2019
FU Capital's Funds for Health Improvement and Research [2014-2-4013];
   National Natural Science Foundation of Beijing Municipality [7151006];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81330044, 81772424]
FX This work was supported by the Capital's Funds for Health Improvement
   and Research (Grant No. 2014-2-4013), National Natural Science
   Foundation of Beijing Municipality (Grant No. 7151006), and National
   Natural Science Foundation of China (Grant Nos. 81330044 and 81772424).
CR AKBARNIA BA, 2005, SPINE PHILA PA 197 S, V30, pS4
   Akbarnia BA, 2013, SPINE, V38, P665, DOI 10.1097/BRS.0b013e3182773560
   Akbarnia BA, 2010, SPINE, V35, P2193, DOI 10.1097/BRS.0b013e3181f070b5
   Armoiry X, 2012, LANCET, V380, P1229, DOI 10.1016/S0140-6736(12)61713-9
   Ben-Sira L, 2018, WORLD NEUROSURG, V116, pE273, DOI 10.1016/j.wneu.2018.04.187
   Blakemore LC, 2001, SPINE, V26, P2044, DOI 10.1097/00007632-200109150-00021
   Cheung KMC, 2012, LANCET, V379, P1967, DOI 10.1016/S0140-6736(12)60112-3
   Dannawi Z, 2013, BONE JOINT J, V95B, P75, DOI 10.1302/0301-620X.95B1.29565
   DUBOUSSET J, 1989, J PEDIATR ORTHOPED, V9, P541, DOI 10.1097/01241398-198909010-00008
   HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591, DOI 10.2106/00004623-196244040-00001
   Karol LA, 2008, J BONE JOINT SURG AM, V90A, P1272, DOI 10.2106/JBJS.G.00184
   Li K, 2015, SPINE, V40, P767, DOI 10.1097/BRS.0000000000000819
   Li XY, 2018, WORLD NEUROSURG, V118, pE946, DOI 10.1016/j.wneu.2018.07.106
   Liu JM, 2015, SPINE J, V15, P138, DOI 10.1016/j.spinee.2014.07.008
   LUQUE ER, 1982, CLIN ORTHOP RELAT R, P202
   MARDJETKO SM, 1992, SPINE, V17, P582, DOI 10.1097/00007632-199205000-00018
   McCarthy RE, 2014, J PEDIATR ORTHOPED, V34, P1, DOI 10.1097/BPO.0b013e31829f92dc
   McCarthy RE, 2010, CLIN ORTHOP RELAT R, V468, P705, DOI 10.1007/s11999-009-1028-y
   Metkar U, 2017, EXPERT REV MED DEVIC, V14, P117, DOI 10.1080/17434440.2016.1274230
   MOE JH, 1984, CLIN ORTHOP RELAT R, P35
   Ryabykh SO, 2018, WORLD NEUROSURG, V112, pE431, DOI 10.1016/j.wneu.2018.01.058
   Sankar WN, 2011, SPINE, V36, P806, DOI 10.1097/BRS.0b013e318214d78f
   Tang N, 2019, WORLD NEUROSURG, V125, pE593, DOI 10.1016/j.wneu.2019.01.136
   Teoh KH, 2016, SPINE J, V16, pS34, DOI 10.1016/j.spinee.2015.12.098
   Vitale MG, 2008, SPINE, V33, P1242, DOI 10.1097/BRS.0b013e3181714536
   Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337
   Yang JS, 2010, J PEDIATR ORTHOPED, V30, P264, DOI 10.1097/BPO.0b013e3181d40f94
   Xin Z, 2014, J SPINAL DISORD TECH, V27, pE294, DOI 10.1097/BSD.0000000000000117
NR 28
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E653
EP E660
DI 10.1016/j.wneu.2019.02.112
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400080
PM 30831304
DA 2020-05-12
ER

PT J
AU Chen, G
   Sun, SF
   Du, ZG
   Sun, YR
   Pan, ZG
   Che, XM
   Xie, R
AF Chen, Gong
   Sun, Shifeng
   Du, Zunguo
   Sun, Yirui
   Pan, Zhiguang
   Che, Xiaoming
   Xie, Rong
TI Intra-Extracranial Primary Clear Cell Sarcoma: The First Report and
   Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Brain invasion; Clear cell sarcoma (CCS); Ewing sarcoma breakpoint
   region 1(EWSR1); Intra-extracranial region
ID APONEUROSES MALIGNANT-MELANOMA; SOFT-TISSUE; SPONTANEOUS REGRESSION;
   TENDONS; PARTS; BONE; NECK
AB BACKGROUND: Clear cell sarcoma (CCS) is a rare malignant soft tissue tumor with poor prognosis owing to metastasis and insensitive response to chemotherapy and radiotherapy.
   METHODS: We first searched PubMed and Embase using the terms "clear cell sarcoma," "malignant melanoma of soft tissue," "head," and "neck." In the 15 articles selected for literature review, only 27% (4/15) of patients were diagnosed with primary CCS of the head. Pathologically, those tumors arose from either the scalp or the superficial temporal fascia, but none invaded the skull and brain. Next, the search was performed in the same database using the terms "clear cell sarcoma," "malignant melanoma of soft tissue," and "bone," and only 24 articles were selected.
   RESULTS: In the case reported here, a 36-year-old woman was found to have a palpable mass located at the left temporal-occipital region, and surgical finding confirmed the invasion into the skull and the brain. The diagnosis of primary CCS was made because of the detection of t(12;22)(q13;q12) in >50% of tumor cells by fluorescence in situ hybridization, and metastasis to the lymph nodes and lungs was discovered by postoperative positron emission tomography-computed tomography.
   CONCLUSIONS: To the best of our knowledge, this is the first case of primary central nervous system CCS. Primary CCS may involve the skull and should be one of the differential diagnoses for intra-extracranial communicating tumors. Further research on biological characteristics and molecular targeted therapy of CCS are needed to improve its poor prognosis.
C1 [Chen, Gong; Sun, Shifeng; Sun, Yirui; Pan, Zhiguang; Che, Xiaoming; Xie, Rong] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
   [Du, Zunguo] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai, Peoples R China.
RP Xie, R (reprint author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
EM rongxie@fudan.edu.cn
OI Xie, Rong/0000-0002-8277-7280
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81602177]
FX This work was supported by the National Natural Science Foundation of
   China (81571111, 81870909, R.X.), and National Natural Science
   Foundation of China (81602177, G.C.).
CR Antonescu CR, 2006, CLIN CANCER RES, V12, P5356, DOI 10.1158/1078-0432.CCR-05-2811
   Bianchi G, 2014, EJSO-EUR J SURG ONC, V40, P505, DOI 10.1016/j.ejso.2014.01.016
   Brekke MK, 1998, J AM PODIAT MED ASSN, V88, P457, DOI 10.7547/87507315-88-9-457
   Caces DBD, 2012, J CLIN ONCOL, V30, pE24, DOI 10.1200/JCO.2011.38.4164
   Choi JH, 2003, SKELETAL RADIOL, V32, P598, DOI 10.1007/s00256-003-0683-4
   Cornillie J, 2016, EXPERT REV ANTICANC, V16, P839, DOI 10.1080/14737140.2016.1197122
   Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021
   DEBEUCKELEER LH, SKELET RADIOL, V29, P187
   ENZINGER FM, 1965, CANCER, V18, P1163, DOI 10.1002/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0
   Fan CF, 2015, INT J CLIN EXP PATHO, V8, P10935
   Feasel PC, 2016, J CUTAN PATHOL, V43, P838, DOI 10.1111/cup.12755
   Ferguson PC, 2006, CANCER-AM CANCER SOC, V106, P2692, DOI 10.1002/cncr.21949
   Fukada I, 2013, CASE REP ONCOL, V6, P55, DOI 10.1159/000345843
   de Marcos JAG, 2009, J ORAL MAXIL SURG, V67, P910, DOI 10.1016/j.joms.2008.06.092
   Gelczer RK, 1999, SKELETAL RADIOL, V28, P240, DOI 10.1007/s002560050509
   Gollard R, 2008, ACTA ONCOL, V47, P1593, DOI 10.1080/02841860701843068
   Gonzaga MI, 2018, J CANCER RES CLIN, V144, P1711, DOI 10.1007/s00432-018-2693-6
   Hersekli MA, 2005, SKELETAL RADIOL, V34, P167, DOI 10.1007/s00256-004-0801-y
   Hisaoka M, 2008, AM J SURG PATHOL, V32, P452, DOI 10.1097/PAS.0b013e31814b18fb
   Hocar O, 2012, DERMAT RES PRACT, DOI 10.1155/2012/984096
   Hourani M, 2005, SKELETAL RADIOL, V34, P543, DOI 10.1007/s00256-005-0893-z
   Ibrahim RM, 2018, J ORTHOP, V15, P963, DOI 10.1016/j.jor.2018.08.039
   Inaoka T, 2003, SKELETAL RADIOL, V32, P594, DOI 10.1007/s00256-003-0665-6
   Inoue S, 2013, J PEDIAT HEMATOL ONC, V35, P402, DOI 10.1097/MPH.0b013e3182580d1f
   Jakubauskas A, 2011, EXP MOL PATHOL, V90, P194, DOI 10.1016/j.yexmp.2010.12.005
   Jones RL, 2011, MED ONCOL, V28, P859, DOI 10.1007/s12032-010-9502-7
   Keung EZ, 2018, EJSO-EUR J SURG ONC, V44, P170, DOI 10.1016/j.ejso.2017.11.014
   Kraft S, 2013, ARCH PATHOL LAB MED, V137, P1680, DOI 10.5858/arpa.2012-0467-CR
   Lee HL, 2014, J ORTHOP SURG-HONG K, V22, P236, DOI 10.1177/230949901402200226
   Licata Luana, 2014, Folia Med (Plovdiv), V56, P271, DOI 10.1515/folmed-2015-0007
   Lin PP, 2007, CANCER, V109, P598, DOI 10.1002/cncr.22429
   Liu XD, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-163
   LUCAS DR, 1992, AM J SURG PATHOL, V16, P1197, DOI 10.1097/00000478-199212000-00006
   Manoel EM, 2012, BRAZ J OTORHINOLAR, V78, P135, DOI 10.5935/1808-8694.20120021
   Mootha AK, 2012, J KNEE SURG, V25, P75, DOI 10.1055/s-0031-1275399
   MORISHITA S, 1987, CLIN ORTHOP RELAT R, P276
   Nakayama S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-538
   Ogawa T, 2017, J DERMATOL, V44, pE276, DOI 10.1111/1346-8138.13979
   Omori S, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0588-4
   Poignonec S., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P369
   REEVES BR, 1992, CANCER GENET CYTOGEN, V64, P101, DOI 10.1016/0165-4608(92)90336-7
   Rocco G, 2009, ANN THORAC SURG, V87, P1927, DOI 10.1016/j.athoracsur.2008.10.077
   Sadatomo A, 2011, JPN J CLIN ONCOL, V41, P915, DOI 10.1093/jjco/hyr056
   Sandberg AA, 2001, CANCER GENET CYTOGEN, V130, P1, DOI 10.1016/S0165-4608(01)00462-9
   Schoffski P, 2017, ANN ONCOL, V28, P3000, DOI 10.1093/annonc/mdx527
   Sharma K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011012
   Shmookler B, 2001, MUSCULOSKELETAL CANCER SURGERY: TREATMENT OF SARCOMAS AND ALLIED DISEASES, P3
   Sidiropoulos M, 2013, J CUTAN PATHOL, V40, P265, DOI 10.1111/cup.12058
   Singh M, 2014, HISTOPATHOLOGY, V64, P750, DOI 10.1111/his.12299
   STENMAN G, 1992, GENE CHROMOSOME CANC, V4, P122, DOI 10.1002/gcc.2870040204
   Takahashi T, 2007, INTERNAL MED, V46, P1757, DOI 10.2169/internalmedicine.46.0356
   Walker EA, 2011, RADIOL CLIN N AM, V49, P1219, DOI 10.1016/j.rcl.2011.07.006
   Wang WL, 2009, MODERN PATHOL, V22, P1201, DOI 10.1038/modpathol.2009.85
   Yanagawa T, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000225
   Yokoyama R, 2000, SKELETAL RADIOL, V29, P302
   Yu Sheng-ji, 2008, Zhonghua Yi Xue Za Zhi, V88, P1458
   Zhang WB, 2011, SKELETAL RADIOL, V40, P633, DOI 10.1007/s00256-010-1077-z
NR 57
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1140
EP E1146
DI 10.1016/j.wneu.2019.02.216
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400143
PM 30880192
DA 2020-05-12
ER

PT J
AU Cho, SM
   Park, MS
   Yoon, SH
   Kim, MR
   Hu, C
   Chang, YL
AF Cho, Sung Min
   Park, Moon Sung
   Yoon, Soo Han
   Kim, Mi Ran
   Hu, Chul
   Chang, Young Lu
TI Correlation of Neonatal Birth-Associated Greenstick Skull Fractures with
   Perinatal Factors and Long-Term Outcome: Children with a Greater Number
   of Greenstick Skull Fractures Showed Poor Results in Terms of Long-Term
   Neurodevelopment
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3-Dimensional reconstructed computed tomography; Birth injury;
   Greenstick fracture; Neonate; Skull fracture
ID COMPUTED-TOMOGRAPHY; NULLIPAROUS WOMEN; RISK-FACTORS; TRAUMA;
   ENCEPHALOPATHY; INJURIES; DELIVERY; INFANTS; MODE; HEAD
AB OBJECTIVE: Skull fractures caused by birth injury are mainly compression and linear fractures, but the incidence is known to be rare. It has been recently suggested, however, that greenstick fractures (GSFs) are more common than compression or linear fractures that are detected through 3-dimensional reconstructed computed tomography. Therefore, this study was conducted to determine the correlation of GSF with perinatal factors, the accompanying head injury factors, and the long-term outcomes in neonates.
   METHODS: A retrospective study was conducted on correlations between GSF and perinatal and head injury factors for 295 neonates. In 160 neonates, the correlation with long-term outcome was investigated.
   RESULTS: In 295 neonates, 47 cases had 3 or fewer GSFs, 66 cases had 4-6, 82 cases had 7-9, and 100 cases had 10 or more. The number of GSFs was significantly associated with gestational age and mode of delivery among the perinatal factors, with brain swelling and cephalohematoma among the head injury factors. It was also associated with long-term outcomes. The cut-off value of the number of GSFs for a poor outcome by the area under the receiver operating characteristic curve was 6 or greater.
   CONCLUSIONS: It was concluded that GSF most commonly occurs as a birth-related skull fracture and that birth-related GSF is associated with perinatal factors, birth-related head injuries, and deterioration of long-term development. Therefore, efforts should be made to prevent GSF at birth.
C1 [Cho, Sung Min; Hu, Chul] Yonsei Univ, Wonju Severance Christian Hosp, Dept Neurosurg, Wonju Coll Med, Wonju, South Korea.
   [Park, Moon Sung] Ajou Univ, Sch Med, Dept Pediat, Suwon, South Korea.
   [Yoon, Soo Han; Chang, Young Lu] Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea.
   [Kim, Mi Ran] Ajou Univ, Sch Med, Dept Obstet & Gynecol, Suwon, South Korea.
RP Yoon, SH (reprint author), Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea.
EM ee802000@yahoo.co.kr
FU Samjin Pharm Co., Ltd., Seoul, Korea
FX This work was supported by Samjin Pharm Co., Ltd., Seoul, Korea in 2018.
CR ABEDZADEHKALAHROUD, 2015, ARCH TRAUMA RES, V4
   Baskett TF, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.065
   Bhat B. Vishnu, 1994, Indian Journal of Pediatrics, V61, P401, DOI 10.1007/BF02751901
   Borna H, 2010, TAIWAN J OBSTET GYNE, V49, P170, DOI 10.1016/S1028-4559(10)60036-8
   Bowman R, 2009, NEUROLOGICAL SURG, P3481
   Cho SM, 2018, WORLD NEUROSURG, V109, pE305, DOI 10.1016/j.wneu.2017.09.168
   Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996
   Grobman WA, 2016, OBSTET GYNECOL, V127, P667, DOI 10.1097/AOG.0000000000001354
   Hankins GDV, 2003, OBSTET GYNECOL, V102, P628, DOI 10.1016/S0029-7844(03)00574-X
   HARWOODNASH DC, 1971, RADIOLOGY, V101, P151, DOI 10.1148/101.1.151
   Hughes CA, 1999, ARCH OTOLARYNGOL, V125, P193, DOI 10.1001/archotol.125.2.193
   Iliodromiti S, 2014, LANCET, V384, P1749, DOI 10.1016/S0140-6736(14)61135-1
   Kim YI, 2012, J KOREAN NEUROSURG S, V52, P528, DOI 10.3340/jkns.2012.52.6.528
   Linder N, 2013, J MATERN-FETAL NEO M, V26, P1491, DOI 10.3109/14767058.2013.789850
   NATELSON SE, 1973, PEDIATRICS, V51, P169
   Perlow JH, 1996, J REPROD MED, V41, P754
   Pisani F, 2015, EUR J PAEDIATR NEURO, V19, P6, DOI 10.1016/j.ejpn.2014.10.001
   Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403
   RANTAKALLIO P, 1987, EARLY HUM DEV, V15, P75, DOI 10.1016/0378-3782(87)90040-5
   ROBERTSON C, 1985, DEV MED CHILD NEUROL, V27, P473
   Rouse DJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.003
   SALONEN IS, 1990, Z KINDERCHIR, V45, P133
   Sauber-Schatz EK, 2010, PAEDIATR PERINAT EP, V24, P116, DOI 10.1111/j.1365-3016.2009.01077.x
   Takenouchi T, 2012, PEDIATR NEUROL, V46, P106, DOI 10.1016/j.pediatrneurol.2011.11.011
   Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301
   van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8
   Werner EF, 2011, OBSTET GYNECOL, V118, P1239, DOI 10.1097/AOG.0b013e31823835d3
   ZELSON C, 1974, J PEDIATR-US, V85, P371, DOI 10.1016/S0022-3476(74)80118-6
NR 28
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1197
EP E1205
DI 10.1016/j.wneu.2019.03.065
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400150
PM 30885873
DA 2020-05-12
ER

PT J
AU Chotai, S
   Khan, I
   Nian, H
   Archer, KR
   Harrell, FE
   Weisenthal, BM
   Bydon, M
   Asher, AL
   Devin, CJ
AF Chotai, Silky
   Khan, Inamullah
   Nian, Hui
   Archer, Kristin R.
   Harrell, Frank E.
   Weisenthal, Benjamin M.
   Bydon, Mohamad
   Asher, Anthony L.
   Devin, Clinton J.
TI Utility of Anxiety/Depression Domain of EQ-5D to Define Psychological
   Distress in Spine Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anxiety; Depression; EQ-5D; Psychological distress; Spine
ID QUALITY-OF-LIFE; ANTERIOR CERVICAL DISKECTOMY; ADJACENT-SEGMENT DISEASE;
   HEALTH-CARE EXPENDITURES; REVISION LUMBAR SURGERY; UNITED-STATES TRENDS;
   LOW-BACK-PAIN; DEPRESSION SCALE; PATIENT SATISFACTION; PREOPERATIVE
   DEPRESSION
AB BACKGROUND: Prospective patient-reported outcomes (PROs) registries are central to emerging evidence-driven reform models. These registries entail significant operator and responder burden to capture PROs data. It is important to limit the number of PROs administered. We sought to determine whether the anxiety/depression domain of EQ-5D could be used to define preoperative psychological distress in patients undergoing elective spine surgery.
   METHODS: Patients undergoing elective spine surgery and enrolled into a prospective registry were analyzed. The 12-Item Short-Form Health Survey Mental Component Summary, Zung depression scale, Modified Somatic Perception Questionnaire, and EQ-5D were completed. The anxiety/depression domain of EQ-5D was used to define psychological distress; responses were captured as 1) not anxious or depressed, 2) moderately anxious or depressed, or 3) extremely anxious or depressed. Univariate correlation and proportional odds logistic regression analyses were conducted.
   RESULTS: Of 2470 included patients undergoing elective spine surgery, 45% (n = 1109) reported no psychological distress, 47% (n = 1168) reported moderate psychological distress, and 8% (n = 193) reported extreme psychological distress on EQ-5D. Psychological distress on EQ-5D had positive correlation with Zung depression scale (P < 0.0001, r = 0.620) and Modified Somatic Perception Questionnaire (P < 0.0001, r = 0.450) and negative correlation with 12Item Short-Form Health Survey Mental Component Summary (P < 0.0001, r = 0.662). In proportional odds logistic regression models, EQ-5D psychological distress had significant correlations with 12-Item Short-Form Health Survey Mental Component Summary (P < 0.0001, C-index = 0.831), Zung depression scale (P < 0.0001, C-index = 0.802), and Modified Somatic Perception Questionnaire (P < 0.0001, C-index = 0.711).
   CONCLUSIONS: The anxiety/depression domain of EQ-5D could be used to categorize preoperative psychological distress. Spine registries could use this information to potentially limit the number of validated PROs administered.
C1 [Chotai, Silky; Khan, Inamullah; Archer, Kristin R.; Weisenthal, Benjamin M.; Devin, Clinton J.] Vanderbilt Univ, Med Ctr, Dept Orthoped Surg, Nashville, TN 37232 USA.
   [Chotai, Silky; Khan, Inamullah; Devin, Clinton J.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA.
   [Archer, Kristin R.] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, Nashville, TN USA.
   [Nian, Hui; Harrell, Frank E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA.
   [Bydon, Mohamad] Mayo Clin, Dept Neurosurg, Rochester, MN USA.
   [Asher, Anthony L.] Carolina Neurosurg & Spine Associates, Dept Neurol Surg, Charlotte, NC USA.
RP Devin, CJ (reprint author), Vanderbilt Univ, Med Ctr, Dept Orthoped Surg, Nashville, TN 37232 USA.; Devin, CJ (reprint author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA.
EM clintondevin@gmail.com
OI Khan, Inamullah/0000-0002-1519-8940
CR Abtahi AM, 2015, J BONE JOINT SURG AM, V97A, P824, DOI 10.2106/JBJS.N.00916
   Adogwa O, 2014, J NEUROSURG-SPINE, V21, P153, DOI 10.3171/2014.4.SPINE12668
   Adogwa O, 2013, SPINE J, V13, P501, DOI 10.1016/j.spinee.2013.01.017
   Adogwa O, 2012, SPINE J, V12, P179, DOI 10.1016/j.spinee.2011.08.014
   Alvin MD, 2016, GLOB SPINE J, V6, P306, DOI 10.1055/s-0035-1562932
   Anderson JT, 2015, ORTHOPEDICS, V38, pE1065, DOI 10.3928/01477447-20151120-02
   Archer KR, 2016, J PAIN, V17, P76, DOI 10.1016/j.jpain.2015.09.013
   Asher AL, 2016, J NEUROSURG-SPINE, V25, P170, DOI 10.3171/2015.11.SPINE15872
   Asher AL, 2014, SPINE, V39, pS106, DOI 10.1097/BRS.0000000000000579
   Asher AL, 2014, SPINE, V39, pS136, DOI 10.1097/BRS.0000000000000543
   Carreon LY, 2018, SPINE, V43, P35, DOI 10.1097/BRS.0000000000000989
   Carreon LY, 2016, J NEUROSURG-SPINE, V25, P352, DOI 10.3171/2016.2.SPINE151472
   Chaichana KL, 2011, J NEUROSURG-SPINE, V14, P261, DOI 10.3171/2010.10.SPINE10190
   Chapin L, 2017, CLIN SPINE SURG, V30, pE725, DOI 10.1097/BSD.0000000000000331
   Chotai S, 2016, SPINE J, V16, P1342, DOI 10.1016/j.spinee.2016.06.023
   Chotai S, 2015, NEUROSURGERY, V77, P553, DOI 10.1227/NEU.0000000000000886
   Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005
   Daubs MD, 2011, SPINE, V36, pS96, DOI 10.1097/BRS.0b013e31822ef6b9
   Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a
   Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338
   Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002
   FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263
   Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005
   Godil SS, 2014, SPINE J, V14, P2885, DOI 10.1016/j.spinee.2014.04.023
   Gornet MF, 2016, INT J SPINE SURG, V10, DOI 10.14444/3011
   Hoff RA, 1999, PSYCHIATR SERV, V50, P680, DOI 10.1176/ps.50.5.680
   Jutte JE, 2015, J CRIT CARE, V30, P793, DOI 10.1016/j.jcrc.2015.04.006
   Kohlboeck G, 2004, CLIN J PAIN, V20, P455, DOI 10.1097/00002508-200411000-00011
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Larkin DJ, 2016, J EVAL CLIN PRACT, V22, P133, DOI 10.1111/jep.12271
   Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8
   Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F
   MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5
   Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656
   Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1
   McGirt MJ, 2014, SPINE, V39, pS117, DOI 10.1097/BRS.0000000000000552
   Melloh M, 2008, EUR SPINE J, V17, P1201, DOI 10.1007/s00586-008-0665-2
   Pakarinen M, 2014, SPINE J, V14, P2392, DOI 10.1016/j.spinee.2014.01.047
   Parker SL, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15355
   Parker SL, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15356
   Parker SL, 2015, WORLD NEUROSURG, V83, P608, DOI 10.1016/j.wneu.2014.12.018
   Parker SL, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.09.013
   R Core Team, 2015, R LANG ENV STAT COMP
   Schluessmann E, 2009, EUR SPINE J, V18, P851, DOI 10.1007/s00586-009-0934-8
   Sinikallio S, 2011, SPINE, V36, P677, DOI 10.1097/BRS.0b013e3181dcaf4a
   Supina AL, 2007, QUAL LIFE RES, V16, P749, DOI 10.1007/s11136-006-9159-z
   Taylor R, 2005, CLIN J PAIN, V21, P91, DOI 10.1097/00002508-200501000-00011
   Tetreault L, 2017, SPINE, V42, P372, DOI 10.1097/BRS.0000000000001777
   Trief PM, 2006, SPINE, V31, P823, DOI 10.1097/01.brs.0000206362.03950.5b
   Wahlman M, 2014, EUR SPINE J, V23, P129, DOI 10.1007/s00586-013-2896-0
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Waterman BR, 2012, SPINE J, V12, P63, DOI 10.1016/j.spinee.2011.09.002
   Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe
   Whitmore RG, 2015, J NEUROSURG-SPINE, V23, P459, DOI 10.3171/2015.1.SPINE14890
   Wilhelm M, 2017, PHYSIOTHER RES INT, V22, DOI 10.1002/pri.1648
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008
NR 57
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1075
EP E1080
DI 10.1016/j.wneu.2019.02.211
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400136
PM 30880196
DA 2020-05-12
ER

PT J
AU Chung, J
   Park, W
   Park, JC
   Kwun, BD
   Ahn, JS
AF Chung, Jaewoo
   Park, Wonhyoung
   Park, Jung Cheol
   Kwun, Byung Duk
   Ahn, Jae Sung
TI Characteristics of Peri-Internal Carotid Artery Bifurcation Aneurysms
   According to a New Anatomic Classification: How to Overcome Difficulties
   in the Microsurgical Treatment of Posteroinferiorly Projecting
   Carotid-A1 Junctional Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Carotid-A1 junctional aneurysm; ICA bifurcation aneurysm; Proximal A1
   aneurysm
ID ANTERIOR CEREBRAL-ARTERY; ENDOVASCULAR TREATMENT; COIL EMBOLIZATION; A1
   SEGMENT; MANAGEMENT
AB OBJECTIVE: Based on our clinical experience, posteroinferiorly projecting carotid-A1 junctional aneurysms are often difficult to treat microsurgically. Our objective was to classify peri-internal carotid artery (ICA) bifurcation aneurysms according to their location and analyze their characteristics.
   METHODS: From January 2008 to October 2017, microsurgical or endovascular treatment of 6777 aneurysms were performed at our hospital. We identified 199 peri-ICA bifurcation aneurysms (2.94%) classified into true ICA bifurcation aneurysm, carotid-A1 junctional aneurysm, and carotid-M1 junctional aneurysm according to the anatomic location. Medical records including patient characteristics, aneurysm location, surgical method, any neurologic deficits, clinical outcomes, medical history, and radiologic findings were retrospectively reviewed. The anatomic position of the aneurysm was defined from the virtual surgical, anteroposterior, and lateral views, and the degree of agreement was calculated.
   RESULTS: There were 103 true ICA bifurcation aneurysms, 92 carotid-A1 junctional aneurysms, and 4 carotid-M1 junctional aneurysms. Carotid-A1 junctional aneurysms tended to be smaller, elongated, and more often posteroinferiorly projecting than true ICA bifurcation aneurysms. Posteroinferiorly projecting carotid-A1 junctional aneurysms tended to require complex aneurysm surgery. The virtual surgical view had an almost perfect degree of agreement with the actual surgical view.
   CONCLUSIONS: The characteristics of carotid-A1 junctional aneurysms and true ICA bifurcation aneurysms differ. In particular, carotid-A1 junctional aneurysms tend to have a posteroinferior projection and that causes difficulty in surgical treatment. We recommend the virtual surgical view for preoperative planning. Furthermore, an adequate Sylvian fissure opening and a strategic approach using appropriate devices to inspect blind spots should be considered for a successful treatment outcome..
C1 [Chung, Jaewoo; Park, Wonhyoung; Park, Jung Cheol; Ahn, Jae Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea.
   [Kwun, Byung Duk] Kyung Hee Univ, Coll Med, Dept Neurosurg, Med Ctr, Seoul, South Korea.
RP Ahn, JS (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea.
EM jsahn@amc.seoul.kr
OI Park, Jung Cheol/0000-0001-6677-455X; Chung, Jaewoo/0000-0002-3512-6610
CR BULL JWD, 1962, BRIT MED J, P1701
   Cho YD, 2014, NEURORADIOLOGY, V56, P219, DOI 10.1007/s00234-014-1319-1
   Czepko R, 2005, J Neurosurg Sci, V49, P85
   Dashti R, 2007, SURG NEUROL, V68, P366, DOI 10.1016/j.surneu.2007.07.084
   Gupta SK, 2007, NEUROL MED-CHIR, V47, P153, DOI 10.2176/nmc.47.153
   HANDA J, 1984, SURG NEUROL, V22, P486, DOI 10.1016/0090-3019(84)90308-2
   Hino A, 2002, ACTA NEUROCHIR, V144, P1291, DOI 10.1007/s00701-002-1014-6
   Ko JK, 2013, J KOREAN NEUROSURG S, V54, P75, DOI 10.3340/jkns.2013.54.2.75
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee WJ, 2014, CLIN RADIOL, V69, pE273, DOI 10.1016/j.crad.2014.01.017
   Lehecka M, 2009, SURG NEUROL, V71, P649, DOI 10.1016/j.surneu.2009.01.028
   LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219
   Lubicz B, 2009, NEURORADIOLOGY, V51, P99, DOI 10.1007/s00234-008-0474-7
   Miyazawa N, 2002, CLIN NEUROL NEUROSUR, V104, P103, DOI 10.1016/S0303-8467(01)00195-0
   Oshiro EM, 1997, J NEUROSURG, V87, P163, DOI 10.3171/jns.1997.87.2.0163
   Park J, 2007, ACTA NEUROCHIR, V149, P817, DOI 10.1007/s00701-007-1223-0
   Park W, 2014, ACTA NEUROCHIR, V156, P869, DOI 10.1007/s00701-014-2059-z
   SUZUKI M, 1992, J NEUROSURG, V76, P455, DOI 10.3171/jns.1992.76.3.0455
   van Rooij WJ, 2008, NEURORADIOLOGY, V50, P583, DOI 10.1007/s00234-008-0375-9
   WAKABAYASHI T, 1985, SURG NEUROL, V24, P31, DOI 10.1016/0090-3019(85)90059-X
   Wanibuchi M, 2001, SURG NEUROL, V55, P148, DOI 10.1016/S0090-3019(01)00396-2
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1219
EP E1227
DI 10.1016/j.wneu.2019.02.232
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400153
PM 30885871
DA 2020-05-12
ER

PT J
AU Clarke, MJ
   Steffens, FL
   Mallory, GW
   Starr, SR
   Porter, BL
   Krauss, WE
   Dankbar, EC
AF Clarke, Michelle J.
   Steffens, Fay L.
   Mallory, Grant W.
   Starr, Stephanie R.
   Porter, Barbara L.
   Krauss, William E.
   Dankbar, Eugene C.
TI Incorporating Quality Improvement into Resident Education: Structured
   Curriculum, Evaluation, and Quality Improvement Projects
SO WORLD NEUROSURGERY
LA English
DT Article
DE Curriculum; Neurosurgery residency; Quality improvement
ID MEDICAL-EDUCATION
AB BACKGROUND: Quality Improvement (QI) is essential for improving health care delivery and is now a required component of neurosurgery residency. However, neither a formal curriculum nor implementation strategies have been established by the Accreditation Council for Graduate Medical Education.
   METHODS: We describe our experience with implementing a formal QI curriculum, including structured didactics and resident led group-based QI projects. Course materials and didactics were provided by the Mayo Quality Academy. Participants were required to take a 30-question multiple-choice exam to demonstrate basic proficiency in QI methods following completion of didactic. An anonymous survey also was performed to elicit feedback from course participants.
   RESULTS: All of the 40 student participants (17 residents) were able to demonstrate basic proficiency in QI methods on a standardized exam upon course completion. Of the 9 attempted QI projects, 7 were completed, with 5 of those resulting in sustained process changes. The majority of participants felt formal training improved confidence in QI processes and was a valuable professional tool for their careers.
   CONCLUSIONS: A formal didactic curriculum and practical application of QI methodologies adds value to resident training. Further, it has the potential to positively impact practice. Consideration should be given to adopting a formal QI curriculum by other neurosurgery departments and perhaps standardization on national level.
C1 [Clarke, Michelle J.; Mallory, Grant W.; Krauss, William E.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
   [Steffens, Fay L.; Starr, Stephanie R.; Porter, Barbara L.; Dankbar, Eugene C.] Mayo Clin, Mayo Qual Acad, Rochester, MN USA.
   [Starr, Stephanie R.] Mayo Clin, Commun Pediat & Adolescent Med, Rochester, MN USA.
RP Clarke, MJ (reprint author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
EM Clarke.michelle@mayo.edu
CR Abrampah NM, 2018, INT J QUAL HEALTH C, V30, P5, DOI 10.1093/intqhc/mzy007
   American Board of Neurological Surgery, 2013, NEWSLETTER
   Barber KH, 2015, ACAD MED, V90, P1363, DOI 10.1097/ACM.0000000000000851
   de Koning Henk, 2006, J Healthc Qual, V28, P4
   Fargen KM, 2014, WORLD NEUROSURG, V82, pE61, DOI 10.1016/j.wneu.2013.01.075
   Groman R, 2015, NEUROSURG CLIN N AM, V26, P167, DOI 10.1016/j.nec.2014.11.006
   Han SJ, 2014, J NEUROSURG, V120, P173, DOI 10.3171/2013.8.JNS13512
   Hull L, 2017, ANN SURG, V265, P1104, DOI 10.1097/SLA.0000000000002013
   Khalessi AA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12317
   McCulloch P, 2017, ANN SURG, V265, P90, DOI 10.1097/SLA.0000000000001589
   McLaughlin N, 2015, J NEUROSURG, V123, P198, DOI 10.3171/2014.9.JNS14666
   Medbery RL, 2014, J SURG EDUC, V71, P613, DOI 10.1016/j.jsurg.2013.12.004
   Parker SL, 2015, NEUROSURG CLIN N AM, V26, P231, DOI 10.1016/j.nec.2014.11.012
   Potts S, 2016, FAM MED, V48, P477
   Rolston JD, 2015, NEUROSURG CLIN N AM, V26, pXIII, DOI 10.1016/j.nec.2015.01.001
   Runnacles J, 2013, BMJ QUAL SAF, V22, P956, DOI 10.1136/bmjqs-2012-001718
   Swensen SJ, 2012, AM J MED QUAL, V27, P58, DOI 10.1177/1062860611410966
   The Accreditation Council for Graduate Medical Education, 2015, COMM PROGR REQ
   The Accreditation Council for Graduate Medical Education The American Board of Neurological Surgery, 2015, NEUR SURG MIL PROJ
   Titsworth WL, 2016, J NEUROSURG, V125, P1523, DOI 10.3171/2015.10.JNS15698
   White Christine, 2009, Perm J, V13, P16
   Witiw CD, 2015, NEUROSURG CLIN N AM, V26, P197, DOI 10.1016/j.nec.2014.11.003
   Wong BM, 2012, MED EDUC, V46, P107, DOI 10.1111/j.1365-2923.2011.04154.x
   Yanamadala Mamata, 2014, J Grad Med Educ, V6, P147, DOI 10.4300/JGME-D-13-00140.1
   Yang I, 2015, NEUROSURG CLIN N AM, V26, P301, DOI 10.1016/j.nec.2014.11.017
   Zafar MA, 2014, ACAD MED, V89, P1341, DOI 10.1097/ACM.0000000000000424
   Ziewacz JE, 2015, NEUROSURG CLIN N AM, V26, P157, DOI 10.1016/j.nec.2014.11.014
NR 27
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1112
EP E1120
DI 10.1016/j.wneu.2019.02.214
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400140
PM 30880201
DA 2020-05-12
ER

PT J
AU Cote, DJ
   Barnett, I
   Onnela, JP
   Smith, TR
AF Cote, David J.
   Barnett, Ian
   Onnela, Jukka-Pekka
   Smith, Timothy R.
TI Digital Phenotyping in Patients with Spine Disease: A Novel Approach to
   Quantifying Mobility and Quality of Life
SO WORLD NEUROSURGERY
LA English
DT Article
DE Digital phenotyping; Outcomes; Spine
ID REPORTED OUTCOME MEASURES; SURGERY; QUESTIONNAIRE; RISK; PAIN
AB OBJECTIVE: To identify trends in mobility and daily pain levels among a cohort of patients with clinically diagnosed spine disease.
   METHODS: Participants with spine disease were enrolled from a general neurosurgical clinic and installed a smartphone application (Beiwe) designed for digital phenotyping to their personal smartphone. This application collected passive meta-data on a minute-to-minute basis, including global positioning system (GPS), WiFi, accelerometer, text and telephone logs, and screen on and off time. The application also administered daily visual analog scale pain surveys. A linear mixed model framework was used to test for associations between self-reported pain and mobility and sociability from the passively collected data.
   RESULTS: A total of 105 patients were enrolled, with a median follow-up time of 94.5 days; 55 patients underwent a surgical intervention during the follow-up period. The weekly pain survey response rate was 73.2%. By the end of follow-up, the mean change in pain for all patients was -1.3 points (4.96 at the start of follow-up to 3.66 by the end of follow-up). Increased pain was significantly associated with reduced patient mobility as measured using 3 daily GPS summary statistics (i.e., average flight length, maximum diameter travelled, total distance travelled).
   CONCLUSIONS: Patients with spine disease who reported greater pain had reduced mobility, as measured by the passively collected smartphone GPS data. Smartphone-based digital phenotyping appears to be a promising and scalable approach to assess mobility and quality of life of patients with spine disease.
C1 [Cote, David J.; Smith, Timothy R.] Harvard Med Sch, Brigham & Womens Hosp, Computat Neurosci Outcomes Ctr, Boston, MA 02115 USA.
   [Barnett, Ian; Onnela, Jukka-Pekka] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.
RP Cote, DJ (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Computat Neurosci Outcomes Ctr, Boston, MA 02115 USA.
EM david_cote@hms.harvard.edu
FU National Institutes of Health Training GrantUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [T32
   CA009001]
FX The present study was supported by a National Institutes of Health
   Training Grant (grant T32 CA009001 to D. J. C.).
CR Ammendolia C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0106-y
   Auffinger BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067408
   Barnett I, 2018, BIOSTATISTICS
   Baron R, 2006, SPINE, V31, P2575, DOI 10.1097/01.brs.0000240694.83621.52
   Belisario JSM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000042.pub2
   BenDebba M, 2002, SPINE, V27, P2116, DOI 10.1097/00007632-200210010-00007
   Benjamini Y, 2001, ANN STAT, V29, P1165
   Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031
   BRAZIER J, 1993, QUAL LIFE RES, V2, P169, DOI 10.1007/BF00435221
   Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006
   Deb S, 2017, J NEURO-ONCOL, V132, P447, DOI 10.1007/s11060-017-2391-2
   Demir S, 2014, EUR J PHYS REHAB MED, V50, P627
   Devlin NJ, 2010, HEALTH ECON, V19, P886, DOI 10.1002/hec.1608
   Dhand A, 2016, NAT REV NEUROL, V12, P605, DOI 10.1038/nrneurol.2016.119
   Elsworth C, 2009, CLIN REHABIL, V23, P171, DOI 10.1177/0269215508098895
   Faherty LJ, 2017, J AM MED INFORM ASSN, V24, P746, DOI 10.1093/jamia/ocx005
   Falavigna A, 2017, WORLD NEUROSURG, V108, P328, DOI 10.1016/j.wneu.2017.09.002
   Faraj SSA, 2017, EUR SPINE J, V26, P2084, DOI 10.1007/s00586-017-5125-4
   Foley S, 2010, OSTEOPOROSIS INT, V21, P1809, DOI 10.1007/s00198-009-1137-1
   Forsth P, 2016, NEW ENGL J MED, V374, P1413, DOI 10.1056/NEJMoa1513721
   Gasmi H, 2018, THIRTEENTH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING ADVANCES (ICSEA 2018), P1
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Insel TR, 2017, JAMA-J AM MED ASSOC, V318, P1215, DOI 10.1001/jama.2017.11295
   Johnson AM, 2001, AIDS, V15, P111, DOI 10.1097/00002030-200101050-00016
   Khanolkar AR, 2016, J EPIDEMIOL COMMUNIT, V70
   Kim CH, 2016, SPINE J, V16, P843, DOI 10.1016/j.spinee.2016.02.048
   MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241
   Moojen Wouter A, 2016, Eur J Orthop Surg Traumatol, V26, P681, DOI 10.1007/s00590-016-1828-1
   Moojen WA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6415
   Nagayoshi M, 2014, STROKE, V45, P2868, DOI 10.1161/STROKEAHA.114.005815
   Nayak Nikhil R, 2015, Surg Neurol Int, V6, pS490, DOI 10.4103/2152-7806.166892
   Paulsen RT, 2018, NEUROSURGERY, V82, P645, DOI 10.1093/neuros/nyx298
   Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618
   Saeb S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4273
   Smith A, 2015, US SMARTPHONE USE 20
   Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110
   Torous J, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.5165
   Torous J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.3889
   Torous J, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0602-0
   Wang R, 2016, UBICOMP'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P886, DOI 10.1145/2971648.2971740
   Zanoli G, 2005, ACTA ORTHOP, V76, P5
NR 41
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E241
EP E249
DI 10.1016/j.wneu.2019.01.297
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400030
PM 30797933
DA 2020-05-12
ER

PT J
AU Dauleac, C
   Beuriat, PA
   Di Rocco, F
   Szathmari, A
   Mottolese, C
AF Dauleac, Corentin
   Beuriat, Pierre-Aurelien
   Di Rocco, Federico
   Szathmari, Alexandru
   Mottolese, Carmine
TI Surgical Management of Pediatric Spine Trauma: 12 Years of Experience
SO WORLD NEUROSURGERY
LA English
DT Article
DE Magerl; Pediatric; Posterior wall recession; Spine trauma; Surgery
ID INJURY CLASSIFICATION; CORD-INJURY; CHILDREN; FRACTURES; MRI
AB OBJECTIVE: Spine trauma management in children varies from one team to another, and to date, no clear consensus has been reached. The goal of this study was to describe the epidemiology of spine trauma in children and evaluate the timing and techniques of surgery when it was required.
   METHODS: A retrospective review of all patients admitted to our pediatric trauma center for spine traumas that required surgical management, between 2005 and 2016, was performed. All patients were followed with clinical and radiologic examination to evaluate the quality of fusion and realignment.
   RESULTS: Seventy-three children, with a mean age of 14.1 years, were admitted. Spinal injuries were more common in the teenage group (14-18 years). The predominant etiology of spine injuries was motor vehicle collision (36%). The spinal level of injury varied according to the age group: young children presented more cervical traumas (P < 0.01), while teenagers presented more lumbar traumas. There were more fractures alone in the teenage group (P < 0.005), while there were more luxations alone in the school-age group (P < 0.05). Median timing for surgical intervention in patients with neurologic deficits was 1 day. Patients with posterior wall recession >5 mm underwent surgical management quicker than patients with no posterior wall recession (P < 0.03). At follow-up, out of the 37 patients with initial neurologic deficits, 14 had improved (38%).
   CONCLUSIONS: Diskoligament maturation is an essential concept in spine traumas in children, as well as in surgical management. Surgical procedures should be carried out as soon as possible when patients present with neurologic deficits. At the thoracolumbar junction, a 2-level up-and-down fixation is recommended.
C1 [Dauleac, Corentin; Beuriat, Pierre-Aurelien; Szathmari, Alexandru; Mottolese, Carmine] Hosp Civils Lyon, Hosp Neurol & Neurosurg Pierre Wertheimer, Dept Neurosurg, Lyon, France.
   [Dauleac, Corentin; Beuriat, Pierre-Aurelien; Di Rocco, Federico] Univ Lyon, Univ Claude Bernard, Lyon, France.
   [Beuriat, Pierre-Aurelien; Di Rocco, Federico; Szathmari, Alexandru; Mottolese, Carmine] Hosp Civils Lyon, Hop Femme Mere Enfant, Dept Pediat Neurosurg, Lyon, France.
RP Dauleac, C (reprint author), Hosp Civils Lyon, Hosp Neurol & Neurosurg Pierre Wertheimer, Dept Neurosurg, Lyon, France.; Dauleac, C (reprint author), Univ Lyon, Univ Claude Bernard, Lyon, France.
EM corentin.dauleac@chu-lyon.fr
OI Di Rocco, Federico/0000-0003-2145-5533
CR [Anonymous], 1996, Rev Chir Orthop Reparatrice Appar Mot, V82 Suppl 1, P61
   Basu Saumyajit, 2012, Front Neurol, V3, P96, DOI 10.3389/fneur.2012.00096
   Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665
   Carreon LY, 2004, J SPINAL DISORD TECH, V17, P477, DOI 10.1097/01.bsd.0000132290.50455.99
   Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011
   da Silva MR, 2016, INT ORTHOP, V40, P1111, DOI 10.1007/s00264-016-3158-7
   DAVIS PC, 1993, AM J NEURORADIOL, V14, P607
   Dawkins RL, 2019, NEUROSURGERY, V84, pE362, DOI 10.1093/neuros/nyy408
   Dawkins RL, 2018, J NEUROSURG-PEDIATR, V21, P284, DOI 10.3171/2017.7.PEDS1720
   DICKMAN CA, 1991, J SPINAL DISORD, V4, P296, DOI 10.1097/00002517-199109000-00006
   Erfani M A, 2014, Musculoskelet Surg, V98, P107, DOI 10.1007/s12306-014-0313-4
   HAMILTON MG, 1992, J NEUROSURG, V77, P700, DOI 10.3171/jns.1992.77.5.0700
   Kim C, 2016, CAN J SURG, V59, P205, DOI 10.1503/cjs.014515
   Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040
   Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591
   Mascarenhas D, 2016, AM J ROENTGENOL, V206, P1292, DOI 10.2214/AJR.15.15492
   Mendoza-Lattes Sergio, 2015, Iowa Orthop J, V35, P135
   Mortazavi MM, 2011, CHILD NERV SYST, V27, P1095, DOI 10.1007/s00381-010-1348-y
   Onen MR, 2015, J SPINE, V4, P211
   Parent S, 2011, J NEUROTRAUM, V28, P1515, DOI 10.1089/neu.2009.1153
   Saul D, 2018, PEDIATRIC REP, V10, DOI 10.4081/pr.2018.7232
   Sayama C, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1490
   Suttor S, 2013, EUR SPINE J, V22, P510, DOI 10.1007/s00586-012-2582-7
   Wang HW, 2012, J NEUROSURG-SPINE, V17, P459, DOI 10.3171/2012.8.SPINE111003
   Yucesoy K, 2008, CLIN NEUROL NEUROSUR, V110, P429, DOI 10.1016/j.clineuro.2008.02.004
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1494
EP E1502
DI 10.1016/j.wneu.2019.03.134
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400188
PM 30910750
DA 2020-05-12
ER

PT J
AU Dayyani, M
   Zabihyan, S
   Salehi, M
   Baharvandat, H
   Ahmadi, S
   Etemadrezaie, H
AF Dayyani, Mojtaba
   Zabihyan, Samira
   Salehi, Maryam
   Baharvandat, Humain
   Ahmadi, Sina
   Etemadrezaie, Hamid
TI Association of Opium Addiction with Rupture of Intracranial Aneurysms: A
   Case-Control Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intracranial aneurysms; Opium dependence; Risk factors; Subarachnoid
   hemorrhage
ID INTRAVENOUS MORPHINE; VASCULAR-DISEASE; RISK; ATHEROSCLEROSIS;
   HYPERTENSION; INFLAMMATION; APOPTOSIS; RECEPTOR; SITES
AB BACKGROUND: Disorders related to opioid use account for the most substantial burden of disease attributable to drug use disorders. We aimed to justify if there is an association between either opium consumption or addiction and rupture of intracranial aneurysms.
   METHODS: In this case-control study, we enrolled 50 cases with ruptured intracranial aneurysms and 43 control subjects with an incidental finding of an intracranial aneurysm without history of subarachnoid hemorrhage (SAH). Four major risk factors of rupture including age, sex, size, and site of aneurysm were matched among both groups. All participants were asked about cigarette smoking state, opium addiction, opium consumption, and duration and route of opium consumption. Eight other trigger factors were assessed in the period soon before SAH (hazard period). The odds ratio (OR) of all factors was calculated separately, and then a logistic regression for the factors with significant odds was calculated.
   RESULTS: Sixty-two percent of cases and 32.6% of control subjects were addicted to opium. The OR for opium consumption in the hazard period was 8.1 (95% confidence interval [CI], 2.2-30.1) and for opium addiction was 3.3 (95% CI, 1.4-7.9). Of those trigger factors, cola consumption was included in the logistic regression model. After adjustment, results demonstrated an OR of 9.2 (95% CI, 2.4-34.7) for opium consumption in the hazard period.
   CONCLUSIONS: There is an association between opium addiction and opium consumption in the hazard period with the occurrence of aneurysmal SAH. Replication of the study with a larger sample size and conduction of prospective studies is suggested.
C1 [Dayyani, Mojtaba; Zabihyan, Samira; Baharvandat, Humain; Ahmadi, Sina; Etemadrezaie, Hamid] Mashhad Univ Med Sci, Dept Neurosurg, Ghaem Teaching Hosp, Fac Med, Mashhad, Razavi Khorasan, Iran.
   [Salehi, Maryam] Mashhad Univ Med Sci, Dept Community Med, Fac Med, Mashhad, Razavi Khorasan, Iran.
RP Zabihyan, S (reprint author), Mashhad Univ Med Sci, Dept Neurosurg, Ghaem Teaching Hosp, Fac Med, Mashhad, Razavi Khorasan, Iran.
EM zabihyan@yahoo.com
RI Dayyani, Mojtaba/AAB-1733-2019
OI Dayyani, Mojtaba/0000-0002-1802-0662; Zabihyan,
   Samira/0000-0003-0742-6664
CR Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751
   Aoki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535921
   Davoudi GR, 2006, J TEHRAN HEART CTR, V1, P43
   Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36
   EVANS AGJ, 1952, BRIT J PHARM CHEMOTH, V7, P542, DOI 10.1111/j.1476-5381.1952.tb00720.x
   Feldberg W, 1981, CENTRAL NERVOUS SYST, V6, P229
   FENNESSY MR, 1971, EUR J PHARMACOL, V14, P1, DOI 10.1016/0014-2999(71)90116-6
   Gao YJ, 2002, LIFE SCI, V70, P2675, DOI 10.1016/S0024-3205(02)01525-4
   GOMES C, 1976, N-S ARCH PHARMACOL, V294, P141, DOI 10.1007/BF00507846
   Goodman LS., 2000, GOODMAN GILMANS PHAR
   GRUNDY HF, 1971, BRIT J PHARMACOL, V42, P159, DOI 10.1111/j.1476-5381.1971.tb07098.x
   Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021
   Hsiao PN, 2009, TOXICOLOGY, V256, P83, DOI 10.1016/j.tox.2008.11.015
   Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d
   Kalant H, 1997, ADDICTION, V92, P267
   Karami MT, 2011, J SOC PROBL IRAN, V1, P93
   KAYAALP SO, 1966, BRIT J PHARM CHEMOTH, V26, P196, DOI 10.1111/j.1476-5381.1966.tb01821.x
   Mahmoudian M, 2001, Acta Physiol Hung, V88, P231, DOI 10.1556/APhysiol.88.2001.3-4.5
   Masoomi Mohammad, 2015, Addict Health, V7, P149
   MAY CN, 1989, BRIT J PHARMACOL, V97, P873, DOI 10.1111/j.1476-5381.1989.tb12027.x
   MAY CN, 1988, CLIN SCI, V75, P71, DOI 10.1042/cs0750071
   Meyers PM, 2009, J VASC INTERV RADIOL, V20, pS435, DOI 10.1016/j.jvir.2009.03.004
   Nabati S, 2013, IMMUNOL LETT, V152, P42, DOI 10.1016/j.imlet.2013.04.003
   PFEIFFER A, 1983, ENDOCRINOLOGY, V113, P929, DOI 10.1210/endo-113-3-929
   REES MM, 1993, THROMB RES, V71, P337, DOI 10.1016/0049-3848(93)90160-P
   Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9
   Safaei Nasser, 2008, Pak J Biol Sci, V11, P2594, DOI 10.3923/pjbs.2008.2594.2598
   Schmidt CF, 1933, J PHARMACOL EXP THER, V47, P411
   Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120
   U. S. Department of State, 2015, INT NARCOTICS CONTRO
   United Nations Office on Drugs and Crime, 2017, WORLD DRUG REP 2017
   Vlak MHM, 2012, J NEUROL, V259, P1298, DOI 10.1007/s00415-011-6341-1
   Vlak MHM, 2011, STROKE, V42, P1878, DOI 10.1161/STROKEAHA.110.606558
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P460, DOI 10.1161/01.ATV.14.3.460
   Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601
   Zabihyan S, 2011, WORLD NEUROSURG, V76, P372, DOI 10.1016/j.wneu.2011.08.029
NR 37
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E492
EP E499
DI 10.1016/j.wneu.2019.02.077
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400059
PM 30825629
DA 2020-05-12
ER

PT J
AU Doddamani, RS
   Sawarkar, D
   Meena, RK
   Gurjar, H
   Singh, PK
   Singh, M
   Chandra, PS
   Sathyarthee, G
AF Doddamani, Ramesh Sharanappa
   Sawarkar, Dattaraj
   Meena, Rajesh Kumar
   Gurjar, Hitesh
   Singh, Pankaj Kumar
   Singh, Manmohan
   Chandra, P. Sarat
   Sathyarthee, Gurudatta
TI Remote Cerebellar Hemorrhage Following Surgery for Supratentorial
   Lesions
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebellar bleed; Cerebral venous outflow; Remote bleed; Starling
   resistor
ID INTRACRANIAL-PRESSURE
AB BACKGROUND: Remote cerebellar hemorrhage (RCH) after intracranial surgery is a rare complication. Cerebellar hemorrhage is the most commonly described remote site hemorrhage after surgery for supratentorial pathologies. Although this is a rare complication 0.04% to 0.8%, it can be devastating in terms of patient outcome. There are various hypotheses to explain the occurrence of RCH. We report 6 cases of RCH after surgery for supratentorial lesions, discuss the pathophysiology, and review the pertinent literature.
   METHODS: We retrospectively analyzed data of patients who underwent surgery for supratentorial lesions at our center between 2015 and 2017. We identified 6 patients who developed RCH among 1200 patients who underwent surgery and reviewed the demographic data, diagnosis, surgical procedure, and final outcome.
   RESULTS: A total of 1200 patients underwent surgery for supratentorial pathologies between 2015 and 2017. Six patients developed RCH (incidence, 0.5%); 5 were male and 1 was female, with a mean age of 46.4 years. One patient underwent suboccipital decompression for RCH; the rest 5 were managed with close observation and serial imaging. The Glasgow outcome scale (GOS) of 5 was observed in 4 patients, GOS of 4 in 1 patient at discharge, and GOS of 1 in 1 patient who succumbed to severe pulmonary infection after surgery.
   CONCLUSIONS: RCH is a rare complication but can lead to catastrophic results. Loss of large volumes of cerebrospinal fluid or sudden alteration in intracranial pressure due to removal of a mass lesion is the likely etiology. Although majority of cases may be managed conservatively, in a subset of cases with neurologic deterioration, surgery may be required as a life-saving procedure.
C1 [Doddamani, Ramesh Sharanappa; Sawarkar, Dattaraj; Meena, Rajesh Kumar; Gurjar, Hitesh; Singh, Pankaj Kumar; Singh, Manmohan; Chandra, P. Sarat; Sathyarthee, Gurudatta] All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
RP Doddamani, RS (reprint author), All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
EM drsdramesh@gmail.com
CR Akamatsu Y, 2018, WORLD NEUROSURG, V115, P388, DOI 10.1016/j.wneu.2018.05.010
   Amini A, 2006, AM J NEURORADIOL, V27, P387
   Arnautovic KI, 1997, J NEUROSURG, V86, P252, DOI 10.3171/jns.1997.86.2.0252
   Barami K, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16172
   Barami K, 2016, CHILD NERV SYST, V32, P599, DOI 10.1007/s00381-015-3010-1
   Borkar SA, 2013, BRIT J NEUROSURG, V27, P735, DOI 10.3109/02688697.2013.795521
   Cloft HJ, 1997, AM J NEURORADIOL, V18, P1573
   De Simone R, 2017, PANMINERVA MED, V59, P76, DOI 10.23736/S0031-0808.16.03248-1
   Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3
   Friedman JA, 2001, NEUROSURGERY, V49, P1327, DOI 10.1097/00006123-200112000-00008
   Honegger J, 2002, J NEUROSURG, V96, P248, DOI 10.3171/jns.2002.96.2.0248
   Huang CY, 2012, NEUROL RES, V34, P422, DOI 10.1179/1743132811Y.0000000072
   Karaarslan N, 2017, J CLIN DIAGN RES, V11, pPD15, DOI 10.7860/JCDR/2017/29152.10465
   KETY SS, 1948, J CLIN INVEST, V27, P493, DOI 10.1172/JCI101996
   Knowlton FP, 1912, J PHYSIOL-LONDON, V44, P206
   Koh EJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005938
   Marquardt G, 2002, SURG NEUROL, V57, P241, DOI 10.1016/S0090-3019(02)00642-0
   MATSUSHIMA T, 1983, J NEUROSURG, V59, P63, DOI 10.3171/jns.1983.59.1.0063
   Park JS, 2009, J KOREAN NEUROSURG S, V46, P136, DOI 10.3340/jkns.2009.46.2.136
   Srikijvilaikul Teeradej, 2007, Journal of the Medical Association of Thailand, V90, P1221
   Sturiale CL, 2016, NEUROSURG REV, V39, P565, DOI 10.1007/s10143-015-0691-6
   Sturiale CL, 2016, NEUROSURG REV, V39, P369, DOI 10.1007/s10143-015-0673-8
   Toczek MT, 1996, J NEUROSURG, V85, P718, DOI 10.3171/jns.1996.85.4.0718
   Valdueza JM, 2000, LANCET, V355, P200
   Wang Shanjun, 2018, Br J Neurosurg, P1, DOI 10.1080/02688697.2018.1426723
   Yasargil M G, 1977, Neurosurgery, V1, P22
   YOSHIDA S, 1990, Neurologia Medico-Chirurgica, V30, P738, DOI 10.2176/nmc.30.738
NR 27
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E351
EP E359
DI 10.1016/j.wneu.2019.02.053
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400041
PM 30822579
DA 2020-05-12
ER

PT J
AU dos Santos, EC
   Veronez, DAD
   de Almeida, DB
   Piedade, GS
   Oldoni, C
   de Meneses, MS
   Marques, MS
AF dos Santos, Emanuel Cassou
   da Luz Veronez, Djanira Aparecida
   de Almeida, Daniel Benzecry
   Piedade, Guilherme Santos
   Oldoni, Carolina
   de Meneses, Murilo Sousa
   Marques, Mayara Silva
TI Morphometric Study of the Internal Globus Pallidus Using the Robert,
   Barnard, and Brown Staining Method
SO WORLD NEUROSURGERY
LA English
DT Article
DE Deep brain stimulation; Internal globus pallidus; Neuroanatomy;
   Pallidotomy; Parkinson's disease; Stereotactic atlas
ID DEEP-BRAIN-STIMULATION; BASAL GANGLIA; PALLIDOTOMY; PLACEMENT; MRI
AB BACKGROUND: The globus pallidus internus (Gpi) is a major target in functional neurosurgery. Anatomical studies are crucial for correct planning and good surgical outcomes in this region. The present study described the anatomical coordinates of the Gpi and its relationship with other brain structures and compared the findings with those from previous anatomical studies.
   METHODS: We obtained 35 coronal and 5 horizontal brain specimens from the Department of Anatomy and stained them using the Robert, Barnard, and Brown technique. After excluding defective samples, 60 nuclei were analyzed by assessing their distances to the anatomical references and the trajectories to these nuclei.
   RESULTS: The barycenter of the Gpi was identified at the level of the mammillary bodies and 1 cm above the intercommissural plane. Thereafter, the distances to other structures were found. The mean +/- standard deviation distance was 15.62 +/- 2.66 mm to the wall of the third ventricle and 17.02 +/- 2.69 mm to its midline, 4.74 +/- 1.12 mm to the optic tract, 2.51 +/- 0.8 mm and 13.56 +/- 2 mm to the internal and external capsule, and 21.3 +/- 2.44 mm to the insular cortex. The cortical point of entry should be located 22.03 +/- 4.34 mm to 48.74 +/- 4.44 mm from the midline.
   CONCLUSION: The Gpi has less variability in distance to closer anatomical references, such as the optic tract and internal capsule. Distant locations showed a more inhomogeneous pattern. Anatomical studies such as ours are important for the development of new therapeutic approaches and can be used as a basis for new research involving volumetric and specific group analyses.
C1 [dos Santos, Emanuel Cassou; Piedade, Guilherme Santos; Oldoni, Carolina; de Meneses, Murilo Sousa] Univ Fed Parana, Med Sch, Curitiba, Parana, Brazil.
   [da Luz Veronez, Djanira Aparecida; de Meneses, Murilo Sousa] Fed Univ Parana Jardim Amer, Dept Anat, Curitiba, Parana, Brazil.
   [de Almeida, Daniel Benzecry; de Meneses, Murilo Sousa; Marques, Mayara Silva] Neurol Inst Curitiba, Curitiba, Parana, Brazil.
RP de Meneses, MS (reprint author), Univ Fed Parana, Med Sch, Curitiba, Parana, Brazil.; de Meneses, MS (reprint author), Fed Univ Parana Jardim Amer, Dept Anat, Curitiba, Parana, Brazil.; de Meneses, MS (reprint author), Neurol Inst Curitiba, Curitiba, Parana, Brazil.
EM murilomeneses@gmail.com
RI Piedade, Guilherme Santos/AAG-2731-2019
OI Piedade, Guilherme Santos/0000-0002-1907-4558
CR Alho E, 2011, NEUROIMAGING CLIN CO, P145
   Aquino CC, 2015, MOVEMENT DISORD, V30, P80, DOI 10.1002/mds.26125
   BARNARD JW, 1949, ANAT REC, V105, P11, DOI 10.1002/ar.1091050103
   Brodal P, 2010, CENTRAL NERVOUS SYST, P324
   Carter HK, 1918, ANATOMY HUMAN BODY, P718
   Coffey RJ, 2009, TXB STEREOTACTIC FUN, P347
   de Meneses MS, 2004, ARQ NEURO-PSIQUIAT, V62, P276, DOI 10.1590/S0004-282X2004000200016
   DeLong MR, 2015, JAMA NEUROL, V72, P1354, DOI 10.1001/jamaneurol.2015.2397
   Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281
   Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083
   Kramer FM., 1938, J ANAT, V72, P625
   LAITINEN LV, 1992, J NEUROSURG, V76, P53, DOI 10.3171/jns.1992.76.1.0053
   Lanska DJ, 2009, HDB CLIN NEUROL, V95, P501
   Metman LV, 2015, MOVEMENT DISORD, V30, P1461, DOI 10.1002/mds.26338
   Morel A., 2007, STEREOTACTIC ATLAS H
   Nowacki A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137868
   Olanow CW, 2015, MOVEMENT DISORD, V30, P37, DOI 10.1002/mds.26119
   Park SC, 2017, WORLD NEUROSURG, V98, P734, DOI 10.1016/j.wneu.2016.11.046
   Quester R, 1997, J NEUROSCI METH, V75, P81, DOI 10.1016/S0165-0270(97)00050-2
   ROBERTS M, 1969, STAIN TECHNOL, V44, P143, DOI 10.3109/10520296909063340
   Schaltenbrand G, 1976, ATLAS STEREOTAXY HUM
   SCHALTENBRAND G, 1959, INTRO STEREOTAXIS AT
   Sidiropoulos C, 2016, J NEUROL, V263, P1226, DOI 10.1007/s00415-016-8125-0
   Spiegel EA, 1952, STEREOENCEPHALOTOMY
   Starr PA, 2002, STEREOT FUNCT NEUROS, V79, P118, DOI 10.1159/000070828
   TALAIRACH J, 1957, ATLAS ANATOMIE STERE
   Talairach J., 1988, COPLANAR STEREOTAXIC
   Vitek JL, 1998, J NEUROSURG, V88, P1027, DOI 10.3171/jns.1998.88.6.1027
   Wichmann T, 2011, BASAL GANGLIA, V1, P65, DOI 10.1016/j.baga.2011.05.001
   Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026
NR 30
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E371
EP E378
DI 10.1016/j.wneu.2019.02.059
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400043
PM 30822586
DA 2020-05-12
ER

PT J
AU Ekuma, EM
   Ndubuisi, CA
   Mezue, W
   Ohaegbulam, S
AF Ekuma, Ezeali Mike
   Ndubuisi, Chika Anele
   Mezue, Wilfred
   Ohaegbulam, Samuel
TI Normal Atlanto-Occipital Interval in Adults of Southeast Nigeria: An
   Evaluation of the Effect of Age, Sex, and Race
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anatomy; AOI; Asymptomatic Nigerian adults; Craniocervical junction
ID ATLANTOAXIAL SUBLUXATION; CRANIOCERVICAL JUNCTION
AB BACKGROUND: Imaging of the craniocervical junction (CCJ) after trauma is crucial for injury detection and description. Of all the anatomic measurements of the CCJ, the normal value of atlanto-occipital interval (AOI) is not yet well established in adults. The aim of our study is to determine the normal values of the AOI in Nigerians aged between 21 and 60 years using multidetector computed tomography (MDCT) scan and to determine racial, age, and sex differences.
   METHODS: This was a prospective observational study done at Memfys Hospital for Neurosurgery, Enugu, Nigeria, between May 2016 and April 2017. There were 240 subjects (120 men and 120 women) divided into the following age groups: 21-30, 31-40, 41-50, and 51-60 years. Non-Nigerians and those with preexisting CCJ abnormalities were excluded. Normal values were those within the 95% confidence interval. Results were analyzed for possible sex and age variations and compared with the available literature for racial differences. Ethical approval was obtained for this study.
   RESULTS: The measured normal computed tomography value of the AOI in adult Nigerians was 1.181 +/- 0.018 mm. The values in the age groups of 21-30, 31-40, 41-50, and 51-60 years were 1.279 +/- 0.038, 1.164 +/- 0.033, 1.151 +/- 0.029, and 1.133 +/- 0.033 mm, respectively (P < 0.05). The average normal values in men and women were 1.188 +/- 0.025 and 1.174 +/- 0.026 mm, respectively. The interobserver reliability test using the Cronbach alpha was 0.938.
   CONCLUSIONS: AOI values in this study were higher than previous MDCT-based values in non-African populations. The AOI decreased linearly with age and did not show any sex difference.
C1 [Ekuma, Ezeali Mike; Ndubuisi, Chika Anele; Mezue, Wilfred; Ohaegbulam, Samuel] Memfys Hosp Neurosurg, Enugu, Nigeria.
   [Ekuma, Ezeali Mike] Fed Teaching Hosp, Dept Surg, Abakaliki, Nigeria.
   [Mezue, Wilfred] Univ Nigeria Teaching Hosp, Dept Surg, Enugu, Nigeria.
RP Ekuma, EM (reprint author), Memfys Hosp Neurosurg, Enugu, Nigeria.; Ekuma, EM (reprint author), Fed Teaching Hosp, Dept Surg, Abakaliki, Nigeria.
EM mekumarock@gmail.com
CR Bertozzi JC, 2009, AM J ROENTGENOL, V192, P26, DOI 10.2214/AJR.08.1058
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297
   DICKMAN CA, 1993, J SPINAL DISORD, V6, P300, DOI 10.1097/00002517-199306040-00004
   El-Khouri M, 2014, WORLD NEUROSURG, V82, P215, DOI 10.1016/j.wneu.2014.02.006
   Harris JH, 2001, RADIOLOGY, V218, P337, DOI 10.1148/radiology.218.2.r01fe53337
   Harrison DE, 2000, SPINE, V25, P2072, DOI 10.1097/00007632-200008150-00011
   Iizuka H, 2013, EUR SPINE J, V22, P54, DOI 10.1007/s00586-012-2466-x
   MONTANE I, 1991, SPINE, V16, P112, DOI 10.1097/00007632-199102000-00002
   Radcliff KE, 2010, SPINE J, V10, P219, DOI 10.1016/j.spinee.2010.07.394
   Rojas CA, 2007, AM J NEURORADIOL, V28, P1819, DOI 10.3174/ajnr.A0660
   Saeheng S, 2001, SURG NEUROL, V55, P35, DOI 10.1016/S0090-3019(00)00350-5
   Sathian B, 2010, NEPAL J EPIDEMIOL, V1, P4
   Sorimachi Y, 2011, EUR SPINE J, V20, P798, DOI 10.1007/s00586-010-1611-7
   Wellborn CC, 2000, J PEDIATR ORTHOPED, V20, P66, DOI 10.1097/00004694-200001000-00015
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1012
EP E1016
DI 10.1016/j.wneu.2019.03.023
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400127
PM 30877010
DA 2020-05-12
ER

PT J
AU Eliava, S
   Shekhtman, O
   Varyukhina, M
AF Eliava, Shalva
   Shekhtman, Oleg
   Varyukhina, Mariya
TI Microsurgical Angioarchitectonics of Deep Brain Structures and Deep
   Arterial Anastomoses
SO WORLD NEUROSURGERY
LA English
DT Article
DE Deep arterial anastomoses; Epithalamic arterial circle; Normal brain
   anatomy; Neurosurgery
ID ANTERIOR CHOROIDAL ARTERY; POSTERIOR CEREBRAL-ARTERY; ANATOMY
AB BACKGROUND: Surgeries for deep and eloquent cerebral lesions require a detailed knowledge of normal brain anatomy and accurate planning. Important parts of brain anatomy are the cerebral blood supply and collateral circulation system. In addition to well-known cortical and basal (circle of Willis) anastomoses, there is also a deep interarterial anastomotic circle that is not described in the literature.
   METHODS: Twenty brain specimens were studied for deep arterial anastomotic connections between branches of the anterior and posterior choroidal arteries.
   RESULTS: We have marked 3 symmetric zones of deep arterial anastomoses that form an epithalamic circle.
   CONCLUSIONS: Epithalamic anastomoses provide an additional mechanism of blood distribution that may play a role during surgical interventions or stroke.
C1 [Eliava, Shalva; Shekhtman, Oleg] Burdenko Neurosurg Inst, Vasc Dept, Moscow, Russia.
   [Varyukhina, Mariya] Burdenko Neurosurg Inst, Natl Med Res Ctr, Moscow, Russia.
RP Shekhtman, O (reprint author), Burdenko Neurosurg Inst, Vasc Dept, Moscow, Russia.
EM oshekhtman2@gmail.com
CR CARPENTER MB, 1954, AMA ARCH NEUROL PSY, V71, P714, DOI 10.1001/archneurpsyc.1954.02320420042005
   Cho MS, 2008, J KOREAN NEUROSURG S, V43, P131, DOI 10.3340/jkns.2008.43.3.131
   Eliava ShSh, 1992, THESIS, P41
   Filatov YuM, 1990, ZH VOPR NEIROKHIR, V2, P13
   Filatov YuM, 1990, ZH VOPR NEIROKHIR, V4, P3
   FUJII K, 1980, J NEUROSURG, V52, P165, DOI 10.3171/jns.1980.52.2.0165
   GALATIUSJENSEN F, 1963, RADIOLOGY, V81, P942, DOI 10.1148/81.6.942
   GEORGE AE, 1975, AM J ROENTGENOL, V124, P220, DOI 10.2214/ajr.124.2.220
   HELGASON C, 1986, ARCH NEUROL-CHICAGO, V43, P681, DOI 10.1001/archneur.1986.00520070039015
   Heubner JO, 1872, ZBL MED WISS, V52, P817
   HUSSEIN S, 1988, ACTA NEUROCHIR, V92, P19, DOI 10.1007/BF01401968
   Konovalov AN, 2003, SURG NEUROL, V59, P250, DOI 10.1016/S0090-3019(03)00080-6
   KRAYENBUHL H, 1958, Acta Neurochir (Wien), V6, P30, DOI 10.1007/BF01577673
   MARINKOVIC SV, 1989, STROKE, V20, P1341, DOI 10.1161/01.STR.20.10.1341
   MILISAVLJEVIC MM, 1991, NEUROSURGERY, V28, P523, DOI 10.1227/00006123-199104000-00007
   ONO M, 1984, NEUROSURGERY, V15, P621, DOI 10.1227/00006123-198411000-00002
   Park SQ, 2010, J KOREAN NEUROSURG S, V47, P36, DOI 10.3340/jkns.2010.47.1.36
   Rangel-Castilla L, 2017, J NEUROSURG, V126, P1064, DOI 10.3171/2016.4.JNS16147
   Raz E, 2015, AM J NEURORADIOL, V36, P937, DOI 10.3174/ajnr.A4217
   RHOTON AL, 1979, SURG NEUROL, V12, P171
   ROSNER SS, 1984, J NEUROSURG, V61, P468, DOI 10.3171/jns.1984.61.3.0468
   SAEKI N, 1977, J NEUROSURG, V46, P563, DOI 10.3171/jns.1977.46.5.0563
   SHMIDT E V, 1969, Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova, V69, P1769
   Timurkayanak E, 1996, NEUROSURGERY, V19, P685
   Zaidi HA, 2017, NEUROSURGERY, V81, P620, DOI 10.1093/neuros/nyw139
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1092
EP E1098
DI 10.1016/j.wneu.2019.02.213
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400138
PM 30880194
DA 2020-05-12
ER

PT J
AU Fang, YB
   Zhu, DY
   Peng, Y
   Zhong, M
   Xu, J
   Li, QP
   Liang, GB
   Wang, Y
   Feng, WF
   Wang, DH
   Zhang, Y
   Chen, D
   Guo, QD
   Li, TX
   Xie, XD
   Zhu, G
   Guan, S
   Gu, Z
   Li, G
   Yang, H
   He, XY
   Zhu, Q
   Wan, JQ
   Li, Q
   Yang, PF
   Zhao, R
   Huang, QH
   Hong, B
   Xu, Y
   Liu, JM
AF Fang, Yibin
   Zhu, Deyuan
   Peng, Ya
   Zhong, Ming
   Xu, Jing
   Li, Qiuping
   Liang, Guobiao
   Wang, Yang
   Feng, Wenfeng
   Wang, Donghai
   Zhang, Yang
   Chen, Dong
   Guo, Qingdong
   Li, Tianxiao
   Xie, Xiaodong
   Zhu, Gang
   Guan, Sheng
   Gu, Zhen
   Li, Gang
   Yang, Hua
   He, Xueyang
   Zhu, Qin
   Wan, Jieqing
   Li, Qiang
   Yang, Pengfei
   Zhao, Rui
   Huang, Qianghai
   Hong, Bo
   Xu, Yi
   Liu, Jianmin
TI Treatment of Blood Blisterelike Aneurysms with Stent-Assisted Coiling: A
   Retrospective Multicenter Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Blood blister-like aneurysms; Overlapping stents technique;
   Stent-assisted coiling
ID ENDOVASCULAR TREATMENT; ENTERPRISE STENTS; CENTER EXPERIENCE; FLOW
   DIVERSION; LVIS STENT; HEMODYNAMICS; DEVICE; ARTERY
AB OBJECTIVE: To clarify safety and efficacy of stent-assisted coiling for treatment of blood blisterelike aneurysm (BBA) in a multicenter experience.
   METHODS: A total of 212 consecutive cases (213 BBAs) treated with stent-assisted coiling were retrospectively reviewed and included in the final analysis. Outcomes including complete occlusion, recurrence, perioperative morbidity and mortality, and overall good neurologic outcome during follow-up were analyzed.
   RESULTS: Of 212 patients, 102 (48.1%) were treated with a single stent, 77 (36.3%) were treated with 2 stents, and 33 (15.6%) were treated with >= 3 stents. Angiographic follow-up data were available for 96 BBAs; 64.6% of BBAs showed complete obliteration, and 22.9% showed recurrence. Complete obliteration rates of patients treated with single, 2, and >= 3 stents were 42.9%, 78.4%, and 88.2%. Recurrence rates of patients treated with single, 2, and >= 3 stents were 38.1%, 13.5%, and 5.9%. Using >= 2 stents seemed to result in higher obliteration rates (P < 0.001) and lower recurrence rates (P = 0.002). Clinical follow-up data available for 180 patients showed 91.1% of patients had a good clinical outcome. No difference was found between the 3 stent treatments. There were 14 (6.6%) perioperative ischemic complications and 12 (5.7%) hemorrhagic complications, with 10 (4.7%) cases of perioperative deaths. Using >= 2 stents seemed to result in a lower perioperative hemorrhagic complication rate compared with single stent (P = 0.037).
   CONCLUSIONS: Our data support the use of overlapping (>= 2) stents combined with coiling as a safe and effective therapeutic modality for BBA. Overlapping (>= 2) stents may provide higher obliteration rate, lower recurrence rate, and lower perioperative hemorrhagic risk in treatment of BBA.
C1 [Fang, Yibin; Zhu, Deyuan; Li, Qiang; Yang, Pengfei; Zhao, Rui; Huang, Qianghai; Hong, Bo; Xu, Yi; Liu, Jianmin] Second Mil Med Univ, Changhai Hosp Affiliated, Dept Neurosurg, Shanghai, Peoples R China.
   [Peng, Ya] Soochow Univ, Peoples Hosp Changzhou 1, Cerebral Vasc Dis Ctr, Changzhou, Peoples R China.
   [Zhong, Ming] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Peoples R China.
   [Xu, Jing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol Surg, Hangzhou, Zhejiang, Peoples R China.
   [Li, Qiuping] Fudan Univ, Zhongshan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
   [Liang, Guobiao] Gen Hosp Shenyang Mil Command, Dept Neurosurg, Shenyang, Liaoning, Peoples R China.
   [Wang, Yang] Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China.
   [Feng, Wenfeng] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Nanfang Glioma Ctr, Guangzhou, Guangdong, Peoples R China.
   [Wang, Donghai] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China.
   [Zhang, Yang] Anhui Prov Hosp, Dept Neurosurg, Hefei, Anhui, Peoples R China.
   [Chen, Dong] Shenzhen Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China.
   [Guo, Qingdong] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China.
   [Li, Tianxiao] Zhengzhou Univ, Dept Cerebrovasc Dis, Peoples Hosp, Zhengzhou, Henan, Peoples R China.
   [Li, Tianxiao] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China.
   [Xie, Xiaodong] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
   [Zhu, Gang] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.
   [Guan, Sheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China.
   [Gu, Zhen] Kunming Med Univ, Hosp 4, Dept Neurosurg, Kunming, Yunnan, Peoples R China.
   [Li, Gang] Zunyi Med Coll, Affiliated Hosp 1, Dept Cerebrovasc Dis, Zunyi, Guizhou, Peoples R China.
   [Yang, Hua] Guizhou Med Univ, Affiliated Hosp, Dept Neurosurg, Guiyang, Guizhou, Peoples R China.
   [He, Xueyang] Quanzhou First Hosp, Dept Neurosurg, Quanzhou, Fujian, Peoples R China.
   [Zhu, Qin] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.
   [Wan, Jieqing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China.
   [Zhu, Deyuan] Xuzhou Med Univ, Affiliated Huaihai Hosp, Grp Army Hosp CPLA Army 71, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China.
RP Liu, JM (reprint author), Second Mil Med Univ, Changhai Hosp Affiliated, Dept Neurosurg, Shanghai, Peoples R China.
EM chstroke@163.com
OI Liang, Guobiao/0000-0001-6332-190X
FU National Key R&D Program of China [2016YFC1300700]; Project on research
   and application of effective intervention techniques for high risk
   population of stroke from the National Health and Family Planning
   Commission in China [GN-2016R0012]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [81301004]
FX This study was supported by the National Key R&D Program of China (Grant
   No. 2016YFC1300700), Project on research and application of effective
   intervention techniques for high risk population of stroke from the
   National Health and Family Planning Commission in China (Grant No.
   GN-2016R0012), and National Natural Science Foundation of China (Grant
   No. 81301004).
CR Aydin K, 2015, J NEUROINTERV SURG, V7, P202, DOI 10.1136/neurintsurg-2013-011090
   Chalouhi N, 2014, NEUROSURGERY, V74, P527, DOI 10.1227/NEU.0000000000000309
   Fang YB, 2014, CLIN NEUROL NEUROSUR, V123, P34, DOI 10.1016/j.clineuro.2014.04.023
   Fang YB, 2013, CLIN NEUROL NEUROSUR, V115, P920, DOI 10.1016/j.clineuro.2012.09.022
   Gonzalez AM, 2014, EUR J RADIOL, V83, P197, DOI 10.1016/j.ejrad.2013.09.017
   Lim YC, 2013, NEUROSURGERY, V73, P480, DOI 10.1227/NEU.0000000000000005
   Linfante I, 2017, J NEUROINTERV SURG, V9, P29, DOI 10.1136/neurintsurg-2016-012287
   Lv N, 2018, AM J NEURORADIOL, V39, P118, DOI 10.3174/ajnr.A5452
   Meckel S, 2011, AM J NEURORADIOL, V32, P764, DOI 10.3174/ajnr.A2392
   Mokin M, 2018, J NEUROINTERV SURG, V10, P1074, DOI 10.1136/neurintsurg-2017-013701
   Ogawa A, 2000, NEUROSURGERY, V47, P578, DOI 10.1097/00006123-200009000-00008
   Peitz GW, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS1751
   Princiotta C, 2011, INTERV NEURORADIOL, V17, P365, DOI 10.1177/159101991101700314
   Song J, 2016, ACTA NEUROCHIR, V158, P803, DOI 10.1007/s00701-016-2721-8
   Tremmel M, 2010, WORLD NEUROSURG, V74, P306, DOI 10.1016/j.wneu.2010.05.008
   Turner RD, 2013, J NEUROINTERV SURG, V5, P157, DOI 10.1136/neurintsurg-2011-010187
   Wang C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0959-9
   Yang PF, 2012, CHINESE MED J-PEKING, V125, P1817, DOI 10.3760/cma.j.issn.0366-6999.2012.10.024
   Zhu DY, 2017, WORLD NEUROSURG, V104, P729, DOI 10.1016/j.wneu.2017.03.092
NR 19
TC 1
Z9 1
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E486
EP E491
DI 10.1016/j.wneu.2019.02.076
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400058
PM 30825633
DA 2020-05-12
ER

PT J
AU Feng, R
   Schwartz, J
   Loewenstern, J
   Kohli, K
   Lenina, S
   Ultakan, S
   Iloreta, AM
   Govindaraj, S
   Bederson, J
   Banik, R
   Shrivastava, R
AF Feng, Rui
   Schwartz, Jeffrey
   Loewenstern, Joshua
   Kohli, Karan
   Lenina, Svetlana
   Ultakan, Sedat
   Iloreta, Alfred-Marc
   Govindaraj, Satish
   Bederson, Joshua
   Banik, Rudrani
   Shrivastava, Raj
TI The Predictive Role of Intraoperative Visual Evoked Potentials in Visual
   Improvement After Endoscopic Pituitary Tumor Resection in Large and
   Complex Tumors: Description and Validation of a Method
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic resection; Intraoperative monitoring; Pituitary tumor; Visual
   evoked potential (VEP)
ID ENDONASAL SURGERY; ADENOMAS; EXPERIENCE; VISION
AB BACKGROUND: With the advent of extensive endoscopic approaches for pituitary tumors, there has also been an increase in surgery for larger and more complex tumors. Intraoperative manipulation during endoscopic resection of sellar tumors poses potential risk in postoperative visual function in this tumor population. This study proposes a method of accurate intraoperative monitoring of visual evoked potentials (VEPs) and its role in predicting visual function outcomes.
   METHODS: Intraoperative VEPs were monitored for 42 resections from a single surgical team, with average tumor size of 2.84 cm. Changes in VEP amplitude and latency in excess of 50% were considered significant. Preoperative and postoperative visual information was obtained from ophthalmology and hospital records, along with patient demographics, comorbidities, and tumor characteristics.
   RESULTS: Patients were stratified as experiencing deteriorations in VEPs that did not restore to baseline (n = 4), deteriorations in VEPs that did restore to baseline (n = 6), no change in VEPs (n = 31), and improvement in VEPs (n = 1). Correlation between VEP changes and postoperative visual fields was measured through univariate ordered logistic regression. Improved intraoperative VEP measurements were associated with odds ratio (OR) of visual field improvement of 3.15 (95% confidence interval, 1.15-8.59). Specifically, changes in VEP amplitude were positively associated with visual field improvement with OR of 4.35 (OR, 1.29-14.7). No association was observed between VEPs and other patient or tumor characteristics.
   CONCLUSION: Changes in VEP amplitude during endoscopic sellar tumor resection correlate with postoperative visual function. Intraoperative VEP monitoring can serve an important role in preventing postoperative visual field loss.
C1 [Feng, Rui; Schwartz, Jeffrey; Loewenstern, Joshua; Kohli, Karan; Lenina, Svetlana; Ultakan, Sedat; Bederson, Joshua; Shrivastava, Raj] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.
   [Iloreta, Alfred-Marc; Govindaraj, Satish; Shrivastava, Raj] Icahn Sch Med Mt Sinai, Dept Otolaryngol, New York, NY 10029 USA.
   [Banik, Rudrani] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA.
RP Feng, R (reprint author), Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.
EM rui.feng@icahn.mssm.edu
OI Kohli, Karan/0000-0001-6248-1880
CR Berker M, 2012, PITUITARY, V15, P288, DOI 10.1007/s11102-011-0368-2
   BLACK PM, 1988, SURG NEUROL, V29, P443, DOI 10.1016/0090-3019(88)90138-3
   Carrim ZI, 2007, ACTA NEUROCHIR, V149, P255, DOI 10.1007/s00701-006-1108-7
   CEDZICH C, 1988, ELECTROEN CLIN NEURO, V71, P142, DOI 10.1016/0168-5597(88)90072-X
   CEDZICH C, 1987, NEUROSURGERY, V21, P709, DOI 10.1227/00006123-198711000-00018
   CEDZICH C, 1990, INT ANESTHESIOL CLIN, V28, P165, DOI 10.1097/00004311-199002830-00006
   Chung SB, 2012, ACTA NEUROCHIR, V154, P1505, DOI 10.1007/s00701-012-1426-x
   Gondim JA, 2006, ARQ NEURO-PSIQUIAT, V64, P971, DOI 10.1590/S0004-282X2006000600016
   Ho RW, 2015, J KOREAN NEUROSURG S, V57, P23, DOI 10.3340/jkns.2015.57.1.23
   Jones NS, 1997, J LARYNGOL OTOL, V111, P513, DOI 10.1017/S0022215100137806
   Juraschka K, 2014, J NEUROSURG, V121, P75, DOI 10.3171/2014.3.JNS131679
   Kamio Y, 2014, NEUROL MED-CHIR, V54, P606, DOI 10.2176/nmc.oa.2014-0023
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P813, DOI 10.1016/S0002-9394(00)00539-0
   Kodama K, 2010, ACTA NEUROCHIR, V152, P643, DOI 10.1007/s00701-010-0600-2
   Koutourousiou M, 2013, J NEUROSURG, V118, P621, DOI 10.3171/2012.11.JNS121190
   Kurozumi K, 2017, ACTA NEUROCHIR, V159, P1043, DOI 10.1007/s00701-017-3111-6
   Lee IH, 2015, AM J ROENTGENOL, V205, pW512, DOI 10.2214/AJR.15.14527
   Lee Jung Pil, 2011, Korean J Ophthalmol, V25, P37, DOI 10.3341/kjo.2011.25.1.37
   Luo YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120525
   Metwali H, 2018, WORLD NEUROSURG, V110, P217, DOI 10.1016/j.wneu.2017.11.039
   Nagata Y, 2017, CLIN NEUROPHYSIOL, V128, pe236
   Nakagawa Itsuo, 2006, Masui, V55, P692
   Nishioka H, 2017, NEUROL MED-CHIR, V57, P151, DOI 10.2176/nmc.ra.2016-0276
   POON A, 1995, AUST NZ J OPHTHALMOL, V23, P107, DOI 10.1111/j.1442-9071.1995.tb00138.x
   Sasaki T, 2010, J NEUROSURG, V112, P273, DOI 10.3171/2008.9.JNS08451
   Tokumaru AM, 2006, AM J NEURORADIOL, V27, P250
   Wiedemayer H, 2003, J NEUROSURG ANESTH, V15, P19, DOI 10.1097/00008506-200301000-00004
NR 27
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E136
EP E143
DI 10.1016/j.wneu.2019.01.278
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400018
PM 30794978
DA 2020-05-12
ER

PT J
AU Ferrari, M
   Vural, A
   Schreiber, A
   Mattavelli, D
   Gualtieri, T
   Taboni, S
   Bertazzoni, G
   Rampinelli, V
   Tomasoni, M
   Buffoli, B
   Doglietto, F
   Rodella, LF
   Deganello, A
   Nicolai, P
AF Ferrari, Marco
   Vural, Alperen
   Schreiber, Alberto
   Mattavelli, Davide
   Gualtieri, Tommaso
   Taboni, Stefano
   Bertazzoni, Giacomo
   Rampinelli, Vittorio
   Tomasoni, Michele
   Buffoli, Barbara
   Doglietto, Francesco
   Rodella, Luigi Fabrizio
   Deganello, Alberto
   Nicolai, Piero
TI Side-Door Temporoparietal Fascia Flap: A Novel Strategy for Anterior
   Skull Base Reconstruction
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebrospinal fluid leak; Pedicled flaps; Reconstruction; Skull base
ID INFERIOR TURBINATE FLAP; PERICRANIAL FLAP; 3-LAYER RECONSTRUCTION;
   VASCULARIZED FLAPS; ILIOTIBIAL TRACT; DEFECTS; REPAIR; TRANSPOSITION;
   RESECTION; ANATOMY
AB BACKGROUND: The armamentarium for anterior skull base (ASB) reconstruction includes a variegate spectrum of grafts, endonasal pedicled flaps, regional pedicled flaps, and free flaps, which are selected to face specific scenarios. The use of a vascularized flap in case of large ABS defects ensures an adequate blood supply. The aim of this study was to evaluate the possible role of temporoparietal fascia flap (TPFF) in ASB reconstruction.
   METHODS: Eight fresh-frozen head specimens were dissected to evaluate the adequacy of TPFF and pericranial flap (PF) for the reconstruction of ASB defects. The percentage of coverage of the ASB was calculated for TPFF and PF. An anatomic-radiologic analysis was performed to provide useful practical information for flap harvesting and positioning.
   RESULTS: The TPFF was easily transposed to the ABS defect through an epidural corridor; the edges of the TPFF were successfully placed in the intradural space, in the epidural space, or on the extracranial surface of the ABS defect. The PF was particularly adequate for median defects, and the TPFF was shown to be useful also in cases with paramedian-supraorbital extension. The median percentage of coverage of the ASB was significantly higher for TPFF (85.1%) than PF (65.7%) (P = 0.018).
   CONCLUSIONS: The supraorbital epidural corridor is a possible novel pathway for transposition of the TPFF for ASB reconstruction. Side-door TPFF was shown to be an ideal choice for large ASB defect with lateral supraorbital extension and could be useful in the scenario of salvage reconstruction for recurrent ABS cerebrospinal fluid leak.
C1 [Ferrari, Marco; Vural, Alperen; Schreiber, Alberto; Mattavelli, Davide; Gualtieri, Tommaso; Taboni, Stefano; Bertazzoni, Giacomo; Rampinelli, Vittorio; Tomasoni, Michele; Buffoli, Barbara; Deganello, Alberto; Nicolai, Piero] Univ Brescia, Fac Med, Units Otorhinolaryngol, Brescia, Italy.
   [Ferrari, Marco; Vural, Alperen; Schreiber, Alberto; Mattavelli, Davide; Gualtieri, Tommaso; Taboni, Stefano; Bertazzoni, Giacomo; Rampinelli, Vittorio; Tomasoni, Michele; Buffoli, Barbara; Deganello, Alberto; Nicolai, Piero] Univ Brescia, Fac Med, Units Head & Neck Surg, Brescia, Italy.
   [Doglietto, Francesco] Univ Brescia, Fac Med, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Unit Neuosurg, Brescia, Italy.
   [Rodella, Luigi Fabrizio] Univ Brescia, Dept Clin & Expt Sci, Sect Anat & Physiopathol, Brescia, Italy.
   [Vural, Alperen] Erciyes Univ, Fac Med, Dept Otorhinolaryngol, Kayseri, Turkey.
RP Ferrari, M (reprint author), Univ Brescia, Fac Med, Units Otorhinolaryngol, Brescia, Italy.; Ferrari, M (reprint author), Univ Brescia, Fac Med, Units Head & Neck Surg, Brescia, Italy.
EM 1990marcoferrari@gmail.com
RI rampinelli, vittorio/AAF-5514-2019; Schreiber, Alberto/AAB-6722-2020;
   Ferrari, Marco/AAC-7179-2019; Mattavelli, Davide/AAC-1548-2019;
   Deganello, Alberto/I-2742-2014; Vural, Alperen/L-9365-2013
OI Ferrari, Marco/0000-0002-4023-0121; Mattavelli,
   Davide/0000-0001-7023-6746; Deganello, Alberto/0000-0003-1008-7333;
   Vural, Alperen/0000-0003-1969-7760; Schreiber,
   Alberto/0000-0002-1580-3928
CR CHENEY ML, 1993, ARCH OTOLARYNGOL, V119, P618
   Daraei P, 2014, INT FORUM ALLERGY RH, V4, P937, DOI 10.1002/alr.21369
   Fortes FSG, 2007, LARYNGOSCOPE, V117, P1329, DOI 10.1097/mlg.0b013e318062111f
   Fortes FSG, 2007, LARYNGOSCOPE, V117, P970, DOI 10.1097/MLG.0b013e3180471482
   Gil Z, 2007, SKULL BASE-INTERD AP, V17, P25, DOI 10.1055/s-2006-959333
   Gil Z, 2012, OTOLARYNG HEAD NECK, V146, P842, DOI 10.1177/0194599811434516
   Gilbert RW, 2012, ARCH OTOLARYNGOL, V138, P484, DOI 10.1001/archoto.2012.410
   Goljo E, 2018, AM J OTOLARYNG, V39, P253, DOI 10.1016/j.amjoto.2017.12.015
   Gun R, 2014, J CRANIOFAC SURG, V25, P1967, DOI 10.1097/SCS.0000000000000977
   Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4
   Hadad G, 2011, LARYNGOSCOPE, V121, P1606, DOI 10.1002/lary.21889
   Harvey RJ, 2012, LARYNGOSCOPE, V122, P452, DOI 10.1002/lary.22475
   Herr MW, 2013, ADV OTO-RHINO-LARYNG, V74, P81, DOI 10.1159/000342283
   JOHNS ME, 1981, LARYNGOSCOPE, V91, P952
   Kang SY, 2018, HEAD NECK-J SCI SPEC, V40, pE45, DOI 10.1002/hed.25094
   Karligkiotis A, 2015, AM J RHINOL ALLERGY, V29, P449, DOI 10.2500/ajra.2015.29.4230
   Kim GG, 2013, ADV OTO-RHINO-LARYNG, V74, P71, DOI 10.1159/000342282
   Kim J C, 2001, Arch Facial Plast Surg, V3, P170, DOI 10.1001/archfaci.3.3.170
   Kircher M, 2015, LARYNGOSCOPE, V125, P2796, DOI 10.1002/lary.25331
   Kwon D, 2017, SEMIN PLAST SURG, V31, P189, DOI 10.1055/s-0037-1607273
   Lam D, 2014, ORAL MAXIL SURG CLIN, V26, P359, DOI 10.1016/j.coms.2014.05.004
   Llorente JL, 2013, J NEUROL SURG PART B, V74, P324, DOI 10.1055/s-0033-1353364
   Lund V, 2011, RHINOLOGY, P1
   Macia G, 2016, INT J ORAL MAX SURG, V45, P158, DOI 10.1016/j.ijom.2015.09.001
   Majer J, 2016, LARYNGOSCOPE, V126, P1736, DOI 10.1002/lary.25686
   Markey J, 2015, LARYNGOSCOPE, V125, P2247, DOI 10.1002/lary.25209
   Mattavelli D, 2018, HEAD NECK-J SCI SPEC, V40, P63, DOI 10.1002/hed.24931
   Mattavelli D, 2017, WORLD NEUROSURG, V101, P486, DOI 10.1016/j.wneu.2017.02.066
   Neligan PC, 1996, PLAST RECONSTR SURG, V98, P1159, DOI 10.1097/00006534-199612000-00005
   Neligan PC, 1996, PLAST RECONSTR SURG, V98, P1167, DOI DOI 10.1097/00006534-199612000-00005
   NICOLAI P, 2006, OP TECH OTOLARYNGOL, V17, P80
   Oliver CL, 2008, LARYNGOSCOPE, V118, P2102, DOI 10.1097/MLG.0b013e318184e719
   Patel R, 2013, J NEUROL SURG PART B, V74, P311, DOI 10.1055/s-0033-1349059
   Rastatter JC, 2016, J NEUROSURG-PEDIATR, V17, P371, DOI 10.3171/2015.6.PEDS1588
   Reyes C, 2017, J NEUROL SURG PART B, V78, P393, DOI 10.1055/s-0037-1602245
   Rivera-Serrano CM, 2010, LARYNGOSCOPE, V120, P1922, DOI 10.1002/lary.21049
   Safavi-Abbasi S, 2016, J NEUROSURG, V125, P419, DOI 10.3171/2015.5.JNS15529
   Santamaria A, 2017, LARYNGOSCOPE, V127, P2482, DOI 10.1002/lary.26574
   Schreiber A, 2017, INT FORUM ALLERGY RH, V7, P199, DOI [10.1002/alr.21857, 10.1002/alr.22001]
   Julian JAS, 2011, ACTA NEUROCHIR, V153, P1827, DOI 10.1007/s00701-011-1064-8
   Siniscalchi EN, 2007, J CRANIOFAC SURG, V18, P622, DOI 10.1097/scs.0b013e318052ff6c
   Tang IP, 2015, J LARYNGOL OTOL, V129, P752, DOI 10.1017/S002221511500167X
   Thorp BD, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14350
   Veyrat M, 2016, ACTA NEUROCHIR, V158, P2291, DOI 10.1007/s00701-016-2969-z
   Villaret AB, 2013, EUR ARCH OTO-RHINO-L, V270, P1473, DOI 10.1007/s00405-012-2187-0
   Zeiler FA, 2015, J NEUROSURG, V123, P1312, DOI 10.3171/2014.11.JNS141979
NR 46
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E360
EP E370
DI 10.1016/j.wneu.2019.02.056
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400042
PM 30822581
DA 2020-05-12
ER

PT J
AU Finet, P
   Santos, LP
   El Tahry, R
   Santos, SF
   Vaz, GR
   Raftopoulos, C
AF Finet, Patrice
   Santos, Laura Pradini
   El Tahry, Riem
   Santos, Susana Ferrao
   Vaz, Geraldo Ribeiro
   Raftopoulos, Christian
TI Clinical Outcome of Radiating Multiple Subpial Transections Alone for
   Drug Resistant Epilepsy After More Than 5 Years Follow-Up
SO WORLD NEUROSURGERY
LA English
DT Article
DE Drug resistant epilepsy surgery; MST; Multiple subpial transections
AB OBJECTIVE: Multiple subpial transection (MST) is a possible surgical treatment for patients with epileptogenic foci located in eloquent cortical areas. Commonly, it is performed in addition to other surgical techniques. In some cases, however, it is performed alone. We report the clinical results of 12 patients who received solely radiating MST with a minimal follow-up of 5 years.
   METHODS: All patients who underwent a surgical intervention between 2003 and 2012 for refractory epilepsy were studied. Among them, 12 had radiating MST (rMST) as the only surgical treatment with a follow-up of at least 5 years.
   RESULTS: At 5-year follow-up, 50% of the patients were Engel class I, 25% were Engel class II, 0% were Engel class III, and 25% were Engel class IV. At last follow-up, 8 patients (67%) were free of seizures, 1 patient (8%) had an over 75% decrease, and 3 patients (25%) did not improve after the procedure. None of the Engel I patients had seizure recurrence, and those belonging to an intermediate class improved during follow-up, in some cases in association with an antiepileptic drug modification. Two patients (17%) had a minor transient complication, and 1 patient (8%) had a minor permanent complication.
   CONCLUSIONS: rMST performed alone gives a favorable outcome in 75% of the patients at a minimum 5-year follow-up with few minor complications. This procedure appears to be effective even with a prolonged follow-up in drug resistant epilepsy with the epileptogenic foci located in eloquent areas.
C1 [Finet, Patrice; Santos, Laura Pradini; Vaz, Geraldo Ribeiro; Raftopoulos, Christian] Catholic Univ Louvain, Clin Univ St Luc, Dept Neurosurg, Ctr Refractory Epilepsy, Brussels, Belgium.
   [El Tahry, Riem; Santos, Susana Ferrao] Catholic Univ Louvain, Clin Univ St Luc, Dept Neurol, Ctr Refractory Epilepsy, Brussels, Belgium.
RP Raftopoulos, C (reprint author), Catholic Univ Louvain, Clin Univ St Luc, Dept Neurosurg, Ctr Refractory Epilepsy, Brussels, Belgium.
EM christian.raftopoulos@uclouvain.be
CR Blount JP, 2004, J NEUROSURG, V100, P118, DOI 10.3171/ped.2004.100.2.0118
   Krishnaiah B, 2015, COCHRANE DB SYST REV, V12
   Leonhardt G, 2000, NEUROSCI LETT, V292, P63, DOI 10.1016/S0304-3940(00)01432-4
   LIU ZH, 1995, CHINESE MED J-PEKING, V108, P539
   MORRELL F, 1989, J NEUROSURG, V70, P231, DOI 10.3171/jns.1989.70.2.0231
   Mulligan LP, 2001, EPILEPSIA, V42, P226
   Ntsambi-Eba G, 2013, NEUROSURGERY, V72, P890, DOI 10.1227/NEU.0b013e31828ba750
   Orbach D, 2001, EPILEPSIA, V42, P1130, DOI 10.1046/j.1528-1157.2001.45300.x
   Patil AA, 1997, STEREOT FUNCT NEUROS, V69, P210, DOI 10.1159/000099876
   Rougier A, 1996, EPILEPSY RES, V24, P57, DOI 10.1016/0920-1211(96)00010-1
   SAWHNEY IMS, 1995, J NEUROL NEUROSUR PS, V58, P344, DOI 10.1136/jnnp.58.3.344
   Schramm J, 2002, J NEUROSURG, V97, P39, DOI 10.3171/jns.2002.97.1.0039
   Smith MC, 1998, EPILEPSIA, V39, pS81, DOI 10.1111/j.1528-1157.1998.tb05128.x
   Spencer SS, 2002, EPILEPSIA, V43, P141, DOI 10.1046/j.1528-1157.2002.28101.x
   Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1
   Vaz G, 2008, NEUROCHIRURGIE, V54, P311, DOI 10.1016/j.neuchi.2008.02.009
   Whisler WW, 1997, EPILEPSIA, V38, P258, DOI 10.1111/j.1528-1157.1997.tb01109.x
   WYLER AR, 1995, NEUROSURGERY, V37, P1122, DOI 10.1227/00006123-199512000-00012
   Wyler AR, 1995, NEUROSURGERY, V37, P1127
NR 19
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1155
EP E1159
DI 10.1016/j.wneu.2019.02.218
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400145
PM 30880211
DA 2020-05-12
ER

PT J
AU Fukutomi, Y
   Yoshimitsu, K
   Tamura, M
   Masamune, K
   Muragaki, Y
AF Fukutomi, Yoshihiro
   Yoshimitsu, Kitaro
   Tamura, Manabu
   Masamune, Ken
   Muragaki, Yoshihiro
TI Quantitative Evaluation of Efficacy of Intraoperative Examination
   Monitor for Awake Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Awake craniotomy; Functional mapping; Functional monitoring; Glioma;
   Intraoperative examination; Language area
ID RESECTION; TUMORS
AB BACKGROUND: When brain tumors are located near the language area, a test to assess language function is required. During the test, it is practical to display combined information obtained from all the equipment so that the surgeon can confirm the patient's response to the tasks. We developed the intraoperative examination monitor for awake surgery (IEMAS) mainly to combine all information so that the language function test could be performed efficiently. The IEMAS has proved to be useful in clinical settings; however, no quantitative evaluation has been performed. This study aimed to demonstrate the clinical usefulness of the IEMAS through comparison of cases with and without IEMAS use in language function test simulation.
   METHODS: The language function test simulator was created to eliminate any uncertain factors, such as symptoms, which vary among patients. Neurosurgeons participated in the test, and the usefulness of the IEMAS was investigated. We analyzed test duration and number of information exchanges between surgeon and examiner.
   RESULTS: Total test duration with IEMAS use was significantly shorter than without IEMAS use (116.1 +/- 23.1 seconds vs. 147.8 +/- 48.7 seconds; P < 0.02). The number of information exchanges between surgeon and examiner was significantly lower with IEMAS use than without IEMAS use (0.2 +/- 0.6 times vs. 16.1 +/- 15.6 times; P < 0.02).
   CONCLUSIONS: We compared cases with and without IEMAS use. Total test duration decreased with IEMAS use, and number of information exchanges was reduced, thus demonstrating the usefulness of the IEMAS.
C1 [Fukutomi, Yoshihiro; Yoshimitsu, Kitaro; Tamura, Manabu; Masamune, Ken; Muragaki, Yoshihiro] Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Fac Adv Technosurg, Tokyo, Japan.
   [Tamura, Manabu; Muragaki, Yoshihiro] Tokyo Womens Med Univ, Dept Neurosurg, Neurol Inst, Tokyo, Japan.
   [Fukutomi, Yoshihiro] Zendai Kogyo Corp, Tokyo, Japan.
RP Muragaki, Y (reprint author), Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Fac Adv Technosurg, Tokyo, Japan.; Muragaki, Y (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Neurol Inst, Tokyo, Japan.
EM ymuragaki@twmu.ac.jp
CR BERGER MS, 1989, NEUROSURGERY, V25, P786, DOI 10.1227/00006123-198911000-00015
   BLACK PM, 1991, NEW ENGL J MED, V324, P1471, DOI 10.1056/NEJM199105233242105
   Duffau H, 2002, BRAIN, V125, P199, DOI 10.1093/brain/awf016
   Guidelines Committee of the Japan Awake Surgery Conference, 2012, NEUROL MED CHIR TOKY, V52, P119
   Iseki Hiroshi, 2005, Magn Reson Med Sci, V4, P129, DOI 10.2463/mrms.4.129
   Larkin M, 1999, LANCET, V353, P1772, DOI 10.1016/S0140-6736(05)75877-3
   Noh Y, 2012, IEEE INT C ROB BIOM, P1224, DOI [10.1109/ROBIO.2012.6491137, DOI 10.1109/ROBIO.2012.6491137]
   Saito T, 2016, J NEUROSURG, V125, P803, DOI 10.3171/2015.8.JNS151204
   Saito T, 2015, NEUROL MED-CHIR, V55, P1, DOI 10.2176/nmc.ra.2014-0215
   Saito T, 2014, J NEUROSURG, V121, P827, DOI 10.3171/2014.4.JNS131195
   Sakurai Y, 2011, J TOKYO WOMENS MED U, V81, P32
   Tamura M, 2015, NEUROL MED-CHIR, V55, P383, DOI 10.2176/nmc.ra.2014-0415
   Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035
   Uhm JH, 1997, CAN J NEUROL SCI, V24, P3, DOI 10.1017/S0317167100021028
   Willems PWA, 2006, J NEUROSURG, V104, P360, DOI 10.3171/jns.2006.104.3.360
   Yoshimitsu K, 2011, NEUROL MED-CHIR, V51, P472, DOI 10.2176/nmc.51.472
   Yoshimitsu K, 2010, IEEE ENG MED BIO, P6050, DOI 10.1109/IEMBS.2010.5627616
NR 17
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E432
EP E438
DI 10.1016/j.wneu.2019.02.069
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400051
PM 30825617
DA 2020-05-12
ER

PT J
AU Funakoshi, Y
   Imamura, H
   Tani, S
   Adachi, H
   Fukumitsu, R
   Sunohara, T
   Suzuki, K
   Omura, Y
   Matsui, Y
   Sasaki, N
   Bando, T
   Fukuda, T
   Akiyama, R
   Horiuchi, K
   Kajiura, S
   Shigeyasu, M
   Sakai, N
AF Funakoshi, Yusuke
   Imamura, Hirotoshi
   Tani, Shoichi
   Adachi, Hidemitsu
   Fukumitsu, Ryu
   Sunohara, Tadashi
   Suzuki, Keita
   Omura, Yoshihiro
   Matsui, Yuichi
   Sasaki, Natsuhi
   Bando, Toshiaki
   Fukuda, Tatsumaru
   Akiyama, Ryo
   Horiuchi, Kazufumi
   Kajiura, Shinji
   Shigeyasu, Masashi
   Sakai, Nobuyuki
TI Effect of Straightening the Parent Vessels in Stent-Assisted Coil
   Embolization for Anterior Communicating Artery Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysmal stenting; Anterior communicating artery; Progressive
   thrombosis; Stent-assisted coil embolization; Straightening of parent
   vessels
ID ENDOVASCULAR TREATMENT; INTRACRANIAL ANEURYSMS
AB BACKGROUND: Stent-assisted coil embolization (SAC) for treating anterior communicating artery (AcomA) aneurysms is safe and effective. Straightening of parent vessels by stent placement can lead to progressive thrombosis. We describe our experience with SAC for AcomA aneurysms and demonstrate the effect of straightening the parent vessels.
   METHODS: A total of 26 patients with AcomA aneurysms were treated using SAC in our institute between July 2010 and December 2017. Follow-up digital subtraction angiography was performed 6 months after treatment, magnetic resonance angiography was performed every year, and outcomes were analyzed.
   RESULTS: From all aneurysms (n = 24), 12 (50.0%) were neck remnant, and 12 (50.0%) were dome-filling types immediately after the procedure. At the 6-month digital subtraction angiography follow-up (n = 22), 13 (59.1%) aneurysms were complete obliteration, 8 (36.4%) were neck remnant, and 1 (4.5%) was dome filling. The median parent vessel anglewas measured preoperatively at 98.1 degrees, increased to 124.8 degrees immediately after stent deployment, and further increased to 149.6 degrees at the 6-month follow-up. Progressive thrombosis was observed in 13 of 22 (59.1%) aneurysms. The parent vessel angle change immediately after stent deployment in the progressive thrombosis group tended to be larger than that observed in the no thrombosis group; this change was significant at the 6-month follow-up. The median followup term was 18 months. No patients required retreatment.
   CONCLUSIONS: Good SAC outcomes were achieved for AcomA aneurysms, and hemodynamic changes related to straightening of the parent vessels is a consideration in SAC.
C1 [Funakoshi, Yusuke; Imamura, Hirotoshi; Tani, Shoichi; Adachi, Hidemitsu; Fukumitsu, Ryu; Sunohara, Tadashi; Suzuki, Keita; Omura, Yoshihiro; Matsui, Yuichi; Sasaki, Natsuhi; Fukuda, Tatsumaru; Akiyama, Ryo; Horiuchi, Kazufumi; Kajiura, Shinji; Shigeyasu, Masashi; Sakai, Nobuyuki] Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan.
   [Bando, Toshiaki] Shinko Hosp, Dept Neurosurg & Stroke Ctr, Kobe, Hyogo, Japan.
RP Funakoshi, Y (reprint author), Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan.
EM sf1wan0610@gmail.com
CR Cho YD, 2015, NEURORADIOLOGY, V57, P615, DOI 10.1007/s00234-015-1514-8
   Fang S, 2014, AM J NEURORADIOL, V35, P943, DOI 10.3174/ajnr.A3802
   Feng MT, 2016, WORLD NEUROSURG, V93, P271, DOI 10.1016/j.wneu.2016.06.014
   Gao BL, 2013, NEUROSURGERY, V72, P739, DOI 10.1227/NEU.0b013e318286fab3
   Geyik S, 2013, AM J NEURORADIOL, V34, P2157, DOI 10.3174/ajnr.A3574
   Gonzalez N, 2008, STROKE, V39, P2776, DOI 10.1161/STROKEAHA.107.505222
   Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082311
   Huang Q, 2009, AM J NEURORADIOL, V30, P1502, DOI 10.3174/ajnr.A1618
   Huang QH, 2011, AM J NEURORADIOL, V32, P1721, DOI 10.3174/ajnr.A2597
   Huang QH, 2013, J CLIN NEUROSCI, V20, P261, DOI 10.1016/j.jocn.2012.02.027
   Ishii A, 2017, J NEUROSURG, V127, P1063, DOI 10.3171/2016.9.JNS16501
   Johnson AK, 2013, J NEUROINTERV SURG, V5, pIII62, DOI 10.1136/neurintsurg-2012-010503
   Kocur D, 2016, POL J RADIOL, V81, P374, DOI 10.12659/PJR.896818
   Kono K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108033
   Nyberg EM, 2014, J STROKE CEREBROVASC, V23, P80, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.012
   Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114
   Roszelle BN, 2013, NEURORADIOLOGY, V55, P751, DOI 10.1007/s00234-013-1169-2
   Schuette AJ, 2011, NEUROSURGERY, V68, P731, DOI 10.1227/NEU.0b013e3182077373
NR 18
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E410
EP E416
DI 10.1016/j.wneu.2019.02.066
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400048
PM 30822575
DA 2020-05-12
ER

PT J
AU Gambhir, S
   Wang, T
   Pelletier, MH
   Walsh, WR
   Ball, JR
AF Gambhir, Shanu
   Wang, Tian
   Pelletier, Matthew H.
   Walsh, William R.
   Ball, Jonathon R.
TI How Does Cage Lordosis Influence Postoperative Segmental Lordosis in
   Lumbar Interbody Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Fusion; Lordosis; Lumbar; Segmental
ID SAGITTAL BALANCE; ALIGNMENT; RESTORATION; MANAGEMENT; DEFORMITY; SURGERY
AB BACKGROUND: Consideration of sagittal alignment is an integral part of spinal fusion surgery correlating with superior outcomes. Segmental lordosis is an important contributor to sagittal alignment. This study assessed surgical factors influencing segmental lordosis in a 360 degrees fusion model, including cage dimensions, anterior longitudinal ligament resection, facetectomy, and posterior compression.
   METHODS: Six L3-4 synthetic spinal motion segments were used in a repeated measures design. Each sample was sequentially instrumented with lateral cages of increasing height and angle. Lordosis was assessed from lateral radiographs of intact and each instrumented condition. The effect of anterior longitudinal ligament resection, posterior compression with pedicle screws, and bilateral facetectomy was additionally examined.
   RESULTS: A linear relationship between segmental lordosis and cage height was found. This effect was greater with the anterior longitudinal ligament divided. In cages of the same anterior height, increased intrinsic cage lordosis did not result in increased segmental lordosis; cages with no intrinsic lordosis resulted in the highest segmental lordosis. In examining this finding, it was shown that posterior cage height had a larger influence on segmental lordosis. Posterior compression with pedicle screws and bilateral facetectomy increased the segmental lordosis by a further 3.4 degrees and 2.6 degrees, respectively.
   CONCLUSIONS: Cage height was a key factor, with posterior compression further increasing lordosis. The finding that 0 degrees cages results in the most segmental lordosis was an unexpected finding and highlights the importance of appropriate sizing on resulting lordosis. These findings are relevant to cage selection but require further study prior to applying to clinical practice and may influence future cage design.
C1 [Gambhir, Shanu; Ball, Jonathon R.] Royal North Shore Hosp, St Leonards, NSW, Australia.
   [Wang, Tian; Pelletier, Matthew H.; Walsh, William R.] UNSW Sydney, Prince Wales Hosp, Prince Wales Clin Sch, Surg & Orthopaed Res Labs, Sydney, NSW, Australia.
RP Pelletier, MH (reprint author), UNSW Sydney, Prince Wales Hosp, Prince Wales Clin Sch, Surg & Orthopaed Res Labs, Sydney, NSW, Australia.
EM m.pelletier@unsw.edu.au
CR Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6
   Barrey C, 2015, WORLD J ORTHOP, V6, P117, DOI 10.5312/wjo.v6.i1.117
   Campbell JR, 2012, P CANADIAN BIOMECHAN
   Du L, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1845-1
   Farcy JPC, 1997, SPINE, V22, P2452, DOI 10.1097/00007632-199710150-00025
   GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005
   Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96
   Godde S, 2003, SPINE, V28, P1693, DOI 10.1097/00007632-200308010-00012
   Goh JCH, 2000, SPINE, V25, P35, DOI 10.1097/00007632-200001010-00008
   IZUMI Y, 2001, EUR J ORTHOP SURG TR, V11, P9
   Kakkar R, 2007, EUR J ORTHOP SURG TR, V17, P125, DOI 10.1007/s00590-006-0137-5
   Kumar MN, 2001, EUR SPINE J, V10, P314, DOI 10.1007/s005860000239
   Lazennec JY, 2000, EUR SPINE J, V9, P47, DOI 10.1007/s005860050008
   Lee CH, 2017, J NEUROSURG-SPINE, V27, P540, DOI 10.3171/2017.3.SPINE161134
   Manwaring JC, 2014, J NEUROSURG-SPINE, V20, P515, DOI 10.3171/2014.2.SPINE1347
   Melikian R, 2016, SPINE, V41, pE1016, DOI 10.1097/BRS.0000000000001562
   Phan K, 2015, J CLIN NEUROSCI, V22, P1714, DOI 10.1016/j.jocn.2015.03.050
   Saville PA, 2016, J NEUROSURG-SPINE, V25, P713, DOI 10.3171/2016.4.SPINE151206
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shiga Y, 2017, SPINE SURG RELAT RES, V1, P197, DOI 10.22603/ssrr.1.2017-0001
   Uribe JS, 2012, J NEUROSURG-SPINE, V17, P476, DOI 10.3171/2012.8.SPINE111121
   Uribe JS, 2015, EUR SPINE J, V24, pS420, DOI 10.1007/s00586-015-3872-7
   Wang Tian, 2014, J Exp Orthop, V1, P3, DOI 10.1186/s40634-014-0003-z
NR 23
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E606
EP E611
DI 10.1016/j.wneu.2019.02.100
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400073
PM 30831285
DA 2020-05-12
ER

PT J
AU Gao, Z
   Jia, XH
   Xu, J
   Yu, J
   Wang, J
   Zhao, WD
   Chi, FL
   Dai, CF
   Li, HW
   Zhong, P
   Chen, B
   Yuan, YS
AF Gao, Zhen
   Jia, Xian-hao
   Xu, Jian
   Yu, Jing
   Wang, Jing
   Zhao, Wei-dong
   Chi, Fang-lu
   Dai, Chun-fu
   Li, Hua-wei
   Zhong, Ping
   Chen, Bing
   Yuan, Ya-sheng
TI Neurorrhaphy for Facial Reanimation with Interpositional Graft: Outcome
   in 23 Patients and the Impact of Timing on the Outcome
SO WORLD NEUROSURGERY
LA English
DT Article
DE End-to-end anastomosis; End-to-side hypoglossal-facial anastomosis;
   Facial paralysis; Interpositional graft; Neurorrhaphy
ID NERVE ANASTOMOSIS; HYPOGLOSSAL
AB OBJECTIVE: Neurorrhaphy with interpositional graft is a practical technique to achieve facial reanimation when the continuity of the facial nerve is interrupted and a large gap between the proximal and distal stump exists. The aim of this study was to report long-term outcomes of neurorrhaphy for facial reanimation with interpositional graft. The roles of some variable factors in the outcome of neurorrhaphy with interpositional graft were also evaluated and compared.
   METHODS: A retrospective case series from a single tertiary referral center comprised 23 patients with facial nerve interruptions who underwent neurorrhaphy with interpositional graft using either end-to-end anastomosis or end-to-side hypoglossal-facial technique. Preoperative data (age, sex, primary lesion, interval from paralysis to surgery, facial nerve function), intraoperative data (surgical approach, graft and type of neurorrhaphy), and postoperative data (facial nerve function) were collected and analyzed.
   RESULTS: Mean follow-up time was 26.6 +/- 11.9 months. Patients who underwent neurorrhaphy for facial reanimation within 1 year after onset of facial paralysis were more likely to achieve House-Brackmann grade <= 3 compared with patients who underwent neurorrhaphy >1 year after onset of facial paralysis (odds ratio = 23.85, P = 0.04). No other factors were associated with improved outcomes.
   CONCLUSIONS: Early neurorrhaphy with interpositional graft (<= 1 year) for facial reanimation resulted in better final facial nerve function outcomes compared with a delayed procedure.
C1 [Gao, Zhen; Jia, Xian-hao; Yu, Jing; Wang, Jing; Zhao, Wei-dong; Chi, Fang-lu; Dai, Chun-fu; Li, Hua-wei; Chen, Bing; Yuan, Ya-sheng] Fudan Univ, Dept Otol & Skull Base Surg, Eye & ENT Hosp, Shanghai, Peoples R China.
   [Gao, Zhen; Jia, Xian-hao; Yu, Jing; Wang, Jing; Zhao, Wei-dong; Chi, Fang-lu; Dai, Chun-fu; Li, Hua-wei; Chen, Bing; Yuan, Ya-sheng] Fudan Univ, NHC Key Lab Hearing Med, Shanghai, Peoples R China.
   [Xu, Jian; Zhong, Ping] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai, Peoples R China.
RP Yuan, YS (reprint author), Fudan Univ, Dept Otol & Skull Base Surg, Eye & ENT Hosp, Shanghai, Peoples R China.; Yuan, YS (reprint author), Fudan Univ, NHC Key Lab Hearing Med, Shanghai, Peoples R China.
EM yuanyasheng@163.com
FU Youth Fund of National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81400460]; National Nature Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81200739]; Training Program of Outstanding Academic Leaders of Shanghai
   Municipal Commission of Health and Family Planning [2017BR057]
FX This project received funding from Youth Fund of National Natural
   Science Foundation of China (Grant No. 81400460), National Nature
   Science Foundation of China (Grant No. 81200739), and Training Program
   of Outstanding Academic Leaders of Shanghai Municipal Commission of
   Health and Family Planning (Grant No. 2017BR057).
CR ARAI H, 1995, J NEUROSURG, V82, P51, DOI 10.3171/jns.1995.82.1.0051
   Asaoka K, 1999, J NEUROSURG, V91, P268, DOI 10.3171/jns.1999.91.2.0268
   Atlas MD, 1997, LARYNGOSCOPE, V107, P984, DOI 10.1097/00005537-199707000-00028
   Bianchi B, 2012, CURR OPIN OTOLARYNGO, V20, P114, DOI 10.1097/MOO.0b013e32834fa744
   CONLEY J, 1979, PLAST RECONSTR SURG, V63, P63, DOI 10.1097/00006534-197901000-00011
   Coombs CJ, 2009, J PLAST RECONSTR AES, V62, P1580, DOI 10.1016/j.bjps.2008.05.046
   CUSIMANO MD, 1994, NEUROSURGERY, V35, P532, DOI 10.1227/00006123-199409000-00027
   Garcia RM, 2015, PLAST RECONSTR SURG, V135, p1025E, DOI 10.1097/PRS.0000000000001273
   Guntinas-Lichius O, 2006, AM J SURG, V191, P61, DOI 10.1016/j.amjsurg.2005.05.054
   HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202
   Kunihiro T, 1996, ORL J OTO-RHINO-LARY, V58, P32, DOI 10.1159/000276791
   Mark M, 2003, FACIAL PARALYSIS REH
   Matthies C, 1997, NEUROSURGERY, V40, P1
   MAY M, 1991, OTOLARYNG HEAD NECK, V104, P818, DOI 10.1177/019459989110400609
   McRackan TR, 2012, OTOL NEUROTOL, V33, P78, DOI 10.1097/MAO.0b013e31823c8ef1
   Melvin TAN, 2008, FACIAL PLAST SURG, V24, P155, DOI 10.1055/s-2008-1075830
   Nakatsuka H, 2002, J RECONSTR MICROSURG, V18, P509, DOI 10.1055/s-2002-33323
   SAMII M, 1994, ACTA NEUROCHIR, V130, P125, DOI 10.1007/BF01405512
   Scaramella L F, 1996, Ear Nose Throat J, V75, P347
   Scaramella LF, 1996, ENT-EAR NOSE THROAT, V75, P347
   Scaramella LF, 1996, ENT-EAR NOSE THROAT, V75, P354
   SHIOBARA R, 1988, J NEUROSURG, V68, P358, DOI 10.3171/jns.1988.68.3.0358
   Yawn RJ, 2016, AM J OTOLARYNG, V37, P493, DOI 10.1016/j.amjoto.2016.05.001
   Yetiser S, 2007, ANN OTO RHINOL LARYN, V116, P542, DOI 10.1177/000348940711600710
NR 24
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E688
EP E693
DI 10.1016/j.wneu.2019.02.124
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400084
PM 30844532
DA 2020-05-12
ER

PT J
AU Gelinne, A
   Thakrar, R
   Tranmer, BI
   Durham, SR
   Jewell, RP
   Penar, PL
   Lollis, SS
AF Gelinne, Aaron
   Thakrar, Raj
   Tranmer, Bruce, I
   Durham, Susan R.
   Jewell, Ryan P.
   Penar, Paul L.
   Lollis, S. Scott
TI Differential Patterns of Referral to Neurosurgery: A Comparison of
   Allopathic Physicians, Osteopathic Physicians, Nurse Practitioners,
   Physician Assistants, and Chiropractors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Neurosurgery; Nurse; Physician; Referral; Surgery
ID EDUCATION; CARE
AB BACKGROUND: Rising cost and limited resources remain major challenges to U.S. health care and neurosurgery in particular. To ensure an efficient and cost-effective health care system, it is important that referrals to neurosurgery clinics are appropriate, and that referred patients have a reasonably high probability of requiring surgical intervention or, at a minimum, ongoing neurosurgical follow-up. This retrospective study tests the null hypothesis that the probability of a referred patient requiring surgery is independent of referring provider credentials and referring service specialty.
   METHODS: A database of all patients referred to the neurosurgery clinic from 2015 through 2018 (n = 5677) was reviewed; the database included referring provider, referring provider specialty, number of subsequent clinic visits, and outcome of surgery or no surgery. Associations between categorical variables were tested using a chi(2) analysis with post hoc relative risk (RR) calculations and binary logistical regression.
   RESULTS: Compared with patients referred by allopathic physicians, patients referred by osteopathic physicians (RR, 0.63; 95% confidence interval [CI], 0.48-0.84) and those referred by nurse practitioners (RR, 0.66; 95% CI, 0.51-0.86) were significantly less likely to require surgery. Probability of surgical intervention also varied by referrer specialty. Patients referred by neurologists required surgery 35% of the time, whereas patients referred by family practitioners required surgery 19% of the time, and patients referred by pediatricians required surgery only 7% of the time (P < 0.01). Binary logistic regression revealed that referrals from nurse practitioners and osteopathic physicians were independently associated with a decreased probability of surgical intervention.
   CONCLUSIONS: Our data strengthen the concept of having interdisciplinary teams led by physicians at the primary care level to ensure appropriate referrals. Training and adherence to guidelines must continually be reinforced to ensure proper referrals.
C1 [Gelinne, Aaron; Thakrar, Raj; Tranmer, Bruce, I; Durham, Susan R.; Jewell, Ryan P.; Penar, Paul L.; Lollis, S. Scott] Univ Vermont, Div Neurol Surg, Med Ctr, Burlington, VT 05405 USA.
RP Lollis, SS (reprint author), Univ Vermont, Div Neurol Surg, Med Ctr, Burlington, VT 05405 USA.
EM scott.lollis@uvmhealth.org
CR Aiken LH, 2018, NEW ENGL J MED, V378, P2360, DOI 10.1056/NEJMp1800567
   American Association of Colleges of Osteopathic Medicine Research Department, 2018, TRENDS OST MED SCH A
   Association of American Medical Colleges Research, 2012, US MED SCH APPL STUD
   Association of American Medical Colleges Research, 2017, 2017 APPL MATR DAT T
   Auerbach DI, 2013, HEALTH AFFAIR, V32, P1933, DOI 10.1377/hlthaff.2013.0596
   Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797
   Gevitz N, 2009, ACAD MED, V84, P701, DOI 10.1097/ACM.0b013e3181a4049e
   GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624
   Hicks KE, 2018, J PROF NURS, V34, P454, DOI 10.1016/j.profnurs.2017.12.012
   Imanieh Mohammad Hadi, 2017, Electron Physician, V9, P5676, DOI 10.19082/5676
   Institute of Medicine, 2011, FUT NURS LEAD CHANG
   McLaughlin N, 2014, NEUROSURG FOCUS, V37
   McLaughlin N, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14535
   Mehrotra A, 2011, MILBANK Q, V89, P39, DOI 10.1111/j.1468-0009.2011.00619.x
   Mukerji N, 2013, BRIT J NEUROSURG, V27, P334, DOI 10.3109/02688697.2012.717979
   Phillips SJ, 2016, NURSE PRACT, V41, P21, DOI 10.1097/01.NPR.0000475369.78429.54
   Rosenow JM, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14427
   Shalala DE, 2010, FUTURE NURSING FOCUS
   Shannon SC, 2009, ACAD MED, V84, P707, DOI 10.1097/ACM.0b013e3181a43be8
   Song ZR, 2014, JAMA-J AM MED ASSOC, V312, P597, DOI 10.1001/jama.2014.7878
NR 20
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E564
EP E569
DI 10.1016/j.wneu.2019.02.095
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400068
PM 30831280
DA 2020-05-12
ER

PT J
AU Goertz, L
   Dorn, F
   Kraus, B
   Borggrefe, J
   Forbrig, R
   Schlamann, M
   Liebig, T
   Turowski, B
   Kabbasch, C
AF Goertz, Lukas
   Dorn, Franziska
   Kraus, Bastian
   Borggrefe, Jan
   Forbrig, Robert
   Schlamann, Marc
   Liebig, Thomas
   Turowski, Bernd
   Kabbasch, Christoph
TI Improved Occlusion Rate of Intracranial Aneurysms Treated with the
   Derivo Embolization Device: One-Year Clinical and Angiographic Follow-Up
   in a Multicenter Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysm; Angiography; Derivo Embolization Device; Flow diverter;
   Intervention
ID FLOW-DIVERTOR; ISCHEMIC COMPLICATIONS; ENDOVASCULAR TREATMENT; PIPELINE;
   SAFETY
AB OBJECTIVE: The Derivo Embolization Device (DED) is a novel flow-diverter stent consisting of a flexible structure and a surface modification that aims to reduce thrombogenicity. Here, we report 1-year clinical and angiographic follow-up results of the second-generation DED for the treatment of intracranial aneurysms.
   METHODS: This is a retrospective study of 59 consecutive patients (mean age: 53 years, 81% women) treated with the DED for 59 aneurysms (mean size: 8.1 mm) between November 2015 and February 2018 at 3 German tertiary care centers. We evaluated the rate of ischemic stroke, functional outcome, and angiographic results during a 1-year follow-up period.
   RESULTS: Deployment of the DED was successful in all cases. Adverse events were observed in 6 procedures (10.2%), of which 2 were symptomatic (3.4%). No delayed ischemic or hemorrhagic events occurred during the 1-year follow-up and there were no deaths. Permanent morbidity due to in-stent thrombosis and consecutive ischemic stroke occurred in 1 patient (1.7%). Complete (O'Kelly-Marotta grading scale D) and favorable (O'Kelly-Marotta grading scale C+D) aneurysm occlusion was obtained in 70.5% (31/44) and 88.7% (39/44) at 6 months and 82.8% (24/29) and 100% (29/29) at 12 months, respectively.
   CONCLUSIONS: Our results demonstrate that treatment of intracranial aneurysms with the DED is associated with low rates of ischemic complications and adequate aneurysm occlusion at 1-year follow-up.
C1 [Goertz, Lukas] Univ Hosp Cologne, Ctr Neurosurg, Cologne, Germany.
   [Dorn, Franziska; Forbrig, Robert; Liebig, Thomas] Univ Hosp Munich LMU, Dept Neuroradiol, Munich, Germany.
   [Kraus, Bastian; Turowski, Bernd] Univ Hosp Duesseldorf, Dept Neuroradiol, Dusseldorf, Germany.
   [Borggrefe, Jan; Schlamann, Marc; Kabbasch, Christoph] Univ Hosp Cologne, Dept Neuroradiol, Cologne, Germany.
RP Goertz, L (reprint author), Univ Hosp Cologne, Ctr Neurosurg, Cologne, Germany.
EM lukas.goertz@uk-koeln.de
RI Borggrefe, Jan/N-6549-2018; Dorn, Franziska/AAA-7754-2020; Forbrig,
   Robert/AAE-2365-2020
OI Borggrefe, Jan/0000-0003-2908-7560; Dorn, Franziska/0000-0001-9093-8307;
   Kabbasch, Christoph/0000-0003-3712-2258
CR Awad AJ, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS1748
   Becske T, 2013, RADIOLOGY, V267, P858, DOI 10.1148/radiol.13120099
   Bhogal P, 2017, WORLD NEUROSURG, V103, P789, DOI 10.1016/j.wneu.2017.04.092
   Brinjikji W, 2016, AM J NEURORADIOL, V37, P1673, DOI 10.3174/ajnr.A4807
   Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151
   Chalouhi N, 2015, J NEUROSURG, V122, P1498, DOI 10.3171/2014.12.JNS14411
   Chalouhi N, 2013, STROKE, V44, P2150, DOI 10.1161/STROKEAHA.113.001785
   Chiu AHY, 2015, AM J NEURORADIOL, V36, P1728, DOI 10.3174/ajnr.A4329
   Guedon A, 2016, J NEUROSURG, V125, P929, DOI 10.3171/2015.10.JNS15703
   Hwang G, 2014, RADIOLOGY, V273, P194, DOI 10.1148/radiol.14140070
   Kallmes DF, 2015, AM J NEURORADIOL, V36, P108, DOI 10.3174/ajnr.A4111
   Kallmes DF, 2017, J NEUROSURG, V127, P775, DOI 10.3171/2016.8.JNS16467
   Kallmes DF, 2016, INTERV NEUROL, V5, P89, DOI 10.1159/000446503
   Kraus B, 2019, J NEUROINTERV SURG, V11, P68, DOI 10.1136/neurintsurg-2018-013963
   Ley D, 2017, CLIN NEURORADIOL, V27, P335, DOI 10.1007/s00062-015-0493-9
   Manning NW, 2019, J NEUROINTERV SURG, V11, P694, DOI 10.1136/neurintsurg-2018-014363
   Martinez-Galdamez M, 2019, J NEUROINTERV SURG, V11, P396, DOI 10.1136/neurintsurg-2018-014204
   Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982
   O'Kelly CJ, 2010, INTERV NEURORADIOL, V16, P133, DOI 10.1177/159101991001600204
   Puffer RC, 2012, J NEUROSURG, V116, P892, DOI 10.3171/2011.11.JNS111612
   Rezek I, 2014, AM J NEURORADIOL, V35, P124, DOI 10.3174/ajnr.A3623
   Rossen JD, 2012, J NEUROSURG, V117, P929, DOI 10.3171/2012.8.JNS12185
   Saatci I, 2012, AM J NEURORADIOL, V33, P1436, DOI 10.3174/ajnr.A3246
   Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145
   Shankar JJS, 2016, J NEUROINTERV SURG, V8, P273, DOI 10.1136/neurintsurg-2015-011708
   Simgen A, 2016, NEURORADIOLOGY, V58, P987, DOI 10.1007/s00234-016-1730-x
   Wakhloo Ajay K, 2014, Neurosurgery, V61 Suppl 1, P111, DOI 10.1227/NEU.0000000000000392
NR 27
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1503
EP E1509
DI 10.1016/j.wneu.2019.03.137
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400189
PM 30910748
DA 2020-05-12
ER

PT J
AU Goertz, L
   Liebig, T
   Siebert, E
   Herzberg, M
   Borggrefe, J
   Lichtenstein, T
   Dorn, F
   Kabbasch, C
AF Goertz, Lukas
   Liebig, Thomas
   Siebert, Eberhard
   Herzberg, Moriz
   Borggrefe, Jan
   Lichtenstein, Thorsten
   Dorn, Franziska
   Kabbasch, Christoph
TI Extending the Indication of Woven EndoBridge (WEB) Embolization to
   Internal Carotid Artery Aneurysms: A Multicenter Safety and Feasibility
   Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Internal carotid artery; Intracranial aneurysm; WEB; Woven EndoBridge
ID STENT-ASSISTED COILING; UNRUPTURED INTRACRANIAL ANEURYSMS; ENDOVASCULAR
   TREATMENT; CEREBRAL ANEURYSMS; FLOW DIVERSION; COMPLICATIONS; OCCLUSION;
   DEVICE; SERIES
AB OBJECTIVE: Woven Endobridge (WEB) embolization is an approved technique for endovascular treatment of wide-necked and bifurcation aneurysms. However, the WEB has not yet been routinely used for internal carotid artery (ICA) sidewall aneurysms. In this multicenter study, we evaluate the safety and efficacy of WEB for treatment of these aneurysms.
   METHODS: We reviewed all patients with ICA sidewall aneurysms who were treated with WEB at 3 German neurovascular centers between 2011 and 2018. Technical success, complication rates, and angiographic outcome were retrospectively assessed.
   RESULTS: Twenty patients (mean age, 56.3 +/- 13.0 years) with 20 ICA aneurysms (6 ruptured) were identified. The aneurysms were located at the paraophthalmic segment (n = 10), the posterior communicating artery segment (n = 9), and the anterior choroidal artery segment (n = 1). The mean aneurysm size was 8.1 +/- 5.2 mm and 60% were wide-necked. The aneurysms were treated with a single WEB (n = 11) or in combination with coiling and/or stent implantation (n = 7). WEB implantation failed in 2 aneurysms because of a sharp aneurysm angle. There were 1 periprocedural thromboembolic event and 1 in-stent stenosis at follow-up, which remained asymptomatic in both cases. There was no procedure-related morbidity and mortality. At follow-up, complete occlusion was achieved in 76.5%, neck remnants in 17.6%, and aneurysms remnants in 5.9%.
   CONCLUSIONS: The WEB device can be used for treatment of ICA sidewall aneurysms with a high level of procedural safety and a high degree of technical success.
C1 [Goertz, Lukas; Borggrefe, Jan; Lichtenstein, Thorsten; Kabbasch, Christoph] Univ Hosp Cologne, Dept Neuroradiol, Cologne, Germany.
   [Goertz, Lukas] Univ Hosp Cologne, Ctr Neurosurg, Cologne, Germany.
   [Liebig, Thomas; Herzberg, Moriz; Dorn, Franziska] Univ Hosp Munich LMU, Dept Neuroradiol, Munich, Germany.
   [Siebert, Eberhard] Univ Hosp Berlin, Dept Neuroradiol, Charite, Berlin, Germany.
RP Goertz, L (reprint author), Univ Hosp Cologne, Dept Neuroradiol, Cologne, Germany.; Goertz, L (reprint author), Univ Hosp Cologne, Ctr Neurosurg, Cologne, Germany.
EM lukas.goertz@uk-koeln.de
RI Dorn, Franziska/AAA-7754-2020; Borggrefe, Jan/N-6549-2018
OI Dorn, Franziska/0000-0001-9093-8307; Borggrefe, Jan/0000-0003-2908-7560;
   Kabbasch, Christoph/0000-0003-3712-2258
CR Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342
   Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151
   Chalouhi N, 2014, AM J NEURORADIOL, V35, P546, DOI 10.3174/ajnr.A3696
   Chalouhi N, 2013, STROKE, V44, P2150, DOI 10.1161/STROKEAHA.113.001785
   Chalouhi N, 2013, STROKE, V44, P1348, DOI 10.1161/STROKEAHA.111.000641
   Clajus C, 2017, J NEUROINTERV SURG, V9, P411, DOI 10.1136/neurintsurg-2016-012276
   Colby GP, 2012, J NEUROINTERV SURG, V4, P116, DOI 10.1136/jnis.2011.004911
   Ding YH, 2011, AM J NEURORADIOL, V32, P607, DOI 10.3174/ajnr.A2399
   Gawlitza M, 2018, J NEUROINTERV SURG, V10, P629, DOI 10.1136/neurintsurg-2017-013287
   Gresele P, 2013, BLOOD TRANSFUS-ITALY, V11, P349, DOI 10.2450/2013.0248-12
   Herbreteau D, 2016, AM J NEURORADIOL, V37, P2280, DOI 10.3174/ajnr.A4918
   Hetts SW, 2014, AM J NEURORADIOL, V35, P698, DOI 10.3174/ajnr.A3755
   Kabbasch C, 2019, J NEUROINTERV SURG, V11, P390, DOI 10.1136/neurintsurg-2018-014230
   Liebig T, 2015, AM J NEURORADIOL, V36, P1721, DOI 10.3174/ajnr.A4347
   Lubicz B, 2013, AM J NEURORADIOL, V34, P1209, DOI 10.3174/ajnr.A3387
   Lv XL, 2018, WORLD NEUROSURG, V110, P20, DOI 10.1016/j.wneu.2017.10.113
   Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8
   Naggara ON, 2012, RADIOLOGY, V263, P828, DOI 10.1148/radiol.12112114
   Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982
   Pierot L, 2017, J NEURORADIOLOGY, V44, P203, DOI 10.1016/j.neurad.2016.12.011
   Pierot L, 2018, J NEUROINTERV SURG, V10, P553, DOI 10.1136/neurintsurg-2017-013448
   Popielski J, 2018, AM J NEURORADIOL, V39, P111, DOI 10.3174/ajnr.A5413
   Rezek I, 2014, AM J NEURORADIOL, V35, P124, DOI 10.3174/ajnr.A3623
   Sivan-Hoffmann R, 2015, AM J NEURORADIOL, V36, P2320, DOI 10.3174/ajnr.A4457
   Tumialan LM, 2008, J NEUROSURG, V108, P1122, DOI 10.3171/JNS/2008/108/6/1122
   van Rooij SBT, 2018, AM J NEURORADIOL, V39, P859, DOI 10.3174/ajnr.A5608
   Zanaty M, 2014, STROKE, V45, P2656, DOI 10.1161/STROKEAHA.114.006247
   Zhu Y, 2015, WORLD NEUROSURG, V84, P1726, DOI 10.1016/j.wneu.2015.07.036
   ZUBILLAGA AF, 1994, AM J NEURORADIOL, V15, P815
NR 29
TC 5
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E965
EP E974
DI 10.1016/j.wneu.2019.02.198
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400121
PM 30876989
DA 2020-05-12
ER

PT J
AU Gubian, A
   Ganau, M
   Cebula, H
   Todeschi, J
   Scibilia, A
   Noel, G
   Spatola, G
   Chaussemy, D
   Nannavecchia, B
   Gallinaro, P
   Coca, A
   Pop, R
   Signorelli, F
   Proust, F
   Lhermitte, B
   Chibbaro, S
AF Gubian, Arthur
   Ganau, Mario
   Cebula, Helene
   Todeschi, Julien
   Scibilia, Antonino
   Noel, Georges
   Spatola, Giorgio
   Chaussemy, Dominique
   Nannavecchia, Beniamino
   Gallinaro, Paolo
   Coca, Andres
   Pop, Raoul
   Signorelli, Francesco
   Proust, Francois
   Lhermitte, Benoit
   Chibbaro, Salvatore
TI Intracranial Solitary Fibrous Tumors: A Heterogeneous Entity with an
   Uncertain Clinical Behavior
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anaplasia; Hemangiopericytoma; Intracranial solitary fibrous tumors;
   Radiotherapy; Recurrence
ID CENTRAL-NERVOUS-SYSTEM; NAB2-STAT6 GENE FUSION; MENINGES;
   TUMORS/HEMANGIOPERICYTOMAS; CLASSIFICATION; VARIANTS; DISTINCT
AB BACKGROUND: Intracranial solitary fibrous tumors (ISFTs) are rare mesenchymal neoplasms originating in the meninges and characterized by very different biologic and clinical behaviors. Benign histotypes, such as hemangiopericytomas, are now considered a cellular phenotypic variant of this heterogeneous group of rare spindle-cell tumors. Owing to their rarity and resemblance to other, more common brain tumors, ISFTs are often poorly recognized and remain a diagnostic challenge.
   METHODS: We describe a surgical series of 29 patients treated for ISFTs confirmed histologically and through immunohistochemistry. We attempt to provide a focus on the natural history of these pathologies and the need for tailored management.
   RESULTS: This was a retrospective consecutive series of 29 patients with either solitary fibrous tumor (n = 14) or hemangiopericytoma (n = 15) over a 10-year period. Mean follow-up time was 37.71 months. Recurrence rate was 42.9% for solitary fibrous tumors versus 26.7% for hemangiopericytomas. STAT6 expression was 66.7% in hemangiopericytomas versus 42.9% in SFTs.
   CONCLUSIONS: Histopathology and immunohistochemical staining (characterized by positive expression of mainly STAT6 but also CD34, Bcl-2 protein, and vimentin) are key in diagnosis and management of ISFTs. Although ISFTs are still considered benign lesions with very rare aggressive evolution, their clinical behavior is largely unpredictable. This study highlights the importance of relying on immunohistochemistry for a thorough definition of the management strategy.
C1 [Gubian, Arthur] Heidelberg Univ Hosp, Dept Neurosurg, Heidelberg, Germany.
   [Ganau, Mario; Cebula, Helene; Todeschi, Julien; Scibilia, Antonino; Spatola, Giorgio; Chaussemy, Dominique; Nannavecchia, Beniamino; Gallinaro, Paolo; Coca, Andres; Pop, Raoul; Proust, Francois; Chibbaro, Salvatore] Strasbourg Univ Hosp, Dept Neurosurg, Strasbourg, France.
   [Lhermitte, Benoit] Strasbourg Univ Hosp, Dept Histopathol, Strasbourg, France.
   [Noel, Georges] Paul Strauss Ctr, Dept Radiotherapy, Strasbourg, France.
   [Signorelli, Francesco] Bari Univ Hosp, Dept Neurosurg, Bari, Italy.
RP Gubian, A (reprint author), Heidelberg Univ Hosp, Dept Neurosurg, Heidelberg, Germany.
EM arthur.gubian@yahoo.com
RI Chibbaro, Salvatore/AAI-6368-2020
OI Gubian, Arthur/0000-0002-3236-8163; NOEL, Georges/0000-0003-4952-5572
CR Aljohani HT, 2017, INT J HEALTH SCI-IJH, V11, P69
   Alston SR, 1997, AM J SURG PATHOL, V21, P477, DOI 10.1097/00000478-199704000-00015
   Apra C, 2018, J NEUROSURG, V128, P1719, DOI 10.3171/2017.1.JNS162593
   Barthelmess S, 2014, AM J PATHOL, V184, P1209, DOI 10.1016/j.ajpath.2013.12.016
   Bisceglia M, 2011, INT J SURG PATHOL, V19, P476, DOI 10.1177/1066896911405655
   Carneiro SS, 1996, AM J CLIN PATHOL, V106, P217, DOI 10.1093/ajcp/106.2.217
   Clarencon F, 2011, EUR J RADIOL, V80, P387, DOI 10.1016/j.ejrad.2010.02.016
   Cummings TJ, 2001, ACTA NEUROPATHOL, V102, P349
   Fargen KM, 2011, CLIN NEUROL NEUROSUR, V113, P703, DOI 10.1016/j.clineuro.2011.07.024
   Fuller GN, 2008, ARCH PATHOL LAB MED, V132, P906, DOI 10.1043/1543-2165(2008)132[906:TWCOTO]2.0.CO;2
   Ganly I, 2006, ARCH OTOLARYNGOL, V132, P517, DOI 10.1001/archotol.132.5.517
   GOODLAD JR, 1991, HISTOPATHOLOGY, V19, P515, DOI 10.1111/j.1365-2559.1991.tb01499.x
   Hu YC, 2009, APPL IMMUNOHISTO M M, V17, P451, DOI 10.1097/PAI.0b013e318198f23e
   Jeong AK, 2002, AM J NEURORADIOL, V23, P473
   Kim KA, 2004, NEUROSURGERY, V54, P1004, DOI 10.1227/01.NEU.0000115675.74366.87
   Klemperer P, 1992, Am J Ind Med, V22, P1
   Lawlor MW, 2008, NEUROPATH APPL NEURO, V34, P569, DOI 10.1111/j.1365-2990.2008.00943.x
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Macfarlane RG, 2005, NEUROSURGERY, V56, P1378, DOI 10.1227/01.NEU.0000159717.37748.B5
   Martin AJ, 2001, J NEURO-ONCOL, V54, P57, DOI 10.1023/A:1012553119349
   Miyashita K, 2004, J NEUROSURG, V101, P1045, DOI 10.3171/jns.2004.101.6.1045
   Nakada S, 2016, BRAIN TUMOR PATHOL, V33, P169, DOI 10.1007/s10014-016-0264-6
   Nawashiro H, 2000, NEUROL MED-CHIR, V40, P432, DOI 10.2176/nmc.40.432
   Ogawa K, 2004, VIRCHOWS ARCH, V444, P459, DOI 10.1007/s00428-004-0991-7
   Prayson RA, 1997, J NEUROSURG, V86, P1049, DOI 10.3171/jns.1997.86.6.1049
   Sano M, 2007, NEUROL SURG TOKYO, V35, P697
   Suzuki SO, 2000, PATHOL INT, V50, P808, DOI 10.1046/j.1440-1827.2000.01120.x
   Tihan T, 2003, ARCH PATHOL LAB MED, V127, P432
   Waldron JS, 2006, NEUROSURGERY, V59, P939, DOI 10.1227/01.NEU.0000232660.21537.60
   Weon YC, 2007, AM J NEURORADIOL, V28, P1466, DOI 10.3174/ajnr.A0609
   Yuzawa S, 2016, AM J SURG PATHOL, V40, P1031, DOI 10.1097/PAS.0000000000000625
NR 31
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E48
EP E56
DI 10.1016/j.wneu.2019.01.142
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400008
PM 30716501
DA 2020-05-12
ER

PT J
AU Guinto, G
   Nettel, B
   Hernandez, E
   Gallardo, D
   Arechiga, N
   Mercado, M
AF Guinto, Gerardo
   Nettel, Barbara
   Hernandez, Eli
   Gallardo, David
   Arechiga, Norma
   Mercado, Moises
TI Osseous Remodeling Technique of the Sella Turcica: A New Surgical Option
   for Primary Empty Sella Syndrome
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chiasmapexy; Empty sella syndrome; Sella turcica; Sellar arachnoidocele;
   Transsphenoidal surgery
ID TRANSSPHENOIDAL TREATMENT; CHIASMAPEXY
AB BACKGROUND: Empty sella is an anatomic finding that is usually asymptomatic. However, when patients with empty sella finding present with visual deficits, surgical treatment may be necessary. The main goal of surgery is to elevate sellar content through a transsphenoidal approach. The aim of this study was to demonstrate a new technique for precise reconstruction of the sellar floor using a heterologous bone block to restore the anatomic elements of the sella turcica.
   METHODS: Three patients with primary empty sella who presented with visual field defects were prospectively included. Surgery was performed through a microsurgical transsphenoidal approach and involved elevating the sellar content by using a tricortical heterologous bone graft, the dimensions of which were obtained considering the exact dimensions of each patient's sella turcica. The graft was premodeled outside the surgical bed and carefully introduced into the sella turcica to achieve the required elevation (chiasmapexy).
   RESULTS: Vision of all 3 patients improved, and the improvement persisted throughout the follow-up period. 2 patients, this improvement was noted immediately after surgery, and in the third patient, this change in vision occurred 1 week later. Long-term imaging studies showed the persistence of the bone graft in the sella turcica and the exact elevation of the sellar content at the end of the follow-up period. There were no complications in the present series.
   CONCLUSIONS: The technique presented here is simple and reproducible and allows an almost exact and persistent elevation of the sellar content.
C1 [Guinto, Gerardo; Hernandez, Eli] Univ Nacl Autonoma Mexico, Skull Base Program, Mexico City, DF, Mexico.
   [Nettel, Barbara; Gallardo, David] Ctr Med Nacl Siglo 21, Dept Neurosurg, Hosp Especialidades, Mexico City, DF, Mexico.
   [Guinto, Gerardo; Arechiga, Norma] Ctr Neurol ABC, Mexico City, DF, Mexico.
   [Mercado, Moises] Ctr Med ABC, Res Program, Mexico City, DF, Mexico.
RP Guinto, G (reprint author), Univ Nacl Autonoma Mexico, Skull Base Program, Mexico City, DF, Mexico.; Guinto, G (reprint author), Ctr Neurol ABC, Mexico City, DF, Mexico.
EM gguinto@prodigy.net.mx
CR Barzaghi LR, 2018, PITUITARY, V21, P98, DOI 10.1007/s11102-017-0842-6
   Berastegui GRA, 2016, J NEUROSURG, V124, P1025, DOI 10.3171/2015.2.JNS142015
   BRAATVEDT GD, 1992, BRIT J HOSP MED, V47, P523
   Charteris DG, 1996, J NEURO-OPHTHALMOL, V16, P110, DOI 10.1097/00041327-199606000-00006
   Chiloiro S, 2017, EUR J ENDOCRINOL, V177, pR275, DOI 10.1530/EJE-17-0505
   Ginto G, 2007, CONT NEUROSURG, V29, P1
   Guinto G, 2002, SURG NEUROL, V58, P42, DOI 10.1016/S0090-3019(02)00766-8
   Guinto-Balanzar G, 2008, GAC MED MEX, V144, P15
   Guiot G, 1973, Rev Esp Otoneurooftalmol Neurocir, V31, P97
   Guitelman M, 2013, PITUITARY, V16, P270, DOI 10.1007/s11102-012-0416-6
   Kadam A, 2016, INT J SPINE SURG, V10, DOI 10.14444/3033
   Kubo S, 2005, NEUROL MED-CHIR, V45, P428, DOI 10.2176/nmc.45.428
   LECLERCQ TA, 1974, SURG NEUROL, V2, P295
   Lenz Anne M, 2012, Pediatr Endocrinol Rev, V9, P710
   Mroz Thomas E, 2006, Spine J, V6, P34, DOI 10.1016/j.spinee.2005.10.007
   Rudnik A, 2006, MINIM INVAS NEUROSUR, V49, P376, DOI 10.1055/s-2006-955069
   Tsukiyama A, 2017, WORLD NEUROSURG, V107, DOI 10.1016/j.wneu.2017.08.080
   Tuchman A, 2017, GLOB SPINE J, V7, P59, DOI 10.1055/s-0036-1580610
   Wood J G, 1975, Surg Neurol, V3, P291
   Zona G, 2002, NEUROSURGERY, V51, P1299, DOI 10.1097/00006123-200211000-00032
NR 20
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E953
EP E958
DI 10.1016/j.wneu.2019.02.195
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400119
PM 30877013
DA 2020-05-12
ER

PT J
AU Guo, C
   Zhang, LF
   Kong, QQ
   Wang, Y
   Yang, J
   Yan, YQ
   Wu, H
   Peng, ZY
AF Guo, Chuan
   Zhang, Lifeng
   Kong, Qingquan
   Wang, Yu
   Yang, Jin
   Yan, Yuqing
   Wu, Hao
   Peng, Zhiyu
TI Full Endoscopic Key Hole Technique for Cervical Foraminal Stenosis: Is
   Mere Dorsal Decompression Enough?
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical stenosis; Decompression; Dorsal; Full endoscopic; Key hole;
   Ventral
ID ANTERIOR; DISC; DISKECTOMY; FUSION; SPINE; REMOVAL; DISEASE; SYSTEM;
   PAIN
AB OBJECTIVE: To study whether and when mere dorsal decompression is enough in the full endoscopic key hole technique for foraminal stenosis.
   METHODS: We retrospectively reviewed a total of 22 patients with cervical foraminal stenosis who underwent full endoscopic key hole mere dorsal decompression in our institute from October 2016 to October 2017.
   RESULTS: Preoperative neck disability index, neck visual analog scale score, and arm visual analog scale score were 25.8 +/- 0.8, 4.9 +/- 0.6, and 7.5 +/- 0.5 in the group. Immediate postoperative scores were 6.9 +/- 0.9, 1.3 +/- 0.9, and 1.4 +/- 0.5. Follow-up scores at 3 months (7.0 +/- 0.9, 1.9 +/- 0.6, and 2.7 +/- 0.9), 6 months (7.3 +/- 0.9, 2.1 +/- 0.9, and 1.9 +/- 0.5), and 12 months (7.6 +/- 0.5, 2.5 +/- 0.8, and 2.1 +/- 0.7). The symptoms had improved significantly (P < 0.05). According to the Macnab criteria, 15 patients reported excellent results, 2 reported good results, and 2 reported fair results at the 12-month follow-up.
   CONCLUSIONS: Stenosis is mainly caused by dorsal structures; mere dorsal decompression is enough. In both cases, the ventral and dorsal structures contributed to the stenosis. When there is no herniated soft fragment contributing to the stenosis, ventral decompression is not always necessary. If intraoperative exploration detects less tension formed by the ventral abnormal structures, mere dorsal decompression is enough to settle the symptoms.
C1 [Guo, Chuan; Zhang, Lifeng; Kong, Qingquan; Wang, Yu; Yang, Jin; Yan, Yuqing; Wu, Hao; Peng, Zhiyu] Sichuan Univ, West China Hosp, Orthopaed Dept, Chengdu, Sichuan, Peoples R China.
RP Kong, QQ (reprint author), Sichuan Univ, West China Hosp, Orthopaed Dept, Chengdu, Sichuan, Peoples R China.
EM kqqspine@126.com
OI Wang, Yu/0000-0002-0939-5606
CR Ahn Y, 2005, NEURORADIOLOGY, V47, P924, DOI 10.1007/s00234-005-1436-y
   Alonso F, 2018, SPINE, V43, P161, DOI 10.1097/BRS.0000000000002281
   Barakat M, 2012, EUR SPINE J, V21, P1383, DOI 10.1007/s00586-012-2158-6
   BLAND JH, 1990, SEMIN ARTHRITIS RHEU, V20, P1, DOI 10.1016/0049-0172(90)90090-3
   CASPAR W, 1989, NEUROSURGERY, V25, P491, DOI 10.1227/00006123-198910000-00001
   Chen BH, 2001, J SPINAL DISORD, V14, P17, DOI 10.1097/00002517-200102000-00004
   Choi G, 2017, J KOREAN NEUROSURG S, V60, P485, DOI 10.3340/jkns.2017.0203.004
   CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602
   Del Curto D, 2013, COMPUT AIDED SURG, V18, P76, DOI 10.3109/10929088.2012.760650
   Dickman CA, 2017, MINIM INVASIV THER, V8, P303
   Fessler RG, 2002, NEUROSURGERY, V51, pS37, DOI 10.1227/01.NEU.0000030928.34393.63
   FLANNIGAN BD, 1987, AM J ROENTGENOL, V148, P785, DOI 10.2214/ajr.148.4.785
   Fountas KN, 2006, SPINE J, V6, P2310
   Hijikata S, 1975, J TODEN HOSP, V5, P5
   Hilton DL, 2007, SPINE J, V7, P154, DOI 10.1016/j.spinee.2006.03.007
   Hosono N, 1996, SPINE, V21, P1969, DOI 10.1097/00007632-199609010-00005
   HUKUDA S, 1985, J BONE JOINT SURG BR, V67, P609
   KAMBIN P, 1983, CLIN ORTHOP RELAT R, P127
   Kim CH, 2015, GLOB SPINE J, V5, P31, DOI 10.1055/s-0034-1395423
   Kim S, 2015, KOREAN J RADIOL, V16, P1294, DOI 10.3348/kjr.2015.16.6.1294
   Kurakawa T, 2016, EUR SPINE J, V25, P2060, DOI 10.1007/s00586-016-4548-7
   Li M, 2015, PAIN PHYSICIAN, V18, P359
   Loumeau TP, 2016, EUR SPINE J, V25, P2263, DOI 10.1007/s00586-016-4431-6
   MAIR WGP, 1953, BRAIN, V76, P70, DOI 10.1093/brain/76.1.70
   Nunley PD, 2012, SPINE, V37, P445, DOI 10.1097/BRS.0b013e31822174b3
   NURICK S, 1972, BRAIN, V95, P87
   Oppenheimer JH, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.7.FOCUS09121
   Park DK, 2011, SPINE, V36, P721, DOI 10.1097/BRS.0b013e3181df10fc
   Park HJ, 2015, ACTA RADIOL, V56, P727, DOI 10.1177/0284185114537929
   Park HJ, 2013, BRIT J RADIOL, V86, P400
   Park JH, 2017, ORTHOPEDICS, V40, pE779, DOI 10.3928/01477447-20170531-02
   RANAWAT CS, 1979, J BONE JOINT SURG AM, V61, P1003, DOI 10.2106/00004623-197961070-00006
   Roh SW, 2000, SPINE, V25, P260, DOI 10.1097/00007632-200001150-00019
   Ruetten S, 2008, SPINE, V33, P940, DOI 10.1097/BRS.0b013e31816c8b67
   Ruetten S, 2009, INT ORTHOP, V33, P1677, DOI 10.1007/s00264-008-0684-y
   Sheikh Taha Abdel Majid, 2015, HSS J, V11, P31, DOI 10.1007/s11420-014-9426-4
   SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009
   Tureyen K, 2003, ACTA NEUROCHIR, V145, P565, DOI 10.1007/s00701-003-0050-1
   Tzaan WC, 2011, J SPINAL DISORD TECH, V24, P421, DOI 10.1097/BSD.0b013e31820ef328
   Van Zundert J, 2006, REGION ANESTH PAIN M, V31, P152, DOI 10.1016/j.rapm.2005.11.014
   Wen HQ, 2017, BIOMED RES INT, DOI 10.1155/2017/3610385
   Zhang C, 2018, PAIN PHYSICIAN, V21, pE215
NR 42
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E16
EP E26
DI 10.1016/j.wneu.2019.01.045
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400004
PM 30685369
DA 2020-05-12
ER

PT J
AU Hall, S
   Smedley, A
   Sparrow, O
   Mathad, N
   Waters, R
   Chakraborty, A
   Tsitouras, V
AF Hall, Samuel
   Smedley, Alex
   Sparrow, Owen
   Mathad, Nijuguna
   Waters, Ryan
   Chakraborty, Aabir
   Tsitouras, Vassilios
TI Natural History of Intracranial Arachnoid Cysts
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arachnoid cyst; Congenital abnormality
ID ENDOSCOPIC TREATMENT; INCIDENTAL FINDINGS; PREVALENCE; FEATURES;
   CHILDREN
AB BACKGROUND: Intracranial arachnoid cysts are a common incidental finding. Most of these remain asymptomatic with surgical intervention being reserved for those cysts causing symptoms from mass effect or hydrocephalus. It is not properly understood why cysts enlarge nor is it possible to predict in which cysts this will occur. The aim of this study is to review the natural history of incidental arachnoid cysts.
   METHODS: A retrospective case review was conducted of all patients diagnosed with an arachnoid cyst between 2007 and 2016. Case notes and radiology reports were reviewed for demographics, symptoms, and changes in cyst sizes.
   RESULTS: Four hundred and eighty-five patients were diagnosed with an arachnoid cyst during this time period; of these, 425 (87.6%) were asymptomatic. Patients with symptomatic cysts were significantly younger and more likely to have associated hydrocephalus. The most common indications for imaging which resulted in the diagnosis of the cyst were headaches (n = 106), stroke (n = 51), and seizures (n = 41). The cyst size remained stable or reduced in 147 patients (99.3%) with follow-up imaging (n = 148), and the enlarging cyst remained asymptomatic.
   CONCLUSIONS: Asymptomatic arachnoid cysts have a low rate of cyst enlargement on follow-up imaging, which supports not routinely imaging these patients. However, serial imaging and surgery may still be indicated in asymptomatic patients at risk of obstructive hydrocephalus which, in this series, was only seen in the pediatric population. A better understanding of the natural history of intracranial arachnoid cysts allows for more efficient follow-up planning.
C1 [Hall, Samuel; Smedley, Alex; Sparrow, Owen; Mathad, Nijuguna; Waters, Ryan; Chakraborty, Aabir; Tsitouras, Vassilios] Univ Hosp Southampton NHS Fdn Trust, Wessex Neurol Ctr, Dept Neurosurg, Southampton, Hants, England.
RP Hall, S (reprint author), Univ Hosp Southampton NHS Fdn Trust, Wessex Neurol Ctr, Dept Neurosurg, Southampton, Hants, England.
EM Samuel.hall@doctors.org.uk
RI Tsitouras, Vassilios/AAD-7620-2020
CR Al-Holou WN, 2013, J NEUROSURG, V118, P222, DOI 10.3171/2012.10.JNS12548
   Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464
   Basaldella Luca, 2007, Neurosurg Focus, V22, pE4
   Chen Y, 2016, WORLD NEUROSURG, V92, P480, DOI 10.1016/j.wneu.2016.06.046
   Ersahin Y, 2008, CHILD NERV SYST, V24, P1013, DOI 10.1007/s00381-008-0615-7
   Gosalakkal JA, 2002, PEDIATR NEUROL, V26, P93, DOI 10.1016/S0887-8994(01)00329-0
   Gui SB, 2016, CHILD NERV SYST, V32, P647, DOI 10.1007/s00381-015-2962-5
   Halani SH, 2013, J NEUROSURG-PEDIATR, V12, P62, DOI 10.3171/2013.4.PEDS12609
   HARRISON MJ, 1971, J NEUROL NEUROSUR PS, V34, P316, DOI 10.1136/jnnp.34.3.316
   Huang JH, 2015, INT J CLIN EXP MED, V8, P18343
   Ibrahim GM, 2017, NEUROLOGY, V88, P331, DOI 10.1212/WNL.0000000000003522
   Kim KH, 2019, CHILD NERV SYST, V35, P517, DOI 10.1007/s00381-018-4026-0
   Lee JY, 2012, CHILD NERV SYST, V28, P1203, DOI 10.1007/s00381-012-1722-z
   Mattei TA, 2013, J NEUROSURG-PEDIATR, V12, P555, DOI 10.3171/2013.8.PEDS1399
   Palin M, 2015, BMJ CASE REP, V2015
   Preuss M, 2015, CHILD NERV SYST, V31, P347, DOI 10.1007/s00381-014-2518-0
   Qin XW, 2019, CHILD NERV SYST, V35, P607, DOI 10.1007/s00381-019-04060-z
   Rabiei K, 2016, J NEUROL, V263, P689, DOI 10.1007/s00415-016-8035-1
   Sandberg DI, 2005, J NEUROSURG, V103, P427, DOI 10.3171/ped.2005.103.5.0427
   Schulz M, 2015, WORLD NEUROSURG, V84, P327, DOI 10.1016/j.wneu.2015.03.026
   Seizeur R, 2007, ACTA NEUROCHIR, V149, P75, DOI 10.1007/s00701-006-1073-1
   Struck AF, 2006, J NEUROSURG, V104, P426, DOI 10.3171/ped.2006.104.6.426
   Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972
   Wang YB, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013665
   Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1315
EP E1320
DI 10.1016/j.wneu.2019.03.087
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400166
PM 30898748
DA 2020-05-12
ER

PT J
AU Hanihara, M
   Yoshioka, H
   Kanemaru, K
   Hashimoto, K
   Shimizu, M
   Nishigaya, K
   Fukamachi, A
   Kinouchi, H
AF Hanihara, Mitsuto
   Yoshioka, Hideyuki
   Kanemaru, Kazuya
   Hashimoto, Koji
   Shimizu, Masahiro
   Nishigaya, Kazuyuki
   Fukamachi, Akira
   Kinouchi, Hiroyuki
TI Long-Term Clinical and Angiographic Outcomes of Wrap-Clipping for
   Ruptured Blood Blister-Like Aneurysms of the Internal Carotid Artery
   Using Advanced Monitoring
SO WORLD NEUROSURGERY
LA English
DT Article
DE Blood blister-like aneurysm; Internal carotid artery;
   Polytetrafluoroethylene; Wrap-clipping
ID DIGITAL-SUBTRACTION-ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; NONBRANCHING
   SITES; CENTER EXPERIENCE; BYPASS; GRAFT; TOMOGRAPHY; GRANULOMA; SURGERY;
   DEVICE
AB BACKGROUND: Wrap-clipping is one of the recommended treatments for ruptured blood blister-like aneurysms (BBAs) of the internal carotid artery (ICA). However, the long-term clinical and angiographic outcomes of this procedure have not yet been elucidated. The present study examined the long-term efficacy of wrap-clipping using a polytetrafluoroethylene membrane, an ideal wrapping material, for BBAs.
   METHODS: The data from 9 patients with ruptured BBAs treated at our institutes from 2007 to 2016 were retrospectively analyzed. Wrap-clipping was performed with advanced monitoring techniques, including fluorescence video angiography and endoscopy. Angiographic follow-up was achieved using 3-dimensional computed tomography angiography or digital subtraction angiography. Clinical outcomes were assessed using the modified Rankin scale.
   RESULTS: Wrap-clipping was performed without any permanent morbidity in all patients. Endoscopy visualized accurate margins of the aneurysmal pathological wall with high magnification and revealed the position of the clip blades and the surrounding perforators in the dead angles of the microscope. Fluorescence video angiography could confirm the blood flow of the ICA and the surrounding arteries. Regrowth of the aneurysm owing to the presence of a neck remnant occurred 1 month after treatment in 1 case that was repaired surgically. However, no other recurrence of BBAs or progression of ICA stenosis was observed by angiography with a mean follow-up period of 37 months. No repeat rupture or ischemic complications occurred, and all patients had a modified Rankin scale score of 0 with a mean follow-up period of 61 months.
   CONCLUSION: Wrap-clipping using a polytetrafluoroethylene membrane for ruptured BBAs is a useful and acceptable procedure with long-term effectiveness. The effectiveness of this method can be ensured using modern monitoring methods.
C1 [Hanihara, Mitsuto; Yoshioka, Hideyuki; Kanemaru, Kazuya; Hashimoto, Koji; Kinouchi, Hiroyuki] Univ Yamanashi, Dept Neurosurg, Interdisciplinary Grad Sch Med & Engn, Chuo, Japan.
   [Shimizu, Masahiro] Kantoh Neurosurg Hosp, Dept Neurosurg, Kumagaya, Saitama, Japan.
   [Nishigaya, Kazuyuki] Kanbara Publ Hosp, Dept Neurosurg, Fuji, Shizuoka, Japan.
   [Fukamachi, Akira] Nasu Neurosurg Ctr, Dept Neurosurg, Nasushiobara, Japan.
RP Kinouchi, H (reprint author), Univ Yamanashi, Dept Neurosurg, Interdisciplinary Grad Sch Med & Engn, Chuo, Japan.
EM hkinouchi@yamanashi.ac.jp
CR Abe M, 1998, J NEUROSURG, V89, P419, DOI 10.3171/jns.1998.89.3.0419
   Andres RH, 2007, ACTA NEUROCHIR, V149, P953, DOI 10.1007/s00701-007-1260-8
   Aydin K, 2015, J NEUROINTERV SURG, V7, P202, DOI 10.1136/neurintsurg-2013-011090
   Chalouhi N, 2014, NEUROSURGERY, V74, P527, DOI 10.1227/NEU.0000000000000309
   Dehdashti AR, 2006, J NEUROSURG, V104, P395, DOI 10.3171/jns.2006.104.3.395
   DYSTE GN, 1989, NEUROSURGERY, V24, P88, DOI 10.1227/00006123-198901000-00014
   Fang YB, 2014, CLIN NEUROL NEUROSUR, V123, P34, DOI 10.1016/j.clineuro.2014.04.023
   FUJITSU K, 1994, J NEUROSURG, V80, P336, DOI 10.3171/jns.1994.80.2.0336
   Golitz P, 2014, NEUROSURGERY, V74, P606, DOI 10.1227/NEU.0000000000000326
   Gonzalez AM, 2014, EUR J RADIOL, V83, P197, DOI 10.1016/j.ejrad.2013.09.017
   HAISA T, 1990, J NEUROSURG, V72, P292, DOI 10.3171/jns.1990.72.2.0292
   Ishikawa T, 2009, NEUROL MED-CHIR, V49, P553, DOI 10.2176/nmc.49.553
   Kalani MYS, 2013, NEUROSURGERY, V73, P1026, DOI 10.1227/NEU.0000000000000147
   Kamijo K, 2010, J NEUROSURG, V113, P781, DOI 10.3171/2009.10.JNS09970
   Kazumata K, 2014, OPER NEUROSURG, V10, P66, DOI 10.1227/NEU.0000000000000076
   Kinouchi H, 2004, J NEUROSURG, V101, P989, DOI 10.3171/jns.2004.101.6.0989
   Kubo Y, 2006, J NEUROSURG, V105, P785, DOI 10.3171/jns.2006.105.5.785
   Lawton MT, 1996, NEUROSURGERY, V38, P83, DOI 10.1097/00006123-199601000-00020
   Lee JW, 2009, ACTA NEUROCHIR, V151, P125, DOI 10.1007/s00701-008-0165-5
   Linfante I, 2017, J NEUROINTERV SURG, V9, P29, DOI 10.1136/neurintsurg-2016-012287
   Mazur MD, 2016, NEUROSURGERY, V79, pE634, DOI 10.1227/NEU.0000000000001412
   Meling TR, 2008, J NEUROSURG, V108, P662, DOI 10.3171/JNS/2008/108/4/0662
   Murai Y, 2012, WORLD NEUROSURG, V77, P166, DOI 10.1016/j.wneu.2011.05.020
   NAKAGAWA F, 1986, J NEUROSURG, V65, P303, DOI 10.3171/jns.1986.65.3.0303
   Nerva JD, 2015, J NEUROINTERV SURG, V7, P210, DOI 10.1136/neurintsurg-2013-011047
   Ogawa A, 2000, NEUROSURGERY, V47, P578, DOI 10.1097/00006123-200009000-00008
   Owen CM, 2017, NEUROSURGERY, V80, P235, DOI 10.1227/NEU.0000000000001259
   Rouchaud A, 2015, AM J NEURORADIOL, V36, P2331, DOI 10.3174/ajnr.A4438
   Safavi-Abbasi S, 2016, WORLD NEUROSURG, V90, P281, DOI 10.1016/j.wneu.2016.02.109
   Shah SS, 2017, J NEUROSURG, V127, P1361, DOI 10.3171/2016.9.JNS161526
   SHIGETA H, 1992, ACTA NEUROCHIR, V119, P42, DOI 10.1007/BF01541780
   Shimizu H, 2010, NEUROSURG REV, V33, P205, DOI 10.1007/s10143-009-0234-0
   Sim SY, 2006, J NEUROSURG, V105, P400, DOI 10.3171/jns.2006.105.3.400
   Yashar M, 2016, J NEUROINTERV SURG, V8, P495, DOI 10.1136/neurintsurg-2015-011659
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E439
EP E446
DI 10.1016/j.wneu.2019.02.070
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400052
PM 30825634
DA 2020-05-12
ER

PT J
AU Harary, M
   Segar, DJ
   Hayes, MT
   Cosgrove, GR
AF Harary, Maya
   Segar, David J.
   Hayes, Michael T.
   Cosgrove, G. Rees
TI Unilateral Thalamic Deep Brain Stimulation Versus Focused Ultrasound
   Thalamotomy for Essential Tremor
SO WORLD NEUROSURGERY
LA English
DT Article
DE Deep brain stimulation; Essential tremor; Focused ultrasound;
   Thalamotomy; Ventral intermedius nucleus
ID TERM-FOLLOW-UP; PARKINSONS-DISEASE; NUCLEUS; EFFICACY; SAFETY; TRIAL
AB BACKGROUND: The predominant neurosurgical approach to medication-refractory essential tremor is thalamic deep brain stimulation (DBS). The emergence of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy has reawakened the debate surrounding the use of DBS versus thalamotomy for this indication. Herein, we aimed to provide a contemporary comparison between DBS and MRgFUS.
   METHODS: Two controlled trials that evaluated DBS and MRgFUS for the unilateral treatment of refractory essential tremor were compared. Clinical outcomes extracted included postural tremor score in the treated upper extremity, quality of life (QoL), and incidence of adverse events (AE).
   RESULTS: Baseline patient characteristics were comparable in the 2 studies, except that DBS patients were younger and had more severe baseline tremor. Both DBS- and MRgFUS-treated patients had significant tremor improvement that was sustained for 1-year posttreatment, and significant improvement in QoL. The MRgFUS cohort had higher rates of persistent neurologic AE, whereas the DBS group had higher rates of surgery- and hardware-related AEs, including intracranial hemorrhage.
   CONCLUSIONS: In context of prior literature, both DBS and MRgFUS significantly improve tremor control and QoL. The 2 approaches are predominantly differentiated by their AE-profile. Additional head-to-head comparison on matched clinical populations are required to more accurately compare clinical efficacy and long-term outcomes.
C1 [Harary, Maya; Segar, David J.; Cosgrove, G. Rees] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA.
   [Hayes, Michael T.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.
RP Cosgrove, GR (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA.
EM rcosgrove2@partners.org
RI Harary, Maya/AAG-9361-2019
OI Harary, Maya/0000-0002-9962-8900
CR ALESCH F, 1995, ACTA NEUROCHIR, V136, P75, DOI 10.1007/BF01411439
   Alterman RL, 2017, ANN NEUROL, V81, P348, DOI 10.1002/ana.24893
   Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203
   Benabid AL, 1998, MOVEMENT DISORD, V13, P119
   Blomstedt P, 2007, BRIT J NEUROSURG, V21, P504, DOI 10.1080/02688690701552278
   Bond AE, 2017, JAMA NEUROL, V74, P1412, DOI 10.1001/jamaneurol.2017.3098
   Chang JW, 2018, ANN NEUROL, V83, P107, DOI 10.1002/ana.25126
   Chang WS, 2015, J NEUROL NEUROSUR PS, V86, P257, DOI 10.1136/jnnp-2014-307642
   Crowell JL, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0627-8
   Elias WJ, 2016, NEW ENGL J MED, V375, P730, DOI 10.1056/NEJMoa1600159
   Elias WJ, 2013, NEW ENGL J MED, V369, P640, DOI 10.1056/NEJMoa1300962
   Fahn SE, 1988, PARKINSONS DIS MOVEM, P225
   Gallay MN, 2019, J NEUROSURG, V130, P1234, DOI 10.3171/2017.12.JNS172054
   Gross RE, 2006, MOVEMENT DISORD, V21, pS259, DOI 10.1002/mds.20960
   Harary M, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2017.11.FOCUS17587
   Insightec, 2016, PMA P150038 FDA SUMM
   Jeanmonod D, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.10.FOCUS11248
   Jung HH, 2015, MOL PSYCHIATR, V20, P1205, DOI 10.1038/mp.2014.154
   Jung HH, 2015, J NEUROSURG, V122, P162, DOI 10.3171/2014.8.JNS132603
   Kim M, 2017, STEREOT FUNCT NEUROS, V95, P279, DOI 10.1159/000478866
   Kluger BM, 2009, NEUROL CLIN, V27, P633, DOI 10.1016/j.ncl.2009.04.006
   Koller WC, 2001, MOVEMENT DISORD, V16, P464, DOI 10.1002/mds.1089
   Limousin P, 1999, J NEUROL NEUROSUR PS, V66, P289, DOI 10.1136/jnnp.66.3.289
   Lipsman N, 2013, LANCET NEUROL, V12, P462, DOI 10.1016/S1474-4422(13)70048-6
   Louis ED, 2001, NEW ENGL J MED, V345, P887, DOI 10.1056/NEJMcp010928
   Louis ED, 2017, ANN NEUROL, V81, P351, DOI 10.1002/ana.24892
   Magara A, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-11
   NAGASEKI Y, 1986, J NEUROSURG, V65, P296, DOI 10.3171/jns.1986.65.3.0296
   Pahwa R, 2001, MOVEMENT DISORD, V16, P140, DOI 10.1002/1531-8257(200101)16:1<140::AID-MDS1025>3.0.CO;2-T
   Palur RS, 2002, J NEUROSURG, V96, P1058, DOI 10.3171/jns.2002.96.6.1058
   Schuurman PR, 2008, MOVEMENT DISORD, V23, P1146, DOI 10.1002/mds.22059
   Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703
   St. Jude Medical, 2015, PMA P140009 FDA SUMM
   Sydow O, 2003, J NEUROL NEUROSUR PS, V74, P1387, DOI 10.1136/jnnp.74.10.1387
   Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X
   Tasker RR, 1997, ADV STER F, V12, P49
   Wharen RE, 2017, PARKINSONISM RELAT D, V40, P18, DOI 10.1016/j.parkreldis.2017.03.017
   Wintermark M, 2014, AM J NEURORADIOL, V35, P891, DOI 10.3174/ajnr.A3808
   Young RF, 2010, J NEUROSURG, V112, P1311, DOI 10.3171/2009.10.JNS09332
NR 39
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E144
EP E152
DI 10.1016/j.wneu.2019.01.281
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400019
PM 30794976
DA 2020-05-12
ER

PT J
AU Hasegawa, T
   Kato, T
   Naito, T
   Taner, T
   Torii, J
   Ishii, K
   Tsukamoto, E
   Hatanaka, KC
   Sugiyama, T
AF Hasegawa, Toshinori
   Kato, Takenori
   Naito, Takehiro
   Taner, Takafumi
   Torii, Jun
   Ishii, Kazuki
   Tsukamoto, Eisuke
   Hatanaka, Kanako C.
   Sugiyama, Taku
TI Long-Term Outcomes for Pediatric Patients with Brain Arteriovenous
   Malformations Treated with Gamma Knife Radiosurgery, Part 2: The
   Incidence of Cyst Formation, Encapsulated Hematoma, and
   Radiation-Induced Tumor
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cyst formation; Encapsulated hematoma; Gamma knife; Intracranial
   arteriovenous malformation; Pediatric; Radiation-induced tumor;
   Stereotactic radiosurgery
ID CENTRAL-NERVOUS-SYSTEM; STEREOTACTIC RADIOSURGERY; CHILDHOOD-CANCER;
   ADULT SURVIVORS; FOLLOW-UP; SURGERY; COMPLICATIONS; RADIOTHERAPY;
   NEOPLASMS; RISK
AB OBJECTIVE: Long-term data about the incidence of late adverse radiation effects (AREs) in pediatric brain arteriovenous malformations (AVMs) treated with Gamma Knife radiosurgery (GKRS) are lacking. This study addresses the incidence of late AREs, including cyst formation (CF), chronic encapsulated hematoma (CEH), and radiation-induced tumor, in pediatric patients with AVM treated with GKRS.
   METHODS: This is a single-institutional study involving pediatric patients with AVM who underwent GKRS between 1991 and 2014. Among 201 pediatric patients with AVM (age <= 15 years), 189 who had at least 12 months of follow-up were assessed in this study. The median treatment volume was 2.2 cm(3), and the median marginal dose was 20 Gy.
   RESULTS: The mean follow-up period was 136 months. During the follow-up period, symptomatic radiation-induced perilesional edema was found in 5 patients (3%), CFs in 7 patients (4%), CEHs in 7 patients (4%), and radiation-induced tumors in 2 patients (1%). The cumulative incidences of late AREs including CF, CEH, and radiation-induced tumor were 1.2% at 5 years, 5.2% at 8 years, 6.1% at 10 years, 7.2% at 15 years, and 17.0% at 20 years. In the multivariate analysis, treatment volume alone was a significant factor for late AREs (P < 0.001; hazard ratio, 1.111).
   CONCLUSIONS: GKRS is a reasonable treatment option for pediatric AVMs to prevent future intracranial hemorrhages, particularly in the eloquent regions. However, considerable attention should be paid to late AREs such as CFs, CEHs, and radiation-induced tumors because of longer life expectancy in pediatric patients.
C1 [Hasegawa, Toshinori; Kato, Takenori; Naito, Takehiro; Taner, Takafumi; Torii, Jun; Ishii, Kazuki; Tsukamoto, Eisuke] Komaki City Hosp, Gamma Knife Ctr, Dept Neurosurg, Komaki, Japan.
   [Hatanaka, Kanako C.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan.
   [Sugiyama, Taku] Hokkaido Univ Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan.
RP Hasegawa, T (reprint author), Komaki City Hosp, Gamma Knife Ctr, Dept Neurosurg, Komaki, Japan.
EM h-toshi@komakihp.gr.jp
RI Sugiyama, Taku/U-9482-2018
OI Sugiyama, Taku/0000-0003-0398-225X
CR Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148
   Berman Edwina L, 2007, Neurosurgery, V61, pE1099
   Bir SC, 2015, J CLIN NEUROSCI, V22, P1117, DOI 10.1016/j.jocn.2014.12.017
   Cahan WG, 1998, CANCER-AM CANCER SOC, V82, P8, DOI 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W
   Chemaitilly W, 2015, J CLIN ONCOL, V33, P492, DOI 10.1200/JCO.2014.56.7933
   Chen CJ, 2018, WORLD NEUROSURG, V119, pE429, DOI 10.1016/j.wneu.2018.07.178
   Ding D, 2017, WORLD NEUROSURG, V102, P507, DOI 10.1016/j.wneu.2017.03.061
   Ding D, 2017, NEUROSURGERY, V80, P888, DOI 10.1093/neuros/nyx181
   Ding DL, 2017, J NEUROSURG, V126, P859, DOI 10.3171/2016.1.JNS152564
   Ding D, 2014, J NEURO-ONCOL, V119, P513, DOI 10.1007/s11060-014-1501-7
   Flickinger JC, 1999, INT J RADIAT ONCOL, V44, P67, DOI 10.1016/S0360-3016(98)00518-5
   Hasegawa H, 2018, WORLD NEUROSURG, V116, pE556, DOI 10.1016/j.wneu.2018.05.038
   Hasegawa H, 2018, NEUROL MED-CHIR, V58, P231, DOI 10.2176/nmc.st.2018-0008
   Hasegawa T, 2013, J NEUROSURG, V118, P557, DOI 10.3171/2012.10.JNS12523
   Ipekci SH, 2015, EXP CLIN ENDOCR DIAB, V123, P411, DOI 10.1055/s-0035-1549963
   Izawa M, 2005, J NEUROSURG, V102, P34, DOI 10.3171/jns.2005.102.s_supplement.0034
   Izawa M, 2007, SURG NEUROL, V68, P400, DOI 10.1016/j.surneu.2006.11.051
   Kaido T, 2001, J NEUROSURG, V95, P710, DOI 10.3171/jns.2001.95.4.0710
   Kano H, 2012, J NEUROSURG-PEDIATR, V9, P1, DOI 10.3171/2011.9.PEDS10458
   Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907
   Matsuo T, 2014, CLIN NEUROL NEUROSUR, V121, P10, DOI 10.1016/j.clineuro.2014.03.006
   Meneghelli P, 2018, WORLD NEUROSURG, V114, pE840, DOI 10.1016/j.wneu.2018.03.097
   Minniti G, 2005, J CLIN ENDOCR METAB, V90, P800, DOI 10.1210/jc.2004-1152
   Nakajima H, 2016, J CLIN NEUROSCI, V33, P96, DOI 10.1016/j.jocn.2016.01.044
   Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411
   Patel TR, 2014, WORLD NEUROSURG, V81, P594, DOI 10.1016/j.wneu.2013.10.043
   Patibandla MR, 2018, J NEUROSURG, V129, P498, DOI 10.3171/2017.3.JNS162635
   Patibandla MR, 2017, WORLD NEUROSURG, V102, P613, DOI 10.1016/j.wneu.2017.03.064
   Pettorini BL, 2008, CHILD NERV SYST, V24, P793, DOI 10.1007/s00381-008-0631-7
   Pinkham MB, 2015, CLIN ONCOL-UK, V27, P630, DOI 10.1016/j.clon.2015.06.005
   Rowe J, 2007, NEUROSURGERY, V60, P60, DOI 10.1227/01.NEU.0000255492.34063.32
   Sheehan J, 2006, J NEUROSURG, V105, P325, DOI 10.3171/jns.2006.105.2.325
   Shuto T, 2015, ACTA NEUROCHIR, V157, P293, DOI 10.1007/s00701-014-2298-z
   Shuto T, 2012, J NEUROSURG, V117, P135, DOI 10.3171/2012.6.GKS12318
   SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476
   Starke RM, 2017, J NEUROSURG-PEDIATR, V19, P136, DOI 10.3171/2016.9.PEDS16284
   Starke RM, 2017, J NEUROSURG, V126, P36, DOI 10.3171/2015.9.JNS151311
   Starke RM, 2014, WORLD NEUROSURG, V82, P395, DOI 10.1016/j.wneu.2013.02.008
   Tallet AV, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-77
   Xhumari A, 2015, ACTA NEUROCHIR, V157, P889, DOI 10.1007/s00701-015-2377-9
   Yamamoto M, 1996, NEUROSURGERY, V38, P906, DOI 10.1097/00006123-199605000-00010
   Yamanaka R, 2017, WORLD NEUROSURG, V98, P818, DOI 10.1016/j.wneu.2016.11.008
   Yen CP, 2010, J NEUROSURG-PEDIATR, V6, P426, DOI 10.3171/2010.8.PEDS10138
   Yoshida K, 2014, J CLIN NEUROSCI, V21, P1453, DOI 10.1016/j.jocn.2013.10.039
NR 44
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1526
EP E1536
DI 10.1016/j.wneu.2019.03.177
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400192
PM 30922905
DA 2020-05-12
ER

PT J
AU Hasegawa, T
   Kato, T
   Naito, T
   Tanei, T
   Torii, J
   Ishii, K
   Tsukamoto, E
AF Hasegawa, Toshinori
   Kato, Takenori
   Naito, Takehiro
   Tanei, Takafumi
   Torii, Jun
   Ishii, Kazuki
   Tsukamoto, Eisuke
TI Long-Term Outcomes for Pediatric Patients with Brain Arteriovenous
   Malformations Treated with Gamma Knife Radiosurgery, Part 1: Analysis of
   Nidus Obliteration Rates and Related Factors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Gamma knife; Intracranial arteriovenous malformation; Intracranial
   hemorrhage; Pediatric; Stereotactic radiosurgery; Stroke; Vascular
   malformation
ID STEREOTACTIC RADIOSURGERY; NATURAL-HISTORY; MICROSURGICAL TREATMENT;
   MANAGEMENT; CHILDREN; EMBOLIZATION; SURGERY; MULTICENTER; HEMORRHAGE;
   ADULTS
AB OBJECTIVE: Little is known about long-term outcomes for pediatric brain arteriovenous malformations (AVMs) treated with Gamma Knife radiosurgery (GKRS). This study investigated annual hemorrhage rates and nidus obliteration rates, and the factors affecting them, in pediatric AVMs treated with GKRS.
   METHODS: We examined 189 pediatric AVM patients (age <= 15 years) who underwent GKRS and had at least 12 months of follow-up. The Spetzler-Martin (S-M) grade was I in 29 patients (15%), II in 57 (30%), III in 82 (43%), IV in 16 (9%), and V in 5 (3%). The median treatment volume was 2.2 cm(3), and the median marginal dose was 20 Gy.
   RESULTS: The mean follow-up period was 136 months. During a cumulative latency period to nidus obliteration of 813 years, 23 hemorrhages occurred, resulting in an annual post-GKRS hemorrhage rate of 2.8%. The cumulative hemorrhage rates after GKRS were 3.3%, 8.5%, and 11.9% at 3, 5, and 10 years, respectively. Higher S-M grade was significantly associated with intracranial hemorrhages during the latency period (P < 0.001). The actuarial nidus obliteration rates with repeated GKRS were 64% and 81% at 5 and 10 years, respectively. Absence of pre-GKRS embolization (P = 0.023) and higher marginal dose (P = 0.029) were significant factors predicting nidus obliteration.
   CONCLUSIONS: GKRS is a reasonable treatment option in pediatric AVMs to prevent future hemorrhages. Because higher S-M grade AVMs are more likely to hemorrhage during the latency period, a combined therapy with endovascular embolization should be considered to prevent AVM rupture.
C1 [Hasegawa, Toshinori; Kato, Takenori; Naito, Takehiro; Tanei, Takafumi; Torii, Jun; Ishii, Kazuki; Tsukamoto, Eisuke] Komaki City Hosp, Gamma Knife Ctr, Dept Neurosurg, Komaki, Japan.
RP Hasegawa, T (reprint author), Komaki City Hosp, Gamma Knife Ctr, Dept Neurosurg, Komaki, Japan.
EM h-toshi@komakihp.gr.jp
CR Abecassis IJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS14250
   Barr JC, 2012, NEUROSURG CLIN N AM, V23, P63, DOI 10.1016/j.nec.2011.09.010
   Beslow LA, 2010, STROKE, V41, P313, DOI 10.1161/STROKEAHA.109.568071
   Blauwblomme T, 2014, STROKE, V45, P1664, DOI 10.1161/STROKEAHA.113.004292
   Chen CJ, 2018, STROKE, V49, P1939, DOI 10.1161/STROKEAHA.118.022052
   Cohen-Gadol AA, 2006, J NEUROSURG, V104, P388, DOI 10.3171/ped.2006.104.6.388
   Derdeyn CP, 2017, STROKE, V48, pE200, DOI 10.1161/STR.0000000000000134
   Di Rocco C, 2000, ACTA NEUROCHIR, V142, P145, DOI 10.1007/s007010050017
   Dinca EB, 2012, J NEUROSURG-PEDIATR, V10, P445, DOI 10.3171/2012.8.PEDS1241
   El-Ghanem M, 2016, INTERV NEUROL, V5, P218, DOI 10.1159/000447605
   Goldberg J, 2018, J NEUROSURG SCI, V62, P437, DOI 10.23736/S0390-5616.18.04452-1
   Gross BA, 2015, J NEUROSURG-PEDIATR, V15, P71, DOI 10.3171/2014.9.PEDS146
   Gross BA, 2013, J NEUROSURG, V118, P437, DOI 10.3171/2012.10.JNS121280
   Hasegawa H, 2018, NEUROL MED-CHIR, V58, P231, DOI 10.2176/nmc.st.2018-0008
   Kano H, 2012, J NEUROSURG, V117, P265, DOI 10.3171/2012.4.JNS111935
   Kano H, 2012, J NEUROSURG-PEDIATR, V9, P1, DOI 10.3171/2011.9.PEDS10458
   Kim H, 2014, NEUROLOGY, V83, P590, DOI 10.1212/WNL.0000000000000688
   KONDZIOLKA D, 1992, CAN J NEUROL SCI, V19, P40, DOI 10.1017/S0317167100042517
   Levy EI, 2000, NEUROSURGERY, V47, P834, DOI 10.1097/00006123-200010000-00008
   Marks MP, 2017, WORLD NEUROSURG, V99, P471, DOI 10.1016/j.wneu.2016.12.059
   Meyer-Heim AD, 2003, BRAIN DEV-JPN, V25, P416, DOI 10.1016/S0387-7604(03)00029-9
   Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8
   Nicolato A, 2006, INT J RADIAT ONCOL, V64, P914, DOI 10.1016/j.ijrobp.2005.09.013
   Nicolato A, 2015, J NEUROSURG-PEDIATR, V16, P736, DOI 10.3171/2015.4.PEDS158
   Oermann EK, 2015, NEUROSURGERY, V77, P406, DOI 10.1227/NEU.0000000000000772
   Pan DHC, 2008, J NEUROSURG-PEDIATR, V1, P296, DOI 10.3171/PED/2008/1/4/296
   Pikus HJ, 1998, J NEUROSURG, V88, P641, DOI 10.3171/jns.1998.88.4.0641
   Potts MB, 2014, J NEUROSURG-PEDIATR, V14, P1, DOI 10.3171/2014.3.PEDS13381
   Reyns N, 2007, NEUROSURGERY, V60, P268, DOI 10.1227/01.NEU.0000249277.72063.BD
   Sanchez-Mejia RO, 2006, J NEUROSURG, V105, P82, DOI 10.3171/ped.2006.105.2.82
   Schramm J, 2017, J NEUROSURG, V126, P1056, DOI 10.3171/2016.4.JNS153017
   Smyth MD, 2002, J NEUROSURG, V97, P48, DOI 10.3171/jns.2002.97.1.0048
   SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476
   Starke RM, 2011, J NEUROSURG, V69, P129
   Starke RM, 2017, J NEUROSURG-PEDIATR, V19, P136, DOI 10.3171/2016.9.PEDS16284
   Tanaka T, 1996, STEREOT FUNCT NEUROS, V66, P288, DOI 10.1159/000099820
   van Essen MJ, 2018, ACTA NEUROCHIR, V160, P2199, DOI 10.1007/s00701-018-3665-y
   WILKINS RH, 1985, NEUROSURGERY, V16, P421, DOI 10.1227/00006123-198503000-00026
   Yen CP, 2010, J NEUROSURG-PEDIATR, V6, P426, DOI 10.3171/2010.8.PEDS10138
   Yeon JY, 2011, CHILD NERV SYST, V27, P1109, DOI 10.1007/s00381-011-1401-5
   Zabel-Du Bois A, 2006, INT J RADIAT ONCOL, V65, P1206, DOI 10.1016/j.ijrobp.2006.01.041
NR 41
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1518
EP E1525
DI 10.1016/j.wneu.2019.03.176
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400191
PM 30922904
DA 2020-05-12
ER

PT J
AU Hayashi, T
   Karibe, H
   Akamatsu, Y
   Narisawa, A
   Shoji, T
   Sasaki, T
   Kameyama, M
   Tominaga, T
AF Hayashi, Toshiaki
   Karibe, Hiroshi
   Akamatsu, Yosuke
   Narisawa, Ayumi
   Shoji, Takuhiro
   Sasaki, Tatsuya
   Kameyama, Motonobu
   Tominaga, Teiji
TI Endoscopic Hematoma Evacuation for Intracerebral Hemorrhage Under Local
   Anesthesia: Factors That Affect the Hematoma Removal Rate
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic removal; Hemodialysis; Hypertensive intracerebral hemorrhage;
   Liver cirrhosis; Removal rate
ID INTRACRANIAL HEMORRHAGE; SURGERY
AB OBJECTIVE: Recent advances in endoscopic surgery have led to more patients being able to undergo endoscopic removal of hypertensive intracerebral hemorrhage (HICH). However, because of the minimal invasiveness, endoscopic HICH removal through a narrow surgical window can result in a low removal rate. The goal of the present study was to investigate the factors that affect the removal rate of HICH evacuation.
   METHODS: The data from 28 patients with supratentorial HICH who had undergone endoscopic hematoma evacuation were retrospectively analyzed. The inclusion criteria were spontaneous supratentorial HICH with a hematoma volume >30 mL, admission to the hospital within 24 hours of ictus, and a Glasgow coma scale score of >= 4.
   RESULTS: Of the 28 patients, 9 were women and 19 were men, ranging in age from 41 to 86 years (mean, 60.7 +/- 12.7). The hematoma location was the basal ganglia in 25 patients and subcortical in 3 patients. The mean preoperative hematoma volume was 62.4 +/- 22.5 mL. The hematoma removal rate was <60% for 11 patients (poor evacuation group) and >= 60% for in 17 patients (good evacuation group). Comparing the 2 groups, chronic renal failure treated with hemodialysis (P = 0.0072, chi(2) test), liver cirrhosis (P = 0.023, chi(2) test), and surgeon experience with >= 10 cases of endoscopic HICH removal (P = 0.016, chi(2) test) were significant factors related to the HICH removal rate.
   CONCLUSION: To achieve a good removal rate, surgeons should have experience performing the endoscopic procedure. Also, patients with end-stage chronic renal failure or liver cirrhosis should be excluded.
C1 [Hayashi, Toshiaki; Shoji, Takuhiro; Sasaki, Tatsuya] Tohoku Med & Pharmaceut Univ, Dept Neurosurg, Sendai, Miyagi, Japan.
   [Karibe, Hiroshi; Akamatsu, Yosuke; Narisawa, Ayumi; Kameyama, Motonobu] Tohoku Univ, Sendai City Hosp, Dept Neurosurg, Sendai, Miyagi, Japan.
   [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan.
RP Hayashi, T (reprint author), Tohoku Med & Pharmaceut Univ, Dept Neurosurg, Sendai, Miyagi, Japan.
EM hayashi-t@tohoku--mpu.ac.jp
CR Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338
   Darlington A, 2011, THROMB HAEMOSTASIS, V106, P67, DOI 10.1160/TH10-12-0785
   Fiorella David, 2016, Neurosurgery, V63 Suppl 1, P187, DOI 10.1227/01.neu.0000489793.60158.20
   Huang HH, 2008, CLIN NEUROL NEUROSUR, V110, P253, DOI 10.1016/j.clineuro.2007.11.010
   Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304
   Kuo LT, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS10313
   Miki K, 2019, J NEUROSURG, V130, P1485, DOI 10.3171/2017.12.JNS172335
   Molshatzki N, 2011, CEREBROVASC DIS, V31, P271, DOI 10.1159/000322155
   Nishihara T, 2005, NEUROCRIT CARE, V2, P67, DOI 10.1385/NCC:2:1:067
   Vespa P, 2016, STROKE, V47, P2749, DOI 10.1161/STROKEAHA.116.013837
   Xu XH, 2018, J NEUROSURG, V128, P553, DOI 10.3171/2016.10.JNS161589
   Yasaka M, 2017, CIRC J, V81, P1564, DOI 10.1253/circj.CJ-17-0428
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1330
EP E1336
DI 10.1016/j.wneu.2019.03.089
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400168
PM 30898753
DA 2020-05-12
ER

PT J
AU Hayashi, Y
   Kobayashi, M
   Sasagawa, Y
   Oishi, M
   Tachibana, O
   Nakada, M
AF Hayashi, Yasuhiko
   Kobayashi, Masaaki
   Sasagawa, Yasuo
   Oishi, Masahiro
   Tachibana, Osamu
   Nakada, Mitsutoshi
TI Entirely Suprasellar Rathke Cleft Cysts: Clinical Features and Surgical
   Efficacy of Endoscopic Endonasal Transtuberculum Sellae Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscope; Entirely suprasellar; Headache; Magnetic resonance imaging;
   Rathke cleft cyst; Transtuberculum sellae approach
ID TRANSSPHENOIDAL SURGERY; CRANIOPHARYNGIOMA; MANAGEMENT; RECURRENCE;
   APOPLEXY; HEADACHE; OUTCOMES
AB BACKGROUND: Rathke cleft cysts (RCCs) arise from the remnant of Rathke pouch and are usually found in the intermediate lobe. In most cases, RCCs remain intrasellar and extend into the suprasellar region. Rarely, they emerge entirely into the suprasellar cistern-entirely suprasellar Rathke cleft cyst (ESSRCC).
   METHODS: We retrospectively reviewed medical records of 7 patients (5.5%) with ESSRCC among 128 patients with a diagnosis of RCC from January 1994 to September 2018. Of RCC cases, 70 were treated surgically. Patient age and sex, symptoms, magnetic resonance imaging findings, cyst diameter, presence of preoperative or postoperative hypopituitarism, operative procedures and complications, and functional outcomes at the final follow-up were investigated.
   RESULTS: All patients with ESSRCC were women with mean age 45.7 years (range, 29-69 years) at diagnosis. All patients experienced headache, mainly in the retro-orbital region. Mean ESSRCC diameter was 9.9 mm (range, 6-14 mm). Most cases exhibited hyperintensity on both T1-weighted and T2-weighted imaging. The endoscopic endonasal transtuberculum sellae approach relieved headache effectively and safely in 5 patients. Postoperative endocrinologic functions were almost entirely preserved. No patient experienced recurrence during the follow-up period.
   CONCLUSIONS: RCCs should be considered in the differential diagnosis of suprasellar cysts. The endoscopic endonasal transtuberculum sellae approach has an advantage in visualizing these lesions owing to the direction of light from the endoscope. Headache could be treated effectively with the endoscopic endonasal transtuberculum sellae approach without recurrence of cysts or pituitary dysfunction.
C1 [Hayashi, Yasuhiko; Kobayashi, Masaaki; Sasagawa, Yasuo; Oishi, Masahiro; Nakada, Mitsutoshi] Kanazawa Med Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan.
   [Tachibana, Osamu] Kanazawa Med Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan.
RP Hayashi, Y (reprint author), Kanazawa Med Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan.
EM yahayashi@med.kanazawa-u.ac.jp
OI Oishi, Masahiro/0000-0002-9776-2399
CR Aho CJ, 2005, J NEUROSURG, V102, P189, DOI 10.3171/jns.2005.102.2.0189
   BARROW DL, 1985, NEUROSURGERY, V16, P766, DOI 10.1227/00006123-198506000-00005
   BASKIN DS, 1984, J NEUROSURG, V60, P8, DOI 10.3171/jns.1984.60.1.0008
   Binning MJ, 2008, J NEUROSURG, V108, P3, DOI 10.3171/JNS/2008/108/01/0003
   Chaiban JT, 2011, J NEUROSURG, V114, P318, DOI 10.3171/2010.5.JNS091905
   Chotai S, 2015, J NEUROSURG, V122, P1380, DOI 10.3171/2014.12.JNS14596
   Cohan P, 2004, J ENDOCRINOL INVEST, V27, P943, DOI 10.1007/BF03347537
   Cohen-Gadol AA, 2005, J NEUROSURG, V103, P570, DOI 10.3171/jns.2005.103.3.0570
   FAGER CA, 1966, J NEUROSURG, V24, P77, DOI 10.3171/jns.1966.24.1.0077
   Frank G, 2005, NEUROSURGERY, V56, P124, DOI 10.1227/01.NEU.0000144824.80046.1F
   Fukui I, 2017, WORLD NEUROSURG, V99, P362, DOI 10.1016/j.wneu.2016.12.111
   Han SJ, 2014, J NEURO-ONCOL, V117, P197, DOI 10.1007/s11060-013-1272-6
   Hayashi Y, 1999, J COMPUT ASSIST TOMO, V23, P34, DOI 10.1097/00004728-199901000-00008
   Hayashi Y, 2016, CHILD NERV SYST, V32, P1625, DOI 10.1007/s00381-016-3160-9
   Hayashi Y, 2015, TURK NEUROSURG, V25, P332, DOI 10.5137/1019-5149.JTN.9776-13.0
   Hensen J, 1999, CLIN ENDOCRINOL, V50, P431, DOI 10.1046/j.1365-2265.1999.00666.x
   ITOH J, 1992, NEUROSURGERY, V30, P581
   Kim JE, 2004, J NEUROSURG, V100, P33, DOI 10.3171/jns.2004.100.1.0033
   Larkin S, 2014, HAND CLINIC, V124, P255, DOI 10.1016/B978-0-444-59602-4.00017-4
   Madhok R, 2010, J NEUROSURG, V112, P1333, DOI 10.3171/2009.10.JNS09348
   McLaughlin N, 2010, CAN J NEUROL SCI, V37, P402, DOI 10.1017/S0317167100010349
   Mendelson ZS, 2014, J CLIN NEUROSCI, V21, P378, DOI 10.1016/j.jocn.2013.07.008
   Neidert MC, 2013, J NEUROL SURG PART A, V74, pE229, DOI 10.1055/s-0033-1343985
   Nishioka H, 1999, NEURORADIOLOGY, V41, P832, DOI 10.1007/s002340050851
   Nishioka H, 2006, CLIN ENDOCRINOL, V64, P184, DOI 10.1111/j.1365-2265.2006.02446.x
   Nishioka H, 2006, HEADACHE, V46, P1580, DOI 10.1111/j.1526-4610.2006.00539.x
   Ogawa Y, 2013, ACTA NEUROCHIR, V155, P1069, DOI 10.1007/s00701-012-1593-9
   Oishi M, 2018, CLIN NEUROL NEUROSUR, V167, P141, DOI 10.1016/j.clineuro.2018.02.031
   Oka H, 1995, Noshuyo Byori, V12, P97
   Pawar SJ, 2002, J CLIN NEUROSCI, V9, P76, DOI 10.1054/jocn.2001.0974
   Peng YP, 2016, WORLD NEUROSURG, V92, P120, DOI 10.1016/j.wneu.2016.04.121
   Saeki N, 1991, ACTA NEUROCHIR WIEN, V141, P1055
   Sato K, 2006, CLIN NEUROPATHOL, V25, P25
   STEINBERG GK, 1982, J NEUROSURG, V56, P290, DOI 10.3171/jns.1982.56.2.0290
   SUWANWELA N, 1994, HEADACHE, V34, P435, DOI 10.1111/j.1526-4610.1994.hed3407435.x
   VOELKER JL, 1991, J NEUROSURG, V74, P535, DOI 10.3171/jns.1991.74.4.0535
   Wait SD, 2010, NEUROSURGERY, V67, P837, DOI 10.1227/01.NEU.0000374768.16291.03
   Wenger M, 2001, J CLIN NEUROSCI, V8, P564, DOI 10.1054/jocn.2000.0925
   Wolfe SQ, 2010, J NEUROSURG, V112, P1322, DOI 10.3171/2009.10.JNS091265
   YOSHIDA J, 1977, J NEUROSURG, V47, P451, DOI 10.3171/jns.1977.47.3.0451
   Zada G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.5.FOCUS1183
NR 41
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E921
EP E929
DI 10.1016/j.wneu.2019.03.011
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400115
PM 30872194
DA 2020-05-12
ER

PT J
AU Hofler, RC
   Pecoraro, N
   Jones, GA
AF Hofler, Ryan C.
   Pecoraro, Nathan
   Jones, G. Alexander
TI Outcomes of Surgical Correction of Atlantoaxial Instability in Patients
   with Down Syndrome: Systematic Review and Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Atlantoaxial instability; Down syndrome; Meta-analysis; PRISMA
ID SPINAL-CORD COMPRESSION; UPPER CERVICAL-SPINE; CRANIOVERTEBRAL JUNCTION
   ABNORMALITIES; OCCIPITOCERVICAL RECONSTRUCTION; AXIAL SUBLUXATION;
   VERTEBRAL ARTERY; GROWTH CHARTS; CHILDREN; FUSION; DISLOCATION
AB BACKGROUND: Atlantoaxial instability (AAI) is a common cause of neurologic dysfunction and pain in patients with Down syndrome (DS), frequently requiring instrumented fusion of the upper cervical spine. Despite this, optimal treatment strategy is controversial.
   METHODS: A systematic review of the literature was performed according to the Preferred Reporting Items for Systemic Reviews and Meta-Analysis statement to identify patients with AAI and DS were treated with upper cervical spine fusion. Patient demographics, preoperative symptoms, fixation type, and outcome measures including complications, neurologic outcomes, and bony fusion status were gathered for patients in the included publications. Meta-analysis was performed to compare outcomes of different types of fixation constructs.
   RESULTS: Of the 1191 publications retrieved, 51 met inclusion criteria, yielding 137 patients. Six fixation strategies were identified: noninstrumented (n = 6), wiring (n = 77), wiring with rods (n = 14), screw fixation (n = 33), hook and rod fixation (n = 2), and screw and wire fixation (n = 5). Constructs with screws and rods had greater bony union (P = 0.003) and a lower rate of revision surgery (P = 0.047), loss of reduction or pseudoarthrosis (P = 0.009), halo utilization (P < 0.001), and early neurologic decline (P = 0.004) compared with wiring alone. Constructs with wires and rods had greater bony union (P = 0.036) than wiring alone.
   CONCLUSIONS: Numerous fixation strategies exist for AAI in patients with DS. Using a combination of screws, rods, and wiring in appropriately selected patients may help reduce the high rate of surgical complications in these patients.
C1 [Hofler, Ryan C.; Jones, G. Alexander] Loyola Univ Med Ctr, Dept Neurosurg, Maywood, IL 60153 USA.
   [Pecoraro, Nathan] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA.
RP Jones, GA (reprint author), Loyola Univ Med Ctr, Dept Neurosurg, Maywood, IL 60153 USA.
EM alexander.jones@lumc.edu
OI Hofler, Ryan/0000-0002-0186-3284; Jones, G.
   Alexander/0000-0002-0009-5463
CR Abumi K, 1999, SPINE, V24, P1425, DOI 10.1097/00007632-199907150-00007
   Briggs R G, 1992, S D J Med, V45, P279
   Brockmeyer DL, 1999, J NEUROSURG, V90, P271, DOI 10.3171/spi.1999.90.2.0271
   Bull MJ, 2011, PEDIATRICS, V128, P393, DOI 10.1542/peds.2011-1605
   CHAUDHRY V, 1987, ANN NEUROL, V21, P606, DOI 10.1002/ana.410210616
   Cohen MW, 2001, SPINE, V26, P825, DOI 10.1097/00007632-200104010-00026
   CRONK C, 1988, PEDIATRICS, V81, P102
   CURTIS BH, 1968, J AMER MED ASSOC, V205, P464
   Dedlow ER, 2013, CLIN PEDIATR, V52, P633, DOI 10.1177/0009922813482178
   Doyle JS, 1996, SPINE, V21, P1223, DOI 10.1097/00007632-199605150-00016
   DZENITIS AJ, 1966, J NEUROSURG, V25, P458, DOI 10.3171/jns.1966.25.4.0458
   El-Khouri M, 2014, WORLD NEUROSURG, V82, P215, DOI 10.1016/j.wneu.2014.02.006
   FINERMAN GAM, 1976, J BONE JOINT SURG AM, V58, P408, DOI 10.2106/00004623-197658030-00021
   GIBLIN PE, 1979, CLIN ORTHOP RELAT R, P66
   Giussani C, 2009, PEDIATR NEUROSURG, V45, P29, DOI 10.1159/000202621
   Hankinson TC, 2010, NEUROSURGERY, V66, pA32, DOI 10.1227/01.NEU.0000365803.22786.F0
   Hedequist D, 2010, SPINE, V35, pE128, DOI 10.1097/BRS.0b013e3181bad0c2
   HERRING JA, 1982, J PEDIATR ORTHOPED, V2, P205, DOI 10.1097/01241398-198202020-00017
   Heuer GG, 2009, EUR SPINE J, V18, P884, DOI 10.1007/s00586-009-0969-x
   HIGO M, 1995, J PEDIATR ORTHOPED, V15, P539, DOI 10.1097/01241398-199507000-00026
   HOLMES JC, 1978, ORTHOP CLIN N AM, V9, P923
   Hui JHP, 1997, J ORTHOPAED SURG, V5, P73
   Ito K, 2017, J PEDIATR ORTHOP B, V26, P86, DOI 10.1097/BPB.0000000000000299
   Johnson CS, 2013, J CLIN NEUROSCI, V20, P323, DOI 10.1016/j.jocn.2012.03.030
   KOBORI M, 1986, SPINE, V11, P195, DOI 10.1097/00007632-198604000-00003
   Kohno Michihiro, 1995, Neurologia Medico-Chirurgica, V35, P753, DOI 10.2176/nmc.35.753
   KOOP SE, 1984, J BONE JOINT SURG AM, V66A, P403, DOI 10.2106/00004623-198466030-00013
   Kosnik-Infinger L, 2014, J NEUROSURG-PEDIATR, V13, P45, DOI 10.3171/2013.9.PEDS131
   Kuroki H, 2012, INT J SPINE SURG, V6, P210, DOI 10.1016/j.ijsp.2012.05.002
   Lowry DW, 1997, J NEUROSURG, V87, P671, DOI 10.3171/jns.1997.87.5.0671
   Lu DC, 2007, J NEUROSURG, V106, P480, DOI 10.3171/ped.2007.106.6.480
   Magrini S, 2008, NEUROSURGERY, V63, P373, DOI 10.1227/01.NEU.0000315285.84524.74
   MARTICH V, 1992, RADIOLOGY, V183, P125, DOI 10.1148/radiology.183.1.1532260
   Masuda Kazuhiro, 2003, J Orthop Sci, V8, P227, DOI 10.1007/s007760300038
   MENEZES AH, 1992, PEDIATR NEUROSURG, V18, P24, DOI 10.1159/000120638
   MILLER JDR, 1986, J CAN ASSOC RADIOL, V37, P85
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Molinari RW, 2015, GLOBAL SPINE J, V6, pe46
   Nader-Sepahi A, 2005, J NEUROSURG, V103, P231, DOI 10.3171/ped.2005.103.3.0231
   NORDT JC, 1981, SPINE, V6, P437, DOI 10.1097/00007632-198109000-00003
   North American Spine Society, 2015, LEV EV PRIM RES QUES
   Oda I, 1999, SPINE, V24, P2377, DOI 10.1097/00007632-199911150-00015
   Odent T, 2015, EUR SPINE J, V24, P94, DOI 10.1007/s00586-014-3436-2
   Pait TG, 1999, J NEUROSURG, V90, P1, DOI 10.3171/spi.1999.90.1.0001
   Parisini P, 2003, SPINE, V28, P566, DOI 10.1097/01.BRS.0000049961.22749.49
   Rasmussen SA, 2008, AM J MED GENET A, V146A, P2998, DOI 10.1002/ajmg.a.32581
   Reilly CW, 2006, J PEDIATR ORTHOPED, V26, P582, DOI 10.1097/01.bpo.0000230337.26652.55
   SEGAL LS, 1991, J BONE JOINT SURG AM, V73A, P1547, DOI 10.2106/00004623-199173100-00013
   SHERK HH, 1982, CLIN ORTHOP RELAT R, P37
   Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157
   SHIELD LK, 1981, AUST PAEDIATR J, V17, P114
   SHIKATA J, 1989, INT ORTHOP, V13, P187, DOI 10.1007/BF00268046
   Siemionow K, 2017, J NEUROL SURG PART A, V78, P113, DOI 10.1055/s-0036-1584905
   Siemionow Kris, 2014, Evid Based Spine Care J, V5, P112, DOI 10.1055/s-0034-1386749
   Singh SK, 2003, J NEUROSURG, V98, P239, DOI 10.3171/spi.2003.98.3.0239
   SMITH MD, 1991, SPINE, V16, P695, DOI 10.1097/00007632-199107000-00001
   Takeshima Yasuhiro, 2017, Surg Neurol Int, V8, P262, DOI 10.4103/sni.sni_57_17
   Tseng SH, 1998, SPINAL CORD, V36, P520, DOI 10.1038/sj.sc.3100615
   Visocchi M, 2003, ACTA NEUROCHIR, V145, P265, DOI 10.1007/s00701-002-1067-6
   Visocchi M, 2009, ACTA NEUROCHIR, V151, P551, DOI 10.1007/s00701-009-0271-z
   Yamazaki M, 2004, J NEUROSURG-SPINE, V1, P338, DOI 10.3171/spi.2004.1.3.0338
   Yamazaki M, 2008, NEURORADIOLOGY, V50, P485, DOI 10.1007/s00234-008-0368-8
   Zemel BS, 2015, PEDIATRICS, V136, pE1204, DOI 10.1542/peds.2015-1652
NR 63
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E125
EP E135
DI 10.1016/j.wneu.2019.01.267
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400017
PM 30790735
DA 2020-05-12
ER

PT J
AU Hosmann, A
   Micko, A
   Frischer, JM
   Roetzer, T
   Vila, G
   Wolfsberger, S
   Knosp, E
AF Hosmann, Arthur
   Micko, Alexander
   Frischer, Josa M.
   Roetzer, Thomas
   Vila, Greisa
   Wolfsberger, Stefan
   Knosp, Engelbert
TI Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk
   Factor for Recurrent Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cavernous sinus; Pituitary adenoma; Pituitary apoplexy; Transsphenoidal
ID FOLLOW-UP; CONSERVATIVE MANAGEMENT; NATURAL-HISTORY; GAMMA-KNIFE;
   ADENOMAS; SURGERY; SERIES; SPACE
AB OBJECTIVE: Pituitary apoplexy is a rare but potentially life-threatening disorder that occurs in up to 10% of adenomas. Whereas risk factors for the initial hemorrhagic event are well described, there is minor knowledge on clinical symptomatic recurrent pituitary apoplexies.
   METHODS: At the Medical University of Vienna, 76 patients were surgically treated for clinical symptomatic pituitary apoplexy between 1990 and 2017. Four patients (5.3%) suffered multiple pituitary apoplexies after initial surgery. In this retrospective study, neuroradiologic images, clinical data, and intraoperative findings were reviewed for potential risk factors of multiple apoplexies in pituitary adenomas.
   RESULTS: Patients with multiple apoplexies had significantly higher Knosp grading on preoperative imaging (median grade 4), and more frequently observed cavernous sinus invasion intraoperatively (P = 0.01). Consequently, all cases with multiple pituitary apoplexies remained with residual adenoma postoperatively. In cases of residual tumor within the cavernous sinus, recurrent apoplexy occurred in 23.5% of patients. A tumor recurrence/residual was resected significantly earlier in patients with single apoplexy (median 2.2 years) than in patients with multiple apoplexies (median 5.4 years; P = 0.05). Multiple pituitary apoplexies caused significantly greater rates of ophthalmoplegia (75% vs. 14.1%; P = 0.01) and long-term hormone-replacement therapy was necessary in all cases.
   CONCLUSIONS: Cavernous sinus invasion and subtotal resection are high risk factors for multiple apoplexies in pituitary adenomas. Early treatment is recommended for residual tumor in the cavernous sinus to minimize the risk of recurrent apoplexy with subsequent worse clinical outcome.
C1 [Hosmann, Arthur; Micko, Alexander; Frischer, Josa M.; Wolfsberger, Stefan; Knosp, Engelbert] Med Univ Vienna, Dept Internal Med 3, Dept Neurosurg, Vienna, Austria.
   [Roetzer, Thomas] Med Univ Vienna, Dept Internal Med 3, Inst Neurol, Vienna, Austria.
   [Vila, Greisa] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria.
RP Knosp, E (reprint author), Med Univ Vienna, Dept Internal Med 3, Dept Neurosurg, Vienna, Austria.
EM engelbert.knosp@meduniwien.ac.at
RI Vila, Greisa/P-1335-2018; Micko, Alexander/AAI-6123-2020; Hosmann,
   Arthur/V-5385-2019
OI Vila, Greisa/0000-0003-1918-1959; Micko, Alexander/0000-0001-9105-3519;
   Hosmann, Arthur/0000-0001-7396-4239; Frischer, Josa/0000-0002-6638-3476
CR Abbott J, 2004, BRIT MED J, V329, P218, DOI 10.1136/bmj.329.7459.218
   Abdulbaki Arif, 2017, Surg Neurol Int, V8, P16, DOI 10.4103/2152-7806.199557
   Abe T, 2001, ACTA NEUROPATHOL, V102, P435
   Acikgoz B, 2004, J CLIN NEUROSCI, V11, P555
   AHMED M, 1989, HORM RES, V31, P125, DOI 10.1159/000181101
   Albani A, 2016, INT J ENDOCRINOL, DOI 10.1155/2016/7951536
   Arita K, 2006, J NEUROSURG, V104, P884, DOI 10.3171/jns.2006.104.6.884
   Ayuk J, 2004, CLIN ENDOCRINOL, V61, P747, DOI 10.1111/j.1365-2265.2004.02162.x
   BILLS DC, 1993, NEUROSURGERY, V33, P602, DOI 10.1227/00006123-199310000-00007
   Biousse V, 2001, J NEUROL NEUROSUR PS, V71, P542, DOI 10.1136/jnnp.71.4.542
   Capatina C, 2015, EUR J ENDOCRINOL, V172, pR179, DOI 10.1530/EJE-14-0794
   Chen LK, 2011, J NEURO-ONCOL, V102, P129, DOI 10.1007/s11060-010-0302-x
   Cinar N, 2013, PITUITARY, V16, P483, DOI 10.1007/s11102-012-0444-2
   Couture Nathalie, 2012, Endocr Pract, V18, pe147, DOI 10.4158/EP12106.CR
   El-Shehaby AMN, 2012, J NEUROSURG, V117, P84, DOI 10.3171/2012.6.GKS12986
   Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x
   Giammattei L, 2016, J ENDOCRINOL INVEST, V39, P739, DOI 10.1007/s40618-015-0424-2
   Gruber A, 2006, BRIT J NEUROSURG, V20, P379, DOI 10.1080/02688690601046678
   Jho DH, 2014, WORLD NEUROSURG, V82, P781, DOI 10.1016/j.wneu.2014.06.005
   Karavitaki N, 2007, CLIN ENDOCRINOL, V67, P938, DOI 10.1111/j.1365-2265.2007.02990.x
   KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008
   Lee CC, 2019, J NEURO-ONCOL, V142, P291, DOI 10.1007/s11060-019-03095-1
   Lenders N, 2016, CLIN ENDOCRINOL, V84, P222, DOI 10.1111/cen.12879
   Leyer C, 2011, J ENDOCRINOL INVEST, V34, P502, DOI 10.3275/7241
   MACCAGNAN P, 1995, J CLIN ENDOCR METAB, V80, P2190, DOI 10.1210/jc.80.7.2190
   Micko ASG, 2017, PITUITARY, V20, P643, DOI 10.1007/s11102-017-0829-3
   Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
   Moller-Goede DL, 2011, EUR J ENDOCRINOL, V164, P37, DOI 10.1530/EJE-10-0651
   Nawar Rita N, 2008, J Intensive Care Med, V23, P75, DOI 10.1177/0885066607312992
   Oldfield EH, 2015, J NEUROSURG, V122, P1444, DOI 10.3171/2014.10.JNS141720
   Pal A, 2011, CLIN ENDOCRINOL, V75, P501, DOI 10.1111/j.1365-2265.2011.04068.x
   Pomeraniec IJ, 2018, J NEUROSURG, V129, P648, DOI 10.3171/2017.5.JNS163069
   Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x
   Randall BR, 2010, ACTA NEUROCHIR, V152, P1737, DOI 10.1007/s00701-010-0706-6
   Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x
   Rutkowski MJ, 2018, J NEUROSURG, V129, P417, DOI 10.3171/2017.2.JNS1784
   Semple PL, 2005, NEUROSURGERY, V56, P65, DOI 10.1227/01.NEU.0000144840.55247.38
   Seo Y, 2018, WORLD NEUROSURG, V115, pE703, DOI 10.1016/j.wneu.2018.04.139
   Seuk JW, 2011, J KOREAN NEUROSURG S, V49, P339, DOI 10.3340/jkns.2011.49.6.339
   Sheehan JP, 2013, J NEUROSURG, V119, P446, DOI 10.3171/2013.3.JNS12766
   Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3
   Singh TD, 2015, J NEUROSURG, V122, P1450, DOI 10.3171/2014.10.JNS141204
   SYMON L, 1982, ACTA NEUROCHIR, V65, P41, DOI 10.1007/BF01405440
   Tu M, 2016, J NEUROL SCI, V370, P258, DOI 10.1016/j.jns.2016.09.047
   WAKAI S, 1981, J NEUROSURG, V55, P187, DOI 10.3171/jns.1981.55.2.0187
   WEISBERG LA, 1977, AM J MED, V63, P109, DOI 10.1016/0002-9343(77)90122-X
   Yokoyama S, 2001, NEUROSURGERY, V49, P857, DOI 10.1097/00006123-200110000-00014
   Zeiler FA, 2013, CAN J NEUROL SCI, V40, P546, DOI 10.1017/S0317167100014645
   Zoli M, 2017, WORLD NEUROSURG, V106, P331, DOI [10.1016/J.WNEU.2017.06.117, 10.1016/j.wneu.2017.06.117]
NR 49
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E723
EP E730
DI 10.1016/j.wneu.2019.02.138
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400089
PM 30851467
DA 2020-05-12
ER

PT J
AU Hu, JT
   Lin, ZC
   Zhang, Y
   Zheng, X
   Ran, Q
   Zhang, D
   Wu, J
   Li, S
   Yang, H
AF Hu, Jintao
   Lin, Zhichao
   Zhang, Yin
   Zheng, Xin
   Ran, Qian
   Zhang, Dong
   Wu, Jun
   Li, Song
   Yang, Hui
TI Prevalence of Unruptured Intracranial Aneurysms Coexisting with
   Pituitary Adenomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Coexistence; Intracranial aneurysm; Pituitary adenoma; Prevalence
ID CEREBRAL ANEURYSMS; MEDICAL PROGRESS; MENINGIOMAS; ANGIOGRAPHY;
   ASSOCIATION; RUPTURE; RISK; SEX
AB OBJECTIVE: The objective of this study was to evaluate the association between asymptomatic unruptured intracranial aneurysms (IAs) and pituitary adenomas (PAs) in Chinese people.
   METHODS: In total, 434 patients with newly diagnosed PA and 252 control subjects from the general population who underwent brain computed tomography angiography examination were included. The incidence of IAs and the location of IAs in patients with PA were compared with those in control subjects. The patients with PA with IA were compared with the patients without IA to identify the risk factors for an increased incidence of IA.
   RESULTS: The coexistence of PA and IA was found in 36 patients (8.3%), whereas IAs were found in only 2.4% of the general control subjects, resulting in a significant difference. After stratifying by age, the prevalence of IAs among the patients with PA was still higher than that among the general control subjects in the 5th decade (P = 0.023) and 6th decade (P = 0.035). Most IAs (66.7%) were located in the internal carotid artery, and the location of the IAs did not differ between the patients with PA and the general population. The stepwise multivariate logistic regression indicated that age (P = 0.004) and cavernous sinus invasion (P = 0.022) were related to an increased prevalence of IAs in patients with PA. However, hormone type and sex were not significantly associated with IA prevalence.
   CONCLUSIONS: The patients with PA have an increased incidence of IA compared with age-matched control subjects. Older age and cavernous sinus invasion might be correlated with the increased prevalence of IAs in Chinese patients with PA.
C1 [Hu, Jintao; Lin, Zhichao; Zhang, Yin; Zheng, Xin; Li, Song; Yang, Hui] Army Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing, Peoples R China.
   [Ran, Qian; Zhang, Dong] Army Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China.
   [Wu, Jun] Army Med Univ, Xinqiao Hosp, Phys Examinat Ctr, Chongqing, Peoples R China.
RP Yang, H (reprint author), Army Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing, Peoples R China.
EM huiyangxinqiao@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81801369]; Foundation of Xinqiao Hospital
   [2016D417]
FX This work was supported by the National Natural Science Foundation of
   China (81801369) and Foundation of Xinqiao Hospital (2016D417).
CR Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760
   Chen XD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010771
   Etminan N, 2014, TRANSL STROKE RES, V5, P167, DOI 10.1007/s12975-013-0294-x
   Franklin B, 2010, J CLIN NEUROSCI, V17, P579, DOI 10.1016/j.jocn.2009.09.015
   Frosen J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-71
   Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3
   Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051
   Horikoshi T, 2002, NEUROL MED-CHIR, V42, P105, DOI 10.2176/nmc.42.105
   Horiuchi T, 2006, NEUROL MED-CHIR, V46, P328, DOI 10.2176/nmc.46.328
   HOUSEPIAN EM, 1958, J NEUROPATH EXP NEUR, V17, P409, DOI 10.1097/00005072-195807000-00001
   JAKUBOWSKI J, 1978, J NEUROL NEUROSUR PS, V41, P972, DOI 10.1136/jnnp.41.11.972
   Kim HJ, 2017, NEURORADIOLOGY, V59, P491, DOI 10.1007/s00234-017-1826-y
   Kim YH, 2015, J NEUROSURG, V123, P357, DOI 10.3171/2014.10.JNS14710
   KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008
   Li MH, 2013, ANN INTERN MED, V159, P514, DOI 10.7326/0003-4819-159-8-201310150-00004
   Low Hu Liang, 2005, Neurosurgery, V56, pE1166
   Manara R, 2011, J CLIN ENDOCR METAB, V96, P1292, DOI 10.1210/jc.2010-2721
   Oh MC, 2012, J NEUROSURG, V116, P942, DOI 10.3171/2011.12.JNS11875
   Oshino S, 2013, PITUITARY, V16, P195, DOI 10.1007/s11102-012-0404-x
   Pant B, 1997, NEUROSURG REV, V20, P13, DOI 10.1007/BF01390519
   Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251
   Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106
   Sluis WM, 2018, EUR J NEUROL, V25, pE5, DOI 10.1111/ene.13479
   Spitler K, 2013, ISRN NEUROL, V2013
   Thien A, 2017, WORLD NEUROSURG, V97, P326, DOI 10.1016/j.wneu.2016.09.118
   Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
   Zhong ZH, 2013, NEUROSURG REV, V36, P645, DOI 10.1007/s10143-013-0477-7
NR 27
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E526
EP E533
DI 10.1016/j.wneu.2019.02.084
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400063
PM 30825620
DA 2020-05-12
ER

PT J
AU Huang, C
   You, C
AF Huang, Chong
   You, Chao
TI Clipping Versus Coiling in the Management of Unruptured Aneurysms with
   Multiple Risk Factors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Clipping; Coiling; Outcome; Risk factor; Unruptured intracranial
   aneurysms
ID INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; ENDOVASCULAR COILING;
   NATURAL-HISTORY; MORBIDITY; MORTALITY; SCORE; SEX; AGE
AB OBJECTIVE: We investigated the outcomes of patients with an unruptured intracranial aneurysm (UIA) and >2 risk factors concerning complications, obliteration rate, and other factors after surgical or endovascular treatment.
   METHODS: Coiling and clipping were compared in patients with UIAs treated in West China Hospital from January 2015 to May 2017. Patient survival, dependency, retreatment, complications, and other clinical outcome indexes were compared between the 2 groups.
   RESULTS: A total of 82 patients (92 aneurysms) had undergone treatment for UIAs with multiple risk factors. Of these 82 patients, 45 (54.9%) had undergone clipping and 37 (45.1%) had undergone coiling. No deaths were related to either treatment. Morbidity (modified Rankin scale score >2) at 1 year had developed in 1 of 45 and 1 of 37 patients in the clipping and coiling groups, without a statistically significant difference. Hospitalization >5 days (30 of 45 vs. 12 of 37; P < 0.05) was less frequent after coiling. The number of aneurysms with complete occlusion (48 of 51 vs. 33 of 41; P < 0.05) was greater in the surgical group. No differences in peritreatment complications were found in the surgical and endovascular groups (8 of 45 vs. 6 of 37; P > 0.05).
   CONCLUSIONS: In our study, clipping and coiling showed advantages for the treatment of UIAs with multiple risk factors. Surgical clipping of UIAs is achievable with a low rate of unfavorable outcomes and a high rate of complete obliteration for patients with multiple risk factors. However, endovascular treatment was also successful, with a shorter length of stay and low procedure-related morbidity. Additional randomized evidence are required to support the superior efficacy of clipping.
C1 [Huang, Chong; You, Chao] West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
RP You, C (reprint author), West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM youchaocd@126.com
CR Ambekar S, 2016, EXPERT REV NEUROTHER, V16, P1205, DOI 10.1080/14737175.2016.1199958
   Brinjikji W, 2011, AM J NEURORADIOL, V32, P1065, DOI 10.3174/ajnr.A2446
   David CA, 1999, J NEUROSURG, V91, P396, DOI 10.3171/jns.1999.91.3.0396
   Etminan N, 2015, NEUROLOGY, V85, P881, DOI 10.1212/WNL.0000000000001891
   Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1
   Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674
   Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838
   Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743
   Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5
   Molyneux Andrew, 2002, J Stroke Cerebrovasc Dis, V11, P304, DOI 10.1053/jscd.2002.130390
   Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260
   Moroi J, 2005, NEUROSURGERY, V56, P224, DOI 10.1227/01.neu.0000148897.28828.85
   Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7
   Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059
   Taha MA, 2006, SURG NEUROL, V66, P277, DOI 10.1016/j.surneu.2005.12.031
   Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
   Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
NR 18
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E545
EP E549
DI 10.1016/j.wneu.2019.02.090
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400065
PM 30831295
DA 2020-05-12
ER

PT J
AU Jiang, QJ
   Zou, SL
   Wu, JJ
   Bai, J
   Jin, J
   Qu, LF
AF Jiang, Qingjun
   Zou, Sili
   Wu, Jianjin
   Bai, Jun
   Jin, Jie
   Qu, Lefeng
TI Reduced Facial Swelling and Incision Numbness After Q-Modified Eversion
   Carotid Endarterectomy in Patients with Severe Carotid Stenosis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Carotid endarterectomy; Facial swelling; Incision numbness; Modified;
   Quality of life
AB BACKGROUND: Carotid endarterectomy, especially eversion carotid endarterectomy (ECEA), is a standard treatment of carotid artery stenosis but continues to have deficiencies. We have described a modified ECEA technique that focuses on the quality of life (QoL), called Q-modified eversion carotid endarterectomy (QCEA). The modifications mainly include the skin incision, surgical approach, and arterial anastomosis. The purpose of the present study was to evaluate the clinical efficacy of QCEA and the QoL of patients after QCEA.
   METHODS: We performed a retrospective study of 109 patients were had undergone ECEA or QCEA from October 2016 to December 2017. The data from all interventions were prospectively collected in a dedicated database. The primary efficacy outcome was the composite of any stroke, myocardial infarction, or death through the 1-year follow-up period. The secondary endpoint was the QoL of patients after ECEA or QCEA on the seventh postoperative day, including incision hematoma, incision numbness, facial swelling, and scar length.
   RESULTS: QCEA was performed in 41 patients and ECEA in 45 patients. No statistically significant differences were found in operating or clamping time between the 2 groups. The incidence of facial swelling (4.9% vs. 28.9%; P = 0.040) and incision numbness (4.9% vs. 24.4%; P = 0.011) in the QCEA group was significantly lower than that in the ECEA group. The average scar length of the QCEA group was significantly shorter than that of the ECEA group (5.1 +/- 1.4 cm vs. 7.6 +/- 2.1 cm; P < 0.001). No transient ischemic attack, stroke, myocardial infarction, or mortality occurred in either group during the 1-year follow-up.
   CONCLUSIONS: Our results suggest that QCEA can reduce incision numbness, facial edema, and scar length, thereby improving the QoL of patients.
C1 [Jiang, Qingjun; Zou, Sili; Wu, Jianjin; Bai, Jun; Jin, Jie; Qu, Lefeng] Second Mil Med Univ, Changzheng Hosp, Dept Vasc & Endovasc Surg, Shanghai, Peoples R China.
RP Qu, LF (reprint author), Second Mil Med Univ, Changzheng Hosp, Dept Vasc & Endovasc Surg, Shanghai, Peoples R China.
EM qulefeng@ammu.edu.cn
OI Qu, lefeng/0000-0002-6122-2569
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81700408]; Fund of Shanghai Science and Technology
   Commission [16411966500]; Special Professor Fund of University in
   Shanghai [GZ2016008]
FX The present study was supported by the National Natural Science
   Foundation of China (grant 81870347), National Natural Science
   Foundation of China (grant 81700408), Fund of Shanghai Science and
   Technology Commission (grant 16411966500), and Special Professor Fund of
   University in Shanghai (grant GZ2016008).
CR Antonopoulos CN, 2011, EUR J VASC ENDOVASC, V42, P751, DOI 10.1016/j.ejvs.2011.08.012
   Beirer M, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0592-4
   Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215
   DEBAKEY ME, 1975, JAMA-J AM MED ASSOC, V233, P1083, DOI 10.1001/jama.233.10.1083
   Demirel S, 2015, VASCULAR, V23, P474, DOI 10.1177/1708538114552836
   Djedovic Muhamed, 2017, Med Arch, V71, P89, DOI 10.5455/medarh.2017.71.89-92
   Kumar S, 2013, ANN VASC SURG, V27, P178, DOI 10.1016/j.avsg.2012.01.008
   Lee JH, 2014, ANN SURG TREAT RES, V87, P192, DOI 10.4174/astr.2014.87.4.192
   McBride R, 2017, J VASC SURG, V65, P263, DOI 10.1016/j.jvs.2016.10.057
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Musicant SE, 2017, ANN VASC SURG, V42, P16, DOI 10.1016/j.avsg.2016.10.046
   Naylor AR, 2018, EUR J VASC ENDOVASC, V55, P3, DOI 10.1016/j.ejvs.2017.06.021
   Schneider JR, 2015, J VASC SURG, V61, P1216, DOI 10.1016/j.jvs.2015.01.049
NR 13
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1063
EP E1068
DI 10.1016/j.wneu.2019.02.205
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400134
PM 30878744
DA 2020-05-12
ER

PT J
AU Jiang, QJ
   Lin, T
   Qu, LF
AF Jiang, Qingjun
   Lin, Tao
   Qu, Lefeng
TI Predictors of Health-Related Quality of Life for Mental Health Status in
   Patients After Carotid Endarterectomy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Carotid endarterectomy; Dizziness; Health-related quality of life;
   Mental health
ID CRANIAL NERVE INJURY; REVASCULARIZATION ENDARTERECTOMY; OUTCOMES;
   STROKE; RISK
AB OBJECTIVE: To evaluate the health-related quality of life (HRQoL) in patients with carotid stenosis and identify the predictive factors that affect the mental health status in patients after carotid endarterectomy (CEA).
   METHODS: A retrospective study was conducted of all patients presenting with carotid stenosis treated with CEA. Clinical data and demographics were collected for logistic regression analysis. The Short-Form General Health Survey Questionnaire (SF-36) and minimum clinically important difference were used to evaluate the mental health status of patients after CEA.
   RESULTS: Between January 2015 and September 2017, a total of 224 patients were enrolled in this study. At baseline, mean SF-36 scores for physical component summary (PCS) (60.1 +/- 26.3) and mental component summary (MCS) (59.9 +/- 23.1) were significantly lower in patients with carotid disease than the urban population (P < 0.001). After CEA, the SF-36 scores for PCS (62.5 +/- 21.7) and MCS (68.4 +/- 18.7) were increased. However, only the improvement of MCS achieved minimum clinically important difference. After multiple logistic regression analysis, contralateral stenosis >= 50% (odds ratio [OR] 0.266, 95% confidence interval [CI] 0.141-0.517) and hoarseness (OR 0.160, 95% CI 0.040-0.644) had negative effects on MCS. Dizziness improvement had positive effects on MCS (OR 2.882, 95% CI 1.569-0.298).
   CONCLUSIONS: Contralateral stenosis, dizziness improvement, and hoarseness may be the predictive factors that affect the mental health status in patients after CEA.
C1 [Jiang, Qingjun; Qu, Lefeng] Second Mil Mod Univ, Changzheng Hosp, Dept Vasc & Endovasc Surg, Shanghai, Peoples R China.
   [Lin, Tao] Second Mil Mod Univ, Changzheng Hosp, Dept Orthoped, Shanghai, Peoples R China.
RP Qu, LF (reprint author), Second Mil Mod Univ, Changzheng Hosp, Dept Vasc & Endovasc Surg, Shanghai, Peoples R China.
EM qulefeng@smmu.edu.cn
OI Qu, lefeng/0000-0002-6122-2569
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81700408]; Science and Technology Commission of
   Shanghai, ChinaScience & Technology Commission of Shanghai Municipality
   (STCSM) [16411966500]; Special Professor Fund of University in Shanghai,
   China [GZ2016008]
FX This work was supported by the National Natural Science Foundation of
   China (grant numbers 81870347); National Natural Science Foundation of
   China (grant numbers 81700408); Science and Technology Commission of
   Shanghai, China (grant numbers 16411966500); and Special Professor Fund
   of University in Shanghai, China (grant numbers GZ2016008).
CR Abah U, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006904
   Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215
   Chen HX, 2015, NEUROREPORT, V26, P1112, DOI 10.1097/WNR.0000000000000478
   Cohen DJ, 2011, J AM COLL CARDIOL, V58, P1557, DOI 10.1016/j.jacc.2011.05.054
   Dardik A, 2001, J VASC SURG, V33, P329, DOI 10.1067/mva.2001.111735
   Favate AS, 2016, NEUROL CLIN, V34, P967, DOI 10.1016/j.ncl.2016.06.013
   Goodwin RD, 2008, J GERIATR PSYCH NEUR, V21, P41, DOI 10.1177/0891988707311041
   Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X
   Hsu LC, 2014, J CHIN MED ASSOC, V77, P403, DOI 10.1016/j.jcma.2014.05.005
   Hye RJ, 2015, J VASC SURG, V61, P1208, DOI 10.1016/j.jvs.2014.12.039
   JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6
   Kakisis JD, 2017, EUR J VASC ENDOVASC, V53, P320, DOI 10.1016/j.ejvs.2016.12.026
   Kazmierski Piotr, 2012, Pol Przegl Chir, V84, P17, DOI 10.2478/v10035-012-0003-6
   Lloyd AJ, 2004, J CLIN EXP NEUROPSYC, V26, P817, DOI 10.1080/13803390490509420
   Luijendijk HJ, 2011, STROKE, V42, P1857, DOI 10.1161/STROKEAHA.110.604405
   Mays RJ, 2011, J VASC SURG, V53, P1410, DOI 10.1016/j.jvs.2010.11.092
   PARKER JC, 1986, J CONSULT CLIN PSYCH, V54, P676, DOI 10.1037/0022-006X.54.5.676
   Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI [10.1056/NEJMoa1515706, 10.1016/j.jvs.2016.06.057]
   Stolker JM, 2010, JACC-CARDIOVASC INTE, V3, P515, DOI 10.1016/j.jcin.2010.02.009
   Vlajinac H, 2013, POSTGRAD MED J, V89, P8, DOI 10.1136/postgradmedj-2012-131005
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Xue C, 2017, ONCOTARGET, V8, P94580, DOI 10.18632/oncotarget.21811
   Zhao Longchao, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P370
NR 23
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E379
EP E384
DI 10.1016/j.wneu.2019.02.060
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400044
PM 30822584
DA 2020-05-12
ER

PT J
AU Jitpun, E
   Howe, BM
   Amrami, KK
   Trousdale, RT
   Spinner, RJ
AF Jitpun, Ekkapot
   Howe, Benjamin (Matthew) M.
   Amrami, Kimberly K.
   Trousdale, Robert T.
   Spinner, Robert J.
TI Obturator Intraneural Ganglion Cysts: Joint Connected and Underdiagnosed
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intraneural ganglion cyst; Obturator cyst; Obturator nerve; Unified
   articular theory
ID NEUROPATHY
AB BACKGROUND: Intraneural ganglion cysts of the obturator nerve are rare. Our aim is to review cases of obturator intraneural ganglion cysts at our institution and those reported in the literature.
   METHODS: We reviewed all cases evaluated by the senior author. A literature search was performed using the PubMed database and Google Scholar with the following terms: "obturator cyst," "obturator intraneural ganglion cyst," and "obturator intraneural ganglia." All cases underwent a retrospective review. Patient demographic data, including age, sex, and presenting signs and symptoms were recorded. Imaging studies were re-evaluated by 2 musculoskeletal radiologists experienced in the diagnosis of intraneural ganglion cysts.
   RESULTS: We identified 2 cases of obturator intraneural ganglia at our institution; both were connected to the hip joint. We found 4 cases that were clearly diagnosed as intraneural ganglia in the literature, of which only 1 was recognized by the original authors as being joint connected, but based on our reinterpretation, 3 of 4 were joint connected. An additional 9 cases identified in the literature did not definitely report the nerve-cyst relationship, but based on our reinterpretation, were believed to be intraneural; 8 were joint connected.
   CONCLUSIONS: We believe that obturator intraneural ganglion cysts adhere to the principles of the unifying articular theory. They arise from the anteromedial hip joint and extend into an articular branch and can reach the parent obturator nerve. Surgery should address the hip disease and/or the articular branch connection. Not appreciating the pathoanatomy of these cysts can lead to persistent or recurrent cysts.
C1 [Jitpun, Ekkapot; Spinner, Robert J.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA.
   [Howe, Benjamin (Matthew) M.; Amrami, Kimberly K.] Mayo Clin, Dept Radiol, Rochester, MN USA.
   [Trousdale, Robert T.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA.
   [Jitpun, Ekkapot] Prasat Neurol Inst, Dept Neurosurg, Bangkok, Thailand.
RP Spinner, RJ (reprint author), Mayo Clin, Dept Neurol Surg, Rochester, MN USA.
EM spinner.robert@mayo.edu
CR Adamek D, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-150
   Avnieli IB, 2018, J HIP PRESERV SURG, V5, P319, DOI 10.1093/jhps/hny023
   Birnbaum K, 1997, SURG RADIOL ANAT, V19, P371, DOI 10.1007/BF01628504
   Botchu R, 2013, J ORTHOP SURG-HONG K, V21, P380, DOI 10.1177/230949901302100324
   Campeas Susan, 2002, Bull Hosp Jt Dis, V61, P89
   Desy NM, 2016, J NEUROSURG, V125, P615, DOI 10.3171/2015.9.JNS141368
   Fadul DA, 2009, J BONE JOINT SURG AM, V91A, P138, DOI 10.2106/JBJS.H.01449
   Field RE, 2011, J BONE JOINT SURG AM, V93A, P22, DOI 10.2106/JBJS.J.01710
   Franssen G, 2013, BMJ CASE REP, V2013
   GARDNER E, 1948, ANAT REC, V101, P353, DOI 10.1002/ar.1091010309
   He Rui, 2013, Zhonghua Wai Ke Za Zhi, V51, P417
   Heinen C, 2016, COMMUNICATION
   Hwang DS, 2010, KNEE SURG SPORT TR A, V18, P681, DOI 10.1007/s00167-009-1013-8
   Kim JL, 2019, PM&R, V11, P895, DOI 10.1002/pmrj.12090
   Kim SH, 2014, ANN REHABIL MED-ARM, V38, P427, DOI 10.5535/arm.2014.38.3.427
   Kitagawa R, 2009, NEUROSURGERY, V65, pA24, DOI 10.1227/01.NEU.0000335652.61676.CC
   Munugani S, 2019, ANZ J SURG, V89, pE552, DOI 10.1111/ans.14896
   Panwar J, 2017, WORLD J RADIOL, V9, P230, DOI 10.4329/wjr.v9.i5.230
   Prasad N, 2016, CLIN ANAT, V29, P978, DOI 10.1002/ca.22782
   Prasad NK, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.6.FOCUS15201
   Schwabegger AH, 2004, J NEUROL NEUROSUR PS, V75, P775, DOI 10.1136/jnnp.2003.021030
   Spinner RJ, 2003, J NEUROSURG, V99, P330, DOI 10.3171/jns.2003.99.2.0330
   Spinner RJ, 2016, ACTA NEUROCHIR, V158, P1891, DOI 10.1007/s00701-016-2926-x
   Spinner RJ, 2009, J NEUROSURG, V111, P317, DOI 10.3171/2009.2.JNS081720
   Stuplich M, 2005, MUSCLE NERVE, V32, P552, DOI 10.1002/mus.20364
   Sureka J, 2012, ACTA NEUROL BELG, V112, P229, DOI 10.1007/s13760-012-0041-1
   Uchida A, 2006, INT J UROL, V13, P471, DOI 10.1111/j.1442-2042.2006.01334.x
   Vidoni A, 2019, SKELETAL RADIOL, V48, P163, DOI 10.1007/s00256-018-2992-7
   Wilson TJ, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.12.FOCUS16439
   Yukata K, 2005, AM J ROENTGENOL, V184, pS112, DOI 10.2214/ajr.184.3_supplement.0184s112
   Yukata K, 2015, WORLD J ORTHOP, V6, P688, DOI 10.5312/wjo.v6.i9.688
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E259
EP E269
DI 10.1016/j.wneu.2019.02.029
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400032
PM 30797927
DA 2020-05-12
ER

PT J
AU Johans, SJ
   Hofler, RC
   Nockels, RP
AF Johans, Stephen J.
   Hofler, Ryan C.
   Nockels, Russ P.
TI Management of Adolescent Idiopathic Scoliosis: Institutional Experience,
   Integration into Neurosurgical Practice, and Impact on Resident Training
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adolescent idiopathic scoliosis; Kyphosis; Neurosurgery resident
   training; Pediatric; Spine deformity
ID POSTERIOR SPINAL-FUSION; DEFORMITY SURGERY; COMPLICATIONS;
   INSTRUMENTATION; OUTCOMES
AB OBJECTIVE: Management of adolescent idiopathic scoliosis (AIS) in neurosurgery residency training may have a significant impact on resident experience, even though few trainees are likely to pursue careers in the field of AIS. The impact of this exposure on resident knowledge in adult spinal disease management is the subject of our retrospective analysis.
   METHODS: An analysis was performed of all adolescent patients undergoing surgical correction of spinal deformity between 2006 and 2016. Patient characteristics, including age at operation, Cobb angles, length of stay, operative time, blood loss, and complications, were collected. Objective benchmarks were created for resident education in the management of AIS. A survey was sent to the last 7 years of graduates to assess the impact of exposure to AIS during neurosurgery training on their current practice.
   RESULTS: Nine male and 37 female patients ages 11 to 22 years were identified. Neurosurgical residents assisted in all procedures without fellows or surgical assistants. Average operative time was 336 minutes (range, 215-575 minutes), and blood loss per procedure was 603 mL (range, 200-4000 mL). The average Cobb angle correction was 72.2% (range, 35.3%-90.9%). Zero of the past 7 graduates currently treat AIS surgically. All 7 graduates agreed that exposure to AIS during residency enhanced their knowledge of adult spinal disease management.
   CONCLUSIONS: Treatment of AIS by surgeons with specialized training can be effective and safe. Resident exposure to these patients enhances their understanding of spinal biomechanics and deformity correction, which is applicable to treating AIS and adult spinal deformity.
C1 [Johans, Stephen J.; Hofler, Ryan C.; Nockels, Russ P.] Loyola Univ Med Ctr, Dept Neurol Surg, Maywood, IL 60153 USA.
RP Nockels, RP (reprint author), Loyola Univ Med Ctr, Dept Neurol Surg, Maywood, IL 60153 USA.
EM rpnockels@mac.com
OI Hofler, Ryan/0000-0002-0186-3284
CR Carreon LY, 2007, J BONE JOINT SURG AM, V89A, P2427, DOI 10.2106/JBJS.F.00995
   Chan P, 2017, SPINE, V42, pE1245, DOI 10.1097/BRS.0000000000002147
   Chen ZH, 2016, EUR SPINE J, V25, P363, DOI 10.1007/s00586-015-3968-0
   Clark AJ, 2014, J NEUROSURG-SPINE, V21, P640, DOI 10.3171/2014.5.SPINE121146
   Daniels Alan H, 2014, Spine Deform, V2, P176, DOI 10.1016/j.jspd.2014.02.005
   de Kleuver M, 2014, EUR SPINE J, V23, P2603, DOI 10.1007/s00586-014-3356-1
   Ferguson J, 2014, J NEUROSURG-PEDIATR, V13, P247, DOI 10.3171/2013.12.PEDS13188
   Godzik J, 2015, SPINE J, V15, P2002, DOI 10.1016/j.spinee.2015.04.048
   HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591, DOI 10.2106/00004623-196244040-00001
   Helenius I, 2013, J CHILD ORTHOP, V7, P63, DOI 10.1007/s11832-012-0467-2
   Kim YJ, 2004, SPINE, V29, P2040, DOI 10.1097/01.brs.0000138268.12324.1a
   KING HA, 1983, J BONE JOINT SURG AM, V65, P1302, DOI 10.2106/00004623-198365090-00012
   Kuklo TR, 2005, J SPINAL DISORD TECH, V18, P139, DOI 10.1097/01.bsd.0000159033.89623.bc
   Kundnani VK, 2010, INDIAN J ORTHOP, V44, P64, DOI 10.4103/0019-5413.58608
   LAGRONE MO, 1988, J BONE JOINT SURG AM, V70A, P569, DOI 10.2106/00004623-198870040-00014
   Lee TT, 1999, SURG NEUROL, V52, P641, DOI 10.1016/S0090-3019(99)00086-5
   Lenke LG, 2001, SPINE, V26, P2347, DOI 10.1097/00007632-200111010-00011
   Lykissas MG, 2013, SPINE, V38, pE113, DOI 10.1097/BRS.0b013e31827ae3d0
   Pasha S, 2016, EUR SPINE J, V25, P3137, DOI 10.1007/s00586-016-4582-5
   Puffer RC, 2017, SPINE, V42, pE687, DOI 10.1097/BRS.0000000000001920
   Pugely AJ, 2014, SPINE, V39, P1225, DOI 10.1097/BRS.0000000000000365
   Ramos RD, 2016, J NEUROSURG-PEDIATR, V18, P730, DOI 10.3171/2016.6.PEDS16200
   Roussouly P, 2013, EUR SPINE J, V22, pS203, DOI 10.1007/s00586-012-2571-x
   Rumalla K, 2016, J NEUROSURG-SPINE, V25, P500, DOI 10.3171/2016.2.SPINE151377
   Sheehan Jason, 2013, World Neurosurg, V80, pe27, DOI 10.1016/j.wneu.2012.09.007
   Smith JS, 2015, J NEUROSURG-SPINE, V23, P349, DOI 10.3171/2014.12.SPINE14777
   Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337
   Wiggins GC, 2001, J NEUROSURG, V95, P17, DOI 10.3171/spi.2001.95.1.0017
   WILBER RG, 1984, J BONE JOINT SURG AM, V66A, P1178, DOI 10.2106/00004623-198466080-00005
NR 29
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E181
EP E189
DI 10.1016/j.wneu.2019.01.291
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400024
PM 30797921
DA 2020-05-12
ER

PT J
AU Kabbasch, C
   Goertz, L
   Siebert, E
   Herzberg, M
   Borggrefe, J
   Mpotsaris, A
   Dorn, F
   Liebig, T
AF Kabbasch, Christoph
   Goertz, Lukas
   Siebert, Eberhard
   Herzberg, Moriz
   Borggrefe, Jan
   Mpotsaris, Anastasios
   Dorn, Franziska
   Liebig, Thomas
TI Comparison of WEB Embolization and Coiling in Unruptured Intracranial
   Aneurysms: Safety and Efficacy Based on a Propensity Score Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Coiling; Propensity score; Unruptured intracranial aneurysm; WEB; Woven
   EndoBridge
ID ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; WOVEN ENDOBRIDGE; RUPTURED
   ANEURYSMS; TRIAL; THERAPY; DEVICE; COHORT; SERIES; ISAT
AB OBJECTIVE: To compare the safety and efficacy between Woven EndoBridge (WEB) embolization and conventional coiling for treatment of unruptured intracranial aneurysms using a propensity score-matched analysis.
   METHODS: Consecutive patients treated with the WEB at 3 German neurovascular centers and with coiling at a single center during 2011 and 2018 were analyzed. Procedure-related complications, clinical outcome, and angiographic results were retrospectively evaluated and compared.
   RESULTS: Sixty-seven patients treated by coiling and 56 patients treated with the WEB were identified. Significant differences between the 2 groups were observed in patient age (P = 0.048), aneurysm location (P < 0.01), aneurysm size (P = 0.02), and neck width (P < 0.01). The overall complication rate was comparable between the coil group (9.0%) and the WEB group (8.9%, P = 1.0). Favorable outcome (modified Rankin Scale <= 2) was obtained in 98.5% after coiling and 98.2% after WEB treatment. At last available angiographic follow-up, WEB yielded a higher complete aneurysm occlusion rate (87.2%) than coiling (60.8%, P < 0.01). Nine patients in the coil cohort (17.6%) and 2 patients in the WEB cohort (4.3%) underwent retreatment (P = 0.05). After 1:1 propensity score matching, there were no significant differences in complication (P = 1.0) and morbidity rates (P = 1.0), whereas there was a trend toward a higher complete aneurysm occlusion rate after WEB treatment (P = 0.08).
   CONCLUSIONS: Treatment of unruptured aneurysms with the WEB provides potentially higher aneurysm occlusion rates than conventional coiling while having similar complication rates and no additional morbidity.
C1 [Kabbasch, Christoph; Goertz, Lukas; Borggrefe, Jan; Mpotsaris, Anastasios] Univ Hosp Cologne, Dept Neuroradiol, Cologne, Germany.
   [Goertz, Lukas] Univ Hosp Cologne, Ctr Neurosurg, Cologne, Germany.
   [Siebert, Eberhard] Univ Hosp Berlin Charite, Dept Neuroradiol, Berlin, Germany.
   [Herzberg, Moriz; Dorn, Franziska; Liebig, Thomas] Univ Hosp Munich LMU, Dept Neuroradiol, Munich, Germany.
   [Mpotsaris, Anastasios] Univ Hosp Aachen, Dept Neuroradiol, Aachen, Germany.
RP Goertz, L (reprint author), Univ Hosp Cologne, Dept Neuroradiol, Cologne, Germany.; Goertz, L (reprint author), Univ Hosp Cologne, Ctr Neurosurg, Cologne, Germany.
EM lukas.goertz@uk-koeln.de
RI Borggrefe, Jan/N-6549-2018; Dorn, Franziska/AAA-7754-2020
OI Borggrefe, Jan/0000-0003-2908-7560; Dorn, Franziska/0000-0001-9093-8307;
   Kabbasch, Christoph/0000-0003-3712-2258
CR Abdihalim M, 2014, J NEUROIMAGING, V24, P171, DOI 10.1111/j.1552-6569.2012.00786.x
   Behme D, 2015, AM J NEURORADIOL, V36, P1501, DOI 10.3174/ajnr.A4323
   Bender MT, 2017, WORLD NEUROSURG, V106, P919, DOI [10.1016/J.WNEU.2017.07.074, 10.1016/j.wneu.2017.07.074]
   Chalouhi N, 2013, STROKE, V44, P2150, DOI 10.1161/STROKEAHA.113.001785
   Ding YH, 2011, AM J NEURORADIOL, V32, P607, DOI 10.3174/ajnr.A2399
   Herbreteau D, 2016, AM J NEURORADIOL, V37, P2280, DOI 10.3174/ajnr.A4918
   Hetts SW, 2014, AM J NEURORADIOL, V35, P698, DOI 10.3174/ajnr.A3755
   Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082311
   Kabbasch C, 2019, J NEUROINTERV SURG, V11, P812, DOI 10.1136/neurintsurg-2018-014555
   Kabbasch C, 2019, J NEUROINTERV SURG, V11, P503, DOI 10.1136/neurintsurg-2018-014361
   Kabbasch C, 2019, J NEUROINTERV SURG, V11, P390, DOI 10.1136/neurintsurg-2018-014230
   Liebig T, 2015, AM J NEURORADIOL, V36, P1721, DOI 10.3174/ajnr.A4347
   Lin N, 2012, J NEUROINTERV SURG, V4, P182, DOI 10.1136/jnis.2011.004978
   Lubicz B, 2013, AM J NEURORADIOL, V34, P1209, DOI 10.3174/ajnr.A3387
   Lv XL, 2018, WORLD NEUROSURG, V110, P20, DOI 10.1016/j.wneu.2017.10.113
   Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6
   Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5
   Molyneux AJ, 2015, LANCET, V385, P691, DOI 10.1016/S0140-6736(14)60975-2
   Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8
   Naggara ON, 2012, RADIOLOGY, V263, P828, DOI 10.1148/radiol.12112114
   Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982
   Pierot L, 2017, AM J NEURORADIOL, V38, P1151, DOI 10.3174/ajnr.A5178
   Pierot L, 2017, J NEURORADIOLOGY, V44, P203, DOI 10.1016/j.neurad.2016.12.011
   Pierot L, 2015, AM J NEURORADIOL, V36, P2314, DOI 10.3174/ajnr.A4445
   Pierot L, 2018, J NEUROINTERV SURG, V10, P553, DOI 10.1136/neurintsurg-2017-013448
   Pierot L, 2016, J NEUROSURG, V124, P1250, DOI 10.3171/2015.2.JNS142634
   Popielski J, 2018, AM J NEURORADIOL, V39, P111, DOI 10.3174/ajnr.A5413
   Rezek I, 2014, AM J NEURORADIOL, V35, P124, DOI 10.3174/ajnr.A3623
   Tau N, 2018, CLIN NEUROL NEUROSUR, V166, P110, DOI 10.1016/j.clineuro.2018.01.025
   van Rooij SBT, 2017, AM J NEURORADIOL, V38, P2282, DOI 10.3174/ajnr.A5371
   van Rooij SBT, 2018, INTERV NEURORADIOL, V24, DOI 10.1177/1591019918772174
   Wakhloo Ajay K, 2014, Neurosurgery, V61 Suppl 1, P111, DOI 10.1227/NEU.0000000000000392
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
NR 33
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E937
EP E943
DI 10.1016/j.wneu.2019.03.016
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400117
PM 30862582
DA 2020-05-12
ER

PT J
AU Kalamatianos, T
   Mavridis, IN
   Karakosta, E
   Drosos, E
   Skandalakis, GP
   Kalyvas, A
   Piagkou, M
   Koutsamakis, C
   Stranjalis, G
AF Kalamatianos, Theodosis
   Mavridis, Ioannis N.
   Karakosta, Eleni
   Drosos, Evangelos
   Skandalakis, Georgios P.
   Kalyvas, Aristotelis
   Piagkou, Maria
   Koutsamakis, Christos
   Stranjalis, George
TI The Parieto-Occipital Artery Revisited: A Microsurgical Anatomic Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anastomoses; Calcarine artery; Cuneus; Parieto-occipital artery;
   Parieto-occipital sulcus; Posterior cerebral artery; Precuneus
ID POSTERIOR CEREBRAL-ARTERY; ANGIOGRAPHIC ANALYSIS; CORTICAL BRANCHES;
   ORBITAL VOLUME; ANEURYSMS; SEGMENT; ATRIUM; ORIGIN
AB BACKGROUND: The parieto-occipital artery (PoA) is the terminal posterior cerebral artery branch, which typically runs in the parieto-occipital sulcus. Previous studies have highlighted variation in the PoA origin and branching pattern and their clinical implications. Nevertheless, PoA anastomoses have not been systematically investigated. The present study aimed to assess whether putative variation in PoA origin and its branching as well as anastomotic pattern is associated with differences in demographic/anthropometric variables.
   METHODS: In 15 cadaveric heads, PoA anatomic features were quantified and assessed in relation to demographic/anthropometric variables.
   RESULTS: The mean distance of PoA origin from the posterior limit of the splenium and the occipital pole (OP) is 3.1 and 53.1 mm, respectively. The latter is significantly longer in taller individuals. The PoA supplies a mean of 10.5 and 9.1 branches to the precuneus and cuneus, respectively. PoA anastomoses primarily involve the precuneal artery complex (PAc) and the calcarine artery. The analysis indicated significant, positive correlations between the distance of PoA origin from the OP and the number of PoA anastomoses and between the number of PoA precuneal and cuneal branches.
   CONCLUSIONS: Although the PoA invariably supplies the precuneus and almost always the cuneus, its direct contribution to the former seems inferior to PAc. Nevertheless, the PoA frequently shows putative collateral supply networks to the precuneus and cuneus via anastomoses with the PAc and calcarine artery, respectively. The distance between PoA origin and OP varies with an individual's height; the frequency of intrahemispheric PoA anastomoses varies with its site of origin.
C1 [Kalamatianos, Theodosis; Mavridis, Ioannis N.; Karakosta, Eleni; Drosos, Evangelos; Skandalakis, Georgios P.; Kalyvas, Aristotelis; Koutsamakis, Christos; Stranjalis, George] Evangelismos Med Ctr, Athens Microneurosurg Lab, Dept Neurosurg, Athens, Greece.
   [Piagkou, Maria] Univ Athens, Sch Med, Dept Anat, Athens, Greece.
RP Kalamatianos, T (reprint author), Evangelismos Med Ctr, Athens Microneurosurg Lab, Dept Neurosurg, Athens, Greece.
EM tkalamatian@med.uoa.gr
RI Piagkou, Maria/AAK-6109-2020; Kalyvas, Aristotelis/AAI-4966-2020
OI Piagkou, Maria/0000-0002-4831-8005
CR Awad AJ, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS1748
   Baik SK, 2004, INTERV NEURORADIOL, V10, P231, DOI 10.1177/159101990401000305
   Britz Gavin W, 2017, Asian J Neurosurg, V12, P273, DOI 10.4103/1793-5482.144186
   Burkhardt JK, 2018, J NEUROSURG, V129, P198, DOI 10.3171/2017.2.JNS162750
   BUXTON PJ, 1993, NEURORADIOLOGY, V35, P212, DOI 10.1007/BF00588497
   Chang SW, 2010, NEUROSURGERY, V67, P16, DOI 10.1227/01.NEU.0000370008.04869.BF
   Cho KC, 2019, J NEUROSURG, V131, P453, DOI 10.3171/2018.2.JNS1832
   Choi CY, 2011, SURG RADIOL ANAT, V33, P641, DOI 10.1007/s00276-011-0776-z
   Cilliers K, 2019, TURK NEUROSURG, V29, P1, DOI 10.5137/1019-5149.JTN.21443-17.2
   Cooke DL, 2014, INTERV NEURORADIOL, V20, P261, DOI 10.15274/NRJ-2014-10027
   Dimmick SJ, 2009, RADIOGRAPHICS, V29, P1027, DOI 10.1148/rg.294085730
   Furuta M, 2001, JPN J OPHTHALMOL, V45, P600, DOI 10.1016/S0021-5155(01)00419-1
   Geyik M, 2017, TURK NEUROSURG, V27, P325, DOI 10.5137/1019-5149.JTN.16296-15.1
   Goehre F, 2016, WORLD NEUROSURG, V92, P521, DOI 10.1016/j.wneu.2016.03.063
   Goehre F, 2014, NEUROSURGERY, V75, P134, DOI 10.1227/NEU.0000000000000363
   Gurer B, 2013, CLIN ANAT, V26, P667, DOI 10.1002/ca.22277
   Gunnal S A, 2015, ANAT RES INT, V2015
   Honda M, 2004, NEUROL MED-CHIR, V44, P164, DOI 10.2176/nmc.44.164
   ISHIBASHI Y, 1989, Neurological Surgery, V17, P659
   KAUL SN, 1974, J NEUROL NEUROSUR PS, V37, P1022, DOI 10.1136/jnnp.37.9.1022
   Ladzinski P, 2005, ANAT REC PART A, V282A, P74, DOI 10.1002/ar.a.20100
   Lawton MT., 2014, PARIETO OCCIPITAL AR, P115
   Lesley WS, 2004, AM J NEURORADIOL, V25, P425
   Madhavan K, 2010, J CLIN NEUROSCI, V17, P1334, DOI 10.1016/j.jocn.2010.04.003
   MARGOLIS MT, 1971, NEURORADIOLOGY, V2, P127, DOI 10.1007/BF00335041
   MARINKOVIC SV, 1987, STROKE, V18, P728, DOI 10.1161/01.STR.18.4.728
   Masters M, 2015, J ANAT, V227, P460, DOI 10.1111/joa.12364
   Mavridis IN, 2016, OPER NEUROSURG, V12, P68, DOI 10.1227/NEU.0000000000001082
   MILISAVLJEVIC M, 1988, SURG RADIOL ANAT, V10, P259, DOI 10.1007/BF02107896
   Orita Tetsuj, 1994, Neurologia Medico-Chirurgica, V34, P692, DOI 10.2176/nmc.34.692
   Osborn AG, 1999, DIAGNOSTIC CEREBRAL
   Parraga RG, 2011, WORLD NEUROSURG, V75, P233, DOI 10.1016/j.wneu.2010.10.053
   Pearce E, 2013, ANN HUM BIOL, V40, P531, DOI 10.3109/03014460.2013.815272
   Qian Z, 2017, CHIN NEUROSURG J, V3, P7
   Ramakrishnamurthy TV, 1999, NEUROL INDIA, V47, P318
   Rhoton AL, 2002, NEUROSURGERY, V51, pS53, DOI 10.1227/01.NEU.0000028484.12422.23
   SIMPSON RK, 1986, J NEUROSURG, V64, P669, DOI 10.3171/jns.1986.64.4.0669
   SMITH CG, 1966, AM J OPHTHALMOL, V61, P1391, DOI 10.1016/0002-9394(66)90475-2
   Sogawa K, 2013, INTERV NEURORADIOL, V19, P461, DOI 10.1177/159101991301900409
   TAKAHASHI S, 1990, AM J NEURORADIOL, V11, P719
   Ture U, 1996, NEUROSURGERY, V39, P1075
   Uchino A, 2012, NEURORADIOLOGY, V54, P445, DOI 10.1007/s00234-011-0903-x
   Uz A, 2019, NEUROSURG REV, V42, P155, DOI 10.1007/s10143-018-0972-y
   Wang S, 2010, J NEUROSURG, V113, P949, DOI 10.3171/2010.1.JNS091169
   Xie T, 2015, OPER NEUROSURG, V11, P110, DOI 10.1227/NEU.0000000000000643
   Yamahata H, 2010, NEUROL MED-CHIR, V50, P1084, DOI 10.2176/nmc.50.1084
   Yonekawa Y, 2011, ACTA NEUROCHIR SUPPL, V112, P85, DOI 10.1007/978-3-7091-0661-7_15
   ZEAL AA, 1978, J NEUROSURG, V48, P534, DOI 10.3171/jns.1978.48.4.0534
NR 48
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1130
EP E1139
DI 10.1016/j.wneu.2019.02.215
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400142
PM 30880193
DA 2020-05-12
ER

PT J
AU Kanemaru, K
   Yoshioka, H
   Hashimoto, K
   Murayama, H
   Ogiwara, M
   Yagi, T
   Horikoshi, T
   Kinouchi, H
AF Kanemaru, Kazuya
   Yoshioka, Hideyuki
   Hashimoto, Koji
   Murayama, Hiroaki
   Ogiwara, Masakazu
   Yagi, Takashi
   Horikoshi, Tohru
   Kinouchi, Hiroyuki
TI Efficacy of Intraarterial Fluorescence Video Angiography in Surgery for
   Dural and Perimedullary Arteriovenous Fistula at Craniocervical Junction
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical spine; Craniocervical junction; Digital subtraction
   angiography; Dural arteriovenous fistula; Fluorescence video
   angiography; Intraarterial injection; Perimedullary arteriovenous
   fistula
ID INDOCYANINE GREEN ANGIOGRAPHY; VIDEOANGIOGRAPHY; ANEURYSM; SHUNTS; FLOW;
   HEAD
AB OBJECTIVE: Confirming the exact location of a fistula and the origins of draining veins during surgery for dural and perimedullary arteriovenous fistulas (AVFs) is crucial but sometimes inadequately performed, which can result in incomplete elimination of the lesion. Intraoperative digital subtraction angiography (DSA) is the gold standard for confirming the hemodynamics of an AVF; however, it cannot reveal the location of an AVF in the operative field. In this study, the efficacy of intraoperative intraarterial fluorescence video angiography during surgery for craniocervical junction dural and perimedullary AVFs was investigated.
   METHODS: We repeatedly employed this technology to evaluate its usefulness in revealing the flow dynamics and anatomy of AVFs and to confirm complete elimination of the fistula.
   RESULTS: Seven AVFs were included in this study. Their locations were C1 in 5 cases and C2 in 2 cases. Intraarterial fluorescence video angiography precisely revealed the locations of 3 dural AVFs, 1 perimedullary AVF, and 3 co-occurring dural and perimedullary AVFs. Frame-by-frame review of the fluorescence video angiography clearly demonstrated that fluorescence appeared earlier in the perimedullary AVF than in the draining vein through the dural AVF after intraarterial injection in all 3 co-occurring cases. Complete elimination of the AVF was also confirmed in all cases by fluorescence video angiography, as well as intraoperative and follow-up DSA.
   CONCLUSIONS: Intraarterial fluorescence video angiography, particularly frame-by-frame review, enables surgeons to distinguish the flow dynamics of AVFs and contributes to the planning of effective surgical strategies for optimal results.
C1 [Kanemaru, Kazuya; Yoshioka, Hideyuki; Hashimoto, Koji; Murayama, Hiroaki; Ogiwara, Masakazu; Yagi, Takashi; Horikoshi, Tohru; Kinouchi, Hiroyuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurosurg, Kofu, Yamanashi, Japan.
RP Kinouchi, H (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurosurg, Kofu, Yamanashi, Japan.
EM hkinouchi@yamanashi.ac.jp
CR Colby GP, 2009, J NEUROSURG-SPINE, V11, P705, DOI 10.3171/2009.6.SPINE09315
   Fuwa N, 2008, ORAL SURG ORAL MED O, V105, P783, DOI 10.1016/j.tripleo.2007.07.031
   Gilard V, 2013, NEUROCHIRURGIE, V59, P210, DOI 10.1016/j.neuchi.2013.06.003
   Hettige S, 2010, ACTA NEUROCHIR, V152, P533, DOI 10.1007/s00701-009-0445-8
   Horie N, 2012, SPINE, V37, pE264, DOI 10.1097/BRS.0b013e31822ba834
   Jeon JP, 2015, INTERV NEURORADIOL, V21, P733, DOI 10.1177/1591019915609128
   Kinouchi H, 1998, J NEUROSURG, V89, P755, DOI 10.3171/jns.1998.89.5.0755
   Kuroda K, 2013, NEUROSURGERY, V72, P141, DOI 10.1227/NEU.0b013e3182752f32
   Lane B, 2015, J NEUROSURG, V122, P618, DOI 10.3171/2014.10.JNS132766
   Murakami T, 2011, NEUROSURGERY, V68, pE241, DOI 10.1227/NEU.0b013e318207b6b5
   Nagaoka S, 1989, J Biomater Appl, V4, P3, DOI 10.1177/088532828900400101
   Nesbit GM, 2011, J NEUROINTERV SURG, V3, P186, DOI 10.1136/jnis.2010.003376
   Ogawa Akiko, 2012, No Shinkei Geka, V40, P121
   Oh JK, 2011, SPINE, V36, pE1578, DOI 10.1097/BRS.0b013e318213c41e
   Ohba S, 2011, NEUROL MED-CHIR, V51, P299, DOI 10.2176/nmc.51.299
   Sato K, 2013, J NEUROSURG, V118, P451, DOI 10.3171/2012.10.JNS121028
   Suzuki K, 2009, SURG CEREB STROKE JP, V37, P240, DOI DOI 10.2335/SCS.37.240
   Suzuki K, 2007, J NEUROSURG, V107, P68, DOI 10.3171/JNS-07/07/0068
   Wang JY, 2015, J CLIN NEUROSCI, V22, P1701, DOI 10.1016/j.jocn.2015.05.014
   Xia YP, 2007, J SPINAL DISORD TECH, V20, P442, DOI 10.1097/BSD.0b013e318031afa1
   Yoshioka H, 2014, SURG CEREB STROKE JP, V42, P31
   Yoshioka H, 2014, NEUROL MED-CHIR, V54, P192, DOI 10.2176/nmc.cr2012-0256
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E573
EP E579
DI 10.1016/j.wneu.2019.02.097
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400070
PM 30831279
DA 2020-05-12
ER

PT J
AU Kang, DH
   Kim, YW
   Hwang, YH
   Kim, YS
AF Kang, Dong-Hun
   Kim, Yong-Won
   Hwang, Yang-Ha
   Kim, Yong-Sun
TI Endovascular Recanalization of Acute Tandem Cervical Carotid and
   Intracranial Occlusions: Efficacy of Cervical Balloon Angioplasty Alone
   Then Intracranial Target Recanalization Strategy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Balloon angioplasty; Carotid artery stenting; Endovascular; Stroke;
   Tandem occlusion; Thrombectomy
ID STENT-RETRIEVER THROMBECTOMY; MIDDLE CEREBRAL-ARTERY; ACUTE
   ISCHEMIC-STROKE; MECHANICAL THROMBECTOMY; THERAPY; THROMBOLYSIS;
   REOCCLUSION; PREDICTORS; STENOSIS; TRIAL
AB OBJECTIVE: Tandem cervical carotid and intracranial occlusions are a well-known cause of complicated endovascular thrombectomy (EVT) in acute ischemic stroke. We aimed to evaluate safety and efficacy of an anterograde approach, which involved carotid balloon angioplasty (BA) alone without carotid artery stenting (CAS) followed by intracranial target recanalization (TR).
   METHODS: Between April 2009 and March 2017, 62 patients with tandem lesions confirmed in the cervical carotid and simultaneously in the intracranial arteries had EVT performed to target these lesions. Clinical, imaging, and angiographic outcomes for these patients were analyzed and compared.
   RESULTS: Overall, successful reperfusion was achieved in 80.6% (50/62) and a favorable outcome in 61.3% (38/62) of patients. BA alone was enough to maintain access for TR in 85.5% (group A and B; 53/62), although more than one half (31/53; group B) required rescue CAS at the end of EVT due to elastic recoil. In contrast, emergent CAS was additionally required for the remaining 9 patients to maintain distal access (group C). In a subgroup comparison, procedure time (PT) to target recanalization was significantly shorter in group A and B than group C (P = 0.002). A multivariate regression model revealed age, parenchymal hematoma, and PT to target recanalization as independent predictors of favorable outcome.
   CONCLUSIONS: EVT for tandem cervical carotid and intracranial occlusions showed optimistic results in terms of clinical and angiographic outcome. The anterograde EVT strategy of cervical BA alone then intracranial TR was effective in 85.5% of patients, which was likely to reduce PT to target recanalization.
C1 [Kang, Dong-Hun] Kyungpook Natl Univ, Dept Neurosurg, Sch Med, Daegu, South Korea.
   [Kim, Yong-Won; Hwang, Yang-Ha] Kyungpook Natl Univ, Dept Neurol, Sch Med, Daegu, South Korea.
   [Kang, Dong-Hun; Kim, Yong-Won; Kim, Yong-Sun] Kyungpook Natl Univ, Dept Radiol, Sch Med, Daegu, South Korea.
RP Hwang, YH (reprint author), Kyungpook Natl Univ, Dept Neurol, Sch Med, Daegu, South Korea.
EM yangha.hwang@gmail.com
RI Hwang, Yang-Ha/F-3068-2013
OI Hwang, Yang-Ha/0000-0002-6665-7481; Kang, Dong-Hun/0000-0002-2977-9340
CR Adams HP, 1999, NEUROLOGY, V53, P122, DOI 10.1212/WNL.53.1.122
   Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862
   Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6
   Burgin WS, 2001, NEUROLOGY, V56, P568
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Dorado L, 2013, J STROKE CEREBROVASC, V22, P1326, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.006
   Fiehler J, 2016, INT J STROKE, V11, P701, DOI 10.1177/1747493016647735
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X
   Grigoryan M, 2016, CEREBROVASC DIS, V41, P306, DOI 10.1159/000444069
   Heck DV, 2015, J NEUROINTERV SURG, V7, P170, DOI 10.1136/neurintsurg-2014-011224
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Kang DH, 2011, AM J NEURORADIOL, V32, P283, DOI 10.3174/ajnr.A2299
   Kang DH, 2017, J KOREAN NEUROSURG S, V60, P335, DOI 10.3340/jkns.2016.0809.005
   Kang DH, 2013, STROKE, V44, P3577, DOI 10.1161/STROKEAHA.113.002673
   Kim BM, 2017, J STROKE, V19, P131, DOI 10.5853/jos.2017.00283
   Kim DJ, 2008, CEREBROVASC DIS, V26, P184, DOI 10.1159/000145326
   Kwak HS, 2013, AM J NEURORADIOL, V34, P841, DOI 10.3174/ajnr.A3304
   Linfante I, 2002, STROKE, V33, P2066, DOI 10.1161/01.STR.0000021001.18101.A5
   Lockau H, 2015, NEURORADIOLOGY, V57, P589, DOI 10.1007/s00234-014-1465-5
   Malik AM, 2011, STROKE, V42, P1653, DOI 10.1161/STROKEAHA.110.595520
   Manning NW, 2016, CEREBROVASC DIS, V42, P170, DOI 10.1159/000445449
   Mpotsaris A, 2013, CLIN NEURORADIOL, V23, P207, DOI 10.1007/s00062-013-0197-y
   Ozdemir O, 2008, AM J NEURORADIOL, V29, P1596, DOI 10.3174/ajnr.A1163
   Puri AS, 2015, J NEUROINTERV SURG, V7, P158, DOI 10.1136/neurintsurg-2013-011010
   Rahme R, 2011, WORLD NEUROSURG, V76, pS60, DOI 10.1016/j.wneu.2011.08.016
   Rubiera M, 2005, STROKE, V36, P1452, DOI 10.1161/01.STR.0000170711.43405.81
   Rubiera M, 2006, STROKE, V37, P2301, DOI 10.1161/01.STR.0000237070.80133.1d
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   Son S, 2015, J NEUROINTERV SURG, V7, P238, DOI 10.1136/neurintsurg-2014-011141
   Spiotta AM, 2015, J NEUROINTERV SURG, V7, P164, DOI 10.1136/neurintsurg-2013-011040
   Stampfl S, 2014, AM J NEURORADIOL, V35, P741, DOI 10.3174/ajnr.A3763
   Yoon W, 2015, NEUROSURGERY, V76, P321, DOI 10.1227/NEU.0000000000000610
NR 34
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1268
EP E1275
DI 10.1016/j.wneu.2019.02.240
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400160
PM 30898749
DA 2020-05-12
ER

PT J
AU Kaya, MO
   Ozturk, S
   Ercan, I
   Gonen, M
   Erol, FS
   Kocabicak, E
AF Kaya, Mehmet Onur
   Ozturk, Sait
   Ercan, Ilker
   Gonen, Murat
   Erol, Fatih Serhat
   Kocabicak, Ersoy
TI Statistical Shape Analysis of Subthalamic Nucleus in Patients with
   Parkinson Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE Deep brain stimulation; Deformation; Parkinson disease; Statistical
   shape analysis; Subthalamic nucleus
ID NEURONAL-ACTIVITY
AB OBJECTIVE: Subthalamic nucleus (STN) is the most targeted localization in the treatment of Parkinson disease (PD) with deep brain stimulation. However, no studies have been found in the literature about possible shape changes of STN in the literature. We aimed to investigate possible shape changes in the STN and the relationship between shape changes and disease duration in PD patients by using statistical analysis.
   METHODS: Patients who were diagnosed with idiopathic PD and controls were enrolled in this study. Age, sex, and disease duration of all cases were recorded. Turbo-spin-echo T2-weighted axial series parallel to the skull base in each case containing midbrain images were obtained, including the whole STN. Standard anatomic landmarks were selected and marked on each digital image using a special software in all cases. Statistical geometric shape and deformation analysis of STN was performed in 2 groups.
   RESULTS: Forty-three patients with PD and 50 age/sex-matched controls were enrolled in this study. There were statistically significant left and right STN shape differences between the groups. Maximum deformation was seen in the dorsolateral parts of both STNs. General shape variability of the STNs was found on the left (0.096) and right (0.049).
   CONCLUSIONS: Significant shape differences and remarkable deformation of STN are seen in patients with PD compared with controls. Maximum deformation was observed in the dorsolateral part of the STN, and with the increase in the duration of the PD, shape differences and deformations became more prominent.
C1 [Kaya, Mehmet Onur] Firat Univ, Sch Med, Dept Biostat, Elazig, Turkey.
   [Kaya, Mehmet Onur] Firat Univ, Sch Med, Dept Med Informat, Elazig, Turkey.
   [Ozturk, Sait; Erol, Fatih Serhat] Firat Univ, Sch Med, Dept Neurosurg, Elazig, Turkey.
   [Ercan, Ilker] Uludag Univ, Sch Med, Dept Biostat, Bursa, Turkey.
   [Gonen, Murat] Firat Univ, Sch Med, Dept Neurol, Elazig, Turkey.
   [Kocabicak, Ersoy] Ondokuz Mays Univ, Dept Neurosurg, Sch Med, Samsun, Turkey.
RP Ozturk, S (reprint author), Firat Univ, Sch Med, Dept Neurosurg, Elazig, Turkey.
EM drsaitozturk@yahoo.com
RI KAYA, Mehmet Onur/V-9415-2018; Ozturk, Sait/Q-1953-2016
OI KAYA, Mehmet Onur/0000-0001-8052-0484; Ozturk, Sait/0000-0002-7655-0127
CR Bejjani BP, 2000, J NEUROSURG, V92, P615, DOI 10.3171/jns.2000.92.4.0615
   BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507
   Bharath K, 2018, J R STAT SOC C-APPL, V67, P1357, DOI 10.1111/rssc.12272
   Bookstein F, 1999, ANAT RECORD, V257, P217, DOI 10.1002/(SICI)1097-0185(19991215)257:6<217::AID-AR7>3.0.CO;2-W
   Bookstein FL, 1993, GEOMETRY AND BIOL, V35, P512
   Bot M, 2018, J NEUROL NEUROSUR PS, V89, P493, DOI 10.1136/jnnp-2017-316907
   Brunenberg EJL, 2011, J NEUROSURG, V115, P971, DOI 10.3171/2011.6.JNS101571
   Camlidag I, 2014, INT J NEUROSCI, V124, P291, DOI 10.3109/00207454.2013.843091
   Carpenter MB, 1983, HUMAN NEUROANATOMY
   Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008
   Cury C, 2019, NEUROIMAGE, V188, P282, DOI 10.1016/j.neuroimage.2018.11.063
   Cury C, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00803
   Dryden I, SHAPES STAT SHAPE AN
   Ercan I, 2012, TURK KLIN J BIOSTAT, V4, P27
   ERCAN I, 2008, INT J TOMOGR STAT, V9, P51
   Ercan I, 2013, TURK KLIN J BIOSTAT, V5, P42
   Ercan I, 2013, TURK KLIN J BIOSTAT, V5, P37
   Franklin D, 2005, HOMO, V56, P17, DOI 10.1016/j.jchb.2004.07.004
   Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8
   Herzlinger G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207890
   Kocabicak E, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00046
   Miller W. C., 1987, BASAL GANGLIA, P415
   Ocakoglu G, 2015, ACTA NEUROCHIR, V157, P1897, DOI 10.1007/s00701-015-2555-9
   Ocakoglu G, 2014, HACET J MATH STAT, V43, P141
   RICHTSMEIER JT, 1992, ANNU REV ANTHROPOL, V21, P283
   Sun ZY, 2017, J PSYCHIATR NEUROSCI, V42, P27, DOI 10.1503/jpn.150291
   Toda H, 2009, J NEUROSURG, V111, P737, DOI 10.3171/2008.12.JNS0861
   Tonge M, 2015, CLIN NEUROL NEUROSUR, V139, P183, DOI 10.1016/j.clineuro.2015.10.017
   Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6
   Yelnik J, 2002, MOVEMENT DISORD, V17, pS15, DOI 10.1002/mds.10138
NR 30
TC 2
Z9 2
U1 7
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E835
EP E841
DI 10.1016/j.wneu.2019.02.180
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400104
PM 30862597
DA 2020-05-12
ER

PT J
AU Kayaci, S
   Cakir, T
   Aydin, MD
   Kanat, A
   Omeroglu, M
   Levent, A
   Kantarci, AM
   Diyarbakirli, S
   Demirci, E
AF Kayaci, Salim
   Cakir, Tayfun
   Aydin, Mehmet Dumlu
   Kanat, Ayhan
   Omeroglu, Muhammed
   Levent, Akin
   Kantarci, A. Mecit
   Diyarbakirli, Semih
   Demirci, Elif
TI Brachial Artery Vasospasm Caused by Cervical Dorsal Root Ganglion
   Degeneration After Subarachnoid Hemorrhage: An Experimental Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brachial artery; Dorsal root ganglion; Hypertension; Subarachnoid
   hemorrhage; Vasospasm
ID GLOSSOPHARYNGEAL NERVE; CAROTID-BODY; HYDROCEPHALUS; DISRUPTION;
   MECHANISM
AB PURPOSE: Subarachnoid hemorrhage (SAH) may lead to vasospasm in various vessels. The cervical nerves have a vasodilatory effect on the upper extremity arteries. The aim of this study was to investigate if there is a relationship between C6 dorsal root ganglion (DRG) degeneration and brachial artery (BA) vasospasm after spinal SAH.
   METHODS: This experimental study was conducted on 23 rabbits. The animals were divided into 3 groups: control (n = 5), SHAM (n = 5), and study group (n = 13). One cubic centimeter (cc) of serum saline was injected into the cisterna magna of animals of the SHAM group; the same procedure was performed by 1 cc of homologous blood in the study group. Degenerated neuron densities (DNDs) of DRGs (n/mm(3)) at C6 levels and BA vasospasm indexes (VSI; wall surface/lumen surface) of all animals were determined and results were analyzed statistically.
   RESULTS: Mean VSI values of BAs and DNDs of C(6)DRGs of the control, SHAM, and study groups were estimated as 10 +/- 3/1.12 +/- 0.11 n/mm(3), 34 +/- 9/1.27 +/- 0.24 n/mm(3), and 1031 +/- 145/2.93 +/- 0.78 n/mm(3), respectively. Mean DNDs and VSI values were statistically significantly different between the control and study groups (P < 0.0001).
   CONCLUSIONS: C(6)DRG degeneration may be considered as an important factor in the etiopathogenesis of severe BA vasospasm after SAH.
C1 [Kayaci, Salim; Cakir, Tayfun] Binali Yildirim Univ, Med Fac Erzincan, Dept Neurosurg, Erzincan, Turkey.
   [Aydin, Mehmet Dumlu] Ataturk Univ, Med Fac, Dept Neurosurg, Erzurum, Turkey.
   [Kanat, Ayhan] Recep Tayyip Erdogan Univ, Med Fac, Dept Neurosurg, Rize, Turkey.
   [Omeroglu, Muhammed] Toyotasa Emergency Hosp, Dept Neurosurg, Sakarya, Turkey.
   [Levent, Akin; Kantarci, A. Mecit] Binali Yildirim Univ, Med Fac Erzincan, Dept Radiol, Erzincan, Turkey.
   [Diyarbakirli, Semih] Binali Yildirim Univ, Med Fac Erzincan, Dept Anat, Erzincan, Turkey.
   [Demirci, Elif] Ataturk Univ, Med Fac, Dept Pathol, Erzurum, Turkey.
RP Aydin, MD (reprint author), Ataturk Univ, Med Fac, Dept Neurosurg, Erzurum, Turkey.
EM nmda11@hotmail.com
RI Kanat, Ayhan/N-2296-2015; Cakir, Tayfun/AAD-6595-2019
OI Kanat, Ayhan/0000-0002-8189-2877; CAKIR, TAYFUN/0000-0002-9979-9291
CR Aydin MD, 2006, MINIM INVAS NEUROSUR, V49, P359, DOI 10.1055/s-2006-955071
   Aydin MD, 2011, EXP NEUROL, V230, P90, DOI 10.1016/j.expneurol.2010.09.018
   Aydin MD, 2019, TURK NEUROSURG, V29, P434, DOI 10.5137/1019-5149.JTN.24446-18.1
   Aydin MD, 2017, WORLD NEUROSURG, V106, P570, DOI 10.1016/j.wneu.2017.06.176
   Aydin MD, 2012, NEUROSURG QUART, V22, P1, DOI 10.1097/WNQ.0b013e3182011683
   Bostan H, 2018, NORTH CLIN ISTANB, V5, P176, DOI [10.14744/nci.2017.28190, 10.14744/ncl.2017.28190]
   Celiker M, 2019, INT J NEUROSCI, V129, P794, DOI 10.1080/00207454.2019.1569651
   Gasenzer ER, 2018, BRIT J NEUROSURG, V32, P303, DOI 10.1080/02688697.2018.1467000
   Gasenzer ER, 2017, WORLD NEUROSURG, V102, P313, DOI 10.1016/j.wneu.2017.02.081
   Gasenzer ER, 2017, WORLD NEUROSURG, V101, P444, DOI 10.1016/j.wneu.2016.11.144
   Gasenzer ER, 2017, J NEUROL SURG PART A, V78, P260, DOI 10.1055/s-0036-1597895
   Goertz L, 2019, WORLD NEUROSURG, V125, pE1196, DOI 10.1016/j.wneu.2019.01.279
   Kanat A, 2003, NEUROSURGERY, V52, P1508, DOI 10.1227/01.NEU.0000068349.22859.C6
   Kanat A, 2017, WORLD NEUROSURG, V104, P330, DOI 10.1016/j.wneu.2017.04.105
   Kanat A, 2013, WORLD NEUROSURG, V80, P390, DOI 10.1016/j.wneu.2012.12.020
   Kanat A, 2010, ACTA NEUROCHIR, V152, P2167, DOI 10.1007/s00701-010-0793-4
   Kayaci S, 2011, AUTON NEUROSCI-BASIC, V165, P163, DOI 10.1016/j.autneu.2011.06.008
   Kilic M, 2018, WORLD NEUROSURG, V119, pE1029, DOI 10.1016/j.wneu.2018.08.054
   Musluman AM, 2011, TURK NEUROSURG, V21, P559, DOI [10.5137/1019-5149.JTN .4553-11.1, 10.5137/1019-5149.JTN.4553-11.1]
   Onen MR, 2016, WORLD NEUROSURG, V92, P463, DOI 10.1016/j.wneu.2016.04.067
   Ozdemir NG, 2017, TURK NEUROSURG, V27, P874, DOI 10.5137/1019-5149.JTN.17206-16.2
   Ozturk C, 2015, J CRANIOVERTEBRAL JU, V6, P69, DOI 10.4103/0974-8237.156056
   Pajic SS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00493
   Pellerin M, 2010, SURG RADIOL ANAT, V32, P251, DOI 10.1007/s00276-009-0619-3
   Torres MJO, 2019, WORLD NEUROSURG, V125, P247, DOI 10.1016/j.wneu.2019.01.239
   Turkmenoglu Osman N, 2017, Asian J Neurosurg, V12, P22, DOI 10.4103/1793-5482.145572
   Yilmaz A, 2011, TURK NEUROSURG, V21, P477, DOI [10.5137/1019-5149.JTN .4204-11.1, 10.5137/1019-5149.JTN.4204-11.1]
   Yolas C, 2016, WORLD NEUROSURG, V90, P484, DOI 10.1016/j.wneu.2016.03.049
   Yolas C, 2016, WORLD NEUROSURG, V89, P208, DOI 10.1016/j.wneu.2016.01.082
   Yolas C, 2014, J NEUROL SCI, V336, P220, DOI 10.1016/j.jns.2013.10.047
NR 30
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E895
EP E900
DI 10.1016/j.wneu.2019.03.007
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400111
PM 30872193
DA 2020-05-12
ER

PT J
AU Kellett, CG
   Siva, V
   Norman, ICF
   Jung, J
   Grahovac, G
   Minhas, P
AF Kellett, Christopher Graham
   Siva, Vino
   Norman, Irena Claudine Fiorina
   Jung, Josephine
   Grahovac, Gordan
   Minhas, Pawanjit
TI Symptomatic Idiopathic Spinal Epidural Lipomatosis in 9 Patients:
   Clinical, Radiologic, and Pathogenetic Features
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cauda equina; Epidural lipomatosis; Venous insufficiency
ID CAUDA-EQUINA SYNDROME; INTRAABDOMINAL PRESSURE; COMPRESSION
AB BACKGROUND: Symptomatic spinal epidural lipomatosis (SSEL) is characterized by hypertrophy of adipose tissue within the spinal canal and consequent neural compromise. The exact pathogenesis remains enigmatic. The authors describe a retrospective case series, define the full clinical spectrum, and discuss possible pathogenetic mechanisms.
   METHODS: The medical notes and imaging of 9 patients with SSEL undergoing surgery from 2008-2018 were analyzed. Seven patients presented secondary to lumbosacral spinal epidural lipomatosis (SEL); 3 patients with chronic incomplete cauda equina syndrome (CES), 3 patients with acute CES (including a 25-week gravid patient and a 40-year-old patient with intravenous leiomyomatosis, both of whom had mild SEL) and 1 patient with chronic lumbar radiculopathy. In addition, 2 patients presented with progressive myelopathy secondary to thoracic SEL.
   RESULTS: Patients presenting with acute CES had a mean age of 37 years (range 23-49 years) and mean extradural fat (EF)-to-spinal canal (SC) ratio of 47% (range 41%-58%), in comparison with patients with chronic CES; mean age 61 years (range 58-65 years) and EF: SC ratio 72% (range 65%-80%). Patients underwent laminectomy and resection of EF at compressive levels. All patients with CES experienced complete resolution of symptoms at follow-up (range 1-48 months).
   CONCLUSIONS: The clinician should be astute to the radiologic features of SEL, particularly in patients presenting with CES in the absence of acute disk herniation. The outcome of patients with CES and SEL after surgery is excellent regardless of symptom duration. Venous impedance related to increased body mass index and EF deposition may play the predominant role in addition to mechanical compression in the pathogenesis of SSEL.
C1 [Kellett, Christopher Graham; Siva, Vino; Minhas, Pawanjit] St George Hosp, Atkinson Morley Neurosurg Dept, Tooting, England.
   [Norman, Irena Claudine Fiorina; Jung, Josephine; Grahovac, Gordan] Kings Coll Hosp London, Neurosurg Dept, London, England.
RP Kellett, CG (reprint author), St George Hosp, Atkinson Morley Neurosurg Dept, Tooting, England.
EM C.Kellet@nhs.net
CR Al-Khawaja D, 2008, J CLIN NEUROSCI, V15, P1323, DOI 10.1016/j.jocn.2008.03.001
   Boos N., 2008, SPINAL DISORDERS FUN
   Borre DG, 2003, EUR RADIOL, V13, P1709, DOI 10.1007/s00330-002-1716-4
   Bushkar John B, 2017, Clin Pract Cases Emerg Med, V1, P305, DOI 10.5811/cpcem.2017.6.34778
   Cersosimo MG, 2002, CLIN NEUROPHARMACOL, V25, P51, DOI 10.1097/00002826-200201000-00009
   Ferlic PW, 2016, SPINE J, V16, P1333, DOI 10.1016/j.spinee.2016.06.022
   Fogel Guy R, 2005, Spine J, V5, P202, DOI 10.1016/j.spinee.2004.05.252
   Fuchs F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077324
   Fujita N, 2016, SPINE, V41, pE1402, DOI 10.1097/BRS.0000000000001646
   Kim SS, 2017, INT J SURG CASE REP, V33, P12, DOI 10.1016/j.ijscr.2017.02.017
   LEE M, 1975, MED J AUSTRALIA, V1, P201, DOI 10.5694/j.1326-5377.1975.tb111328.x
   Linicus Y, 2016, OBESITY, V24, P1648, DOI 10.1002/oby.21506
   Malone JB, 2018, J ORTHOP, V15, P36, DOI 10.1016/j.jor.2017.11.001
   Mariotto S, 2013, CLIN NEUROL NEUROSUR, V115, P1549, DOI 10.1016/j.clineuro.2012.12.034
   Morishita S, 2018, EUR SPINE J, V27, P1653, DOI 10.1007/s00586-018-5584-2
   Papastefan ST, 2018, CHILD NERV SYST, V34, P757, DOI 10.1007/s00381-017-3706-5
   Sugerman H, 1997, J INTERN MED, V241, P71, DOI 10.1046/j.1365-2796.1997.89104000.x
   Valcarenghi J, 2018, Eur J Orthop Surg Traumatol, V28, P1437, DOI 10.1007/s00590-018-2206-y
   Varela JE, 2009, SURG OBES RELAT DIS, V5, P524, DOI 10.1016/j.soard.2009.04.003
   Wells AJ, 2014, J CLIN NEUROSCI, V21, P1262, DOI 10.1016/j.jocn.2013.09.027
   Wilson A, 2010, J TRAUMA, V69, P78, DOI 10.1097/TA.0b013e3181e05a79
   Yasuda T, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1988-8
NR 22
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E33
EP E40
DI 10.1016/j.wneu.2019.01.098
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400006
PM 30708081
DA 2020-05-12
ER

PT J
AU Khalid, SI
   Carlton, A
   Wu, R
   Kelly, R
   Peta, A
   Adogwa, O
AF Khalid, Syed, I
   Carlton, Adam
   Wu, Rita
   Kelly, Ryan
   Peta, Akhil
   Adogwa, Owoicho
TI Outpatient and Inpatient Readmission Rates of 1-and 2-Level Anterior
   Cervical Discectomy and Fusion Surgeries
SO WORLD NEUROSURGERY
LA English
DT Article
DE ACDF; Inpatient; Outpatient; Readmission
ID SAFETY
AB OBJECTIVE: This study looks at the various comorbidities and postoperative complications and their impact on readmission rates of patients undergoing outpatient versus inpatient 1- and 2-level anterior cervical discectomy and fusion (ACDF). With increasing costs within the United States medical system, one emerging cost-saving strategy is to evolve traditional inpatient procedures into outpatient same-day surgeries. However, patient safety remains a crucial priority.
   METHODS: A total of 28,427 patients were analyzed, with 26,368 undergoing inpatient ACDF surgery and 2059 undergoing outpatient ACDF surgery. Age, sex, comorbidities, postoperative complications, readmission rates, and overall financial cost were compared between both cohorts.
   RESULTS: Data from 28,427 one-and two-level ACDF procedures that were split between inpatient and outpatient were collected. Thirty-day readmission rates were significantly lower in outpatients than inpatients (4% vs. 10.1%, P < 0.001). Inpatients had higher rates of urinary tract infection (2.4% vs. 1.4%), deep vein thrombosis (0.6% vs. 0%), and myocardial infarction (0.2% vs. 0%), whereas outpatients had higher rates of pulmonary embolism (7.7% vs. 0.4%). Outpatients had increased readmission risk with comorbidities of diabetes (odds ratio [OR], 48.93; P < 0.001), smoking (OR, 4.6; P < 0.001), body mass index >= 30 (OR, 2392; P < 0.001). The average cost of outpatient surgery was less than that of inpatient surgery ($7774.8 vs. $7956.75, P = 0.0444).
   CONCLUSION: This study suggests that in the appropriately selected patients, ACDF can safely be performed in an outpatient setting.
C1 [Khalid, Syed, I; Adogwa, Owoicho] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA.
   [Khalid, Syed, I; Carlton, Adam; Wu, Rita; Peta, Akhil] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA.
   [Kelly, Ryan] Georgetown Univ, Sch Med, Washington, DC USA.
RP Khalid, SI (reprint author), Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA.; Khalid, SI (reprint author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA.
EM syed.khalid@me.com
RI Khalid, Syed/U-4117-2019
OI Khalid, Syed/0000-0003-4710-1688; Carlton, Adam/0000-0001-5678-7111; Wu,
   Rita/0000-0001-5930-9537
CR Adamson T, 2016, J NEUROSURG-SPINE, V24, P878, DOI 10.3171/2015.8.SPINE14284
   Cullen KA, 2009, NATL HLTH STAT REPOR, P1
   Fu MC, 2017, SPINE, V42, P1044, DOI 10.1097/BRS.0000000000001988
   Garringer SM, 2010, J SPINAL DISORD TECH, V23, P439, DOI 10.1097/BSD.0b013e3181bd0419
   Lied B, 2013, ACTA NEUROL SCAND, V127, P31, DOI 10.1111/j.1600-0404.2012.01674.x
   Liu JT, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-3
   Marawar S, 2010, SPINE, V35, P1454, DOI 10.1097/BRS.0b013e3181bef3cb
   Martin CT, 2014, J BONE JOINT SURG AM, V96A, P1288, DOI 10.2106/JBJS.M.00767
   McClelland S, 2017, INT J SPINE SURG, V11, DOI 10.14444/4011
   McGirt MJ, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15335
   Mullins J, 2018, J NEUROSURG-SPINE, V28, P630, DOI [10.3171/2017.10.SPINE17938, 10.1080/08952841.2018.1529474]
   Patil PG, 2005, NEUROSURGERY, V57, P753, DOI 10.1227/01.NEU.0000175729.79119.1d
   Purger DA, 2018, NEUROSURGERY, V82, P454, DOI 10.1093/neuros/nyx215
   Sheperd CS, 2012, INT SURG, V97, P86, DOI 10.9738/CC35.1
   Silvers HR, 1996, J SPINAL DISORD, V9, P287
   Stieber Jonathan R, 2005, Spine J, V5, P503
   Villavicencio AT, 2007, SPINE J, V7, P148, DOI 10.1016/j.spinee.2006.04.009
NR 17
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1475
EP E1481
DI 10.1016/j.wneu.2019.03.124
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400185
PM 30904810
DA 2020-05-12
ER

PT J
AU Khan, AN
   Bronstein, A
   Bain, P
   Pavese, N
   Nandi, D
AF Khan, Amad Naseer
   Bronstein, Adolfo
   Bain, Peter
   Pavese, Nicola
   Nandi, Dipankar
TI Pedunculopontine and Subthalamic Nucleus Stimulation Effect on Saccades
   in Parkinson Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE Antisaccades; Deep brain stimulation; Parkinson disease;
   Pedunculopontine nucleus; Saccades; Subthalamic nucleus
ID DEEP BRAIN-STIMULATION; BASAL GANGLIA; FREQUENCY STIMULATION;
   EYE-MOVEMENTS; NEURONS; MODEL; COORDINATION; ANTISACCADES; ANTEROGRADE;
   INITIATION
AB BACKGROUND: Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) has been explored as a target to treat axial motor symptoms of advanced Parkinson disease (PD). The aim of this study was to consider relative effects of bilateral subthalamic nucleus (STN) and PPN DBS on both initiation and inhibition of saccades in advanced PD.
   METHODS: Five patients with advanced PD performed 2 different oculomotor tasks off stimulation, with bilateral STN DBS, with bilateral PPN DBS, and with simultaneous bilateral STN and PPN DBS. The first task involved visually guided saccades, and the second task involved antisaccades (ASs). Saccadic latency, accuracy, and velocity were recorded for both the visually guided saccade and AS tasks, and prosaccades were measured for the AS task alone. Control subjects included patients with advanced PD without DBS, age-matched healthy subjects, and young healthy subjects (n = 12 in each group).
   RESULTS: Simultaneous bilateral STN and PPN DBS produced the greatest improvement in mean latencies, velocities, and accuracies for visually guided saccades and ASs compared with DBS off (P < 0.001). Bilateral STN and PPN DBS caused a significant additional improvement compared with STN DBS alone by reducing the number of prosaccades (P < 0.01).
   CONCLUSIONS: It is known that the frontal lobe is involved in saccadic inhibition during AS tasks. Hence, our novel finding of an improvement in the AS task suggests an ascending, frontally mediated effect of PPN DBS. This implies that there may be PPN-to-frontal lobe connections that may partly explain the benefits of PPN DBS in axial motor function.
C1 [Khan, Amad Naseer; Bronstein, Adolfo; Bain, Peter; Pavese, Nicola; Nandi, Dipankar] Imperial Coll, Neuromodulat Grp, Ctr Restorat Neurosci, Div Brain Sci, Charing Cross Hosp Campus, London, England.
RP Khan, AN (reprint author), Imperial Coll, Neuromodulat Grp, Ctr Restorat Neurosci, Div Brain Sci, Charing Cross Hosp Campus, London, England.
EM amadnaseer@gmail.com
OI Pavese, Nicola/0000-0002-6801-6194
FU Medical Research CouncilMedical Research Council UK (MRC) [G0701698]
CR ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041
   Anastasopoulos D, 2011, MOVEMENT DISORD, V26, P2201, DOI 10.1002/mds.23798
   Androulidakis AG, 2008, EXP NEUROL, V211, P59, DOI 10.1016/j.expneurol.2008.01.002
   Ballanger B, 2009, HUM BRAIN MAPP, V30, P3901, DOI 10.1002/hbm.20815
   Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8
   Briand KA, 2001, NEUROPSYCHOLOGIA, V39, P1240, DOI 10.1016/S0028-3932(01)00045-8
   Briand KA, 1999, EXP BRAIN RES, V129, P38, DOI 10.1007/s002210050934
   BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361
   BRONSTEIN AM, 1985, BRAIN, V108, P925, DOI 10.1093/brain/108.4.925
   Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009
   Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026
   Condy C, 2004, NEUROLOGY, V63, P1571, DOI 10.1212/01.WNL.0000142990.44979.5A
   Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7
   Fawcett AP, 2005, EXP BRAIN RES, V162, P357, DOI 10.1007/s00221-004-2184-7
   Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150
   Hikosaka O, 2000, PHYSIOL REV, V80, P953
   HIKOSAKA O, 1989, REV NEUROL, V145, P580
   Hollands MA, 2004, EXP BRAIN RES, V154, P261, DOI 10.1007/s00221-003-1718-8
   Inagaki K, 2011, NEURAL NETWORKS, V24, P990, DOI 10.1016/j.neunet.2011.06.007
   JACKSON A, 1983, NEUROSCIENCE, V10, P725, DOI 10.1016/0306-4522(83)90213-0
   Jenkinson N, 2005, NEUROREPORT, V16, P1875, DOI 10.1097/01.wnr.0000189756.49541.3c
   Jenkinson N, 2006, NEUROREPORT, V17, P639, DOI 10.1097/00001756-200604240-00016
   Kan JYY, 2012, J NEUROPHYSIOL, V107, P1413, DOI 10.1152/jn.00534.2011
   KATO M, 1995, J NEUROSCI, V15, P912
   KITAGAWA M, 1994, NEUROLOGY, V44, P2285, DOI 10.1212/WNL.44.12.2285
   LASKER AG, 1987, NEUROLOGY, V37, P364, DOI 10.1212/WNL.37.3.364
   LAVOIE B, 1994, J COMP NEUROL, V344, P210, DOI 10.1002/cne.903440204
   MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615
   Mazzone P, 2012, BRAIN STIMUL, V5, P634, DOI 10.1016/j.brs.2012.01.002
   Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009
   Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345
   Murer MG, 2002, CELL MOL NEUROBIOL, V22, P611, DOI 10.1023/A:1021840504342
   Nandi D, 2002, BRAIN, V125, P2418, DOI 10.1093/brain/awf259
   Nandi D, 2002, J CLIN NEUROSCI, V9, P170, DOI 10.1054/jocn.2001.0943
   Nandi D, 2008, Br J Neurosurg, V22 Suppl 1, pS4, DOI 10.1080/02688690802448350
   Okada K, 2014, EUR J NEUROSCI, V40, P2641, DOI 10.1111/ejn.12632
   Peltsch A, 2008, EXP BRAIN RES, V186, P457, DOI 10.1007/s00221-007-1248-x
   Pereira EAC, 2011, J NEURAL TRANSM, V118, P1453, DOI 10.1007/s00702-011-0631-8
   Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005
   RASCOL O, 1989, BRAIN, V112, P1193, DOI 10.1093/brain/112.5.1193
   Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000
   Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346
   Thevathasan W, 2010, J NEUROL NEUROSUR PS, V81, P1099, DOI 10.1136/jnnp.2009.189324
   Tian YY, 2011, NEUROL SCI, V32, P23, DOI 10.1007/s10072-010-0461-8
   Trottier L, 2005, VISION RES, V45, P1349, DOI 10.1016/j.visres.2004.12.007
   VIDAILHET M, 1994, ANN NEUROL, V35, P420, DOI 10.1002/ana.410350408
   WHITE OB, 1983, BRAIN, V106, P571, DOI 10.1093/brain/106.3.571
   Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696
   Yousif N, 2012, EUR J NEUROSCI, V36, P2252, DOI 10.1111/j.1460-9568.2012.08086.x
   Yousif N, 2010, J NEUROSCI METH, V188, P105, DOI 10.1016/j.jneumeth.2010.01.026
   Yugeta A, 2010, NEUROLOGY, V74, P743, DOI 10.1212/WNL.0b013e3181d31e0b
   Zanini S, 2009, PARKINSONISM RELAT D, V15, P606, DOI 10.1016/j.parkreldis.2008.12.003
NR 52
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E219
EP E231
DI 10.1016/j.wneu.2019.02.014
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400028
PM 30797925
DA 2020-05-12
ER

PT J
AU Khan, KA
   Choudhary, M
   Sinha, VD
   Gora, N
   Bairwa, M
AF Khan, Khursheed Alam
   Choudhary, Madhur
   Sinha, Virendra D.
   Gora, Nandkishore
   Bairwa, Mohan
TI Predictors of Outcome After Traumatic Brain Injuries: Experience of a
   Tertiary Health Care Institution in Northwest India
SO WORLD NEUROSURGERY
LA English
DT Article
DE Glasgow coma score; Injury severity score; Prehospital care; Rotterdam
   score; Traumatic brain injury
ID PROGNOSTIC MODELS; SEVERITY SCORE; HEAD-INJURIES; EPIDEMIOLOGY; IMPACT;
   COMA; CLASSIFICATION; DESIGN
AB BACKGROUND AND OBJECTIVE: Traumatic brain injury (TBI) is a major health issue in developing nations such as India along with underreporting of TBI data because of a lack of major studies targeting the population with TBI. Various lacunae from field to tertiary centers are responsible for this significant burden of TBIs. We studied the epidemiologic profile of 1150 patients with TBI including the predictors of the outcome of TBIs in a tertiary health care institution in North India to identify the modifiable factors that could be used to improve the outcome and reduce the TBI burden.
   METHODS: Patients presenting with TBI to a level I trauma center were identified and enrolled in the study. Data regarding patient information from accident to discharge or death were collected as per designed format and analyzed to determine outcome predictors.
   RESULTS: Mean age was 36 +/- 15.8 years and 84.6% of patients were male; road traffic accident was the mode of injury in 64.26% of cases. Lack of adequate prehospital care was seen in our study. Glasgow Coma Scale score on admission, Injury Severity Score, and Rotterdam CT score were found to be the 3 statistically significant predictors of outcome in patients with TBI.
   CONCLUSIONS: Knowledge about the causes, pattern, and distribution of patients with TBI from this study is helpful in policy making, research, health management, and rehabilitation at the national level in ours and in other nations.
C1 [Khan, Khursheed Alam; Choudhary, Madhur; Sinha, Virendra D.; Gora, Nandkishore] Sawai Maan Singh Med Coll, Dept Neurosurg, Jaipur, Rajasthan, India.
   [Bairwa, Mohan] Indian Inst Hlth Management Res, Dept Publ Hlth & Epidemiol, Jaipur, Rajasthan, India.
RP Khan, KA (reprint author), Sawai Maan Singh Med Coll, Dept Neurosurg, Jaipur, Rajasthan, India.
EM kkneuro15@gmail.com
RI Bairwa, Mohan/G-9463-2015; Khan, Ikhlas/AAA-1490-2020
OI Bairwa, Mohan/0000-0001-7763-2530; 
CR Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915
   Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034
   Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x
   FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8
   Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503
   Gururaj G, 2005, USITC PUBL, V61
   Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038
   JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291
   Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637
   Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568
   Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1
   Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0
   Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150
   Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3
   Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668
   Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029
   Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036
   McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031
   Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292
   Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99
   Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77
   Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25
   Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974
   Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723
   Tay SY, 2004, J TRAUMA, V56, P162, DOI 10.1097/01.TA.0000058311.67607.07
   TEASDALE G, 1974, LANCET, V2, P81
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E699
EP E705
DI 10.1016/j.wneu.2019.02.126
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400086
PM 30844525
DA 2020-05-12
ER

PT J
AU Kim, BJ
   Kim, SH
   Lee, SH
   Ha, SK
   Kim, SD
   Lim, DJ
AF Kim, Bum-Joon
   Kim, Se-Hoon
   Lee, Seung-Hwan
   Ha, Sung-Kon
   Kim, Sang-Dae
   Lim, Dong-Jun
TI Segmental Motion of the Cervical Spine After Total Disc Replacement
   Using ActivC Versus Discectomy and Fusion Using Stand-alone Cage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arthroplasty; Cervical vertebrae; Diskectomy; Intervertebral disc
   degeneration; Range of motion; Spinal fusion; Total disc replacement
ID LEVEL INTRADISCAL PRESSURE; HETEROTOPIC OSSIFICATION; ADJACENT;
   ARTHROPLASTY; MULTICENTER; KINEMATICS; PREVALENCE; DEFORMITY
AB OBJECTIVE: Anterior cervical discectomy and fusion (ACDF) has been a widely accepted procedure for the treatment of cervical disc diseases. However, due to several reports regarding postfusion exacerbation of adjacent segments, a motion-preserving prosthesis was developed. In the present retrospective analysis, total disc replacement (TDR) using ActivC (Aesculap AG, Tuttlingen, Germany) was compared with ACDF using a stand-alone cage.
   METHODS: Among patients diagnosed with cervical disc diseases, those who received either ACDF or TDR at a single level between C3 and C7 from January 2010 to December 2015 were reviewed. Clinical outcomes were assessed using the visual analogue scale for arm and neck pain and the neck disability index. Clinical scales, lateral neutral, and flexion-extension radiographs were taken for all patients preoperatively and 2 months, 6 months, 1 year, and 2 years postoperatively. Global lordosis, C2-C7 Sagittal vertical axis, and T1 slope were measured on lateral neutral radiographs. The segmental range of motion (ROM) of the operated level, cranial adjacent level, and caudal adjacent level were defined as the difference between Cobb angles on flexion-extension lateral radiographs.
   RESULTS: A total of 53 patients (mean age 48.5 years) were reviewed. Thirty patients were treated with ACDF and the remaining 23 patients received TDR. At the 2-year follow-up, the segmental ROM of operated level was significantly preserved in the TDR group compared with the ACDF group (P = 0.007). Conversely, no significant differences in the ROM at the adjacent segments were observed between the TDR and ACDF groups (P > 0.05). The clinical outcome was excellent in both ACDF and TDR groups and was maintained until the 2-year follow-up.
   CONCLUSIONS: In the present study, TDR using ActivC showed successful motion preservation at the operated level and equivalent results were observed with ACDF based on clinical and radiologic results.
C1 [Kim, Bum-Joon; Kim, Se-Hoon; Lee, Seung-Hwan; Ha, Sung-Kon; Kim, Sang-Dae; Lim, Dong-Jun] Korea Univ, Dept Neurosurg, Ansan Hosp, Ansan, South Korea.
RP Kim, SH (reprint author), Korea Univ, Dept Neurosurg, Ansan Hosp, Ansan, South Korea.
EM nsseankim@gmail.com
RI Kim, Bum-Joon/T-7221-2017
OI Kim, Bum-Joon/0000-0002-3701-4030
CR AN HS, 1995, SPINE, V20, P2211, DOI 10.1097/00007632-199510001-00006
   Brenke C, 2012, J NEUROSURG-SPINE, V17, P141, DOI 10.3171/2012.4.SPINE12223
   Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513
   Chang CC, 2018, NEUROSPINE, V15, P296, DOI 10.14245/ns.1836186.093
   Coric D, 2018, J NEUROSURG-SPINE, V28, P252, DOI 10.3171/2017.5.SPINE16824
   Cummins BH, 1998, J NEUROSURG, V88, P943, DOI 10.3171/jns.1998.88.6.0943
   Dmitriev AE, 2005, SPINE, V30, P1165, DOI 10.1097/01.brs.0000162441.23824.95
   Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003
   Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011
   GOFFIN J, 1995, J SPINAL DISORD, V8, P500
   Grob D, 2007, EUR SPINE J, V16, P669, DOI 10.1007/s00586-006-0254-1
   Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009
   Hou Y, 2014, SPINE J, V14, P867, DOI 10.1016/j.spinee.2013.07.432
   Jawahar A, 2010, SPINE J, V10, P1043, DOI 10.1016/j.spinee.2010.08.014
   Kolstad F, 2007, SPINE, V32, P512, DOI 10.1097/01.brs.0000256448.04035.bb
   Leung C, 2005, NEUROSURGERY, V57, P759, DOI 10.1227/01.NEU.0000175856.31210.58
   Ling Ji Min, 2015, Asian J Neurosurg, V10, P5, DOI 10.4103/1793-5482.151501
   Link Helmut D, 2004, Spine J, V4, p294S, DOI 10.1016/j.spinee.2004.07.022
   McAfee PC, 2003, J SPINAL DISORD TECH, V16, P384, DOI 10.1097/00024720-200308000-00010
   McAviney J, 2005, J MANIP PHYSIOL THER, V28, P187, DOI 10.1016/j.jmpt.2005.02.015
   McGonagle L, 2011, J CRANIOVERTEBRAL JU, V2, P82, DOI 10.4103/0974-8237.100062
   Mehren C, 2006, SPINE, V31, P2802, DOI 10.1097/01.brs.0000245852.70594.d5
   Murrey D, 2009, SPINE J, V9, P275, DOI 10.1016/j.spinee.2008.05.006
   Nunley PD, 2018, NEUROSURGERY, V83, P1087, DOI 10.1093/neuros/nyx579
   Park HW, 2009, SPINE, V34, pE591, DOI 10.1097/BRS.0b013e3181ab8b9a
   Park JH, 2008, J KOREAN NEUROSURG S, V44, P217, DOI 10.3340/jkns.2008.44.4.217
   Radcliff K, 2017, CURR REV MUSCULOSKE, V10, P170, DOI 10.1007/s12178-017-9399-2
   Sasso RC, 2008, J SPINAL DISORD TECH, V21, P19, DOI 10.1097/BSD.0b013e3180500778
   Smith JS, 2014, SPINE, V39, pE1001, DOI 10.1097/BRS.0000000000000432
   Suchomel P, 2014, EUR SPINE J, V23, P1124, DOI 10.1007/s00586-014-3223-0
   Suchomel P, 2010, EUR SPINE J, V19, P307, DOI 10.1007/s00586-009-1259-3
   Suchomel PJEMR, 2008, EUROPEAN MUSCULOSKEL, V3, P65
   Tan LA, 2017, NEUROSURGERY, V81, P197, DOI 10.1093/neuros/nyx249
   Wigfield C, 2002, J NEUROSURG, V96, P17, DOI 10.3171/spi.2002.96.1.0017
   Yi S, 2013, SPINE J, V13, P1048, DOI 10.1016/j.spinee.2013.02.036
NR 35
TC 1
Z9 1
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1228
EP E1234
DI 10.1016/j.wneu.2019.02.233
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400154
PM 30885861
DA 2020-05-12
ER

PT J
AU Kim, CS
   Patel, U
   Pastena, G
   Higgins, M
   Peris-Celda, M
   Kenning, TJ
   Pinheiro-Neto, CD
AF Kim, Christine S.
   Patel, Umesh
   Pastena, Gaetano
   Higgins, Mamie
   Peris-Celda, Maria
   Kenning, Tyler J.
   Pinheiro-Neto, Carlos D.
TI The Magnetic Resonance Imaging Appearance of Endoscopic Endonasal Skull
   Base Defect Reconstruction Using Free Mucosal Graft
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic endonasal pituitary surgery; Free mucosal graft; Magnetic
   resonance imaging; Skull base reconstruction
ID TRANSSPHENOIDAL SURGERY; PITUITARY-ADENOMAS; SELLAR RECONSTRUCTION;
   REPAIR
AB OBJECTIVE: At our institution, skull base reconstruction using a free mucosal graft from the nasal cavity floor has been the standardized technique after pituitary adenoma resection via transsellar approach. In this study, the expected appearance of the reconstruction on postoperative magnetic resonance imaging (MRI) scans is described and its integrity and impact on the sinonasal cavity are assessed.
   METHODS: Fifty patients were selected, and their electronic medical records were reviewed for postoperative course, Sino-Nasal Outcome Test-22 (SNOT-22) scores, and nasal endoscopy reports. A total of 116 postoperative MRI scans were available to evaluate 1) the appearance and thickness of the graft, 2) the enhancement of the graft, and 3) the T2 signal in sphenoid sinus as a potential indication for inflammatory disease.
   RESULTS: There was no significant change in the thickness of the graft over time. Except for the 7 scans that were obtained without intravenous contrast, all scans showed enhancement of the graft. About half of the patients showed persistent T2 hyperintense signal at 12 and 24 months. However, this finding was not clinically significant, because postoperative SNOT-22 scores showed minimal sinonasal impact.
   CONCLUSIONS: Postoperative MRI surveillance scans showed a stable appearance of the graft that mimics the native mucosa, with enhancement through time, reflecting its robust vascularization and integration to the skull base. Although persistent T2 hyperintense signal was detected in the sphenoid sinus, clinical evidence based on nasal endoscopy reports and SNOT-22 scores indicated minimal sinonasal morbidity.
C1 [Kim, Christine S.; Higgins, Mamie; Pinheiro-Neto, Carlos D.] Albany Med Ctr, Div Otolaryngol, Albany, NY 12208 USA.
   [Patel, Umesh; Pastena, Gaetano] Albany Med Ctr, Dept Radiol, Albany, NY USA.
   [Kenning, Tyler J.] Albany Med Ctr, Dept Neurosurg, Albany, NY USA.
   [Peris-Celda, Maria] Mayo Clin, Dept Neurosurg, Rochester, MN USA.
RP Pinheiro-Neto, CD (reprint author), Albany Med Ctr, Div Otolaryngol, Albany, NY 12208 USA.
EM PinheiC@amc.edu
CR Alobid I, 2013, NEUROSURGERY, V72, P540, DOI 10.1227/NEU.0b013e318282a535
   Awad AJ, 2015, CLIN NEUROL NEUROSUR, V130, P162, DOI 10.1016/j.clineuro.2015.01.004
   Cappabianca P, 2002, NEUROSURGERY, V51, P1365, DOI 10.1227/01.NEU.0000035904.77559.9F
   Ciric I, 1997, NEUROSURGERY, V40, P225, DOI 10.1097/00006123-199702000-00001
   de Almeida JR, 2011, HEAD NECK-J SCI SPEC, V33, P547, DOI 10.1002/hed.21483
   DeConde AS, 2013, J NEUROL SURG PART B, V74, P351, DOI 10.1055/s-0033-1347371
   Dehdashti AR, 2008, NEUROSURGERY, V62, P1006, DOI 10.1227/01.neu.0000325862.83961.12
   Gondim JA, 2010, PITUITARY, V13, P68, DOI 10.1007/s11102-009-0195-x
   Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4
   Harvey RJ, 2012, LARYNGOSCOPE, V122, P452, DOI 10.1002/lary.22475
   Hegazy HM, 2000, LARYNGOSCOPE, V110, P1166, DOI 10.1097/00005537-200007000-00019
   Jang JH, 2016, WORLD NEUROSURG, V96, P545, DOI 10.1016/j.wneu.2016.09.051
   Jyotirmay H, 2017, J CLIN DIAGN RES, V11
   Kang MD, 2009, AM J NEURORADIOL, V30, P781, DOI 10.3174/ajnr.A1453
   Langdon C, 2016, AM J OTOLARYNG, V37, P103, DOI 10.1016/j.amjoto.2015.12.006
   Learned KO, 2013, EUR J RADIOL, V82, P544, DOI 10.1016/j.ejrad.2012.09.029
   Lee DD, 2017, WORLD NEUROSURG, V98, P303, DOI 10.1016/j.wneu.2016.10.114
   Paluzzi A, 2014, PITUITARY, V17, P307, DOI 10.1007/s11102-013-0502-4
   Peris-Celda M, 2017, WORLD NEUROSURG, V101, P180, DOI 10.1016/j.wneu.2017.01.102
   Rivera-Serrano CM, 2011, LARYNGOSCOPE, V121, P990, DOI 10.1002/lary.21419
   Sanders-Taylor C, 2015, J NEUROL SURG PART B, V76, P281, DOI 10.1055/s-0034-1544118
   Shiley SG, 2003, LARYNGOSCOPE, V113, P1283, DOI 10.1097/00005537-200308000-00003
   Vaezeafshar R, 2012, AM J OTOLARYNG, V33, P634, DOI 10.1016/j.amjoto.2012.05.003
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E165
EP E172
DI 10.1016/j.wneu.2019.02.010
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400022
PM 30794981
DA 2020-05-12
ER

PT J
AU Kim, JY
   Shin-Jung
   Song, TW
   Kim, IY
   Moon, KS
   Jung, TY
   Jang, WY
AF Kim, Jae-Young
   Shin-Jung
   Song, Tae-wook
   Kim, In-Young
   Moon, Kyung-Sub
   Jung, Tae-Young
   Jang, Woo-Youl
TI The Cornerstone Technique of Microvascular Decompression for Hemifacial
   Spasm with Vertebral Artery Offender
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cornerstone technique; Hemifacial spasm; Microvascular decompression;
   Vertebral artery
ID SLING TECHNIQUE; TRANSPOSITION
AB BACKGROUND: Microvascular decompression surgery is the most effective treatment for hemifacial spasm (HFS). The vertebral artery (VA) is a larger and more elastic vessel, which makes surgical management more difficult. We introduce a surgical technique of proximal Teflon transposition with interposition (PTTI) in the vertebromedullary space for HFS with a VA offender.
   METHODS: In 112 patients with HFS, 22 patients had a VA offender on the facial nerve exit zone. Six of 22 patients with a VA offender underwent surgery by traditional microvascular decompression at the facial nerve exit zone, and 16 patients underwent the PTTI technique. We compared surgical outcomes of the PTTI technique and the conventional technique for HFS associated with the VA. We also compared surgical outcomes of the PTTI technique with outcomes of other alternative techniques.
   RESULTS: The PTTI technique was associated with a good operative prognosis and fewer complications. The PTTI technique is an easy, safe, and effective method for treatment of patients with HFS with a VA offender.
   CONCLUSIONS: The PTTI technique can be considered as another treatment option in addition to the transposition technique reported previously.
C1 [Kim, Jae-Young; Shin-Jung; Song, Tae-wook; Kim, In-Young; Moon, Kyung-Sub; Jung, Tae-Young; Jang, Woo-Youl] Chonnam Natl Univ, Dept Neurosurg, Res Inst Med Sci, Hwasun Hosp & Med Sch, Gwangju, South Korea.
RP Shin-Jung (reprint author), Chonnam Natl Univ, Dept Neurosurg, Res Inst Med Sci, Hwasun Hosp & Med Sch, Gwangju, South Korea.
EM sjung@chonnam.ac.kr
CR Attabib N, 2007, J NEUROSURG, V106, P929, DOI 10.3171/jns.2007.106.5.929
   BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201
   Bejjani GK, 1997, J NEUROSURG, V86, P728, DOI 10.3171/jns.1997.86.4.0728
   Dannenbaum M, 2008, J NEUROSURG, V109, P410, DOI 10.3171/JNS/2008/109/9/0410
   Ferreira M, 2011, J NEUROSURG, V114, P1800, DOI 10.3171/2010.12.JNS10891
   HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202
   Ichikawa T, 2011, NEUROSURGERY, V68, P377, DOI 10.1227/NEU.0b013e318217141c
   Kondo A, 2012, ACTA NEUROCHIR, V154, P773, DOI 10.1007/s00701-012-1277-5
   Kurokawa Y, 2004, SURG NEUROL, V61, P398, DOI 10.1016/S0090-3019(03)00425-7
   Kwon Hyung-Min, 2011, Curr Treat Options Cardiovasc Med, V13, P261, DOI 10.1007/s11936-011-0123-z
   Lee SH, 2016, J KOREAN NEUROSURG S, V59, P505, DOI 10.3340/jkns.2016.59.5.505
   Lin CF, 2012, CLIN NEUROL NEUROSUR, V114, P951, DOI 10.1016/j.clineuro.2012.02.021
   Lu Alex Y, 2014, ScientificWorldJournal, V2014, P349319, DOI 10.1155/2014/349319
   Masuoka J, 2011, NEUROSURG REV, V34, P373, DOI 10.1007/s10143-011-0310-0
   Rawlinson J N, 1988, Br J Neurosurg, V2, P173, DOI 10.3109/02688698808992667
   Rosenstengel C, 2012, DTSCH ARZTEBL INT, V109, P667, DOI 10.3238/arztebl.2012.0667
   Shimano H, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.06.026
   Zaidi HA, 2015, J CLIN NEUROSCI, V22, P62, DOI 10.1016/j.jocn.2014.09.008
   Zhang X, 2017, WORLD NEUROSURG, V104, P186, DOI 10.1016/j.wneu.2017.04.048
NR 19
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E94
EP E100
DI 10.1016/j.wneu.2019.01.199
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400013
PM 30743039
DA 2020-05-12
ER

PT J
AU Kim, JH
   Jung, NY
   Chang, WS
   Jung, HH
   Cho, SR
   Chang, JW
AF Kim, Ji Hee
   Jung, Na Young
   Chang, Won Seok
   Jung, Hyun Ho
   Cho, Sung-Rae
   Chang, Jin Woo
TI Intrathecal Baclofen Pump Versus Globus Pallidus Interna Deep Brain
   Stimulation in Adult Patients with Severe Cerebral Palsy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral palsy; Deep brain stimulation; Dystonia; Globus pallidus
   interna; Intrathecal baclofen pump
ID PRIMARY GENERALIZED DYSTONIA; NON-AMBULANT CHILDREN; QUALITY-OF-LIFE;
   FOLLOW-UP; THERAPY; INFUSION; COMPLICATIONS; MANAGEMENT; EFFICACY
AB OBJECTIVE: There is no consensus on a standardized approach to spasticity or dystonia management of cerebral palsy (CP). This study aimed to investigate clinical outcomes and compare therapeutic responses for pallidal stimulation versus intrathecal baclofen (ITB) therapy in adult patients with severe CP.
   METHODS: We retrospectively reviewed patients with CP treated with deep brain stimulation (DBS) of the globus pallidus internus (GPi) or implantation of ITB pump between June 2003 and April 2017. Patients were included if they were clinically diagnosed with medically intractable CP and had >12 months of postprocedural follow-up data. Patients were assessed before and 12 months post-treatment using the visual analogue scale, Burke-Fahn-Marsden Dystonia Rating Scale, self-rating improvement scale, and 36-Item Short-Form General Health Survey Questionnaire.
   RESULTS: Patients (n = 22) were divided into GPi DBS (n = 12) and ITB therapy (n = 10) groups. For the Burke-Fahn-Marsden Dystonia Rating Scale, DBS group movement scores and ITB group disability scores were significantly improved post-treatment. Although visual analogue scales did not differ between groups, self-rating improvement scores differed significantly between groups. For quality of life, physical functioning, body pain, vitality, social functioning, and mental health significantly improved in ITB group 12 months post-treatment compared with those of preoperative period. Only mental health differed significantly between groups.
   CONCLUSIONS: Despite retrospective design and relatively low number of cases, this study indicated that ITB therapy was less invasive and more effective in improving the quality of life compared with GPi DBS. ITB therapy should be considered an alternative treatment for patients with severe CP.
C1 [Kim, Ji Hee] Hallym Univ, Dept Neurosurg, Sacred Heart Hosp, Anyang, Gyeonggi Do, South Korea.
   [Jung, Na Young; Chang, Won Seok; Jung, Hyun Ho; Chang, Jin Woo] Yonsei Univ, Div Stereotact & Funct Neurosurg, Severance Intrathecal Pump Clin, Dept Neurosurg,Coll Med, Seoul, South Korea.
   [Cho, Sung-Rae] Yonsei Univ, Dept & Res Inst Rehabil Med, Severance Intrathecal Pump Clin, Coll Med, Seoul, South Korea.
RP Chang, WS (reprint author), Yonsei Univ, Div Stereotact & Funct Neurosurg, Severance Intrathecal Pump Clin, Dept Neurosurg,Coll Med, Seoul, South Korea.
EM changws0716@yuhs.ac
OI Chang, Jin Woo/0000-0002-2717-0101; Kim, Ji Hee/0000-0001-6937-8093;
   Chang, Won Seok/0000-0003-3145-4016
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT,
   and Future Planning [2016M3C7A1914123]; Industrial Strategic Technology
   Development Program [10062880]
FX This study was supported by a grant from the Brain Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science, ICT, and Future Planning (2016M3C7A1914123) and the
   Industrial Strategic Technology Development Program (10062880).
CR Albright AL, 2004, J NEUROSURG, V101, P64, DOI 10.3171/ped.2004.101.2.0064
   ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418
   Awaad Y, 2003, J CHILD NEUROL, V18, P26, DOI 10.1177/08830738030180010701
   Bonouvrie L, 2016, EUR J PAEDIATR NEURO, V20, P538, DOI 10.1016/j.ejpn.2016.02.013
   Borggraefe I, 2010, BRAIN DEV-JPN, V32, P223, DOI 10.1016/j.braindev.2009.03.010
   Butler C, 2000, DEV MED CHILD NEUROL, V42, P634, DOI 10.1017/S0012162200001183
   Campbell WM, 2002, DEV MED CHILD NEUROL, V44, P660
   Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189
   Dan B, 2010, EUR J PAEDIATR NEURO, V14, P19, DOI 10.1016/j.ejpn.2009.05.002
   Davis E, 2010, DEV MED CHILD NEUROL, V52, P174, DOI 10.1111/j.1469-8749.2009.03382.x
   DRALLE D, 1985, LANCET, V2, P1003
   Eek MN, 2018, DEV MED CHILD NEUROL, V60, P94, DOI 10.1111/dmcn.13625
   Eltahawy HA, 2004, NEUROSURGERY, V54, P613, DOI 10.1227/01.NEU.0000108643.94730.21
   Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009
   Gilmartin R, 2000, J CHILD NEUROL, V15, P71, DOI 10.1177/088307380001500201
   Gray N, 2014, EUR J PAEDIATR NEURO, V18, P45, DOI 10.1016/j.ejpn.2013.08.003
   Hoving MA, 2009, EUR J PAEDIATR NEURO, V13, P240, DOI 10.1016/j.ejpn.2008.04.013
   Kim AR, 2014, ANN REHABIL MED-ARM, V38, P209, DOI 10.5535/arm.2014.38.2.209
   Kim JP, 2012, STEREOT FUNCT NEUROS, V90, P292, DOI 10.1159/000338093
   Koy A, 2013, MOVEMENT DISORD, V28, P647, DOI 10.1002/mds.25339
   Krach Linda E, 2005, Pediatr Rehabil, V8, P207
   Kraus T, 2017, EUR J PAEDIATR NEURO, V21, P565, DOI 10.1016/j.ejpn.2017.01.016
   Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618
   Miller F, 2011, DEV MED CHILD NEUROL, V53, P679, DOI 10.1111/j.1469-8749.2011.04026.x
   Motta F, 2016, J NEUROSURG-PEDIATR, V18, P493, DOI 10.3171/2016.4.PEDS15646
   Motta F, 2014, J NEUROSURG-PEDIATR, V13, P301, DOI 10.3171/2013.11.PEDS13253
   MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547
   NARAYAN RK, 1991, NEUROLOGY, V41, P1141, DOI 10.1212/WNL.41.7.1141
   O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642
   Parr JR, 2007, ARCH DIS CHILD, V92, P708, DOI 10.1136/adc.2006.095380
   PENN RD, 1984, LANCET, V1, P1078
   Reeuwijk A, 2006, CLIN REHABIL, V20, P375, DOI 10.1191/0269215506cr956oa
   Romito LM, 2015, EUR J NEUROL, V22, P426, DOI 10.1111/ene.12596
   Shamsoddinri A, 2014, IRAN J PEDIATR, V24, P345
   Tisch S, 2007, IEEE T NEUR SYS REH, V15, P166, DOI 10.1109/TNSRE.2007.896994
   Vercueil L, 2002, MOVEMENT DISORD, V17, pS89, DOI 10.1002/mds.10148
   Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187
   Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2
   Vidailhet M, 2009, LANCET NEUROL, V8, P709, DOI 10.1016/S1474-4422(09)70151-6
   Vles GF, 2013, EUR J PAEDIATR NEURO, V17, P639, DOI 10.1016/j.ejpn.2013.06.003
NR 40
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E550
EP E556
DI 10.1016/j.wneu.2019.02.092
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400066
PM 30831291
DA 2020-05-12
ER

PT J
AU Kim, JE
   Choi, DJ
   Park, EJ
AF Kim, Ju-Eun
   Choi, Dae-Jung
   Park, Eugene J.
TI Evaluation of Postoperative Spinal Epidural Hematoma After Biportal
   Endoscopic Spine Surgery for Single-Level Lumbar Spinal Stenosis:
   Clinical and Magnetic Resonance Imaging Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arthroscopy; Endoscopy; Epidural hematoma; Lumbar spine; MRI; Spinal
   stenosis
ID DECOMPRESSION SURGERY; RISK-FACTORS; COMPUTED-TOMOGRAPHY; COMPLICATIONS;
   PREVENTION; DISK
AB BACKGROUND: Symptomatic postoperative spinal epidural hematoma is a serious complication that may occur after lumbar spine surgery. We analyzed epidural hematoma using postoperative magnetic resonance imaging (MRI) after biportal endoscopic spinal surgery and its impact on clinical outcome.
   METHODS: The subjects of this study were 158 patients who underwent single-level decompression using the biportal endoscopic spinal surgery technique from 2015 to 2017. MRI was performed in all patients before and after surgery, and postoperative MRI was used to identify epidural hematoma. The preoperative and postoperative visual analog scale (VAS) score for leg and back pain, Oswestry Disability Index (ODI), and modified Macnab criteria were recorded for evaluation of clinical outcome. The group with postoperative spinal epidural hematoma (group A) and without hematoma (group B) were comparatively analyzed, both radiologically and clinically.
   RESULTS: The mean age of the patients was 67.9 +/- 11.1 years (range, 49-89). The total number with grade 0 (no hematoma) was 119 levels patients (75.3%) on the T2 axial image of postoperative MRI. The total number of patients with hematoma was 39 (24.7%) according to T2-weighted axial postoperative MRI. Two patients underwent revision surgery because of hematoma-related symptoms. The improvement of clinical outcome measures including VAS leg, VAS back, and ODI was significantly different between group A and B (P < 0.05).
   CONCLUSIONS: The incidence of postoperative spinal epidural hematoma after biportal endoscopic spinal surgery according to postoperative MRI was higher than expected, regardless of the patients' postoperative symptoms. Postoperative hematoma has a decisive influence on postoperative results, and revision surgery might be necessary if canal encroachment is >50% with concomitant symptoms.
C1 [Kim, Ju-Eun; Choi, Dae-Jung] Himnaera Hosp, Dept Orthoped Surg, Busan, South Korea.
   [Park, Eugene J.] Chungnam Natl Univ, Dept Orthoped Surg, Sch Med, Daejeon, South Korea.
RP Kim, JE (reprint author), Himnaera Hosp, Dept Orthoped Surg, Busan, South Korea.
EM dspfuture@hanmail.net
CR Ahn DK, 2017, ASIAN SPINE J, V11, P898, DOI 10.4184/asj.2017.11.6.898
   Ali Y, 2012, ASIAN SPINE J, V6, P152, DOI 10.4184/asj.2012.6.2.152
   Amiri AR, 2013, SPINE J, V13, P134, DOI 10.1016/j.spinee.2012.10.028
   Aono H, 2011, J NEUROSURG-SPINE, V15, P202, DOI 10.3171/2011.3.SPINE10716
   Awad JN, 2005, J BONE JOINT SURG BR, V87B, P1248, DOI 10.1302/0301-620X.87B9.16518
   Boe Chelsea C, 2017, J Spine Surg, V3, P112, DOI 10.21037/jss.2017.03.01
   Cabana F, 2000, REV CHIR ORTHOP, V86, P335
   Choi DJ, 2018, ASIAN SPINE J, V12, P569, DOI 10.4184/asj.2018.12.3.569
   Choi DJ, 2016, ASIAN SPINE J, V10, P624, DOI 10.4184/asj.2016.10.4.624
   Cramer DE, 2009, J SPINAL DISORD TECH, V22, P565, DOI 10.1097/BSD.0b013e318193452a
   DINA TS, 1995, AM J ROENTGENOL, V164, P665, DOI 10.2214/ajr.164.3.7863890
   Djukic S, 1992, Bildgebung, V59, P136
   Eldin MMM, 2015, ASIAN SPINE J, V9, P370, DOI 10.4184/asj.2015.9.3.370
   Fujiwara Y, 2017, EUR SPINE J, V26, P2606, DOI 10.1007/s00586-017-5165-9
   Ikuta K, 2006, J NEUROSURG-SPINE, V5, P404, DOI 10.3171/spi.2006.5.5.404
   Jain NK, 2014, NEUROIMAG CLIN N AM, V24, P375, DOI 10.1016/j.nic.2014.01.001
   Kim JE, 2018, J ORTHOP, V15, P354, DOI 10.1016/j.jor.2018.01.034
   Kou J, 2002, SPINE, V27, P1670, DOI 10.1097/00007632-200208010-00016
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   Leonardi MA, 2010, EUR SPINE J, V19, P2216, DOI 10.1007/s00586-010-1483-x
   Matsumoto M, 2010, J ORTHOP SCI, V15, P92, DOI 10.1007/s00776-009-1428-6
   MONTALDI S, 1988, NEUROSURGERY, V22, P1014, DOI 10.1227/00006123-198806010-00007
   Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053
   ROSS JS, 1987, RADIOLOGY, V164, P851, DOI 10.1148/radiology.164.3.3615887
   Scavarda D, 1997, NEUROCHIRURGIE, V43, P220
   Schubert GA, 2013, SPINE, V38, pE1263, DOI 10.1097/BRS.0b013e31829fc6a6
   Sokolowski MJ, 2008, SPINE, V33, P108, DOI 10.1097/BRS.0b013e31815e39af
   Sokolowski MJ, 2008, SPINE, V33, P114, DOI 10.1097/BRS.0b013e31815e3a26
   Soliman HM, 2015, SPINE J, V15, P2282, DOI 10.1016/j.spinee.2015.07.009
   TEPLICK JG, 1983, AM J ROENTGENOL, V141, P865, DOI 10.2214/ajr.141.5.865
   YONGHING K, 1980, SPINE, V5, P59, DOI 10.1097/00007632-198001000-00011
NR 31
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E786
EP E792
DI 10.1016/j.wneu.2019.02.150
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400098
PM 30878758
DA 2020-05-12
ER

PT J
AU Kim, MK
   Lim, YC
AF Kim, Mi Kyung
   Lim, Yong Cheol
TI Conservative Management of Unruptured Spontaneous Intracranial Vertebral
   Artery Dissection
SO WORLD NEUROSURGERY
LA English
DT Article
DE Basilar artery; Vascular system injuries/therapy; Vertebral artery;
   Vertebral artery dissection
ID SUBARACHNOID HEMORRHAGE; NATURAL-HISTORY; PASSIVE SMOKING; ANEURYSMS;
   OUTCOMES
AB OBJECTIVE: The present study investigated the clinical and morphological characteristics of the vertebrobasilar artery associated with vascular healing in patients with unruptured spontaneous intracranial vertebral artery (VA) dissection (VAD).
   METHODS: We retrospectively reviewed the data from 69 consecutive patients with a diagnosis of unruptured VAD who were treated conservatively for >= 21 days from November 2003 to February 2018 at our institute. Univariate and multivariate analyses were performed to evaluate the clinical characteristics and morphological findings of VAD.
   RESULTS: Of the 69 patients, vascular normalization of VAD was observed in 26, including a significantly greater proportion of women and nonsmokers (P = 0.04 and P = 0.034, respectively). Patients with normalization of VAD had a significantly lower proportion of posteroinferior cerebellar artery involvement and a smaller vertebralunion- basilar angle of the nondissecting VA, smaller vertebral-union-vertebral angle, distal dissection from the VA union, and less basilar artery bending. Luminal irregularity/steno-occlusion of the VAD on the initial images exhibited vascular resolution/normalization in 25 patients (67.6%) on subsequent images. The morphology of VAD in the dominant or codominant VAs included fusiform/ aneurysmal dilatation in 25 patients (78.1%). The morphology in the nondominant VA included luminal irregularity/steno-occlusion in 23 patients (62.2%).
   CONCLUSIONS: Spontaneous vascular normalization of unruptured spontaneous intracranial VAD might be associated with female sex, nonsmoking, no posteroinferior cerebellar artery involvement, a smaller vertebral-union-basilar angle and vertebral-union-vertebral angle, distal dissection from the VA union, less basilar artery bending, and luminal irregularity/steno-occlusion.
C1 [Kim, Mi Kyung; Lim, Yong Cheol] Ajou Univ Hosp, Dept Neurosurg, Suwon, South Korea.
RP Lim, YC (reprint author), Ajou Univ Hosp, Dept Neurosurg, Suwon, South Korea.
EM nsyclim@gmail.com
OI Kim, Mi Kyung/0000-0002-8824-0505
CR AOKI N, 1990, STROKE, V21, P1628, DOI 10.1161/01.STR.21.11.1628
   Arnold M, 2010, STROKE, V41, P802, DOI 10.1161/STROKEAHA.109.570655
   Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215
   Bassetti C, 1996, STROKE, V27, P1804, DOI 10.1161/01.STR.27.10.1804
   Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2
   Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303
   ENDO S, 1993, NEUROSURGERY, V33, P732, DOI 10.1227/00006123-199310000-00026
   FARRELL MA, 1985, J NEUROL NEUROSUR PS, V48, P111, DOI 10.1136/jnnp.48.2.111
   Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662
   Kim BM, 2011, NEUROLOGY, V76, P1735, DOI 10.1212/WNL.0b013e31821a7d94
   Kurata A, 2001, AM J NEURORADIOL, V22, P11
   Lucas C, 1998, STROKE, V29, P2646, DOI 10.1161/01.STR.29.12.2646
   Matsukawa H, 2012, CEREBROVASC DIS, V34, P393, DOI 10.1159/000345079
   Matsukawa H, 2011, J NEUROSURG, V115, P108, DOI 10.3171/2011.2.JNS101708
   MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003
   MOKRI B, 1988, NEUROLOGY, V38, P880, DOI 10.1212/WNL.38.6.880
   Naito I, 2002, NEUROSURGERY, V51, P930, DOI 10.1227/01.NEU.0000027636.42239.8E
   Nishikata M, 2004, ARCH GERONTOL GERIAT, V38, P251, DOI 10.1016/j.archger.2003.10.006
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   Park KW, 2008, J KOREAN NEUROSURG S, V44, P109, DOI 10.3340/jkns.2008.44.3.109
   Santos-Franco JA, 2008, NEUROSURG REV, V31, P131, DOI 10.1007/s10143-008-0124-x
   SCHIEVINK WI, 1994, NEW ENGL J MED, V330, P393, DOI 10.1056/NEJM199402103300604
   SCHIEVINK WI, 1994, NEUROLOGY, V44, P1607, DOI 10.1212/WNL.44.9.1607
   Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206
   Schmid P, 1996, THROMB RES, V81, P451, DOI 10.1016/0049-3848(96)00017-5
   Srinivasan J, 1996, STROKE, V27, P1226, DOI 10.1161/01.STR.27.7.1226
   Turjman F, 1998, AM J NEURORADIOL, V19, P1645
   VANHOUTTE PM, 1986, ANNU REV PHYSIOL, V48, P307
   Yamada M, 2004, J NEUROSURG, V101, P25, DOI 10.3171/jns.2004.101.1.0025
   YAMAURA A, 1990, J NEUROSURG, V72, P183, DOI 10.3171/jns.1990.72.2.0183
   Yoshimoto Y, 1997, STROKE, V28, P370, DOI 10.1161/01.STR.28.2.370
NR 31
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E402
EP E409
DI 10.1016/j.wneu.2019.02.063
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400047
PM 30822585
DA 2020-05-12
ER

PT J
AU Kim, W
   Choi, KS
   Lim, T
   Ahn, C
   Cho, Y
   Yi, HJ
   Lee, SH
AF Kim, Wonhee
   Choi, Kyu-Sun
   Lim, Taeho
   Ahn, Chiwon
   Cho, Youngsuk
   Yi, Hyeong-Joong
   Lee, Seon-Heui
TI Prognostic Value of Echocardiography for Left Ventricular Dysfunction
   After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and
   Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Echocardiography; Meta-analysis; Mortality; Prognosis; Subarachnoid
   hemorrhage
ID WALL-MOTION ABNORMALITIES; NEUROGENIC STUNNED MYOCARDIUM; TAKOTSUBO
   CARDIOMYOPATHY; CLINICAL CHARACTERISTICS; STRESS CARDIOMYOPATHY; CARDIAC
   DYSFUNCTION; OUTCOMES; BRAIN; PREDICTORS; ELEVATION
AB OBJECTIVE: Cardiac dysfunction may worsen outcomes after aneurysmal subarachnoid hemorrhage (SAH). This study quantitatively assessed the prognostic value of left ventricular dysfunction with respect to functional outcomes and mortality in patients with aneurysmal SAH.
   METHODS: We searched MEDLINE and EMBASE databases to retrieve relevant studies evaluating echocardiographic left ventricular dysfunction following aneurysmal SAH. Fourteen relevant observational studies evaluating 2234 patients were finally included in this study.
   RESULTS: Echocardiographic regional wall motion abnormalities (RWMA) and neurogenic cardiomyopathy (NCM) of the left ventricle occurring after SAH were significantly related to an increase of in-hospital mortality (in 8 studies for RWMA, odds ratio [OR] 2.37; 95% confidence interval [CI] 1.74-3.25 and in 5 studies for NCM, OR 2.82; 95% CI 1.2-6.6). Decreased ejection fraction on echocardiography was not associated with the increase of in-hospital mortality (in 4 studies, OR 1.76; 95% CI 0.86-3.61). The heterogeneities of decreased ejection fraction and NCM were significantly resolved by analyzing only the studies based on echocardiogram measurements obtained within 72 hours after admission.
   CONCLUSIONS: The present meta-analysis suggests that the identification of echocardiographic left ventricular dysfunction identified by RWMA and NCM after SAH could provide better prognostic information for in-hospital mortality.
C1 [Kim, Wonhee; Cho, Youngsuk] Hallym Univ, Coll Med, Dept Emergency Med, Seoul, South Korea.
   [Choi, Kyu-Sun; Yi, Hyeong-Joong] Hanyang Univ, Coll Med, Dept Neurosurg, Seoul, South Korea.
   [Lim, Taeho; Ahn, Chiwon] Hanyang Univ, Coll Med, Dept Emergency Med, Seoul, South Korea.
   [Lee, Seon-Heui] Gachon Univ, Coll Nursing, Dept Nursing Sci, Incheon, South Korea.
RP Lee, SH (reprint author), Gachon Univ, Coll Nursing, Dept Nursing Sci, Incheon, South Korea.
EM sunarea87@gachon.ac.kr
CR Abd TT, 2014, INT J CARDIOL, V176, P1362, DOI 10.1016/j.ijcard.2014.07.279
   Ako J, 2006, AM J MED, V119, P10, DOI 10.1016/j.amjmed.2005.08.022
   Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15
   Bihorac A, 2016, ANESTH ANALG, V122, P1594, DOI 10.1213/ANE.0000000000001231
   Chalouhi N, 2016, J NEUROSURG, V125, P730, DOI 10.3171/2015.7.JNS15956
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Elgendy AY, 2016, EUR HEART J-ACUTE CA, V16, P16
   Elgendy IY, 2015, CIRC C AM HEART ASS, P132
   Elgendy IY, 2015, J AM SOC ECHOCARDIOG, V28, pB69
   Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009
   Higgins J, 2011, COCHRANE COLLAB, V5, P1, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290
   Hravnak M, 2009, STROKE, V40, P3478, DOI 10.1161/STROKEAHA.109.556753
   Inamasu J, 2012, NEUROL MED-CHIR, V52, P49, DOI 10.2176/nmc.52.49
   Jangra K, 2016, J NEUROSURG ANESTHES, V16
   Kerro A, 2017, J CRIT CARE, V38, P27, DOI 10.1016/j.jcrc.2016.10.010
   Kilbourn KJ, 2015, CLIN NEUROL NEUROSUR, V128, P4, DOI 10.1016/j.clineuro.2014.10.017
   Kilbourn KJ, 2013, CLIN NEUROL NEUROSUR, V115, P909, DOI 10.1016/j.clineuro.2012.09.006
   KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6
   Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014
   Kurisu S, 2016, CIRC J, V80, P1905, DOI 10.1253/circj.CJ-16-0737
   KUROIWA T, 1995, ACTA NEUROCHIR, V133, P141, DOI 10.1007/BF01420064
   Liang CW, 2013, J STROKE CEREBROVASC, V22, P601, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.006
   Malik AN, 2015, WORLD NEUROSURG, V83, P880, DOI 10.1016/j.wneu.2015.01.013
   Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780
   Moussouttas M, 2012, CEREBROVASC DIS, V33, P173, DOI 10.1159/000334660
   Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0
   Ono R, 2016, INT J CARDIOL, V209, P196, DOI 10.1016/j.ijcard.2016.02.012
   POLLICK C, 1988, J AM COLL CARDIOL, V12, P600, DOI 10.1016/S0735-1097(88)80044-5
   Sakr YL, 2004, INT J CARDIOL, V96, P369, DOI 10.1016/j.ijcard.2003.07.027
   Sandhu R, 2008, AM J CARDIOL, V102, P632, DOI 10.1016/j.amjcard.2008.04.036
   Sugimoto K, 2008, INT HEART J, V49, P75, DOI 10.1536/ihj.49.75
   Sugimoto K, 2013, NEUROSURG REV, V36, P259, DOI 10.1007/s10143-012-0424-z
   Talahma M, 2016, CLIN NEUROL NEUROSUR, V141, P65, DOI 10.1016/j.clineuro.2015.12.005
   van der Bilt I, 2014, NEUROLOGY, V82, P351, DOI 10.1212/WNL.0000000000000057
   Yarlagadda S, 2006, NEUROCRIT CARE, V5, P102, DOI 10.1385/NCC:5:2:102
   Zaroff JG, 2000, STROKE, V31, P1136, DOI 10.1161/01.STR.31.5.1136
   Zhang LM, 2015, J STROKE CEREBROVASC, V24, P2375, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.030
   Zolnourian A, 2015, NEUROSURGERY, V76, P705
NR 40
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1099
EP E1111
DI 10.1016/j.wneu.2019.03.054
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400139
PM 30880203
DA 2020-05-12
ER

PT J
AU Kimura, T
   Morita, A
AF Kimura, Toshikazu
   Morita, Akio
TI Early Visualization of Optic Canal for Safe Anterior Clinoidectomy:
   Operative Technique and Supporting Computed Tomography Findings
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anatomic land mark; Anterior clinoidectomy; Cancellous bone; Compact
   bone; Optic canal; Pneumatization
ID SURGICAL ANATOMY; EXPOSURE
AB BACKGROUND: Anterior clinoidectomy is considered difficult because important structures are adjacent to but hidden behind the anterior clinoid process (ACP). We sought to make anterior clinoidectomy a simpler procedure.
   METHODS: A modification of anterior clinoidectomy is presented. To obtain a radiologic basis, original images from 357 consecutive sets of computed tomography angiography data were assessed.
   RESULTS: Anterior clinoidectomy was performed in 77 consecutive patients, as follows. By making a small window in the lateral wall of the ACP and curetting out the content inside, the lateral wall of the optic canal was easily exposed and functioned as a landmark for removal of the remaining bone. In addition, by removing the posterior edge and thinning the lateral part, the ACP was fractured and removed. The optic canal was opened if needed. No complications due to anterior clinoidectomy were observed.
   Among the 689 sides evaluated, 641 sides showed cancellous bone and 29 showed well-developed pneumatization inside the ACP. In each ACP examined, we observed the presence of compact bone facing the optic nerve, which constitutes the lateral wall of the optic canal. On 180 sides, part of the compact bone between the clinoid process and the internal carotid artery was absent; in other cases, thin compact bone was present.
   CONCLUSIONS: Visualizing the optic canal in the early stage of the procedure allows anterior clinoidectomy to be performed safely.
C1 [Kimura, Toshikazu] Japanese Red Cross Med Ctr, Dept Neurosurg, Shibuya Ku, Tokyo, Japan.
   [Morita, Akio] Nippon Med Univ, Dept Neurosurg, Bukyo Ku, Tokyo, Japan.
RP Kimura, T (reprint author), Japanese Red Cross Med Ctr, Dept Neurosurg, Shibuya Ku, Tokyo, Japan.
EM tkim-tky@umin.ac.jp
OI Morita, Akio/0000-0002-2497-5772; Kimura, Toshikazu/0000-0003-4308-7778
CR Andrade-Barazarte H, 2017, WORLD NEUROSURG, V100, P159, DOI 10.1016/j.wneu.2016.12.087
   Chang DJ, 2009, NEUROSURGERY S3, V64
   Chang DJ, 2009, NEUROSURGERY, V64, pS96, DOI 10.1227/01.NEU.0000335172.68267.01
   Chang HS, 2006, J NEUROSURG, V104, P621, DOI 10.3171/jns.2006.104.4.621
   Chi JH, 2006, NEUROSURGERY, V59, P101, DOI 10.1227/01.NEU.0000219962.15984.34
   Citardi MJ, 2004, AM J RHINOL, V18, P173, DOI 10.1177/194589240401800308
   Coscarella E, 2003, NEUROSURGERY, V53, P162, DOI 10.1227/01.NEU.0000068866.22176.07
   DOLENC V, 1983, J NEUROSURG, V58, P824, DOI 10.3171/jns.1983.58.6.0824
   Figueiredo EG, 2006, J NEUROSURG, V104, P957, DOI 10.3171/jns.2006.104.6.957
   Froelich SC, 2007, NEUROSURGERY, V61, P179, DOI 10.1227/01.neu.0000303215.76477.cd
   Hadeishi H, 2003, NEUROSURGERY, V52, P867, DOI 10.1227/01.NEU.0000053147.67715.58
   Hayashi N, 2004, MINIM INVAS NEUROSUR, V47, P355, DOI 10.1055/s-2004-830121
   Kantarci M, 2004, EUR J RADIOL, V50, P296, DOI 10.1016/j.ejrad.2003.08.012
   Komatsu F, 2011, NEUROSURGERY, V68, P334, DOI 10.1227/NEU.0b013e31821144e5
   Kulwin Charles, 2011, Surg Neurol Int, V2, P140, DOI 10.4103/2152-7806.85981
   Mikami T, 2007, J NEUROSURG, V106, P170, DOI 10.3171/jns.2007.106.1.170
   Mori K, 2010, SKULL BASE-INTERD AP, V20, P229, DOI 10.1055/s-0030-1247632
   Noguchi A, 2005, J NEUROSURG, V102, P945, DOI 10.3171/jns.2005.102.5.0945
   Ota N, 2015, WORLD NEUROSURG, V83, P635, DOI 10.1016/j.wneu.2014.12.014
   Otani Naoki, 2016, Surg Neurol Int, V7, pS454, DOI 10.4103/2152-7806.185774
   Sade B, 2005, SKULL BASE-INTERD AP, V15, P157, DOI 10.1055/s-2005-871523
   Takahashi JA, 2004, ACTA NEUROCHIR, V146, P505, DOI 10.1007/s00701-004-0249-9
   Yang Y, 2006, NEUROSURGERY, V59, P253, DOI 10.1227/01.NEU.0000236122.28434.13
   Yonekawa Y, 1997, J NEUROSURG, V87, P636, DOI 10.3171/jns.1997.87.4.0636
NR 24
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E447
EP E452
DI 10.1016/j.wneu.2019.02.071
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400053
PM 30825628
DA 2020-05-12
ER

PT J
AU Kocur, D
   Przybylko, N
   Niedbala, M
   Rudnik, A
AF Kocur, Damian
   Przybylko, Nikodem
   Niedbala, Marcin
   Rudnik, Adam
TI Alternative Definitions of Cerebral Aneurysm Morphologic Parameters Have
   an Impact on Rupture Risk Determination
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intracranial aneurysm; Morphology; Rupture
ID UNRUPTURED INTRACRANIAL ANEURYSMS; ASPECT RATIO; BOTTLENECK FACTOR;
   NATURAL-HISTORY; GUIDELINE; PATIENT; SIZE; MM
AB BACKGROUND: A discrepancy between definitions of morphologic parameters describing cerebral aneurysms across studies leads to conflicting results concerning performances of these factors and threshold values for rupture status prediction. The aim of the study was to evaluate how various definitions of morphologic parameters may influence the prediction of the risk for aneurysm rupture.
   METHODS: A total of 425 intracranial aneurysms were reviewed. Analyzed factors included demographic and clinical parameters, aneurysm maximal height (Hmax), dome length (Dlength), dome width (Dwidth), dome maximal diameter (Dmax) and dome minimal diameter (Dmin), neck length (Nlength), neck width (Nwidth), and neck maximal diameter (Nmax) and neck minimal diameter (Nmin). Alternative definitions of aspect ratio (AR), bottleneck factor (BNF), and height-to-width ratio (HW) were used. Univariate and multivariate analysis were performed to identify predictors for aneurysm rupture.
   RESULTS: Hmax, AR defined as Hmax/Nwidth and Hmax/Nmin, BNF definitions using Nwidth and Nmin, and selected definitions of HW (Hmax/Dlength and Hmax/Dmin) were indicated as potential predictors for rupture. Aneurysm location was found to be a confounding factor with statistical significance. AR defined as Hmax/Nwidth and Hmax/Nmin were the best performers (P < 0.001; area under the curve, 0.64). In multivariate analysis, AR defined as Hmax/Nwidth and aneurysm location with significantly higher risk for rupture of anterior communicating artery aneurysms were independent predictors for subarachnoid hemorrhage.
   CONCLUSIONS: Different definitions of aneurysm parameters affect various rupture risk determination. AR defined as Hmax/Nwidth and aneurysm location with significantly higher rupture risk of anterior communicating artery aneurysms are independent predictors for aneurysm rupture.
C1 [Kocur, Damian; Przybylko, Nikodem; Niedbala, Marcin; Rudnik, Adam] Med Univ Silesia, Sch Med Katowice, Dept Neurosurg, Katowice, Poland.
RP Kocur, D (reprint author), Med Univ Silesia, Sch Med Katowice, Dept Neurosurg, Katowice, Poland.
EM damkocur@gmail.com
CR Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770
   Beck J, 2003, ACTA NEUROCHIR, V145, P861, DOI 10.1007/s00701-003-0124-0
   Cai W, 2018, WORLD NEUROSURG, V109, P119, DOI 10.1016/j.wneu.2017.09.118
   Cai W, 2015, WORLD NEUROSURG, V84, P1278, DOI 10.1016/j.wneu.2015.05.060
   Cebral JR, 2005, AM J NEURORADIOL, V26, P2550
   Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81
   Forbes G, 1996, AM J NEURORADIOL, V17, P1407
   Grochowski C, 2018, J CLIN NEUROSCI, V48, P181, DOI 10.1016/j.jocn.2017.10.064
   Ho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094837
   Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF
   Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674
   Jiang H, 2016, ACTA NEUROCHIR, V158, P1367, DOI 10.1007/s00701-016-2826-0
   Joo SW, 2009, J KOREAN NEUROSURG S, V45, P85, DOI 10.3340/jkns.2009.45.2.85
   Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9
   Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635
   Lv N, 2016, WORLD NEUROSURG, V87, P311, DOI 10.1016/j.wneu.2015.12.055
   Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210
   Morita A, 2005, J NEUROSURG, V102, P601, DOI 10.3171/jns.2005.102.4.0601
   Nader-Sepahi A, 2004, NEUROSURGERY, V54, P1343, DOI 10.1227/01.NEU.0000124482.03676.8B
   Orz Y, 1997, BRIT J NEUROSURG, V11, P144
   Prestigiacomo CJ, 2009, J NEUROSURG, V110, P1, DOI 10.3171/2008.5.17558
   Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355
   Ryu CW, 2015, AM J NEURORADIOL, V36, P1682, DOI 10.3174/ajnr.A4365
   Shojima M, 2006, INTERV NEURORADIOL, V12, P49, DOI 10.1177/15910199060120S105
   Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
   Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007
   Wang GX, 2017, ASIAN PAC J TROP MED, V10, P1011, DOI 10.1016/j.apjtm.2017.09.015
   Wang GX, 2016, YONSEI MED J, V57, P1178, DOI 10.3349/ymj.2016.57.5.1178
   Weir B, 2003, J NEUROSURG, V99, P447, DOI 10.3171/jns.2003.99.3.0447
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
   Yasuda R, 2011, NEUROSURGERY, V68, P310, DOI 10.1227/NEU.0b013e3182010ed0
   Yonekura M, 2004, NEUROL MED-CHIR, V44, P213, DOI 10.2176/nmc.44.213
   Yu J, 2010, J INT MED RES, V38, P1785, DOI 10.1177/147323001003800525
   Zeng ZJ, 2011, J BIOMECH, V44, P2809, DOI 10.1016/j.jbiomech.2011.08.002
NR 36
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E157
EP E164
DI 10.1016/j.wneu.2019.01.283
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400021
PM 30794982
DA 2020-05-12
ER

PT J
AU Koenig, JL
   Shi, SY
   Sborov, K
   Gensheimer, MF
   Le, G
   Nagpal, S
   Chang, SD
   Gibbs, IC
   Soltys, SG
   Pollom, EL
AF Koenig, Julie L.
   Shi, Siyu
   Sborov, Katherine
   Gensheimer, Michael F.
   Le, Gordon
   Nagpal, Seema
   Chang, Steven D.
   Gibbs, Iris C.
   Soltys, Scott G.
   Pollom, Erqi L.
TI Adverse Radiation Effect and Disease Control in Patients Undergoing
   Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for
   Brain Metastases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adverse radiation effect; Anticytotoxic T-lymphocyte-associated protein
   4; Anti-programmed cell death receptor/ligand 1; Brain metastases;
   Immune checkpoint inhibitors; Radiation therapy; Stereotactic
   radiosurgery
ID CELL LUNG-CANCER; OPEN-LABEL; MELANOMA; IPILIMUMAB; RADIOTHERAPY;
   EFFICACY; SAFETY; PEMBROLIZUMAB; N107C/CEC.3; SRS
AB BACKGROUND: Immune checkpoint inhibitors (ICIs) and stereotactic radiosurgery (SRS) are increasingly used together to manage brain metastases (BMs). We assessed adverse radiation effect, disease control, and overall survival in patients with BMs who received SRS with anti-cytotoxic T-lymphocyteeassociated protein 4 and/or anti-programmed cell death protein receptor/ligand therapies.
   METHODS: We retrospectively reviewed the records of patients with intact or resected BMs treated with SRS and ICIs within 5 months of SRS between 2010 and 2018. Patients were defined as receiving concurrent SRS and ICI if a dose of ICI was given within 4 weeks of SRS. Local failure, distant intracranial failure, extracranial failure, and adverse radiation effect were assessed using cumulative incidence rates and competing risk regressions with death as a competing risk. Overall survival was assessed using the Kaplan-Meier method and Cox proportional hazards models.
   RESULTS: A total of 97 patients with 580 BMs were included in our analysis. Competing risk analyses showed that concurrent SRS-ICI therapy is associated with higher rates of adverse radiation effect (6.4% vs. 2.0% at 1 year; multivariable hazard ratio [HR], 4.47; 95% confidence interval [CI], 1.57-12.73; P = 0.005), lower rates of extracranial failure (69.7% vs. 80.8% at 1 year; multivariable HR, 0.60; 95% CI, 0.42-0.87; P = 0.007), and better overall survival (48.6% vs. 25.4% at 1 year; multivariable HR, 0.57; 95% CI, 0.33-0.99; P = 0.044) compared with nonconcurrent therapy. SRS-ICI timing was not associated with local failure or distant intracranial failure.
   CONCLUSIONS: Concurrent SRS-ICI therapy has a tolerable adverse event profile and may improve extracranial disease control and overall survival, supporting concurrent use in the management of BMs.
C1 [Koenig, Julie L.; Shi, Siyu; Sborov, Katherine; Gensheimer, Michael F.; Gibbs, Iris C.; Soltys, Scott G.; Pollom, Erqi L.] Stanford Canc Inst, Dept Radiat Oncol, Stanford, CA 94305 USA.
   [Le, Gordon; Chang, Steven D.] Stanford Canc Inst, Dept Neurosurg, Stanford, CA USA.
   [Nagpal, Seema] Stanford Canc Inst, Dept Neurol & Neurol Sci, Stanford, CA USA.
   [Koenig, Julie L.; Shi, Siyu] Stanford Univ, Stanford Sch Med, Stanford, CA 94305 USA.
RP Pollom, EL (reprint author), Stanford Canc Inst, Dept Radiat Oncol, Stanford, CA 94305 USA.
EM erqiliu@stanford.edu
RI Nagpal, Seema/Z-6009-2019
OI Nagpal, Seema/0000-0002-0289-2319; Shi, Siyu/0000-0001-9010-7431
CR An Y, 2017, RADIOTHER ONCOL, V125, P80, DOI 10.1016/j.radonc.2017.08.009
   Anderson ES, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0282-x
   Badiyan SN, 2016, J ONCOL PRACT, V12, P702, DOI 10.1200/JOP.2016.012922
   BIDOLI P, 2016, ANN ONCOL, V27, P1228, DOI DOI 10.1093/ANNONC/MDW383.28
   Brown PD, 2016, INT J RADIAT ONCOL, V96, P937, DOI 10.1016/j.ijrobp.2016.09.045
   Brown PD, 2017, LANCET ONCOL, V18, P1049, DOI 10.1016/S1470-2045(17)30441-2
   Brown PD, 2016, JAMA-J AM MED ASSOC, V316, P401, DOI 10.1001/jama.2016.9839
   Chen LD, 2018, INT J RADIAT ONCOL, V100, P916, DOI 10.1016/j.ijrobp.2017.11.041
   Choi CYH, 2012, INT J RADIAT ONCOL, V84, P336, DOI 10.1016/j.ijrobp.2011.12.009
   Cohen JV, 2016, CANCER IMMUNOL RES, V4, P179, DOI 10.1158/2326-6066.CIR-15-0160
   Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265
   Goldberg SB, 2016, LANCET ONCOL, V17, P976, DOI 10.1016/S1470-2045(16)30053-5
   Kang J, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0156-7
   Kiess AP, 2015, INT J RADIAT ONCOL, V92, P368, DOI 10.1016/j.ijrobp.2015.01.004
   Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210
   Kim JM, 2017, J NEURO-ONCOL, V133, P357, DOI 10.1007/s11060-017-2442-8
   Knisely JPS, 2012, J NEUROSURG, V117, P227, DOI 10.3171/2012.5.JNS111929
   Lehrer EJ, 2019, RADIOTHER ONCOL, V130, P104, DOI 10.1016/j.radonc.2018.08.025
   Lin NU, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0276-z
   Long GV, 2017, P AN M AM SOC CLIN, V35, P9508, DOI DOI 10.1200/JC0.2017.35.15_
   Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6
   Martin AM, 2018, JAMA ONCOL, V4, P1123, DOI 10.1001/jamaoncol.2017.3993
   Mathew M, 2013, MELANOMA RES, V23, P191, DOI 10.1097/CMR.0b013e32835f3d90
   Minniti G, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-48
   Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861
   Nayak L, 2012, CURR ONCOL REP, V14, P48, DOI 10.1007/s11912-011-0203-y
   Okada Hideho, 2015, Lancet Oncol, V16, pe534, DOI 10.1016/S1470-2045(15)00088-1
   Parakh S, 2017, BRIT J CANCER, V116, P1558, DOI 10.1038/bjc.2017.142
   Park HS, 2016, J NEUROSURG, V124, P1018, DOI 10.3171/2015.4.JNS1573
   Patel KR, 2017, AM J CLIN ONCOL-CANC, V40, P444, DOI 10.1097/COC.0000000000000199
   Prins RM, 2006, J IMMUNOL, V177, P8448, DOI 10.4049/jimmunol.177.12.8448
   Qian JM, 2016, CANCER-AM CANCER SOC, V122, P3051, DOI 10.1002/cncr.30138
   Queirolo P, 2014, J NEURO-ONCOL, V118, P109, DOI 10.1007/s11060-014-1400-y
   Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494
   Schapira E, 2018, INT J RADIAT ONCOL, V101, P624, DOI 10.1016/j.ijrobp.2018.02.175
   Schartz NEC, 2010, MELANOMA RES, V20, P247, DOI 10.1097/CMR.0b013e3283364a37
   Schoenfeld JD, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0095-8
   Sharabi AB, 2015, LANCET ONCOL, V16, pE498, DOI 10.1016/S1470-2045(15)00007-8
   Shultz DB, 2015, INT J RADIAT ONCOL, V92, P993, DOI 10.1016/j.ijrobp.2015.04.036
   Silk AW, 2013, CANCER MED-US, V2, P899, DOI 10.1002/cam4.140
   Tawbi HA, 2018, NEW ENGL J MED, V379, P722, DOI 10.1056/NEJMoa1805453
   TRNOVEC T, 1990, INT J RADIAT ONCOL, V19, P1581, DOI 10.1016/0360-3016(90)90376-U
   Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292
   Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052
   Weber JS, 2011, MELANOMA RES, V21, P530, DOI 10.1097/CMR.0b013e32834d3d88
   Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911
   Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0
   Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005
NR 48
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1399
EP E1411
DI 10.1016/j.wneu.2019.03.110
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400177
PM 30902777
DA 2020-05-12
ER

PT J
AU Komune, N
   Matsuo, S
   Nakagawa, T
AF Komune, Noritaka
   Matsuo, Satoshi
   Nakagawa, Takashi
TI The Fascial Layers Attached to the Skull Base: A Cadaveric Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cadaveric study; Fascia; Skull base; Surgical anatomy
ID RETROPHARYNGEAL SPACE; INFRATEMPORAL FOSSA; PTERYGOSPINOUS BAR; SURGICAL
   ANATOMY; FORAMEN OVALE; ALAR FASCIA; NECK; LIGAMENT
AB OBJECTIVE: A profound understanding of the relationship between the deep cervical fasciae and the skull base is essential for skull base surgery. To our knowledge, there has been little research on the relationship between the deep cervical fasciae and inferior surface of the skull base; thus, this study aims to examine the fascial network of the skull base.
   METHODS: Two cadaveric heads are dissected to reveal the fascial network of the skull base and 19 sides of cadaveric heads were used to reveal an anatomical variant of the pterygospinous and pterygoalar ligaments/muscles.
   RESULTS: The interpterygoid fascia is attached to the skull base along the sphenopetrosal fissure and tympanosquamous suture. The tensor vascular styloid fascia extends from the inferior border of the tensor veli palatini and covers the tympanic bone and styloid apparatus laterally. The pharyngobasilar fascia attaches to the pharyngeal tubercle on the inferior surface of the basilar part of the occipital bone and petro-occipital synchondrosis. In the middle of the clivus, we found thick fibrocartilaginous tissue and the prevertebral fascia fused to this area. Fascia of the longus capitis, the tensor-vascular styloid fascia, and stylopharyngeal fascia extend laterally and form the complex fascial network around the internal jugular vein and the internal carotid artery. The carotid sheath attaches anteriorly to the vaginal process and posteriorly to the fibrocartilaginous tissue around the jugular foramen and carotid canal.
   CONCLUSIONS: This study comprehensively exposes the fascial network of the skull base. Our cadaveric dissection findings support those from previous imaging-anatomical studies. Precise knowledge of these fascial layers is essential for accurate diagnosis and understanding the spread of disease, as well as helping skull base surgeons safely perform challenging procedures.
C1 [Komune, Noritaka; Nakagawa, Takashi] Natl Hosp Org, Kyushu Med Ctr, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka, Fukuoka, Japan.
   [Matsuo, Satoshi] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Neurosurg, Fukuoka, Fukuoka, Japan.
RP Komune, N (reprint author), Natl Hosp Org, Kyushu Med Ctr, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka, Fukuoka, Japan.
EM norikomu007@gmail.com
RI Matsuo, Satoshi/AAE-3849-2020
OI Matsuo, Satoshi/0000-0002-2052-0471
FU University of Florida FoundationUniversity of Florida; JSPS
   KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [JP 18K16895]
FX Part of this work was supported by the University of Florida Foundation
   and JSPS KAKENHI Grant Number JP 18K16895.
CR Antonopoulou M, 2008, J CRANIO MAXILL SURG, V36, P104, DOI 10.1016/j.jcms.2007.05.009
   Barker B C, 1972, Br J Oral Surg, V10, P43, DOI 10.1016/S0007-117X(72)80008-8
   Bejjani GK, 1998, NEUROSURGERY, V43, P842, DOI 10.1097/00006123-199810000-00072
   CARLSON GW, 1993, SURG CLIN N AM, V73, P837
   Chouke KS, 1947, AM J PHYS ANTHROP-NE, V5, P79, DOI 10.1002/ajpa.1330050108
   CROSS RR, 1989, RADIOL CLIN N AM, V27, P353
   Das S, 2007, BRATISL MED J, V108, P141
   DAVIS WL, 1990, RADIOLOGY, V174, P59, DOI 10.1148/radiology.174.1.2294573
   DAVIS WL, 1990, SEMIN ULTRASOUND CT, V11, P520
   Funaki T, 2013, NEUROSURGERY, V73, P155, DOI 10.1227/01.neu.0000431469.82215.93
   Garg A, 2001, Aust Endod J, V27, P22
   Gavid M, 2018, SURG RADIOL ANAT, V40, P917, DOI 10.1007/s00276-018-1977-5
   GERBER AM, 1994, J NEUROSURG, V80, P156, DOI 10.3171/jns.1994.80.1.0156
   GIANOLI GJ, 1991, OTOLARYNG HEAD NECK, V105, P92, DOI 10.1177/019459989110500113
   Grodinsky M, 1938, AM J ANAT, V63, P367, DOI 10.1002/aja.1000630303
   Grodinsky M, 1939, ANN SURG, V110, P177, DOI 10.1097/00000658-193908000-00003
   Kavitha C, 2014, J CLIN DIAGN RES, V8, pWC1, DOI 10.7860/JCDR/2014/9692.4752
   Komune N, 2015, J LARYNGOL OTOL, V129, pS12, DOI 10.1017/S0022215114002321
   Komune N, 2018, WORLD NEUROSURG, V112, pE172, DOI 10.1016/j.wneu.2018.01.003
   LEVITT GW, 1970, LARYNGOSCOPE, V80, P409
   McCoul ED, 2011, OPER TECH OTOLARYNGO, V22, P6
   Natsis K, 2014, J CRANIO MAXILL SURG, V42, pE266, DOI 10.1016/j.jcms.2013.10.003
   Nayak SR, 2007, SURG RADIOL ANAT, V29, P5, DOI 10.1007/s00276-006-0154-4
   Poland J, 1890, J Anat Physiol, V24, P567
   Scali F, 2015, ANN OTO RHINOL LARYN, V124, P814, DOI 10.1177/0003489415588129
   Seker A, 2010, WORLD NEUROSURG, V74, P583, DOI 10.1016/j.wneu.2010.06.033
   TEBO HG, 1968, ORAL SURG ORAL MED O, V26, P654, DOI 10.1016/0030-4220(68)90433-7
   Tubbs RS, 2007, SURG RADIOL ANAT, V29, P219, DOI 10.1007/s00276-007-0196-2
   Tubbs RS, 2009, NEUROSURGERY, V65, P60, DOI 10.1227/01.NEU.0000345952.64041.9C
   von Ludinghausen M, 2006, SURG RADIOL ANAT, V28, P284, DOI 10.1007/s00276-006-0078-z
   WEBER AL, 1992, ISRAEL J MED SCI, V28, P241
   Williams DW, 1997, SEMIN ULTRASOUND CT, V18, P157, DOI 10.1016/S0887-2171(97)90018-4
NR 32
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E500
EP E509
DI 10.1016/j.wneu.2019.02.078
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400060
PM 30825625
DA 2020-05-12
ER

PT J
AU Kong, GG
   Ji, W
   Lin, JY
   Liu, Q
   Huang, ZC
   Zhu, QG
AF Kong, Ganggang
   Ji, Wei
   Lin, Junyu
   Liu, Qi
   Huang, Zucheng
   Zhu, Qingan
TI The Anatomic Study of Intracranial Structures Related to Clival Screw
   Placement
SO WORLD NEUROSURGERY
LA English
DT Article
DE Basilar plexus; Brainstem; Clival screw fixation; Craniovertebral
   junction; Vertebrobasilar artery
ID EN-BLOC RESECTION; CRANIOVERTEBRAL JUNCTION; MORPHOMETRIC-ANALYSIS;
   CERVICAL CHORDOMA; FIXATION; OCCLUSION; PATIENT; ARTERY; C-2
AB BACKGROUND: A clival plate and screw fitted to the craniovertebral junction (CVJ) were developed in our previous studies. However, the anatomy of intracranial structures related to clival screw placement has not been studied.
   OBJECTIVE: To measure the intracranial anatomic parameters delineating the basilar plexus and vertebrobasilar artery (VBA) course and to determine the relationship between brainstem and clivus for safer screw placement.
   METHODS: Morphometric analysis of the VBA was conducted on 95 patients (48 men, 47 women) by CT angiography (CTA) and of the basilar plexus and brainstem on 80 patients (44 men, 36 women) by magnetic resonance imaging (MRI) The narrowest distance between the VBA and the intracranial clivus and the distance between the VBA and the median line of the skull were measured on the axial plane at different parts. The relative positions of point I (intersection of vertebral artery and basilar artery) and the pharyngeal tubercle were analyzed. The distance between the clivus and the brainstem was measured at different levels.
   RESULTS: As the VBA ascended the distances to the intracranial clivus and the midline decreased. In 83.3% cases, point I was above the pharyngeal tubercle, and in only 9.5% cases was it located on the vertical line drawn from pharyngeal tubercle. The smallest safe space between the intracranial clivus and the brainstem was 7.46 mm at the lower part.
   CONCLUSION: Appropriate screw size at the lower clivus and the pharyngeal tubercle may help avoiding inadvertent injury to the brainstem and the VBA. Preoperative CTA and MRI of the CVJ are suggested to guide the surgeon in this regard.
C1 [Kong, Ganggang; Ji, Wei; Lin, Junyu; Liu, Qi; Huang, Zucheng; Zhu, Qingan] Southern Med Univ, Nanfang Hosp, Dept Spinal Surg, Guangzhou, Guangdong, Peoples R China.
   [Kong, Ganggang] Sun Yat Sen Univ, Dept Orthopaed Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.
RP Ji, W (reprint author), Southern Med Univ, Nanfang Hosp, Dept Spinal Surg, Guangzhou, Guangdong, Peoples R China.
EM spineji@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81702192]; Outstanding Youths Development Scheme of
   Nanfang Hospital, Southern Medical University, China [2017J008];
   President Foundation of Nanfang Hospital, Southern Medical University,
   China [2016C021]
FX This study was sponsored by the National Natural Science Foundation of
   China (No. 81702192), the Outstanding Youths Development Scheme of
   Nanfang Hospital, Southern Medical University, China (No. 2017J008) and
   the President Foundation of Nanfang Hospital, Southern Medical
   University, China (No. 2016C021).
CR Chikkannaiah M, 2014, J CHILD NEUROL, V29, P633, DOI 10.1177/0883073813488826
   Demel SL, 2015, NEUROHOSPITALIST, V5, P142, DOI 10.1177/1941874415583847
   Guppy KH, 2013, J NEUROSURG-SPINE, V19, P232, DOI 10.3171/2013.5.SPINE121039
   Hofmann E, 2012, CLIN NEURORADIOL, V22, P123, DOI 10.1007/s00062-011-0083-4
   Ji W, 2016, WORLD NEUROSURG, V94, P42, DOI 10.1016/j.wneu.2016.06.104
   Ji W, 2016, SCI REP-UK, V6, DOI 10.1038/srep31648
   Ji W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001492
   Ji W, 2015, EUR SPINE J, V24, P1658, DOI 10.1007/s00586-015-4025-8
   Ji W, 2015, SPINE, V40, pE259, DOI 10.1097/BRS.0000000000000749
   Ji W, 2012, EUR SPINE J, V21, P1483, DOI 10.1007/s00586-012-2151-0
   Lee SC, 2004, BRIT J NEUROSURG, V18, P590, DOI 10.1080/02688690400022813
   Mamatha H, 2012, SINGAP MED J, V53, P760
   Mizutani K, 2017, WORLD NEUROSURG, V97, DOI 10.1016/j.wneu.2016.10.022
   Papantchev V, 2007, EUR J CARDIO-THORAC, V31, P982, DOI 10.1016/j.ejcts.2007.03.020
   Park Bum-Soo, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P137, DOI 10.7461/jcen.2013.15.3.137
   Rhines LD, 2005, J NEUROSURG-SPINE, V2, P199, DOI 10.3171/spi.2005.2.2.0199
   Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500
   Stulik J, 2005, Acta Chir Orthop Traumatol Cech, V72, P22
   Tomasino A, 2010, J NEUROSURG-SPINE, V13, P52, DOI 10.3171/2010.3.SPINE09231
   Tubbs RS, 2007, CLIN ANAT, V20, P755, DOI 10.1002/ca.20494
   Wang ZY, 2014, J NEUROL SURG PART B, V75, P133, DOI 10.1055/s-0033-1363170
   Zerbo S, 2018, LEGAL MED-TOKYO, V30, P42, DOI 10.1016/j.legalmed.2017.11.006
NR 22
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1005
EP E1011
DI 10.1016/j.wneu.2019.03.021
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400126
PM 30877008
DA 2020-05-12
ER

PT J
AU Krivoshapkin, AL
   Sergeev, GS
   Gaytan, AS
   Kalneus, LE
   Kurbatov, VP
   Abdullaev, OA
   Salim, N
   Bulanov, DV
   Simonovich, AE
AF Krivoshapkin, Alexey L.
   Sergeev, Gleb S.
   Gaytan, Alekey S.
   Kalneus, Leonid E.
   Kurbatov, Vladislav P.
   Abdullaev, Orkhan A.
   Salim, Nidal
   Bulanov, Dmitry, V
   Simonovich, Alexander E.
TI Automated Volumetric Analysis of Postoperative Magnetic Resonance
   Imaging Predicts Survival in Patients with Glioblastoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Glioblastoma management; Gross total resection; MRI evaluation; Software
   for MRI; Volumetric tumor estimation
ID CENTRAL-NERVOUS-SYSTEM; MALIGNANT GLIOMA; PROGNOSTIC-FACTORS; RESIDUAL
   TUMOR; RESECTION; EXTENT; MULTIFORME; SURGERY
AB BACKGROUND: Glioblastomas (GBMs) are primary brain tumors that are very difficult to treat. Magnetic resonance imaging (MRI) is the reference tool for diagnosis, postoperative control, and follow-up of GBM. The MRI tumor contrast enhancement part serves as a target for surgery. However, there are controversial data about the influence of pre- and postoperative tumor volumetric MRI parameters on overall survival (OS).
   METHODS: Data of 57 patients with GBM were analyzed retrospectively. All patients had maximum safe resection and standard adjuvant treatment. All patients underwent 1.5-T MRI with contrast in the first 24 hours postoperatively. The data of pre- and postoperative volumetric parameters were analyzed using the original software.
   RESULTS: Correlation analysis between the postoperative volume of the tumor contrast enhancement part and the patient's OS revealed a significant level (on the Chaddock scale) of inverse correlation. Residual tumor volume associated with OS of >6 months was determined as <2.5 cm(3). The mortality risk in the first 6 months after tumor resection is 3.4 times higher when the tumor remnant is >2.5 cm(3) (risk ratio, 3.4; P = 0.0002).
   CONCLUSIONS: The volume of MRI contrast-enhancing GBM remnants after surgery, automatically measured by the software, was a significant predictor for early postoperative progression and death.
C1 [Krivoshapkin, Alexey L.; Abdullaev, Orkhan A.; Simonovich, Alexander E.] Novosibirsk State Med Univ, Dept Neurosurg, Novosibirsk, Russia.
   [Sergeev, Gleb S.; Gaytan, Alekey S.] European Med Ctr, Neurosurg Dept, Moscow, Russia.
   [Salim, Nidal] European Med Ctr, Radiotherapy Ctr, Moscow, Russia.
   [Bulanov, Dmitry, V] European Med Ctr, Pathol Lab, Moscow, Russia.
   [Kalneus, Leonid E.] Novosibirsk State Univ, Phys Dept, Novosibirsk, Russia.
   [Kurbatov, Vladislav P.] Clin & Diagnost Ctr MEDSI Krasnaya Presnya, Moscow, Russia.
RP Krivoshapkin, AL (reprint author), Novosibirsk State Med Univ, Dept Neurosurg, Novosibirsk, Russia.
EM alkr01@yandex.ru
OI Simonovich, Alexandr/0000-0003-2822-3479
CR ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008
   Brown TJ, 2016, JAMA ONCOL, V2, P1460, DOI 10.1001/jamaoncol.2016.1373
   Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031
   Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137
   Chow KL, 2000, AM J NEURORADIOL, V21, P471
   Grabowski MM, 2014, J NEUROSURG, V121, P1115, DOI 10.3171/2014.7.JNS132449
   James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523
   Keles GE, 1999, SURG NEUROL, V52, P371, DOI 10.1016/S0090-3019(99)00103-2
   Krivoshapkin A L, 2014, Zh Vopr Neirokhir Im N N Burdenko, V78, P33
   Kubben PL, 2010, NEUROSURGERY, V67, P1329, DOI 10.1227/NEU.0b013e3181efbb08
   Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190
   Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277
   Meier R, 2017, J NEUROSURG, V127, P798, DOI 10.3171/2016.9.JNS16146
   Nabors LB, 2017, J NATL COMPR CANC NE, V15, P1331, DOI 10.6004/jnccn.2017.0166
   Naeini KM, 2013, NEURO-ONCOLOGY, V15, P626, DOI 10.1093/neuonc/not008
   Nestler U, 2015, ACTA NEUROCHIR, V157, P179, DOI 10.1007/s00701-014-2271-x
   Osher S., 2003, LEVEL SET METHODS DY
   Richard S., 2006, IMAGE ALIGNMENT STIT, V2, P1
   Schucht P, 2012, NEUROSURGERY, V71, P927, DOI 10.1227/NEU.0b013e31826d1e6b
   Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6
   Sinclair AG, 2010, RADIOGRAPHICS, V30, P461, DOI 10.1148/rg.302095115
   Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.neu.0000317304.31579.17, 10.1227/01.NEU.0000346230.80425.3A]
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   Vuorinen V, 2003, ACTA NEUROCHIR, V145, P5, DOI 10.1007/s00701-002-1030-6
   Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1510
EP E1517
DI 10.1016/j.wneu.2019.03.142
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400190
PM 30910753
DA 2020-05-12
ER

PT J
AU Kwinta, BM
   Klis, KM
   Krzyzewski, RM
   Wilk, A
   Dragan, M
   Grzywna, E
   Popiela, T
AF Kwinta, Borys M.
   Klis, Kornelia M.
   Krzyzewski, Roger M.
   Wilk, Aleksander
   Dragan, Marcin
   Grzywna, Ewelina
   Popiela, Tadeusz
TI Elective Management of Unruptured Intracranial Aneurysms in Elderly
   Patients in a High-Volume Center
SO WORLD NEUROSURGERY
LA English
DT Article
DE Elderly patients; Endovascular treatment; Microsurgical clipping;
   Unruptured intracranial aneurysm
ID ENDOVASCULAR TREATMENT; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSMS;
   NEUROLOGICAL COMPLICATIONS; SURGICAL-TREATMENT; NATURAL-HISTORY; PHASES
   SCORE; RISK; RUPTURE; AGE
AB BACKGROUND: The number of elderly patients with unruptured intracranial aneurysms is increasing with time in aging populations; however, the choice of the proper treatment method remains inconclusive. The goal of the study is to evaluate the possible complications and treatment outcome among elderly patients with unruptured intracranial aneurysm.
   METHODS: We analyzed 139 patients >65 years old, hospitalized between 2007 and 2017 in the high-volume neurosurgical center and diagnosed with unruptured intracranial aneurysm. From their medical records, we obtained medical history and aneurysm characteristics. Patients functional status was measured by modified Rankin Scale score on admission and at discharge.
   RESULTS: Seventy-two patients (55.97%) underwent aneurysm clipping and 39 (27.04%) coiling. Eighteen patients (11.90%) required stent assisted coiling and 4 (5.00%) had a single stent placement. A total of 133 patients (95.71%) had good treatment outcomes (modified Rankin Scale score 0-3, surgical 0.32 +/- 1.03 vs. endovascular group 0.40 +/- 1.12, P = 0.65). Complete or near-complete occlusion in the endovascular group was achieved in 83% directly after treatment and in 89% at 6-12 months after procedure. The microsurgical group presented 100% occlusion at follow-up.
   CONCLUSIONS: Despite the high prevalence of comorbidities in the age group >65 years old, the vast majority of patients in our series treated invasively for unruptured intracranial aneurysms presented with good treatment outcomes. Based on our results, among elderly patients, modern microsurgical as well as endovascular management of brain aneurysms in a high-volume center seems to be a safe and effective method of treatment.
C1 [Kwinta, Borys M.; Klis, Kornelia M.; Krzyzewski, Roger M.; Wilk, Aleksander; Dragan, Marcin; Grzywna, Ewelina] Jagiellonian Univ, Med Coll, Dept Neurosurg & Neurotraumatol, Krakow, Poland.
   [Popiela, Tadeusz] Jagiellonian Univ, Med Coll, Dept Radiol, Krakow, Poland.
RP Kwinta, BM (reprint author), Jagiellonian Univ, Med Coll, Dept Neurosurg & Neurotraumatol, Krakow, Poland.
EM borys.kwinta@uj.edu.pl
RI Krzyzewski, Roger M./AAD-3383-2019; K, Kornelia/AAJ-9526-2020
CR Ajiboye N, 2015, SCI WORLD J, V2015
   Backes D, 2015, STROKE, V46, P1221, DOI 10.1161/STROKEAHA.114.008198
   Barker FG, 2004, NEUROSURGERY, V54, P18, DOI 10.1227/01.NEU.0000097195.48840.C4
   Bijlenga P, 2013, STROKE, V44, P3018, DOI 10.1161/STROKEAHA.113.001667
   BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497
   Brinjikji W, 2011, STROKE, V42, P1320, DOI 10.1161/STROKEAHA.110.607986
   Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x
   Chernyshev OY, 2017, J CLIN NEUROSCI, V43, P94, DOI 10.1016/j.jocn.2017.05.015
   Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839
   de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655
   Dickey P, 1994, Conn Med, V58, P583
   Gizewski ER, 2008, AM J NEURORADIOL, V29, P1575, DOI 10.3174/ajnr.A1165
   Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1
   Higashida RT, 2007, AM J NEURORADIOL, V28, P146
   HisHikawa T, 2017, NEUROL MED-CHIR, V57, P247, DOI 10.2176/nmc.ra.2016-0286
   Horiuchi T, 2005, NEUROSURGERY, V56, P469, DOI 10.1227/01.NEU.0000153926.67713.B8
   Im SH, 2009, AM J NEURORADIOL, V30, P79, DOI 10.3174/ajnr.A1290
   Jampathong N, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1032-5
   Jang EW, 2015, YONSEI MED J, V56, P987, DOI 10.3349/ymj.2015.56.4.987
   Ji WJ, 2016, STROKE, V47, P971, DOI 10.1161/STROKEAHA.115.012097
   Khosla A, 2012, AM J NEURORADIOL, V33, P953, DOI 10.3174/ajnr.A2881
   Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E
   Lawson MF, 2013, WORLD NEUROSURG, V79, P472, DOI 10.1016/j.wneu.2012.01.038
   Li MH, 2013, ANN INTERN MED, V159, P514, DOI 10.7326/0003-4819-159-8-201310150-00004
   Murayama Y, 2016, STROKE, V47, P365, DOI 10.1161/STROKEAHA.115.010698
   Nasr DM, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0763-4
   Nishido H, 2014, AM J NEURORADIOL, V35, P339, DOI 10.3174/ajnr.A3658
   Park Jun Hee, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P193, DOI 10.7461/jcen.2014.16.3.193
   Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114
   Raftopoulos C, 2003, NEUROSURGERY, V52, P1280, DOI 10.1227/01.NEU.0000064568.71648.EC
   Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251
   Ryttlefors M, 2008, STROKE, V39, P2720, DOI 10.1161/STROKEAHA.107.506030
   Sturiale CL, 2013, STROKE, V44, P1897, DOI 10.1161/STROKEAHA.113.001524
   TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812
   Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070
   van Rooij WJ, 2010, STROKE, V41, pE191, DOI 10.1161/STROKEAHA.109.575928
   Vlak MHM, 2013, STROKE, V44, P1256, DOI 10.1161/STROKEAHA.111.000679
   Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
   Weir B, 2002, J NEUROSURG, V96, P3, DOI 10.3171/jns.2002.96.1.0003
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
   Yasui N, 1996, NEUROSURGERY, V39, P1096, DOI 10.1097/00006123-199612000-00004
   Zacharia BE, 2011, STROKE, V42, P2844, DOI 10.1161/STROKEAHA.111.619767
NR 42
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1343
EP E1351
DI 10.1016/j.wneu.2019.03.094
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400170
PM 30898743
DA 2020-05-12
ER

PT J
AU Labak, CM
   Holdhoff, M
   Bettegowda, C
   Gallia, GL
   Lim, M
   Weingart, JD
   Mukherjee, D
AF Labak, Collin M.
   Holdhoff, Matthias
   Bettegowda, Chetan
   Gallia, Gary L.
   Lim, Michael
   Weingart, Jon D.
   Mukherjee, Debraj
TI Surgical Resection for Primary Central Nervous System Lymphoma: A
   Systematic Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Biopsy; Cytoreductive surgery; PCNSL; Primary central nervous system
   lymphoma; Resection
ID PRIMARY CNS LYMPHOMA; INTRACEREBRAL MALIGNANT-LYMPHOMA;
   NON-HODGKINS-LYMPHOMA; RADIATION-THERAPY; SURVIVAL; BRAIN; MANAGEMENT;
   DIAGNOSIS; SURGERY; PCNSL
AB BACKGROUND: Primary central nervous system lymphomas (PCNSLs) account for 1%-2% of primary central nervous system tumors. Until recently, treatment has centered on biopsy, radiotherapy, and high-dose methotrexate, without a clear role for cytoreductive surgery. The objective of this article is to compare the impact of biopsy versus cytoreductive surgery in outcomes of patients with PCNSL, including postoperative complications and survival.
   METHODS: We performed a systematic review of literature published from January 1, 1968 to May 2, 2018 related to PCNSL treatment in patients undergoing biopsy or resection. Data on morbidity, progression-free survival, and overall survival were extracted and analyzed.
   RESULTS: A total of 1291 nonduplicate citations were identified, with 244 articles selected for full-text review. Twenty-four articles were included for data abstraction including 2 level IIb studies, 4 level IIIb studies, and the remaining 18 articles representing level IVb studies. Of these articles, 15 failed to show benefit with cytoreductive surgery; most of these articles included relatively small sample sizes and predated standardization of high-dose systemic methotrexate treatment. Larger, more recent series included 9 articles providing evidence in support of cytoreductive surgery. Patient age, functional status, and treatment with chemotherapy and/or radiation were associated with improved survival across studies.
   CONCLUSIONS: The treatment of PCNSL is challenging and ever-evolving. Earlier, smaller studies failed to show the benefit of cytoreductive surgery over biopsy in patients with PCNSL. Larger, more recent series seem to show the possible benefit of cytoreductive surgery in PCNSL. Future well-designed prospective studies may help further elucidate the role of resection in the modern treatment of PCNSL.
C1 [Labak, Collin M.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA.
   [Holdhoff, Matthias] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.
   [Bettegowda, Chetan; Gallia, Gary L.; Lim, Michael; Weingart, Jon D.; Mukherjee, Debraj] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
RP Mukherjee, D (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
EM dmukher1@jhmi.edu
CR ABELSON HT, 1981, CANCER TREAT REP, V65, P137
   Bataille B, 2000, J NEUROSURG, V92, P261, DOI 10.3171/jns.2000.92.2.0261
   Bellinzona M, 2005, EJSO, V31, P100, DOI 10.1016/j.ejso.2004.10.002
   BERRY MP, 1981, INT J RADIAT ONCOL, V7, P55, DOI 10.1016/0360-3016(81)90060-2
   Caroli E, 2004, TUMORI J, V90, P294
   Cloney MB, 2017, J NEURO-ONCOL, V132, P189, DOI 10.1007/s11060-016-2358-8
   DAVIES KG, 1994, BRIT J NEUROSURG, V8, P487, DOI 10.3109/02688699408995120
   DEANGELIS LM, 1990, NEUROLOGY, V40, P80, DOI 10.1212/WNL.40.1.80
   DeAngelis LM, 2004, SEMIN ONCOL, V31, P684, DOI 10.1053/j.seminoncol.2004.07.011
   Dubuisson A, 2004, CLIN NEUROL NEUROSUR, V107, P55, DOI 10.1016/j.clineuro.2004.03.005
   Ferreri AJM, 2000, ANN ONCOL, V11, P927, DOI 10.1023/A:1008376412784
   Ghogawala Z, 2016, ANN SURG, V264, P81, DOI 10.1097/SLA.0000000000001483
   HAYAKAWA T, 1994, J NEURO-ONCOL, V19, P197, DOI 10.1007/BF01053274
   HELLE TL, 1984, J NEUROSURG, V60, P94, DOI 10.3171/jns.1984.60.1.0094
   HENRY JM, 1974, CANCER, V34, P1293, DOI 10.1002/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P
   Hoang-Xuan K, 2015, LANCET ONCOL, V16, pE322, DOI 10.1016/S1470-2045(15)00076-5
   Holdhoff M, 2014, ONCOLOGY-NY, V28, P641
   Jahr G, 2018, NEUROSURG REV, V41, P1037, DOI 10.1007/s10143-018-0946-0
   Jahr G, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.928
   Jelicic J, 2016, BRIT J NEUROSURG, V30, P80, DOI 10.3109/02688697.2015.1071328
   Jellinger K, 1975, Acta Neuropathol Suppl, VSuppl 6, P95
   Kellogg RG, 2014, ACTA NEUROCHIR, V156, P355, DOI 10.1007/s00701-013-1878-7
   Lai R, 2002, NEUROLOGY, V59, P1557, DOI 10.1212/01.WNL.0000034256.20173.EA
   MENDENHALL NP, 1983, CANCER-AM CANCER SOC, V52, P1993, DOI 10.1002/1097-0142(19831201)52:11<1993::AID-CNCR2820521104>3.0.CO;2-C
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   MURRAY K, 1986, J NEUROSURG, V65, P600, DOI 10.3171/jns.1986.65.5.0600
   Neira JA, 2017, J NEUROSURG, V127, P111, DOI 10.3171/2016.7.JNS16232
   O'Neill BP, 1999, INT J RADIAT ONCOL, V43, P559, DOI 10.1016/S0360-3016(98)00450-7
   Partovi S, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130684
   POLLACK IF, 1989, CANCER, V63, P939, DOI 10.1002/1097-0142(19890301)63:5<939::AID-CNCR2820630526>3.0.CO;2-V
   Rae AI, 2018, NEUROSURGERY, V43, P199
   Sampson JH, 2014, J NEUROSURG, V120, P791, DOI 10.3171/2013.10.JNS13724
   Schlegel Uwe, 2009, Ther Adv Neurol Disord, V2, P93, DOI 10.1177/1756285608101222
   Shibamoto Y, 2004, J CANCER RES CLIN, V130, P351, DOI 10.1007/s00432-004-0547-x
   Sonstein W, 1998, MED ONCOL, V15, P61, DOI 10.1007/BF02787347
   Su L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011072
   Thiel E, 2010, LANCET ONCOL, V11, P1036, DOI 10.1016/S1470-2045(10)70229-1
   TOMLINSON FH, 1995, J NEUROSURG, V82, P558, DOI 10.3171/jns.1995.82.4.0558
   Weller M, 2012, NEURO-ONCOLOGY, V14, P1481, DOI 10.1093/neuonc/nos159
   WOODMAN R, 1985, MEDICINE, V64, P425, DOI 10.1097/00005792-198511000-00006
   Yun J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00478
   Zebian Bassel, 2017, CNS Oncol, V6, P71, DOI 10.2217/cns-2016-0022
NR 42
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1436
EP E1448
DI 10.1016/j.wneu.2019.02.252
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400181
PM 30904794
DA 2020-05-12
ER

PT J
AU Lacy, M
   Parikh, S
   Costello, R
   Bolton, C
   Frim, DM
AF Lacy, Maureen
   Parikh, Shravan
   Costello, Rosalie
   Bolton, Corey
   Frim, David M.
TI Neurocognitive Functioning in Unoperated Adults with Chiari Malformation
   Type I
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebellar cognitive affective syndrome; Chiari; Cognition; Depression;
   Neuropsychology
AB OBJECTIVE: Adults with Chiari malformation type 1 (CM1) often report cognitive impairment. This cross-sectional study investigates the cognitive and emotional functioning of a sample of adults with CM1 who presented for neurosurgical evaluation prior to intervention.
   METHODS: A total of 36 participants (18 patients with CM1 and 18 healthy control subjects) completed a comprehensive neurocognitive battery of tests.
   RESULTS: Demographic variables (sex, age, handedness, and education) were not statistically significant between the groups. Measures of gross cognition (Mini-Mental State Examination and Repeatable Battery for the Assessment of Neuropsychological Status) were statistically significant between the groups. On a more focused assessment of neurocognitive abilities, the CM1 group performed significantly worse on measures of learning, memory, fluency, and figural copy. A high rate of clinical depression was seen in the CM1 group; however, this did not correlate with cognitive performance.
   CONCLUSIONS: The CM1 group displayed subtle learning, semantic fluency, and complex construction difficulties compared with healthy control subjects. Although not correlated with cognition, adults with CM1 are at high risk for clinical depression.
C1 [Lacy, Maureen; Parikh, Shravan; Costello, Rosalie; Bolton, Corey] Univ Chicago Med, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.
   [Frim, David M.] Univ Chicago Med, Sect Neurosurg, Chicago, IL USA.
RP Lacy, M (reprint author), Univ Chicago Med, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.
EM mlacy@yoda.bsd.uchicago.edu
CR Allen PA, 2018, PSYCHOL MED, V48, P1634, DOI 10.1017/S0033291717003117
   Allen PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094844
   Bakim B, 2013, INT J PSYCHIAT CLIN, V17, P259, DOI 10.3109/13651501.2013.778295
   Chiari H, 1891, DEUT MED WOCHENSCHR, V17, P1172, DOI 10.1055/s-0029-1206803
   Delis DC, 2001, DELIS KAPLAN EXECUTI
   Fischbein R, 2015, NEUROL SCI, V36, P1617, DOI 10.1007/s10072-015-2219-9
   Garcia M, 2018, CEREBELLUM, V17, P564, DOI 10.1007/s12311-018-0940-7
   Kumar M, 2011, WORLD NEUROSURG, V76, P189, DOI 10.1016/j.wneu.2011.02.022
   Lacy M, 2018, PEDIATR NEUROSURG, V53, P371, DOI 10.1159/000488460
   Lezak MD, 2004, NEUROPSYCHOLOGICAL A
   Mueller D, 2015, NEUROSURG FOCUS, V18, P1
   Noroozian M, 2014, NEUROL CLIN, V32, P1081, DOI 10.1016/j.ncl.2014.07.005
   Oktem H., 2016, ANATOMY, V10, P40
   Pindrik J, 2015, NEUROSURG CLIN N AM, V26, P509, DOI 10.1016/j.nec.2015.06.004
   Randolph C, 1998, RBANS MANUAL REPEATA
   Rogers JM, 2018, NEUROPSYCHOL REV, V28, P176, DOI 10.1007/s11065-018-9368-6
   Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561
   Schmahmann JD, 2019, NEUROSCI LETT, V688, P62, DOI 10.1016/j.neulet.2018.07.005
   Strauss E, 2006, COMPENDIUM NEUROPSYC
NR 19
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E641
EP E645
DI 10.1016/j.wneu.2019.02.105
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400078
PM 30831298
DA 2020-05-12
ER

PT J
AU Lai, HY
   Chen, MM
   Chen, CT
   Chang, TW
   Lee, ST
   Lee, CY
AF Lai, Hung-Yi
   Chen, Mi-Mi
   Chen, Chun-Ting
   Chang, Ting-Wei
   Lee, Shih-Tseng
   Lee, Ching-Yi
TI A Scoping Review of Medical Education Research in Neurosurgery
SO WORLD NEUROSURGERY
LA English
DT Review
DE Medical education research; Neurosurgery; Scoping review
ID TECHNOLOGY-ENHANCED SIMULATION; TRAINING MODELS; CARE
AB BACKGROUND: Little is known about the state of medical education (ME) research in neurosurgery. As ME started to develop in neurosurgery in recent years, it is important to understand the current status and develop the theory for advancement in neurosurgery. The aim of this study was to undertake a scoping review of neurosurgery literature on ME research.
   METHODS: MEDLINE, SCOPUS, and PubMed databases were searched. Inclusion criteria were full-text articles in English published from January 2006 to December 2017. Research aspects included country of publication, annual number of publications, journal types, type of participants, frequently researched topics, and research design. Search terms included neurosurgery, medical education, teaching, training, learning, and curriculum.
   RESULTS: A total of 9863 references were found across 3 databases. After duplicate removal and further screening, 533 references remained for coding analysis. ME research activity in neurosurgery is increasing and commonly observed in Western countries. Identified articles were mostly quantitative, with curriculum, assessment (especially simulation), and teaching and learning being the most dominant research themes.
   CONCLUSIONS: This study highlights the need for enhanced quantity and quality of ME research in neurosurgery. It identifies areas of highest priority and aspects to be improved and provides us with a rationale for future development in ME in neurosurgery. These findings reveal future education research direction and programmatic research areas, while also establishing a benchmark to assess changes in educational scholarship over time.
C1 [Lai, Hung-Yi; Chen, Chun-Ting; Chang, Ting-Wei; Lee, Shih-Tseng; Lee, Ching-Yi] Chang Gung Mem Hosp, Dept Neurosurg, Linkou Med Ctr, Taoyuan, Taiwan.
   [Lai, Hung-Yi; Chen, Chun-Ting; Chang, Ting-Wei; Lee, Shih-Tseng; Lee, Ching-Yi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan.
   [Lai, Hung-Yi; Chen, Mi-Mi; Lee, Ching-Yi] Chang Gung Med Educ Res Ctr, Taoyuan, Taiwan.
RP Lee, CY (reprint author), Chang Gung Mem Hosp, Dept Neurosurg, Linkou Med Ctr, Taoyuan, Taiwan.; Lee, CY (reprint author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Lee, CY (reprint author), Chang Gung Med Educ Res Ctr, Taoyuan, Taiwan.
EM 8702021@adm.cgmh.org.tw
FU Chang Gung Memorial Hospital in TaiwanChang Gung Memorial Hospital
   [CDRPG3E0111, CDRPG3F0041, CDRPG3E0101]
FX This work was supported by Chang Gung Memorial Hospital in Taiwan (grant
   numbers CDRPG3E0111, CDRPG3F0041 and CDRPG3E0101).
CR Abla AA, 2011, J NEUROSURG, V115, P1231, DOI 10.3171/2011.7.JNS102013
   Ackel-Eisnach K, 2015, GMS Z MED AUSBILD, V32
   Aoun SG, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2012.05.024
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Brandt B, 2014, J INTERPROF CARE, V28, P393, DOI 10.3109/13561820.2014.906391
   Breimer GE, 2017, OPER NEUROSURG, V13, P89, DOI 10.1227/NEU.0000000000001317
   Collins J, 2006, RADIOLOGY, V240, P639, DOI 10.1148/radiol.2403050542
   Cook DA, 2008, MED EDUC, V42, P128, DOI 10.1111/j.1365-2923.2007.02974.x
   Cook DA, 2013, ACAD MED, V88, P1178, DOI 10.1097/ACM.0b013e31829a365d
   Cook DA, 2011, JAMA-J AM MED ASSOC, V306, P978, DOI 10.1001/jama.2011.1234
   Cook DA, 2007, MED EDUC, V41, P737, DOI 10.1111/j.1365-2923.2007.02777.x
   Derossis AM, 2000, AM J SURG, V180, P58, DOI 10.1016/S0002-9610(00)00420-7
   Doja A, 2014, BMC MED EDUC, V14, DOI 10.1186/s12909-014-0243-8
   Ellaway RH, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0193-3
   Evaniew N, 2015, SCOLIOSIS SPINAL DIS, V10, DOI 10.1186/s13013-014-0026-3
   Faruquee CF, 2015, CAN PHARM J, V148, P325, DOI 10.1177/1715163515608399
   Faucett EA, 2018, JAMA OTOLARYNGOL, V144, P360, DOI 10.1001/jamaoto.2017.3163
   Gasco J, 2013, NEUROSURGERY, V73, P39, DOI 10.1227/NEU.0000000000000102
   Hodges BD, 2011, MED EDUC, V45, P95, DOI 10.1111/j.1365-2923.2010.03737.x
   Hwang G, 2010, J KOREAN NEUROSURG S, V47, P287, DOI 10.3340/jkns.2010.47.4.287
   Kshettry Varun R, 2014, World Neurosurg, V82, P554, DOI 10.1016/j.wneu.2014.05.028
   Lee K, 2013, MED TEACH, V35, P591, DOI 10.3109/0142159X.2013.786168
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   McColl MA, 2012, CAN FAM PHYSICIAN, V58, pe1626
   McColl MA, 2012, CAN FAM PHYSICIAN, V58, P1207
   Nicholls SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133639
   Niven DJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008244
   Norman G, 2002, BRIT MED J, V324, P1560, DOI 10.1136/bmj.324.7353.1560
   Ojha R, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00106
   Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123
   Regehr G, 2004, ACAD MED, V79, P939, DOI 10.1097/00001888-200410000-00008
   Ringsted C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004667
   Rotgans JI, 2012, ADV HEALTH SCI EDUC, V17, P515, DOI 10.1007/s10459-011-9328-x
   Ryu WHA, 2017, WORLD NEUROSURG, V106, P870, DOI 10.1016/j.wneu.2017.07.021
   Spetzger U, 2011, ACTA NEUROCHIR SUPPL, V112, P115, DOI 10.1007/978-3-7091-0661-7_21
   Stefanidis D, 2015, ANN SURG, V261, P846, DOI 10.1097/SLA.0000000000000826
   Thomsen ASS, 2015, OPHTHALMOLOGY, V122, P1111, DOI 10.1016/j.ophtha.2015.02.028
   Todres M, 2007, BRIT MED J, V335, P333, DOI 10.1136/bmj.39253.544688.94
   Webster F, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0350-1
   Williams CK, 2013, MED TEACH, V35, P444, DOI 10.3109/0142159X.2012.737968
   Wohlauer Max V, 2013, J Grad Med Educ, V5, P219, DOI 10.4300/JGME-05-02-39
NR 41
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1293
EP E1301
DI 10.1016/j.wneu.2019.03.080
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400163
PM 30898758
DA 2020-05-12
ER

PT J
AU Lai, PMR
   Du, R
AF Lai, Pui Man Rosalind
   Du, Rose
TI Differentially Expressed Genes Associated with the Estrogen Receptor
   Pathway in Cerebral Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral aneurysms; Estrogen receptor pathway; Gene expression
ID UNRUPTURED INTRACRANIAL ANEURYSMS; GENOME-WIDE ASSOCIATION; HORMONE
   REPLACEMENT THERAPY; SEX-DIFFERENCES; IDENTIFIES 3; HB-EGF; C-JUN;
   RUPTURE; RISK; PROFILES
AB BACKGROUND: The pathophysiology of cerebral aneurysm formation remains to be elucidated. Estrogen is thought to be protective against the development of aneurysms. The aim of this study is to identify differentially expressed genes in the estrogen receptor pathway that may be linked to the development of cerebral aneurysms.
   METHODS: Data from 6 Gene Expression Omnibus (GEO) databases with gene expression profiles of cerebral aneurysm tissue were analyzed (GSE6551, GSE15629, GSE26969, GSE46337, GSE54083, and GSE75436). Ninety-four genes associated with the estrogen receptor pathway were identified from the Kyoto Encyclopedia of Genes and Genomes pathway database. A meta-analysis using a random-effects model was used to evaluate the association of the estrogen receptor pathway genes with aneurysm formation.
   RESULTS: Four genes related to the estrogen receptor pathway were significantly associated with intracranial aneurysms, 2 of which were downregulated (PIK3R1: fold change [FC] = 0.41, false discovery rate [FDR] = 6.1 x 10(-) 5, ADCY9: FC = 0.55, FDR = 2.3 x 10(-4)) and 2 of which were upregulated (HBEGF: FC = 1.46, FDR = 4.9 x 10(-4); ADCY7: FC = 2.11, FDR = 6.0 x 10(-3)). Furthermore, subgroup analysis of 2 GEO databases with information provided about sex demonstrated PIK3R1 to be significant independently in both men (FC = 0.46, FDR = 6.3 x 10(-5)) and women (FC = 0.46, FDR = 2.3 x 10(-4)), whereas JUN, ADCY5, and MMP9 were significant in women only.
   CONCLUSIONS: The analysis of 6 GEO databases revealed 4 differentially expressed genes (PIK3R1, HBEGF, ADCY7, and ADCY9) in cerebral aneurysm tissue that are associated with the estrogen receptor pathway. Further analysis of estrogen-associated differentially expressed genes may provide information about the protective effects of estrogen on cerebral aneurysm development.
C1 [Lai, Pui Man Rosalind; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.
   [Lai, Pui Man Rosalind; Du, Rose] Harvard Med Sch, Boston, MA 02115 USA.
RP Du, R (reprint author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.; Du, R (reprint author), Harvard Med Sch, Boston, MA 02115 USA.
EM rdu@bwh.harvard.edu
RI Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012
OI Du, Rose/0000-0003-2641-6496
CR Amenta PS, 2016, HYPERTENSION, V68, P312, DOI 10.1161/HYPERTENSIONAHA.116.07606
   Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619
   Beeler JA, 2004, BIOCHEMISTRY-US, V43, P15463, DOI 10.1021/bi049088+
   Can A, 2018, NEUROLOGY, V91, pE1175, DOI 10.1212/WNL.0000000000006200
   Can A, 2018, TRANSL STROKE RES, V9, P340, DOI 10.1007/s12975-017-0582-y
   Can A, 2018, STROKE, V49, P1747, DOI 10.1161/STROKEAHA.118.020963
   Can A, 2018, STROKE, V49, P1148, DOI 10.1161/STROKEAHA.117.019972
   Can A, 2018, STROKE, V49, P34, DOI 10.1161/STROKEAHA.117.019249
   Can A, 2018, TRANSL STROKE RES, V9, P13, DOI 10.1007/s12975-017-0557-z
   Can A, 2017, NEUROLOGY, V89, P1408, DOI 10.1212/WNL.0000000000004419
   Caranci F, 2013, EUR J RADIOL, V82, P1598, DOI 10.1016/j.ejrad.2012.12.026
   Chen M, 2011, J NEUROINTERV SURG, V3, P163, DOI 10.1136/jnis.2010.003855
   De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007
   Deer RR, 2016, AM J PHYSIOL-HEART C, V310, pH1285, DOI 10.1152/ajpheart.00645.2015
   DELAMONTE SM, 1985, AM J MED, V78, P957, DOI 10.1016/0002-9343(85)90218-9
   Ding C, 2013, J NEUROINTERV SURG, V5, P327, DOI 10.1136/neurintsurg-2012-010364
   Duckles SP, 2007, CLIN EXP PHARMACOL P, V34, P801, DOI 10.1111/j.1440-1681.2007.04683.x
   Farooq A, 2015, CURR TOP MED CHEM, V15, P1372, DOI 10.2174/1568026615666150413154841
   Foroud T, 2014, STROKE, V45, P3194, DOI 10.1161/STROKEAHA.114.006096
   Friedrich V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080101
   Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051
   Hinterseher I, 2013, PATHOBIOLOGY, V80, P1, DOI 10.1159/000339303
   HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710
   Jamous MA, 2005, J NEUROSURG, V103, P1052, DOI 10.3171/jns.2005.103.6.1052
   Jiang YG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-36
   JIN D, 2007, [No title captured], V68, pS16
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kim SC, 1997, NEUROSURGERY, V41, P642, DOI 10.1097/00006123-199709000-00027
   Kitamura N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005159
   Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005
   Li HW, 2015, J MOL CELL CARDIOL, V87, P92, DOI 10.1016/j.yjmcc.2015.08.008
   Li L, 2009, EUR NEUROL, V62, P330, DOI 10.1159/000236911
   Lin BL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009920
   Lin YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08997
   Liu YF, 2014, CAN J NEUROL SCI, V41, P200, DOI 10.1017/S0317167100016589
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020
   Marchese E, 2010, J BIOL REG HOMEOS AG, V24, P185
   McColgan P, 2010, J NEUROSURG, V112, P714, DOI 10.3171/2009.8.JNS092
   Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070
   Nakaoka H, 2014, STROKE, V45, P2239, DOI 10.1161/STROKEAHA.114.005851
   Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x
   NORRGARD O, 1987, NEUROSURGERY, V20, P236, DOI 10.1227/00006123-198702000-00006
   Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925
   Pera J, 2010, STROKE, V41, P224, DOI 10.1161/STROKEAHA.109.562009
   Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251
   Stehbens WE, 1996, STROKE, V27, P2338
   Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001
   Synowiec E, 2016, CELL MOL BIOL, V62, P73, DOI 10.14715/cmb/2016.62.4.14
   Tada Y, 2014, HYPERTENSION, V63, P1339, DOI 10.1161/HYPERTENSIONAHA.114.03300
   Takagi Y, 2002, NEUROSURGERY, V51, P997, DOI 10.1097/00006123-200210000-00027
   Tu J, 2013, BIOMED RES INT, DOI 10.1155/2013/524324
   Turan N, 2016, TRANSL STROKE RES, V7, P12, DOI 10.1007/s12975-015-0434-6
   Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
   Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673
   Weinsheimer S, 2007, PHYSIOL GENOMICS, V32, P45, DOI 10.1152/physiolgenomics.00015.2007
   Yan LX, 2016, INT J ONCOL, V48, P471, DOI 10.3892/ijo.2015.3287
   Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563
   Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335
   Zhang MM, 2015, J NEUROPATH EXP NEUR, V74, P411, DOI 10.1097/NEN.0000000000000185
   Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085668
NR 61
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E557
EP E563
DI 10.1016/j.wneu.2019.02.094
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400067
PM 30831289
DA 2020-05-12
ER

PT J
AU Lee, CH
   Hong, JT
   Kang, DH
   Kim, KJ
   Kim, SW
   Kim, SW
   Kim, YJ
   Chung, CK
   Shin, JJ
   Oh, JK
   Yi, S
   Lee, JK
   Lee, JH
   Lee, HJ
   Chun, HJ
   Cho, DC
   Jin, YJ
   Choi, KC
   Han, IH
   Hyun, SJ
   Hur, JW
   Song, GS
AF Lee, Chang-Hyun
   Hong, Jae Taek
   Kang, Dong Ho
   Kim, Ki-Jeong
   Kim, Sang-Woo
   Kim, Seok Won
   Kim, Young Jin
   Chung, Chun Kee
   Shin, Jun Jae
   Oh, Jae Keun
   Yi, Seong
   Lee, Jung Kil
   Lee, Jun Ho
   Lee, Ho Jin
   Chun, Hyoung-Joon
   Cho, Dae-Chul
   Jin, Yong Jun
   Choi, Kyung-Chul
   Han, In Ho
   Hyun, Seung-Jae
   Hur, Jung-Woo
   Song, Geun Sung
TI Epidemiology of Iatrogenic Vertebral Artery Injury in Cervical Spine
   Surgery: 21 Multicenter Studies
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cervical spine; Complication; Epidemiology; Iatrogenic; Surgery;
   Vertebral artery injury
ID FIXATION; SCREW
AB BACKGROUND: The overall incidence of iatrogenic vertebral artery injury (IVAI) in cervical spine surgeries (CSSs) is reported to be 0.07%-1.4%. Although IVAI occurred during C1-2 fusion, there is no accurate information regarding the surgery-specific risk of IVAI. This study aimed to stratify incidence of IVAI by surgical method and evaluate the correlation between IVAI and its sequelae.
   METHODS: This retrospective, multicenter study involved clinical and radiologic evaluations for IVAI. All CSSs performed between 2012 and 2016 were included; neck mass excision and pain intervention were excluded. Patient characteristics, diagnosis, surgical technique, complications, and presence of IVAI were collected. In IVAI cases, technique details, characteristics, and sequelae were investigated.
   RESULTS: This study included 14,722 patients with 15,582 CSSs in 21 centers. IVAIs were identified in 13 (0.08%) patients. Surgery-specific incidence of IVAI was 1.35% in cases involving C1-2 posterior fixation and 0.20% in cases involving C3-6 posterior fixation. Common injury mechanisms were screw-in (31%) and high-speed drilling (23%). Screw-related IVAI occurred in 9 (69%) patients, and IVAI of the C1 lateral mass and C2 pedicle screws occurred in 4 and 3 patients, respectively. Of 13 cases of IVAI, 3 (23%) involved cerebellar or stem infarction; the infarction had no substantial correlation with injury grade or dominancy.
   CONCLUSIONS: Overall incidence of IVAI in CSSs was 0.08%. C1-2 posterior fixation had the highest incidence of IVAI (1.35%). Although clinical results of IVAI can be highly variable, controlling risk factors of IVAI is important.
C1 [Lee, Chang-Hyun; Chung, Chun Kee] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea.
   [Kang, Dong Ho] Gyeongsang Natl Univ, Dept Neurosurg, Sch Med, Jinju, South Korea.
   [Kim, Ki-Jeong; Hyun, Seung-Jae] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Spine Ctr,Coll Med, Seongnam, South Korea.
   [Kim, Sang-Woo] Yeungnam Univ, Dept Neurosurg, Med Ctr, Daegu, South Korea.
   [Kim, Seok Won] Chosun Univ Hosp, Dept Neurosurg, Gwangju, South Korea.
   [Kim, Young Jin] Dankook Univ Hosp, Dept Neurosurg, Cheonan, South Korea.
   [Chung, Chun Kee] Seoul Natl Univ, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea.
   [Chung, Chun Kee] Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea.
   [Chung, Chun Kee] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea.
   [Shin, Jun Jae] Inje Univ, Sanggye Paik Hosp, Dept Neurosurg, Seoul, South Korea.
   [Oh, Jae Keun] Hallym Univ, Dept Neurosurg, Sacred Heart Hosp, Anyang, South Korea.
   [Yi, Seong] Yonsei Univ, Severance Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea.
   [Lee, Jung Kil] Chonnam Natl Univ, Chonnam Univ Hosp, Dept Neurosurg, Coll Med, Gwangju, South Korea.
   [Lee, Jun Ho] Kyung Hee Univ, Med Ctr, Coll Med, Dept Neurosurg, Seoul, South Korea.
   [Lee, Ho Jin] Incheon St Maria Hosp, Dept Neurosurg, Incheon, South Korea.
   [Chun, Hyoung-Joon] Hanyang Univ, Dept Neurosurg, Seoul Hosp, Seoul, South Korea.
   [Cho, Dae-Chul] Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Kyungpook Natl Univ Hosp, Daegu, South Korea.
   [Jin, Yong Jun] Inje Univ, Dept Neurosurg, Seoul Paik Hosp, Seoul, South Korea.
   [Choi, Kyung-Chul] Leon Wiltse Mem Hosp, Dept Neurosurg, Anyang, South Korea.
   [Han, In Ho] Pusan Natl Univ Hosp, Dept Neurosurg, Pusan, South Korea.
   [Hong, Jae Taek; Hur, Jung-Woo] Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Neurosurg, Seoul, South Korea.
   [Song, Geun Sung] Pusan Natl Univ, Dept Neurosurg, Yangsan Hosp, Yangsan, South Korea.
   [Hong, Jae Taek] Catholic Univ Korea, St Vincents Hosp, Dept Neurosurg, Seoul, South Korea.
RP Song, GS (reprint author), Pusan Natl Univ, Dept Neurosurg, Yangsan Hosp, Yangsan, South Korea.
EM gnsong@pusan.ac.kr
RI Lee, Jun-Ho/Y-1578-2019; Chung, Chun Kee/J-5650-2012
OI Chung, Chun Kee/0000-0003-3485-2327; LEE, JUN HO/0000-0001-6246-8053;
   Lee, Chang-Hyun/0000-0003-0134-2101
CR Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004
   Burke James P, 2005, Spine J, V5, P508, DOI 10.1016/j.spinee.2004.11.015
   Cooney F Donald, 2003, Spine J, V3, P89, DOI 10.1016/S1529-9430(02)00575-2
   Devin Clinton J, 2009, Instr Course Lect, V58, P717
   Fink KR, 2011, EMERG RADIOL, V18, P545, DOI 10.1007/s10140-011-0981-4
   Guan Q, 2017, WORLD NEUROSURG, V106, P715, DOI 10.1016/j.wneu.2017.07.027
   Hsu WK, 2017, GLOB SPINE J, V7, P215, DOI 10.1177/2192568216686753
   Lee CH, 2018, NEUROSPINE, V15, P66, DOI 10.14245/ns.1836038.019
   Lee Jung Hwan, 2017, Korean J Spine, V14, P84, DOI 10.14245/kjs.2017.14.3.84
   Lee SH, 2018, NEUROSPINE, V15, P91, DOI 10.14245/ns.1834864.432
   Lunardini DJ, 2014, SPINE J, V14, P1520, DOI 10.1016/j.spinee.2013.09.016
   Malla HP, 2018, NEUROSPINE, V15, P163, DOI 10.14245/ns.1836004.022
   Maughan PH, 2013, NEUROSURGERY, V73, P271, DOI 10.1227/01.neu.0000431468.74591.5f
   Neo M, 2005, SPINE, V30, P2800, DOI 10.1097/01.brs.0000192297.07709.5d
   Nourbakhsh A, 2018, J CRANIOVERTEBRAL JU, V9, P44, DOI 10.4103/jcvjs.JCVJS_125_17
   Park HK, 2012, EUR SPINE J, V21, P2475, DOI 10.1007/s00586-012-2423-8
   Patkar SV, 2016, NEUROL RES, V38, P93, DOI 10.1080/01616412.2015.1105582
   Peng CW, 2009, SPINE J, V9, P70, DOI 10.1016/j.spinee.2008.03.006
   Stulik J, 2007, EUR SPINE J, V16, P479, DOI 10.1007/s00586-006-0241-6
   Wakao N, 2016, SPINE, V41, P293, DOI 10.1097/BRS.0000000000001241
   Wright NM, 1998, J NEUROSURG, V88, P634, DOI 10.3171/jns.1998.88.4.0634
NR 21
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1050
EP E1054
DI 10.1016/j.wneu.2019.03.042
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400132
PM 30878743
DA 2020-05-12
ER

PT J
AU Lee, JG
   Park, SH
   Park, KS
   Kang, DH
   Hwang, JH
   Hwang, SK
AF Lee, Jae-Gwang
   Park, Seong-Hyun
   Park, Ki-Su
   Kang, Dong-Hun
   Hwang, Jeong-Hyun
   Hwang, Sung-Kyoo
TI Do Serum Vascular Endothelial Growth Factor and Endostatin Reflect
   Radiological Radiation-Induced Changes After Stereotactic Radiosurgery
   for Cerebral Arteriovenous Malformations?
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Biomarker; Endostatin; Radiosurgery; VEGF
ID GRADING SCALE; PLASMA-LEVELS; MORPHOGENESIS; TISSUE; CELLS
AB OBJECTIVE: The aim of this study was to analyze serum levels of vascular endothelial growth factor (VEGF) and endostatin in patients with cerebral treated by stereotactic radiosurgery (SRS), and to assess their association with radiological radiation-induced changes (RICs).
   METHODS: To measure serum biomarkers, peripheral venous blood was collected before SRS and 1 week, 1 month, 3 months, and 6 months after SRS. To evaluate RICs, clinical and neuroimaging follow-up were performed concurrently every 6 months after SRS.
   RESULTS: Twenty-seven patients were enrolled (11 in the group with RIC, 16 in the group without RIC). Serum VEGF and endostatin levels were positively correlated (P = 0.036, r = 0.405). In the group with RIC, the median serum VEGF 6 months after SRS (58.98 pg/mL) was significantly higher than that of the group without RIC (15.17 pg/mL) (P = 0.001). Multivariate analysis revealed that higher VEGF 6 months after SRS (P = 0.001, hazard ratio, 1.032; 95% confidence interval, 1.012-1.052) and lower endostatin 1 month after SRS (P = 0.007, hazard ratio, 0.964; 95% confidence interval, 0.935-0.993) were significantly associated with RICs.
   CONCLUSIONS: Our results show that serum levels of VEGF 6 months after SRS were higher in the group with RIC. Serum levels of VEGF 6 months and endostatin 1 month after SRS were associated with the radiological RICs. Thus, serial measurements of serum VEGF and endostatin after SRS might help predict RICs in patients with arteriovenous malformation treated by SRS.
C1 [Lee, Jae-Gwang; Park, Seong-Hyun; Park, Ki-Su; Kang, Dong-Hun; Hwang, Jeong-Hyun; Hwang, Sung-Kyoo] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Neurosurg, Daegu, South Korea.
   [Kang, Dong-Hun] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Radiol, Daegu, South Korea.
RP Hwang, JH (reprint author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Neurosurg, Daegu, South Korea.
EM nsdoctor@naver.com
OI Hwang, Jeong-Hyun/0000-0002-5306-6922; Kang,
   Dong-Hun/0000-0002-2977-9340
CR BROWN RD, 1988, J NEUROSURG, V68, P352, DOI 10.3171/jns.1988.68.3.0352
   Cohen-Inbar O, 2017, J NEUROSURG, V127, P503, DOI 10.3171/2016.7.JNS161194
   Cohen-Inbar O, 2015, J NEUROSURG, V123, P945, DOI 10.3171/2014.10.JNS142264
   Dashti SR, 2015, J NEUROSURG-PEDIATR, V15, P20, DOI 10.3171/2014.9.PEDS14198
   Ding D, 2013, J NEUROSURG, V118, P958, DOI 10.3171/2013.2.JNS121239
   Feldman AL, 2001, ANN SURG ONCOL, V8, P741, DOI 10.1245/aso.2001.8.9.741
   Flickinger JC, 2000, INT J RADIAT ONCOL, V46, P1143, DOI 10.1016/S0360-3016(99)00513-1
   Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48
   Hashimoto T, 2005, NEUROSURGERY, V56, P1058
   Ilyas A, 2018, J NEUROSURG, V128, P154, DOI 10.3171/2016.9.JNS161571
   Kim GH, 2008, STROKE, V39, P2274, DOI 10.1161/STROKEAHA.107.512442
   Koizumi T, 2002, NEUROSURGERY, V50, P117, DOI 10.1097/00006123-200201000-00020
   Levegrun S, 2004, STRAHLENTHER ONKOL, V180, P758, DOI 10.1007/s00066-004-1266-6
   Nonoguchi N, 2011, J NEURO-ONCOL, V105, P423, DOI 10.1007/s11060-011-0610-9
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Sandalcioglu IE, 2006, CEREBROVASC DIS, V21, P154, DOI 10.1159/000090526
   Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164
   SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476
   Starke RM, 2013, J NEUROSURG, V119, P981, DOI 10.3171/2013.5.JNS1311
   Wegner RE, 2011, INT J RADIAT ONCOL, V79, P1147, DOI 10.1016/j.ijrobp.2009.12.056
   Xu M, 2018, BRAIN RES BULL, V140, P220, DOI 10.1016/j.brainresbull.2018.05.007
   Xue LX, 2017, METAB BRAIN DIS, V32, P641, DOI 10.1007/s11011-017-9953-z
   Yu F, 2017, J STROKE CEREBROVASC, V26, P1061, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.021
   Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.0.CO;2-A
NR 24
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E612
EP E618
DI 10.1016/j.wneu.2019.02.101
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400074
PM 30831282
DA 2020-05-12
ER

PT J
AU Lee, JB
   Kim, IS
   Lee, JJ
   Park, JH
   Cho, CB
   Yang, SH
   Sung, JH
   Hong, JT
AF Lee, Jong Beom
   Kim, Il Sup
   Lee, Jung Jae
   Park, Jong-Hyeok
   Cho, Chul Bum
   Yang, Seung Ho
   Sung, Jae Hoon
   Hong, Jae Taek
TI Validity of a Smartphone Application (Sagittalmeter Pro) for the
   Measurement of Sagittal Balance Parameters
SO WORLD NEUROSURGERY
LA English
DT Article
DE PACS; Reliability; SagittalMeter Pro; Spinopelvic parameter; Variability
ID COBB-ANGLE; RADIOGRAPHIC PARAMETERS; INTRAOBSERVER; INTEROBSERVER;
   SCOLIOSIS; ALIGNMENT; IPHONE
AB OBJECTIVE: The study was aimed to compare the validity, reproducibility, precision, and efficiency of a picture archiving and communication system (PACS) and a smart-phone application, which is an educative app to easily measure sagittal balance parameters (SagittalMeter Pro), for measuring spinopelvic sagittal parameters.
   METHODS: Three spine surgeons measured lumbar lordosis (LL), pelvic incidence (PI), sacral slope (SS), and pelvic tilt (PT) on standing posteroanterior radiographs of 30 patients using PACS and SagittalMeter Pro. Measurements were repeated a week after the original measurements. Intraobserver and interobserver variabilities and reliabilities of each parameter (LL, PI, SS, and PT) were calculated for both techniques. Comparisons were performed using the paired t-test. Results are expressed as mean +/- standard deviation and P values of < 0.05 were considered significant.
   RESULTS: PACS to SagittalMeter Pro differences between the mean absolute values of LL, PI, SS, PT were 0.50 degrees, 0.82 degrees, 0.81 degrees, 0.34 degrees, respectively, and intraobserver and interobserver variabilities were similar. Excellent intraobserver and interobserver reliabilities were obtained for PACS and SagittalMeter Pro as demonstrated by values >0.86 and >0.84, respectively. Measurement times for PACS and SagittalMeter Pro were 36.63 +/- 7.55 and 14.57 +/- 1.96 seconds, respectively, and this difference was significant (P = 0.001).
   CONCLUSIONS: The study shows PACS and SagittalMeter Pro are equivalent in terms of their abilities to measure spinopelvic sagittal parameters, and that the time required to obtain measurements was significantly less for SagittalMeter Pro. We believe that SagittalMeter Pro may be helpful when planning spinal surgery.
C1 [Lee, Jong Beom; Kim, Il Sup; Park, Jong-Hyeok; Cho, Chul Bum; Yang, Seung Ho; Sung, Jae Hoon; Hong, Jae Taek] Catholic Univ Korea, St Vincents Hosp, Dept Neurosurg, Suwon, South Korea.
   [Lee, Jung Jae] Gangneung Asan Hosp, Asan Med Ctr, Dept Neurosurg, Kangnung, South Korea.
RP Kim, IS (reprint author), Catholic Univ Korea, St Vincents Hosp, Dept Neurosurg, Suwon, South Korea.
EM nsman72@hanmail.net
OI Sung, Jae Hoon/0000-0003-3738-6413
CR Al-Hadithy N, 2012, INT ORTHOP, V36, P1543, DOI 10.1007/s00264-012-1527-4
   Allam Y, 2016, EUR SPINE J, V25, P444, DOI 10.1007/s00586-015-4162-0
   Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   CARMAN DL, 1990, J BONE JOINT SURG AM, V72A, P328, DOI 10.2106/00004623-199072030-00003
   COBB JR, 1947, ARCH SURG-CHICAGO, V55, P76, DOI 10.1001/archsurg.1947.01230080079007
   COBB JR, 1960, J BONE JOINT SURG AM, V42, P1413, DOI 10.2106/00004623-196042080-00012
   DUVALBEAUPERE G, 1992, ANN BIOMED ENG, V20, P451, DOI 10.1007/BF02368136
   Furness J, 2018, PEERJ, V6, DOI 10.7717/peerj.4431
   Glassman SD, 2005, SPINE, V30, P682, DOI 10.1097/01.brs.0000155425.04536.f7
   Gstoettner M, 2007, EUR SPINE J, V16, P1587, DOI 10.1007/s00586-007-0401-3
   Jackson RP, 2003, SPINE, V28, P151, DOI 10.1097/00007632-200301150-00011
   Jacquot F, 2012, INT ORTHOP, V36, P1655, DOI 10.1007/s00264-012-1579-5
   Johnson RD, 2013, J CLIN NEUROSCI, V20, P191, DOI 10.1016/j.jocn.2012.05.023
   Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219
   Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P699, DOI 10.1007/s00586-011-1938-8
   Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038
   Lotz JC, 2012, RADIOLOGY, V264, P6, DOI 10.1148/radiol.12110339
   Meng HZ, 2015, J ORTHOP RES, V33, P1250, DOI 10.1002/jor.22872
   MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002
   O'Shaughnessy BA, 2007, NEUROSURG CLIN N AM, V18, P347, DOI 10.1016/j.nec.2007.02.008
   Qiao J, 2012, J SPINAL DISORD TECH, V25, pE67, DOI 10.1097/BSD.0b013e3182463964
   Smith JS, 2013, NEUROSURG CLIN N AM, V24, P143, DOI 10.1016/j.nec.2012.12.009
   Yang X, 2014, EUR SPINE J, V23, P569, DOI 10.1007/s00586-013-3067-z
NR 24
TC 1
Z9 1
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E8
EP E15
DI 10.1016/j.wneu.2018.11.242
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400003
PM 30557655
DA 2020-05-12
ER

PT J
AU Lee, JJ
   An, SB
   Kim, TW
   Shin, DA
   Yi, S
   Kim, KN
   Yoon, DH
   Shin, HC
   Ha, Y
AF Lee, Jong Joo
   An, Seong Bae
   Kim, Tae Woo
   Shin, Dong Ah
   Yi, Seong
   Kim, Keung Nyun
   Yoon, Do Heum
   Shin, Hyun Chul
   Ha, Yoon
TI Analysis of Risk Factors Associated with Hospital Readmission Within 360
   Days After Degenerative Lumbar Spine Surgery in Elderly Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Elderly patients; Readmission; Regression analysis; Risk factors; Spinal
   surgery
ID FUSION SURGERY; COMPLICATIONS; DISORDERS; DATABASE; OUTCOMES; STENOSIS
AB OBJECTIVE: There is a paucity of studies on readmission rates in elderly patients over a period of 360 days after spinal surgery.
   METHODS: We identified 1248 patients older than 70 years who underwent degenerative lumbar spinal surgery from November 2005 to April 2015. We reviewed the patients who were readmitted within 360 days and compared them by univariate and multivariate analysis with the nonreadmitted patients for each period of 0-30, 30-90, 90-180, and 180-360 days postoperatively to determine risk factors for hospital readmission.
   RESULTS: A total of 1248 patients (733 female, 58.7%) were enrolled in the study. The number of readmitted patients was 37 (2.96%), 94 (7.53%), 145 (11.62%), 182 (14.58%), and 213 (17.07%) at 30, 90, 180, 270, and 360 days, respectively. Surgical site-related problems decreased gradually in the first 0-90 days and slightly increased after then. Non-surgical site-related problems gradually increased with time. Logistic multiple regression analysis showed that electrocardiographic abnormalities, male sex, low hemoglobin levels, asthma, heart disease, intensive care unit admission, low alanine aminotransferase level, high body mass index, and high platelet level were risk factors for readmission.
   CONCLUSIONS: We found that electrocardiographic abnormalities, male sex, low hemoglobin levels, asthma, heart disease, intensive care unit admission, low aspartate aminotransferase level, high body mass index, and high platelet level were risk factors for readmission. As the postoperative observational period became longer, the reasons for readmission tended to be more related to nonsurgical site-related problems than to surgical-related problems.T
C1 [Lee, Jong Joo; An, Seong Bae; Kim, Tae Woo; Shin, Dong Ah; Yi, Seong; Kim, Keung Nyun; Yoon, Do Heum; Ha, Yoon] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurosurg,Spine & Spinal Cord Inst, Seoul, South Korea.
   [Shin, Hyun Chul] Sungkyunkwan Univ, Coll Med, Kangbuk Samsung Hosp, Dept Neurosurg, Seoul, South Korea.
RP Ha, Y (reprint author), Yonsei Univ, Coll Med, Severance Hosp, Dept Neurosurg,Spine & Spinal Cord Inst, Seoul, South Korea.
EM hayoon@yuhs.ac
OI Kim, Keung Nyun/0000-0003-2248-9188
CR Adogwa O, 2016, WORLD NEUROSURG, V94, P432, DOI 10.1016/j.wneu.2016.07.045
   Baaj AA, 2017, SPINE, V42, P1706, DOI 10.1097/BRS.0000000000002208
   Bernatz JT, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS1534
   Choi JM, 2017, J KOREAN NEUROSURG S, V60, P684, DOI 10.3340/jkns.2017.0203
   Cloyd JM, 2008, J AM GERIATR SOC, V56, P1318, DOI 10.1111/j.1532-5415.2008.01771.x
   Cusimano MD, 2016, J NEUROSURG-SPINE, V24, P281, DOI 10.3171/2015.4.SPINE15445
   Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338
   Elsamadicy AA, 2019, NEUROSURGERY, V84, P758, DOI 10.1093/neuros/nyy215
   Fehlings MG, 2015, NEUROSURGERY, V77, pS1, DOI 10.1227/NEU.0000000000000953
   Gerhardt J, 2018, WORLD NEUROSURG, V112, pE555, DOI 10.1016/j.wneu.2018.01.082
   Hills J, 2018, SPINE, V43, P991, DOI 10.1097/BRS.0000000000002535
   Jakola AS, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-34
   Jansson KA, 2004, J BONE JOINT SURG BR, V86B, P841, DOI 10.1302/0301-620X.86B6.14740
   Kim BD, 2014, J NEUROSURG-SPINE, V20, P606, DOI 10.3171/2014.3.SPINE13699
   Kim JH, 2018, NEUROSPINE, V15, P131, DOI 10.14245/ns.1836046.023
   Lee BH, 2016, YONSEI MED J, V57, P1214, DOI 10.3349/ymj.2016.57.5.1214
   Lee CH, 2018, NEUROSPINE, V15, P66, DOI 10.14245/ns.1836038.019
   Lee CH, 2017, J KOREAN NEUROSURG S, V60, P125, DOI 10.3340/jkns.2016.0607.001
   Lee JH, 2012, J KOREAN NEUROSURG S, V51, P350, DOI 10.3340/jkns.2012.51.6.350
   Noordzij PG, 2006, AM J CARDIOL, V97, P1103, DOI 10.1016/j.amjcard.2005.10.058
   Parker SL, 2018, J NEUROSURG-SPINE, V29, P327, DOI 10.3171/2018.1.SPINE17505
   Pugely AJ, 2014, SPINE, V39, P761, DOI 10.1097/BRS.0000000000000270
   Saleh A, 2017, SPINE J, V17, P1106, DOI 10.1016/j.spinee.2017.03.019
   Wadhwa RK, 2017, J NEUROSURG-SPINE, V27, P131, DOI 10.3171/2016.12.SPINE16714
   Wang MC, 2012, SPINE J, V12, P902, DOI 10.1016/j.spinee.2012.09.051
NR 25
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E196
EP E207
DI 10.1016/j.wneu.2019.01.293
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400026
PM 30797909
DA 2020-05-12
ER

PT J
AU Lee, JM
   Jeong, SW
   Kim, MY
   Park, JB
   Kim, MS
AF Lee, Jong Min
   Jeong, Sung Woo
   Kim, Myoung Young
   Park, Jun Bum
   Kim, Min Soo
TI The Effect of Vitamin D Supplementation in Patients with Acute Traumatic
   Brain Injury
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain injuries; Cognition; Glasgow outcome scale; Traumatic; Vitamin D
ID COGNITIVE DECLINE; D INSUFFICIENCY; CALCIUM; PATHOPHYSIOLOGY;
   PREVENTION; GUIDELINES; DEMENTIA; SCALE; RISK
AB OBJECTIVE: To investigate the acute and long-term effects of vitamin D supplementation on the recovery of patients with traumatic brain injury (TBI).
   METHODS: A retrospective study was conducted involving 345 patients with TBI who visited a single trauma center. Vitamin D serum levels were measured without supplementation at admission, 1 month, and 3 months post-TBI (control group) from August to December 2016. From January 2017, vitamin D supplementation was provided to patients with TBI with low vitamin D serum levels at admission (supplement group). The outcomes were investigated by assessing performance function (Extended Glasgow Outcome Scale) and cognitive function (Mini-Mental Status Examination, and Clinical Dementia Rating) at 1 week and 3 months post-TBI.
   RESULTS: The mean vitamin D serum level in patients with TBI at admission was 13.62 +/- 9.01 ng/mL. The level significantly increased from 14.03 +/- 8.68 ng/mL at admission to 37.42 +/- 12.57 ng/mL at 3 months post TBI in the supplement group (P < 0.001). The cognitive outcomes (Mini-Mental Status Examination/Clinical Dementia Rating, P = 0.042/P = 0.044) and GOS-E score (total TBI, P = 0.003; mild-to-moderate TBI, P = 0.002) significantly improved from the first week to 3 months post TBI in the patients with vitamin D supplementation.
   CONCLUSIONS: Administration of vitamin D supplements in mild-to-moderate TBI patients with significant vitamin D deficiency during the acute phase of the injury may improve long-term performance and cognitive outcomes. Therefore, the treatment strategies should be individually planned for the patients with TBI based on their baseline vitamin D level.
C1 [Lee, Jong Min; Jeong, Sung Woo; Park, Jun Bum; Kim, Min Soo] Univ Ulsan, Ulsan Univ Hosp, Dept Neurosurg, Coll Med, Ulsan, South Korea.
   [Kim, Myoung Young] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Thorac & Cardiovasc Surg, Sch Med, Chang Won, South Korea.
RP Kim, MS (reprint author), Univ Ulsan, Ulsan Univ Hosp, Dept Neurosurg, Coll Med, Ulsan, South Korea.
EM kist1817@gmail.com
OI Kim, Min Soo/0000-0002-8901-7241; Park, Jun Bum/0000-0001-6005-9221
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science and ICT [2017R1C1B5018173]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Science and ICT (grant number: 2017R1C1B5018173).
CR Annweiler C, 2016, J INTERN MED, V280, P300, DOI 10.1111/joim.12491
   Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360
   Asad M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0928-6
   BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006
   Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp
   Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003
   Bischoff-Ferrari Heike A, 2014, Adv Exp Med Biol, V810, P500
   Calvo MS, 2005, J NUTR, V135, P310
   Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017
   Choi HS, 2013, ENDOCRINOL METAB, V28, P12, DOI 10.3803/EnM.2013.28.1.12
   Clelland JD, 2014, SCHIZOPHR RES, V156, P15, DOI 10.1016/j.schres.2014.03.017
   Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8
   Fogli-Cawley JJ, 2006, J NUTR, V136, P2908
   Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9
   Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353
   Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S
   Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/BF02509538
   HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
   Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218
   Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9
   Landel V, 2016, J ALZHEIMERS DIS, V53, P419, DOI 10.3233/JAD-150943
   Miller JW, 2015, JAMA NEUROL, V72, P1295, DOI 10.1001/jamaneurol.2015.2115
   Norman AW, 2008, AM J CLIN NUTR, V88, p491S
   Pangman VC, 2000, APPL NURS RES, V13, P209, DOI 10.1053/apnr.2000.9231
   Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282
   Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585
   Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565
   Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638
   Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747
   Toffanello ED, 2014, NEUROLOGY, V83, P2292, DOI 10.1212/WNL.0000000000001080
   Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131
   Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573
   Wong MSK, 2014, CIRCULATION, V130, P976, DOI 10.1161/CIRCULATIONAHA.114.010650
   Zold E, 2011, AUTOIMMUN REV, V10, P155, DOI 10.1016/j.autrev.2010.09.018
NR 34
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1421
EP E1426
DI 10.1016/j.wneu.2019.02.244
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400179
PM 30904798
DA 2020-05-12
ER

PT J
AU Li, C
   Sullivan, PZ
   Cho, S
   Nasrallah, MP
   Buch, L
   Chen, HCI
   Lee, JYK
AF Li, Carrie
   Sullivan, Patricia Zadnik
   Cho, Steve
   Nasrallah, MacLean P.
   Buch, Love
   Chen, Han-Chiao Isaac
   Lee, John Y. K.
TI Intraoperative Molecular Imaging with Second Window Indocyanine Green
   Facilitates Confirmation of Contrast-Enhancing Tissue During
   Intracranial Stereotactic Needle Biopsy: A Case Series
SO WORLD NEUROSURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Congress-of-Neurological-Surgeons
CY OCT 06-10, 2018
CL Houston, TX
SP Congress Neurol Surg
DE Brain biopsy; Fluorescence; Indocyanine green; Intraoperative molecular
   imaging; Minimally invasive; Near-infrared
ID FLUORESCEIN SODIUM FLUORESCENCE; 5-AMINOLEVULINIC ACID; GUIDED SURGERY;
   COMPLICATIONS; DIAGNOSIS; GLIOMAS; IMPROVE; TUMORS
AB BACKGROUND: Stereotactic needle biopsy provides a minimally invasive option for the diagnosis of intracranial lesions but is limited by inconclusive diagnoses on frozen pathology. For rapid pathology, 5-aminovelunic acid and sodium fluorescein have previously demonstrated potential as diagnostic adjuvants. Stereotactic biopsy with near-infrared (NIR) fluorophores has not been reported. We identified 5 representative cases using NIR fluorescent dye indocyanine green (ICG) administered in a high dose, delayed manner.
   METHODS: Five patients underwent second window indocyanine green (SWIG)-guided stereotactic biopsy for diagnosis of suspected glioma or tumor recurrence. Up to 5 mg/kg ICG was administered approximately 24 hours prior to surgery. Biopsies were conducted in the standard fashion, targeting regions of suspected tumor using intraoperative frameless navigation. Samples were examined intraoperatively under standard visible light and for fluorescence using conventional NIR imaging platforms. Findings were correlated with frozen and final tumor pathology for all cases.
   RESULTS: A total of 10 biopsy specimens were obtained. Three did not fluoresce and did not demonstrate tumor on preliminary or final pathology, including a non-gadolinium-enhancing sample taken proximal to the final target. The remaining 7 fluoresced, of which 6 contained tumor and 1 contained necrosis. Fluorescence was also noted in a patient with radiation treatment effect. Overall fluorescence characteristics were highly concordant with preliminary and final diagnoses.
   CONCLUSIONS: SWIG provides rapid intraoperative confirmation of pathologic brain tissue by permeating neoplastic or inflammatory brain tissue via a mechanism similar to that of gadolinium enhancement. SWIG-guided stereotactic biopsy can improve surgical efficiency by enhancing confidence in acquisition of target tissue.
C1 [Li, Carrie; Sullivan, Patricia Zadnik; Cho, Steve; Buch, Love; Chen, Han-Chiao Isaac; Lee, John Y. K.] Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.
   [Nasrallah, MacLean P.] Hosp Univ Penn, Dept Neuropathol, 3400 Spruce St, Philadelphia, PA 19104 USA.
   [Li, Carrie; Cho, Steve] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Lee, JYK (reprint author), Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.
EM leejohn@uphs.upenn.edu
FU National Center for Advancing Translational Sciences of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001878]
FX This work was supported by the National Center for Advancing
   Translational Sciences of the National Institutes of Health under Award
   Number UL1TR001878.
CR Catapano G, 2019, NEUROSURG REV, V42, P309, DOI 10.1007/s10143-018-0947-z
   Chen CC, 2009, CLIN NEUROL NEUROSUR, V111, P835, DOI 10.1016/j.clineuro.2009.08.013
   Cozzens JW, 2017, NEUROSURGERY, V81, P46, DOI 10.1093/neuros/nyw182
   Della Puppa A, 2013, ACTA NEUROCHIR, V155, P965, DOI 10.1007/s00701-013-1660-x
   Jiang JX, 2015, AM J NUCL MED MOLEC, V5, P390
   Kiesel B, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.3.FOCUS1859
   Kongkham PN, 2008, CAN J NEUROL SCI, V35, P79, DOI 10.1017/S0317167100007605
   Lee JYK, 2018, J NEUROSURG, V128, P380, DOI 10.3171/2016.10.JNS161636
   Lee JYK, 2017, WORLD NEUROSURG, V106, P120, DOI [10.1016/j.wneu.2017.06.128, 10.1016/j.WNEU.2017.06.128]
   Lee JYK, 2016, NEUROSURGERY, V79, P856, DOI 10.1227/NEU.0000000000001450
   Malikova H, 2014, NEUROENDOCRINOL LETT, V35, P613
   Malone H, 2015, WORLD NEUROSURG, V84, P1084, DOI 10.1016/j.wneu.2015.05.025
   Marbacher S, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.12.FOCUS13464
   Millesi M, 2017, PHOTODIAGN PHOTODYN, V17, pA74, DOI [10.1016/j.pdpdt.2017.01.167, DOI 10.1016/J.PDPDT.2017.01.167]
   Millesi M, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.12.FOCUS13485
   Moriuchi S, 2011, J NEUROSURG, V115, P278, DOI 10.3171/2011.4.JNS102137
   Nishihara Masamitsu, 2011, Kobe J Med Sci, V56, pE148
   Nishiyama Y, 2012, J NEUROSURG, V117, P302, DOI 10.3171/2012.5.JNS112300
   Rey-Dios R, 2014, ACTA NEUROCHIR, V156, P1071, DOI 10.1007/s00701-014-2097-6
   Schucht P, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.10.FOCUS14524
   Senders JT, 2017, ACTA NEUROCHIR, V159, P151, DOI 10.1007/s00701-016-3028-5
   Stummer W, 2017, NEUROSURGERY, V81, P230, DOI 10.1093/neuros/nyx074
   Thien A, 2018, ACTA NEUROCHIR, V160, P317, DOI 10.1007/s00701-017-3429-0
   Uematsu Y, 2007, BRAIN TUMOR PATHOL, V24, P47, DOI 10.1007/s10014-007-0219-z
   von Campe G, 2012, ACTA NEUROCHIR, V154, P585, DOI 10.1007/s00701-012-1290-8
   Waters J Dawn, 2013, Surg Neurol Int, V4, pS176, DOI 10.4103/2152-7806.110677
   Widhalm G, 2012, NEUROSURG REV, V35, P381, DOI 10.1007/s10143-012-0374-5
   Zach L, 2015, NEURO-ONCOLOGY, V17, P457, DOI 10.1093/neuonc/nou230
   Zeh R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182034
   Zhang DY, 2019, NEUROSURGERY, V85, P312, DOI 10.1093/neuros/nyy315
NR 30
TC 6
Z9 6
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1211
EP E1218
DI 10.1016/j.wneu.2019.02.231
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400152
PM 30885869
DA 2020-05-12
ER

PT J
AU Li, K
   Zhang, T
   Gao, K
   Lv, CL
AF Li, Kang
   Zhang, Tao
   Gao, Kai
   Lv, Chao-liang
TI The Utility of Diagnostic Transforaminal Epidural Injection in Selective
   Percutaneous Endoscopic Lumbar Discectomy for Multilevel Disc Herniation
   with Monoradicular Symptom: A Prospective Randomized Control Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Diagnostic transforaminal epidural injection; Monoradicular symptom;
   Multilevel disc herniation; Selective percutaneous endoscopic lumbar
   discectomy
ID NERVE ROOT BLOCKS; STEROID INJECTION; DECOMPRESSION; PREDICTORS
AB BACKGROUND: The aim of this study was to analyze the clinical outcomes of diagnostic transforaminal epidural injection (DTEI) in selective percutaneous endoscopic lumbar discectomy for multilevel disc herniation with monoradicular symptom.
   METHODS: A prospective randomized clinical study was performed from November 2013 to January 2018. A total of 99 consecutive patients with multilevel disc herniation and monoradicular symptom were divided randomly into the DTEI (n = 48) or control (n = 51) group based on a random number list. Operation time, blood loss, intraoperative fluoroscopy, and length of hospital stay were recorded and analyzed statistically. Visual analog scale (VAS) scores, Oswestry Disability Index (ODI), and the improved MacNab standard were used to assess the clinical outcomes of the 2 groups.
   RESULTS: No differences were observed between the 2 groups in aspect of baseline data. The patients of both groups had significant improvement in VAS and ODI scores compared with preoperative value. However, the postoperative VAS and ODI scores of the DTEI group were significantly lower compared with the control group. The clinical outcomes of the DTEI group according to the improved MacNab standard were significantly better than that of the control group.
   CONCLUSIONS: DTEI can improve the clinical outcomes of selective percutaneous endoscopic lumbar discectomy for multilevel disc herniation with monoradicular symptom, through improving the accuracy of confirmation of responsible level.
C1 [Li, Kang; Zhang, Tao; Lv, Chao-liang] Jining 1 Peoples Hosp, Dept Spine Surg, Jining, Shandong, Peoples R China.
   [Gao, Kai] Jining 1 Peoples Hosp, Dept Joint Surg, Jining, Shandong, Peoples R China.
   [Li, Kang; Zhang, Tao; Lv, Chao-liang] Jining Med Univ, Affiliated Jining Peoples Hosp 1, Dept Spine Surg, Jining, Shandong, Peoples R China.
RP Lv, CL (reprint author), Jining 1 Peoples Hosp, Dept Spine Surg, Jining, Shandong, Peoples R China.; Lv, CL (reprint author), Jining Med Univ, Affiliated Jining Peoples Hosp 1, Dept Spine Surg, Jining, Shandong, Peoples R China.
EM lvchaoliang2018@126.com
FU Shandong Science and Technology Development Plan on Medicine and Hygiene
   in China [2017WS519]; Natural Science Foundation of Shandong Province of
   ChinaNatural Science Foundation of Shandong Province [ZR2015YL034]
FX This work was supported by Shandong Science and Technology Development
   Plan on Medicine and Hygiene in China (grant number: 2017WS519), and
   Natural Science Foundation of Shandong Province of China (grant number:
   ZR2015YL034).
CR Beynon R, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17190
   DERBY R, 1992, SPINE, V17, pS176, DOI 10.1097/00007632-199206001-00020
   Hoogland T, 2008, SPINE, V33, P973, DOI 10.1097/BRS.0b013e31816c8ade
   Kim JH, 2018, CHIROPR MAN THER, V26, DOI 10.1186/s12998-018-0207-x
   Leung SM, 2015, HONG KONG MED J, V21, P394, DOI 10.12809/hkmj144310
   Lewandrowski KU, 2018, CLIN NEUROL NEUROSUR, V173, P38, DOI 10.1016/j.clineuro.2018.07.015
   Rho ME, 2011, PHYS MED REH CLIN N, V22, P139, DOI 10.1016/j.pmr.2010.10.006
   Slosar PJ, 1998, SPINE, V23, P2253, DOI 10.1097/00007632-199810150-00021
   Tsou Paul M, 2004, Spine J, V4, P564
   Tsou Paul Moody, 2002, Spine J, V2, P41, DOI 10.1016/S1529-9430(01)00153-X
   Wilson CA, 2016, SPINE J, V16, P1413, DOI 10.1016/j.spinee.2016.08.003
   Wilson-MacDonald J, 2005, J BONE JOINT SURG BR, V87B, P352, DOI 10.1302/0301-620X.87B3.15338
   Yeung AT, 2007, ORTHOP CLIN N AM, V38, P363, DOI 10.1016/j.ocl.2007.04.005
   Yeung AT, 2002, SPINE, V27, P722, DOI 10.1097/00007632-200204010-00009
NR 14
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E619
EP E624
DI 10.1016/j.wneu.2019.02.102
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400075
PM 30831300
DA 2020-05-12
ER

PT J
AU Li, XF
   Jin, LY
   Lv, ZD
   Su, XJ
   Wang, K
   Song, XX
   Shen, HX
AF Li, Xin-Feng
   Jin, Lin-Yu
   Lv, Zhen-Dong
   Su, Xin-Jin
   Wang, Kun
   Song, Xiao-Xing
   Shen, Hong-Xing
TI Endoscopic Ventral Decompression for Spinal Stenosis with Degenerative
   Spondylolisthesis by Partially Removing Posterosuperior Margin
   Underneath the Slipping Vertebral Body: Technical Note and Outcome
   Evaluation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Decompression; Degenerative lumbar spondylolisthesis; Percutaneous
   transforaminal endoscopy; Spinal stenosis
ID LATERAL RECESS STENOSIS; LUMBAR DISC HERNIATION; LOW-BACK-PAIN;
   MICROENDOSCOPIC DISKECTOMY; BILATERAL DECOMPRESSION; INTERLAMINAR
   APPROACH; UNILATERAL APPROACH; FUSION; ADAPTATION
AB BACKGROUND: Decompression alone is a treatment option in patients with lumbar spinal stenosis (LSS) and degenerative lumbar spondylolisthesis (DLS). This study aims to describe the procedure of percutaneous transforaminal endoscopic ventral decompression technique and to demonstrate the clinical outcomes.
   METHODS: Two years of retrospective data were collected from 26 patients with predominant unilateral leg pain caused by LSS and low-grade DLS (Meyerding grades I and II). All patients underwent endoscopic ventral decompression by removing the posterosuperior margin underneath the slipping vertebral body, combined with dorsal decompression without excessive resection of facet joints. The surgical outcomes were assessed using the visual analog scale (VAS), Oswestry Disability Index (ODI), modified MacNab criteria, and walking distance improvement evaluation.
   RESULTS: The mean age of the 18 women and 8 men was 69.2 years. The mean preoperative ODI and VAS of the leg and the back scores were 64.7 +/- 8.1, 7.0 +/- 1.4, and 3.0 +/- 1.2, respectively. All mean scores improved postoperatively to 31.4 +/- 5.6, 2.4 +/- 1.1, and 1.7 +/- 1.1 at the final follow-up. In 88.5% of cases, patients' estimated walking distance improved. The outcomes of the modified MacNab criteria showed that 81.3% of patients obtained good-to-excellent rate. There were no statistically significant differences between the percent slip of spondylolisthesis before surgery and at the end of follow-up.
   CONCLUSIONS: Based on the initial short-term follow-up results, transforaminal endoscopic ventral decompression by partially removing the posterosuperior margin underneath the slipping vertebral body, combined with dorsal decompression, might be an efficient alternative treatment for leg dominant symptoms in patients with LSS and low-grade DLS.
C1 [Li, Xin-Feng; Jin, Lin-Yu; Lv, Zhen-Dong; Su, Xin-Jin; Wang, Kun; Shen, Hong-Xing] Renji Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.
   [Song, Xiao-Xing] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Anesthesiol, Sch Med, Shanghai, Peoples R China.
RP Shen, HX (reprint author), Renji Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.
EM shenhxgk@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81270027, 81772292]; Medico-Engineering Cooperation
   Fund of Shanghai Jiao Tong University [YG2012MS25, YG2016MS54]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81270027 and 81772292) and the Medico-Engineering
   Cooperation Fund of Shanghai Jiao Tong University (YG2012MS25 and
   YG2016MS54).
CR Ahn JS, 2018, J NEUROSURG-SPINE, V28, P492, DOI 10.3171/2017.8.SPINE17771
   Ahn Y, 2014, EXPERT REV MED DEVIC, V11, P605, DOI 10.1586/17434440.2014.940314
   Ahn Y, 2012, EXPERT REV MED DEVIC, V9, P361, DOI [10.1586/erd.12.23, 10.1586/ERD.12.23]
   Benditz A, 2019, J ORTHOP RES, V37, P737, DOI 10.1002/jor.24251
   Cavanaugh JM, 1997, CLIN ORTHOP RELAT R, P166
   Chen JG, 2018, WORLD NEUROSURG, V116, P412, DOI 10.1016/j.wneu.2018.05.075
   Dijkerman ML, 2018, EUR SPINE J, V27, P1629, DOI 10.1007/s00586-017-5436-5
   Dohzono S, 2013, J NEUROSURG-SPINE, V18, P472, DOI 10.3171/2013.2.SPINE12633
   Eum JH, 2016, J NEUROSURG-SPINE, V24, P602, DOI 10.3171/2015.7.SPINE15304
   Fairbank J C, 1980, Physiotherapy, V66, P271
   FREDRICKSON BE, 1984, J BONE JOINT SURG AM, V66A, P699, DOI 10.2106/00004623-198466050-00008
   Ghogawala Z, 2016, NEW ENGL J MED, V374, P1424, DOI 10.1056/NEJMoa1508788
   Golob AL, 2014, MED CLIN N AM, V98, P405, DOI 10.1016/j.mcna.2014.01.003
   Jang JW, 2016, CLIN SPINE SURG, V29, P268, DOI 10.1097/BSD.0b013e31827566a8
   Kambin P, 1997, CLIN ORTHOP RELAT R, P49
   Kim HS, 2017, WORLD NEUROSURG, V103, P201, DOI 10.1016/j.wneu.2017.03.130
   KIRKALDY-WILLIS W H, 1978, Spine, V3, P319, DOI 10.1097/00007632-197812000-00004
   Komp M, 2015, PAIN PHYSICIAN, V18, P61
   Lee CW, 2018, WORLD NEUROSURG, V113, pE129, DOI 10.1016/j.wneu.2018.01.195
   Li HY, 2018, WORLD NEUROSURG, V112, pE255, DOI 10.1016/j.wneu.2018.01.030
   Li ZZ, 2016, CLIN NEUROL NEUROSUR, V143, P90, DOI 10.1016/j.clineuro.2016.02.008
   Liu XY, 2018, J NEUROSURG-SPINE, V28, P317, DOI 10.3171/2017.6.SPINE172
   MAYER HM, 1994, SPINE, V19, P2719, DOI 10.1097/00007632-199412000-00023
   MONTGOMERY DM, 1994, J SPINAL DISORD, V7, P167, DOI 10.1097/00002517-199407020-00011
   Mori G, 2016, J NEUROSURG-SPINE, V24, P367, DOI 10.3171/2015.6.SPINE141298
   Mummaneni PV, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17188
   Nie HF, 2016, SPINE, V41, pB30, DOI 10.1097/BRS.0000000000001810
   Pan FM, 2016, INT J SURG, V35, P134, DOI 10.1016/j.ijsu.2016.09.091
   Ruetten S, 2009, J NEUROSURG-SPINE, V10, P476, DOI 10.3171/2008.7.17634
   Saltychev M, 2017, INT J REHABIL RES, V40, P202, DOI 10.1097/MRR.0000000000000226
   Samuel AM, 2017, CURR REV MUSCULOSKE, V10, P521, DOI 10.1007/s12178-017-9442-3
   Scholler K, 2017, NEUROSURGERY, V80, P355, DOI 10.1093/neuros/nyw091
   Schuller S, 2011, EUR SPINE J, V20, P713, DOI 10.1007/s00586-010-1640-2
   Sheahan PJ, 2015, DISABIL REHABIL, V37, P2367, DOI 10.3109/09638288.2015.1019647
   Shi R, 2019, INT ORTHOP, V43, P923, DOI 10.1007/s00264-018-4253-8
   Shin SH, 2018, WORLD NEUROSURG, V114, pE873, DOI 10.1016/j.wneu.2018.03.107
   Xiong CJ, 2019, EUR SPINE J, V28, P78, DOI 10.1007/s00586-018-5655-4
   Yao M, 2016, SPINE, V41, pE1470, DOI 10.1097/BRS.0000000000001891
   Yilmaz C, 2010, J SPINAL DISORD TECH, V23, P480, DOI 10.1097/BSD.0b013e3181bf1c76
   Zhu YJ, 2018, PAIN PHYSICIAN, V21, pE347
NR 40
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E517
EP E525
DI 10.1016/j.wneu.2019.02.083
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400062
PM 30825627
DA 2020-05-12
ER

PT J
AU Liang, KN
   Feng, PY
   Feng, XR
   Cheng, H
AF Liang, Kang-Ning
   Feng, Ping-Yong
   Feng, Xu-Ran
   Cheng, Hao
TI Diffusion Tensor Imaging and Fiber Tractography Reveal Significant
   Microstructural Changes of Cervical Nerve Roots in Patients with
   Cervical Spondylotic Radiculopathy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Apparent diffusion coefficient (ADC); Cervical spondylotic
   radiculopathy; Diffusion tensor imaging; Fiber tractography; Fractional
   anisotropy (FA); International Standards for Neurological Classification
   of Spinal Cord Injury (ISNCSCI) scale; Nerve roots
ID WATER DIFFUSION; SPINAL-CORD; MYELOPATHY
AB OBJECTIVE: To delineate the fractional anisotropy (FA) and apparent diffusion coefficient (ADC) values of patients with cervical spondylotic radiculopathy by diffusion tensor imaging and fiber bundle tracing.
   METHODS: Thirty patients with cervical spondylotic radiculopathy and 24 healthy volunteers were assessed using the International Standards for Neurological Classification of Spinal Cord Injury scale. All subjects underwent conventional sagittal T1- and T2-weighted imaging and horizontal 3-dimensional T2 driven equilibrium radiofrequency reset pulse and diffusion tensor imaging scan. The ADC and FA values were measured in the cervical nerve at most stenotic segment and heterolateral nonstenotic segment of patients.
   RESULTS: Fiber tractography revealed thinned and sparse nerve roots and disruption of the fiber bundles in patients with cervical spondylotic radiculopathy. The FA values of C5-C8 in healthy volunteers or heterolateral nonstenotic nerve of patients with cervical spondylotic radiculopathy were significantly greater than those of the stenotic cervical segments of patients with cervical spondylotic radiculopathy (both P < 0.01). Furthermore, the ADC values of C5-C8 in healthy volunteers or heterolateral nonstenotic nerve of patients with cervical spondylotic radiculopathy were significantly lower than those of the stenotic cervical segments of cervical spondylotic radiculopathy patients (both P < 0.01).
   CONCLUSIONS: Fiber tractography is capable of delineating microstructural changes of cervical nerve roots and cervical spondylotic radiculopathy exhibits significant changes in FA and ADC values.
C1 [Liang, Kang-Ning] Shanghai Corps Hosp Chinese Peoples Armed Police, Dept Med Imaging, Shanghai, Peoples R China.
   [Feng, Ping-Yong; Feng, Xu-Ran; Cheng, Hao] Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei, Peoples R China.
RP Feng, PY (reprint author), Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei, Peoples R China.
EM xjfpy@163.com
CR Arima H, 2015, J CRANIOVERTEBRAL JU, V6, P120, DOI 10.4103/0974-8237.161593
   BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408
   Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419
   Budzik JF, 2013, EUR RADIOL, V23, P1361, DOI 10.1007/s00330-012-2710-0
   Chen YY, 2014, ACAD RADIOL, V21, P338, DOI 10.1016/j.acra.2013.11.005
   Committee Membership:, 2012, Top Spinal Cord Inj Rehabil, V18, P85, DOI 10.1310/sci1801-85
   Dallaudiere B, 2014, DIAGN INTERV IMAG, V95, P63, DOI 10.1016/j.diii.2013.08.019
   Eguchi Y, 2016, BONE JOINT J, V98B, P387, DOI 10.1302/0301-620X.98B3.36036
   Eguchi Y, 2011, AM J NEURORADIOL, V32, P1824, DOI 10.3174/ajnr.A2681
   Facon D, 2005, AM J NEURORADIOL, V26, P1587
   Gao SJ, 2013, EUR J RADIOL, V82, P1940, DOI 10.1016/j.ejrad.2013.06.011
   Hori M, 2006, J MAGN RESON IMAGING, V23, P183, DOI 10.1002/jmri.20488
   Li ZC, 2008, ZHONGHUA WAIKE ZAZHI, V46, P1796
   [刘记存 Liu Jicun], 2011, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V27, P222
   Maki S, 2017, EUR SPINE J, V26, P2459, DOI 10.1007/s00586-017-5191-7
   Rindler RS, 2017, WORLD NEUROSURG, V99, P150, DOI 10.1016/j.wneu.2016.11.141
   [芮炳峰 RUI Bingfeng], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P2296
   Song T, 2011, EUR SPINE J, V20, P422, DOI 10.1007/s00586-010-1587-3
   Todd NV, 2015, BONE JOINT J, V97B, P1390, DOI 10.1302/0301-620X.97B10.35922
   Toktas ZO, 2016, J CRANIOVERTEBRAL JU, V7, P26, DOI 10.4103/0974-8237.176617
   Vedantam A, 2017, WORLD NEUROSURG, V97, P489, DOI 10.1016/j.wneu.2016.03.075
   Weis E B Jr, 1991, J Bone Joint Surg Am, V73, P1113
NR 22
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E57
EP E64
DI 10.1016/j.wneu.2019.01.154
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400009
PM 30735862
DA 2020-05-12
ER

PT J
AU Lin, T
   Meng, YC
   Ji, Z
   Jiang, H
   Shao, W
   Gao, R
   Zhou, XH
AF Lin, Tao
   Meng, Yichen
   Ji, Zhe
   Jiang, Heng
   Shao, Wei
   Gao, Rui
   Zhou, Xuhui
TI Extent of Depression in Juvenile and Adolescent Patients with Idiopathic
   Scoliosis During Treatment with Braces
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adolescent; Depression; Idiopathic scoliosis; Juvenile; Spine
ID QUALITY-OF-LIFE; PSYCHOLOGICAL IMPACT; PREVENTION; CHILDREN; HEALTH;
   GENDER; FEMALE
AB OBJECTIVE: We compared the depression levels of juvenile and adolescent patients with idiopathic scoliosis who had undergone bracing and identified the factors that influenced the extent of depression in these patients.
   METHODS: Our study included 112 patients with adolescent idiopathic scoliosis (AIS) and 96 patients with juvenile idiopathic scoliosis (JIS). The demographic characteristics and Zung Self-Rating Depression Scale, Strengths and Difficulties Questionnaire, and Center for Epidemiological Studies Depression Scale for Children scores were evaluated to select the relative factors of depression in patients and parents. Cognitive evaluations, using the Wechsler Intelligence Scale for Children-Revised scale, and an independent evaluation using the Functional Independence Measure for Children scale, were conducted.
   RESULTS: The mean Center for Epidemiological Studies Depression Scale for Children score in the AIS group (38.3 +/- 3.0) was greater than that in the JIS group (23.8 +/- 4.6), a statistically significant difference (P < 0.05). Age at initial bracing, bracing duration, parental depression, Cobb angle at initial bracing, cognitive function, independence, peer problems, prosocial behaviors, emotional symptoms, and total difficulties were significant factors in our regression model for JIS. The AIS patients showed similar results, except for the age at initial bracing, cognitive function, and independence.
   CONCLUSIONS: Patients with AIS and JIS who had undergone bracing showed differences in the extent of depression, and female adolescents were more vulnerable to depressive psychological status. Higher levels of cognitive function and independence and older age at bracing, longer bracing duration, larger Cobb angle, negative parental attitudes, and undesirable Strengths and Difficulties Questionnaire scores contributed to greater depression.
C1 [Lin, Tao; Meng, Yichen; Ji, Zhe; Jiang, Heng; Shao, Wei; Gao, Rui; Zhou, Xuhui] Second Mil Med Univ, Affiliated Hosp 2, Changzheng Hosp, Dept Orthoped, Shanghai, Peoples R China.
   [Shao, Wei] 359th Hosp PLA, Dept Trauma, Zhenjiang, Jiangsu, Peoples R China.
RP Zhou, XH (reprint author), Second Mil Med Univ, Affiliated Hosp 2, Changzheng Hosp, Dept Orthoped, Shanghai, Peoples R China.
EM xhzhouspine@163.com
RI Meng, Yichen/AAN-3085-2020
OI Meng, Yichen/0000-0003-3044-3913
CR Barrera M, 2006, AM J PREV MED, V31, pS182, DOI 10.1016/j.amepre.2006.07.019
   BENGTSSON G, 1974, ACTA PSYCHIAT SCAND, V50, P50, DOI 10.1111/j.1600-0447.1974.tb07656.x
   Carnevale TD, 2013, J SCH NURS, V29, P181, DOI 10.1177/1059840512469231
   Chang WP, 2016, SPINE, V41, P253, DOI 10.1097/BRS.0000000000001187
   CLAYSON D, 1981, SPINE, V6, P9, DOI 10.1097/00007632-198101000-00003
   Danielsson AJ, 2001, EUR SPINE J, V10, P278, DOI 10.1007/s005860100309
   ELIASON MJ, 1984, J DEV BEHAV PEDIATR, V5, P169
   Gladstone TRG, 2009, CAN J PSYCHIAT, V54, P212, DOI 10.1177/070674370905400402
   Glowacki M, 2013, J DEV PHYS DISABIL, V25, P325, DOI 10.1007/s10882-012-9310-4
   HAAGA DAF, 1995, BEHAV RES THER, V33, P41, DOI 10.1016/0005-7967(94)E0016-C
   Hankin BL, 2009, J CLIN PSYCHOL, V65, P1327, DOI 10.1002/jclp.20625
   Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128
   Hearst Daniela, 2007, Dev Neurorehabil, V10, P105, DOI 10.1080/17518420701263146
   Helfenstein A, 2006, SPINE, V31, P339, DOI 10.1097/01.brs.0000197412.70050.0d
   KAHANOVITZ N, 1989, SPINE, V14, P483, DOI 10.1097/00007632-198905000-00001
   Korovessis P, 2007, EUR SPINE J, V16, P537, DOI 10.1007/s00586-006-0214-9
   Lakdawalla Z, 2007, CLIN CHILD FAM PSYCH, V10, P1, DOI 10.1007/s10567-006-0013-1
   Law D., 2016, ERGONOMICS, V139, P1
   Lee H, 2016, AORN J, V90, P347
   Matsunaga S, 2005, SPINE, V30, P547, DOI 10.1097/01.brs.0000154648.53535.52
   Misterska E, 2014, J CHILD FAM STUD, V23, P1163, DOI 10.1007/s10826-013-9776-4
   Morley TE, 2011, CLIN PSYCHOL REV, V31, P1071, DOI 10.1016/j.cpr.2011.06.006
   Payne WK, 1997, SPINE, V22, P1380, DOI 10.1097/00007632-199706150-00017
   Schwieger T, 2016, SPINE, V41, P311, DOI 10.1097/BRS.0000000000001210
   Sims BE, 2006, AM J PREV MED, V31, pS99, DOI 10.1016/j.amepre.2006.07.014
   Talic G, 2016, PSYCHIAT DANUB, V28, P357
   Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4
   Tones M, 2006, SPINE, V31, P3027, DOI 10.1097/01.brs.0000249555.87601.fc
   Yu ZJ, 2011, CURR PSYCHIAT REP, V13, P116, DOI 10.1007/s11920-011-0178-2
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E27
EP E32
DI 10.1016/j.wneu.2019.01.095
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400005
PM 30703588
DA 2020-05-12
ER

PT J
AU Lindlof, M
   Lindgren, A
   Paavola, J
   Vantti, N
   von und zu Fraunberg, M
   Koivisto, T
   Jaaskelainen, JE
   Kamarainen, OP
   Huttunen, J
AF Lindlof, Minna
   Lindgren, Antti
   Paavola, Juho
   Vantti, Nelli
   von und zu Fraunberg, Mikael
   Koivisto, Timo
   Jaaskelainen, Juha E.
   Kamarainen, Olli-Pekka
   Huttunen, Jukka
TI Analgesic Use after Aneurysmal Subarachnoid Hemorrhage: A
   Population-Based Case-Control Study of 1187 Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Analgesics; Case-control studies; Pain; Subarachnoid hemorrhage
ID QUALITY-OF-LIFE; CASE-FATALITY; RISK-FACTORS; PAIN; STROKE; DEPRESSION;
   PREVALENCE; MORTALITY; HEADACHE; FATIGUE
AB BACKGROUND: The purpose of this population-based case-control study was to evaluate analgesic use after subarachnoid hemorrhage (SAH) caused by rupture of a saccular intracranial aneurysm (sIA).
   METHODS: The study consisted of 1187 patients alive 12 months after an sIA-SAH who were admitted to Kuopio University Hospital (KUH) between 1995 and 2014. Three controls, matched with age, sex, and birthplace, were included for each patient. Data on ruptured sIA cases admitted to KUH from a defined catchment population in Eastern Finland were obtained from the KUH intracranial aneurysm database. Analgesics were classified according to the Anatomical Therapeutic Chemical Classification system. Data on analgesic medication were retrieved from the Finnish national registry of prescribed medicines of the Social Insurance Institution of Finland.
   RESULTS: Among 1187 patients with sIA-SAH who were alive 12 months after admission, 83 (7.0%) commenced analgesics use within 12 months after the sIA-SAH versus 53 (1.5%) of the 3561 population controls. The results revealed significantly greater initiation rate of analgesic use among patients with sIA-SAH within a year after sIA-SAH as compared with that of matched population controls (odds ratio 5.0; 95% confidence interval 3.5-7.0; P < 0.001). Analgesic use commencement within 12 months of an sIA-SAH was independently associated with the presence of an intracerebral hematoma. Among patients, commencing analgesic use increased 11% when we compared a year before and a year after sIA-SAH.
   CONCLUSIONS: Our results indicate that patients with sIA-SAH had an increased risk for new pain after sIA-SAH as compared with that of matched control population.
C1 [Lindlof, Minna; Lindgren, Antti; Paavola, Juho; Vantti, Nelli; von und zu Fraunberg, Mikael; Koivisto, Timo; Jaaskelainen, Juha E.; Kamarainen, Olli-Pekka; Huttunen, Jukka] Kuopio Univ Hosp, KUH NeuroCtr, Neurosurg, Kuopio, Finland.
   [Lindlof, Minna; Paavola, Juho; Vantti, Nelli; Jaaskelainen, Juha E.; Kamarainen, Olli-Pekka] Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Clin Med, Kuopio, Finland.
RP Lindlof, M (reprint author), Kuopio Univ Hosp, KUH NeuroCtr, Neurosurg, Kuopio, Finland.; Lindlof, M (reprint author), Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Clin Med, Kuopio, Finland.
EM minnalin@student.uef.fi
OI Lindlof, Minna/0000-0002-4148-2080; Lindgren, Antti/0000-0002-1264-7667
FU Finnish Medical Foundation; Petri Honkanen Foundation; Paivikki and
   Sakari Sohlberg Foundation; Maire Taponen Foundation; Emil Aaltonen
   Foundation; North Savo Regional Fund of Finnish Cultural Foundation;
   Academy of FinlandAcademy of Finland; Kuopio University Hospital
FX This study was funded with research funds from The Finnish Medical
   Foundation, The Petri Honkanen Foundation, The Paivikki and Sakari
   Sohlberg Foundation, The Maire Taponen Foundation, The Emil Aaltonen
   Foundation, The North Savo Regional Fund of Finnish Cultural Foundation,
   The Academy of Finland, and The Kuopio University Hospital.
CR Appelros P, 2006, INT J REHABIL RES, V29, P329, DOI 10.1097/MRR.0b013e328010c7b8
   Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433
   D'Souza S, 2015, J NEUROSURG ANESTH, V27, P222, DOI 10.1097/ANA.0000000000000130
   Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0
   Glisic EK, 2016, AM J CRIT CARE, V25, P136, DOI 10.4037/ajcc2016486
   Hansen AP, 2012, EUR J PAIN, V16, P1128, DOI 10.1002/j.1532-2149.2012.00123.x
   Hong CK, 2015, HEADACHE, V55, P992, DOI 10.1111/head.12612
   Huttunen J, 2016, STROKE, V47, P2242, DOI 10.1161/STROKEAHA.116.014327
   Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413
   Jonsson AC, 2006, J NEUROL NEUROSUR PS, V77, P590, DOI 10.1136/jnnp.2005.079145
   Karamanakos PN, 2012, WORLD NEUROSURG, V78, P631, DOI 10.1016/j.wneu.2011.08.033
   Kim JS, 2009, EXPERT REV NEUROTHER, V9, P711, DOI [10.1586/ern.09.19, 10.1586/ERN.09.19]
   Klit H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027607
   Lundstrom E, 2009, EUR J NEUROL, V16, P188, DOI 10.1111/j.1468-1331.2008.02378.x
   Meyer B, 2010, CEREBROVASC DIS, V30, P423, DOI 10.1159/000317078
   Naess H, 2012, VASC HEALTH RISK MAN, V8, P407, DOI 10.2147/VHRM.S32780
   Naess H, 2010, J NEUROL, V257, P1446, DOI 10.1007/s00415-010-5539-y
   Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7
   O'Donnell MJ, 2013, STROKE, V44, P1238, DOI 10.1161/STROKEAHA.111.671008
   Ronne-Engstrom E, 2013, ACTA NEUROCHIR, V155, P587, DOI 10.1007/s00701-012-1612-x
   van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6
   Widar M, 2004, J CLIN NURS, V13, P497, DOI 10.1046/j.1365-2702.2003.00815.x
   Zeiler FA, 2016, CRIT CARE MED, V44, P973, DOI 10.1097/CCM.0000000000001602
   Zorowitz Richard D, 2005, Top Stroke Rehabil, V12, P37
NR 24
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1276
EP E1286
DI 10.1016/j.wneu.2019.02.241
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400161
PM 30898755
DA 2020-05-12
ER

PT J
AU Liu, DT
   Liu, YY
   Kong, YQ
   Zhou, LC
   Hu, WL
AF Liu, Dong-Tao
   Liu, Yue-Yang
   Kong, You-Qi
   Zhou, Li-Chun
   Hu, Wen-Li
TI Clinical Correlation of Magnetic Resonance Imaging Features of Cerebral
   Small Vessel Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE Basal ganglia perivascular space; Centrum semiovale white matter lesion;
   Cerebral small vessel disease; Periventricular white matter lesion
ID COGNITIVE IMPAIRMENT; RISK; PATHOGENESIS; INFARCTS; PROFILE; STROKE
AB OBJECTIVE: We have discussed the clinical features and neuroimaging findings and investigated the correlations between the clinical characteristics and different neuroradiologic phenotypes of cerebral small vessel disease (CSVD).
   METHODS: A total of 1106 patients with a diagnosis of CSVD were enrolled. The demographic data, medical history, laboratory test results, and neuroimaging findings were retrieved for analysis. The differences in clinical parameters between patient groups were examined. The relationships between the clinical parameters and neuroradiologic phenotypes (i.e., white matter lesions [WMLs] and enlarged perivascular spaces) were assessed. The magnetic resonance imaging features were clustered using the fast clustering algorithm.
   RESULTS: Approximately one third of our patients presented with a lacune, which was associated with atrial fibrillation (P = 0.029), lacunar syndrome (P < 0.001), periventricular WMLs (P = 0.001), cerebral WMLs (P = 0.021), basal ganglia perivascular space grade (P < 0.001) and severity (P = 0.001), and semiovale perivascular space grade (P = 0.010) and severity (P = 0.002). Hypertension was associated with periventricular WMLs (P = 0.048), centrum semiovaleWMLs (P = 0.026), and basal ganglia perivascular space grade (P < 0.001) and severity (P < 0.001). A novel clustering algorithm was derived to stratify our cohort into 3 different groups according to the differing severity of the cerebral WMLs and perivascular space enlargement.
   CONCLUSION: The present study has provided a comprehensive analysis of the clinical correlation of characteristics and neuroradiologic phenotypes in patients with CSVD. The insights from these findings could be used to refine the management strategy for patients with CSVD.
C1 [Liu, Dong-Tao; Kong, You-Qi; Zhou, Li-Chun; Hu, Wen-Li] Capital Med Univ, Dept Neurol, Beijing Chao Yang Hosp, Beijing, Peoples R China.
   [Liu, Yue-Yang] Civil Aviat Gen Hosp, Dept Neurol, Beijing, Peoples R China.
RP Zhou, LC (reprint author), Capital Med Univ, Dept Neurol, Beijing Chao Yang Hosp, Beijing, Peoples R China.
EM lichunzhoubayer@163.com
CR Dearborn JL, 2015, STROKE, V46, P3131, DOI 10.1161/STROKEAHA.115.010060
   Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921
   Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496
   Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549
   Liem MK, 2007, STROKE, V38, P923, DOI 10.1161/01.STR.0000257968.24015.bf
   Palacio S, 2014, STROKE, V45, P2689, DOI 10.1161/STROKEAHA.114.005018
   Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143
   Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6
   Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B
   Shi Y, 2017, STROKE VASC NEUROL, V1, P83
   Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072
   Umemura T, 2017, J DIABETES INVEST, V8, P134, DOI 10.1111/jdi.12545
   Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9
NR 13
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E586
EP E605
DI 10.1016/j.wneu.2019.02.099
PG 20
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400072
PM 30831301
DA 2020-05-12
ER

PT J
AU Liu, H
   Zhang, JX
   Liang, X
   Qian, ZL
   Zhou, ZZ
   Lu, H
   Bou, EH
   Meng, B
   Mao, HQ
   Yang, HL
   Liu, T
AF Liu, Hao
   Zhang, Junxin
   Liang, Xiao
   Qian, Zhonglai
   Zhou, Zhangzhe
   Lu, Hui
   Bou, Emily Hong
   Meng, Bin
   Mao, Haiqing
   Yang, Huilin
   Liu, Tao
TI Distribution Pattern Making Sense: Patients Achieve Rapider Pain Relief
   with Confluent Rather Than Separated Bilateral Cement in Percutaneous
   Kyphoplasty for Osteoporotic Vertebral Compression Fractures
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bone cement; Distribution; OVCF; Pain; Percutaneous kyphoplasty
ID BALLOON KYPHOPLASTY; BED REST; VOLUME; VERTEBROPLASTY; IMMOBILIZATION;
   COMPLICATIONS; AUGMENTATION; METAANALYSIS; DIAGNOSIS
AB BACKGROUND: It has been reported the distribution of bone cement in percutaneous kyphoplasty (PKP) has an impact on the curative effect. No studies have compared between confluent and separated cement pattern of bilateral bone cement in PKP for patients with osteoporotic vertebral compression fractures.
   METHODS: Between 2010 and 2016, 1341 patients were enrolled and divided into 2 groups. Group A (n = 723), bilateral cement was confluent; Group B (n = 618), bilateral cement was separated. The visual analogue scale (VAS), Oswestry Disability Index (ODI), anterior vertebral height (AVH), and local kyphotic angle (LKA) were obtained preoperatively, 2 days after surgery, and at the final follow-up to assess the functional and radiographic efficacy of the surgery.
   RESULTS: The VAS, ODI, AVH, and LKA 2 days after operation and at the final follow-up were significantly improved compared with the preoperative for both groups (P < 0.05). There existed no significant difference between groups at various time point in ODI, AVH, and LKA (P > 0.05). Group A showed better VAS than group B 2 days after surgery (1.91 +/- 0.98 vs. 2.35 +/- 0.78, P < 0.001), also with better pre-postoperative VAS change (6.23 +/- 0.76 vs. 5.75 +/- 1.02, P < 0.001). Multiple linear regression for pain relief degree revealed group A (P < 0.001), older age (P < 0.001), and more cement volume (P < 0.001) contribute to rapid improvement of back pain. The cement leakage rate was 3.7% in group A and 2.9% in group B, with no significant difference (P = 0.405).
   CONCLUSIONS: Patients achieved rapider pain relief with confluent rather than separated bilateral bone cement pattern in PKP for osteoporotic vertebral compression fracture.
C1 [Liu, Hao; Zhang, Junxin; Liang, Xiao; Qian, Zhonglai; Zhou, Zhangzhe; Meng, Bin; Mao, Haiqing; Yang, Huilin; Liu, Tao] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Suzhou, Jiangsu, Peoples R China.
   [Lu, Hui] Integrated Tradit Chinese & Western Med Hosp, Dept Orthopaed Surg, Suzhou, Jiangsu, Peoples R China.
   [Bou, Emily Hong] Univ Waterloo, Biochem Dept, Waterloo, ON, Canada.
RP Liu, T (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Suzhou, Jiangsu, Peoples R China.
EM sudalt@126.com
CR Afzal Suhail, 2007, Pain Physician, V10, P559
   Belkoff SM, 2001, SPINE, V26, P1537, DOI 10.1097/00007632-200107150-00007
   Boonen S, 2011, OSTEOPOROSIS INT, V22, P2915, DOI 10.1007/s00198-011-1639-5
   Chen BL, 2011, EUR SPINE J, V20, P1272, DOI 10.1007/s00586-011-1744-3
   Chevalier Y, 2008, SPINE, V33, P1722, DOI 10.1097/BRS.0b013e31817c750b
   DITTMER DK, 1993, CAN FAM PHYSICIAN, V39, P1428
   Eck JC, 2008, SPINE J, V8, P488, DOI 10.1016/j.spinee.2007.04.004
   Edidin AA, 2015, SPINE, V40, P1228, DOI 10.1097/BRS.0000000000000992
   Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017
   Fu ZY, 2016, DOSE-RESPONSE, V14, DOI 10.1177/1559325816682867
   He X, 2016, PAIN PHYSICIAN, V19, P495
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   Lee MJ, 2009, SPINE, V34, P1228, DOI 10.1097/BRS.0b013e3181a3c742
   Li LH, 2013, CHINESE MED J-PEKING, V126, P3956, DOI 10.3760/cma.j.issn.0366-6999.20131398
   Lieberman Isador H, 2005, Spine J, V5, p305S, DOI 10.1016/j.spinee.2005.02.020
   Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009
   Lin DS, 2017, CLIN SPINE SURG, V30, pE270, DOI 10.1097/BSD.0000000000000204
   Mao HQ, 2012, NEURORADIOLOGY, V54, P1137, DOI 10.1007/s00234-012-1018-8
   Mattia C, 2016, CLIN CASES MINER BON, V13, P97, DOI 10.11138/ccmbm/2016.13.2.097
   Molloy S, 2003, SPINE, V28, P1549, DOI 10.1097/00007632-200307150-00014
   Molloy S, 2005, AM J NEURORADIOL, V26, P401
   Niu JJ, 2015, ACTA RADIOL, V56, P1380, DOI 10.1177/0284185114556016
   Ochia RS, 2002, SPINE, V27, P1160, DOI 10.1097/00007632-200206010-00005
   Polikeit A, 2003, SPINE, V28, P991, DOI 10.1097/00007632-200305150-00006
   PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4
   Rebolledo BJ, 2013, BONE JOINT J, V95B, P401, DOI 10.1302/0301-620X.95B3.29819
   Sun ZY, 2012, PAIN PHYSICIAN, V15, P95
   Tanigawa N, 2007, AM J ROENTGENOL, V189, pW348, DOI 10.2214/AJR.07.2186
   TEASELL R, 1993, CAN FAM PHYSICIAN, V39, P1440
   Tighe PJ, 2015, PAIN, V156, P609, DOI 10.1097/01.j.pain.0000460352.07836.0d
   Tolba R, 2014, PAIN PRACT, V14, pE91, DOI 10.1111/papr.12131
   Yang HL, 2016, SPINE, V41, pB52, DOI 10.1097/BRS.0000000000001804
   Yang HL, 2012, EUR SPINE J, V21, P1410, DOI 10.1007/s00586-012-2278-z
   Yang HL, 2011, ARTIF CELL BLOOD SUB, V39, P87, DOI 10.3109/10731199.2010.503319
   Zou J, 2010, INJURY, V41, P360, DOI 10.1016/j.injury.2009.09.033
NR 35
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1190
EP E1196
DI 10.1016/j.wneu.2019.03.063
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400149
PM 30880212
DA 2020-05-12
ER

PT J
AU Liu, YP
   Liu, Q
   Li, R
   Yang, Z
   Huang, ZP
   Huang, ZC
   Liu, JH
   Wu, XH
   Lin, JY
   Wu, XL
   Zhu, QG
AF Liu, Yapu
   Liu, Qi
   Li, Rong
   Yang, Zhou
   Huang, Zhiping
   Huang, Zucheng
   Liu, Junhao
   Wu, Xiuhua
   Lin, Junyu
   Wu, Xiaoliang
   Zhu, Qingan
TI Three-Dimensional Changes in Cervical Spinal Cord Microvasculature
   During the Chronic Phase of Hemicontusion Spinal Cord Injury in Rats
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic phase; Hemicontusion; Microvasculature; Spinal cord injury;
   Three-dimensional
ID MICRO-CT; MODEL
AB BACKGROUND: The angioarchitecture of the spinal cord and microvascular changes after acute and subacute spinal cord injury ( SCI) have been reported in rodents. Microvascular changes after chronic SCI have not been explored. We characterized three-dimensional microvascular changes during the chronic phase of cervical hemicontusion SCI in rats.
   METHODS: At 12 weeks after 1.2-mm hemicontusion injury, microvascular parameters, including vascular volume, ratio of vascular volume to tissue volume, vascular number, and vascular separation, were measured at the epicenter and each cord segment, and the percentage and volume of spinal vessels with different diameters were measured by micro computed tomography at the injury segment.
   RESULTS: The 1.2-mm hemicontusion injury applied a compressive force of 1.050 +/- 0.103 N to the cord, resulting in a cavity and a significant decrease in microvasculature at the epicenter. The vascular volume, ratio of vascular volume to tissue volume, and vascular number of the C5 cord decreased by 40%, 38%, and 36% at 12 weeks after SCI, whereas vascular separation increased by 54% compared with the control group. In the chronic phase after SCI, the percentage and volume of spinal microvessels at the contusion segment decreased significantly (especially vessels with diameters <40 mu m).
   CONCLUSIONS: Blood supply to the cervical spinal cord is insufficient during the chronic phase of cervical hemicontusion SCI, especially in microvessels with diameters < 40 mu m. These results may provide a basis to explore microvascular changes of SCI during the chronic phase.
C1 [Liu, Yapu; Liu, Qi; Li, Rong; Yang, Zhou; Huang, Zhiping; Huang, Zucheng; Liu, Junhao; Wu, Xiuhua; Lin, Junyu; Wu, Xiaoliang; Zhu, Qingan] Southern Med Univ, Nanfang Hosp, Dept Spinal Surg, Guangzhou, Guangdong, Peoples R China.
   [Liu, Yapu] Luohe Med Coll, Affiliated Hosp 2, Dept Spinal Surg, Luohe, Peoples R China.
RP Zhu, QG (reprint author), Southern Med Univ, Nanfang Hosp, Dept Spinal Surg, Guangzhou, Guangdong, Peoples R China.
EM qinganzhu@gmail.com
OI Wu, Xiaoliang/0000-0001-8643-3840
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81472084, 81601904]; Guangdong Province Natural
   Science Foundation of ChinaNational Natural Science Foundation of
   Guangdong Province [2016A030313553]; Guangdong Medical Science and
   Technology Research Fund of China [A2016008]; Luohe Youth Talents Fund
   of China [2018QNBJRC01004]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 81472084 and 81601904), Guangdong Province Natural
   Science Foundation of China (Grant No. 2016A030313553), Guangdong
   Medical Science and Technology Research Fund of China (Grant No.
   A2016008), and Luohe Youth Talents Fund of China (Grant No.
   2018QNBJRC01004).
CR Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006
   Cao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12643
   Cheng X, 2015, NEUROSCI LETT, V606, P106, DOI 10.1016/j.neulet.2015.08.050
   Dong XM, 2016, NEUROSCIENTIST, V22, P579, DOI 10.1177/1073858415610541
   Duran RCD, 2017, SCI REP-UK, V7, DOI 10.1038/srep41008
   Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119
   Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034
   Hu J, 2015, SPINAL CORD, V53, P585, DOI 10.1038/sc.2015.49
   Hu JZ, 2012, J NEUROSCI METH, V204, P150, DOI 10.1016/j.jneumeth.2011.10.018
   Huang ZC, 2018, NEUROSCI LETT, V664, P116, DOI 10.1016/j.neulet.2017.11.019
   Jansen O, 2017, GLOB SPINE J, V7, P735, DOI 10.1177/2192568217713754
   Kingston MJ, 2016, CONTRAST MEDIA MOL I, V11, P319, DOI 10.1002/cmmi.1695
   Long HQ, 2014, INT J MOL SCI, V15, P12061, DOI 10.3390/ijms150712061
   Ni SF, 2018, SPINE, V43, P1241, DOI 10.1097/BRS.0000000000002629
   Weidner N, 1996, Cancer Treat Res, V83, P265
   Wu TD, 2018, SPINE, V43, pE504, DOI 10.1097/BRS.0000000000002408
   Wu XH, 2017, CALCIFIED TISSUE INT, V101, P412, DOI 10.1007/s00223-017-0292-1
NR 17
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E385
EP E391
DI 10.1016/j.wneu.2019.02.061
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400045
PM 30822573
DA 2020-05-12
ER

PT J
AU Liu, YK
   Zhang, Y
   Hua, W
   Li, ZQ
   Wu, BW
   Liu, WL
AF Liu, Yikui
   Zhang, Yi
   Hua, Wei
   Li, Zhiqi
   Wu, Biwu
   Liu, Wenli
TI Clinical and Molecular Characteristics of Thalamic Gliomas:
   Retrospective Report of 26 Cases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Clinical Features; Molecular Features; Thalamic gliomas
ID CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; K27M MUTATIONS; PROGNOSIS;
   FEATURES; TUMORS; CLASSIFICATION; GENES; H3.3; TP53
AB OBJECTIVE: Thalamic glioma is a type of midline glioma with poor outcomes. In the present study, we investigated the clinical and molecular features of thalamic gliomas in Chinese patients.
   METHODS: The data from 26 patients with thalamic glioma who had undergone surgery at Shanghai Huashan Hospital from January 2011 to August 2015 were retrospectively analyzed. Various clinical and molecular factors were evaluated to explore their effects on prognosis. H3K27M mutation status and its association with relevant molecular factors were also investigated.
   RESULTS: The mean age of the patients was 38.88 years, and no significant difference was found in sex. The most common initial symptoms were headaches (38.46%; 10 of 26) and motor deficits (30.77%; 8 of 26). The H3K27M mutation was identified in 12 patients, and mutant thalamic glioma showed less frequent O-6-methylguanine DNA methyltransferase (MGMT) promoter methylation compared with the wild-type group (P = 0.015; chi(1) test). Multivariate analysis showed that the H3K27M mutation was an independent unfavorable prognostic factor for overall survival. MGMT promoter unmethylation and the TP53 mutation were identified as negative prognostic factors for progression-free survival.
   CONCLUSIONS: Our results revealed the clinical and molecular characteristics of thalamic glioma in China. Our data have shown the absence of MGMT promoter methylation in H3K27M mutant thalamic glioma, validating it as a hallmark of H3K27M mutant gliomas. In addition, H3K27M mutation was identified as the sole unfavorable prognostic factor on overall survival. MGMT promoter unmethylation and TP53 mutation were identified as independent prognostic factors for progression-free survival.
C1 [Liu, Yikui] Fudan Univ, Dept Neurosurg, Peoples Hosp Shanghai 5, Shanghai, Peoples R China.
   [Zhang, Yi; Hua, Wei; Li, Zhiqi; Wu, Biwu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
   [Liu, Wenli] GenomiCare Biotechnol Co, Shanghai, Peoples R China.
RP Zhang, Y (reprint author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
EM zhangtang1218@vip.sina.com
CR Aihara K, 2014, NEURO-ONCOLOGY, V16, P140, DOI 10.1093/neuonc/not144
   Banan R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0500-2
   Bozkurt SU, 2018, CHILD NERV SYST, V34, P107, DOI 10.1007/s00381-017-3633-5
   Buckner JC, 2016, NEW ENGL J MED, V374, P1344, DOI 10.1056/NEJMoa1500925
   Buczkowicz P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00147
   Cao L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0487-x
   Diaz AK, 2014, SEMIN RADIAT ONCOL, V24, P240, DOI 10.1016/j.semradonc.2014.06.003
   Esquenazi Y, 2018, NEUROSURGERY, V83, P76, DOI 10.1093/neuros/nyx349
   Fan CH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.388
   Feng J, 2015, HUM PATHOL, V46, P1626, DOI 10.1016/j.humpath.2015.07.002
   Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799
   Gillet E, 2014, J NEURO-ONCOL, V118, P131, DOI 10.1007/s11060-014-1407-4
   Hilmani S, 2013, J MOL NEUROSCI, V49, P567, DOI 10.1007/s12031-012-9868-4
   Illic R, 2017, WORLD NEUROSURG, V104, P581, DOI 10.1016/j.wneu.2017.05.018
   Kallappagoudar S, 2015, CHROMOSOMA, V124, P177, DOI 10.1007/s00412-015-0510-4
   Karremann M, 2018, NEURO-ONCOLOGY, V20, P123, DOI 10.1093/neuonc/nox149
   Komori T, 2017, NEUROL MED-CHIR, V57, P301, DOI 10.2176/nmc.ra.2017-0010
   Kramm CM, 2011, NEURO-ONCOLOGY, V13, P680, DOI 10.1093/neuonc/nor045
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Meyronet D, 2017, NEURO-ONCOLOGY, V19, P1127, DOI 10.1093/neuonc/now274
   Pollack IF, 2003, PEDIATR NEUROSURG, V39, P114, DOI 10.1159/000071647
   Pratt D, 2018, ACTA NEUROPATHOL, V135, P299, DOI 10.1007/s00401-018-1805-3
   Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833
   Solomon DA, 2016, BRAIN PATHOL, V26, P569, DOI 10.1111/bpa.12336
   Stokland T, 2010, NEURO-ONCOLOGY, V12, P1257, DOI 10.1093/neuonc/noq092
   Williams Maria J, 2017, Front Oncol, V7, P45, DOI 10.3389/fonc.2017.00045
   Wu BW, 2018, J CLIN NEUROSCI, V49, P56, DOI 10.1016/j.jocn.2017.12.008
   Wurtz RH, 2011, TRENDS COGN SCI, V15, P177, DOI 10.1016/j.tics.2011.02.004
   Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995
   Zawlik I, 2009, BRAIN PATHOL, V19, P188, DOI 10.1111/j.1750-3639.2008.00170.x
   Zhang P, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0820-x
NR 31
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1169
EP E1182
DI 10.1016/j.wneu.2019.03.061
PG 14
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400147
PM 30885860
DA 2020-05-12
ER

PT J
AU Longo, M
   Agarwal, V
AF Longo, Michael
   Agarwal, Vijay
TI Postoperative Pulmonary Complications Following Brain Tumor Resection: A
   National Database Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain tumor; Craniotomy; Outcomes; Postoperative pulmonary complications
ID RISK-FACTORS; EXTUBATION; PNEUMONIA; SURGERY; FAILURE
AB OBJECTIVE: There is sparse literature that investigates the adverse effects of postoperative pulmonary complication (PPCs) specifically in postcraniotomy tumor patients. In this study, we describe the rate of PPCs, determine predictive factors, and delineate associations with adverse outcomes.
   METHODS: The National Surgical Quality Improvement Program (2006-2016) database was queried for patients who underwent craniotomy for brain tumors. A total of 28,700 eligible patients were identified. Univariate tests and/or multivariate logistic regression were used to determine predictors of PPC and associations with adverse outcomes.
   RESULTS: A total of 19 predictors of PPC across 14 different categories were identified: age 65-79 years (odds ratio [OR] 1.6; P < 0.001), age >= 80 years (OR 2.3; P < 0.001), male sex (OR 1.3; P < 0.001), operative time >= 360 minutes (OR 4.3; P < 0.001), operative time 300-359 minutes (OR 2.5; P < 0.001), operative time 240-299 minutes (OR 1.8; P < 0.001), operative time 180-239 minutes (OR 1.3; P < 0.001), total functional dependence (OR 3.8; P < 0.001), partial functional dependence (OR 1.7; P < 0.001), insulin-dependent diabetes (OR 1.5; P < 0.001), preoperative dyspnea (OR 1.3; P = 0.01), chronic steroid use (OR 1.4; P < 0.001), chronic obstructive pulmonary disease (OR 1.8; P < 0.001), preoperative leukocytosis (OR 1.4; P < 0.001), anemia (OR 1.2; P < 0.001), American Society of Anesthesiologists (ASA) classification >= 3 (OR 2.0; P < 0.001), emergency case status (OR 2.0; P < 0.001), and infratentorial lesions (OR 1.4; P < 0.001). PPCs were significantly associated with higher reoperation, readmission, and mortality rates as well as longer length of stay (univariate).
   CONCLUSIONS: There are several predictive factors of PPCs in patients that undergo surgical resection of brain tumors, and PPC development is associated with numerous adverse outcomes. It is critically important to understand and, if possible, mitigate controllable circumstances that may reduce morbidity and mortality associated with PPCs.
C1 [Longo, Michael; Agarwal, Vijay] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol Surg, Bronx, NY 10467 USA.
RP Longo, M (reprint author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol Surg, Bronx, NY 10467 USA.
EM mlongo@mail.einstein.yu.edu
OI Longo, Michael/0000-0002-2462-6118
CR Alluri RK, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.10.49
   Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005
   Billett H. H., 1990, CLIN METHODS HIST PH
   Cai YH, 2016, MED SCI MONITOR, V22, P2431, DOI 10.12659/MSM.899780
   Cai YH, 2013, J INT MED RES, V41, P208, DOI 10.1177/0300060513475964
   Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a
   Chu H, 2014, ONCOL LETT, V8, P1477, DOI 10.3892/ol.2014.2374
   Davies OJ, 2017, BJA EDUC, V17, P295, DOI 10.1093/bjaed/mkx012
   De la Garza-Ramos R, 2016, CLIN NEUROL NEUROSUR, V140, P6, DOI 10.1016/j.clineuro.2015.11.005
   Fernandez-Bustamante A, 2017, JAMA SURG, V152, P157, DOI 10.1001/jamasurg.2016.4065
   Flexman AM, 2014, J NEUROSURG ANESTH, V26, P198, DOI 10.1097/ANA.0b013e3182a43ed8
   Hosmer DW, 2000, APPL LOGISTIC REGRES
   Miskovic A, 2017, BRIT J ANAESTH, V118, P317, DOI 10.1093/bja/aex002
   Oh T, 2014, CLIN NEUROL NEUROSUR, V118, P76, DOI 10.1016/j.clineuro.2013.12.017
   Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008
   Raval MV, 2018, JAMA SURG, V153, P764, DOI 10.1001/jamasurg.2018.0486
   Sabate S, 2014, CURR OPIN ANESTHESIO, V27, P201, DOI 10.1097/ACO.0000000000000045
   Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031
   Su ZB, 2018, WORLD NEUROSURG, V112, pE39, DOI 10.1016/j.wneu.2017.12.014
   Tillquist MN, 2016, J CLIN ANESTH, V31, P80, DOI 10.1016/j.jclinane.2015.12.038
   Yin S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207657
   Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1147
EP E1154
DI 10.1016/j.wneu.2019.03.058
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400144
PM 30880210
DA 2020-05-12
ER

PT J
AU Lorente, L
   Martin, MM
   Gonzalez-Rivero, AF
   Ramos, L
   Argueso, M
   Caceres, JJ
   Sole-Violan, J
   Jimenez, A
   Borreguero-Leon, JM
   Garcia-Marin, V
AF Lorente, Leonardo
   Martin, Maria M.
   Gonzalez-Rivero, Agustin F.
   Ramos, Luis
   Argueso, Monica
   Caceres, Juan J.
   Sole-Violan, Jordi
   Jimenez, Alejandro
   Borreguero-Leon, Juan M.
   Garcia-Marin, Victor
TI Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained
   High Serum sCD40L Levels
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain trauma; Injury; Mortality; Patients; sCD40L
ID SOLUBLE CD40 LIGAND; TISSUE FACTOR; ENDOTHELIAL-CELLS; PLATELET
   ACTIVATION; HEAD-INJURY; INFLAMMATION; EXPRESSION; MORTALITY;
   EPIDEMIOLOGY; METAANALYSIS
AB BACKGROUND: Soluble cluster of differentiation 40 ligand (sCD40L) is a member of the tumor necrosis factor family with proinflamatory and procoagulant effects. A previous study found higher serum sCD40L levels at day 1 of traumatic brain injury (TBI) in nonsurviving than surviving patients. Thus the objective of this study was to compare serum sCD40L levels during the first week of a severe TBI between surviving and nonsurviving patients and to determine whether it could be used as a mortality predictor biomarker.
   METHODS: In this multicenter study severe TBI patients (with Glasgow Coma Scale score <9) with an Injury Severity Score in noncranial item <9 were included. Serum sCD40L concentrations at days 1, 4, and 8 of TBI were determined. We performed receiver operating characteristic analyses to determine the capacity of 30-day TBI mortality prediction by serum sCD40L levels at days 1, 4, and 8 of TBI.
   RESULTS: We found that nonsurviving (n = 34) patients in comparison with surviving (n = 90) patients had higher sCD40L levels on days 1 (P < 0.001), 4 (P = 0.004), and 8 (P < 0.001) of TBI. We also found that the areas under curve of serum sCD40L concentrations at days 1, 4, and 8 of TBI to 30-day mortality prediction were 82% (P < 0.001), 72% (P = 0.01) and 83% (P < 0.001), respectively.
   CONCLUSIONS: The existence of higher serum sCD40L levels in nonsurviving than surviving patients during the first week of TBI and fact that serum sCD40L levels during the first week of TBI can be used as a mortality predictor biomarker are the new findings of our study.
C1 [Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Spain.
   [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Dept, San Cristobal la Laguna, Spain.
   [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Spain.
   [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, San Cristobal la Laguna, Spain.
   [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain.
   [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain.
   [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain.
   [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain.
   [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain.
RP Lorente, L (reprint author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Spain.
EM lorentemartin@msn.com
OI Argueso, Monica/0000-0001-5917-1056; Borreguero Leon, Juan
   Maria/0000-0001-7414-5278
FU Fundacion DISA a la Investigacion Medica [OA18/011]
FX This study was supported by a grant (OA18/011) from Fundacion DISA a la
   Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain).
CR Anand SX, 2003, THROMB HAEMOSTASIS, V90, P377, DOI 10.1160/TH03-05-0268
   Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247
   Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076
   Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998
   Casault C, 2019, NEUROCRIT CARE, V30, P22, DOI 10.1007/s12028-018-0522-z
   Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277
   Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007
   Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539
   Ferroni P, 2007, CURR MED CHEM, V14, P2170
   Bernal EF, 2013, MED INTENSIVA, V37, P327, DOI 10.1016/j.medin.2012.05.015
   Hamdan Righab, 2011, J Med Liban, V59, P65
   Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021
   Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102
   Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329
   Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Li J, 2004, CLIN CHEM, V50, P1696, DOI 10.1373/clinchem.2003.030940
   Lin R, 2006, CURR NEUROVASC RES, V3, P41, DOI 10.2174/156720206775541796
   Lorente L, 2017, J CRIT CARE, V41, P177, DOI 10.1016/j.jcrc.2017.05.021
   Lorente L, 2015, INT J MOL SCI, V16, P12147, DOI 10.3390/ijms160612147
   Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034
   Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104
   Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400
   Lukasik M, 2012, THROMB HAEMOSTASIS, V107, P346, DOI 10.1160/TH11-05-0345
   Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931
   MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287
   de Lizarrondo SM, 2012, ARTERIOSCL THROM VAS, V32, P1477, DOI 10.1161/ATVBAHA.112.248773
   Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010
   Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373
   NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550
   Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC
   Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732
   Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed
   Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100
   Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008
   TEASDALE G, 1974, LANCET, V2, P81
   Tsai NW, 2009, THROMB RES, V124, P213, DOI 10.1016/j.thromres.2009.01.012
   Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13
   Weber M, 2006, CLIN CHEM, V52, P888, DOI 10.1373/clinchem.2005.062083
   Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003
   Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Zagara G, 1991, J Neurosurg Sci, V35, P77
   Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025
NR 46
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1537
EP E1541
DI 10.1016/j.wneu.2019.03.179
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400193
PM 30926559
DA 2020-05-12
ER

PT J
AU Maas, SLN
   Draaisma, K
   Snijders, TJ
   Senders, JT
   Berendsen, S
   Seute, T
   Schiffelers, RM
   van Solinge, WW
   Ten Berg, MJ
   Robe, PA
   Broekman, MLD
AF Maas, Sybren L. N.
   Draaisma, Kaspar
   Snijders, Tom J.
   Senders, Joeky T.
   Berendsen, Sharon
   Seute, Tatjana
   Schiffelers, Raymond M.
   van Solinge, Wouter W.
   Ten Berg, Maarten J.
   Robe, Pierre A.
   Broekman, Marike L. D.
TI Routine Blood Tests Do Not Predict Survival in Patients with
   Glioblastoma-Multivariable Analysis of 497 Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Biomarkers; Blood tests; Glioblastoma; Hemoglobin; Prognostic markers;
   Prognosticators; Survival
ID CENTRAL-NERVOUS-SYSTEM; HEMOGLOBIN LEVEL; ADJUVANT TEMOZOLOMIDE;
   PROGNOSTIC IMPACT; RADIOTHERAPY; CANCER; OXYGENATION; NEUTROPHILS;
   CARCINOMA; HYPOXIA
AB BACKGROUND: Multiple reports have attributed a prognostic value to routine blood tests results for patients with glioblastoma. However, these studies have reported conflicting results and have often had small sample sizes. We sought to validate the prognostic value of the described tests in an independent glioblastoma patient population.
   METHODS: We performed a retrospective single-center multivariable analysis of 497 patients with glioblastoma who had postoperatively undergone radiotherapy and/or chemotherapy to identify the prognostic value for median overall survival of hemoglobin, white blood cell, monocyte, neutrophil, leukocyte, and platelet counts, neutrophil/lymphocyte ratio, C-reactive protein, erythrocyte sedimentation rate, activated partial thromboplastin time, prothrombin time, and lactate dehydrogenase. We also evaluated known prognostic factors for survival such as patient age, intervention type, IDH1 status, Karnofsky clinical performance status, and postoperative treatment modality.
   RESULTS: In a multivariable model, after correcting for multiple testing bias, biopsy alone (hazard ratio, 0.35; 95% confidence interval, 0.26-0.49; false discovery rateadjusted P < 0.001) and monotherapy after surgery (hazard ratio, 0.46; 95% confidence interval, 0.33-0.66; false discovery rate-adjusted P < 0.001) remained significantly associated with worse median overall survival. Patient age and Karnofsky performance status score >= 70 did not significantly influence survival in the multivariable model. No routine blood test included in the multivariable analysis was significantly associated with survival.
   CONCLUSIONS: In the present study, hemoglobin, white blood cell, monocyte, neutrophil, leukocyte, and platelet counts, neutrophil/lymphocyte ratio, C-reactive protein, erythrocyte sedimentation rate, activated partial thromboplastin time, prothrombin time, and lactate dehydrogenase levels did not independently predict for overall survival in patients with glioblastoma.
C1 [Maas, Sybren L. N.; Draaisma, Kaspar; Snijders, Tom J.; Senders, Joeky T.; Berendsen, Sharon; Seute, Tatjana; Robe, Pierre A.; Broekman, Marike L. D.] Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands.
   [Maas, Sybren L. N.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.
   [Schiffelers, Raymond M.; van Solinge, Wouter W.; Ten Berg, Maarten J.] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands.
RP Broekman, MLD (reprint author), Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands.
EM m.broekman@haaglandenmc.nl
OI Van Solinge, Wouter/0000-0003-2867-2581; Snijders,
   Tom/0000-0003-0857-081X; Berendsen, Sharon/0000-0001-5837-0758
FU Hersenstichting Nederland (Foundation Concerned with Diseases of the
   Brain); Schumacher Kramer Stichting; T & P Bohnenn Foundation
FX The present study was financially supported, in part, by the
   Hersenstichting Nederland (Foundation Concerned with Diseases of the
   Brain), the Schumacher Kramer Stichting, and the T & P Bohnenn
   Foundation.
CR Abels ER, 2016, CELL MOL NEUROBIOL, V36, P301, DOI 10.1007/s10571-016-0366-z
   Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820
   Aravanis AM, 2017, CELL, V168, P571, DOI 10.1016/j.cell.2017.01.030
   Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111
   Bambury RM, 2013, J NEURO-ONCOL, V114, P149, DOI 10.1007/s11060-013-1164-9
   Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034
   Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4
   Brockmann MA, 2007, NEURO-ONCOLOGY, V9, P335, DOI 10.1215/15228517-2007-013
   Broekman ML, 2018, NAT REV NEUROL, V14, P482, DOI 10.1038/s41582-018-0025-8
   Cefaro GA, 2011, STRAHLENTHER ONKOL, V187, P778, DOI 10.1007/s00066-011-1129-x
   Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52
   Fiorentino A, 2013, INT J NEUROSCI, V123, P133, DOI 10.3109/00207454.2012.744309
   Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4
   Han S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1629-7
   Han S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1125-0
   Kros JM, 2015, NEURO-ONCOLOGY, V17, P343, DOI 10.1093/neuonc/nou207
   Lally BE, 2004, CANCER J, V10, P391, DOI 10.1097/00130404-200411000-00010
   Liang J, 2014, CLIN CANCER RES, V20, P187, DOI 10.1158/1078-0432.CCR-13-1279
   LILES WC, 1995, BLOOD, V86, P3181
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Lutterbach J, 2003, STRAHLENTHER ONKOL, V179, P8, DOI 10.1007/s00066-003-1004-5
   Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003
   Mateescu B, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1286095
   McNamara MG, 2014, J NEURO-ONCOL, V117, P147, DOI 10.1007/s11060-014-1366-9
   Mineo JF, 2007, ACTA NEUROCHIR, V149, P245, DOI 10.1007/s00701-006-1092-y
   Odrazka K, 2003, STRAHLENTHER ONKOL, V179, P615, DOI 10.1007/s00066-003-1097-x
   Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151
   PEDERSEN D, 1995, ACTA ONCOL, V34, P787, DOI 10.3109/02841869509127188
   QUILTY PM, 1986, INT J RADIAT ONCOL, V12, P1735, DOI 10.1016/0360-3016(86)90313-5
   Reynes G, 2011, J NEURO-ONCOL, V102, P35, DOI 10.1007/s11060-010-0290-x
   Rudat V, 2001, STRAHLENTHER ONKOL, V177, P462, DOI 10.1007/PL00002427
   Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800
   Strojnik T, 2014, ANTICANCER RES, V34, P339
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   ten Berg MJ, 2007, CLIN CHEM LAB MED, V45, P13, DOI 10.1515/CCLM.2007.009
   Therneau TM, 2000, STAT BIOL HEALTH
   Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10
   Williams M, 2012, J CANCER RES CLIN, V138, P1683, DOI 10.1007/s00432-012-1243-x
   Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064
   Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031
NR 41
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1081
EP E1091
DI 10.1016/j.wneu.2019.03.053
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400137
PM 30880204
DA 2020-05-12
ER

PT J
AU Massimi, L
   Rapisarda, A
   Bianchi, F
   Frassanito, P
   Tamburrini, G
   Pelo, S
   Caldarelli, M
AF Massimi, Luca
   Rapisarda, Alessandro
   Bianchi, Federico
   Frassanito, Paolo
   Tamburrini, Gianpiero
   Pelo, Sandro
   Caldarelli, Massimo
TI Piezosurgery in Pediatric Neurosurgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bone graft; Bone harvesting; Craniofacial surgery; Craniotomy;
   Osteointegration; Piezosurgery
ID PIEZOELECTRIC SURGERY; BONE SURGERY; OSTEOTOMY; EXPERIENCE; DEVICE
AB BACKGROUND: Piezosurgery (PS) has gained increasing dispersion in neurosurgery. In pediatric neurosurgery, the experience is limited to craniosynostosis surgery. The present study assesses PS in the pediatric population, also considering outcomes and complications in cranial and spinal procedures.
   METHODS: All consecutive craniotomies and laminotomies, performed with PS (group A) or conventional osteotomes (group B) in the 2014-2017 period were reviewed. The following variables were analyzed: dural tears, estimated blood loss and need of transfusion, cosmetic outcome (Sloan score), and operative times. A review of the pertinent literature is included.
   RESULTS: 172 children were enrolled, 90 in group A and 82 in group B. The mean follow-up time was 2.1 years. A statistically significant difference in favor of group A was found about EBL (105 vs. 113 ml) and late outcome (Sloan class A 98.5% vs. 91.5%). PS also reduced the risk of dural tears (1 vs. 7 cases in groups A and B, respectively) and blood transfusion (52% vs. 55.5%) but without statistical significance. The operative times were significantly shorter in group B (13 vs. 23 minutes), although the newer PS plus (PSP) was demonstrated to significantly shorten these times compared with the traditional PS (3.5 vs. 6.5 minutes for orbitotomy and 7.5 vs. 9.5 minutes for hemicraniotomy).
   CONCLUSIONS: PS is a safe and effective tool that can be specifically recommended for bone splitting and graft, laminotomy, and craniotomy in cosmetically eloquent areas. The limit of operation times can be overcome by a learning curve in neurosurgery and PSP.
C1 [Massimi, Luca; Rapisarda, Alessandro; Bianchi, Federico; Frassanito, Paolo; Tamburrini, Gianpiero; Caldarelli, Massimo] Univ Cattolica Sacro Cuore, Neurochirurgia Pediat, Rome, Italy.
   [Pelo, Sandro] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Chirurgia Maxillo Facciale, Rome, Italy.
   [Massimi, Luca; Tamburrini, Gianpiero; Caldarelli, Massimo] Univ Cattolica Sacro Cuore, Ist Neurochirurgia, Rome, Italy.
   [Pelo, Sandro] Univ Cattolica Sacro Cuore, Ist Odontoiatria & Chirurgia Maxillo Facciale, Rome, Italy.
RP Massimi, L (reprint author), Univ Cattolica Sacro Cuore, Neurochirurgia Pediat, Rome, Italy.; Massimi, L (reprint author), Univ Cattolica Sacro Cuore, Ist Neurochirurgia, Rome, Italy.
EM lmassimi@email.it
RI FRASSANITO, Paolo/K-4099-2018; Rapisarda, Alessandro/AAF-3354-2019;
   Pelo, Sandro/AAB-3400-2019
OI FRASSANITO, Paolo/0000-0003-0071-3126; 
CR Acharya AN, 2015, OTOL NEUROTOL, V36, P444, DOI 10.1097/MAO.0000000000000645
   Barone A, 2010, J ORAL MAXIL SURG, V68, P330, DOI 10.1016/j.joms.2009.03.053
   Bartuli F N, 2013, Oral Implantol (Rome), V6, P5
   Chaichana KL, 2013, CHILD NERV SYST, V29, P1163, DOI 10.1007/s00381-013-2043-6
   Crosetti E, 2009, ACTA OTORHINOLARYNGO, V29, P1
   Esteves JC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-221
   Franzini A, 2018, WORLD NEUROSURG, V114, P58, DOI [10.1016/J.WNEU.2018.03.026, 10.1016/j.wneu.2018.03.026]
   Gellner V, 2017, CLIN OTOLARYNGOL, V42, P927, DOI 10.1111/coa.12760
   Gleizal A, 2007, CHILD NERV SYST, V23, P509, DOI 10.1007/s00381-006-0250-0
   Grauvogel J, 2014, J NEUROSURG SCI, V58, P17
   Grauvogel J, 2018, J NEUROSURG-PEDIATR, V21, P322, DOI 10.3171/2017.8.PEDS17327
   Grauvogel J, 2018, OPER NEUROSURG, V15, P664, DOI 10.1093/ons/opx272
   Grauvogel J, 2017, WORLD NEUROSURG, V106, P422, DOI 10.1016/j.wneu.2017.06.180
   Grauvogel J, 2011, ACTA NEUROCHIR, V153, P1941, DOI 10.1007/s00701-011-1092-4
   Iacoangeli M, 2015, J NEUROL SURG PART A, V76, P112, DOI 10.1055/s-0034-1368685
   Iacoangeli M, 2013, INT J SURG CASE REP, V4, P188, DOI 10.1016/j.ijscr.2012.11.006
   Itro A, 2012, Minerva Stomatol, V61, P213
   Jiang Q, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001685
   Kotrikova B, 2006, INT J ORAL MAX SURG, V35, P461, DOI 10.1016/j.ijom.2005.12.006
   Kramer FJ, 2006, J NEUROSURG, V104, P68, DOI 10.3171/ped.2006.104.1.68
   Labanca M, 2008, BRIT J ORAL MAX SURG, V46, P265, DOI 10.1016/j.bjoms.2007.12.007
   Ma L, 2013, INT ORTHOP, V37, P1597, DOI 10.1007/s00264-013-1908-3
   Martini M, 2017, J CRANIO MAXILL SURG, V45, P395, DOI 10.1016/j.jcms.2016.12.018
   Mouraret S, 2014, INT J ORAL MAX SURG, V43, P966, DOI 10.1016/j.ijom.2013.11.018
   Pavlikova G, 2011, INT J ORAL MAX SURG, V40, P451, DOI 10.1016/j.ijom.2010.11.013
   Ramieri V, 2015, J CRANIOFAC SURG, V26, P840, DOI 10.1097/SCS.0000000000001574
   Rana M, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-49
   Robiony M, 2014, J CRANIOFAC SURG, V25, P1448, DOI 10.1097/SCS.0000000000000793
   Rullo R, 2013, J CRANIO MAXILL SURG, V41, pE33, DOI 10.1016/j.jcms.2012.07.007
   Shen WM, 2017, ANN PLAS SURG, V78, P511, DOI 10.1097/SAP.0000000000000939
   Shirota T, 2014, BRIT J ORAL MAX SURG, V52, P219, DOI 10.1016/j.bjoms.2013.11.015
   Pereira CCS, 2018, J CRANIOFAC SURG, V29, P1578, DOI 10.1097/SCS.0000000000004542
   Sloan GM, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.1.e2
   Spinelli G, 2015, J CRANIO MAXILL SURG, V43, P1422, DOI 10.1016/j.jcms.2015.07.012
   Tirelli G, 2015, AM J OTOLARYNG, V36, P666, DOI 10.1016/j.amjoto.2015.05.006
   Tomazic PV, 2014, BIOMED RES INT, DOI 10.1155/2014/341876
   Vetrano IG, 2019, WORLD NEUROSURG, V122, pE1398, DOI 10.1016/j.wneu.2018.11.064
NR 37
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E625
EP E633
DI 10.1016/j.wneu.2019.02.103
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400076
PM 30831297
DA 2020-05-12
ER

PT J
AU McMahon, JT
   Tora, MS
   Bentley, JN
   Texakalidis, P
   Campbell, MA
   Keifer, OP
   Boulis, NM
AF McMahon, J. Tanner
   Tora, Muhibullah S.
   Bentley, J. Nicole
   Texakalidis, Pavlos
   Campbell, Melissa A.
   Keifer, Orion P., Jr.
   Boulis, Nicholas M.
TI Percutaneous Trigeminal Nerve Stimulation for Persistent Idiopathic
   Facial Pain: A Case Series
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atypical facial pain; Chronic pain; Neuromodulation; Percutaneous
   trigeminal stimulation; Persistent idiopathic facial pain; Trigeminal
   neuralgia
ID MOTOR CORTEX STIMULATION; BLOCK
AB BACKGROUND: Persistent idiopathic facial pain (PIFP) can be refractory to conventional management approaches. Neuromodulatory procedures such as percutaneous trigeminal nerve stimulation (TNS) have been sparsely reported as potential treatment options for amelioration of debilitating refractory pain associated with PIFP. The present study investigated the use of percutaneous TNS in a series of patients with PIFP to evaluate the potential efficacy of pain relief.
   METHODS: We performed a retrospective medical record review for patients with PIFP who had presented to Emory University Hospital and had undergone TNS for PIFP. The primary outcomes were postoperative pain using the visual analog scale (VAS) for pain and morphine equivalent use. Descriptive statistics, mean +/- standard deviation, and the nonparametric Wilcoxon sign rank test were used, as appropriate. A P value of <0.05 was considered statistically significant.
   RESULTS: A total of 23 patients underwent percutaneous TNS for PIFP. Of the 23 patients, 20 (86.9%) reported a >50% improvement after trial stimulation. Of the patients who had received permanent TNS implants, 13 of 17 (76.4%) had VAS scores available. For these patients, the mean preoperative VAS score had decreased from 5.69 +/- 2.09 to 0.15 +/- 0.55 postoperatively. The VAS scores displayed a statistically significant decrease after TNS (P = 0.0014). A subset of 9 patients with available data also demonstrated a significant reduction in morphine equivalent use after TNS (before, 50.54 +/- 51.30; after, 25.83 +/- 33.58; P = 0.048).
   CONCLUSION: The results from the present study have indicated that percutaneous stimulation of the trigeminal nerve is efficacious in the treatment of PIFP and can significantly decrease morphine equivalent use. Further longitudinal studies are required to validate our results.
C1 [McMahon, J. Tanner; Tora, Muhibullah S.; Bentley, J. Nicole; Texakalidis, Pavlos; Campbell, Melissa A.; Keifer, Orion P., Jr.; Boulis, Nicholas M.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
RP Tora, MS (reprint author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
EM mtora@emory.edu
OI Tora, Muhibullah/0000-0002-3300-6367; Boulis,
   Nicholas/0000-0002-7271-3953; Bentley, Nicole/0000-0002-8303-071X
CR Abrahamsen R, 2008, PAIN, V136, P44, DOI 10.1016/j.pain.2007.06.013
   Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658
   Cornelissen P, 2009, PAIN PRACT, V9, P443, DOI 10.1111/j.1533-2500.2009.00332.x
   Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001
   Ebel H, 1996, ACTA NEUROCHIR, V138, P1300, DOI 10.1007/BF01411059
   Esfahani DR, 2011, J NEUROSURG, V114, P189, DOI 10.3171/2010.5.JNS091696
   Evans RW, 2006, HEADACHE, V46, P1298, DOI 10.1111/j.1526-4610.2006.00541.x
   Hodaj H, 2015, BRAIN STIMUL, V8, P801, DOI 10.1016/j.brs.2015.01.416
   Isagulyan E D, 2015, Zh Vopr Neirokhir Im N N Burdenko, V79, P46, DOI 10.17116/neiro201579646-60
   Jurgens TP, 2012, J HEADACHE PAIN, V13, P199, DOI 10.1007/s10194-012-0417-x
   Nader A, 2013, PAIN PHYSICIAN, V16, pE537
   Nguyen CT, 2013, OTOLARYNG CLIN N AM, V46, P367, DOI 10.1016/j.otc.2013.01.002
   Nguyen JP, 1997, ADV STER F, V12, P54
   PFAFFENRATH V, 1993, CEPHALALGIA, V13, P84, DOI 10.1177/0333102493013S1218
   Rahimpour S, 2016, NEUROSURG CLIN N AM, V27, P365, DOI 10.1016/j.nec.2016.02.010
   Sokal P, 2015, ADV CLIN EXP MED, V24, P289, DOI 10.17219/acem/40452
   Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137
   Weiss AL, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0609-9
   William A, 2016, ACTA NEUROCHIR, V158, P513, DOI 10.1007/s00701-015-2695-y
   YOUNG RF, 1995, J NEUROSURG, V83, P72, DOI 10.3171/jns.1995.83.1.0072
   Zakrzewska JM, 2016, NEUROSURG CLIN N AM, V27, P345, DOI 10.1016/j.nec.2016.02.012
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1379
EP E1386
DI 10.1016/j.wneu.2019.03.107
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400175
PM 30902776
DA 2020-05-12
ER

PT J
AU Meybodi, AT
   Moreira, LB
   Zhao, XC
   Preul, MC
   Lawton, MT
AF Meybodi, Ali Tayebi
   Moreira, Leandro Borba
   Zhao, Xiaochun
   Preul, Mark C.
   Lawton, Michael T.
TI Anatomical Analysis of the Vagoaccessory Triangle and the Triangles
   Within: The Suprahypoglossal, Infrahypoglossal, and
   Hypoglossal-Hypoglossal Triangles
SO WORLD NEUROSURGERY
LA English
DT Article
DE Far-lateral approach; Hypoglossal-hypoglossal triangle; Infrahypoglossal
   triangle; Posterior inferior cerebellar artery; Suprahypoglossal
   triangle; Vagoaccessory triangle; Vertebral artery
ID FAR-LATERAL APPROACH; VERTEBRAL ARTERY; MANAGEMENT; BYPASS
AB BACKGROUND: Rootlets of the lower cranial nerves create a web that limits microsurgical maneuverability in the cerebellomedullary cistern (CMC). The vagoaccessory triangle (VAT) and 2 triangles within it were defined to identify surgical routes to aneurysms of the posterior inferior cerebellar artery (PICA). Dividing the VAT into 2 triangles (suprahypoglossal [SHT] and infrahypoglossal [IHT]), although elegant, oversimplifies CMC anatomy. The triangle formed by the superior and inferior hypoglossal rootlets (hypoglossal-hypoglossal triangle [HHT]) needs consideration as well.
   METHODS: Far-lateral craniotomy was performed on 10 cadaveric heads bilaterally. Areas of CMC triangles were calculated. Relationships between the PICA origin and the adjacent triangles were analyzed. Vertebral artery (VA) exposure and clipping lengths were recorded for each triangle.
   RESULTS: The area of SHT was almost twice those of IHT and HHT. The average VA depth relative to VAT increased significantly when moving distally from proximal VA (P < 0.001), but VA exposure and clipping lengths were not significantly different between triangles. IHT, HHT, and SHT defined VA subsegments (V-4i, V-4h, and V-4s), with PICA most commonly originating from V-4h. Based on our cadaveric measurements, the V-4 subsegments were identified with 76% accuracy in angiograms.
   CONCLUSIONS: Based on this study, VAT should be divided into 3 triangles, not 2. Splayed rootlets of cranial nerve XII and multiple outlet foramina create an important space different from the previously recognized SHT and IHT. These triangles provide corridors to vascular pathologies. V4 subsegments may be approximated from imaging studies and may help with preoperative planning.
C1 [Meybodi, Ali Tayebi; Moreira, Leandro Borba; Zhao, Xiaochun; Preul, Mark C.; Lawton, Michael T.] Barrow Neurol Inst, Div Neurol Surg, 350 W Thomas Rd, Phoenix, AZ 85013 USA.
RP Lawton, MT (reprint author), Barrow Neurol Inst, Div Neurol Surg, 350 W Thomas Rd, Phoenix, AZ 85013 USA.
EM Michael.Lawton@BarrowBrainandSpine.com
FU Barrow Neurological Foundation; Newsome Chair in Neurosurgery Research
FX We are grateful to the Barrow Neurological Foundation and to the Newsome
   Chair in Neurosurgery Research held by Dr. Preul for funding for this
   project. The authors also thank Ms. Kristen Larson Keil and Ms. Cindy
   Giljames from Barrow Neurological Institute Neuroscience Publications
   for their assistance with preparation of the artwork.
CR Abla AA, 2016, J NEUROSURG, V124, P1275, DOI 10.3171/2015.5.JNS15368
   Abla AA, 2014, OPER NEUROSURG, V10, P472, DOI 10.1227/NEU.0000000000000389
   AKAR ZC, 1994, NEUROL RES, V16, P171
   BERTALANFFY H, 1991, NEUROSURGERY, V29, P815, DOI 10.1227/00006123-199112000-00002
   Choudhri O, 2017, NEUROSURGERY, V81, P367, DOI 10.1093/neuros/nyx110
   Couldwell WT, 2018, OPER NEUROSURG, V15, P474, DOI 10.1093/ons/opx302
   Evans JJ, 2004, NEUROSURGERY, V55, P1036, DOI 10.1227/01.NEU.0000140822.64362.C6
   Flores BC, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13332
   HEROS RC, 1986, J NEUROSURG, V64, P559, DOI 10.3171/jns.1986.64.4.0559
   Inoue T, 2015, NEUROSURG FOCUS S1, V38
   Kubota H, 2014, WORLD NEUROSURG, V81, DOI 10.1016/j.wneu.2013.01.025
   Kubota H, 2013, ACTA NEUROCHIR, V155, P1517, DOI 10.1007/s00701-013-1715-z
   Leon-Ariza DS, 2017, WORLD NEUROSURG, V106, P477, DOI 10.1016/j.wneu.2017.07.029
   Luo W, 2016, WORLD NEUROSURG, V95, P117, DOI 10.1016/j.wneu.2016.07.094
   Meybodi AT, 2016, J NEUROSURG, V125, P909, DOI 10.3171/2015.8.JNS151411
   Rodriguez-Hernandez A, 2011, J NEUROSURG, V114, P1088, DOI 10.3171/2010.8.JNS10759
   Saito N, 2016, NEUROSURG REV, V39, P289, DOI 10.1007/s10143-015-0686-3
   SEN CN, 1990, NEUROSURGERY, V27, P197, DOI 10.1227/00006123-199008000-00004
   Seoane P, 2017, NEUROSURGERY, V81, P268, DOI 10.1093/neuros/nyw136
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E463
EP E472
DI 10.1016/j.wneu.2019.02.073
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400055
PM 30825626
DA 2020-05-12
ER

PT J
AU Morshed, RA
   Young, JS
   Safaee, M
   Sankaran, S
   Berger, MS
   McDermott, MW
   Hervey-Jumper, SL
AF Morshed, Ramin A.
   Young, Jacob S.
   Safaee, Michael
   Sankaran, Sujatha
   Berger, Mitchel S.
   McDermott, Michael W.
   Hervey-Jumper, Shawn L.
TI Delirium Risk Factors and Associated Outcomes in a Neurosurgical Cohort:
   A Case-Control Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cranial; Craniotomy; Delirium; Neurosurgery
ID INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; POSTOPERATIVE
   DELIRIUM; PREDICTIVE MODEL; SURGERY; MORTALITY; HEMATOMA; VALIDITY;
   LENGTH; IMPACT
AB OBJECTIVE: There are limited reports examining delirium in cohorts of neurosurgical patients across inpatient settings without separation based on subspecialty distinction. It is of interest to identify consistent delirium risk factors across various cranial pathologies and inpatient settings that will inform future interventional studies.
   METHODS: Delirium rates, patient and hospitalization risk factors, and clinical outcomes in 235 patients undergoing a cranial procedure were examined in a retrospective fashion.
   RESULTS: Fifty-two (22.1%) patients experienced delirium during their hospital stay. Patient factors predictive of delirium on univariate logistic regression were older age, a diagnosis of hydrocephalus or intracranial infection, transfer from an outside hospital, and admission through the emergency department. Hospitalization factors predictive of delirium included longer length of intensive care unit (ICU) stay, abnormal sodium values preceding delirium, a new postoperative infection, and the presence of a neurologic deficit. Using recursive partitioning, age >= 72.56 years and ICU length of stay >= 5 days were identified as critical thresholds for predicting delirium (odds ratio [OR] 4.61 and 18.2, respectively). On multivariate logistic regression analysis, age (unit OR 1.05), length of ICU stay (unit OR 1.2), and a neurologic deficit (OR 5.4) were predictive of delirium. Furthermore, delirium was also significantly associated with a longer length of admission as well as decreased likelihood for discharge home.
   CONCLUSIONS: Delirium is a frequent occurrence after neurosurgery with older age, longer ICU stay, and a neurologic deficit being consistent risk factors across inpatient settings. These results help identify at-risk patients for delirium on a neurosurgical service to enact interventions preemptively.
C1 [Morshed, Ramin A.; Young, Jacob S.; Safaee, Michael; Berger, Mitchel S.; McDermott, Michael W.; Hervey-Jumper, Shawn L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.
   [Sankaran, Sujatha] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
RP Morshed, RA (reprint author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.
EM ramin.morshed@ucsf.edu
RI Young, Jacob/AAE-6194-2020
CR Carlson JD, 2014, J CLIN NEUROSCI, V21, P1192, DOI 10.1016/j.jocn.2013.12.007
   Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703
   Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012
   Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2
   Fineberg SJ, 2013, SPINE, V38, P1790, DOI 10.1097/BRS.0b013e3182a0d507
   Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009
   Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1
   Gleason LJ, 2015, JAMA SURG, V150, P1134, DOI 10.1001/jamasurg.2015.2606
   Harasawa N, 2014, ARCH GERONTOL GERIAT, V59, P264, DOI 10.1016/j.archger.2014.05.007
   Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1
   INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005
   Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852
   Koster S, 2008, ANN THORAC SURG, V86, P1883, DOI 10.1016/j.athoracsur.2008.08.020
   Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721
   Lynch EP, 1998, ANESTH ANALG, V86, P781
   Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501
   Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857
   MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518
   MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134
   Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7
   Matano F, 2017, WORLD NEUROSURG, V103, P424, DOI 10.1016/j.wneu.2017.03.139
   Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92
   Naidech AM, 2016, NEUROCRIT CARE, V24, P397, DOI 10.1007/s12028-015-0210-1
   Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8
   Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d
   Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759
   Tanaka M, 2018, WORLD NEUROSURG, V114, pE518, DOI 10.1016/j.wneu.2018.03.021
   Thomason JWW, 2005, CRIT CARE, V9, pR375, DOI 10.1186/cc3729
   Wang J, 2018, J CLIN NURS, V27, P407, DOI 10.1111/jocn.13943
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E930
EP E936
DI 10.1016/j.wneu.2019.03.012
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400116
PM 30872201
DA 2020-05-12
ER

PT J
AU Moser, M
   Farshad, M
   Farshad-Amacker, NA
   Betz, M
   Spirig, JM
AF Moser, Manuel
   Farshad, Mazda
   Farshad-Amacker, Nadja A.
   Betz, Michael
   Spirig, Jose Miguel
TI Accuracy of Patient-Specific Template-Guided Versus Freehand Cervical
   Pedicle Screw Placement from C2 to C7: A Randomized Cadaveric Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Accuracy; Cervical spine; Patient-specific; Pedicle screw; Screw
   misplacement
ID INSERTION PROCEDURE; CLINICAL ACCURACY; DRILL TEMPLATE; SPINE;
   FLUOROSCOPY; FIXATION; RECONSTRUCTION; SAFETY
AB BACKGROUND: Dorsal spinal instrumentation with cervical pedicle screws (CPS) and rod constructs is performed for numerous pathologies of the cervical spine, although technically demanding. Screw misplacement is biomechanically disadvantageous and carries the risk of neurovascular sequelae. The aim of this study was to assess the accuracy of patient-specific, template-guided CPS placement from C2 to C7 compared with the freehand technique.
   METHODS: Patient-specific targeting guides were used for placement of 3.5 mm CPS from C2 to C7 in 4 cadaveric specimens. Template-guided instrumentation was randomized for each cervical level and side and the contralateral side instrumented likewise but with the freehand technique. No fluoroscopy was used at all, and the spinal canal was not opened for the freehand technique. Accuracy was assessed by computed tomography, grading perforations using a 2-mm increment method, and time efficiency was compared between the 2 techniques.
   RESULTS: In total, 48 screws were inserted with an equal distribution of 24 screws (50%) in each of the 2 groups. Outer pedicle width averaged 5.1 +/- 1.0 mm (range 2.7-7.8); 66.7% (n = 16) of template-guided versus 20.8% (n = 5) of freehand CPS were fully contained within the pedicle (P = 0.001), whereas 91.7% (n = 22) versus 50% (n = 12) were within the <2 mm "safe" zone (P = 0.001). The mean time for instrumentation per level and side was 03:09 +/- 01:37 minutes for the template-guided versus 02:32 +/- 01:04 minutes for the freehand technique (P = 0.132).
   CONCLUSIONS: In a cadaver model, template-guided CPS placement has a significantly greater accuracy than the freehand technique. This accuracy is comparable with navigated techniques reported in the literature.
C1 [Moser, Manuel; Farshad, Mazda; Betz, Michael; Spirig, Jose Miguel] Balgrist Univ Hosp Zurich, Dept Orthoped, Spine Div, Zurich, Switzerland.
   [Moser, Manuel] Cantonal Hosp Lucerne, Dept Spine Surg, Luzern, Switzerland.
   [Farshad-Amacker, Nadja A.] Balgrist Univ Hosp Zurich, Dept Radiol, Zurich, Switzerland.
RP Moser, M (reprint author), Balgrist Univ Hosp Zurich, Dept Orthoped, Spine Div, Zurich, Switzerland.; Moser, M (reprint author), Cantonal Hosp Lucerne, Dept Spine Surg, Luzern, Switzerland.
EM manuel.moser@luks.ch
OI Betz, Michael/0000-0002-0214-4003; Farshad-Amacker,
   Nadja/0000-0003-2258-8899; Moser, Manuel/0000-0003-4517-359X; Farshad,
   Mazda/0000-0002-7190-1127
CR ABUMI K, 1994, J SPINAL DISORD, V7, P19, DOI 10.1097/00002517-199407010-00003
   Abumi K, 2012, SPINE, V37, pE349, DOI 10.1097/BRS.0b013e318239cf1f
   Aoude AA, 2015, EUR SPINE J, V24, P990, DOI 10.1007/s00586-015-3853-x
   Bredow J, 2015, EUR SPINE J, V24, P2967, DOI 10.1007/s00586-015-3974-2
   Chachan S, 2018, EUR SPINE J, V27, P2729, DOI 10.1007/s00586-018-5585-1
   Dunlap BJ, 2010, EUR SPINE J, V19, P803, DOI 10.1007/s00586-010-1278-0
   Farshad M, 2017, EUR SPINE J, V26, P738, DOI 10.1007/s00586-016-4728-5
   GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004
   Hojo Y, 2014, EUR SPINE J, V23, P2166, DOI 10.1007/s00586-014-3470-0
   Ishikawa Y, 2011, J NEUROSURG-SPINE, V15, P472, DOI 10.3171/2011.6.SPINE10809
   Ishikawa Y, 2010, J NEUROSURG-SPINE, V13, P606, DOI 10.3171/2010.5.SPINE09993
   Ito Y, 2008, J NEUROSURG-SPINE, V9, P450, DOI 10.3171/SPI.2008.9.11.450
   Ito Z, 2012, J SPINAL DISORD TECH, V27, P1
   Johnston Todd L, 2006, Spine J, V6, P667
   Kaneyama S, 2015, SPINE, V40, pE341, DOI 10.1097/BRS.0000000000000772
   Karaikovic EE, 1997, SPINE, V22, P493, DOI 10.1097/00007632-199703010-00005
   Kawaguchi Y, 2012, SPINE, V37, P1983, DOI 10.1097/BRS.0b013e31825ab547
   Kothe R, 2004, SPINE, V29, P1869, DOI 10.1097/01.brs.0000137287.67388.0b
   Lamartina C, 2015, EUR SPINE J, V24, pS937, DOI 10.1007/s00586-015-4261-y
   Lee DH, 2011, EUR SPINE J, V20, P905, DOI 10.1007/s00586-010-1655-8
   Lee SH, 2012, J SPINAL DISORD TECH, V25, P415, DOI 10.1097/BSD.0b013e3182309657
   Lu S, 2011, COMPUT AIDED SURG, V16, P240, DOI 10.3109/10929088.2011.605173
   Lu S, 2009, SPINE, V34, pE959, DOI 10.1097/BRS.0b013e3181c09985
   Ludwig SC, 2000, SPINE, V25, P1655, DOI 10.1097/00007632-200007010-00009
   Miller RM, 1996, SPINE, V21, P2317, DOI 10.1097/00007632-199610150-00003
   Neo M, 2005, SPINE, V30, P2800, DOI 10.1097/01.brs.0000192297.07709.5d
   Park JH, 2014, SPINE, V39, P280, DOI 10.1097/BRS.0000000000000133
   Rao RD, 2008, J BONE JOINT SURG AM, V90A, P1914, DOI 10.2106/JBJS.G.01166
   Ryken T, 2009, J NEUROSURG-SPINE, V10, P21, DOI 10.3171/2008.9.SPI08229
   Shimokawa N, 2017, NEUROSURG REV, V40, P251, DOI 10.1007/s10143-016-0757-0
   Sugawara T, 2018, SPINE, V43, P1685, DOI 10.1097/BRS.0000000000002810
   Sugawara T, 2013, J NEUROSURG-SPINE, V19, P185, DOI 10.3171/2013.4.SPINE121059
   Tofuku K, 2012, EUR SPINE J, V21, P353, DOI 10.1007/s00586-011-1969-1
   Uehara M, 2014, EUR SPINE J, V23, P2189, DOI 10.1007/s00586-014-3502-9
   Wasinpongwanich K, 2014, NEUROL MED-CHIR, V54, P736, DOI 10.2176/nmc.oa.2013-0287
   Yoshihara H, 2013, J NEUROSURG-SPINE, V19, P614, DOI 10.3171/2013.8.SPINE13136
   Yu ZX, 2017, EUR SPINE J, V26, P2348, DOI 10.1007/s00586-017-5118-3
   Yukawa Y, 2006, J NEUROSURG-SPINE, V5, P488, DOI 10.3171/spi.2006.5.6.488
   Yukawa Y, 2009, EUR SPINE J, V18, P1293, DOI 10.1007/s00586-009-1032-7
   Zhang Hong-lei, 2011, Orthop Surg, V3, P52, DOI 10.1111/j.1757-7861.2010.00110.x
NR 40
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E803
EP E813
DI 10.1016/j.wneu.2019.02.152
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400100
PM 30862583
DA 2020-05-12
ER

PT J
AU Nagahama, A
   Goto, T
   Nagm, A
   Tanoue, Y
   Watanabe, Y
   Arima, H
   Nakajo, K
   Morisako, H
   Uda, T
   Ichinose, T
   Yamanaka, K
   Ohata, K
AF Nagahama, Atsufumi
   Goto, Takeo
   Nagm, Alhusain
   Tanoue, Yuta
   Watanabe, Yusuke
   Arima, Hironori
   Nakajo, Kosuke
   Morisako, Hiroki
   Uda, Takehiro
   Ichinose, Tsutomu
   Yamanaka, Kazuhiro
   Ohata, Kenji
TI Spheno-Orbital Meningioma: Surgical Outcomes and Management of
   Recurrence
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hyperostosis; Intraorbital extension; Recurrence; Spheno-orbital
   meningioma; Surgical strategy
ID GRADE; RADIOSURGERY; RADIOTHERAPY; RESECTION; SERIES
AB OBJECTIVE: Spheno-orbital meningioma (SOM) is a rare intracranial tumor that arises at the sphenoid wing, extends into the orbit, and is associated with hyperostosis of the sphenoid bone. These tumors often invade important neurovascular structures around the orbital apex, superior orbital fissure, and cavernous sinus. Aggressive tumor removal could achieve acceptable control; however, residual tumor can regrow. In this article, our surgical management and long-term outcomes are described.
   METHODS: Retrospectively, 12 patients with SOM who were treated surgically over a 21-year period were included. The clinical features and long-term tumor control were evaluated.
   RESULTS: Participants comprised 12 patients (5 men and 7 women). Mean follow-up was 74.4 months (range, 10-262 months). Ten patients (83%) were identified as World Health Organization grade 1 (WHO-I), and 2 patients (17%) were identified as WHO grade 2 (WHO-II). We encountered 4 recurrences, 2 of which needed additional surgeries. One patient with WHO-I (10%) experienced recurrence 10 years after the initial surgery and required a second surgery. Two patients with WHO-I (20%) showed slight regrowth of residual tumor around the superior orbital fissure; nevertheless, additive therapy was not recommended. Despite radical tumor resection, including eyeball and adjunctive radiotherapy for 1 patient with WHO-II, tumor recurrence in the posterior fossa was documented 19 years after the initial aggressive surgery.
   CONCLUSIONS: SOM follows a relatively benign clinical course given the invasive radiologic findings. Abnormal bone resection is paramount to prevent early-stage recurrence. Although intradural residual tumor might regrow, additional surgery could achieve reasonable long-term tumor control with better outcome.
C1 [Nagahama, Atsufumi; Goto, Takeo; Nagm, Alhusain; Tanoue, Yuta; Watanabe, Yusuke; Arima, Hironori; Nakajo, Kosuke; Morisako, Hiroki; Uda, Takehiro; Ichinose, Tsutomu; Yamanaka, Kazuhiro; Ohata, Kenji] Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.
   [Nagm, Alhusain] Al Azhar Univ, Dept Neurosurg, Fac Med Nasr City, Cairo, Egypt.
   [Nagm, Alhusain] Shinshu Univ, Dept Neurosurg, Sch Med, Matsumoto, Nagano, Japan.
RP Nagahama, A (reprint author), Osaka City Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan.
EM naga.atsu0327@gmail.com
RI Nagm, Alhusain/AAF-5478-2020
OI Nagahama, Atsufumi/0000-0002-8975-513X; Uda,
   Takehiro/0000-0001-6422-4140
CR Aboukais R, 2013, ACTA NEUROCHIR, V155, P1385, DOI 10.1007/s00701-013-1775-0
   Alzhrani G, 2017, CUREUS, V9, DOI 10.7759/cureus.1540
   Bikmaz K, 2007, J NEUROSURG, V107, P905, DOI 10.3171/JNS-07/11/0905
   Bowers CA, 2016, J NEUROSURG, V125, P544, DOI 10.3171/2015.9.JNS15761
   Cohen-Inbar O, 2016, NEUROSURGERY, V79, P58, DOI 10.1227/NEU.0000000000001045
   Debus J, 2001, J CLIN ONCOL, V19, P3547, DOI 10.1200/JCO.2001.19.15.3547
   Eisenhardt HC, 1938, MENINGIOMAS THEIR CL
   Flannery TJ, 2017, J NEUROSURG, V127, P67, DOI 10.3171/2009.8.JNS09695
   Freeman JL, 2017, WORLD NEUROSURG, V99, P369, DOI 10.1016/j.wneu.2016.12.063
   Gonen L, 2018, NEUROSURG REV, V41, P291, DOI 10.1007/s10143-017-0855-7
   Ichinose T, 2010, J NEUROSURG, V113, P1072, DOI 10.3171/2010.2.JNS091118
   MAROON JC, 1994, J NEUROSURG, V80, P202, DOI 10.3171/jns.1994.80.2.0202
   Nanda A, 2017, J NEUROSURG, V126, P201, DOI 10.3171/2016.1.JNS151842
   Oya S, 2012, J NEUROSURG, V117, P121, DOI 10.3171/2012.3.JNS111945
   Oya S, 2011, J NEUROSURG, V114, P1241, DOI 10.3171/2010.10.JNS101128
   Ringel F, 2007, NEUROSURGERY, V60, P214, DOI 10.1227/01.NEU.0000255415.4793/.IA
   Rogers L, 2018, J NEUROSURG, V129, P35, DOI 10.3171/2016.11.JNS161170
   Saeed P, 2011, BRIT J OPHTHALMOL, V95, P996, DOI 10.1136/bjo.2010.189050
   Scarone P, 2009, J NEUROSURG, V111, P1069, DOI 10.3171/2009.1.JNS081263
   Sheehan JP, 2015, J NEUROSURG, V122, P1479, DOI 10.3171/2014.10.JNS14139
   Shrivastava RK, 2005, J NEUROSURG, V103, P491, DOI 10.3171/jns.2005.103.3.0491
   SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22
   Terrier LM, 2018, WORLD NEUROSURG, V112, pE145, DOI 10.1016/j.wneu.2017.12.182
   Weber DC, 2018, RADIOTHER ONCOL, V128, P260, DOI 10.1016/j.radonc.2018.06.018
   Winther TL, 2017, WORLD NEUROSURG, V99, P104, DOI 10.1016/j.wneu.2016.11.034
   Zhi M, 2019, WORLD NEUROSURG, V122, pE1153, DOI 10.1016/j.wneu.2018.11.006
NR 26
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E679
EP E687
DI 10.1016/j.wneu.2019.02.123
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400083
PM 30844527
DA 2020-05-12
ER

PT J
AU Nakagawa, I
   Park, HS
   Kotsugi, M
   Wada, T
   Takeshima, Y
   Matsuda, R
   Nishimura, F
   Yamada, S
   Motoyama, Y
   Park, YS
   Kichikawa, K
   Nakase, H
AF Nakagawa, Ichiro
   Park, Hun Soo
   Kotsugi, Masashi
   Wada, Takeshi
   Takeshima, Yasuhiro
   Matsuda, Ryosuke
   Nishimura, Fumihiko
   Yamada, Syuichi
   Motoyama, Yasushi
   Park, Young Su
   Kichikawa, Kimihiko
   Nakase, Hiroyuki
TI Enhanced Hematoma Membrane on DynaCT Images During Middle Meningeal
   Artery Embolization for Persistently Recurrent Chronic Subdural Hematoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Cone-beam computed tomography; Embolization;
   Hematoma membrane; Middle meningeal artery
AB OBJECTIVE: Chronic subdural hematoma (CSDH) is generally treated by burr-hole irrigation, but it can recur despite repeating these procedures. Embolization of the middle meningeal artery (MMA) has recently been proposed as a curative treatment for CSDH, but evidence for the indication and timing of MMA embolization is not definitive. The present study retrospectively analyzed the effects and safety of MMA embolization among patients with persistent CSDH recurrence.
   METHODS: We retrospectively assessed data from 381 consecutive patients who underwent burr-hole irrigation for CSDH between 2009 and 2017. Recurrent symptomatic ipsilateral CSDH in 71 (18%) patients was treated by a second burr-hole irrigation, and 20 of them had a further symptomatic CSDH recurrence thereafter. Those with persistent ipsilateral CSDH recurrence were treated by MMA embolization. Before the MMA embolization procedures, the amount of hematoma membrane enhancement determined using superselective MMA angiography-DynaCT imaging was classified into 3 stages.
   RESULTS: Embolization of the MMA proceeded without perioperative complications or further CSDH recurrence. The interval between recurrence and the amount of hematoma membrane enhancement significantly correlated (first to second and second to third treatments: P = 0.012 and P = 0.017, respectively). The frequency of bilateral CSDH was significantly higher and the recurrence interval between the first and second treatments was significantly shorter in the repeated recurrences group compared with the recurrence group (P = 0.023 and P = 0.006, respectively).
   CONCLUSIONS: Repeatedly recurrent CSDH can be safely treated and cured by MMA embolization. Hematoma membrane enhancement pattern using DynaCT images can predict repeated recurrences CSDH.
C1 [Nakagawa, Ichiro; Park, Hun Soo; Kotsugi, Masashi; Takeshima, Yasuhiro; Matsuda, Ryosuke; Nishimura, Fumihiko; Yamada, Syuichi; Motoyama, Yasushi; Park, Young Su; Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, Nara, Japan.
   [Wada, Takeshi; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Nara, Japan.
RP Nakagawa, I (reprint author), Nara Med Univ, Dept Neurosurg, Nara, Japan.
EM nakagawa@naramed-u.ac.jp
OI yamada, shuichi/0000-0002-7278-3978
CR Abouzari M, 2009, NEUROSURG REV, V32, P479, DOI 10.1007/s10143-009-0215-3
   Ban SP, 2018, RADIOLOGY, V286, P909, DOI 10.1148/radiol.2017170053
   HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017
   Han MH, 2017, J NEUROSURG, V127, P1117, DOI 10.3171/2016.8.JNS16867
   Killeffer JA, 2000, NEUROSURG CLIN N AM, V11, P407, DOI 10.1016/S1042-3680(18)30102-5
   Kim E, 2017, WORLD NEUROSURG, V101, P520, DOI 10.1016/j.wneu.2017.02.070
   Kwon CS, 2018, WORLD NEUROSURG, V109, pE707, DOI 10.1016/j.wneu.2017.10.058
   Link TW, 2018, INTERV NEURORADIOL, V24, DOI 10.1177/1591019918769336
   Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715
   Mandai S, 2000, J NEUROSURG, V93, P686, DOI 10.3171/jns.2000.93.4.0686
   Matsumoto H, 2018, NEUROSURG REV, V41, P447, DOI 10.1007/s10143-017-0861-9
   Matsumoto H, 2018, J CLIN NEUROSCI, V49, P40, DOI 10.1016/j.jocn.2017.11.009
   Matsumoto H, 2017, WORLD NEUROSURG, V107, P706, DOI 10.1016/j.wneu.2017.08.101
   Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371
   Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256
   Namba K, 2009, INTERV NEURORADIOL, V15, P67, DOI 10.1177/159101990901500110
   Ohnishi H, 2017, NEUROL MED-CHIR, V57, P44, DOI 10.2176/nmc.tn.2016-0144
   ORLIN JR, 1991, ANAT RECORD, V230, P22, DOI 10.1002/ar.1092300104
   Osuka K, 2017, NEUROSURGERY, V80, P571, DOI 10.1093/neuros/nyw100
   Pont LMEB, 2012, EUR J NEUROL, V19, P1397, DOI 10.1111/j.1468-1331.2012.03768.x
   Qiu S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007290
   Ro HW, 2016, ACTA NEUROCHIR, V158, P135, DOI 10.1007/s00701-015-2625-z
   Srinivasan VM, 2016, J NEUROINTERV SURG, V8, P69, DOI 10.1136/neurintsurg-2014-011422
   Tempaku A, 2015, INTERV NEURORADIOL, V21, P366, DOI 10.1177/1591019915583224
   Toi H, 2018, J NEUROSURG, V128, P222, DOI 10.3171/2016.9.JNS16623
   Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17
   TYSON G, 1980, J NEUROSURG, V52, P776, DOI 10.3171/jns.1980.52.6.0776
   Xu M, 2016, WORLD NEUROSURG, V91, P23, DOI 10.1016/j.wneu.2016.03.067
   YAMASHIMA T, 1984, NEUROSURGERY, V15, P672, DOI 10.1227/00006123-198411000-00006
NR 29
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E473
EP E479
DI 10.1016/j.wneu.2019.02.074
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400056
PM 30825631
DA 2020-05-12
ER

PT J
AU Nia, AM
   Branch, DW
   Maynard, K
   Frank, T
   Zavlin, D
   Patterson, JT
   Lall, RR
AF Nia, Anna M.
   Branch, Daniel W.
   Maynard, Ken
   Frank, Thomas
   Zavlin, Dmitry
   Patterson, Joel T.
   Lall, Rishi R.
TI Metabolic Syndrome Associated with Increased Rates of Medical
   Complications After Intracranial Tumor Resection
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hypertension; Medical complications; Metabolic syndrome; Obesity;
   Postoperative outcomes; Supratentorial tumor resection; Surgical
   complications
ID PERIOPERATIVE OUTCOMES; RISK; DISPARITIES; DEFINITION; PREVALENCE;
   SURGERY; ADULTS
AB BACKGROUND: When diagnosed simultaneously, obesity, diabetes, and hypertension form a medical constellation called metabolic syndrome (MetS). The prevalence of MetS in Western cultures has been on a steady increase and MetS has been associated with increased postoperative complications in multiple surgical settings.
   OBJECTIVE: In this study, we evaluate the relationship between MetS and the outcomes of craniotomy for supratentorial brain tumor.
   METHODS: Cases of craniotomy for supratentorial brain tumors were extracted from the American College of Surgeons National Surgical Quality Improvement Program for 2012-2016. The 15,136 patients identified were divided into 2 cohorts based on the presence (4.1%) or absence (95.9%) of MetS. We compared the 2 cohorts for preoperative comorbidities, intraoperative details, and postoperative morbidity and mortality.
   RESULTS: Patients in the MetSD cohort were significantly older (63.4 vs. 56.1 years) and were more likely to show comorbidities of various organ systems (all P <= 0.05). However, operative times were similar (P = 0.573). The number of medical complications was almost double in patients with MetS (15.8% vs. 8.5%; P <= 0.001). Unplanned readmissions (14.6% vs. 10.4%; P = 0.004), reoperations (6.9% vs. 4.6%; P = 0.007), and mortality (5.6% vs. 2.9%; P <= 0.001) were also more frequent in our MetSD group. Nevertheless, surgical complications localized to the operative site were not statistically increased (7.4% vs. 5.8%; P = 0.098).
   CONCLUSIONS: A diagnosis of MetS does not seem to be associated with increased rates of surgical site events. However, neurosurgeons should be aware that these patients have a significantly higher likelihood of general medical complications, readmissions, reoperations, and death.
C1 [Nia, Anna M.; Branch, Daniel W.; Maynard, Ken; Frank, Thomas; Patterson, Joel T.; Lall, Rishi R.] Univ Texas Med Branch, Div Neurosurg, Galveston, TX 77555 USA.
   [Zavlin, Dmitry] Drexel Univ, Easton Hosp, Dept Surg, Coll Med, Easton, PA USA.
RP Nia, AM (reprint author), Univ Texas Med Branch, Div Neurosurg, Galveston, TX 77555 USA.
EM amnia@utmb.edu
OI Nia, Anna/0000-0003-2757-7267
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   American College of Surgeons, 2016, ACS NSQIP PART US DA
   American Medical Association, 2016, CPT 2017 PROF ED
   Ao HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117671
   Bhayani NH, 2012, SURGERY, V152, P218, DOI 10.1016/j.surg.2012.05.037
   Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337
   Chung AS, 2018, SPINE, V43, P661, DOI 10.1097/BRS.0000000000002397
   Curry WT, 2009, J NEURO-ONCOL, V93, P25, DOI 10.1007/s11060-009-9840-5
   Curry WT, 2005, NEUROSURGERY, V57, P406, DOI 10.1093/neurosurgery/57.2.406
   Davis Matthew C, 2012, Surg Neurol Int, V3, P49, DOI 10.4103/2152-7806.96071
   Della Valle AG, 2012, J ARTHROPLASTY, V27, P1743, DOI 10.1016/j.arth.2012.04.011
   Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Glance LG, 2010, ANESTHESIOLOGY, V113, P859, DOI 10.1097/ALN.0b013e3181eff32e
   Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   Karhade AV, 2017, WORLD NEUROSURG, V97, P205, DOI 10.1016/j.wneu.2016.09.056
   Kaur J, 2014, CARDIOL RES PRACT, DOI 10.1155/2014/943162
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Nayeri A, 2016, J NEUROL SURG PART B, V77, P226, DOI 10.1055/s-0035-1566122
   [R-Core-Team Computing R.F. f.S], 2014, R LANG ENV STAT COMP
   Schubert A, 1996, ANESTHESIOLOGY, V85, P513, DOI 10.1097/00000542-199609000-00010
   Schultheiss KE, 2009, NEUROSURGERY, V64, P316, DOI 10.1227/01.NEU.0000336329.90648.17
   Selph JP, 2014, UROLOGY, V83, P1051, DOI 10.1016/j.urology.2014.01.014
   Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623
   Tee MC, 2016, J GASTROINTEST SURG, V20, P189, DOI 10.1007/s11605-015-3007-9
   Watson Karol, 2006, Curr Cardiol Rep, V8, P433, DOI 10.1007/s11886-006-0101-3
   Zavlin D, 2018, SURG OBES RELAT DIS, V14, P206, DOI 10.1016/j.soard.2017.09.521
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1055
EP E1062
DI 10.1016/j.wneu.2019.03.046
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400133
PM 30878753
DA 2020-05-12
ER

PT J
AU Niu, L
   Zhou, XM
   Duan, CF
   Zhao, JP
   Sui, QL
   Liu, XJ
   Zhang, XX
AF Niu, Lei
   Zhou, Xiaoming
   Duan, Chongfeng
   Zhao, Jiping
   Sui, Qinglan
   Liu, Xuejun
   Zhang, Xuexi
TI Differentiation Researches on the Meningioma Subtypes by Radiomics from
   Contrast-Enhanced Magnetic Resonance Imaging: A Preliminary Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cross validation; Fisher discriminant analysis; Meningioma subtype; MRI;
   Radiomics
ID STEREOTACTIC RADIOSURGERY; PROGNOSTIC-FACTORS; INTRACRANIAL MENINGIOMAS;
   MALIGNANT MENINGIOMA; ATYPICAL MENINGIOMAS; TEXTURE ANALYSIS;
   TUMOR-CONTROL; OUTCOMES; EPIDEMIOLOGY; RADIOTHERAPY
AB BACKGROUND: Meningioma subtypes are one of the most common key points to the treatment and prognosis of patients. The purpose of this study was to investigate the differential diagnostic value of radiomics features on meningioma.
   METHODS: A total of 241 patients with meningioma who had undergone tumor resection were randomly selected including 80 with meningothelial meningioma, 80 with fibrous meningioma, and 81 with transitional meningioma. These meningiomas were divided into 4 groups including: meningothelial versus fibrous (group 1), fibrous versus transitional (group 2), meningothelial versus transitional (group 3), and meningothelial versus fibrous versus transitional (group 4). All patients were examined using the same magnetic resonance scanner (GE 3.0 T) and the preoperative contrast-enhanced T1-weighted images were available. Radiomics features from the contrast-enhanced T1-weighted images of 241 patients were evaluated by 2 experienced radiology specialists.
   RESULTS: A total of 385 radiomics features were extracted from the images of each patient. Several preprocessing methods were applied on the radiomics dataset to reduce the redundancy and highlight differences between different meningioma before the Fisher discrimination analysis was adopted and leave one out cross validation methods were used for the model validation. The differentiation accuracies of the Fisher discriminant analysis model for groups 1, 2, 3, and 4 were 99.4%, 98.8%, 100% and 100%, respectively; leave one out cross validation method was achieved for group 1, 2, 3, and 4 with the accuracies of 91.3%, 95.0%, 100%, and 94.2%, respectively.
   CONCLUSIONS: Radiomics features and the combined Fisher discriminant analysis could provide satisfactory performance in the preoperative differential diagnosis of meningioma subtypes and enable the potential ability for clinical application.U
C1 [Niu, Lei; Zhou, Xiaoming; Duan, Chongfeng; Zhao, Jiping; Sui, Qinglan; Liu, Xuejun] Qingdao Univ, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China.
   [Zhang, Xuexi] GE Healthcare, Shanghai, Peoples R China.
RP Liu, XJ (reprint author), Qingdao Univ, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China.
EM bncz@sina.com
CR Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006
   Aghi MK, 2009, NEUROSURGERY, V64, P56, DOI 10.1227/01.NEU.0000330399.55586.63
   Alcaide-Leon P, 2017, AM J NEURORADIOL, V38, P1145, DOI 10.3174/ajnr.A5173
   Bo LF, 2006, NEURAL COMPUT, V18, P961, DOI 10.1162/089976606775774642
   Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008
   Cawley GC, 2003, PATTERN RECOGN, V36, P2585, DOI 10.1016/S0031-3203(03)00136-5
   Chen H, 2011, ACTA NEUROCHIR, V153, P1769, DOI 10.1007/s00701-011-1052-z
   Claus EB, 2005, NEUROSURGERY, V57, P1088, DOI 10.1227/01.NEU.0000188281.91351.B9
   Davis FG, 2001, NEURO-ONCOLOGY, V3, P152, DOI 10.1093/neuonc/3.3.152
   Detti B, 2013, J NEURO-ONCOL, V115, P421, DOI 10.1007/s11060-013-1239-7
   DiBiase SJ, 2004, INT J RADIAT ONCOL, V60, P1515, DOI 10.1016/j.ijrobp.2004.05.073
   Flickinger JC, 2003, INT J RADIAT ONCOL, V56, P801, DOI 10.1016/S0360-3016(03)00126-3
   Goyal LK, 2000, INT J RADIAT ONCOL, V46, P57, DOI 10.1016/S0360-3016(99)00349-1
   Korah MP, 2010, INT J RADIAT ONCOL, V76, P181, DOI 10.1016/j.ijrobp.2009.01.066
   Metellus P, 2010, INT J RADIAT ONCOL, V78, P836, DOI 10.1016/j.ijrobp.2009.08.006
   Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455
   Narayan S, 2003, INT J RADIAT ONCOL, V56, P537, DOI 10.1016/S0360-3016(03)00005-1
   Nowak A, 2015, NEUROL NEUROCHIR POL, V49, P1, DOI 10.1016/j.pjnns.2014.11.003
   Palma L, 1997, J NEUROSURG, V86, P793, DOI 10.3171/jns.1997.86.5.0793
   Parekh V, 2016, EXPERT REV PRECIS ME, V1, P207, DOI 10.1080/23808993.2016.1164013
   Pasquier D, 2008, INT J RADIAT ONCOL, V71, P1388, DOI 10.1016/j.ijrobp.2007.12.020
   Paulsen F, 2012, INT J RADIAT ONCOL, V82, P773, DOI 10.1016/j.ijrobp.2010.11.018
   Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008
   Pollock BE, 2003, INT J RADIAT ONCOL, V55, P1000, DOI 10.1016/S0360-3016(02)04356-0
   Pollock BE, 2012, INT J RADIAT ONCOL, V83, P1414, DOI 10.1016/j.ijrobp.2011.10.033
   Pollock BE, 2012, CANCER-AM CANCER SOC, V118, P1048, DOI 10.1002/cncr.26362
   Rogers L, 2015, J NEUROSURG, V122, P4, DOI 10.3171/2014.7.JNS131644
   Shiroishi MS, 2016, NEUROSURG CLIN N AM, V27, P145, DOI 10.1016/j.nec.2015.11.007
   SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22
   Skogen K, 2016, EUR J RADIOL, V85, P824, DOI 10.1016/j.ejrad.2016.01.013
   Stafford SL, 1998, MAYO CLIN PROC, V73, P936, DOI 10.4065/73.10.936
   Stessin AM, 2012, J NEUROSURG, V117, P669, DOI 10.3171/2012.7.JNS111439
   Turbin RE, 2002, OPHTHALMOLOGY, V109, P890, DOI 10.1016/S0161-6420(02)01017-5
   Willis J, 2005, NEUROPATH APPL NEURO, V31, P141, DOI 10.1111/j.1365-2990.2004.00621.x
   Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150
   Zada G, 2011, J NEUROSURG, V114, P286, DOI 10.3171/2010.8.JNS10520
NR 36
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E646
EP E652
DI 10.1016/j.wneu.2019.02.109
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400079
PM 30831287
DA 2020-05-12
ER

PT J
AU Nurminen, V
   Kivipelto, L
   Kivisaari, R
   Niemela, M
   Lehecka, M
AF Nurminen, Ville
   Kivipelto, Leena
   Kivisaari, Riku
   Niemela, Mika
   Lehecka, Martin
TI Bypass Surgery for Complex Internal Carotid Artery Aneurysms: 39
   Consecutive Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bypass; Complex aneurysm; Cranial nerve dysfunction; ELANA; Intracranial
   aneurysm
ID HIGH-FLOW BYPASS; ISCHEMIC COMPLICATIONS; CEREBRAL REVASCULARIZATION;
   INTRACRANIAL BYPASS; GIANT ANEURYSMS; RISK-FACTORS; PATENCY; OCCLUSION
AB OBJECTIVE: Bypass surgery is a special technique used to treat complex internal carotid artery (ICA) aneurysms. The aim of this retrospective study is to provide a comprehensive description of treatment and outcome of complex ICA aneurysms at different ICA segments (cavernous, supraclinoid, ICA bifurcation) treated with bypass procedures.
   METHODS: We identified 39 consecutive patients with 41 complex ICA aneurysms that were treated with 44 bypass procedures between 1998 and 2016. We divided the aneurysms into 3 anatomic subgroups to review our treatment strategy. All the imaging studies and medical records were reviewed for relevant information.
   RESULTS: The aneurysm occlusion (n = 34, 83%) or flow modification (n = 5, 12%) was achieved in 39 aneurysms (95%). The long-term bypass patency rate was 68% (n = 30). Minor postoperative ischemia or hemorrhage was commonly seen (n = 20, 51%), but large-scale strokes were rare (n = 1, 3%). Preoperative dysfunction of extraocular muscles (cranial nerves III, IV, and VI) showed low-to-moderate improvement rates (20%-50%). Preoperative vision disturbance (cranial nerve II) improved seldom (22%). At the latest follow-up (mean; 51 months) 29 patients (74%) were independent (modified Rankin Scale <= 2).
   CONCLUSIONS: Bypass surgery for complex ICA aneurysms is a feasible treatment method with an acceptable risk profile. Patients should be informed of the uncertainty related to improvement of pretreatment cranial nerve dysfunctions.
C1 [Nurminen, Ville] Univ Helsinki, Dept Neurosurg, Helsinki, Finland.
   Helsinki Univ Hosp, Helsinki, Finland.
RP Nurminen, V (reprint author), Univ Helsinki, Dept Neurosurg, Helsinki, Finland.
EM ville.nurminen@hus.fi
OI Nurminen, Ville/0000-0003-0084-9349; Lehecka, Martin/0000-0003-4088-1116
CR Abdulrauf SI, 2017, WORLD NEUROSURG, V105, P557, DOI 10.1016/j.wneu.2017.04.016
   Andaluz N, 2011, SKULL BASE-INTERD AP, V21, P233, DOI 10.1055/s-0031-1280685
   ANDREWS RJ, 1993, NEUROSURGERY, V33, P1052
   Ban Seung Pil, 2017, Oper Neurosurg (Hagerstown), V13, P679, DOI 10.1093/ons/opx039
   Bremmer JP, 2009, J NEUROSURG, V110, P887, DOI 10.3171/2008.9.JNS08646
   Brinjikji W, 2013, J NEUROINTERV SURG, V5, P45, DOI 10.1136/neurintsurg-2011-010165
   Clarencon F, 2011, NEURORADIOLOGY, V53, P973, DOI 10.1007/s00234-010-0800-8
   Daou B, 2019, J NEUROSURG, V130, P1376, DOI 10.3171/2017.12.JNS163090
   Durner G, 2018, ACTA NEUROCHIR, V160, P1653, DOI 10.1007/s00701-018-3580-2
   Guedon A, 2016, J NEUROSURG, V125, P929, DOI 10.3171/2015.10.JNS15703
   Hahn CD, 2000, J NEURO-OPHTHALMOL, V20, P253, DOI 10.1097/00041327-200020040-00010
   Hanel RA, 2008, NEUROSURGERY, V62, P1289, DOI [10.1227/01.NEU.0000318092.86562.F, 10.1227/01.neu.0000333794.13844.d9]
   Horiuchi T, 2015, J NEUROSURG, V123, P460, DOI 10.3171/2014.12.JNS141218
   Ishishita Y, 2014, WORLD NEUROSURG, V82, P130, DOI 10.1016/j.wneu.2013.02.063
   Kalani MYS, 2014, NEUROSURGERY, V74, P482, DOI 10.1227/NEU.0000000000000312
   Kim LJ, 2014, NEUROSURGERY, V74, P51, DOI 10.1227/NEU.0000000000000192
   Matano F, 2017, WORLD NEUROSURG, V98, P182, DOI 10.1016/j.wneu.2016.10.082
   Matsukawa H, 2018, J NEUROSURG, V128, P1753, DOI 10.3171/2016.11.JNS161986
   Matsukawa H, 2017, NEUROSURGERY, V81, P672, DOI 10.1093/neuros/nyx075
   Matsukawa H, 2016, J NEUROSURG, V125, P239, DOI 10.3171/2015.5.JNS142524
   Matsukawa H, 2016, WORLD NEUROSURG, V85, P49, DOI 10.1016/j.wneu.2015.09.095
   Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260
   Murakami K, 2009, SURG NEUROL, V71, P434, DOI 10.1016/j.surneu.2008.03.036
   Ono H, 2018, NEUROSURG REV, V41, P655, DOI 10.1007/s10143-017-0911-3
   Ramanathan D, 2012, NEUROSURGERY, V70, P1442, DOI 10.1227/NEU.0b013e31824c046f
   REGLI L, 1995, J NEUROSURG, V83, P806, DOI 10.3171/jns.1995.83.5.0806
   Sekhar LN, 2008, NEUROSURGERY, V62, P1373, DOI [10.1227/01.NEU.0000315873.41953.74, 10.1227/01.neu.0000333803.97703.c6]
   Shimizu H, 2010, CLIN NEUROL NEUROSUR, V112, P32, DOI 10.1016/j.clineuro.2009.10.002
   Shimizu K, 2017, J CLIN NEUROSCI, V37, P73, DOI 10.1016/j.jocn.2016.11.009
   Sia SF, 2011, NEUROSURGERY, V69, P308, DOI 10.1227/NEU.0b013e318214b300
   SPETZLER RF, 1980, J NEUROSURG, V53, P22, DOI 10.3171/jns.1980.53.1.0022
   Straus DC, 2017, NEUROSURGERY, V80, P759, DOI 10.1093/neuros/nyx064
   Surdell Daniel L, 2008, Neurosurg Focus, V24, pE21, DOI 10.3171/FOC.2008.25.2.E21
   Trivelato FP, 2019, J NEUROSURG, V130, P543, DOI 10.3171/2017.10.JNS172175
   Verweij BH, 2008, NEUROSURGERY S, V62, P328
   Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401
NR 36
TC 0
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E453
EP E462
DI 10.1016/j.wneu.2019.02.072
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400054
PM 30825624
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Oertel, J
   Keiner, D
AF Oertel, Joachim
   Keiner, Doerthe
TI Visual-Controlled Endoscopic Biopsy of Paraventricular Intraparenchymal
   Tumors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intraparenchymal tumors; Neuroendoscopy; Neuronavigation; Tumor biopsy
ID GUIDED STEREOTACTIC BIOPSY; NEUROENDOSCOPIC BIOPSY; BRAIN-TUMORS; 3RD
   VENTRICULOSTOMY; FRAMELESS; ACCURACY; HEMORRHAGE; EXPERIENCE; DIAGNOSIS;
   SAFETY
AB OBJECTIVE: Frame-based stereotaxy represents the gold standard for biopsy of deep-seated lesions. Visual control of possible bleeding in these lesions is not possible. Neuroendoscopic biopsy represents an alternative procedure for tissue sampling in deep-seated intraventricular lesions. The authors present a technique for transventricular-navigated endoscopic biopsy of lesions that are located in the paraventricular region.
   METHODS: Biopsy of paraventricular pathologies was performed in 6 male and 6 female patients between March 2013 and September 2018. The patient age ranged from 18 to 82 years. All patients underwent a pure endoscopic procedure over a burr hole trepanation supported by frameless navigation of the sedan probe.
   RESULTS: Histologic diagnoses were established in all biopsies. In all patients, a direct control of the biopsy area was feasible, and hemostasis could be obtained. In 5 patients, endoscopic third ventriculostomy was performed first due to obstructive hydrocephalus. In 1 patient suffering from obstructive hydrocephalus, a pellucidotomy was performed. In 9 cases, the initial postoperative course was uneventful. Three patients suffered from persistent hydrocephalus and had to be treated with ventriculoperitoneal shunt insertion.
   CONCLUSIONS: Endoscopically conducted biopsies with the aid of navigated tracking of the probe represent a possible additional technique in selected paraventricular intraparenchymal pathologies. The endoscopic approach enables the direct visualization of the intraventricular surface and its vessels. In contrast to standard stereotactic biopsy, direct visual control of hemostasis can be obtained even in paraventricular tumors.
C1 [Oertel, Joachim] Saarland Univ, Med Ctr, Dept Neurosurg, Homburg, Germany.
   Saarland Univ, Fac Med, Homburg, Germany.
RP Oertel, J (reprint author), Saarland Univ, Med Ctr, Dept Neurosurg, Homburg, Germany.
EM oertelj@freenet.de
RI Keiner, Doerthe/AAK-1195-2020
OI Keiner, Doerthe/0000-0003-2975-7704
CR Antes S, 2016, CHILD NERV SYST, V32, P359, DOI 10.1007/s00381-015-2902-4
   Bjartmarz H, 2007, STEREOT FUNCT NEUROS, V85, P235, DOI 10.1159/000103262
   Callovini GM, 1998, MINIM INVAS NEUROSUR, V41, P187, DOI 10.1055/s-2008-1052039
   Chrastina J, 2014, J NEUROL SURG PART A, V75, P110, DOI 10.1055/s-0032-1320032
   Constantini S, 2013, J NEUROSURG-PEDIATR, V11, P704, DOI 10.3171/2013.3.PEDS12416
   Dammers R, 2008, ACTA NEUROCHIR, V150, P23, DOI 10.1007/s00701-007-1473-x
   Decq P, 2000, J NEUROSURG, V93, P509, DOI 10.3171/jns.2000.93.3.0509
   Di Vincenzo J, 2014, J NEUROL SURG PART A, V75, P20, DOI 10.1055/s-0032-1328953
   Fiorindi A, 2008, ACTA NEUROCHIR, V150, P1235, DOI 10.1007/s00701-008-0155-7
   Gaab MR, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2012.02.032
   Gaab MR, 1998, J NEUROSURG, V88, P496, DOI 10.3171/jns.1998.88.3.0496
   Grossmann R, 2005, ACTA NEUROCHIR WIEN, V150, P23
   Grunert P, 2013, MINIM INVASIVE SURG, V2013, DOI 10.1155/2013/171369
   GRUNERT P, 1994, NEUROSURG REV, V17, P59, DOI 10.1007/BF00309989
   Hall WA, 1998, CANCER, V82, P1749, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2
   Hellwig D, 2003, NEUROSURGERY, V52, P525, DOI 10.1227/01.NEU.0000047671.27057.55
   Hellwig D, 1999, NEUROL RES, V21, P67, DOI 10.1080/01616412.1999.11740895
   Iijima K, 2015, J NEUROSURG, V123, P978, DOI 10.3171/2014.10.JNS14963
   Knaus H, 2011, CHILD NERV SYST, V27, P1233, DOI 10.1007/s00381-011-1405-1
   Kongkham PN, 2008, CAN J NEUROL SCI, V35, P79, DOI 10.1017/S0317167100007605
   Kreth FW, 2001, ACTA NEUROCHIR, V143, P539, DOI 10.1007/s007010170058
   Lee MH, 2014, CHILD NERV SYST, V30, P1055, DOI 10.1007/s00381-014-2367-x
   Li CZ, 2016, WORLD NEUROSURG, V88, P548, DOI 10.1016/j.wneu.2015.10.041
   LOBATO RD, 1987, ACTA NEUROCHIR, V87, P14, DOI 10.1007/BF02076009
   LUNSFORD LD, 1984, SURG NEUROL, V22, P222
   McGirt MJ, 2005, J NEUROSURG, V102, P897, DOI 10.3171/jns.2005.102.5.0897
   Munyon CN, 2013, STEREOT FUNCT NEUROS, V91, P399, DOI 10.1159/000351524
   Nagahisa S, 2013, NEUROSURG REV, V36, P595, DOI 10.1007/s10143-013-0467-9
   Oertel JMK, 2009, J NEUROSURG, V111, P1119, DOI 10.3171/2009.4.JNS081149
   Oertel JMK, 2009, J NEUROSURG-PEDIATR, V3, P81, DOI 10.3171/2008.11.PEDS0887
   Oppido PA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10326
   Ortler M, 2011, NEUROSURGERY, V68, P881, DOI 10.1227/NEU.0b013e3182098e31
   Quinones-Hinojosa A, 2006, J NEURO-ONCOL, V76, P65, DOI 10.1007/s11060-005-2915-z
   Ragel BT, 2015, J NEURO-ONCOL, V125, P481, DOI 10.1007/s11060-015-1866-2
   Rohde V, 2012, NEUROSURG REV, V35, P351, DOI 10.1007/s10143-011-0369-7
   Sato S, 2018, STEREOT FUNCT NEUROS, V96, P244, DOI 10.1159/000492057
   Schroeder HWS, 2008, NEUROSURGERY, V62, P1084, DOI [10.1227/01.NEU.0000249242.17805.E3, 10.1227/01.neu.0000333774.81563.d8]
   Schroeder HWS, 2001, J NEUROSURG, V94, P72, DOI 10.3171/jns.2001.94.1.0072
   Shakal AAS, 2014, J NEUROL SURG PART A, V75, P177, DOI 10.1055/s-0032-1325633
   Somji M, 2016, WORLD NEUROSURG, V85, P315, DOI 10.1016/j.wneu.2015.09.011
   Thomas D G, 1989, Br J Neurosurg, V3, P321, DOI 10.3109/02688698909002810
   Tirakotai W, 2007, CHILD NERV SYST, V23, P653, DOI 10.1007/s00381-007-0328-3
   Yamada K, 2004, J CLIN NEUROSCI, V11, P263, DOI 10.1016/j.jocn.2003.03.004
NR 43
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E208
EP E218
DI 10.1016/j.wneu.2019.02.012
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400027
PM 30797910
DA 2020-05-12
ER

PT J
AU Ogilvy, CS
   Jordan, NJ
   Ascanio, LC
   Enriquez-Marulanda, AA
   Salem, MM
   Moore, JM
   Thomas, AJ
AF Ogilvy, Christopher S.
   Jordan, Noah J.
   Ascanio, Luis C.
   Enriquez-Marulanda, Alejandro A.
   Salem, Mohamed M.
   Moore, Justin M.
   Thomas, Ajith J.
TI Surgical and Endovascular Comprehensive Treatment Outcomes of Unruptured
   Intracranial Aneurysms: Reduction of Treatment Bias
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endovascular treatment; Intracranial aneurysm; Microsurgical clipping
ID CEREBRAL ANEURYSMS; COILING; SAFETY
AB BACKGROUND: Determining the risks of treatment of unruptured intracranial aneurysms is critical in the decision-making process of management. Most studies have reported the results for endovascular or surgical management. Our objective was to better delineate the risk estimates for unruptured intracranial aneurysms treated with surgical or endovascular techniques in a comprehensive fashion, according to the patients' risk profiles.
   METHODS: Data were gathered from 553 patients with 658 unruptured intracranial aneurysms treated at a single institution from 2014 to 2017. The decision to treat was determined by a projected morbidity that was lower than the natural history rupture risk. Data on aneurysm size, location, patient age, and outcome at the last clinical visit (modified Rankin scale scores) were collected and analyzed retrospectively.
   RESULTS: The mean patient age was 59 years, and the mean lesion size was 7.3 mm. Microsurgical clipping was used in 251 lesions (38.2%), endovascular coiling in 70 (10.6%), stent-assisted coiling in 89 (13.5%), and a pipeline embolization device in 248 (37.7%). Complications from the procedures or during hospital admission occurred 66 lesions (10% of the total). Of these 66 complications, 28 (4.32% of the total) were non-neurological, treated, and resolved without permanent morbidity. Neurologic complications occurred in 38 procedures (5.7% of the total). Of these, 7 (1%) resulted in a permanent poor outcome (modified Rankin scale score, 3-6).
   CONCLUSION: Aneurysmal obliteration using endovascular and surgical approaches in a comprehensive fashion has low treatment risks for unruptured aneurysms. The nomograms generated are useful in the discussion with patients and families regarding the risks of total institutional treatment of unruptured aneurysms.
C1 [Ogilvy, Christopher S.; Jordan, Noah J.; Ascanio, Luis C.; Enriquez-Marulanda, Alejandro A.; Salem, Mohamed M.; Moore, Justin M.; Thomas, Ajith J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Neurosurg Serv, Boston, MA 02115 USA.
RP Ogilvy, CS (reprint author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Neurosurg Serv, Boston, MA 02115 USA.
EM cogilvy@bidmc.harvard.edu
OI Enriquez-Marulanda, Alejandro/0000-0001-6091-390X; Ascanio,
   Luis/0000-0001-9914-1599
CR Alexander BL, 2009, SURG NEUROL, V72, P596, DOI 10.1016/j.surneu.2009.06.027
   Algra AM, 2019, JAMA NEUROL, V76, P282, DOI 10.1001/jamaneurol.2018.4165
   Brinjikji W, 2011, AM J NEURORADIOL, V32, P1071, DOI 10.3174/ajnr.A2453
   Darsaut TE, 2017, J NEUROL NEUROSUR PS, V88, P663, DOI 10.1136/jnnp-2016-315433
   FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044
   Gupta R, 2016, WORLD NEUROSURG, V96, P285, DOI 10.1016/j.wneu.2016.09.013
   Ji WJ, 2016, STROKE, V47, P971, DOI 10.1161/STROKEAHA.115.012097
   Kim YD, 2018, J NEUROINTERV SURG, V10, P1218, DOI 10.1136/neurintsurg-2018-013757
   KING JT, 1994, J NEUROSURG, V81, P837, DOI 10.3171/jns.1994.81.6.0837
   Maragkos GA, 2019, WORLD NEUROSURG, V121, pE500, DOI 10.1016/j.wneu.2018.09.148
   Mazur MD, 2018, J NEUROL NEUROSUR PS, V89, P277, DOI 10.1136/jnnp-2016-314477
   Morgan MK, 2016, NEUROSURGERY, V78, P648, DOI 10.1227/NEU.0000000000001113
   Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260
   Naggara ON, 2012, RADIOLOGY, V263, P828, DOI 10.1148/radiol.12112114
   Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982
   Ogilvy CS, 2003, NEUROSURGERY, V52, P82, DOI 10.1097/00006123-200301000-00010
   Park JC, 2016, J NEUROSURG, V124, P777, DOI 10.3171/2015.3.JNS142835
   Pierot L, 2008, STROKE, V39, P2497, DOI 10.1161/STROKEAHA.107.512756
   Qureshi AI, 2014, NEUROSURGERY, V75, P380, DOI 10.1227/NEU.0000000000000450
   Ruan CH, 2015, BRIT J NEUROSURG, V29, P485, DOI 10.3109/02688697.2015.1023771
   Shigematsu T, 2013, STROKE, V44, P2735, DOI 10.1161/STROKEAHA.111.000609
   Shimizu K, 2016, AM J NEURORADIOL, V37, P679, DOI 10.3174/ajnr.A4577
   VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
NR 24
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E878
EP E887
DI 10.1016/j.wneu.2019.03.005
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400109
PM 30872200
DA 2020-05-12
ER

PT J
AU Oh, SH
   Choi, JH
   Kim, BS
   Lee, KS
   Shin, YS
AF Oh, Sol Hooy
   Choi, Jai Ho
   Kim, Bum-Soo
   Lee, Kwan Sung
   Shin, Yong Sam
TI Treatment Outcomes According to Various Treatment Modalities for
   Intracranial Dural Arteriovenous Fistulas in the Onyx Era: A 10-Year
   Single-Center Experience
SO WORLD NEUROSURGERY
LA English
DT Article
DE Dural arteriovenous fistula; Embolization; Radiosurgery; Surgery
ID TRANSARTERIAL EMBOLIZATION; STEREOTACTIC RADIOSURGERY; TRANSVENOUS
   EMBOLIZATION; MULTIMODALITY TREATMENT; SURGICAL-TREATMENT;
   MALFORMATIONS; DRAINAGE; CLASSIFICATION; MANAGEMENT; OCCLUSION
AB BACKGROUND: Although transarterial embolization (TAE) with Onyx has become popular for the treatment of dural arteriovenous fistulas (DAVFs), transvenous embolization (TVE), surgery, and radiosurgery have continued to have a role. The aim of the present study was to compare the treatment outcomes stratified by the different treatment modalities.
   METHODS: The data from 92 patients with DAVFs treated from January 2009 to June 2018 were retrospectively reviewed. The treatment strategies were decided by a multidisciplinary team according to the patient's clinical status and angiographic findings. The clinical and radiologic data were analyzed and correlated with the treatment modality.
   RESULTS: A total of 101 procedures were performed in the 92 patients. TAE, TVE, surgery, and radiosurgery were performed in 31, 49, 12, and 9 procedures, respectively. Complete and near complete occlusion was achieved in 13 cases treated with TAE (41.9%), 41 treated with TVE (83.7%), and 10 with surgery (83.3%), as shown on immediate postprocedural angiography (P < 0.001). Retreatment was needed in 9 patients in the TAE group and none in the TVE or surgery groups (P < 0.001). Surgery (n = 1), TVE (n = 3), TAE (n = 1), and radiosurgery (n = 4) were used for patients requiring retreatment. At the last follow-up examination (mean, 26.5 +/- 23.9 months), 66 of 72 DAVFs (91.6%) showed angiographic complete occlusion. Clinically, the initial symptoms had disappeared or improved in 87 of 90 patients (96.7%) at the last follow-up evaluation (mean, 26.4 +/- 26.8 months).
   CONCLUSIONS: Even in the Onyx era, other treatment modalities still have important roles, as shown in the present study. Therefore, the selection of the appropriate treatment modality should be individualized by the angiographic findings and clinical symptoms.
C1 [Oh, Sol Hooy; Choi, Jai Ho; Lee, Kwan Sung; Shin, Yong Sam] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
   [Kim, Bum-Soo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.
RP Choi, JH (reprint author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
EM bivalvia@catholic.ac.kr
RI KIM, Bum-soo/F-3086-2018
OI KIM, Bum-soo/0000-0002-3870-6813
CR Abud TG, 2011, AM J NEURORADIOL, V32, P2185, DOI 10.3174/ajnr.A2702
   Abud TG, 2018, CLIN NEURORADIOL, V28, P579, DOI 10.1007/s00062-017-0615-7
   Ambekar S, 2016, J NEUROSURG, V124, P1123, DOI 10.3171/2015.3.JNS1558
   Azuma M, 2015, MAGN RESON MED SCI, V14, P285, DOI 10.2463/mrms.2014-0120
   BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166
   BROWN RD, 1994, J NEUROSURG, V81, P531, DOI 10.3171/jns.1994.81.4.0531
   Chandra RV, 2014, AM J NEURORADIOL, V35, P1793, DOI 10.3174/ajnr.A3938
   Chen CJ, 2015, J NEUROSURG, V122, P353, DOI 10.3171/2014.10.JNS14871
   Choi JH, 2017, ACTA NEUROCHIR, V159, P1479, DOI 10.1007/s00701-017-3226-9
   Choi JH, 2015, NEURORADIOLOGY, V57, P1153, DOI 10.1007/s00234-015-1597-2
   Choo DM, 2016, INTERV NEURORADIOL, V22, P212, DOI 10.1177/1591019915622170
   COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961
   Collice M, 2000, NEUROSURGERY, V47, P56
   da Costa LB, 2007, ACTA NEUROCHIR, V149, P1103, DOI 10.1007/s00701-007-1316-9
   De Keukeleire K, 2011, J NEUROINTERV SURG, V3, P224, DOI 10.1136/jnis.2010.004119
   Elhammady MS, 2010, J NEUROSURG, V112, P589, DOI 10.3171/2009.6.JNS09132
   Fifi Johanna, 2013, J Neurointerv Surg, V5, pe5, DOI 10.1136/neurintsurg-2011-010179
   FRANSEN P, 1993, ACTA NEUROCHIR, V121, P26, DOI 10.1007/BF01405179
   Friedman JA, 2001, J NEUROSURG, V94, P886, DOI 10.3171/jns.2001.94.6.0886
   Gemmete JJ, 2009, NEUROIMAG CLIN N AM, V19, P241, DOI 10.1016/j.nic.2009.01.006
   Gruter BE, 2018, WORLD NEUROSURG, V120, pE932, DOI 10.1016/j.wneu.2018.08.193
   Herial NA, 2015, OPER NEUROSURG, V11, P404, DOI 10.1227/NEU.0000000000000839
   Herial Nabeel A, 2014, J Vasc Interv Neurol, V7, P64
   Hirai Toshinori, 2003, Radiat Med, V21, P205
   Kim B, 2016, WORLD NEUROSURG, V88, P609, DOI 10.1016/j.wneu.2015.10.052
   Kiyosue H, 2004, RADIOGRAPHICS, V24, P1637, DOI 10.1148/rg.246045026
   Kong DS, 2007, SURG NEUROL, V68, P72, DOI 10.1016/j.surneu.2006.10.018
   Kwon BJ, 2005, AM J NEURORADIOL, V26, P2500
   LEWIS AI, 1994, J NEUROSURG, V81, P851, DOI 10.3171/jns.1994.81.6.0851
   Link MJ, 1996, J NEUROSURG, V84, P804, DOI 10.3171/jns.1996.84.5.0804
   Maimon S, 2011, AM J NEURORADIOL, V32, P2180, DOI 10.3174/ajnr.A2728
   Mantilla D, 2018, J NEUROINTERV SURG, V10, P958, DOI 10.1136/neurintsurg-2017-013476
   Mironov A, 1998, AM J NEURORADIOL, V19, P389
   Natarajan SK, 2008, NEUROSURGERY, V62, P1213, DOI 10.1227/01.neu.0000333293.74986.e5
   Natarajan SK, 2010, WORLD NEUROSURG, V73, P365, DOI 10.1016/j.wneu.2010.01.009
   Nogueira RG, 2008, AM J NEURORADIOL, V29, P91, DOI 10.3174/ajnr.A0768
   Nogueira RG, 2009, NEUROSURGERY, V64, P197, DOI 10.1227/01.NEU.0000335157.90249.97
   Perrini P, 2004, ACTA NEUROCHIR, V146, P1279, DOI 10.1007/s00701-004-0365-6
   Pierot L, 1998, NEUROSURGERY, V42, P194, DOI 10.1097/00006123-199801000-00044
   Piippo A, 2013, J NEUROSURG, V119, P164, DOI 10.3171/2013.3.JNS121547
   Piippo A, 2013, J NEUROSURG, V118, P923, DOI 10.3171/2012.11.JNS111604
   Rabinov JD, 2013, J NEUROINTERV SURG, V5, P306, DOI 10.1136/neurintsurg-2011-010237
   Roy D, 1997, NEUROSURGERY, V40, P1133, DOI 10.1097/00006123-199706000-00004
   Sarma D, 2003, EUR J RADIOL, V46, P206, DOI 10.1016/S0720-048X(03)00092-5
   Singh V, 2008, NEUROSURGERY, V62, P628, DOI 10.1227/01.neu.0000317311.69697.fc
   Soderman M, 2008, STROKE, V39, P1735, DOI 10.1161/STROKEAHA.107.506485
   Suzuki S, 2006, AM J NEURORADIOL, V27, P1346
   Ushikoshi S, 2002, SURG NEUROL, V57, P253, DOI 10.1016/S0090-3019(02)00641-9
   van Dijk JMC, 2002, STROKE, V33, P1233, DOI 10.1161/01.STR.0000014772.02908.44
   Zipfel GJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS0928
NR 50
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E825
EP E834
DI 10.1016/j.wneu.2019.02.173
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400103
PM 30862595
DA 2020-05-12
ER

PT J
AU Ohba, S
   Yamada, Y
   Murayama, K
   Sandika, E
   Sasaki, H
   Yamada, S
   Abe, M
   Hasegawa, M
   Hirose, Y
AF Ohba, Shigeo
   Yamada, Yasuhiro
   Murayama, Kazuhiro
   Sandika, Eriel
   Sasaki, Hikaru
   Yamada, Seiji
   Abe, Masato
   Hasegawa, Mitsuhiro
   Hirose, Yuichi
TI c-Met Expression Is a Useful Marker for Prognosis Prediction in
   IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chromosome 7; c-Met; Glioma; IDH; Immunohistochemistry; MIB-1 index
ID PROTEIN EXPRESSION; ASTROCYTIC TUMORS; OVEREXPRESSION; TEMOZOLOMIDE
AB OBJECTIVE: c-Met has been shown to be associated with tumor growth in several human cancers. This study aims to evaluate the correlation between the c-Met expression and histopathologic/clinical characteristics.
   METHODS: A total of 153 patients with histologically defined World Health Organization grade IIeIV diffuse astrocytic and oligodendroglial tumors were analyzed.
   RESULTS: For each histopathologic diagnosis, the number of cases and positive rate of c-Met expression are as follows: oligodendroglioma, IDH-mutant, and 1p19q codeletion (OD): 16 cases, 6.3%; anaplastic oligodendroglioma, IDHmutant, and 1p19q codeletion (AO): 11 cases, 36.4%; diffuse astrocytoma (DA), IDH-mutant: 21 cases, 28.6%; anaplastic astrocytoma (AA), IDH-mutant: 15 cases, 20%; glioblastoma, IDH-mutant: 2, 100%, DA, IDH-wildtype: 9 cases, 33.3%; AA, IDH-wildtype: 20 cases, 30.0%; and glioblastoma, IDH-wildtype: 59 cases, 52.5%. c-Met expression was correlated with progression-free survival in oligodendroglial tumors and glioblastoma, IDH-wildtype. Furthermore, it was correlated with overall survival in AO, oligodendroglial tumors, DA, IDH-mutant, DA, IDH-wildtype, and glioblastoma, IDH-wildtype, and tend to be correlated with overall survival in IDHmutant lower-grade astrocytic tumors.
   CONCLUSIONS: c-Met expression was revealed to be a useful marker for prognosis prediction in IDH-mutant lower-grade gliomas and glioblastoma, IDH-wildtype, representing a new independent prognostic marker that can be easily measured.
C1 [Ohba, Shigeo; Hasegawa, Mitsuhiro; Hirose, Yuichi] Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan.
   [Murayama, Kazuhiro] Fujita Hlth Univ, Dept Radiol, Toyoake, Aichi, Japan.
   [Yamada, Seiji; Abe, Masato] Fujita Hlth Univ, Dept Pathol, Toyoake, Aichi, Japan.
   [Abe, Masato] Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan.
   [Yamada, Yasuhiro] Fujita Hlth Univ, Dept Neurosurg, Banbuntane Hotokukai Hosp, Toyoake, Aichi, Japan.
   [Sandika, Eriel; Sasaki, Hikaru] Keio Univ, Sch Med, Dept Neurosurg, Tokyo, Japan.
RP Ohba, S (reprint author), Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan.
EM shigeo.ohba@gmail.com
CR Aoki K, 2018, NEURO-ONCOLOGY, V20, P66, DOI 10.1093/neuonc/nox132
   Awad AJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14520
   Bell EH, 2017, JAMA ONCOL, V3, P784, DOI 10.1001/jamaoncol.2016.6020
   Ezaki T, 2011, MOL MED REP, V4, P1101, DOI 10.3892/mmr.2011.573
   Faria MHG, 2006, NEUROPATHOLOGY, V26, P519, DOI 10.1111/j.1440-1789.2006.00724.x
   Hattori N, 2016, CANCER SCI, V107, P1159, DOI 10.1111/cas.12969
   Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331
   Hirose Y, 1998, ACTA NEUROPATHOL, V95, P345, DOI 10.1007/s004010050809
   Hirose Y, 2001, J MOL DIAGN, V3, P62, DOI 10.1016/S1525-1578(10)60653-8
   Hirose Y, 1998, NEUROL MED-CHIR, V38, P851, DOI 10.2176/nmc.38.851
   Hirose Y, 2011, NEUROSURGERY, V69, P376, DOI 10.1227/NEU.0b013e318212bcd8
   Huang MG, 2016, J CLIN INVEST, V126, P1801, DOI 10.1172/JCI84876
   Kong DS, 2009, CANCER-AM CANCER SOC, V115, P140, DOI 10.1002/cncr.23972
   Kwak Y, 2015, INT J CLIN EXP PATHO, V8, P14932
   Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21141
   Liu W, 2011, J CLIN NEUROSCI, V18, P119, DOI 10.1016/j.jocn.2010.05.010
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Nabeshima K, 1997, HISTOPATHOLOGY, V31, P436, DOI 10.1046/j.1365-2559.1997.3010889.x
   Olmez OF, 2014, CLIN TRANSL ONCOL, V16, P173, DOI 10.1007/s12094-013-1059-4
   Ozasa H, 2014, CANCER SCI, V105, P1032, DOI 10.1111/cas.12447
   Petterson SA, 2015, J NEURO-ONCOL, V122, P517, DOI 10.1007/s11060-015-1723-3
   Pierscianek D, 2013, BRAIN PATHOL, V23, P13, DOI 10.1111/j.1750-3639.2012.00609.x
   Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y
NR 23
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1042
EP E1049
DI 10.1016/j.wneu.2019.03.040
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400131
PM 30878754
DA 2020-05-12
ER

PT J
AU Oka, M
   Kushamae, M
   Aoki, T
   Yamaguchi, T
   Kitazato, K
   Abekura, Y
   Kawamata, T
   Mizutani, T
   Miyamoto, S
   Takagi, Y
AF Oka, Mieko
   Kushamae, Mika
   Aoki, Tomohiro
   Yamaguchi, Tadashi
   Kitazato, Keiko
   Abekura, Yu
   Kawamata, Takakazu
   Mizutani, Tohru
   Miyamoto, Susumu
   Takagi, Yasushi
TI KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Endothelial cell; KRAS; Somatic mutation
ID SMOOTH-MUSCLE-CELLS; PROGNOSTIC VALUE; EXPRESSION; ACTIVATION; RISK
AB BACKGROUND: Brain arteriovenous malformations (BAVMs) are vascular malformations composed of tangles of abnormally developed vasculature without capillaries. Abnormal shunting of arteries and veins is formed, resulting in high-pressure vascular channels, which potentially lead to rupture. BAVMs are generally considered a congenital disorder. But clinical evidence regarding involution, regrowth, and de novo formation argue against the static condition of this disease. Recently, the presence of the somatic activating KRAS mutations in more than half of BAVM cases was reported, suggesting the role of KRAS function in the pathogenesis.
   METHODS: KRAS mutation in codon35 (G -> A, G12D; G -> T, G12V) was examined by a digital polymerase chain reaction analysis using genome purified from paraffin-embedded slides of human BAVMs. We also examined protein expression of KRAS G12D in lesions to corroborate results from digital polymerase chain reaction analysis.
   RESULTS: We detected codon35 G -> A mutation in 15 (39.5%) among 38 samples and codon35 G -> T mutation in 10 (27.0%) among 37 samples we could assess mutations. There were no samples positive for both codon35 G -> A and G -> T mutation. The ratio of codon35 G -> A mutation ranged from 0.60% to 12.28% and that of G -> T was from 1.20% to 8.99%. We next examined protein expression of KRAS G12D in BAVM lesions in immunohistochemistry. A KRAS G12D mutant was detected mainly in endothelial cells of dilated vessels in lesions.
   CONCLUSIONS: KRAS mutations in codon35 were detected in about two thirds of specimens examined. KRAS function may actively contribute to the pathobiology of BAVM and can become a therapeutic target.
C1 [Oka, Mieko; Kushamae, Mika; Aoki, Tomohiro] Natl Cerebral & Cardiovasc Ctr, Japan Agcy Med Res & Dev AMED, Dept Mol Pharmacol, Res Inst, Suita, Osaka, Japan.
   [Oka, Mieko; Aoki, Tomohiro] Natl Cerebral & Cardiovasc Ctr, Japan Agcy Med Res & Dev AMED, CREST, Suita, Osaka, Japan.
   [Oka, Mieko; Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo, Japan.
   [Kushamae, Mika; Mizutani, Tohru] Showa Univ, Dept Neurosurg, Sch Med, Shinagawa Ku, Tokyo, Japan.
   [Yamaguchi, Tadashi; Takagi, Yasushi] Tokushima Univ, Grad Sch Biomed Sci, Dept Neurosurg, Tokushima, Tokushima, Japan.
   [Abekura, Yu; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Kyoto, Japan.
RP Takagi, Y (reprint author), Tokushima Univ, Grad Sch Biomed Sci, Dept Neurosurg, Tokushima, Tokushima, Japan.
EM ytakagi@tokushima-u.ac.jp
FU Japan Society for the Promotion of ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [16H05437]; Ministry of Education, Culture,
   Sports, ScienceMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) [24390343, 25293308]; Core Research for
   Evolutional Science and Technology (CREST) on Mechanobiology from the
   Japan Agency for Medical Research and Development (AMED) [JP18gm0810006]
FX This work was supported by Grant-in-Aid for Scientific Research from
   Japan Society for the Promotion of Science (grant ID; 16H05437, Y.T.);
   The Ministry of Education, Culture, Sports, Science (grant ID; 24390343
   and 25293308, Y.T.) and Technology; and the Core Research for
   Evolutional Science and Technology (CREST) on Mechanobiology from the
   Japan Agency for Medical Research and Development (AMED) (grant ID;
   JP18gm0810006, T.A.).
CR Al-Olabi L, 2018, J CLIN INVEST, V128, P5185, DOI 10.1172/JCI124649
   Aziz MM, 2012, WORLD NEUROSURG, V78, P487, DOI 10.1016/j.wneu.2011.12.086
   Aziz MM, 2010, NEUROSURGERY, V67, P1669, DOI 10.1227/NEU.0b013e3181fa00f1
   Bournet B, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.18
   Chen WQ, 2014, STROKE, V45, P900, DOI 10.1161/STROKEAHA.113.003655
   Chen YM, 2008, NEUROSURGERY, V62, P1340, DOI 10.1227/01.neu.0000333306.64683.b5
   Fiala O, 2016, TUMOR BIOL, V37, P6823, DOI 10.1007/s13277-015-4523-7
   Koizumi T, 2002, NEUROSURGERY, V50, P117, DOI 10.1097/00006123-200201000-00020
   Komiyama M, 2016, NEUROL MED-CHIR, V56, P317, DOI 10.2176/nmc.ra.2016-0051
   Matsubara S, 2000, STROKE, V31, P2653, DOI 10.1161/01.STR.31.11.2653
   Morales-Valero SF, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS14234
   Nielsen CM, 2016, STROKE, V47, P293, DOI 10.1161/STROKEAHA.115.002869
   Nikolaev SI, 2018, NEW ENGL J MED, V378, P250, DOI 10.1056/NEJMoa1709449
   Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2
   Pawlikowska L, 2004, STROKE, V35, P2294, DOI 10.1161/01.STR.0000141932.44613.b1
   Renaud S, 2015, BRIT J CANCER, V113, P1206, DOI 10.1038/bjc.2015.327
   Satomi J, 2003, STROKE, V34, P783, DOI 10.1161/01.STR.0000056170.47815.37
   Schwartz ED, 2002, SURG NEUROL, V58, P139, DOI 10.1016/S0090-3019(02)00769-3
   Takagi Y, 2006, NEUROSURGERY, V58, P740, DOI 10.1227/01.NEU.0000192167.54627.3A
   Takagi Yasushi, 2011, Surg Neurol Int, V2, P61, DOI 10.4103/2152-7806.80356
   Takagi Y, 2010, WORLD NEUROSURG, V73, P100, DOI 10.1016/j.surneu.2009.07.008
   Walker EJ, 2011, ANN NEUROL, V69, P954, DOI 10.1002/ana.22348
   Wu CY, 2005, NEUROSURGERY, V56, P851, DOI 10.1227/01.NEU.0000156618.10291.F2
   Yamada S, 2007, J NEUROSURG, V107, P965, DOI 10.3171/JNS-07/11/0965
   ZhuGe QC, 2013, J CELL MOL MED, V17, P1458, DOI 10.1111/jcmm.12115
   ZhuGe QC, 2009, BRAIN, V132, P3231, DOI 10.1093/brain/awp246
NR 26
TC 2
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1365
EP E1373
DI 10.1016/j.wneu.2019.03.105
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400173
PM 30902772
DA 2020-05-12
ER

PT J
AU Okuma, Y
   Hirotsune, N
   Sato, Y
   Tanabe, T
   Muraoka, K
   Nishino, S
AF Okuma, Yu
   Hirotsune, Nobuyuki
   Sato, Yu
   Tanabe, Tomoyuki
   Muraoka, Kenichiro
   Nishino, Shigeki
TI Midterm Follow-Up of Patients with Middle Meningeal Artery Embolization
   in Intractable Chronic Subdural Hematoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; Embosphere; Middle meningeal artery
   embolization; NBCA
ID RECURRENCE
AB OBJECTIVE: A subset of patients with chronic subdural hematoma (CSDH) remains refractory to standard treatment with hematoma drainage by burr-hole craniotomy and irrigation. We recently reported the usefulness of middle meningeal artery (MMA) embolization for intractable CSDH in patients with multiple intractable risk factors. We present the midterm outcomes of MMA embolization in patients with intractable CSDHs.
   METHODS AND RESULTS: Seventeen consecutive patients (average age, 76.4 years; 12 men [71%]) underwent MMA embolization of CSDH from January 2014 to July 2017. Earlier interventions included embolization using N-butyl-2-cyanoacrylate (although trisacryl gelatin microspheres were used in recent cases), followed by burr-hole craniotomy and irrigation in all cases. None of the patients experienced perioperative complications or postoperative recurrence. The modified Rankin Scale scores, which were unfavorable at admission, improved significantly at discharge but were comparable to those at the time of hospitalization when measured during the follow-up period. Although the patients required rehospitalization at other departments for unrelated causes, none required rehospitalization in our department.
   CONCLUSIONS: Despite the known unfavorable outcomes of patients with intractable CSDHs, MMA embolization was not associated with recurrent CSDH or rehospitalization in our department in the current case series. MMA embolization should be considered a preferred therapeutic option for intractable CSDHs.
C1 [Okuma, Yu; Hirotsune, Nobuyuki; Sato, Yu; Tanabe, Tomoyuki; Muraoka, Kenichiro; Nishino, Shigeki] Hiroshima City Hiroshima Citizens Hosp, Dept Neurol Surg, Hiroshima, Japan.
RP Okuma, Y (reprint author), Hiroshima City Hiroshima Citizens Hosp, Dept Neurol Surg, Hiroshima, Japan.
EM y8u2bear4@hotmail.com
OI Okuma, Yu/0000-0003-4769-8111
CR Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232
   Arai S, 2018, WORLD NEUROSURG, V111, pE113, DOI 10.1016/j.wneu.2017.12.003
   Ban SP, 2018, RADIOLOGY, V286, P909, DOI 10.1148/radiol.2017170053
   Chihara Hideo, 2014, NMC Case Rep J, V1, P1, DOI 10.2176/nmccrj.2013-0343
   Hashimoto Takao, 2013, Surg Neurol Int, V4, P104, DOI 10.4103/2152-7806.116679
   Ishihara H, 2007, Interv Neuroradiol, V13 Suppl 1, P141
   Jung YG, 2015, J KOREAN NEUROSURG S, V57, P266, DOI 10.3340/jkns.2015.57.4.266
   Kalamatianos T, 2013, J NEUROSURG, V118, P353, DOI 10.3171/2012.10.JNS12327
   Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149
   Kim E, 2017, WORLD NEUROSURG, V101, P520, DOI 10.1016/j.wneu.2017.02.070
   Kitazono M, 2012, NEUROL MED-CHIR, V52, P810, DOI 10.2176/nmc.52.810
   KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207
   Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026
   Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715
   Mandai S, 2000, J NEUROSURG, V93, P686, DOI 10.3171/jns.2000.93.4.0686
   Matsumoto H, 2018, J CLIN NEUROSCI, V49, P40, DOI 10.1016/j.jocn.2017.11.009
   Meguro Toshinari, 2013, No Shinkei Geka, V41, P995
   Mino M, 2013, SURG NEUROL INT, V1, P78
   Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256
   Shiomi N, 2001, NEUROL SURG TOKYO, V29, P39
   Takahashi K, 2002, NEUROL SURG TOKYO, V30, P535
   Takizawa K, 2016, J NEUROSURG, V124, P1679, DOI 10.3171/2015.5.JNS1567
   Tempaku A, 2015, INTERV NEURORADIOL, V21, P366, DOI 10.1177/1591019915583224
   Toi H, 2018, J NEUROSURG, V128, P222, DOI 10.3171/2016.9.JNS16623
   Uno M, 2017, NEUROL MED-CHIR, V57, P402, DOI 10.2176/nmc.ra.2016-0337
   Yu JL, 2016, INT J MED SCI, V13, P790, DOI 10.7150/ijms.16489
   Yuan SM, 2013, CARDIOL J, V20, P121, DOI 10.5603/CJ.2013.0023
NR 27
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E671
EP E678
DI 10.1016/j.wneu.2019.02.121
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400082
PM 30844521
DA 2020-05-12
ER

PT J
AU Ou, YW
   Dong, JQ
   Wu, L
   Xu, L
   Wang, L
   Liu, BY
   Li, JS
   Liu, WM
AF Ou, Yunwei
   Dong, Jinqian
   Wu, Liang
   Xu, Long
   Wang, Lei
   Liu, Baiyun
   Li, Jingsheng
   Liu, Weiming
TI An Exhaustive Drainage Strategy in Burr-hole Craniostomy for Chronic
   Subdural Hematoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Chronic subdural hematoma; CSDH; Drainage; Outcome; Recurrence; Strategy
ID RECURRENCE; METAANALYSIS; EVACUATION; PREDICTORS; MANAGEMENT; UROKINASE;
   OUTCOMES; TIME
AB OBJECTIVE: To introduce an effective strategy to treat patients with chronic subdural hematoma (CSDH) that can achieve a low recurrence rate and good outcome.
   METHODS: Surgical patients with CSDH from August 2011 to May 2017 in our hospital were collected retrospectively. An exhaustive drainage strategy to treat CSDH with burr-hole craniostomy was conducted. All patients were drained, and catheter was removed when natural drainage ceased or when drainage was complete using urokinase. Clinical characteristics were reviewed and analyzed. Following this strategy, predictors of recurrence requiring reoperation and outcome were analyzed.
   RESULTS: In total, 1126 patients with CSDH who were treated with burr-hole craniostomy were included. Using the exhaustive drainage strategy, recurrence rate was only 1.9% (21/1117) with follow-up rate of 99.2%. 97.0% (1092/1117) of patients gained good outcome (modified Rankin scale scores 0-3) at 6 months after discharge. Postoperative hematoma volume (P = 0.001, B = 0.028, Exp (B) = 1.028, 95% CI 1.011-1.046), diabetes (P = 0.022, B = 1.082, Exp (B) = 2.950, 95% CI 1.169-7.440), bilateral hematoma (P = 0.011, B = 1.213, Exp (B) = 3.363, 95% CI 1.323-8.547), and complications (P = 0.013, B = 1.483, Exp (B) = 4.408, 95% CI 1.365-14.235) significantly increased the probability of recurrence. In contrast, use of urokinase (P = 0.007, B = L1.435, Exp (B) = 0.238, 95% CI 0.085-0.671) reduced recurrence. Finally, age (P = 0.026, B = 0.056, Exp (B) = 1.057, 95% CI 1.007-1.110), complications (P < 0.001, B = 1.710, Exp (B) = 5.529, 95% CI 2.104-14.531), and Bender grade (P < 0.001, B = 1.165, Exp B) = 3.205, 95% CI 1.325-7.750) were significant predictors of outcome.
   CONCLUSIONS: The exhaustive drainage strategy is safe and effective for reducing recurrence rate and achieving good outcome in patients with CSDH. This procedure merits recommendation in clinical practice.
C1 [Ou, Yunwei; Dong, Jinqian; Wu, Liang; Xu, Long; Wang, Lei; Liu, Baiyun; Li, Jingsheng; Liu, Weiming] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Ou, Yunwei; Dong, Jinqian; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.
   [Ou, Yunwei; Xu, Long; Liu, Weiming] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.
   [Liu, Weiming] Ningxia Peoples Hosp, Neurol Ctr, Ningxia, Peoples R China.
   [Ou, Yunwei] Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Beijing, Peoples R China.
RP Liu, WM (reprint author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, WM (reprint author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, WM (reprint author), Ningxia Peoples Hosp, Neurol Ctr, Ningxia, Peoples R China.
EM liuweimingnsok@sina.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81502150]; Beijing Outstanding Talent Training
   Project [2015000021469G222]; National Key Technology Research and
   Development Program of the Ministry of Science and Technology of
   ChinaNational Key Technology R&D Program [2014BAI04B01, 2015BAI12B04,
   2013BAI09B03]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AR064874, AR068950]
FX This work was supported by the National Natural Science Foundation of
   China (81502150), the Beijing Outstanding Talent Training Project
   (2015000021469G222), and National Key Technology Research and
   Development Program of the Ministry of Science and Technology of China
   (2014BAI04B01, 2015BAI12B04 and 2013BAI09B03). C.W. was supported by
   National Institutes of Health grants (AR064874 and AR068950).
CR Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67
   Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290
   Bakheet MF, 2015, INT J STROKE, V10, P501, DOI 10.1111/ijs.12419
   Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6
   Brennan PM, 2017, J NEUROSURG, V127, P732, DOI 10.3171/2016.8.JNS16134
   Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024
   Jablawi F, 2017, WORLD NEUROSURG, V100, P480, DOI 10.1016/j.wneu.2017.01.037
   KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207
   Kurabe S, 2010, ACTA NEUROCHIR, V152, P1171, DOI 10.1007/s00701-010-0627-4
   Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064
   Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715
   Lu J, 2015, CLIN NEUROL NEUROSUR, V136, P61, DOI 10.1016/j.clineuro.2015.05.037
   MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X
   Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371
   Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256
   Neils DM, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.08.032
   Qiu S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007290
   ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263
   Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Shapey J, 2016, CURR GERIATR REP, V5, P71, DOI 10.1007/s13670-016-0166-9
   Stanisic M, 2017, NEUROSURGERY, V81, P752, DOI 10.1093/neuros/nyx090
   Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937
   Yu GJ, 2009, BRIT J NEUROSURG, V23, P606, DOI 10.3109/02688690903386983
   Zhang Y, 2017, WORLD NEUROSURG, V105, P115, DOI 10.1016/j.wneu.2017.05.135
NR 25
TC 3
Z9 3
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1412
EP E1420
DI 10.1016/j.wneu.2019.03.111
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400178
PM 30902781
DA 2020-05-12
ER

PT J
AU Ozturk, PA
   Yilmaz, T
   Ozturk, U
AF Ozturk, Pinar Aydin
   Yilmaz, Tevfik
   Ozturk, Unal
TI Effects of Bemiparin Sodium Versus Dabigatran Etexilate After
   Anastomosis in Rat Carotid Arteries on the Development of Neointima and
   Thrombolytic Efficacy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bemiparin sodium; Carotid artery anastomosis; Dabigatran etexilate;
   Neointima; Thrombosis
ID HEPARIN
AB BACKGROUND: Revascularization before infarct development after cerebral ischemia may affect morbidity. The success of revascularization can be less than expected because of spontaneous thrombosis or restenosis with intimal hyperplasia. The aim of this study was to compare dabigatran etexilate, a direct thrombin inhibitor, with bemiparin sodium, a second-generation low-molecular-weight heparin, after carotid artery anastomosis.
   METHODS: This study used 24 randomly selected Sprague-Dawley rats. The rats were separated into 3 equal groups: group 1 (control group); group 2 (dabigatran group), in which dabigatran 10 mg/kg was orally administered for 7 days; and group 3 (bemiparin group), in which bemiparin 250 IU/kg was subcutaneously administered for 7 days. The right-side carotid artery of rats was used for anastomosis and the left-side carotid artery was used for the control. The carotid artery was explored and transected. Anastomosis was applied using 10/0 polypropylene sutures. After 7 days of treatment, the right and left carotid arteries were removed. Lumen diameter, lumen area, tunica media thickness, edema, vessel wall injury, intimal hyperplasia, thrombus, and inflammation were evaluated in tissue biopsy specimens.
   RESULTS: Bemiparin used after anastomosis caused less thickening of tunica media and reduced intimal hyperplasia but did not decrease lumen diameter and area. Dabigatran increased edema and inflammation but did not prevent intimal hyperplasia.
   CONCLUSIONS: Bemiparin reduced intimal hyperplasia and prevented thrombosis angiogenesis, but dabigatran did not prevent intimal hyperplasia, and its anticoagulation effect was more than the antithrombotic effect.
C1 [Ozturk, Pinar Aydin; Yilmaz, Tevfik] Dicle Univ, Med Fac, Dept Neurosurg, Diyarbakir, Turkey.
   [Ozturk, Unal] Dicle Univ, Med Fac, Dept Neurol, Diyarbakir, Turkey.
   [Ozturk, Pinar Aydin] Hlth Sci Univ, Dept Neurosurg, Gazi Yasargil Educ Res Hosp, Diyarbakir, Turkey.
RP Ozturk, PA (reprint author), Dicle Univ, Med Fac, Dept Neurosurg, Diyarbakir, Turkey.; Ozturk, PA (reprint author), Hlth Sci Univ, Dept Neurosurg, Gazi Yasargil Educ Res Hosp, Diyarbakir, Turkey.
EM aydinpinar12@gmail.com
FU Turkish Neurosurgical Society
FX The preparation of this article for publication was partly supported by
   the Turkish Neurosurgical Society.
CR Demirtas S, 2015, KAOHSIUNG J MED SCI, V31, P115, DOI 10.1016/j.kjms.2014.12.005
   Deveci B, 2018, FOLIA MORPHOL, V77, P471, DOI 10.5603/FM.a2018.0004
   Dogan OT, 2011, THROMB RES, V128, pE29, DOI 10.1016/j.thromres.2011.05.005
   Egemen N, 1992, TURK NOROSIRURJI DER, V3, P219
   Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8
   Grosskreutz CL, 1999, MICROVASC RES, V58, P128, DOI 10.1006/mvre.1999.2171
   Gurbuz H, 1998, ACTA ORTOP TRAUMATOL, V32, P329
   Hadlock Tessa A, 2003, Arch Facial Plast Surg, V5, P36
   Hankey GJ, 2011, CIRCULATION, V123, P1436, DOI 10.1161/CIRCULATIONAHA.110.004424
   Ishida A, 2001, J CELL PHYSIOL, V188, P359, DOI 10.1002/jcp.1121
   Khurana R, 2004, CIRCULATION, V110, P2436, DOI 10.1161/01.CIR.0000145138.25577.F1
   King AE, 2015, NEUROHOSPITALIST, V5, P234, DOI 10.1177/1941874415569069
   Lacin N, 2019, FOLIA MORPHOL, V78, P545, DOI 10.5603/FM.a2018.0110
   Martinez-Gonzalez Jose, 2008, Expert Rev Cardiovasc Ther, V6, P793, DOI 10.1586/14779072.6.6.793
   Murthy P, 2003, OTOLARYNG HEAD NECK, V129, P176, DOI 10.1016/S0194-5998(03)00603-X
   Newell DW, 2005, SKULL BASE-INTERD AP, V15, P133, DOI 10.1055/s-2005-870599
   Ohtani K, 2004, CIRCULATION, V110, P2444, DOI 10.1161/01.CIR.0000145123.85083.66
   PAULETTO P, 1994, CLIN SCI, V87, P467, DOI 10.1042/cs0870467
   Sanchez-Ferrer CF, 2010, DRUGS, V70, P19, DOI 10.2165/1158581-S0-000000000-00000
   Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004
   Tanoue S, 2015, J STROKE CEREBROVASC, V24, P374, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.010
   Taylor A, 1996, AUST NZ J SURG, V66, P764, DOI 10.1111/j.1445-2197.1996.tb00739.x
   Yilmaz T, NEUROSURGICAL ATLAS, DOI [10.18791/nsatlas.v3cho5.3, DOI 10.18791/NSATLAS.V3CHO5.3]
   Yousef MAA, 2015, J HAND MICROSURG, V7, P256, DOI 10.1007/s12593-015-0196-0
NR 24
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E731
EP E735
DI 10.1016/j.wneu.2019.02.139
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400090
PM 30851469
DA 2020-05-12
ER

PT J
AU Parab, A
   Khatri, D
   Singh, S
   Gosal, JS
   Deora, H
   Das, KK
   Verma, P
   Mehrotra, A
   Srivastava, AK
   Behari, S
   Jaiswal, S
   Jaiswal, AK
AF Parab, Abhijit
   Khatri, Deepak
   Singh, Suyash
   Gosal, Jaskaran S.
   Deora, Harsh
   Das, Kuntal Kanti
   Verma, Pawan
   Mehrotra, Anant
   Srivastava, Arun Kumar
   Behari, Sanjay
   Jaiswal, Sushila
   Jaiswal, Awadhesh K.
TI Endoscopic Keyhole Retromastoid Approach in Neurosurgical Practice:
   Ant-Man's View of the Neurosurgical Marvel
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic neurosurgery; Keyhole neurosurgery; Retromastoid approach
ID VESTIBULAR SCHWANNOMA RESECTION; REMOVAL
AB BACKGROUND: Endoscopy is now a staple of any neurosurgical practice. The versatility of this approach and gratifying results has resulted in its increased popularity. The objective of this paper is to report our experience of managing various cerebellopontine angle (CPA) pathologies by endoscopic keyhole retromastoid suboccipital craniectomy (RMSO) approach.
   METHODS: A retrospective review of the medical records of patients operated in our department by endoscopic keyhole RMSO approach was done along with a collection of relevant patient particulars.
   RESULTS: Forty-four patients (24 men and 20 women) were operated via an endoscopic keyhole RMSO approach for various lesions in and around the CPA. The craniectomy was of 2.0-2.5 cm in size. An endoscope was used as the sole visualizing tool throughout the procedure in all cases. Primarily 2 kinds of pathologies were approached: neoplasms, mostly benign (n = 33), and vascular loops (n = 11). The extent of excision in 33 tumor cases was gross total (n [ 20), near total (n = 12), and subtotal (n = 1). In cases of a vascular loop, microvascular decompression was performed. Anatomic facial nerve preservation was ensured in all cases of vascular loops and in 30 tumor cases. Postoperative complications included new-onset/worsening of facial nerve paresis (n = 12, 27.3%), 9 of which improved in follow-up, transient facial hypoesthesia (n = 2, 4.5%), transient abducens paresis (n = 4, 9%), transient lower cranial nerve paresis (n = 3, 6.8%), pseudomeningocele (n = 1, 2.3%), cerebrospinal fluid leak with meningitis (n = 1, 2.3%) and operative site hematoma (n = 1, 2.3%) which required evacuation.
   CONCLUSIONS: Endoscopic keyhole RMSO approach is minimally invasive and yields an excellent outcome in the management of various CPA lesions.
C1 [Parab, Abhijit; Khatri, Deepak; Singh, Suyash; Gosal, Jaskaran S.; Deora, Harsh; Das, Kuntal Kanti; Verma, Pawan; Mehrotra, Anant; Srivastava, Arun Kumar; Behari, Sanjay; Jaiswal, Awadhesh K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Neurosurg, Lucknow, Uttar Pradesh, India.
   [Jaiswal, Sushila] Sanjay Gandhi Post Grad Inst Med Sci, Dept Pathol, Lucknow, Uttar Pradesh, India.
RP Jaiswal, AK (reprint author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Neurosurg, Lucknow, Uttar Pradesh, India.
EM jaiswal_dr_2002@yahoo.co.in
RI DEORA, HARSH/A-5817-2019; Khatri, Deepak/C-3554-2019
OI DEORA, HARSH/0000-0003-3247-1117; Khatri, Deepak/0000-0003-1902-9623
CR Chen L, 2010, CHINESE MED J-PEKING, V123, P274, DOI 10.3760/cma.j.issn.0366-6999.2010.03.004
   Cui DM, 2014, J CRANIOFAC SURG, V25, P463, DOI 10.1097/SCS.0000000000000528
   Halpern CH, 2013, MINIM INVASIVE SURG, V2013, P1
   Hoshide R, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2017.11.FOCUS17607
   Hu ZG, 2016, J NEUROL SURG PART A, V77, P381, DOI 10.1055/s-0035-1558818
   Jaiswal AK, 2017, NEUROL INDIA, V65, P1102, DOI 10.4103/neuroindia.NI_723_17
   Kabil MS, 2005, MINIM INVAS NEUROSUR, V48, P207, DOI 10.1055/s-2005-870928
   Magnan J, 1997, OTOLARYNG HEAD NECK, V117, P308, DOI 10.1016/S0194-5998(97)70118-9
   Mostafa BE, 2008, SKULL BASE-INTERD AP, V18, P371, DOI 10.1055/s-0028-1087220
   Peng YP, 2014, CHILD NERV SYST, V30, P1261, DOI 10.1007/s00381-014-2357-z
   Shahinian HK, 2011, MINIM INVAS NEUROSUR, V54, P61, DOI 10.1055/s-0031-1275335
   Teo C., 2006, NEUROSURGERY, V59, P489
   Wick CC, 2017, OTOL NEUROTOL, V38, pE490, DOI 10.1097/MAO.0000000000001588
NR 13
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E982
EP E988
DI 10.1016/j.wneu.2019.02.203
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400123
PM 30877012
DA 2020-05-12
ER

PT J
AU Park, SE
   Park, EK
   Shim, KW
   Kim, DS
AF Park, Seong-eun
   Park, Eun-Kyung
   Shim, Kyu-Won
   Kim, Dong-Seok
TI Modified Cranioplasty Technique Using 3-Dimensional Printed Implants in
   Preventing Temporalis Muscle Hollowing
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3D Printing; Cranioplasty; Temporalis muscle hollowing
ID DEEP
AB BACKGROUND: Temporalis muscle (TM) hollowing is a complication of cranioplasty which diminishes the aesthetical outcome of the surgery and results in suboptimal functional outcome. We present and compare a modified split-temporalis muscle elevated margin cranioplasty using 3-dimensional printed titanium implant with conventional 3-dimensional printed titanium implant cranioplasty to determine an effective treatment method.
   METHODS: A modified 3-dimensional printed cranial implant was designed where the anteroinferior border of the implant was extended and elevated between the frontozygomatic suture and root of zygomatic process. Furthermore, the implant was placed in between superficial and deep layers of the temporalis muscle. Aesthetical evaluation was carried out at the outpatient clinic, and a quantitative analysis showing the percentage difference in length of the operated and nonoperated sides was performed.
   RESULTS: For both conventional and augmented groups, there were 0% major or minor complications. Out of 10 conventional cranioplasty patients, there were 3 cases of mild and 1 case of severe TM hollowing, whereas for 10 augmented cranioplasty patients, there was only 1 patient with mild TM hollowing. When a quantitative analysis was carried out, the overall percentage difference in length at the coronal view for conventional and augmented cranioplasty was -2.17% and 0.07%, respectively.
   CONCLUSIONS: The augmented cranioplasty leads to superior aesthetical outcome, and the quantitative analysis also supports the efficacy of augmented cranioplasty. The surgery is technically simpler than the conventional method, therefore lowering the risk of surgical complications. Therefore, we hope that the modified cranioplasty method will be considered as an effected cranioplasty method for preventing TM hollowing.
C1 [Park, Seong-eun; Park, Eun-Kyung; Shim, Kyu-Won; Kim, Dong-Seok] Yonsei Univ, Dept Pediat Neurosurg, Severance Hosp, Coll Med, Seoul, South Korea.
RP Shim, KW (reprint author), Yonsei Univ, Dept Pediat Neurosurg, Severance Hosp, Coll Med, Seoul, South Korea.
EM shimkyuwon@yuhs.ac
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education [2017R1D1A1B03034927]; Yonsei
   University College of Medicine [6-2016-0075]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea funded by the Ministry
   of Education (2017R1D1A1B03034927) and by a faculty research grant of
   Yonsei University College of Medicine (6-2016-0075).
CR Akita K, 2001, CLIN ANAT, V14, P288, DOI 10.1002/ca.1050
   Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584
   Brett-Major DM, 2008, MIL MED, V173, P697, DOI 10.7205/MILMED.173.7.697
   Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091
   Gaudy JF, 2001, SURG RADIOL ANAT, V23, P389
   Geers C, 2005, SURG RADIOL ANAT, V27, P184, DOI 10.1007/s00276-004-0306-3
   Guo J, 2012, ANN PLAS SURG, V68, P279, DOI 10.1097/SAP.0b013e3181ff76a1
   Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004
   Honeybul S, 2016, J NEUROSURG-PEDIATR, V17, P701, DOI 10.3171/2015.11.PEDS15556
   Huang GJ, 2015, J CRANIOFAC SURG, V26, P68, DOI 10.1097/SCS.0000000000001315
   Kadri PAS, 2004, J NEUROSURG, V100, P517, DOI 10.3171/jns.2004.100.3.0517
   Kuttenberger JJ, 2001, J CRANIO MAXILL SURG, V29, P75, DOI 10.1054/jcms.2001.0197
   McNichols CH, 2012, J CRANIOFAC SURG, V23, pE234, DOI 10.1097/SCS.0b013e31824de5b8
   Oikawa S, 1996, J NEUROSURG, V84, P297, DOI 10.3171/jns.1996.84.2.0297
   Palomari ET, 2013, INT J MORPHOL, V31, P1158, DOI 10.4067/S0717-95022013000400002
   Park EK, 2016, J CRANIOFAC SURG, V27, P943, DOI 10.1097/SCS.0000000000002656
   Park T-Y, 2013, KOREAN J NEUROTRAUMA, V9, P154
   Sahoo NK, 2018, J CRANIOFAC SURG, V29, P1344, DOI 10.1097/SCS.0000000000004478
   Sedlmayr JC, 2009, CLIN ANAT, V22, P655, DOI 10.1002/ca.20837
   Shimokawa T, 1998, SURG RADIOL ANAT, V20, P329, DOI 10.1007/BF01630615
   Vaca EE, 2017, J PLAST RECONSTR AES, V70, P401, DOI 10.1016/j.bjps.2016.10.008
   Webster K, 1999, J CRANIO MAXILL SURG, V27, P211, DOI 10.1016/S1010-5182(99)80031-6
   Zhong ST, 2015, OPER NEUROSURG, V11, P220, DOI 10.1227/NEU.0000000000000679
NR 23
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1160
EP E1168
DI 10.1016/j.wneu.2019.02.221
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400146
PM 30880206
DA 2020-05-12
ER

PT J
AU Penner, F
   Marengo, N
   Ajello, M
   Petrone, S
   Cofano, F
   Santonio, FV
   Zenga, F
   Garbossa, D
AF Penner, Federica
   Marengo, Nicola
   Ajello, Marco
   Petrone, Salvatore
   Cofano, Fabio
   Santonio, Filippo Veneziani
   Zenga, Francesco
   Garbossa, Diego
TI Preoperative 3D CT Planning for Cortical Bone Trajectory Screws: A
   Retrospective Radiological Cohort Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cortical bone trajectory; Lumbar arthrodesis; Lumbar spine surgery;
   Minimally invasive surgery; Planning
ID PEDICLE SCREWS; ACCURACY; FIXATION; SURGERY
AB BACKGROUND: Pedicle screw instrumentation is a standard procedure in lumbar spinal fusion. The cortical bone trajectory (CBT) screw is an alternative technique, less invasive but harder to perform. The identification of the entry point and the appropriate direction can be tricky especially to the surgeons just at the beginning. Therefore, the aim of this study is to evaluate the reliability of pre-operative computed tomography (CT) planning in the CBT screw placement.
   METHODS: We retrospectively evaluated 82 patients who underwent a single-level posterior lumbar arthrodesis with CBT screws. The correct entry point and the best trajectory were identified on a 3-dimensional (3D) multi-planar reconstruction CT view. The concordance between achieved and planned trajectories was assessed on a postoperative CT.
   RESULTS: A total of 328 screws was positioned. The average entry point distance from the target was 1.1 mm (standard deviation, +/- 0.15 mm). In 301 screws (91.8%), the obtained trajectory differed no more than 2 degrees from the planned one. No screws misplaced or new neurological deficit was recorded.
   CONCLUSIONS: The CBT screw placement is a great alternative to the pedicle screw. Accurate preoperative 3D planning is useful to predict the entry point and the direction with accuracy similar to navigation systems, avoiding its costs and technical difficulties. The 3D CT planning is helpful in the customization of spine surgery, and the results underline the radiological reliability of this technique.
C1 [Penner, Federica; Marengo, Nicola; Ajello, Marco; Petrone, Salvatore; Cofano, Fabio; Santonio, Filippo Veneziani; Zenga, Francesco; Garbossa, Diego] Univ Turin, Sect Neurosurg, Dept Neurosci, Turin, Italy.
RP Petrone, S (reprint author), Univ Turin, Sect Neurosurg, Dept Neurosci, Turin, Italy.
EM svt.petrone@gmail.com
RI Ajello, Marco/AAC-9910-2019; Garbossa, Diego/AAC-8888-2019
OI Penner, Federica/0000-0002-4491-1725
CR Aoude AA, 2015, EUR SPINE J, V24, P990, DOI 10.1007/s00586-015-3853-x
   Berjano P, 2015, EUR SPINE J, V24, P2096, DOI 10.1007/s00586-015-3829-x
   Cofano F, 2018, NEUROSURG REV
   Dayani F, 2019, J CLIN NEUROSCI, V61, P106, DOI 10.1016/j.jocn.2018.10.131
   Fan Y, 2018, MEDICINE US, V97, P1
   Gautschi OP, 2017, J NEUROSURG SCI, V61, P335, DOI 10.23736/S0390-5616.16.03230-6
   Gejo R, 1999, SPINE, V24, P1023, DOI 10.1097/00007632-199905150-00017
   GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004
   Kaito T, 2018, J ORTHOP SCI
   Keorochana G, 2017, WORLD NEUROSURG, V102, P340, DOI 10.1016/j.wneu.2017.03.010
   Kojima K, 2015, ACTA NEUROCHIR, V157, P1173, DOI 10.1007/s00701-015-2432-6
   Lamartina C, 2015, EUR SPINE J, V24, pS937, DOI 10.1007/s00586-015-4261-y
   Marengo N, 2018, EUR SPINE J, V27, P213, DOI 10.1007/s00586-018-5599-8
   Marengo N, 2018, BIOMED RES INT, DOI 10.1155/2018/7424568
   Mason A, 2014, J NEUROSURG-SPINE, V20, P196, DOI 10.3171/2013.11.SPINE13413
   Matsukawa K, 2015, J NEUROSURG-SPINE, V23, P471, DOI 10.3171/2015.1.SPINE141103
   Matsukawa K, 2014, SPINE, V39, pE240, DOI 10.1097/BRS.0000000000000116
   Ninomiya K, 2016, ASIAN SPINE J, V10, P901, DOI 10.4184/asj.2016.10.5.901
   Parker SL, 2011, J NEUROSURG-SPINE, V15, P130, DOI 10.3171/2011.3.SPINE101
   Raley DA, 2012, SPINE, V37, P1092, DOI 10.1097/BRS.0b013e31823c80d8
   Santoni BG, 2009, SPINE J, V9, P366, DOI 10.1016/j.spinee.2008.07.008
   Senoglu M, 2017, WORLD NEUROSURG, V103, P694, DOI 10.1016/j.wneu.2017.03.137
   Snyder LA, 2016, WORLD NEUROSURG, V88, P205, DOI 10.1016/j.wneu.2015.12.065
   Than KD, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17479
   Wilcox Ben, 2017, J Spine Surg, V3, P433, DOI 10.21037/jss.2017.09.01
   Yamauchi T, 2010, J CLIN NEUROSCI, V17, P756, DOI 10.1016/j.jocn.2009.09.037
NR 26
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1468
EP E1474
DI 10.1016/j.wneu.2019.03.121
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400184
PM 30904792
OA Green Published
DA 2020-05-12
ER

PT J
AU Perez, JJ
   Yanamadala, V
   Wright, AK
   Bohl, MA
   Leveque, JCA
   Sethi, RK
AF Perez, Josiah J.
   Yanamadala, Vijay
   Wright, Anna K.
   Bohl, Michael A.
   Leveque, Jean-Christophe A.
   Sethi, Rajiv K.
TI Outcomes Surrounding Perioperative Transfusion Rates and Hemoglobin
   Nadir Values Following Complex Spine Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hemoglobin nadir; Postoperative outcomes; Spinal surgery; Transfusion
   threshold
ID BLOOD-LOSS; CLINICAL-OUTCOMES; COMPLICATIONS; METAANALYSIS; STRATEGIES;
   FUSION
AB BACKGROUND: Optimal transfusion thresholds have been extensively studied for various surgical procedures; however, no transfusion threshold has been set for patients undergoing complex spine surgery. The aim of this study was to compare postoperative outcomes relative to perioperative hemoglobin (Hb) levels for patients undergoing complex spine surgery for adult spinal deformity and to evaluate impact of blood transfusion timing on clinical outcomes.
   METHODS: Retrospective chart review of patients with adult spinal deformity undergoing spine surgery lasting >6 hours or involving >= 6 levels of fusion was performed. Patients were divided into 2 cohorts based on whole hospitalization Hb nadir <9.0 g/dL versus >= 9.0 g/dL.
   RESULTS: Among 104 patients, 55 (52.9%) had Hb nadir <9.0 g/dL. Compared with the cohort with higher Hb nadir, patients with Hb nadir <9.0 g/dL were more likely to be female (84.5% vs. 65.3%, P = 0.016), present with lower preoperative Hb (12.6 = 1.5] g/dL vs. 13.8 [1.2] g/dL, P < 0.001), experience greater change in Hb after surgery (4.4 [1.5] g/dL vs. 3.7 [1.5] g/dL, P = 0.030), receive a postoperative blood transfusion (69.1% vs. 44.9%, P = 0.013), and have a longer length of stay (9.1 [4.8] days vs. 6.2 [3.2] days, P < 0.001).
   CONCLUSIONS: In patients with adult spinal deformity undergoing complex spine surgery, earlier targeted blood transfusions during surgery, rather than in the postoperative period, may lead to improved postoperative outcomes.
C1 [Perez, Josiah J.] Virginia Mason Hosp, Grad Med Educ, Washington, DC USA.
   [Wright, Anna K.; Bohl, Michael A.; Leveque, Jean-Christophe A.; Sethi, Rajiv K.] Virginia Mason Hosp, Neurosci Inst, Washington, DC 98101 USA.
   [Yanamadala, Vijay] Albert Einstein Coll Med, Dept Neurol Surg, Bronx, NY 10467 USA.
   [Sethi, Rajiv K.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
RP Sethi, RK (reprint author), Virginia Mason Hosp, Neurosci Inst, Washington, DC 98101 USA.; Sethi, RK (reprint author), Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
EM sethir@uw.edu
RI Leveque, Jean-Christophe/L-6367-2017
OI Leveque, Jean-Christophe/0000-0003-2465-444X
CR Acosta FL, 2011, J NEUROSURG-SPINE, V15, P667, DOI 10.3171/2011.7.SPINE10640
   Barrey Cedric, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS21, DOI 10.1007/s00590-014-1470-8
   Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4
   Daubs MD, 2016, GLOB SPINE J, V6, P630, DOI 10.1055/s-0035-1570088
   Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6
   GUAY J, 1994, CAN J ANAESTH, V41, P775, DOI 10.1007/BF03011583
   Hovaguimian F, 2016, ANESTHESIOLOGY, V125, P46, DOI 10.1097/ALN.0000000000001162
   Janssen SJ, 2015, SPINE J, V15, P901, DOI 10.1016/j.spinee.2015.02.010
   Kim Yong H, 2010, Am J Orthop (Belle Mead NJ), V39, pE130
   Liang JQ, 2015, EUR SPINE J, V24, P270, DOI 10.1007/s00586-014-3282-2
   Nuttall GA, 2000, SPINE, V25, P569
   PHILLIPS WA, 1988, CLIN ORTHOP RELAT R, P88
   Pong RP, 2018, J BONE JOINT SURG AM, V100, P758, DOI 10.2106/JBJS.17.00860
   Purvis TE, 2017, SPINE J, V17, P1255, DOI 10.1016/j.spinee.2017.04.028
   RAPHAEL BG, 1982, CLIN ORTHOP RELAT R, P41
   Ripolles Melchor J, 2016, MINERVA ANESTESIOL, V82, P582
   Salpeter SR, 2014, AM J MED, V127, P124, DOI 10.1016/j.amjmed.2013.09.017
   Shander A, 2004, AM J MED, V116, P58, DOI 10.1016/j.amjmed.2003.12.013
   Theusinger OM, 2016, BEST PRACT RES-CLIN, V30, P41, DOI 10.1016/j.bpa.2015.11.007
   Young EY, 2013, SPINE J, V13, P1253, DOI 10.1016/j.spinee.2013.05.052
   Zheng FY, 2002, SPINE, V27, P818, DOI 10.1097/00007632-200204150-00008
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1287
EP E1292
DI 10.1016/j.wneu.2019.03.079
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400162
PM 30898746
DA 2020-05-12
ER

PT J
AU Pitskhelauri, D
   Konovalov, A
   Kudieva, E
   Bykanov, A
   Pronin, I
   Eliseeva, N
   Melnikova-Pitskhelauri, T
   Melikyan, A
   Sanikidze, A
AF Pitskhelauri, David
   Konovalov, Alexander
   Kudieva, Elina
   Bykanov, Andrey
   Pronin, Igor
   Eliseeva, Natalya
   Melnikova-Pitskhelauri, Tatiana
   Melikyan, Armen
   Sanikidze, Alexander
TI Burr Hole Microsurgery for Intracranial Tumors and Mesial Temporal Lobe
   Epilepsy: Results of 200 Consecutive Operations
SO WORLD NEUROSURGERY
LA English
DT Article
DE Burr hole; Epilepsy; Hippocampal sclerosis; Mari device; Microsurgery;
   Tumor
ID SUPRAORBITAL KEYHOLE APPROACH; SELECTIVE AMYGDALOHIPPOCAMPECTOMY;
   SURGERY; CRANIOTOMY; RESECTION; LESIONS; REMOVAL
AB OBJECTIVE: Recently, in modern neurosurgery, a tendency toward low-traumatic surgical approaches has become clear. To provide a minimal degree of injury to the brain tissue, we have offered microsurgical approaches through a burr hole.
   METHODS: From February 2016 to November 2017, 200 microsurgical interventions through a single burr hole with a diameter of 14 mm were performed. The age of the patients varied from 16 to 79 years. The female/male ratio was 1.6:1. In 176 cases, the procedure was performed on an intracranial mass lesion in various locations. In the remaining 24 cases, selective amygdalohippocampectomy was performed in patients with hippocampal sclerosis.
   RESULTS: Various surgical approaches were used, including transcortical in 81 (40.5%), retrosigmoid in 38 (19%), subtemporal in 32 (16%), infratentorial supracerebellar in 25 (12.5%), interhemispheric in 17 (8.5%), telovelar in 5 (2.5%), and eyebrow in 2. The extent of lesion removal was evaluated in 167 patients for whom maximal tumor resection had been planned before surgery. Gross total and near total removal was achieved in 145 patients (87%), subtotal in 15 patients (9%), and partial in 7 patients (4%). The operative time ranged from 35 to 300 minutes (median, 80). The interval to extubation postoperatively varied from 5 minutes to 5 days (median, 70 minutes). Of the 200 patients, 195 (97.5%) were mobilized during the first 3 postoperative days.
   CONCLUSIONS: Burr hole microsurgery provides the ability to perform successful surgery on patients with the most diverse intracranial pathological features through a smaller opening than that used for keyhole surgery.
C1 [Pitskhelauri, David; Konovalov, Alexander; Kudieva, Elina; Bykanov, Andrey; Melikyan, Armen; Sanikidze, Alexander] Burdenko Neurosurg Ctr, Dept Neurooncol, Moscow, Russia.
   [Pronin, Igor; Melnikova-Pitskhelauri, Tatiana] Burdenko Neurosurg Ctr, Dept Neuroradiol, Moscow, Russia.
   [Eliseeva, Natalya] Burdenko Neurosurg Ctr, Dept Neuroophthalmol, Moscow, Russia.
RP Pitskhelauri, D (reprint author), Burdenko Neurosurg Ctr, Dept Neurooncol, Moscow, Russia.
EM davidpneuro@gmail.com
RI Bykanov, Andrey/R-1370-2017
CR Almenawer SA, 2013, NEUROSURG REV, V36, P321, DOI 10.1007/s10143-012-0442-x
   Vanegas MAA, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13684
   Baker CM, 2017, WORLD NEUROSURG, V106, P359, DOI [10.1016/J.WNEU.2017.06.118, 10.1016/j.wneu.2017.06.118]
   Barbara S, 2017, EPILEPSY BEHAV, V76, P39, DOI 10.1016/j.yebeh.2017.08.037
   Bonney PA, 2015, J CLIN NEUROSCI, V22, P1105, DOI 10.1016/j.jocn.2014.12.029
   BROCK M, 1978, NEUROCHIRURGIA, V21, P185
   Burks JD, 2018, NEUROSURGERY, V82, P388, DOI 10.1093/neuros/nyx213
   Burks JD, 2016, CUREUS, V8, DOI 10.7759/cureus.588
   Cai Q, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005823
   Charalampaki P, 2008, NEUROSURGERY, V62, P1049, DOI [10.1227/01.NEU.0000176638.86772.2D, 10.1227/01.neu.0000333770.58693.ed]
   Chen I, 2013, IEEE T BIO-MED ENG, V60, P3494, DOI 10.1109/TBME.2013.2272658
   Conner AK, 2018, J NEUROSURG, V128, P1388, DOI 10.3171/2016.12.JNS162168
   Delev D, 2016, ACTA NEUROCHIR, V158, P1757, DOI 10.1007/s00701-016-2860-y
   Duckworth EA, 2008, NEUROSURGERY S1, V63
   Duckworth EA, 2008, NEUROSURGERY S1, V63
   Duckworth EAM, 2008, NEUROSURGERY, V63, P156
   Eivazi S, 2015, ACTA NEUROCHIR, V157, P1147, DOI 10.1007/s00701-015-2433-5
   Fatemi N, 2009, NEUROSURGERY, V64, P269, DOI 10.1227/01.NEU.0000327857.22221.53
   Figueiredo EG, 2007, NEUROSURGERY, V61, P256, DOI 10.1227/01.neu.0000303978.11752.45
   Fischer G, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e31820934ca
   Hernesniemi J, 2005, ACT NEUR S, V94, P17
   Hoshide R, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2017.11.FOCUS17607
   Kalani MYS, 2016, WORLD NEUROSURG, V94, P442, DOI 10.1016/j.wneu.2016.07.024
   Kotwica Z, 2017, TRANSL NEUROSCI, V8, P207, DOI 10.1515/tnsci-2017-0028
   Li P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28654
   Li Z, 2010, EUR SURG RES, V44, P56, DOI 10.1159/000264636
   Little AS, 2009, J NEUROSURG, V111, P1263, DOI 10.3171/2008.10.17673
   Makarenko S, 2017, J NEUROSURG, V126, P1191, DOI 10.3171/2016.3.JNS152307
   Manji H, 2000, J NEUROL NEUROSUR PS, V68, P80, DOI 10.1136/jnnp.68.1.80
   Mathon B, 2016, ACTA NEUROCHIR, V158, P785, DOI 10.1007/s00701-016-2717-4
   Mori K, 2019, J NEUROSURG, V130, P1359, DOI 10.3171/2017.10.JNS171973
   Mostafa BE, 2008, SKULL BASE-INTERD AP, V18, P371, DOI 10.1055/s-0028-1087220
   Nathal Edgar, 2005, Neurosurgery, V56, P178
   Paladino J, 2005, MINIM INVAS NEUROSUR, V48, P251, DOI 10.1055/s-2005-915599
   Peng YP, 2016, WORLD NEUROSURG, V92, P120, DOI 10.1016/j.wneu.2016.04.121
   Perneczky A, 2008, KEYHOLE APPROACHES N
   Pitskhelauri D I, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P89, DOI 10.17116/neiro201781689-98
   Pitskhelauri DI, 2014, J NEUROSURG, V121, P161, DOI 10.3171/2014.3.JNS12578
   Ray A, 2002, BRIT J NEUROSURG, V16, P456, DOI 10.1080/0268869021000030258
   Reisch R, 2003, SURG NEUROL, V59, P223, DOI 10.1016/S0090-3019(02)01037-6
   Reisch R, 2009, MINIM INVAS NEUROSUR, V52, P163, DOI 10.1055/s-0029-1238285
   Reisch R, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2012.02.024
   Renovanz M, 2015, CHILD NERV SYST, V31, P665, DOI 10.1007/s00381-015-2620-y
   Roberts William C, 2009, Proc (Bayl Univ Med Cent), V22, P178
   Shahinian HK, 2011, MINIM INVAS NEUROSUR, V54, P61, DOI 10.1055/s-0031-1275335
   Singh H, 2017, J NEUROSURG, V126, P940, DOI 10.3171/2016.3.JNS1634
   Sughrue ME, 2016, TURK NEUROSURG, V26, P475, DOI 10.5137/1019-5149.JTN.14534-15.0
   WILSON DH, 1971, J NEUROSURG, V34, P102, DOI 10.3171/jns.1971.34.1.0102
   Yang PF, 2016, NEUROSURG REV, V39, P99, DOI 10.1007/s10143-015-0657-8
NR 49
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1257
EP E1267
DI 10.1016/j.wneu.2019.02.239
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400159
PM 30902775
DA 2020-05-12
ER

PT J
AU Plitt, AR
   El Ahmadieh, TY
   Aoun, SG
   Wardak, Z
   Barnett, SL
AF Plitt, Aaron R.
   El Ahmadieh, Tarek Y.
   Aoun, Salah G.
   Wardak, Zabi
   Barnett, Samuel L.
TI Fractionated CyberKnife Stereotactic Radiotherapy for Perioptic
   Pituitary Adenomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE CyberKnife; Fractionated; Perioptic; Pituitary adenoma; Stereotactic
   radiosurgery
ID VISUAL-FIELD PRESERVATION; LOCAL-CONTROL; RADIOSURGERY; MACROADENOMAS;
   EFFICACY
AB OBJECTIVE: Stereotactic radiosurgery (SRS) is the reference standard for radiotherapy for pituitary adenomas but has been limited to lesions with sufficient distance (i.e., >3 mm) from the optic apparatus. We used marginless, fractionated (i.e., 25-28 fractions) stereotactic radiotherapy and the CyberKnife to treat pituitary adenomas that were not eligible for SRS. We present the clinical outcomes, including local control, endocrine function, and toxicity from modern fractionated radiotherapy.
   METHODS: A total of 53 patients were treated for pituitary adenomas within 3 mm of the optic apparatus. The primary endpoint was tumor control with the secondary endpoints of vision and pituitary function preservation and endocrine control in hormone-secreting tumors.
   RESULTS: The tumor control rate as measured on magnetic resonance imaging as either stable or decreased in size was 98.1% (52 of 53) at a mean follow-up of 32.5 months (range, 3-77). All patients experienced preservation or improvement of their preexisting vision status. No change in pituitary function was noted in 52 of the 53 patients (98.1%). One patient experienced worsening of pituitary function secondary to pituitary apoplexy that occurred 4 months after treatment. The endocrine control rate in hormone-secreting tumors was 75% (6 of 8).
   CONCLUSIONS: Marginless, fractionated CyberKnife radiotherapy demonstrated excellent local tumor control and endocrine control rates, comparable to those with SRS, with preservation of vision in patients with adenomas in close proximity to the optic pathway.
C1 [Plitt, Aaron R.; El Ahmadieh, Tarek Y.; Aoun, Salah G.; Barnett, Samuel L.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA.
   [Wardak, Zabi] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.
RP Plitt, AR (reprint author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA.
EM aaron.plitt@phhs.org
RI Aoun, Salah G./J-2406-2019
OI Aoun, Salah G./0000-0003-3499-7569
CR Adler JR, 2006, NEUROSURGERY, V59, P244, DOI 10.1227/01.NEU.0000223512.09115.3E
   Chang SD, 2003, NEUROSURGERY, V52, P140, DOI 10.1097/00006123-200301000-00018
   Chen YH, 2013, J RADIOSURGERY SBRT, V2, P105
   Collins SP, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-46
   Ezzat S, 2004, CANCER, V101, P613, DOI 10.1002/cncr.20412
   Heilbrun MP, 2003, CYBERKNIFE RADIOSURG
   Hoban PW, 1999, INT J RADIAT ONCOL, V43, P199, DOI 10.1016/S0360-3016(98)00369-1
   Iwata H, 2016, J NEURO-ONCOL, V128, P267, DOI 10.1007/s11060-016-2105-1
   Iwata H, 2011, NEURO-ONCOLOGY, V13, P916, DOI 10.1093/neuonc/nor055
   Juergen V, 2006, CANCER, V107, P1355
   Killory BD, 2009, NEUROSURGERY, V64, pA19, DOI 10.1227/01.NEU.0000341630.42160.18
   Kong DS, 2007, CANCER, V110, P854, DOI 10.1002/cncr.22860
   Leavitt JA, 2013, INT J RADIAT ONCOL, V87, P524, DOI 10.1016/j.ijrobp.2013.06.2047
   Leber KA, 1998, J NEUROSURG, V88, P43, DOI 10.3171/jns.1998.88.1.0043
   Milker-Zabel S, 2001, INT J RADIAT ONCOL, V50, P1279, DOI 10.1016/S0360-3016(01)01535-8
   Minniti G, 2006, CLIN ENDOCRINOL, V64, P542, DOI 10.1111/j.1365-2265.2006.02506.x
   Minniti G, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0710-y
   Narayan V, 2018, WORLD NEUROSURG, V114, pE824, DOI 10.1016/j.wneu.2018.03.094
   Pekic S, 2000, ENDOTEXT
   Petrovich Z, 2003, NEUROSURGERY, V53, P51, DOI 10.1227/01.NEU.0000068702.00330.47
   Pham CJ, 2004, NEUROSURGERY, V54, P799, DOI 10.1227/01.NEU.0000114261.18723.6A
   Puataweepong P, 2018, J NEURO-ONCOL, V139, P679, DOI 10.1007/s11060-018-2913-6
   Puataweepong P, 2016, TECHNOL CANCER RES T, V15, pNP10, DOI 10.1177/1533034615607113
   Purdy JA, 2008, HEALTH PHYS, V95, P666, DOI 10.1097/01.HP.0000326342.47348.06
   Schalin-Jantti C, 2010, CLIN ENDOCRINOL, V73, P72, DOI 10.1111/j.1365-2265.2009.03755.x
   Sheehan JP, 2013, J NEUROSURG, V119, P446, DOI 10.3171/2013.3.JNS12766
   Sheehan JP, 2005, J NEUROSURG, V102, P678, DOI 10.3171/jns.2005.102.4.0678
   Starke RM, 2012, J NEUROSURG, V117, P129, DOI 10.3171/2012.4.JNS112250
   Tanase CP, 2012, ELSEV INSIGHT, P19, DOI 10.1016/B978-0-12-415830-6.00002-0
   Van den Bergh ACM, 2007, INT J RADIAT ONCOL, V67, P863, DOI 10.1016/j.ijrobp.2006.09.049
   Yoon SC, 1998, INT J RADIAT ONCOL, V41, P849, DOI 10.1016/S0360-3016(98)00124-2
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1359
EP E1364
DI 10.1016/j.wneu.2019.03.102
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400172
PM 30902774
DA 2020-05-12
ER

PT J
AU Qi, HJ
   Yang, XY
   Hao, CG
   Zhang, F
   Pang, XF
   Zhou, ZB
   Dai, JL
AF Qi, Haijun
   Yang, Xiaoyan
   Hao, Chunguang
   Zhang, Fang
   Pang, Xuefei
   Zhou, Zhibiao
   Dai, Jilu
TI Clinical Value of Controlling Nutritional Status Score in Patients with
   Aneurysmal Subarachnoid Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysmal subarachnoid hemorrhage; Controlling nutritional status
   score; Immune-nutritional status; Prognostic nutrition index
ID DELAYED CEREBRAL-ISCHEMIA; PROGNOSTIC-SIGNIFICANCE; STROKE; ALBUMIN;
   IMPACT; INDEX; COMPLICATIONS; ASSOCIATION; LYMPHOCYTE; PLATELET
AB OBJECTIVE: The aim of present study was to assess the predictive value of the admission prognostic nutrition index (PNI), controlling nutritional status (CONUT) associated with delayed cerebral ischemia (DCI), and 3-month neurological outcomes after aneurysmal subarachnoid hemorrhage (aSAH).
   METHODS: The clinical data from 252 patients with aSAH were retrospectively analyzed. Receiver operating characteristic analysis was performed to assess the predictive ability of the PNI and CONUT score and identify the cutoff point. Multivariate analysis was conducted to assess the role of the PNI and CONUT score in predicting for DCI and outcomes at 3 months after aSAH treatment.
   RESULTS: We enrolled 252 patients with aSAH in our study. Of the 252 patients, 53 experienced DCI and 57 patients had a poor outcome. Patients with unfavorable outcomes had a lower serum albumin, lymphocyte count, total cholesterol, and PNI but a high CONUT score, Hunt-Hess grade, and aneurysm size (P < 0.05). Both the PNI and CONUT score correlated with the Hunt-Hess grade (r = -0.289 and P < 0.001; r = 0.512 and P < 0.001), modified Rankin scale score at 3 months (r = -0386 and P < 0.001; r = 0.533 and P < 0.001), aneurysm size (r = -0.219 and P < 0.001; r = 0.422 and P < 0.001). Only a CONUT score <4 (odds ratio, 0.241; 95% confidence interval, 0.071-0.842; P = 0.022) independently predicted the functional outcome status but not DCI at 3 months after aSAH. However, PNI was an unrelated factor associated with DCI and the clinical outcome.
   CONCLUSIONS: Our results have indicated that the CONUT score might efficiently predict for the clinical outcomes at 3 month after aSAH.
C1 [Qi, Haijun; Zhou, Zhibiao] Ulanqab Cent Hosp, Dept Neurosurg, Ulanqab, Peoples R China.
   [Pang, Xuefei] Ulanqab Cent Hosp, Dept Med Engn, Ulanqab, Peoples R China.
   [Dai, Jilu] Ulanqab Cent Hosp, Dept Lab, Ulanqab, Peoples R China.
   [Yang, Xiaoyan] Inner Mongolia Med Univ, Affiliated Hosp 3, Dept Pathol, Baotou, Peoples R China.
   [Hao, Chunguang] Inner Mongolia Med Univ, Affiliated Hosp 3, Dept Anesthesia, Baotou, Peoples R China.
   [Zhang, Fang] Hohhot Hosp Tradit Mongolian & Chinese Med, Dept Gynaecol, Hohhot, Inner Mongolia, Peoples R China.
RP Qi, HJ (reprint author), Ulanqab Cent Hosp, Dept Neurosurg, Ulanqab, Peoples R China.
EM m18947857700@163.com
CR Badjatia N, 2015, NEUROLOGY, V84, P680, DOI 10.1212/WNL.0000000000001259
   Badjatia N, 2010, JPEN-PARENTER ENTER, V34, P64, DOI 10.1177/0148607109348797
   Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395
   Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839
   Perez JID, 2014, NUTR HOSP, V29, P797, DOI 10.3305/nh.2014.29.4.7275
   Fukushima K, 2011, TOHOKU J EXP MED, V224, P215, DOI 10.1620/tjem.224.215
   Kasius KM, 2010, CEREBROVASC DIS, V29, P576, DOI 10.1159/000306645
   Kimura Y, 2017, J STROKE CEREBROVASC, V26, P448, DOI 10.1016/j.jstrokecerebrovasdis.2016.10.008
   Liang RF, 2017, CLIN CHIM ACTA, V474, P155, DOI 10.1016/j.cca.2017.09.021
   Makris K, 2016, CLIN CHEM LAB MED, V54, P143, DOI 10.1515/cclm-2015-0281
   Martin RH, 2016, STROKE, V47, P2355, DOI 10.1161/STROKEAHA.116.012825
   Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026
   Moraes L, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0970-2
   Nishi I, 2017, HEART VESSELS, V32, P1337, DOI 10.1007/s00380-017-1001-8
   Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705
   Shen HC, 2011, ARCH GERONTOL GERIAT, V53, pE149, DOI 10.1016/j.archger.2010.08.001
   Srinivasan A, 2016, WORLD NEUROSURG, V90, P91, DOI 10.1016/j.wneu.2016.02.049
   Suarez Jose I, 2015, Acta Neurochir Suppl, V120, P287, DOI 10.1007/978-3-319-04981-6_48
   Sun KY, 2014, J CANCER RES CLIN, V140, P1537, DOI 10.1007/s00432-014-1714-3
   Sun XN, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015649
   Tao CY, 2017, NEUROCRIT CARE, V26, P393, DOI 10.1007/s12028-016-0332-0
   Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275
   Vincent JL, 2009, BEST PRACT RES-CLIN, V23, P183, DOI 10.1016/j.bpa.2008.11.004
   Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35
   Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X
NR 25
TC 0
Z9 0
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1352
EP E1358
DI 10.1016/j.wneu.2019.03.100
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400171
PM 30902773
DA 2020-05-12
ER

PT J
AU Raheja, A
   Suri, A
   Sreenivasan, SA
   Singla, R
AF Raheja, Amol
   Suri, Ashish
   Sreenivasan, Sanjeev A.
   Singla, Raghav
TI Insurance and Flow-Alteration Superficial Temporal Artery to Middle
   Cerebral Artery (STA-MCA) Bypass in Management of Complex Anterior
   Intracranial Circulation Aneurysms in Postendovascular Era
SO WORLD NEUROSURGERY
LA English
DT Article
DE Internal carotid artery aneurysms; Middle cerebral artery aneurysms;
   STA-MCA bypass; Surgical strategy; Technical nuances
ID INFERIOR CEREBELLAR ARTERY; DISTAL OUTFLOW OCCLUSION; INTERNAL
   CAROTID-ARTERY; PIPELINE EMBOLIZATION; COMPLICATIONS; EXPERIENCE;
   SURGERY; OPTION
AB BACKGROUND: Optimal management of complex anterior circulation aneurysms is an enigmatic challenge because of frequent involvement of major vessel bifurcation, choroidal vessels, and lenticulostriate/thalamostriate perforators. Cerebral ischemia associated with prolonged clipping time is a major concern pertinent to their surgical management, especially in patients with poor cross-flow. To circumvent this hurdle, single/double-barrel low-flow superficial temporal artery (STA) to middle cerebral artery (M3/M4-MCA) can be performed, which can maintain distal cerebral perfusion while facilitating safe clip reconstruction of complex MCA and supraclinoidal internal carotid artery (ICA) aneurysms involving ICA bifurcation or supraclinoidal ICA aneurysms with poor cross-circulation-insurance bypass, as well as supplement/alter blood flow after MCA aneurysm trapping-flow-alteration bypass.
   METHODS: A retrospective chart review of consecutive neurosurgical patients operated over 2 years at this center was performed. Patients with complex MCA and ICA aneurysms who were treated with STA-MCA bypass were included. The clinical profile, pre- and postoperative images, intraoperative imaging, and patient outcomes were recorded. Surgical reconstruction of aneurysm was the treatment of choice due to involvement of choroidal/thalamostriate perforators, MCA/ICA bifurcation, complex aneurysm morphology, or dissecting/thrombosed nature of aneurysm. STA-MCA low-flow bypass was performed using M3/M4 segment of MCA as the recipient in anticipation of prolonged temporary clipping time on M1-MCA, supraclinoidal ICA aneurysms with suspected ICA terminus involvement, or need for possible trapping of fusiform MCA aneurysm. The saccular/fusiform part of aneurysm was clip reconstructed and the partially thrombosed dissecting segment was opened for thrombectomy and trapped using proximal and distal clips after good patency of bypass was confirmed. The distal MCA flow was restored adequately and confirmed intraoperatively using indocyanine green angiography and micro-Doppler ultrasonography.
   RESULTS: MCA (n = 4) and supraclinoid-ICA (n = 1) aneurysms were managed successfully using this strategy, which involved 6 STA-MCA bypass procedures (insurance and flow-alteration bypass, 3 each). Postoperative check angiograms demonstrated patent bypass in all 5 patients. Four patients had favorable outcome (modified Rankin Scale score 0/1); one had recovering hemiparesis and aphasia (modified Rankin Scale score 4).
   CONCLUSIONS: This series highlights the surgical strategy and safety for successfully managing complex MCA and ICA aneurysms using low-flow STA-MCA revascularization procedures.
C1 [Raheja, Amol; Suri, Ashish; Sreenivasan, Sanjeev A.; Singla, Raghav] All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
RP Suri, A (reprint author), All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
EM surineuro@gmail.com
OI Singla, Raghav/0000-0003-4426-5089
CR Alaraj A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E7
   Ashley WW, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E20
   Chen LK, 2007, CEREBROVASC DIS, V23, P381, DOI 10.1159/000101460
   Cruz JP, 2013, AM J NEURORADIOL, V34, P271, DOI 10.3174/ajnr.A3380
   Esposito G, 2016, ACTA NEUROCHIR, V158, P1523, DOI 10.1007/s00701-016-2868-3
   Esposito G, 2014, ACTA NEUROCHIR SUPPL, V119, P3, DOI 10.1007/978-3-319-02411-0_1
   Hara Takayuki, 2016, Acta Neurochir Suppl, V123, P57, DOI 10.1007/978-3-319-29887-0_8
   Hongo K, 2003, NEUROSURGERY, V52, P597, DOI 10.1227/01.NEU.0000047892.12003.58
   HOROWITZ MB, 1994, SURG NEUROL, V41, P221, DOI 10.1016/0090-3019(94)90126-0
   Kalani MYS, 2013, NEUROSURGERY, V72, P428, DOI 10.1227/NEU.0b013e3182804381
   Kobayashi S, 2003, NEUROSURGERY, V52, P33
   Matano F, 2013, CLIN NEUROL NEUROSUR, V115, P718, DOI 10.1016/j.clineuro.2012.08.007
   MATHIS JM, 1995, AM J NEURORADIOL, V16, P749
   Meybodi AT, 2017, J NEUROSURG, V127, P463, DOI 10.3171/2016.7.JNS16772
   Nussbaum ES, 2009, J NEUROSURG, V111, P78, DOI 10.3171/2009.1.JNS081250
   SAMSON D, 1994, NEUROSURGERY, V34, P22
   Seo BR, 2009, CLIN NEUROL NEUROSUR, V111, P670, DOI 10.1016/j.clineuro.2009.06.002
   Shi XG, 2015, NEUROSURG REV, V38, P109, DOI 10.1007/s10143-014-0571-5
   Siddiqui AH, 2012, NEUROSURGERY, V71, pE509, DOI 10.1227/NEU.0b013e318258e1f8
   Siddiqui AH, 2012, J NEUROSURG, V116, P1258, DOI 10.3171/2012.2.JNS111942
   STEINBERG GK, 1993, J NEUROSURG, V79, P161, DOI 10.3171/jns.1993.79.2.0161
   TANAKA A, 1993, NEUROSURGERY, V33, P742, DOI 10.1227/00006123-199310000-00028
   Zhu W, 2013, ACTA NEUROCHIR, V155, P1481, DOI 10.1007/s00701-013-1751-8
NR 23
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1387
EP E1398
DI 10.1016/j.wneu.2019.03.109
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400176
PM 30902771
DA 2020-05-12
ER

PT J
AU Rashidi, A
   Adolf, D
   Karagiannis, D
   Melhem, OB
   Luchtmann, M
AF Rashidi, Ali
   Adolf, Daniela
   Karagiannis, Dimitrios
   Melhem, Osamah Bani
   Luchtmann, Michael
TI Incidence and Risk Factors for Skull Implant Displacement After Cranial
   Surgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cranioplasty; Miniplates; Skull implant displacement; Titanium clamps
ID COMPLICATIONS FOLLOWING CRANIOPLASTY; FLAP FIXATION TECHNIQUES; GRAFT
   INFECTION; EXPERIENCE; BONE
AB OBJECTIVE: Various complications that can occur during and after cranial surgery have been investigated extensively. One of the less frequent complications has thus far received little attention, however: displacement of the skull implant after craniotomy or craniectomy. The purpose of this study is to identify prognostic factors for the development of skull implant displacement (SID).
   METHODS: In this study, 9087 cranial surgeries performed between 2002 and 2017 were retrospectively examined for the occurrence of SID. Because a first analysis of the investigated data revealed that a notable number of SIDs occurred after a cranioplasty (CP) performed after a decompressive craniectomy (DC), we focused our investigation on these cases. A total of 669 DCs and 329 subsequently performed CPs were analyzed. Several factors were analyzed unadjusted as possible factors influencing the risk for the development of SID.
   RESULTS: A total of 13 implant dislocations occurred after CP (3.95%). Fixation technique is the only factor that seems to have had a significant influence, specifically not using miniplates as the fixation technique, which was associated with a higher risk of SID (P = 0.043). However, if fixation techniques are distinguished in more detail, no significant advantage of the miniplates over titanium clamps can be proven (P = 0.123). None of the remaining observed factors showed a statistically provable impact in our data.
   CONCLUSIONS: A notable number of SIDs only occur after CPs that follow a DC. An advantage in successful placement was observed when fixation of the skull implant during cranioplasty was performed using miniplates.
C1 [Rashidi, Ali; Karagiannis, Dimitrios; Melhem, Osamah Bani; Luchtmann, Michael] Otto von Guericke Univ, Med Fac, Dept Neurosurg, Magdeburg, Germany.
   [Adolf, Daniela] Gesell Klin & Versorgungsforsch MbH, StatConsult, Magdeburg, Germany.
RP Luchtmann, M (reprint author), Otto von Guericke Univ, Med Fac, Dept Neurosurg, Magdeburg, Germany.
EM michael.luchtmann@med.ovgu.de
OI Luchtmann, Michael/0000-0002-9947-9095
CR ABBOTT KH, 1953, J NEUROSURG, V10, P380, DOI 10.3171/jns.1953.10.4.0380
   Andrzejak S, 2005, ACTA NEUROCHIR, V147, P973, DOI 10.1007/s00701-005-0581-8
   Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013
   Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6
   Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091
   Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022
   Grossman N., 2007, Cell and Tissue Banking, V8, P243, DOI 10.1007/s10561-006-9032-x
   Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7
   Lerch KD, 1999, NEUROSURGERY, V44, P902, DOI 10.1097/00006123-199904000-00137
   Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017
   Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6
   Rosseto RS, 2015, WORLD NEUROSURG, V84, P431, DOI 10.1016/j.wneu.2015.03.045
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   Shimizu S, 2011, SKULL BASE-INTERD AP, V21, P322, DOI 10.1055/s-0031-1284214
   Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9
   Wang YR, 2007, ANN PLAS SURG, V58, P388, DOI 10.1097/01.sap.0000239352.89088.26
   Winston KR, 2003, J NEUROSURG, V99, P484, DOI 10.3171/jns.2003.99.3.0484
   Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031
NR 18
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E814
EP E818
DI 10.1016/j.wneu.2019.02.157
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400101
PM 30857999
DA 2020-05-12
ER

PT J
AU Reese, JC
   Twitchell, S
   Wilde, H
   Azab, MA
   Guan, J
   Karsy, M
   Couldwell, WT
AF Reese, Jared C.
   Twitchell, Spencer
   Wilde, Herschel
   Azab, Mohammed A.
   Guan, Jian
   Karsy, Michael
   Couldwell, William T.
TI Analysis of Treatment Cost Variation Among Multiple Neurosurgical
   Procedures Using the Value-Driven Outcomes Database
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cost-effectiveness; Health care costs; Value-driven outcome
ID HEALTH-CARE COSTS; SURGICAL-TREATMENT; UNITED-STATES
AB BACKGROUND: Health care costs comprise a substantial portion of total national expenditure. Although interest in cost-effectiveness analysis in neurosurgery has increased, there has been little cross-comparison of neurosurgical procedures. The aim of this study was to compare costs across elective neurosurgical procedures to understand whether drivers of cost differ.
   METHODS: The Value Driven Outcomes database was used to evaluate treatment costs for resection of vestibular schwannoma, intracranial meningioma, gliomas, and pituitary adenoma; anterior cervical discectomy and fusion and lumbar spinal fusion; and aneurysm treatment.
   RESULTS: A total of 1997 patients (mean age 54.6 +/- 14.5 years; 45.2% male) were evaluated. The mean length of stay (LOS) was 4.0 +/- 4.4 days. For cases involving hardware implantation, including spine fusion or aneurysm treatment, supplies and implants (49.1%) accounted for the largest fraction of costs followed by facility costs (37.9%). For cases that did not involve hardware, including tumor cases, facility costs (63.9%) were the largest fraction, followed by supplies and implants (16.2%). Aneurysm treatment and lumbar fusion were 1.5-3 times more costly than cranial tumor resection and anterior cervical discectomy and fusion per patient. Multivariate linear regression demonstrated that LOS (beta = 0.7, P = 0.0001) and patient treatment type (beta = 0.2, P = 0.0001) had the greatest effect on costs. LOS correlated with cost differently depending on case type; its effect was largest for patients with meningioma and smallest for patients with vestibular schwannoma. Costs across time increased similarly for all case types.
   CONCLUSIONS: Costs for neurosurgical procedures vary widely depending on treatment type and correlated directly with LOS. Strategies to reduce cost may require different approaches depending on procedure type.
C1 [Reese, Jared C.; Twitchell, Spencer; Wilde, Herschel] Univ Utah, Sch Med, Clin Neurosci Ctr, Salt Lake City, UT USA.
   [Azab, Mohammed A.; Guan, Jian; Karsy, Michael; Couldwell, William T.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84112 USA.
RP Couldwell, WT (reprint author), Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84112 USA.
EM neuropub@hsc.utah.edu
RI Karsy, Michael/AAH-8583-2020
OI Karsy, Michael/0000-0002-0422-7937; Guan, Jian/0000-0002-4762-7113
CR Abou-Al-Shaar H, 2018, WORLD NEUROSURG, V119, pE357, DOI 10.1016/j.wneu.2018.07.161
   Al-Khouja LT, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.4.FOCUS1449
   Ament JD, 2018, WORLD NEUROSURG, V110, pE496, DOI 10.1016/j.wneu.2017.11.046
   Bekelis K, 2016, J NEUROINTERV SURG, V8, P316, DOI 10.1136/neurintsurg-2014-011575
   Brinjikji W, 2012, AM J NEURORADIOL, V33, P49, DOI 10.3174/ajnr.A2739
   Carreon LY, 2016, J NEUROSURG-SPINE, V24, P916, DOI 10.3171/2015.10.SPINE15917
   Cheikh A, 2016, NEUROL THER, V5, P145, DOI 10.1007/s40120-016-0044-6
   Guan J, 2019, J NEUROSURG, V131, P903, DOI 10.3171/2018.5.JNS18569
   Guan J, 2018, NEUROSURGERY, V83, P726, DOI 10.1093/neuros/nyx471
   Harrop JS, 2014, SPINE, V39, pS75, DOI 10.1097/BRS.0000000000000545
   Karsy M, 2018, J NEUROSURG, V129, P841, DOI 10.3171/2018.3.JNS18725
   Karsy M, 2019, NEUROSURGERY, V84, P1104, DOI 10.1093/neuros/nyy269
   Karsy M, 2017, WORLD NEUROSURG, V105, P818, DOI 10.1016/j.wneu.2017.05.148
   Karsy M, 2015, ACTA NEUROCHIR, V157, P231, DOI 10.1007/s00701-014-2268-5
   Kawamoto K, 2015, J AM MED INFORM ASSN, V22, P223, DOI 10.1136/amiajnl-2013-002511
   Lee VS, 2016, JAMA-J AM MED ASSOC, V316, P1061, DOI 10.1001/jama.2016.12226
   McLaughlin N, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14445
   Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150
   Ray S, 2014, AM HEALTH DRUG BENEF, V7, P140
   Reese JC, 2019, NEUROSURGERY, V84, P485, DOI 10.1093/neuros/nyy126
   Twitchell S, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17775
   Twitchell S, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17724
   Yoon S, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17782
NR 23
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E914
EP E920
DI 10.1016/j.wneu.2019.03.010
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400114
PM 30872202
DA 2020-05-12
ER

PT J
AU Richardson, AM
   McCarthy, DJ
   Sandhu, J
   Mayrand, R
   Guerrero, C
   Rosenberg, C
   Gernsback, JE
   Komotar, R
   Ivan, M
AF Richardson, Angela M.
   McCarthy, David J.
   Sandhu, Jagteshwar
   Mayrand, Roxanne
   Guerrero, Christina
   Rosenberg, Cathy
   Gernsback, Joanna E.
   Komotar, Ricardo
   Ivan, Michael
TI Predictors of Successful Discharge of Patients on Postoperative Day 1
   After Craniotomy for Brain Tumor
SO WORLD NEUROSURGERY
LA English
DT Article; Proceedings Paper
CT Tumor Symposium
CY 2016
CL San Diego, CA
DE Brain tumor; Craniotomy; Early discharge; Frailty; Length of stay;
   Modified frailty index
ID SAME-DAY DISCHARGE; LENGTH-OF-STAY; LAPAROSCOPIC CHOLECYSTECTOMY;
   CRANIAL NEUROSURGERY; OUTPATIENT PROCEDURE; RISK-FACTORS; SURGERY;
   OUTCOMES; FRAILTY; COMPLICATIONS
AB BACKGROUND: Shorter hospital stays have been associated with decreased complication rates, fewer hospital-acquired infections, and lower costs. We evaluated an optimized treatment paradigm for patients undergoing craniotomy allowing for postoperative day 1 (POD1) discharge if the criteria were met. We compared the complication and readmission rates between the POD1 patients and those with longer stays, and examined the patient and surgical variables for predictors of POD1 discharge.
   METHODS: We performed a retrospective review of craniotomies performed for tumor from 2011 to 2015. Craniotomies for tumors were included, and laser ablations and biopsies were excluded.
   RESULTS: A total 424 of patients were included, 132 (31%) of whom had been discharged on POD1. The mean length of stay was 6 days. The POD1 patients had had significantly better preoperative Karnofsky performance scale scores (P < 0.0001) and modified Rankin scale scores (P < 0.0001). Patient frailty, measured using the modified frailty index, was negatively predictive of POD1 discharge (P = 0.0183). Surgical factors predictive of early discharge were awake surgery (P < 0.0001) and supratentorial location (P < 0.0001). No POD1 patients experienced deep venous thrombosis (DVT), pulmonary embolus (PE), or urinary tract infections. However, of the patients with a length of stay >1 day, 4.4% and 2.7% developed DVT or PE (P = 0.0119) and urinary tract infections (P = 0.0202), respectively. Multivariate regression identified patient factors (male gender, low preoperative modified Rankin scale score), tumor factors (right-sided, supratentorial, smaller size), lower modified frailty index score, and operative factors (lack of a cerebrospinal fluid drain, awake surgery) as independent predictors of successful early discharge.
   CONCLUSIONS: Patients with good functional status can be safely discharged on POD1 after tumor craniotomy if the appropriate postoperative criteria have been met. Patients with early discharge had lower 30-day readmission and DVT/PE rates, likely owing to better baseline health status.
C1 [Richardson, Angela M.; Rosenberg, Cathy; Gernsback, Joanna E.; Komotar, Ricardo; Ivan, Michael] Univ Miami, Dept Neurol Surg, Miami, FL USA.
   [Mayrand, Roxanne] Univ Miami, Dept Neurosci, Miami, FL USA.
   [McCarthy, David J.; Sandhu, Jagteshwar] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Guerrero, Christina] Boston Univ, Sch Med, Boston, MA 02118 USA.
RP McCarthy, DJ (reprint author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
EM djm77@med.miami.edu
OI Gernsback, Joanna/0000-0001-7463-4346; Richardson,
   Angela/0000-0003-2656-7438
CR Au K, 2016, J NEUROSURG, V125, P1130, DOI 10.3171/2015.11.JNS152151
   Best MJ, 2015, SPINE, V40, P1703, DOI 10.1097/BRS.0000000000001109
   Blanshard HJ, 2001, ANESTH ANALG, V92, P89
   Bonuel N, 2013, CRIT CARE NURS Q, V36, P181, DOI 10.1097/CNQ.0b013e318283d0f3
   Carpelan A, 2015, SCAND J SURG, V104, P96, DOI 10.1177/1457496914526872
   Chiang HY, 2014, J NEUROSURG, V120, P509, DOI 10.3171/2013.9.JNS13843
   Chin KR, 2015, SPINE, V40, pE36, DOI 10.1097/BRS.0000000000000604
   Cloney Michael, 2016, World Neurosurg, V89, P362, DOI 10.1016/j.wneu.2015.12.096
   Dalton BGA, 2015, J SURG RES, V195, P418, DOI 10.1016/j.jss.2015.02.024
   Dravet F, 2000, ANN CHIR, V125, P668, DOI 10.1016/S0003-3944(00)00258-3
   Eckman WW, 2014, CLIN ORTHOP RELAT R, V472, P1806, DOI 10.1007/s11999-013-3366-z
   Florman JE, 2017, J NEUROSURG, V127, P1392, DOI 10.3171/2016.10.JNS16954
   Fonseca AL, 2014, JAMA SURG, V149, P687, DOI 10.1001/jamasurg.2013.4658
   Gaujal L, 2016, B CANCER, V103, P330, DOI 10.1016/j.bulcan.2016.01.018
   Grundy PL, 2008, BRIT J NEUROSURG, V22, P360, DOI 10.1080/02688690801961858
   Ji W, 2010, HEPATOB PANCREAT DIS, V9, P60
   Kim SH, 2015, BRIT J NEUROSURG, V29, P243, DOI 10.3109/02688697.2014.967749
   Laliberte AS, 2015, SURG ENDOSC, V29, P3454, DOI 10.1007/s00464-015-4158-1
   Legnani FG, 2013, ACTA NEUROCHIR, V155, P2281, DOI 10.1007/s00701-013-1882-y
   Loftus PD, 2016, J PEDIATR SURG, V51, P149, DOI 10.1016/j.jpedsurg.2015.10.037
   Long DM, 2003, NEUROSURGERY, V52, P1056, DOI 10.1227/01.NEU.0000057745.48813.93
   Ma RC, 2016, WORLD NEUROSURG, V93, P246, DOI 10.1016/j.wneu.2016.06.015
   Marcus LP, 2014, J NEUROSURG, V120, P1201, DOI 10.3171/2014.1.JNS131264
   Moghavem N, 2015, J NEUROSURG, V123, P189, DOI 10.3171/2014.12.JNS14447
   Mouton A, 2015, ORTHOP TRAUMATOL-SUR, V101, pS217, DOI 10.1016/j.otsr.2015.06.004
   Obeid NM, 2012, J TRAUMA ACUTE CARE, V72, P878, DOI 10.1097/TA.0b013e31824d0f70
   Purzner T, 2011, NEUROSURGERY, V69, P119, DOI 10.1227/NEU.0b013e318215a270
   Trinh QD, 2013, UROL ONCOL-SEMIN ORI, V31, P1022, DOI 10.1016/j.urolonc.2011.10.007
   Reponen E, 2016, WORLD NEUROSURG, V91, P567, DOI 10.1016/j.wneu.2016.03.102
   Reponen E, 2014, ANESTH ANALG, V119, P420, DOI 10.1213/ANE.0000000000000234
   Sarkissian S, 1995, Axone, V17, P42
   Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x
   Sughrue ME, 2015, WORLD NEUROSURG, V84, P505, DOI 10.1016/j.wneu.2015.04.019
   Theodosopoulos PV, 2012, J NEUROSURG, V117, P947, DOI 10.3171/2012.7.JNS111622
   Tsiouris A, 2013, J SURG RES, V183, P40, DOI 10.1016/j.jss.2012.11.059
   Vaziri S, 2014, WORLD NEUROSURG, V82, P376, DOI 10.1016/j.wneu.2014.02.028
   Venkatraghavan L, 2016, CAN J ANESTH, V63, P1245, DOI 10.1007/s12630-016-0717-8
NR 37
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E869
EP E877
DI 10.1016/j.wneu.2019.03.004
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400108
PM 30862575
DA 2020-05-12
ER

PT J
AU Riva, M
   Lopci, E
   Castellano, A
   Olivari, L
   Gallucci, M
   Pessina, F
   Fernandes, B
   Simonelli, M
   Navarria, P
   Grimaldi, M
   Ruda, R
   Castello, A
   Rossi, M
   Alfiero, T
   Soffietti, R
   Chiti, A
   Bello, L
AF Riva, Marco
   Lopci, Egesta
   Castellano, Antonella
   Olivari, Laura
   Gallucci, Marcello
   Pessina, Federico
   Fernandes, Bethania
   Simonelli, Matteo
   Navarria, Pierina
   Grimaldi, Marco
   Ruda, Roberta
   Castello, Angelo
   Rossi, Marco
   Alfiero, Tommaso
   Soffietti, Riccardo
   Chiti, Arturo
   Bello, Lorenzo
TI Lower Grade Gliomas: Relationships Between Metabolic and Structural
   Imaging with Grading and Molecular Factors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Clinical trials observational study; MRI; PET; Primary brain tumor;
   Surgical therapy for tumor
ID POSITRON-EMISSION-TOMOGRAPHY; C-11-METHIONINE PET; EUROPEAN ASSOCIATION;
   PROGNOSTIC MARKER; CLASSIFICATION; MANAGEMENT; 1P/19Q; TUMORS;
   PROGRESSION; DIAGNOSIS
AB BACKGROUND: Positron emission tomography (PET) is a valuable tool for the characterization of brain tumors in vivo. However, few studies have investigated the correlation between carbon-11-methionine (11C-METH) PET metrics and the clinical, radiological, histological, and molecular features of patients affected by lower grade gliomas (LGGs). The present observational study evaluated the relationships between 11C-METH PET metrics and structural magnetic resonance imaging (MRI) findings with the histomolecular biomarkers in patients with LGGs who were candidates for surgery.
   METHODS: We enrolled 96 patients with pathologically proven LGG (51 men, 45 women; age 44.1 +/- 13.7 years; 45 with grade II, 51 with grade III), who had been referred from March 2012 to January 2015 for tumor resection and had undergone preoperative 11C-METH PET. The semiquantitative metrics for 11C-METH PET included maximum standardized uptake value (SUVmax), SUV ratio to normal brain, and metabolic tumor burden (MTB). The PET semiquantitative metrics were analyzed and compared with the MRI features, histological diagnosis, isocitrate dehydrogenase-1/2 status, and 1p/19q codeletion.
   RESULTS: Histological grade was associated with SUVmax (P = 0.002), SUV ratio (P = 0.011), and MTB (P = 0.001), with grade III lesions showing higher values. Among the nonenhancing lesions on MRI, SUVmax (P = 0.001), SUV ratio (P = 0.003) and MTB (P < 0.001) were significantly different statistically for grade II versus grade III. The MRI lesion volume correlated poorly with MTB (r(2) = 0.13). The SUVmax and SUV ratio were greater (P < 0.05) in isocitrate dehydrogenase-1/2 wild-type lesions, and the SUV ratio was associated with the presence of the 1p19q codeletion.
   CONCLUSIONS: The 11C-METH PET metrics correlated significantly with histological grade and the molecular profile. Semiquantitative PET metrics can improve the preoperative evaluation of LGGs and thus support clinical decision-making.
C1 [Riva, Marco] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.
   [Bello, Lorenzo] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.
   [Riva, Marco; Pessina, Federico; Rossi, Marco; Alfiero, Tommaso; Bello, Lorenzo] Humanitas Clin & Res Ctr IRCCS, Unit Oncol Neurosurg, Milan, Italy.
   [Lopci, Egesta; Olivari, Laura; Castello, Angelo; Chiti, Arturo] Humanitas Clin & Res Ctr IRCCS, Unit Nucl Med, Milan, Italy.
   [Fernandes, Bethania] Humanitas Clin & Res Ctr IRCCS, Unit Pathol, Milan, Italy.
   [Simonelli, Matteo] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Milan, Italy.
   [Navarria, Pierina] Humanitas Clin & Res Ctr IRCCS, Unit Radiotherapy & Radiosurg, Milan, Italy.
   [Grimaldi, Marco] Humanitas Clin & Res Ctr IRCCS, Unit Neuroradiol, Milan, Italy.
   [Castellano, Antonella] Univ Vita Salute San Raffaele, Neuroradiol Unit, Milan, Italy.
   [Castellano, Antonella] Univ Vita Salute San Raffaele, CERMAC, Milan, Italy.
   [Castellano, Antonella] IRCCS San Raffaele Sci Inst, Milan, Italy.
   [Gallucci, Marcello] Univ Milano Bicocca, Fac Psychol, Milan, Italy.
   [Simonelli, Matteo] Humanitas Univ, Dept Biomed Sci, Rozzano, Italy.
   [Chiti, Arturo] Humanitas Clin & Res Ctr IRCCS, Unit Nucl Med, Milan, Italy.
   [Ruda, Roberta; Soffietti, Riccardo] Univ & City Hlth & Sci Hosp, Dept Neurooncol, Turin, Italy.
RP Riva, M (reprint author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.; Riva, M (reprint author), Humanitas Clin & Res Ctr IRCCS, Unit Oncol Neurosurg, Milan, Italy.
EM marco.riva@unimi.it
RI Riva, Marco/AAC-1357-2019; Navarria, Pierina/AAB-2595-2019; CASTELLANO,
   Antonella/I-3973-2018; Lopci, Egesta/K-8966-2016; Gallucci,
   Marcello/AAC-5495-2019; Pessina, Federico/K-7198-2016; Simonelli,
   Matteo/K-3364-2017
OI Riva, Marco/0000-0003-4643-6451; CASTELLANO,
   Antonella/0000-0002-4137-9016; Lopci, Egesta/0000-0001-9732-1094;
   Gallucci, Marcello/0000-0003-3546-0093; Pessina,
   Federico/0000-0002-8717-4999; Castello, Angelo/0000-0002-5868-3372;
   Rossi, Marco/0000-0002-0196-2370; Simonelli, Matteo/0000-0002-5264-1251
FU Fondazione Italiana per la Ricerca sul CancroAssociazione Italiana per
   la Ricerca sul Cancro (AIRC)
FX M. Riva was supported by the Fellowship for Abroad 2013 of the
   Fondazione Italiana per la Ricerca sul Cancro. The remaining authors
   declare that the article content was composed in the absence of any
   commercial or financial relationships that could be construed as a
   potential conflict of interest.
CR Albert NL, 2016, NEURO-ONCOLOGY, V18, P1199, DOI 10.1093/neuonc/now058
   Aoki K, 2018, NEURO-ONCOLOGY, V20, P66, DOI 10.1093/neuonc/nox132
   Bailey DL, 2016, MOL IMAGING BIOL, V18, P637, DOI 10.1007/s11307-016-0993-2
   Bello L, 2014, NEURO-ONCOLOGY, V16, P1110, DOI 10.1093/neuonc/not327
   Bette S, 2016, WORLD NEUROSURG, V89, P230, DOI 10.1016/j.wneu.2016.01.085
   Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121
   Castellano A, 2016, CURR OPIN ONCOL, V28, P484, DOI 10.1097/CCO.0000000000000328
   Castellano A, 2016, EUR RADIOL, V26, P1263, DOI 10.1007/s00330-015-3934-6
   Chang EF, 2008, J NEUROSURG, V109, P817, DOI 10.3171/JNS/2008/109/11/0817
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279
   Galldiks N, 2013, J NUCL MED, V54, P2046, DOI 10.2967/jnumed.113.123836
   Galldiks N, 2010, J NEURO-ONCOL, V96, P231, DOI 10.1007/s11060-009-9953-x
   Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
   Herholz K, 1998, NEUROLOGY, V50, P1316, DOI 10.1212/WNL.50.5.1316
   Herholz K, 2007, LANCET NEUROL, V6, P711, DOI 10.1016/S1474-4422(07)70192-8
   Inano R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30344
   Iwadate Y, 2016, J NEUROL NEUROSUR PS, V87, P1016, DOI 10.1136/jnnp-2015-311516
   Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947
   Kato T, 2008, AM J NEURORADIOL, V29, P1867, DOI 10.3174/ajnr.A1242
   Keunen O, 2014, ADV DRUG DELIVER REV, V76, P98, DOI 10.1016/j.addr.2014.07.010
   Kim S, 2005, EUR J NUCL MED MOL I, V32, P52, DOI 10.1007/s00259-004-1598-6
   Langen KJ, 2017, NAT REV NEUROL, V13, P279, DOI 10.1038/nrneurol.2017.44
   Law M, 2003, AM J NEURORADIOL, V24, P1989
   Lopci E, 2017, EUR J NUCL MED MOL I, V44, P1411, DOI 10.1007/s00259-017-3708-2
   Lopci E, 2017, EUR J NUCL MED MOL I, V44, P1155, DOI 10.1007/s00259-017-3618-3
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Nariai T, 2005, J NEUROSURG, V103, P498, DOI 10.3171/jns.2005.103.3.0498
   Navarria P, 2014, RADIOTHER ONCOL, V112, P425, DOI 10.1016/j.radonc.2014.09.004
   Pallud J, 2013, NEURO-ONCOLOGY, V15, P595, DOI 10.1093/neuonc/nos331
   Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399
   Plotkin M, 2010, EUR RADIOL, V20, P2496, DOI 10.1007/s00330-010-1819-2
   Riva M, 2017, INT J COMPUT ASS RAD, V12, P1711, DOI 10.1007/s11548-017-1578-5
   Riva M, 2016, J NEUROSURG, V124, P1479, DOI 10.3171/2015.4.JNS14333
   Riva M, 2014, CURR OPIN ONCOL, V26, P615, DOI 10.1097/CCO.0000000000000120
   Saito T, 2013, AM J NEURORADIOL, V34, P85, DOI 10.3174/ajnr.A3173
   Shinozaki N, 2011, J NEUROSURG, V114, P1640, DOI 10.3171/2010.11.JNS10553
   Singhal T, 2012, J NUCL MED, V53, P1709, DOI 10.2967/jnumed.111.102533
   Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337
   Suchorska B, 2018, NEURO-ONCOLOGY, V20, P279, DOI 10.1093/neuonc/nox153
   van den Bent MJ, 2017, LANCET, V390, P1645, DOI 10.1016/S0140-6736(17)31442-3
   Verger A, 2018, EUR J NUCL MED MOL I, V45, P443, DOI 10.1007/s00259-017-3846-6
   Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8
NR 44
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E270
EP E280
DI 10.1016/j.wneu.2019.02.031
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400033
PM 30797926
DA 2020-05-12
ER

PT J
AU Saadeh, YS
   Joseph, JR
   Smith, BW
   Kirsch, MJ
   Sabbagh, AM
   Park, P
AF Saadeh, Yamaan S.
   Joseph, Jacob R.
   Smith, Brandon W.
   Kirsch, Michael J.
   Sabbagh, Amr M.
   Park, Paul
TI Comparison of Segmental Lordosis and Global Spinopelvic Alignment After
   Single-Level Lateral Lumbar Interbody Fusion or Transforaminal Lumbar
   Interbody Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Lateral lumbar interbody fusion; Lumbar lordosis; Sagittal alignment;
   Segmental lordosis; Spinopelvic alignment; Transforaminal lumbar
   interbody fusion
ID ADULT SPINAL DEFORMITY; PELVIC INCIDENCE; SAGITTAL ALIGNMENT;
   CLINICAL-OUTCOMES; PARAMETERS; MISMATCH; DISEASE; MULTICENTER;
   IMBALANCE; PLANE
AB BACKGROUND: Lateral lumbar interbody fusion (LLIF) has steadily increased in popularity. Compared with the traditional transforaminal lumbar interbody fusion (TLIF), LLIF is thought to allow for greater improvement in lordosis. However, there are limited direct comparison data on the degree of regional and global alignment change after single-level LLIF and TLIF procedures. This study compared the changes in spinal sagittal alignment in patients who underwent either procedure.
   METHODS: A retrospective analysis of patients who underwent LLIF or TLIF for lumbar degenerative disease at a single institution was performed. Twenty patients who underwent single-level LLIF were matched to 20 patients who underwent single-level TLIF by gender and level of interbody fusion. All included patients had preoperative and postoperative standing scoliosis radiographs. Changes in segmental lordosis (SL) at the fused level, lumbar lordosis (LL), sagittal vertical axis, and pelvic incidencee-LL mismatch (PI-LL) were measured. Statistical analysis was performed using paired and unpaired Student's t-tests. Means were reported with standard error.
   RESULTS: Within each group, 2, 4, and 14 patients had cages placed at L2-3, L3-4, and L4-5, respectively. The LLIF group demonstrated significantly increased SL compared with the TLIF group (+/- 4.9 degrees +/- 3.0 vs. +/- 2.6 degrees +/- 1.7, P = 0.01). LL, sagittal vertical axis, and PI-LL changes did not differ significantly between groups.
   CONCLUSIONS: LLIF achieved greater improvements in SL than TLIF. However, regionally and globally, there were no significant differences with either procedure after a single-level intervention. The increased lordosis from LLIF compared with TLIF may be more impactful globally in multilevel fusions.
C1 [Saadeh, Yamaan S.; Joseph, Jacob R.; Smith, Brandon W.; Park, Paul] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.
   [Kirsch, Michael J.; Sabbagh, Amr M.] Univ Michigan, Sch Med, Ann Arbor, MI USA.
RP Park, P (reprint author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.
EM ppark@med.umich.edu
OI Kirsch, Michael/0000-0003-2324-844X
CR Acosta FL, 2011, J NEUROSURG-SPINE, V15, P92, DOI 10.3171/2011.3.SPINE10425
   Aoki Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0676-1
   Chapman TM, 2016, SPINE, V41, P1701, DOI 10.1097/BRS.0000000000001613
   Damasceno Luiz Henrique Fonseca, 2006, Acta ortop. bras., V14, P193, DOI 10.1590/S1413-78522006000400003
   Frisch Richard F, 2018, J Spine Surg, V4, P62, DOI 10.21037/jss.2018.03.16
   Hawasli AH, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17197
   JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010
   Kepler Christopher K, 2012, Orthop Surg, V4, P15, DOI 10.1111/j.1757-7861.2011.00165.x
   Korovessis P, 1999, J SPINAL DISORD, V12, P131
   Lee YS, 2014, J KOREAN NEUROSURG S, V56, P469, DOI 10.3340/jkns.2014.56.6.469
   Liang Y, 2015, EUR SPINE J, V24, P2560, DOI 10.1007/s00586-015-3933-y
   Lv Y, 2017, MINIM INVASIV THER, V26, P168, DOI 10.1080/13645706.2016.1273837
   Matsumoto T, 2017, J NEUROSURG-SPINE, V26, P435, DOI 10.3171/2016.9.SPINE16232
   Mobbs Ralph J, 2015, J Spine Surg, V1, P2, DOI 10.3978/j.issn.2414-469X.2015.10.05
   Pawar A, 2015, ASIAN SPINE J, V9, P978, DOI 10.4184/asj.2015.9.6.978
   Rhee C, 2017, J CLIN NEUROSCI, V44, P95, DOI 10.1016/j.jocn.2017.06.039
   Rice JW, 2016, GLOB SPINE J, V6, P229, DOI 10.1055/s-0035-1559583
   Rothenfluh DA, 2015, EUR SPINE J, V24, P1251, DOI 10.1007/s00586-014-3454-0
   Schuler TC, 2004, J SPINAL DISORD TECH, V17, P372, DOI 10.1097/01.bsd.0000109836.59382.47
   Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4
   Schwab FJ, 2013, SPINE, V38, pE803, DOI 10.1097/BRS.0b013e318292b7b9
   Sembrano JN, 2015, INT J SPINE SURG, V9, DOI 10.14444/2016
   Sharma AK, 2011, J SPINAL DISORD TECH, V24, P242, DOI 10.1097/BSD.0b013e3181ecf995
   Tempel ZJ, 2017, NEUROSURGERY, V80, P880, DOI 10.1093/neuros/nyw073
   Watkins RG, 2014, J SPINAL DISORD TECH, V27, P253, DOI 10.1097/BSD.0b013e31828a8447
NR 25
TC 1
Z9 1
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1374
EP E1378
DI 10.1016/j.wneu.2019.03.106
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400174
PM 30902780
DA 2020-05-12
ER

PT J
AU Sahlu, A
   Laeke, T
   Kassahun, A
   Tirsit, A
   Debebe, T
   Gemechu, T
   Lund-Johansen, M
AF Sahlu, Abat
   Laeke, Tsegazaeb
   Kassahun, Azarias
   Tirsit, Abenezer
   Debebe, Tequam
   Gemechu, Tufa
   Lund-Johansen, Morten
TI One Hundred Skull Base Meningiomas Operated at Black Lion Specialized
   Hospital, Addis Ababa, Ethiopia
SO WORLD NEUROSURGERY
LA English
DT Article
DE Ethiopia; Meningioma; Outcomes; Skull base; Surgery
ID INTRACRANIAL MENINGIOMA; TREATMENT OUTCOMES; RECURRENCE; NEUROSURGERY;
   REMOVAL
AB OBJECTIVE: After 10 years of training in their home country, neurosurgeons at Black Lion Specialized Hospital (Addis Ababa, Ethiopia) operated on skull base meningiomas independent of their external teachers. The present study used a retrospective design of an in-hospital series with short-term follow-up.
   METHODS: A total of 100 patients (mean age, 40.2 years; 80% women) had undergone surgery for skull base meningiomas from 2016 to 2017. Their symptoms included headache in 90%, impairment of vision in 47%, gait impairment in 25%, cognitive dysfunction in 29%, and seizures in 18%. Of the 100 tumors, 44% had a diameter >50 mm. Microsurgery was performed using the Hudson drill, Gigli saw, and conventional microsurgical instruments.
   RESULTS: A total of 59 complications in 39 patients occurred. Eleven patients had died within 3 months post-operatively. The cranial infection rate was 14%. The rate of Simpson grade I and II was 63%. We present the 3-12-month outcomes for 84 of the 100 patients. Of the 16 remaining patients, 4 were lost to follow-up (mean, 6.7 months) and 12 had died. Headache was noted in 65 of 74 patients preoperatively and in 20 during follow-up. Overall, 33 patients reported better vision, 48 reported similar vision, and 3 patients reported worse vision. Finally, 20 patients had gait difficulties preoperatively and 9 reported impaired gait during follow-up.
   CONCLUSION: A young faculty of neurosurgeons in a low income country was trained to perform neurosurgery for skull base meningiomas. The patients had presented at a young age with severe disabilities due to advanced disease. Surgery led to symptom improvement in a large proportion of patients; however, the complication and mortality rates were high.
C1 [Sahlu, Abat; Laeke, Tsegazaeb; Kassahun, Azarias; Tirsit, Abenezer] Black Lion Specialized Hosp, Dept Neurosurg, Addis Ababa, Ethiopia.
   [Debebe, Tequam] Black Lion Specialized Hosp, Dept Radiol, Addis Ababa, Ethiopia.
   [Gemechu, Tufa] Black Lion Specialized Hosp, Dept Pathol, Addis Ababa, Ethiopia.
   [Lund-Johansen, Morten] Haukeland Hosp, Dept Neurosurg, Bergen, Norway.
   [Lund-Johansen, Morten] Univ Bergen, Inst Clin Sci, Bergen, Norway.
RP Lund-Johansen, M (reprint author), Haukeland Hosp, Dept Neurosurg, Bergen, Norway.; Lund-Johansen, M (reprint author), Univ Bergen, Inst Clin Sci, Bergen, Norway.
EM morten.lundjohansen@gmail.com
OI Admasu, Azarias/0000-0001-6404-9135
CR Bassiouni H, 2009, J NEUROSURG, V111, P1078, DOI 10.3171/2009.3.17685
   Burkhardt JK, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS117
   Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500
   Goldbrunner R, 2016, LANCET ONCOL, V17, pE383, DOI 10.1016/S1470-2045(16)30321-7
   Ibebuike K, 2013, AFR HEALTH SCI, V13, P118, DOI 10.4314/ahs.v13i1.16
   JAASKELAINEN J, 1986, SURG NEUROL, V26, P461, DOI 10.1016/0090-3019(86)90259-4
   Karan Abraar, 2016, AMA J Ethics, V18, P665, DOI 10.1001/journalofethics.2016.18.7.ecas1-1607
   Liu M, 2015, S AFR J SURG, V53, P20
   Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051
   Mangat HS, 2018, WORLD NEUROSURG, V113, P411, DOI 10.1016/j.wneu.2018.01.086
   Mathiesen T, 1996, NEUROSURGERY, V39, P2, DOI 10.1097/00006123-199607000-00002
   Meling TR, 2019, NEUROSURG REV, V42, P163, DOI 10.1007/s10143-018-0976-7
   Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5
   Motebejane MS, 2018, WORLD NEUROSURG, V109, pE292, DOI 10.1016/j.wneu.2017.09.161
   Nakamura M, 2007, NEUROSURGERY, V60, P844, DOI 10.1227/01.NEU.0000255453.20602.80
   Nakamura M, 2006, NEUROSURGERY, V59, P1019, DOI 10.1227/01.NEU.0000245600.92322.06
   Nakao N, 2011, J CLIN NEUROSCI, V18, P895, DOI 10.1016/j.jocn.2010.10.020
   Narayan V, 2018, WORLD NEUROSURG, V110, pE32, DOI 10.1016/j.wneu.2017.09.184
   Odebode TO, 2006, J CLIN NEUROSCI, V13, P649, DOI 10.1016/j.jocn.2005.07.023
   Park HY, 2012, J CLIN NEUROSCI, V19, P1654, DOI 10.1016/j.jocn.2011.11.044
   PIA HW, 1976, ACTA NEUROCHIR, V35, P243, DOI 10.1007/BF01406120
   Rogers L, 2015, J NEUROSURG, V122, P4, DOI 10.3171/2014.7.JNS131644
   Scheitzach J, 2014, J NEURO-ONCOL, V116, P381, DOI 10.1007/s11060-013-1309-x
   Seifert V, 2010, ACTA NEUROCHIR, V152, P1099, DOI 10.1007/s00701-010-0633-6
   Vivier J, 2009, BRIT J NEUROSURG, V23, P63, DOI 10.1080/02688690802593064
   Wu A, 2018, WORLD NEUROSURG, V111, pE142, DOI 10.1016/j.wneu.2017.12.012
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1321
EP E1329
DI 10.1016/j.wneu.2019.03.088
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400167
PM 30902778
DA 2020-05-12
ER

PT J
AU Sanchis-Gimeno, JA
   Quiles-Guinau, L
   Llido-Torrent, S
   Aparicio, L
   Nalla, S
   Miquel-Feutch, M
AF Sanchis-Gimeno, Juan A.
   Quiles-Guinau, Laura
   Llido-Torrent, Susanna
   Aparicio, Luis
   Nalla, Shahed
   Miquel-Feutch, Marcos
TI Possible Clinical Implications of Geographic Differences in Prevalence
   of Double Transverse Foramen
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anatomic variations; Clinical symptoms; Geographical variations; Spine;
   Transverse foramen
AB BACKGROUND: The double transverse foramen (DBLTF) is a cervical spine anatomic variant. Current literature has presented prevalence values of DBLTF in Caucasian Mediterranean subjects that seem to be higher than those observed in other samples of subjects. Therefore we aimed to test if Caucasian Mediterranean subjects present a higher prevalence of the DBLTF than sub-Saharan African subjects.
   METHODS: We analyzed the presence of DBLTF in cervical spines of 100 skeletons from Caucasian Mediterranean subjects and 91 skeletons from sub-Saharan African subjects, resulting in a total of 1337 cervical vertebrae having been studied.
   RESULTS: No DBLTF was found in vertebrae C1, C2, and C3. The pattern of prevalence observed in all samples analyzed indicated the prevalence ranged from exhibiting the most to the least prevalence as C6 > C5 > C7 > C4. The sub-Saharan African subjects presented a significant reduced DBLTF prevalence of 2.2%, 14.3%, 19.8%, and 3.3% in C4 (P = 0.043), C5 (P = 0.004), C6 (P < 0.001), and C7 (P = 0.041), respectively, than that presented by Caucasian Mediterranean subjects (9.0%, 32.0%, 45.0%, 11.0% in C4, C5, C6, and C7, respectively).
   CONCLUSIONS: Our study has revealed that this anatomic variation is more frequently found in Caucasian Mediterranean subjects than in sub-Saharan African subjects.
C1 [Sanchis-Gimeno, Juan A.; Quiles-Guinau, Laura; Llido-Torrent, Susanna; Aparicio, Luis; Nalla, Shahed; Miquel-Feutch, Marcos] Univ Valencia, Fac Med, Dept Anat & Human Embryol, GIAVAL Res Grp, Valencia, Spain.
   [Nalla, Shahed] Univ Johannesburg, Fac Hlth Sci, Dept Human Anat & Physiol, Johannesburg, South Africa.
RP Sanchis-Gimeno, JA (reprint author), Univ Valencia, Fac Med, Dept Anat & Human Embryol, GIAVAL Res Grp, Valencia, Spain.
EM juan.sanchis@uv.es
RI Nalla, Shahed/U-2213-2017; Sanchis-Gimeno, Juan A./G-9976-2015
OI Nalla, Shahed/0000-0002-0957-1067; Sanchis-Gimeno, Juan
   A./0000-0002-2599-8474
FU Ministry of Economy, Industry and Competitiveness of Spain
   [CGL2015-63648-P]
FX This research is funded in part by Ministry of Economy, Industry and
   Competitiveness of Spain (CGL2015-63648-P).
CR Das S., 2005, INT MED J, V12, P311
   De Boeck M, 1974, J COMPUT TOMOGR, V8, P117
   JOVANOVIC MS, 1990, SURG RADIOL ANAT, V12, P167, DOI 10.1007/BF01624518
   Laxmi Chandravadiya, 2013, INT J RES MED, V2, P103
   Metin Tellioglu A, 2018, TURK NEUROSURG, V28, P557, DOI 10.5137/1019-5149.JTN.18839-17.3
   Murlimanju BV, 2011, TURK NEUROSURG, V21, P384, DOI 10.5137/1019-5149.JTN.4047-10.0
   Patil NP, 2014, J DENT MED SCI, V13, P85
   Quiles-Guinau Laura, 2017, Italian Journal of Anatomy and Embryology, V122, P27, DOI 10.13128/IJAE-20924
   Quiles-Guinau L, 2016, EUR J ANAT, V20, P337
   Rios L, 2014, ANN ANAT, V196, P167, DOI 10.1016/j.aanat.2013.12.003
   Sanchis-Gimeno JA, 2005, OSTEOPOROSIS INT, V16, P1171, DOI 10.1007/s00198-005-1908-2
   Sanchis-Gimeno JA, 2018, J ANAT, V233, P341, DOI 10.1111/joa.12839
   Sanchis-Gimeno JA, 2017, CLIN ANAT, V30, P761, DOI 10.1002/ca.22897
   Sharma A, 2010, J ANAT SOC INDIA, V59, P229
   TAITZ C, 1978, J NEUROL NEUROSUR PS, V41, P170, DOI 10.1136/jnnp.41.2.170
   Wysocki Jaroslaw, 2003, Folia Morphol (Warsz), V62, P357
NR 16
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E570
EP E572
DI 10.1016/j.wneu.2019.02.096
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400069
PM 30831296
DA 2020-05-12
ER

PT J
AU Sebastian, A
   Goyal, A
   Alvi, MA
   Wahood, W
   Elminawy, M
   Habermann, EB
   Bydon, M
AF Sebastian, Arjun
   Goyal, Anshit
   Alvi, Mohammed Ali
   Wahood, Waseem
   Elminawy, Mohamed
   Habermann, Elizabeth B.
   Bydon, Mohamad
TI Assessing the Performance of National Surgical Quality Improvement
   Program Surgical Risk Calculator in Elective Spine Surgery: Insights
   from Patients Undergoing Single-Level Posterior Lumbar Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Lumbar fusion; NSQIP; Predictive algorithm; Risk calculator; Spine
   surgery
ID UNRUPTURED INTRACRANIAL ANEURYSM; GYNECOLOGIC ONCOLOGY PATIENTS;
   ACS-NSQIP; AMERICAN-COLLEGE; POSTOPERATIVE COMPLICATIONS; 30-DAY
   COMPLICATIONS; INFORMED-CONSENT; FAIR PREDICTOR; MORBIDITY; MORTALITY
AB INTRODUCTION: The American College of Surgeons-National Surgical Quality Improvement Program Surgical Risk Calculator is a tool developed to use 21 individual patient characteristics to make predictions for occurrence of 13 general and 2 procedure-specific outcomes. The goal of this study was to evaluate the performance of the Surgical Risk Calculator in predicting outcomes in patients receiving posterior lumbar fusion.
   METHODS: American College of Surgeons-National Surgical Quality Improvement Program Participant Use File for 2015 was queried for patients with age >= 18 years undergoing single-level posterior lumbar fusion (PLF) surgery. Individual patient characteristics were entered into the online risk calculator interface to retrieve the predicted estimated risk for perioperative outcomes and complications. Following this, predictive performance was analyzed by computing Brier score, c-statistic, and sensitivity values for all observed outcomes.
   RESULTS: A total of 2808 patients undergoing single-level PLF were included in the analysis. Overall, a very low incidence of 30-day postoperative complications was observed with the procedure (0.9%-6.3%). Poor predictive performance was found for all outcomes, including read-missions (c-statistic = 0.63; sensitivity = 15.28%; Brier score = 0.048) and returns to operating room (c-statistic = 0.56; sensitivity = 21.05%; Brier score = 0.032). The best performance was observed for venous thromboembolism (c-statistic = 0.66: Brier score = 0.008), although sensitivity was poor (3.85%) on account of low incidence. Predictive performance for length of stay revealed good agreement between observed and predicted values with the exception of prolonged predicted hospital stays (>3.5 days).
   CONCLUSIONS: This study assesses the performance of the risk calculator for a homogenous population of patients undergoing a single-level PLF. Although the calculator did not fare well in predicting most outcomes, results need to be interpreted in the context of the low incidence rate of such outcomes.
C1 [Sebastian, Arjun] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Goyal, Anshit; Alvi, Mohammed Ali; Wahood, Waseem; Elminawy, Mohamed; Bydon, Mohamad] Mayo Clin, Neuroinformat Lab, Rochester, MN 55905 USA.
   [Goyal, Anshit; Alvi, Mohammed Ali; Wahood, Waseem; Elminawy, Mohamed; Bydon, Mohamad] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
   [Habermann, Elizabeth B.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.
RP Bydon, M (reprint author), Mayo Clin, Neuroinformat Lab, Rochester, MN 55905 USA.; Bydon, M (reprint author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
EM Bydon.Mohamad@mayo.edu
RI Alvi, Mohammed Ali/AAE-1490-2019
OI Alvi, Mohammed Ali/0000-0002-7131-079X; Wahood,
   Waseem/0000-0002-2963-4096
CR Adegboyega TO, 2017, AM J SURG, V213, P30, DOI 10.1016/j.amjsurg.2016.04.011
   Arce K, 2016, J ORAL MAXIL SURG, V74, P1850, DOI 10.1016/j.joms.2016.02.024
   Austin PC, 2013, MED CARE, V51, P275, DOI 10.1097/MLR.0b013e31827ff0dc
   Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385
   Cohen ME, 2017, J AM COLL SURGEONS, V224, P787, DOI 10.1016/j.jamcollsurg.2016.12.057
   Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787
   Cologne KG, 2015, J AM COLL SURGEONS, V220, P281, DOI 10.1016/j.jamcollsurg.2014.12.007
   Cusworth BM, 2017, HPB, V19, P147, DOI 10.1016/j.hpb.2016.10.015
   Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338
   Edelstein AI, 2015, J ARTHROPLASTY, V30, P5, DOI 10.1016/j.arth.2015.01.057
   Evans RP, 2016, CLIN ORTHOP RELAT R, V474, P2067, DOI 10.1007/s11999-016-4922-0
   Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011
   Forum on Medicine Public Health Preparedness for Catastrophic Events Board on Health Sciences Policy Board on Health Care Services Institute of Medicine, 2014, ACA WILL CHANG HLTH
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Goltz DE, 2018, J ARTHROPLASTY, V33, P25, DOI 10.1016/j.arth.2017.08.008
   Hamilton DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002525
   Hu WH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002999
   Johnson C, 2017, J INVEST MED, V65, P722, DOI 10.1136/jim-2016-000224
   Keller DS, 2016, AM J SURG, V212, P433, DOI 10.1016/j.amjsurg.2015.10.033
   Kerezoudis P, 2016, CLIN NEUROL NEUROSUR, V149, P75, DOI 10.1016/j.clineuro.2016.07.027
   Lyle B, 2016, AM J SURG, V211, P820, DOI 10.1016/j.amjsurg.2015.07.013
   Massoumi RL, 2017, WORLD J SURG, V41, P935, DOI 10.1007/s00268-016-3816-3
   McCutcheon BA, 2016, WORLD NEUROSURG, V91, P272, DOI [10.1016/j.wneu.2016.04.039, 10.1016/J.WNEU.2016.04.039]
   McMillan MT, 2017, ANN SURG, V265, P978, DOI 10.1097/SLA.0000000000001796
   Mitchell TO, 2016, J SURG RES, V203, P56, DOI 10.1016/j.jss.2016.03.040
   Mogal HD, 2016, J SURG ONCOL, V114, P157, DOI 10.1002/jso.24276
   Mohanty S, 2015, JAMA SURG, V150, P480, DOI 10.1001/jamasurg.2014.3176
   NQF, 2013, MAP PRER REP FEBR 20
   O'Neill AC, 2016, J PLAST RECONSTR AES, V69, P1356, DOI 10.1016/j.bjps.2016.05.021
   Osorio JA, 2016, CURR REV MUSCULOSKE, V9, P333, DOI 10.1007/s12178-016-9354-7
   Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101
   Pitt HA, 2009, HPB, V11, P405, DOI 10.1111/j.1477-2574.2009.00074.x
   Prasad KG, 2016, OTOLARYNG HEAD NECK, V155, P740, DOI 10.1177/0194599816655976
   Rivard C, 2016, GYNECOL ONCOL, V141, P281, DOI 10.1016/j.ygyno.2016.02.015
   Samson P, 2016, J THORAC CARDIOV SUR, V151, P697, DOI 10.1016/j.jtcvs.2015.08.058
   Schenker Y, 2011, MED DECIS MAKING, V31, P151, DOI 10.1177/0272989X10364247
   Schneider AL, 2016, JAMA OTOLARYNGOL, V142, P972, DOI 10.1001/jamaoto.2016.1809
   Slump J, 2016, J SURG ONCOL, V114, P570, DOI 10.1002/jso.24357
   Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2
   Teoh D, 2017, J MINIM INVAS GYN, V24, P48, DOI 10.1016/j.jmig.2016.10.005
   Vaziri S, 2018, J NEUROSURG, V128, P942, DOI 10.3171/2016.11.JNS161377
   Veeravagu A, 2017, J NEUROSURG-SPINE, V27, P81, DOI 10.3171/2016.12.SPINE16969
   Whitmore RG, 2012, SPINE, V37, P1065, DOI 10.1097/BRS.0b013e31823da22d
   Wingert NC, 2016, CLIN ORTHOP RELAT R, V474, P1643, DOI 10.1007/s11999-016-4717-3
NR 44
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E323
EP E329
DI 10.1016/j.wneu.2019.02.049
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400038
PM 30822574
DA 2020-05-12
ER

PT J
AU Senger, S
   Keiner, D
   Schwerdtfeger, K
   Oertel, J
AF Senger, Sebastian
   Keiner, Doerthe
   Schwerdtfeger, Karsten
   Oertel, Joachim
TI Imaging of Microhemodynamics in Peripheral Nerves by Contact Endoscope
SO WORLD NEUROSURGERY
LA English
DT Article
DE Contact endoscope; Endoscopy; Entrapment neuropathy; Microhemodynamics;
   Peripheral nerves
ID CUBITAL TUNNEL-SYNDROME; CARPAL-TUNNEL; DECOMPRESSION; RELEASE; MUCOSA
AB BACKGROUND: Entrapment neuropathies include a wide field of locations. In most cases, the microsurgical decompression is still the therapy of choice. However, the role of venous stasis and ischemia is still discussed controversially. Here the authors evaluated the visualization of microvessels and the microperfusion at peripheral nerves with a contact endoscope during the surgical decompression for the first time.
   METHODS: Eight patients were subjected to endoscopic or endoscopically assisted peripheral nerve decompression. In 3 patients with nerve tumors, the tumor carrying nerve was inspected endoscopically proximal and distal to the tumor site before and after resection. Microcirculation was assessed by a contact endoscope, allowing a 150-fold magnification, at superficial areas proximal and distal to the compression site. The electronically stored records were analyzed retrospectively using image processing software. Vessel diameter, red blood cell velocity, and blood flow, before and after decompression, were extracted.
   RESULTS: The contact endoscope was easy to handle intraoperatively without problems. All minimally invasive procedures were performed without complications. In the offline computer-assisted analysis, single arterioles and veins were visualized showing decreased red blood cell velocity prior to decompression. After surgical treatment, a statistically significant increase of blood flow was observed.
   CONCLUSIONS: Basically, the application of a contact endoscope for visualization of peripheral nerves' microcirculation is feasible. The observed effect of increased blood flow after decompression should be compared with the clinical outcome in a further prospective randomized study.
C1 [Senger, Sebastian; Keiner, Doerthe; Schwerdtfeger, Karsten; Oertel, Joachim] Saarland Univ, Dept Neurosurg, Med Sch, Homburg, Saar, Germany.
RP Oertel, J (reprint author), Saarland Univ, Dept Neurosurg, Med Sch, Homburg, Saar, Germany.
EM oertelj@freenet.de
RI Keiner, Doerthe/AAK-1195-2020
OI Keiner, Doerthe/0000-0003-2975-7704
CR Assmus H, 2011, CENT EUR NEUROSURG, V72, P90, DOI 10.1055/s-0031-1271800
   BARONE CM, 1992, J RECONSTR MICROSURG, V8, P319, DOI 10.1055/s-2007-1006715
   BROWN RA, 1993, J BONE JOINT SURG AM, V75A, P1265, DOI 10.2106/00004623-199309000-00002
   Cikojevic D, 2008, J LARYNGOL OTOL, V122, P836, DOI 10.1017/S0022215107000539
   Dedivitis RA, 2009, ACTA OTORHINOLARYNGO, V29, P16
   Dezawa A, 2002, SPINE, V27, P2844, DOI 10.1097/00007632-200212150-00022
   Gao YM, 2013, NEURAL REGEN RES, V8, P1041, DOI 10.3969/j.issn.1673-5374.2013.11.010
   Gruber H, 2007, EUR RADIOL, V17, P2880, DOI 10.1007/s00330-007-0645-7
   Gupta R, 2012, MUSCLE NERVE, V45, P231, DOI 10.1002/mus.22276
   Haxel BR, 2010, EUR ARCH OTO-RHINO-L, V267, P443, DOI 10.1007/s00405-009-1035-3
   Ju MS, 2006, J BIOMECH, V39, P97, DOI 10.1016/j.jbiomech.2004.10.026
   Katz JN, 1998, J HAND SURG-AM, V23A, P697, DOI 10.1016/S0363-5023(98)80058-0
   Keiner D, 2011, ACTA NEUROCHIR, V153, P2225, DOI 10.1007/s00701-011-1091-5
   Keiner D, 2009, ACTA NEUROCHIR, V151, P311, DOI 10.1007/s00701-009-0218-4
   Keiner D, 2009, NEUROSURGERY, V64, P131, DOI 10.1227/01.NEU.0000335784.90217.9D
   Kleinman WB, 1999, J HAND SURG-AM, V24A, P886
   Kobayashi S, 2000, SPINE, V25, P298, DOI 10.1097/00007632-200002010-00007
   Laschke MW, 2005, J INFECT DIS, V191, P435, DOI 10.1086/427193
   Nakayama Y, 2004, HELICOBACTER, V9, P95, DOI 10.1111/j.1083-4389.2004.00204.x
   NEARY D, 1975, J NEUROL SCI, V24, P283, DOI 10.1016/0022-510X(75)90248-8
   Oertel J, 2010, NEUROSURGERY, V66, P817, DOI 10.1227/01.NEU.0000367551.41503.58
   Ozmen S, 2008, J PLAST RECONSTR AES, V61, P939, DOI 10.1016/j.bjps.2007.05.017
   Saeki N, 2011, AURIS NASUS LARYNX, V38, P233, DOI 10.1016/j.anl.2010.08.006
   Stadie AT, 2010, NEUROSURGERY, V66, pONS325, DOI 10.1227/01.NEU.0000369949.97016.B1
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1302
EP E1308
DI 10.1016/j.wneu.2019.03.081
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400164
PM 30898754
DA 2020-05-12
ER

PT J
AU Shafiq, F
   Parkash, J
   Enam, A
   Khan, MF
   Baig, T
AF Shafiq, Faraz
   Parkash, Jai
   Enam, Ather
   Khan, Muhammad Faheem
   Baig, Tanveer
TI An Awake Throughout Approach for Awake Craniotomy: A Perspective from a
   Resource-Limited Country
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anesthesia; Brain tumor; Craniotomy; Wakefulness
ID TECHNICAL ASPECTS; BRAIN-TUMORS; MORBIDITY; SEDATION
AB BACKGROUND: An awake throughout (AT) approach for awake craniotomy is mostly under utilized. The purpose of this study was to review the efficacy of the technique at our tertiary care center. The primary objective was to identify the incidence of perioperative complications. The secondary objective was to review the patients' satisfaction, satisfaction of surgical team, length of stay (LOS) in special care unit (SCU), and overall LOS in the hospital.
   METHODS: The study was a retrospective review of patients data. All patients were treated with the AT technique. This included preoperative assessment, psychologic preparation, and institution of scalp block. The incidence of perioperative complications, including satisfaction of surgical team was noted. The patients' satisfaction and the LOS in SCU and in the hospital was also recorded.
   RESULTS: In total, the data from 55 patients were reviewed. Their mean age was 41 years, and 63% were reported to have seizures at presentation. The AT approach was successful in 100% of cases. The incidence of intraoperative seizures was 7.4%, of vomiting was 5.4%, and of conversion to general anesthesia was 0%. The surgical team was able to perform gross total resection in 53% of patients and rated a satisfaction score of 8 out of 10. Postoperative seizures occurred in 5.4% of patients and vomiting in 3.6%. The mean LOS in SCU was 1.2 days, and the overall hospital LOS was 4 days. The patients remained fully satisfied, as evidenced by a mean satisfaction score of 8.6.
   CONCLUSION: An AT approach might be very useful in resource-limited setups because of the low incidence of complications, the use of resources, and significant surgeon and patient satisfaction.
C1 [Shafiq, Faraz; Parkash, Jai; Baig, Tanveer] Aga Khan Univ, Natl Inst Cardiovasc Dis, Dept Anaesthesiol, Karachi, Pakistan.
   [Enam, Ather] Aga Khan Univ, Dept Neurosurg, Karachi, Pakistan.
   [Khan, Muhammad Faheem] Kings Coll Hosp NHS Fdn Trust, Dept Neurosurg, London, England.
RP Shafiq, F (reprint author), Aga Khan Univ, Natl Inst Cardiovasc Dis, Dept Anaesthesiol, Karachi, Pakistan.
EM faraz.shafiq@aku.edu
CR Akay A, 2018, TURK NEUROSURG, V28, P186, DOI 10.5137/1019-5149.JTN.19391-16.1
   Gernsback JE, 2018, WORLD NEUROSURG, V118, pE842, DOI 10.1016/j.wneu.2018.07.064
   Goettel N, 2016, BRIT J ANAESTH, V116, P811, DOI 10.1093/bja/aew024
   Grossman R, 2013, ANN SURG ONCOL, V20, P1722, DOI 10.1245/s10434-012-2748-x
   Hamer PCD, 2012, J CLIN ONCOL, V30, P2559, DOI 10.1200/JCO.2011.38.4818
   Hansen E, 2013, ACTA NEUROCHIR, V155, P1417, DOI 10.1007/s00701-013-1801-2
   Kamata K, 2016, J ANESTH, V30, P941, DOI 10.1007/s00540-016-2243-9
   Keles GE, 2004, J NEUROSURG, V100, P369, DOI 10.3171/jns.2004.100.3.0369
   Khan SA, 2017, IJS SHORT REP, V2, P5
   Khan SA, 2016, J PAK MED ASSOC, V66, pS68
   Klimek M, 2018, WORLD NEUROSURG, V109, pE258, DOI 10.1016/j.wneu.2017.09.158
   Kulikov A S, 2015, Zh Vopr Neirokhir Im N N Burdenko, V79, P15, DOI 10.17116/neiro201579615-21
   Lobo FA, 2016, BRIT J ANAESTH, V116, P740, DOI 10.1093/bja/aew113
   Leal RTM, 2018, WORLD NEUROSURG, V113, P67, DOI 10.1016/j.wneu.2018.02.013
   Maldaun MV, 2014, J NEUROSURG, V8, P1
   Mansur A, 2018, WORLD NEUROSURG, V118, P332, DOI 10.1016/j.wneu.2018.07.149
   McColl MA, 2012, CAN FAM PHYSICIAN, V58, pe1626
   Nossek E, 2013, NEUROSURGERY, V73, P135, DOI 10.1227/01.neu.0000429847.91707.97
   Potters JW, 2015, CURR OPIN ANESTHESIO, V28, P511, DOI 10.1097/ACO.0000000000000231
   Shafiq F, 2017, JCPSP-J COLL PHYSICI, V27, P775, DOI 2771
   Stevanovic A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156448
   Trimble G, 2015, BRIT J NEUROSURG, V29, P836, DOI 10.3109/02688697.2015.1054354
NR 22
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1489
EP E1493
DI 10.1016/j.wneu.2019.03.127
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400187
PM 30905650
DA 2020-05-12
ER

PT J
AU Shen, J
   Shao, XF
   Gao, YL
   Li, QF
   Ge, RX
   Wang, QF
   Zhou, W
   Jiang, XC
AF Shen, Jun
   Shao, Xuefei
   Gao, YaLong
   Li, Qifeng
   Ge, Ruixiang
   Wang, Qifu
   Zhou, Wei
   Jiang, XiaoChun
TI Risk Factors for Contralateral Hematoma Progression after Unilateral
   Evacuation of Bilateral Chronic Subdural Hematomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Bilateral; Chronic subdural hematoma; Progression; Recurrence; Risk
   factor
ID INDEPENDENT PREDICTORS; RECURRENCE; MANAGEMENT; VOLUME
AB OBJECTIVE: To find risk factors for contralateral hematoma progression (CHP) in bilateral chronic subdural hematomas after initial unilateral evacuation.
   METHODS: We retrospectively analyzed 53 patients with bilateral chronic subdural hematomas who underwent unilateral surgical evacuation in our department. Risk factors for CHP were identified by univariate analysis, a P value < 0.05 were entered into multivariate logistic regression model and a predictive receiver operating characteristic curve model.
   RESULTS: The progression rate was 32.08%, the average progression interval was 2.32 months. The progression rate of the homogeneous hypodense group was significantly higher than that of the other density group (P = 0.017). The limited type of contralateral hematoma had a significantly lower progression rate than that of the widespread type (P = 0.001). Both pre- and postoperative volume of contralateral hematoma were significantly more in the CHP group compared with the contralateral hematoma without progression group (P = 0.031 and P = 0.001, respectively). Of the 4 risk factors, only postoperative volume of contralateral hematoma was an independent risk factor in multivariate logistic regression model (P = 0.033; 95% confidence interval, 1.005-1.124). The cut-off values of contralateral hematoma volume before and after operation were 29.27 cm(3) and 37.84 cm(3), respectively.
   CONCLUSIONS: Contralateral hematoma volume after operation is an independent risk predictor for CHP after unilateral evacuation. An additional surgery on contralateral hematoma or medical treatment should be taken into consideration if the volume is >37.84 cm(3) in the first cranial computed tomography scan after surgery.
C1 [Shen, Jun; Shao, Xuefei; Ge, Ruixiang; Wang, Qifu; Zhou, Wei; Jiang, XiaoChun] Yijishan Hosp, Dept Neurosurg, Wannan Med Coll, Wuhu, Peoples R China.
   [Gao, YaLong; Li, Qifeng] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China.
RP Shen, J (reprint author), Yijishan Hosp, Dept Neurosurg, Wannan Med Coll, Wuhu, Peoples R China.
EM shenyuanziyan@163.com
CR Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67
   Abouzari M, 2009, NEUROSURG REV, V32, P479, DOI 10.1007/s10143-009-0215-3
   Andersen-Ranberg NC, 2017, J NEUROSURG, V126, P1905, DOI 10.3171/2016.4.JNS152642
   Avanali R, 2016, WORLD NEUROSURG, V96, P355, DOI 10.1016/j.wneu.2016.09.010
   Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9
   De Bonis P, 2018, CLIN NEUROL NEUROSUR, V170, P88, DOI 10.1016/j.clineuro.2018.05.002
   Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y
   Bae ME, 2011, ACTA NEUROCHIR, V153, P1097, DOI 10.1007/s00701-010-0903-3
   Fujitani S, 2017, J NEUROSURG, V126, P755, DOI 10.3171/2016.1.JNS152655
   Gelabert-Gonzalez M, 2015, MED CLIN-BARCELONA, V144, P514, DOI 10.1016/j.medcli.2015.01.006
   Huang YH, 2014, INJURY, V45, P1327, DOI 10.1016/j.injury.2014.02.023
   Jiang RC, 2018, JAMA NEUROL, V75, P1338, DOI 10.1001/jamaneurol.2018.2030
   Kawabata S, 2018, NEUROL MED-CHIR, V58, P247, DOI 10.2176/nmc.oa.2018-0019
   Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064
   Motiei-Langroudi R, 2019, NEUROSURGERY, V85, P648, DOI 10.1093/neuros/nyy432
   Motiei-Langroudi R, 2018, J NEUROSURG, V129, P1143, DOI 10.3171/2017.6.JNS17130
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Scheichel F, 2019, J NEUROSURG, V131, P1227, DOI 10.3171/2018.6.JNS18467
   Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002
   Stanisic M, 2013, ACTA NEUROCHIR, V155, P323, DOI 10.1007/s00701-012-1565-0
   Takahashi Satoru, 2018, Asian J Neurosurg, V13, P1134, DOI 10.4103/ajns.AJNS_124_18
   Xu CS, 2018, EXP THER MED, V16, P959, DOI 10.3892/etm.2018.6265
   Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217
   You CG, 2018, CLIN NEUROL NEUROSUR, V166, P56, DOI 10.1016/j.clineuro.2018.01.029
   Zhang Y, 2017, WORLD NEUROSURG, V105, P115, DOI 10.1016/j.wneu.2017.05.135
NR 25
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E773
EP E778
DI 10.1016/j.wneu.2019.02.148
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400096
PM 30853519
DA 2020-05-12
ER

PT J
AU Shen, SC
   Shen, CC
   Pu, TW
   Cheng, WY
AF Shen, Shih-Chieh
   Shen, Chiung-Chyi
   Pu, Ta-Wei
   Cheng, Wen-Yu
TI Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin
   Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of
   Experience in a Single Institute
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acromegaly; Long-term; Macroadenoma; Somatostatin analog;
   Transsphenoidal
ID TRANSSPHENOIDAL SURGERY; ACROMEGALIC PATIENTS; SURGICAL DEBULKING;
   ADENOMAS; OCTREOTIDE; MORTALITY; RESECTION; METAANALYSIS; PASIREOTIDE;
   LANREOTIDE
AB OBJECTIVE: Long-term effects of endoscopic endonasal transsphenoidal intracapsular debulking and adjuvant somatostatin analogs (SSAs) were evaluated in patients with growth hormone- (GH) secreting pituitary macroadenomas.
   METHODS: We retrospectively reviewed the medical records of 45 patients with acromegalic macroadenoma who underwent endonasal endoscopic transsphenoidal intracapsular debulking and received adjuvant SSAs (octreotide) between 2006 and 2015 who had >1 year of follow-up. To evaluate the predictive factors for 1 year and long-term biochemical outcomes, univariate and multivariate analyses were performed.
   RESULTS: Biochemical remission was achieved in 1 year in 20 of the 45 (44.4%) patients, and in 31 of the 45 patients after long-term adjuvant SSA treatment. Tumor control was achieved in 43 of the 45 (93.3%) patients. The univariate analysis showed age (>= 55 years), tumor size (diameter <= 1.5 cm), premedication GH levels (>= 2.8 ng/mL), premedication insulin-like growth factor 1 levels (<= 2-fold of upper limit of normal range), cavernous sinus invasion (Knops grades 2, 3, and 4), and near-total tumor resection were associated with long-term outcomes. The multivariate analysis showed near-total resection was a significant predictor for long-term outcomes (P = 0.019). There were no new pituitary dysfunctions. The observed complications included one case of cerebrospinal fluid leakage and one case of epistaxis requiring intervention.
   CONCLUSIONS: Intracapsular debulking and adjuvant SSAs are a safe and viable treatment for patients with GH secreting pituitary macroadenoma to achieve biochemical remission and tumor control. Although adjuvant SSA treatment enhances residual tumor control, cavernous sinus invasion impedes the remission of endocrine tumors.
C1 [Shen, Shih-Chieh; Pu, Ta-Wei] Triserv Gen Hosp, Songshan Branch, Dept Surg, Taipei, Taiwan.
   [Shen, Chiung-Chyi] Natl Def Med Ctr, Dept Med, Taipei, Taiwan.
   [Shen, Shih-Chieh; Shen, Chiung-Chyi; Cheng, Wen-Yu] Taichung Vet Gen Hosp, Neurol Inst, Dept Minimally Invas Skull Base Neurosurg, Taichung, Taiwan.
   [Shen, Chiung-Chyi; Cheng, Wen-Yu] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan.
   [Shen, Chiung-Chyi; Cheng, Wen-Yu] Natl Def Med Ctr, Taipei, Taiwan.
RP Cheng, WY (reprint author), Taichung Vet Gen Hosp, Neurol Inst, Dept Minimally Invas Skull Base Neurosurg, Taichung, Taiwan.; Cheng, WY (reprint author), Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan.; Cheng, WY (reprint author), Natl Def Med Ctr, Taipei, Taiwan.
EM wycheng07@yahoo.com.tw
OI Shen, Shih-Chieh/0000-0002-2835-1924
CR Berker M, 2012, PITUITARY, V15, P288, DOI 10.1007/s11102-011-0368-2
   Bronstein MD, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0096-8
   Campbell PG, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10153
   Carlsen SM, 2008, J CLIN ENDOCR METAB, V93, P2984, DOI 10.1210/jc.2008-0315
   Caron PJ, 2014, J CLIN ENDOCR METAB, V99, P1282, DOI 10.1210/jc.2013-3318
   Carvalho P, 2015, PITUITARY, V18, P844, DOI 10.1007/s11102-015-0661-6
   Chamoun R, 2014, J NEUROL SURG PART A, V75, P48, DOI 10.1055/s-0032-1326940
   Colao A, 2006, J CLIN ENDOCR METAB, V91, P85, DOI 10.1210/jc.2005-1208
   Colao A, 2014, J CLIN ENDOCR METAB, V99, P791, DOI 10.1210/jc.2013-2480
   Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191
   Fahlbusch R, 2017, PITUITARY, V20, P668, DOI 10.1007/s11102-017-0832-8
   Fukuda I, 2014, PITUITARY, V17, P90, DOI 10.1007/s11102-013-0472-6
   Gadelha MR, 2014, LANCET DIABETES ENDO, V2, P875, DOI 10.1016/S2213-8587(14)70169-X
   Giustina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036411
   Gondim JA, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10167
   Gondim JA, 2010, PITUITARY, V13, P68, DOI 10.1007/s11102-009-0195-x
   Hofstetter CP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.7.FOCUS10173
   Holdaway IM, 2008, EUR J ENDOCRINOL, V159, P89, DOI 10.1530/EJE-08-0267
   Karavitaki N, 2008, CLIN ENDOCRINOL, V68, P970, DOI 10.1111/j.1365-2265.2007.03139.x
   Katznelson L, 2011, ENDOCR PRACT, V17, P636, DOI 10.4158/EP.17.4.636
   Kinoshita Y, 2016, WORLD NEUROSURG, V93, P430, DOI 10.1016/j.wneu.2016.07.036
   KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008
   Melmed S, 2015, J CLIN ENDOCR METAB, V100, P1699, DOI 10.1210/jc.2014-4113
   Mercado M, 2014, J CLIN ENDOCR METAB, V99, P4438, DOI 10.1210/jc.2014-2670
   Murray RD, 2008, J CLIN ENDOCR METAB, V93, P2957, DOI 10.1210/jc.2008-0027
   Nunes VS, 2014, PITUITARY, V17, P30, DOI 10.1007/s11102-013-0462-8
   Petrossians P, 2005, EUR J ENDOCRINOL, V152, P61, DOI 10.1530/eje.1.01824
   Sherlock M, 2010, ENDOCR REV, V31, P301, DOI 10.1210/er.2009-0033
   Shin SS, 2013, PITUITARY, V16, P435, DOI 10.1007/s11102-012-0440-6
   Taslipinar A, 2009, MED ONCOL, V26, P62, DOI 10.1007/s12032-008-9084-9
   WILSON CB, 1984, J NEUROSURG, V61, P814, DOI 10.3171/jns.1984.61.5.0814
   Yamada S, 2010, NEUROSURGERY, V67, P949, DOI 10.1227/NEU.0b013e3181ec4379
NR 32
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E41
EP E47
DI 10.1016/j.wneu.2019.01.125
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400007
PM 30716503
DA 2020-05-12
ER

PT J
AU Shen, ZT
   Zhong, ZM
   Wu, Q
   Zheng, S
   Shen, X
   Chen, JT
AF Shen, Zetao
   Zhong, Zhao-Ming
   Wu, Qian
   Zheng, Shuai
   Shen, Xing
   Chen, Jianting
TI Predictors for Poor Outcomes After Percutaneous Endoscopic Lumbar
   Discectomy: A Retrospective Study of 241 Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic discectomy; Lumbar disc herniation; Lumbar fusion; Modic
   changes; Numbness; Two-level Discectomy
ID DISC HERNIATION; PERIPHERAL-NERVES; PATHOPHYSIOLOGY; DISEASE; SURGERY
AB OBJECTIVE: Percutaneous endoscopic lumbar discectomy (PELD) is a popular surgical procedure for the treatment of lumbar disc herniation (LDH). However, a small proportion of patients will have poor surgical outcomes. We sought to identify the predictors for poor outcomes after PELD.
   METHODS: A total of 241 patients who had undergone PELD were followed up. Their numerical rating scale (NRS) for pain and Oswestry Disability Index scoreswere analyzed. They were divided by outcome (excellent, good, fair, poor) using the MacNab criteria. Their clinical history, physical examination, imaging, and surgical findings were compared among the groups. Ordinal logistic regression analysis was used to identify independent predictors for poor outcomes.
   RESULTS: The preoperative mean total NRS for back pain, NRS for leg pain, and Oswestry Disability Index scores were 4.3 +/- 2.6, 5.6 +/- 2.5, and 52.1% +/- 23.0%. At 2 years after PELD, the corresponding scores had decreased to 1.2 +/- 1.7, 0.9 +/- 1.5, and 8.4% +/- 11.2% (P < 0.001). The excellent, good, fair, and poor outcome rates were 44.4%, 31.5%, 17.4%, and 6.6%, respectively. Ordinal logistic regression analysis revealed that 2-level PELD (P = 0.001), a history of lumbar fusion (P = 0.007), and Modic changes (P = 0.011) were independent predictors for poor outcomes. Numbness was an independent predictor for excellent outcomes (P = 0.014).
   CONCLUSIONS: PELD appears to be an effective surgery for LDH. Two-level PELD, a history of lumbar fusion, and Modic changes at the same level were independent predictors for poor outcomes after PELD. Patients with LDH with numbness were more likely to have excellent outcomes.
C1 [Shen, Zetao; Zhong, Zhao-Ming; Wu, Qian; Zheng, Shuai; Shen, Xing; Chen, Jianting] Southern Med Univ, Nanfang Hosp, Dept Spinal Surg, Guangzhou, Guangdong, Peoples R China.
RP Chen, JT (reprint author), Southern Med Univ, Nanfang Hosp, Dept Spinal Surg, Guangzhou, Guangdong, Peoples R China.
EM chenjt99@tom.com
CR Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014
   Baker D, 1989, BACK PAIN NEW APPROA, P174
   Chen ZH, 2018, J NEUROSURG-SPINE, V28, P300, DOI 10.3171/2017.7.SPINE161434
   Dudli S, 2016, EUR SPINE J, V25, P3723, DOI 10.1007/s00586-016-4459-7
   Eun SS, 2016, PAIN PHYSICIAN, V19, pE1161
   Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022
   Gadjradj PS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2015.10.FOCUS15484
   Gibson JNA, 2017, EUR SPINE J, V26, P847, DOI 10.1007/s00586-016-4885-6
   Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7
   Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2
   KAMBIN P, 1992, ARTHROSCOPY, V8, P287, DOI 10.1016/0749-8063(92)90058-J
   Kido T, 2016, J ORTHOP SCI, V21, P419, DOI 10.1016/j.jos.2016.03.003
   Kim JM, 2007, MINIM INVAS NEUROSUR, V50, P82, DOI 10.1055/s-2007-982504
   Kool JP, 2002, EUR SPINE J, V11, P258, DOI 10.1007/s005860100335
   Lundborg G, 1996, HAND CLIN, V12, P185
   Lurie JD, 2013, SPINE, V38, P1216, DOI 10.1097/BRS.0b013e31828ce66d
   Ma XL, 2011, MED HYPOTHESES, V76, P692, DOI 10.1016/j.mehy.2011.01.035
   MACNAB I, 1971, J BONE JOINT SURG AM, VA 53, P891, DOI 10.2106/00004623-197153050-00004
   MIXTER WJ, 1934, NEW ENGL J MED, V211, P210, DOI DOI 10.1056/NEJM193408022110506
   MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Qian J, 2018, Zhonghua Yi Xue Za Zhi, V98, P1013, DOI 10.3760/cma.j.issn.0376-2491.2018.13.012
   Rempel D, 1999, J BONE JOINT SURG AM, V81A, P1600, DOI 10.2106/00004623-199911000-00013
   Ruetten S, 2007, J NEUROSURG-SPINE, V6, P521, DOI 10.3171/spi.2007.6.6.521
   Ruetten S, 2008, SPINE, V33, P931, DOI 10.1097/BRS.0b013e31816c8af7
   Schubert Michael, 2005, Oper Orthop Traumatol, V17, P641, DOI 10.1007/s00064-005-1156-9
   Sorlie A, 2012, EUR SPINE J, V21, P2252, DOI 10.1007/s00586-012-2419-4
   Telfeian AE, 2017, WORLD NEUROSURG, V97, P231, DOI 10.1016/j.wneu.2016.09.099
   WHITE AA, 1999, LUMBAR SEGMENTAL INS, P15
   Yeung AT, 2002, SPINE, V27, P722, DOI 10.1097/00007632-200204010-00009
NR 30
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E422
EP E431
DI 10.1016/j.wneu.2019.02.068
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400050
PM 30825632
DA 2020-05-12
ER

PT J
AU Singh, R
   Baby, B
   Suri, A
AF Singh, Ramandeep
   Baby, Britty
   Suri, Ashish
TI A Virtual Repository of Neurosurgical Instrumentation for
   Neuroengineering Research and Collaboration
SO WORLD NEUROSURGERY
LA English
DT Article
DE Blue light scanning; Innovation; Neurosurgical instruments; Reverse
   engineering; Simulation; Virtual repository
ID SIMULATION
AB BACKGROUND: Advancements in microscopy and more recently in neuroendoscopy have revolutionized the field of neurosurgery. Handheld neurosurgical instruments are integral components of these procedures. However, these instruments have many limitations, such as poor ergonomics, constrained maneuverability, and limited degrees of freedom. A need for developing better instruments is commonly felt by neurosurgeons. Also, the focus of modern neurosurgical training is shifting toward simulation models. The baseline data of surgical instruments play a vital role in the development of virtual and physical simulators. A primary factor impeding development of novel instruments and simulators is lack of a comprehensive surgical instrument database. The aim of this study was to develop and validate a virtual repository of microscopic and neuroendoscopic instruments.
   METHODS: Standard neurosurgical instrument sets were scanned, reverse engineered, and stored in various file formats at the file transfer protocol server. The developed database was validated by 4 groups of experts by creating different neurosurgery applications.
   RESULTS: Four groups of experts used the repository content to create novel ergonomic instrument designs, e-learning material, computer visionebased surgical skills evaluation and virtual reality and validated the contents. The validation results showed that quality of content (75%), usefulness of content (85.6%), and time saving using content (88.1%) received high scores, and the effectiveness of the virtual repository contents was appreciated.
   CONCLUSIONS: The virtual database is an efficient starting aid to foster research collaborations related to neurosurgical instruments and surgical simulation platforms.
C1 [Singh, Ramandeep; Suri, Ashish] All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
   [Baby, Britty] Indian Inst Technol Delhi, Amar Nath & Shashi Khosla Sch Informat Technol, New Delhi, India.
RP Suri, A (reprint author), All India Inst Med Sci, Dept Neurosurg, New Delhi, India.
EM surineuro@gmail.com
FU Department of Biotechnology, Ministry of Science and Technology,
   Government of IndiaDepartment of Biotechnology (DBT) IndiaMinistry of
   Science and Technology, Government of India [BT/PR13455/CoE/34/24/2015,
   BT/HRD/35/01/01/2015, BT/HRD/NBA/37/01/2014]; Department of Science and
   Technology -DST, Ministry of Science and Technology, Govt. of
   IndiaDepartment of Science & Technology (India) [SR/FST/LSII-029/2012];
   Dept. of Health Research (DHR), Indian Council of Medical Research
   (ICMR), Ministry of Health and Family Welfare, Govt. of India
   [GIA/3/2014-DHR]
FX This article is the result of research projects funded by extramural
   grants from the Department of Biotechnology, Ministry of Science and
   Technology, Government of India (BT/PR13455/CoE/34/24/2015,
   BT/HRD/35/01/01/2015, and BT/HRD/NBA/37/01/2014), Department of Science
   and Technology -DST, Ministry of Science and Technology, Govt. of India
   (SR/FST/LSII-029/2012) and Dept. of Health Research (DHR), Indian
   Council of Medical Research (ICMR), Ministry of Health and Family
   Welfare, Govt. of India. (GIA/3/2014-DHR).
CR Allan M, 2018, IEEE T MED IMAGING, V37, P1204, DOI 10.1109/TMI.2018.2794439
   Bergeles C, 2014, IEEE T BIO-MED ENG, V61, P1565, DOI 10.1109/TBME.2013.2293815
   Breimer GE, 2017, OPER NEUROSURG, V13, P89, DOI 10.1227/NEU.0000000000001317
   CANNONE JJ, 2002, BMC BIOINFORMATICS, V3
   Cappabianca P, 2007, SURG NEUROL, V67, P496, DOI 10.1016/j.surneu.2006.09.039
   Dawe SR, 2014, BRIT J SURG, V101, P1063, DOI 10.1002/bjs.9482
   Galantucci L. M., 2006, Journal of Medical Engineering & Technology, V30, P102, DOI 10.1080/03091900500131714
   Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215
   Iwama H, 2012, IEEE T INF FOREN SEC, V7, P1511, DOI 10.1109/TIFS.2012.2204253
   Jotwani P, 2014, NEUROL INDIA, V62, P352, DOI 10.4103/0028-3886.141208
   Li K. W., 2005, NEUROSURG FOCUS, V19, P1
   Malone HR, 2010, NEUROSURGERY, V67, P1105, DOI 10.1227/NEU.0b013e3181ee46d0
   Rutherford CJ, 2011, DIFFERENTIATING SURG
   Schwenzer-Zimmerer K, 2008, J MED SYST, V32, P59, DOI 10.1007/s10916-007-9108-6
   Singh R., 2017, IEEE VEH TECHN C SYD, P1
   Singh R, 2016, SURG INNOV, V23, P606, DOI 10.1177/1553350616656282
   Singh R, 2016, 2016 3RD INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND INTEGRATED NETWORKS (SPIN), P301, DOI 10.1109/SPIN.2016.7566708
   Singh R, 2016, WORLD NEUROSURG, V86, P259, DOI 10.1016/j.wneu.2015.09.045
   Uluc K, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.6.FOCUS09120
   van Ginneken B, 2006, MED IMAGE ANAL, V10, P19, DOI 10.1016/j.media.2005.02.002
NR 20
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E84
EP E93
DI 10.1016/j.wneu.2019.01.192
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400012
PM 30743031
DA 2020-05-12
ER

PT J
AU Song, KR
   Li, ZH
   Shuang, F
   Yin, X
   Cao, Z
   Zhao, HL
   Qin, J
   Li, ZZ
AF Song, Keran
   Li, Zhonghai
   Shuang, Feng
   Yin, Xin
   Cao, Zheng
   Zhao, Hongliang
   Qin, Jiang
   Li, Zhenzhou
TI Comparison of the Effectiveness of Radiofrequency Neurotomy and
   Endoscopic Neurotomy of Lumbar Medial Branch for Facetogenic Chronic Low
   Back Pain: A Randomized Controlled Trial
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic; Facetogenic chronic low back pain; Neurotomy; Radiofrequency
ID ZYGAPOPHYSIAL JOINT PAIN; DENERVATION; MANAGEMENT; EFFICACY; DISKECTOMY;
   SUCCESS; SURGERY; BLOCKS; SPINE
AB OBJECTIVE: To compare the effectiveness of radiofrequency neurotomy (RN) and endoscopic neurotomy (EN) of lumbar medial branch (MB) for facetogenic chronic low back pain (FCLBP).
   METHODS: Forty patients with FCLBP were included and randomly assigned to the control group and the experimental group. The control group (20 cases) underwent X-rayassisted RN and the experimental group (20 cases) underwent EN of the lumbar MB. The patients' Visual Analogue Scale (VAS) score and Oswestry Disability Index (ODI) score were evaluated and compared preoperatively, and at 3 weeks, 6 months, 1 year, and 2 years postoperatively.
   RESULTS: First, the RN group demonstrated successful treatment results (P < 0.05) at 3 weeks, 6 months, and 1 year after surgery. At 2 years, patients reported no significant effectiveness (P > 0.05). Second, the EN group demonstrated more prolonged successful treatment outcomes compared with the RN group. At 2 years, although the efficacy declined further, the VAS and ODI scores showed significant improvements compared with the preoperative data (P < 0.05). Third, there was no difference in VAS and ODI scores between the 2 groups at 3 weeks after surgery (P > 0.05). At 6 months and later, the EN group demonstrated better outcomes (P < 0.05).
   CONCLUSIONS: For FCLBP, EN and X-ray-assisted RN of lumbar MB are both effective treatments. However, endoscopic lumbar MB neurotomy has the better and longer effectiveness.
C1 [Song, Keran; Yin, Xin; Cao, Zheng; Zhao, Hongliang; Qin, Jiang; Li, Zhenzhou] Peoples Liberat Army, Gen Hosp, Med Ctr 4, Dept Orthoped, Beijing, Peoples R China.
   [Li, Zhonghai] Dalian Med Univ China, Affiliated Hosp 1, Dept Orthoped, Dalian, Liaoning, Peoples R China.
   [Shuang, Feng] Peoples Liberat Army, 94 Hosp, Dept Orthoped, Nanchang, Jiangxi, Peoples R China.
RP Li, ZZ (reprint author), Peoples Liberat Army, Gen Hosp, Med Ctr 4, Dept Orthoped, Beijing, Peoples R China.
EM Drlizz304@163.com
RI Li, Zhonghai/N-6670-2018
OI Li, Zhonghai/0000-0003-4735-1193
CR Al-Najjim M, 2018, J ORTHOP, V15, P1, DOI 10.1016/j.jor.2017.10.001
   Bogduk N, 2005, PAIN MED, V6, P139, DOI 10.1111/j.1526-4637.2005.05023.x
   BOGDUK N, 1987, NEUROSURGERY, V20, P529, DOI 10.1227/00006123-198704000-00004
   Bogduk N, 2008, SPINE J, V8, P56, DOI 10.1016/j.spinee.2007.10.010
   Boswell Mark V, 2003, Pain Physician, V6, P449
   Cohen SP, 2008, SPINE J, V8, P498, DOI 10.1016/j.spinee.2007.04.022
   Feigl GC, 2018, SCHMERZ, V32, P99, DOI 10.1007/s00482-018-0283-9
   Haufe SMW, 2010, INT J MED SCI, V7, P120
   Hoogland T, 2006, SPINE, V31, pE890, DOI 10.1097/01.brs.0000245955.22358.3a
   Klessinger S, 2013, PAIN MED, V14, P374, DOI 10.1111/pme.12012
   Lamer TJ, 2016, PAIN MED, V17, P1634, DOI 10.1093/pm/pnv078
   Lau P, 2004, PAIN MED, V5, P289, DOI 10.1111/j.1526-4637.2004.04042.x
   Lee CH, 2017, SPINE J, V17, P1770, DOI 10.1016/j.spinee.2017.05.006
   Li ZZ, 2014, CLIN NEUROL NEUROSUR, V126, P11, DOI 10.1016/j.clineuro.2014.08.014
   Manchikanti L, 2000, Curr Rev Pain, V4, P437
   Manchikanti L, 2007, ARCH PHYS MED REHAB, V88, P449, DOI 10.1016/j.apmr.2007.01.015
   Manchikanti L, 2016, WORLD J ORTHOP, V7, P315, DOI 10.5312/wjo.v7.i5.315
   Masala S, 2012, NEURORADIOLOGY, V54, P737, DOI 10.1007/s00234-011-0968-6
   Park CH, 2010, KOREAN J PAIN, V23, P137, DOI 10.3344/kjp.2010.23.2.137
   Ruetten S, 2005, SPINE, V30, P2570, DOI 10.1097/01.brs.0000186327.21435.cc
   Schutte KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141957
   SHEALY CN, 1976, CLIN ORTHOP RELAT R, P157
   Smuck M, 2015, SPINE J, V15, P1415, DOI 10.1016/j.spinee.2013.06.096
   Smuck M, 2012, PM&R, V4, P686, DOI 10.1016/j.pmrj.2012.06.007
   Staender M, 2005, J NEUROSURG-SPINE, V3, P444, DOI 10.3171/spi.2005.3.6.0444
   Tessitore E, 2015, EUR J RADIOL, V84, P765, DOI 10.1016/j.ejrad.2014.03.016
   van Tilburg CWJ, 2016, BONE JOINT J, V98B, P1526, DOI 10.1302/0301-620X.981311.BJJ-2016-0379.R2
   Yeung AT, 2000, MT SINAI J MED, V67, P327
NR 28
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E109
EP E115
DI 10.1016/j.wneu.2019.01.251
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400015
PM 30790724
DA 2020-05-12
ER

PT J
AU Soriano-Baron, H
   Newcomb, AGUS
   Malhotra, D
   del Campo, EM
   Palma, AE
   Theodore, N
   Crawford, NR
   Kelly, BP
   Kaibara, T
AF Soriano-Baron, Hector
   Newcomb, Anna G. U. S.
   Malhotra, Devika
   del Campo, Eduardo Martinez
   Palma, Atilt E., Jr.
   Theodore, Nicholas
   Crawford, Neil R.
   Kelly, Brian P.
   Kaibara, Taro
TI Biomechanical Effects of an Oblique Lumbar PEEK Cage and Posterior
   Augmentation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Biomechanics; Direct lateral interbody fusion; DLIF; Interbody spacer;
   Lumbar; Oblique lateral interbody fusion; OLIF; PEEK; Polyether ether
   ketone; Range of motion
ID PEDICLE SCREW FIXATION; INTERBODY FUSION; IN-VITRO; SPINE; ANTERIOR;
   STABILITY; INSTRUMENTATION; STABILIZATION; COMPLICATIONS; STRENGTH
AB OBJECTIVE: Lumbar interbody spacers are widely used in lumbar spinal fusion. The goal of this study is to analyze the biomechanics of a lumbar interbody spacer (Clydesdale Spinal System, Medtronic Sofamor Danek, Memphis, Tennessee, USA) inserted via oblique lumbar interbody fusion (OLIF) or direct lateral interbody fusion (DLIF) approaches, with and without posterior cortical screw and rod (CSR) or pedicle screw and rod (PSR) instrumentation.
   METHODS: Lumbar human cadaveric specimens (L2-L5) underwent nondestructive flexibility testing in intact and instrumented conditions at L3-L4, including OLIF or DLIF, with and without CSR or PSR.
   RESULTS: OLIF alone significantly reduced range of motion (ROM) in flexion-extension (P = 0.005) but not during lateral bending or axial rotation (P >= 0.63). OLIF alone reduced laxity in the lax zone (LZ) during flexion-extension (P < 0.001) but did not affect the LZ during lateral bending or axial rotation (P >= 0.14). The stiff zone (SZ) was unaffected in all directions (P >= 0.88). OLIF plus posterior instrumentation (cortical, pedicle, or hybrid) reduced the mean ROM in all directions of loading but only significantly so with PSR during lateral bending (P = 0.004), without affecting the compressive stiffness (P > 0.20). The compressive stiffness with the OLIF device without any posterior instrumentation did not differ from that of the intact condition (P = 0.97). In terms of ROM, LZ, or SZ, there were no differences between OLIF and DLIF as standalone devices or OLIF and DLIF with posterior instrumentation (CSR or PSR) (P > 0.5).
   CONCLUSIONS: OLIF alone significantly reduced mobility during flexion-extension while maintaining axial compressive stiffness compared with the intact condition. Adding posterior instrumentation to the interbody spacer increased the construct stability significantly, regardless of cage insertion trajectory or screw type.
C1 [Soriano-Baron, Hector; Newcomb, Anna G. U. S.; Malhotra, Devika; del Campo, Eduardo Martinez; Theodore, Nicholas; Kelly, Brian P.; Kaibara, Taro] St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, Phoenix, AZ 85013 USA.
   [Palma, Atilt E., Jr.] Wake Forest Baptist Hosp, Dept Neurosurg, Winston Salem, NC USA.
   [Crawford, Neil R.] Exelsius Surg LLC, Phoenix, AZ USA.
RP Kaibara, T (reprint author), St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, Phoenix, AZ 85013 USA.
EM Neuropub@dignityhealth.org
CR Bhatia NN, 2012, SPINE, V37, pE79, DOI 10.1097/BRS.0b013e3182226ba6
   BRANCH CL, 1987, SURG NEUROL, V27, P449, DOI 10.1016/0090-3019(87)90252-7
   BRANTIGAN JW, 1991, SPINE, V16, pS277, DOI 10.1097/00007632-199106001-00020
   BRIGGS H, 1947, J BONE JOINT SURG, V29, P328
   CLOWARD RB, 1953, J NEUROSURG, V10, P154, DOI 10.3171/jns.1953.10.2.0154
   Cole CD, 2009, CURR REV MUSCULOSKE, V2, P118, DOI 10.1007/s12178-009-9053-8
   Crawford NR, 1999, CLIN BIOMECH, V14, P153, DOI 10.1016/S0268-0033(98)00080-1
   CRAWFORD NR, 1995, SPINE, V20, P2097, DOI 10.1097/00007632-199510000-00005
   Crawford NR, 1997, SPINE, V22, P559, DOI 10.1097/00007632-199703010-00020
   Crawford NR, 1998, J SPINAL DISORD, V11, P416
   Fogel GR, 2014, J NEUROSURG-SPINE, V20, P291, DOI 10.3171/2013.11.SPINE13617
   Folman Y, 2003, J SPINAL DISORD TECH, V16, P455, DOI 10.1097/00024720-200310000-00004
   Hasegawa K, 2001, SPINE, V26, P957, DOI 10.1097/00007632-200104150-00022
   Humphreys SC, 2001, SPINE, V26, P567
   HUTTER CG, 1985, CLIN ORTHOP RELAT R, P103
   Inceoglu S, 2011, J NEUROSURG-SPINE, V14, P670, DOI 10.3171/2010.11.SPINE09886
   Isaacs RE, 2005, J NEUROSURG-SPINE, V3, P98, DOI 10.3171/spi.2005.3.2.0098
   Jost B, 1998, Eur Spine J, V7, P132
   Kettler A, 2005, SPINE, V30, pE665, DOI 10.1097/01.brs.0000186466.01542.8c
   Kim MC, 2013, J SPINAL DISORD TECH, V26, P87, DOI 10.1097/BSD.0b013e318237b9b1
   Kim SM, 2005, J NEUROSURG-SPINE, V2, P62, DOI 10.3171/spi.2005.2.1.0062
   Kornblum MB, 2013, SPINE J, V13, P77, DOI 10.1016/j.spinee.2012.11.013
   LIN PM, 1985, CLIN ORTHOP RELAT R, P90
   Lowe TG, 2004, SPINE, V29, P2389, DOI 10.1097/01.brs.0000143623.18098.e5
   Lund T, 1998, J BONE JOINT SURG BR, V80B, P351, DOI 10.1302/0301-620X.80B2.7693
   Miura T, 2002, SPINE, V27, P43, DOI 10.1097/00007632-200201010-00011
   Niemeyer TK, 2006, NEUROSURGERY, V59, P1271, DOI 10.1227/01.NEU.0000245609.01732.E4
   Oxland TR, 2000, J BONE JOINT SURG AM, V82A, P383, DOI 10.2106/00004623-200003000-00009
   PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001
   PANJABI MM, 1988, SPINE, V13, P1129, DOI 10.1097/00007632-198810000-00013
   Panjabi MM, 2001, SPINE, V26, P2214, DOI 10.1097/00007632-200110150-00012
   Patwardhan AG, 1999, SPINE, V24, P1003, DOI 10.1097/00007632-199905150-00014
   Perez-Orribo L, 2013, SPINE, V38, P635, DOI 10.1097/BRS.0b013e318279a95e
   Reis MT, 2016, J NEUROSURG-SPINE, V25, P720, DOI 10.3171/2016.4.SPINE151386
   Resnick DK, 2005, J NEUROSURG-SPINE, V2, P673, DOI 10.3171/spi.2005.2.6.0673
   Silvestre C, 2012, ASIAN SPINE J, V6, P89, DOI 10.4184/asj.2012.6.2.89
   Sim HB, 2010, J NEUROSURG-SPINE, V12, P700, DOI 10.3171/2009.12.SPINE09123
   SIMMONS JW, 1985, CLIN ORTHOP RELAT R, P85
   Stevens KJ, 2006, J SPINAL DISORD TECH, V19, P77, DOI 10.1097/01.bsd.0000193820.42522.d9
   Tan JS, 2005, SPINE, V30, P638, DOI 10.1097/01.brs.0000155419.24198.35
   Tokuhashi Y, 2009, ORTHOPEDICS, V32, P877
   Trouillier Hans, 2006, Acta Orthop Belg, V72, P460
   Tzermiadianos MN, 2008, SPINE, V33, pE38, DOI 10.1097/BRS.0b013e3181604644
   Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce
   Weiner BK, 1998, SPINE, V23, P634, DOI 10.1097/00007632-199803010-00020
   Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014
   Yucesoy K, 2008, J NEUROSURG-SPINE, V8, P44, DOI 10.3171/SPI-08/01/044
NR 47
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E975
EP E981
DI 10.1016/j.wneu.2019.02.200
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400122
PM 30876999
DA 2020-05-12
ER

PT J
AU Sparks, H
   Hovsepian, A
   Wilson, B
   De Salles, A
   Selch, M
   Kaprealian, T
   Pouratian, N
AF Sparks, Hiro
   Hovsepian, Arev
   Wilson, Bayard
   De Salles, Antonio
   Selch, Michael
   Kaprealian, Tania
   Pouratian, Nader
TI Dose Hypofractionated Stereotactic Radiotherapy for Intracranial
   Arteriovenous Malformations: A Case Series and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Dose fractionation; Intracranial arteriovenous malformations;
   Radiosurgery; Radiotherapy dosage
ID VOLUME-STAGED RADIOSURGERY; LINEAR-ACCELERATOR; BRAIN; OUTCOMES;
   MANAGEMENT; RADIATION; RESECTION; RISK
AB BACKGROUND: Brain arteriovenous malformations (AVMs) are pathologic tangles of intracerebral vessels. The treatment of AVMs aims to reduce the risk of devastating intracranial hemorrhage (ICH). Hypofractionated stereotactic radiotherapy (HSRT) can be used to treat large lesions and reduce the risk of radiation toxicity to the surrounding structures. We analyzed the data from our institutional experience of the past 15 years in treating large AVMs with both 5- and 6-fraction HSRT and evaluated the pretreatment characteristics that are most predictive of the radiographic response.
   METHODS: We included 37 patients and 42 treatments of intracranial AVMs measuring >3 cm in their largest dimension. Data were collected retrospectively by reviewing the electronic health records. The AVM volume was measured before HSRT and at the most recent follow-up appointment. Symptomatic outcomes, including treatment-related inflammation, were measured and defined categorically.
   RESULTS: Complete obliteration was achieved in 11.9% of the patients. The mean AVM volume had decreased significantly after HSRT (P = 8.7e-8). The percentage of volume reduction differed significantly between patients receiving 30-Gy fractions, (partial derivative V = -48.7%) and those receiving 25-Gy fractions (partial derivative V = -29.1%; P = 0.035). Patients with partial or complete obliteration were more likely to have received a total dose of 30 Gy rather than 25 Gy (P = 0.056) and showed a trend toward being treatment naive (P = 0.053).
   CONCLUSION: HSRT can be used as a method to manage large AVMs, with obliteration in some cases and sufficient volume reduction in most others for adjuvant treatment with other modalities. The 30-Gy total dose was generally superior to 25 Gy in achieving obliteration or volume reduction. Further studies focused on longer follow-up periods are warranted.
C1 [Sparks, Hiro; Wilson, Bayard; De Salles, Antonio; Pouratian, Nader] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.
   [Hovsepian, Arev; Selch, Michael; Kaprealian, Tania] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA.
RP Pouratian, N (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.
EM NPouratian@mednet.ucla.edu
OI Pouratian, Nader/0000-0002-0426-3241
CR Abla AA, 2015, J NEUROSURG, V122, P419, DOI 10.3171/2014.10.JNS1424
   Aoyama H, 2001, RADIOTHER ONCOL, V59, P323, DOI 10.1016/S0167-8140(01)00303-6
   Bervini D, 2014, J NEUROSURG, V121, P878, DOI 10.3171/2014.7.JNS132691
   Blamek S, 2013, RADIOL ONCOL, V47, P50, DOI 10.2478/v10019-012-0046-7
   Chang SD, 2003, NEUROSURGERY, V53, P1
   Chen JCT, 2016, J CLIN NEUROSCI, V29, P155, DOI 10.1016/j.jocn.2015.12.006
   COLOMBO F, 1994, ACT NEUR S, V62, P5
   Franzin A, 2016, J NEUROSURG, V125, P104, DOI 10.3171/2016.7.GKS161549
   Hanakita S, 2016, WORLD NEUROSURG, V87, P242, DOI 10.1016/j.wneu.2015.12.020
   Huang PP, 2012, NEUROSURGERY, V71, P632, DOI 10.1227/NEU.0b013e31825fd247
   Ilyas A, 2018, J NEUROSURG, V128, P154, DOI 10.3171/2016.9.JNS161571
   Jayaraman MV, 2007, STROKE, V38, P325, DOI 10.1161/01.STR.0000254497.24545.de
   Jones Jesse, 2007, Neurosurg Focus, V23, pE7
   Kano H, 2012, J NEUROSURG, V116, P54, DOI 10.3171/2011.9.JNS11177
   Karlsson B, 2005, NEUROSURGERY, V57, P42, DOI 10.1227/01.NEU.0000163095.56638.26
   Karlsson B, 2007, J NEUROSURG, V107, P740, DOI 10.3171/JNS-07/10/0740
   Laakso A, 2012, NEUROSURG CLIN N AM, V23, P1, DOI 10.1016/j.nec.2011.09.012
   Lindvall P, 2003, NEUROSURGERY, V53, P1036, DOI 10.1227/01.NEU.0000088566.82699.E6
   Miyamoto S, 2000, NEUROSURGERY, V46, P589, DOI 10.1097/00006123-200003000-00013
   Miyawaki L, 1999, INT J RADIAT ONCOL, V44, P1089, DOI 10.1016/S0360-3016(99)00102-9
   Moosa S, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS14205
   Ogilvy CS, 2001, CIRCULATION, V103, P2644
   Rivera R, 2017, INTERV NEURORADIOL, V23, DOI 10.1177/1591019917721867
   Sanchez-Mejia RO, 2009, NEUROSURGERY, V64, P231, DOI 10.1227/01.NEU.0000338068.44060.EA
   Seymour ZA, 2016, J NEUROSURG, V124, P163, DOI 10.3171/2014.12.JNS141308
   Silander H, 2004, ACTA NEUROL SCAND, V109, P85, DOI 10.1046/j.1600-0404.2003.00154.x
   Sisti M B, 1993, Neurosurg Clin N Am, V4, P497
   Stapf C, 2001, Neurosurg Focus, V11, pe1
   Starke RM, 2008, STEREOT FUNCT NEUROS, V86, P191, DOI 10.1159/000126945
   Starke RM, 2009, BRIT J NEUROSURG, V23, P376, DOI 10.1080/02688690902977662
   Steinberg GK, 1996, J NEUROSURG, V84, P920, DOI 10.3171/jns.1996.84.6.0920
   Subramanian S, 2012, INT J RADIAT ONCOL, V82, P1278, DOI 10.1016/j.ijrobp.2011.02.005
   van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632
   Veznedaroglu E, 2004, NEUROSURGERY, V55, P519, DOI 10.1227/01.NEU.0000134285.41701.83
   Voges J, 1996, INT J RADIAT ONCOL, V36, P1055, DOI 10.1016/S0360-3016(96)00422-1
   Wang Huan-Chih, 2012, Surg Neurol Int, V3, pS105, DOI 10.4103/2152-7806.95421
   Xiao FR, 2010, NEUROSURGERY, V67, P1253, DOI 10.1227/NEU.0b013e3181efbaef
   Yuki I, 2010, J NEUROSURG, V113, P715, DOI 10.3171/2009.9.JNS081588
   Zabel-Du Bois A, 2006, INT J RADIAT ONCOL, V64, P1049, DOI 10.1016/j.ijrobp.2005.09.021
NR 39
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1456
EP E1467
DI 10.1016/j.wneu.2019.03.119
PG 12
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400183
PM 30904809
DA 2020-05-12
ER

PT J
AU Stopa, BM
   Yan, SC
   Dasenbrock, HH
   Kim, DH
   Gormley, WB
AF Stopa, Brittany M.
   Yan, Sandra C.
   Dasenbrock, Hormuzdiyar H.
   Kim, Dong H.
   Gormley, William B.
TI Variance Reduction in Neurosurgical Practice: The Case for
   Analytics-Driven Decision Support in the Era of Big Data
SO WORLD NEUROSURGERY
LA English
DT Article
DE Artificial intelligence; Clinical decision support; Electronic health
   records; Machine learning; Medical informatics; Neurosurgery; Variance
   reduction
ID ELECTRONIC HEALTH RECORDS; EVIDENCE-BASED RECOMMENDATIONS;
   CLINICAL-PRACTICE GUIDELINES; EVIDENCE-BASED MEDICINE; LOW-GRADE GLIOMA;
   MANAGEMENT-SYSTEMS; PATIENT SAFETY; INTENSIVE-CARE; QUALITY; INFORMATION
AB OBJECTIVE: Variance between providers in neurosurgery can lead to inefficiencies and poor patient outcomes. Evidence-based guidelines (EBGs) have been developed; however, they have not been well implemented into the clinician workflow. Therefore, clinicians have been left to make decisions with incomplete information. Equally underused are the electronic health records (EHRs), which house enormous amounts of health data, but the power of that "big data" has failed to be capitalized on.
   METHODS: Early attempts at EBGs were rigid and nonadaptive; however, with the current advances in data informatics and machine learning algorithms, it is now possible to integrate "big data" and rapid data processing into clinical decision support tools. We have presented an overview of the background of EHRs and EBGs in neurosurgery and explored the possibility of integrating them to reduce unwanted variance.
   RESULTS: As we strive toward variance reduction in healthcare, the integration of "big data" and EBGs for decision-making will be key. We have proposed that EHRs are an ideal platform for integrating EBGs into the clinician workflow and have presented as an example of a successful early generation model, Neurocore. With this approach, it will be possible to build EBGs into the EHR software, to continuously update and optimize EBGs according to the flow of patient data into the EHR, and to present data-driven clinical decision support at the point of care.
   CONCLUSIONS: Variance reduction in neurosurgery through the integration of evidence-based decision support in EHRs will lead to improved patient safety, a reduction in medical errors, maximization of the use of the available data, and enhanced decision-making power for clinicians.
C1 [Stopa, Brittany M.; Yan, Sandra C.; Dasenbrock, Hormuzdiyar H.; Gormley, William B.] Harvard Med Sch, Brigham & Womens Hosp, Computat Neurosurg Outcomes Ctr, Dept Neurol Surg, Boston, MA 02115 USA.
   [Kim, Dong H.] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX 77030 USA.
RP Gormley, WB (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Computat Neurosurg Outcomes Ctr, Dept Neurol Surg, Boston, MA 02115 USA.
EM wgormley@partners.org
CR Adler-Milstein J, 2017, HEALTH AFFAIR, V36, P1416, DOI 10.1377/hlthaff.2016.1651
   Aghi MK, 2015, J NEURO-ONCOL, V125, P503, DOI 10.1007/s11060-015-1867-1
   Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006
   Asher AL, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.10.FOCUS12311
   BADAOUI S, 1993, MED INFORM, V18, P23, DOI 10.3109/14639239309034465
   Bandopadhayay P, 2008, J CLIN NEUROSCI, V15, P373, DOI 10.1016/j.jocn.2007.08.014
   Baron R., 2015, GMS German Medical Science, V13, pDoc19
   Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847
   Berger E, 2013, ANN EMERG MED, V62, p19A, DOI 10.1016/j.annemergmed.2013.05.011
   Bernat JL, 2013, NEUROLOGY, V80, P1057, DOI 10.1212/WNL.0b013e318287288c
   Blumenthal D, 2015, NEW ENGL J MED, V372, P2451, DOI 10.1056/NEJMhpr1503614
   Bracco D, 2015, CRIT CARE MED, V43, P1342, DOI 10.1097/CCM.0000000000001007
   De Turck F, 2007, COMPUT BIOL MED, V37, P97, DOI 10.1016/j.compbiomed.2005.10.004
   DICKSON JF, 1966, J AMER MED ASSOC, V196, P967
   Djulbegovic B, 2017, LANCET, V390, P415, DOI 10.1016/S0140-6736(16)31592-6
   Ducis K, 2016, WORLD NEUROSURG, V90, P322, DOI 10.1016/j.wneu.2016.02.044
   ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6
   Esene IN, 2016, NEUROSCIENCES, V21, P197, DOI 10.17712/nsj.2016.3.20150553
   Evans RS, 2016, YB MED INFORM S, P48
   Fargen KM, 2014, WORLD NEUROSURG, V82, pE61, DOI 10.1016/j.wneu.2013.01.075
   Fehlings MG, 2015, NEUROSURG CLIN N AM, V26, P271, DOI 10.1016/j.nec.2014.11.005
   Fineberg HV, 2012, NEW ENGL J MED, V366, P1020, DOI 10.1056/NEJMsa1114777
   Fisher CG, 2015, SPINE, V40, pE309, DOI 10.1097/BRS.0000000000000763
   Flodgren G, 2016, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD010669.PUB2
   Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x
   Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223
   Gianino John W, 2012, Mo Med, V109, P384
   Goitein L, 2016, JAMA INTERN MED, V176, P835, DOI 10.1001/jamainternmed.2016.1641
   Hamani C, 2014, NEUROSURGERY, V75, P327, DOI 10.1227/NEU.0000000000000499
   Hayrinen K, 2008, INT J MED INFORM, V77, P291, DOI 10.1016/j.ijmedinf.2007.09.001
   James B, 2003, MED CARE, V41, pI71
   Jones SS, 2012, NEW ENGL J MED, V366, P2243, DOI 10.1056/NEJMp1204980
   Kalkanis SN, 2010, J NEURO-ONCOL, V96, P33, DOI 10.1007/s11060-009-0061-8
   Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F
   Kim DH, 2017, NEUROSURGERY, V80, pS65, DOI 10.1093/neuros/nyw158
   Kohn LT, 2000, ERR IS HUMAN BUILDIN
   Kreiner DS, 2016, SPINE J, V16, P1478, DOI 10.1016/j.spinee.2016.08.034
   Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003
   Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384
   Leatherman ST, 2003, MED CARE, V41, pI80
   Nguyen L, 2014, INT J MED INFORM, V83, P779, DOI 10.1016/j.ijmedinf.2014.06.011
   LENZER J, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/bmj.j326
   Linskey Mark E, 2006, Prog Neurol Surg, V19, P1, DOI 10.1159/000095175
   Matz PG, 2016, SPINE J, V16, P439, DOI 10.1016/j.spinee.2015.11.055
   McGlynn EA, 2003, MED CARE, V41, pI16
   McGlynn EA, 2003, MED CARE, V41, pI1
   McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615
   METNITZ PGH, 1995, INT J CLIN MONIT COM, V12, P147, DOI 10.1007/BF02332689
   Nordin-Johansson A, 2000, J INTERN MED, V247, P94, DOI 10.1046/j.1365-2796.2000.00583.x
   Ovretveit J, 2016, J HEALTH ORGAN MANAG, V30, P1105, DOI 10.1108/JHOM-06-2016-0110
   Paek SH, 2010, STEREOT FUNCT NEUROS, V88, P216, DOI 10.1159/000314356
   Panzarasa S, 2006, NEUROL SCI, V27, pS245, DOI 10.1007/s10072-006-0628-5
   Panzarasa S, 2002, J BIOMED INFORM, V35, P123, DOI 10.1016/S1532-0464(02)00505-1
   Panzarasa Silvia, 2006, AMIA Annu Symp Proc, P619
   Panzarasa S, 2007, STUD HEALTH TECHNOL, V129, P834
   Prabhu VC, 2016, WORLD NEUROSURG, V91, P611, DOI 10.1016/j.wneu.2016.03.029
   Quaglini S, 2001, ARTIF INTELL MED, V22, P65, DOI 10.1016/S0933-3657(00)00100-7
   Ragel BT, 2015, J NEURO-ONCOL, V125, P481, DOI 10.1007/s11060-015-1866-2
   Rodriguez-Yanez M, 2013, NEUROLOGIA, V28, P236, DOI 10.1016/j.nrl.2011.03.010
   Rolston JD, 2015, NEUROSURG CLIN N AM, V26, P149, DOI 10.1016/j.nec.2014.11.011
   Rothman B, 2012, MT SINAI J MED, V79, P757, DOI 10.1002/msj.21351
   Ryken TC, 2014, J NEURO-ONCOL, V118, P479, DOI 10.1007/s11060-013-1336-7
   Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273
   Senders JT, 2018, NEUROSURGERY, V83, P181, DOI 10.1093/neuros/nyx384
   Senders JT, 2018, ACTA NEUROCHIR, V160, P29, DOI 10.1007/s00701-017-3385-8
   Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149
   Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151
   Shor R, 2015, J AM COLL CARDIOL, V65, P2660, DOI 10.1016/j.jacc.2015.05.004
   Sicurello F, 1995, Medinfo, V8 Pt 1, P485
   Sim I, 2001, J AM MED INFORM ASSN, V8, P527, DOI 10.1136/jamia.2001.0080527
   Sissons B, 2007, MED INFORM INTERNET, V32, P11, DOI 10.1080/14639230601097804
   Stack SJ, 2015, AMA NEWS
   Steudel WI, 2001, ACT NEUR S, V78, P217
   Stone S, 2007, NEUROSURGERY, V60, P1075, DOI 10.1227/01.NEU.0000255466.22387.15
   Suarez-Varela MMM, 1999, EUR J EPIDEMIOL, V15, P815, DOI 10.1023/A:1007609926935
   Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae
   Theodosopoulos PV, 2015, NEUROSURG CLIN N AM, V26, P265, DOI 10.1016/j.nec.2014.11.013
   Torbey MT, 2015, NEUROCRIT CARE, V22, P146, DOI 10.1007/s12028-014-0085-6
   Vaccaro AR, 2016, SPINE, V41, pE165, DOI 10.1097/BRS.0000000000001369
   Vachhrajani S, 2009, J NEUROSURG-PEDIATR, V3, P249, DOI 10.3171/2008.12.PEDS08278
   van Bemmel J H, 2016, Yearb Med Inform, VSuppl 1, pS12, DOI 10.15265/IYS-2016-s011
   van der Marck MA, 2017, LANCET, V390, P2244, DOI 10.1016/S0140-6736(17)32851-9
   Van Essen TA, 2016, J NEUROTRAUM, V33, pA20
   Wachter RM, 2015, NY TIMES, P5
   WACHTER RM, 2004, [No title captured]
   Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785
   Wesorick Bonnie, 2008, AMIA Annu Symp Proc, P1254
   Wong STC, 2004, ACAD RADIOL, V11, P345, DOI 10.1016/S1076-6332(03)00676-7
   Yang I, 2015, NEUROSURG CLIN N AM, V26, P301, DOI 10.1016/j.nec.2014.11.017
NR 89
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E190
EP E195
DI 10.1016/j.wneu.2019.01.292
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400025
PM 30797905
DA 2020-05-12
ER

PT J
AU Sun, Y
   Li, XW
   Xiong, JN
   Yu, JJ
   Lv, XL
AF Sun, Ying
   Li, Xiaowan
   Xiong, Jianing
   Yu, Jianjun
   Lv, Xianli
TI Transarterial Onyx Embolization of Residual Arteriovenous Malformation
   After Surgical Resection
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Embolization; Residual; Surgery
AB OBJECTIVE: We sought to report transarterial Onyx embolization of residual brain arteriovenous malformation (AVM) after surgical resection.
   METHODS: From January 2017 to January 2019, 7 patients with residual AVM after surgery were treated by transarterial Onyx embolization. Demographics, angioarchitectural characteristics, complications, and results were retrospectively reviewed.
   RESULTS: All patients presented initially with a ruptured AVM. Residual AVM was found on control angiograms within 1 month after surgery. All residual AVMs were cured by transarterial Onyx embolization. One patients experienced feeding artery perforation without adding new neurologic deficits.
   CONCLUSIONS: Complete obliteration of residual AVMs can be obtained by salvage transarterial Onyx embolization.
C1 [Sun, Ying] Capital Med Univ, Beijing Shijitan Hosp, Radiat Ctr, Beijing, Peoples R China.
   [Li, Xiaowan] Liaocheng Peoples Hosp, Neurol Dept, Liaocheng, Shandong, Peoples R China.
   [Xiong, Jianing] Huantai Peoples Hosp, Neurosurg Dept, Huantai, Shandong, Peoples R China.
   [Yu, Jianjun] Linyi Peoples Hosp, Weifang Med Coll, Linyi, Shandong, Peoples R China.
   [Lv, Xianli] Tsinghua Univ, Beijing Rsinghua Changgung Hosp, Sch Clin Med, Neurosurg Dept, Beijing, Peoples R China.
RP Lv, XL (reprint author), Tsinghua Univ, Beijing Rsinghua Changgung Hosp, Sch Clin Med, Neurosurg Dept, Beijing, Peoples R China.
EM lvxianli000@163.com
OI Lv, Xianli/0000-0001-8270-8464
CR Ding DL, 2016, WORLD NEUROSURG, V85, P263, DOI 10.1016/j.wneu.2015.10.001
   Lenck S, 2018, WORLD NEUROSURG, V116, pE1105, DOI 10.1016/j.wneu.2018.05.180
   Lv XL, 2018, NEURORADIOL J, V31, P224, DOI 10.1177/1971400918759811
   Lv Xianli, 2017, Oper Neurosurg (Hagerstown), V13, pE37, DOI 10.1093/ons/opx211
   Morgan MK, 2017, ACTA NEUROCHIR, V159, P1457, DOI 10.1007/s00701-017-3217-x
   Yamada S, 2004, NEUROL RES, V26, P288, DOI 10.1179/016164104225013987
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1242
EP E1245
DI 10.1016/j.wneu.2019.03.073
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400156
PM 30878741
DA 2020-05-12
ER

PT J
AU Szathmari, A
   Zerah, M
   Vinchon, M
   Dufour, C
   Gimbert, E
   Di Rocco, F
   Chabaud, S
   Conter, C
   Mottolese, C
   Frappaz, D
AF Szathmari, Alexandru
   Zerah, Michel
   Vinchon, Matthieu
   Dufour, Christelle
   Gimbert, Edouard
   Di Rocco, Federico
   Chabaud, Sylvie
   Conter, Cecile
   Mottolese, Carmine
   Frappaz, Didier
TI Ependymoma of the Spinal Cord in Children: A Retrospective French Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Ependymoma in children; Radiation therapy; Spine surgery
ID MYXOPAPILLARY EPENDYMOMA; INTRAMEDULLARY EPENDYMOMAS; RADIATION-THERAPY;
   TUMORS; OUTCOMES; SURGERY; GRADE; CLASSIFICATION; EPIDEMIOLOGY;
   RADIOTHERAPY
AB BACKGROUND: Ependymoma is the most frequent spinal tumor in adults but it is rather uncommon in children. The aim of the present study was to retrospectively summarize the clinical and therapeutic experience in the treatment of pediatric spinal ependymomas in France.
   METHODS: In the present retrospective multicenter study, data from patients aged <18 years who had been treated from 2000 to 2010 for spinal ependymomas were collected. Epidemiologic and tumor- and treatment-related data were analyzed. The prognostic factors for progression-free survival (PFS) were assessed.
   RESULTS: We identified 28 patients (22 males, 6 females). Their median age at surgery was 13.67 years (range, 0.7-17.6). Initial gross total resection (GTR) was achieved in 22 children and subtotal resection (STR) in 6. Histologically, 15 tumors were myxopapillary ependymomas and 11 were grade II and 2 grade III ependymomas. Adjuvant initial radiotherapy (RT) was performed in 6 patients. The median follow-up period was of 40 months (range, 2.3-127.5). The 5-year PFS rate was 51% (95% confidence interval, 26.3%-71.2%), and the overall survival rate was 100%. On univariate analysis, only GTR had a significant influence on PFS (P = 0.0013). A subgroup analysis showed a benefit of RT delivered to patients with GTR; however, RT failed to prevent relapse in the group with initial STR.
   CONCLUSIONS: Our data suggest that initial adjuvant RT might improve PFS after GTR but will not prevent relapse in patients with STR. Further studies are needed to define more specific treatments for the latter group.
C1 [Szathmari, Alexandru; Di Rocco, Federico; Mottolese, Carmine] Claude Bernard Lyon 1 Univ, Dept Pediat Neurosurg, Hop Femme Mere Enfant, Hosp Civils Lyon, Lyon, France.
   [Zerah, Michel] Univ Paris 05, Dept Pediat Neurosurg, Hop Necker Enfants Malad, Paris, France.
   [Vinchon, Matthieu] Ctr Hosp Roger Salengro, Dept Pediat Neurosurg, Lille, France.
   [Dufour, Christelle] Inst Gustave Roussy, Dept Child & Adolescent Canc, Villejuif, France.
   [Gimbert, Edouard] Ctr Hosp Pellegrin, Dept Pediat Neurosurg, Bordeaux, France.
   [Chabaud, Sylvie] Ctr Leon Berard, Directorate Clin Res & Innovat, Lyon, France.
   [Chabaud, Sylvie; Conter, Cecile; Frappaz, Didier] Hosp Civils Lyon, Lyon, France.
   [Conter, Cecile; Frappaz, Didier] Ctr Leon Berard, Inst Hematol Oncol Pediat, Lyon, France.
RP Szathmari, A (reprint author), Claude Bernard Lyon 1 Univ, Dept Pediat Neurosurg, Hop Femme Mere Enfant, Hosp Civils Lyon, Lyon, France.
EM alexandru.szathmari@chu-lyon.fr
OI Di Rocco, Federico/0000-0003-2145-5533
CR Aghakhani N, 2017, NEUROCHIRURGIE, V63, P391, DOI 10.1016/j.neuchi.2016.07.002
   Akyurek S, 2006, J NEURO-ONCOL, V80, P177, DOI 10.1007/s11060-006-9169-2
   Al-Halabi H, 2010, PEDIATR BLOOD CANCER, V55, P639, DOI 10.1002/pbc.22614
   Bagley CA, 2007, J NEUROSURG, V106, P261, DOI 10.3171/ped.2007.106.4.261
   Bagley CA, 2009, NEUROSURG REV, V32, P321, DOI 10.1007/s10143-009-0190-8
   Benesch M, 2012, CHILD NERV SYST, V28, P2017, DOI 10.1007/s00381-012-1908-4
   Benesch M, 2010, J NEUROSURG-PEDIATR, V6, P137, DOI 10.3171/2010.5.PEDS09553
   Bostrom A, 2011, NEUROSURGERY, V68, P302, DOI 10.1227/NEU.0b013e3182004c1e
   Chamberlain MC, 2002, CANCER, V95, P997, DOI 10.1002/cncr.10826
   Chang UK, 2002, J NEURO-ONCOL, V57, P133
   Constantini S, 2000, J NEUROSURG, V93, P183, DOI 10.3171/spi.2000.93.2.0183
   DIMARCO A, 1988, ACTA ONCOL, V27, P371
   Fakhrai N, 2004, ACTA NEUROCHIR, V146, P1255, DOI 10.1007/s00701-004-0374-5
   Fassett DR, 2005, J NEUROSURG, V102, P59, DOI 10.3171/ped.2005.102.1.0059
   Feldman WB, 2013, J NEUROSURG-SPINE, V19, P471, DOI 10.3171/2013.6.SPINE12927
   GAGLIARDI FM, 1993, CHILD NERV SYST, V9, P3, DOI 10.1007/BF00301925
   Korshunov A, 2003, AM J PATHOL, V163, P1721, DOI 10.1016/S0002-9440(10)63530-4
   Kukreja S, 2014, J NEUROSURG-PEDIATR, V13, P400, DOI 10.3171/2014.1.PEDS13532
   Landriel Federico, 2012, Surg Neurol Int, V3, P102, DOI 10.4103/2152-7806.100859
   Lee TT, 1998, ACTA NEUROCHIR, V140, P309, DOI 10.1007/s007010050103
   Lin YH, 2005, J NEURO-ONCOL, V71, P205, DOI 10.1007/s11060-004-1386-y
   Lin YM, 2015, NEUROL RES, V37, P650, DOI 10.1179/1743132815Y.0000000041
   Lin YM, 2015, J NEUROSURG-PEDIATR, V15, P243, DOI 10.3171/2014.9.PEDS1473
   Lonjon M, 1998, PEDIATR NEUROSURG, V29, P178, DOI 10.1159/000028718
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Lucchesi KM, 2016, J NEURO-ONCOL, V130, P133, DOI 10.1007/s11060-016-2218-6
   Madden JR, 2001, MED PEDIATR ONCOL, V37, P67, DOI 10.1002/mpo.1168
   McGuire CS, 2009, J NEUROSURG, V110, P725, DOI 10.3171/2008.9.JNS08117
   Merchant TE, 2000, PEDIATR NEUROSURG, V32, P30, DOI 10.1159/000028894
   Merchant TE, 2009, CHILD NERV SYST, V25, P1261, DOI 10.1007/s00381-009-0892-9
   OSULLIVAN C, 1994, J NEUROSURG, V81, P507, DOI 10.3171/jns.1994.81.4.0507
   Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002
   Palm T, 2009, CANCER-AM CANCER SOC, V115, P3955, DOI 10.1002/cncr.24476
   Pedziwiatr K, 2013, RADIOTHER ONCOL, V106, P181, DOI 10.1016/j.radonc.2013.02.007
   Pica A, 2009, INT J RADIAT ONCOL, V74, P1114, DOI 10.1016/j.ijrobp.2008.09.034
   POLLACK IF, 1995, NEUROSURGERY, V37, P655, DOI 10.1227/00006123-199510000-00008
   ROSS DA, 1993, CANCER, V71, P3114, DOI 10.1002/1097-0142(19930515)71:10<3114::AID-CNCR2820711036>3.0.CO;2-Q
   Safaee M, 2014, J NEUROSURG-PEDIATR, V13, P393, DOI 10.3171/2013.12.PEDS13383
   Schellinger KA, 2008, J NEURO-ONCOL, V87, P173, DOI 10.1007/s11060-007-9507-z
   SONNELAND PRL, 1985, CANCER, V56, P883, DOI 10.1002/1097-0142(19850815)56:4<883::AID-CNCR2820560431>3.0.CO;2-6
   Tarapore PE, 2013, NEUROSURGERY, V73, P247, DOI 10.1227/01.neu.0000430764.02973.78
   Wahab SH, 2007, J NEURO-ONCOL, V83, P85, DOI 10.1007/s11060-006-9310-2
   WHITAKER SJ, 1991, J NEUROSURG, V74, P720, DOI 10.3171/jns.1991.74.5.0720
NR 44
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1035
EP E1041
DI 10.1016/j.wneu.2019.03.033
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400130
PM 30877001
DA 2020-05-12
ER

PT J
AU Tarabay, B
   Abdallah, Y
   Kobaiter-Maarrawi, S
   Yammine, P
   Maarrawi, J
AF Tarabay, Bilal
   Abdallah, Youmna
   Kobaiter-Maarrawi, Sandra
   Yammine, Pierre
   Maarrawi, Joseph
TI Outcome and Prognosis of Microsurgical Decompression in Idiopathic
   Severe Common Fibular Nerve Entrapment: Prospective Clinical Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Common fibular nerve; Drop foot; Entrapment syndrome; Nerve
   microsurgical decompression
ID PERONEAL NERVE
AB OBJECTIVE: Compression of the common fibular nerve at the level of the fibular neck is considered to be the most frequent lower limb entrapment syndrome, which can be either idiopathic or secondary. Decompressive surgery is indicated only after failure of conservative treatment and/or severe neurologic deficit. The effectiveness of micro-surgical decompression has been established only for secondary entrapment syndrome. The aim of this study is to assess the results of microsurgical decompression and establish the prognosis of idiopathic severe common fibular nerve entrapment.
   METHODS: Fifteen patients were included in this prospective clinical study and were followed at day 1 after surgery and later at 1, 6, and 12 months. More than half (64.3%) of patients had a total motor deficit (0/5). The median motor function preoperatively was 0/5. The average time of conservative treatment before surgery was 25.7 days (range 5-110 days). One patient refused surgical management.
   RESULTS: Thirteen out of 14 patients who underwent surgery showed significant motor function improvement. The median motor strength at 12 months was 4.5/5. Half of the patients regained normal motor function. The only patient who did not improve had the longest time to surgery interval (110 days). The patient who refused surgery showed no improvement (0/5 at 12 months).
   CONCLUSIONS: Microsurgical decompression should be considered early in the context of severe idiopathic common fibular nerve entrapment in order to get a favorable outcome.
C1 [Abdallah, Youmna; Kobaiter-Maarrawi, Sandra; Maarrawi, Joseph] St Joseph Univ, Lab Res Neurosci, Fac Med, Beirut, Lebanon.
   [Tarabay, Bilal; Maarrawi, Joseph] Hotel Dieu France Hosp, Dept Neurosurg, Beirut, Lebanon.
   [Yammine, Pierre; Maarrawi, Joseph] Nord Hosp, Ctr Hosp, Dept Neurol & Neurosurg, Zgharta, Lebanon.
RP Maarrawi, J (reprint author), St Joseph Univ, Lab Res Neurosci, Fac Med, Beirut, Lebanon.; Maarrawi, J (reprint author), Hotel Dieu France Hosp, Dept Neurosurg, Beirut, Lebanon.; Maarrawi, J (reprint author), Nord Hosp, Ctr Hosp, Dept Neurol & Neurosurg, Zgharta, Lebanon.
EM joseph.maarrawi@usj.edu.lb
OI Maarrawi, Joseph/0000-0001-6743-8996
CR Anderson JC, 2016, CLIN PODIATR MED SUR, V33, P283, DOI 10.1016/j.cpm.2015.12.005
   Dallari D, 2004, J SPORT MED PHYS FIT, V44, P436
   Fabre T, 1998, J BONE JOINT SURG AM, V80A, P47, DOI 10.2106/00004623-199801000-00009
   Humphreys DB, 2007, J NEUROSURG, V107, P314, DOI 10.3171/JNS-07/08/0314
   Marciniak C, 2013, PHYS MED REH CLIN N, V24, P121, DOI 10.1016/j.pmr.2012.08.016
   McKean KA, 2009, PHYS MED REH CLIN N, V20, P249, DOI 10.1016/j.pmr.2008.10.019
   Peskun CJ, 2012, CLIN ORTHOP RELAT R, V470, P774, DOI 10.1007/s11999-011-1981-0
   Ramanan M, 2011, ANZ J SURG, V81, P707, DOI 10.1111/j.1445-2197.2010.05607.x
   RICKHAM PP, 1964, BRIT MED J, V2, P173
   Socolovsky M, 2018, MANUAL PERIPHERAL NE
   Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393
   Thoma A, 2001, PLAST RECONSTR SURG, V107, P1183, DOI 10.1097/00006534-200104150-00013
   Uzenot D, 2007, REV RHUM, V74, P401
   VASTAMAKI M, 1986, ACTA ORTHOP SCAND, V57, P551, DOI 10.3109/17453678609014792
   VAUGHAN DW, 1992, J COMP NEUROL, V323, P219, DOI 10.1002/cne.903230207
   Weyns FJM, 2007, OBES SURG, V17, P1209, DOI 10.1007/s11695-007-9203-2
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E281
EP E287
DI 10.1016/j.wneu.2019.02.042
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400034
PM 30822592
DA 2020-05-12
ER

PT J
AU Teramoto, S
   Oishi, H
   Arai, H
AF Teramoto, Shinichiro
   Oishi, Hidenori
   Arai, Hajime
TI Comparative Analysis of Long-Term Effect of Stent-Assisted Coiling in
   Unruptured Sidewall-Type and Terminal-Type Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Sidewall-type aneurysm; Stent-assisted coiling; Terminal-type aneurysm;
   Unruptured intracranial aneurysm
ID INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; EMBOLIZATION
AB BACKGROUND: Stent-assisted coiling is recognized as effective to induce progressive occlusion and prevent recurrence of aneurysm. The long-term effects of stent-assisted coiling of sidewall-type and terminal-type aneurysms were comparatively analyzed focusing on the different hemodynamic characteristics.
   METHODS: Retrospective analysis included a total of 120 unruptured aneurysms in 116 consecutive patients who underwent stent-assisted coiling and completed 2-year follow-up. The stent systems, baseline characteristics, and postcoiling occlusion status of sidewall-type and terminal-type aneurysms were assessed.
   RESULTS: Sidewall-type aneurysms had a significantly larger dome size (P = 0.02) and greater diameter of the parent vessel (P < 0.001) than terminal-type aneurysms. Initial occlusion status of the aneurysms was significantly maintained for 2 years in both sidewall-type and terminal-type aneurysms as follows: sidewall-type aneurysms showed that complete occlusion (CO), neck remnants (NRs), and body filling (BF) immediately posttreatment were significantly correlated with CO (P < 0.05), NRs (P < 0.01), and BF (P < 0.05) at 2-year follow-up, respectively, and terminal-type aneurysms showed that CO, NRs, and BF immediately posttreatment were significantly correlated with CO (P < 0.05), NRs (P < 0.05), and BF (P < 0.05) at 2-year follow-up, respectively. In addition, sidewall-type aneurysms with CO immediately posttreatment were significantly correlated with non-NRs (P < 0.01) and non-BF (P < 0.01) at 2-year follow-up.
   CONCLUSIONS: Stent-assisted coiling allows higher coil packing for sidewall-type aneurysms, but the indication should be carefully considered for terminal-type aneurysms.
C1 [Teramoto, Shinichiro] Koshigaya Municipal Hosp, Dept Neurosurg, Koshigaya, Saitama, Japan.
   [Oishi, Hidenori; Arai, Hajime] Juntendo Univ, Dept Neurosurg, Sch Med, Bunkyo Ku, Tokyo, Japan.
RP Teramoto, S (reprint author), Koshigaya Municipal Hosp, Dept Neurosurg, Koshigaya, Saitama, Japan.
EM tera.2@hotmail.co.jp
OI Teramoto, Shinichiro/0000-0001-6198-3387
CR Akpek S, 2005, AM J NEURORADIOL, V26, P1223
   Alshekhlee A, 2010, STROKE, V41, P1471, DOI 10.1161/STROKEAHA.110.580647
   Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311
   Biondi A, 2007, NEUROSURGERY, V61, P460, DOI 10.1227/01.NEU.0000290890.62201.A9
   Cheung NK, 2018, J NEUROINTERV SURG, V10, P669, DOI 10.1136/neurintsurg-2017-013402
   Cheung NK, 2018, J NEUROINTERV SURG, V10, P560, DOI 10.1136/neurintsurg-2017-013399
   Gao BL, 2013, NEUROSURGERY, V72, P617, DOI 10.1227/NEU.0b013e3182846d9f
   Grunwald IQ, 2007, NEURORADIOLOGY, V49, P41, DOI 10.1007/s00234-006-0153-5
   Holmin S, 2008, STROKE, V39, P2288, DOI 10.1161/STROKEAHA.107.508234
   Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082311
   Hwang G, 2011, AM J NEURORADIOL, V32, P1707, DOI 10.3174/ajnr.A2592
   Izar B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024875
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Kaufmann TJ, 2010, AM J NEURORADIOL, V31, P912, DOI 10.3174/ajnr.A1932
   Lanterna LA, 2004, NEUROSURGERY, V55, P767, DOI 10.1227/01.NEU.0000137653.93173.1C
   Lubicz B, 2009, NEURORADIOLOGY, V51, P419, DOI 10.1007/s00234-009-0519-6
   Ohta M, 2005, CARDIOVASC INTER RAD, V28, P768, DOI 10.1007/s00270-004-7148-6
   Oishi H, 2008, NEUROL SURG TOKYO, V36, P755
   Peng TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092407
   Pierot L, 2010, AM J NEURORADIOL, V31, P1010, DOI 10.3174/ajnr.A1999
   Pierot L, 2008, STROKE, V39, P2497, DOI 10.1161/STROKEAHA.107.512756
   Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114
   Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9
   Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600
   Santillan A, 2018, INTERV NEURORADIOL, V24, P246, DOI 10.1177/1591019918759307
   Wanke I, 2008, NEURORADIOLOGY, V50, P991, DOI 10.1007/s00234-008-0460-0
NR 26
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E753
EP E757
DI 10.1016/j.wneu.2019.02.145
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400093
PM 30853515
DA 2020-05-12
ER

PT J
AU Texakalidis, P
   Tora, MS
   Lamanna, JJ
   Wetzel, J
   Boulis, NM
AF Texakalidis, Pavlos
   Tora, Muhibullah S.
   Lamanna, Jason J.
   Wetzel, Jeremy
   Boulis, Nicholas M.
TI Combined Radial to Axillary and Spinal Accessory Nerve (SAN) to
   Suprascapular Nerve (SSN) Transfers May Confer Superior Shoulder
   Abduction Compared with Single SA to SSN Transfer
SO WORLD NEUROSURGERY
LA English
DT Article
DE Axillary; Brachial plexus injury; Nerve transfer; Radial; Shoulder
   abduction; Spinal accessory; Suprascapular
ID BRACHIAL-PLEXUS PALSY; RECONSTRUCTION; RESTORATION; OUTCOMES; INJURY
AB BACKGROUND: The restoration of shoulder function after brachial plexus injury is a high priority. Shoulder abduction and stabilization can be achieved by nerve transfer procedures including spinal accessory nerve (SAN) to suprascapular nerve (SSN) and radial to axillary nerve transfer. The objective of this study is to compare functional outcomes after SAN to SSN transfer versus the combined radial to axillary and SA to SSN transfer.
   METHODS: This retrospective chart review included 14 consecutive patients with brachial plexus injury who underwent SAN to SSN transfer, 4 of whom had both SA to SSN and radial to axillary nerve transfer.
   RESULTS: SAN to SSN transfer achieved successful shoulder abduction (>= M3) in 64.3% of this cohort (9/14). During the long-term follow-up, patients achieved an average increase of 67.5 degrees in shoulder abduction. There was no association between motor recovery and time from injury to surgery, age, body mass index (BMI), sex, or smoking status. The 4 patients who had SAN to SSN combined with radial to axillary nerve transfer demonstrated a statistically significant increase in the range of abduction (median, 90 degrees vs. 42.5 degrees, respectively; P = 0.022) compared with those who had SAN to SSN transfer alone; however, the difference in Medical Research Council (MRC) grades (MRC > M3) did not reach statistical significance (P = 0.07).
   CONCLUSIONS: Patients with brachial plexus injury and an intact C7 root could benefit from radial to axillary transfer in addition to SAN to SSN transfer. There was no association between recovery of shoulder abduction and time interval from injury to surgery, age, sex, smoking, and BMI.
C1 [Texakalidis, Pavlos; Tora, Muhibullah S.; Lamanna, Jason J.; Wetzel, Jeremy; Boulis, Nicholas M.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
RP Texakalidis, P (reprint author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
EM Pavlos.texakalidis@emory.edu
OI Boulis, Nicholas/0000-0002-7271-3953; Tora,
   Muhibullah/0000-0002-3300-6367
CR Baltzer HL, 2017, MICROSURG, V37, P365, DOI 10.1002/micr.30070
   Bentolila V, 1999, J BONE JOINT SURG AM, V81A, P20, DOI 10.2106/00004623-199901000-00004
   Bertelli JA, 2016, J NEUROSURG-SPINE, V24, P990, DOI 10.3171/2015.8.SPINE15434
   CHUANG DCC, 1995, PLAST RECONSTR SURG, V96, P122, DOI 10.1097/00006534-199507000-00019
   Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274
   Elhassan B, 2012, J BONE JOINT SURG AM, V94A, P1391, DOI 10.2106/JBJS.J.01913
   Emamhadi M, 2016, ARCH BONE JT SURG-AB, V4, P253
   Emamhadi M, 2016, ACTA NEUROCHIR, V158, P1801, DOI 10.1007/s00701-016-2886-1
   Kim DH, 2003, J NEUROSURG, V98, P1005, DOI 10.3171/jns.2003.98.5.1005
   Leechavengvongs S, 2006, J HAND SURG-AM, V31A, P183, DOI 10.1016/j.jhsa.2005.09.019
   Lu JZ, 2012, MICROSURG, V32, P111, DOI 10.1002/micr.20962
   Ruhmann O, 1999, INJURY, V30, P609, DOI 10.1016/S0020-1383(99)00165-5
   Rui J, 2013, J HAND SURG-EUR VOL, V38E, P242, DOI 10.1177/1753193412447495
   Shin AY, 2005, J AM ACAD ORTHOP SUR, V13, P382, DOI 10.5435/00124635-200510000-00003
   Sulaiman OAR, 2009, NEUROSURGERY, V65, pA55, DOI 10.1227/01.NEU.0000341165.83218.AC
   Terzis JK, 2006, PLAST RECONSTR SURG, V117, P613, DOI 10.1097/01.prs.0000203410.35395.fa
   Terzis JK, 2006, MICROSURG, V26, P316, DOI 10.1002/micr.20245
   Terzis JK, 2010, PLAST RECONSTR SURG, V125, P233, DOI 10.1097/PRS.0b013e3181c496e4
   Tsai YJ, 2015, MICROSURG, V35, P107, DOI 10.1002/micr.22283
NR 19
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1251
EP E1256
DI 10.1016/j.wneu.2019.03.075
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400158
PM 30898759
DA 2020-05-12
ER

PT J
AU Than, KD
   Park, P
   Tran, S
   Mundis, GM
   Fu, KM
   Uribe, JS
   Okonkwo, DO
   Nunley, PD
   Fessler, RG
   Eastlack, RK
   Kanter, A
   Anand, N
   LaMarca, F
   Passias, PG
   Mummaneni, PV
AF Than, Khoi D.
   Park, Paul
   Tran, Stacie
   Mundis, Gregory M.
   Fu, Kai-Ming
   Uribe, Juan S.
   Okonkwo, David O.
   Nunley, Pierce D.
   Fessler, Richard G.
   Eastlack, Robert K.
   Kanter, Adam
   Anand, Neel
   LaMarca, Frank
   Passias, Peter G.
   Mummaneni, Praveen V.
CA Int Spine Study Grp
TI Analysis of Complications with Staged Surgery for Less Invasive
   Treatment of Adult Spinal Deformity
SO WORLD NEUROSURGERY
LA English
DT Article; Proceedings Paper
CT 34th Annual Meeting of the
   Section-on-Disorders-of-the-Spine-and-Peripheral-Nerves (Spine Summit)
CY 2018
CL Orlando, FL
SP Sect Disorders Spine & Peripheral Nerves
DE Adult spinal deformity; Complications; Minimally invasive; Staging;
   Surgery
ID PERIOPERATIVE COMPLICATIONS; OUTCOMES; IMPACT
AB BACKGROUND: Spinal deformity surgery is often invasive and lengthy. Staging surgery over separate operative days may reduce complications. Staging is often used in minimally invasive treatment of adult spinal deformity (ASD).
   OBJECTIVE: To investigate the impact of staging on complication rates between hybrid (HYB; minimally invasive interbody with open posterior screw and rod fixation) and circumferential minimally invasive surgery (cMIS; minimally invasive interbody and screw/rod placement) procedures in patients with ASD.
   METHODS: A multicenter database of patients with ASD was reviewed. Patients who underwent staging (at least 3 levels) and 2 years of follow-up were analyzed. A total of 99 patients underwent staging: 53 cMIS and 46 HYB surgeries. Propensity matching for levels fused resulted in 19 patients in each group. Intra-and perioperative complications were assessed.
   RESULTS: Three HYB but no cMIS intraoperative complications occurred. More HYB patients had perioperative complications than cMIS patients. Neurologic complications were more frequent in HYB versus cMIS. Other complications did not differ significantly. Thirty-day reoperations were higher with cMIS than HYB, but there was no difference in reoperation rate at long-term follow-up. cMIS patients had greater improvement in the Oswestry Disability Index. There was no difference in complications between staged versus unstaged cMIS surgeries.
   CONCLUSIONS: cMIS staged surgeries appear safer than HYB staged surgeries, and equally safe to cMIS unstaged surgeries. Perioperative complications were significantly higher for HYB staged surgeries. HYB surgeries may have better results when performed in a single setting, whereas cMIS surgeries can be performed in 1 or 2 stages depending on surgeon preference.
C1 [Than, Khoi D.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA.
   [Park, Paul] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.
   [LaMarca, Frank] Henry Ford Hosp, Dept Neurol Surg, Detroit, MI 48202 USA.
   [Park, Paul; Int Spine Study Grp] San Diego Ctr Spinal Disorders, La Jolla, CA USA.
   [Mundis, Gregory M.; Eastlack, Robert K.] Scripps Clin Med Grp, Div Orthopaed Surg, La Jolla, CA USA.
   [Anand, Neel] Cedars Sinai Med Ctr, Dept Orthoped, Los Angeles, CA 90048 USA.
   [Mummaneni, Praveen V.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA.
   [Fu, Kai-Ming] Weill Cornell Med, Dept Neurol Surg, New York, NY USA.
   [Passias, Peter G.] New York Spine Inst, Dept Orthoped Surg, New York, NY USA.
   [Uribe, Juan S.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.
   [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.
   [Nunley, Pierce D.] Spine Inst Louisiana, Dept Neurosurg, Shreveport, LA USA.
   [Fessler, Richard G.] Rush Med Coll, Dept Neurosurg, Chicago, IL 60612 USA.
RP Than, KD (reprint author), Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA.
EM thank@ohsu.edu
FU DePuy Spine
FX K. D. Than reports being a consultant for Bioventus and Medtronic. P.
   Park reports being a consultant for Globus Medical, NuVasive,
   Allosource, and Medtronic; receives royalties from Globus Medical; and
   receives research support from Pfizer and Vertex. G. M. Mundis reports
   being a consultant for NuVasive, K2M, Viseon, Seaspine, and Allosource;
   receives royalties from K2M and NuVasive; and is a speaker for DePuy.
   K-M. Fu reports being a consultant for SI-Bone, DePuy, Globus, and 4web.
   J. S. Uribe reports being a consultant for NuVasive and receives
   royalties from NuVasive. D. O. Okonkwo reports being a consultant for
   NuVasive, Zimmer Biomet, and Stryker; is a patent holder with Zimmer
   Biomet; and receives royalties from Zimmer Biomet and NuVasive. P. D.
   Nunley is a consultant for K2M; receives royalties from K2M and LDR; has
   stock or stock options in Amedica, Paradigm Spine, and Spineology; and
   receives research support from Mesoblast, Organogenesis, Pfizer,
   Seikagaku, Simplify, Spinal Kinetics, Spineology, Vertiflex, and
   Zimmer-Biomet. R. G. Fessler reports being a consultant for DePuy;
   receives royalties from DePuy; receives speaker fees from Benvenue; and
   has ownership in In Queue Innovations. R. K. Eastlack reports being a
   consultant for Aesculap, K2M, NuVasive, Seaspine, SI-Bone, Spine
   Innovation, and Titan; receives royalties from Globus Medical; has
   direct stock ownership in Carevature, DiFusion, NuVasive, Alphatec,
   Spine Innovation, Seaspine, and Invuity; has received clinical or
   research support for the present study from NuVasive, Scripps Clinic
   Medical Group, and Seaspine; and holds patents with Invuity, Globus
   Medical, and NuTech. A. Kanter receives royalties from NuVasive and
   Zimmer. N. Anand reports being a consultant for Medtronic and Spinal
   Balance; has direct stock ownership in Atlas Spine, Globus Medical, GYS
   Tech, Medtronic, Paradigm Spine, and Theracell; is a patent holder with
   Medtronic; and receives royalties from Medtronic, Globus Medical, and
   Elsevier. P. V. Mummaneni reports being a consultant for Globus, DePuy
   Spine, and Stryker; has direct stock ownership in Spinicity/ISD;
   receives support for a none study-related clinical or research effort
   that he oversees from Neurosurgery Research and Education Foundation;
   receives honoraria from AOSpine and Spineart; and receives royalties
   from DePuy Spine, Thieme Publishers, Taylor and Francis, and Springer
   Publishers. Funding for the International Spine Study Group Foundation,
   through which this study was conducted, was provided by research grants
   from DePuy Spine and individual donations.
CR Glassman SD, 2007, SPINE, V32, P2764, DOI 10.1097/BRS.0b013e31815a7644
   Gum JL, 2016, SPINE DEFORM, V4, P131, DOI DOI 10.1016/J.JSPD.2015.08.005
   Hassanzadeh H, 2013, SPINE J, V13, P1717, DOI 10.1016/j.spinee.2013.03.005
   Maddox JJ, 2014, SPINE J, V14, P1159, DOI 10.1016/j.spinee.2013.07.485
   Passias PG, 2017, SPINE J, V17, P1091, DOI 10.1016/j.spinee.2017.03.012
   Passias PG, 2012, SPINE, V37, P247, DOI 10.1097/BRS.0b013e31821350d0
   Siemionow K, 2014, NEUROL NEUROCHIR POL, V48, P403, DOI 10.1016/j.pjnns.2014.10.001
   Strom RG, 2016, J NEUROSURG-SPINE, V25, P697, DOI 10.3171/2016.4.SPINE16157
   Uribe JS, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS13534
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1337
EP E1342
DI 10.1016/j.wneu.2019.03.090
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400169
PM 30898739
DA 2020-05-12
ER

PT J
AU Tian, RF
   Liu, WM
   Dong, JQ
   Zhang, J
   Xu, L
   Zhang, B
   Tao, XG
   Li, JS
   Liu, BY
AF Tian, Runfa
   Liu, Weiming
   Dong, Jinqian
   Zhang, Ji
   Xu, Long
   Zhang, Bin
   Tao, Xiaogang
   Li, Jingsheng
   Liu, Baiyun
TI Prognostic Predictors of Early Outcomes and Discharge Status of Patients
   Undergoing Decompressive Craniectomy After Severe Traumatic Brain Injury
SO WORLD NEUROSURGERY
LA English
DT Article
DE Decompressive craniectomy; Discharge status; Prognostic predictors;
   Severe traumatic brain injury
ID SEVERE HEAD-INJURIES; SUBDURAL-HEMATOMA; SURGERY; AGE; COAGULOPATHY;
   MULTICENTER
AB OBJECTIVE: Although several prognostic factors for traumatic brain injury (TBI) have been evaluated, a useful predictive scoring model for the outcomes has not been developed for patients with severe TBI who undergo decompressive craniectomy (DC). The aim of the present study was to determine independent predictors and develop a multivariate logistic regression equation to predict the early outcome and discharge status for patients with severe TBI who have undergone DC.
   METHODS: A total of 13 different variables were evaluated. The data from all 278 patients with severe TBI who had undergone DC in the present study were retrospectively evaluated from July 2011 to June 2017. Using univariate, multiple logistic regression and prognostic regression scoring equations it was possible to draw receiver operating characteristic curves to predict the early outcomes and discharge status after TBI.
   RESULTS: We found that younger age (P = 0.012), no significant medical history (P = 0.044), diameter of both pupils < 4 mm (P = 0.032), higher admission Glasgow coma scale score (P = 0.004), no tracheotomy (P < 0.001), and DC for severe TBI were associated with a favorable early outcome and discharge status. Using receiver operating characteristic curves to predict the probability of a favorable outcome, the sensitivity was 80.0% and the specificity was 79.5%.
   CONCLUSIONS: Our preliminary findings have shown that 5 variables can be used as independent predictors in assessing the early outcome and discharge status for patients with severe TBI after DC.
C1 [Tian, Runfa; Liu, Weiming; Dong, Jinqian; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Tian, Runfa; Liu, Weiming; Dong, Jinqian; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.
   [Tian, Runfa; Liu, Weiming; Dong, Jinqian; Xu, Long; Zhang, Bin; Tao, Xiaogang; Li, Jingsheng; Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.
   [Tian, Runfa; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China.
   [Zhang, Ji] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.
   [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.
RP Liu, BY (reprint author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (reprint author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, BY (reprint author), Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (reprint author), Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China.; Liu, BY (reprint author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.
EM liubaiyun1212@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81801225, 81171144, 81471238]; Natural Science
   Foundation of Capital Medical University [PYZ2017075]; Youth Foundation
   of Beijing Tian Tan Hospital [2017-YQN-03]
FX The present study was supported by the National Natural Science
   Foundation of China (grants 81801225, 81171144, and 81471238), Natural
   Science Foundation of Capital Medical University (grant PYZ2017075), and
   Youth Foundation of Beijing Tian Tan Hospital (grant 2017-YQN-03).
CR Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2
   Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044
   CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242
   Carter BG, 2007, ANAESTH INTENS CARE, V35, P984, DOI 10.1177/0310057X0703500623
   Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077
   De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889
   Fotakopoulos George, 2016, Surg Neurol Int, V7, P19, DOI 10.4103/2152-7806.176671
   Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682
   Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102
   Hoffmann M, 2011, BR J SURG S1, V99, P122
   Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017
   Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666
   Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215
   Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623
   Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012
   Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011
   Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3
   Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042
   Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X
   Liu B, 2008, J NEUROSURG, V24, P153
   Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820
   Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33
   Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732
   Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244
   Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722
   Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502
   Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587
   Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311
   Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 30
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E101
EP E108
DI 10.1016/j.wneu.2019.01.246
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400014
PM 30790726
DA 2020-05-12
ER

PT J
AU Tokugawa, J
   Kudo, K
   Mitsuhashi, T
   Yanagisawa, N
   Nojiri, S
   Hishii, M
AF Tokugawa, Joji
   Kudo, Kentaro
   Mitsuhashi, Takashi
   Yanagisawa, Naotake
   Nojiri, Shuko
   Hishii, Makoto
TI Surgical Results of Carotid Endarterectomy for Twisted Carotid
   Bifurcation
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anatomy; Carotid stenosis; Revascularization stroke; Surgical procedure;
   Surgical result
ID LATERAL POSITION; RISK-FACTOR; ARTERY
AB BACKGROUND: The internal carotid artery is normally positioned posterolateral to the external carotid artery at the carotid bifurcation. An anatomic variation with the internal carotid artery positioned medial to the external carotid artery, the so-called twisted carotid bifurcation (TCB), is sometimes encountered in patients undergoing carotid endarterectomy (CEA). Little is known about the TCB or the implications for CEA.
   OBJECTIVE: The present study investigated the demographics and surgical results of our patients with TCB who underwent CEA, and demonstrates the surgery in a video clip.
   METHODS: Eleven of our series of 73 consecutive CEA patients (15.1%) had a TCB (TCB group). The basic surgical method was the same for both the TCB and non-TCB groups.
   RESULTS: The patient demographics were almost identical between the 2 groups. No significant difference was observed in the degree of stenosis, the duration of operation, or the surgery-related complications between the 2 groups. However, 9 of 11 cases were right-sided in the TCB group; the only significant difference between the groups.
   CONCLUSIONS: CEA for TCB can be safely performed by extension of the normal procedure, but with more meticulous preoperative assessment and gentle maneuvers. The reason for the right-side dominance is still unknown. Further investigation is needed of this anatomic entity.
C1 [Tokugawa, Joji; Kudo, Kentaro; Mitsuhashi, Takashi; Hishii, Makoto] Juntendo Univ, Nerima Hosp, Dept Neurosurg, Tokyo, Japan.
   [Yanagisawa, Naotake; Nojiri, Shuko] Juntendo Univ, Med Technol Innovat Ctr, Tokyo, Japan.
RP Tokugawa, J (reprint author), Juntendo Univ, Nerima Hosp, Dept Neurosurg, Tokyo, Japan.
EM j.tokugawa@juntendo-nerima.jp
OI Mitsuhashi, Takashi/0000-0002-3333-490X
CR Ackerstaff RGA, 2000, STROKE, V31, P1817, DOI 10.1161/01.STR.31.8.1817
   Aso K, 2009, EUR J NUCL MED MOL I, V36, P294, DOI 10.1007/s00259-008-0886-y
   Bailey MA, 2007, EUR J VASC ENDOVASC, V14, P22
   HANDA J, 1972, RADIOLOGY, V102, P361, DOI 10.1148/102.2.361
   Ito Masaki, 2016, Acta Neurochir Suppl, V123, P115, DOI 10.1007/978-3-319-29887-0_16
   Kamide T, 2016, ACTA NEUROCHIR, V158, P2393, DOI 10.1007/s00701-016-2948-4
   Katano H, 2010, WORLD NEUROSURG, V73, P147, DOI 10.1016/j.surneu.2009.02.015
   Loftus CM., 2006, SIDE BY SIDE, P158
   Lucev N, 2000, OTOLARYNG HEAD NECK, V122, P590, DOI 10.1067/mhn.2000.97982
   Marcucci G, 2011, INTERACT CARDIOV TH, V13, P471, DOI 10.1510/icvts.2011.272914
   Ozgur Z, 2008, SURG RADIOL ANAT, V30, P475, DOI 10.1007/s00276-008-0351-4
   Sitzer M, 2003, STROKE, V34, P950, DOI 10.1161/01.STR.0000060895.38298.C4
   TEAL JS, 1973, RADIOLOGY, V108, P77, DOI 10.1148/108.1.77
   TRIGAUX JP, 1990, BRIT J RADIOL, V63, P181, DOI 10.1259/0007-1285-63-747-181
   UEDA S, 1984, STROKE, V15, P736, DOI 10.1161/01.STR.15.4.736
   Wolf O, 2004, STROKE, V35, pE373, DOI 10.1161/01.STR.0000143184.69343.ec
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E153
EP E156
DI 10.1016/j.wneu.2019.01.282
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400020
PM 30794973
DA 2020-05-12
ER

PT J
AU Urakov, TM
   Wang, MY
   Levi, AD
AF Urakov, Timur M.
   Wang, Michael Y.
   Levi, Allan D.
TI Workflow Caveats in Augmented Reality-Assisted Pedicle Instrumentation:
   Cadaver Lab
SO WORLD NEUROSURGERY
LA English
DT Article
DE Augmented; Fluoroscopy; Mixed reality; Pedicle screw; Spine surgery;
   Virtual
ID SURGERY
AB BACKGROUND: Augmented reality (AR) is gaining popularity in gaming, industrial, military, and medical fields. Neurosurgical applications are currently limited and underdeveloped.
   METHODS: The cadaver lab session was prepared with the currently available AR equipment and software. Pedicle instrumentation was performed from thoracic 1 to the pelvis with either fluoroscopy or AR.
   RESULTS: A total of 38 screws were placed. There were no major breaches on the fluoroscopy-assisted side. Among the AR screws, 3 had a major medial breach and 4 had a major inferior breach. The cause of a 3 breaches appeared to be related to an error in the starting position, as their overall orientation remained correctly parallel to the original trajectory.
   CONCLUSIONS: The article discusses the potential and limitations of AR in its current state and identifies strategies for successful AR application in future surgery.
C1 [Urakov, Timur M.; Wang, Michael Y.; Levi, Allan D.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
RP Urakov, TM (reprint author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.
EM timur.urakov@jhsmiami.org
CR Bernardo A, 2017, WORLD NEUROSURG, V106, P1015, DOI 10.1016/j.wneu.2017.06.140
   Cabrilo I, 2014, OPER NEUROSURG, V10, P252, DOI 10.1227/NEU.0000000000000328
   Elmi-Terander A, 2019, SPINE, V44, P517, DOI 10.1097/BRS.0000000000002876
   GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004
   Suess O, 2016, ADV MED, V2016
   Urakov TM, 2018, WORLD NEUROSURG, V120, pE752, DOI 10.1016/j.wneu.2018.08.158
   Vassallo R, 2018, HEALTHC TECHNOL LETT, V5, P158, DOI 10.1049/htl.2018.5069
   Yoon JW, 2017, INT J MED ROBOT, V13
NR 8
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1449
EP E1455
DI 10.1016/j.wneu.2019.03.118
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400182
PM 30904807
DA 2020-05-12
ER

PT J
AU Voormolen, EH
   Diederen, SJH
   Woerdeman, P
   van der Sprenkel, JWB
   Noordmans, HJ
   Visser, F
   Viergever, MA
   Luijten, P
   Hoogduin, H
   Robe, PA
AF Voormolen, Eduard H.
   Diederen, Sander J. H.
   Woerdeman, Peter
   van der Sprenkel, Jan Willem Berkelbach
   Noordmans, Herke Jan
   Visser, Fredy
   Viergever, Max A.
   Luijten, Peter
   Hoogduin, Hans
   Robe, Pierre A.
TI Implications of Extracranial Distortion in Ultra-High-Field Magnetic
   Resonance Imaging for Image-Guided Cranial Neurosurgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE 7 Tesla; Brain tumors; Geometric distortion; Image guidance;
   Neuronavigation; Ultra-high-field MRI
ID GEOMETRIC DISTORTION; BRAIN; MRI; SURGERY
AB BACKGROUND: Ultra-high-field magnetic resonance imaging (MRI) of the brain is attractive for image guidance during neurosurgery because of its high tissue contrast and detailed vessel visualization. However, high-field MRI is prone to distortion artifacts, which may compromise image guidance. Here we investigate intra-and extracranial distortions in 7-T MRI scans.
   METHODS: Five patients with and 5 patients without skin-adhesive fiducials received magnetization-prepared T1-weighted 7-T MRI and standard 3-T MRI scans. The 7- and 3-T images were rigidly coregistered and compared. Intracranial distortions were evaluated qualitatively, whereas shifts at the skin surface and shifts of the center positions of skin-adhesive fiducials were measured quantitatively. Moreover, we present an illustrative case of an ultra-highfield image-guided skull base meningioma resection.
   RESULTS: We found excellent intracranial correspondence between 3- and 7-T MRI scans. However, the average maximum skin shift was 6.8 +/- 2.0 mm in group A and 5.2 +/- 0.9 mm in group B. The average maximum difference between the skin-adhesive fiducial positions was 5.6 +/- 3.1 mm in group B. In our tumor resection case, the meningioma blood supply could be targeted early thanks to 7-T image guidance, which made subsequent tumor removal straightforward.
   CONCLUSIONS: There are no visible intracranial distortions in magnetization-prepared T1-weighted 7-T MRI cranial images. However, we found considerable extracranial shifts. These shifts render 7-T images unreliable for patient-to-image registration. We recommend performing patient-to-image registration on a routine (computed tomography scan or 3-T magnetic resonance) image and subsequently fusing the 7-T magnetic resonance image with the routine image on the image guidance machine, until this issue is resolved.
C1 [Voormolen, Eduard H.; Diederen, Sander J. H.; Woerdeman, Peter; van der Sprenkel, Jan Willem Berkelbach; Robe, Pierre A.] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands.
   [Voormolen, Eduard H.; Viergever, Max A.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.
   [Noordmans, Herke Jan] Univ Med Ctr Utrecht, Dept Clin Phys, Utrecht, Netherlands.
   [Visser, Fredy] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.
   [Visser, Fredy; Luijten, Peter; Hoogduin, Hans] Philips Healthcare, Best, Netherlands.
RP Diederen, SJH (reprint author), Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands.
EM s.j.h.diederen-2@umcutrecht.nl
OI Noordmans, Herke Jan/0000-0002-9913-4556
FU Alexandre Suerman personal grant from the University Medical Center
   Utrecht, Utrecht, The Netherlands
FX This work was partly funded by the Alexandre Suerman personal grant
   received by Dr. Voormolen from the University Medical Center Utrecht,
   Utrecht, The Netherlands. The sponsor had no role in the design or
   conduct of this research. Dr. Visser is employed by Philips Healthcare,
   Best, The Netherlands, which is a manufacturer of 7.0-Tesla MRI
   scanners.
CR Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105
   Archip N, 2008, NEUROSURGERY, V63, P209, DOI [10.1227/01.NEU.0000297081.51540.45, 10.1227/01.neu.0000317395.08466.e6]
   Barrett TF, 2017, WORLD NEUROSURG, V103, P600, DOI 10.1016/j.wneu.2017.03.088
   Dammann P, 2011, ACAD RADIOL, V18, P910, DOI 10.1016/j.acra.2011.02.011
   Dean D, 1998, IEEE T MED IMAGING, V17, P810, DOI 10.1109/42.736049
   Duchin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037328
   Harteveld AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121051
   Kang CK, 2016, MAGN RESON MED, V75, P1640, DOI 10.1002/mrm.25600
   Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616
   Li Y, 2015, J MAGN RESON IMAGING, V41, P1332, DOI 10.1002/jmri.24672
   Noebauer-Huhmann IM, 2015, EUR RADIOL, V25, P106, DOI 10.1007/s00330-014-3351-2
   Planting BR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00876
   van Laar PJ, 2016, WORLD NEUROSURG, V93, P410, DOI 10.1016/j.wneu.2016.06.084
   Wang H, 2013, PHYS MED BIOL, V58, P465, DOI 10.1088/0031-9155/58/3/465
   Woerdeman PA, 2007, NEUROSURGERY, V60, P100, DOI 10.1227/01.NEU.0000249231.747471.C3
   Zaiss M, 2015, NEUROIMAGE, V112, P180, DOI 10.1016/j.neuroimage.2015.02.040
NR 16
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E250
EP E258
DI 10.1016/j.wneu.2019.02.028
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400031
PM 30797931
DA 2020-05-12
ER

PT J
AU Wang, BJ
   Hua, WB
   Ke, WC
   Lu, SD
   Li, XS
   Zeng, XL
   Yang, C
AF Wang, Bingjin
   Hua, Wenbin
   Ke, Wencan
   Lu, Saideng
   Li, Xingsheng
   Zeng, Xianlin
   Yang, Cao
TI Biomechanical Evaluation of Transforaminal Lumbar Interbody Fusion and
   Oblique Lumbar Interbody Fusion on the Adjacent Segment: A Finite
   Element Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adjacent segment degeneration; Finite element analysis; Oblique lumbar
   interbody fusion; Transforaminal lumbar interbody fusion
ID DISC DEGENERATION; SPINAL-FUSION; POSTERIOR; RISK; SCREW
AB OBJECTIVE: To analyze the biomechanical changes of lumbar adjacent segment by comparing the biomechanics after the surgery of transforaminal lumbar interbody fusion (TLIF) and oblique lumbar interbody fusion (OLIF).
   METHODS: The finite element model of the L1-S1 was reconstructed via computed tomography scan images. The models of TLIF and OLIF were constructed and analyzed. A 400-N vertical axial pre-load was imposed on the superior surface of L1 and a 10-N.m moment was applied on the L1 superior surface along the radial direction to simulate 4 different physiological motions: flexion, extension, bending, and torsion. The range of motion (ROM) and the intradiscal pressure (IDP) were evaluated and compared with investigate the biomechanical influences of TLIF and OLIF on the adjacent segments (L3-L4 and L5-S1).
   RESULTS: Compared with the normal model, TLIF and OLIF in all motion patterns increased the ROM and the IDP of adjacent segments. However, the ROM and the IDP between TLIF and OLIF had no significant difference.
   CONCLUSIONS: The biomechanical analysis showed that both TLIF and OLIF can increase ROM and IDP. It indicates that TLIF and OLIF probably increase the potential risk of adjacent segment degeneration similarly.
C1 [Wang, Bingjin; Hua, Wenbin; Ke, Wencan; Lu, Saideng; Zeng, Xianlin; Yang, Cao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan, Hubei, Peoples R China.
   [Li, Xingsheng] Valeo Foshan Tech Ctr, Foshan, Peoples R China.
RP Yang, C (reprint author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan, Hubei, Peoples R China.
EM caoyangunion@hust.edu.cn
RI Hua, Wenbin/W-9025-2019
OI Yang, Cao/0000-0002-0058-614X
FU National Key R&D program of China [2018YFB1105700]
FX This study was supported by the National Key R&D program of China
   (2018YFB1105700).
CR Castellvi Antonio E, 2007, SAS J, V1, P74, DOI 10.1016/SASJ-2007-0004-RR
   Chen CS, 2001, MED ENG PHYS, V23, P483
   Chiang MF, 2006, SPINE, V31, pE682, DOI 10.1097/01.brs.0000232714.72699.8e
   Goto Keisuke, 2003, J Orthop Sci, V8, P577, DOI 10.1007/s00776-003-0675-1
   Huang YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166452
   Kim HJ, 2015, EUR SPINE J, V24, P827, DOI 10.1007/s00586-014-3462-0
   Kim HJ, 2011, SPINE, V36, P1367, DOI 10.1097/BRS.0b013e318221a595
   Lee CH, 2017, J NEUROSURG-SPINE, V27, P643, DOI 10.3171/2017.3.SPINE161169
   Lin GX, 2018, WORLD NEUROSURG, V119, pE898, DOI 10.1016/j.wneu.2018.08.003
   Liu C, 2018, WORLD NEUROSURG, V120, pE88, DOI 10.1016/j.wneu.2018.07.167
   Liu C, 2018, WORLD NEUROSURG, V120, pE72, DOI 10.1016/j.wneu.2018.07.146
   Liu CL, 2010, J SPINAL DISORD TECH, V23, P410, DOI 10.1097/BSD.0b013e3181b63d89
   Min JH, 2007, J NEUROSURG-SPINE, V7, P21, DOI 10.3171/SPI-07/07/021
   Natarajan RN, 2017, J ORTHOP RES, V35, P123, DOI 10.1002/jor.23283
   Natarajan RN, 2003, SPINE, V28, P1103, DOI 10.1097/00007632-200306010-00005
   Schmidt H, 2007, CLIN BIOMECH, V22, P377, DOI 10.1016/j.clinbiomech.2006.11.008
   Srinivas GR, 2017, ASIAN SPINE J, V11, P538, DOI 10.4184/asj.2017.11.4.538
   Srinivas GR, 2016, ASIAN SPINE J, V10, P205, DOI 10.4184/asj.2016.10.2.205
   Tang SJ, 2015, SAUDI MED J, V36, P993, DOI 10.15537/smj.2015.8.11759
   Tang SJ, 2011, J ORTHOP SCI, V16, P221, DOI 10.1007/s00776-011-0037-3
   Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea
   YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020
   Yan JZ, 2011, INT J MED ROBOT COMP, V7, P96, DOI 10.1002/rcs.374
   Zhao X, 2018, WORLD NEUROSURG, V114, pE114, DOI 10.1016/j.wneu.2018.02.073
NR 24
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E819
EP E824
DI 10.1016/j.wneu.2019.02.164
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400102
PM 30862579
DA 2020-05-12
ER

PT J
AU Wang, DR
   Norton, C
   Helenius, J
   Xu, XM
   Liu, M
   Selim, M
   Lioutas, VA
AF Wang, Deren
   Norton, Casey
   Helenius, Johanna
   Xu, Xiaomeng
   Liu, Ming
   Selim, Magdy
   Lioutas, Vasileios-Arsenios
TI Progression of White Matter Injury After Intracerebral Hemorrhage: A
   Magnetic Resonance Imaging Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Intracerebral hemorrhage; Magnetic resonance imaging; Prognosis; White
   matter hyperintensities
ID SMALL VESSEL DISEASE; LEUKOARAIOSIS; PRESSURE; STROKE; HYPERINTENSITIES;
   ASSOCIATION; MRI; HYDROCEPHALUS; STATEMENT; LESIONS
AB BACKGROUND: White matter injury (WMI) has been observed after experimental intracerebral hemorrhage (ICH). The supporting clinical data have been sparse. We assessed the presence, extent, and progression of WMI in patients with ICH.
   METHODS: We performed a retrospective review of data from 65 consecutive patients with spontaneous supratentorial ICH who had undergone baseline brain magnetic resonance imaging (MRI) within 7 days of ICH onset and repeat MRI afterward. We used the Fazekas scale (FZKS) to grade the severity of WMI. The clinical and imaging characteristics of the patients with and without WMI progression (WMIP) were compared using uni- and multi-variate logistic regression analyses.
   RESULTS: We observed WMIP in 23 patients (35.4%). WMIP was noted in both hemispheres but more commonly ipsilateral to the ICH (33% vs. 21%). The mean total FZKS score had increased from 3 (interquartile range [IQR], 1-4) at baseline to 4 (IQR, 2-5) on repeat MRI (P < 0.0001). Patients with lobar ICH had a greater median FZKS score than those with deep ICH (median, 3; IQR, 2-4; vs. 1.5, IQR, 1-3.25; P = 0.027). The baseline parenchymal ICH volume (odds ratio [OR], 1.067; 95% confidence interval [CI], 1.018-1.119; P = 0.007) and ventricular volume on baseline MRI (OR, 1.073; 95% CI, 1.019-1.130; P = 0.007) were predictors of WMIP after adjustment. Multivariate analyses showed an independent association between WMIP and unfavorable 3-month outcomes (OR, 5.196; 95% CI, 1.059-25.483; P = 0.042).
   CONCLUSIONS: WMI will progress over time in patients with ICH, and WMIP has been associated with worse outcomes. This novel finding could represent a potential therapeutic target. Future prospective larger studies are needed to confirm our findings.
C1 [Wang, Deren; Liu, Ming] Sichuan Univ, West China Hosp, Ctr Cerebrovasc Dis, Dept Neurol, Chengdu, Sichuan, Peoples R China.
   [Wang, Deren; Norton, Casey; Helenius, Johanna; Xu, Xiaomeng; Selim, Magdy; Lioutas, Vasileios-Arsenios] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Stroke Div, Boston, MA 02115 USA.
   [Xu, Xiaomeng] Nanjing Univ, Med Sch, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.
RP Selim, M (reprint author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Stroke Div, Boston, MA 02115 USA.
EM mselim@bidmc.harvard.edu
OI Wang, Deren/0000-0002-2388-3585; Selim, Magdy/0000-0002-1936-3173
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81620108009]; National Key R&D Program of China
   [2016YFC1300500-505]; National Institute of Neurological Disorders and
   StrokeUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [U01NS 074425]; American Heart
   AssociationAmerican Heart Association [15CSA24540001]
FX Deren Wang was supported by the National Natural Science Foundation of
   China (grants 81870923 and 81620108009) and the National Key R&D Program
   of China (grants 2017YFC1308401 and 2016YFC1300500-505). Ming Liu was
   supported by the National Natural Science Foundation of China (grant
   81620108009) and the National Key R&D Program of China (grant
   2016YFC1300500-505). Magdy Selim was supported by the National Institute
   of Neurological Disorders and Stroke (grant U01NS 074425) and American
   Heart Association (grant 15CSA24540001).
CR Allan CL, 2015, BRIT J PSYCHIAT, V206, P308, DOI 10.1192/bjp.bp.114.153536
   Caprio FZ, 2013, STROKE, V44, P642, DOI 10.1161/STROKEAHA.112.676890
   Charidimou A, 2016, NEUROLOGY, V86, P505, DOI 10.1212/WNL.0000000000002362
   Chen XM, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00471
   Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666
   DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027
   FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351
   Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535
   Helenius J, 2015, STROKE, V46, P1857, DOI 10.1161/STROKEAHA.115.009258
   Jang SH, 2013, INT J NEUROSCI, V123, P420, DOI 10.3109/00207454.2012.763164
   Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9
   Krauss JK, 1997, NEUROSURGERY, V40, P491, DOI 10.1097/00006123-199703000-00011
   Lou M, 2010, STROKE, V41, P34, DOI 10.1161/STROKEAHA.109.564955
   Markus HS, 2005, STROKE, V36, P1410, DOI 10.1161/01.STR.0000169924.60783.d4
   Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131
   Ninds I C H, 2005, STROKE, V36, pe23
   Prins ND, 2004, NEUROLOGY, V62, P1533, DOI 10.1212/01.WNL.0000123264.40498.B6
   Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10
   Ramirez J, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/fnagi.2010.00062, 10.3389/fnagi.2016.00062]
   Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132
   Smith EE, 2017, STROKE, V48, pE44, DOI 10.1161/STR.0000000000000116
   Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986
   Sykora M, 2017, J STROKE CEREBROVASC, V26, P1328, DOI 10.1016/j.jstrokecerebrovasdis.2017.02.003
   Tveiten A, 2013, J STROKE CEREBROVASC, V22, P919, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.017
   van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8
   Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010
   Yao XY, 2015, NEUROCRIT CARE, V23, P179, DOI 10.1007/s12028-015-0147-4
   Yeo SS, 2011, EUR NEUROL, V66, P235, DOI 10.1159/000330942
   Ziegelitz D, 2014, J MAGN RESON IMAGING, V39, P1533, DOI 10.1002/jmri.24292
   Zuo SL, 2017, BIOMED RES INT, DOI 10.1155/2017/6138424
NR 32
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E534
EP E544
DI 10.1016/j.wneu.2019.02.089
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400064
PM 30831290
DA 2020-05-12
ER

PT J
AU Wang, YX
   Wang, JC
   Wang, H
   Feng, XM
   Tao, Y
   Yang, J
   Cai, J
AF Wang, Yongxiang
   Wang, Jingcheng
   Wang, Hua
   Feng, Xinmin
   Tao, Yuping
   Yang, Jiandong
   Cai, Jun
TI Tet1 Overexpression and Decreased DNA Hydroxymethylation Protect Neurons
   Against Cell Death After Injury by Increasing Expression of Genes
   Involved in Cell Survival
SO WORLD NEUROSURGERY
LA English
DT Article
DE Azacytidine; BDNF; Neurons; Spinal cord injury; Tet1
ID METHYLATION; APOPTOSIS; 5-METHYLCYTOSINE; INHIBITION; CONVERSION
AB BACKGROUND: Spinal cord and neuron injury result in loss of muscle function, sensation, or autonomic function in the body. Tet1 produces 5-hydroxymethylcytosin. The conversion was proposed as the initial step of deoxyribonucleic acid demethylation in mammals. However, effects of Tet1 expression and hydroxymethylation status on neuron injury remain unclear. Therefore the current study was designed to explore effects of Tet1 expression and hydroxymethylation status on cell survival and gene expression after neuron injury.
   METHODS: Mouse models of spinal cord injury and cell model of neuron injury were created. Animals were sacrificed, and injured spinal cord tissue was harvested. Neuron-like cells were cultured after scratch injury. Hydroxymethylated deoxyribonucleic acid concentration was detected, and Tet1 expression was examined by qPCR. Neuron-like cells were divided into 3 groups: control, injury, and azacytidine + injury (before injury, cells were pretreated with azacytidine) groups. Culture supernatant was collected, and lactate dehydrogenase concentration was detected. Meanwhile, injured neuron-like cells were divided into 3 groups: negative control, Tet1 overexpression, and Tet1 interference. Relative expression of Tet1, BDNF, NTF3, A20, FLIP, HSP70, HSP90, HSP27, and Bcl2 in neuron-like cells was detected by qPCR. In addition, neuron-like cells were divided into 7 groups.
   RESULTS: Tet1 expression and deoxyribonucleic acid hydroxymethylation increased initially and decreased thereafter after neuron injury in both animal and cell models. Percentages of dead cells increased significantly in neuron-like cells after injury. The percentages of dead cells markedly decreased in injured neuron-like cells that were pretreated with azacytidine. The percentages of dead cells increased markedly in the Tet1 interference group and decreased significantly in the Tet1 overexpression group. Expression of Tet1, BDNF, A20, FLIP, HSP70, HSP90, and Bcl2 decreased significantly after injury. Azacytidine pretreatment in injured neuron-like cells markedly increased expression of Tet1, BDNF, NTF3, A20, FLIP, HSP70, HSP90, HSP27, and Bcl2. Moreover, Tet1 interference significantly decreased the expression of Tet1, BDNF, A20, FLIP, HSP70, and HSP90 in neuron-like cells, whereas Tet1 overexpression markedly increased the expression of Tet1, BDNF, NTF3, A20, FLIP, HSP70, HSP90, HSP27, and Bcl2. BDNF interference significantly increased percentages of dead cells after injury. BDNF interference also markedly decreased the protection of azacytidine and Tet1 overexpression against cell death.
   CONCLUSIONS: Tet1 overexpression and demethylation caused by azacytidine protect neurons against cell death after injury by increasing expression of genes involved in cell survival.
C1 [Wang, Yongxiang; Wang, Jingcheng; Wang, Hua; Feng, Xinmin; Tao, Yuping; Yang, Jiandong; Cai, Jun] Yangzhou Univ, Clin Med Coll, Dept Orthoped, Yangzhou, Jiangsu, Peoples R China.
   [Wang, Yongxiang; Wang, Jingcheng; Wang, Hua; Feng, Xinmin; Tao, Yuping; Yang, Jiandong; Cai, Jun] Northem Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China.
RP Wang, YX (reprint author), Yangzhou Univ, Clin Med Coll, Dept Orthoped, Yangzhou, Jiangsu, Peoples R China.; Wang, YX (reprint author), Northem Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China.
EM wyx918spine@163.com
OI FENG, Xinmin/0000-0001-9287-858X
FU Natural Science Foundation of Jiangsu ProvinceJiangsu Planned Projects
   for Postdoctoral Research FundsNatural Science Foundation of Jiangsu
   Province [BK20141281]; Special Foundation Project on the Prospective
   Study of Social Development in Jiangsu Province [BE2013911]; Jiangsu Six
   Categories of Talent Summit Fund [WSW-133]; Social Development of
   Science and Technology Research Project in Yangzhou [YZ2011082]; Jiangsu
   Province 333 Talent Project [BRA2016159]
FX This study was supported by grants from Natural Science Foundation of
   Jiangsu Province (BK20141281), Special Foundation Project on the
   Prospective Study of Social Development in Jiangsu Province (BE2013911),
   Jiangsu Six Categories of Talent Summit Fund (WSW-133), Social
   Development of Science and Technology Research Project in Yangzhou
   (YZ2011082), and Jiangsu Province 333 Talent Project (BRA2016159).
CR Beere HM, 2000, NAT CELL BIOL, V2, P469
   Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308
   Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011
   Eichinger S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193735
   Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617
   Fan AR, 2013, REPRODUCTION, V146, P569, DOI 10.1530/REP-13-0212
   Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410
   Hauke J, 2009, HUM MOL GENET, V18, P304, DOI 10.1093/hmg/ddn357
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597
   Jin CL, 2014, NUCLEIC ACIDS RES, V42, P6956, DOI 10.1093/nar/gku372
   JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006
   Mohsin SK, 2005, J CLIN ONCOL, V23, P2460, DOI 10.1200/JCO.2005.00.661
   Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018
   Nardone S, 2017, CEREB CORTEX, V27, P5739, DOI 10.1093/cercor/bhx250
   Navada SC, 2014, J CLIN INVEST, V124, P40, DOI 10.1172/JCI69739
   Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609
   Qi ZL, 2014, CELL SIGNAL, V26, P1616, DOI 10.1016/j.cellsig.2014.03.015
   Safa A. R., 2012, Experimental Oncology, V34, P176
   Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797
   Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   Tanaka T, 2018, MOL PHARMACOL, V93, P1, DOI 10.1124/mol.117.109553
   Verma N, 2018, NAT GENET, V50, P83, DOI 10.1038/s41588-017-0002-y
   Wen S, 2017, CANC LETT, V413, P35
   Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15
   Xia WY, 2017, MOL MED REP, V15, P1753, DOI 10.3892/mmr.2017.6209
   Yamada K, 2003, J PHARMACOL SCI, V91, P267
   Zhang J, 2016, CELL REP, V17, P2326, DOI 10.1016/j.celrep.2016.10.081
NR 32
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E713
EP E722
DI 10.1016/j.wneu.2019.02.133
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400088
PM 30849555
DA 2020-05-12
ER

PT J
AU Watanabe, T
   Uehara, H
   Takeishi, G
   Chuman, H
   Azuma, M
   Yokogami, K
   Hirai, T
   Takeshima, H
AF Watanabe, Takashi
   Uehara, Hisao
   Takeishi, Go
   Chuman, Hideki
   Azuma, Minako
   Yokogami, Kiyotaka
   Hirai, Toshinori
   Takeshima, Hideo
TI Characteristics of Preoperative Visual Disturbance and Visual Outcome
   After Endoscopic Endonasal Transsphenoidal Surgery for Nonfunctioning
   Pituitary Adenoma in Elderly Patients
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aged; Endonasal endoscopic approach; Pituitary neoplasms; Pituitary
   surgery; Visual acuity; Visual fields
ID SURGICAL-TREATMENT; TUBERCULUM SELLAE; IMPROVEMENT; DECOMPRESSION;
   MACROADENOMAS; MENINGIOMAS; RECOVERY; TUMORS
AB BACKGROUND: Pituitary adenomas in elderly patients may become more common as the population ages. Surgical benefits, especially for visual outcome, after endoscopic endonasal transsphenoidal surgery for pituitary adenomas remain to be elucidated. This retrospective analysis investigated clinical factors affecting visual outcome.
   METHODS: The study included 35 patients with nonfunctional pituitary adenomas who underwent surgery and were subdivided into elderly (>= 70 years old, n = 12) and younger (<70 years old, n = 23) groups for analysis. Clinical characteristics and preoperative and postoperative visual function evaluated using visual impairment score (VIS) were compared between groups.
   RESULTS: Mean age at diagnosis was 75.1 +/- 1.5 years in the elderly group and 55.5 +/- 2.0 years in the younger group. VIS was improved in 91% of elderly patients and 80% of younger patients, but postoperative VIS remained higher in elderly patients. Preoperative VIS and incidence of previous cataract surgery were significantly higher in elderly patients than in younger patients. Preoperative and postoperative VISs were significantly correlated with age. Preoperative VIS was significantly higher in patients with previous cataract surgery and correlated with postoperative VIS.
   CONCLUSIONS: Visual disturbances were improved postoperatively in most patients in both groups at similar rates, but preoperative and postoperative visual disturbances were more severe in elderly patients because the symptoms may have been masked by the presence of lens opacity. Early diagnosis and intervention may be required in elderly patients for better visual outcome.
C1 [Watanabe, Takashi; Uehara, Hisao; Takeishi, Go; Yokogami, Kiyotaka; Takeshima, Hideo] Univ Miyazaki, Fac Med, Dept Neurosurg, Miyazaki, Japan.
   [Chuman, Hideki] Univ Miyazaki, Fac Med, Dept Ophthalmol, Miyazaki, Japan.
   [Azuma, Minako; Hirai, Toshinori] Univ Miyazaki, Fac Med, Dept Radiol, Miyazaki, Japan.
RP Watanabe, T (reprint author), Univ Miyazaki, Fac Med, Dept Neurosurg, Miyazaki, Japan.
EM takashi_watanabe@med.miyazaki-u.ac.jp
CR Anik I, 2018, WORLD NEUROSURG, V112, pE691, DOI 10.1016/j.wneu.2018.01.134
   [Anonymous], 2017, Neurol Med Chir (Tokyo), V57, P9, DOI 10.2176/nmc.sup.2017-0001
   Barzaghi LR, 2012, NEUROSURG REV, V35, P369, DOI 10.1007/s10143-011-0365-y
   Chinezu R, 2017, WORLD NEUROSURG, V106, P315, DOI [10.1016/J.WNEU.2017.06.151, 10.1016/j.wneu.2017.06.151]
   Dekkers OM, 2007, PITUITARY, V10, P61, DOI 10.1007/s11102-007-0007-0
   DELELLIS RA, 2004, PATHOLOGY GENETICS T
   Fahlbusch R, 2002, J NEUROSURG, V96, P235, DOI 10.3171/jns.2002.96.2.0235
   Ferrante L, 2002, J NEURO-ONCOL, V60, P185, DOI 10.1023/A:1020652604014
   Freda PU, 2010, NAT REV ENDOCRINOL, V6, P606, DOI 10.1038/nrendo.2010.170
   Fujimoto Kenji, 2017, Surg Neurol Int, V8, P213, DOI 10.4103/sni.sni_189_17
   Gnanalingham KK, 2005, J NEUROL NEUROSUR PS, V76, P415, DOI 10.1136/jnnp.2004.035576
   Golozar A, 2018, JAMA OPHTHALMOL, V136, P514, DOI 10.1001/jamaophthalmol.2018.0786
   Gondim JA, 2015, J NEUROSURG, V123, P31, DOI 10.3171/2014.10.JNS14372
   Grossman R, 2010, CLIN ENDOCRINOL, V73, P361, DOI 10.1111/j.1365-2265.2010.03813.x
   Hong JF, 2008, J CLIN NEUROSCI, V15, P1091, DOI 10.1016/j.jocn.2007.11.003
   Jakobsson KE, 2002, ACTA OPHTHALMOL SCAN, V80, P512, DOI 10.1034/j.1600-0420.2002.800510.x
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P813, DOI 10.1016/S0002-9394(00)00539-0
   Kurosaki M, 2000, NEUROSURGERY, V47, P843, DOI 10.1097/00006123-200010000-00009
   LAWS ER, 1977, J NEUROSURG, V46, P717, DOI 10.3171/jns.1977.46.6.0717
   Lilja Y, 2017, J NEUROSURG, V127, P569, DOI 10.3171/2016.8.JNS161290
   Luomaranta T, 2017, WORLD NEUROSURG, V105, P422, DOI 10.1016/j.wneu.2017.05.144
   Marenco HA, 2015, ARQ NEURO-PSIQUIAT, V73, P764, DOI 10.1590/0004-282X20150112
   Ministry of Internal Affairs and Communications of Japan, POP ADV AG
   Miyata K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192677
   Musluman AM, 2011, WORLD NEUROSURG, V76, P141, DOI 10.1016/j.wneu.2011.02.009
   Nakamura M, 2006, NEUROSURGERY, V59, P1019, DOI 10.1227/01.NEU.0000245600.92322.06
   Nakao N, 2011, J CLIN NEUROSCI, V18, P71, DOI 10.1016/j.jocn.2010.04.049
   PETER M, 1995, BRIT J NEUROSURG, V9, P151, DOI 10.1080/02688699550041485
   POWELL M, 1995, BRIT J NEUROSURG, V9, P367, DOI 10.1080/02688699550041377
   Robenshtok E, 2014, ENDOCR PRACT, V20, P159, DOI 10.4158/EP13182.OR
   Sasaki H, 2000, OPHTHALMOLOGICA, V214, P412, DOI 10.1159/000027535
   SMITH KJ, 1981, BRAIN, V104, P383, DOI 10.1093/brain/104.2.383
   Turner HE, 1999, EUR J ENDOCRINOL, V140, P383, DOI 10.1530/eje.0.1400383
   Wilson PJ, 2018, J NEUROSURG, V128, P429, DOI 10.3171/2016.11.JNS162286
NR 34
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E706
EP E712
DI 10.1016/j.wneu.2019.02.132
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400087
PM 30849556
DA 2020-05-12
ER

PT J
AU Wei, LX
   Cao, P
   Xu, C
   Wu, HQ
   Hua, DF
   Tian, Y
   Yuan, W
AF Wei, Leixin
   Cao, Peng
   Xu, Chen
   Wu, Huiqiao
   Hua, Dongfang
   Tian, Ye
   Yuan, Wen
TI Comparison of Three Anterior Techniques in the Surgical Treatment of
   Three-Level Cervical Spondylotic Myelopathy with Intramedullary
   T2-Weighted Increased Signal Intensity
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior cervical corpectomy and fusion; Anterior cervical discectomy
   and fusion; Cervical spondylotic myelopathy; Hybrid decompression and
   fusion; Increased signal intensity
ID RECONSTRUCTIVE TECHNIQUES; SPINAL-CORD; COMPRESSION; DISKECTOMY;
   CORPECTOMY; MANAGEMENT; FUSION; DECOMPRESSION; FIXATION; MRI
AB OBJECTIVE: To compare the clinical and radiologic outcomes of 3 anterior surgical techniques for the treatment of 3-level cervical spondylotic myelopathy (CSM) and the evolution of intramedullary T2-weighted increased signal intensity (ISI).
   METHODS: A total of 98 consecutive patients (61 males, 37 females) with 3-level CSM who underwent anterior cervical surgery between January 2006 and January 2016 were retrospectively enrolled. Based on different anterior reconstructive techniques, the patients were divided into 3 groups: anterior cervical discectomy and fusion (ACDF), anterior cervical corpectomy and fusion (ACCF), and hybrid decompression and fusion (HDF) groups. The Japanese Orthopaedic Association score and its recovery rate were used to evaluate the clinical outcomes. The cervical alignment and range of motion were used to assess radiologic outcomes. In addition, the signal change ratio and length of ISI were used to measure the ISI.
   RESULTS: No statistical differences in preoperative factors were found among the 3 groups (P > 0.05). Although the HDF group had intermediate surgery time and blood loss compared with other groups (P < 0.05), it achieved greater postoperative Japanese Orthopaedic Association score and recovery rate than other groups (P < 0.05). The postoperative C2-C7 lordotic angle and postoperative range of motion in the HDF group were similar to that in the ACDF group (P > 0.05), both greater than that in the ACCF group (P < 0.05). The incidence of complications in the HDF group was close to the ACDF group (P > 0.05), and both groups were lower than that in the ACCF group (P < 0.05). In addition, the postoperative signal change ratio in the HDF group was lower than in other groups (P < 0.05). The postoperative length of ISI in the HDF group was similar to the ACCF group (P > 0.05), which was both shorter than that in the ACDF group (P < 0.05).
   CONCLUSIONS: For patients with 3-level CSM with ISI on T2-weighted MRI, HDF can be considered as the optimal technique that achieves better clinical and radiologic outcomes than the ACDF or ACCF procedure. HDF also has a better postoperative regression of ISI compared with the ACDF or ACCF procedure, which may potentially be an important indicator for improving surgical outcomes.
C1 [Wei, Leixin; Cao, Peng; Xu, Chen; Wu, Huiqiao; Hua, Dongfang; Tian, Ye; Yuan, Wen] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Orthopaed, Shanghai, Peoples R China.
RP Yuan, W (reprint author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Orthopaed, Shanghai, Peoples R China.
EM smmuyuanwen@126.com
FU Science and Technology Commission of Shanghai MunicipalityScience &
   Technology Commission of Shanghai Municipality (STCSM) [17140901500]
FX This study was supported by Science and Technology Commission of
   Shanghai Municipality (No. 17140901500).
CR Ashkenazi E, 2005, J NEUROSURG-SPINE, V3, P205, DOI 10.3171/spi.2005.3.3.0205
   Bolesta MJ, 2000, SPINE, V25, P2040, DOI 10.1097/00007632-200008150-00007
   Bolesta MJ, 2000, SPINE, V25, P2045
   de Rota JJF, 2007, J NEUROSURG-SPINE, V6, P17, DOI 10.3171/spi.2007.6.1.4
   Emery SE, 2015, EUR SPINE J, V24, pS150, DOI 10.1007/s00586-015-3784-6
   Hillard Virany H, 2006, Spine J, V6, p242S, DOI 10.1016/j.spinee.2006.05.005
   HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005
   Hwang SL, 2007, J SPINAL DISORD TECH, V20, P565, DOI 10.1097/BSD.0b013e318036b463
   Kato S, 2018, SPINE, V43, P824, DOI 10.1097/BRS.0000000000002426
   Li FN, 2011, J CLIN NEUROSCI, V18, P1592, DOI 10.1016/j.jocn.2011.04.019
   Li Z, 2017, SPINE, V42, pE575, DOI 10.1097/BRS.0000000000001907
   Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9
   Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4
   Machino M, 2018, SPINE, V43, P1595, DOI 10.1097/BRS.0000000000002674
   Machino M, 2018, SPINE, V43, P420, DOI 10.1097/BRS.0000000000002328
   Machino M, 2012, SPINE, V37, pE1243, DOI 10.1097/BRS.0b013e3182659d3e
   Mizuno J, 2003, J NEUROSURG, V99, P162, DOI 10.3171/spi.2003.99.2.0162
   OKADA Y, 1993, SPINE, V18, P2024, DOI 10.1097/00007632-199310001-00016
   Singh K, 2004, SPINE, V29, P845, DOI 10.1097/00007632-200404150-00005
   Song KJ, 2012, EUR SPINE J, V21, P1551, DOI 10.1007/s00586-012-2296-x
   Stewart TJ, 2007, NEUROSURGERY, V60, P143, DOI 10.1227/01.NEU.0000217015.96212.1B
   TAKAHASHI M, 1989, RADIOLOGY, V173, P219, DOI 10.1148/radiology.173.1.2781011
   TAKAHASHI M, 1987, NEURORADIOLOGY, V29, P550, DOI 10.1007/BF00350439
   WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009
   Wei LX, 2018, WORLD NEUROSURG, V118, pE505, DOI 10.1016/j.wneu.2018.06.224
   Wei LX, 2018, WORLD NEUROSURG, V112, pE520, DOI 10.1016/j.wneu.2018.01.071
   Xu WB, 2009, J SPINAL DISORD TECH, V22, P511, DOI 10.1097/BSD.0b013e3181a6a1fa
   YONE K, 1992, SPINE, V17, pS388, DOI 10.1097/00007632-199210001-00008
   Yukawa Y, 2007, SPINE, V32, P1675, DOI 10.1097/BRS.0b013e318074d62e
   Zhang JT, 2015, EUR SPINE J, V24, P2941, DOI 10.1007/s00586-015-4109-5
   Zhang Y, 2007, SPINE, V32, P1482, DOI 10.1097/BRS.0b013e318068b30a
NR 31
TC 3
Z9 3
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E842
EP E852
DI 10.1016/j.wneu.2019.02.182
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400105
PM 30862596
DA 2020-05-12
ER

PT J
AU Wei, XH
   Chang, TJ
   Shen, HC
AF Wei, Xinhua
   Chang, Tianjing
   Shen, Huicong
TI Radiologic Features of Primary Intracranial Myxomas from the Skull Base:
   14 Case Reports and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Computed tomography; Magnetic resonance imaging; Myxomas; Skull base
AB BACKGROUND: Primary intracranial myxomas (PIMs) are extremely rare benign tumors that arise from the skull base. The aim of this study was to characterize the radiologic manifestation of PIMs in a series of 14 cases.
   METHODS: We reviewed the imaging and clinical data of 14 patients with pathologically proven PIMs. Assessed features of lesions include shape, margin, bony destruction, attenuation and/or signal intensity, and pattern of enhancement.
   RESULTS: Extremely high-density foci indicating calcification or bony debris within the tumors were observed in 5 cases on computed tomography images. On magnetic resonance images, the tumors demonstrated heterogeneous hypointensity on T1-weighted images (T1WI) and hyperintensity on T2-weighted images (T2WI). A honeycomb pattern on enhanced T1WIs was observed in 63.6% (7/11) of the cases.
   CONCLUSIONS: Radiologic findings of PIMs include calcified foci or bone debris on computed tomography, heterogeneous hypointensity on T1WI and predominantly hyperintensity on T2WI, and honeycomb appearance on enhanced T1WI.
C1 [Wei, Xinhua] South China Univ Technol, Affiliated Hosp 2, Guangzhou Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China.
   [Chang, Tianjing; Shen, Huicong] Capital Med Univ, Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China.
RP Shen, HC (reprint author), Capital Med Univ, Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China.
EM bjttyyshc@126.com
CR Andrews T, 2000, AM J OTOLARYNG, V21, P184, DOI 10.1016/S0196-0709(00)85022-X
   ATAMAN M, 1993, INT J PEDIATR OTORHI, V27, P183, DOI 10.1016/0165-5876(93)90134-O
   BATSAKIS JG, 1987, ANN OTO RHINOL LARYN, V96, P618, DOI 10.1177/000348948709600527
   Bingaman KD, 2000, NEUROSURGERY, V46, P207
   DeFatta RJ, 2006, OTOLARYNG HEAD NECK, V134, P931, DOI 10.1016/j.otohns.2006.02.008
   Hamilton JD, 2011, AM J NEURORADIOL, V32, P1212, DOI 10.3174/ajnr.A2471
   KLEIN MV, 1990, NEURORADIOLOGY, V32, P250, DOI 10.1007/BF00589124
   Liu A, 1996, J CLIN NEUROSCI, V3, P29, DOI 10.1016/S0967-5868(96)90080-6
   Menon RK, 2008, J NEURO-ONCOL, V88, P157, DOI 10.1007/s11060-008-9555-z
   Moore BA, 2008, OCHSNER J, V8, P166
   Mueller OM, 2010, CHILD NERV SYST, V26, P829, DOI 10.1007/s00381-009-1046-9
   Oruckaptan HH, 2010, TURK NEUROSURG, V20, P86
   Osterdock RJ, 2001, NEUROSURGERY, V48, P945, DOI 10.1097/00006123-200104000-00055
   Sato H, 2004, OTOLARYNG HEAD NECK, V130, P378, DOI 10.1016/S0194-5998(03)01594-8
   Virchow R, 1871, CELLULARPATHOLOGIE I, P53
   Windfuhr JP, 2004, LARYNGOSCOPE, V114, P249, DOI 10.1097/00005537-200402000-00014
   Yin H, 2007, ACTA NEUROCHIR, V149, P713, DOI 10.1007/s00701-007-1225-y
   Zhang LW, 2007, SURG NEUROL, V68, P22, DOI 10.1016/j.sumeu.2007.09.015
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E77
EP E83
DI 10.1016/j.wneu.2019.01.174
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400011
PM 30738938
DA 2020-05-12
ER

PT J
AU Westbroek, EM
   Ahmed, AK
   Pennington, Z
   Goodwin, ML
   Xia, YX
   Boone, C
   Gailloud, P
   Sciubba, DM
AF Westbroek, Erick M.
   Ahmed, A. Karim
   Pennington, Zach
   Goodwin, Matthew L.
   Xia, Yuanxuan
   Boone, Christine
   Gailloud, Philippe
   Sciubba, Daniel M.
TI Hypervascular Metastatic Spine Tumor Angiographic Relationships with the
   Artery of Adamkiewicz and Other Radiculomedullary Arteries
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hypervascular metastases; Preoperative embolization; Spine oncology;
   Vascular anatomy
ID PREOPERATIVE EMBOLIZATION; CORD COMPRESSION; CANCER; BREAST
AB BACKGROUND: Preoperative endovascular embolization of hypervascular metastatic spine tumors can reduce intraoperative blood loss. One frequent objection to embolizing these tumors is the concern for associated arteries feeding the spinal cord, such as the artery of Adamkiewicz. This study aimed to elucidate a relationship between spinal levels affected by hypervascular spine metastases and associated radiculomedullary arteries (RMAs).
   METHODS: A retrospective review of 46 patients who underwent preoperative embolization of hypervascular metastatic spine tumors was conducted. A total of 484 spinal levels were evaluated by diagnostic spinal angiography during embolization procedures. Each spinal level was categorized based on the presence or absence of tumor and RMA.
   RESULTS: No statistically significant associations were found. The relative risk of affected spinal levels having an associated RMA was 1.10 (95% confidence interval, 0.66-1.85). The attributable risk was 0.01 (-0.01 to 0.02). Chi-squared statistic was 0.13, with a P value of 0.7. Sub-group analysis in renal cell patients was also statistically insignificant, with a relative risk of 0.97 (95% confidence interval, 0.43-2.16). Chi-square statistic was 0.01, with a P value 0.94. A total of 32 patients (69.6%) had an RMA identified on their regional angiogram. Seventeen patients (37%) had an RMA at an embolized level.
   CONCLUSIONS: In this study, no association was found between spinal levels affected by hypervascular metastatic spine tumors and RMAs feeding the spinal cord by diagnostic spinal angiography. This suggests that these tumors have little intrinsic affinity for spinal levels with an RMA. However, given that tumor embolization frequently requires accessing multiple levels, the risk of encountering an RMA during embolization remains significant.
C1 [Westbroek, Erick M.; Ahmed, A. Karim; Pennington, Zach; Goodwin, Matthew L.; Xia, Yuanxuan; Sciubba, Daniel M.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
   [Gailloud, Philippe] Johns Hopkins Univ, Sch Med, Div Intervent Neuroradiol, Baltimore, MD USA.
   [Boone, Christine] Univ Calif San Diego, Sch Med, Div Intervent Radiol, La Jolla, CA 92093 USA.
RP Westbroek, EM (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.
EM erickw@jhmi.edu
OI Boone, Christine/0000-0002-7204-8666; Pennington,
   Zachary/0000-0001-8012-860X
CR Ahmed AK, 2018, SPINE J, V18, P1804, DOI 10.1016/j.spinee.2018.03.011
   Bell GR, 1997, CLIN ORTHOP RELAT R, P54
   Bilsky M H, 1999, Oncologist, V4, P459
   COBB CA, 1977, J NEUROSURG, V47, P653, DOI 10.3171/jns.1977.47.5.0653
   Gokaslan ZL, 1998, J NEUROSURG, V89, P599, DOI 10.3171/jns.1998.89.4.0599
   GRUNDY BL, 1982, CAN ANAESTH SOC J, V29, P452, DOI 10.1007/BF03009408
   Guzman R, 2005, EUR SPINE J, V14, P263, DOI 10.1007/s00586-004-0757-6
   Hong CG, 2017, WORLD J SURG ONCOL, V15, P1, DOI 10.1186/s12957-017-1118-3
   Kato S, 2013, SPINE, V38, P1964, DOI 10.1097/BRS.0b013e3182a46576
   Khanna A Jay, 2005, Am J Orthop (Belle Mead NJ), V34, P472
   Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037
   Lenz M, 1931, ANN SURG, V93, P278, DOI 10.1097/00000658-193101000-00036
   Luksanapruksa P, 2018, J NEUROINTERV SURG, V10, P596, DOI 10.1136/neurintsurg-2017-013350
   Nair S, 2013, INTERV NEURORADIOL, V19, P377, DOI 10.1177/159101991301900317
   Ozkan E, 2011, TECH VASC INTERV RAD, V14, P129, DOI 10.1053/j.tvir.2011.02.005
   Brufau BP, 2013, RADIOGRAPHICS, V33, P1691, DOI 10.1148/rg.336125110
   Prabhu VC, 2003, J NEUROSURG, V98, P156, DOI 10.3171/spi.2003.98.2.0156
   Sciubba DM, 2010, J NEUROSURG-SPINE, V13, P94, DOI 10.3171/2010.3.SPINE09202
   SUNDARESAN N, 1986, J CLIN ONCOL, V4, P1851, DOI 10.1200/JCO.1986.4.12.1851
   SUNDARESAN N, 1991, NEUROSURGERY, V29, P645, DOI 10.1227/00006123-199111000-00001
   ter Gunne AFP, 2009, SPINE, V34, P1422, DOI 10.1097/BRS.0b013e3181a03013
   Walsh GL, 1997, ANN THORAC SURG, V64, P1611, DOI 10.1016/S0003-4975(97)01034-5
   Wright E, 2018, WORLD NEUROSURG, V114, pE809, DOI 10.1016/j.wneu.2018.03.091
   Yuh WTC, 1996, SPINE, V21, P2243, DOI 10.1097/00007632-199610010-00012
   Zaborovskii Nikita, 2018, Eur J Orthop Surg Traumatol, V28, P1047, DOI 10.1007/s00590-018-2162-6
NR 25
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E480
EP E485
DI 10.1016/j.wneu.2019.02.075
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400057
PM 30825630
DA 2020-05-12
ER

PT J
AU White, MD
   Agarwal, N
   Tonetti, DA
AF White, Michael D.
   Agarwal, Nitin
   Tonetti, Daniel A.
TI The Utility of Whole Body Imaging in the Evaluation of Solitary Brain
   Tumors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain metastasis; Brain tumor; Solitary tumor; Whole body CT
ID STEREOTACTIC RADIOSURGERY; METASTASIS; DIFFERENTIATION; GLIOBLASTOMAS;
   MANAGEMENT
AB BACKGROUND: Solitary brain tumors can propose a diagnostic dilemma owing to the difficulty in differentiating between primary brain tumors and metastatic disease. The similar radiologic appearance on routine magnetic resonance imaging will necessitate the need for additional noninvasive testing. We sought to determine the clinical utility of preoperative whole body screening with computed tomography (CT) to detect metastatic disease in patients with solitary brain tumors.
   METHODS: A prospectively maintained surgical database for a large quaternary care academic institution was retrospectively reviewed for all patients undergoing craniotomy for a new diagnosis of enhancing solitary brain lesion from January 2011 to January 2016. Patients were excluded if the imaging findings had demonstrated multiple brain tumors, they had a known diagnosis of malignancy, or they had undergone previous craniotomy. The demographic and radiographic information and clinical and histopathologic data were collected and tallied.
   RESULTS: A total of 218 patients with solitary brain tumors met the inclusion criteria and were included in the present study. Histopathologic analysis confirmed primary central nervous system tumors in 152 patients (74.4%) and metastatic disease in 66 (25.6%). Preoperative screening with whole body CT had a sensitivity of 0.92 and specificity of 0.95 for detecting systemic metastases in the patients. Preoperative whole body CT correctly identified systemic malignancy in 88% of the patients ultimately diagnosed with metastasis (positive predictive value, 88%). Of those with negative whole body imaging findings, 97% had a diagnosis of a primary central nervous system neoplasm (negative predictive value, 97%).
   CONCLUSIONS: Preoperative whole body CT had a positive predictive value of 88% and negative predictive value of 97% in the present study and was both sensitive (92%) and specific (95%) for the detection of extracranial tumors. The identification of extracranial tumors on whole body CT screening might alter management.
C1 [White, Michael D.; Agarwal, Nitin; Tonetti, Daniel A.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15261 USA.
RP Tonetti, DA (reprint author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15261 USA.
EM tonettida@upmc.odu
RI Tonetti, Daniel/AAB-1158-2020
OI Tonetti, Daniel/0000-0002-9258-1820; White, Michael/0000-0002-6291-3943;
   Agarwal, Nitin/0000-0003-0256-3897
CR Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007
   Boyd TS, 1999, ONCOLOGY-NY, V13, P1397
   Boyd TS, 1999, ONCOLOGY WILLISTON P, V13, P1409
   Boyd TS, 1999, ONCOLOGY WILLISTON P, V13, P1310
   BOYD TS, 1999, ONCOLOGY WILLISTON P, V13, P1413
   Bulakbasi N, 2005, AM J NEURORADIOL, V26, P2187
   Campos S, 2009, CURR ONCOL, V16, P62
   Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484
   Dong H, 2016, ACAD RADIOL, V23, P600, DOI 10.1016/j.acra.2015.12.024
   Lassman AB, 2003, NEUROL CLIN, V21, P1, DOI 10.1016/S0733-8619(02)00035-X
   Lefranc F, 2006, EXPERT REV ANTICANC, V6, P719, DOI 10.1586/14737140.6.5.719
   Neska-Matuszewska M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191341
   Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479
   Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1
   Qin H, 2015, MED SCI MONITOR, V21, P144, DOI 10.12659/MSM.892405
   Schwartz KM, 2006, NEURORADIOLOGY, V48, P143, DOI 10.1007/s00234-005-0024-5
   She DJ, 2019, J COMPUT ASSIST TOMO, V43, P13, DOI 10.1097/RCT.0000000000000771
   Soffietti R, 2002, J NEUROL, V249, P1357, DOI 10.1007/s00415-002-0870-6
   Wang S, 2014, AM J NEURORADIOL, V35, P928, DOI 10.3174/ajnr.A3871
   Wang SM, 2009, NEUROIMAGE, V44, P653, DOI 10.1016/j.neuroimage.2008.09.027
NR 20
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1206
EP E1210
DI 10.1016/j.wneu.2019.02.228
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400151
PM 30885857
DA 2020-05-12
ER

PT J
AU White, SJW
   Carrillo, O
   Cheung, ZB
   Ranson, WA
   Cho, SKW
AF White, Samuel J. W.
   Carrillo, Oscar
   Cheung, Zoe B.
   Ranson, William A.
   Cho, Samuel Kang-Wook
TI The Effects of Preoperative Steroid Therapy on Perioperative
   Complications After Elective Anterior Lumbar Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE ACS-NSQIP; Anterior lumbar fusion; Complications; Corticosteroid;
   Glucocorticoid
ID SURGICAL QUALITY IMPROVEMENT; INFECTIOUS COMPLICATIONS; ALVEOLAR
   MACROPHAGES; PULMONARY-DISEASE; SITE INFECTIONS; ILIAC ARTERY;
   RISK-FACTORS; OUTCOMES; PROGRAM; SURGERY
AB OBJECTIVE: To examine the effects of chronic preoperative steroid therapy on 30-day perioperative complications after anterior lumbar fusion (ALF).
   METHODS: We retrospectively analyzed data from the American College of Surgeons National Surgical Quality Improvement Program between 2008 and 2015. Adult patients who underwent ALF were included and divided into 2 groups: steroids and no steroids. We compared baseline patient demographics, comorbidities, and operative variables between these 2 groups and then performed a multivariate regression analysis to determine complications that were independently associated with chronic steroid therapy. We also performed a subgroup analysis of the steroid group to identify additional risk factors that further predispose these patients to postoperative complications.
   RESULTS: A total of 9483 patients were included, of whom 289 (3.0%) were on chronic steroid therapy. Univariate analysis showed that chronic steroid use was independently associated with 4 perioperative complications, including deep surgical site infection (odds ratio [OR], 2.78; confidence interval [CI], 1.09-7.10; P = 0.033), pulmonary complications (OR, 1.98; CI, 1.02-3.86; P = 0.044), blood transfusion (OR, 1.60; CI, 1.15-2.23; P = 0.005), and extended length of stay (OR, 1.58; CI, 1.17-2.16; P = 0.003). In patients on chronic steroid therapy, pulmonary comorbidity and extended operative time were additional risk factors that further predisposed to perioperative complications, including deep surgical site infection, blood transfusion, and extended length of stay.
   CONCLUSIONS: Chronic preoperative steroid therapy is associated with perioperative complications after ALF. Decisions about the discontinuing or holding steroid therapy preoperatively should be determined through an interdisciplinary approach between the medical and surgical teams.
C1 [White, Samuel J. W.; Carrillo, Oscar; Cheung, Zoe B.; Ranson, William A.; Cho, Samuel Kang-Wook] Icahn Sch Med Mt Sinai, Dept Orthopaed Surg, New York, NY 10029 USA.
RP Cho, SKW (reprint author), Icahn Sch Med Mt Sinai, Dept Orthopaed Surg, New York, NY 10029 USA.
EM samuel.cho@mountsinai.org
RI Cheung, Zoe/AAG-4511-2020
OI Cheung, Zoe/0000-0002-0189-5390
CR Abt NB, 2016, CLIN NEUROL NEUROSUR, V143, P126, DOI 10.1016/j.clineuro.2016.02.024
   Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684
   BAKER JK, 1993, SPINE, V18, P2227, DOI 10.1097/00007632-199311000-00014
   Ballard JL, 2014, ANN VASC SURG, V28, P465, DOI 10.1016/j.avsg.2013.06.026
   Baschant U, 2013, MOL CELL ENDOCRINOL, V380, P108, DOI 10.1016/j.mce.2013.06.009
   BLACKWOOD LL, 1982, AM REV RESPIR DIS, V126, P1045
   Bronheim RS, 2017, GLOB SPINE J, V7, P762, DOI 10.1177/2192568217696691
   Cheng H, 2017, SURG INFECT, V18, P722, DOI 10.1089/sur.2017.089
   Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013
   Cornella N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09833-7
   Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005
   Czarnetzki C, 2008, JAMA-J AM MED ASSOC, V300, P2621, DOI 10.1001/jama.2008.794
   Del Prado P, 2014, OBES SURG, V24, P584, DOI 10.1007/s11695-013-1122-9
   Dunn G, 2015, AM J SURG, V210, P1009
   Fields AC, 2016, SURGERY, V159, P1210, DOI 10.1016/j.surg.2015.11.007
   Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011
   FRASER CG, 1952, JAMA-J AM MED ASSOC, V149, P1542, DOI 10.1001/jama.1952.72930340001009
   Fritzell P, 2002, SPINE, V27, P1131, DOI 10.1097/00007632-200206010-00002
   GREAVES MW, 1976, POSTGRAD MED J, V52, P631, DOI 10.1136/pgmj.52.612.631
   Hardy KL, 2014, AESTHET SURG J, V34, P614, DOI 10.1177/1090820X14528503
   Hegde V, 2012, WORLD J ORTHOP, V3, P182, DOI 10.5312/wjo.v3.i11.182
   Hooten Joanna N, 2014, Skin Therapy Lett, V19, P1
   Hrabalek L, 2014, BIOMED PAP, V158, P127, DOI 10.5507/bp.2012.079
   HUNNINGHAKE GW, 1977, J IMMUNOL, V118, P146
   Ismael H, 2011, AM J SURG, V201, P305, DOI 10.1016/j.amjsurg.2010.09.018
   JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U
   JORGENSEN KA, 1982, ACTA HAEMATOL-BASEL, V68, P39
   Kantar RS, 2015, EUR J INTERN MED, V26, P528, DOI 10.1016/j.ejim.2015.06.005
   Karhade AV, 2017, WORLD NEUROSURG, V97, P205, DOI 10.1016/j.wneu.2016.09.056
   Karhade AV, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.5.FOCUS16168
   Kerolus M, 2016, EXPERT REV MED DEVIC, V13, P1127, DOI 10.1080/17434440.2016.1254039
   Khazim R, 1998, Eur Spine J, V7, P239, DOI 10.1007/s005860050064
   Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006
   Kim W, 2008, ANN SURG, V248, P793, DOI 10.1097/SLA.0b013e3181887516
   LEWIS L, 1953, ANN INTERN MED, V39, P116, DOI 10.7326/0003-4819-39-1-116
   Lieber B, 2016, WORLD NEUROSURG, V89, P517, DOI 10.1016/j.wneu.2015.12.085
   Lin SH, 2013, INT J TUBERC LUNG D, V17, P1638, DOI 10.5588/ijtld.13.0330
   LIVANOU T, 1967, LANCET, V2, P856
   Lubelski Daniel, 2017, CNS Oncol, DOI 10.2217/cns-2016-0048
   Luijten RKMAC, 2013, AUTOIMMUN REV, V12, P617, DOI 10.1016/j.autrev.2012.12.001
   Manian FA, 2003, CLIN INFECT DIS, V36, P863, DOI 10.1086/368195
   Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87
   MARSICANO J, 1994, SPINE, V19, P357, DOI 10.1097/00007632-199402000-00019
   Mathie SA, 2015, ALLERGY, V70, P80, DOI 10.1111/all.12536
   McAlister RK, 2019, J ONCOL PHARM PRACT, V25, P706, DOI 10.1177/1078155217750463
   McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435
   Merkler AE, 2014, NEUROHOSPITALIST, V4, P80, DOI 10.1177/1941874413510920
   Moghadamyeghaneh Z, 2015, AM J SURG, V210, P1003, DOI 10.1016/j.amjsurg.2015.07.002
   Molina CS, 2015, CLIN ORTHOP RELAT R, V473, P1574, DOI 10.1007/s11999-014-3597-7
   Narum S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004587
   Nguyen GC, 2014, J CROHNS COLITIS, V8, P1661, DOI 10.1016/j.crohns.2014.07.007
   Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515
   Patel H, 2017, SURG INFECT, V18, P461, DOI 10.1089/sur.2016.186
   PENNINGTON JE, 1981, AM REV RESPIR DIS, V123, P299
   Quraishi NA, 2013, EUR SPINE J, V22, pS16, DOI 10.1007/s00586-012-2616-1
   Raskas DS, 1997, CLIN ORTHOP RELAT R, P86
   Rowell KS, 2007, J AM COLL SURGEONS, V204, P1293, DOI 10.1016/j.jamcollsurg.2007.03.024
   Rubins JB, 2003, AM J RESP CRIT CARE, V167, P103, DOI 10.1164/rccm.2210007
   Sassoon CSH, 2011, MUSCLE NERVE, V43, P103, DOI 10.1002/mus.21821
   Snider JT, 2012, CURR MED RES OPIN, V28, P1959, DOI 10.1185/03007995.2012.743459
   STUCK AE, 1989, REV INFECT DIS, V11, P954
   Subramanian V, 2008, AM J GASTROENTEROL, V103, P2373, DOI 10.1111/j.1572-0241.2008.01942.x
   Supinski GS, 2015, PHYSIOLOGY, V30, P336, DOI 10.1152/physiol.00025.2015
   Valizadeh N, 2017, TECH COLOPROCTOL, V21, P217, DOI 10.1007/s10151-017-1591-2
   van der Goes MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4686
   VANGIEZEN JJJ, 1994, BLOOD COAGUL FIBRIN, V5, P249, DOI 10.1097/00001721-199404000-00015
   Wagner ER, 2015, J HAND SURG-AM, V40, P224, DOI 10.1016/j.jhsa.2014.10.032
   Yawn BP, 2013, INT J CHRONIC OBSTR, V8, P295, DOI 10.2147/COPD.S42366
NR 68
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E314
EP E322
DI 10.1016/j.wneu.2019.02.048
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400037
PM 30822580
DA 2020-05-12
ER

PT J
AU Worm, PV
   Finger, G
   Brasil, AVB
   Teles, AR
AF Worm, Paulo Valdeci
   Finger, Guilherme
   Berthier Brasil, Albert Vincent
   Teles, Alisson Roberto
TI Postoperative Supine Position Increases the Risk of Infection After
   Spinal Surgery by Posterior Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE Decubitus; Spinal surgery; Supine position; Surgical site infection;
   Surgical wound infection
ID SURGICAL SITE INFECTION; WOUND-INFECTION; FUSION; DISEASE
AB BACKGROUND: Spine surgeries performed via the posterior approach have a higher infection rate. Several theories have been proposed, including poor hygienic condition of bed sheets and traumatized muscle associated with supine position promoting circulatory impairment. We investigated the influence of supine position on the rate of deep wound infection after spine surgery by the posterior approach.
   METHODS: A total of 106 patients were randomly divided into 2 groups: lateral decubitus only versus dorsal and lateral decubitus. Patient follow-up after hospital discharge was performed at 30, 60, 180, and 360 days. Deep wound infection was diagnosed according to U.S. Centers for Disease Control and Prevention criteria.
   RESULTS: Patient sample was mainly composed of patients with neoplastic disease and patients with trauma. Postoperative wound infection developed in 12 cases (11.3%), and Streptococcus aureus was the most common pathogen. Incidence of postsurgical deep wound infection was significantly greater in the control group (P = 0.004).
   CONCLUSIONS: Supine position was significantly correlated with higher rates of wound infection among patients who underwent spine surgery by the posterior approach. Avoidance of supine position may represent a modifiable risk factor to diminish postoperative spine infection rates.
C1 [Worm, Paulo Valdeci; Berthier Brasil, Albert Vincent] Complexo Hosp Santa Casa Porto Alegre, Hosp Sao Jose, Dept Neurol Surg, Porto Alegre, RS, Brazil.
   [Worm, Paulo Valdeci; Finger, Guilherme] Cristo Redentor Hosp, Neurosurg Dept, Porto Alegre, RS, Brazil.
   [Teles, Alisson Roberto] McGill Univ, McGill Scoliosis & Spine Grp, Montreal, PQ, Canada.
RP Worm, PV (reprint author), Complexo Hosp Santa Casa Porto Alegre, Hosp Sao Jose, Dept Neurol Surg, Porto Alegre, RS, Brazil.; Worm, PV (reprint author), Cristo Redentor Hosp, Neurosurg Dept, Porto Alegre, RS, Brazil.
EM paulo.worm@ufrgs.br
RI Finger, Guilherme/AAC-5340-2020
OI Finger, Guilherme/0000-0001-8365-8032
CR Beiner John M, 2003, Neurosurg Focus, V15, pE14
   Campbell PG, 2011, J NEUROSURG-SPINE, V14, P16, DOI 10.3171/2010.9.SPINE10151
   CDC and Healthcare Infection Control Practices Advisory, 2015, SURG SIT INF SSI EV
   Chahoud J, 2014, FRONT MED-LAUSANNE, V1, DOI 10.3389/fmed.2014.00007
   Chaichana KL, 2014, J NEUROSURG-SPINE, V20, P45, DOI 10.3171/2013.10.SPINE1364
   De la Garza-Ramos R, 2016, NEUROL RES, V38, P117, DOI 10.1080/01616412.2016.1138669
   Elgafy Hossein, 2016, World J Crit Care Med, V5, P83, DOI 10.5492/wjccm.v5.i1.83
   Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f
   Friedman ND, 2007, INFECT CONT HOSP EP, V28, P1060, DOI 10.1086/519864
   Gerometta A, 2012, INT ORTHOP, V36, P457, DOI 10.1007/s00264-011-1426-0
   Grzywna AM, 2016, J PEDIATR ORTHOP B, V25, P361, DOI 10.1097/BPB.0000000000000340
   Imajo Y, 2015, J ORTHOP SCI, V20, P38, DOI 10.1007/s00776-014-0656-6
   Kamath VHD, 2016, EUR SPINE J, V25, P3242, DOI 10.1007/s00586-016-4491-7
   Kanafani ZA, 2006, SCAND J INFECT DIS, V38, P589, DOI 10.1080/00365540600606440
   Klekamp J, 1999, J SPINAL DISORD, V12, P187
   Linam WM, 2009, INFECT CONT HOSP EP, V30, P109, DOI 10.1086/593952
   Liu JT, 2015, BIOMED RES INT, DOI 10.1155/2015/842010
   Meredith DS, 2012, INT ORTHOP, V36, P439, DOI 10.1007/s00264-011-1427-z
   Molinari Robert W, 2012, Eur Spine J, V21 Suppl 4, pS476, DOI 10.1007/s00586-011-2104-z
   Olsen MA, 2003, J NEUROSURG, V98, P149, DOI 10.3171/spi.2003.98.2.0149
   Parchi PD, 2015, ORTHOP REV, V7, P63, DOI 10.4081/or.2015.5900
   Satake K, 2013, EUR SPINE J, V22, P1854, DOI 10.1007/s00586-013-2783-8
   Schroeder JE, 2016, EUR SPINE J, V25, P1029, DOI 10.1007/s00586-015-4119-3
   Shamji MF, 2009, NEUROSURGERY, V65, P490, DOI 10.1227/01.NEU.0000350863.69524.8E
   Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E580
EP E585
DI 10.1016/j.wneu.2019.02.098
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400071
PM 30831303
DA 2020-05-12
ER

PT J
AU Wu, WJ
   Li, Y
   Hou, TY
   Cheng, P
   Zhang, ZH
   Xu, JZ
   Luo, F
AF Wu, Wen-jie
   Li, Yang
   Hou, Tian-yong
   Cheng, Peng
   Zhang, Ze-hua
   Xu, Jian-Zhong
   Luo, Fei
TI Application of New Allogeneic Lumbar Fusion Cage (Biocage) in
   Single-Segment Lumbar Degenerative Disease: A Prospective Controlled
   Study with Follow-Up for >= 2 Years
SO WORLD NEUROSURGERY
LA English
DT Article
DE Allograft; Fusion rate; Lumbar interbody fusion; PEEK cage
ID PEEK CAGE; INTERBODY; POLYETHERETHERKETONE; ALLOGRAFT; ANTERIOR;
   OUTCOMES
AB OBJECTIVE: We evaluated the clinical efficacy of the Biocage in lumbar fusion surgery and its safety and effectiveness.
   METHODS: A total of 431 patients with single-segment lumbar degenerative disease diagnosed from January 2013 to December 2016 were considered for the present prospective, nonrandomized, and controlled study; 52 patient met the exclusion criteria and were excluded. The patients were divided into 2 groups according to their cage choice: Biocage (n = 206) and polyether ether ketone (PEEK) cage (n = 173). The patients were followed up for 24-48 months (average, 32). The operative time, blood loss, hospitalization duration, mean intervertebral fusion segment height, height of intervertebral foramen, fusion time, fusion rate, internal fixation failure rate, visual analog scale score, and Oswestry disability index were compared between the 2 groups.
   RESULTS: All the patients underwent surgery successfully. No significant differences were found in gender, age, clinical diagnosis, lesion segment, operative time, blood loss, visual analog scale score, or Oswestry disability index between the 2 groups. No significant differences were found in the fusion rate; however, the Biocage group had a greater fusion rate and shorter fusion time than the PEEK group. During follow-up, the mean intervertebral height recovered significantly in the Biocage group compared with the PPEK group (P < 0.05). The height of the intervertebral foramen was significantly different between the 2 groups, and recovery was better in the Biocage group (P < 0.05). The Cobb angle of fusion segment in both groups improved significantly postoperatively compared with preoperatively (P < 0.05). The improvement in Cobb angle was significantly different between the 2 groups (P < 0.05).
   CONCLUSIONS: The Biocage has excellent clinical efficacy in the treatment of lumbar degenerative disease. Although the Biocage achieved good therapeutic effects, it did not show obvious advantages compared with the PEEK cage. Therefore, the Biocage can only be used as a choice of bone graft materials for lumbar fusion surgery and should not completely replace the PEEK cage.
C1 [Wu, Wen-jie; Li, Yang; Hou, Tian-yong; Cheng, Peng; Zhang, Ze-hua; Xu, Jian-Zhong; Luo, Fei] Army Mil Univ, Natl & Reg Engn Lab Tissue Engn, Dept Orthoped, Hosp Affiliated 1,Southwest Hosp, Chongqing, Peoples R China.
RP Luo, F (reprint author), Army Mil Univ, Natl & Reg Engn Lab Tissue Engn, Dept Orthoped, Hosp Affiliated 1,Southwest Hosp, Chongqing, Peoples R China.
EM luofeispine@126.com
FU First Hospital Affiliated to the Army Military University (Southwest
   Hospital) [SWH2013LC23]
FX The present study was supported by the First Hospital Affiliated to the
   Army Military University (Southwest Hospital) (grant SWH2013LC23).
CR Arnold Paul M, 2009, Am J Orthop (Belle Mead NJ), V38, pE115
   Behrbalk E, 2013, EUR SPINE J, V22, P2869, DOI 10.1007/s00586-013-2948-5
   Boissiere L, 2013, ORTHOP TRAUMATOL-SUR, V99, P945, DOI 10.1016/j.otsr.2013.09.003
   Buser Z, 2016, J NEUROSURG-SPINE, V25, P509, DOI 10.3171/2016.1.SPINE151005
   CLOWARD RB, 1953, AM J SURG, V86, P145, DOI 10.1016/0002-9610(53)90421-8
   Cutler AR, 2006, J NEUROSURG-SPINE, V5, P534, DOI 10.3171/spi.2006.5.6.534
   de Kunder SL, 2018, SPINE, V43, P1161, DOI 10.1097/BRS.0000000000002534
   Diedrich O, 2001, Spine (Phila Pa 1976), V26, pE274, DOI 10.1097/00007632-200106150-00019
   Gibson S, 2002, SPINE, V27, P1599, DOI 10.1097/00007632-200208010-00002
   Glassman SD, 2016, NEUROSURGERY, V79, P397, DOI 10.1227/NEU.0000000000001118
   HIBBS RA, 1988, CLIN ORTHOP RELAT R, P4
   Janssen ME, 2001, EUR SPINE J, V10, pS158, DOI 10.1007/s005860100292
   Liljenqvist U, 1998, Eur Spine J, V7, P125, DOI 10.1007/s005860050042
   MCAFEE PC, 2005, SPINE PHILA PA 197 S, V30, pS6
   Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb
   Ray CD, 1997, NEUROSURG QUART, V7, P135
   Rivet DJ, 2004, J NEUROSURG-SPINE, V1, P261, DOI 10.3171/spi.2004.1.3.0261
   Schimmel J. J. P., 2012, J SPINAL DISORD TECH, V29, P252, DOI [10.1097/BSD.0b013e31826eaf74, DOI 10.1097/BSD.0B013E31826EAF74]
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   von Salis-Soglio GF, 2005, ORTHOPADE, V34, P1033, DOI 10.1007/s00132-005-0840-7
NR 20
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1309
EP E1314
DI 10.1016/j.wneu.2019.03.084
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400165
PM 30898751
DA 2020-05-12
ER

PT J
AU Xia, L
   Han, Q
   Ni, XY
   Chen, B
   Yang, X
   Chen, Q
   Cheng, GL
   Liu, CF
AF Xia, Lei
   Han, Qiu
   Ni, Xiao-Yu
   Chen, Bing
   Yang, Xiu
   Chen, Quan
   Cheng, Guan-Liang
   Liu, Chun-Feng
TI Different Techniques of Minimally Invasive Craniopuncture for the
   Treatment of Hypertensive Intracerebral Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain injury; Hypertension; Intracerebral hemorrhage; Minimally
   invasive; Soft-channel
ID INITIAL CONSERVATIVE TREATMENT; EARLY SURGERY; BRAIN; TRIAL; STICH
AB OBJECTIVE: Efficacy of minimally invasive craniopuncture with the YL-1 puncture needle (hard-channel) and soft drainage tube (soft-channel) in treating hypertensive intracerebral hemorrhage (HICH).
   MATERIALS AND METHODS: A total of 150 patients with HICH were randomly assigned into 3 groups: conservative group (n = 50), hard-channel group (n = 50), and soft-channel group (n = 50). Computed tomography, National Institutes of Health Stroke Scale (NIHSS) and the levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), superoxide dismutase (SOD), and malondialdehyde (MDA) in serum and in drainage fluid were examined on days 2, 4, and 6 after operation.
   RESULTS: Compared with the conservative group, the serum levels of IL-6, TNF-alpha, and MDA were decreased and SOD was increased (P < 0.05); volumes of hematoma and perihematomal edema as well as NIHSS were reduced (P < 0.05) in minimally invasive groups on days 7, 14, and 28 after operation. Compared with the hard-channel group, the serum levels of IL-6, TNF-alpha, MDA, and SOD showed the same trend as above in the soft-channel group. In the soft-channel group, MDA was reduced and SOD was increased in brain drainage fluid on days 2, 4, and 6 (P < 0.05); volumes of hematoma and perihematomal edema on days 14 and 28 were found to be reduced compared with the hard channel group (P < 0.05). There was no significant difference of volumes of hematoma and perihematomal edema on day 7 between minimally invasive groups. NIHSS of the soft-channel group appeared to be significantly reduced on days 7, 14, and 28 after operation (P < 0.05).
   CONCLUSIONS: Soft-channel minimally invasive craniopuncture is an ideal technique for treating HICH, with advantages of alleviating cerebral edema, reducing oxidative stress, and inhibiting inflammatory response.
C1 [Xia, Lei; Liu, Chun-Feng] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Peoples R China.
   [Xia, Lei; Ni, Xiao-Yu; Chen, Bing; Yang, Xiu; Chen, Quan; Cheng, Guan-Liang] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China.
   [Han, Qiu] Second Peoples Hosp Huaian, Dept Neurol, Huaian, Jiangsu, Peoples R China.
RP Liu, CF (reprint author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Peoples R China.
EM liuchunfeng@suda.edu.cn
OI Liu, Chun-Feng/0000-0002-8364-0219
FU Nanjing Medical University Science and Technology Development Fund
   Project [2015NJMU154]
FX This work was supported by Nanjing Medical University Science and
   Technology Development Fund Project (2015NJMU154).
CR BROTT T, 1986, STROKE, V17, P1078, DOI 10.1161/01.STR.17.6.1078
   Ducruet AF, 2009, EXP NEUROL, V219, P398, DOI 10.1016/j.expneurol.2009.07.018
   Gram M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-100
   Haley MD, 2018, STROKE, V49, P325, DOI 10.1161/STROKEAHA.117.016677
   Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD
   Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870
   Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78
   Junfeng W, 2017, CLIN J TRADIT CHIN M, V11, P115
   Li W, 1996, CHINESE J NEUROL, V29, P379
   Lorente L, 2018, WORLD NEUROSURG, V113, pE542, DOI 10.1016/j.wneu.2018.02.085
   Mendelow AD, 2005, LANCET, V365, P387
   MORIOKA T, 1993, J COMP NEUROL, V327, P123, DOI 10.1002/cne.903270110
   Okamura K, 2014, NEUROL RES, V36, P65, DOI 10.1179/1743132813Y.0000000259
   Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022
   Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b
   Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3
   Wang WZ, 2009, INT J STROKE, V4, P11, DOI 10.1111/j.1747-4949.2009.00239.x
   Weijie Z, 2015, J MINIMAL INV MED, V4, P52
   YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093
   Zhou XY, 2012, STROKE, V43, P2923, DOI 10.1161/STROKEAHA.112.667535
NR 20
TC 1
Z9 2
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E888
EP E894
DI 10.1016/j.wneu.2019.03.006
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400110
PM 30872203
DA 2020-05-12
ER

PT J
AU Xiao, HM
   Bai, JF
   Yan, MB
   Ji, K
   Tian, W
   Liu, DG
   Ning, TB
   Liu, XY
   Zou, JD
AF Xiao, Huaming
   Bai, Jianfeng
   Yan, Mingbu
   Ji, Kai
   Tian, Wei
   Liu, Dagang
   Ning, Tongbo
   Liu, Xiaoyun
   Zou, Jidian
TI Discovery of 5-Signature Predicting Survival of Patients with
   Lower-Grade Glioma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Biomarker; Lower-grade glioma; MicroRNA; Survival analysis
ID CELL PROLIFERATION; MICRORNAS; PROGNOSIS; INVASION; TARGETS
AB OBJECTIVE: In the study, we aimed to identify key microRNAs (miRNAs) and clinical factors associated with survival time of lower-grade glioma (LGG) and develop an expression-based miRNA signature to provide survival risk prediction for patients with LGG.
   METHODS: We obtained miRNA expression profiles and clinical information of patients with LGG from The Cancer Genome Atlas dataset. All 591 miRNAs were modeled using random Forest Survival, Regression, and Classification to construct a random forest model for survival analysis, and feature selection was performed. We used univariate and multivariate Cox regression analysis to screen differentially expressed miRNAs and clinical factors related to overall survival of patients with LGG.
   RESULTS: A total of 591 differentially expressed miRNAs were obtained between LGG and normal tissues. After univariate and multivariate Cox regression analysis, 2 predictive miRNAs (hsa-miR-10b-5p and hsa-miR-15b-5p) and 3 clinical factors (grade, age, and cancer status) were finally screened out to construct a 5-signature, based on which patients in the training dataset were divided into high-risk and low-risk groups. The competitive performance of the 5-signature was revealed by receiver operating characteristic curve analysis. The prognostic value of the 5-signature was successfully validated in the testing and validation dataset.
   CONCLUSIONS: Our study demonstrated the promising potential of the novel 5-signature as an independent biomarker for survival prediction of patients with LGG.
C1 [Xiao, Huaming; Bai, Jianfeng; Yan, Mingbu; Ji, Kai; Tian, Wei; Liu, Dagang; Ning, Tongbo; Zou, Jidian] Cent Hosp Weihai, Dept Neurosurg, Weihai, Peoples R China.
   [Liu, Xiaoyun] Cent Hosp Weihai, Dept Oncol, Weihai, Peoples R China.
RP Zou, JD (reprint author), Cent Hosp Weihai, Dept Neurosurg, Weihai, Peoples R China.
EM jidianzou_doctor@163.com
CR Aanes H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089158
   Aibaidula A, 2017, NEURO-ONCOLOGY, V19, P1327, DOI 10.1093/neuonc/nox078
   Baraniskin A, 2010, NEURO-ONCOLOGY, V14, P29
   Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x
   Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323
   Choi PJ, 2018, CUREUS, V10, DOI 10.7759/cureus.2305
   Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030
   Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4
   Diksin M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112342
   Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568
   Godlewski J, 2013, CANCER RES, V2013, P68
   Guan Y, 2016, CLIN CANCER RES, V16, P4289
   Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818
   Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409
   Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027
   Kannan K, 2012, ONCOTARGET, V3, P1194
   Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107
   Lee KH, 2015, ONCOTARGET, V6, P3240, DOI 10.18632/oncotarget.3087
   Li CT, 2016, ONCOTARGET, V7, P36247, DOI 10.18632/oncotarget.9198
   Liu X, 2019, AGING-US, V11, P673, DOI 10.18632/aging.101769
   Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012
   Mouekouba LDO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102690
   Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522
   Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960
   Shi R, 2015, ONCOTARGET, V6, P26971, DOI 10.18632/oncotarget.4699
   Sun G, 2018, J CELL BIOCHEM, V119, P4540, DOI 10.1002/jcb.26591
   Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877
   Wang Y, 2013, CANCER RES, V73, P4801, DOI 10.1158/0008-5472.CAN-12-3273
   Xue K, 2018, ARTIF CELL NANOMED B, V46, P815, DOI 10.1080/21691401.2017.1345923
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E765
EP E772
DI 10.1016/j.wneu.2019.02.147
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400095
PM 30853516
DA 2020-05-12
ER

PT J
AU Xu, EJ
   Gao, R
   Jiang, H
   Lin, T
   Shao, W
   Zhou, XH
AF Xu, Enjie
   Gao, Rui
   Jiang, Heng
   Lin, Tao
   Shao, Wei
   Zhou, Xuhui
TI Combined Halo Gravity Traction and Dual Growing Rod Technique for the
   Treatment of Early Onset Dystrophic Scoliosis in Neurofibromatosis Type
   1
SO WORLD NEUROSURGERY
LA English
DT Article
DE Dystrophic scoliosis; Early onset; Growing rod; Halo gravity;
   Neurofibromatosis type 1; Traction
ID SEVERE SPINAL DEFORMITIES; YOUNG-CHILDREN; NERVE INJURY; FUSION;
   INSTRUMENTATION; MANAGEMENT; FIXATION; EFFICACY; CURVES; SINGLE
AB OBJECTIVE: To determine the safety and effectiveness of the combined halo gravity traction and dual growing rod technique in achieving and maintaining scoliosis correction while allowing spinal growth.
   METHODS: From January 2014 to July 2017, 11 patients with dystrophic neurofibromatosis type 1 (NF1)-associated scoliosis, including 7 men and 4 women, underwent combined halo gravity traction and dual growing rod technique procedures. Diagnoses were all dystrophic NF1-associated scoliosis. Patients with a Cobb angle of major curve >60 degrees and flexibility of spine <30% were included in our research. Analysis included age at the time of treatment, levels of instrumentation, number and frequency of lengthening, lengthening distance, and complications. The changes in Cobb angle of scoliosis and T1-S1 length of spine over the treatment period were measured by radiographic evaluation.
   RESULTS: The average age of treated patients was 7.2 years (range, 5-9 years). Growing rods were lengthened every 6 months through exposure. The mean number of times of lengthening was 3.9 (range, 3-5). The distance of each extension was 1.6 cm (range, 1.0-2.0 cm). The Cobb angle was corrected 41.7% on average after traction, 48.4% after initial surgery, and 53.3% at the last follow-up. T1-S1 length increased 3.4 cm (range, 1.2-5.1 cm) on average over a mean treatment period of 2.2 years, with an average of 1.5 cm/y (range, 0.5-2.3 cm/y). During the treatment period, complication of hook dislodgement occurred in 1 of 11 patients (9.1%).
   CONCLUSIONS: The combined halo gravity traction and dual growing rod technique can safely and effectively correct NF1-associated scoliosis. This is an ongoing study that requires long-term follow-up.
C1 [Xu, Enjie; Gao, Rui; Jiang, Heng; Lin, Tao; Shao, Wei; Zhou, Xuhui] Second Mil Med Univ, Affiliated Hosp 2, Changzheng Hosp, Dept Orthoped, Shanghai, Peoples R China.
RP Zhou, XH (reprint author), Second Mil Med Univ, Affiliated Hosp 2, Changzheng Hosp, Dept Orthoped, Shanghai, Peoples R China.
EM zhouxuhui@smmu.edu.cn
CR Acaroglu E, 2002, J PEDIATR ORTHOPED, V22, P492, DOI 10.1097/00004694-200207000-00014
   Akbarnia BA, 2005, SPINE, V30, pS46, DOI 10.1097/01.brs.0000175190.08134.73
   AKBARNIA BA, 1992, SPINE, V17, pS244
   Akbarnia BA, 2008, SPINE, V33, P984, DOI 10.1097/BRS.0b013e31816c8b4e
   Bess S, 2010, J BONE JOINT SURG AM, V92A, P2533, DOI 10.2106/JBJS.I.01471
   Blakemore LC, 2001, SPINE, V26, P2044, DOI 10.1097/00007632-200109150-00021
   Boyd KP, 2009, J AM ACAD DERMATOL, V61, P1, DOI 10.1016/j.jaad.2008.12.051
   BRANTHWAITE MA, 1986, BRIT J DIS CHEST, V80, P360, DOI 10.1016/0007-0971(86)90089-6
   CALVERT PT, 1989, J BONE JOINT SURG BR, V71, P246
   Campbell RM, 2003, J BONE JOINT SURG AM, V85A, P399, DOI 10.2106/00004623-200303000-00001
   CRAWFORD AH, 1989, CLIN ORTHOP RELAT R, P29
   Durrani AA, 2000, SPINE, V25, P69, DOI 10.1097/00007632-200001010-00013
   FUNASAKI H, 1994, J BONE JOINT SURG AM, V76A, P692, DOI 10.2106/00004623-199405000-00010
   Gajeski BL, 2003, J MANIP PHYSIOL THER, V26, P116, DOI 10.1067/mmt.2003.7
   Gillingham BL, 2006, J AM ACAD ORTHOP SUR, V14, P101, DOI 10.5435/00124635-200602000-00005
   Ginsburg GM, 1998, SPINE, V23, P1490, DOI 10.1097/00007632-199807010-00011
   HARRINGTON PR, 1962, J BONE JOINT SURG AM, V44, P591, DOI 10.2106/00004623-196244040-00001
   HUMBYRD DE, 1981, SPINE, V6, P365, DOI 10.1097/00007632-198107000-00006
   Jain A, 2016, J BONE JOINT SURG AM, V98, P1073, DOI 10.2106/JBJS.15.01241
   Karol LA, 2011, CLIN ORTHOP RELAT R, V469, P1323, DOI 10.1007/s11999-010-1622-z
   Kim HW, 1997, SPINE, V22, P2770, DOI 10.1097/00007632-199712010-00014
   Klemme WR, 1997, J PEDIATR ORTHOPED, V17, P734, DOI 10.1097/00004694-199711000-00007
   Koptan W, 2010, EUR SPINE J, V19, P1569, DOI 10.1007/s00586-010-1464-0
   Lenke LG, 2007, J BONE JOINT SURG AM, V89A, P55, DOI 10.2106/JBJS.F.00644
   Mineiro J, 2002, J PEDIATR ORTHOPED, V22, P290, DOI 10.1097/00004694-200205000-00004
   MOE JH, 1984, CLIN ORTHOP RELAT R, P35
   NICKEL VL, 1968, J BONE JOINT SURG AM, VA 50, P1400, DOI 10.2106/00004623-196850070-00009
   Parisini P, 1999, SPINE, V24, P2247, DOI 10.1097/00007632-199911010-00013
   Park DK, 2013, J SPINAL DISORD TECH, V26, P146, DOI 10.1097/BSD.0b013e318237828c
   Qian BP, 2006, ST HEAL T, V123, P538
   Rinella A, 2005, SPINE, V30, P475, DOI 10.1097/01.brs.0000153707.80497.a2
   Shen Jian-xiong, 2005, Chinese Medical Sciences Journal, V20, P88
   Sink EL, 2001, J PEDIATR ORTHOPED, V21, P519, DOI 10.1097/00004694-200107000-00020
   Sponseller PD, 2008, SPINE, V33, P2305, DOI 10.1097/BRS.0b013e318184ef79
   Sucato DJ, 2010, SPINE, V35, P2186, DOI 10.1097/BRS.0b013e3181feab19
   Thompson GH, 2005, SPINE, V30, P2039, DOI 10.1097/01.brs.0000179082.92712.89
   TOLEDO LC, 1982, J PEDIATR ORTHOPED, V2, P554, DOI 10.1097/01241398-198212000-00016
   Tsirikos AI, 2005, EUR SPINE J, V14, P427, DOI 10.1007/s00586-004-0829-7
   Wattenbarger JM, 2000, SPINE, V25, P1680, DOI 10.1097/00007632-200007010-00011
   WILKINS C, 1977, CLIN ORTHOP RELAT R, P106
NR 40
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E173
EP E180
DI 10.1016/j.wneu.2019.01.290
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400023
PM 30797914
DA 2020-05-12
ER

PT J
AU Xu, LL
   Yang, XF
   Wang, YW
   Wu, ZC
   Xia, C
   Qiu, Y
   Zhu, ZZ
AF Xu, Leilei
   Yang, Xianfeng
   Wang, Yuwen
   Wu, Zhichong
   Xia, Chao
   Qiu, Yong
   Zhu, Zezhang
TI Brace Treatment in Adolescent Idiopathic Scoliosis Patients with Curve
   Between 40 degrees and 45 degrees: Effectiveness and Related Factors
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brace treatment; Effectiveness; Factors; Idiopathic scoliosis; Large
   curve
ID NATURAL-HISTORY; PROGRESSION; GIRLS; SURGERY; SUCCESS
AB OBJECTIVE: To investigate effectiveness of brace treatment in patients with adolescent idiopathic scoliosis with curve between 40 degrees and 45 degrees and to determine predictive factors associated with bracing outcome.
   METHODS: Bracing was used to treat 90 patients with curve > 40 degrees. Factors including Risser sign, age, sex, curve pattern, curve magnitude, and initial curve correction were compared between patients with curve improvement and patients with curve progression. Logistic regression analysis was used to determine the independent predictors of curve progression.
   RESULTS: Curve was improved in 34 (37.8%) patients and stabilized in 12 (13.3%) patients. Remarkable curve progression > 50 degrees was observed in 44 (48.9%) patients. Intergroup comparison showed significant differences between the 2 groups in terms of age (12.3 +/- 1.4 years vs. 13.2 +/- 1.6 years, P = 0.01), initial curve correction (2.2% +/- 5.4% vs. 19.7% +/- 12.2%, P < 0.001), and curve pattern (P = 0.03). Logistic regression analysis showed that initial curve correction of < 10% (odds ratio = 12.82, P < 0.001) and Risser grade of 0 (odds ratio = 1.46, P = 0.04) were significant indicators of curve progression.
   CONCLUSIONS: Bracing may produce a favorable outcome in certain patients with curve between 40 degrees and 45 degrees. It should be cautiously used in this situation, as there was a higher probability of bracing failure. It is important to differentiate patients at high risk of curve progression at an early stage to avoid overtreatment.
C1 [Xu, Leilei; Wang, Yuwen; Wu, Zhichong; Xia, Chao; Qiu, Yong; Zhu, Zezhang] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Spine Surg, Nanjing, Jiangsu, Peoples R China.
   [Yang, Xianfeng] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China.
RP Zhu, ZZ (reprint author), Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Spine Surg, Nanjing, Jiangsu, Peoples R China.
EM zezhangzhu@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81501849, 81201385]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 81501849 and No. 81201385).
CR Agabegi SS, 2015, J AM ACAD ORTHOP SUR, V23, P714, DOI 10.5435/JAAOS-D-14-00037
   Aulisa AG, 2019, EUR J PHYS REHAB MED, V55, P231, DOI 10.23736/S1973-9087.18.04782-2
   Busscher I, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-93
   Danielsson AJ, 2013, J CHILD ORTHOP, V7, P37, DOI 10.1007/s11832-012-0462-7
   Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009
   Hung ALH, 2017, J BONE JOINT SURG AM, V99, P1438, DOI 10.2106/JBJS.16.01078
   Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782
   Karol LA, 2016, J BONE JOINT SURG AM, V98, P1253, DOI 10.2106/JBJS.15.01313
   Karol LA, 2016, J BONE JOINT SURG AM, V98, P9, DOI 10.2106/JBJS.O.00359
   Katz DE, 2010, J BONE JOINT SURG AM, V92A, P1343, DOI 10.2106/JBJS.I.01142
   Negrini S, 2011, SPINE J, V11, P369, DOI 10.1016/j.spinee.2010.12.001
   PETERSON LE, 1995, J BONE JOINT SURG AM, V77A, P823, DOI 10.2106/00004623-199506000-00002
   Richards BS, 2005, SPINE, V30, P2068, DOI 10.1097/01.brs.0000178819.90239.d0
   Ryan PM, 2007, J PEDIATR ORTHOPED, V27, P671, DOI 10.1097/BPO.0b013e3181373ba8
   Stokes OM, 2013, BONE JOINT J, V95B, P1308, DOI 10.1302/0301-620X.95B10.31474
   Thompson RM, 2017, J BONE JOINT SURG AM, V99, P923, DOI 10.2106/JBJS.16.01050
   UPADHYAY SS, 1995, SPINE, V20, P537, DOI 10.1097/00007632-199503010-00006
   Wang SF, 2007, SPINE, V32, P1648, DOI 10.1097/BRS.0b013e318074c3ed
   Weinstein SL, 2015, J BONE JOINT SURG AM, V97A, P1899, DOI 10.2106/JBJS.O.00330
   Weinstein SL, 2013, SPINE, V38, P1832, DOI 10.1097/01.brs.0000435048.23726.3e
   Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337
   Xu LL, 2017, CLIN SPINE SURG, V30, pE475, DOI 10.1097/BSD.0000000000000343
   Yrjonen T, 2007, EUR SPINE J, V16, P393, DOI 10.1007/s00586-006-0167-z
   Zheng X, 2012, EUR SPINE J, V21, P1157, DOI 10.1007/s00586-012-2258-3
   Zhu ZZ, 2017, CLIN SPINE SURG, V30, P85, DOI 10.1097/BSD.0b013e3182a1de29
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E901
EP E906
DI 10.1016/j.wneu.2019.03.008
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400112
PM 30872192
DA 2020-05-12
ER

PT J
AU Xu, Y
   Lin, FY
   Lin, X
   Yin, XM
AF Xu, Yang
   Lin, Fei-Yue
   Lin, Xi
   Yin, Xiao-Ming
TI Second Sacral Alar Screw Fixation: Anatomic Study of Three-Dimensional
   Computed Tomography and Case Report
SO WORLD NEUROSURGERY
LA English
DT Article
DE Alar screw; S2; Second sacral; Three-dimensional computed tomography (3D
   CT)
ID LUMBOSACRAL FIXATION; SACROPELVIC FIXATION; S2-ALAR-ILIAC SCREWS; PELVIC
   FIXATION; PEDICLE SCREWS; ILIAC SCREWS; S2
AB OBJECTIVE: S2 alar screw would be an alternative choice without breaking the sacroiliac joint. The aim of this study was to measure radiographic parameters for optimal placement of posterior S2 alar screw for instrumentation and fusion.
   METHODS: Three-dimensional computed tomography scans of the pelvis of 60 normal adults were used to map the S2 alar screw. Entry point was typically chosen lateral and superior to the S2 dorsal foramen. Ideal S2 alar screw trajectories were explored by rotating the three-dimensional pelvis, while ensuring trajectories were of maximum length and width. After identification of an optimal trajectory, related linear anatomic parameters and sagittal and transverse angles were determined.
   RESULTS: Ideal S2 alar screw trajectories were identified in each computed tomography scan. According to this morphometric study, trajectories for female patients were more lateral in the transverse plane (female 33.73 +/- 5.99 degrees vs. male 29.82 +/- 4.11 degrees, P < 0.001). Maximal length of trajectory in male patients was significantly longer than in female patients (female 40.82 +/- 4.29 mm vs. male 43.42 +/- 4.02 mm, P = 0.001). Fourteen S2 alar screws were used in 7 patients with high-grade spondylolisthesis, scoliosis, or nonunion at lumbosacral site. No complications occurred during S2 alar screw placement. One S2 screw failed owing to severe local osteoporosis. No patient developed local pain or wound-related problems.
   CONCLUSIONS: S2 alar screw is an alternative sacral fixation point to provide additional biomechanical stability of lumbosacral constructs. A trajectory with maximum length through the S2 ala can be determined using three-dimensional computed tomography.
C1 [Xu, Yang; Lin, Fei-Yue; Lin, Xi; Yin, Xiao-Ming] FuJian Prov Hosp, Dept Orthoped, Fuzhou, Fujian, Peoples R China.
RP Lin, X (reprint author), FuJian Prov Hosp, Dept Orthoped, Fuzhou, Fujian, Peoples R China.
EM 258377643@qq.com
CR Birknes JK, 2008, NEUROSURGERY, V63, pA94, DOI 10.1227/01.NEU.0000325485.49323.B2
   Ebraheim NA, 1997, SURG RADIOL ANAT, V19, P353, DOI 10.1007/BF01628500
   Elder BD, 2017, SPINE, V42, pE142, DOI 10.1097/BRS.0000000000001722
   Erickson MA, 2004, SPINE, V29, P1314, DOI 10.1097/01.BRS.0000127182.36142.95
   Guler UO, 2015, EUR SPINE J, V24, P1085, DOI 10.1007/s00586-014-3615-1
   Ishida W, 2016, WORLD NEUROSURG, V93, P253, DOI 10.1016/j.wneu.2016.06.042
   Jain A, 2017, WORLD NEUROSURG, V108, P474, DOI 10.1016/j.wneu.2017.08.169
   Koller H, 2013, OPER ORTHOP TRAUMATO, V25, P294, DOI 10.1007/s00064-012-0160-0
   Kwan MK, 2012, SURG RADIOL ANAT, V34, P217, DOI 10.1007/s00276-011-0919-2
   Lebwohl NH, 2002, SPINE, V27, P2312, DOI 10.1097/00007632-200211010-00003
   Lee MC, 2018, SPINE J, V18, P648, DOI 10.1016/j.spinee.2017.08.253
   Leong JCY, 1998, SPINE, V23, P2289, DOI 10.1097/00007632-199811010-00008
   Myung KS, 2015, J PEDIATR ORTHOPED, V35, P258, DOI 10.1097/BPO.0000000000000254
   Nottmeier EW, 2010, SPINE J, V10, P595, DOI [10.1016/j.spinee.2010.04.013, 10.1016/j.spinee.2010.03.023]
   O'Brien JR, 2009, SPINE, V34, pE439, DOI 10.1097/BRS.0b013e3181a4e3e4
   O'Shaughnessy BA, 2012, SPINE, V37, P1175, DOI 10.1097/BRS.0b013e3182426970
   Orita S, 2010, SPINE, V35, pE1230, DOI 10.1097/BRS.0b013e3181e5092c
   Phillips JH, 2007, SPINE, V32, P1566, DOI 10.1097/BRS.0b013e318067dcff
   Shen FH, 2013, EUR SPINE J, V22, pS265, DOI 10.1007/s00586-012-2525-3
   Shillingford JN, 2018, J BONE JOINT SURG AM, V100, P334, DOI 10.2106/JBJS.17.00052
   Yoshihara H, 2012, EUR SPINE J, V21, P1788, DOI 10.1007/s00586-012-2350-8
   Zhu F, 2013, EUR SPINE J, V22, P1683, DOI 10.1007/s00586-013-2734-4
   Zhuang XM, 2010, SPINE, V35, pE925, DOI 10.1097/BRS.0b013e3181c5fb21
   ZINDRICK MR, 1986, CLIN ORTHOP RELAT R, P99
NR 24
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1542
EP E1548
DI 10.1016/j.wneu.2019.03.191
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400194
PM 30928580
DA 2020-05-12
ER

PT J
AU Xu, ZK
   Li, FC
   Chen, G
   Chen, QX
AF Xu, Zhengkuan
   Li, Fangcai
   Chen, Gang
   Chen, Qixin
TI Reassessment System and Staged Surgical Strategy with Minimally Invasive
   Techniques for Treatment of Severe Adult Spinal Deformities
SO WORLD NEUROSURGERY
LA English
DT Article
DE Adult spinal deformity; Anterior column realignment; Lateral lumbar
   interbody fusion; Minimally invasive surgery; Staged surgery
ID ANTERIOR COLUMN REALIGNMENT; PERIOPERATIVE COMPLICATIONS; INTERBODY
   FUSION; SURGERY; OSTEOTOMY; OUTCOMES; ACR
AB OBJECTIVE: We determined the feasibility of minimally invasive surgery for severe adult spinal deformities and proposed a reassessment system and staged minimally invasive surgical strategy.
   METHODS: We treated 53 patients from June 2016 to August 2017 using a reassessment system and a staged surgical strategy with minimally invasive techniques for minimally invasive spinal deformity surgery, class III. Patients with scoliotic apex vertebrae above L1-L2 or spontaneous fusion of the facet joints were excluded. The reassessment system was applied. The first stage involved multisegmental lateral lumbar interbody fusion and anterior column realignment (ACR), and the second stage involved posterior minimally invasive surgery. The pre- and postoperative visual analog scale scores, Oswestry disability index, surgical data, and radiographic images were collected. The major and minor complications were recorded.
   RESULTS: All the patients were followed up for 11.5 months (range, 6-20). Lateral lumbar interbody fusion was performed in 168 segments, of which 113 had ACR. The average sagittal correction angle of each ACR segment was 15.6 degrees +/- 6.3 degrees (range, 7 degrees-28 degrees). The correction rate of the Cobb angle for lumbar scoliosis after first stage was 55.4%, and the total correction rate was 75.6%. The lumbar lordosise-pelvic index mismatch was improved from -32.8 degrees +/- 14.9 degrees to -2.5 degrees +/- 9.4 degrees, reaching the sagittal matching state of the lumbar spine.
   CONCLUSIONS: A reassessment system and minimally invasive staged surgery for severe adult spinal deformity can achieve good clinical outcomes and deformity correction and might have the advantage of decreasing unnecessary iatrogenic injury.
C1 [Xu, Zhengkuan; Li, Fangcai; Chen, Gang; Chen, Qixin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China.
RP Chen, QX (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China.
EM zrcqx@zju.edu.cn
CR Abe K, 2017, SPINE, V42, P55, DOI 10.1097/BRS.0000000000001650
   Akbarnia BA, 2014, J SPINAL DISORD TECH, V27, P29, DOI 10.1097/BSD.0b013e318287bdc1
   Anand N, 2017, NEUROSURGERY, V81, P733, DOI 10.1093/neuros/nyx353
   Bae J, 2018, J NEUROSURG-SPINE, V28, P40, DOI 10.3171/2017.5.SPINE161370
   Berjano P, 2015, EUR SPINE J, V24, pS433, DOI 10.1007/s00586-015-3930-1
   Costanzo G, 2014, EUR SPINE J, V23, pS699, DOI 10.1007/s00586-014-3561-y
   Deukmedjian AR, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13173
   Flouzat-Lachaniette CH, 2015, J NEUROSURG-SPINE, V23, P739, DOI 10.3171/2015.3.SPINE14772
   Glassman SD, 2007, SPINE, V32, P2764, DOI 10.1097/BRS.0b013e31815a7644
   Kanter AS, 2016, SPINE, V41, pS59, DOI 10.1097/BRS.0000000000001481
   Leveque JC, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17195
   Madhavan K, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2015.11.FOCUS15511
   Mummaneni PV, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1413
   Mummaneni PV, 2013, NEUROSURG CLIN N AM, V24, P231, DOI 10.1016/j.nec.2012.12.004
   Mundis GM, 2017, WORLD NEUROSURG, V105, P249, DOI 10.1016/j.wneu.2017.05.122
   Park P, 2015, J NEUROSURG-SPINE, V22, P374, DOI 10.3171/2014.9.SPINE131004
   Pateder DB, 2008, SPINE, V33, P1224, DOI 10.1097/BRS.0b013e3181714a66
   Pimenta L, 2013, J NEUROL SURG PART A, V74, P343, DOI 10.1055/s-0032-1333420
   Saigal R, 2016, SPINE, V41, pS66, DOI 10.1097/BRS.0000000000001483
   Smith JS, 2017, J NEUROSURG-SPINE, V27, P444, DOI 10.3171/2016.10.SPINE16849
   Smith JS, 2011, SPINE, V36, P817, DOI 10.1097/BRS.0b013e3181e21783
   Turner JD, 2015, EUR SPINE J, V24, pS427, DOI 10.1007/s00586-015-3842-0
   Yang Y, 2017, BIOMED RES INT, DOI 10.1155/2017/3742182
NR 23
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E860
EP E868
DI 10.1016/j.wneu.2019.03.001
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400107
PM 30862576
DA 2020-05-12
ER

PT J
AU Xue, GC
   Zuo, Q
   Duan, GL
   Zhang, XX
   Zhao, R
   Li, Q
   Fang, YB
   Yang, PF
   Dai, DW
   Zhao, KJ
   Hong, B
   Xu, Y
   Liu, JM
   Huang, QH
AF Xue, Gaici
   Zuo, Qiao
   Duan, Guoli
   Zhang, Xiaoxi
   Zhao, Rui
   Li, Qiang
   Fang, Yibin
   Yang, Pengfei
   Dai, Dongwei
   Zhao, Kaijun
   Hong, Bo
   Xu, Yi
   Liu, Jianmin
   Huang, Qinghai
TI Dual Stent-Assisted Coil Embolization for Intracranial Wide-Necked
   Bifurcation Aneurysms: A Single-Center Experience and a Systematic
   Review and Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Dual stents; Efficacy; Meta-analysis; Safety; Wide-necked bifurcation
   aneurysm
ID BASILAR TIP ANEURYSMS; ENDOVASCULAR TREATMENT; Y-CONFIGURATION; CELL
   STENTS; TERM; COMPLEX; EMPHASIS; DEVICE; TRIAL
AB OBJECTIVE: To evaluate the safety and efficacy of dual stent-assisted coiling in treatment of intracranial complex and wide-necked bifurcation aneurysms, we have reported our own center experience and performed a systematic review and meta-analysis of the reported data.
   METHODS: The experience in our center was reviewed and a comprehensive search of the reported data on dual stent-assisted treatment of intracranial complex and wide-necked bifurcation aneurysms was performed using the databases PubMed, Ovid EMBASE, and Ovid MEDLINE before October 1, 2018. Information was extracted regarding patient demographic data, clinical characteristics, radiographic data, treatment outcomes, complications, and clinical and angiographic follow-up data. The data were analyzed using random effects and fixed effects meta-analyses.
   RESULTS: Including our series of 26 patients, the data from 21 studies with 721 patients were analyzed. The procedure was technically successful in 97.6% (95% confidence interval [CI], 96.5%-98.7%). The complete occlusion rate was 61.6% (95% CI, 47.3%-75.8%) immediately after the procedure compared with 88.4% (95% CI, 84.6%-92.2%) at the last follow-up examination. The rate of periprocedural complications, total complications, procedure-related mortality was 8.8% (95% CI, 5.8%-11.9%), 9.5% (95% CI, 6.2%-12.9%), and 1.1% (95% CI, 0.3%-1.8%), respectively. The recurrence rate, retreatment rate, and good neurologic outcome rate was 3.3% (95% CI, 2.0%-4.7%), 2.7% (95% CI, 1.5%-4.0%), and 96.6% (95% CI, 95.0%-98.1%), respectively.
   CONCLUSIONS: The dual stent-assisted coiling technique is a feasible and effective option for the treatment of intracranial complex and wide-necked bifurcation aneurysms. It results in a relatively low rate of procedure-related complications and mortality and recurrence and a high rate of mid-term complete occlusion and good neurologic outcomes.
C1 [Xue, Gaici; Zuo, Qiao; Duan, Guoli; Zhang, Xiaoxi; Zhao, Rui; Li, Qiang; Fang, Yibin; Yang, Pengfei; Dai, Dongwei; Zhao, Kaijun; Hong, Bo; Xu, Yi; Liu, Jianmin; Huang, Qinghai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.
RP Huang, QH (reprint author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.
EM ocinhqh@163.com
OI Zuo, Qiao/0000-0003-4512-6363
FU National Research and Development Project of Key Chronic Diseases of
   china [2016YFC1300700]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81701136]
FX The present study was supported by the National Research and Development
   Project of Key Chronic Diseases of china (grant 2016YFC1300700) and the
   National Natural Science Foundation of China (grant 81701136).
CR Adeeb N, 2018, NEUROSURGERY, V82, P710, DOI 10.1093/neuros/nyx310
   Akgul E, 2015, INTERV NEURORADIOL, V21, P29, DOI 10.1177/1591019915575436
   Akmangit I, 2015, AM J NEURORADIOL, V36, P323, DOI 10.3174/ajnr.A4106
   Aydin K, 2017, J NEUROSURG, V127, P1288, DOI 10.3171/2016.9.JNS161909
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Bartolini B, 2014, AM J NEURORADIOL, V35, P2153, DOI 10.3174/ajnr.A4060
   Castano C, 2017, INTERV NEURORADIOL, V23, P362, DOI 10.1177/1591019917708568
   Cekirge HS, 2011, AM J NEURORADIOL, V32, P1262, DOI 10.3174/ajnr.A2475
   Chalouhi N, 2012, NEUROSURGERY, V71, P785, DOI 10.1227/NEU.0b013e318265a416
   Cheung NK, 2018, J NEUROINTERV SURG, V10, P560, DOI 10.1136/neurintsurg-2017-013399
   Choi HH, 2018, WORLD NEUROSURG, V114, pE1152, DOI 10.1016/j.wneu.2018.03.164
   De Keukeleire K, 2008, AM J NEURORADIOL, V29, P73, DOI 10.3174/ajnr.A0767
   DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002
   Eller JL, 2014, NEUROL RES, V36, P339, DOI 10.1179/1743132814Y.0000000323
   Fargen KM, 2012, NEUROSURGERY, V71, P239, DOI 10.1227/NEU.0b013e3182571953
   Gawlitza M, 2016, J NEUROINTERV SURG, V8, P481, DOI 10.1136/neurintsurg-2015-011682
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012
   Heller RS, 2014, J CLIN NEUROSCI, V21, P1368, DOI 10.1016/j.jocn.2013.11.028
   Henkes H, 2005, J NEUROSURG, V103, P990, DOI 10.3171/jns.2005.103.6.0990
   Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082311
   Huang Q, 2009, AM J NEURORADIOL, V30, P1502, DOI 10.3174/ajnr.A1618
   Jeon P, 2014, ACTA NEUROCHIR, V156, P1677, DOI 10.1007/s00701-014-2163-0
   Jin SC, 2013, NEURORADIOLOGY, V55, P321, DOI 10.1007/s00234-012-1119-4
   Ko JK, 2015, CLIN NEUROL NEUROSUR, V132, P54, DOI 10.1016/j.clineuro.2015.02.002
   Lee Kwangho, 2016, J Cerebrovasc Endovasc Neurosurg, V18, P355, DOI 10.7461/jcen.2016.18.4.355
   Lee WJ, 2012, J KOREAN NEUROSURG S, V52, P187, DOI 10.3340/jkns.2012.52.3.187
   Limbucci N, 2016, J NEUROINTERV SURG, V8, P158, DOI 10.1136/neurintsurg-2014-011483
   Lindgren A, 2018, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD00X3085
   Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6
   Molyneux AJ, 2015, LANCET, V385, P691, DOI 10.1016/S0140-6736(14)60975-2
   Morales-Valero SF, 2014, AM J NEURORADIOL, V35, P1948, DOI 10.3174/ajnr.A3992
   Muskens IS, 2018, NEUROSURGERY, P1
   Park KY, 2019, J NEUROINTERV SURG, V11, P400, DOI 10.1136/neurintsurg-2018-014128
   Peluso JPP, 2008, J NEUROL NEUROSUR PS, V79, P706, DOI 10.1136/jnnp.2007.127480
   Peng TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092407
   Pierot L, 2012, AM J NEURORADIOL, V33, P12, DOI 10.3174/ajnr.A2403
   Raymond J, 2013, AM J NEURORADIOL, V34, P570, DOI 10.3174/ajnr.A3231
   Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9
   Rho MH, 2013, ACTA NEUROCHIR, V155, P2009, DOI 10.1007/s00701-013-1866-y
   Samaniego EA, 2018, INTERV NEUROL, V7, P271, DOI 10.1159/000487545
   Spiotta AM, 2011, NEUROSURGERY, V69, P421, DOI 10.1227/NEU.0b013e318214abbd
   Sychra V, 2011, NEURORADIOLOGY, V53, P961, DOI 10.1007/s00234-010-0766-6
   Tateshima S, 2009, J NEUROSURG, V111, P22, DOI 10.3171/2009.2.JNS081324
   Tureli D, 2016, ACTA NEUROCHIR, V158, P1545, DOI 10.1007/s00701-016-2839-8
   Wainberg RC, 2019, WORLD NEUROSURG, V124, P4, DOI 10.1016/j.wneu.2018.12.093
   Wanke I, 2008, NEURORADIOLOGY, V50, P991, DOI 10.1007/s00234-008-0460-0
   Yavuz K, 2013, AM J NEURORADIOL, V34, P1778, DOI 10.3174/ajnr.A3464
   Zhao B, 2016, AM J NEURORADIOL, V37, P1700, DOI 10.3174/ajnr.A4834
   Zuo Q, 2019, J NEUROSURG, V131, P435, DOI 10.3171/2018.3.JNS172199
NR 49
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E295
EP E313
DI 10.1016/j.wneu.2019.02.047
PG 19
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400036
PM 30826458
DA 2020-05-12
ER

PT J
AU Yamamoto, S
   Kashiwazaki, D
   Uchino, H
   Saito, H
   Akioka, N
   Kuwayama, N
   Noguchi, K
   Kuroda, S
AF Yamamoto, Shusuke
   Kashiwazaki, Daina
   Uchino, Haruto
   Saito, Hisayasu
   Akioka, Naoki
   Kuwayama, Naoya
   Noguchi, Kyo
   Kuroda, Satoshi
TI Stenosis Severity-Dependent Shrinkage of Posterior Cerebral Artery in
   Moyamoya Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3D-CISS; Moyamoya disease; Outer diameter; Posterior cerebral artery
ID CONSTRUCTIVE INTERFERENCE; CIRCULATION; STATE; FEATURES
AB OBJECTIVE: The involved carotid forks in moyamoya disease (MMD) will show decreases in both luminal caliber and outer diameter. The present study aimed to clarify the changes in the outer diameter associated with luminal stenosis/occlusion of the posterior cerebral artery (PCA) in patients with MMD.
   METHODS: The present study included 24 pediatric and 48 adult patients with MMD and 17 healthy adult controls. Using magnetic resonance angiography, the degree of PCA involvement was classified into 3 grades: grade 0, normal; grade 1, stenotic; and grade 2, occluded. Using 3-dimensional constructive interference in steady state, the outer diameters were quantified in the P2 segment. All the patients were followed up to identify the disease progression in the PCA.
   RESULTS: The outer diameter of the P2 segment significantly decreased in a stepwise fashion in parallel with the severity of the luminal stenosis. In pediatric patients, the outer diameters of the P2 segments were 2.0 +/- 0.26 mm, 1.5 +/- 0.42 mm, and 0.87 +/- 0.15 mm in those with grade 0, 1, and 2, respectively (P < 0.001). In adult patients, the outer diameters of the P2 segments were 2.0 +/- 0.34 mm, 1.5 +/- 0.34 mm, and 1.1 +/- 0.17 mm in those with grade 0, 1, and 2, respectively (P < 0.001). We found no significant difference between grade 0 PCA of the adult patients and the PCA of the healthy controls (P = 0.92). Disease progression led to further arterial shrinkage of the P2 segment (n = 4).
   CONCLUSIONS: The results of our study have shown that the involved PCA demonstrates, not only luminal stenosis, but also arterial shrinkage in MMD. This finding strongly suggests that the underlying mechanism in the development of MMD is common in both the carotid fork and PCA.
C1 [Yamamoto, Shusuke; Kashiwazaki, Daina; Uchino, Haruto; Saito, Hisayasu; Akioka, Naoki; Kuwayama, Naoya; Kuroda, Satoshi] Univ Toyama, Dept Neurosurg, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.
   [Noguchi, Kyo] Univ Toyama, Dept Radiol, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.
RP Yamamoto, S (reprint author), Univ Toyama, Dept Neurosurg, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.
EM s.yamamoto1007@gmail.com
RI Uchino, Haruto/L-6627-2019
OI Uchino, Haruto/0000-0001-6567-8136; Noguchi, Kyo/0000-0002-6305-8045
FU Research Committee on Moyamoya Disease; Ministry of Health, Labor, and
   Welfare of JapanMinistry of Health, Labour and Welfare, Japan [H26-078]
FX The present study was supported by a grant from the Research Committee
   on Moyamoya Disease, sponsored by the Ministry of Health, Labor, and
   Welfare of Japan (grant H26-078 to S.K.).
CR COAKHAM HB, 1979, J NEUROL NEUROSUR PS, V42, P289, DOI 10.1136/jnnp.42.4.289
   Fukui M, 1997, SURG NEUROL, V47, P138, DOI 10.1016/S0090-3019(96)00358-8
   Funaki T, 2018, J NEUROSURG, V128, P777, DOI 10.3171/2016.11.JNS161650
   HALTIA M, 1982, CLIN NEUROPATHOL, V1, P11
   Huang APH, 2009, CEREBROVASC DIS, V28, P247, DOI 10.1159/000228254
   Kaku Y, 2012, ACTA NEUROCHIR, V154, P2151, DOI 10.1007/s00701-012-1472-4
   Kim YJ, 2013, EUR J NEUROL, V20, P1311, DOI 10.1111/ene.12202
   Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99
   Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0
   Kuroda S, 2015, NEUROL MED-CHIR, V55, P796, DOI 10.2176/nmc.oa.2015-0044
   MIYAMOTO S, 1984, J NEUROSURG, V61, P1032, DOI 10.3171/jns.1984.61.6.1032
   Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477
   MOFFAT D B, 1962, Ann R Coll Surg Engl, V30, P368
   Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, Neurol Med Chir (Tokyo), V52, P245
   Ryoo S, 2014, STROKE, V45, P2457, DOI 10.1161/STROKEAHA.114.004761
   SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012
   YAMADA I, 1995, RADIOLOGY, V197, P239, DOI 10.1148/radiology.197.1.7568830
   Yamamoto S, 2019, WORLD NEUROSURG, V122, pE253, DOI 10.1016/j.wneu.2018.10.001
   Yamamoto S, 2016, J STROKE CEREBROVASC, V25, P1509, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.029
NR 19
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E661
EP E670
DI 10.1016/j.wneu.2019.02.120
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400081
PM 30844529
DA 2020-05-12
ER

PT J
AU Yayik, AM
   Cesur, S
   Ozturk, F
   Ahiskalioglu, A
   Ay, AN
   Celik, EC
   Karaavci, NC
AF Yayik, Ahmet Murat
   Cesur, Sevim
   Ozturk, Figen
   Ahiskalioglu, Ali
   Ay, Ayse Nur
   Celik, Erkan Cem
   Karaavci, Nuh Cagri
TI Postoperative Analgesic Efficacy of the Ultrasound-Guided Erector Spinae
   Plane Block in Patients Undergoing Lumbar Spinal Decompression Surgery:
   A Randomized Controlled Study
SO WORLD NEUROSURGERY
LA English
DT Article
DE Erector spinae plane block; Postoperative analgesia; Spinal
   decompression surgery
ID OPIOID CONSUMPTION; ANESTHESIA
AB BACKGROUND: Spinal surgery is a procedure that causes intense and severe pain in the postoperative period. Erector spinae plane (ESP) block can target the dorsal-ventral rami of thoracolumbar nerves, but its effect on lumbar surgery is unclear. The aim of this study was to investigate the effect of the ESP block on postoperative opioid consumption and pain scores in patients undergoing spinal surgery.
   METHODS: Sixty patients undergoing open lumbar decompression surgery were randomly assigned to 2 groups. The ESP Group (n = 30) received ultrasound-guided bilateral ESP block with 0.25% bupivacaine 20 mL. In the Control Group (n = 30), no intervention was performed. Postoperative analgesia was performed intravenously twice a day with 400 mg ibuprofen and patient-controlled analgesia with tramadol. Postoperative visual analogue scale scores, opioid consumption, rescue analgesia, and opioid-related side effects were evaluated.
   RESULTS: Compared with the Control Group, the visual analogue scale scores were statistically lower in the ESP Group during all measurements of time, both at rest and active movement (P < 0.05). Tramadol consumption was lower in the ESP Group compared with the Control Group at all time periods (P < 0.05). Twenty-four hour tramadol consumption in the Control Group was significantly higher compared with the ESP Group (370.33 +/- 73.27 mg and 268.33 +/- 71.44 mg; P < 0.001, respectively) and the difference was 28%, and time to first analgesic requirement was significantly longer in the ESP Group than in the Control Group.
   CONCLUSIONS: ESP block can be used in multimodal analgesia practice to reduce opioid consumption and relieve acute postoperative pain in patients undergoing open lumbar decompression surgery.
C1 [Yayik, Ahmet Murat; Cesur, Sevim; Ozturk, Figen; Ay, Ayse Nur; Celik, Erkan Cem] Reg Training & Res Hosp, Dept Anesthesiol & Reanimat, Erzurum, Turkey.
   [Karaavci, Nuh Cagri] Reg Training & Res Hosp, Dept Neurosurg, Erzurum, Turkey.
   [Ahiskalioglu, Ali] Ataturk Univ, Dept Anesthesiol & Reanimat, Sch Med, Erzurum, Turkey.
RP Yayik, AM (reprint author), Reg Training & Res Hosp, Dept Anesthesiol & Reanimat, Erzurum, Turkey.
EM m.yayik@hotmail.com
RI CELIK, Erkan Cem/A-3047-2019; Ahiskalioglu, Ali/B-7473-2016
OI Ahiskalioglu, Ali/0000-0002-8467-8171
CR Ahiskalioglu A, 2018, CAN J ANESTH, V65, P603, DOI 10.1007/s12630-018-1051-0
   Bajwa SJS, 2015, J CRANIOVERTEBRAL JU, V6, P105, DOI 10.4103/0974-8237.161589
   Bohl DD, 2016, SPINE, V41, P994, DOI 10.1097/BRS.0000000000001380
   Cesur S, 2018, CUREUS, V10, DOI 10.7759/cureus.3603
   Cesur S, 2019, ANAESTH CRIT CARE PA, V38, P189, DOI 10.1016/j.accpm.2018.01.002
   Chin KJ, 2019, SPINE, V44, pE379, DOI 10.1097/BRS.0000000000002855
   Chin KJ, 2017, REGION ANESTH PAIN M, V42, P372, DOI 10.1097/AAP.0000000000000581
   Chin KJ, 2017, REGION ANESTH PAIN M, V42, P133, DOI 10.1097/AAP.0000000000000545
   De Rojas JO, 2014, CLIN NEUROL NEUROSUR, V119, P39, DOI 10.1016/j.clineuro.2014.01.016
   Dunn LK, 2016, BEST PRACT RES-CLIN, V30, P79, DOI 10.1016/j.bpa.2015.11.002
   Ead Heather, 2006, J Perianesth Nurs, V21, P259, DOI 10.1016/j.jopan.2006.05.006
   Forero M, 2017, A A CASE REP, V8, P254, DOI 10.1213/XAA.0000000000000478
   Forero M, 2016, REGION ANESTH PAIN M, V41, P621, DOI 10.1097/AAP.0000000000000451
   Gottschalk A, 2011, ANESTH ANALG, V112, P218, DOI 10.1213/ANE.0b013e3181d8a095
   Gurkan Y, 2018, J CLIN ANESTH, V50, P65, DOI 10.1016/j.jclinane.2018.06.033
   Hand WR, 2015, CAN J ANESTH, V62, P1196, DOI 10.1007/s12630-015-0431-y
   Kumar A, 2018, A A PRACT, V10, P239, DOI 10.1213/XAA.0000000000000674
   Kurd MF, 2017, J AM ACAD ORTHOP SUR, V25, P260, DOI 10.5435/JAAOS-D-16-00049
   Mathiesen O, 2013, EUR SPINE J, V22, P2089, DOI 10.1007/s00586-013-2826-1
   Melvin JP, 2018, CAN J ANESTH, V65, P1057, DOI 10.1007/s12630-018-1145-8
   Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493
   Singh S, 2019, J NEUROSURG ANESTH, V31, P354, DOI 10.1097/ANA.0000000000000518
   Tsui BCH, 2019, J CLIN ANESTH, V53, P29, DOI 10.1016/j.jclinane.2018.09.036
   Tulgar S, 2018, J CLIN ANESTH, V49, P101, DOI 10.1016/j.jclinane.2018.06.019
   Ueshima H, 2019, ASIAN SPINE J, V13, P254, DOI 10.31616/asj.2018.0114
   Ueshima H, 2017, J CLIN ANESTH, V38, P137, DOI 10.1016/j.jclinane.2016.12.028
   Vidal E, 2018, REV ESP ANEST REANIM, V65, P514, DOI 10.1016/j.redar.2018.07.004
NR 27
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E779
EP E785
DI 10.1016/j.wneu.2019.02.149
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400097
PM 30853517
DA 2020-05-12
ER

PT J
AU Yi, HJ
   Sung, JH
   Lee, MH
   Lee, DH
AF Yi, Ho Jun
   Sung, Jae Hoon
   Lee, Min Hyung
   Lee, Dong Hoon
TI Experience of the New FlowGate(2) Device as a Balloon Guide Catheter for
   Ischemic Stroke Intervention
SO WORLD NEUROSURGERY
LA English
DT Article
DE Balloon guide catheter; Intervention; Stents; Stroke; Thrombectomy
ID STENT-RETRIEVER THROMBECTOMY; MECHANICAL THROMBECTOMY;
   CLINICAL-OUTCOMES; REVASCULARIZATION; METAANALYSIS; THERAPY; SYSTEM
AB BACKGROUND: We report the experience of the FlowGate(2) (FG2) as a new balloon guide catheter in endovascular stroke intervention.
   METHODS: We evaluated the various outcomes and complications of patients with intracranial large artery occlusion undergoing endovascular stroke intervention with FG2 at our center. Baseline characteristics (failure rate of device application, sex, age, risk factors, arterial occlusion sites, and time intervals) were reviewed. Outcomes were evaluated according to National Institutes of Health Stroke Scale score, modified Rankin Scale (mRS) score, number of stent passages required, and Thrombolysis in Cerebral Infarction score. The incidence of hemorrhage, vessel damage, distal emboli, and mortality rate were evaluated as indicators of complications.
   RESULTS: Overall, 70 patients were enrolled, except the 2 patients with application failure of FG2. Seventy patients with a median age of 69 years were treated with FG2. Arterial occlusion involved the M1 (50%) and M2 (14.3%) segments, internal carotid artery (25.7%), and posterior circulation (10%). Median value of mRS at 90 days was 2.8, and 37 patients (52.8%) had a mRS score <= 2. The recanalization rate in patients with a Thrombolysis in Cerebral Infarction score of 2b or 3 was 91.4%. The hemorrhage rate was 5.7%, but none were symptomatic. In terms of complications, distal emboli occurred in 4.3% of cases.
   CONCLUSIONS: Endovascular stroke intervention with the FG2 is safe and effective with good accessibility and less occurrence of distal emboli. Its trackability, stability, and luminal size make the FG2 suitable for stroke intervention.
C1 [Yi, Ho Jun; Sung, Jae Hoon; Lee, Min Hyung; Lee, Dong Hoon] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
RP Sung, JH (reprint author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.
EM jaehoonsung@gmail.com
OI Yi, Ho Jun/0000-0003-3061-0689; Sung, Jae Hoon/0000-0003-3738-6413
CR Almandoz JED, 2016, J NEUROINTERV SURG, V8, P1123, DOI 10.1136/neurintsurg-2015-012122
   Almekhlafi MA, 2013, AM J NEURORADIOL, V34, P140, DOI 10.3174/ajnr.A3276
   Ansel GM, 2010, CATHETER CARDIO INTE, V76, P1, DOI 10.1002/ccd.22439
   Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587
   Bersin RM, 2012, CATHETER CARDIO INTE, V80, P1072, DOI 10.1002/ccd.24433
   Brinjikji W, 2018, J NEUROINTERV SURG, V10, P335, DOI 10.1136/neurintsurg-2017-013179
   Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792
   Chueh JY, 2016, J NEUROINTERV SURG, V8, P197, DOI 10.1136/neurintsurg-2014-011491
   Chueh JY, 2013, STROKE, V44, P1396, DOI 10.1161/STROKEAHA.111.670463
   Clair DG, 2011, CATHETER CARDIO INTE, V77, P420, DOI 10.1002/ccd.22789
   Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905
   Haussen DC, 2015, STROKE, V46, P2838, DOI 10.1161/STROKEAHA.115.010044
   Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780
   Lee DH, 2017, ACTA NEUROCHIR, V159, P1671, DOI 10.1007/s00701-017-3256-3
   Nguyen TN, 2017, RADIOLOGY, V284, P607, DOI 10.1148/radiol.2017170375
   Nguyen TN, 2014, STROKE, V45, P141, DOI 10.1161/STROKEAHA.113.002407
   Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9
   Oh JS, 2017, J KOREAN NEUROSURG S, V60, P155, DOI 10.3340/jkns.2016.0809.003
   Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232
   Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061
   Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1
   Teleb MS, 2018, INTERV NEUROL, V7, P327, DOI 10.1159/000488601
   Velasco A, 2016, RADIOLOGY, V280, P169, DOI 10.1148/radiol.2015150575
   Wong JHY, 2017, J NEUROINTERV SURG, V9, P1103, DOI 10.1136/neurintsurg-2016-012750
NR 24
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E736
EP E742
DI 10.1016/j.wneu.2019.02.140
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400091
PM 30851472
DA 2020-05-12
ER

PT J
AU You, MS
   Shin, JK
   Goh, TS
   Lee, JS
AF You, Myung Soo
   Shin, Jong Ki
   Goh, Tae Sik
   Lee, Jung Sub
TI Predictors of Clinical Outcome After Endoscopic Partial Facetectomy for
   Degenerative Lumbar Foraminal Stenosis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic; Facetectomy; Foraminal stenosis; Lumbar; Risk factors
ID RADIOLOGICAL OUTCOMES; INTERVERTEBRAL FORAMEN; PARTIAL PEDICULECTOMY;
   FLEXION-EXTENSION; RISK-FACTORS; NERVE; DECOMPRESSION; ENTRAPMENT
AB OBJECTIVE: Endoscopic partial facetectomy (EPF) is an effective option for decompressing the lumbar exiting root without causing spinal instabilities in the treatment of patients with degenerative lumbar foraminal stenosis. The aim of the present study was to identify the preoperative risk factors of poor clinical outcomes after EPF in patients with degenerative lumbar foraminal stenosis.
   METHODS: A total of 51 consecutive patients who had undergone EPF from 2012 to 2015 were included in the present study. The clinical outcomes were evaluated using the visual analog scale (VAS), Oswestry disability index (ODI), and Short-Form 36-item (SF-36) outcome questionnaires. The preoperative radiological risk factors were measured using the lumbar Cobb's angle, disc wedging angle, lumbar lordosis (LL), segmental lordosis, disc height index, presence of spondylolisthesis, and morphological changes (no change, horizontal collapse, vertical collapse) of the exiting root within the most stenotic level on preoperative magnetic resonance imaging.
   RESULTS: The VAS, ODI, and SF-36 scores had significantly improved at the 1-month follow-up visit compared with the baseline mean values and were maintained within the 2-year follow-up period. A correlation analysis revealed significant relationships between various preoperative factors and clinical outcomes. On multiple regression analysis, the morphological change of vertical collapse significantly predicted the VAS, ODI, and SF-36 scores, and LL significantly predicted the ODI and SF-36 scores.
   CONCLUSIONS: A morphological change in vertical collapse found on preoperative magnetic resonance imaging and decreased LL were significant predictors of poor clinical outcomes after EPF in the treatment of lumbar foraminal stenosis.
C1 [You, Myung Soo; Shin, Jong Ki] Myungeun Hosp, Dept Orthopaed Surg, Busan, South Korea.
   [Goh, Tae Sik; Lee, Jung Sub] Pusan Natl Univ Hosp, Med Res Inst, Dept Orthopaed Surg, Busan, South Korea.
RP Lee, JS (reprint author), Pusan Natl Univ Hosp, Med Res Inst, Dept Orthopaed Surg, Busan, South Korea.
EM jungsublee@pusan.ac.kr
FU Pusan National UniversityPusan National University
FX This work was supported by a 2-year research grant from Pusan National
   University.
CR Ahn Y, 2014, NEUROSURGERY, V75, P124, DOI 10.1227/NEU.0000000000000361
   Bae JS, 2016, J KOREAN NEUROSURG S, V59, P143, DOI 10.3340/jkns.2016.59.2.143
   Chang HS, 2018, WORLD NEUROSURG, V109, pE684, DOI 10.1016/j.wneu.2017.10.055
   Chang SB, 2006, SPINE, V31, P1163, DOI 10.1097/01.brs.0000216431.69359.91
   Fujiwara A, 2001, SPINE, V26, P876, DOI 10.1097/00007632-200104150-00010
   Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96
   Haimoto S, 2018, NEUROL MED-CHIR, V58, P49, DOI 10.2176/nmc.oa.2017-0121
   Haufe SMW, 2007, J SPINAL DISORD TECH, V20, P146, DOI 10.1097/01.bsd.0000211256.05626.6b
   Inoue H, 1999, SKELETAL RADIOL, V28, P638, DOI 10.1007/s002560050566
   Inufusa A, 1996, SPINE, V21, P2412, DOI 10.1097/00007632-199611010-00002
   Jenis LG, 2000, SPINE, V25, P389, DOI 10.1097/00007632-200002010-00022
   Kang K, 2014, ADV ORTHOP, V2014, DOI 10.1155/2014/534658
   KUNOGI J, 1991, SPINE, V16, P1312, DOI 10.1097/00007632-199111000-00012
   Lee S, 2010, AM J ROENTGENOL, V194, P1095, DOI 10.2214/AJR.09.2772
   NATHAN H, 1982, INT ORTHOP, V6, P197, DOI 10.1007/BF00267730
   Ozeki N, 2008, J SPINAL DISORD TECH, V21, P324, DOI 10.1097/BSD.0b013e318149e681
   Ploumis A, 2006, SPINE, V31, P2353, DOI 10.1097/01.brs.0000240206.00747.cb
   PORTER RW, 1984, SPINE, V9, P418, DOI 10.1097/00007632-198405000-00017
   Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4
   Shenouda EF, 2002, BRIT J NEUROSURG, V16, P494, DOI 10.1080/0268869021000030320
   WILTSE LL, 1984, SPINE, V9, P31, DOI 10.1097/00007632-198401000-00008
   Yamada K, 2013, SPINE, V38, pE723, DOI 10.1097/BRS.0b013e31828f4e12
   Yamada K, 2011, EUR SPINE J, V20, P947, DOI 10.1007/s00586-010-1597-1
   Youn MS, 2017, ACTA NEUROCHIR, V159, P1129, DOI 10.1007/s00701-017-3186-0
NR 24
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1482
EP E1488
DI 10.1016/j.wneu.2019.03.126
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400186
PM 30905646
DA 2020-05-12
ER

PT J
AU Yu, ZY
   Zheng, J
   Ma, L
   Li, H
   You, C
   Jiang, Y
AF Yu, Zhiyuan
   Zheng, Jun
   Ma, Lu
   Li, Hao
   You, Chao
   Jiang, Yan
TI Predictive Value of Cerebral Autoregulation Impairment for Delayed
   Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral autoregulation; Delayed cerebral ischemia; Subarachnoid
   hemorrhage
ID CEREBROVASCULAR AUTOREGULATION; ANGIOGRAPHIC VASOSPASM; DOUBLE-BLIND;
   CLAZOSENTAN; NIMODIPINE; DEFICITS; VOLUME; TRIAL
AB OBJECTIVE: Delayed cerebral ischemia (DCI) happens in about 30% of patients with aneurysmal subarachnoid hemorrhage (SAH) and is related to higher mortality and disability. Some studies have shown cerebral autoregulation impairment can be a predictor of DCI in aneurysmal SAH. We conducted this meta-analysis to evaluate the predictive value of cerebral autoregulation impairment for DCI based on the current literature.
   METHODS: A systematic literature search was performed in PubMed and Embase. According to inclusion and exclusion criteria, 2 authors screened the records and extracted data from the included studies. Pooled sensitivity, specificity, and their 95% confidence intervals (CIs) were obtained. To investigate the overall accuracy, a summary receiver operating characteristic (SROC) curve was built and the area under SROC curve was calculated. Deeks' linear regression was used to assess the publication bias. All statistical analyses were performed with Stata 14.0.
   RESULTS: A total of 7 studies were finally included in this meta-analysis. The pooled sensitivity and specificity values of impaired cerebral autoregulation for DCI prediction were 0.79 (95% CI, 0.65-0.88) and 0.85 (95% CI, 0.615-0.96). Moreover, the area under the SROC curve of cerebral autoregulation impairment for DCI prediction was 0.87 (95% CI, 0.835-0.89). No obvious publication bias was found in Deeks' linear regression (P = 0.99).
   CONCLUSIONS: Cerebral autoregulation impairment can be a helpful predictor of DCI in aneurysmal SAH. Its accuracy for DCI prediction should be verified by more studies in the future.
C1 [Yu, Zhiyuan; Zheng, Jun; Ma, Lu; Li, Hao; You, Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
   [Jiang, Yan] Sichuan Univ, West China Hosp, Dept Nursing, Chengdu, Sichuan, Peoples R China.
RP Jiang, Y (reprint author), Sichuan Univ, West China Hosp, Dept Nursing, Chengdu, Sichuan, Peoples R China.
EM jiangyanhuaxi@sohu.com
CR ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103
   Amin-Hanjani S, 2004, NEUROSURGERY, V54, P326, DOI 10.1227/01.NEU.0000103488.94855.4F
   Brown RJ, 2013, NEUROSURGERY, V72, P702, DOI 10.1227/NEU.0b013e318285c3db
   Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711
   Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11
   Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189
   Burrell C, 2016, EXPERT REV NEUROTHER, V16, P1251, DOI 10.1080/14737175.2016.1203257
   Calviere L, 2015, NEUROCRIT CARE, V23, P253, DOI 10.1007/s12028-015-0125-x
   Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005
   Duan YX, 2017, J STROKE CEREBROVASC, V26, P162, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.004
   Fontana J, 2015, NEUROCRIT CARE, V23, P355, DOI 10.1007/s12028-014-0104-7
   Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6
   Gaasch M, 2018, CRIT CARE MED, V46, P774, DOI 10.1097/CCM.0000000000003016
   Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215
   Hanggi D, 2015, NEUROCRIT CARE, V23, P274, DOI 10.1007/s12028-015-0112-2
   HASAN D, 1989, STROKE, V20, P1156, DOI 10.1161/01.STR.20.9.1156
   Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99
   Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888
   Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004
   Liu GJ, 2018, WORLD NEUROSURG, V118, pE269, DOI 10.1016/j.wneu.2018.06.170
   Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942
   Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9
   Otite F, 2014, STROKE, V45, P677, DOI 10.1161/STROKEAHA.113.002630
   Park S, 2015, J KOREAN NEUROSURG S, V57, P167, DOI 10.3340/jkns.2015.57.3.167
   Ratsep T, 2001, J NEUROSURG, V95, P393, DOI 10.3171/jns.2001.95.3.0393
   Santos GA, 2016, NEUROLOGY, V86, P1950, DOI 10.1212/WNL.0000000000002696
   Tagami T, 2014, CRIT CARE MED, V42, P1348, DOI 10.1097/CCM.0000000000000163
   Veldeman M, 2016, BRIT J ANAESTH, V117, P17, DOI 10.1093/bja/aew095
   Vergouwen MDI, 2011, J CEREBR BLOOD F MET, V31, P1545, DOI 10.1038/jcbfm.2011.56
   Zijlstra IA, 2016, AM J NEURORADIOL, V37, P1588, DOI 10.3174/ajnr.A4771
NR 30
TC 3
Z9 4
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E853
EP E859
DI 10.1016/j.wneu.2019.02.188
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400106
PM 30862594
DA 2020-05-12
ER

PT J
AU Yu, ZY
   Zheng, J
   Xia, F
   Guo, R
   Ma, L
   You, C
   Li, H
AF Yu, Zhiyuan
   Zheng, Jun
   Xia, Fan
   Guo, Rui
   Ma, Lu
   You, Chao
   Li, Hao
TI BAT Score Versus Spot Sign in Predicting Intracerebral Hemorrhage
   Expansion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Computed tomography; Hematoma expansion; Prediction score; Spontaneous
   intracerebral hemorrhage; Spot sign
ID BLACK-HOLE SIGN; HEMATOMA EXPANSION; COMPUTED-TOMOGRAPHY; CT
   ANGIOGRAPHY; BLEND SIGN; GROWTH; GUIDELINES; MANAGEMENT; MORTALITY;
   ACCURACY
AB OBJECTIVE: The BAT score is a novel prediction score of hematoma expansion based on noncontrast computed tomography (CT) and consists of the blend sign, hypodensities, and time interval from onset to CT. This study aimed to compare the BAT score and the spot sign on CT angiography in a cohort of patients with spontaneous intracerebral hemorrhage.
   METHODS: Eligible patients with spontaneous intracerebral hemorrhage were analyzed retrospectively. The BAT score and the spot sign were assessed according to the criteria described in previous studies. Receiver operating curve analysis was used to assess the performance of the BAT score and the spot sign in hematoma expansion prediction.
   RESULTS: In 225 included patients, 34 (15.1%) had a BAT score >= 3. The spot sign was shown in 68 (30.2%) patients. Hematoma expansion was identified in 56 (24.9%) patients. In multivariate analysis, both BAT score >= 3 and presence of spot sign were independently correlated with hematoma expansion. BAT score >= 3 had 0.41 sensitivity and 0.93 specificity, and spot sign had 0.64 sensitivity and 0.81 specificity. The area under the curve of BAT score >= 3 and area under the curve of spot sign were 0.673 and 0.727, respectively (P = 0.386).
   CONCLUSIONS: The BAT score based on noncontrast CT is a good predictor of hematoma expansion. When CT angiography spot sign is unobtainable, the BAT score can be used to predict hematoma expansion.
C1 [Yu, Zhiyuan; Zheng, Jun; Xia, Fan; Guo, Rui; Ma, Lu; You, Chao; Li, Hao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
RP Li, H (reprint author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM ns_lihao@126.com
FU Outstanding Subject Development 135 Project of West China Hospital,
   Sichuan University [ZY2016102]
FX This work was supported by Outstanding Subject Development 135 Project
   of West China Hospital, Sichuan University (Grant No. ZY2016102).
CR Barras CD, 2009, STROKE, V40, P1325, DOI 10.1161/STROKEAHA.108.536888
   Boulouis G, 2016, JAMA NEUROL, V73, P961, DOI 10.1001/jamaneurol.2016.1218
   Brouwers HB, 2014, JAMA NEUROL, V71, P158, DOI 10.1001/jamaneurol.2013.5433
   Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99
   Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8
   Du FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115777
   Han JH, 2014, J KOREAN NEUROSURG S, V56, P303, DOI 10.3340/jkns.2014.56.4.303
   Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069
   Hotta K, 2014, ACTA NEUROCHIR, V156, P911, DOI 10.1007/s00701-014-2019-7
   Kim HT, 2015, J KOREAN NEUROSURG S, V58, P309, DOI 10.3340/jkns.2015.58.4.309
   Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304
   Li Q, 2017, STROKE, V48, P3019, DOI 10.1161/STROKEAHA.117.017985
   Li Q, 2016, STROKE, V47, P1777, DOI 10.1161/STROKEAHA.116.013186
   Li Q, 2015, STROKE, V46, P2119, DOI 10.1161/STROKEAHA.115.009185
   Liu LP, 2017, INT J STROKE, V12, P326, DOI 10.1177/1747493017694394
   Morotti A, 2018, STROKE, V49, P1163, DOI 10.1161/STROKEAHA.117.020138
   Morotti A, 2017, JAMA NEUROL, V74, P950, DOI 10.1001/jamaneurol.2017.1014
   Morotti A, 2016, NEUROCRIT CARE, V25, P79, DOI 10.1007/s12028-016-0241-2
   Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8
   Salman RAS, 2018, LANCET NEUROL, V17, P885, DOI 10.1016/S1474-4422(18)30253-9
   Salman RAS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005951.pub4
   Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309
   van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0
   Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3
   Xu XH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011945
   Yu ZY, 2017, NEUROL SCI, V38, P1591, DOI 10.1007/s10072-017-3006-6
   Zheng J, 2017, MED SCI MONITOR, V23, P2250, DOI 10.12659/MSM.901583
NR 27
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E694
EP E698
DI 10.1016/j.wneu.2019.02.125
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400085
PM 30844526
DA 2020-05-12
ER

PT J
AU Yu, ZY
   Wen, DK
   Zheng, J
   Guo, R
   Li, H
   You, C
   Ma, L
AF Yu, Zhiyuan
   Wen, Dingke
   Zheng, Jun
   Guo, Rui
   Li, Hao
   You, Chao
   Ma, Lu
TI Predictive Accuracy of Alpha-Delta Ratio on Quantitative
   Electroencephalography for Delayed Cerebral Ischemia in Patients with
   Aneurysmal Subarachnoid Hemorrhage: Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Alpha-delta ratio; Delayed cerebral ischemia; Quantitative
   electroencephalography; Subarachnoid hemorrhage
ID CONTINUOUS EEG; VASOSPASM; PERFUSION
AB OBJECTIVE: Delayed cerebral ischemia (DCI) is significantly related to death and unfavorable functional outcome in patients with aneurysmal subarachnoid hemorrhage (SAH). The association between alpha-delta ratio (ADR) on quantitative electroencephalography (EEG) and DCI has been reported in several previous studies, but their results are conflicting. This meta-analysis was conducted to assess the accuracy of ADR for DCI prediction in patients with aneurysmal SAH.
   METHODS: PubMed and Embase were systematically searched for related records. Study selection and data collection were completed by 2 investigators. Sensitivity, specificity, and their 95% confidence intervals (CIs) were pooled. A summary receiver operating characteristic curve was plotted to show the pooled accuracy. Deeks funnel plot was used to evaluate publication bias.
   RESULTS: Five studies were included in this meta-analysis. The pooled sensitivity and specificity of worsening ADR for DCI prediction in patients with aneurysmal SAH were 0.83 (95% CI 0.44-0.97) and 0.74 (95% CI 0.50-0.89), respectively. In addition, the area under the summary receiver operating characteristic curve was 0.84 (95% CI 0.81-0.87). No obvious publication bias was found using Deeks funnel plot (P = 0.29).
   CONCLUSIONS: Worsening ADR on quantitative EEG is a reliable predictor of DCI in patients with aneurysmal SAH. Further studies are still needed to confirm the role of quantitative EEG in DCI prediction.
C1 [Yu, Zhiyuan; Wen, Dingke; Zheng, Jun; Guo, Rui; Li, Hao; You, Chao; Ma, Lu] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
RP Ma, L (reprint author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM alex80350305@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81801186]; Outstanding Subject Development 135
   Project of West China Hospital, Sichuan University [ZY2016102]
FX This work was supported by National Natural Science Foundation of China
   (grant 81801186) and Outstanding Subject Development 135 Project of West
   China Hospital, Sichuan University (grant ZY2016102).
CR Balanca B, 2018, CLIN NEUROPHYSIOL, V129, P1926, DOI 10.1016/j.clinph.2018.06.013
   Burrell C, 2016, EXPERT REV NEUROTHER, V16, P1251, DOI 10.1080/14737175.2016.1203257
   Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017
   de Rooij NK, 2013, STROKE, V44, P1288, DOI 10.1161/STROKEAHA.113.001125
   de Rooij NK, 2013, STROKE, V44, P43, DOI 10.1161/STROKEAHA.112.674291
   Da Silva IRF, 2017, J CRIT CARE, V37, P126, DOI 10.1016/j.jcrc.2016.09.011
   Francoeur CL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1447-6
   Gaspard N, 2016, J CLIN NEUROPHYSIOL, V33, P211, DOI 10.1097/WNP.0000000000000279
   Geraghty JR, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0690-x
   Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215
   Kim JA, 2017, CLIN NEUROPHYSIOL, V128, P1091, DOI 10.1016/j.clinph.2017.01.016
   Kondziella D, 2015, NEUROCRIT CARE, V22, P450, DOI 10.1007/s12028-014-0068-7
   Kruyt ND, 2008, J NEUROL NEUROSUR PS, V79, P1382, DOI 10.1136/jnnp.2007.142034
   Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428
   Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7
   Macdonald RL, 2016, STROKE, V47, pe11, DOI 10.1161/STROKEAHA.114.006498
   Muniz CF, 2016, J CLIN NEUROPHYSIOL, V33, P217, DOI 10.1097/WNP.0000000000000281
   Ohnishi H, 2013, J STROKE CEREBROVASC, V22, P520, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.005
   Rathakrishnan R, 2011, NEUROCRIT CARE, V14, P152, DOI 10.1007/s12028-010-9495-2
   Rodriguez-Regent C, 2016, EUR RADIOL, V26, P2956, DOI 10.1007/s00330-015-4135-z
   Rosenthal ES, 2018, ANN NEUROL, V83, P958, DOI 10.1002/ana.25232
   Rots ML, 2016, NEUROCRIT CARE, V24, P207, DOI 10.1007/s12028-015-0205-y
   Roy B, 2017, CEREBROVASC DIS, V43, P266, DOI 10.1159/000458536
   Russin JJ, 2018, J CEREBR BLOOD F MET, V38, P973, DOI 10.1177/0271678X18768670
   Stienen MN, 2014, WORLD NEUROSURG, V82, pE599, DOI 10.1016/j.wneu.2014.05.011
   Sun HG, 2013, NEUROL INDIA, V61, P507, DOI 10.4103/0028-3886.121922
   Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0
   Wickering E, 2016, J CLIN NEUROPHYSIOL, V33, P227, DOI 10.1097/WNP.0000000000000278
NR 28
TC 2
Z9 2
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E510
EP E516
DI 10.1016/j.wneu.2019.02.082
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400061
PM 30825635
DA 2020-05-12
ER

PT J
AU Zarate-Kalfopulos, B
   Reyes-Tarrago, F
   Navarro-Aceves, LA
   Garcia-Ramos, CL
   Reyes-Sanchez, AA
   Alpizar-Aguirre, A
   Rosales-Olivarez, LM
AF Zarate-Kalfopulos, Baron
   Reyes-Tarrago, Fernando
   Alberto Navarro-Aceves, Luis
   Lissette Garcia-Ramos, Carla
   Antonio Reyes-Sanchez, Alejandro
   Alpizar-Aguirre, Armando
   Miguel Rosales-Olivarez, Luis
TI Characteristics of Spinopelvic Sagittal Alignment in Lumbar Degenerative
   Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE Degenerative spondylolisthesis; Lumbar degenerative diseases; Lumbar
   spinal stenosis; Pelvic parameters; Spine sagittal profile
ID SPONDYLOLISTHESIS; CLASSIFICATION; PELVIS; SPINE
AB BACKGROUND: Normal sagittal alignment shows a range of variations and normal values. This study compared sagittal vertebral alignment in patients with different degenerative lumbar diseases.
   METHODS: This cross-sectional study evaluated 300 patients who were enrolled between June 2016 and June 2017. Of these patients, 213 met the study criteria and were included.
   RESULTS: Of the 213 patients, 66 were men (31%) and 147 were women (68.2%). The mean age was 62.7 years. Diagnoses included degenerative spondylolisthesis in 116 patients (52.7%), lumbar disk degeneration in 76 patients (34.5%), lumbar spinal stenosis in 19 patients (8.6%), and lytic spondylolisthesis in 7 patients (3.2%). The most frequent Roussouly type of sagittal alignment was type 3 (33.6%), followed by type 4 (25.9%). No significant correlation was associated with Roussouly type of sagittal alignment and lumbar degenerative disease. Median sagittal vertebral alignment parameters in the series were as follows: pelvic incidence (PI), 60.55 degrees +/- 15.62 degrees; sacral slope, 39.09 degrees +/- 12.48 degrees; pelvic tilt, 20.92 degrees +/- 8.99 degrees; lumbar lordosis, 33.15 degrees +/- 18.49 degrees; and sagittal balance, 19.64 +/- 55.27 mm. One hundred sixteen patients with degenerative spondylolisthesis had significant greater PI than those with other diagnoses (61.56 degrees vs. 58.3 degrees, respectively; P = 0.005), and patients with lumbar spinal stenosis had significantly lower PI than those with other diagnoses (55.89 degrees vs. 60.44 degrees, respectively; P = 0.005).
   CONCLUSIONS: Pelvic incidence may play a predisposing role in the pathogenesis of lumbar degenerative disease. Patients with degenerative spondylolisthesis have greater pelvic incidence with increased lumbar lordosis. In contrast, patients with spinal stenosis have lower pelvic incidence with flatter lumbar lordosis.
C1 [Zarate-Kalfopulos, Baron; Reyes-Tarrago, Fernando; Alberto Navarro-Aceves, Luis; Lissette Garcia-Ramos, Carla; Antonio Reyes-Sanchez, Alejandro; Alpizar-Aguirre, Armando; Miguel Rosales-Olivarez, Luis] Natl Inst Rehabil, Spine Surg Serv, Mexico City, DF, Mexico.
RP Zarate-Kalfopulos, B (reprint author), Natl Inst Rehabil, Spine Surg Serv, Mexico City, DF, Mexico.
EM bzarate@inr.gob.mx
CR Barrey C, 2007, NEUROSURGERY, V61, P981, DOI 10.1227/01.neu.0000303194.02921.30
   Buckland AJ, 2017, SPINE J, V17, P1601, DOI 10.1016/j.spinee.2017.05.021
   Cinotti G, 1997, INT ORTHOP, V21, P337, DOI 10.1007/s002640050180
   DURING J, 1985, SPINE, V10, P83, DOI 10.1097/00007632-198501000-00013
   DUVALBEAUPERE G, 1992, ANN BIOMED ENG, V20, P451, DOI 10.1007/BF02368136
   Farrokhi MR, 2016, CLIN NEUROL NEUROSUR, V151, P136, DOI 10.1016/j.clineuro.2016.10.020
   Funao H, 2012, EUR SPINE J, V21, P2181, DOI 10.1007/s00586-012-2374-0
   GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005
   Korovessis PG, 1998, SPINE, V23, P700, DOI 10.1097/00007632-199803150-00010
   Lim JK, 2013, J KOREAN NEUROSURG S, V53, P96, DOI 10.3340/jkns.2013.53.2.96
   Madkouri R, 2018, WORLD NEUROSURG, V114, pE417, DOI 10.1016/j.wneu.2018.03.002
   Mardare Mihai, 2016, Eur J Orthop Surg Traumatol, V26, P735, DOI 10.1007/s00590-016-1842-3
   Morel E, 2004, 2 JOURNEES RACHIS PA, P107
   Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011
   Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65
   Yang X, 2014, EUR SPINE J, V23, P569, DOI 10.1007/s00586-013-3067-z
   Zarate-Kalfopulos B, 2012, J NEUROSURG-SPINE, V16, P516, DOI 10.3171/2012.2.SPINE11755
NR 17
TC 0
Z9 1
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E417
EP E421
DI 10.1016/j.wneu.2019.02.067
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400049
PM 30822583
DA 2020-05-12
ER

PT J
AU Zhang, LB
   Zeng, FY
   Wang, JY
   Chen, FH
AF Zhang, Longbo
   Zeng, Feiyue
   Wang, Junyu
   Chen, Fenghua
TI Finding the Inferior Petrosal Sinus for Embolizing Cavernous Dural
   Arteriovenous Fistula Using Preoperative Computed Tomography Angiography
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cavernous dural arteriovenous fistula; Computed tomography angiography;
   Endovascular treatment; Inferior petrosal sinus
ID ENDOVASCULAR TREATMENT; CONFLUENCE PATTERN; VEIN; EMBOLIZATION
AB BACKGROUND: Inferior petrosal sinus (IPS) has been commonly adopted as a route for embolizing cavernous dural arteriovenous fistula (cDAVF). According to previous anatomical studies, > 90% of persons have an IPS. Because the exact confluence position of the IPS with an internal jugular vein can be difficult to obtain using preoperative digital subtraction angiography (DSA), catheterizing into the IPS during endovascular treatment can sometimes be very difficult. Because the anatomical information has not been attainable, this route has not been as widely used. Thus, methods remain to be developed to allow the IPS to play its due role in the embolization of cDAVF.
   METHODS: Seven cases of cDAVF were diagnosed by DSA. The 7 patients also underwent preoperative computed tomography angiography (CTA) and were treated by transvenous embolization.
   RESULTS: Compared with DSA, the confluence position of the IPS with the internal jugular vein was easier to find using preoperative CTA in 6 cases. Based on this anatomical information, 6 cases were successfully embolized via the IPS route and 1 via the superior ophthalmic vein route.
   CONCLUSIONS: Detailed anatomical information of the IPS can be obtained from preoperative CTA images. Thus, CTA can help localize the IPS and allow for embolization of cDAVF via the IPS route.
C1 [Zhang, Longbo; Wang, Junyu; Chen, Fenghua] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China.
   [Zeng, Feiyue] Cent S Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China.
RP Chen, FH (reprint author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China.
EM xycfh@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81671123, 81873756]
FX The present study was supported by a grant from the National Natural
   Science Foundation of China (grants 81671123 and 81873756).
CR Kim DJ, 2006, AM J NEURORADIOL, V27, P2078
   Kurata A, 2009, NEURORADIOLOGY, V51, P755, DOI 10.1007/s00234-009-0554-3
   Lv XL, 2015, INTERV NEURORADIOL, V21, P769, DOI 10.1177/1753425915590067
   Mitsuhashi Y, 2007, AM J NEURORADIOL, V28, P1179, DOI 10.3174/ajnr.A0489
   Nishimuta Y, 2017, ACTA NEUROCHIR, V159, P2113, DOI 10.1007/s00701-017-3336-4
   Rhim JK, 2015, NEUROSURGERY, V77, P192, DOI 10.1227/NEU.0000000000000751
   Singh V, 2016, INTERV NEURORADIOL, V22, P108, DOI 10.1177/1591019915617318
   Thiex R, 2014, J CLIN NEUROSCI, V21, P1238, DOI 10.1016/j.jocn.2013.11.011
   Tubbs RS, 2014, CLIN ANAT, V27, P698, DOI 10.1002/ca.22268
   Zhang WG, 2010, SURG RADIOL ANAT, V32, P563, DOI 10.1007/s00276-009-0602-z
NR 10
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1069
EP E1074
DI 10.1016/j.wneu.2019.03.047
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400135
PM 30878755
DA 2020-05-12
ER

PT J
AU Zhang, Q
   Jia, GJ
   Zhang, GB
   Wang, L
   Wu, Z
   Jia, W
   Hao, SY
   Ni, M
   Li, D
   Wang, K
   Zhang, JT
AF Zhang, Qing
   Jia, Gui-Jun
   Zhang, Guo-Bin
   Wang, Liang
   Wu, Zhen
   Jia, Wang
   Hao, Shu-Yu
   Ni, Ming
   Li, Da
   Wang, Ke
   Zhang, Jun-Ting
TI A Logistic Regression Model for Detecting the Presence of Malignant
   Progression in Atypical Meningiomas
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atypical meningioma; Connexin 43; Irregular shape; Malignant progression
ID GAP-JUNCTION PROTEIN; ANAPLASTIC MENINGIOMAS; C-SRC; INTRACRANIAL
   MENINGIOMAS; CELL-DEATH; CONNEXIN43; GROWTH; EXPRESSION; LOCALIZATION;
   FEATURES
AB OBJECTIVE: To develop a method to distinguish atypical meningiomas (AMs) with malignant progression (MP) from primary AMs without a clinical history.
   METHODS: The clinical, radiologic, and pathologic data of 33 previously Simpson grade I resected (if any) as well as no radiotherapy treated intracranial AMs between January 2008 and December 2015 were reviewed. Immunohistochemical staining for connexin 43 (Cx43) and Ki-67 was performed. Descriptive analysis and univariate and multivariate logistic regression analyses were used to explore independent predictors of MP. A multivariable logistic model was developed to estimate the risk of MP, and its diagnostic value was determined from a receiver operating characteristic curve.
   RESULTS: There were 11 AMs (33.3%) with histopathologically confirmed MP from benign meningiomas. The other 22 (66.7%) were initially diagnosed AMs with no histopathologically confirmedMP during a median 60.5 months (range, 42e126 months) of follow-up. Univariate and multivariate logistic analyses showed that irregular tumor shape (P = 0.010) and lowCx43 expression (P=0.010) were independent predictors of the presence of MP, and the predicted probability was calculated by the following formula: P =1/[1+exp.{1.218-(3.2023xShape)+(3.8143xCx43)}]. P > 0.5 for an irregularly shaped (score 1) AM with low Cx43 expression (score 0) indicated a high probability of MP. The sensitivity, specificity, positive predictive value, negative predictive value, and overall predictive accuracy were 63.6, 95.6, 87.5, 84.0, and 84.8%, respectively.
   CONCLUSIONS: Low Cx43 expression and irregular tumor shape were independent predictors of the presence of MP. The relevant logistic regression model was found to be effective in distinguishing MP-AMs from primary AMs.
C1 [Zhang, Qing; Jia, Gui-Jun; Zhang, Guo-Bin; Wang, Liang; Wu, Zhen; Jia, Wang; Hao, Shu-Yu; Ni, Ming; Li, Da; Wang, Ke; Zhang, Jun-Ting] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Zhang, Qing; Jia, Gui-Jun; Zhang, Guo-Bin; Wang, Liang; Wu, Zhen; Jia, Wang; Hao, Shu-Yu; Ni, Ming; Li, Da; Wang, Ke; Zhang, Jun-Ting] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.
   [Zhang, Qing; Jia, Gui-Jun; Zhang, Guo-Bin; Wang, Liang; Wu, Zhen; Jia, Wang; Hao, Shu-Yu; Ni, Ming; Li, Da; Wang, Ke; Zhang, Jun-Ting] Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China.
   [Zhang, Qing; Jia, Gui-Jun; Zhang, Guo-Bin; Wang, Liang; Wu, Zhen; Jia, Wang; Hao, Shu-Yu; Ni, Ming; Li, Da; Wang, Ke; Zhang, Jun-Ting] Beijing Key Lab Brain Tumor, Beijing, Peoples R China.
RP Zhang, JT (reprint author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Zhang, JT (reprint author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Zhang, JT (reprint author), Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing, Peoples R China.; Zhang, JT (reprint author), Beijing Key Lab Brain Tumor, Beijing, Peoples R China.
EM zhangjunting2003@aliyun.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81472370]
FX This work was supported by the National Natural Science Foundation of
   China (grant number 81472370).
CR Aasen T, 2016, NAT REV CANCER, V16, P775, DOI 10.1038/nrc.2016.105
   ADEGBITE AB, 1983, J NEUROSURG, V58, P51, DOI 10.3171/jns.1983.58.1.0051
   Akiyama M, 2005, BIOCHEM BIOPH RES CO, V335, P1264, DOI 10.1016/j.bbrc.2005.08.019
   Al-Mefty O, 2004, J NEUROSURG, V101, P210, DOI 10.3171/jns.2004.101.2.0210
   Arishima H, 2002, J NEUROPATH EXP NEUR, V61, P1048, DOI 10.1093/jnen/61.12.1048
   Blanc EM, 1998, J NEUROCHEM, V70, P958
   Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426
   Cusato K, 2006, CELL DEATH DIFFER, V13, P1707, DOI 10.1038/sj.cdd.4401876
   Dang XT, 2003, MOL CELL BIOCHEM, V242, P35, DOI 10.1023/A:1021152709313
   Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138
   Estin D, 1999, NEUROSURGERY, V44, P361, DOI 10.1097/00006123-199902000-00068
   Gangoso E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.560
   Giaume C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00088
   Harada K, 2009, CANCER SCI, V100, P684, DOI 10.1111/j.1349-7006.2009.01093.x
   Hashiba T, 2006, BRAIN TUMOR PATHOL, V23, P49, DOI 10.1007/s10014-006-0199-4
   Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022
   Huang RP, 1998, CANCER RES, V58, P5089
   JAASKELAINEN J, 1986, SURG NEUROL, V25, P233, DOI 10.1016/0090-3019(86)90233-8
   JAASKELAINEN J, 1985, SURG NEUROL, V24, P165, DOI 10.1016/0090-3019(85)90180-6
   JELLINGER K, 1975, J NEUROL, V208, P279, DOI 10.1007/BF00312803
   Kalamarides M, 2002, GENE DEV, V16, P1060, DOI 10.1101/gad.226302
   Kalamarides M, 2008, BRAIN PATHOL, V18, P62, DOI 10.1111/j.1750-3639.2007.00105.x
   Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008
   Krayenbuhl N, 2007, NEUROSURGERY, V61, P495, DOI 10.1227/01.NEU.0000280009.79813.DE
   Krayenbuhl N, 2007, NEUROSURGERY, V61, P503
   Krutovskikh VA, 2000, ONCOGENE, V19, P505, DOI 10.1038/sj.onc.1203340
   Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001
   Li HJ, 2014, J CELL SCI, V127, P3269, DOI 10.1242/jcs.145193
   Liu H, 2016, J CRANIOFAC SURG, V27, pE229, DOI 10.1097/SCS.0000000000002361
   Mennecier G, 2008, MOL CARCINOGEN, V47, P391, DOI 10.1002/mc.20393
   Meunier C, 2017, J NEUROSCI, V37, P9064, DOI 10.1523/JNEUROSCI.2204-16.2017
   MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179
   Moorby C, 2001, EXP CELL RES, V271, P238, DOI 10.1006/excr.2001.5357
   Moorby CD, 2000, MOL CARCINOGEN, V28, P23, DOI 10.1002/(SICI)1098-2744(200005)28:1<23::AID-MC4>3.0.CO;2-J
   MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357
   Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455
   Olbina G, 2003, MOL CANCER RES, V1, P690
   Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132
   Palma L, 1997, J NEUROSURG, V86, P793, DOI 10.3171/jns.1997.86.5.0793
   ROHRINGER M, 1989, J NEUROSURG, V71, P665, DOI 10.3171/jns.1989.71.5.0665
   Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004
   Sato K, 1997, J NEUROPATH EXP NEUR, V56, P835
   Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627
   Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200
   Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x
   TANI E, 1974, ACTA NEUROPATHOL, V30, P305, DOI 10.1007/BF00697013
   Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200
   Wang J, 2018, NEURO-ONCOLOGY, V20, P885, DOI 10.1093/neuonc/nox207
   Wen Patrick Y, 2017, Continuum (Minneap Minn), V23, P1531, DOI 10.1212/CON.0000000000000536
   Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3
   Yang SY, 2008, J NEUROL NEUROSUR PS, V79, P574, DOI 10.1136/jnnp.2007.121582
   Yu SC, 2012, STEM CELLS, V30, P108, DOI 10.1002/stem.1685
   Zhou JL, 2012, EUR J RADIOL, V81, P3504, DOI 10.1016/j.ejrad.2012.04.034
   ZHU DG, 1992, P NATL ACAD SCI USA, V89, P10218, DOI 10.1073/pnas.89.21.10218
NR 54
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E392
EP E401
DI 10.1016/j.wneu.2019.02.062
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400046
PM 30822595
DA 2020-05-12
ER

PT J
AU Zhang, RP
   Wang, ZH
   Gao, L
   Guo, XP
   Feng, CZ
   Deng, K
   Lian, W
   Yao, Y
   Feng, M
   Bao, XJ
   Wang, RZ
   Xing, B
AF Zhang, Ruopeng
   Wang, Zihao
   Gao, Lu
   Guo, Xiaopeng
   Feng, Chenzhe
   Deng, Kan
   Lian, Wei
   Yao, Yong
   Feng, Ming
   Bao, Xinjie
   Wang, Rengzhi
   Xing, Bing
TI Clinical Characteristics and Postoperative Recovery of Hypopituitarism
   in Patients with Nonfunctional Pituitary Adenoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior pituitary; Hypopituitarism; Nonfunctioning pituitary adenoma;
   Pituitary surgery; Tumor size
ID FOLLOW-UP; MORTALITY; MANAGEMENT; SURGERY
AB OBJECTIVE: To investigate the clinical characteristics of hypopituitarism and its reversibility after surgery for nonfunctional pituitary adenoma (NFPA); analyze the correlation between tumor size and hypopituitarism incidence; and predict hypopituitarism by tumor volume and maximum diameter.
   METHODS: We retrospectively reviewed 164 patients with NFPA who underwent surgical treatment at Peking Union Medical College Hospital from January 2016 to December 2016. Demographic, imaging, and endocrine data were collected during preoperative, postoperative, and long-term follow-up (21.1 +/- 3.3 months) periods. Differences in hormone levels were analyzed by paired and independent samples t-tests. The cut-off values of tumor size and volume to predict hypopituitarism were calculated by receiver operating characteristic curves.
   RESULTS: In total, 80.4% (132/164) of patients had anterior pituitary hypofunction and 48.4% patients had hypogonadism; the recovery rate of luteinizing hormone was 80.9%, and follicular-stimulating hormone was 60%. In total, 36.5% of patients had hypothyroidism; the recovery rate of thyroxine was 85%, free thyroxine was 87.8%, and thyroid-stimulating hormone was 100.0%. Finally, 27.4% of patients had insulin-like growth factor 1 (IGF-1)/growth hormone (GH) hypofunction, and the recovery rate of IGF-1 was 77.8%. The preoperative free thyroxine, thyroxine, GH, IGF-1, follicular-stimulating hormone, and luteinizing hormone levels were significantly lower in the giant adenoma group (n = 43) than in the large adenoma group (n = 121). The hypopituitarism predictive cut-off value of tumor volume was 3105.1 mm(3) and that of tumor diameter was 23.5 mm.
   CONCLUSIONS: NFPA has a significant influence on gonadal hormone, IGF-1/GH, and thyroid hormone. NFPA can cause single- or multiple-hormone reduction in each pituitary target gland. Tumor size is positively correlated with the incidence and degree of hypopituitarism. NFPA-induced hypopituitarism is significantly recovered after surgical treatment.
C1 [Zhang, Ruopeng; Wang, Zihao; Gao, Lu; Guo, Xiaopeng; Feng, Chenzhe; Deng, Kan; Lian, Wei; Yao, Yong; Feng, Ming; Bao, Xinjie; Wang, Rengzhi; Xing, Bing] Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Zhang, Ruopeng; Wang, Zihao; Gao, Lu; Guo, Xiaopeng; Feng, Chenzhe; Deng, Kan; Lian, Wei; Yao, Yong; Feng, Ming; Bao, Xinjie; Wang, Rengzhi; Xing, Bing] Chinese Pituitary Adenoma Coop Rat Ye Grp, China Pituitary Dis Registry Ctr, Beijing, Peoples R China.
   [Zhang, Ruopeng; Wang, Zihao; Guo, Xiaopeng; Feng, Chenzhe] Chinese Acad Med Sci, Beijing, Peoples R China.
   [Zhang, Ruopeng; Wang, Zihao; Guo, Xiaopeng; Feng, Chenzhe] Peking Union Med Coll, Beijing, Peoples R China.
   [Deng, Kan; Lian, Wei; Yao, Yong; Feng, Ming; Bao, Xinjie; Wang, Rengzhi; Xing, Bing] Key Lab Endocrinol Natl Hlth & Family Planning Co, Beijing, Peoples R China.
RP Xing, B (reprint author), Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China.; Xing, B (reprint author), Chinese Pituitary Adenoma Coop Rat Ye Grp, China Pituitary Dis Registry Ctr, Beijing, Peoples R China.; Xing, B (reprint author), Key Lab Endocrinol Natl Hlth & Family Planning Co, Beijing, Peoples R China.
EM xingbingemail@aliyun.com
RI Wang, Zihao/I-9307-2018
OI Gao, Lu/0000-0003-1632-5101; ZHANG, RUOPENG/0000-0003-0878-2900
CR Asa SL, 2017, ENDOCR-RELAT CANCER, V24, pC5, DOI 10.1530/ERC-17-0004
   Bergsneider M, 2014, J NEURO-ONCOL, V117, P477, DOI 10.1007/s11060-014-1386-5
   Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812
   Chanson P, 2015, ANN ENDOCRINOL-PARIS, V76, P239, DOI 10.1016/j.ando.2015.04.002
   Delgado-Lopez PD, 2018, CLIN TRANSL ONCOL, V20, P1233, DOI 10.1007/s12094-018-1868-6
   Drummond JB, 2018, ENDOTEXT
   Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001
   Ferrante E, 2006, EUR J ENDOCRINOL, V155, P823, DOI 10.1530/eje.1.02298
   Jimenez C, 2008, EUR J ENDOCRINOL, V159, P517, DOI 10.1530/EJE-08-0205
   Manoranjan B, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0394-4
   MARAZUELA M, 1994, J ENDOCRINOL INVEST, V17, P703, DOI 10.1007/BF03347763
   MCLANAHAN CS, 1978, NEUROSURGERY, V3, P142
   Molitch ME, 2008, ENDOCRIN METAB CLIN, V37, P151, DOI 10.1016/j.ecl.2007.10.011
   Nguyen A, 2018, HORM METAB RES, V50, P303, DOI 10.1055/s-0043-120673
   Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3
   Ntali G, 2016, EUR J ENDOCRINOL, V174, P137, DOI 10.1530/EJE-15-0967
   O'Reilly MW, 2016, CLIN ENDOCRINOL, V85, P748, DOI 10.1111/cen.13141
   Olsson DS, 2017, EUR J ENDOCRINOL, V176, P67, DOI 10.1530/EJE-16-0450
   Park SS, 2018, WORLD NEUROSURG, V119, pE1035, DOI 10.1016/j.wneu.2018.08.068
   Spiriev Toma, 2017, Surg Neurol Int, V8, P241, DOI 10.4103/sni.sni_419_16
   Tampourlou M, 2018, PITUITARY, V21, P203, DOI 10.1007/s11102-018-0863-9
   Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X
   Wang ZH, 2019, PITUITARY, V22, P13, DOI 10.1007/s11102-018-0922-2
   Wildemberg LE, 2018, PITUITARY, V21, P138, DOI 10.1007/s11102-018-0870-x
   Zhang FF, 2015, INT J CLIN EXP MED, V8, P18990
NR 25
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1183
EP E1189
DI 10.1016/j.wneu.2019.03.062
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400148
PM 30880207
DA 2020-05-12
ER

PT J
AU Zhang, YB
   Zheng, SF
   Shang-Guan, HC
   Kang, DZ
   Chen, GR
   Yao, PS
AF Zhang, Yi-Bin
   Zheng, Shu-Fa
   Shang-Guan, Huang-Cheng
   Kang, De-Zhi
   Chen, Guo-Rong
   Yao, Pei-Sen
TI Lower Iron Levels Predict Acute Hydrocephalus Following Aneurysmal
   Subarachnoid Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Aneurysmal subarachnoid hemorrhage; Hydrocephalus; Serum iron
ID BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; CEREBRAL VASOSPASM; METABOLISM;
   INFLAMMATION; MECHANISMS; MODEL
AB OBJECTIVE: We tested the hypothesis that low serum iron levels are associated with acute hydrocephalus following aneurysmal subarachnoid hemorrhage (aSAH).
   METHODS: Patients presenting with ruptured intracranial aneurysms were enrolled in the prospective observational study. Age, sex, history of diabetes, hypertension and hyperlipidemia, symptom onset, Fisher grade, Hunt-Hess grade, aneurysm location, hemoglobin, and serum iron were collected. Acute hydrocephalus was determined within 72 hours after subarachnoid hemorrhage. A propensity-score matching analysis was performed to correct imbalances in patient characteristics between hydrocephalus and non-hydrocephalus groups.
   RESULTS: A total of 535 patients were included. Incidence of acute hydrocephalus was 20.0%. In multivariate logistic regression analysis, lower serum iron was considered as a risk factor of acute hydrocephalus, as well as delayed ischemic neurologic deficit and lower hemoglobin (P = 0.000). After propensity-score matching, lower serum iron was considered as an independent risk factor for acute hydrocephalus, whereas hemoglobin and delayed ischemic neurologic deficit were not. The matched hydrocephalus group had lower serum iron comparing with the matched non-hydrocephalus group (10.26 +/- 5.33 mmol/L vs. 13.44 +/- 5.18 mmol/L; P = 0.000). The optimal cut-off value for serum iron levels as a predictor for acute hydrocephalus in patients with aSAH was determined as 13.1 mmol/L in the receiver operating characteristic curve. Furthermore, lower serum iron levels (odds ratio 0.305; 95% confidence interval, 0.178-0.524; P = 0.000) and acute hydrocephalus (odds ratio 0.372; 95% confidence interval, 0.202-0.684; P = 0.001) were predictors of poor outcome, as well as higher Hunt-Hess grade and Fisher grade.
   CONCLUSIONS: Lower serum iron levels after aSAH was a predictor of acute hydrocephalus and unfavorable outcome.
C1 [Zheng, Shu-Fa; Kang, De-Zhi; Chen, Guo-Rong; Yao, Pei-Sen] Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.
   [Shang-Guan, Huang-Cheng] Fujian Med Univ, Affiliated Hosp 1, Dept Crit Med, Fuzhou, Fujian, Peoples R China.
   [Zhang, Yi-Bin; Yao, Pei-Sen] Dehua Cty Hosp, Dept Neurosurg, Quanzhou, Fujian, Peoples R China.
RP Yao, PS (reprint author), Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Fuzhou, Fujian, Peoples R China.; Yao, PS (reprint author), Dehua Cty Hosp, Dept Neurosurg, Quanzhou, Fujian, Peoples R China.
EM peisen.yao@163.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81802492]; Research Project of Health and Family
   Planning Commission of Quanzhou City [2018(15)-22]; Dehua County Science
   and Technology Bureau Research Project [2018(5)]; Young and Middle-Aged
   Backbone Key Research Project of National Health and Family Planning
   Commission of Fujian Province [2017-ZQN-46]; Natural Science Funding of
   Fujian Province [2018J01175, 2018J01176]; Special Fund for Public Health
   of Fujian Province Department of Finance [BPB-LZY2013]; Key Clinical
   Specialty Discipline Construction Program of Fujian, P.R.C; Major
   Project of Fujian Provincial Department of Science and Technology
   [2014YZ0003, 2014YZ01]
FX All authors declare no conflict of interest. This study was supported by
   the National Natural Science Foundation of China (No. 81802492 to
   Pei-Sen Yao), Research Project of Health and Family Planning Commission
   of Quanzhou City (No. 2018(15)-22 to Yi-Bin Zhang), Dehua County Science
   and Technology Bureau Research Project (No. 2018(5) to Yi-Bin Zhang),
   Young and Middle-Aged Backbone Key Research Project of National Health
   and Family Planning Commission of Fujian Province (No. 2017-ZQN-46 to
   Pei-Sen Yao), Natural Science Funding of Fujian Province (No. 2018J01175
   to Pei-Sen Yao and No. 2018J01176 to Shu-Fa Zheng), Special Fund for
   Public Health of Fujian Province Department of Finance (No. BPB-LZY2013
   to Zhang-Ya Lin), Key Clinical Specialty Discipline Construction Program
   of Fujian, P.R.C, and Major Project of Fujian Provincial Department of
   Science and Technology (No. 2014YZ0003 and No. 2014YZ01 to De-Zhi Kang).
CR Chen QW, 2015, STROKE, V46, P2902, DOI 10.1161/STROKEAHA.115.009713
   Chen S, 2017, BIOMED RES INT, DOI 10.1155/2017/8584753
   Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755
   Dupont S, 2013, NEUROL RES, V35, P107, DOI 10.1179/1743132812Y.0000000122
   Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56
   Gomes JA, 2014, NEUROCRIT CARE, V21, P285, DOI 10.1007/s12028-014-9977-8
   HASAN D, 1989, STROKE, V20, P747, DOI 10.1161/01.STR.20.6.747
   Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298
   Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10
   IWANOWSKI L, 1960, J NEUROPATH EXP NEUR, V19, P433, DOI 10.1097/00005072-196007000-00010
   Jabbarli R, 2016, EUR J NEUROL, V23, P912, DOI 10.1111/ene.12962
   Kang P, 2016, NEUROCRIT CARE, V24, P104, DOI 10.1007/s12028-015-0152-7
   Karimy JK, 2017, NAT MED, V23, P997, DOI 10.1038/nm.4361
   Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7
   Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6
   Koyanagi M, 2018, J NEUROSURG, V9, P1
   Li Q, 2018, J AM HEART ASS, V7
   Lodhia KR, 2006, ACTA NEUROCHIR SUPPL, V96, P207
   Loftspring MC, 2010, J CEREBR BLOOD F MET, V30, P1791, DOI 10.1038/jcbfm.2010.139
   Lu JJ, 2012, J CLIN NEUROSCI, V19, P669, DOI 10.1016/j.jocn.2011.06.032
   MACDONALD RL, 1991, J NEUROSURG, V75, P415, DOI 10.3171/jns.1991.75.3.0415
   Nishikawa H, 2018, TRANSL STROKE RES, V9, P110, DOI 10.1007/s12975-017-0564-0
   O'Kelly CJ, 2009, J NEUROSURG, V111, P1029, DOI 10.3171/2008.9.JNS08881
   Okubo S, 2013, STROKE, V44, P547, DOI 10.1161/STROKEAHA.112.662312
   Paisan GM, 2018, NEUROSURGERY, V83, P393, DOI 10.1093/neuros/nyx393
   de la Ossa NP, 2010, STROKE, V41, P810, DOI 10.1161/STROKEAHA.109.570168
   Shishido H, 2016, ACTA NEUROCHIR SUPPL, V121, P335, DOI 10.1007/978-3-319-18497-5_58
   Suzuki H, 2003, STROKE, V34, P2796, DOI 10.1161/01.STR.0000103743.62248.12
   Tan Q, 2017, BRAIN RES, V1654, P24, DOI 10.1016/j.brainres.2016.10.016
   Tombini M, 2013, EPILEPSY RES, V107, P244, DOI 10.1016/j.eplepsyres.2013.09.010
   Woernle CM, 2013, J CLIN NEUROSCI, V20, P824, DOI 10.1016/j.jocn.2012.07.015
   Xiong XY, 2015, NEUROL SCI, V36, P1843, DOI 10.1007/s10072-015-2266-2
   Yan H, 2016, BRAIN RES, V1630, P241, DOI 10.1016/j.brainres.2015.11.004
   Yolas C, 2016, WORLD NEUROSURG, V90, P484, DOI 10.1016/j.wneu.2016.03.049
   Zaidi HA, 2015, NEUROSURGERY, V76, P608, DOI 10.1227/NEU.0000000000000677
   Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y
NR 36
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E907
EP E913
DI 10.1016/j.wneu.2019.03.009
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400113
PM 30872197
DA 2020-05-12
ER

PT J
AU Zhao, B
   Xin, HX
   Fan, LH
   Tan, XX
   Zhong, M
   Pan, YH
   Wan, JQ
AF Zhao, Bing
   Xin, Haixia
   Fan, Lianghao
   Tan, Xianxi
   Zhong, Ming
   Pan, Yaohua
   Wan, Jieqing
TI Endovascular Coiling versus Surgical Clipping of Very Small Ruptured
   Anterior Communicating Artery Aneurysms
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior communicating artery aneurysms; Clipping complications;
   Coiling; Rupture; Outcome
ID OUTCOMES; SIZE
AB BACKGROUND: Endovascular coiling of anterior communicating artery (ACoA) aneurysms has evolved dramatically. Ruptured ACoA aneurysms are more likely to be smaller. We aimed to investigate the safety and efficacy of endovascular coiling of very small ruptured ACoA aneurysms compared with surgical clipping.
   METHODS: We conducted a retrospective analysis of consecutive 111 patients with very small ruptured ACoA aneurysms treated with endovascular coiling or surgical clipping in our single center. Very small aneurysms were defined as aneurysm maximal size <= 3.0 mm. Patients were grouped into coiling and clipping groups. Baseline characteristics, postoperative complications, and clinical outcomes were compared between the 2 groups.
   RESULTS: Forty-six patients (41.1%) underwent successfully coiling, and 65 patients (58.0%) underwent surgical clipping, including 2 patients who failed coiling and crossed over to surgical clipping. The mean size of the ruptured ACoA aneurysms was 2.6 +/- 0.5 mm (range, 1.0-3.0 mm). Patients with smaller aneurysms (P = 0.028) or A1 segment complete configuration (P = 0.009) more often underwent surgical clipping, and patients with A1 segment symmetric configuration more often underwent coiling (P = 0.011). There were not statistically significant differences in intraoperative rupture, early rebleeding, cerebral infarction, and seizure in patients treated with clipping and coiling. Clinical outcomes were similar between the 2 groups. There was no retreatment in both groups.
   CONCLUSIONS: Patients with very small ruptured ACoA aneurysms can be safely and effectively treated with endovascular coiling. However, smaller ACoA aneurysms still require surgical clipping. A smaller aneurysm size limits the use of endovascular coiling.
C1 [Zhao, Bing; Pan, Yaohua; Wan, Jieqing] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China.
   [Zhao, Bing; Tan, Xianxi; Zhong, Ming] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Peoples R China.
   [Fan, Lianghao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Peoples R China.
   [Xin, Haixia] Tongji Univ, Shanghai East Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China.
RP Wan, JQ (reprint author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China.
EM jieqingwan@126.com
FU National Key Research and Development Project [2016YFC1300800]; Clinical
   Research Plan of SHDC [16CR3031A, 16CR2045B]; SJTU Medical Engineering
   Cross-cutting Research Foundation [YG2017MS45]; Shanghai Municipal
   Commission of Health and Family Planning [201740080]; Shanghai Municipal
   Education Commission-Gaofeng Clinical Medicine Grant Support [20171914]
FX This study was supported by the National Key Research and Development
   Project (2016YFC1300800), the Clinical Research Plan of SHDC (16CR3031A,
   16CR2045B), the SJTU Medical Engineering Cross-cutting Research
   Foundation (YG2017MS45), Shanghai Municipal Commission of Health and
   Family Planning (201740080), and Shanghai Municipal Education
   Commission-Gaofeng Clinical Medicine Grant Support (20171914).
CR Asif KS, 2016, INTERV NEUROL, V5, P57, DOI 10.1159/000444662
   Chalouhi N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002865
   Fan LH, 2017, J NEUROINTERV SURG, V9, P370, DOI 10.1136/neurintsurg-2016-012335
   Fan LH, 2016, CLIN NEUROL NEUROSUR, V144, P96, DOI 10.1016/j.clineuro.2016.03.020
   Fang S, 2014, AM J NEURORADIOL, V35, P943, DOI 10.3174/ajnr.A3802
   Fontanella M, 2003, ACTA NEUROCHIR, V145, P867, DOI 10.1007/s00701-003-0111-5
   Gonzalez N, 2008, STROKE, V39, P2776, DOI 10.1161/STROKEAHA.107.505222
   Grasso Giovanni, 2015, Surg Neurol Int, V6, P185, DOI 10.4103/2152-7806.171257
   Guglielmi G, 2009, J NEUROSURG, V110, P874, DOI 10.3171/2008.10.JNS081005
   Lee JY, 2015, J KOREAN NEUROSURG S, V57, P159, DOI 10.3340/jkns.2015.57.3.159
   Li J, 2017, WORLD NEUROSURG, V99, P763, DOI 10.1016/j.wneu.2015.11.079
   Moon K, 2015, NEUROSURGERY, V77, P566, DOI 10.1227/NEU.0000000000000878
   Mortimer AM, 2016, J NEUROINTERV SURG, V8, P256, DOI 10.1136/neurintsurg-2014-011620
   Proust F, 2003, J NEUROSURG, V99, P3, DOI 10.3171/jns.2003.99.1.0003
   Schuette AJ, 2011, NEUROSURGERY, V68, P731, DOI 10.1227/NEU.0b013e3182077373
   Tsutsumi M, 2008, NEURORADIOLOGY, V50, P509, DOI 10.1007/s00234-008-0371-0
   van Rooij WJ, 2009, AM J NEURORADIOL, V30, P835, DOI 10.3174/ajnr.A1429
   Xia NZ, 2016, WORLD NEUROSURG, V87, P155, DOI 10.1016/j.wneu.2015.11.094
   Xu T, 2017, J NEUROINTERV SURG, V9, P278, DOI 10.1136/neurintsurg-2016-012294
   Yamaki VN, 2016, AM J NEURORADIOL, V37, P862, DOI 10.3174/ajnr.A4651
NR 20
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1246
EP E1250
DI 10.1016/j.wneu.2019.03.074
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400157
PM 30898747
DA 2020-05-12
ER

PT J
AU Zhu, L
   Dong, L
   Li, YP
   Lu, GY
   Zhang, HZ
   Wang, XD
   Liu, XG
   Teng, ZF
   Xia, BM
   Zhang, P
AF Zhu, Lei
   Dong, Lun
   Li, Yuping
   Lu, Guangyu
   Zhang, Hengzhu
   Wang, Xingdong
   Liu, Xiaoguang
   Teng, Zhenfei
   Xia, Boming
   Zhang, Peng
TI The Diagnostic and Antibiotic Reference Values of Procalcitonin for
   Intracranial Infection After Craniotomy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Antibiotics; Diagnosis; Intracranial infection; Procalcitonin
ID DIFFERENTIAL-DIAGNOSIS; BACTERIAL-MENINGITIS; SERUM PROCALCITONIN;
   LACTATE; MARKER
AB OBJECTIVE: To evaluate values of cerebrospinal fluid (CSF) and serum procalcitonin (PCT) for diagnosis of intracranial infection after craniotomy and relationship between them and to explore value of PCT in guiding clinical use of antibiotics.
   METHODS: The incidence of intracranial infection in 21 patients undergoing craniotomy was reviewed. CSF samples and venous blood were collected for analysis. Diagnostic parameters were calculated via receiver operating characteristic curves, and inflammatory indicators were analyzed before and after administration of antibiotics in the infection group. As a control group, 32 patients without infection were recruited for the same measurements.
   RESULTS: CSF and serum PCT levels in the infection group were higher than levels in the noninfection group (P < 0.05), and diagnostic efficiency of CSF PCT (area under the curve = 0.86, diagnostic odds ratio = 41.40) was superior to serum PCT (area under the curve = 0.66, diagnostic odds ratio = 3.40). Diagnostic efficiency was more powerful when serial testing was used (specificity = 0.99, positive likelihood ratio = 37.10, diagnostic odds ratio = 54.45). All inflammatory indicators decreased after administration of antibiotics except CSF protein (P = 0.129), and no obvious correlation was seen between CSF and serum PCT. Dynamic change of PCT can be used as a reference for adjusting antibiotics. CSF PCT can also be used as an indicator to identify intracranial infection with gram-negative bacteria.
   CONCLUSIONS: CSF PCT is a good marker for intracranial infection and could be used to help confirm intracranial infection and provide guidance for clinical use of antibiotics when combined with serum PCT.
C1 [Zhu, Lei; Teng, Zhenfei; Xia, Boming; Zhang, Peng] DaLian Med Univ, Dept Neurosurg, Dalian, Liaoning, Peoples R China.
   [Dong, Lun; Li, Yuping; Zhang, Hengzhu; Wang, Xingdong; Liu, Xiaoguang] Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China.
   [Lu, Guangyu] Yangzhou Univ, Dept Prevent Med, Yangzhou, Jiangsu, Peoples R China.
RP Zhang, HZ (reprint author), Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China.
EM zhanghengzhu@sina.com
OI zhu, lei/0000-0001-5133-7840
FU Department of Clinical Laboratory at Subei People's Hospital of Northern
   Jiangsu Province
FX We thank the Department of Clinical Laboratory at Subei People's
   Hospital of Northern Jiangsu Province for their support and Guangyu Lu
   at Yangzhou University for help with statistical calculations.
CR Bao Yun, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P169, DOI 10.3760/cma.j.issn.2095-4352.2016.02.016
   Champey J, 2019, J NEUROSURG, V130, P2034, DOI 10.3171/2018.1.JNS172486
   Vieira MADS, 2015, ARQ NEURO-PSIQUIAT, V73, P309, DOI 10.1590/0004-282X20150002
   Drew R J, 2018, Ir Med J, V111, P693
   Folyovich A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-41
   Fuursted K, 2008, SCAND J INFECT DIS, V40, P772, DOI 10.1080/00365540802119994
   Grille P, 2017, J CLIN NEUROSCI, V45, P243, DOI 10.1016/j.jocn.2017.07.031
   Halvorson K, 2017, NEUROCRIT CARE, V27, P237, DOI 10.1007/s12028-016-0337-8
   Hoffmann O, 2001, SCAND J INFECT DIS, V33, P215, DOI 10.1080/00365540151060905
   Kase Y, 2017, COMP BIOCHEM PHYS A, V211, P77, DOI 10.1016/j.cbpa.2017.06.007
   Kurdyumova, 2015, BURDENK, P47
   Li YR, 2015, CLIN BIOCHEM, V48, P50, DOI 10.1016/j.clinbiochem.2014.10.007
   Liu C, 2011, CLIN INFECT DIS, V52, pE18, DOI 10.1093/cid/ciq146
   Liu DB, 2018, EUR REV MED PHARMACO, V22, P3474, DOI 10.26355/eurrev_201806_15173
   Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3
   Miteva D, 2017, CBU INT CONF PROC, V5, P978, DOI 10.12955/cbup.v5.1055
   Schuetz P, 2018, JAMA-J AM MED ASSOC, V319, P925, DOI 10.1001/jama.2018.0852
   Tomio R, 2013, SURG INFECT, V14, P433, DOI 10.1089/sur.2012.087
   Trimboli P, 2018, ENDOCRINOL METAB, V33, P204, DOI 10.3803/EnM.2018.33.2.204
   Wang T, 2016, CHINESE MED J-PEKING, V129, P417, DOI 10.4103/0366-6999.176064
   Xiao X, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1818-2
   Yu Y, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176021, 10.1590/1414-431x20176021]
NR 22
TC 1
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUN
PY 2019
VL 126
BP E1
EP E7
DI 10.1016/j.wneu.2018.10.241
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IA0BU
UT WOS:000469222400002
PM 30550873
DA 2020-05-12
ER

PT J
AU Macreili, M
   Williamson, S
   Mitchell, S
   Pearson, R
   Andrews, L
   Morrison, AA
   Nevel, M
   Smith, R
   Bartley, DJ
AF Macreili, Michele
   Williamson, Susanna
   Mitchell, Sian
   Pearson, Richard
   Andrews, Leigh
   Morrison, Alison A.
   Nevel, Mandy
   Smith, Richard
   Bartley, Dave J.
TI First detection of ivermectin resistance in oesophagostomum dentatum in
   pigs
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Anthelmintic resistance; Ivermectin; Nematodes; Oesophagostomum
   dentatum; Pig
ID VETERINARY PARASITOLOGY WAAVP; ANTHELMINTIC RESISTANCE; WORLD
   ASSOCIATION; NODULAR WORMS; EFFICACY; ADVANCEMENT; POPULATIONS;
   INFECTIONS; PREVALENCE; LEVAMISOLE
AB In 2016 suspected reduced ivermectin (IVM) efficacy in Oesophagostomum species in pigs was reported in England. Following this initial report, APHA raised awareness amongst private pig veterinary practitioners of the need to monitor the efficacy of the worm control on pig units. In 2017 another veterinary practitioner highlighted a potential in-field lack of IVM efficacy in treating Oesophagostomum species in sows on another breeder finisher unit. In this trial, the efficacy of IVM against Oesophagostomum species worms has been investigated to determine whether suspected reduced efficacy (52% reduction in mean faecal egg count 14 days post ivermectin administration) on a mixed indoor and outdoor breeder-finisher pig farm in England reflected true IVM resistance under controlled experimental conditions. On days 0 and 40 of the trial, twenty helminth-naive pigs were artificially infected per os with 5000 Oesophagostomum L3 obtained from the farm under investigation. The pigs were allocated to treatment or control groups (n = 10 per group). Treatment group pigs received IVM (0.3 mg kg body weight) by sub-cutaneous injection as per manufacturer's instructions on day 44. Control group animals were left untreated. Faecal worm egg counts were monitored throughout the trial from day 15 post infection to determine time to patency. On day 50 all pigs were euthanased to assess the worm burdens. Resistance to IVM was confirmed in Oesophagostomum dentatum based on the results of a faecal egg count reduction test (FECRT) and a controlled efficacy test (CET). Efficacy based on mean reduction in faecal egg count of IVM-treated pigs compared to untreated control pigs was 86%. Mean reduction in IVM-treated pig worm burdens was 5% against an adult worm population and 94% against an L3/L4 population. The apparent discrepancy between FECRT and CET efficacy results appears to be due to egg development and/or oviposition suppression in IVM-treated female worms. The detection of IVM resistance in Oesophagostomum species worms for the first time in UK pigs is particularly important considering the global situation where resistance to pyrantel, levamisole and benzimidazole anthelmintics in Oesophagostomum species in pigs have already been reported. The results also provide an opportunity to discuss the wider issue of anthelmintic usage and efficacy on pig farms and highlight the need for wider surveillance for the occurrence of anthelmintic resistance in pigs.
C1 [Macreili, Michele; Williamson, Susanna] APHA, Rougham Hill, Bury St Edmunds IP33 2RX, Suffolk, England.
   [Mitchell, Sian] APHA, Jobs Well Rd, Carmarthen SA31 3EZ, Carmarthen, Wales.
   [Pearson, Richard] George Pig Practice, High St, Malmesbury SN16 9AU, Wilts, England.
   [Andrews, Leigh; Morrison, Alison A.; Bartley, Dave J.] Mission Res Inc, Pentlands Sci Pk, Edinburgh EH26 0PZ, Midlothian, Scotland.
   [Nevel, Mandy] Agr & Hort Dev Boards AHDB Pork, Stoneleigh Pk, Kenilworth CV8 2TL, Warwick, England.
   [Smith, Richard] APHA, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
RP Macreili, M (reprint author), APHA, Rougham Hill, Bury St Edmunds IP33 2RX, Suffolk, England.
EM Michele.macrelli@apha.gov.uk
OI Macrelli, Michele/0000-0001-6317-5244; nevel,
   amanda/0000-0002-9852-3197; Bartley, David/0000-0002-8543-9244
FU Agriculture and Horticulture Development Board (AHDB Pork); Defra
   through the APHA's "Scanning surveillance for Pig Diseases in England
   and Wales" project [ED1200]; Scottish Government's Rural and Environment
   Science and Analytical Services Division (RESAS)
FX The authors wish to thank the farmer involved for providing farm details
   and access to faecal samples for this study. Financial contributions for
   this investigation were provided by the Agriculture and Horticulture
   Development Board (AHDB Pork), Defra through the APHA's "Scanning
   surveillance for Pig Diseases in England and Wales" (ED1200) project and
   The Scottish Government's Rural and Environment Science and Analytical
   Services Division (RESAS). Finally thanks to Moredun Research Institutes
   Bioservice's department and Moredun Scientific for their assistance in
   undertaking the study.
CR APHA, 2017, GB EM THREATS Q REP, V21, P4
   APHA, 2017, LIV DEM DAT GROUP PI
   APHA, 2016, GB EM THREATS Q REP, V20, P4
   Bartley DJ, 2012, VET PARASITOL, V190, P454, DOI 10.1016/j.vetpar.2012.07.022
   BJORN H, 1990, VET PARASITOL, V37, P21, DOI 10.1016/0304-4017(90)90022-4
   Borgsteede FHM, 2007, VET PARASITOL, V146, P288, DOI 10.1016/j.vetpar.2007.02.027
   Christensen CM, 1995, INT J PARASITOL, V25, P1491, DOI 10.1016/0020-7519(95)00085-2
   Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019
   COOP RL, 1982, J AGR SCI, V98, P247, DOI 10.1017/S0021859600041782
   Dangolla A, 1997, VET PARASITOL, V68, P127, DOI 10.1016/S0304-4017(96)01029-1
   DASH KM, 1988, AUST VET J, V65, P66, DOI 10.1111/j.1751-0813.1988.tb07359.x
   Daugschies A, 2013, TIERAERZTL UMSCHAU, V68, P383
   De Graef J, 2013, VLAAMS DIERGEN TIJDS, V82, P113
   DUWEL D, 1986, VET PARASITOL, V21, P69, DOI 10.1016/0304-4017(86)90147-0
   European Medicines Agency, 2017, EMACVMPEWP573536201
   Gerwert S, 2002, PARASITOL RES, V88, P63, DOI 10.1007/s004360100507
   Hennessy DR, 2006, VET PARASITOL, V141, P138, DOI 10.1016/j.vetpar.2006.04.038
   JACKSON F, 1972, T ROY SOC TROP MED H, V66, P546
   JACKSON F, 1993, BRIT VET J, V149, P123, DOI 10.1016/S0007-1935(05)80083-1
   MCKELLAR QA, 1988, VET REC, V122, P444, DOI 10.1136/vr.122.18.444
   MCKENNA PB, 1990, NEW ZEAL VET J, V38, P142, DOI 10.1080/00480169.1990.35640
   MERCY AR, 1989, AUST VET J, V66, P4, DOI 10.1111/j.1751-0813.1989.tb09702.x
   *MIN AGR FISH FOOD, 1986, MAN VET PAR LAB TECH
   Nansen P, 1999, INT J PARASITOL, V29, P877, DOI 10.1016/S0020-7519(99)00048-X
   Nosal P, 2013, ANN ANIM SCI, V13, P133, DOI 10.2478/v10220-012-0065-8
   PATTISON HD, 1980, VET REC, V107, P415, DOI 10.1136/vr.107.18.415
   Peden RSE, 2018, APPL ANIM BEHAV SCI, V204, P1, DOI 10.1016/j.applanim.2018.03.003
   Petersen MB, 1996, VET PARASITOL, V65, P55, DOI 10.1016/0304-4017(96)00948-X
   PHWC, 2017, PIG HLTH WELF COUNC, P9
   ROEPSTORFF A, 1987, VET PARASITOL, V24, P229, DOI 10.1016/0304-4017(87)90044-6
   Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029
   ROSE JH, 1980, PARASITOLOGY, V81, P507, DOI 10.1017/S0031182000061898
   Sargison ND, 2011, VET CLIN N AM-FOOD A, V27, P139, DOI 10.1016/j.cvfa.2010.10.014
   SHOOP WL, 1993, PARASITOL TODAY, V9, P154, DOI 10.1016/0169-4758(93)90136-4
   Taylor M. A., 2016, VET PARASITOL, P578
   THIENPONT D, 1979, DIAGNOSING HELMINTHI
   VANWYK JA, 1989, ONDERSTEPOORT J VET, V56, P41
   Varady M, 1996, INT J PARASITOL, V26, P369, DOI 10.1016/0020-7519(96)00007-0
   VICH GL16 (ANTHELMINTIC: PORCINE, 2001, CVMPVICH83499FINAL
NR 39
TC 0
Z9 0
U1 3
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 1
EP 6
DI 10.1016/j.vetpar.2019.05.002
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400001
PM 31213235
DA 2020-05-12
ER

PT J
AU Wilkes, EJA
   Woodgate, RG
   Raidal, SL
   Hughes, KJ
AF Wilkes, E. J. A.
   Woodgate, R. G.
   Raidal, S. L.
   Hughes, K. J.
TI The application of faecal egg count results and statistical inference
   for clinical decision making in foals
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Horse; McMaster; Ascarid; Parascaris; Cyathostomins
ID PARASCARIS-EQUORUM INFECTION; EQUINE PARASITE CONTROL; ANTHELMINTIC
   RESISTANCE; SELECTIVE THERAPY; DRUG-RESISTANCE; HORSES; SPP.;
   VARIABILITY; STRONGYLES; MANAGEMENT
AB This study investigated the impact of variability in Parascaris spp. and strongyle faecal egg counts (FEC) from foals on treatment decision-making and detection of a patent infection. A single faecal sample was collected once daily for three days from 53 foals and a FEC was performed on three separate portions of each sample (total of nine egg counts per foal). Differences in the decision to administer an anthelmintic using the results of a single count (C-1), the mean of three ((X) over bar (1-3)) or nine counts ((X) over bar (1-9)) and the upper 5% confidence limit of the gamma confidence interval (CI) of the estimate of the distribution mean (mu) from three (UCL1-3) and nine counts (UCL1-9) were determined for a range of egg count thresholds. The UCL1-9 was used as the best estimate of p, hypothesis testing for treatment and the comparison of treatment decision-making using C-1,(X) over bar (1-3), (X) over bar (1-9) and UCL1-3. The results of this study demonstrated that a point estimate (C-1 or (X) over bar (1-3)) was of limited value for estimating the distribution mean of egg counts in faeces and there was overall poor agreement in treatment decision-making for individual foals using C-1 compared with UCL1-9. Of the foals with C-1 of zero eggs per gram, 54% and 47% had Parascaris and strongyle eggs in subsequent counts, respectively. The egg density in faeces is inhomogeneous, resulting in considerable variability in egg count results for an individual foal: between faecal piles, different portions of a faecal pile and days. The use of the negative binomial distribution CI for p takes this variability into account and is recommended for use when interpreting FEC data from horses.
C1 [Wilkes, E. J. A.; Woodgate, R. G.; Raidal, S. L.; Hughes, K. J.] Charles Sturt Univ, Sch Anim & Vet Sci, Locked Bag 588, Wagga Wagga, NSW 2678, Australia.
RP Wilkes, EJA (reprint author), Charles Sturt Univ, Sch Anim & Vet Sci, Locked Bag 588, Wagga Wagga, NSW 2678, Australia.
EM ewilkes@csu.edu.au
RI Wilkes, Edwina/Y-1563-2019
OI Raidal, Sharanne/0000-0001-5558-3133; Wilkes,
   Edwina/0000-0001-8410-5894; Hughes, Kristopher/0000-0002-8405-6268
FU Faculty of Science, CSU; CEVA Animal Health
FX This work was supported by the Faculty of Science, CSU and CEVA Animal
   Health. The funders had no role in the study design, data collection and
   analysis, decision to publish or preparation of the manuscript. The
   authors declare that there are no conflicts of interest. The authors
   thank Associate Professor Ann Cowling for her contribution to the
   statistical analysis, the staff at the Veterinary Diagnostic Laboratory,
   CSU for their valuable assistance in the laboratory and staff at
   participating studs for assisting with sample collection.
CR Armstrong SK, 2014, VET PARASITOL, V205, P575, DOI 10.1016/j.vetpar.2014.08.028
   Becher AM, 2010, VET PARASITOL, V171, P116, DOI 10.1016/j.vetpar.2010.03.001
   Bellaw JL, 2016, VET PARASITOL, V221, P69, DOI 10.1016/j.vetpar.2016.03.018
   Carstensen H, 2013, J EQUINE VET SCI, V33, P161, DOI 10.1016/j.jevs.2012.06.001
   CLAYTON HM, 1979, RES VET SCI, V26, P383, DOI 10.1016/S0034-5288(18)32899-6
   Denwood MJ, 2012, VET PARASITOL, V188, P120, DOI 10.1016/j.vetpar.2012.03.005
   Donoghue EM, 2015, VET PARASITOL, V214, P114, DOI 10.1016/j.vetpar.2015.09.003
   Dowdall SMJ, 2002, VET PARASITOL, V106, P225, DOI 10.1016/S0304-4017(02)00085-7
   DUNCAN JL, 1991, EQUINE VET J, V23, P226, DOI 10.1111/j.2042-3306.1991.tb02762.x
   Erskine M., 2016, AAEP PARASITE CONTRO
   Fabiani JV, 2016, VET PARASITOL, V230, P62, DOI 10.1016/j.vetpar.2016.11.002
   GOMEZ HH, 1991, EQUINE VET J, V23, P198, DOI 10.1111/j.2042-3306.1991.tb02754.x
   Hearn FPD, 2003, J AM VET MED ASSOC, V223, P482, DOI 10.2460/javma.2003.223.482
   Kaplan RM, 2010, EQUINE VET EDUC, V22, P306, DOI 10.1111/j.2042-3292.2010.00084.x
   Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001
   KRECEK RC, 1994, J S AFR VET ASSOC, V65, P97
   Leathwick DM, 2017, VET PARASITOL, V240, P75, DOI 10.1016/j.vetpar.2017.03.026
   Leathwick DM, 2016, VET PARASITOL, V228, P108, DOI 10.1016/j.vetpar.2016.08.019
   Lester HE, 2014, EQUINE VET J, V46, P139, DOI 10.1111/evj.12199
   Lester HE, 2013, VET PARASITOL, V197, P189, DOI 10.1016/j.vetpar.2013.06.009
   Lindgren K, 2008, VET PARASITOL, V151, P337, DOI 10.1016/j.vetpar.2007.10.014
   Little D, 2003, EQUINE VET J, V35, P246, DOI 10.2746/042516403776148264
   Lyons ET, 2008, PARASITOL RES, V103, P287, DOI 10.1007/s00436-008-0966-8
   Matthee S, 2004, J S AFR VET ASSOC, V75, P129
   Mes THM, 2003, VET PARASITOL, V115, P311, DOI 10.1016/S0304-4017(03)00219-X
   MFITILODZE MW, 1987, VET PARASITOL, V23, P121, DOI 10.1016/0304-4017(87)90030-6
   MINES JJ, 1977, AUST VET J, V53, P342, DOI 10.1111/j.1751-0813.1977.tb00247.x
   Nielsen MK, 2016, EQUINE VET J, V48, P380, DOI 10.1111/evj.12478
   Nielsen MK, 2016, EQUINE VET EDUC, V28, P224, DOI 10.1111/eve.12536
   Nielsen MK, 2014, VET PARASITOL, V202, P95, DOI 10.1016/j.vetpar.2014.03.020
   Nielsen MK, 2010, VET PARASITOL, V174, P77, DOI 10.1016/j.vetpar.2010.08.007
   Nielsen MK, 2010, VET PARASITOL, V167, P55, DOI 10.1016/j.vetpar.2009.09.043
   Nielsen MK, 2017, VET PARASITOL, V236, P108, DOI 10.1016/j.vetpar.2017.02.013
   Nielsen MK, 2014, PARASITOL RES, V113, P4485, DOI 10.1007/s00436-014-4135-y
   Nielsen MK, 2006, VET PARASITOL, V135, P333, DOI 10.1016/j.vetpar.2005.09.010
   Nielsen MK, 2006, VET PARASITOL, V135, P47, DOI 10.1016/j.vetpar.2005.10.020
   Nielsen MK, 2013, AAEP PARASITE CONTRO
   Peregrine AS, 2014, VET PARASITOL, V201, P1, DOI 10.1016/j.vetpar.2014.01.004
   Reinemeyer CR, 2017, EQUINE VET EDUC, V29, P225, DOI 10.1111/eve.12541
   Reinemeyer CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S8
   Relf VE, 2013, PARASITOLOGY, V140, P641, DOI 10.1017/S0031182012001941
   Robert M, 2015, EQUINE VET J, V47, P694, DOI 10.1111/evj.12344
   Scheuerle MC, 2016, VET PARASITOL, V228, P103, DOI 10.1016/j.vetpar.2016.08.021
   Southwood LL, 1998, COMP CONT EDUC PRACT, V20, P100
   Torgerson PR, 2014, INT J PARASITOL, V44, P299, DOI 10.1016/j.ijpara.2014.01.005
   Torgerson PR, 2012, VET PARASITOL, V188, P397, DOI 10.1016/j.vetpar.2012.03.043
   Vidyashankar AN, 2012, VET PARASITOL, V185, P45, DOI 10.1016/j.vetpar.2011.10.011
   WARNICK LD, 1992, CORNELL VET, V82, P453
   Wilkes EJA, 2016, VET PARASITOL, V229, P131, DOI 10.1016/j.vetpar.2016.10.010
   Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010
NR 50
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 7
EP 12
DI 10.1016/j.vetpar.2019.04.010
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400002
PM 31213242
DA 2020-05-12
ER

PT J
AU Castaneda-Ramirez, GS
   Torres-Acosta, JFD
   Sandoval-Castro, CA
   Borges-Argaez, R
   Caceres-Farfan, M
   Mancilla-Montelongo, G
   Mathieu, C
AF Sarahi Castaneda-Ramirez, Gloria
   de Jesus Torres-Acosta, Juan Felipe
   Alfredo Sandoval-Castro, Carlos
   Borges-Argaez, Rocio
   Caceres-Farfan, Mirbella
   Mancilla-Montelongo, Gabriela
   Mathieu, Celine
TI Bio-guided fractionation to identify Senegalia gaumeri leaf extract
   compounds with anthelmintic activity against Haemonchus contortus eggs
   and larvae
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Haemonchus contortus; Senegalia gaumeri; Ovicidal; p-Coumaric acid
ID DIFFERENT GEOGRAPHICAL ORIGINS; ACETONEWATER EXTRACTS; SUSCEPTIBILITY;
   EXSHEATHMENT; TANNINS
AB Small ruminants browsing in tropical forests readily consume the foliage of Senegalia gaumeri. A S. gaumeri methanol:water extract was recently shown to have ovicidal activity against Haemonchus contortus eggs in vitro. In the present study, the fraction of a S. gaumeri methanol:water extract with ovicidal activity against H. contortus eggs and the metabolites potentially involved in this activity were identified. Bio-guided fractionation of the S. gaumeri methanol:water extract identified high ovicidal activity (80.29%, EC50 = 58.9 pg/mL) in the non-polar sub-fraction P1. Gas chromatography-mass spectrometry (GC-MS) identified several fatty acids: pentacosane (18.05%), heneicosane (18.05%), triacontane (30.94%), octacosane (18.05%), and hexanedioic acid bis-(2ethylhexyl) ester (32.72%). Purification of the polar components of sub-fraction P1 led to the identification of pcoumaric acid as a major constituent. In egg hatch tests, 400 mu g/mLp-coumaric acid resulted in an ovicidal effect of 8.7%, a larvae failing eclosion effect of 2.9%, and of the emerged larvae (88.4%), many were damaged. In conclusion, the low AH activity of p-coumaric acid against H. contortus eggs indicates that it is not solely responsible for the ovicidal activity of sub-fraction P1 but might act in synergy with other compounds in this fraction. However, p-coumaric acid showed potential anthelmintic effects against the larval stage of H. contortus.
C1 [Sarahi Castaneda-Ramirez, Gloria; de Jesus Torres-Acosta, Juan Felipe; Alfredo Sandoval-Castro, Carlos] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Km 15-5 Carretera Merida Xmatkuil, Merida 97100, Yucatan, Mexico.
   [Borges-Argaez, Rocio; Caceres-Farfan, Mirbella] Ctr Invest Cient Yucatan, Calle 43 130 32 Colonia Chuburna Hidalgo, Merida 97205, Yucatan, Mexico.
   [Mancilla-Montelongo, Gabriela] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, CONACYT, Km 15-5 Carretera Merida Xmatkuil, Merida 97100, Yucatan, Mexico.
   [Mathieu, Celine] Univ Toulouse, INP, ENSIACET, Lab Chim Agro Ind, F-31030 Toulouse, France.
RP Mancilla-Montelongo, G (reprint author), Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, CONACYT, Km 15-5 Carretera Merida Xmatkuil, Merida 97100, Yucatan, Mexico.
EM tacosta@correo.uady.mx; carlos.sandoval@correo.uady.mx; rborges@cicy.mx;
   bella@cicy.mx; maria.mancilla@correo.uady.mx; celine.mathieu@ensiacet.fr
RI Mancilla-Montelongo, Gabriela/AAE-7976-2020; Mathieu,
   Celine/AAK-2725-2020; de Jesus Torres-Acosta, Juan Felipe/V-8920-2019;
   Sandoval-Castro, Carlos Alfredo/A-8097-2008
OI Mancilla-Montelongo, Gabriela/0000-0001-6481-6496; Mathieu,
   Celine/0000-0003-2333-3740; de Jesus Torres-Acosta, Juan
   Felipe/0000-0003-3724-3391; Sandoval-Castro, Carlos
   Alfredo/0000-0003-2778-8240
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [CB-2013-01/221041]
FX This work was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT, Mexico): Project CB-2013-01/221041.
CR Alavi SHR, 2009, IRAN J PHARM RES, V8, P71
   Alonso-Diaz MA, 2008, VET PARASITOL, V153, P313, DOI 10.1016/j.vetpar.2008.01.042
   Arceo-Medina GN, 2016, VET PARASITOL, V228, P121, DOI 10.1016/j.vetpar.2016.08.023
   Castaneda-Ramirez GS, 2017, PARASITOL RES, V116, P3341, DOI 10.1007/s00436-017-5650-4
   Castillo-Mitre GF, 2017, J ETHNOPHARMACOL, V204, P125, DOI 10.1016/j.jep.2017.04.010
   Chan-Perez JI, 2017, VET PARASITOL, V240, P11, DOI 10.1016/j.vetpar.2017.04.023
   Chan-Perez JI, 2016, VET PARASITOL, V217, P53, DOI 10.1016/j.vetpar.2015.11.001
   Gonzalez-Pech PG, 2015, SMALL RUMINANT RES, V133, P128, DOI 10.1016/j.smallrumres.2015.08.020
   HARBORNE J B, 1973, P278
   Hoste H, 2016, ADV PARASIT, V93, P239, DOI 10.1016/bs.apar.2016.02.025
   Hernandez-Bolio GI, 2018, PHYTOCHEM ANALYSIS, V29, P413, DOI 10.1002/pca.2724
   Jackson F, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P25, DOI 10.1007/978-90-481-3297-3_3
   Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001
   Lock O., 2006, PRACT 6 6 ANALISIS F
   Mac Donald D., 2005, BIOTEMPO, V5, P3
   Marie-Magdeleine C, 2010, VET PARASITOL, V173, P85, DOI 10.1016/j.vetpar.2010.06.017
   Marie-Magdeleine C, 2010, RES VET SCI, V89, P88, DOI 10.1016/j.rvsc.2010.01.002
   Martinez-Ortiz-de-Montellano C, 2010, VET PARASITOL, V172, P283, DOI 10.1016/j.vetpar.2010.04.040
   Mendez-Ortiz FA, 2019, TROP ANIM HEALTH PRO, V51, P1591, DOI 10.1007/s11250-019-01855-9
   Merck E., 1974, DYEING REAGENTS THIN, P118
   Sackett D., 2006, ASSESSING EC COST EN, P87, DOI [10.1590/50001-37652008000200005, DOI 10.1590/50001-37652008000200005]
   Souza MMC, 2008, AN ACAD BRAS CIENC, V80, P271, DOI 10.1590/S0001-37652008000200005
   Torres A. J. F. J., 2016, TROP SUBTROP AGROECO, V19, P73
   Vargas-Magana JJ, 2014, VET PARASITOL, V206, P322, DOI 10.1016/j.vetpar.2014.10.008
   von Samson-Himmelstjerna G, 2009, PARASITOL RES, V105, P825, DOI 10.1007/s00436-009-1466-1
   von Son-de Fernex E, 2015, VET PARASITOL, V214, P89, DOI 10.1016/j.vetpar.2015.10.005
   Weller MG, 2012, SENSORS-BASEL, V12, P9181, DOI 10.3390/s120709181
NR 27
TC 3
Z9 3
U1 5
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 13
EP 19
DI 10.1016/j.vetpar.2019.05.001
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400003
PM 31213236
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Anderson, JA
   Alves, DA
   Cerqueira-Cezar, CK
   da Silva, AF
   Murata, FHA
   Norris, JK
   Howe, DK
   Dubey, JP
AF Anderson, Joseph A.
   Alves, Derron A.
   Cerqueira-Cezar, Camila K.
   da Silva, Andressa F.
   Murata, Fernando H. A.
   Norris, Jamie K.
   Howe, Daniel K.
   Dubey, Jitender P.
TI Histologically, immunohistochemically, ultrastructurally, and
   molecularly confirmed neosporosis abortion in an aborted equine fetus
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Neospora, abortion; Horse; Tachyzoites; Diagnosis; Molecular
ID TRANSPLACENTAL TRANSMISSION; SARCOCYSTIS-NEURONA; HUGHESI; CANINUM;
   ANTIBODIES; SPP.; APICOMPLEXA; ASSOCIATION; INFECTION; ISOLATE
AB Neosporosis is a common cause of abortion in cattle worldwide but is rare in horses. Here, the first case of histologically, ultrastructurally, immunohistochemically, and molecularly confirmed equine abortion caused by neosporosis is reported. Samples of lung, heart, liver, skeletal muscle, tongue, brain, and the placenta from a female fetus aborted at 280 days of gestation were fixed in formalin and submitted for diagnosis. Histologically, there was disseminated neosporosis with severe lesions in lungs, liver and the heart. Protozoal tachyzoites in all tissues reacted with polyclonal anti-Neospora caninum rabbit antibodies. Transmission electron microscopic observation on lung tissue revealed tachyzoites consistent with Neospora, including many rhoptries. Polymerasechain reaction (PCR) using primers designed to amplify the rRNA gene internal transcribed spacer 1 (ITS1) of the Sarcocystidae was performed on DNA extracted from fetal tissues. Comparison of the ITS1 amplified from the foal tissue to sequences available in GenBank revealed 100% sequence identity to the ITS1 from three isolates of Neospora hughesi.
C1 [Anderson, Joseph A.] Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   [Alves, Derron A.] JPC, 606 Stephen Sitter Ave, Silver Spring, MD 20910 USA.
   [Cerqueira-Cezar, Camila K.; da Silva, Andressa F.; Murata, Fernando H. A.; Dubey, Jitender P.] ARS, USDA, Beltsville Agr Res Ctr, Anim Parasit Dis Lab, Beltsville, MD 20705 USA.
   [Norris, Jamie K.; Howe, Daniel K.] Univ Kentucky, Dept Vet Sci, MH Gluck Equine Res Ctr, Lexington, KY 40546 USA.
RP Dubey, JP (reprint author), USDA ARS, Beltsville Agr Res Ctr, Anim Parasit Dis Lab, Bldg 1001, Beltsville, MD 20705 USA.
EM jitender.dubey@ars.usda.gov
RI Murata, Fernando Henrique Antunes/AAD-5840-2020
OI Murata, Fernando Henrique Antunes/0000-0002-4642-9553; Norris,
   Jamie/0000-0003-4759-5534
FU DOEUnited States Department of Energy (DOE) [DE-SC0014664]
FX This research was supported in part by an appointment to the
   Agricultural Research Service (ARS) Research Participation Program
   administered by the Oak Ridge Institute for Science and Education
   (ORISE) through an interagency agreement between the U.S. Department of
   Energy (DOE) and the U.S. Department of Agriculture (USDA). ORISE is
   managed by ORAU under DOE contract number DE-SC0014664. All opinions
   expressed in this paper are the author's and do not necessarily reflect
   the policies and views of USDA, ARS, DOE, or ORAU/ORISE.
CR Abreu RA, 2014, VET PARASITOL, V202, P128, DOI 10.1016/j.vetpar.2014.03.022
   Antonello AM, 2012, VET PARASITOL, V187, P367, DOI 10.1016/j.vetpar.2012.02.005
   Duarte PC, 2004, J PARASITOL, V90, P1345, DOI 10.1645/GE-3372
   Dubey JP, 2015, VET PARASITOL, V209, P1, DOI 10.1016/j.vetpar.2015.01.026
   Dubey J.P., 2010, TOXOPLASMOSIS ANIMAL, P1
   DUBEY JP, 1990, J PARASITOL, V76, P732, DOI 10.2307/3282991
   DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269
   Dubey JP, 2001, J PARASITOL, V87, P345, DOI 10.1645/0022-3395(2001)087[0345:COTOIO]2.0.CO;2
   Dubey JP, 2017, NEOSPOROSIS ANIMALS, P1
   Gjerde B, 2015, PARASITOL RES, V114, P873, DOI 10.1007/s00436-014-4251-8
   Gjerde B, 2014, PARASITOL RES, V113, P811, DOI 10.1007/s00436-013-3711-x
   Leon A, 2012, PREV VET MED, V104, P179, DOI 10.1016/j.prevetmed.2011.11.001
   Locatelli-Dittrich R, 2006, VET PARASITOL, V135, P215, DOI 10.1016/j.vetpar.2005.10.010
   Marsh AE, 1999, INT J PARASITOL, V29, P1575, DOI 10.1016/S0020-7519(99)00120-4
   Marsh AE, 1998, J PARASITOL, V84, P983, DOI 10.2307/3284632
   McInnes LM, 2006, VET PARASITOL, V137, P355, DOI 10.1016/j.vetpar.2006.01.018
   Pitel PH, 2003, VET PARASITOL, V118, P1, DOI 10.1016/j.vetpar.2003.10.007
   Pronost S., 1999, Pratique Veterinaire Equine, V31, P111
   Pusterla N, 2011, J PARASITOL, V97, P281, DOI 10.1645/GE-2657.1
   Pusterla N, 2014, VET J, V202, P649, DOI 10.1016/j.tvjl.2014.09.015
   Spencer JA, 2000, J PARASITOL, V86, P1366, DOI 10.1645/0022-3395(2000)086[1366:ARAPDP]2.0.CO;2
   Veronesi F, 2008, VET RES COMMUN, V32, pS223, DOI 10.1007/s11259-008-9155-6
   Villalobos EMC, 2006, VET PARASITOL, V142, P372, DOI 10.1016/j.vetpar.2006.07.016
NR 23
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 20
EP 24
DI 10.1016/j.vetpar.2019.04.009
PG 5
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400004
PM 31213237
DA 2020-05-12
ER

PT J
AU Mancilla-Montelongo, G
   Castaneda-Ramirez, GS
   Torres-Acosta, JFD
   Sandoval-Castro, CA
   Borges-Argaez, R
AF Mancilla-Montelongo, Gabriela
   Sarahi Castaneda-Ramirez, Gloria
   de Jesus Torres-Acosta, Juan Felipe
   Alfredo Sandoval-Castro, Carlos
   Borges-Argaez, Rocio
TI Evaluation of cinnamic acid and six analogues against eggs and larvae of
   Haemonchus contortus
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Haemonchus contortus; Nematode; Egg hatch test; Larval exsheathment
   inhibition test; Cinnamic acid analogues; Chemical standards
ID DIFFERENT GEOGRAPHICAL ORIGINS; ACETONEWATER EXTRACTS; CHLOROGENIC ACID;
   DERIVATIVES; SUSCEPTIBILITY; EXSHEATHMENT; INHIBITION; NEMATODES;
   HELMINTHS; MONOMERS
AB This study evaluated the in vitro anthelmintic (AH) activity of cinnamic acid and six analogues against eggs and larvae of Haemonchus contortus. Stock solutions of each compound (trans-cinnamic acid, p-coumaric acid, caffeic acid, trans-ferulic acid, trans-sinapic acid, 3,4-dimethoxycinnamic acid, and chlorogenic acid) were prepared in PBS:Tween-20 (1%) for use in the egg hatch test (EHT) and larval exsheathment inhibition test (LEIT) at different concentrations (25-400 mu g/mL). The respective effective concentration 50% (ECso) values with 95% confidence intervals were estimated. Mixtures made of all cinnamic acid and its analogues as well as some selected individual compounds were also tested in the EHT. Only ferulic and chlorogenic acids showed AH activity in the EHT (EC50: 245.2 mu g/mL (1.26 mM) and 520.8 mu g/mL (1.47 mM), respectively) (P < 0.05). A higher EC50 (1628.10 mu g/mL) of the mixture of cinnamic acid and its analogues was required to observe activity against eggs mostly blocking the larvae hatching. The analogues' mixtures tested were less active than ferulic or chlorogenic acid alone. The activity of ferulic and chlorogenic acids against eggs was associated with larvae failing to hatch, and the two compounds exhibited antagonistic effects when evaluated together. All standards had an ECso lower than 0.42 mM in the LEIT. Caffeic acid had the best activity in the LEIT (EC50 0.04 mM), followed by ferulic acid (EC50 0.11 mM) (P < 0.05). There was no clear, definitive structure-activity relationship for these non-flavonoid polyphenols against eggs or larvae of H. contortus in vitro. This study is the first to directly evaluate cinnamic acid and its derivatives as active compounds against eggs and larvae of H. contortus.
C1 [Mancilla-Montelongo, Gabriela] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, CONACYT, Km 15-5 Carretera Merida Xmatkuil, Merida 97100, Yucatan, Mexico.
   [Sarahi Castaneda-Ramirez, Gloria; de Jesus Torres-Acosta, Juan Felipe; Alfredo Sandoval-Castro, Carlos] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Km 15-5 Carretera Merida Xmatkuil, Merida 97100, Yucatan, Mexico.
   [Borges-Argaez, Rocio] Ctr Invest Cient Yucatan, Calle 43 130 32 Colonia Chuburna Hidalgo, Merida 97205, Yucatan, Mexico.
RP Sandoval-Castro, CA (reprint author), Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Km 15-5 Carretera Merida Xmatkuil, Merida 97100, Yucatan, Mexico.
EM maria.mancilla@correo.uady.mx; glosahi@hotmail.com;
   tacosta@correo.uady.mx; carlos.sandoval@correo.uady.mx; rborges@cicy.mx
RI Mancilla-Montelongo, Gabriela/AAE-7976-2020; de Jesus Torres-Acosta,
   Juan Felipe/V-8920-2019; Sandoval-Castro, Carlos Alfredo/A-8097-2008
OI Mancilla-Montelongo, Gabriela/0000-0001-6481-6496; de Jesus
   Torres-Acosta, Juan Felipe/0000-0003-3724-3391; Sandoval-Castro, Carlos
   Alfredo/0000-0003-2778-8240
FU CONACYT-MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [7464535353]; Catedras CONACYT-Mexico Programme [692]
FX This work was financed by CONACYT-Mexico (project number:
   CB-2013-01/221041). S.C.R. thanks CONACYT-Mexico for granting her a
   scholarship to pursue PhD studies (Reference number 7464535353). G.M.
   thank the support of the Catedras CONACYT-Mexico Programme (Project
   number 692).
CR Bratt K, 2003, J AGR FOOD CHEM, V51, P594, DOI 10.1021/jf020544f
   Brunet S, 2006, J AGR FOOD CHEM, V54, P7481, DOI 10.1021/jf0610007
   Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266
   Castillo-Mitre GF, 2017, J ETHNOPHARMACOL, V204, P125, DOI 10.1016/j.jep.2017.04.010
   Chan-Perez JI, 2017, VET PARASITOL, V240, P11, DOI 10.1016/j.vetpar.2017.04.023
   Chan-Perez JI, 2016, VET PARASITOL, V217, P53, DOI 10.1016/j.vetpar.2015.11.001
   De P, 2011, CURR MED CHEM, V18, P1672, DOI 10.2174/092986711795471347
   GAMBLE HR, 1989, J PARASITOL, V75, P303, DOI 10.2307/3282779
   Guzman JD, 2014, MOLECULES, V19, P19292, DOI 10.3390/molecules191219292
   Hoste H, 2011, VET PARASITOL, V180, P144, DOI 10.1016/j.vetpar.2011.05.035
   Hernandez-Bolio GI, 2018, PHYTOCHEM ANALYSIS, V29, P413, DOI 10.1002/pca.2724
   Jackson F, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P25, DOI 10.1007/978-90-481-3297-3_3
   Diaz GJ, 2017, MICROB PATHOGENESIS, V109, P162, DOI 10.1016/j.micpath.2017.05.048
   Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001
   Kong JO, 2007, J NEMATOL, V39, P31
   LeOra Software, 2004, POL PLUS PROB LOG AN
   MAFF (Ministry of Agriculture Fisheries and Food), 1986, MAN VET PAR LAB TECH
   Marie-Magdeleine C, 2010, VET PARASITOL, V173, P85, DOI 10.1016/j.vetpar.2010.06.017
   Marie-Magdeleine C, 2010, RES VET SCI, V89, P88, DOI 10.1016/j.rvsc.2010.01.002
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Ndhlala A. R., 2015, FRONT PHARMACOL, V6, P1
   Qiang Z., 2011, BIOAVAILABILITY META
   Raghavendra MP, 2007, J FOOD SCI, V72, pE412, DOI 10.1111/j.1750-3841.2007.00488.x
   ROGERS WP, 1982, INT J PARASITOL, V12, P495, DOI 10.1016/0020-7519(82)90043-1
   Sandoval-Castro CA, 2012, ANIM FEED SCI TECH, V176, P192, DOI 10.1016/j.anifeedsci.2012.07.023
   Castaneda-Ramirez GS, 2019, VET PARASITOL, V270, P13, DOI 10.1016/j.vetpar.2019.05.001
   Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960
   Souza MMC, 2008, AN ACAD BRAS CIENC, V80, P271, DOI 10.1590/S0001-37652008000200005
   Statgraphics Technologies Inc, 2018, STATGR CENT 18 WARR
   Sullivan ML, 2013, J SCI FOOD AGR, V93, P219, DOI 10.1002/jsfa.5781
   Torres-Acosta JFJ, 2012, VET PARASITOL, V189, P89, DOI 10.1016/j.vetpar.2012.03.037
   Vargas-Magana JJ, 2014, VET PARASITOL, V206, P322, DOI 10.1016/j.vetpar.2014.10.008
   von Samson-Himmelstjerna G, 2009, PARASITOL RES, V105, P825, DOI 10.1007/s00436-009-1466-1
   von Son-de Fernex E, 2017, EXP PARASITOL, V178, P1, DOI 10.1016/j.exppara.2017.04.013
   von Son-de Fernex E, 2015, VET PARASITOL, V214, P89, DOI 10.1016/j.vetpar.2015.10.005
NR 35
TC 0
Z9 0
U1 3
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 25
EP 30
DI 10.1016/j.vetpar.2019.05.009
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400005
PM 31213238
DA 2020-05-12
ER

PT J
AU Bell, A
   McNally, J
   Smith, DV
   Rahman, A
   Hunt, P
   Kotze, AC
   Dominik, S
   Ingham, A
AF Bell, Amy
   McNally, Jody
   Smith, Daniel V.
   Rahman, Ashfaqur
   Hunt, Peter
   Kotze, Andrew C.
   Dominik, Sonja
   Ingham, Aaron
TI Quantification of differences in resistance to gastrointestinal nematode
   infections in sheep using a multivariate blood parameter
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Blood parameters; Haemonchus contortus; Resistance; Sex differences;
   Sheep-nematoda
ID QUANTITATIVE TRAIT LOCI; PARASITE RESISTANCE; MERINO SHEEP;
   SUSCEPTIBILITY; RUMINANTS; HELMINTHS; BREED
AB Breeding for resistance to gastrointestinal nematodes (GIN) in sheep relies largely on the use of worm egg counts (WEC) to identify animals that are able to resist infection. As an alternative to such measures of parasite load we aimed to develop a method to identify animals showing resistance to GIN infection based on the impact of the infection on blood parameters. We hypothesized that blood parameters may provide a measure of infection level with a blood-feeding parasite through perturbation of red blood cell parameters due to feeding behaviour of the parasite, and white blood cell parameters through the mounting of an immune response in the host animal. We measured a set of blood parameters in 390 sheep that had been exposed to an artificial regime of repeated challenges with Trichostrongylus colubriforrnis followed by Haemonchus contortus. A simple analysis revealed strong relationships between single blood parameters and WECs with correlation coefficients 0.54 to 0.60. We then used more complex multi-variate methods based on supervised classifier models (including Bayesian Network) as well as regression models (Lasso and Elastic Net) to study the relationships between WECs and blood parameters, and derived algorithms describing the relationships. The ability of these algorithms to classify sheep GIN resistance status was tested using the WEC and blood parameters collected from a different group of 418 sheep that had acquired natural infections of H. contortus from pasture. We identified the most resistant and most susceptible animals (10% percentiles) of this group based on WECs, and then compared the identities of these animals to the identities of animals that were predicted to be most resistant and most susceptible by our algorithms. The models showed varying abilities to predict susceptible and resistant sheep, with up to 65% of the most susceptible animals and 30% of the most resistant animals identified by the Elastic Net model algorithms. The prediction algorithms derived from female sheep data performed better than those for male sheep in some cases, with the predicted animals accounting for up to 50-60% of the actual resistant and susceptible female animals. Heritability values were calculated for blood parameters and the aggregate trait descriptions defined by the novel prediction algorithms. The aggregate trait descriptions were moderately heritable and may therefore be suitable for use in genetic selection strategies. The present study indicates that multivariate models based on blood parameter data showed some ability to predict the resistance status of sheep to infection with H. contortus.
C1 [Bell, Amy; McNally, Jody; Hunt, Peter; Dominik, Sonja] CSIRO, Agr & Food, Armidale, NSW 2350, Australia.
   [Smith, Daniel V.; Rahman, Ashfaqur] CSIRO, Data61, Sandy Bay, Tas 7005, Australia.
   [Kotze, Andrew C.; Ingham, Aaron] CSIRO, Agr & Food, St Lucia, Qld 4067, Australia.
RP Ingham, A (reprint author), CSIRO, Agr & Food, St Lucia, Qld 4067, Australia.
EM Aaron.Ingham@csiro.au
RI Dominik, Sonja/G-9729-2013; Ingham, Aaron B/C-1166-2008; Lehnert,
   Sigrid/A-3676-2013
OI Ingham, Aaron B/0000-0001-8006-9443; Lehnert,
   Sigrid/0000-0003-4891-9094; Rahman, Ashfaqur/0000-0002-0236-5447
FU SheepGenomics which is an initiative of Australian Wool Innovation
   Limited; Meat & Livestock AustraliaMeat and Livestock Australia
FX The authors would like to thank Yutao Li for review of the manuscript
   and Jen Smith for provision of sheep genotypic data from Trial 2. The
   data generated in Trial 1 was supported in part by SheepGenomics which
   is an initiative of Australian Wool Innovation Limited and Meat &
   Livestock Australia.
CR Abuargob O, 2014, VET PARASITOL, V205, P588, DOI 10.1016/j.vetpar.2014.08.024
   ALBERS GAA, 1990, ANIM PROD, V50, P99, DOI 10.1017/S0003356100004505
   Andronicos NM, 2014, VET PARASITOL, V205, P595, DOI 10.1016/j.vetpar.2014.08.009
   BARGER IA, 1993, INT J PARASITOL, V23, P463, DOI 10.1016/0020-7519(93)90034-V
   BARLOW R, 1985, LIVEST PROD SCI, V12, P79, DOI 10.1016/0301-6226(85)90042-9
   Beh KJ, 2002, ANIM GENET, V33, P97, DOI 10.1046/j.1365-2052.2002.00829.x
   Berton MP, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0190-4
   Bishop SC, 2012, ANIMAL, V6, P741, DOI 10.1017/S1751731111000681
   Brown DJ, 2017, ANIM PROD SCI, V57, P209, DOI 10.1071/AN15469
   Burrow HM, 2001, LIVEST PROD SCI, V70, P213, DOI 10.1016/S0301-6226(01)00178-6
   Burrow HM, 2014, P 10 WORLD C GEN APP
   Charlier J, 2014, TRENDS PARASITOL, V30, P361, DOI 10.1016/j.pt.2014.04.009
   Dominik S, 2010, PARASITOLOGY, V137, P1275, DOI 10.1017/S003118201000020X
   Douch PGC, 1996, INT J PARASITOL, V26, P899, DOI 10.1016/S0020-7519(96)80062-2
   Garza JJ, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12572
   Gilmour AR, 2009, ASREML USER GUIDE RE
   Gordon H. McL., 1939, Journal of the Council for Scientific and Industrial Research Australia, V12, P50
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278
   Kim ES, 2014, ANIM GENET, V45, P117, DOI 10.1111/age.12101
   Mavrot F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1164-z
   May K, 2017, J DAIRY SCI, V100, P7330, DOI 10.3168/jds.2017-12901
   Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002
   Ortolani EL, 2013, VET PARASITOL, V196, P230, DOI 10.1016/j.vetpar.2013.02.014
   Safari E, 2005, LIVEST PROD SCI, V92, P271, DOI 10.1016/j.livprodsci.2004.09.003
   Smith J., 2009, P ASS ADV ANIM BREED, V18, P334
   Terefe G, 2007, VET RES, V38, P647, DOI 10.1051/vetres:2007019
   Williams AR, 2010, ANIMAL, V4, P122, DOI 10.1017/S1751731109990802
   Windon RG, 1996, VET IMMUNOL IMMUNOP, V54, P245, DOI 10.1016/S0165-2427(96)05710-8
NR 28
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 31
EP 39
DI 10.1016/j.vetpar.2019.05.007
PG 9
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400006
PM 31213239
DA 2020-05-12
ER

PT J
AU Nixon, SA
   Saez, NJ
   Herzig, V
   King, GF
   Kotze, AC
AF Nixon, Samantha A.
   Saez, Natalie J.
   Herzig, Volker
   King, Glenn F.
   Kotze, Andrew C.
TI The antitrypanosomal diarylamidines, diminazene and pentamidine, show
   anthelmintic activity against Haemonchus contortus in vitro
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Anthelmintic; Drug discovery; Repurposing drugs; Nematodes; Livestock;
   Venom
ID SEA-ANEMONE PEPTIDE; ION CHANNELS; DRUG; RESISTANCE; COMBINATION;
   MONEPANTEL; PSALMOTOXIN-1; CHEMOTHERAPY; ABAMECTIN; BINDING
AB Parasitic nematodes pose a major threat to livestock production worldwide. The blood-feeding parasite Haemonchus contortus is a key small-ruminant pathogen that causes anaemia, and thereby seriously impacts animal health and production. Control of this parasite relies largely upon broad-spectrum anthelmintics, but new drugs are urgently needed to combat the threat of widespread multidrug resistance. Repurposing drugs can accelerate the development pipeline by reducing costs and risks, and can be an effective way of quickly bringing new antiparasitic drugs to market. Diarylamidine compounds such as pentamidine and diminazene have been employed in the treatment of trypanosomiasis and leishmaniasis in both human and veterinary settings, but their activity against parasitic worms has not yet been reported. We screened a small panel of diarylamidine compounds against H. contortus to assess their potential to be repurposed as anthelmintic drugs. Pentamidine and diminazene inhibited H. contortus larval development at low micromolar concentrations (IC50 4.9 mu M and 16.1 mu M, respectively, in a drug-susceptible isolate) with no existing cross-resistance in two multidrug resistant isolates and a monepantel-resistant isolate. Combinations of pentamidine with commercial anthelmintics showed additive activity, with no significant synergism detected. Pentamidine and diminazene showed different life-stage patterns of activity; both were active against early stage larvae in development assays, but only diminazene was active against the infective L3 stage in migration assays. This suggests some differences in uptake of the two drugs across the nematode cuticle, or differences in the nature and expression patterns of their molecular targets. As pentamidine and diminazene have been reported to be potent inhibitors of mammalian acid-sensing ion channels (ASIC), we tested the activity of known ASIC inhibitors against H. contortus to probe whether these channels may represent potential anthelmintic targets in nematodes. Remarkably, the spider venom peptide Hila, a potent inhibitor of ASICla, inhibited H. contortus larval development with an IC50 of 22.9 1.9 mu M. This study highlights the potential use of diarylamidines as anthelmintics, although their activity needs to be confirmed in vivo. In addition, our demonstration that ASIC inhibitors have anthelmintic activity raises the possibility that this family of ion channels may represent a novel anthelmintic target.
C1 [Nixon, Samantha A.; Saez, Natalie J.; Herzig, Volker; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
   [Nixon, Samantha A.; Kotze, Andrew C.] CSIRO, Agr & Food, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.
RP Kotze, AC (reprint author), CSIRO, Agr & Food, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.
EM Andrew.Kotze@csiro.au
RI Nixon, Samantha/C-7966-2017
OI Nixon, Samantha/0000-0003-3157-4114
FU Westpac Bicentennial Foundation Future Leaders Scholarship; Australian
   National Health & Medical Research Council Principal Research Fellowship
FX This work was supported by a Westpac Bicentennial Foundation Future
   Leaders Scholarship awarded to Samantha Nixon and an Australian National
   Health & Medical Research Council Principal Research Fellowship awarded
   to G.F.K. We thank Mr Ben CristoforiArmstrong, Dr Irene Chassagnon, Dr
   Ravi Anangi and Dr Thomas Durek from the Institute for Molecular
   Bioscience, The University of Queensland for kindly sharing venom
   peptides for this study.
CR ALBERS GAA, 1988, VET PARASITOL, V28, P303, DOI 10.1016/0304-4017(88)90077-5
   Anangi R, 2012, MAR DRUGS, V10, P1605, DOI 10.3390/md10071605
   Babokhov P, 2013, PATHOG GLOB HEALTH, V107, P242, DOI 10.1179/2047773213Y.0000000105
   Bartram DJ, 2012, VET PARASITOL, V186, P151, DOI 10.1016/j.vetpar.2011.11.030
   Besier RB, 2016, ADV PARASIT, V93, P95, DOI 10.1016/bs.apar.2016.02.022
   Chassagnon IR, 2017, P NATL ACAD SCI USA, V114, P3750, DOI 10.1073/pnas.1614728114
   Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303
   Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011
   Chou T.-C., 2014, SYNERGY, V1, P3
   Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947
   Cristofori-Armstrong B, 2017, NEUROPHARMACOLOGY, V127, P173, DOI 10.1016/j.neuropharm.2017.04.042
   DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629
   Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917
   Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177
   Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494
   Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200
   Farahat AA, 2017, EUR J MED CHEM, V128, P70, DOI 10.1016/j.ejmech.2017.01.037
   Giordani F, 2016, PARASITOLOGY, V143, P1862, DOI 10.1017/S0031182016001268
   Jospin M, 2004, J PHYSIOL-LONDON, V559, P715, DOI 10.1113/jphysiol.2004.069971
   Joubert KE, 2003, J S AFR VET ASSOC, V74, P69
   Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048
   Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865
   Kotze AC, 2016, ADV PARASIT, V93, P397, DOI 10.1016/bs.apar.2016.02.012
   Kotze AC, 2009, PARASITOLOGY, V136, P1065, DOI 10.1017/S0031182009006386
   Kotze AC, 2006, VET PARASITOL, V137, P294, DOI 10.1016/j.vetpar.2006.01.017
   Kotze AC, 2018, VET PARASITOL, V249, P57, DOI 10.1016/j.vetpar.2017.11.007
   Kuriakose S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048696
   Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88
   Lane J., 2015, BAHE010
   Lanteri CA, 2004, ANTIMICROB AGENTS CH, V48, P3968, DOI 10.1128/AAC.48.10.3968-3974.2004
   Leathwick DM, 2012, VET PARASITOL, V186, P93, DOI 10.1016/j.vetpar.2011.11.050
   Lee JYP, 2018, BRIT J PHARMACOL, V175, P2204, DOI 10.1111/bph.14089
   LEJAMBRE LF, 1995, INT J PARASITOL, V25, P269, DOI 10.1016/0020-7519(94)00118-8
   Lingueglia E, 2013, WIRES MEMBR TRANSP S, V2, P155
   Love SCJ, 2003, AUST VET J, V81, P359, DOI 10.1111/j.1751-0813.2003.tb11514.x
   Lyndal-Murphy M, 2014, AUST VET J, V92, P415, DOI 10.1111/avj.12250
   Nguewa PA, 2005, CHEM BIODIVERS, V2, P1387, DOI 10.1002/cbdv.200590111
   Padhy BM, 2011, J POSTGRAD MED, V57, P153, DOI 10.4103/0022-3859.81870
   Panic G, 2014, INT J PARASITOL-DRUG, V4, P185, DOI 10.1016/j.ijpddr.2014.07.002
   PEREGRINE AS, 1993, ACTA TROP, V54, P185, DOI 10.1016/0001-706X(93)90092-P
   Puttachary S, 2013, MOL BIOCHEM PARASIT, V188, P79, DOI 10.1016/j.molbiopara.2013.02.004
   Raza A, 2016, VET PARASITOL, V220, P77, DOI 10.1016/j.vetpar.2016.02.031
   RIOU G, 1980, BIOCHEM BIOPH RES CO, V96, P350, DOI 10.1016/0006-291X(80)91221-8
   Roeber F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-153
   Rolfe P. F., 2013, United States Patent Application Publication, Patent No. [US2013/0065847Al, 20130065847]
   Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207
   Schroeder CI, 2014, ANGEW CHEM INT EDIT, V53, P1017, DOI 10.1002/anie.201308898
   Stokes JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.28
   Van den Brom R, 2015, VET PARASITOL, V209, P278, DOI 10.1016/j.vetpar.2015.02.026
   Wilson WD, 2008, BIOCHIMIE, V90, P999, DOI 10.1016/j.biochi.2008.02.017
   Wolstenholme AJ, 2011, INT J PARASITOL-DRUG, V1, P2, DOI 10.1016/j.ijpddr.2011.09.003
   Zhang Y, 2000, RNA, V6, P937, DOI 10.1017/S1355838200991726
NR 52
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 40
EP 46
DI 10.1016/j.vetpar.2019.05.008
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400007
PM 31213240
DA 2020-05-12
ER

PT J
AU Hamie, JC
   McAnulty, RW
   Logan, CM
   Lundberg, S
   Greer, AW
AF Hamie, J. C.
   McAnulty, R. W.
   Logan, C. M.
   Lundberg, S.
   Greer, A. W.
TI Comparison of the timing of development of immunity in Romney lambs from
   resistant and resilient selection lines
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Selection; Resistance; Resilience; Immunity; Gastro-intestinal nematode;
   Romney sheep
ID FECAL EGG COUNT; TRICHOSTRONGYLUS-COLUBRIFORMIS ANTIBODY; BODY-WEIGHT
   TRAITS; NEMATODE PARASITES; PHENOTYPIC RELATIONSHIPS;
   HAEMONCHUS-CONTORTUS; BREEDING SHEEP; MATURE WEIGHT; CHALLENGE;
   RESPONSES
AB Variation in the timing of development of immunity to gastro-intestinal nematode parasites was assessed in resistant and resilient Romney selection lines exposed to mixed natural infection. From weaning, at mean 92 days-of-age, animals (n = 53) were sampled for faecal egg count (FEC) expressed as eggs per gram of faeces (epg), saliva for immunoglobulin (IgG and IgA) determination and fasted live weight (LW) every 10 days until 351 days-of-age. Overall, mean back-transformed FEC were consistently low for resistant animals (< 200 epg) whereas resilient counterparts' FEC increased with time to reach a peak of 1400 epg at day 230 for females and 1800 epg for males at day 280 before declining to less than 500 epg by day 300, respectively (P < 0.001). Resistant lambs reached a threshold for Trichoscrongylus colubriformis L3-specific IgG which was indicative of the presence of immunity earlier at 220.6 +/- 8.8 days-of-age compared with resilient-line animals which reach this threshold 40 days later at 263.4 +/- 6.9 days-of-age (P < 0.001). In addition, resistant females reached sexual maturity earlier compared with their resilient counterparts viz. 263.5 +/- 3.7 c.f. 274.4 +/- 3.4 days-of-age, respectively, (P = 0.048). Mean fasted live weight (LW) showed a selection line by time interaction (P < 0.001) which reflected greater LW in the early phase of the study in resilient males but increasing for all groups until day 280 before declining and being similar for all groups from day 330. In summary, differences appear to exist in the timing of immune development between these Romney lines, with resistant animals developing immunity earlier and these resistant-line animals also appear to be more physiologically mature at the same chronological age than resilient animals. These observations have implications on the timing of identification and selection of resistant animals.
C1 [Hamie, J. C.; McAnulty, R. W.; Logan, C. M.; Lundberg, S.; Greer, A. W.] Lincoln Univ, Fac Agr & Life Sci, POB 85084, Christchurch 7647, New Zealand.
RP Hamie, JC (reprint author), Lincoln Univ, Fac Agr & Life Sci, POB 85084, Christchurch 7647, New Zealand.
EM JosephChakana.Hamie@lincolnuni.ac.nz
FU New Zealand AID Commonwealth Scholarship; FRC Writing Scholarship
FX The first author is supported by New Zealand AID Commonwealth
   Scholarship, preparation of the manuscript was supported by FRC Writing
   Scholarship. The authors would also like to thank Caleb Sixtus, Rebecca
   Johnston and James Meyer for their technical assistance.
CR Baker DB, 2004, HLTH INFORMAT SER, P63
   Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006
   Bishop SC, 2012, ANIMAL, V6, P741, DOI 10.1017/S1751731111000681
   Bishop SC, 2004, ANIM SCI, V78, P185, DOI 10.1017/S1357729800053972
   Bishop SC, 2003, VET PARASITOL, V115, P147, DOI 10.1016/S0304-4017(03)00204-8
   Bisset S., 1991, NZ J ZOOLOGY, V18, P85
   Bisset SA, 1996, VET PARASITOL, V61, P249, DOI 10.1016/0304-4017(95)00836-5
   BISSET SA, 1994, NEW ZEAL J AGR RES, V37, P521, DOI 10.1080/00288233.1994.9513091
   Bisset SA, 1996, NEW ZEAL J AGR RES, V39, P313, DOI 10.1080/00288233.1996.9513191
   Bisset SA, 2001, NEW ZEAL VET J, V49, P236, DOI 10.1080/00480169.2001.36238
   Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7
   Brown C., 1990, Proceedings of the New Zealand Grassland Association, V52, P119
   Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9
   Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6
   DOUCH PGC, 1994, INT J PARASITOL, V24, P921, DOI 10.1016/0020-7519(94)90155-4
   DOUCH PGC, 1995, LIVEST PROD SCI, V41, P121, DOI 10.1016/0301-6226(94)00046-A
   Eady SJ, 1998, AUST J AGR RES, V49, P1201, DOI 10.1071/A98069
   GAMBLE HR, 1992, VET PARASITOL, V41, P211, DOI 10.1016/0304-4017(92)90081-J
   Good B, 2006, VET PARASITOL, V136, P317, DOI 10.1016/j.vetpar.2005.12.001
   Green RS, 1999, LIVEST PROD SCI, V58, P129, DOI 10.1016/S0301-6226(98)00201-2
   Greer A., 2016, PHILOS MAG, V96, P1
   Greer AW, 2008, PARASITE IMMUNOL, V30, P123, DOI 10.1111/j.1365-3024.2008.00998.x
   Greer AW, 2018, VET PARASITOL, V250, P60, DOI 10.1016/j.vetpar.2017.12.013
   Greer AW, 2009, ANIMAL, V3, P437, DOI 10.1017/S1751731108003534
   Gruner L, 2003, VET PARASITOL, V116, P239, DOI 10.1016/j.vetpar.2003.07.005
   Lautour M. B. de, 2010, Proceedings of the New Zealand Society of Animal Production, V70, P235
   MAFF, 1979, USDA TECHNICAL B, V18
   Matika O, 2003, SMALL RUMINANT RES, V47, P95, DOI 10.1016/S0921-4488(02)00251-1
   McEwan J. C., 1997, Sustainable control of internal parasites in ruminants: Animal industries workshop., P161
   MCEWAN JC, 1992, PROC NEW ZEAL SOC AN, V52, P53
   McIvor S. D., 2001, Proceedings of the New Zealand Grassland Association, V63, P23
   Morris CA, 2010, NEW ZEAL J AGR RES, V53, P245, DOI 10.1080/00288233.2010.500714
   Morris C. A., 1995, Breeding for resistance to infectious diseases in small ruminants., P77
   Morris CA, 2005, NEW ZEAL J AGR RES, V48, P1, DOI 10.1080/00288233.2005.9513625
   Morris CA, 2000, ANIM SCI, V70, P17, DOI 10.1017/S1357729800051560
   Morris CA, 1997, ANIM SCI, V64, P319, DOI 10.1017/S1357729800015897
   Mugambi JM, 1997, VET PARASITOL, V69, P265, DOI 10.1016/S0304-4017(96)01128-4
   Rendel JM, 2013, PR N Z GRASSL ASSOC, V75, P85
   Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051
   Shaw RJ, 1999, LIVEST PROD SCI, V58, P25, DOI 10.1016/S0301-6226(98)00196-1
   SYKES AR, 1979, RES VET SCI, V26, P372, DOI 10.1016/S0034-5288(18)32896-0
   TAYLOR SCS, 1965, ANIM PROD, V7, P203, DOI 10.1017/S0003356100025629
   TAYLOR SCS, 1971, J ANIM SCI, V33, P726
   TAYLOR SCS, 1985, J ANIM SCI, V61, P118
   Thompson B. R., 2016, Proceedings of the New Zealand Society of Animal Production, V76, P132
   Wheeler M., 2008, Proceedings of the New Zealand Society of Animal Production, V68, P138
NR 46
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 49
EP 55
DI 10.1016/j.vetpar.2019.04.014
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400009
PM 31213241
DA 2020-05-12
ER

PT J
AU McTier, TL
   Pullins, A
   Chapin, S
   Rugg, J
   von Reitzenstein, M
   McCall, JW
   King, VL
   Vatta, AF
AF McTier, Tom L.
   Pullins, Aleah
   Chapin, Sara
   Rugg, Jady
   von Reitzenstein, Marcela
   McCall, John W.
   King, Vickie L.
   Vatta, Adriano F.
TI The efficacy of a novel topical formulation of selamectin plus sarolaner
   (Revolution (R) Plus/Stronghold (R) Plus) in preventing the development
   of Dirofilaria immitis in cats
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Selamectin; Sarolaner; Dirofilaria immitis; Heartworm; Prevention; Cat
ID SPOT-ON FORMULATION; FLEAS CTENOCEPHALIDES-FELIS; HEARTWORM INFECTION;
   ANCYLOSTOMA-TUBAEFORME; OTODECTES-CYNOTIS; MILBEMYCIN OXIME;
   BROAD-SPECTRUM; TOXOCARA-CATI; DOGS; DISEASE
AB Three controlled studies were conducted to investigate the efficacy of selamectin plus sarolaner (Revolution (R) Plus/Stronghold (R) Plus) in preventing feline heartworm disease in cats. In all studies, cats were inoculated with 100 Dirofilaria immitis third stage larvae on Day -30. In the first study, cats were treated with selamectin plus sarolaner as a single dose on Day 0 or as three consecutive monthly doses on Days 0, 28 and 56. In the second and third studies, cats were treated with either sarolaner alone on Day 0, selamectin plus sarolaner on Day 0 or selamectin plus sarolaner as three consecutive monthly doses on Days 0, 28 and 56. In all three studies, dosages were 6 mg/kg selamectin plus 1 mg/kg sarolaner or 1 mg/kg sarolaner alone. Control cats were given a placebo containing inert formulation ingredients (vehicle). All treatments were administered at a single site topically to the skin cranial to the scapulae. Cats were humanely euthanized on Day 145/146 (i.e., 175/176 post-inoculation), and adult D. immitis worms were recovered and enumerated. Across the three studies, adult heartworms were recovered from 87 to 100% of control cats, with geometric mean worm counts ranging from 2.1 to 5.4. No adult D. immitis worms were recovered from cats treated with selamectin plus sarolaner. Cats treated with sarolaner alone were not protected against D. immitis infection, showing geometric mean worm counts of 1.9 to 2.4. In these studies, selamectin (6 mg/kg) plus sarolaner (1 mg/kg) was 100% effective in preventing heart worm development in cats when administered topically as one dose 30 days after inoculation or as three consecutive monthly doses starting 30 days post-inoculation. These studies demonstrated that a single topical administration of selamectin plus sarolaner at the recommended dosage was completely effective in preventing the development of D. immitis in cats.
C1 [McTier, Tom L.; Pullins, Aleah; Chapin, Sara; Rugg, Jady; von Reitzenstein, Marcela; King, Vickie L.; Vatta, Adriano F.] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
   [McCall, John W.] TRS Labs Inc, POB 5112, Athens, GA USA.
RP McTier, TL (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM tom.mctier@zoetis.com
CR Abongwa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146854
   Montoya-Alonso JA, 2015, VET PARASITOL, V212, P456, DOI 10.1016/j.vetpar.2015.06.025
   Arther RG, 2005, VET PARASITOL, V133, P219, DOI 10.1016/j.vetpar.2005.04.001
   Arther RG, 2003, PARASITOL RES, V90, pS137, DOI 10.1007/s00436-003-0917-3
   AVMA, 2012, AM VET MED ASS US PE
   Baker CF, 2014, VET PARASITOL, V202, P49, DOI 10.1016/j.vetpar.2014.02.039
   Becskei C, 2017, VET PARASITOL, V238, pS8, DOI 10.1016/j.vetpar.2017.03.009
   Becskei C, 2017, VET PARASITOL, V238, pS27, DOI 10.1016/j.vetpar.2017.02.029
   Becskei C, 2017, VET PARASITOL, V238, pS18, DOI 10.1016/j.vetpar.2017.03.010
   Becskei C, 2016, VET PARASITOL, V222, P56, DOI 10.1016/j.vetpar.2016.02.017
   Bishop BF, 2000, VET PARASITOL, V91, P163, DOI 10.1016/S0304-4017(00)00289-2
   Blagburn B. L., 2007, VET MED S        MAR, pS7
   Bowman D, 2009, VET PARASITOL, V160, P138, DOI 10.1016/j.vetpar.2008.10.093
   Bowman DD, 2009, VET CLIN N AM-SMALL, V39, P1127, DOI 10.1016/j.cvsm.2009.06.003
   Browne LE, 2005, AM J VET RES, V66, P1544, DOI 10.2460/ajvr.2005.66.1544
   Carmichael J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2445-5
   COURTNEY CH, 1989, J AM ANIM HOSP ASSOC, V25, P643
   CVM, 2001, GOOD CLINICAL PRACTI
   CVM, 2002, EFF ANTH SPEC REC FE
   Dillon AR, 2007, J VET INTERN MED, V21, P608
   Dillon AR, 2008, VET PARASITOL, V158, P171, DOI 10.1016/j.vetpar.2008.09.004
   Dillon AR, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2425-9
   Dillon AR, 2017, PARASITE VECTOR, V10, DOI [10.1186/s13071-017-2452-6, 10.1186/s13071-017-2425-9]
   Dillon AR, 2014, VET PARASITOL, V206, P24, DOI 10.1016/j.vetpar.2014.09.007
   Gates MC, 2010, PREV VET MED, V93, P193, DOI 10.1016/j.prevetmed.2009.10.012
   Genchi C., 1992, Proceedings of the heartworm symposium '92, Austin, Texas, USA, 27-29 March, 1992., P97
   Genchi C, 2004, VET PARASITOL, V122, P287, DOI 10.1016/j.vetpar.2004.04.011
   Genchi C, 2008, VET PARASITOL, V158, P177, DOI 10.1016/j.vetpar.2008.09.005
   Geurden T, 2017, VET PARASITOL, V238, pS31, DOI 10.1016/j.vetpar.2017.02.027
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Gruntmeir JM, 2017, J FELINE MED SURG, V19, P1013, DOI [10.1177/1098612X16670562, 10.1177/1098612x16670562]
   Guerrero J., 1992, Proceedings of the heartworm symposium '92, Austin, Texas, USA, 27-29 March, 1992., P31
   HOLMES RA, 1986, AM J VET RES, V47, P1341
   HOLMES RA, 1993, VET CLIN N AM-SMALL, V23, P125, DOI 10.1016/S0195-5616(93)50008-6
   Jernigan AD, 2000, VET PARASITOL, V91, P359, DOI 10.1016/S0304-4017(00)00305-8
   Lee ACY, 2010, TOP COMPANION ANIM M, V25, P224, DOI 10.1053/j.tcam.2010.09.003
   Levy JK, 2017, JAVMA-J AM VET MED A, V250, P873, DOI 10.2460/javma.250.8.873
   Levy JK, 2011, JAVMA-J AM VET MED A, V238, P311, DOI 10.2460/javma.238.3.311
   Litster AL, 2008, J FELINE MED SURG, V10, P137, DOI 10.1016/j.jfms.2007.09.007
   Little SE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0710-z
   Little SE, 2014, VET PARASITOL, V203, P250, DOI 10.1016/j.vetpar.2014.01.007
   Little SE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-1
   Magi M, 2002, VET REC, V150, P415, DOI 10.1136/vr.150.13.415
   Mansour AE, 1995, PROCEEDINGS OF THE HEARTWORM SYMPOSIUM '95, P87
   McCall JW, 1980, P HEARTW S 80, P126
   McTier T. L., 1992, Proceedings of the heartworm symposium '92, Austin, Texas, USA, 27-29 March, 1992., P165
   McTier T. L., 1992, P HEARTW S 92
   McTier TL, 2000, VET PARASITOL, V91, P333, DOI 10.1016/S0304-4017(00)00303-4
   McTier TL, 2000, VET PARASITOL, V91, P311, DOI 10.1016/S0304-4017(00)00301-0
   McTier TL, 2000, VET PARASITOL, V91, P259, DOI 10.1016/S0304-4017(00)00297-1
   McTier TL, 2000, VET PARASITOL, V91, P177, DOI 10.1016/S0304-4017(00)00290-9
   McTier TL, 2017, PARASITE VECTOR, V10, DOI [10.1186/s13071-017-2429-5, 10.1186/s13071-017-2430-z]
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Morchon R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00196
   Otranto D, 2017, VET PARASITOL, V238, pS1, DOI 10.1016/j.vetpar.2017.03.006
   Robertson-Plouch C K, 2000, Vet Ther, V1, P88
   Ryan WG, 1995, PROCEEDINGS OF THE HEARTWORM SYMPOSIUM '95, P79
   Shanks DJ, 2000, VET PARASITOL, V91, P283, DOI 10.1016/S0304-4017(00)00299-5
   Shanks DJ, 2003, VET REC, V152, P234, DOI 10.1136/vr.152.8.234
   Simon F, 2009, TRENDS PARASITOL, V25, P404, DOI 10.1016/j.pt.2009.06.003
   Six RH, 2016, VET PARASITOL, V222, P23, DOI 10.1016/j.vetpar.2016.02.026
   Six RH, 2016, VET PARASITOL, V222, P28, DOI 10.1016/j.vetpar.2015.12.023
   STEWART VA, 1992, AM J VET RES, V53, P2274
   Vatta A. F., 2018, VET PARASITOL UNDER
   Vatta AF, 2017, VET PARASITOL, V238, pS22, DOI 10.1016/j.vetpar.2017.02.026
   Venco L, 2011, VET PARASITOL, V176, P300, DOI 10.1016/j.vetpar.2011.01.013
   Vidyashankar AN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2440-x
NR 67
TC 5
Z9 5
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
BP 56
EP 62
DI 10.1016/j.vetpar.2018.10.010
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH2IW
UT WOS:000474319400010
PM 30455076
OA Other Gold
DA 2020-05-12
ER

PT J
AU Little, S
   Otranto, D
AF Little, Susan
   Otranto, Domenico
TI Tradition and innovation: Selamectin plus sarolaner. A new tool to
   control endo- and ectoparasites of cats-Studies from North America and
   Japan
SO VETERINARY PARASITOLOGY
LA English
DT Editorial Material
C1 [Little, Susan] Bytown Cat Hosp, Ottawa, ON, Canada.
   [Otranto, Domenico] Univ Bari, Dept Vet Med, Bari, Italy.
RP Little, S (reprint author), Bytown Cat Hosp, Ottawa, ON, Canada.
EM susanlittledvm@gmail.com
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S1
EP S2
DI 10.1016/j.vetpar.2019.05.005
PG 2
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500001
PM 31133493
OA Other Gold
DA 2020-05-12
ER

PT J
AU Reichard, MV
   Rugg, JJ
   Thomas, JE
   Allen, KE
   Barrett, AW
   Murray, JK
   Herrin, BH
   Beam, RA
   King, VL
   Vatta, AF
AF Reichard, Mason V.
   Rugg, Jady J.
   Thomas, Jennifer E.
   Allen, Kelly E.
   Barrett, Annie W.
   Murray, Jill K.
   Herrin, Brian H.
   Beam, Rachel A.
   King, Vickie L.
   Vatta, Adriano F.
TI Efficacy of a topical formulation of selamectin plus sarolaner against
   induced infestations of Amblyomma americanum on cats and prevention of
   Cytauxzoon felis transmission
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Arachnid vectors; Amblyomma americanum; Cats; Cytauxzoon fells;
   Cytauxzoonosis; Protozoan infections; Sarolaner; Selamectin; Ticks;
   Vector transmission
ID SPOT-ON FORMULATION; DOMESTIC CATS; COLLAR SERESTO(R); TICKS;
   ECTOPARASITES; FLORIDA; STATES; SPEED; RISK; KILL
AB Cytauxzoonosis, caused by infection with Cytauxzoon fells, is the most severe tick-borne disease of cats. The purpose of our study was to determine the efficacy of selamectin (6.0 mg/kg) plus sarolaner (1.0 mg/kg) formulated in combination (Revolution (R) Plus / Stronghold (R) Plus, Zoetis) applied topically once a month on cats for three months against induced infestations of Amblyomma americanum adults and to evaluate the effectiveness of the product in preventing the transmission of C. fells. This study was conducted in two phases. Sixteen cats were dosed with selamectin/sarolaner or a placebo (vehicle control) on Days 0, 28, and 56. In phase 1, each cat was infested with 50 (+/- 5) unfed adult A. americanum on Day 4 and tick counts were conducted on Day 6 (48 h post infestation) and Day 7 (72 h post infestation) to evaluate acaricidal efficacy. In phase 2, to confirm acaricidal efficacy and evaluate prevention of C. fells transmission, each cat was infested on Day 60 with 50 (+/- 5) adult A. americanum acquisition fed as nymphs on two C. fells-infected donor cats. Tick counts were conducted on Day 62 (48 h post infestation) and Day 63 (72 h post infestation). Blood samples were collected on Days -9, 60, 70, 76, and 90 and tested for infection with C. fells. Placebo cats were adequately infested on all count days, with least squares (geometric) mean live tick counts ranging from 34.0 (28.8) to 46.1 (46.0). Treatment reduced the least squares (geometric) mean counts compared to placebo by 27.1 (32.1)% and 90.4 (96.8)% on Days 6 and 7, respectively. The corresponding percent reductions were 56.4 (60.6)% and 94.7 (97.3)% on Days 62 and 63, respectively Least squares mean counts were significantly lower in the treated group compared with the placebo group on all count days (P <= 0.0286). All cats were negative for C. fells by PCR prior to study start. In phase 2, seven cats in the control group and no cats in the selamectin/sarolaner group became infected with C. fells (P = 0.0017). Topical treatment with selamectin/sarolaner was > 90% effective in reducing A. americanum tick counts 72 h after infestation and prevented the transmission of C. fells from infected ticks following the third of three monthly treatments. Revolution (R) Plus / Stronghold (R) Plus offers an option for the control of A. americanum infestations on cats and for preventing the transmission of C. fells to cats.
C1 [Reichard, Mason V.; Thomas, Jennifer E.; Allen, Kelly E.; Barrett, Annie W.; Herrin, Brian H.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, 250 McElroy Hall, Stillwater, OK 74078 USA.
   [Rugg, Jady J.; King, Vickie L.; Vatta, Adriano F.] Zoetis, Vet Med Res & Dev, Kalamazoo, MI 49007 USA.
   [Murray, Jill K.; Beam, Rachel A.] Oklahoma State Univ, Anim Resources, Div Vice President Res, Stillwater, OK 74078 USA.
   [Thomas, Jennifer E.] Texas A&M Univ, Dept Clin Sci, College Stn, TX 77845 USA.
   [Herrin, Brian H.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
RP Reichard, MV (reprint author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, 250 McElroy Hall, Stillwater, OK 74078 USA.
EM mason.reichard@okstate.edu
FU Zoetis, Kalamazoo, MI, USA [A186C-US-16-198]
FX This research was funded through a grant (#A186C-US-16-198) from Zoetis,
   Kalamazoo, MI, USA
CR Akucewich LH, 2002, VET PARASITOL, V109, P129, DOI 10.1016/S0304-4017(02)00205-4
   Becskei C, 2017, VET PARASITOL, V238, pS8, DOI 10.1016/j.vetpar.2017.03.009
   BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061
   Blagburn BL, 2009, VET CLIN N AM-SMALL, V39, P1173, DOI 10.1016/j.cvsm.2009.07.001
   BLOUIN E F, 1984, Journal of Wildlife Diseases, V20, P241
   BLOUIN EF, 1987, J WILDLIFE DIS, V23, P499, DOI 10.7589/0090-3558-23.3.499
   Bondy PJ, 2005, J PARASITOL, V91, P458, DOI 10.1645/GE-374R
   Burroughs JE, 2016, EXP APPL ACAROL, V69, P87, DOI 10.1007/s10493-016-0019-4
   Cohn LA, 2011, J VET INTERN MED, V25, P55, DOI 10.1111/j.1939-1676.2010.0646.x
   Council C. A. P., 2018, GEN GUID
   CURRAN KL, 1989, NEW ENGL J MED, V320, P183
   European Medicines Agency, 2016, EMEAVC0041940000
   Fourie JJ, 2015, PARASITOL RES, V114, pS109, DOI 10.1007/s00436-015-4517-9
   Geurden T, 2017, VET PARASITOL, V238, pS12, DOI 10.1016/j.vetpar.2017.03.008
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Jacobs DE, 2000, VET PARASITOL, V91, P161, DOI 10.1016/S0304-4017(00)00288-0
   Little SE, 2018, VET PARASITOL, V257, P15, DOI 10.1016/j.vetpar.2018.05.002
   MAGNARELLI LA, 1990, J AM VET MED ASSOC, V197, P63
   McTier TL, 2019, VET PARASITOL, V270, P56, DOI 10.1016/j.vetpar.2018.10.010
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Meinkoth JH, 2005, VET CLIN N AM-SMALL, V35, P89, DOI 10.1016/j.cvsm.2004.08.003
   Nagamori Y., 2015, Today's Veterinary Practice, V5, P69
   Nagamori Y., 2016, THESIS
   Otranto D, 2017, VET PARASITOL, V238, pS1, DOI 10.1016/j.vetpar.2017.03.006
   Pollard DA, 2017, VET PARASITOL, V244, P136, DOI 10.1016/j.vetpar.2017.08.002
   Reichard MV, 2008, VET PARASITOL, V152, P314, DOI 10.1016/j.vetpar.2007.12.031
   Reichard MV, 2013, PARASITOL RES, V112, P11, DOI 10.1007/s00436-013-3277-7
   Reichard MV, 2010, J MED ENTOMOL, V47, P890, DOI 10.1603/ME10013
   Reichard MV, 2009, VET PARASITOL, V161, P110, DOI 10.1016/j.vetpar.2008.12.016
   Sherrill MK, 2015, J FELINE MED SURG, V17, P940, DOI 10.1177/1098612X15610681
   Shock BC, 2014, TICKS TICK-BORNE DIS, V5, P373, DOI 10.1016/j.ttbdis.2014.01.003
   Society A. H., 2018, HEARTW GUID
   Stanneck D., 2012, PARASITE VECTOR, V5, P18
   Thomas JE, 2018, J FELINE MED SURG, V20, P67, DOI 10.1177/1098612X17691172
   Thomas JE, 2016, VET PARASITOL, V228, P17, DOI 10.1016/j.vetpar.2016.07.034
   Vatta AF, 2019, VET PARASITOL, V270, pS26, DOI 10.1016/j.vetpar.2018.10.016
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
   VICH GL9, 2001, GOOD CLIN PRACTICE G
NR 38
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S31
EP S37
DI 10.1016/j.vetpar.2018.10.018
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500006
PM 30466895
OA Other Gold
DA 2020-05-12
ER

PT J
AU Vatta, AF
   Young, DR
   King, VL
   Myers, MR
AF Vatta, Adrian F.
   Young, David R.
   King, Vickie L.
   Myers, Melanie R.
TI Comparative efficacy of topical treatments with Revolution (R) Plus
   (selamectin and sarolaner) and Bravecto (R) for Cats (fluralaner)
   against Ixodes scapularis ticks on cats
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Bravecto (R); Cats; Comparative efficacy; Fluralaner; Ixodes scapularis;
   Revolution (R) Plus; Sarolaner; Selamectin; Ticks
ID ANAPLASMA-PHAGOCYTOPHILUM; DOMESTIC CATS; INFECTION; FLEA; DOGS
AB The efficacy of three consecutive monthly treatments with a novel topical product (Revolution (R) Plus/Stronghold (R) Plus, Zoetis) containing selamectin in combination with the isoxazoline, sarolaner, was compared with that of another topical isoxazoline, fluralaner [Bravecto (R) (fluralaner topical solution) for Cats, Merck] against Ixodes scapularis ticks on cats. Twenty-four cats were ranked by pre-treatment tick counts to form groups of three and were randomly allocated to be treated with placebo, the minimum label dosage of Revolution (R) Plus (6 mg/kg selamectin plus 1 mg/kg sarolaner) or the minimum label dosage of Bravecto (R) for Cats (40 mg/kg fluralaner) within the groups. On Days 0, 30, and 60, each cat in the placebo and Revolution (R) Plus-treated groups was treated topically, whereas cats in the Bravecto (R) for Cats-treated group were treated topically once on Day 0 with fluralaner and, subsequently, these animals were treated with the placebo on Days 30 and 60 to maintain masking. Doses were calculated based on weight to provide the minimum label dosage for each product; the calculated volume of product to be administered was rounded off to the nearest 0.1 mL. The selamectin plus sarolaner-treated cats received effective dosages of 5.29-7.12 mg/kg selamectin and 0.88-1.19 mg/kg sarolaner, while the fluralaner cats received dosages of 35.21-43.16 mg/kg fluralaner. Cats were infested with approximately 50 unfed viable adult I. scapularis ticks on Days 5, 12, 26, 40, 54, 68, 82, and 88. Efficacy was assessed at 48 h after each infestation.
   There were no adverse reactions to any treatment during the study. The placebo-treated cats maintained adequate tick infestations throughout the study. Three monthly treatments with selamectin plus sarolaner (Revolution (R) Plus) resulted in high and consistent efficacy against I. scapularis for up to 30 days after each treatment. Based on geometric means, efficacy was >= 99.1% at all time points assessed. Treatment with fluralaner (Bravecto (R) for Cats) provided high and consistent efficacy of >= 99.3% up to Day 70. On Day 84, efficacy was 90.1%; however, cats from which ticks were recovered on Day 84 had received approximately 4%-12% less than the minimum dosage of 40 mg/kg fluralaner. Three consecutive monthly treatments with Revolution (R) Plus or a single treatment with Bravecto (R) for Cats provided > 90% control of I. scapularis ticks over a 12-week time period.
C1 [Vatta, Adrian F.; King, Vickie L.; Myers, Melanie R.] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
   [Young, David R.] Young Vet Res Serv, 7243 East Ave, Turlock, CA 95380 USA.
RP Vatta, AF (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM adriano.vatta@zoetis.com
CR [Anonymous], 2018, REVOLUTION PLUS PACK
   [Anonymous], 2001, GOOD CLIN PRACT GUID
   Billeter SA, 2007, VET PARASITOL, V147, P194, DOI 10.1016/j.vetpar.2007.03.028
   CAPC, 2018, GUID CONTR INT EXT P
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   FDA, 2016, CORR FREED INF SUMM
   FDA, 2018, FREED INF SUMM NADA
   Geurden T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2259-5
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Halos L, 2014, TRENDS PARASITOL, V30, P228, DOI 10.1016/j.pt.2014.02.007
   Hoyt K, 2018, TOP COMPANION ANIM M, V33, P40, DOI 10.1053/j.tcam.2018.05.002
   Katrinka Z, 2015, INT AN HEALTH J, V2, P44, DOI DOI 10.1016/J.PT.2014.02.007
   Lappin MR, 2015, J VET DIAGN INVEST, V27, P522, DOI 10.1177/1040638715593598
   Little SE, 2018, VET PARASITOL, V257, P15, DOI 10.1016/j.vetpar.2018.05.002
   Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003
   MCTIER TL, 2019, VET PARASITOL, V270, DOI DOI 10.1016/J.VETPAR.2013.02.003
   *MERCK, 2016, BRAV FLUR TOP SOL CA, DOI DOI 10.1016/J.VETPAR.2018.05.002
   Nagamori Y., 2015, Today's Veterinary Practice, V5, P69
   Otranto D, 2018, VET PARASITOL, V251, P68, DOI 10.1016/j.vetpar.2017.12.021
   Savidge C, 2016, J FELINE MED SURG, V18, P85, DOI 10.1177/1098612X15571148
   Thomas JE, 2016, VET PARASITOL, V228, P17, DOI 10.1016/j.vetpar.2016.07.034
   Vatta AF, 2019, VET PARASITOL, V270, pS52, DOI 10.1016/j.vetpar.2019.05.004
   Vatta AF, 2019, VET PARASITOL, V270, pS3, DOI 10.1016/j.vetpar.2018.11.009
   Vatta AF, 2019, VET PARASITOL, V270, pS26, DOI 10.1016/j.vetpar.2018.10.016
   Vatta AF, 2019, VET PARASITOL, V270, pS45, DOI 10.1016/j.vetpar.2018.10.012
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
   VICH GL9, 2001, GOOD CLIN PRACTICE G
   Zoetis, 2018, REV PLUS PACK INS
NR 28
TC 0
Z9 0
U1 4
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S58
EP S63
DI 10.1016/j.vetpar.2019.05.012
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500010
PM 31182302
DA 2020-05-12
ER

PT J
AU Vatta, AF
   King, VL
   Young, DR
   Chapin, S
AF Vatta, Adriano F.
   King, Vickie L.
   Young, David R.
   Chapin, Sara
TI Efficacy of three consecutive monthly doses of a topical formulation of
   selamectin and sarolaner (Revolution (R) Plus/Stronghold (R) Plus)
   compared with a single dose of fluralaner (Bravecto (R) for Cats)
   against induced infestations of Ctenocephalides felis on cats
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Bravecto (R); Cat; Ctenocephalides fens; Efficacy; Fluralaner;
   Revolution (R) Plus; Sarolaner; Selamectin; Stronghold (R) Plus; Topical
ID SPOT-ON FORMULATION; FLEA
AB In a controlled laboratory study, the efficacy against fleas, Ctenocephalides felis, of a single treatment of fluralaner topical solution (Bravecto (R) for Cats, Merck) was compared with that of three consecutive monthly topical treatments with selamectin and sarolaner (Revolution (R) Plus, Zoetis). Twenty-four domestic short hair cats were ranked based on host suitability flea counts to form groups of three and were randomly assigned within group to one of three treatments. The first group received a topical treatment with (a) placebo (vehicle control for Revolution (R) Plus) on Days 0, 30, and 60, (b) 6 mg/kg selamectin and 1 mg/kg sarolaner on Days 0, 30, and 60, or (c) 40 mg/kg fluralaner on Day 0 and placebo (vehicle control for Revolution (R) Plus) on Days 30 and 60. Because doses were rounded off, the selamectin plus sarolaner-treated cats received effective dosages of 5.25-6.60 mg/kg selamectin and 0.88-1.10 mg/kg sarolaner, while the fluralaner-treated cats received dosages of 34.71-43.08 mg/kg fluralaner. All cats were infested with 100 (+/- 5) fleas on Day -1 and at biweekly intervals after that, from Day 13 to Day 89. Flea comb counts were conducted 24 hours after treatment or after re-infestation.
   There were no adverse events related to treatment during the study. Except for a single cat from which 20 fleas were recovered on Day 90, all other placebo-treated cats had at least 48 fleas at each count, indicating adequacy of infestation of the controls. Based on geometric mean live flea counts, three consecutive monthly treatments with Revolution (R) Plus resulted in consistent and high efficacy of >= 98.6% compared with placebo throughout the study. A single treatment with Bravecto (R) for Cats provided consistent and high efficacy of >= 94.6% on all count days during a period of 12 weeks, the approved duration of efficacy for the product. Based on the efficacy results of the study, both products were equivalent in their ability to control fleas on cats. Use of Bravecto (R) for Cats every 12 weeks or the consecutive monthly use of Revolution (R) Plus is expected to provide extended high residual kill over the respective labeled durations of efficacy of the two products.
C1 [Vatta, Adriano F.; King, Vickie L.; Chapin, Sara] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
   [Young, David R.] Young Vet Res Serv, 7243 East Ave, Turlock, CA 95380 USA.
RP Vatta, AF (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM adriano.vatta@zoetis.com
CR Becskei C, 2017, VET PARASITOL, V238, pS27, DOI 10.1016/j.vetpar.2017.02.029
   Becskei C, 2017, VET PARASITOL, V238, pS18, DOI 10.1016/j.vetpar.2017.03.010
   Companion Animal Parasite Council, 2019, CAPC GUID FLEAS CATS
   Dryden MW, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2995-1
   DRYDEN MW, 2002, COMP CONT EDUC PRACT, V24, P36
   FDA, 2018, 141502 FDA NADA
   FDA, 2016, 141459 FDA NADA FLUR
   Geurden T, 2017, VET PARASITOL, V238, pS31, DOI 10.1016/j.vetpar.2017.02.027
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Lavan R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3142-8
   Lavan RP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2217-2
   Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003
   McTier TL, 2019, VET PARASITOL, V270, P56, DOI 10.1016/j.vetpar.2018.10.010
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Merck, 2016, BRAV FLUR TOP SOL CA
   Rust MK, 2017, INSECTS, V8, DOI 10.3390/insects8040118
   Six RH, 2016, VET PARASITOL, V222, P18, DOI 10.1016/j.vetpar.2016.02.015
   Vatta AF, 2019, VET PARASITOL, V270, pS3, DOI 10.1016/j.vetpar.2018.11.009
   Vatta AF, 2019, VET PARASITOL, V270, pS45, DOI 10.1016/j.vetpar.2018.10.012
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
   VICH GL9, 2001, GOOD CLIN PRACT GUID
   Zoetis, 2018, REV PLUS PACK INS
NR 22
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S52
EP S57
DI 10.1016/j.vetpar.2019.05.004
PG 6
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500009
PM 31133494
OA Other Gold
DA 2020-05-12
ER

PT J
AU Vatta, AF
   Myers, MR
   Rugg, JJ
   Chapin, S
   Pullins, A
   King, VL
   Rugg, D
AF Vatta, Adriano F.
   Myers, Melanie R.
   Rugg, Jady J.
   Chapin, Sara
   Pullins, Aleah
   King, Vickie L.
   Rugg, Douglas
TI Efficacy and safety of a combination of selamectin plus sarolaner for
   the treatment and prevention of flea infestations and the treatment of
   ear mites in cats presented as veterinary patients in the United States
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Sarolaner; Isoxazoline; Selamectin; Revolution (R); Stronghold (R);
   Flea; Ear mite; Efficacy; Safety; Field study
ID SPOT-ON FORMULATION; CTENOCEPHALIDES-FELIS-FELIS; OTODECTES-CYNOTIS;
   TICK INFESTATIONS; BROAD-SPECTRUM; DOGS; SUSCEPTIBILITY; ISOXAZOLINE;
   DISCOVERY; INFECTION
AB Two randomised, single-masked, multi-center field studies were conducted in the United States in cats presented as veterinary patients. The first study evaluated the efficacy and safety of a topically applied formulation of selamectin plus sarolaner (Revolution (R) Plus/Stronghold (R) Plus, Zoetis) against natural flea infestations; the second study evaluated its efficacy against natural ear mite infestations. The product was administered topically by the cats' owners at the dose range provided in the market product of 6.0-12.0 mg selamectin and 1.0-2.0 mg sarolaner per kg bodyweight. Imidacloprid plus moxidectin (Advantage (R) Multi for Cats, Bayer) was used as a positive control in both studies at the label dosage. In the flea study, treatments were administered on Days 0, 30, and 60. Efficacy was calculated based on the mean percent reduction of live flea counts on Days 30, 60, and 90 relative to the pre-treatment count. In the ear mite study, a single treatment was applied on Day 0 and efficacy was determined on Days 14 and 30 based on the presence or absence of ear mites. In both studies, patients were randomly allocated to treatments in the ratio of 2:1, selamectin plus sarolaner: imidacloprid plus moxidectin.
   In the two studies, 405 cats received treatment with selamectin plus sarolaner; of these, 256 cats received three monthly treatments in the flea study. There were no serious adverse reactions to treatment with selamectin plus sarolaner; health issues noted were typical of the normal ailments or minor traumatic injuries expected in the general cat population and were similar in both treatment groups. Efficacy against fleas based on geometric (arithmetic) means was 97.2% (95.9%), 99.5% (99.4%), and 99.8% (99.8%) in the selamectin plus sarolaner group and was 79.7% (70.5%), 91.4% (77.3%), and 95.5% (87.4%) in the imidacloprid plus moxidectin group on Days 30, 60, and 90, respectively. Flea counts for the selamectin plus sarolaner group were significantly lower than the counts for the imidacloprid plus moxidectin group at all time-points after treatment administration on Day 0 (P < 0.001). Treatment reduced the clinical signs of flea allergy dermatitis (alopecia, dermatitis/pyodermatitis, erythema, pruritus, scaling, and papules) in affected cats by 86.7%-100% in the selamectin plus sarolaner group and by 66.7%-100% in the imidacloprid plus moxidectin group.
   In the ear mite study, a single application of selamectin plus sarolaner resulted in the clearance of mites from 87.5% of cats within 14 days and 94.4% of cats within 30 days of treatment. The respective percentages of mite free cats in the imidacloprid plus moxidectin group were 64.0% and 72.0%. There were significantly more cats with no mites noted in the selamectin plus sarolaner group than in the imidacloprid plus moxidectin group on Day 14 and Day 30 (P <= 0.018).
   Selamectin plus sarolaner (Revolution (R) Plus/Stronghold (R) Plus) administered topically at monthly intervals for three months was well tolerated and highly effective for the treatment and prevention of natural infestations of fleas on cats presented as veterinary patients. Clinical signs of flea allergy dermatitis improved in affected cats following treatment administration. A single topical treatment was also safe and highly effective for the treatment of ear mite infestations in naturally infested cats.
C1 [Vatta, Adriano F.; Myers, Melanie R.; Rugg, Jady J.; Chapin, Sara; Pullins, Aleah; King, Vickie L.; Rugg, Douglas] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
RP Vatta, AF (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM adriano.vatta@zoetis.com
CR Becskei C, 2017, VET PARASITOL, V238, pS27, DOI 10.1016/j.vetpar.2017.02.029
   Becskei C, 2017, VET PARASITOL, V238, pS18, DOI 10.1016/j.vetpar.2017.03.010
   Bishop BF, 2000, VET PARASITOL, V91, P163, DOI 10.1016/S0304-4017(00)00289-2
   Blagburn B. L, 2004, DVM360 EXPERT RECOMM
   Boy MG, 2000, VET PARASITOL, V91, P233, DOI 10.1016/S0304-4017(00)00295-8
   Companion Animal Parasite Control, 2018, GEN GUID
   Davis WL, 2007, PARASITOL RES, V101, pS19, DOI 10.1007/s00436-007-0607-7
   Dryden MW, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2995-1
   Dryden MW, 2000, VET PARASITOL, V93, P69, DOI 10.1016/S0304-4017(00)00318-6
   Dryden MW, 2005, VET THER, V6, P228
   Genchi C, 2008, VET PARASITOL, V158, P177, DOI 10.1016/j.vetpar.2008.09.005
   Geurden T, 2017, VET PARASITOL, V238, pS31, DOI 10.1016/j.vetpar.2017.02.027
   Geurden T, 2017, VET PARASITOL, V238, pS12, DOI 10.1016/j.vetpar.2017.03.008
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   GRIFFIN G, 2013, SHELTER MED VET STAF, P146
   Javinsky E, 2012, CAT CLIN MED MANAGEM, P497
   Kopp S, 2013, PARASITOL RES, V112, P47, DOI 10.1007/s00436-013-3280-z
   Kustritz MVR, 2012, MANAGEMENT OF PREGNANT AND NEONATAL DOGS, CATS, AND EXOTIC PETS, P159
   Lappin MR, 2018, VET PARASITOL, V254, P26, DOI 10.1016/j.vetpar.2018.02.022
   Little S. E, 2012, CAT CLIN MED MANAGEM, P1242
   Little SE, 2018, VET PARASITOL, V257, P15, DOI 10.1016/j.vetpar.2018.05.002
   Machado MA, 2018, VET PARASITOL, V256, P29, DOI 10.1016/j.vetpar.2018.04.013
   Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003
   McTier TL, 2000, VET PARASITOL, V91, P177, DOI 10.1016/S0304-4017(00)00290-9
   McTier TL, 2019, VET PARASITOL, V270, P56, DOI 10.1016/j.vetpar.2018.10.010
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Moriello K. A, 2012, CAT CLIN MED MANAGEM, P371
   Ritzhaupt LK, 2002, VET PARASITOL, V106, P165, DOI 10.1016/S0304-4017(02)00051-1
   Rust MK, 2011, MED VET ENTOMOL, V25, P1, DOI 10.1111/j.1365-2915.2010.00934.x
   Rust MK, 2016, INSECTS, V7, DOI 10.3390/insects7010010
   Salant H, 2014, MED VET ENTOMOL, V28, P314, DOI 10.1111/mve.12032
   Six RH, 2000, VET PARASITOL, V91, P291, DOI 10.1016/S0304-4017(00)00300-9
   Six RH, 2016, VET PARASITOL, V222, P62, DOI 10.1016/j.vetpar.2016.02.027
   Thomas JE, 2016, VET PARASITOL, V228, P17, DOI 10.1016/j.vetpar.2016.07.034
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
   VICH GL9, 2001, GOOD CLIN PRACT GUID
   Waller PJ, 2006, VET PARASITOL, V139, P1, DOI 10.1016/j.vetpar.2006.02.036
NR 37
TC 4
Z9 4
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S3
EP S11
DI 10.1016/j.vetpar.2018.11.009
PG 9
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500002
PM 30579753
OA Other Gold
DA 2020-05-12
ER

PT J
AU Vatta, AF
   Everett, WR
   Cherni, JA
   King, VL
   Rugg, D
AF Vatta, Adriano F.
   Everett, William R.
   Cherni, Judith A.
   King, Vickie L.
   Rugg, Douglas
TI The speed of kill of a topical combination of selamectin plus sarolaner
   against induced infestations of Ixodes scapularis ticks on cats
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Ixodes scapularis; Ticks; Speed of kill; Sarolaner; Selamectin; Cat
ID SPOT-ON FORMULATION; ANAPLASMA-PHAGOCYTOPHILUM; BORRELIA-BURGDORFERI;
   DOMESTIC CATS; DOGS; EFFICACY; INFECTION; FLEA; TRANSMISSION; DISEASES
AB The speed of kill of a novel, topical product containing selamectin in combination with sarolaner (selamectin/sarolaner; Revolution (R) Plus/Stronghold (R) Plus) was evaluated against Ixodes scapularis ticks on cats. Sixteen cats were randomly allocated to a treatment group and treated topically on Day 0 with either placebo (vehicle control) or 6 mg/kg selamectin plus 1 mg/kg sarolaner. Cats were infested with approximately 50 unfed viable adult I. scapularis ticks on Days -2, 7, 14, 21, 28 and 35. Efficacy was assessed at 4, 8, 12, 24, 48 and 72 h after treatment on Day 0 and at 4, 8, 12 and 24 h after post-treatment re-infestations.
   There were no adverse reactions to the topical treatment with selamectin/sarolaner. Placebo-treated cats maintained tick infestations throughout the study. Treatment with selamectin/sarolaner significantly reduced tick counts within 12 h (P < 0.0001) and resulted in 100% efficacy by 24 h. For subsequent re-infestations, live tick counts were significantly reduced by 12 h after infestation on Day 7 (P = 0.0120) and by 24 h for Days 14-35 (P < 0.0001). At 24 h after the post-treatment re-infestations, efficacy based on geometric (arithmetic) means was >= 96.1% (94.5%) through Day 21, 75.3% (67.7%) on Day 28 and 66.4% (56.4%) on Day 35.
   Thus, a single topical dose of Revolution (R) Plus/Stronghold (R) Plus at the recommended minimum dose started killing ticks within 12-24 hours after treatment and re-infestations for up to 5 weeks. High acaricidal efficacy (>= 90% reduction in tick burden) was achieved within 24 h after treatment and subsequent re-infestations for at least three weeks.
C1 [Vatta, Adriano F.; Cherni, Judith A.; King, Vickie L.; Rugg, Douglas] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
   [Everett, William R.] BerTek Inc, POB 606, Greenbrier, AR 72058 USA.
RP Vatta, AF (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM adriano.vatta@zoetis.com
CR Becskei C, 2017, VET PARASITOL, V238, pS8, DOI 10.1016/j.vetpar.2017.03.009
   Becskei C, 2017, VET PARASITOL, V238, pS27, DOI 10.1016/j.vetpar.2017.02.029
   Becskei C, 2017, VET PARASITOL, V238, pS18, DOI 10.1016/j.vetpar.2017.03.010
   Billeter SA, 2007, VET PARASITOL, V147, P194, DOI 10.1016/j.vetpar.2007.03.028
   Birkenheuer AJ, 2006, JAVMA-J AM VET MED A, V228, P568, DOI 10.2460/javma.228.4.568
   Burroughs JE, 2016, EXP APPL ACAROL, V69, P87, DOI 10.1007/s10493-016-0019-4
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Dryden MW, 2004, VET THER, V5, P139
   Fourie JJ, 2013, VET PARASITOL, V197, P595, DOI 10.1016/j.vetpar.2013.07.026
   Geurden T, 2017, VET PARASITOL, V238, pS31, DOI 10.1016/j.vetpar.2017.02.027
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Hoyt K, 2018, TOP COMPANION ANIM M, V33, P40, DOI 10.1053/j.tcam.2018.05.002
   Jones EH, 2018, ZOONOSES PUBLIC HLTH, V65, P74, DOI 10.1111/zph.12369
   Katrinka Z, 2015, INT AN HEALTH J, V2, P44, DOI DOI 10.1016/J.PT.2014.02.007
   Lappin MR, 2018, VET PARASITOL, V254, P26, DOI 10.1016/j.vetpar.2018.02.022
   Lappin MR, 2015, J VET DIAGN INVEST, V27, P522, DOI 10.1177/1040638715593598
   Larson MA, 2014, EMERG INFECT DIS, V20, P2068, DOI 10.3201/eid2012.131101
   Little SE, 2007, 2 CAN VECT BORN DIS, P30
   Little SE, 2018, VET PARASITOL, V257, P15, DOI 10.1016/j.vetpar.2018.05.002
   Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004
   Magnarelli LA, 2005, AM J VET RES, V66, P1895, DOI 10.2460/ajvr.2005.66.1895
   Mani R. J., 2016, CURR TROP MED REP, V3, P75, DOI [10.1007/s40475-016-0075-1, DOI 10.1007/S40475-016-0075-1]
   Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003
   McTier TL, 2019, VET PARASITOL, V270, P56, DOI 10.1016/j.vetpar.2018.10.010
   Nagamori Y., 2015, Today's Veterinary Practice, V5, P69
   Nelder MP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1529-y
   Otranto D, 2018, VET PARASITOL, V251, P68, DOI 10.1016/j.vetpar.2017.12.021
   Pantchev N, 2016, BERL MUNCH TIERARZTL, V129, P333, DOI 10.2376/0005-9366-15088
   Savidge C, 2016, J FELINE MED SURG, V18, P85, DOI 10.1177/1098612X15571148
   Thomas JE, 2016, VET PARASITOL, V228, P17, DOI 10.1016/j.vetpar.2016.07.034
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
   VICH GL9, 2001, GOOD CLIN PRACTICE G
NR 32
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S26
EP S30
DI 10.1016/j.vetpar.2018.10.016
PG 5
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500005
PM 30563718
OA Other Gold
DA 2020-05-12
ER

PT J
AU Vatta, AF
   Myers, MR
   Bowman, DD
   Rugg, JJ
   Damrah, L
   Therrien, C
   Liotta, JL
   Lucio-Forster, A
   King, VL
   Rugg, D
AF Vatta, Adriano F.
   Myers, Melanie R.
   Bowman, Dwight D.
   Rugg, Jady J.
   Damrah, Lina
   Therrien, Carole
   Liotta, Janice L.
   Lucio-Forster, Araceli
   King, Vickie L.
   Rugg, Douglas
TI Efficacy and safety of a new topical formulation of selamectin plus
   sarolaner in the treatment and control of natural infections of
   Ancylostoma tubaeforme and Toxocara cati in cats presented as veterinary
   patients in the United States
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Sarolaner; Isoxazoline; Selamectin; Ancylostoma tubaeforme; Toxocara
   cad; Efficacy; Safety; Field study
ID SPOT-ON FORMULATION; DOGS; PREVALENCE; NEMATODES
AB A new topical formulation of selamectin plus sarolaner (Revolution (R) Plus/Stronghold (R) Plus, Zoetis) was evaluated in the treatment and control of naturally occurring infections of Ancylostoma tubaeforme and Toxocara cad in cats presented as veterinary patients in the United States. Three thousand three hundred three (3303) cats were screened in 25 veterinary practices in 15 states and 153 hookworm-positive cats (A. tubaeforme and/or A. braziliense), mainly from Alabama, Mississippi, Texas, and Hawaii, were identified; 135 cats met all the criteria for enrollment and were included on study. The cats were randomly assigned to treatment with Revolution (R) (at the label dosage, to provide a minimum dosage of 6 mg/kg selamectin) or selamectin plus sarolaner (at a dosage of 6-12 mg/kg plus 1-2 mg/kg, respectively). Treatments were administered at the time of enrollment and repeated 30 days later. Fecal samples were collected for differential fecal egg count prior to the first treatment (Day 0), prior to the second treatment (Day 30), and approximately 30 days later (Day 60). Efficacy was based on the percentage reductions in geometric mean fecal egg count for A. tubaeforme on Day 30 and Day 60 compared with Day 0. Where cats were co-infected with T. cati, efficacy against this species was also evaluated. Efficacy data were evaluated for A. tubaeforme for 40 cats on both Day 30 and Day 60 for the group treated with the selamectin/sarolaner combination and reductions in geometric mean fecal egg counts of 99.4% and 99.7% were demonstrated for Day 30 and Day 60, respectively. For the group treated with selamectin alone, 44 and 40 cats were evaluated and percent reductions for Day 30 and Day 60 were 99.5% and 99.9%, respectively. For T. cati, 14 cats were evaluated in the selamectin/sarolaner-treated group for Day 30 and for Day 60, and the reduction in geometric mean fecal egg count was 100% for both days. There were 11 and 9 cats evaluated for Day 30 and Day 60, respectively, for the selamectin-treated group and the reduction was again 100% for both days. The geometric mean fecal egg counts post-treatment were significantly lower than pre-treatment for both A. tubaeforme and T. cati, for both treatments, and for both periods of interest (P < 0.0001). No serious adverse events related to treatment with either product occurred during the study. Thus, both selamectin alone and the combination product of selamectin/sarolaner were safe and effective when administered on a monthly basis for the treatment and control of natural infections of A. tubaeforme and T. cati. The addition of sarolaner to the formulation did not interfere with the efficacy of selamectin against these nematodes.
C1 [Vatta, Adriano F.; Myers, Melanie R.; Rugg, Jady J.; King, Vickie L.; Rugg, Douglas] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
   [Damrah, Lina; Therrien, Carole] Vet Consultancy LLC, 110 Summit Ave, Montvale, NJ 07645 USA.
   [Bowman, Dwight D.; Liotta, Janice L.; Lucio-Forster, Araceli] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, 930 Campus Rd, Ithaca, NY 14853 USA.
RP Vatta, AF (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM adriano.vatta@zoetis.com
CR Anderson TC, 2003, VET PARASITOL, V115, P19, DOI 10.1016/S0304-4017(03)00162-6
   Bishop BF, 2000, VET PARASITOL, V91, P163, DOI 10.1016/S0304-4017(00)00289-2
   BOWMAN DD, 1991, AM J VET RES, V52, P1542
   Bowman DD, 2002, FELINE CLIN PARASITO, DOI [10.1002/9780470376805, DOI 10.1002/9780470376805]
   COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U
   Day MJ, 2012, EMERG INFECT DIS, V18, pe1, DOI DOI 10.3201/EID1812.120664
   De Santis AC, 2006, JAVMA-J AM VET MED A, V228, P885, DOI 10.2460/javma.228.6.885
   Geurden T, 2017, VET PARASITOL, V238, pS31, DOI 10.1016/j.vetpar.2017.02.027
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Hosking BC, 2010, PARASITOL RES, V106, P529, DOI 10.1007/s00436-009-1636-1
   Janecek E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005594
   Little S, 2015, J AM ANIM HOSP ASSOC, V51, P359, DOI 10.5326/JAAHA-MS-6221
   Lucio-Forster A, 2011, J FELINE MED SURG, V13, P300, DOI 10.1016/j.jfms.2010.12.013
   Lucio-Forster A, 2012, J PARASITOL, V98, P1041, DOI 10.1645/GE-2928.1
   McTier TL, 2000, VET PARASITOL, V91, P311, DOI 10.1016/S0304-4017(00)00301-0
   ONWULIRI COE, 1981, Z PARASITENKD, V64, P149
   Otranto D, 2018, VET PARASITOL, V251, P68, DOI 10.1016/j.vetpar.2017.12.021
   Six RH, 2000, VET PARASITOL, V91, P321, DOI 10.1016/S0304-4017(00)00302-2
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
NR 19
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S45
EP S51
DI 10.1016/j.vetpar.2018.10.012
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500008
PM 30470638
OA Other Gold
DA 2020-05-12
ER

PT J
AU Vatta, AF
   Young, DR
   Everett, WR
   King, VL
   Cherni, JA
   von Reitzenstein, M
   Holzmer, SJ
   Chapin, S
   Rugg, D
AF Vatta, Adriano F.
   Young, David R.
   Everett, William R.
   King, Vickie L.
   Cherni, Judith A.
   von Reitzenstein, Marcela
   Holzmer, Susan J.
   Chapin, Sara
   Rugg, Douglas
TI Efficacy of a new topical formulation containing selamectin plus
   sarolaner against three common tick species infesting cats in the United
   States
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Sarolaner; Isoxazoline; Selamectin; Dermacentor variabilis; Ixodes
   scapularis; Amblyomma maculatum; Topical; Tick; Cat; Dose confirmation;
   Non-interference
ID SPOT-ON FORMULATION; ANAPLASMA-PHAGOCYTOPHILUM; DOMESTIC CATS;
   INFECTION; INFESTATIONS; PREVENTION; GUIDELINES; FLEA; DOGS
AB The efficacy of a single topical application of a combination product containing selamectin and sarolaner (selamectin/sarolaner; Revolution (R) Plus/Stronghold (R) Plus) was evaluated in seven laboratory studies against Ixodes scapularis (three studies), Dermacentor variabilis (two studies), or Amblyomma maculatum (two studies). In each study, cats were randomly allocated to treatment groups based on pre-treatment host-suitability tick counts. On Days-2, 5, 12, 19, 26 and 33, the cats were infested with unfed adult ticks. On Day 0, cats were treated with either a placebo (vehicle control) or with the spot-on solution at the minimum dose of 6.0 mg selamectin and 1.0 mg sarolaner/kg bodyweight. In one study with I. scapularis and one with D. variabilis an additional group of cats was treated with selamectin alone (Revolution (R), Zoetis) at 6.0 mg/kg bodyweight. Tick counts were conducted after treatment and after each weekly re-infestation and efficacy determined relative to placebo-treated animals. There were no treatment-related adverse reactions in any of the studies. Geometric mean live tick counts were significantly (P < 0.05) lower in the selamectin/sarolaner-treated groups compared to the geometric mean tick counts in the placebo-treated groups at all time-points in all studies. For all species, a single topical administration of the selamectin/sarolaner combination resulted in > 90% efficacy against existing infestations based on geometric means. Efficacy against weekly re-infestations was > 90% based on geometric means for at least 5 weeks for I. scapularis and D. variabilis, and for at least 4 weeks against A. maculatum. Selamectin alone had no efficacy against I. scapularis, where counts on selamectin-treated cats were not significantly different from placebo at all time points (P > 0.05), and for D. variabilis, counts were not significantly different from placebo at 2, 3 and 5 weeks after treatment (P > 0.05) and efficacy was never greater than 85%. Thus, the activity of the sarolaner against three common tick species found on cats in the US is complementary to the existing broad-spectrum parasite control of selamectin. The inclusion of sarolaner with selamectin in a combination product (Revolution (R) Plus/Stronghold (R) Plus) provides for the treatment of existing tick infestations and gives at least one month of control against re-infestation following a single topical application.
C1 [Vatta, Adriano F.; King, Vickie L.; Cherni, Judith A.; von Reitzenstein, Marcela; Holzmer, Susan J.; Chapin, Sara; Rugg, Douglas] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
   [Young, David R.] YVRS, 7243 East Ave, Turlock, CA 95380 USA.
   [Everett, William R.] BerTek Inc, POB 606, Greenbrier, AR 72058 USA.
RP Vatta, AF (reprint author), Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
EM adriano.vatta@zoetis.com
CR Birkenheuer AJ, 2006, JAVMA-J AM VET MED A, V228, P568, DOI 10.2460/javma.228.4.568
   CAPC, 2018, GUID CONTR INT EXT P
   Cavalleri D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2477-x
   Centers for Disease Control and Prevention, 2018, TICKB DIS US
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   DRYDEN MW, 2004, VET THER, V26, P2
   Geurden T, 2017, VET PARASITOL, V238, pS12, DOI 10.1016/j.vetpar.2017.03.008
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Lappin MR, 2015, J VET DIAGN INVEST, V27, P522, DOI 10.1177/1040638715593598
   Larson MA, 2014, EMERG INFECT DIS, V20, P2068, DOI 10.3201/eid2012.131101
   Lloret A, 2015, J FELINE MED SURG, V17, P637, DOI 10.1177/1098612X15589878
   Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Nagamori Y., 2015, Today's Veterinary Practice, V5, P69
   Nicholson William L., 2009, P493
   Otranto D, 2018, VET PARASITOL, V251, P68, DOI 10.1016/j.vetpar.2017.12.021
   Savidge C, 2016, J FELINE MED SURG, V18, P85, DOI 10.1177/1098612X15571148
   Thomas JE, 2016, VET PARASITOL, V228, P17, DOI 10.1016/j.vetpar.2016.07.034
   VICH GL9, 2001, GOOD CLIN PRACTICE G
NR 19
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S19
EP S25
DI 10.1016/j.vetpar.2018.10.013
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500004
PM 30470637
OA Other Gold
HC Y
HP N
DA 2020-05-12
ER

PT J
AU Yonetake, W
   Fujii, T
   Naito, M
   Maeder, S
   Rugg, D
AF Yonetake, Wakako
   Fujii, Takeshi
   Naito, Masaya
   Maeder, Steven
   Rugg, Douglas
TI Efficacy and safety of a new topical formulation containing selamectin
   and sarolaner in the prevention of heartworm disease and the treatment
   of roundworm infection in cats presented as veterinary patients in Japan
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Selamectin; Sarolaner; Cat; Heartworm; Dirofilaria immitis; Roundworm;
   Toxocara cati; Field study; Efficacy; Safety; Japan
ID DIROFILARIA-IMMITIS INFECTION; PREVALENCE; TOKYO; DOGS
AB The efficacy and safety of a new topical formulation containing selamectin plus sarolaner (Revolution (R) Plus / Stronghold (R) Plus, Zoetis) was evaluated for the prevention of heartworm (Dirofilaria immitis) disease and the treatment of roundworm infection in cats enrolled as veterinary patients in two field studies conducted in Japan.
   In the heartworm field study, 91 cats negative for D. immitis antigen and anti-D. immitis antibody were enrolled and received 9 monthly topical treatments with selamectin plus sarolaner during the period of April to December 2015. Efficacy was assessed by testing post-treatment blood samples collected 8, 12, and 15 months after initiation of treatment for the presence of D. immitis antigen and anti-D. immitis antibody. Eighty-seven cats completed the entire study and were included in the determination of efficacy. No D. immitis antigen or anti-D. immitis antibody were detected in any of the post-treatment samples.
   In the roundworm field study, completed in the period from April to November 2015, 64 cats with >= 100 roundworm eggs per gram (EPG) of feces were enrolled and allocated randomly in a 1:1 ratio, to receive either selamectin plus sarolaner or emodepside plus praziquantel (Profender (R), Bayer). Treatments were administered topically on Days 0 and 30, and efficacy was assessed by fecal EPG counts conducted on Days 14, 30, and 60. All cats completed the entire study. At enrollment, all cats were infected with Toxocara cati. Compared to pre-treatment, geometric mean T. cad EPG counts on Days 14, 30, and 60 were reduced by >99.9% in both treatment groups.
   There were no treatment-related adverse events in either study. Monthly topical administration of Revolution (R) Plus / Stronghold (R) Plus providing a minimum of 6 mg/kg selamectin and 1 mg/kg sarolaner was safe and effective in the prevention of heartworm disease and the treatment of roundworm infection in cats enrolled as veterinary patients in Japan.
C1 [Yonetake, Wakako; Fujii, Takeshi] Zoetis Japan Inc, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1510053, Japan.
   [Naito, Masaya] Shokukanken Inc, 561-21 Arakuchi Machi, Maebashi, Gunma, Japan.
   [Maeder, Steven; Rugg, Douglas] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
RP Yonetake, W (reprint author), Zoetis Japan Inc, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1510053, Japan.
EM wakako.yonetake@zoetis.com
CR American Heartworm Society (AHS), 2014, PREV DIAGN MAN HEART
   [Anonymous], 2019, ABAXIS VETSCAN RAPID
   ASATO R, 1986, Japanese Journal of Parasitology, V35, P209
   Atkins CE, 2000, J AM VET MED ASSOC, V217, P355, DOI 10.2460/javma.2000.217.355
   Bowman D. D, 2014, GEORGIS PARASITOLOGY, P200
   Bowman DD, 2009, VET CLIN N AM-SMALL, V39, P1127, DOI 10.1016/j.cvsm.2009.06.003
   Centers for Disease Control and Prevention (CDC), 2013, PAR TOX ALS KNOWN RO
   Companion Animal Parasite Council (CAPC), 2018, CAPC GUID ASC CATS
   Companion Vector-Borne Diseases (CVBD), 2019, HEARTW DIS DISTR
   Dillon AR, 2017, PARASITE VECTOR, V10, DOI [10.1186/s13071-017-2452-6, 10.1186/s13071-017-2425-9]
   Dillon AR, 2014, VET PARASITOL, V206, P24, DOI 10.1016/j.vetpar.2014.09.007
   Genchi C, 2008, VET PARASITOL, V158, P177, DOI 10.1016/j.vetpar.2008.09.005
   Hirabayashi K., 2014, Proceedings of the 8th International Conference on Urban Pests, 20-23 July 2014, Zurich, Switzerland, P125
   Ito S., 1980, Journal of the Japan Veterinary Medical Association, V33, P424
   Itoh N, 2012, J FELINE MED SURG, V14, P436, DOI 10.1177/1098612X12443633
   Javinsky E, 2012, CAT CLIN MED MANAGEM, P497
   Knight D H, 2001, Vet Ther, V2, P78
   Kyoritsu Seiyaku Corporation, 2016, KS TOP
   Lee ACY, 2010, TOP COMPANION ANIM M, V25, P224, DOI 10.1053/j.tcam.2010.09.003
   Lee ACY, 2010, TRENDS PARASITOL, V26, P155, DOI 10.1016/j.pt.2010.01.002
   Lu TL, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2435-7
   Lucio-Forster A, 2011, J FELINE MED SURG, V13, P300, DOI 10.1016/j.jfms.2010.12.013
   Macuhova K, 2013, J HELMINTHOL, V87, P271, DOI 10.1017/S0022149X12000314
   McTier TL, 2000, VET PARASITOL, V91, P311, DOI 10.1016/S0304-4017(00)00301-0
   McTier TL, 2000, VET PARASITOL, V91, P259, DOI 10.1016/S0304-4017(00)00297-1
   McTier TL, 2019, VET PARASITOL, V270, P56, DOI 10.1016/j.vetpar.2018.10.010
   Nogami S, 1997, J VET MED SCI, V59, P869, DOI 10.1292/jvms.59.869
   Oi M, 2014, PARASITE, V21, DOI 10.1051/parasite/2014008
   Roncalli RA, 1998, VET PARASITOL, V75, P81, DOI 10.1016/S0304-4017(97)00194-5
   Six RH, 2000, VET PARASITOL, V91, P321, DOI 10.1016/S0304-4017(00)00302-2
   Snyder PS, 2000, J AM VET MED ASSOC, V216, P693, DOI 10.2460/javma.2000.216.693
   SUENAGA O, 1973, Tropical Medicine, V15, P131
   Taylor M. A, 2007, VET PARASITOL, P363
   Tsuda Yoshio, 2006, Medical Entomology and Zoology, V57, P75
   UCHIDA A, 1982, Japanese Journal of Parasitology, V31, P55
   Uchikawa K., 1977, Japanese Journal of Sanitary Zoology, V28, P329
   Vatta AF, 2019, VET PARASITOL, V270, pS3, DOI 10.1016/j.vetpar.2018.11.009
   Vatta AF, 2019, VET PARASITOL, V270, pS45, DOI 10.1016/j.vetpar.2018.10.012
   Venco L, 2008, VET PARASITOL, V158, P232, DOI 10.1016/j.vetpar.2008.09.011
   Venco L, 2015, J VET CARDIOL, V17, pS190, DOI 10.1016/j.jvc.2015.08.004
   Yasuda N., 1994, Journal of the Japan Veterinary Medical Association, V47, P777
   Yonetake W, 2019, VET PARASITOL, V270, pS12, DOI 10.1016/j.vetpar.2019.01.008
NR 42
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S38
EP S44
DI 10.1016/j.vetpar.2019.04.001
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500007
PM 31104940
OA Other Gold
DA 2020-05-12
ER

PT J
AU Yonetake, W
   Fujii, T
   Naito, M
   Hodge, A
   Maeder, S
   Rugg, D
AF Yonetake, Wakako
   Fujii, Takeshi
   Naito, Masaya
   Hodge, Andrew
   Maeder, Steven
   Rugg, Douglas
TI Efficacy of a new topical formulation of selamectin plus sarolaner for
   the control of fleas and ticks infesting cats in Japan
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Cat; Efficacy; Field study; Flea; Haemaphysalis longicornis; Laboratory
   study; Safety; Sarolaner; Selamectin; Tick
ID SPOT-ON FORMULATION; THROMBOCYTOPENIA SYNDROME VIRUS; BROAD-SPECTRUM;
   DOMESTIC CATS; SEVERE FEVER; DOGS; INFESTATIONS
AB The efficacy of a single application of a new topical formulation containing selamectin plus sarolaner (Revolution (R) Plus / Stronghold (R) Plus, Zoetis) was evaluated against fleas and ticks infesting cats enrolled as veterinary patients in two field studies conducted in Japan and against Haemaphysalis longicornis ticks on cats in a laboratory study.
   In the laboratory study, sixteen cats were ranked based on pre-treatment tick counts and allocated randomly to treatment on Day 0 with either selamectin plus sarolaner or placebo. Cats were infested with adult H. longicornis on Days -2, 5, 12, 19, 26 and 33. Efficacy relative to placebo was based on live attached tick counts conducted 48 h after treatment and subsequent re-infestations. Selamectin plus sarolaner reduced live, attached H. longicornis counts by 96.4% within 48 h of treatment, and by >= 91.7% within 48 h of weekly re-infestation for 35 days, based on arithmetic means.
   In the field studies, 67 client-owned cats harboring six or more live fleas and 63 cats harboring four or more live attached ticks were enrolled to evaluate selamectin plus sarolaner for efficacy and safety compared with a registered product. Cats were allocated randomly to treatment with selamectin plus sarolaner or fipronil plus (S)-methoprene based on order of presentation. Treatment was administered once on Day 0 and efficacy was assessed by parasite counts conducted on Days 14 and 30 compared to the pre-treatment count. In the flea field study, live flea counts on Days 14 and 30 were reduced by 99.5% and 99.9% in the selamectin plus sarolaner group, and by 97.6% and 98.6% in the fipronil plus (S)-methoprene group, based on least squares mean percentage reductions. Clinical signs typically associated with flea allergy dermatitis improved following treatment. In the tick field study, live tick counts on Days 14 and 30 were reduced by 97.5% and 97.7% in the selamectin plus sarolaner group, and by 91.5% and 93.4% in the fipronil plus (S)-methoprene group, based on least squares mean percentage reductions. Selamectin plus sarolaner was determined to be non-inferior to fipronil plus (S)-methoprene in both field studies.
   There were no treatment-related adverse events in any study. A single topical dose of Revolution (R) Plus / Stronghold (R) Plus providing a minimum dosage of 6.0 mg/kg selamectin and 1.0 mg/kg sarolaner was confirmed to be effective against H. longicornis ticks on cats for one month and safe and effective in the treatment of fleas and ticks on cats enrolled as veterinary patients in Japan.
C1 [Yonetake, Wakako; Fujii, Takeshi] Zoetis Japan Inc, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1510053, Japan.
   [Naito, Masaya] Shokukanken Inc, 561-21 Arakuchi Machi, Maebashi, Gunma, Japan.
   [Hodge, Andrew] Zoetis Australia Res & Mfg, 5 Rider Blvd, Rhodes, NSW 2138, Australia.
   [Maeder, Steven; Rugg, Douglas] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA.
RP Yonetake, W (reprint author), Zoetis Japan Inc, Shibuya Ku, 3-22-7 Yoyogi, Tokyo 1510053, Japan.
EM wakako.yonetake@zoetis.com
CR Becskei C, 2017, VET PARASITOL, V238, pS18, DOI 10.1016/j.vetpar.2017.03.010
   Bishop BF, 2000, VET PARASITOL, V91, P163, DOI 10.1016/S0304-4017(00)00289-2
   Blagburn B. L, 2004, DVM360 EXPERT RECOMM
   Dryden MW, 2004, VET THER, V5, P139
   Ehara S, 1980, ILLUSTRATED BOOK TIC
   Gaowa, 2013, EMERG INFECT DIS, V19, P338, DOI 10.3201/eid1902.120856
   Geurden T, 2017, VET PARASITOL, V238, pS12, DOI 10.1016/j.vetpar.2017.03.008
   Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028
   Hiraoka H, 2005, J VET MED SCI, V67, P1217, DOI 10.1292/jvms.67.1217
   Hiraoka H, 2007, VET PARASITOL, V144, P188, DOI 10.1016/j.vetpar.2005.05.073
   Hoyt K, 2018, TOP COMPANION ANIM M, V33, P40, DOI 10.1053/j.tcam.2018.05.002
   Hwang J, 2017, TICKS TICK-BORNE DIS, V8, P9, DOI 10.1016/j.ttbdis.2016.08.005
   Imai S., 1995, Journal of the Japan Veterinary Medical Association, V48, P775
   Imai S., 2009, ILLUSTRATION VET HYG
   Iwakami S, 2014, J VET MED SCI, V76, P1313, DOI 10.1292/jvms.14-0210
   Iwakami S, 2014, TICKS TICK-BORNE DIS, V5, P771, DOI 10.1016/j.ttbdis.2014.05.008
   Kim CM, 2006, APPL ENVIRON MICROB, V72, P5766, DOI 10.1128/AEM.00431-06
   Ko S, 2010, J VET SCI, V11, P197, DOI 10.4142/jvs.2010.11.3.197
   Lappin MR, 2018, VET PARASITOL, V254, P26, DOI 10.1016/j.vetpar.2018.02.022
   Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126
   Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Oh Jae Young, 2009, Journal of Bacteriology and Virology, V39, P257
   Reichard M. V., 2015, TODAYS VET PRACT, P69
   Reichard MV, 2019, VET PARASITOL, V270, pS31, DOI 10.1016/j.vetpar.2018.10.018
   Rust MK, 2017, INSECTS, V8, DOI 10.3390/insects8040118
   Saeki H., 1998, PARASITE DIFFERENTIA, P162
   Savidge C, 2016, J FELINE MED SURG, V18, P85, DOI 10.1177/1098612X15571148
   Shimada Y, 2003, VET PARASITOL, V111, P231, DOI 10.1016/S0304-4017(02)00352-7
   Tabara K, 2011, J VET MED SCI, V73, P507, DOI 10.1292/jvms.10-0369
   Takada N., 1990, ILLUSTRATED BOOK PAT
   Vatta AF, 2019, VET PARASITOL, V270, pS3, DOI 10.1016/j.vetpar.2018.11.009
   Vatta AF, 2019, VET PARASITOL, V270, pS19, DOI 10.1016/j.vetpar.2018.10.013
   Yonetake W, 2019, VET PARASITOL, V270, pS38, DOI 10.1016/j.vetpar.2019.04.001
NR 34
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUN
PY 2019
VL 270
SU 1
BP S12
EP S18
DI 10.1016/j.vetpar.2019.01.008
PG 7
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA IH7IO
UT WOS:000474677500003
PM 30914264
OA Other Gold
DA 2020-05-12
ER

PT J
AU Liang, BH
   Li, HZ
   Li, L
   Omange, RW
   Hai, Y
   Luo, M
AF Liang, Binhua
   Li, Hongzhao
   Li, Lin
   Omange, Robert Were
   Hai, Yan
   Luo, Ma
TI Current advances in HIV vaccine preclinical studies using Macaque models
SO VACCINE
LA English
DT Review
DE Vaccine; Macaque; Simian immunodeficiency virus; Repeated-low-dose
   challenge; Vaccine efficacy
ID SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; RHESUS MACAQUES;
   CYNOMOLGUS MACAQUES; SIV INFECTION; REVERSE-TRANSCRIPTASE;
   RIBONUCLEASE-ACTIVITY; GAG/POL/NEF VACCINE; SIVMAC239 INFECTION;
   PROTECTIVE EFFICACY
AB The macaque simian or simian/human immunodeficiency virus (SIV/SHIV) challenge model has been widely used to inform and guide human vaccine trials. Substantial advances have been made recently in the application of repeated-low-dose challenge (RLD) approach to assess SIV/SHIV vaccine efficacies (VE). Some candidate HIV vaccines have shown protective effects in preclinical studies using the macaque SIV/SHIV model but the model's true predictive value for screening potential HIV vaccine candidates needs to be evaluated further. Here, we review key parameters used in the RLD approach and discuss their relevance for evaluating VE to improve preclinical studies of candidate HIV vaccines. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.
C1 [Liang, Binhua; Li, Lin; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Liang, Binhua] Univ Manitoba, Biochem & Med Genet, Winnipeg, MB, Canada.
   [Li, Hongzhao; Omange, Robert Were; Hai, Yan; Luo, Ma] Univ Manitoba, Med Microbiol & Infect Dis, Winnipeg, MB, Canada.
RP Liang, BH (reprint author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
EM Binhua.liang@umanitoba.ca
RI Omange, Were/F-1454-2016
OI Omange, Were/0000-0002-0421-110X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI111805]; CIHR/CHVI bridging
   grant; National Microbiology Laboratory of Canada
FX This work was supported by an NIH grant (R01AI111805), a CIHR/CHVI
   bridging grant and funding from National Microbiology Laboratory of
   Canada.
CR Albrecht C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00600
   ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6
   Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004
   Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707
   Andrieu JM, 2018, ARCH VIROL, V163, P2025, DOI 10.1007/s00705-018-3936-1
   Antonucci JM, 2016, NAT MED, V22, P1072, DOI 10.1038/nm.4163
   Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004
   Apetrei C, 2005, J VIROL, V79, P8991, DOI 10.1128/JVI.79.14.8991-9005.2005
   Baroncelli S, 2008, EXPERT REV VACCINES, V7, P1419, DOI 10.1586/14760584.7.9.1419
   Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352
   Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/S0140-6736(18)31364-3, 10.1016/s0140-6736(18)31364-3]
   Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886
   Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061
   Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766
   Beer BE, 2000, J VIROL, V74, P3892, DOI 10.1128/JVI.74.8.3892-3898.2000
   Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09
   Bergamaschi A, 2009, J VIROL, V83, P12253, DOI 10.1128/JVI.01395-09
   Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015
   Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583
   Bradley T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15711
   Butler K, 2013, AIDS RES HUM RETROV, V29, P1091, DOI [10.1089/aid.2012.0383, 10.1089/AID.2012.0383]
   Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715
   Carias AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005885
   Cartwright EK, 2014, J IMMUNOL, V192, P4666, DOI 10.4049/jimmunol.1303193
   Cervasi B, 2013, J VIROL, V87, P9420, DOI 10.1128/JVI.01456-13
   Chahroudi A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1874
   Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550
   Chang HW, 2015, J VIROL, V89, P1965, DOI 10.1128/JVI.03279-14
   Cocklin SL, 2014, CURR OPIN HIV AIDS, V9, P257, DOI 10.1097/COH.0000000000000051
   Cohen J, 2000, SCIENCE, V287, P959, DOI 10.1126/science.287.5455.959
   Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243
   Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06
   Del Prete GQ, 2016, CURR OPIN HIV AIDS, V11, P546, DOI 10.1097/COH.0000000000000311
   Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12
   Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856
   Dubie RA, 2009, VIROLOGY, V386, P109, DOI 10.1016/j.virol.2009.01.007
   Dutta D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196942
   Fauci AS, 2015, NEW ENGL J MED, V373, P2197, DOI 10.1056/NEJMp1502020
   Fenizia C, 2011, J VIROL, V85, P12399, DOI 10.1128/JVI.05707-11
   Forthal DN, 2018, AIDS, V32, P2439, DOI [10.1097/QAD.00000000000002011, 10.1097/QAD.0000000000002011]
   Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112
   GALLIMORE A, 1995, NAT MED, V1, P1167, DOI 10.1038/nm1195-1167
   Garber DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194837
   Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997
   Gupta S, 2015, J INFECT DIS, V211, P45, DOI 10.1093/infdis/jiu300
   Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959
   Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607
   Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519
   Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816
   Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911
   Hearps AC, 2017, MUCOSAL IMMUNOL, V10, P1480, DOI 10.1038/mi.2017.27
   Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004
   HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0
   Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195
   Hsu DC, 2017, HUM VACC IMMUNOTHER, V13, P1018, DOI 10.1080/21645515.2016.1276138
   HU SL, 1992, SCIENCE, V255, P456, DOI 10.1126/science.1531159
   Hudgens MG, 2004, STAT METHODS MED RES, V13, P89, DOI 10.1191/0962280204sm356ra
   Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x
   Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891
   Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11
   Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11
   Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693
   Jensen K, 2016, J VIROL, V90, P7285, DOI 10.1128/JVI.00481-16
   Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429
   Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10
   Kannanganant S, 2014, J VIROL, V88, P5864, DOI 10.1128/JVI.00145-14
   Kasturi SP, 2017, J VIROL, V91, DOI 10.1128/JVI.01844-16
   Keele BF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15740
   Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef
   Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831
   Kersh EN, 2014, J MED PRIMATOL, V43, P310, DOI 10.1111/jmp.12124
   KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735
   Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462
   Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378
   Klatt NR, 2008, J CLIN INVEST, V118, P2039, DOI 10.1172/JCI33814
   Klatt NR, 2012, J VIROL, V86, P1203, DOI 10.1128/JVI.06033-11
   Kurupati R, 2013, J LEUKOCYTE BIOL, V93, P437, DOI 10.1189/jlb.0612287
   Kwa S, 2014, J VIROL, V88, P9579, DOI 10.1128/JVI.00975-14
   Lagenaur LA, 2011, MUCOSAL IMMUNOL, V4, P648, DOI 10.1038/mi.2011.30
   Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117
   Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236
   Lai LL, 2012, VACCINE, V30, P1737, DOI 10.1016/j.vaccine.2011.12.026
   Lakhashe SK, 2011, VACCINE, V29, P5611, DOI 10.1016/j.vaccine.2011.06.017
   Li HZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202997
   Li HZ, 2018, BIOINFORMATION, V14, P48, DOI 10.6026/97320630014048
   Li HZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186079
   Li HZ, 2017, J MED PRIMATOL, V46, P137, DOI 10.1111/jmp.12300
   Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113
   Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539
   Lim SY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000997
   Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738
   Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10
   Lopker M, 2013, J VIROL, V87, P5477, DOI 10.1128/JVI.03419-12
   Ma ZM, 2011, AIDS RES HUM RETROV, V27, P1259, DOI 10.1089/aid.2011.0090
   MACGINNITIE AJ, 1995, J BIOL CHEM, V270, P14768, DOI 10.1074/jbc.270.24.14768
   Manrique M, 2014, J VIROL, V88, P212, DOI 10.1128/JVI.02523-13
   Marsh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040158
   Martins MA, 2018, COLD SPRING HARB PER, V10, DOI [10.1101/RSHPERSNECTA029504, DOI 10.1101/RSHPERSNECTA029504]
   Martins MA, 2018, J VIROL, V92, DOI 10.1128/JVI.00690-18
   Martins MA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006529
   Massud I, 2013, J VIROL, V87, P8952, DOI 10.1128/JVI.01204-13
   MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994
   McClure J, 2000, J MED PRIMATOL, V29, P114, DOI 10.1034/j.1600-0684.2000.290304.x
   Mederle I, 2003, VACCINE, V21, P4153, DOI 10.1016/S0264-410X(03)00537-1
   Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x
   Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200
   Mehrotra DV, 2006, BIOMETRICS, V62, P893, DOI 10.1111/j.1541-0420.2005.00516.x
   Mir KD, 2011, MICROBES INFECT, V13, P14, DOI 10.1016/j.micinf.2010.09.011
   Morris MR, 2015, J MED PRIMATOL, V44, P301, DOI 10.1111/jmp.12177
   Nguyen DC, 2011, IMMUNOGENETICS, V63, P351, DOI 10.1007/s00251-011-0514-z
   Nichols WA, 2015, AM J REPROD IMMUNOL, V74, P508, DOI 10.1111/aji.12422
   Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101
   Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435
   Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09
   Nolen TL, 2015, STAT MED, V34, P1981, DOI 10.1002/sim.6462
   O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524
   OTTEN RA, 1994, AIDS, V8, P297, DOI 10.1097/00002030-199403000-00002
   Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395
   Parsons MS, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0438-x
   Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873
   Pauthner MG, 2019, IMMUNITY, V50, P241, DOI 10.1016/j.immuni.2018.11.011
   Pereira L, 2012, IMMUNODEFICIENCY
   Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039
   Pollara J, 2017, CURR OPIN HIV AIDS, V12, P216, DOI 10.1097/COH.0000000000000362
   Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11
   Radzio J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010297
   Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249
   Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005
   Ren WZ, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-9
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Reynolds MR, 2012, VACCINE, V30, P4465, DOI 10.1016/j.vaccine.2012.04.082
   Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11
   Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10
   Ries M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006506
   Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952
   Ruiz A, 2015, CELL CYCLE, V14, P1657, DOI 10.1080/15384101.2015.1030558
   Ruprecht RM, 1998, AIDS RES HUM RETROV, V14, pS97
   Ryoo J, 2016, NAT MED, V22, P1074, DOI 10.1038/nm.4164
   Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626
   Saunders KO, 2018, J VIROL, V92, DOI 10.1128/JVI.02035-17
   Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006
   Schafer JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005145
   Schmitt K, 2013, VIROLOGY, V442, P82, DOI 10.1016/j.virol.2013.04.002
   Schmitt K, 2011, VIROLOGY, V419, P24, DOI 10.1016/j.virol.2011.07.017
   Semler MR, 2018, IMMUNOGENETICS, V70, P381, DOI 10.1007/s00251-017-1042-2
   Shah SV, 2018, CELL REP, V25, P2766, DOI 10.1016/j.celrep.2018.11.020
   Shaw GM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006965
   Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636
   Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939
   Sholukh AM, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-8
   Silver ZA, 2017, IMMUNOGENETICS, V69, P511, DOI 10.1007/s00251-017-0997-3
   Singh S, 2018, J VIROL, V92, DOI 10.1128/JVI.00281-18
   Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10
   Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013
   Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06
   Strbo N, 2013, J IMMUNOL, V190, P2495, DOI 10.4049/jimmunol.1202655
   Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343
   Sui Y., 2013, CURR PROTOC IMMUNOL, V102, P12, DOI DOI 10.1002/0471142735.IM1214S102
   Takeda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121199
   Tuero I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005101
   UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210
   Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016
   Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105
   Vaccari M, 2013, J VIROL, V87, P3538, DOI 10.1128/JVI.02863-12
   Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001
   Van Rompay KKA, 2017, LAB ANIMAL, V46, P259, DOI 10.1038/laban.1279
   VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06
   Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661
   Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000
   Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108
   Walter L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00540
   Wares M, 2015, ANTIMICROB AGENTS CH, V59, P1942, DOI 10.1128/AAC.04829-14
   Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411
   Weis JF, 2015, AIDS RES HUM RETROV, V31, P288, DOI [10.1089/aid.2014.0209, 10.1089/AID.2014.0209]
   Willer DO, 2010, J VIROL, V84, P2304, DOI 10.1128/JVI.01995-09
   Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06
   Worobey M, 2010, SCIENCE, V329, P1487, DOI 10.1126/science.1193550
   Wu HL, 2018, J IMMUNOL, V200, P49, DOI 10.4049/jimmunol.1700841
   Xiao P, 2012, J VIROL, V86, P4644, DOI 10.1128/JVI.06812-11
   Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017965
   Yeh WW, 2011, J VIROL, V85, P10389, DOI 10.1128/JVI.00854-11
   Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002039
NR 184
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3388
EP 3399
DI 10.1016/j.vaccine.2019.04.094
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300008
PM 31088747
DA 2020-05-12
ER

PT J
AU Shapiro, SZ
AF Shapiro, Stuart Z.
TI Lessons for general vaccinology research from attempts to develop an HIV
   vaccine
SO VACCINE
LA English
DT Review
DE HIV vaccines; Vaccinology; Vaccine design; Affinity maturation;
   Epitopes; T cell-based vaccines
ID BROADLY NEUTRALIZING ANTIBODIES; ORIGINAL ANTIGENIC SIN; T-CELL; DNA
   VACCINE; IMMUNOGENICITY; VECTORS; DESIGN; PROTECTION; EPITOPE;
   IDENTIFICATION
AB In the past when large investments have been made in tackling narrow scientific challenges, the enormous expansion in our knowledge in one small area has had a spill-over effect on research and treatment of other diseases. The large investment in HIV vaccine development in recent years has the potential for such an effect on vaccine development for other diseases. HIV vaccine developers have experienced repeated failure using the standard approaches to vaccine development. This has forced them to consider immune responses in greater depth and detail. It has led to a recognition of the importance of epitopic specificity in both antibody and T cell responses. Also, it has led to an understanding of the importance of affinity maturation in antibody responses and the quality of T cell responses in T cell-mediated immunity. It has advanced the development of many novel vaccine vectors and vehicles that are now available for use in other vaccines. Further, it has focused attention on the impact of research funding mechanisms and community engagement on vaccine development. These developments and considerations have implications for vaccinology more generally. Some suggestions are made for investigators working on other "hard-to-develop" vaccines. Published by Elsevier Ltd.
C1 [Shapiro, Stuart Z.] Natl Inst Allergy & Infect Dis, Vaccine Res Program, Div AIDS, 5601 Fishers Lane,Rm 9C20B, Bethesda, MD 20892 USA.
RP Shapiro, SZ (reprint author), Natl Inst Allergy & Infect Dis, Vaccine Res Program, Div AIDS, 5601 Fishers Lane,Rm 9C20B, Bethesda, MD 20892 USA.
EM sshapiro@niaid.nih.gov
CR Alter G, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177881
   Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003
   Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368
   Barouch DH, 2014, NAT REV MICROBIOL, V12, P765, DOI 10.1038/nrmicro3360
   Bricault CA, 2019, CELL HOST MICROBE, V25, P59, DOI 10.1016/j.chom.2018.12.001
   Burton DR, 2019, NAT REV IMMUNOL, V19, P77, DOI 10.1038/s41577-018-0103-6
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Castillo-Menendez LR, 2018, J VIROL, V92, DOI 10.1128/JVI.00277-18
   Chin'ombe Nyasha, 2013, Open Virol J, V7, P121, DOI 10.2174/1874357901307010121
   DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771
   Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461
   Flaxman A, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030043
   Fruh K, 2017, CURR OPIN IMMUNOL, V47, P52, DOI 10.1016/j.coi.2017.06.010
   Gaiha GD, 2019, SCIENCE
   Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441
   Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365
   Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473
   Hart BE, 2015, CLIN VACCINE IMMUNOL, V22, P726, DOI 10.1128/CVI.00075-15
   Haynes Barton F., 2005, Human Antibodies, V14, P59
   Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Huang YD, 2016, J IMMUNOL, V197, P4603, DOI 10.4049/jimmunol.1601197
   Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815
   Johnson JA, 2013, CURR OPIN HIV AIDS, V8, P412, DOI 10.1097/COH.0b013e328363d3b7
   Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236
   Kelsoe G, 2017, IMMUNOL REV, V275, P79, DOI 10.1111/imr.12508
   Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916
   Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908
   Kunwar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064405
   Kutzler MA, 2016, MUCOSAL IMMUNOL, V9, P13, DOI 10.1038/mi.2015.31
   LaBranche CC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007431
   Larsen D, 2012, AM J HEALTH EDUC, V43, P47, DOI 10.1080/19325037.2012.10599217
   Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053
   Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14
   Luo M, 2013, VACCINE, V31, P3000, DOI 10.1016/j.vaccine.2013.04.057
   Marciani DJ, 2016, J NEUROCHEM, V137, P687, DOI 10.1111/jnc.13608
   Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x
   McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484
   McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283
   McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914
   McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044
   Milone MC, 2018, LEUKEMIA, V32, P1529, DOI 10.1038/s41375-018-0106-0
   Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12
   Mothe B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0392-5
   Nabel GJ, 2009, SCIENCE, V326, P53, DOI 10.1126/science.1177637
   Nene V, 2012, TICKS TICK-BORNE DIS, V3, P188, DOI 10.1016/j.ttbdis.2011.12.001
   Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012
   Nyombayire J, 2017, J INFECT DIS, V215, P95, DOI 10.1093/infdis/jiw500
   Ovchinnikov V, 2018, ELIFE, V7, DOI 10.7554/eLife.33038
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parks CL, 2013, CURR OPIN HIV AIDS, V8, P402, DOI 10.1097/COH.0b013e328363d389
   Parsons MS, 2019, J CLIN INVEST, V129, P182, DOI 10.1172/JCI122466
   Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019
   Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344
   Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002
   Schiller J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004254
   Schwetz TA, 2019, J INFECT DIS, V219, P6, DOI 10.1093/infdis/jiy441
   Sciaranghella G, 2011, VACCINE, V29, P476, DOI 10.1016/j.vaccine.2010.10.072
   Sefton AM, 2001, J APPL MICROBIOL, V91, P592, DOI 10.1046/j.1365-2672.2001.01494.x
   Stebbings R, 2013, VACCINE, V31, P6079, DOI 10.1016/j.vaccine.2013.09.072
   Stephenson KE, 2016, CURR OPIN IMMUNOL, V41, P39, DOI 10.1016/j.coi.2016.05.011
   Trivedi S, 2014, VIROLOGY, V468, P479, DOI 10.1016/j.virol.2014.09.004
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Verkoczy L, 2017, IMMUNOL REV, V275, P89, DOI 10.1111/imr.12505
   Virnik K, 2017, VACCINE, V35, P3272, DOI 10.1016/j.vaccine.2017.04.047
   von Essen MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/163453
   Watle SV, 2016, HUM VACC IMMUNOTHER, V12, P2700, DOI 10.1080/21645515.2016.1217372
   Wiehe K, 2018, CELL HOST MICROBE, V23, P759, DOI 10.1016/j.chom.2018.04.018
   Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802
   Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977
   Yu JS, 2017, J VIROL METHODS, V249, P85, DOI 10.1016/j.jviromet.2017.08.012
   Zhang XS, 2013, VIROLOGY, V446, P25, DOI 10.1016/j.virol.2013.07.012
NR 79
TC 5
Z9 5
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3400
EP 3408
DI 10.1016/j.vaccine.2019.04.005
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300009
PM 30979571
DA 2020-05-12
ER

PT J
AU O'Leary, ST
   Pyrzanowski, J
   Brewer, SE
   Sevick, C
   Dickinson, LM
   Dempsey, AF
AF O'Leary, Sean T.
   Pyrzanowski, Jennifer
   Brewer, Sarah E.
   Sevick, Carter
   Dickinson, L. Miriam
   Dempsey, Amanda F.
TI Effectiveness of a multimodal intervention to increase vaccination in
   obstetrics/gynecology settings
SO VACCINE
LA English
DT Article
DE Vaccine; Attitudes; Health communication; Influenza immunization; Tdap;
   HPV vaccine; Maternal immunization; Ob-gyn physicians; Patient-provider
   communication; Pregnant Women; Gynecological patients
ID CLUSTER-RANDOMIZED-TRIALS; PREGNANT-WOMEN; INFLUENZA VACCINATION;
   UNITED-STATES; OBSTETRICIAN-GYNECOLOGISTS; TDAP VACCINATION; PERTUSSIS
   VACCINATION; VIRUS-INFECTION; COVERAGE; INFANTS
AB Objective: To test the effectiveness of a multimodal intervention in obstetrics/gynecology (ob-gyn) clinics to increase uptake of influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccines in pregnant women and these vaccines plus human papillomavirus (HPV) vaccine in non-pregnant women.
   Methods: A cluster randomized controlled trial among 9 private ob-gyn practices in Colorado from 9/2011 to 5/2014. The intervention consisted of: designation of immunization champions, staff/provider trainings, assistance with vaccine purchasing/management, identification of eligible patients, standing order implementation, chart review/feedback, and patient education materials. Control practices continued usual care. Primary outcomes were receipt of influenza and Tdap vaccines among pregnant women and these vaccines plus HPV vaccine among non-pregnant women, comparing a Baseline period (Year 0/Year 1) to Year 2, intervention versus control. With an estimated sample size of 32,590 per arm, there would be >80% power to detect a 10% difference between groups.
   Results: In the Baseline period, 27% of pregnant women in both intervention and control practices received influenza vaccine. In Year 2, 29% of pregnant women in intervention practices received influenza vaccine versus 41% in control practices. In the Baseline period, 18% of pregnant women in intervention practices received Tdap vaccine versus 22% in control practices. Both intervention and control practices increased to 51% in Year 2, representing an increase of 33% for intervention practices and 29% for control practices, consistent with a change in Tdap recommendations. Relatively few HPV, influenza or Tdap vaccines (<= 6% of eligible patients) were given to non-pregnant patients in either intervention or control practices at any time during the study.
   Conclusion: In this cluster randomized trial designed to increase vaccination uptake, both intervention and control practices showed improved vaccination of pregnant but not non-pregnant patients. Future work should focus on tailoring evidence-based immunization practices or developing new approaches to specifically fit busy ob-gyn offices. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [O'Leary, Sean T.; Pyrzanowski, Jennifer; Brewer, Sarah E.; Sevick, Carter; Dickinson, L. Miriam; Dempsey, Amanda F.] Univ Colorado Denver, Childrens Hosp Colorado, Adult & Child Consortium Outcomes Res & Delivery, Denver, CO USA.
   [O'Leary, Sean T.; Dempsey, Amanda F.] Univ Colorado, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Dickinson, L. Miriam] Univ Colorado, Sch Med, Dept Family Med, Anschutz Med Campus, Aurora, CO 80045 USA.
RP O'Leary, ST (reprint author), Univ Colorado, Dept Pediat, Mail Stop F443,13199 E Montview Blvd,Suite 300, Aurora, CO 80045 USA.
EM sean.oleary@ucdenver.edu
RI Brewer, Sarah/AAG-7535-2019
OI Brewer, Sarah E./0000-0003-0063-6626
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA [1
   U01 IP000501-01, RFA-IP-11-009]
FX This investigation was funded by the Centers for Disease Control and
   Prevention (Award # 1 U01 IP000501-01), awarded in response to
   RFA-IP-11-009, Effectiveness in an Intervention to Promote a Targeted
   Vaccination Program in the Obstetrician Gynecologist Setting. The
   findings and conclusions in this report are those of the authors and do
   not necessarily represent the official position of the Centers for
   Disease Control and Prevention.
CR American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, 2011, Obstet Gynecol, V117, P1008, DOI 10.1097/AOG.0b013e318219226e
   Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3
   Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475
   Barnard JG, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.096
   Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309
   Berenson AB, 2016, HUM VACC IMMUNOTHER, V12, P1965, DOI 10.1080/21645515.2016.1157241
   Carter BR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-65
   Chamberlain AT, 2015, VACCINE, V33, P3571, DOI 10.1016/j.vaccine.2015.05.048
   Cortese MM, 2008, PEDIATRICS, V121, P484, DOI 10.1542/peds.2007-1393
   Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947
   Dabrera G, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.45.20959
   Dempsey AF, 2015, VACCINE, V33, P1773, DOI 10.1016/j.vaccine.2015.02.044
   Dickinson LM, 2015, J AM BOARD FAM MED, V28, P663, DOI 10.3122/jabfm.2015.05.150001
   Diggle P. J., 2002, ANAL LONGITUDINAL DA
   Ding HL, 2015, MMWR-MORBID MORTAL W, V64, P1000, DOI 10.3201/mmwr.mm6436a2
   Ding H, 2014, MMWR-MORBID MORTAL W, V63, P816
   Eckert LO, 2016, OBSTET GYNECOL, V127, pE104
   Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192
   Harper Scott A., 2004, Morbidity and Mortality Weekly Report, V53, P1
   Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3
   Ivers NM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-120
   Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402
   Kerr S, 2016, MMWR-MORBID MORTAL W, V65, P1370, DOI 10.15585/mmwr.mm6548a3
   Kharbanda EO, 2014, JAMA-J AM MED ASSOC, V312, P1897, DOI 10.1001/jama.2014.14825
   Kharbanda EO, 2016, VACCINE, V34, P968, DOI 10.1016/j.vaccine.2015.12.046
   Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871
   Kim DK, 2017, ANN INTERN MED, V166, P209, DOI 10.7326/M16-2936
   Kissin DM, 2011, OBSTET GYNECOL, V118, P1074, DOI 10.1097/AOG.0b013e3182329681
   Koepke R, 2015, MMWR-MORBID MORTAL W, V64, P746
   Leddy MA, 2009, J PEDIATR ADOL GYNEC, V22, P239, DOI 10.1016/j.jpag.2008.09.002
   Li P, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0026-x
   Li P, 2015, STAT MED, V34, P281, DOI 10.1002/sim.6344
   Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444
   Mazzoni S, 2017, J REPROD MED, V62, P3
   Morel JG, 2003, BIOMETRICAL J, V45, P395, DOI 10.1002/bimj.200390021
   Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa
   MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019
   Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587
   Nordin JD, 2013, OBSTET GYNECOL, V121, P519, DOI 10.1097/AOG.0b013e3182831b83
   O'Leary ST, 2016, HUM VACC IMMUNOTHER, V12, P866, DOI 10.1080/21645515.2015.1130194
   O'Leary ST, 2015, PEDIATR INFECT DIS J, V34, P1244, DOI 10.1097/INF.0000000000000873
   Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042
   Power ML, 2009, AM J PREV MED, V37, P231, DOI 10.1016/j.amepre.2009.05.019
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Scholle SH, 2004, AM J OBSTET GYNECOL, V190, P1119, DOI 10.1016/j.ajog.2003.09.059
   Scholle SH, 2003, WOMEN HEALTH, V37, P15, DOI 10.1300/J013v37n01_02
   Shakib JH, 2013, J PEDIATR-US, V163, P1422, DOI 10.1016/j.jpeds.2013.06.021
   Stockwell MS, 2014, AM J PUBLIC HEALTH, V104, pE7, DOI 10.2105/AJPH.2013.301620
   Stupiansky NW, 2012, J ADOLESCENT HEALTH, V50, P103, DOI 10.1016/j.jadohealth.2011.04.010
   Sukumaran L, 2015, JAMA-J AM MED ASSOC, V314, P1581, DOI 10.1001/jama.2015.12790
   Szilagyi P, 2002, COCHRANE DB SYST REV, V4
   Szilagyi PG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e58
   Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012
   Williams WW, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6611a1
   Winter K, 2016, CLIN INFECT DIS
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
NR 58
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3409
EP 3418
DI 10.1016/j.vaccine.2019.05.034
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300010
PM 31103367
DA 2020-05-12
ER

PT J
AU Zhou, M
   Qu, SJ
   Zhao, LD
   Kong, N
   Campy, KS
   Wang, S
AF Zhou, Min
   Qu, Shujuan
   Zhao, Lindu
   Kong, Nan
   Campy, Kathryn S.
   Wang, Song
TI Trust collapse caused by the Changsheng vaccine crisis in China
SO VACCINE
LA English
DT Article
DE DPT vaccine; Trust; Social media; Vaccine crisis; China
ID HEPATITIS-B; HPV VACCINATION; IMMUNIZATION; INFORMATION; CONFIDENCE;
   SAFETY; VIRUS; MEDIA; RISK
AB Background: The public acceptance and implementation of vaccination programs is essential to prevent infectious diseases. However, vaccine adverse events may cause public panic and eventually lead to an increasing number of populations who were hesitant or refuse to participate in these vaccination programs. In 2018, the Changsheng vaccine crisis broke out in mainland China, and 252,600 unqualified DTP vaccines were reported to be used for child vaccination. In this study, we observed media and public reactions toward the vaccine crisis.
   Methods: This study conducted Internet surveillance by four mainstream indicators from July 15th to August 7th, including social media (WeChat, Sina Weibo), online news and Baidu search index. We also analyzed the emotional perceptions of people in crisis through an online questionnaire survey.
   Results: During the crisis, huge number of articles emerged on Internet, 125,882,894 articles (including forwarding) on WeChat friends circle, 1,877,660 Sina Weibo posts, 648,265 online news and 4,986,521 Baidu search indexes. Most of these articles were negative and expressed the public's weak confidence to the China-made vaccines. Public confidence in vaccines was undermined by the actions of the manufacturer and the government.
   Conclusions: The DTP vaccine crisis led to panic about immunization and eroded trust in the immunization program and in the government. Restoring public confidence in Chinese-made vaccines will take a long time, and meticulous management in vaccine production, and strict government regulation will help to alleviate public anxiety about vaccine safety and ultimately restore confidence. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhou, Min; Wang, Song] Hunan Univ Commerce, Coll Business Adm, Changsha, Hunan, Peoples R China.
   [Qu, Shujuan] Cent S Univ, Xiangya Hosp 3, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.
   [Zhou, Min; Zhao, Lindu] Southeast Univ, Sch Econ & Management, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.
   [Zhou, Min; Kong, Nan] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Campy, Kathryn S.] Univ Penn, Ctr Publ Hlth Initiat, Philadelphia, PA 19104 USA.
RP Qu, SJ (reprint author), Cent S Univ, Xiangya Hosp 3, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.; Zhao, LD (reprint author), Southeast Univ, Sch Econ & Management, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.
EM qushujuan25@gmail.com; ldzhao@seu.edu.cn
OI Qu, Shujuan/0000-0002-4219-0856; Zhou, Min/0000-0002-2565-9405
FU NSFC (National Natural Science Foundation of China)National Natural
   Science Foundation of China [71601043, 71671039, 71671040]; 2017 Youth
   Innovation Driven Project in Hunan University of Commerce [17QD06]
FX This work was supported by <NSFC (National Natural Science Foundation of
   China)> under Grant <number 71601043, 71671039, 71671040>; and <2017
   Youth Innovation Driven Project in Hunan University of Commerce> under
   Grant <number 17QD06>.
CR BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305
   Casiday RE, 2006, DRUG SAFETY, V29, P1105, DOI 10.2165/00002018-200629120-00002
   Chen B, 2015, VACCINE, V33, P1780, DOI 10.1016/j.vaccine.2015.02.046
   Cronin JJ, 2000, J RETAILING, V76, P193, DOI 10.1016/S0022-4359(00)00028-2
   De Winter FL, 2015, NEUROIMAGE, V106, P340, DOI 10.1016/j.neuroimage.2014.11.020
   Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381
   Dong TC, 2017, TELEMAT INFORM, V34, P726, DOI 10.1016/j.tele.2016.05.024
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fung ICH, 2016, AM J INFECT CONTROL, V44, P1194, DOI 10.1016/j.ajic.2016.04.248
   Garcia D, 2018, VACCINE, V36, P2721, DOI 10.1016/j.vaccine.2017.11.004
   Gold MS, 2003, MED J AUSTRALIA, V179, P191, DOI 10.5694/j.1326-5377.2003.tb05497.x
   Guo SR, 2016, LECT NOTES COMPUT SC, V10102, P744, DOI 10.1007/978-3-319-50496-4_67
   Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6
   KANAI K, 1980, JPN J MED SCI BIOL, V33, P107, DOI 10.7883/yoken1952.33.107
   Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063
   Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8
   Li TG, 2018, VACCINE, V36, P3772, DOI 10.1016/j.vaccine.2018.05.054
   Madhivanan P, 2009, VACCINE, V27, P5203, DOI 10.1016/j.vaccine.2009.06.073
   MANNING RL, 1994, J LAW ECON, V37, P247, DOI 10.1086/467313
   MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391
   Meggiolaro A, 2018, HUM VACC IMMUNOTHER, V14, P1266, DOI 10.1080/21645515.2017.1423155
   Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477
   Ongkudon CM, 2011, CRIT REV BIOTECHNOL, V31, P32, DOI 10.3109/07388551.2010.483460
   Pakingking R, 2018, VACCINE, V36, P5002, DOI 10.1016/j.vaccine.2018.07.015
   PING RA, 1995, J MARKETING RES, V32, P336, DOI 10.2307/3151985
   Seo J, 2018, VACCINE, V36, P3666, DOI 10.1016/j.vaccine.2018.05.024
   Shah DV, 2001, COMMUN RES, V28, P464, DOI 10.1177/009365001028004005
   Thomas S, 2018, VACCINE, V36, P2596, DOI 10.1016/j.vaccine.2018.03.072
   Yao MZ, 2016, CHIN J COMMUN, V9, P327, DOI 10.1080/17544750.2016.1207346
   Yuan X, 2018, LANCET, V392, P371, DOI 10.1016/S0140-6736(18)31725-2
   Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321
   Zhou L, 2003, J AM SOC INF SCI TEC, V54, P115, DOI 10.1002/asi.10193
   Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018
   Zhu DW, 2014, VACCINE, V32, P6705, DOI 10.1016/j.vaccine.2013.06.095
NR 34
TC 2
Z9 2
U1 9
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3419
EP 3425
DI 10.1016/j.vaccine.2019.05.020
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300011
PM 31097351
DA 2020-05-12
ER

PT J
AU Ko, EJ
   Lee, Y
   Lee, YT
   Jung, YJ
   Ngo, VL
   Kim, MC
   Kim, KH
   Wang, BZ
   Gewirtz, AT
   Kang, SM
AF Ko, Eun-Ju
   Lee, Youri
   Lee, Young-Tae
   Jung, Yu-Jin
   Ngo, Vu L.
   Kim, Min-Chul
   Kim, Ki-Hye
   Wang, Bao-Zhong
   Gewirtz, Andrew T.
   Kang, Sang-Moo
TI Flagellin-expressing virus-like particles exhibit adjuvant effects on
   promoting IgG isotype-switched long-lasting antibody induction and
   protection of influenza vaccines in CD4-deficient mice
SO VACCINE
LA English
DT Article
DE Adjuvant; Flagellin; VLP; Influenza; CD4 T cells
ID MONOPHOSPHORYL-LIPID-A; CD4(+) T-CELLS; BACTERIAL FLAGELLIN;
   ALUMINUM-HYDROXIDE; NLRP3 INFLAMMASOME; DENDRITIC CELLS; ACTIVATION;
   IMMUNOGENICITY; RESPONSES; REQUIRES
AB Incorporation of membrane-anchored flagellin molecules into the surfaces of influenza virus-like particles (VLP) was previously reported to promote T helper (Th) 1-biased IgG antibody production and protective efficacy of co-presented vaccine antigens. Herein, we investigated the potential adjuvant effects and mechanisms of flagellin-expressing VLP (FliC-VLP) as an independent component on influenza vaccination in wild-type and mutant mouse models. FliC-VLP adjuvanted influenza vaccination was highly effective in promoting the induction of Th1-biased IgG isotype switched antibodies, enhanced protection, and long-lasting IgG antibody responses in both wild-type and CD4-knockout mice. In contrast, the adjuvant effects of soluble flagellin were Th2-biased and required CD4 T helper cells. The adjuvant effects of FliC-VLP were less dependent on CD4 T cells and flagellin-mediated innate immune signaling pathways. The results suggest that FliC-VLP might play an effective adjuvant role in an immune competent condition as well as in a defect of CD4 T cells. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ko, Eun-Ju; Lee, Youri; Lee, Young-Tae; Jung, Yu-Jin; Ngo, Vu L.; Kim, Ki-Hye; Wang, Bao-Zhong; Gewirtz, Andrew T.; Kang, Sang-Moo] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA.
   [Ko, Eun-Ju] NCI, Vaccine Branch Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Kim, Min-Chul] Komipharm Co Ltd, Shihung, Gyeonggi Do, South Korea.
RP Kang, SM (reprint author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.
EM yjung8@gsu.edu; vngo2@gsu.edu; bwang23@gsu.edu; agewirtz@gsu.edu;
   skang24@gsu.edu
OI Kang, SAng Moo/0000-0001-6198-331X; Wang, Bao-Zhong/0000-0002-1561-4318
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI105170, AI134132, AI093772]
FX This work was supported by NIH/NIAID grants AI105170 (S.M. K.), AI134132
   (S.M.K.), and AI093772 (S.M.K.)
CR Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Cui BF, 2018, EXPERT REV VACCINES, V17, P335, DOI 10.1080/14760584.2018.1457443
   Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922
   Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549
   Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186
   Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106
   Gaspal FMC, 2005, J IMMUNOL, V174, P3891, DOI 10.4049/jimmunol.174.7.3891
   Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882
   Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062
   Kamath AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005771
   Kang SM, 2011, J VIROL, V85, P11391, DOI 10.1128/JVI.00080-11
   Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11
   Kim MH, 2009, KOREAN J PHYSIOL PHA, V13, P169, DOI 10.4196/kjpp.2009.13.3.169
   Kim YJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01730
   Ko EJ, 2017, IMMUNE NETW, V17, P326, DOI 10.4110/in.2017.17.5.326
   Ko EJ, 2017, J IMMUNOL, V198, P279, DOI 10.4049/jimmunol.1600173
   Ko EJ, 2016, J VIROL, V90, P6976, DOI 10.1128/JVI.00339-16
   Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842
   Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646
   Liu WC, 2016, ANTIVIR RES, V133, P110, DOI 10.1016/j.antiviral.2016.07.021
   Lopez-Macias C, 2011, VACCINE, V29, P7826, DOI 10.1016/j.vaccine.2011.07.099
   Martinez O, 2007, VIROLOGY, V364, P342, DOI 10.1016/j.virol.2007.03.020
   Matusiak M, 2015, P NATL ACAD SCI USA, V112, P1541, DOI 10.1073/pnas.1417945112
   McAleer JP, 2010, TRENDS IMMUNOL, V31, P429, DOI 10.1016/j.it.2010.08.005
   Mckee AS, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-37
   McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914
   Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165
   Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344
   Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Pitoiset F, 2017, J VIROL, V91, DOI 10.1128/JVI.01230-17
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Ren ZG, 2018, VACCINE, V36, P5990, DOI 10.1016/j.vaccine.2018.08.053
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI 10.1586/ERV.10.115
   Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810
   Serre K, 2011, EUR J IMMUNOL, V41, P1573, DOI 10.1002/eji.201041126
   Seubert A, 2011, P NATL ACAD SCI USA, V108, P11169, DOI 10.1073/pnas.1107941108
   Skountzou I, 2009, VACCINE
   Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023
   Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045
   Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041
   Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961
   Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421
   Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972
   Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08
   Wang C, 2018, NANOMED-NANOTECHNOL, V14, P1349, DOI 10.1016/j.nano.2018.03.007
NR 48
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3426
EP 3434
DI 10.1016/j.vaccine.2019.05.018
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300012
PM 31101421
DA 2020-05-12
ER

PT J
AU Fernandez-Sainz, I
   Gavitt, TD
   Koster, M
   Ramirez-Medina, E
   Rodriguez, YY
   Wu, P
   Silbart, LK
   de Los Santos, T
   Szczepanek, SM
AF Fernandez-Sainz, Ignacio
   Gavitt, Tyler D.
   Koster, Marla
   Ramirez-Medina, Elizabeth
   Rodriguez, Yelitza Y.
   Wu, Ping
   Silbart, Lawrence K.
   de Los Santos, Teresa
   Szczepanek, Steven M.
TI The VP1 G-H loop hypervariable epitope contributes to protective
   immunity against Foot and Mouth Disease Virus in swine
SO VACCINE
LA English
DT Article
DE Foot and Mouth Disease; Serotype O-1; Manisa; Vaccine; Xenoepitope; G-H
   loop
ID ANTIGENIC SITE; VACCINE; CELL; SEROTYPE; PROTEIN; SEQUENCE; FMDV; FLAG;
   HETEROGENEITY; REPLICATION
AB Foot and Mouth Disease is a highly contagious and economically important disease of livestock. While vaccination is often effective at controlling viral spread, failures can occur due to strain mismatch or viral mutation. Foot and Mouth Disease Virus (FMDV) possesses a hypervariable region within the G-H Loop of VP1, a capsid protein commonly associated with virus neutralization. Here, we investigate the effect of replacement of the G-H loop hypervariable epitope with a xenoepitope from PRRS virus on the immunogenicity and efficacy of an adenovirus vectored FMDV vaccine (Ad5-FMD). Pigs were vaccinated with Ad5-FMD, the modified Ad5-FMDxeno, or PBS, followed by intradermal challenge with FDMV strain O-1 Manisa at 21 days post-vaccination. While overall serum antibody titers were significantly higher in Ad5-FMDxeno vaccinated animals, neutralizing antibody titers were decreased in pigs that received Ad5-FMDxeno, when compared to those vaccinated with Ad5-FMD, prior to viral challenge, indicative of immune redirection away from VP1 towards non-neutralizing epitopes. As expected, animals vaccinated with unmodified Ad5-FMD were protected from lesions, fever, and viremia. In contrast, animals vaccinated with Ad5-FMDxeno developed clinical signs and viremia, but at lower levels than that observed in PBS-treated controls. No significant difference was found in nasal shedding of virions between the two Ad5-FMD vaccinated groups. This data suggests that the hypervariable epitope of the VP1 G-H loop contributes to protective immunity conferred by Ad5 vector-delivered FMD vaccines in swine, and cannot be substituted without a loss of immunogenicity. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fernandez-Sainz, Ignacio; Koster, Marla; Rodriguez, Yelitza Y.; Wu, Ping; de Los Santos, Teresa] ARS, Plum Isl Anim Dis Ctr, North East Area, USDA, Orient, NY USA.
   [Gavitt, Tyler D.; Silbart, Lawrence K.; Szczepanek, Steven M.] Univ Connecticut, Ctr Excellence Vaccine Res, Storrs, CT USA.
   [Fernandez-Sainz, Ignacio; Gavitt, Tyler D.; Szczepanek, Steven M.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA.
   [Silbart, Lawrence K.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT USA.
   [Ramirez-Medina, Elizabeth] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA.
   [Rodriguez, Yelitza Y.; Wu, Ping] US Anim & Plant Hlth Inspect Serv, Plum Isl Anim Dis Ctr, North East Area, USDA, Orient, NY USA.
   [Rodriguez, Yelitza Y.; Wu, Ping] US Anim & Plant Hlth Inspect Serv, Plum Isl Anim Dis Ctr, Natl Vet Serv Lab, North East Area,USDA, Orient, NY USA.
RP Szczepanek, SM (reprint author), Univ Connecticut, Dept Pathobiol & Vet Sci, Ctr Excellence Vaccine Res, Storrs, CT 06269 USA.
EM steven.szczepanek@uconn.edu
OI Gavitt, Tyler/0000-0002-3014-4166
FU USDA-NIFA-AFRIUnited States Department of Agriculture (USDA)
   [CONS2014-06262]; University of Connecticut [58-1940-4-003]; United
   States Department of AgricultureUnited States Department of Agriculture
   (USDA) [58-1940-4-003]
FX This work was funded in part by USDA-NIFA-AFRI CONS2014-06262.
   Additional funding was provided by Specific Cooperative Agreement
   #58-1940-4-003 between the United States Department of Agriculture and
   the University of Connecticut.
CR ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0
   Lavoria MA, 2012, VACCINE, V30, P6845, DOI 10.1016/j.vaccine.2012.09.011
   Baranowski E, 2000, J VIROL, V74, P1641, DOI 10.1128/JVI.74.4.1641-1647.2000
   Baranowski E, 2001, VIROLOGY, V288, P192, DOI 10.1006/viro.2001.1096
   BORREGO B, 1995, VIRAL IMMUNOL, V8, P11, DOI 10.1089/vim.1995.8.11
   Brown F, 1999, VACCINE, V18, P50, DOI 10.1016/S0264-410X(99)00169-3
   Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06
   BURROWS R, 1966, J HYG-CAMB, V64, P419, DOI 10.1017/S0022172400040729
   Carr BV, 2013, J GEN VIROL, V94, P97, DOI 10.1099/vir.0.045732-0
   Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005
   Cooke JN, 2008, INFECT GENET EVOL, V8, P855, DOI 10.1016/j.meegid.2008.08.004
   de Avila Botton S, 2006, VACCINE, V24, P3446, DOI 10.1016/j.vaccine.2006.02.011
   de los Santos T, 2018, CURR OPIN VIROL, V29, P16, DOI 10.1016/j.coviro.2018.02.005
   Diaz-San Segundo F, 2017, VET MICROBIOL, V206, P102, DOI 10.1016/j.vetmic.2016.12.018
   Fernandez-Sainz I, 2017, VIROLOGY, V502, P123, DOI 10.1016/j.virol.2016.12.021
   Fowler VL, 2010, VACCINE, V28, P3428, DOI 10.1016/j.vaccine.2010.02.074
   FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625
   Frimann TH, 2007, VACCINE, V25, P6191, DOI 10.1016/j.vaccine.2007.06.002
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004
   Han SC, 2015, ARCH VIROL, V160, P1, DOI 10.1007/s00705-014-2278-x
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Knowles NJ, 2012, EMERG INFECT DIS, V18, P499, DOI 10.3201/eid1803.110908
   Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5
   Kotecha A, 2015, NAT STRUCT MOL BIOL, V22, P788, DOI 10.1038/nsmb.3096
   LaRocco M, 2015, J CLIN MICROBIOL, V53, P755, DOI 10.1128/JCM.03220-14
   LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12
   Lawrence P, 2013, VIROLOGY, V436, P150, DOI 10.1016/j.virol.2012.11.001
   MATEU MG, 1994, J VIROL, V68, P1407, DOI 10.1128/JVI.68.3.1407-1417.1994
   MATEU MG, 1990, J GEN VIROL, V71, P629, DOI 10.1099/0022-1317-71-3-629
   MATEU MG, 1995, VIROLOGY, V206, P298, DOI 10.1016/S0042-6822(95)80045-X
   Mayr GA, 1999, VIROLOGY, V263, P496, DOI 10.1006/viro.1999.9940
   Moraes MP, 2001, BIOTECHNIQUES, V31, P1050, DOI 10.2144/01315st05
   PARRY NR, 1989, J GEN VIROL, V70, P1493, DOI 10.1099/0022-1317-70-6-1493
   Brito BP, 2014, VACCINE, V32, P433, DOI 10.1016/j.vaccine.2013.12.007
   Pena L, 2008, VACCINE, V26, P5689, DOI 10.1016/j.vaccine.2008.08.022
   Rieder E, 2005, J VIROL, V79, P12989, DOI 10.1128/JVI.79.20.12989-12998.2005
   Seago J, 2012, J GEN VIROL, V93, P2371, DOI 10.1099/vir.0.043521-0
   Segundo FDS, 2016, VIROLOGY, V499, P340, DOI 10.1016/j.virol.2016.09.027
   Sevilla N, 1996, VIROLOGY, V225, P400, DOI 10.1006/viro.1996.0615
   Suryanarayana V, 1998, VIRUS GENES, V16, P167, DOI 10.1023/A:1007993606750
   Szczepanek SM, 2012, CLIN VACCINE IMMUNOL, V19, P461, DOI 10.1128/CVI.00035-12
   Ullah H, 2015, LETT APPL MICROBIOL, V60, P168, DOI 10.1111/lam.12354
   VERDAGUER N, 1995, EMBO J, V14, P1690, DOI 10.1002/j.1460-2075.1995.tb07158.x
   Wang GX, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0246-z
   Wang HW, 2012, J GEN VIROL, V93, P1442, DOI 10.1099/vir.0.040253-0
   World Organization for Animal Health, 2012, MANUAL DIAGNOSTIC TE, V2, P145
   Yang B, 2016, VIRUS RES, V213, P246, DOI 10.1016/j.virusres.2015.12.013
   ZAMORANO P, 1995, VIROLOGY, V212, P614, DOI 10.1006/viro.1995.1519
   Zhu YY, 2018, J INTEGR AGR, V17, P1655, DOI [10.1016/s2095-3119(18)61916-1, 10.1016/S2095-3119(18)61916-1]
NR 50
TC 2
Z9 2
U1 4
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3435
EP 3442
DI 10.1016/j.vaccine.2019.05.019
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300013
PM 31085001
DA 2020-05-12
ER

PT J
AU Bernstein, DI
   Flechtner, JB
   McNeil, LK
   Heineman, T
   Oliphant, T
   Tasker, S
   Wald, A
   Hetherington, S
   Bernstein, D
   Van Wagoner, N
   Desai, N
   Mayer, K
   Lucksinger, G
   Koltun, W
   Leone, P
   Warren, T
   Panther, L
   Lalezari, J
AF Bernstein, David, I
   Flechtner, Jessica B.
   McNeil, Lisa K.
   Heineman, Thomas
   Oliphant, Tom
   Tasker, Sybil
   Wald, Anna
   Hetherington, Seth
   Bernstein, David
   Van Wagoner, Nicholas
   Desai, Nisha
   Mayer, Kenneth
   Lucksinger, Gregg
   Koltun, William
   Leone, Peter
   Warren, Terri
   Panther, Lori
   Lalezari, Jacob
CA Genocea Study Grp
TI Therapeutic HSV-2 vaccine decreases recurrent virus shedding and
   recurrent genital herpes disease
SO VACCINE
LA English
DT Article
ID ANTIVIRAL THERAPY; CONTROLLED-TRIAL; SAFETY
AB Background: Genital herpes simplex virus (HSV) type 2 is a common persistent infection that frequently reactivates to cause recurrent lesions and recurrent viral shedding which is incompletely controlled by antiviral therapy. GEN-003 is a candidate therapeutic vaccine containing 2 HSV-2 proteins, gD2 and ICP4, and Matrix-M2 adjuvant (M2).
   Methods: HSV-2 seropositive persons with genital herpes were randomized into three dose cohorts of Gen-003 (60 mu g antigen/50 mu g M2, 60 mu g/75 mu g M2 or Placebo). Three intramuscular doses 21 days apart of GEN-003 or placebo were administered. Participants obtained genital area swabs twice-daily for HSV-2 detection and monitored genital lesions for 12 months. The rates of virus shedding and lesion rates before vaccination were compared to 3 defined periods after vaccination; Days 43-71, Month 6 and Month 12.
   Results: GEN-003 at a dose of 60 mu g each antigen/50 mu g M2 reduced HSV shedding immediately after dosing with a rate ratio of 0.58, compared to 0.75 for the GEN-003 6014/75 mu g M2 and 1.06 for placebo. Lesion rates, recurrence rates, and duration of recurrences were also reduced. Reactogenicity was higher with the 75 mu g M2 dose than the 50 mu g M2 dose, specifically for pain, tenderness, malaise and fatigue. Antibody and cellular immune responses were stimulated by both doses and persisted to 12 months.
   Conclusions: GEN-003 vaccine manufactured with a scalable process gave results similar to those observed in prior clinical trials. GEN-003 had an acceptable safety profile and stimulated both humoral and cellular immune responses. The 60 mu g antigen/50 mu g M2 provided the maximal effect on virologic and clinical measures and warrants further development. (C) 2019 Published by Elsevier Ltd.
C1 [Bernstein, David, I] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.
   [Flechtner, Jessica B.; McNeil, Lisa K.; Heineman, Thomas; Tasker, Sybil; Hetherington, Seth] Genocea Biosci, Cambridge, MA USA.
   [Oliphant, Tom] Innovat Analyt, Kalamazoo, MI USA.
   [Wald, Anna] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA.
   [Tasker, Sybil] Altimmune Inc, Gaithersburg, MD USA.
   [Bernstein, David] Cincinnati Childrens Hosp, Cincinnati, OH USA.
   [Wald, Anna] Univ Washington, Seattle, WA 98195 USA.
   [Van Wagoner, Nicholas] Univ Alabama, Tuscaloosa, AL 35487 USA.
   [Desai, Nisha] NW Dermatol & Res Ctr, Portland, OR USA.
   [Mayer, Kenneth] Fenway Inst, Boston, MA USA.
   [Lucksinger, Gregg] Tekton Res, Austin, TX USA.
   [Koltun, William] Med Ctr Clin Res, Rochester, MN USA.
   [Leone, Peter] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Warren, Terri] Westover Hts, Portland, OR USA.
   [Panther, Lori] Fenwav Inst, Boston, MA USA.
   [Lalezari, Jacob] Quest Clin Res, Chennai, Tamil Nadu, India.
RP Bernstein, DI (reprint author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM david.bernstein@cchmc.org
FU Genocea Biosciences Inc. (Cambridge, MA)
FX This study was funded by Genocea Biosciences Inc. (Cambridge, MA).
CR Baccari A, 2016, VACCINE, V34, P3901, DOI 10.1016/j.vaccine.2016.05.033
   Bernstein DI, 2017, J INFECT DIS, V215, P856, DOI 10.1093/infdis/jix004
   Casanova G, 2002, CUTIS, V70, P235
   Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144
   Daum LT, 2011, EPIDEMIOL INFECT, V139, P1764, DOI 10.1017/S0950268810002384
   de Bruyn G, 2006, VACCINE, V24, P914, DOI 10.1016/j.vaccine.2005.08.088
   Flechtner JB, 2016, VACCINE, V34, P5314, DOI 10.1016/j.vaccine.2016.09.001
   Gupta R, 2006, EXPERT OPIN PHARMACO, V7, P665, DOI 10.1517/14656566.7.6.665
   Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9
   KUTINOVA L, 1988, VACCINE, V6, P223, DOI 10.1016/0264-410X(88)90215-0
   Le Cleach L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009036.pub2
   Long D, 2014, VIROLOGY, DOI [10.1016/jvirol2014.07.018, DOI 10.1016/JVIROL2014.07.018]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Madhun AS, 2009, VACCINE, V27, P7367, DOI 10.1016/j.vaccine.2009.09.044
   Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12
   STRAUS SE, 1994, LANCET, V343, P1460, DOI 10.1016/S0140-6736(94)92581-X
   Van Wagoner N, 2018, TRIAL J INFEC DIS
   Wald A, 2011, VACCINE, V29, P8520, DOI 10.1016/j.vaccine.2011.09.046
NR 18
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3443
EP 3450
DI 10.1016/j.vaccine.2019.05.009
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300014
PM 31103365
DA 2020-05-12
ER

PT J
AU Davies, J
   Lokuge, K
   Glass, K
AF Davies, Josephine
   Lokuge, Kamalini
   Glass, Kathryn
TI Routine and pulse vaccination for Lassa virus could reduce high levels
   of endemic disease: A mathematical modelling study
SO VACCINE
LA English
DT Article
DE Lassa virus; Vaccine; Mathematical model; Endemic transmission
ID HANTAVIRUS INFECTION; FEVER; EPIDEMIOLOGY; TRANSMISSION; STRATEGY;
   RODENTS
AB Lassa fever is an acute viral illness caused by Lassa virus (LASV), a rodent-borne pathogen. LASV is endemic to much of Sub-Saharan West Africa, where seasonal outbreaks cause significant morbidity and mortality. Increased global awareness of LASV has led to development of improved diagnostic tests, treatments and vaccines. As vaccine candidates are trialled, it is essential to assess the potential outcomes of introducing a LASV vaccination program in endemic regions. This study investigates the potential outcomes of routine and pulse vaccination strategies using a deterministic mathematical model that captures seasonal LASV transmission between rodents and humans. For plausible parameter values, we find that immunization of 40% of infants at 70% vaccine effectiveness achieves a population-level reduction in infectious case numbers of 30%, while coverage of 60% at 90% vaccine effectiveness achieves a 56% reduction. Similar reductions can be achieved more rapidly via population-wide pulse vaccination at 11% coverage (30% reduction at 70% effectiveness) or 23% coverage (56% reduction at 90% effectiveness) repeated every 10 years. Similar pulse vaccine doses delivered at reduced frequency, but increased coverage achieves a greater reduction in infectious cases. Findings around infant vaccination are sensitive to our assumption that immunity is life-long, while pulse-vaccination has only slightly reduced effect if immunity lasts 10-30 years. An effective LASV vaccination program would incorporate pulse vaccination in addition to routine childhood immunization to limit disease. Estimates of feasible vaccine coverage and effectiveness are needed to fully quantify the likely benefits of a vaccination program in LASV endemic regions. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.
C1 [Davies, Josephine] Australian Natl Univ, Med Sch, Canberra, ACT, Australia.
   [Lokuge, Kamalini; Glass, Kathryn] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.
RP Glass, K (reprint author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.
EM Kathryn.Glass@anu.edu.au
OI Glass, Kathryn/0000-0001-5905-1310; Lokuge, Kamalini/0000-0002-6287-1296
CR Abramson G, 2003, B MATH BIOL, V65, P519, DOI 10.1016/S0092-8240(03)00013-2
   Abreu-Mota T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06741-w
   Adepoju P, 2019, LANCET, V393, P627, DOI 10.1016/S0140-6736(19)30357-5
   Adewale S, 2016, ASIAN J NAT APPL SCI, V5
   Agbonlahor DE, 2017, J VECTOR DIS, V54, P146
   Aguirre MA, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041908
   Akanni J, 2018, ASIAN RES J MATH, V9, P1
   Allen LJS, 2006, B MATH BIOL, V68, P511, DOI 10.1007/s11538-005-9034-4
   Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839
   Bonwitt J, 2017, AM J TROP MED HYG, V96, P935, DOI 10.4269/ajtmh.16-0675
   Burger R, 2018, MATH BIOSCI ENG, V15, P95, DOI 10.3934/mbe.2018004
   Burki T., 2018, LANCET, V391
   d'Onofrio A, 2002, MATH BIOSCI, V179, P57, DOI 10.1016/S0025-5564(02)00095-0
   Emmerich P, 2006, J CLIN VIROL, V37, P277, DOI 10.1016/j.jcv.2006.08.015
   Faniran TA, 2017, INT J MATH TRENDS TE, V47, P305
   Fisher-Hoch SP, 2001, REV MED VIROL, V11, P331, DOI 10.1002/rmv.329
   Gibb R, 2017, PATHOG GLOB HEALTH, V111, P276, DOI 10.1080/20477724.2017.1369643
   Greenky D, 2018, JAMA PEDIATR, V172, P407, DOI 10.1001/jamapediatrics.2017.5223
   Gunnala R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167835
   Hallam HJ, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0049-5
   Lo Iacono G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003398
   Martins O, 2016, INT J MATH TRENDS TE, V30, P1
   MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437
   Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381
   Olschlager S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003212
   Okuonghae D, 2008, J NIGERIAN ASS MATH, V1, P10
   Raabe V, 2017, J CLIN MICROBIOL, V55, P1629, DOI 10.1128/JCM.00170-17
   Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271
   s NA, 2018, LANCET INFECT DIS, V18, pe228
   Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2
   Sogoba N, 2016, EMERG INFECT DIS, V22, P657, DOI 10.3201/eid2204.151814
   terMeulen J, 1996, AM J TROP MED HYG, V55, P661
NR 33
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3451
EP 3456
DI 10.1016/j.vaccine.2019.05.010
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300015
PM 31088745
DA 2020-05-12
ER

PT J
AU Kesherwani, V
   Tarang, S
AF Kesherwani, Varun
   Tarang, Shikha
TI An immunoinformatic approach to universal therapeutic vaccine design
   against BK virus
SO VACCINE
LA English
DT Article
DE BK virus (BKV); BKV-associated nephropathy (BKVAN); Kidney-transplant
   recipients (KTRs); Reverse vaccinology; Multi-epitope subunit vaccine
   for BKV (MVBKV); HLA (human leukocyte antigen)
ID KIDNEY-TRANSPLANT RECIPIENTS; T-CELL RESPONSES; POLYOMAVIRUS BK;
   IMMUNE-RESPONSES; NEPHROPATHY; PEPTIDE; REPLICATION; ANTIGEN; CD8;
   CYTOMEGALOVIRUS
AB In kidney transplant recipients (KTRs) long-term immunosuppression leads to BK virus (BKV) reactivation, with an increased incidence of BKV-associated pathologies and allograft rejection. The current approaches to limit BKV infection include a reduction in immunosuppression and use of anti-BKV drugs, which are clinically sub-optimal and lead to undesirable therapeutic outcomes. Here, we adopted an immune-based approach to augment the endogenous BKV specific T-cells. Using reverse vaccinology based in silico analyses, we designed a peptide-based multi-epitope vaccine for BKV (MVBKV). A major advantage of our approach is that the selected epitopes show an affinity towards all the 12 superfamilies of HLA class I alleles and 27 reference alleles of HLA class II. This suggests MVBKV's universal nature and its potential effectiveness in a wide-population base. To improve MVBKV's immunogenic properties, a synthetic Toll-like Receptor (TLR) 4 peptide ligand (RS09) was added to the final vaccine construct. The sequences of the individual epitopes were molecularly linked to form a 3D-stable synthetic protein. Overall, our immunoinformatic-based approach led to the design of a new MVBKV vaccine, which remains to be validated experimentally. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kesherwani, Varun] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Tarang, Shikha] Creighton Univ, Sch Dent, Dept Oral Biol, 780729 Calif Plaza, Omaha, NE 68178 USA.
RP Tarang, S (reprint author), Creighton Univ, Sch Dent, Dept Oral Biol, 780729 Calif Plaza, Omaha, NE 68178 USA.
EM shikhatarang@creighton.edu
CR Ambalathingal GR, 2017, CLIN MICROBIOL REV, V30, P503, DOI 10.1128/CMR.00074-16
   Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610
   Binggeli S, 2007, AM J TRANSPLANT, V7, P1131, DOI 10.1111/j.1600-6143.2007.01754.x
   Chatterjee N, 2018, INT J BIOL MACROMOL, V118, P180, DOI 10.1016/j.ijbiomac.2018.06.080
   Chen YP, 2006, J VIROL, V80, P3495, DOI 10.1128/JVI.80.7.3495-3505.2006
   Cioni M, 2016, AM J TRANSPLANT, V16, P1193, DOI 10.1111/ajt.13598
   Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677
   Comoli P, 2006, TRANSPL INFECT DIS, V8, P86, DOI 10.1111/j.1399-3062.2006.00167.x
   Comoli P, 2004, TRANSPLANTATION, V78, P1229, DOI 10.1097/01.TP.0000137932.44791.D3
   Comoli P, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/256923
   Dasari V, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.58
   Dharnidharka VR, 2009, TRANSPLANTATION, V87, P1019, DOI 10.1097/TP.0b013e31819cc383
   DUCIBELLA T, 1975, DEV BIOL, V47, P45, DOI 10.1016/0012-1606(75)90262-6
   Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126
   Farrell D, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000071
   Ginevri F, 2007, AM J TRANSPLANT, V7, P2727, DOI 10.1111/j.1600-6143.2007.01984.x
   Imperiale MJ, 2000, VIROLOGY, V267, P1, DOI 10.1006/viro.1999.0092
   Kesherwani V, 2018, TRANSPL P, V50, P1504, DOI 10.1016/j.transproceed.2018.03.021
   Khairkhah N, 2018, PROTEINS
   Khalil MAM, 2018, INDIAN J NEPHROL, V28, P257, DOI 10.4103/ijn.IJN_251_17
   Khatoon N, 2018, VACCINE, V36, P6290, DOI 10.1016/j.vaccine.2018.09.004
   La Rosa C, 2012, J INFECT DIS, V205, P1294, DOI 10.1093/infdis/jis107
   Lamarche C, 2017, TRANSPLANTATION, V101, P2713, DOI 10.1097/TP.0000000000001698
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Leboeuf C, 2017, AM J TRANSPLANT, V17, P2591, DOI 10.1111/ajt.14282
   Lee HM, 2015, KOREAN J INTERN MED, V30, P865, DOI 10.3904/kjim.2015.30.6.865
   Li J, 2006, J GEN VIROL, V87, P2951, DOI 10.1099/vir.0.82094-0
   Li M, 2016, MOL PHARMACEUT, V13, P885, DOI 10.1021/acs.molpharmaceut.5b00802
   Moldovan I, 2016, CANCER IMMUNOL IMMUN, V65, P847, DOI 10.1007/s00262-016-1840-7
   Mueller K, 2011, TRANSPLANTATION, V91, P100, DOI 10.1097/TP.0b013e3181fe1335
   Negahdaripour M, 2017, INFECT GENET EVOL, V54, P402, DOI 10.1016/j.meegid.2017.08.002
   Pandey RK, 2018, VACCINE, V36, P2262, DOI 10.1016/j.vaccine.2018.03.042
   Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1
   Pandey RK, 2018, INT J BIOL MACROMOL
   Pandey RK, 2018, J CELL BIOCH
   Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Polo C, 2004, CLIN MICROBIOL INFEC, V10, P640, DOI 10.1111/j.1469-0691.2004.00882.x
   Ramos E, 2009, TRANSPLANTATION, V87, P621, DOI 10.1097/TP.0b013e318197c17d
   Randhawa PS, 2006, CLIN VACCINE IMMUNOL, V13, P1057, DOI 10.1128/CVI.00114-06
   Randhawa PS, 2006, HUM IMMUNOL, V67, P298, DOI 10.1016/j.humimm.2006.02.031
   Renner FC, 2013, TRANSPL P, V45, P1608, DOI 10.1016/j.transproceed.2013.01.026
   Rinaldo CH, 2013, APMIS, V121, P681, DOI 10.1111/apm.12125
   Sawinski D, 2015, NEPHROL DIAL TRANSPL, V30, P209, DOI 10.1093/ndt/gfu023
   Schachtner T, 2011, AM J TRANSPLANT, V11, P2443, DOI 10.1111/j.1600-6143.2011.03693.x
   Schaenman JM, 2017, TRANSPLANTATION, V101, P1479, DOI [10.1097/TP.0000000000001314, 10.1097/tp.0000000000001314]
   Schmidt T, 2014, AM J TRANSPLANT, V14, P1334, DOI 10.1111/ajt.12689
   STEADMAN R, 1991, J INFECT DIS, V163, P1033, DOI 10.1093/infdis/163.5.1033
   Theodoropoulos N, 2013, AM J TRANSPLANT, V13, P197, DOI 10.1111/j.1600-6143.2012.04314.x
   Trydzenskaya H, 2011, TRANSPLANTATION, V92, P1269, DOI 10.1097/TP.0b013e318234e0e5
   Tzannou I, 2017, J CLIN ONCOL, V35, P3547, DOI [10.1200/JCO.2017.73.0655, 10.1200/jco.2017.73.0655]
   van Aalderen MC, 2012, NETH J MED, V70, P172
   Weist BJD, 2014, MED MICROBIOL IMMUN, V203, P395, DOI 10.1007/s00430-014-0348-z
   Yang Y, 2015, HUM VACC IMMUNOTHER, V11, P795, DOI 10.1080/21645515.2015.1012017
   Zhou W, 2007, VIRAL IMMUNOL, V20, P379, DOI 10.1089/vim.2007.0030
NR 55
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3457
EP 3463
DI 10.1016/j.vaccine.2019.04.096
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300016
PM 31097352
DA 2020-05-12
ER

PT J
AU Hause, AM
   Avadhanula, V
   Maccato, ML
   Pinell, PM
   Bond, N
   Santarcangelo, P
   Ferlic-Stark, L
   Ye, XY
   Iwuchukwu, O
   Maurer, L
   Aideyan, L
   Dao, K
   McBride, T
   Piedra, PA
   Munoz, FM
AF Hause, Anne M.
   Avadhanula, Vasanthi
   Maccato, Maurizio L.
   Pinell, Phillip M.
   Bond, Nanette
   Santarcangelo, Patricia
   Ferlic-Stark, Laura
   Ye, Xunyan
   Iwuchukwu, Obinna
   Maurer, Lauren
   Aideyan, Letisha
   Dao, Kelly
   McBride, Trevor
   Piedra, Pedro A.
   Munoz, Flor M.
TI Clinical characteristics and outcomes of respiratory syncytial virus
   infection in pregnant women
SO VACCINE
LA English
DT Article
DE Respiratory syncytial virus; Acute respiratory illness; Pregnancy;
   Maternal infection; Maternal vaccine
ID NEUTRALIZING ANTIBODIES; HEALTHY WOMEN; UNITED-STATES; INFLUENZA;
   VACCINE; IMMUNIZATION; CHILDREN; MULTICENTER; PREVENTION; ADULTS
AB Objective: To describe the clinical presentation and laboratory diagnosis of pregnant women with respiratory syncytial virus (RSV) infection.
   Methods: Pregnant women in their second and third trimester were enrolled during the course of routine prenatal care visits when they were asymptomatic within the preceding two weeks (healthy controls) or when they reported symptoms of acute respiratory illness (ARI) of <= 7 days of duration (cases). Clinical outcomes were assessed at enrollment and two weeks after. Re-enrollment was allowed. Nasal-pharyngeal secretions were evaluated for respiratory pathogens by real-time reverse transcription polymerase chain reaction (PCR). Sera were tested for RSV-specific antibody responses by Western Blot, microneutralization assay, and palivizumab competitive antibody assay.
   Results: During the 2015-2016 respiratory virus season, 7 of 65 (11%) pregnant women with ARI at their initial enrollment and 8 of 77 (10%) pregnant women with ARI during the study period (initial or reenrollment) had PCR-confirmed RSV infection. Four (50%) PCR-confirmed RSV ARI cases reported symptoms of a lower respiratory tract illness (LRTI), one was hospitalized. Combining PCR and serology data, the RSV attack rate at initial enrollment was 12% (8 of 65), and 13% (10 of 77) based on ARI episodes. Among healthy controls, 28 of 88 (32%) had a Western Blot profile suggestive of a recent RSV infection either in the prior and/or current season.
   Conclusion: RSV had an attack rate of 10-13% among ambulatory pregnant women receiving routine prenatal care during the respiratory virus season. The serology results of healthy controls suggest a potentially higher attack rate. Future studies should be aware of the combined diagnostic strength of PCR and serology to identify RSV infection. As maternal RSV vaccine candidates are evaluated to protect young infants, additional priority should be placed on outcomes of pregnant women. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hause, Anne M.; Avadhanula, Vasanthi; Maccato, Maurizio L.; Pinell, Phillip M.; Bond, Nanette; Santarcangelo, Patricia; Ferlic-Stark, Laura; Ye, Xunyan; Iwuchukwu, Obinna; Maurer, Lauren; Aideyan, Letisha; Dao, Kelly; McBride, Trevor; Piedra, Pedro A.; Munoz, Flor M.] Baylor Coll Med, Dept Mol Virol, Houston, TX 77030 USA.
   [Hause, Anne M.; Avadhanula, Vasanthi; Maccato, Maurizio L.; Pinell, Phillip M.; Bond, Nanette; Santarcangelo, Patricia; Ferlic-Stark, Laura; Ye, Xunyan; Iwuchukwu, Obinna; Maurer, Lauren; Aideyan, Letisha; Dao, Kelly; McBride, Trevor; Piedra, Pedro A.; Munoz, Flor M.] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA.
   [Hause, Anne M.] Baylor Coll Med, Translat Biol & Mol Med, Houston, TX 77030 USA.
   [Maccato, Maurizio L.; Pinell, Phillip M.; Piedra, Pedro A.; Munoz, Flor M.] Baylor Coll Med, Pediat, Houston, TX 77030 USA.
   [Maccato, Maurizio L.; Pinell, Phillip M.] Womans OB GYN Specialists, Houston, TX 77054 USA.
   [Hause, Anne M.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
RP Piedra, PA; Munoz, FM (reprint author), Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA.
EM anne.hause@emory.edu; ppiedra@bcm.edu; florm@bcm.edu
CR August A, 2017, VACCINE, V35, P3749, DOI 10.1016/j.vaccine.2017.05.045
   Beckham JD, 2005, J INFECTION, V50, P322, DOI 10.1016/j.jinf.2004.07.011
   Beigi RH, 2014, OBSTET GYN CLIN N AM, V41, P535, DOI 10.1016/j.ogc.2014.08.002
   Chaw L, 2016, PLOS ONE, V11, DOI [10.1371/JOURNAL.PONE.0148421E0148421, DOI 10.1371/JOURNAL.PONE.0148421E0148421]
   Chu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152015
   Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316
   Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951
   Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002
   Glenn GM, 2016, J INFECT DIS, V213, P411, DOI 10.1093/infdis/jiv406
   Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1
   HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803
   Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657
   Hause AM, 2018, J INFECT DIS, V218, P528, DOI 10.1093/infdis/jiy167
   Luchsinger V, 2012, CLIN INFECT DIS, V54, P905, DOI 10.1093/cid/cir955
   Madhi SA, 2017, CLIN INFECT DIS, DOI [10.1093/CIDLCIX1088, DOI 10.1093/CIDLCIX1088]
   Mansbach JM, 2012, PEDIATRICS, V130, pE492, DOI 10.1542/peds.2012-0444
   Midgley CM, 2017, J INFECT DIS, V216, P345, DOI 10.1093/infdis/jix275
   Munoz FM, 2001, VACCINE, V20, P826, DOI 10.1016/S0264-410X(01)00397-8
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039
   Piedra PA, 2003, VACCINE, V21, P2448, DOI 10.1016/S0264-410X(03)00098-7
   Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4
   Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068
   Regan AK, 2018, CLIN INFECT DIS, V67, P1915, DOI 10.1093/cid/ciy439
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]
   StataCorp, 2015, STAT STAT SOFTW REL
   Steinhoff MC, 2012, CAN MED ASSOC J, V184, P645, DOI 10.1503/cmaj.110754
   Suara RO, 1996, CLIN DIAGN LAB IMMUN, V3, P477, DOI 10.1128/CDLI.3.4.477-479.1996
   Texas Department of State Health Services, 2017, RESP SYNC VIR HOM
   Wheeler SM, 2015, EMERG INFECT DIS, V21, P1951, DOI 10.3201/eid2111.150497
   Ye X, 2018, J INFECT DIS, DOI [10.1093/INFDIS/ITY026, DOI 10.1093/INFDIS/ITY026]
   Ye XY, 2018, J INFECT DIS, V217, P1247, DOI 10.1093/infdis/jiy026
NR 33
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3464
EP 3471
DI 10.1016/j.vaccine.2019.04.098
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300017
PM 31085002
OA Green Published
DA 2020-05-12
ER

PT J
AU Masoud, H
AF Masoud, Hussein
TI Novel adjuvants derived from attenuated lipopolysaccharides and lipid As
   of purple non-sulfur photosynthetic bacteria
SO VACCINE
LA English
DT Article
DE Adjuvant; Rhodocyclus tenuis; Rhodobacter sphaeroides; Lipid A; LPS;
   Oil-in-water emulsion
ID A MPL; POLYSACCHARIDE
AB Adjuvants are substances that enhance adaptive immune response to antigen. Development of a safe and effective immunostimulant adjuvant is essential for the efficacy of a vaccine to protect against infectious pathogens. Purple non-sulfur photosynthetic bacteria exhibited nontoxic natural lipid A variants that are distinct in their chemical structures from that of the Escherichia coli-type lipid A. In this study, the adjuvant efficacy of attenuated lipid A variants and their corresponding lipopolysaccharides (LPSs), derived from purple photosynthetic bacteria (Rhodocyclus tenuis and Rhodobacter sphaeroides) were evaluated. LPS was extracted using modified phenol-chloroform-petroleum ether method and lipid A was separated by mild acid hydrolysis. Trinitrophenol (TNP) was conjugated to hen egg albumin (TNP-HEA) and used as haptenic antigen. The LPS and lipid A adjuvant candidates were formulated in oil-in-water emulsion (OIWE) and evaluated to elicit anti-TNP IgG against TNP-HEA conjugate in BALB/c female mice. The anti-TNP IgG titers were measured using ELISA. The intact LPS-based adjuvants present in OIWE formulation showed significantly higher efficacy to elicit anti-TNP IgG titers against TNP-HEA conjugate compared to their corresponding lipid A-based adjuvants. As expected, the OIWE formulations of all LPS- and lipid A-based adjuvant candidates showed higher activities compared to the aqueous formulations. Slow reduction in the levels of anti-TNP IgG antibodies in the serum was observed over 4 months after immunization using the LPS- and lipid A-based adjuvant candidates which may provide a long protection against pathogens. The attenuated LPSs and lipid A's from the photosynthetic bacteria showed promising results to develop novel safe and effective adjuvants that can evoke the immune response. The most promising adjuvant candidate was the LPS-based adjuvant from R. tenuis. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Masoud, Hussein] Univ Jordan, Sch Sci, Dept Biol Sci, Amman 11942, Jordan.
RP Masoud, H (reprint author), Univ Jordan, Sch Sci, Dept Biol Sci, Amman 11942, Jordan.
EM hmasoud@ju.edu.jo
FU Deanship of Academic Research, University of Jordan, Amman-Jordan
FX The author would like to thank Dr James C. Richards for his critical
   reading of the manuscript. This work was partially supported by Deanship
   of Academic Research, University of Jordan, Amman-Jordan.
CR Al-Zeer M, 2007, WORLD J MICROB BIOT, V23, P1541, DOI 10.1007/s11274-007-9399-2
   Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834
   BENNETT B, 1992, J IMMUNOL METHODS, V153, P31, DOI 10.1016/0022-1759(92)90302-A
   BRADE H, 1982, EUR J BIOCHEM, V122, P233, DOI 10.1111/j.1432-1033.1982.tb05871.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Didierlaurent AM, 2017, EXPERT REV VACCINES, V16, P55, DOI 10.1080/14760584.2016.1213632
   FRANK S, 1977, J IMMUNOL, V119, P855
   GALANOS C, 1975, EUR J BIOCHEM, V54, P603, DOI 10.1111/j.1432-1033.1975.tb04172.x
   Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/ERV.11.29, 10.1586/erv.11.29]
   Garvey JS, 1977, METHOD IMMUNOL, P153
   Han JS, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/4/046012
   LEBBAR S, 1986, EUR J IMMUNOL, V16, P87, DOI 10.1002/eji.1830160117
   Lodmell DL, 2000, METH MOLEC MED, V29, P261, DOI 10.1385/1-59259-688-6:261
   Maier M, 2005, VACCINE, V23, P5149, DOI 10.1016/j.vaccine.2005.06.018
   MASOUD H, 1994, EUR J BIOCHEM, V220, P209, DOI 10.1111/j.1432-1033.1994.tb18616.x
   MAYER H, 1989, PURE APPL CHEM, V61, P1271, DOI 10.1351/pac198961071271
   Mayer H., 1985, METHOD MICROBIOL, V18, P157, DOI DOI 10.1016/S0580-9517(08)70475-6
   McCluskie Michael J., 2001, Current Drug Targets - Infectious Disorders, V1, P263, DOI 10.2174/1568005014605991
   McElrath MJ, 1995, SEMIN CANCER BIOL, V6, P375, DOI 10.1016/1044-579X(95)90007-1
   Plested JS, 2000, J IMMUNOL METHODS, V237, P73, DOI 10.1016/S0022-1759(00)00142-3
   RADZIEJEWSKALEBRECHT J, 1981, J BACTERIOL, V145, P138, DOI 10.1128/JB.145.1.138-144.1981
   Rietschel ETH, SURF STRUCT MICR THE, P1
   SALIMATH PV, 1984, EUR J BIOCHEM, V144, P227, DOI 10.1111/j.1432-1033.1984.tb08454.x
   SALIMATH PV, 1983, EUR J BIOCHEM, V136, P195, DOI 10.1111/j.1432-1033.1983.tb07726.x
   Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/ERV.11.21, 10.1586/erv.11.21]
   SCHNEERSON R, 1991, J IMMUNOL, V147, P2136
   Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5
NR 27
TC 0
Z9 0
U1 2
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3472
EP 3477
DI 10.1016/j.vaccine.2019.04.097
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300018
PM 31097350
DA 2020-05-12
ER

PT J
AU Bruxvoort, KJ
   Liang, AS
   Harpaz, R
   Qian, L
   Sy, LS
   LaRussa, P
   Schmid, DS
   Luo, Y
   Takhar, H
   Tseng, HF
AF Bruxvoort, Katia J.
   Liang, Anna S.
   Harpaz, Rafael
   Qian, Lei
   Sy, Lina S.
   LaRussa, Philip
   Schmid, D. Scott
   Luo, Yi
   Takhar, Harpreet
   Tseng, Hung Fu
TI Patient report of herpes zoster pain: Incremental benefits of zoster
   vaccine live
SO VACCINE
LA English
DT Article
DE Postherpetic neuralgia; Herpes zoster; Zoster vaccine
ID QUALITY-OF-LIFE; POSTHERPETIC NEURALGIA; IMMUNIZATION PRACTICES;
   ADVISORY-COMMITTEE; TERM PERSISTENCE; SUBUNIT VACCINE; POPULATION;
   PREVENTION; EFFICACY; HEALTH
AB Introduction: Pain following herpes zoster (HZ) can persist for months and negatively impact quality of life. To evaluate the effect of zoster vaccine live (ZVL) on progression of pain following HZ, we conducted a prospective cohort study of HZ cases at Kaiser Permanente Southern California.
   Methods: ZVL vaccinated and unvaccinated members aged >= 60 years with laboratory-confirmed HZ from January 18, 2012 to February 26, 2015 were followed up within 5 days of HZ diagnosis, and at 30, 60, and 90 days after diagnosis. Pain was assessed with the Zoster Brief Pain Inventory (ZBPI) on a 0-10 scale, using cut-points of >= 3, >= 5, and >= 7, with postherpetic neuralgia (PHN) defined as pain >= 3 at 90 days. Log binomial regression was used to estimate adjusted risk ratios (aRRs) and 95% confidence intervals (Cls) associated with pain, comparing vaccinated versus unvaccinated HZ patients.
   Results: We interviewed 509 vaccinated and 509 unvaccinated HZ patients. ZVL was associated with significantly lower risks of HZ-related pain at all time-points. The risk of PHN in vaccinated and unvaccinated patients, respectively, was 9.2% and 15.4% (aRR = 0.594, 95% CI: 0.413, 0.854); 2.0% and 4.8% of these patients reported pain >= 7 (aRR = 0.332, 95% CI: 0.153, 0.721). Irrespective of vaccination, the risk of PHN was lower in adults aged <70 years versus those >= 70 years and was similar or lower in females versus males.
   Conclusion: We used laboratory confirmation of HZ cases and patient survey to show that aside from preventing HZ, ZVL reduced HZ-related pain and prevented PHN among vaccine recipients who experienced HZ. Observational studies will be needed to evaluate long-term effectiveness of the new recombinant zoster vaccine and its benefits in protecting patients against PHN. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bruxvoort, Katia J.; Liang, Anna S.; Qian, Lei; Sy, Lina S.; Luo, Yi; Takhar, Harpreet; Tseng, Hung Fu] Kaiser Permanente Southern Calif, Dept Res & Evaluat, 100 S Robles Ave, Pasadena, CA 91101 USA.
   [Harpaz, Rafael; Schmid, D. Scott] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
   [LaRussa, Philip] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY USA.
RP Bruxvoort, KJ (reprint author), Kaiser Permanente Southern Calif, Dept Res & Evaluat, 100 S Robles Ave, Pasadena, CA 91101 USA.
EM Katia.Bruxvoort@kp.org; Shuhua.Liang@kp.org; rzh6@cdc.gov;
   Lei.X.Qian@kp.org; Lina.S.Sy@kp.org; plarussa@columbia.edu;
   dss1@cdc.gov; Yi.X.Luo@kp.org; Harpreet.S.Takhar@kp.org;
   Hung-Fu.X.Tseng@kp.org
OI Bruxvoort, Katia/0000-0001-8277-2431
FU National Institute of Allergy and Infectious Diseases (NIAID), National
   Institute of Health (NIH) [5R01AI089930]
FX This study was supported by the National Institute of Allergy and
   Infectious Diseases (NIAID), National Institute of Health (NIH). Funding
   Number: 5R01AI089930.
CR Baxter R, 2018, AM J EPIDEMIOL, V187, P161, DOI 10.1093/aje/kwx245
   Coplan PM, 2004, J PAIN, V5, P344, DOI 10.1016/j.jpain.2004.06.001
   Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800
   Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5
   Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711
   Dworkin RH, 2008, J PAIN, V9, pS37, DOI 10.1016/j.jpain.2007.10.008
   Forbes HJ, 2016, PAIN, V157, P30, DOI 10.1097/j.pain.0000000000000307
   Hales CM, 2016, ANN EPIDEMIOL, V26, P441, DOI 10.1016/j.annepidem.2016.04.006
   Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1
   Insinga RP, 2005, J GEN INTERN MED, V20, P748, DOI 10.1111/j.1525-1497.2005.0150.x
   Izurieta HS, 2017, CLIN INFECT DIS, V64, P785, DOI 10.1093/cid/ciw854
   Johnson BH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1262-8
   Katz J, 2004, CLIN INFECT DIS, V39, P342, DOI 10.1086/421942
   Kawai K, 2016, CLIN INFECT DIS, V63, P221, DOI 10.1093/cid/ciw296
   Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833
   Koebnick Corinna, 2012, Perm J, V16, P37
   Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184
   Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420
   Leung J, 2010, CLIN INFECT DIS, V51, P23, DOI 10.1086/653113
   Marin M, 2015, HUM VACC IMMUNOTHER, V11, P1157, DOI 10.1080/21645515.2015.1016681
   Morrison VA, 2015, CLIN INFECT DIS, V60, P900, DOI 10.1093/cid/ciu918
   Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016
   Petersen MR, 2009, OCCUP ENVIRON MED, V66, P639, DOI 10.1136/oem.2008.043018
   Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638
   Schmader KE, 2007, CLIN J PAIN, V23, P490, DOI 10.1097/AJP.0b013e318065b6c9
   Shingrix, 2017, PRESCRIBING INFORM
   Tseng HF, 2015, J INFECT DIS, V212, P1222, DOI 10.1093/infdis/jiv244
   Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983
   Yawn BP, 2011, MAYO CLIN PROC, V86, P88, DOI 10.4065/mcp.2010.0618
   Zostavax, 2017, PRESCRIBING INFORM
NR 30
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3478
EP 3484
DI 10.1016/j.vaccine.2019.04.095
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300019
PM 31088744
DA 2020-05-12
ER

PT J
AU Osowicki, J
   Azzopardi, KI
   Baker, C
   Waddington, CS
   Pandey, M
   Schuster, T
   Grobler, A
   Cheng, AC
   Pollard, AJ
   McCarthy, JS
   Good, MF
   Walker, MJ
   Dale, JB
   Batzloff, MR
   Carapetis, JR
   Smeesters, PR
   Steer, AC
AF Osowicki, Joshua
   Azzopardi, Kristy, I
   Baker, Ciara
   Waddington, Claire S.
   Pandey, Manisha
   Schuster, Tibor
   Grobler, Anneke
   Cheng, Allen C.
   Pollard, Andrew J.
   McCarthy, James S.
   Good, Michael F.
   Walker, Mark J.
   Dale, James B.
   Batzloff, Michael R.
   Carapetis, Jonathan R.
   Smeesters, Pierre R.
   Steer, Andrew C.
TI Controlled human infection for vaccination against Streptococcus
   pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis
   human infection study
SO VACCINE
LA English
DT Article
DE Group A Streptococcus; Streptococcus pyogenes; Human infection studies;
   Controlled human infection; Human challenge; Vaccine development
ID M-PROTEIN VACCINE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RHEUMATIC
   HEART-DISEASE; HUMAN CHALLENGE; UNITED-STATES; BURDEN; FEVER;
   EPIDEMIOLOGY; IMMUNIZATION; VOLUNTEERS
AB Group A Streptococcus (GAS) is a highly-adapted and human-restricted pathogen responsible for a high global burden of disease across a diverse clinical spectrum. Vaccine development has been impeded by scientific, regulatory, and commercial obstacles. Human infection studies (HIS) are increasingly contributing to drug, diagnostics, and vaccine development, reducing uncertainty at early stages, especially for pathogens with animal models that incompletely reproduce key elements of human disease. We review the small number of historical GAS HIS and present the study protocol for a dose-ranging inpatient study in healthy adults. The primary objective of the study is to establish a new GAS pharyngitis HIS with an attack rate of at least 60% as a safe and reliable platform for vaccine evaluation and pathogenesis research. According to an adaptive dose-ranging study design, emm75 GAS doses manufactured in keeping with principles of Good Manufacturing Practice will be directly applied by swab to the pharynx of carefully screened healthy adult volunteers at low risk of severe complicated GAS disease. Participants will remain as closely monitored inpatients for up to six days, observed for development of the primary outcome of acute symptomatic pharyngitis, as defined by clinical and microbiological criteria. All participants will be treated with antibiotics and followed as outpatients for six months. An intensive sampling schedule will facilitate extensive studies of host and organism dynamics during experimental pharyngitis. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Osowicki, Joshua; Azzopardi, Kristy, I; Baker, Ciara; Smeesters, Pierre R.; Steer, Andrew C.] Murdoch Childrens Res Inst, Trop Dis, Melbourne, Vic, Australia.
   [Osowicki, Joshua; Grobler, Anneke; Smeesters, Pierre R.; Steer, Andrew C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Osowicki, Joshua; Steer, Andrew C.] Royal Childrens Hosp Melbourne, Dept Gen Med, Infect Dis Unit, Melbourne, Vic, Australia.
   [Waddington, Claire S.; Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.
   [Waddington, Claire S.; Carapetis, Jonathan R.] Perth Childrens Hosp, Perth, WA, Australia.
   [Waddington, Claire S.] Univ Cambridge, Dept Med, Cambridge, England.
   [Pandey, Manisha; Good, Michael F.; Batzloff, Michael R.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.
   [Schuster, Tibor; Grobler, Anneke] Murdoch Children Res Inst, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia.
   [Schuster, Tibor] McGill Univ, Dept Family Med, Montreal, PQ, Canada.
   [Cheng, Allen C.] Alfred Hosp, Infect Prevent & Healthcare Epidemiol Unit, Melbourne, Vic, Australia.
   [Cheng, Allen C.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.
   [Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.
   [Pollard, Andrew J.] Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England.
   [McCarthy, James S.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [McCarthy, James S.] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
   [Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
   [Dale, James B.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA.
   [Smeesters, Pierre R.] Univ Libre Bruxelles, Paediat Dept, Acad Children Hosp Queen Fabiola, Brussels, Belgium.
   [Smeesters, Pierre R.] Univ Libre Bruxelles, Mol Bacteriol Lab, Brussels, Belgium.
RP Osowicki, J (reprint author), Murdoch Childrens Res Inst, Trop Dis, 50 Flemington Rd, Parkville, Vic 3052, Australia.
EM joshua.osowicki@rch.org.au
RI Carapetis, Jonathan R/H-8933-2014
OI Carapetis, Jonathan R/0000-0002-1182-9792; Grobler,
   Anneke/0000-0002-7809-7688; McCarthy, James/0000-0001-6596-9718
FU Australian National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [GNT1099183]
FX This work is supported by the Australian National Health and Medical
   Research Council [GNT1099183].
CR Acute pharyngitis and/or tonsillitis. In: Antibiotic Expert Groups, 2014, THER GUID ANT, P235
   Bambery B, 2016, PUBLIC HEALTH ETH-UK, V9, P92, DOI 10.1093/phe/phv026
   Barnett ML, 2014, JAMA INTERN MED, V174, P138, DOI 10.1001/jamainternmed.2013.11673
   Basille D, 2017, LUNG, V195, P201, DOI 10.1007/s00408-016-9973-1
   Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693
   Bowen AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136789
   Bryant AE, 2015, CURR OPIN INFECT DIS, V28, P231, DOI 10.1097/QCO.0000000000000160
   Cannon JW, 2018, VACCINE, V36, P6968, DOI 10.1016/j.vaccine.2018.10.001
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583
   Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483
   Cohen DM, 2015, J CLIN MICROBIOL, V53, P2258, DOI 10.1128/JCM.00490-15
   Dale J. B., 2016, STREPTOCOCCUS PYOGEN
   Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005
   DALESSANDRI R, 1978, J INFECT DIS, V138, P712, DOI 10.1093/infdis/138.6.712
   Darton TC, 2015, LANCET INFECT DIS, V15, P840, DOI 10.1016/S1473-3099(15)00068-7
   de Graaf H, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018594
   Dunne EM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-312
   Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950
   FOX EN, 1973, J CLIN INVEST, V52, P1885, DOI 10.1172/JCI107372
   Frost HR, 2017, CLIN INFECT DIS, V65, P1523, DOI 10.1093/cid/cix599
   Gritzfeld JF, 2013, JOVE-J VIS EXP, DOI 10.3791/50115
   Group A Streptococcus Vaccine Development Technology Roadmap, 2018, GROUP A STREPT VACC
   Guilherme L, 2013, AUTOIMMUN HIGHLIGHTS, V4, P81, DOI 10.1007/s13317-013-0053-8
   Habibi MS, 2017, VACCINE, V35, P489, DOI 10.1016/j.vaccine.2016.08.086
   Heart Foundation of New Zealand, 2014, NZ GUID RHEUM FEV GR
   Hoy WE, 2012, KIDNEY INT, V81, P1026, DOI 10.1038/ki.2011.478
   Hysmith ND, 2017, J PEDIATR INFECT DIS, V6, P187, DOI 10.1093/jpids/piw070
   Jack SJ, 2018, INT J EPIDEMIOL, V47, P1585, DOI 10.1093/ije/dyy150
   Jin C, 2017, LANCET, V390, P2472, DOI 10.1016/S0140-6736(17)32149-9
   Kalil JA, 2012, FUTURE MICROBIOL, V7, P481, DOI [10.2217/fmb.12.15, 10.2217/FMB.12.15]
   Katzenellenbogen JM, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2747-5
   Lambkin-Williams R, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0784-1
   Lawrence JG, 2013, CIRCULATION, V128, P492, DOI 10.1161/CIRCULATIONAHA.113.001477
   MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115
   Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248
   NHMRC, 2010, AUSTR GUID PREV CONT
   Osowicki J, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00647-18
   Osowicki J, 2018, VACCINE, V36, P3397, DOI 10.1016/j.vaccine.2018.02.068
   Pelucchi C, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2012.03766.x
   Pfoh E, 2008, PEDIATRICS, V121, P229, DOI 10.1542/peds.2007-0484
   Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, 2018, PHARM INSP CONV PHAR
   POLLY SM, 1975, J INFECT DIS, V131, P217, DOI 10.1093/infdis/131.3.217
   Ralph AP, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1166-y
   RAMMELKAMP C H Jr, 1955, Harvey Lect, V51, P113
   Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7
   Rivera-Hernandez T, 2016, MBIO, V7, DOI 10.1128/mBio.00618-16
   Robertson Katharine A, 2005, BMC Cardiovasc Disord, V5, P11, DOI 10.1186/1471-2261-5-11
   Roestenberg M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00297
   Roestenberg M, 2018, LANCET INFECT DIS, V18, pE312, DOI 10.1016/S1473-3099(18)30177-4
   Schodel F, 2017, VACCINE, V35, P2007, DOI 10.1016/j.vaccine.2017.02.060
   Schwartz RH, 2015, PEDIATR INFECT DIS J, V34, P1302, DOI 10.1097/INF.0000000000000883
   Sekuloski S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198658
   Skinner JM, 2011, MICROB PATHOGENESIS, V50, P39, DOI 10.1016/j.micpath.2010.10.004
   Steer AC, 2016, VACCINE, V34, P2953, DOI 10.1016/j.vaccine.2016.03.073
   Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000
   STOLLERMAN GH, 1967, ARTHRITIS RHEUM-US, V10, P245, DOI 10.1002/art.1780100311
   Tsoi SK, 2015, J IMMUNOL RES, DOI 10.1155/2015/167089
   Vekemans J, 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciy-1141, DOI 10.1093/CID/CIY-1141]
   Waldman R H, 1975, Dev Biol Stand, V28, P429
   Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13
   Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693
   Watson ME, 2016, STREPTOCOCCUS PYOGEN
   Zuhlke Liesl J, 2017, Curr Treat Options Cardiovasc Med, V19, P15, DOI 10.1007/s11936-017-0513-y
NR 64
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3485
EP 3494
DI 10.1016/j.vaccine.2019.03.059
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300020
PM 31101422
DA 2020-05-12
ER

PT J
AU Manning, J
   Dunne, EM
   Wang, N
   Pedersen, JS
   Ogier, JM
   Burt, RA
   Mulholland, EK
   Robins-Browne, RM
   Malley, R
   Wijburg, OL
   Satzke, C
AF Manning, Jayne
   Dunne, Eileen M.
   Wang, Nancy
   Pedersen, John S.
   Ogier, Jacqueline M.
   Burt, Rachel A.
   Mulholland, E. Kim
   Robins-Browne, Roy M.
   Malley, Richard
   Wijburg, Odilia L.
   Satzke, Catherine
TI Effect of a pneumococcal whole cell vaccine on influenza A-induced
   pneumococcal otitis media in infant mice
SO VACCINE
LA English
DT Article
DE Otitis media; Streptococcus pneumoniae; Pneumococcus; Vaccine; Whole
   cell vaccine; Influenza A virus; Mouse model
ID STREPTOCOCCUS-PNEUMONIAE; MIDDLE-EAR; COLONIZATION; CHILDREN; ANTIBODY;
   DISEASE; PROTECTION; INFECTION; BACTERIAL; IMMUNITY
AB The pneumococcus remains a common cause of otitis media (OM) despite the widespread introduction of pneumococcal conjugate vaccines. In mice, a pneumococcal whole cell vaccine (WCV) induces serotype-independent protection against pneumococcal colonisation and invasive disease via T(H)17- and antibody-mediated immunity, respectively. We investigated the effect of WCV on influenza A-induced pneumococcal OM in an infant mouse model.
   C57BL/6 mice were immunised subcutaneously with a single dose of WCV or adjuvant at 6 days of age, infected with pneumococci (EF3030 [serotype 19F] or PMP1106 [16F]) at 12 days of age, and given influenza A virus (A/Udorn/72/307 [H3N2], IAV) at 18 days of age to induce pneumococcal OM. Pneumococcal density in middle ear and nasopharyngeal tissues was determined 6 and 12 days post-virus. Experiments were repeated in antibody (B6.mu MT-/-)- and CD4(+) T-cell-deficient mice to investigate the immune responses involved.
   A single dose of WCV did not prevent the development of pneumococcal OM, nor accelerate pneumococcal clearance compared with mice receiving adjuvant alone. However, WCV reduced the density of EF3030 in the middle ear at 6 days post-viral infection (p = 0.022), and the density of both isolates in the nasopharynx at 12 days post-viral infection (EF3030, p = 0.035; PMP1106, p = 0.011), compared with adjuvant alone. The reduction in density in the middle ear required antibodies and CD4(+) T cells: WCV did not reduce EF3030 middle ear density in B6.mu MT-/- mice (p = 0.35) nor in wild-type mice given anti-CD4 monoclonal antibody before and after IAV inoculation (p = 0.91); and WCV-immunised CD4(+) T cell-deficient GK1.5 mice had higher levels of EF3030 in the middle ear than their adjuvant-immunised counterparts (p = 0.044).
   A single subcutaneous dose of WCV reduced pneumococcal density in the middle ears of co-infected mice in one of two strains tested, but did not prevent OM from occurring in this animal model. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Manning, Jayne; Dunne, Eileen M.; Mulholland, E. Kim; Wijburg, Odilia L.; Satzke, Catherine] Royal Childrens Hosp, Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia.
   [Manning, Jayne; Wang, Nancy; Robins-Browne, Roy M.; Wijburg, Odilia L.; Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
   [Dunne, Eileen M.; Ogier, Jacqueline M.; Burt, Rachel A.; Satzke, Catherine] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia.
   [Pedersen, John S.] TissuPath Pty Ltd, Hawthorn, Vic, Australia.
   [Ogier, Jacqueline M.; Burt, Rachel A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Neurogenet, Parkville, Vic, Australia.
   [Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Robins-Browne, Roy M.] Murdoch Childrens Res Inst, Infect Dis, Parkville, Vic, Australia.
   [Malley, Richard] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA.
RP Satzke, C (reprint author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
EM catherine.satzke@mcri.edu.au
RI ; Satzke, Catherine/D-6501-2013
OI Ogier, Jacqueline/0000-0002-7468-4009; Dunne,
   Eileen/0000-0001-5542-0780; Wang, Nancy/0000-0001-7623-1858; Satzke,
   Catherine/0000-0003-3164-8849
FU Murdoch Children's Research Institute; Victorian Government's
   Operational Infrastructure Support Program; Australian Postgraduate
   AwardAustralian Government; Australian NHMRC Career Development
   FellowshipNational Health and Medical Research Council of Australia;
   Veski Inspiring Women Fellowship
FX This study was supported by funding from the Murdoch Children's Research
   Institute and the Victorian Government's Operational Infrastructure
   Support Program. JM was supported by an Australian Postgraduate Award.
   CS was funded by an Australian NHMRC Career Development Fellowship and a
   Veski Inspiring Women Fellowship. Funding bodies were not involved in
   the study design; collection, analysis or interpretation of data;
   manuscript preparation or decision to submit the article for
   publication.
CR Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293
   Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953
   Alderson MR, 2016, VACCINE, V34, P2959, DOI 10.1016/j.vaccine.2016.03.107
   Bakaletz LO, 1997, CLIN DIAGN LAB IMMUN, V4, P223, DOI 10.1128/CDLI.4.2.223-225.1997
   Basha S, 2017, J INFECT DIS, V215, P1321, DOI 10.1093/infdis/jix090
   Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08
   Campos IB, 2017, VACCINE, V35, P1306, DOI 10.1016/j.vaccine.2017.01.030
   Chelvarajan L, 2007, J LEUKOCYTE BIOL, V82, P403, DOI 10.1189/jlb.0107071
   Conklin L, 2014, PEDIATR INFECT DIS J, V33, pS109, DOI 10.1097/INF.0000000000000078
   Croucher NJ, 2017, P NATL ACAD SCI USA, V114, pE357, DOI 10.1073/pnas.1613937114
   DeAntonio R, 2016, INT J PEDIATR OTORHI, V85, P65, DOI 10.1016/j.ijporl.2016.03.032
   Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779
   Estrada J, 2016, PEDIATR INFECT DIS J, V35, P205, DOI 10.1097/INF.0000000000000964
   FitzPatrick M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22751
   Fletcher MA, 2012, INT J OTOLARYNGOL, V9
   Forseni M, 1999, AM J OTOL, V20, P152
   Greene CJ, 2016, INFECT IMMUN, V84, P1693, DOI 10.1128/IAI.01478-15
   Habets MN, 2016, VACCINE, V34, P5968, DOI 10.1016/j.vaccine.2016.09.057
   HENDERSON FW, 1982, NEW ENGL J MED, V306, P1377, DOI 10.1056/NEJM198206103062301
   Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443
   Huang YF, 2016, PEDIATR RES, V80, P886, DOI 10.1038/pr.2016.154
   Jecker P, 2001, CLIN EXP IMMUNOL, V126, P421, DOI 10.1046/j.1365-2249.2001.01543.x
   John M., 2014, THESIS
   Khan MN, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00530-16
   KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0
   Leach AJ, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0483-8
   Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159
   Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031
   Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10
   Mackenzie GA, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-14
   Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102
   Malley R, 2004, INFECT IMMUN, V72, P4290, DOI 10.1128/IAI.72.7.4290-4292.2004
   Malley R, 2001, INFECT IMMUN, V69, P4870, DOI 10.1128/IAI.69.8.4870-4873.2001
   Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13
   Moffitt KL, 2012, VACCINE, V30, P4316, DOI 10.1016/j.vaccine.2012.01.034
   Ogier JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097559
   Ortigoza MB, 2018, MBIO, V9, DOI 10.1128/mBio.02359-18
   Pettigrew MM, 2017, OTOLARYNG HEAD NECK, V156, pS76, DOI 10.1177/0194599816632178
   Pettigrew MM, 2011, J CLIN MICROBIOL, V49, P3750, DOI 10.1128/JCM.01186-11
   Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1033, DOI 10.1097/INF.0000000000001217
   Rosch JW, 2014, EMBO MOL MED, V6, P141, DOI 10.1002/emmm.201202150
   Sharma SK, 2011, J INFECT DIS, V204, P645, DOI 10.1093/infdis/jir340
   Short KR, 2014, INFECT IMMUN, V82, P364, DOI 10.1128/IAI.01104-13
   Short KR, 2011, JOVE-J VIS EXP, DOI 10.3791/2357
   Short KR, 2012, MBIO, V3, DOI 10.1128/mBio.00255-12
   Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618
   Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10
   Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657
   Turner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067933
   Van Dyke MK, 2017, PEDIATR INFECT DIS J, V36, P274, DOI 10.1097/INF.0000000000001420
   van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001
   Wang W, 2014, INFECT IMMUN, V82, P2368, DOI 10.1128/IAI.00006-14
   Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8
   Wiertsema SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049061
   Xiang Y, 2017, INNATE IMMUN-LONDON, V23, P296, DOI 10.1177/1753425917693907
   Xu Q, 2015, MUCOSAL IMMUNOL, V8, P1110, DOI 10.1038/mi.2015.1
   Zangari T, 2017, MBIO, V8
   Zhan YF, 2000, J IMMUNOL, V165, P3612, DOI 10.4049/jimmunol.165.7.3612
NR 58
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 6
PY 2019
VL 37
IS 26
BP 3495
EP 3504
DI 10.1016/j.vaccine.2019.03.013
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IC8DK
UT WOS:000471206300021
PM 31103366
OA Other Gold
DA 2020-05-12
ER

PT J
AU Qian, YN
   Zhan, JH
   Yu, Y
   Xu, GW
   Liv, XX
AF Qian, Yanan
   Zhan, Jinhui
   Yu, Yin
   Xu, Guangwen
   Liv, Xiaoxing
TI CFD model of coal pyrolysis in fixed bed reactor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Coal pyrolysis; Fixed bed; Heat transfer; Internals; Secondary cracking
   of tar; CFD
ID OIL-SHALE PYROLYSIS; HIGH-QUALITY TAR; HEAT-TRANSFER; BROWN-COAL;
   BIOMASS; KINETICS; CHAR; COMBUSTION; INTERNALS; DEVOLATILIZATION
AB A three dimensional transient model was developed to simulate the pyrolysis process of coal in fixed bed reactor. The model considered a number of aspects associated with coal pyrolysis such as the evaporation and condensation of physical water, the release of volatiles, secondary cracking of pyrolysis tar and the variation of porosity. Conductive, radiative and convective types of heat transfer were all taken into account in the model. The phase transformation of physical water was modeled using the Lee model (Lee, 1980) available in the commercial CFD software Fluent. The multiple independent parallel reaction (MIPR) model was applied to predict the generations of volatile products. The secondary cracking of tar was described using the model proposed by Wurzenberger et al. (2002). The model was implemented in Fluent and validated through modeling the pyrolysis process of low-rank sub-bituminous coal in four laboratory-scale and externally heated fixed-bed reactors with or without internals. The predicted temperature evolutions of coal charge were in all quantitative agreements with experimental results. And the influences of internals on the yield of tar were also successfully captured by the simulations. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Qian, Yanan; Zhan, Jinhui; Liv, Xiaoxing] Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, Beijing 100190, Peoples R China.
   [Qian, Yanan; Liv, Xiaoxing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Qian, Yanan] SINOPEC Res Inst Safety Engn, State Key Lab Safety & Control Chem, Qingdao 266071, Peoples R China.
   [Yu, Yin] CAEP, Natl Key Lab Shock Wave & Detonat Phys, Inst Fluid Phys, Mianyang 621900, Peoples R China.
   [Xu, Guangwen] Shenyang Univ Chem Technol, Inst Ind Chem & Energy Technol, Shenyang 110142, Liaoning, Peoples R China.
RP Liv, XX (reprint author), Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, Beijing 100190, Peoples R China.; Xu, GW (reprint author), Shenyang Univ Chem Technol, Inst Ind Chem & Energy Technol, Shenyang 110142, Liaoning, Peoples R China.
EM gwxu@syuct.edu.cn; xxliu@ipe.ac.cn
FU NSAF [U1630105]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [21576265]; National Key Research
   and Development Program of China [2017YFE0300602]; State Key Laboratory
   of Multiphase Complex Systems [MPCS-2017-A-07]
FX The work presented in this paper is financially supported by NSAF, Grant
   No. U1630105, National Natural Science Foundation of China, Grant No.
   21576265, The National Key Research and Development Program of China,
   Grant No. 2017YFE0300602, and State Key Laboratory of Multiphase Complex
   Systems, Grant No. MPCS-2017-A-07. Xiaoxing Liu sincerely appreciates
   the pertinent comments from anonymous reviewers which have greatly
   improved the quality of this manuscript.
CR Agroskin A. A., 1957, BERGAKADEMIA FREIBER, V9, P177
   Agroskin A. A., 1970, KOKI CHIMIJA, V5, P8
   Al-Abbas AH, 2012, FUEL, V102, P646, DOI 10.1016/j.fuel.2012.06.028
   Arno D. K., 2003, AICHE J, V49, P2022
   BADZIOCH S, 1970, IND ENG CHEM PROC DD, V9, P521, DOI 10.1021/i260036a005
   Bai X. F., 2010, COAL QUAL TECHNOL, V6, P9
   BAUER R, 1978, INT CHEM ENG, V18, P189
   Bhuiyan AA, 2015, FUEL, V139, P268, DOI 10.1016/j.fuel.2014.08.034
   BREITBACH G, 1980, NUCL TECHNOL, V49, P392, DOI 10.13182/NT80-A17687
   Cheng S, 2017, CHINESE J CHEM ENG, V25, P507, DOI 10.1016/j.cjche.2016.09.013
   FRANKLIN HD, 1982, FUEL, V61, P155, DOI 10.1016/0016-2361(82)90227-7
   GUNN DJ, 1978, INT J HEAT MASS TRAN, V21, P467, DOI 10.1016/0017-9310(78)90080-7
   Guo ZC, 2005, FUEL, V84, P893, DOI 10.1016/j.fuel.2004.11.020
   Hart J, 2013, HEAT MASS TRANSFER, V49, P1725, DOI 10.1007/s00231-013-1205-0
   Hayashi J, 2000, ENERG FUEL, V14, P400, DOI 10.1021/ef9901490
   Hu EF, 2017, FUEL, V200, P186, DOI 10.1016/j.fuel.2017.03.060
   Hu EF, 2017, ENERG FUEL, V31, P1347, DOI 10.1021/acs.energyfuels.6b02780
   Jamil K, 2004, FUEL, V83, P833, DOI 10.1016/j.fuel.2003.09.017
   Jeong HJ, 2017, FUEL, V196, P371, DOI 10.1016/j.fuel.2017.01.103
   Jia YB, 2004, ENERG FUEL, V18, P1625, DOI 10.1021/ef034077v
   JUNTGEN H, 1984, FUEL, V63, P731, DOI 10.1016/0016-2361(84)90058-9
   Karim MR, 2018, FUEL, V222, P656, DOI 10.1016/j.fuel.2018.02.195
   Karim MR, 2018, APPL THERM ENG, V128, P772, DOI 10.1016/j.applthermaleng.2017.09.061
   KHAN MR, 1989, FUEL, V68, P1522, DOI 10.1016/0016-2361(89)90289-5
   Kobayashi H., 1976, P 16 INT S COMB CAMB
   Lee W.H., 1980, MULTIPHASE TRANSPORT, V1
   LI CZ, 1993, FUEL, V72, P3, DOI 10.1016/0016-2361(93)90368-C
   Liang P, 2008, FUEL, V87, P435, DOI 10.1016/j.fuel.2007.06.022
   Lin LX, 2016, FUEL, V163, P48, DOI 10.1016/j.fuel.2015.09.024
   Lin LX, 2015, FUEL PROCESS TECHNOL, V138, P147, DOI 10.1016/j.fuproc.2015.05.023
   Lin W, 2015, APPL THERM ENG, V81, P353, DOI 10.1016/j.applthermaleng.2015.02.056
   Liu P, 2017, FUEL, V207, P244, DOI 10.1016/j.fuel.2017.06.081
   Meesri C, 2003, COMBUST SCI TECHNOL, V175, P793, DOI 10.1080/00102200302392
   Modest M. F., 2003, RAD HEAT TRANSFER
   Nikolopoulos A, 2014, FUEL, V115, P401, DOI 10.1016/j.fuel.2013.06.036
   NIKSA S, 1991, ENERG FUEL, V5, P673, DOI 10.1021/ef00029a008
   Pielsticker S, 2017, FUEL, V190, P420, DOI 10.1016/j.fuel.2016.10.085
   Polesek-Karczewska S, 2015, J ANAL APPL PYROL, V113, P259, DOI 10.1016/j.jaap.2015.01.022
   Pretorius GN, 2017, J ANAL APPL PYROL, V128, P156, DOI 10.1016/j.jaap.2017.10.014
   Qian YN, 2018, INT J HEAT MASS TRAN, V127, P573, DOI 10.1016/j.ijheatmasstransfer.2018.06.127
   Qian YN, 2018, FUEL, V233, P685, DOI 10.1016/j.fuel.2018.06.100
   Shu Z, 2016, IND ENG CHEM RES, V55, P2634, DOI 10.1021/acs.iecr.5b04150
   Siramard S, 2016, FUEL PROCESS TECHNOL, V148, P248, DOI 10.1016/j.fuproc.2016.02.033
   Slupik L, 2015, FUEL, V150, P415, DOI 10.1016/j.fuel.2015.02.044
   SOLOMON PR, 1988, ENERG FUEL, V2, P405, DOI 10.1021/ef00010a006
   SUUBERG EM, 1978, IND ENG CHEM PROC DD, V17, P37, DOI 10.1021/i260065a008
   Tchapda AH, 2015, FUEL, V156, P254, DOI 10.1016/j.fuel.2015.04.015
   van Antwerpen W, 2010, NUCL ENG DES, V240, P1803, DOI 10.1016/j.nucengdes.2010.03.009
   van Hecke M, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/3/033101
   Vascellari M, 2015, FUEL, V152, P58, DOI 10.1016/j.fuel.2015.01.038
   Wiktorsson LP, 2000, FUEL, V79, P701, DOI 10.1016/S0016-2361(99)00138-6
   Wurzenberger JC, 2002, AICHE J, V48, P2398, DOI 10.1002/aic.690481029
   Xiong QG, 2013, ENERG FUEL, V27, P5948, DOI 10.1021/ef4012966
   Xue FF, 2017, ENERGY TECHNOL-GER, V5, P1897, DOI 10.1002/ente.201700203
   Zhang C, 2014, ENERG FUEL, V28, P7294, DOI 10.1021/ef501923f
   Zhang C, 2014, ENERG FUEL, V28, P236, DOI 10.1021/ef401546n
   Zhang JW, 2013, ENERG FUEL, V27, P1951, DOI 10.1021/ef400118b
   Zhang K, 2016, FUEL, V185, P701, DOI 10.1016/j.fuel.2016.08.038
   Zhang Y, 2015, PARTICUOLOGY, V21, P154, DOI 10.1016/j.partic.2014.06.015
   Zhu WK, 2008, ENERG FUEL, V22, P2482, DOI 10.1021/ef800143h
NR 60
TC 2
Z9 2
U1 11
U2 50
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 1
EP 11
DI 10.1016/j.ces.2018.12.064
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000001
DA 2020-05-12
ER

PT J
AU Xiao, J
   Yang, SJ
   George, OA
   Putranto, A
   Wu, WD
   Chen, XD
AF Xiao, Jie
   Yang, Shujun
   George, Oluwafemi Ayodele
   Putranto, Aditya
   Wu, Winston Duo
   Chen, Xiao Dong
TI Numerical simulation of mono-disperse droplet spray dryer: Coupling
   distinctively different sized chambers
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Mono-disperse droplet spray dryer; CFD simulation; Discrete phase model;
   Reaction engineering approach (REA); Skim milk powder
ID REACTION-ENGINEERING APPROACH; DRYING CONDITIONS; MILK DROPLET;
   PARTICLES; CONSTANT; SYSTEMS; IMPACT; MODEL; DRAG
AB The discrete phase model (DPM) has been widely used in CFD simulations to track discrete particles or droplets in a continuum fluid filed. This powerful technique, however, may face tremendous difficulty in tracking droplets flying through chambers with significantly different sizes. In such cases, it becomes very challenging to develop effective mesh for the big and small chambers together with the transition zone that can ensure solution convergence within reasonable computational time. In this work, a systematic method is introduced to tackle this problem. This method allows simulation of different sized chambers separately to avoid the meshing difficulty. A unique coupling approach offers smooth transition of droplets from one chamber to the other with rigorous conservation of their mass, energy and momentum. The effectiveness of the method is demonstrated through the simulation of skim milk droplet drying in a mono-disperse droplet spray dryer (MDSD), where droplets must pass through a small dispersion chamber before entering the main big drying chamber. For the first time, droplet drying process from exiting nozzle to the arrival at the dryer outlet can be simulated. The new model can be used in the future to optimize the spray drying process. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Xiao, Jie; Yang, Shujun; George, Oluwafemi Ayodele; Wu, Winston Duo; Chen, Xiao Dong] Soochow Univ, Coll Chem Chem Engn & Mat Sci, China Australia Joint Res Ctr Future Dairy Mfg, Sch Chem & Environm Engn, Suzhou 215123, Jiangsu, Peoples R China.
   [Putranto, Aditya] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT7 1NN, Antrim, North Ireland.
RP Xiao, J; Chen, XD (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, China Australia Joint Res Ctr Future Dairy Mfg, Sch Chem & Environm Engn, Suzhou 215123, Jiangsu, Peoples R China.
EM jie.xiao@suda.edu.cn; xdchen@mail.suda.edu.cn
OI Chen, xiao dong/0000-0002-0150-0491
FU Natural Science Foundation of Jiangsu ProvinceJiangsu Planned Projects
   for Postdoctoral Research FundsNatural Science Foundation of Jiangsu
   Province [BK20170062]; National Key Research and Development Program of
   China (International S& T Cooperation Program, ISTCP) [2016YFE0101200];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21406148]; Jiangsu Innovation and Entrepreneurship
   (Shuang Chuang) Program; Jiangsu Specially-Appointed Professors Program;
   Priority Academic Program Development (PAPD) of Jiangsu Higher Education
   Institutions
FX We are grateful for the financial support from the Natural Science
   Foundation of Jiangsu Province (BK20170062), the National Key Research
   and Development Program of China (International S& T Cooperation
   Program, ISTCP, 2016YFE0101200), the National Natural Science Foundation
   of China (21406148), the "Jiangsu Innovation and Entrepreneurship
   (Shuang Chuang) Program", the "Jiangsu Specially-Appointed Professors
   Program", and the "Priority Academic Program Development (PAPD) of
   Jiangsu Higher Education Institutions".
CR Baldwin AJ, 2007, FOOD BIOPROD PROCESS, V85, P202, DOI 10.1205/fbp07008
   BALTAS L, 1969, AICHE J, V15, P772, DOI 10.1002/aic.690150525
   Chen XD, 2005, AICHE J, V51, P1790, DOI 10.1002/aic.10449
   Chen XD, 2008, DRY TECHNOL, V26, P627, DOI 10.1080/07373930802045908
   Fletcher DF, 2009, CHEM ENG RES DES, V87, P1371, DOI 10.1016/j.cherd.2009.03.006
   Foerster M, 2016, COLLOID SURFACE B, V140, P460, DOI 10.1016/j.colsurfb.2016.01.012
   George OA, 2015, AICHE J, V61, P4140, DOI 10.1002/aic.14940
   HAIDER A, 1989, POWDER TECHNOL, V58, P63, DOI 10.1016/0032-5910(89)80008-7
   Huang LX, 2006, CHEM ENG PROCESS, V45, P461, DOI 10.1016/j.cep.2005.11.004
   Huang LX, 2003, DRY TECHNOL, V21, P385, DOI 10.1081/DRT-120018454
   Jin Y, 2009, DRY TECHNOL, V27, P1018, DOI 10.1080/07373930903203588
   Jin Y, 2009, DRY TECHNOL, V27, P371, DOI 10.1080/07373930802682957
   Kavoshi L, 2015, CHEM ENG RES DES, V98, P157, DOI 10.1016/j.cherd.2015.04.023
   Lin SXQ, 2005, J FOOD ENG, V68, P257, DOI 10.1016/j.jfoodeng.2004.05.036
   Lin SXQ, 2004, FOOD BIOPROD PROCESS, V82, P213, DOI [10.1205/fbio.82.3.213.44178, 10.1205/096030899532493]
   Liu WF, 2011, INT J CHEM ENG, P1, DOI DOI 10.1155/2011/267218
   Mezhericher M, 2008, DRY TECHNOL, V26, P265, DOI 10.1080/07373930801897523
   Mezhericher M, 2007, DRY TECHNOL, V25, P1025, DOI 10.1080/07373930701394902
   Mezhericher M, 2015, DRY TECHNOL, V33, P2, DOI 10.1080/07373937.2014.941110
   Patel K, 2010, DAIRY SCI TECHNOL, V90, P181, DOI 10.1051/dst/2009059
   Patel KC, 2008, FOOD BIOPROD PROCESS, V86, P185, DOI 10.1016/j.fbp.2007.10.013
   Patel KC, 2009, AICHE J, V55, P217, DOI 10.1002/aic.11642
   Pawar S, 2015, CHEM ENG SCI, V138, P17, DOI 10.1016/j.ces.2015.07.048
   Putranto A, 2016, AICHE J, V62, P2144, DOI 10.1002/aic.15176
   RANZ WE, 1952, CHEM ENG PROG, V48, P141
   RANZ WE, 1952, CHEM ENG PROG, V48, P173
   Re MI, 2006, DRY TECHNOL, V24, P433, DOI 10.1080/07373930600611877
   Rogers S. L., 2011, THESIS
   Rogers S, 2012, CHEM ENG SCI, V71, P75, DOI 10.1016/j.ces.2011.11.041
   Sagadin G, 2017, INT J HEAT MASS TRAN, V108, P1220, DOI 10.1016/j.ijheatmasstransfer.2016.12.107
   Schmitz-Schug I, 2016, CHEM ENG SCI, V141, P315, DOI 10.1016/j.ces.2015.11.008
   Shakiba S, 2016, ADV POWDER TECHNOL, V27, P2299, DOI 10.1016/j.apt.2016.07.001
   Song CM, 2016, POWDER TECHNOL, V294, P437, DOI 10.1016/j.powtec.2016.02.052
   Vicente J, 2013, POWDER TECHNOL, V247, P1, DOI 10.1016/j.powtec.2013.06.038
   VOJIR DJ, 1994, INT J MULTIPHAS FLOW, V20, P547, DOI 10.1016/0301-9322(94)90028-0
   Woo MW, 2012, POWDER TECHNOL, V223, P39, DOI 10.1016/j.powtec.2011.06.030
   Woo MW, 2011, CHEM ENG PROCESS, V50, P417, DOI 10.1016/j.cep.2011.02.007
   Woo MW, 2008, DRY TECHNOL, V26, P1180, DOI 10.1080/07373930802306953
   [杨树俊 Yang Shujun], 2018, [化工学报, CIESC Journal], V69, P3814
   Xiao J, 2018, PARTICUOLOGY, V38, P44, DOI 10.1016/j.partic.2017.04.008
   Xiao J, 2014, AICHE J, V60, P2416, DOI 10.1002/aic.14452
   Yang XF, 2015, DRY TECHNOL, V33, P742, DOI 10.1080/07373937.2014.990565
   You X, 2014, DRY TECHNOL, V32, P528, DOI 10.1080/07373937.2013.840650
   Zastawny M, 2012, INT J MULTIPHAS FLOW, V39, P227, DOI 10.1016/j.ijmultiphaseflow.2011.09.004
NR 44
TC 1
Z9 2
U1 5
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 12
EP 26
DI 10.1016/j.ces.2019.01.030
PG 15
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000002
DA 2020-05-12
ER

PT J
AU Roy, S
   Kamalanathan, P
   Al-Dahhan, M
AF Roy, Shaibal
   Kamalanathan, Premkumar
   Al-Dahhan, Muthanna
TI Integration of phase distribution from gamma-ray tomography technique
   with monolith reactor scale modeling
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Monoliths; CT; Phase distribution; Reactor modeling
ID GAS-LIQUID DISTRIBUTION; TRICKLE-BED REACTORS; 2-PHASE FLOW;
   MASS-TRANSFER; HYDROGENATION; DESIGN
AB In this work, a monolith reactor model was developed to study the effect of phase distribution on the performance of the monolith reactors by integrating phase distribution data from the experiments. To obtain the phase distribution at the reactions conditions, gamma ray computed tomography (CT) was used. Effect of gas density, surface tension of liquid and operating conditions on the phase distribution were studied using gamma-ray computed tomography. Experiments were conducted in Taylor flow regime. With the increase in gas density, uniformity increases. Surface tension has little effect on the distribution in the investigated conditions. Liquid with lower surface tension and gas with lower density has higher cross-sectional liquid saturation. Further, the monolith reactor model with uniform phase distribution and actual distribution were compared. It was found that at higher velocities both gives the same reactor performance irrespective of the maldistribution, however at low velocities, they differ significantly due to the maldistribution. If the maldistribution is present at both low and high velocities, catalyst utilization plays a major role, thus it is recommended to operate at higher velocities where catalyst utilization is high due to high mass transfer. (C) 2019 Published by Elsevier Ltd.
C1 [Roy, Shaibal] Washington Univ, Chem React Engn Lab, St Louis, MO 63130 USA.
   [Kamalanathan, Premkumar; Al-Dahhan, Muthanna] Missouri Univ Sci & Technol, Chem & Biochem Engn Dept, Rolla, MO 65409 USA.
   [Roy, Shaibal] Chemours Co, Wilmington, DE USA.
RP Al-Dahhan, M (reprint author), Missouri Univ Sci & Technol, Rolla, MO 65409 USA.
EM aldahhanm@mst.edu
OI Kamalanathan, Premkumar/0000-0001-9425-8675
FU Bayer AGBayer AG
FX The authors would like to acknowledge financial support from Bayer AG
   and other CREL sponsors made this work possible.
CR Al-Dahhan MH, 2007, CHEM ENG J, V130, P147, DOI 10.1016/j.cej.2006.06.022
   ALDAHHAN MH, 1995, CHEM ENG SCI, V50, P2377, DOI 10.1016/0009-2509(95)00092-J
   Bauer T, 2005, CHEM ENG SCI, V60, P3101, DOI 10.1016/j.ces.2004.12.041
   Bauer T., 2003, THESIS
   Bauer T, 2011, CHEM ENG J, V169, P263, DOI 10.1016/j.cej.2011.02.033
   Bercic G, 1997, CHEM ENG SCI, V52, P3709, DOI 10.1016/S0009-2509(97)00217-0
   Chen JW, 2001, AICHE J, V47, P994, DOI 10.1002/aic.690470506
   Chugh D, 2017, AICHE J, V63, P327, DOI 10.1002/aic.15586
   CYBULSKI A, 1998, STRUCTURED CATALYSTS
   Degaleesan S, 1996, CHEM ENG SCI, V51, P1967, DOI 10.1016/0009-2509(96)00054-1
   Derevich IV, 2012, INT J HEAT MASS TRAN, V55, P1695, DOI 10.1016/j.ijheatmasstransfer.2011.11.024
   Edvinsson RK, 1994, CHEM ENG SCI, V49, P5653, DOI 10.1016/0009-2509(94)00370-X
   Gladden LF, 2003, CATAL TODAY, V79, P203, DOI 10.1016/S0920-5861(03)00006-3
   Hamidipour M, 2010, CHEM ENG SCI, V65, P504, DOI 10.1016/j.ces.2009.06.040
   Heibel AK, 2003, AICHE J, V49, P3007, DOI 10.1002/aic.690491203
   IRANDOUST S, 1988, CHEM ENG SCI, V43, P1983, DOI 10.1016/0009-2509(88)87072-6
   Kreutzer MT, 2001, CHEM ENG SCI, V56, P6015, DOI 10.1016/S0009-2509(01)00271-8
   Kumar S. R, 1994, THESIS
   Lei ZG, 2016, CATAL TODAY, V276, P150, DOI 10.1016/j.cattod.2016.04.017
   Meitzner C, 2017, CHEM ENG TECHNOL, V40, P2058, DOI 10.1002/ceat.201700125
   Mishima K, 1996, INT J MULTIPHAS FLOW, V22, P703, DOI 10.1016/0301-9322(96)00010-9
   Moulijn JA, 2013, CURR OPIN CHEM ENG, V2, P346, DOI 10.1016/j.coche.2013.05.003
   Nijhuis TA, 2003, CHEM ENG SCI, V58, P1113, DOI 10.1016/S0009-2509(02)00547-X
   Pangarkar K, 2008, IND ENG CHEM RES, V47, P3720, DOI 10.1021/ie800067r
   Roy S, 2005, CATAL TODAY, V105, P396, DOI 10.1016/j.cattod.2005.06.062
   Roy S, 2005, CHEM ENG PROCESS, V44, P59, DOI 10.1016/j.cep.2004.03.010
   Roy S, 2004, CHEM ENG SCI, V59, P957, DOI 10.1016/j.ces.2003.12.001
   Roy S., 2006, THESIS
   Schafer T, 2016, INT J MULTIPHAS FLOW, V86, P56, DOI 10.1016/j.ijmultiphaseflow.2016.07.008
   Schubert M, 2016, AICHE J, V62, P4346, DOI 10.1002/aic.15334
   Sederman AJ, 2003, MAGN RESON IMAGING, V21, P359, DOI 10.1016/S0730-725X(03)00138-3
   THULASIDAS TC, 1995, CHEM ENG SCI, V50, P183, DOI 10.1016/0009-2509(94)00225-G
   Yawalkar AA, 2005, IND ENG CHEM RES, V44, P2046, DOI 10.1021/ie049338i
   Zhou Y, 2012, CHINESE J CHEM ENG, V20, P693, DOI 10.1016/S1004-9541(11)60237-1
NR 34
TC 2
Z9 2
U1 2
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 27
EP 37
DI 10.1016/j.ces.2018.12.053
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000003
DA 2020-05-12
ER

PT J
AU Shan, YL
   Xu, L
   Hu, YJ
   Jiang, H
   Li, CZ
AF Shan, Yilin
   Xu, Lei
   Hu, Yanjie
   Jiang, Hao
   Li, Chunzhong
TI Internal-diffusion controlled synthesis of V2O5 hollow microspheres for
   superior lithium-ion full batteries
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE V2O5; Hollow microsphere; Hierarchical surface; Diffusion control;
   Lithium-ion batteries
ID CATHODE MATERIALS; STORAGE; CARBON; LI
AB Exploiting a simple and effective strategy to build shell-tuned hollow nanomaterials with unchanged surface microstructure is a great challenge but important for lithium-ion batteries (LIBs). Herein, we demonstrate the synthesis of V2O5 hollow microspheres, where the hierarchical shell thickness can be changed by controlling internal-diffusion rate of the core precursor. The fascinating nanostructures can guarantee the full contact with electrolyte with shortened ions diffusion path. Meantime, the self-created pores can effectively alleviate the volume change in the charge/discharge process. When evaluated as cathode materials, the V2O5 hollow microspheres can deliver a high reversible specific capacity of 287 and 140 mAh g(-1) at 1/3 C and 10 C, respectively with a good cycling stability. After inserting Li+, the corresponding Li3VO4/CNTs nanoparticles are obtained as anode materials, also exhibiting a high specific capacity of 200 mAh g(-1) even after 800 cycles at 1000 mA g(-1). An all-vanadium-based lithium-ion full battery (V2O5//Li3VO4/CNTs) is assembled, which gives a high specific capacity of 55 mAh g(-1) at 5000 mA g(-1) even after 1000 cycles based on the cathode material weight. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Shan, Yilin; Xu, Lei; Hu, Yanjie; Jiang, Hao; Li, Chunzhong] East China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
RP Jiang, H; Li, CZ (reprint author), East China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
EM jianghao@ecust.edu.cn; czli@ecust.edu.cn
RI Li, Chunzhong/B-1103-2015; Hu, Yanjie/U-5465-2017
OI Li, Chunzhong/0000-0001-7897-5850; Hu, Yanjie/0000-0003-4531-8429
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [91534202, 21838003]; Basic Research Program of
   Shanghai [17JC1402300, 18DZ2252400]; Innovation Program of Shanghai
   Municipal Education CommissionInnovation Program of Shanghai Municipal
   Education Commission; Shanghai Scientific and Technological Innovation
   Project [18JC1410500]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [222201718002]
FX This work was supported by the National Natural Science Foundation of
   China (91534202 and 21838003), the Basic Research Program of Shanghai
   (17JC1402300 and 18DZ2252400), the Innovation Program of Shanghai
   Municipal Education Commission, the Shanghai Scientific and
   Technological Innovation Project (18JC1410500) and the Fundamental
   Research Funds for the Central Universities (222201718002).
CR ABELLO L, 1983, SPECTROCHIM ACTA A, V39, P641, DOI 10.1016/0584-8539(83)80040-3
   Aliahmad N, 2018, ACS APPL MATER INTER, V10, P16490, DOI 10.1021/acsami.8b02721
   Chen L, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201602782
   Deng ZN, 2018, AICHE J, V64, P1965, DOI 10.1002/aic.16068
   Deng ZN, 2018, SMALL, V14, DOI 10.1002/smll.201800148
   Deng ZN, 2017, ADV MATER, V29, DOI 10.1002/adma.201603020
   Drosos C, 2018, J POWER SOURCES, V384, P355, DOI 10.1016/j.jpowsour.2018.02.074
   Jiang H, 2015, IND ENG CHEM RES, V54, P2960, DOI 10.1021/acs.iecr.5b00132
   Jiang H, 2009, CHEM COMMUN, P3618, DOI 10.1039/b904408f
   Lai XY, 2011, ANGEW CHEM INT EDIT, V50, P2738, DOI 10.1002/anie.201004900
   Li GZ, 2015, J MATER CHEM A, V3, P1103, DOI 10.1039/c4ta04864d
   Li YW, 2013, ADV ENERGY MATER, V3, P1171, DOI 10.1002/aenm.201300188
   Liu J, 2010, J MATER CHEM, V20, P4595, DOI 10.1039/b925201k
   Liu J, 2009, J AM CHEM SOC, V131, P12086, DOI 10.1021/ja9053256
   Lou XW, 2007, ADV MATER, V19, P3328, DOI 10.1002/adma.200700357
   Lu AH, 2010, ANGEW CHEM INT EDIT, V49, P1615, DOI 10.1002/anie.200906445
   Mai LQ, 2014, SMALL, V10, P3032, DOI 10.1002/smll.201302991
   Nayak PK, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702397
   Niu CJ, 2016, NANO ENERGY, V27, P147, DOI 10.1016/j.nanoen.2016.06.057
   Niu CJ, 2014, NANO LETT, V14, P2873, DOI 10.1021/nl500915b
   Odani A, 2006, ADV MATER, V18, P1431, DOI 10.1002/adma.200501611
   Pan AQ, 2013, ANGEW CHEM INT EDIT, V52, P2226, DOI 10.1002/anie.201209535
   Ren WH, 2018, SMALL, V14, DOI 10.1002/smll.201800659
   Ren XC, 2016, ACS APPL MATER INTER, V8, P17205, DOI 10.1021/acsami.6b03257
   Shang H, 2018, ADV MATER, V30, DOI 10.1002/adma.201801459
   Shao LY, 2014, CERAM INT, V40, P6115, DOI 10.1016/j.ceramint.2013.11.063
   Shen LF, 2015, ANGEW CHEM INT EDIT, V54, P1868, DOI 10.1002/anie.201409776
   Sun YK, 2011, ADV MATER, V23, P5050, DOI 10.1002/adma.201102497
   Wang G., 2015, ANGEW CHEM INT EDIT, V54, P1
   Wang Hung-Chia, 2016, ANGEW CHEM INT EDIT, V55, P1
   Wang QH, 2018, J MATER CHEM A, V6, P8815, DOI 10.1039/c8ta01627e
   Wang X, 2010, ADV FUNCT MATER, V20, P1680, DOI 10.1002/adfm.200902295
   Wang YP, 2018, J MATER CHEM A, V6, P6792, DOI 10.1039/c8ta01390j
   Wang Y, 2011, J MATER CHEM, V21, P2362, DOI 10.1039/c0jm02727h
   Wei QL, 2015, ADV FUNCT MATER, V25, P1773, DOI 10.1002/adfm.201404311
   Wu HB, 2013, ADV FUNCT MATER, V23, P5669, DOI 10.1002/adfm.201300976
   Yang LP, 2016, J AM CHEM SOC, V138, P5916, DOI 10.1021/jacs.6b00773
   Yang Y, 2016, CHEM MATER, V28, P2417, DOI 10.1021/acs.chemmater.6b00761
   Yi TF, 2016, J POWER SOURCES, V316, P85, DOI 10.1016/j.jpowsour.2016.03.070
   Yu H, 2013, NANOSCALE, V5, P4937, DOI [10.1039/c3nr00548h, 10.1039/C3NR00548H]
   Yu L, 2016, ADV MATER, V28, P92, DOI 10.1002/adma.201504024
   Yue Q, 2014, CHEM COMMUN, V50, P13362, DOI [10.1039/c4cc06733a, 10.1039/C4CC06733A]
   Zhang CF, 2013, ENERG ENVIRON SCI, V6, P974, DOI 10.1039/c3ee24134c
   Zheng JM, 2015, CHEM MATER, V27, P1381, DOI 10.1021/cm5045978
NR 44
TC 4
Z9 4
U1 21
U2 130
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 38
EP 45
DI 10.1016/j.ces.2019.01.043
PG 8
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000004
DA 2020-05-12
ER

PT J
AU Wang, JY
   Sun, Y
   Gao, XD
   Mannan, MS
   Wilhite, B
AF Wang, Jingyao
   Sun, Yue
   Gao, Xiaodan
   Mannan, M. Sam
   Wilhite, Benjamin
TI Experimental study of electrostatic hazard inside scrubber column using
   response surface methodology
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Scrubber column; Bubble column; Absorption column; Process safety;
   Aerosol ignition; Aerosol hazards
ID DROPWISE CONDENSATION; FLAMMABILITY LIMIT; SULFUR-DIOXIDE; STATIC
   HAZARDS; ABSORPTION; IGNITION; LIQUIDS; DROPS; WATER; SO2
AB Electrostatic ignition has triggered significant fire/explosion incidents in liquid processing industries including chemical, oil/gas, food, pharmaceutical and transportation. In this work, the impact of gas-velocity and temperature on the electrostatic energy accumulation in a scrubber column was studied. An in-situ charge measurement apparatus combined with a particle scattering laser function was installed inside a pilot-scale column filled with water through which nitrogen was sparged; the formed aerosol particle size distribution, concentration, mass and charge were measured simultaneously. Response surface methodology was employed to construct a quadratic model correlating the electrostatic energy response with the gas velocity and column temperature. Four scenarios were considered and their capacity to provoke ignition was evaluated. Temperature was found affect the charged aerosol droplet size but also to facilitate the charge relaxation in the liquid phase. The faster the gas velocity the higher the electrostatic energy accumulation and the probability of ignition. In the presence of non-grounded conductors, the maximum electrostatic energy from spark discharge was found above the minimum ignition energy of some flammable chemicals and poses as significant fires or explosion risk. In contrast, if there is no ungrounded conductor, the corona discharge was found not sufficient for electrostatic ignition in the range of temperature and gas velocity in this study. To reduce the electrostatic hazards, it is recommended to remove ungrounded conductors within the column. And the gas flow should be maintained at minimum if ungrounded conductors are present. (C) 2019 Published by Elsevier Ltd.
C1 [Wilhite, Benjamin] Texas A&M Univ, Artie McFerrin Dept Chem Engn, Dept Chem Engn, College Stn, DC 77843 USA.
   Texas A&M Univ, Mary Kay OConnor Proc Safety Ctr, 3122 TAMU, College Stn, DC 77843 USA.
RP Wilhite, B (reprint author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, Dept Chem Engn, College Stn, DC 77843 USA.
EM benjaminwilhite@mail.che.tamu.edu
RI ; Sun, Yue/R-9565-2018
OI Wang, Jingyao/0000-0002-3511-4724; Sun, Yue/0000-0001-9530-1516
FU Mary Kay O'Connor Process Safety Center, Texas AM University
FX This research was sponsored by the Mary Kay O'Connor Process Safety
   Center, Texas A&M University.
CR ASHGRIZ N, 1990, J FLUID MECH, V221, P183, DOI 10.1017/S0022112090003536
   Bandyopadhyay A, 2007, SCI TOTAL ENVIRON, V383, P25, DOI 10.1016/j.scitotenv.2007.04.024
   BARRETT JC, 1988, J AEROSOL SCI, V19, P223, DOI 10.1016/0021-8502(88)90225-X
   Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024
   Bassett J., 1975, J ELECTROSTAT, V1, P47, DOI 10.1016/0304-3886(75)90006-6
   Berthier J., 2012, MICRODROPS DIGITAL M
   Besagni Giorgio, 2018, ChemEngineering, V2, DOI 10.3390/chemengineering2020013
   Besagni G, 2018, ENERGY, V165, P369, DOI 10.1016/j.energy.2018.09.108
   Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019
   Britton LG, 2012, J LOSS PREVENT PROC, V25, P309, DOI 10.1016/j.jlp.2011.11.012
   Brogren C, 1997, CHEM ENG SCI, V52, P3085, DOI 10.1016/S0009-2509(97)00126-7
   Bustin W.M., 1983, ELECTROSTATIC HAZARD
   CHIN HB, 1979, J RHEOL, V23, P557
   Cho M, 2018, IND ENG CHEM RES, V57, P3065, DOI 10.1021/acs.iecr.7b05309
   Chubb J., 2004, ELECTROSTATIC IGNITI
   Chubb J.N., 1975, J ELECTROSTAT, V1, P61, DOI [10.1016/0304-3886(75)90008-X, DOI 10.1016/0304-3886(75)90008-X]
   CSB, 2008, BART SOLV STAT SPARK
   CSB, 2008, STAT SPARK IGN FLAMM
   DANCKWERTS PV, 1951, IND ENG CHEM, V43, P1460, DOI 10.1021/ie50498a055
   Darake S, 2016, CHEM ENG RES DES, V109, P180, DOI 10.1016/j.cherd.2015.11.027
   de Santiago M.R., 1991, MEASUREMENT SIZE VEL, P203
   Egan S, 2017, J ELECTROSTAT, V88, P183, DOI 10.1016/j.elstat.2017.01.002
   FENN JB, 1951, IND ENG CHEM, V43, P2865, DOI 10.1021/ie50504a057
   Gan N, 2018, J THERM ANAL CALORIM, V134, P1169, DOI 10.1007/s10973-018-7413-6
   Ganan-Calvo AM, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.204502
   Ghabache E, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4902820
   Gunther A, 2003, INT J MULTIPHAS FLOW, V29, P795, DOI 10.1016/S0301-9322(03)00041-7
   Hadlocon LS, 2014, T ASABE, V57, P647
   Haruhiko Itagaki M.T., 1997, EXPLOSION CHARGING O
   He M, 2015, J ELECTROSTAT, V75, P77, DOI 10.1016/j.elstat.2015.03.002
   Heinz F., 2018, NBC 5 NEWS
   Hu Y., 2012, 7 INT C APPL EL
   Ingram JM, 2014, PROCESS SAF ENVIRON, V92, P750, DOI 10.1016/j.psep.2014.02.002
   Jackson J.D., 1975, ELECTRODYNAMICS
   JIANG YJ, 1992, J FLUID MECH, V234, P171, DOI 10.1017/S0022112092000740
   JOHNSON JK, 1977, J ELECTROSTAT, V4, P53, DOI 10.1016/0304-3886(77)90108-5
   KAATZE U, 1989, J CHEM ENG DATA, V34, P371, DOI 10.1021/je00058a001
   Kelbaliyev GI, 2011, THEOR FOUND CHEM EN+, V45, P248, DOI 10.1134/S0040579511020084
   Khuri AI, 1996, RESPONSE SURFACES DE
   Kohl A.L, 1997, GAS PURIFICATION
   KOSZMAN I, 1962, CHEM ENG SCI, V17, P1013, DOI 10.1016/0009-2509(62)80080-3
   KRAMER H, 1979, J ELECTROSTAT, V6, P361, DOI 10.1016/0304-3886(79)90005-6
   Krishna K, 2003, J HAZARD MATER, V104, P215, DOI 10.1016/S0304-3894(03)00273-5
   Kurella S, 2017, J ENVIRON SCI HEAL A, V52, P515, DOI 10.1080/10934529.2017.1281690
   Leach RN, 2006, LANGMUIR, V22, P8864, DOI 10.1021/la061901+
   Lian P, 2012, J LOSS PREVENT PROC, V25, P103, DOI 10.1016/j.jlp.2011.07.006
   Lindbauer R., 1975, J ELECTROSTAT, V1, P273, DOI [10.1016/0304-3886(75)90023-6, DOI 10.1016/0304-3886(75)90023-6]
   Liu DY, 2015, INT J GREENH GAS CON, V37, P115, DOI 10.1016/j.ijggc.2015.03.006
   Luttgens S, 2015, CHEM ENG TECHNOL, V38, P1261, DOI 10.1002/ceat.201400747
   Makhlouf A. S. Hamdy, 2015, HDB NANOCERAMIC NANO, P688
   Malvern Instruments, 2006, SPRAYT US MAN
   Mannan, 2010, ANAL TECHNICAL SUPPO
   Marek R, 2001, INT J HEAT MASS TRAN, V44, P39, DOI 10.1016/S0017-9310(00)00086-7
   Mhatre S, 2015, CHEM ENG RES DES, V96, P177, DOI 10.1016/j.cherd.2015.02.012
   Mohan BR, 2008, SEP PURIF TECHNOL, V61, P96, DOI 10.1016/j.seppur.2007.09.018
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Neveux T, 2011, IND ENG CHEM RES, V50, P7579, DOI 10.1021/ie102239q
   Nivolianitou Z, 2006, J HAZARD MATER, V137, P1, DOI 10.1016/j.jhazmat.2004.12.042
   NTSB, 2004, PIP ACC REP STOR TAN
   Ott R. L., 2015, INTRO STAT METHODS D
   Padding JT, 2015, ADV CHEM ENG, P137
   Pak SI, 2006, J HAZARD MATER, V138, P560, DOI 10.1016/j.jhazmat.2006.05.105
   Park AHA, 2007, CHEM ENG SCI, V62, P371, DOI 10.1016/j.ces.2006.08.058
   POST L, 1989, J ELECTROSTAT, V23, P99, DOI 10.1016/0304-3886(89)90036-3
   Qian J, 1997, J FLUID MECH, V331, P59, DOI 10.1017/S0022112096003722
   Qing Z., 2011, ENERGY, V4, P519, DOI DOI 10.1016/J.EGYPR0.2011.01.083
   Rabe C, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3392768
   REES WD, 1981, J ELECTROSTAT, V11, P13, DOI 10.1016/0304-3886(81)90073-5
   Rose JW, 2002, P I MECH ENG A-J POW, V216, P115, DOI 10.1243/09576500260049034
   Sarkar S, 2007, CHEM ENG J, V131, P263, DOI 10.1016/j.cej.2006.12.013
   Sauter J., 1926, GROSSENBESTIMMUNG GE
   Schafer D., 2012, STAT SLEUTH COURSE M
   Spiel DE, 1998, J GEOPHYS RES-OCEANS, V103, P24907, DOI 10.1029/98JC02233
   SPIEL DE, 1995, J GEOPHYS RES-OCEANS, V100, P4995, DOI 10.1029/94JC03055
   Staggs K., 2001, ARE PUBLISHED MINIMU
   Strakey P.A., 2003, ASSESSMENT MULTIPLE
   STROCK TW, 1994, CHEM ENG SCI, V49, P4667
   TABATA Y, 1987, J HAZARD MATER, V17, P47, DOI 10.1016/0304-3894(87)85041-0
   Tanda T, 2011, IND ENG CHEM RES, V50, P13554, DOI 10.1021/ie200989k
   Team M., 2015, MFRAME MARITIME NEWS
   Thulin A, 2016, CHEM ENG TECHNOL, V39, P1972, DOI 10.1002/ceat.201500687
   Van de Weerd J., 1975, J ELECTROSTAT, V1, P295, DOI 10.1016/0304-3886(75)90024-8
   Van Der Meer D., 1975, ELECTROSTATIC CHARGE
   Viswanathan S, 1998, CHEM ENG SCI, V53, P3161, DOI 10.1016/S0009-2509(98)00123-7
   Volkov RS, 2015, TECH PHYS LETT+, V41, P128, DOI 10.1134/S1063785015020145
   Volkov RS, 2015, INT J HEAT MASS TRAN, V85, P1, DOI 10.1016/j.ijheatmasstransfer.2015.01.078
   Wang J., 2018, IND ENG CHEM RES
   Wang ZK, 2015, IND ENG CHEM RES, V54, P8670, DOI 10.1021/acs.iecr.5b02146
   WIERZBA A, 1990, EXP FLUIDS, V9, P59, DOI 10.1007/BF00575336
   Zarnik MS, 2012, RADIOENGINEERING, V21, P201
   Zhang JQ, 2015, IND ENG CHEM RES, V54, P3989, DOI 10.1021/acs.iecr.5b00341
   Zhang Z, 2016, J NAT GAS SCI ENG, V31, P589, DOI 10.1016/j.jngse.2016.03.052
NR 92
TC 8
Z9 8
U1 1
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 46
EP 68
DI 10.1016/j.ces.2018.12.060
PG 23
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000005
DA 2020-05-12
ER

PT J
AU Yang, JJ
   Wang, DW
   Yan, H
   Lei, M
AF Yang, Jianjian
   Wang, Dawei
   Yan, Hua
   Lei, Meng
TI Effects of lyophobic-functionalized iron particles to the stability and
   magnetorheological response of MR suspensions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
ID FLUIDS; NANOPARTICLES; AGGREGATION; ACID
AB We developed lyophobic magnetorheological suspensions with improved gravitational stability. The space-spanning particle network arising from lyophobic aggregation is responsible for this enhancement. The lyophobic effect in the presence of the magnetic field can be overcome by decreasing the number of lyophobic particles or through the addition of magnetic nanoparticles, leaving a considerable magnetorheological response in the sample. This work emphasizes the advantages of lyophobic force in the control of the sedimentation stability of magnetorheological suspensions without the need for anti-setting additives. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yang, Jianjian; Wang, Dawei; Yan, Hua; Lei, Meng] Logist Engn Univ, Dept Chem & Mat Engn, Chongqing 401311, Peoples R China.
   [Yang, Jianjian] Acad Mil Med Sci, Res Inst Chem Def, Beijing, Peoples R China.
RP Yan, H (reprint author), Logist Engn Univ, Dept Chem & Mat Engn, Chongqing 401311, Peoples R China.
EM 892496530@qq.com
CR [Anonymous], SMART MATER STRUCT, V26, DOI 10.1088/1361-665X/aa7cb9
   Bica D, 2007, J MAGN MAGN MATER, V311, P17, DOI 10.1016/j.jmmm.2006.11.158
   Bossis G, 2011, PHYSICA A, V390, P2655, DOI 10.1016/j.physa.2011.02.044
   Dong YZ, 2018, COLLOID SURFACE A, V537, P102, DOI 10.1016/j.colsurfa.2017.10.017
   Hu Y, 2013, COLLOID SURFACE A, V434, P281, DOI 10.1016/j.colsurfa.2013.05.074
   Lopez-Lopez MT, 2008, J RHEOL, V52, P901, DOI 10.1122/1.2931008
   Lopez-Lopez MT, 2008, RHEOL ACTA, V47, P787, DOI 10.1007/s00397-008-0271-6
   Martinez-Pedrero F, 2007, COLLOID SURFACE A, V306, P158, DOI 10.1016/j.colsurfa.2007.03.029
   Mertelj A, 2011, SOFT MATTER, V7, P125, DOI 10.1039/c0sm00388c
   Park BJ, 2010, SOFT MATTER, V6, P5246, DOI 10.1039/C0SM00014K
   Patel R, 2011, J MAGN MAGN MATER, V323, P1360, DOI 10.1016/j.jmmm.2010.11.046
   Phule PP, 1999, J MATER RES, V14, P3037, DOI 10.1557/JMR.1999.0407
   Spruijt E, 2011, SOFT MATTER, V7, P8281, DOI 10.1039/c1sm05881a
   Thormann E, 2008, LANGMUIR, V24, P7278, DOI 10.1021/la8005162
   Xu DH, 2010, MACROMOLECULES, V43, P3556, DOI 10.1021/ma100093b
   Yamanaka S, 2012, COLLOID SURFACE A, V415, P239, DOI 10.1016/j.colsurfa.2012.10.012
   Yang JJ, 2016, J MAGN MAGN MATER, V417, P214, DOI 10.1016/j.jmmm.2016.05.085
   Yang JJ, 2016, MATER LETT, V167, P27, DOI 10.1016/j.matlet.2015.12.098
   Zeng HB, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4937465
NR 19
TC 0
Z9 0
U1 2
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 69
EP 72
DI 10.1016/j.ces.2019.01.063
PG 4
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000006
DA 2020-05-12
ER

PT J
AU Baiguzin, FA
   Burmistrov, DA
   Kuznetsov, VA
   Farakhov, MI
AF Baiguzin, F. A.
   Burmistrov, D. A.
   Kuznetsov, V. A.
   Farakhov, M., I
TI Theoretical description and numerical modelling of dehydration of
   tert-butanol via reactive distillation at concurrent flow of liquid and
   vapor phases
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Mathematical model; Dehydration; Tert-butyl alcohol; Isobutylene;
   Downward concurrent flow
ID KINETICS; MATRIX; UNIFAC
AB An original simplified mathematical model of the process of tert-butyl alcohol dehydration in a catalytic zone of the reactive distillation unit with the downward concurrent flow of liquid and vapor phases is developed. The system of heat and mass balance equations includes relationships that allow determining changes in temperature as well as gas and liquid compositions caused by a chemical reaction along the catalyst bed height. Results of calculation of the temperature profile along the catalyst bed height, carried out using the developed model, are in good agreement with data from our previous laboratory studies as well as with data obtained during trial operation of an industrial reactor. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Baiguzin, F. A.] Kazan Natl Res Technol Univ, Dept Chem Engn, 68 Karl Marx Str, Kazan 420015, Russia.
   LLC Engn Promot Ctr Inzhekhim, 14-83 Shalyapin Str, Kazan 420049, Russia.
RP Baiguzin, FA (reprint author), Kazan Natl Res Technol Univ, Dept Chem Engn, 68 Karl Marx Str, Kazan 420015, Russia.
EM umns_inform@rambler.ru
CR Abella LC, 1999, INT J CHEM KINET, V31, P854, DOI 10.1002/(SICI)1097-4601(1999)31:12<854::AID-KIN3>3.0.CO;2-6
   Baiguzin F. A., 2015, Russian patent, Patent No. 2567556
   Baiguzin F. A., 2016, CHEM IND TODAY, P5
   Bender M, 2014, CHEMBIOENG REV, V1, P136, DOI 10.1002/cben.201400016
   Burmistrov D. A., 2017, KATALIZ PROMYSHL, V17, P252
   Burmistrov D. A., 2018, VESTNIK KAZAN TEKHNO, V21, P113
   Chaplitz D. N., 1971, IND METHODS PRODUCTI
   Elizarov D. V., 2011, VESTNIK KAZAN TEKHNO, V14, P104
   Elizarov D. V., 1998, THESIS
   GATES BC, 1972, J CATAL, V24, P320, DOI 10.1016/0021-9517(72)90076-0
   GATES BC, 1973, J CATAL, V31, P27, DOI 10.1016/0021-9517(73)90266-2
   GMEHLING J, 1993, IND ENG CHEM RES, V32, P178, DOI 10.1021/ie00013a024
   Honkela ML, 2004, IND ENG CHEM RES, V43, P4060, DOI 10.1021/ie049846s
   Iborra M, 2002, IND ENG CHEM RES, V41, P5359, DOI 10.1021/ie010640q
   Kato Y, 1996, INT J ENERG RES, V20, P681, DOI 10.1002/(SICI)1099-114X(199608)20:8<681::AID-ER182>3.3.CO;2-6
   Kirpichnikov P. A., 1981, FLOWSHEETS MAJOR PRO
   Lohmann J, 2001, IND ENG CHEM RES, V40, P957, DOI 10.1021/ie0005710
   Lu SQ, 2011, ADV MATER RES-SWITZ, V233-235, P1419, DOI 10.4028/www.scientific.net/AMR.233-235.1419
   PETRUS L, 1986, CHEM ENG SCI, V41, P217, DOI 10.1016/0009-2509(86)87002-6
   Ramm V. M., 1976, ABSORPTION OF GASES
   Sundmacher K, 1996, CHEM ENG SCI, V51, P2359, DOI 10.1016/0009-2509(96)00092-9
   Taylor R, 2000, CHEM ENG SCI, V55, P5183, DOI 10.1016/S0009-2509(00)00120-2
NR 22
TC 0
Z9 0
U1 0
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 73
EP 79
DI 10.1016/j.ces.2019.02.005
PG 7
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000007
DA 2020-05-12
ER

PT J
AU Wen, KC
   Xia, MF
   Deng, P
   Lv, WQ
   He, WD
AF Wen, Kechun
   Xia, Mingfu
   Deng, Pan
   Lv, Weiqiang
   He, Weidong
TI A sandwich-structured double-battery device for direct evaluation of
   lithium diffusion coefficients and phase transition in electrodes of
   lithium ion batteries
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Li ion batteries; Diffusion coefficient; Double-battery device; Graphite
   electrode
ID POTENTIOSTATIC INTERMITTENT TITRATION; GRAPHITIZED MESOCARBON
   MICROBEADS; SPINEL LIMN2O4; THIN-FILMS; INTERCALATION; LIFEPO4;
   CHEMISTRY; KINETICS; BEHAVIOR; ANODES
AB Li diffusion efficiency reflects the kinetics of Li intercalation/de-intercalation in solid electrode materials and determines the rate performances of Li ion batteries. Traditional techniques including the electrochemical impedance spectroscopy, potential intermittent titration technique, potential relaxation technique, galvanostatic intermittent titration technique, and cyclic voltammetry, could lead to significant disagreement on Li chemical diffusion coefficients due to the limited reliability of the parameters required for calculating Li diffusion coefficients. Based on the Nernst-Einstein equation, a double-battery system is proposed for the direct measurement of chemical diffusion coefficients of Li in solid electrodes. With the double-battery system, Li diffusion coefficients in the intercalation/deintercalation of graphite electrodes featured with phase-transition and double-phase regions, are measured efficiently, with consistent values in the range of 10(-10)-10(-9) cm(2)/s. The direct measurement then allows for the evaluation of the diffusion barrier associated with Li intercalation/de-intercalation in the electrodes. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wen, Kechun; Xia, Mingfu; Deng, Pan; Lv, Weiqiang; He, Weidong] Harbin Inst Technol, Ctr Composite Mat & Struct, Natl Key Lab Sci & Technol Adv Composites Special, Harbin 150080, Heilongjiang, Peoples R China.
   [Wen, Kechun] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.
   [He, Weidong] Shenzhen Li S Technol Co Ltd, Shenzhen, Peoples R China.
   [He, Weidong] Sichuan Alpha Scenery & Green Energy Co Ltd, Chengdu, Sichuan, Peoples R China.
   [He, Weidong] Univ Elect Sci & Technol China, Sch Phys, Chengdu 610054, Sichuan, Peoples R China.
RP He, WD (reprint author), Harbin Inst Technol, Ctr Composite Mat & Struct, Natl Key Lab Sci & Technol Adv Composites Special, Harbin 150080, Heilongjiang, Peoples R China.
EM weidong.he@hit.edu.cn
RI Lv, Weiqiang/B-3578-2014
OI Lv, Weiqiang/0000-0002-0148-0849
FU Fundamental Research Funds for the Chinese Central Universities
   [ZYGX2015Z003]; Science & Technology Support Funds of Sichuan Province
   [2016GZ0151]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [51501030]
FX The work was supported by the Fundamental Research Funds for the Chinese
   Central Universities (Grant No. ZYGX2015Z003), the Science & Technology
   Support Funds of Sichuan Province (Grant No. 2016GZ0151) and the
   National Natural Science Foundation of China (Grant No. 51501030).
CR Antolini E, 2004, SOLID STATE IONICS, V170, P159, DOI 10.1016/j.ssi.2004.04.003
   Aurbach D, 2001, J POWER SOURCES, V97-8, P92, DOI 10.1016/S0378-7753(01)00594-8
   Balke N, 2010, NAT NANOTECHNOL, V5, P749, DOI 10.1038/nnano.2010.174
   Billaud J, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.97, 10.1038/NENERGY.2016.97]
   Cabanero MA, 2018, J ELECTROCHEM SOC, V165, pA847, DOI 10.1149/2.0301805jes
   Chen YH, 2010, J POWER SOURCES, V195, P2851, DOI 10.1016/j.jpowsour.2009.11.044
   Cho W, 2017, ADV MATER, V29, DOI 10.1002/adma.201605578
   Churikov AV, 2014, J SOLID STATE ELECTR, V18, P1425, DOI 10.1007/s10008-013-2358-y
   Churikov AV, 2010, ELECTROCHIM ACTA, V55, P2939, DOI 10.1016/j.electacta.2009.12.079
   Churikov AV, 2003, ELECTROCHIM ACTA, V48, P3677, DOI 10.1016/S0013-4686(03)00505-X
   DAHN JR, 1991, PHYS REV B, V44, P9170, DOI 10.1103/PhysRevB.44.9170
   Dees DW, 2009, J POWER SOURCES, V189, P263, DOI 10.1016/j.jpowsour.2008.09.045
   Delacourt C, 2011, J ELECTROCHEM SOC, V158, pA741, DOI 10.1149/1.3581087
   Ecker M, 2015, J ELECTROCHEM SOC, V162, pA1836, DOI 10.1149/2.0551509jes
   HO C, 1980, J ELECTROCHEM SOC, V127, P343, DOI 10.1149/1.2129668
   Hong L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01315-8
   Huang HT, 2001, J ELECTROCHEM SOC, V148, pA279, DOI 10.1149/1.1351756
   Itou N, 2001, J NUCL MATER, V290, P281, DOI 10.1016/S0022-3115(00)00630-9
   Jiang J., 2018, ACS APPL MAT INTERFA
   Kim JC, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401916
   Kulova TL, 2006, RUSS J ELECTROCHEM+, V42, P259, DOI 10.1134/S1023193506030086
   Levi MD, 2007, J ELECTROANAL CHEM, V600, P13, DOI 10.1016/j.jelechem.2005.11.037
   Levi MD, 2004, J ELECTROANAL CHEM, V562, P187, DOI 10.1016/j.jelechem.2003.08.032
   Levi MD, 1997, J ELECTROANAL CHEM, V421, P89, DOI 10.1016/S0022-0728(96)04833-4
   Levi MD, 1997, J PHYS CHEM B, V101, P4641, DOI 10.1021/jp9701911
   Li H., 2018, ACS APPL MAT
   Li J., 2015, ADV ENERGY MAT, V5
   Li JC, 2012, ELECTROCHIM ACTA, V75, P56, DOI 10.1016/j.electacta.2012.04.050
   Liu JL, 2009, J POWER SOURCES, V194, P536, DOI 10.1016/j.jpowsour.2009.05.007
   Magasinski A, 2010, NAT MATER, V9, P353, DOI [10.1038/NMAT2725, 10.1038/nmat2725]
   MURCH GE, 1983, RADIAT EFF DEFECT S, V73, P299, DOI 10.1080/00337578308220688
   Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716
   Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618
   Park M, 2010, J POWER SOURCES, V195, P7904, DOI 10.1016/j.jpowsour.2010.06.060
   Persson K, 2010, J PHYS CHEM LETT, V1, P1176, DOI 10.1021/jz100188d
   Prosini PP, 2002, SOLID STATE IONICS, V148, P45, DOI 10.1016/S0167-2738(02)00134-0
   Rui XH, 2010, ELECTROCHIM ACTA, V55, P2384, DOI 10.1016/j.electacta.2009.11.096
   Sato H, 1996, J NUCL SCI TECHNOL, V33, P950, DOI 10.1080/18811248.1996.9732037
   Strauss F, 2018, J PHYS CHEM C, V122, P6508, DOI 10.1021/acs.jpcc.7b12296
   Taberna L, 2006, NAT MATER, V5, P567, DOI 10.1038/nmat1672
   Takahashi M, 2002, SOLID STATE IONICS, V148, P283, DOI 10.1016/S0167-2738(02)00064-4
   TAKAMI N, 1995, J ELECTROCHEM SOC, V142, P371, DOI 10.1149/1.2044017
   Tang K, 2011, ELECTROCHIM ACTA, V56, P4869, DOI 10.1016/j.electacta.2011.02.119
   Umegaki I, 2017, PHYS CHEM CHEM PHYS, V19, P19058, DOI 10.1039/c7cp02047c
   Verbrugge MW, 1996, J ELECTROCHEM SOC, V143, P600, DOI 10.1149/1.1836486
   Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/NCHEM.1802, 10.1038/nchem.1802]
   Wang JY, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.50
   Wang Q, 2001, J ELECTROCHEM SOC, V148, pA737, DOI 10.1149/1.1377897
   Wei Y, 2015, J AM CHEM SOC, V137, P8364, DOI 10.1021/jacs.5b04040
   WEINERT U, 1980, PHYS REV A, V21, P681, DOI 10.1103/PhysRevA.21.681
   WEN CJ, 1979, J ELECTROCHEM SOC, V126, P2258, DOI 10.1149/1.2128939
   WEPPNER W, 1977, J ELECTROCHEM SOC, V124, P1569, DOI 10.1149/1.2133112
   Wi S, 2017, NANO ENERGY, V39, P371, DOI 10.1016/j.nanoen.2017.07.016
   Winter M, 1998, ADV MATER, V10, P725, DOI 10.1002/(SICI)1521-4095(199807)10:10<725::AID-ADMA725>3.0.CO;2-Z
   Xiao L, 2013, J POWER SOURCES, V225, P286, DOI 10.1016/j.jpowsour.2012.10.070
   Xie J, 2008, SOLID STATE IONICS, V179, P362, DOI 10.1016/j.ssi.2008.02.051
   Xuan W. Y., 2004, WORLD SCI
   Ye SH, 2010, ELECTROCHIM ACTA, V55, P2972, DOI 10.1016/j.electacta.2010.01.018
   Yu P, 1999, J ELECTROCHEM SOC, V146, P8, DOI 10.1149/1.1391556
   Zhang Y., 2017, ANGEW CHEM, V129, P15043
   ZHENG T, 1995, PHYS REV B, V51, P734, DOI 10.1103/PhysRevB.51.734
NR 61
TC 3
Z9 3
U1 10
U2 81
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 80
EP 86
DI 10.1016/j.ces.2019.01.062
PG 7
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000008
DA 2020-05-12
ER

PT J
AU Fei, Y
   Pang, MJ
AF Fei, Yang
   Pang, Mingjun
TI A treatment for contaminated interfaces and its application to study the
   hydrodynamics of a spherical bubble contaminated by surfactants
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Contaminated interface; Spherical bubble; Marangoni effect; Interfacial
   characteristics; Wake flow
ID MASS-TRANSFER; STAGNANT CAP; SOLUBLE SURFACTANTS; WAKE STRUCTURE;
   MOTION; FLOW; REYNOLDS; DRAG; VISUALIZATION; TRACKING
AB A numerical model for the contaminated interface is discussed, and then it is applied to investigate detailedly the interfacial surfactant concentration, the interfacial properties and the wake flow of a contaminated spherical bubble. For the present model, the surfactant molecules adsorbed on the bubble surface are assumed to be distributed over the concentration boundary layer adjacent to the bubble. The thickness of concentration boundary layer is obtained through the revised value from a theoretical formula. Then, the interfacial surfactant concentration is evaluated by coupling the transport equations of interfacial and bulk surfactant concentrations with the Navier-Stokes equations. The connection between the tangential stress and the interfacial surfactant concentration is set through the Marangoni stress and the state equation. The current results show that the present numerical model is reliable. The convention from the main flow, the Marangoni effect and the wake vortex determine the distribution of interfacial surfactant concentration on the bubble surface. The gradient of interfacial surfactant concentration along the bubble surface further affects the interfacial properties which react on the surrounding flow as feedbacks. The gradient of interfacial surfactant concentration at the front edge of the "contaminated" interface (FECI) is closely related to the location of FECI to the strongest convection position in the bulk around the bubble. The peak point on the curves of tangential stress and interfacial vorticity corresponds to the inflection point on the curve of interfacial surfactant concentration. The vortex size is affected by the positive pressure gradient at the bubble rear in bulk and the abrupt change of interfacial vorticity at FECI. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fei, Yang; Pang, Mingjun] Changzhou Univ, Sch Mech Engn, Changzhou 213164, Peoples R China.
   [Fei, Yang; Pang, Mingjun] Changzhou Univ, Jiangsu Key Lab Green Proc Equipment, Changzhou 213164, Peoples R China.
RP Pang, MJ (reprint author), Changzhou Univ, Sch Mech Engn, Changzhou 213164, Peoples R China.; Pang, MJ (reprint author), Changzhou Univ, Jiangsu Key Lab Green Proc Equipment, Changzhou 213164, Peoples R China.
EM pangmj@cczu.edu.cn
OI Fei, Yang/0000-0001-9330-0296
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [51376026]; Qinglan Project of Jiangsu province
FX We gratefully acknowledge the financial support from the National Nature
   Science Foundation of China (No. 51376026) and Qinglan Project of
   Jiangsu province. We also wish to thank the reviewers and editors for
   valuable suggestions.
CR Aoyama S, 2016, INT J MULTIPHAS FLOW, V79, P23, DOI 10.1016/j.ijmultiphaseflow.2015.10.003
   Aoyama S, 2018, EXP THERM FLUID SCI, V96, P460, DOI 10.1016/j.expthermflusci.2018.03.015
   Barrett JW, 2015, J COMPUT PHYS, V297, P530, DOI 10.1016/j.jcp.2015.05.029
   Batchelor G. K., 2000, INTRO FLUID DYNAMICS
   Clift R., 2005, BUBBLES DROPS PARTIC
   Crowe C., 2012, MULTIPHASE FLOWS DRO
   Cuenot B, 1997, J FLUID MECH, V339, P25, DOI 10.1017/S0022112097005053
   Dieter-Kissling K, 2015, COMPUT FLUIDS, V113, P93, DOI 10.1016/j.compfluid.2015.01.017
   Dukhin SS, 2015, ADV COLLOID INTERFAC, V222, P260, DOI 10.1016/j.cis.2014.10.002
   Fdhila RB, 1996, PHYS FLUIDS, V8, P310, DOI 10.1063/1.868787
   Fei Y, 2018, INT J HEAT MASS TRAN, V121, P79, DOI 10.1016/j.ijheatmasstransfer.2017.12.154
   FUKUTA M, 2005, THEOR APPL MECH JPN, V54, P227
   Fukuta M, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2911040
   HARPER JF, 1992, J FLUID MECH, V237, P23, DOI 10.1017/S0022112092003331
   Hayashi K, 2018, INT J MULTIPHAS FLOW, V99, P86, DOI 10.1016/j.ijmultiphaseflow.2017.10.003
   Hayashi K, 2012, INT J MULTIPHAS FLOW, V39, P78, DOI 10.1016/j.ijmultiphaseflow.2011.11.001
   Hosokawa S, 2018, EXP THERM FLUID SCI, V96, P397, DOI 10.1016/j.expthermflusci.2018.03.026
   Hosokawa S, 2017, INT J MULTIPHAS FLOW, V97, P157, DOI 10.1016/j.ijmultiphaseflow.2017.08.007
   Huang J, 2017, CHEM ENG SCI, V170, P105, DOI 10.1016/j.ces.2017.03.030
   Huang J, 2017, CHEM ENG SCI, V157, P182, DOI 10.1016/j.ces.2016.05.013
   Jia HW, 2017, INT J HEAT MASS TRAN, V110, P43, DOI 10.1016/j.ijheatmasstransfer.2017.02.095
   Kishore N, 2013, IND ENG CHEM RES, V52, P6049, DOI 10.1021/ie4003188
   LEVICH VG, 1962, PHYSICOCHEMICAL HYDR
   MAGNAUDET J, 1995, J FLUID MECH, V284, P97, DOI 10.1017/S0022112095000280
   Malysa K, 2005, ADV COLLOID INTERFAC, V114, P205, DOI 10.1016/j.cis.2004.08.004
   Muradoglu M, 2008, J COMPUT PHYS, V227, P2238, DOI 10.1016/j.jcp.2007.10.003
   Muradoglu M, 2014, J COMPUT PHYS, V274, P737, DOI 10.1016/j.jcp.2014.06.024
   Nalajala VS, 2015, INT J MINER PROCESS, V140, P8, DOI 10.1016/j.minpro.2015.04.022
   Nalajala VS, 2014, COLLOID SURFACE A, V443, P240, DOI 10.1016/j.colsurfa.2013.11.014
   Palaparthi R, 2006, J FLUID MECH, V559, P1, DOI 10.1017/S0022112005007019
   Probstein R. F., 1994, PHYSICOCHEMICAL HYDR
   Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920
   Saboni A, 2011, AICHE J, V57, P1684, DOI 10.1002/aic.12391
   SADHAL SS, 1983, J FLUID MECH, V126, P237, DOI 10.1017/S0022112083000130
   Sanada T, 2007, CHEM ENG SCI, V62, P7264, DOI 10.1016/j.ces.2007.08.037
   Shin S, 2018, J COMPUT PHYS, V359, P409, DOI 10.1016/j.jcp.2018.01.010
   Stohr M, 2009, EXP FLUIDS, V47, P135, DOI 10.1007/s00348-009-0633-6
   Takagi S, 2011, ANNU REV FLUID MECH, V43, P615, DOI 10.1146/annurev-fluid-122109-160756
   Tasoglu S, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2912441
   Yan XK, 2017, CHEM ENG J, V316, P553, DOI 10.1016/j.cej.2017.01.137
   Zhang L, 2012, ADV MECH ENG, DOI 10.1155/2012/785798
NR 41
TC 0
Z9 0
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 87
EP 102
DI 10.1016/j.ces.2019.01.052
PG 16
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000009
DA 2020-05-12
ER

PT J
AU Li, MZ
   Jiao, LK
   Nawaz, MA
   Cheng, LK
   Meng, C
   Yang, TH
   Tariq, M
   Liu, DH
AF Li, Minzhe
   Jiao, Lengkang
   Nawaz, Muhammad Asif
   Cheng, Like
   Meng, Chen
   Yang, Tianhui
   Tariq, Muhammad
   Liu, Dianhua
TI A one-step synthesis method of durene directly from syngas using
   integrated catalyst of Cu/ZnO/Al2O3 and Co-Nb/HZSM-5
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Review
DE Syngas; Aromatics; Methanol synthesis catalyst; HZSM-5; Niobium; Durene
ID GASOLINE-RANGE HYDROCARBONS; FISCHER-TROPSCH SYNTHESIS; SYNTHESIS GAS;
   DIRECT CONVERSION; PARTIAL OXIDATION; BIFUNCTIONAL CATALYSTS; ZEOLITE
   CATALYSTS; CUZNAL CATALYSTS; CARBON-MONOXIDE; LIQUID FUEL
AB In recent years, the demand for durene has been increased as the raw material of polyimide. However, traditional synthesis methods of durene require a large number of steps with lower efficiency. In this study, a novel synthesis method of a bifunctional integrated catalyst had been utilized, in which the methanol synthesis catalyst Cu/ZnO/Al2O3 (CZA) and the aromatization catalyst Co-Nb/HZSM-5 were combined, to synthesize durene from syngas in one step. Syngas was converted to methanol and dimethyl ether (DME) followed by the production of different aromatics with a high concentration of durene through the shape selectivity of zeolite. The optimal reaction conditions of 330 degrees C, 4 MPa, 200 h(-1), 3% Co loading, CZA/HZSM-5 = 3:2 and a unique pseudo-physical coating (PC) integrated method were applied to increase durene selectivity up to 39.71% in aromatics. Different techniques such as XRD, BET, XPS and NH3-TPD were employed to characterize different catalysts, and a variety of experiments were proceeded to compare different routes of methanol and FT synthesis. These results explain that the high selectivity of tetra-methylbenzene (tetra-MB) was due to the alkylation of trimethylbenzene (tri-MB) induced by methanol on HZSM-5 surface. This work demonstrated that the integrated catalyst could be advantageous for direct conversion of syngas to tri-MB and finally to the desired durene and it would open up the new avenues in future perspectives. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Minzhe; Jiao, Lengkang; Nawaz, Muhammad Asif; Cheng, Like; Meng, Chen; Yang, Tianhui; Tariq, Muhammad; Liu, Dianhua] East China Univ Sci & Technol, State Key Lab Chem Engn, Shanghai 200237, Peoples R China.
RP Liu, DH (reprint author), East China Univ Sci & Technol, State Key Lab Chem Engn, Shanghai 200237, Peoples R China.
EM dhliu@ecust.edu.cn
OI Nawaz, Muhammad Asif/0000-0003-3234-031X; Tariq,
   Muhammad/0000-0003-3999-9758
FU National Key R&D Program of China [2017YFB0602204]
FX This work was supported by the National Key R&D Program of China
   (2017YFB0602204).
CR Baltes C, 2008, J CATAL, V258, P334, DOI 10.1016/j.jcat.2008.07.004
   Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.1219831, 10.1126/science.12198331]
   Beiramar JM, 2014, CHEMCATCHEM, V6, P1788, DOI 10.1002/cctc.201402037
   Botes FG, 2005, APPL CATAL A-GEN, V284, P21, DOI 10.1016/j.apcata.2005.01.012
   CHANG CD, 1979, J CATAL, V56, P268, DOI 10.1016/0021-9517(79)90113-1
   Chen LF, 2008, J CATAL, V257, P172, DOI 10.1016/j.jcat.2008.04.021
   Cheng K, 2017, CHEM-US, V3, P334, DOI 10.1016/j.chempr.2017.05.007
   Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288
   Dagle RA, 2014, FUEL PROCESS TECHNOL, V123, P65, DOI 10.1016/j.fuproc.2014.01.041
   Dagle VML, 2014, IND ENG CHEM RES, V53, P13928, DOI 10.1021/ie502425d
   Daramola MO, 2017, J ENVIRON CHEM ENG, V5, P54, DOI 10.1016/j.jece.2016.11.019
   Erena J, 2005, CATAL TODAY, V107-08, P467, DOI 10.1016/j.cattod.2005.07.116
   Erena J, 1998, IND ENG CHEM RES, V37, P1211, DOI 10.1021/ie970568p
   Gervasini A, 2006, J PHYS CHEM B, V110, P7851, DOI 10.1021/jp056604c
   GORMLEY RJ, 1988, J CATAL, V113, P193, DOI 10.1016/0021-9517(88)90248-5
   Guan N, 1996, CATAL TODAY, V30, P207, DOI 10.1016/0920-5861(96)00014-4
   Han JR, 2018, NANO ENERGY, V52, P264, DOI 10.1016/j.nanoen.2018.07.045
   Horn R, 2007, J CATAL, V249, P380, DOI 10.1016/j.jcat.2007.05.011
   ISHIHARA T, 1989, CHEM LETT, P1699, DOI 10.1246/cl.1989.1699
   Jia YM, 2017, J ENERGY CHEM, V26, P540, DOI 10.1016/j.jechem.2016.10.014
   Li CL, 2017, NANO ENERGY, V40, P195, DOI 10.1016/j.nanoen.2017.08.013
   Li SZ, 2015, IND ENG CHEM RES, V54, P11929, DOI 10.1021/acs.iecr.5b03311
   Li XH, 2004, CATAL TODAY, V89, P439, DOI 10.1016/j.cattod.2004.03.054
   Liu DH, 2011, FUEL, V90, P1738, DOI 10.1016/j.fuel.2011.01.038
   Liu YJ, 2015, APPL SURF SCI, V356, P124, DOI 10.1016/j.apsusc.2015.08.039
   Martinez A, 2005, APPL CATAL A-GEN, V294, P251, DOI 10.1016/j.apcata.2005.07.038
   Martinez A, 2007, J CATAL, V249, P162, DOI 10.1016/j.jcat.2007.04.012
   Mohanty P, 2011, FUEL PROCESS TECHNOL, V92, P600, DOI 10.1016/j.fuproc.2010.11.017
   Nimz M, 1988, CATAL LETT, V1, P93, DOI 10.1007/BF00772771
   Pabst K, 2013, IND ENG CHEM RES, V52, P8988, DOI 10.1021/ie3030483
   Perez-Ramirez J, 2009, ADV FUNCT MATER, V19, P3972, DOI 10.1002/adfm.200901394
   Phienluphon R, 2015, CHEM ENG J, V270, P605, DOI 10.1016/j.cej.2015.02.071
   Rapagna S, 1998, INT J HYDROGEN ENERG, V23, P551, DOI 10.1016/S0360-3199(97)00108-0
   Rocha AS, 2012, CATAL TODAY, V192, P104, DOI 10.1016/j.cattod.2012.02.062
   Sartipi S, 2013, APPL CATAL A-GEN, V456, P11, DOI 10.1016/j.apcata.2013.02.012
   Sartipi S, 2013, CATAL SCI TECHNOL, V3, P572, DOI 10.1039/c2cy20744c
   SIMARD F, 1995, APPL CATAL A-GEN, V125, P81, DOI 10.1016/0926-860X(94)00275-4
   Tang C, 2016, J MATER CHEM A, V4, P12407, DOI 10.1039/c6ta05604k
   VARMA RL, 1985, CAN J CHEM ENG, V63, P72, DOI 10.1002/cjce.5450630112
   VARMA RL, 1986, CAN J CHEM ENG, V64, P141, DOI 10.1002/cjce.5450640120
   Wang DS, 2002, CHINESE J CATAL+, V23, P333
   Wang HY, 1999, J CATAL, V186, P181, DOI 10.1006/jcat.1999.2535
   Xiong XL, 2017, ELECTROCHIM ACTA, V253, P517, DOI 10.1016/j.electacta.2017.09.104
   Xu YF, 2018, MOL CATAL, V454, P104, DOI 10.1016/j.mcat.2018.05.019
   Xu YB, 2018, APPL CATAL A-GEN, V552, P168, DOI 10.1016/j.apcata.2018.01.012
   Yan QG, 2004, J CATAL, V226, P247, DOI 10.1016/j.jcat.2004.05.028
   Yan QG, 2008, J PHYS CHEM C, V112, P11847, DOI 10.1021/jp801640c
   Yan QG, 2014, ENERG FUEL, V28, P2027, DOI 10.1021/ef402507u
   Yu J, 2013, SENSOR ACTUAT B-CHEM, V184, P118, DOI 10.1016/j.snb.2013.03.135
   Zang ZG, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5017002
   Zang ZG, 2016, OPT LETT, V41, P3463, DOI 10.1364/OL.41.003463
   Zhang QD, 2013, J IND ENG CHEM, V19, P975, DOI 10.1016/j.jiec.2012.11.019
   Zhao B, 2017, CHEM-US, V3, P323, DOI 10.1016/j.chempr.2017.06.017
   Zhu ZZ, 2013, ACS CATAL, V3, P1154, DOI 10.1021/cs400068v
NR 54
TC 1
Z9 1
U1 25
U2 145
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 103
EP 112
DI 10.1016/j.ces.2019.02.006
PG 10
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000010
DA 2020-05-12
ER

PT J
AU Lacatusu, I
   Badea, N
   Badea, G
   Mihaila, M
   Ott, C
   Stan, R
   Meghea, A
AF Lacatusu, I
   Badea, N.
   Badea, G.
   Mihaila, M.
   Ott, C.
   Stan, R.
   Meghea, A.
TI Advanced bioactive lipid nanocarriers loaded with natural and synthetic
   anti-inflammatory actives
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Phytochemicals; Skin inflammation; Lipid nanocarriers; Indomethacin;
   Willow bark extract
ID RASPBERRY SEED OIL; EXTRACT STW 33-I; RICE BRAN OIL; DRUG-DELIVERY;
   IN-VIVO; LINOLEIC-ACID; CARRIERS; NANOPARTICLES; STABILITY; DESIGN
AB Current research is focused toward the development of a new approach based on efficient bioactive lipid nanocarriers (BLN) in order to obtain enhanced benefit to risk ratios of natural and synthetic actives. For this purpose, the bioactivities of several BLN (prepared with raspberry oil, Rso, and rice bran oil, Rbo) containing a natural extract (willow bark extract, Wbe) or a blend of Wbe and the synthetic anti-inflammatory drug indomethacin (Ind) have been comparatively analysed. BLN exhibited homogeneity regarding the particle size (diameters less than 140 nm), excellent physical stability (negative surface charge of -40 and -48 mV) and high encapsulation efficiency (89 to 91% for salicin from Wbe and 65 to 72.5% for Ind). The association of Wbe together with Ind co-loaded BLN resulted in a noticeable amplification of the antioxidant activity (the scavenging of free oxygen radicals exceeds 90%), a protective effect on L929 cells (low apoptosis values of 11.6 and 15.9%) and a significant ability to reduce the TNF-alpha and IL-6 inflammatory marker levels. The in vitro release, achieved on BLN-Wbe-Ind based-hydrogels, has revealed a gradual release of both kinds of actives. BLN may represent a valuable strategy for overcoming the side effects of synthetic drugs while treating inflammation-related skin disorders. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Lacatusu, I; Badea, N.; Badea, G.; Ott, C.; Stan, R.; Meghea, A.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1, Bucharest 011061, Romania.
   [Mihaila, M.] Romanian Acad, Virol Inst Stefan S Nicolau, Mihai Bravu St 285, Bucharest 030304, Romania.
RP Badea, N (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Polizu 1, Bucharest 011061, Romania.
EM nicoleta.badea@gmail.com
RI Mihaila, Mirela/AAE-1845-2019; Stan, Raluca/L-7419-2014
OI Stan, Raluca/0000-0002-4490-5173; Nicoleta, Badea/0000-0002-9450-8387
FU Ministry National Education, CNCS-UEFISCDI
   [PCE_PN-II-ID-PCE-2012-4-0111]
FX The work was supported by a grand of the Ministry National Education,
   CNCS-UEFISCDI, project number PCE_PN-II-ID-PCE-2012-4-0111.
CR Alvarez-Suarez JM, 2017, FOOD CHEM TOXICOL, V102, P46, DOI 10.1016/j.fct.2017.01.024
   Angelova A, 2017, ADV COLLOID INTERFAC, V249, P331, DOI 10.1016/j.cis.2017.04.006
   Aqil F, 2013, CANCER LETT, V334, P133, DOI 10.1016/j.canlet.2013.02.032
   Arora R, 2017, EXPERT OPIN DRUG DEL, V14, P165, DOI 10.1080/17425247.2017.1264386
   Badea G, 2015, IND CROP PROD, V67, P18, DOI 10.1016/j.indcrop.2014.12.049
   Beloqui A, 2016, COLLOID SURFACE B, V143, P327, DOI 10.1016/j.colsurfb.2016.03.038
   Bhise K, 2017, INT J PHARMACEUT, V526, P506, DOI 10.1016/j.ijpharm.2017.04.078
   Bonaterra GA, 2010, PHYTOMEDICINE, V17, P1106, DOI 10.1016/j.phymed.2010.03.022
   Carrillo-Conde BR, 2015, CHEM ENG SCI, V125, P98, DOI 10.1016/j.ces.2014.08.015
   Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408
   Chen P, 2016, COLLOID SURFACE A, V506, P356, DOI 10.1016/j.colsurfa.2016.06.054
   Chen SY, 2013, DRUG DEV IND PHARM, V39, P20, DOI 10.3109/03639045.2011.650648
   Falcao D. Q., 2018, CURRENT CHALLENGES L, P139
   Ferreira M, 2017, COLLOID SURFACE B, V159, P23, DOI 10.1016/j.colsurfb.2017.07.080
   Forbes-Hernandez TY, 2014, FOOD CHEM TOXICOL, V68, P154, DOI 10.1016/j.fct.2014.03.017
   Freitas C, 1998, INT J PHARM, V168, P221, DOI 10.1016/S0378-5173(98)00092-1
   Gasparrini M, 2017, FOOD CHEM TOXICOL, V102, P1, DOI 10.1016/j.fct.2017.01.018
   Ghitman J, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10060579
   Godugu C, 2016, EUR J PHARM BIOPHARM, V108, P168, DOI 10.1016/j.ejpb.2016.08.006
   Gratieri T, 2013, EUR J PHARM SCI, V50, P609, DOI 10.1016/j.ejps.2013.03.019
   Han F, 2012, INT J PHARMACEUT, V439, P349, DOI 10.1016/j.ijpharm.2012.08.040
   Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008
   Hori T, 2006, J BIOCHEM, V140, P457, DOI 10.1093/jb/mvj176
   Islam MS, 2014, WHEAT AND RICE IN DISEASE PREVENTION AND HEALTH: BENEFITS, RISKS AND MECHANISMS OF WHOLE GRAINS IN HEALTH PROMOTION, P443, DOI 10.1016/B978-0-12-401716-0.00034-9
   Istrati D, 2016, MAT SCI ENG C-MATER, V64, P249, DOI 10.1016/j.msec.2016.03.087
   Jain AK, 2014, COLLOID SURFACE B, V121, P222, DOI 10.1016/j.colsurfb.2014.05.041
   Khurana S, 2015, DRUG DEV IND PHARM, V41, P1368, DOI 10.3109/03639045.2014.950586
   Khurana S, 2013, LIFE SCI, V93, P763, DOI 10.1016/j.lfs.2013.09.027
   Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174
   Krasodomska O, 2015, COLLOID SURFACE A, V481, P468, DOI 10.1016/j.colsurfa.2015.06.022
   Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002
   Lacatusu I, 2017, IND CROP PROD, V109, P141, DOI 10.1016/j.indcrop.2017.08.030
   Lacatusu I, 2016, RSC ADV, V6, P77243, DOI 10.1039/c6ra12016d
   Lee HJ, 2015, J FOOD BIOCHEM, V39, P612, DOI 10.1111/jfbc.12169
   Lee SG, 2014, J NUTR BIOCHEM, V25, P404, DOI 10.1016/j.jnutbio.2013.12.001
   Letawe C, 1998, CLIN EXP DERMATOL, V23, P56
   Liu CJ, 2013, INT IMMUNOPHARMACOL, V16, P165, DOI 10.1016/j.intimp.2013.03.032
   Luan JJ, 2015, COLLOID SURFACE A, V466, P154, DOI 10.1016/j.colsurfa.2014.11.015
   Luan JJ, 2013, DRUG DELIV, V20, P324, DOI 10.3109/10717544.2013.835007
   Marques A. C., 2017, DEV CHARACTERIZATION, DOI [10.1016/j.ijpharm.2017.04.025, DOI 10.1016/J.IJPHARM.2017.04.025]
   Mitri K, 2011, INT J PHARMACEUT, V414, P267, DOI 10.1016/j.ijpharm.2011.05.008
   Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116
   Niculae G, 2014, CENT EUR J CHEM, V12, P837, DOI 10.2478/s11532-014-0503-9
   Niculae G, 2014, PHOTOCH PHOTOBIO SCI, V13, P703, DOI 10.1039/c3pp50290b
   Noratto GD, 2017, FOOD CHEM, V227, P305, DOI 10.1016/j.foodchem.2017.01.097
   Ott C, 2015, IND CROP PROD, V77, P342, DOI 10.1016/j.indcrop.2015.08.057
   Pradhan M, 2015, STEROIDS, V101, P56, DOI 10.1016/j.steroids.2015.05.012
   Radhakrishnan R, 2016, CHEM PHYS LIPIDS, V198, P51, DOI 10.1016/j.chemphyslip.2016.05.006
   Rao YPC, 2016, BIOCHEM BIOPH RES CO, V479, P747, DOI 10.1016/j.bbrc.2016.09.140
   Rigo LA, 2015, EUR J PHARM BIOPHARM, V93, P11, DOI 10.1016/j.ejpb.2015.03.020
   Rigo LA, 2014, WHEAT AND RICE IN DISEASE PREVENTION AND HEALTH: BENEFITS, RISKS AND MECHANISMS OF WHOLE GRAINS IN HEALTH PROMOTION, P311, DOI 10.1016/B978-0-12-401716-0.00023-4
   Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X
   Shigeta Y, 2004, BIOL PHARM BULL, V27, P591, DOI 10.1248/bpb.27.591
   Singh R, 2017, NANOTECH AGRIFOOD, V5, P413, DOI 10.1016/B978-0-12-804304-2.00011-1
   Uehleke B, 2013, PHYTOMEDICINE, V20, P980, DOI 10.1016/j.phymed.2013.03.023
   Wang S, 2014, J NUTR BIOCHEM, V25, P363, DOI 10.1016/j.jnutbio.2013.10.002
   Zhai YJ, 2014, J CONTROL RELEASE, V193, P90, DOI 10.1016/j.jconrel.2014.05.054
   Zong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044107
NR 58
TC 1
Z9 1
U1 9
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 113
EP 126
DI 10.1016/j.ces.2019.01.044
PG 14
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000011
DA 2020-05-12
ER

PT J
AU Li, C
   Guo, YT
   Shen, LM
   Ji, C
   Bao, NZ
AF Li, Chang
   Guo, Yantao
   Shen, Liming
   Ji, Cheng
   Bao, Ningzhong
TI Scalable concentration process of graphene oxide dispersions via
   cross-flow membrane filtration
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Graphene oxide; High concentration; Cross-flow filtration; Fouling
   mechanism; Liquid crystal
ID LIQUID-CRYSTALS; ULTRAFILTRATION; FIBERS; WATER; MICROFILTRATION;
   SUSPENSIONS; ROUTE; MODEL; SIZE
AB Fundamental research on developing a facile, industrially viable approach for producing concentrated single-layered graphene oxide (GO) aqueous dispersions is crucial for applications in related industrial fields. In this innovative work, cross-flow membrane filtration is reported for the first time for preparing stable GO dispersions with concentrations controlled from 1 to 16 g.L-1. The flux behavior with different process conditions (membrane pore diameter, transmembrane pressure, and tangential velocity), the relevant hydraulic resistances, and fouling mechanism have been systematically studied for optimization of the process parameters. The physicochemical properties of GO products are characterized by various methods, and the results show that all the concentrated dispersions possess good fluidity, with hydrolysis of functional groups resulting in a pH decline, and no re-stacking or agglomeration of the GO sheets occurring during the concentration process. The concentrated GO dispersions, presenting distinctive liquid crystal phases, offer tremendous potential in the fabrication of highly ordered macroscopic structures as well as the development of novel graphene-based devices. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Chang; Guo, Yantao; Shen, Liming; Bao, Ningzhong] Nanjing Tech Univ, State Key Lab Mat Oriented Chem Engn, Coll Chem Engn, Nanjing 210009, Jiangsu, Peoples R China.
   [Ji, Cheng; Bao, Ningzhong] Jiangsu Ind Technol Res Inst, Inst Graphene, Nanjing 210009, Jiangsu, Peoples R China.
   [Ji, Cheng; Bao, Ningzhong] Jiangnan Graphene Res Inst, Changzhou 213149, Jiangsu, Peoples R China.
RP Shen, LM; Bao, NZ (reprint author), Nanjing Tech Univ, State Key Lab Mat Oriented Chem Engn, Coll Chem Engn, Nanjing 210009, Jiangsu, Peoples R China.
EM lshen@njtech.edu.cn; nzhbao@njtech.edu.cn
RI Li, Chang/A-8690-2019
OI Li, Chang/0000-0003-1341-2672
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [51425202, 51772150]; Natural Science Foundation of Jiangsu
   ProvinceJiangsu Planned Projects for Postdoctoral Research FundsNatural
   Science Foundation of Jiangsu Province [BK20160093]; Key Research and
   Development Program of Jiangsu Province [BE2016006-1]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD)
FX This research was supported by the Natural Science Foundation of China
   (No. 51425202, No. 51772150), the Natural Science Foundation of Jiangsu
   Province (No. BK20160093), the Key Research and Development Program of
   Jiangsu Province (No. BE2016006-1), and the Project Funded by the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD). The authors thank Dr. Arunava Gupta for his
   professional revision of the English language in the manuscript. The
   authors are grateful to reviewers for their helpful suggestions and
   comments.
CR Ahmad AL, 2006, CHEM ENG SCI, V61, P5057, DOI 10.1016/j.ces.2006.03.017
   Akbari A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10891
   Behabtu N, 2010, NAT NANOTECHNOL, V5, P406, DOI [10.1038/NNANO.2010.86, 10.1038/nnano.2010.86]
   BELFORT G, 1993, J MEMBRANE SCI, V77, P1, DOI 10.1016/0376-7388(93)85231-K
   BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7
   Bowen WR, 2001, CHEM ENG SCI, V56, P3083
   Chakrabarty B, 2010, CHEM ENG J, V165, P447, DOI 10.1016/j.cej.2010.09.031
   Chen J, 2015, ADV MATER, V27, P3654, DOI 10.1002/adma.201501271
   Cruz-Silva R, 2014, ACS NANO, V8, P5959, DOI 10.1021/nn501098d
   Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016
   Dimiev AM, 2013, ACS NANO, V7, P576, DOI 10.1021/nn3047378
   Dizge N, 2011, J MEMBRANE SCI, V366, P278, DOI 10.1016/j.memsci.2010.10.010
   Eigler S, 2014, ANGEW CHEM INT EDIT, V53, P7720, DOI 10.1002/anie.201402780
   Eigler S, 2013, ADV MATER, V25, P3583, DOI 10.1002/adma.201300155
   Fan ZJ, 2011, ACS NANO, V5, P191, DOI 10.1021/nn102339t
   Farizoglu B, 2006, J MEMBRANE SCI, V279, P578, DOI 10.1016/j.memsci.2005.12.050
   Furukawa T, 2008, J MEMBRANE SCI, V322, P491, DOI 10.1016/j.memsci.2008.05.068
   Hanspal NS, 2009, CHEM ENG J, V149, P132, DOI 10.1016/j.cej.2008.10.012
   Hao Y, 2012, IND ENG CHEM RES, V51, P14850, DOI 10.1021/ie302111w
   He DF, 2014, AICHE J, V60, P2757, DOI 10.1002/aic.14499
   Huang HB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3979
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Hwang KJ, 2011, CHEM ENG J, V166, P669, DOI 10.1016/j.cej.2010.11.044
   Jalili R, 2013, ACS NANO, V7, P3981, DOI 10.1021/nn305906z
   Juang RS, 2008, J MEMBRANE SCI, V323, P193, DOI 10.1016/j.memsci.2008.06.032
   Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p
   Kim JE, 2011, ANGEW CHEM INT EDIT, V50, P3043, DOI 10.1002/anie.201004692
   Li C, 2018, CHEM ENG SCI, V176, P319, DOI 10.1016/j.ces.2017.10.028
   Liu SY, 2003, CHEM MATER, V15, P3240, DOI 10.1021/cm034201o
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Luo JY, 2011, ACS NANO, V5, P8943, DOI 10.1021/nn203115u
   Macedo A, 2011, J MEMBRANE SCI, V381, P34, DOI 10.1016/j.memsci.2011.07.012
   Mondal S, 2014, AICHE J, V60, P4279, DOI 10.1002/aic.14594
   Mueller S, 2010, P ROY SOC A-MATH PHY, V466, P1201, DOI 10.1098/rspa.2009.0445
   Narayan R, 2016, ADV MATER, V28, P3045, DOI [10.1002/adma.201505122, 10.1002/adma.201670110]
   ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x
   OUSMAN M, 1995, J MEMBRANE SCI, V105, P1, DOI 10.1016/0376-7388(94)00266-2
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   PIRON E, 1995, J MEMBRANE SCI, V108, P57, DOI 10.1016/0376-7388(95)00141-4
   Song WH, 2003, SCIENCE, V302, P1363, DOI 10.1126/science.1089764
   Wang K, 2018, IND ENG CHEM RES, V57, P3773, DOI 10.1021/acs.iecr.7b04850
   Xiang CS, 2013, ADV MATER, V25, P4592, DOI 10.1002/adma.201301065
   Xin GQ, 2015, SCIENCE, V349, P1083, DOI 10.1126/science.aaa6502
   Xu Z, 2016, ADV MATER, V28, P6449, DOI 10.1002/adma.201506426
   Xu Z, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1583
   Xu Z, 2011, ACS NANO, V5, P2908, DOI 10.1021/nn200069w
   Yao BW, 2016, ADV MATER, V28, P1623, DOI 10.1002/adma.201504594
   Zhang F, 2009, IND ENG CHEM RES, V48, P10637, DOI 10.1021/ie900512g
NR 48
TC 4
Z9 4
U1 8
U2 66
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 127
EP 137
DI 10.1016/j.ces.2019.01.045
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000012
DA 2020-05-12
ER

PT J
AU Coenen, K
   Gallucci, F
   Mezari, B
   Verhoeven, T
   Hensen, E
   Annaland, MV
AF Coenen, Kai
   Gallucci, Fausto
   Mezari, Brahim
   Verhoeven, Tiny
   Hensen, Emiel
   Annaland, Martin van Sint
TI Investigating the role of the different metals in hydrotalcite
   Mg/Al-based adsorbents and their interaction with acidic sorbate species
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hydrotalcite; Semi in-situ characterization; NMR; CO2 and H2S adsorption
ID HIGH-TEMPERATURE H2S; CO2 CAPTURE; THERMODYNAMIC ANALYSIS;
   HYDROGEN-PRODUCTION; SORPTION; ADSORPTION; OXIDES; CAPACITY; SORBENTS;
   KINETICS
AB The role of aluminum in the structure of hydrotalcite-based sorbents was investigated with Al-27-NMR and XPS with respect to the chemisorption mechanism of different sorbate species, such as CO2, H2O and H2S, at elevated temperatures. Sorbent materials with different ratios of Al/Mg were studied in order to elucidate the influence of the material composition on the Al coordination. Two different tetrahedrally and octahedrally coordinated Al species were detected. It was found that their quantitative appearance depends on the ratio of Al/Mg within the sorbent material. A higher Mg content leads to a higher distortion and to the formation of more tetrahedrally coordinated Al with a high chemical shift. Whereas CO2 and H2O adsorption does not seem to influence well-coordinated Al, as observed with NMR, chemisorption of H2S showed a clear interaction with Al leading to the formation of an additional tetrahedrally coordinated site with a high chemical shift. XPS showed that a reversible metal sulfate complex was formed on the sorbent, which was reversible upon exposure to H2O. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Coenen, Kai; Gallucci, Fausto; Mezari, Brahim; Verhoeven, Tiny; Hensen, Emiel; Annaland, Martin van Sint] Eindhoven Univ Technol, Dept Chem Engn & Chem, POB 513, Eindhoven, Netherlands.
RP Gallucci, F (reprint author), Eindhoven Univ Technol, Dept Chem Engn & Chem, POB 513, Eindhoven, Netherlands.
EM F.Gallucci@tue.nl
RI Hensen, Emiel/B-4973-2013; Gallucci, Fausto/E-7375-2013
OI Hensen, Emiel/0000-0002-9754-2417; Gallucci, Fausto/0000-0001-6379-773X
FU ADEM innovation lab program [TUE-P05]
FX The research leading to these results has received support through the
   ADEM innovation lab program TUE-P05.
CR Cairon O, 2007, J PHYS CHEM C, V111, P8015, DOI 10.1021/jp0673011
   Cobden PD, 2007, INT J GREENH GAS CON, V1, P170, DOI 10.1016/S1750-5836(07)00021-7
   Coenen K, 2018, INT J HYDROGEN ENERG, V43, P20758, DOI 10.1016/j.ijhydene.2018.09.146
   Coenen K, 2018, J CO2 UTIL, V25, P180, DOI 10.1016/j.jcou.2018.04.002
   Coenen K, 2018, J CO2 UTIL, V24, P228, DOI 10.1016/j.jcou.2018.01.008
   Coenen K, 2018, CHEM ENG J, V334, P2115, DOI 10.1016/j.cej.2017.11.161
   Coenen K, 2017, CHEM ENG J, V314, P554, DOI 10.1016/j.cej.2016.12.013
   Coenen K, 2016, CHEM ENG J, V293, P9, DOI 10.1016/j.cej.2016.02.050
   CORMA A, 1994, J CATAL, V148, P205, DOI 10.1006/jcat.1994.1202
   DATTA A, 1985, J PHYS CHEM-US, V89, P454, DOI 10.1021/j100249a016
   Di Cosimo JI, 1998, J CATAL, V178, P499, DOI 10.1006/jcat.1998.2161
   Dragicevic D., 2013, ADSORBENTS SORPTION
   Ebner AD, 2006, IND ENG CHEM RES, V45, P6387, DOI 10.1021/ie060389k
   Gallucci K, 2015, INT J CHEM REACT ENG, V13, P335, DOI 10.1515/ijcre-2014-0167
   Jang HM, 2012, CHEM ENG SCI, V73, P431, DOI 10.1016/j.ces.2012.02.015
   Kim S, 2016, ACS APPL MATER INTER, V8, P5763, DOI 10.1021/acsami.5b12598
   Lu H, 2013, INT J HYDROGEN ENERG, V38, P6663, DOI 10.1016/j.ijhydene.2013.03.067
   Marono M, 2013, INT J GREENH GAS CON, V14, P183, DOI 10.1016/j.ijggc.2013.01.024
   Prescott HA, 2005, J CATAL, V234, P119, DOI 10.1016/j.jcat.2005.06.004
   Reijers HTJ, 2009, IND ENG CHEM RES, V48, P6966, DOI 10.1021/ie801319q
   Reshetenko TV, 2002, INT J HYDROGEN ENERG, V27, P387, DOI 10.1016/S0360-3199(01)00143-4
   Sahoo P, 2014, ACS APPL MATER INTER, V6, P18352, DOI 10.1021/am5060405
   Shen JY, 1998, J SOLID STATE CHEM, V137, P295, DOI 10.1006/jssc.1997.7739
   Shylesh S, 2016, IND ENG CHEM RES, V55, P10635, DOI 10.1021/acs.iecr.6b03601
   Sideris PJ, 2008, SCIENCE, V321, P113, DOI 10.1126/science.1157581
   Torres-Rodriguez DA, 2011, J PHYS CHEM A, V115, P12243, DOI 10.1021/jp207836m
   VanSelow E. R., 2009, CARBON CAPTURE SORPT, P4184
   WAKKER JP, 1993, IND ENG CHEM RES, V32, P139, DOI 10.1021/ie00013a019
   Wang Q, 2012, APPL CLAY SCI, V55, P18, DOI 10.1016/j.clay.2011.07.024
   Wu YJ, 2013, CHEM ENG TECHNOL, V36, P567, DOI 10.1002/ceat.201200694
   [Yu Guiyun 郁桂云], 2015, [波谱学杂志, Chinese Journal of Magnetic Resonance], V32, P228
NR 31
TC 3
Z9 3
U1 6
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 138
EP 146
DI 10.1016/j.ces.2019.01.046
PG 9
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000013
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Boyce, CM
   Penn, A
   Lehnert, M
   Pruessmann, KP
   Muller, CR
AF Boyce, C. M.
   Penn, A.
   Lehnert, M.
   Pruessmann, K. P.
   Mueller, C. R.
TI Magnetic resonance imaging of single bubbles injected into incipiently
   fluidized beds
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fluidization; Bubble injection; Magnetic resonance imaging; Tomographic
   imaging
ID ORIFICE
AB Rapid magnetic resonance imaging is used to investigate the volume, shape and rise velocity of single isolated bubbles injected into incipiently fluidized beds as well as the particle velocity field surrounding these bubbles. The volume of gas injected and particle size are varied to investigate their effects on bubble behavior. Image processing is used to quantify data into plots which can be compared directly with predictions from analytical and numerical models. Results show that more injected gas leaks into the interstitial flow in beds of large particles than beds of small particles because of the higher permeability to gas flow. Bubbles develop from a taller shape with a large wake angle into a wider shape with a smaller wake angle as they develop from a spherical shape to a spherical cap shape as they rise. Bubble rise velocities for fully formed bubbles are consistent with correlations in the literature. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Boyce, C. M.; Penn, A.; Lehnert, M.; Mueller, C. R.] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Zurich, Switzerland.
   [Boyce, C. M.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   [Penn, A.; Pruessmann, K. P.] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland.
   [Penn, A.; Pruessmann, K. P.] Univ Zurich, Zurich, Switzerland.
RP Boyce, CM (reprint author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
EM cmb2302@columbia.edu
RI Penn, Alexander/E-9692-2013; Muller, Christoph R/J-6025-2016
OI Penn, Alexander/0000-0001-5596-6310; Muller, Christoph
   R/0000-0003-2234-6902
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200021_153290]
FX This work was supported by the Swiss National Science Foundation under
   grant number 200021_153290.
CR Boyce CM, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.074201
   CALLAGHAN PT, 1991, PRINCIPLES NUCL MAGN
   CARAM HS, 1986, CHEM ENG SCI, V41, P1445, DOI 10.1016/0009-2509(86)85230-7
   COLLINS R, 1965, CHEM ENG SCI, V20, P747, DOI 10.1016/0009-2509(65)80062-8
   Davidson J.F., 1963, FLUIDISED PARTICLES
   DAVIES RM, 1950, PROC R SOC LON SER-A, V200, P375, DOI 10.1098/rspa.1950.0023
   Dennis JS, 2013, WOODHEAD PUBL SER EN, P77, DOI 10.1533/9780857098801.1.77
   Fennell PS, 2005, CHEM ENG SCI, V60, P2085, DOI 10.1016/j.ces.2004.11.040
   GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3
   Kozeny J., 1927, Sitzungsberichte der Akademie der Wissenschaften in Wien, Mathematisch-Naturwissenschaftliche Klasse, V136, P271
   Mudde RF, 2011, AICHE J, V57, P2684, DOI 10.1002/aic.12469
   Muller CR, 2007, IND ENG CHEM RES, V46, P1642, DOI 10.1021/ie0611397
   Muller CR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154504
   MURRAY JD, 1965, J FLUID MECH, V21, P465, DOI 10.1017/S0022112065000277
   Olaofe OO, 2011, CHEM ENG SCI, V66, P2764, DOI 10.1016/j.ces.2011.03.030
   Pavlin T, 2007, APPL MAGN RESON, V32, P93, DOI 10.1007/s00723-007-0002-7
   Penn A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701879
   Santana D, 2005, POWDER TECHNOL, V150, P1, DOI 10.1016/j.powtec.2004.11.013
   Savelsberg R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.020301
   STEHLING MK, 1991, SCIENCE, V254, P43, DOI 10.1126/science.1925560
   Verma V, 2014, CHEM ENG J, V245, P217, DOI 10.1016/j.cej.2014.02.026
   YATES JG, 1994, CHEM ENG SCI, V49, P1885
NR 22
TC 6
Z9 6
U1 2
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 147
EP 166
DI 10.1016/j.ces.2019.01.047
PG 20
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000014
DA 2020-05-12
ER

PT J
AU Men, YL
   Liu, Y
   Wang, QQ
   Luo, ZH
   Shao, S
   Li, YB
   Pan, YX
AF Men, Yu-Long
   Liu, Yi
   Wang, Qianqian
   Luo, Zheng-Hong
   Shao, Shuai
   Li, Yi-Bao
   Pan, Yun-Xiang
TI Highly dispersed Pt-based catalysts for selective CO2 hydrogenation to
   methanol at atmospheric pressure
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Methanol; Highly-dispersed Pt nanoparticles; Atmospheric-pressure CO2
   hydrogenation; CO2 adsorption; Cold plasma
ID CARBON-DIOXIDE; ELECTRON-TRANSFER; OXYGEN VACANCY; PD; ADSORPTION;
   CAPTURE; CU; REDUCTION; STATE; ACID
AB Hydrogenation of CO2 into methanol is promising for achieving the sustainable energy economy, but still has some problems, e. g. low methanol selectivity and high operation pressures (> 10 atm). Herein, we prepared a Pt/film hybrid with highly dispersed Pt nanoparticles, and combined Pt/film with In2O3 to form a Pt/film/In2O3 catalyst. By using a dielectric barrier discharge (DBD) plasma reactor, a CO2 conversion of 37.0% and a methanol selectivity of 62.6% are achieved in the hydrogenation of CO2 with H-2 on Pt/film/In2O3 at 1 atm and 30 degrees C. These are higher than those on Pt/In2O3 prepared by the conventional high-temperature H-2 reduction (24.9% and 36.5%) and commercial Cu/ZnO/Al2O3 (25.6% and 35.1%). The high-energy electrons of the DBD plasma trigger the CO2 hydrogenation at 1 atm and 30 degrees C. The higher Pt nanoparticles dispersion, film and In2O3 promote the adsorption of CO2 on Pt/film/In2O3, thus enhancing the hydrogenation of CO2 into methanol. These results are helpful for efficient methanol production from CO2 hydrogenation under atmospheric pressure. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Men, Yu-Long; Liu, Yi; Wang, Qianqian; Pan, Yun-Xiang] Shanghai Jiao Tong Univ, Dept Instrument Sci & Engn, Sch Elect Informat & Elect Engn, Shanghai 200240, Peoples R China.
   [Liu, Yi; Li, Yi-Bao] Gannan Normal Univ, Key Lab Organo Pharmaceut Chem, Ganzhou 341000, Peoples R China.
   [Luo, Zheng-Hong] Shanghai Jiao Tong Univ, Dept Chem Engn, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China.
   [Shao, Shuai] Univ Elect Sci & Technol China, Sch Optoelect Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.
RP Pan, YX (reprint author), Shanghai Jiao Tong Univ, Dept Instrument Sci & Engn, Sch Elect Informat & Elect Engn, Shanghai 200240, Peoples R China.
EM yxpan81@sjtu.edu.cn
RI Li, Yibao/AAM-2264-2020
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [U1662138]
FX This work is supported by the National Natural Science Foundation of
   China (Grant No. U1662138).
CR Al-Janabi N, 2018, AICHE J, V64, P2189, DOI 10.1002/aic.16135
   Alvarez A, 2017, CHEM REV, V117, P9804, DOI 10.1021/acs.chemrev.6b00816
   Bernskoetter WH, 2017, ACCOUNTS CHEM RES, V50, P1049, DOI 10.1021/acs.accounts.7b00039
   Brandenburg R, 2017, PLASMA SOURCES SCI T, V26, DOI 10.1088/1361-6595/aa6426
   Chen K, 2018, CATAL SCI TECHNOL, V8, P1062, DOI 10.1039/c7cy01998j
   Deerattrakul V, 2016, J CO2 UTIL, V16, P104, DOI 10.1016/j.jcou.2016.07.002
   Diez-Ramirez J, 2018, FUEL PROCESS TECHNOL, V173, P173, DOI 10.1016/j.fuproc.2018.01.024
   Din IU, 2018, CHEM ENG J, V334, P619, DOI 10.1016/j.cej.2017.10.087
   Du XL, 2016, CHEMSUSCHEM, V9, P322, DOI 10.1002/cssc.201501013
   Guo HX, 2018, CHEM ENG J, V336, P376, DOI 10.1016/j.cej.2017.11.186
   Gupta M, 2007, ADV MATER, V19, P858, DOI 10.1002/adma.200601774
   Hao GP, 2013, ENERG ENVIRON SCI, V6, P3740, DOI 10.1039/c3ee41906a
   Thang HV, 2018, ACS CATAL, V8, P4110, DOI 10.1021/acscatal.7b03896
   Thang HV, 2014, CATAL TODAY, V227, P50, DOI 10.1016/j.cattod.2013.10.036
   Jia J, 2017, CHEM SOC REV, V46, P4631, DOI 10.1039/c7cs00026j
   Kar S, 2018, J CO2 UTIL, V23, P212, DOI 10.1016/j.jcou.2017.10.023
   Kar S, 2018, J AM CHEM SOC, V140, P1580, DOI 10.1021/jacs.7b12183
   Kattel S, 2017, J AM CHEM SOC, V139, P9739, DOI 10.1021/jacs.7b05362
   Kim YK, 2011, ENERG ENVIRON SCI, V4, P685, DOI 10.1039/c0ee00330a
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385
   Lei FC, 2014, J AM CHEM SOC, V136, P6826, DOI 10.1021/ja501866r
   Leonzio G, 2018, J CO2 UTIL, V27, P326, DOI 10.1016/j.jcou.2018.08.005
   Li SW, 2017, ANGEW CHEM INT EDIT, V56, P10761, DOI 10.1002/anie.201705002
   Lin Y, 2009, ACS NANO, V3, P871, DOI 10.1021/nn8009097
   Malik AS, 2018, APPL CATAL A-GEN, V560, P42, DOI 10.1016/j.apcata.2018.04.036
   Nomura N, 1998, APPL CATAL A-GEN, V166, P321, DOI 10.1016/S0926-860X(97)00271-8
   Pan YX, 2017, J AM CHEM SOC, V139, P4123, DOI 10.1021/jacs.7b00266
   Pan YX, 2015, ACS NANO, V9, P11258, DOI 10.1021/acsnano.5b04884
   Pan YX, 2012, CHEM-EUR J, V18, P14614, DOI 10.1002/chem.201200745
   Pan YX, 2010, LANGMUIR, V26, P5551, DOI 10.1021/la903836v
   Perko D, 2014, AICHE J, V60, P613, DOI 10.1002/aic.14280
   Rubert-Nason P, 2014, AICHE J, V60, P1336, DOI 10.1002/aic.14322
   Rui N, 2017, APPL CATAL B-ENVIRON, V218, P488, DOI 10.1016/j.apcatb.2017.06.069
   Ryu J, 2008, CHEM MATER, V20, P4284, DOI 10.1021/cm800015p
   Schaidle JA, 2010, J CATAL, V272, P235, DOI 10.1016/j.jcat.2010.04.004
   Song CP, 2012, CHEM COMMUN, V48, P2119, DOI 10.1039/c2cc16890a
   Sun XC, 2017, AICHE J, V63, P4022, DOI 10.1002/aic.15759
   Wang JJ, 2018, ACS APPL MATER INTER, V10, P21321, DOI 10.1021/acsami.8b04578
   Wang L, 2018, ACS CATAL, V8, P90, DOI 10.1021/acscatal.7b02733
   Wang WH, 2015, CHEM REV, V115, P12936, DOI 10.1021/acs.chemrev.5b00197
   Wang W, 2017, CHEM SCI, V8, P3310, DOI 10.1039/c7sc00069c
   Yan JM, 2013, LANGMUIR, V29, P16051, DOI 10.1021/la4036908
   Yan XL, 2016, ACS APPL MATER INTER, V8, P17060, DOI 10.1021/acsami.6b03106
   Yang HY, 2017, CATAL SCI TECHNOL, V7, P4580, DOI 10.1039/c7cy01403a
   Ye JY, 2013, ACS CATAL, V3, P1296, DOI 10.1021/cs400132a
   Yin YZ, 2018, APPL CATAL B-ENVIRON, V234, P143, DOI 10.1016/j.apcatb.2018.04.024
NR 46
TC 2
Z9 2
U1 28
U2 184
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 167
EP 175
DI 10.1016/j.ces.2019.02.004
PG 9
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000015
DA 2020-05-12
ER

PT J
AU Bueno, L
   Laso, C
   Amador, C
   Bakalis, S
AF Bueno, L.
   Laso, C.
   Amador, C.
   Bakalis, S.
TI Modelling the kinetics of stain removal from knitted cotton fabrics in a
   commercial Front Loader Washing Machine (FLWM)
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Stain removal; Cleaning; FLWM; Knitted cotton
ID TEXTILE MATERIALS; FLOW RESISTANCE; DETERGENCY; DYNAMICS; TEMPERATURE;
   BEHAVIOR; QUALITY; ACID
AB The kinetics of stain removal from knitted cotton textiles during the washing process in a Front Loader Washing Machine (FLWM) has been investigated as a function of the ballast load, agitation, drum rotational speed and washing time, which result in different levels of mechanical action during the wash. The study was conducted using a set of stains comprising grease, enzymatic, particulate and coloured beverage type of soils that are representative of typical domestic washing loads. A mechanistic model has been developed to describe the stain removal process which takes into consideration the dual porosity of the textiles by allowing two different regions where the soil is located (inter-yarn and intra-yarn porosity). The location of the soil affects its exposure to the hydrodynamic forces and surfactant system resulting in a more challenging removal for the portion of the stain located in the inner area of the textiles. Good agreement between the experimental and predicted stain removal by the proposed mathematical model has been observed for the range of variables considered. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bueno, L.] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
   [Laso, C.] Ind Complex A Coruna, Repsol YPF, La Coruna 15080, Spain.
   [Amador, C.] Procter & Gamble Ltd, Newcastle Innovat Ctr, Newcastle Upon Tyne NE12 9BZ, Tyne & Wear, England.
   [Bakalis, S.] Univ Nottingham, Dept Chem & Environm Engn, Nottingham NG7 2RD, England.
RP Bueno, L (reprint author), Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
EM lxb269@bham.ac.uk
FU Engineering and Physical Sciences Research Council (EPSRC),
   (UK)Engineering & Physical Sciences Research Council (EPSRC); Procter
   and Gamble, (UK)
FX We would like to thank the Engineering and Physical Sciences Research
   Council (EPSRC), (UK) and Procter and Gamble, (UK) for funding this
   project.
CR AGUILAR C, 1991, J TEXTURE STUD, V22, P59, DOI 10.1111/j.1745-4603.1991.tb00006.x
   BACON OC, 1948, IND ENG CHEM, V40, P2361, DOI 10.1021/ie50468a028
   Bae S, 2002, J SOUND VIB, V257, P3, DOI 10.1006/jsvi.2001.4162
   BOURNE MC, 1963, J AM OIL CHEM SOC, V40, P523, DOI 10.1007/BF02822457
   BOURNE MC, 1963, J AM OIL CHEM SOC, V40, P517, DOI 10.1007/BF02822456
   Cooke T.F., 1987, SOIL RELEASE FINISHE, V19, P31
   Cooper KA, 2008, J AGR FOOD CHEM, V56, P260, DOI 10.1021/jf072153c
   Copley T., 2017, SOFW-J, V143, P38
   De Boer L.M., 1961, AM WATER WORKS ASS, V53, P809
   De la Poterie V., 2005, Patent, Patent No. [0191258-A1, 0191258]
   Diamond W.J., 1957, TEXT RES J, P787
   Farah A., 2012, COFFEE EMERGING HLTH, P22, DOI http://dx.doi.org/10.1002/9781119949893.ch2
   FEIGHNER GC, 1984, J AM OIL CHEM SOC, V61, P1645, DOI 10.1007/BF02541650
   Gooijer H, 2003, TEXT RES J, V73, P480, DOI 10.1177/004051750307300603
   Gooijer H, 2003, TEXT RES J, V73, P437, DOI 10.1177/004051750307300511
   GRINDSTAFF TH, 1967, TEXT RES J, V37, P564, DOI 10.1177/004051756703700703
   Groot-Marcus A. P., 1996, J CONSUMER STUDIES H, V20, P261
   Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154
   Homann JP, 2009, X MEDIA PUBL, P17
   Ishikawa Y., 2006, J OLEO SCI, V55, P511, DOI [10.5650/jos.55.511, DOI 10.5650/JOS.55.511]
   Ishikawa Yusuke, 2007, J Oleo Sci, V56, P163
   KISSA E, 1979, TEXT RES J, V49, P384, DOI 10.1177/004051757904900703
   KISSA E, 1981, TEXT RES J, V51, P508, DOI 10.1177/004051758105100803
   Lasic E, 2015, TENSIDE SURFACT DET, V52, P193, DOI 10.3139/113.110365
   Lim YK, 2007, DENT MATER, V23, P1262, DOI 10.1016/j.dental.2006.11.022
   LOEB L, 1964, J AM OIL CHEM SOC, V41, P120, DOI 10.1007/BF02673487
   Lynn J.L., 2005, BAILEYS IND OIL FAT, V6, P4
   Mac Namara C, 2012, CHEM ENG SCI, V75, P14, DOI 10.1016/j.ces.2012.03.009
   Matsui H., 1978, J TEXT MACH SOC JPN, V24, P41
   MCDONALD R., 1997, COLOUR PHYS IND
   MORRIS MA, 1982, TEXT RES J, V52, P280, DOI 10.1177/004051758205200409
   NEIDITCH OW, 1980, J AM OIL CHEM SOC, V57, P426, DOI 10.1007/BF02678931
   Park J, 2003, PARTICUL SCI TECHNOL, V21, P157, DOI 10.1080/02726350307491
   PATRICK RL, 1961, J COLL SCI IMP U TOK, V16, P93, DOI 10.1016/0095-8522(61)90010-1
   RAAIJMAKERS JGW, 1987, BIOMETRICS, V43, P793, DOI 10.2307/2531533
   Rudenauer I, 2005, J IND ECOL, V9, P105, DOI 10.1162/108819805775248061
   Schanda J, 2007, COLORIMETRY: UNDERSTANDING THE CIE SYSTEM, P1, DOI 10.1002/9780470175637
   Scheid F, 2016, TENSIDE SURFACT DET, V53, P438, DOI 10.3139/113.110462
   Schmitz A, 2014, ENERG EFFIC, V7, P937, DOI 10.1007/s12053-014-9268-4
   SCHOTT H, 1975, J AM OIL CHEM SOC, V52, P225, DOI 10.1007/BF02639146
   Scott B. A., 1963, J APPL CHEM-USSR, V13, P133, DOI DOI 10.1002/JCTB.5010130307
   Sonwai S, 2008, CRYST GROWTH DES, V8, P3165, DOI 10.1021/cg070503h
   Terpstra P., 2001, ENERGY EFFICIENCY HO
   Tomaszewska-Gras J, 2016, FOOD CONTROL, V60, P629, DOI 10.1016/j.foodcont.2015.09.001
   Turkay OS, 1998, J VIB ACOUST, V120, P534, DOI 10.1115/1.2893862
   Vaughn TH, 1941, IND ENG CHEM, V33, P1011, DOI 10.1021/ie50380a011
   Ward D, 2000, J TEXT I, V91, P207, DOI 10.1080/00405000008659501
   Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019
   Yamada I., 1984, J HOME EC JPN, V35, P184
   Yamada I., 1988, J JPN OIL CHEM SOC, V37, P447
   Yun C, 2017, TEXT RES J, V87, P708, DOI 10.1177/0040517516636005
NR 51
TC 0
Z9 0
U1 2
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 176
EP 185
DI 10.1016/j.ces.2019.02.008
PG 10
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000016
DA 2020-05-12
ER

PT J
AU Leonard, C
   Ferrasse, JH
   Lefevre, S
   Viand, A
   Boutin, O
AF Leonard, Clement
   Ferrasse, Jean-Henry
   Lefevre, Sebastien
   Viand, Alain
   Boutin, Olivier
TI Gas hold up in bubble column at high pressure and high temperature
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Gas liquid contactor; Gas holdup; High pressure; High temperature;
   Bubble column
ID LIQUID MASS-TRANSFER; ELEVATED PRESSURE; INTERFACIAL AREA; FLOW REGIME;
   SCALE-UP; REACTORS; HYDRODYNAMICS; SIZE; DENSITY; PHASE
AB Gas holdup of water/nitrogen, water-phenol/nitrogen and water-phenol/air systems was successfully measured by a method based on the use of a differential pressure sensor installed on a bubble column reactor, in a wide domain of temperature (from 100 to 300 degrees C) and pressure (from 10 to 30 MPa). These experimental conditions are little or no explored in literature. Results show a predominant influence of the superficial gas velocity, the evaporation of the liquid phase, the ratio of the gas volume flowrate on the liquid volume flowrate and the phenol concentration. Pressure and chemical reaction have little effect on gas holdup. The temperature has an effect in the case of phenol solutions. The different correlations and parameters influence determined in this work are very helpful for the design of gas liquid contactors (for instance bubble column) at high pressure and high temperature. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Leonard, Clement; Ferrasse, Jean-Henry; Boutin, Olivier] Aix Marseille Univ, CNRS, Centrale Marseille, M2P2, Marseille, France.
   [Leonard, Clement; Lefevre, Sebastien; Viand, Alain] SARI A3i, 255 Rue Gustave Eiffel, F-26290 Donzere, France.
RP Boutin, O (reprint author), Aix Marseille Univ, CNRS, Centrale Marseille, M2P2, Marseille, France.
EM olivier.boutin@univ-amu.fr
OI Olivier, Boutin/0000-0003-1133-122X
CR Baz-Rodriguez SA, 2014, CHEM ENG RES DES, V92, P2352, DOI 10.1016/j.cherd.2014.02.023
   Behkish A, 2007, CHEM ENG J, V128, P69, DOI 10.1016/j.cej.2006.10.016
   BENJAMIN TB, 1986, J FLUID MECH, V169, P251, DOI 10.1017/S0022112086000617
   Bin AK, 2001, CHEM ENG SCI, V56, P6233, DOI 10.1016/S0009-2509(01)00213-5
   Bouaifi M, 2001, CHEM ENG PROCESS, V40, P97, DOI 10.1016/S0255-2701(00)00129-X
   Boyer C, 2002, CHEM ENG SCI, V57, P3185, DOI 10.1016/S0009-2509(02)00193-8
   Chaumat H, 2005, CHEM ENG SCI, V60, P5930, DOI 10.1016/j.ces.2005.04.026
   Chilekar V.P., 2007, HYDRODYNAMICS MASS T, DOI [10.6100/IR6270232007, DOI 10.6100/IR6270232007]
   Chilekar VP, 2010, AICHE J, V56, P584, DOI 10.1002/aic.11987
   CLARK KN, 1990, CHEM ENG SCI, V45, P2301, DOI 10.1016/0009-2509(90)80109-R
   DEBRUIJN TJW, 1988, CAN J CHEM ENG, V66, P330, DOI 10.1002/cjce.5450660223
   DECKWER WD, 1980, IND ENG CHEM PROC DD, V19, P699, DOI 10.1021/i260076a032
   Dewes I, 1997, CHEM ENG SCI, V52, P4105, DOI 10.1016/S0009-2509(97)00252-2
   Forret A, 2003, CHEM ENG SCI, V58, P719, DOI 10.1016/S0009-2509(02)00600-0
   FRIEDEL L, 1979, EUR 2 PHAS FLOW GROU
   FUKUMA M, 1987, J CHEM ENG JPN, V20, P28, DOI 10.1252/jcej.20.28
   Garcia-Abuin A, 2012, CHEM ENG SCI, V75, P334, DOI 10.1016/j.ces.2012.03.054
   GROVER GS, 1986, CAN J CHEM ENG, V64, P501, DOI 10.1002/cjce.5450640321
   Han L, 2007, CHEM ENG SCI, V62, P131, DOI 10.1016/j.ces.2006.08.010
   Hashemi S, 2009, CHEM ENG SCI, V64, P3709, DOI 10.1016/j.ces.2009.05.023
   Hikita H., 1974, Chemical Engineering Journal, V8, P191, DOI 10.1016/0300-9467(74)85024-0
   Himmelblau D.M., 1960, J CHEM ENG DATA, V5, P10
   Idogawa K., 1986, INT CHEM ENG, V26, P468
   Ishibashi H, 2001, FUEL, V80, P655, DOI 10.1016/S0016-2361(00)00131-9
   Ishiyama H, 2001, CHEM ENG SCI, V56, P6273, DOI 10.1016/S0009-2509(01)00252-4
   JIANG P, 1995, CHEM ENG RES DES, V73, P269
   Jin HB, 2007, FLOW MEAS INSTRUM, V18, P191, DOI 10.1016/j.flowmeasinst.2007.07.005
   Jin HB, 2010, J CHEM TECHNOL BIOT, V85, P1278, DOI 10.1002/jctb.2428
   Jordan U, 2001, CHEM ENG SCI, V56, P6267, DOI 10.1016/S0009-2509(01)00255-X
   Kang Y, 2000, CHEM ENG SCI, V55, P411, DOI 10.1016/S0009-2509(99)00336-X
   Kang Y, 1999, CHEM ENG SCI, V54, P4887, DOI 10.1016/S0009-2509(99)00209-2
   Kantarci N, 2005, PROCESS BIOCHEM, V40, P2263, DOI 10.1016/j.procbio.2004.10.004
   Kemoun A, 2001, INT J MULTIPHAS FLOW, V27, P929, DOI 10.1016/S0301-9322(00)00037-9
   Kluytmans JHJ, 2003, CHEM ENG SCI, V58, P4719, DOI 10.1016/j.ces.2003.05.004
   KOLBEL H, 1971, CHEM-ING-TECH, V43, P103, DOI 10.1002/cite.330430303
   Krishna R, 1996, AICHE J, V42, P2627, DOI 10.1002/aic.690420923
   KRISHNA R, 1991, CHEM ENG SCI, V46, P2491, DOI 10.1016/0009-2509(91)80042-W
   Krishna R, 2000, FUEL PROCESS TECHNOL, V64, P73, DOI 10.1016/S0378-3820(99)00128-9
   Kumar S, 2012, PROCEDIA ENGINEER, V42, P842, DOI 10.1016/j.proeng.2012.07.477
   Lau R, 2004, IND ENG CHEM RES, V43, P1302, DOI 10.1021/ie030416w
   Lefevre S, 2011, CHEMOSPHERE, V84, P1208, DOI 10.1016/j.chemosphere.2011.05.049
   Leonard C, 2018, AICHE J, V64, P4110, DOI 10.1002/aic.16216
   Letzel HM, 1999, CHEM ENG SCI, V54, P2237, DOI 10.1016/S0009-2509(98)00418-7
   Letzel HM, 1997, CHEM ENG SCI, V52, P3733, DOI 10.1016/S0009-2509(97)00219-4
   Letzel MH, 1998, AICHE J, V44, P2333, DOI 10.1002/aic.690441022
   Lin TJ, 1998, AICHE J, V44, P545, DOI 10.1002/aic.690440306
   Lin TJ, 2001, CHEM ENG SCI, V56, P6241, DOI 10.1016/S0009-2509(01)00258-5
   Lorenz O, 2005, CHEM ENG SCI, V60, P3573, DOI 10.1016/j.ces.2005.01.032
   Luo XK, 1999, AICHE J, V45, P665, DOI 10.1002/aic.690450402
   Majumder SK, 2006, CHEM ENG J, V122, P1, DOI 10.1016/j.cej.2006.04.007
   Muroyama K, 2013, CHEM ENG SCI, V100, P464, DOI 10.1016/j.ces.2013.03.043
   OHKI Y, 1970, CHEM ENG SCI, V25, P1, DOI 10.1016/0009-2509(70)85016-3
   OYEVAAR MH, 1991, CHEM ENG SCI, V46, P1217, DOI 10.1016/0009-2509(91)85050-8
   Pjontek D, 2014, CHEM ENG SCI, V111, P153, DOI 10.1016/j.ces.2014.02.024
   Pohorecki R, 1999, CHEM ENG SCI, V54, P5187, DOI 10.1016/S0009-2509(99)00238-9
   REILLY IG, 1986, CAN J CHEM ENG, V64, P705, DOI 10.1002/cjce.5450640501
   REILLY IG, 1994, CAN J CHEM ENG, V72, P3, DOI 10.1002/cjce.5450720102
   Ruzicka MC, 2001, CHEM ENG SCI, V56, P6117, DOI 10.1016/S0009-2509(01)00215-9
   Ruzicka MC, 2001, CHEM ENG SCI, V56, P4609, DOI 10.1016/S0009-2509(01)00116-6
   Sangnimnuan A, 1984, CHEM ENG COMMUN, V25, P193, DOI 10.1080/00986448408940107
   Schafer R, 2002, EXP THERM FLUID SCI, V26, P595, DOI 10.1016/S0894-1777(02)00189-9
   Shah M, 2012, IND ENG CHEM RES, V51, P14268, DOI 10.1021/ie301227t
   Shaikh A, 2005, FLOW MEAS INSTRUM, V16, P91, DOI 10.1016/j.flowmeasinst.2005.02.004
   Simonnet M, 2007, CHEM ENG SCI, V62, P858, DOI 10.1016/j.ces.2006.10.012
   Smith JS, 1996, IND ENG CHEM RES, V35, P1700, DOI 10.1021/ie950366y
   Soong Y, 1997, CATAL TODAY, V35, P427, DOI 10.1016/S0920-5861(96)00211-8
   Tang CZ, 2006, INT J MULTIPHAS FLOW, V32, P850, DOI 10.1016/j.ijmultiphaseflow.2006.02.008
   Tarmy B., 1984, CHEM ENG, V407, P18
   Therning P, 2001, CHEM ENG J, V81, P331, DOI 10.1016/S1385-8947(00)00222-9
   Veera UP, 2000, CHEM ENG RES DES, V78, P425
   WALLIS GB, 1969, ONE DIMENSIONAL 2 PH
   Whalley P. B., 1978, AERER9187 UKAEA
   WILKINSON PM, 1990, CHEM ENG SCI, V45, P2309, DOI 10.1016/0009-2509(90)80110-Z
   WILKINSON PM, 1992, AICHE J, V38, P544, DOI 10.1002/aic.690380408
   Xue JL, 2008, AICHE J, V54, P350, DOI 10.1002/aic.11386
   Yang GQ, 2003, AICHE J, V49, P1995, DOI 10.1002/aic.690490810
   Yang WG, 2001, CHEM ENG TECHNOL, V24, P651, DOI 10.1002/1521-4125(200106)24:6<651::AID-CEAT651>3.0.CO;2-X
   Zahradnik J, 1997, CHEM ENG SCI, V52, P3811, DOI 10.1016/S0009-2509(97)00226-1
   ZUBER N, 1965, J HEAT TRANSF, V87, P453, DOI 10.1115/1.3689137
NR 79
TC 1
Z9 1
U1 5
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 186
EP 202
DI 10.1016/j.ces.2019.01.055
PG 17
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000017
DA 2020-05-12
ER

PT J
AU Wu, MY
   Zhang, YG
   Szeto, W
   Pan, WD
   Huang, HB
   Leung, DYC
AF Wu, Muyan
   Zhang, Yingguang
   Szeto, Wai
   Pan, Wending
   Huang, Haibao
   Leung, Dennis Y. C.
TI Vacuum ultraviolet (VUV)-based photocatalytic oxidation for toluene
   degradation over pure CeO2
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Cerium dioxide; VUV photolysis; Photocatalysis; Catalytic ozonation
ID CATALYTIC OZONATION; GASEOUS BENZENE; VUV IRRADIATION; GAS-PHASE;
   EFFICIENT DEGRADATION; ACTIVATED CARBON; MESOPOROUS TIO2; WATER; OZONE;
   CERIUM
AB Volatile organic compounds (VOCs) are one of the biggest concerns in the ambient environment that have attracted a great number of studies related to its remediation. Vacuum ultraviolet (VUV)-based photocatalytic oxidation (PCO) is a promising technology in controlling VOCs. CeO2 is found to be a promising catalyst for the VUV-PCO technology possessing catalytic capacities in both the photocatalysis and ozonation processes. In this study, three typical kinds of pure CeO2 with various nanostructures were synthesized and creatively applied for VUV-photocatalytic oxidation of toluene. Material characterizations, including BET, SEM, TEM, XRD, Raman, XPS, H-2-TPR and DRS, were conducted to characterize different CeO2 samples. Results indicated that synthetic CeO2 samples have a much more remarkable enhancement in degrading toluene compared to commercial ones. Higher COx generation and mineralization rates were obtained with the use of all the synthetic CeO2 samples. Compared to commercial CeO2, the synthetic samples have much better capacity towards removing ozone and the best activity in ozone decomposition was observed in CeO2 Nanorods catalysts. Both the effects of photocatalysis and catalytic ozonation exist in all the CeO2 catalysts. The amount of Ce3+ plays a critical role in both the catalytic activity of photocatalysis and ozonation that higher ratio of Ce3+ leads to better performance in toluene removal. The differences in photocatalytic activity were further explained by the results of electrochemical behaviors of different CeO2 samples which showed varying responses to UV irradiation. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wu, Muyan; Zhang, Yingguang; Szeto, Wai; Pan, Wending; Leung, Dennis Y. C.] Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Peoples R China.
   [Huang, Haibao] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.
RP Leung, DYC (reprint author), Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Peoples R China.; Huang, HB (reprint author), Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.
EM seabao8@gmail.com; ycleung@hku.hk
OI Leung, Dennis Y.C./0000-0002-8917-0916; Huang,
   Haibao/0000-0002-9259-7179
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [51561165015, N_HKU718/15]; Research Grants
   Council (RGC) of Hong KongHong Kong Research Grants Council
   [51561165015, N_HKU718/15]; NSFCNational Natural Science Foundation of
   China [21677179]; Guangdong Special Fund for Science & Technology
   Development (Hong Kong Technology Cooperation Funding Scheme)
   [2016A050503022, ITF GHP/025/16GD, InP/272/16]; Innovation Platform
   Construction of Guangdong and Hong Kong [2017B050504001]; National Key
   Research and Development Program of China [2016YFC0204800]; Guangzhou
   Science and Technology Project [201504301654288]; Key Fundamental
   Research Fund for the Central Universities [17lgjc17]
FX The authors gratefully acknowledge the financial supports from the
   National Natural Science Foundation of China (NSFC) and The Research
   Grants Council (RGC) of Hong Kong Joint Research Scheme (No.
   51561165015, No. N_HKU718/15), NSFC (21677179), Guangdong Special Fund
   for Science & Technology Development (Hong Kong Technology Cooperation
   Funding Scheme) (No. 2016A050503022, ITF GHP/025/16GD & InP/272/16),
   Innovation Platform Construction of Guangdong and Hong Kong (No.
   2017B050504001), National Key Research and Development Program of China
   (No. 2016YFC0204800) and Guangzhou Science and Technology Project (No.
   201504301654288), the Key Fundamental Research Fund for the Central
   Universities (17lgjc17).
CR Aslam M, 2016, APPL CATAL B-ENVIRON, V180, P391, DOI 10.1016/j.apcatb.2015.06.050
   Avellaneda CO, 2008, SOL ENERG MAT SOL C, V92, P240, DOI 10.1016/j.solmat.2007.03.035
   Bamwenda GR, 2000, J MOL CATAL A-CHEM, V161, P105, DOI 10.1016/S1381-1169(00)00270-3
   Bianchi CL, 2014, APPL CATAL B-ENVIRON, V146, P123, DOI 10.1016/j.apcatb.2013.02.047
   Braslavsky SE, 2007, PURE APPL CHEM, V79, P293, DOI 10.1351/pac200779030293
   Campbell CT, 2005, SCIENCE, V309, P713, DOI 10.1126/science.1113955
   Channei D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05757
   Choudhury B, 2015, J EXP NANOSCI, V10, P103, DOI 10.1080/17458080.2013.801566
   Chung KH, 1996, CATAL TODAY, V30, P157, DOI 10.1016/0920-5861(96)00006-5
   Cooper C, 1999, WATER RES, V33, P3695, DOI 10.1016/S0043-1354(99)00091-3
   Einaga H, 2013, J CATAL, V305, P227, DOI 10.1016/j.jcat.2013.05.016
   Fang RM, 2018, CHEM ENG J, V334, P2050, DOI 10.1016/j.cej.2017.11.176
   Faria PCC, 2008, CATAL COMMUN, V9, P2121, DOI 10.1016/j.catcom.2008.04.009
   Faria PCC, 2009, CHEMOSPHERE, V74, P818, DOI 10.1016/j.chemosphere.2008.10.016
   Fu PF, 2011, APPL CATAL B-ENVIRON, V105, P220, DOI 10.1016/j.apcatb.2011.04.021
   Georgiev VF, 2017, BULG CHEM COMMUN, V49, P30
   Han ZN, 2013, CHEM ENG J, V218, P9, DOI 10.1016/j.cej.2012.12.025
   Hariz R, 2017, CHEM ENG SCI, V157, P264, DOI 10.1016/j.ces.2016.06.008
   Hashem TM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(97)00007-3
   He F, 2014, CHEM ENG J, V237, P312, DOI 10.1016/j.cej.2013.10.028
   Huang HB, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00017
   Huang HB, 2017, APPL CATAL B-ENVIRON, V203, P870, DOI 10.1016/j.apcatb.2016.10.083
   Huang HB, 2017, CATAL TODAY, V281, P649, DOI 10.1016/j.cattod.2016.07.005
   Huang HB, 2017, APPL SURF SCI, V391, P662, DOI 10.1016/j.apsusc.2016.07.040
   Huang H, 2015, CHEM ENG J, V264, P24, DOI 10.1016/j.cej.2014.11.072
   Huang HB, 2015, CHEM ENG J, V259, P534, DOI 10.1016/j.cej.2014.08.057
   Huang HL, 2016, APPL CATAL B-ENVIRON, V186, P62, DOI 10.1016/j.apcatb.2015.12.055
   Jarnstrom H, 2006, ATMOS ENVIRON, V40, P7178, DOI 10.1016/j.atmosenv.2006.06.021
   Jeong J, 2005, J PHOTOCH PHOTOBIO A, V169, P279, DOI 10.1016/j.jphotochem.2004.07.014
   Ji J, 2017, CHEM ENG J, V327, P490, DOI 10.1016/j.cej.2017.06.130
   Le Bechec M, 2015, APPL CATAL B-ENVIRON, V179, P78, DOI 10.1016/j.apcatb.2015.05.015
   Lee Y, 2011, J AM CHEM SOC, V133, P12952, DOI 10.1021/ja204479j
   Legube B, 1999, CATAL TODAY, V53, P61, DOI 10.1016/S0920-5861(99)00103-0
   Liu GY, 2017, CHEM ENG J, V324, P44, DOI 10.1016/j.cej.2017.04.105
   Liu XW, 2009, J AM CHEM SOC, V131, P3140, DOI 10.1021/ja808433d
   Matheswaran M, 2007, CATAL COMMUN, V8, P1497, DOI 10.1016/j.catcom.2006.12.017
   Muduli SK, 2014, BEILSTEIN J NANOTECH, V5, P517, DOI 10.3762/bjnano.5.60
   Patsalas P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035104
   Qin HD, 2014, J CHEM TECHNOL BIOT, V89, P1402, DOI 10.1002/jctb.4222
   Quinones DH, 2015, APPL CATAL B-ENVIRON, V178, P74, DOI 10.1016/j.apcatb.2014.10.036
   Ren HJ, 2017, J HAZARD MATER, V325, P340, DOI 10.1016/j.jhazmat.2016.08.072
   Shi WQ, 2013, J MATER CHEM A, V1, P728, DOI 10.1039/c2ta00504b
   Shiraishi F, 2009, CHEM ENG SCI, V64, P2466, DOI 10.1016/j.ces.2009.02.024
   Shu YJ, 2018, APPL CATAL B-ENVIRON, V220, P78, DOI 10.1016/j.apcatb.2017.08.019
   Sundell J, 2004, INDOOR AIR, V14, P51, DOI 10.1111/j.1600-0668.2004.00273.x
   Tana, 2009, CATAL TODAY, V148, P179, DOI 10.1016/j.cattod.2009.02.016
   Pham TD, 2015, J HAZARD MATER, V300, P493, DOI 10.1016/j.jhazmat.2015.07.048
   Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464
   TRUDEAU ML, 1995, SURF INTERFACE ANAL, V23, P219, DOI 10.1002/sia.740230405
   Voskanyan AA, 2016, CHEM MATER, V28, P2768, DOI 10.1021/acs.chemmater.6b00505
   Wang YG, 2013, APPL CATAL B-ENVIRON, V130, P277, DOI 10.1016/j.apcatb.2012.11.019
   Weon S, 2017, APPL CATAL B-ENVIRON, V205, P386, DOI 10.1016/j.apcatb.2016.12.048
   Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044
   Wu M., 2018, CHEM ENG SCI
   Wu ZL, 2012, J CATAL, V285, P61, DOI 10.1016/j.jcat.2011.09.011
   Wu ZL, 2010, LANGMUIR, V26, P16595, DOI 10.1021/la101723w
   Yang P, 2017, CHEM ENG SCI, V162, P218, DOI 10.1016/j.ces.2017.01.009
   Yin BS, 2014, CRYSTENGCOMM, V16, P9999, DOI 10.1039/c4ce01302f
   Yoon M, 2005, CHEM MATER, V17, P6069, DOI 10.1021/cm0515855
   Yu QL, 2009, APPL CATAL B-ENVIRON, V92, P454, DOI 10.1016/j.apcatb.2009.09.004
   Zeng M, 2015, ACS CATAL, V5, P3278, DOI 10.1021/acscatal.5b00292
   Zhai Y, 2007, MATER LETT, V61, P1863, DOI 10.1016/j.matlet.2006.07.146
   Zhang PY, 2004, CHEM LETT, V33, P1242, DOI 10.1246/cl.2004.1242
   Zhang PY, 2003, J PHOTOCH PHOTOBIO A, V156, P189, DOI 10.1016/S1010-6030(02)00432-X
NR 64
TC 4
Z9 4
U1 44
U2 224
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 203
EP 213
DI 10.1016/j.ces.2019.01.056
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000018
DA 2020-05-12
ER

PT J
AU Xiao, H
   Geng, SJ
   Chen, AQ
   Yang, C
   Gao, F
   He, TB
   Huang, QS
AF Xiao, Hang
   Geng, Shujun
   Chen, Aqiang
   Yang, Chao
   Gao, Fei
   He, Taobo
   Huang, Qingshan
TI Bubble formation in continuous liquid phase under industrial jetting
   conditions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Bubble formation; Bubble diameter; Orifice superficial gas velocity;
   Liquid viscosity; Surface tension; Jetting condition
ID AIRLIFT-LOOP REACTOR; WETTING CONDITIONS; INVISCID LIQUID; GAS-BUBBLES;
   FLOW; ORIFICE; PHOTOBIOREACTOR; CULTIVATION; SURFACTANT; EVOLUTION
AB Accurate prediction of bubble diameter is crucial for the proper design, optimization, and scale-up of gas-liquid apparatuses. Bubble formation at submerged multiple orifices in a gas-liquid apparatus under industrial conditions is systematically investigated in this work. It is found that the bubble diameter firstly increases and then approaches to a relatively constant value in the low viscous liquid when increasing the orifice superficial gas velocity. Parametric studies demonstrate that large orifice diameter and high liquid viscosity lead to larger bubble diameter, and the inflection point in the curve of bubble diameter versus orifice superficial gas velocity is also affected. With surfactant added in solutions, the bubble diameter decreases markedly. Based on the experimental data, a semi-empirical correlation for predicting the bubble diameter is proposed using nonlinear least square optimization. The new correlation, containing the influence of orifice diameter, orifice superficial gas velocity and liquid properties on the bubble diameter, is further validated by comparing prediction results with experimental data over a wide range of operating conditions and working systems from the literature. Therefore, it is thought useful for the industrial design of gas-liquid apparatus. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Xiao, Hang; Geng, Shujun; Chen, Aqiang; Yang, Chao; Huang, Qingshan] Chinese Acad Sci, Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China.
   [Xiao, Hang; Geng, Shujun; Chen, Aqiang; Huang, Qingshan] Dalian Natl Lab Clean Energy, Dalian 116023, Liaoning, Peoples R China.
   [Yang, Chao; Huang, Qingshan] Chinese Acad Sci, Inst Proc Engn, Key Lab Green Proc & Engn, Beijing 100190, Peoples R China.
   [Gao, Fei; He, Taobo] CNPC, Petrochem Res Inst, Beijing 100083, Peoples R China.
RP Geng, SJ; Huang, QS (reprint author), Chinese Acad Sci, Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China.
EM gengsj@qibebt.ac.cn; qshuang@ipe.ac.cn
RI Yang, Chao/B-4039-2008
OI Yang, Chao/0000-0001-6067-7505; Huang, Qingshan/0000-0002-7558-3250
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21878318, 21808234, 91434114]; Instrument
   Developing Project of the CAS [YZ201641]; "Transformational Technologies
   for Clean Energy and Demonstration", Strategic Priority Research Program
   of the CAS [XDA21060400]; CAS Key Technology Talent Program; Project of
   CNPC-DICP Joint Research Center; Supercomputing Center of USTC
   (University of Science and Technology of China)
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 21878318; 21808234; 91434114), the Instrument Developing
   Project of the CAS (YZ201641), "Transformational Technologies for Clean
   Energy and Demonstration", Strategic Priority Research Program of the
   CAS (XDA21060400), CAS Key Technology Talent Program, and Project of
   CNPC-DICP Joint Research Center. Our gratitude goes to the
   Supercomputing Center of USTC (University of Science and Technology of
   China) for the support
CR ACHARYA A, 1978, AICHE J, V24, P348, DOI 10.1002/aic.690240227
   AKITA K, 1974, IND ENG CHEM PROC DD, V13, P84, DOI 10.1021/i260049a016
   Arunkumar RP, 2010, IND ENG CHEM RES, V49, P4995, DOI 10.1021/ie900713v
   BENZING RJ, 1955, IND ENG CHEM, V47, P2087, DOI 10.1021/ie50550a022
   Byakova AV, 2003, COLLOID SURFACE A, V229, P19, DOI 10.1016/j.colsurfa.2003.08.009
   [陈阿强 Chen Aqiang], 2016, [化工学报, CIESC Journal], V67, P2300
   [陈阿强 Chen Aqiang], 2015, [化工学报, CIESC Journal], V66, P4780
   Davidson J., 1960, T I CHEM ENG-LOND, V38, P144, DOI DOI 10.1016/S0263-8762(97)80008-1
   Davidson J.F., 1963, FLUIDIZED PARTICLES
   Davidson JF, 1997, CHEM ENG RES DES, V75, pS105, DOI 10.1016/S0263-8762(97)80008-1
   DAVIDSON L, 1956, AICHE J, V2, P337, DOI 10.1002/aic.690020309
   GADDIS ES, 1986, CHEM ENG SCI, V41, P97, DOI 10.1016/0009-2509(86)85202-2
   Gnyloskurenko SV, 2003, COLLOID SURFACE A, V218, P73, DOI 10.1016/S0927-7757(02)00592-7
   Guo X, 2015, BIORESOURCE TECHNOL, V190, P189, DOI 10.1016/j.biortech.2015.04.077
   Han C, 2018, IND ENG CHEM RES, V57, P8529, DOI 10.1021/acs.iecr.8b00703
   Hanafizadeh P, 2018, MECCANICA, V53, pCP5, DOI 10.1007/s11012-018-0835-1
   Hsu SH, 2000, IND ENG CHEM RES, V39, P1473, DOI 10.1021/ie990578l
   Huang Q., 2014, J CHEM IND ENG, V65, P2465
   Huang QS, 2007, CHEM ENG TECHNOL, V30, P870, DOI 10.1002/ceat.200700038
   Huang QS, 2017, ENGINEERING-PRC, V3, P318, DOI 10.1016/J.ENG.2017.03.020
   Huang QS, 2015, CHEM ENG SCI, V135, P441, DOI 10.1016/j.ces.2015.01.003
   Huang QS, 2012, CHEM ENG SCI, V84, P718, DOI 10.1016/j.ces.2012.09.017
   Huang QS, 2011, CHEM ENG SCI, V66, P3930, DOI 10.1016/j.ces.2011.05.032
   Huang QS, 2010, CHEM ENG SCI, V65, P5527, DOI 10.1016/j.ces.2010.07.021
   Huang QS, 2008, CHEM ENG TECHNOL, V31, P1790, DOI 10.1002/ceat.200700278
   HUGHES RR, 1955, CHEM ENG PROG, V51, P557
   IDOGAWA K, 1987, CHEM ENG COMMUN, V59, P201, DOI 10.1080/00986448708911995
   Jamialahmadi M, 2001, CHEM ENG RES DES, V79, P523, DOI 10.1205/02638760152424299
   KHURANA AK, 1969, CHEM ENG SCI, V24, P1711, DOI 10.1016/0009-2509(69)87036-3
   Krishna R, 2003, CHEM ENG PROCESS, V42, P15, DOI 10.1016/S0255-2701(02)00012-0
   Kulkarni AA, 2005, IND ENG CHEM RES, V44, P5873, DOI 10.1021/ie049131p
   KUMAR R, 1970, CAN J CHEM ENG, V48, P383, DOI 10.1002/cjce.5450480407
   LEIBSON I, 1956, AICHE J, V2, P296, DOI 10.1002/aic.690020305
   Liow JL, 2000, CHEM ENG SCI, V55, P4515, DOI 10.1016/S0009-2509(00)00095-6
   Luo XM, 2018, CHEM ENG RES DES, V132, P822, DOI 10.1016/j.cherd.2018.02.033
   MARMUR A, 1973, CHEM ENG SCI, V28, P1455, DOI 10.1016/0009-2509(73)85150-4
   MARMUR A, 1976, CHEM ENG SCI, V31, P453, DOI 10.1016/0009-2509(76)80030-9
   MERSMANN A, 1983, CHEM-ING-TECH, V55, P865, DOI 10.1002/cite.330551113
   MIYAHARA T, 1986, CAN J CHEM ENG, V64, P718, DOI 10.1002/cjce.5450640502
   PARK Y, 1977, CHEM ENG SCI, V32, P907, DOI 10.1016/0009-2509(77)80077-8
   Rabiger N., 1986, ENCY FLUID MECH, V3, P58
   RAMAKRIS.S, 1969, CHEM ENG SCI, V24, P731, DOI 10.1016/0009-2509(69)80065-5
   Scargiali F, 2014, CHEM ENG TECHNOL, V37, P1507, DOI 10.1002/ceat.201300511
   Shi S., 2012, FDN ENG COAL HYDROLI
   [陶金亮 Tao Jinliang], 2018, [化工学报, CIESC Journal], V69, P2878
   TERASAKA K, 1993, CHEM ENG SCI, V48, P3417, DOI 10.1016/0009-2509(93)80159-N
   TSUGE H, 1983, CHEM ENG COMMUN, V22, P63, DOI 10.1080/00986448308940046
   [王凤坤 WANG Fengkun], 2008, [河南师范大学学报. 自然科学版, Journal of Henan Normal University. Natural Science], V36, P66
   Wang HY, 2011, CHINESE J CHEM ENG, V19, P529, DOI 10.1016/S1004-9541(11)60017-7
   Wang TF, 2007, IND ENG CHEM RES, V46, P5824, DOI 10.1021/ie070330t
   WRAITH AE, 1971, CHEM ENG SCI, V26, P1659, DOI 10.1016/0009-2509(71)86055-4
   Xiao ZY, 2005, CHEM ENG SCI, V60, P179, DOI 10.1016/j.ces.2004.07.064
   Yang XF, 2014, PROCEEDINGS OF THE ASME INTERNAL COMBUSTION ENGINE DIVISION FALL TECHNICAL CONFERENCE, 2013, VOL 2
   Zhang Li, 2008, THESIS
   [张立英 Zhang Liying], 2011, [过程工程学报, The Chinese Journal of Process Engineering], V11, P162
   Zhang WH, 2012, PATTERN RECOGN LETT, V33, P1543, DOI 10.1016/j.patrec.2012.03.027
NR 56
TC 3
Z9 3
U1 11
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 214
EP 224
DI 10.1016/j.ces.2019.02.009
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000019
DA 2020-05-12
ER

PT J
AU Kihara, T
   Obata, H
   Hirano, H
AF Kihara, Tomohiko
   Obata, Hideaki
   Hirano, Hiroyuki
TI Quantitative visualization of fluid mixing in slug flow for arbitrary
   wall-shaped microchannel using Shannon entropy
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Micro-reactor; Slug flow; CFD; Fluid mixing index; Shannon entropy
ID PARTICLE TRACKING METHOD; MASS-TRANSFER; GAS-LIQUID; MICROFLUIDICS; LAB;
   DROPLET; MODEL
AB Micro-reactors based on slug flow are among the most promising developments for improving the efficiencies of chemical reactions and unit operations in chemical engineering. Quantitative understanding of the local and global fluid dynamics and their effects on fluid mixing is required for designing effective slug flow micro-reactors. This paper proposes a new method for quantitative two-dimensional assessment of fluid mixing in slug flow. Pixel-wise calculation of local entropy inside a slug is discussed. The proposed method is based on two-phase simulation using the volume of fraction (VOF) algorithm and is thus applicable to the flow pattern in arbitrary wall-shaped micro-reactors. The method consists of three steps. (1) Flow analysis using two-phase VOF algorithm: A series of two-dimensional velocity fields inside the slug along time is obtained for a certain duration. (2) Backward particle tracking from the target image to the initial image: The slug in the initial image is divided into small regions, and each region is assigned a different label. Accumulation of backward particle tracking results reveals a two-dimensional distribution of labels in the target image. (3) Pixel-wise calculation of entropy on the obtained distribution of labels: The resulting image is a quantitative two-dimensional mixing pattern inside the slug. The proposed method was applied to three types of microchannels with different bumps on the walls. The results could quantitatively distinguish the differences in fluid mixing capability among the systems. (C) 2019 Published by Elsevier Ltd.
C1 [Kihara, Tomohiko; Obata, Hideaki] Okayama Univ Sci, Dept Biomed Engn, Fac Engn, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.
   [Hirano, Hiroyuki] Okayama Univ Sci, Dept Appl Chem & Biotechnol, Fac Engn, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.
RP Obata, H (reprint author), Okayama Univ Sci, Dept Biomed Engn, Fac Engn, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.
EM hobata@bme.ous.ac.jp
FU Grant for the Promotion of OUS Research Project of Okayama University of
   Science [OUS-RP-30-4]
FX This work was supported by the Grant for the Promotion of OUS Research
   Project (OUS-RP-30-4) of Okayama University of Science.
CR Aoki N, 2011, CHEM ENG J, V167, P651, DOI 10.1016/j.cej.2010.07.071
   Aref H, 2002, PHYS FLUIDS, V14, P1315, DOI 10.1063/1.1458932
   AREF H, 1984, J FLUID MECH, V143, P1, DOI 10.1017/S0022112084001233
   BARRY R, 2004, J NANOBIOTECHNOL, V2, P2
   Blanchette F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066316
   Camesasca M, 2005, J MICROMECH MICROENG, V15, P2038, DOI 10.1088/0960-1317/15/11/007
   Camesasca M, 2006, MACROMOL THEOR SIMUL, V15, P595, DOI 10.1002/mats.200600037
   Chandra AK, 2016, CHEM BIOCHEM ENG Q, V30, P149, DOI 10.15255/CABEQ.2015.2289
   Chang CC, 2006, J MICROMECH MICROENG, V16, P1453, DOI 10.1088/0960-1317/16/8/003
   Che ZZ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066309
   DANCKWERTS PV, 1952, APPL SCI RES, V3, P279, DOI 10.1007/BF03184936
   Daw R, 2006, NATURE, V442, P367, DOI 10.1038/442367a
   Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985
   Dogan H, 2009, INT J MULTIPHAS FLOW, V35, P1149, DOI 10.1016/j.ijmultiphaseflow.2009.07.006
   Ehrnstrom R, 2002, LAB CHIP, V2, p26N, DOI 10.1039/b203480h
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Fodor PS, 2009, EUR PHYS J-APPL PHYS, V47, DOI 10.1051/epjap/2009108
   Fries DM, 2009, CHEM ENG SCI, V64, P1326, DOI 10.1016/j.ces.2008.11.019
   Harries N, 2003, INT J HEAT MASS TRAN, V46, P3313, DOI 10.1016/S0017-9310(03)00120-0
   Kang LF, 2008, DRUG DISCOV TODAY, V13, P1, DOI 10.1016/j.drudis.2007.10.003
   Kang TG, 2008, MICROFLUID NANOFLUID, V4, P589, DOI 10.1007/s10404-007-0206-z
   Kang TG, 2007, CHEM ENG SCI, V62, P6677, DOI 10.1016/j.ces.2007.07.044
   Kang TG, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066303
   Kang TG, 2004, J MICROMECH MICROENG, V14, P891, DOI 10.1088/0960-1317/14/7/008
   Kashid MN, 2007, J COMPUT APPL MATH, V203, P487, DOI 10.1016/j.cam.2006.04.010
   Kashid MN, 2011, CHEM ENG SCI, V66, P3876, DOI 10.1016/j.ces.2011.05.015
   Kashid MN, 2005, IND ENG CHEM RES, V44, P5003, DOI 10.1021/ie0490536
   Khinchin A. I., 1957, MATH FDN INFORM THEO
   Krasnopolskaya TS, 1999, EUR J MECH B-FLUID, V18, P793, DOI 10.1016/S0997-7546(99)00119-3
   Mora AEM, 2019, CHEM ENG SCI, V196, P514, DOI 10.1016/j.ces.2018.11.020
   MANZ A, 1999, MICROSYSTEM TECHNOLO
   Matsumoto H, 2012, J CHEM ENG JPN, V45, P74, DOI 10.1252/jcej.11we131
   Matsuno H, 2012, ASIA-PAC J CHEM ENG, V7, pS48, DOI 10.1002/apj.633
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.3.CO;2-3
   Muradoglu M, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1992514
   Muradoglu M, 2004, J APPL MECH-T ASME, V71, P857, DOI 10.1115/1.1795222
   Nakata Y., 2017, J SOC POWDER TECHNOL, V54, P296
   Oosterbroek R.E., 2006, LAB CHIP MINIATURIZE
   Raimondi ND, 2008, CHEM ENG SCI, V63, P5522, DOI 10.1016/j.ces.2008.07.025
   Sarrazin F, 2008, MICROFLUID NANOFLUID, V5, P131, DOI 10.1007/s10404-007-0233-9
   Shannon C.E., 1963, MATH THEORY COMMUNIC
   Sivasamy J, 2010, CHEM ENG SCI, V65, P5382, DOI 10.1016/j.ces.2010.06.017
   Song H, 2003, ANGEW CHEM INT EDIT, V42, P768, DOI 10.1002/anie.200390203
   Sotowa KI, 2014, J CHEM ENG JPN, V47, P213, DOI 10.1252/jcej.13we141
   Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124
   Stone ZB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1929547
   SWANSON PD, 1990, J FLUID MECH, V213, P227, DOI 10.1017/S0022112090002300
   Tung KY, 2009, MICROFLUID NANOFLUID, V7, P545, DOI 10.1007/s10404-009-0415-8
   Vainchtein DL, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2738846
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Yang L, 2017, CHEM ENG SCI, V169, P106, DOI 10.1016/j.ces.2016.12.003
NR 51
TC 0
Z9 0
U1 6
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 225
EP 235
DI 10.1016/j.ces.2019.02.007
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000020
DA 2020-05-12
ER

PT J
AU Fedunik-Hofman, L
   Bayon, A
   Hinkley, J
   Lipinski, W
   Donne, SW
AF Fedunik-Hofman, Larissa
   Bayon, Alicia
   Hinkley, James
   Lipinski, Wojciech
   Donne, Scott W.
TI Friedman method kinetic analysis of CaO-based sorbent for
   high-temperature thermochemical energy storage
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Thermochemical energy storage; Chemical Looping; Carbonates;
   Thermochemistry; Thermogravimetry; Chemical Kinetics
ID CO2 CAPTURE; THERMAL-DECOMPOSITION; CARBONATION KINETICS; CALCIUM-OXIDE;
   MODEL; CALCINATION; PERFORMANCE; MECHANISMS; CONVERSION; EVOLUTION
AB A CaO-based sorbent synthesized using the Pechini method is shown to have improved stability and cyclability over commercial calcium carbonates and other Ca-based sorbents for thermochemical energy storage and other chemical looping processes under N-2 and a 100%-CO2 atmosphere. The improved performance is ascribed to the greater surface area and smaller grain and particle sizes of the synthesized material. A modified isoconversional approach (the Friedman method) was used to model the kinetics of the decomposition and carbonation reaction under different atmospheres. The model accounts for the dependence of the reaction rate on equilibrium pressure under different atmospheres, including a CO2 atmosphere similar to reactor conditions. For calcination, values of energy of 164 kJ mol(-1) (under N-2) and 307 kJ mol(-1) (under CO2) were found for the calcination of Pechini-synthesized CaCO3. For the carbonation of the synthesized CaO, approximate values of 200 kJ mol(-1) (25% v/v CO2) and 450 kJ mol(-1) (100% CO2) were obtained for the activation energies of the chemical reaction regions. Further research into Pechini-synthesized Ca-based sorbents with supports will be carried out to further improve energy storage density and cyclic stability of sorbents. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.
C1 [Fedunik-Hofman, Larissa; Donne, Scott W.] Univ Newcastle, Discipline Chem, Callaghan, NSW 2308, Australia.
   [Fedunik-Hofman, Larissa; Bayon, Alicia] CSIRO Energy, POB 330, Newcastle, NSW N2300, Australia.
   [Hinkley, James] Victoria Univ Wellington, Sustainable Energy Syst, Sch Engn & Comp Sci, Wellington, New Zealand.
   [Lipinski, Wojciech] Australian Natl Univ, Res Sch Elect Energy & Mat Engn, Canberra, ACT 2601, Australia.
RP Donne, SW (reprint author), Univ Newcastle, Discipline Chem, Callaghan, NSW 2308, Australia.
EM scott.donne@newcastle.edu.au
RI Fedunik-Hofman, Larissa/M-1201-2019
OI Fedunik-Hofman, Larissa/0000-0002-5484-6840; Donne,
   Scott/0000-0001-9389-7870; Lipinski, Wojciech/0000-0001-5478-6887;
   Hinkley, James/0000-0002-4069-7362; Bayon, Alicia/0000-0002-6422-0884
FU Australian Solar Thermal Research Institute (ASTRI) - Australian
   Government through the Australian Renewable Energy Agency (ARENA)
FX This research was performed with the support of the Australian Solar
   Thermal Research Institute (ASTRI), a program supported by the
   Australian Government through the Australian Renewable Energy Agency
   (ARENA). The authors would like to thank Jennifer Zobec and Yun Lin from
   the Electron Microscope and X-Ray Unit (EMX), Central Scientific
   Services, the University of Newcastle for their contribution to material
   characterisation.
CR Abanades JC, 2003, ENERG FUEL, V17, P308, DOI 10.1021/ef020152a
   Bader R, 2017, WOODHEAD PUBL SER EN, P403, DOI 10.1016/B978-0-08-100516-3.00018-6
   BARKER R, 1973, J APPL CHEM BIOTECHN, V23, P733
   Barnes P., 2006, TEMPERATURE EFFECTS
   Bayon A, 2018, ENERGY, V149, P473, DOI 10.1016/j.energy.2017.11.084
   BHATIA SK, 1983, AICHE J, V29, P79, DOI 10.1002/aic.690290111
   Biasin A, 2015, CHEM ENG SCI, V127, P13, DOI 10.1016/j.ces.2014.12.058
   CALDWELL KM, 1977, THERMOCHIM ACTA, V18, P15, DOI 10.1016/0040-6031(77)80031-2
   Cockcroft J. K., 2006, CASE STUDY
   Degen T., 2014, HIGHSCORE PLUS 3, V3
   Edwards SEB, 2012, SOL ENERGY, V86, P2494, DOI 10.1016/j.solener.2012.05.019
   Fan LS, 2012, ENERG ENVIRON SCI, V5, P7254, DOI 10.1039/c2ee03198a
   GALLAGHER PK, 1976, THERMOCHIM ACTA, V14, P255, DOI 10.1016/0040-6031(76)85002-2
   Garcia-Labiano F, 2002, CHEM ENG SCI, V57, P2381, DOI 10.1016/S0009-2509(02)00137-9
   Grasa G, 2009, AICHE J, V55, P1246, DOI 10.1002/aic.11746
   Grasa GS, 2008, CHEM ENG J, V137, P561, DOI 10.1016/j.cej.2007.05.017
   Grasa GS, 2006, IND ENG CHEM RES, V45, P8846, DOI 10.1021/ie0606946
   Grazulis S, 2012, NUCLEIC ACIDS RES, V40, pD420, DOI 10.1093/nar/gkr900
   Gupta H, 2002, IND ENG CHEM RES, V41, P4035, DOI 10.1021/ie010867l
   Jana P, 2010, INT J HYDROGEN ENERG, V35, P10285, DOI 10.1016/j.ijhydene.2010.07.125
   Jiang L, 2016, ENERG FUEL, V30, P9563, DOI 10.1021/acs.energyfuels.6b01368
   Kalafati D. D., 1991, Journal of Engineering Physics, V61, P1234, DOI 10.1007/BF00872591
   Khawam A, 2006, J PHYS CHEM B, V110, P17315, DOI 10.1021/jp062746a
   Kierzkowska AM, 2013, CHEMSUSCHEM, V6, P1130, DOI 10.1002/cssc.201300178
   Lee DK, 2004, CHEM ENG J, V100, P71, DOI 10.1016/j.cej.2003.12.003
   Li CC, 2014, J MATER CHEM A, V2, P8252, DOI 10.1039/c4ta00516c
   Li ZS, 2013, CHEM ENG SCI, V89, P235, DOI 10.1016/j.ces.2012.12.006
   Li ZS, 2012, ENERG FUEL, V26, P4607, DOI 10.1021/ef300607z
   Li ZS, 2005, ENERG FUEL, V19, P1447, DOI 10.1021/ef0496799
   Liavitskaya T, 2017, J PHYS CHEM C, V121, P15392, DOI 10.1021/acs.jpcc.7b05066
   Liavitskaya T, 2016, PHYS CHEM CHEM PHYS, V18, P32021, DOI 10.1039/c6cp04507c
   Liu W, 2016, CHEM ENG SCI, V139, P15, DOI 10.1016/j.ces.2015.09.016
   Liu W, 2012, CHEM ENG SCI, V69, P644, DOI 10.1016/j.ces.2011.11.036
   Lu H, 2009, ENERG FUEL, V23, P1093, DOI 10.1021/ef8007882
   Matthews L, 2012, ENERGY, V45, P900, DOI 10.1016/j.energy.2012.06.072
   Molinder R, 2012, ENERG ENVIRON SCI, V5, P8958, DOI 10.1039/c2ee21779a
   Pardo P, 2014, RENEW SUST ENERG REV, V32, P591, DOI 10.1016/j.rser.2013.12.014
   READING M, 1991, J THERM ANAL, V37, P2165, DOI 10.1007/BF01905585
   Rodriguez-Navarro C, 2009, AM MINERAL, V94, P578, DOI 10.2138/am.2009.3021
   Roine A., 2018, HSC CHEM 8 OUTOTEC
   Salaudeen SA, 2018, J CO2 UTIL, V23, P179, DOI 10.1016/j.jcou.2017.11.012
   Schaube F, 2011, J SOL ENERG-T ASME, V133, DOI 10.1115/1.4004245
   Stamnore BR, 2005, FUEL PROCESS TECHNOL, V86, P1707, DOI 10.1016/j.fuproc.2005.01.023
   Strohle J, 2014, FUEL, V127, P13, DOI 10.1016/j.fuel.2013.12.043
   Sun P, 2008, CHEM ENG SCI, V63, P57, DOI 10.1016/j.ces.2007.08.054
   Sun P, 2008, CHEM ENG SCI, V63, P47, DOI 10.1016/j.ces.2007.08.055
   Vyazovkin S, 1998, INT REV PHYS CHEM, V17, P407, DOI 10.1080/014423598230108
   Vyazovkin S, 2000, NEW J CHEM, V24, P913, DOI 10.1039/b004279j
   Vyazovkin S, 1997, ANNU REV PHYS CHEM, V48, P125, DOI 10.1146/annurev.physchem.48.1.125
   Vyazovkin S, 2016, PHYS CHEM CHEM PHYS, V18, P18643, DOI 10.1039/c6cp02491b
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   Wang JS, 2007, CHEM ENG COMMUN, V194, P1409, DOI 10.1080/00986440701401594
   Wang JY, 2014, ENERG ENVIRON SCI, V7, P3478, DOI 10.1039/c4ee01647e
   Wu SF, 2012, AICHE J, V58, P1570, DOI 10.1002/aic.12675
   Yue L, 2015, AICHE J, V61, P2647, DOI 10.1002/aic.14840
   Zhou ZM, 2013, CHEM ENG SCI, V95, P283, DOI 10.1016/j.ces.2013.03.047
NR 56
TC 9
Z9 9
U1 4
U2 45
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 236
EP 247
DI 10.1016/j.ces.2019.02.003
PG 12
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000021
DA 2020-05-12
ER

PT J
AU Liang, D
   Ma, R
   Fu, TT
   Zhu, CY
   Wang, K
   Ma, YG
   Luo, GS
AF Liang, Di
   Ma, Rui
   Fu, Taotao
   Zhu, Chunying
   Wang, Kai
   Ma, Youguang
   Luo, Guangsheng
TI Dynamics and formation of alternating droplets under magnetic field at a
   T-junction
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Microfluidics; Alternating droplets; Ferrofluid droplet; Magnetic field;
   Interface
ID SHEAR-THINNING FLUIDS; BREAKUP DYNAMICS; STEP-EMULSIFICATION;
   GENERATION; FERROFLUID; DEVICE; COALESCENCE; MECHANISM
AB The formation process of alternating droplets at the T-junction with a cross-sectional area of 400 mu m x 400 mu m was investigated using a high-speed camera. The alternating droplets were consisted of glycerol aqueous solution and ferrofluid droplets. Two formation types of alternating droplets were observed: normal formation and the upstream droplet squeezing formation. The existence of the magnetic field delayed the transition from the normal farmation to the upstream droplet squeezing formation. The effects of two-phase flow rate and magnetic flux density on the dynamics of the tip and the neck of the ferrofluid and the formation period were studied. The results show that the neck evolution of ferrofluid could be divided into the expansion stage and pinch-off stage. The expansion stage was dominated by the flow of ferrofluid, and the pinch-off stage was insensitive to fluid flow and was a self-similar process. The length of the tip of ferrofluid increases almost linearly with time during the pinch-off stage, and the increasing rate rose with the flow rates. The formation period of the droplets reduces as the fluid flow rate increases. When the formation type is normal formation, the existence of the magnetic field shortens the formation period. When the formation type is the upstream droplet squeezing regime, the existence of the magnetic field prolongs the formation period. This paper provides a new method for the generation of alternating droplets. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Liang, Di; Ma, Rui; Fu, Taotao; Zhu, Chunying; Ma, Youguang] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China.
   [Wang, Kai; Luo, Guangsheng] Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
   [Ma, Rui] China Petr & Chem Corp, SINOPEC Tianjin Co, Tianjin 300271, Peoples R China.
RP Fu, TT; Ma, YG (reprint author), Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China.
EM ttfu@tju.edu.cn; ygma@tju.edu.cn
OI Fu, Taotao/0000-0003-1881-1509; Wang, Kai/0000-0002-0873-6421
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21776200, 21576186, 91634105, 91434204]
FX This work was supported by the National Natural Science Foundation of
   China (No. 21776200, 21576186, 91634105, 91434204).
CR Akartuna I, 2015, LAB CHIP, V15, P1140, DOI 10.1039/c4lc01285b
   Beeran AE, 2015, COLLOID SURFACE B, V136, P1089, DOI 10.1016/j.colsurfb.2015.11.010
   Belder D, 2005, ANGEW CHEM INT EDIT, V44, P3521, DOI 10.1002/anie.200500620
   Chen XM, 2017, CHEM ENG SCI, V163, P1, DOI 10.1016/j.ces.2017.01.029
   Chokkalingam V, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3050461
   Chong ZZ, 2016, LAB CHIP, V16, P35, DOI 10.1039/c5lc01012h
   De Menech M, 2008, J FLUID MECH, V595, P141, DOI 10.1017/S002211200700910X
   Du W, 2018, CHEM ENG SCI, V176, P66, DOI 10.1016/j.ces.2017.10.019
   Du W, 2016, CHEM ENG SCI, V153, P255, DOI 10.1016/j.ces.2016.07.038
   Du W, 2016, AICHE J, V62, P325, DOI 10.1002/aic.15043
   Fu TT, 2016, CHEM ENG SCI, V144, P75, DOI 10.1016/j.ces.2015.12.031
   Garstecki P, 2006, LAB CHIP, V6, P693
   Ghaderi A, 2018, EUR J MECH B-FLUID, V67, P87, DOI 10.1016/j.euromechflu.2017.08.010
   Hirama H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15196
   Hoang DA, 2013, J FLUID MECH, V717, DOI 10.1017/jfm.2013.18
   Hung LH, 2006, LAB CHIP, V6, P174, DOI 10.1039/b513908b
   Li D, 2018, SENSOR ACTUAT B-CHEM, V255, P1048, DOI 10.1016/j.snb.2017.08.152
   Li XB, 2012, CHEM ENG SCI, V69, P340, DOI 10.1016/j.ces.2011.10.048
   Li Z, 2015, LAB CHIP, V15, P1023, DOI 10.1039/c4lc01289e
   Liu YY, 2018, AICHE J, V64, P376, DOI 10.1002/aic.15920
   Liu ZM, 2016, SOFT MATTER, V12, P5797, DOI 10.1039/c6sm01158f
   Mathieu JB, 2007, BIOMED MICRODEVICES, V9, P801, DOI 10.1007/s10544-007-9092-0
   Odenbach S, 2003, COLLOID SURFACE A, V217, P171, DOI 10.1016/S0927-7757(02)00573-3
   Phimsen S, 2017, CHEM ENG J, V314, P594, DOI 10.1016/j.cej.2016.12.017
   Postek W, 2017, LAB CHIP, V17, P1323, DOI 10.1039/c7lc00014f
   Ravaud R, 2010, TRIBOL INT, V43, P76, DOI 10.1016/j.triboint.2009.04.050
   Samie M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.053003
   Seemann R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016601
   Seo YS, 2010, J IND ENG CHEM, V16, P879, DOI 10.1016/j.jiec.2010.09.009
   Tan SH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/4/045004
   Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g
   Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163
   Tian L, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8020039
   Weltin A, 2014, LAB CHIP, V14, P138, DOI 10.1039/c3lc50759a
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b
   Wu YN, 2015, MICROFLUID NANOFLUID, V18, P19, DOI 10.1007/s10404-014-1414-y
   Wu YN, 2013, SOFT MATTER, V9, P9792, DOI 10.1039/c3sm51860d
   Xi HD, 2016, LAB CHIP, V16, P2982, DOI 10.1039/c6lc00448b
   Yao CQ, 2017, AICHE J, V63, P1727, DOI 10.1002/aic.15536
   Zhang QD, 2018, COLLOID SURFACE A, V537, P572, DOI 10.1016/j.colsurfa.2017.10.056
   Zheng B, 2004, ANAL CHEM, V76, P4977, DOI 10.1021/ac0495743
NR 42
TC 2
Z9 3
U1 14
U2 48
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 248
EP 256
DI 10.1016/j.ces.2019.01.053
PG 9
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000022
DA 2020-05-12
ER

PT J
AU Ahmad, N
   Tong, Y
   Lu, BN
   Wang, W
AF Ahmad, Nouman
   Tong, Ying
   Lu, Bona
   Wang, Wei
TI Extending the EMMS-bubbling model to fluidization of binary particle
   mixture: Parameter analysis and model validation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Binary mixture; Fluidization; EMMS; Segregation; Drag; CFD
ID GAS-SOLID FLOWS; SIZE DISTRIBUTION; CFD SIMULATIONS; SEGREGATION; BED;
   DRAG; RISERS; HYDRODYNAMICS; EXTENSION
AB Bubbling fluidized beds with binary particle mixture have broad industrial applications. The difference in particle size/density leads to segregation phenomenon thus should be taken into account in modeling. In this work, we propose a binary EMMS-bubbling drag model by considering such difference and formation of bubbles which are associated with solid segregation. The model is validated through simulation of two fluidized beds with different binary particle mixtures. The new drag model is found to enable capturing the pronounced movement of bubbles, thus well predicts the segregation behavior, while using conventional drag leads to over-mixing of different particles. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ahmad, Nouman; Tong, Ying; Lu, Bona; Wang, Wei] Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, Beijing 100190, Peoples R China.
   [Tong, Ying; Lu, Bona; Wang, Wei] Univ Chinese Acad Sci, Sinodanish Coll, Beijing 100049, Peoples R China.
   [Lu, Bona] Dalian Natl Lab Clean Energy, Dalian 116023, Peoples R China.
RP Lu, BN (reprint author), Chinese Acad Sci, Inst Proc Engn, State Key Lab Multiphase Complex Syst, Beijing 100190, Peoples R China.
EM bnlu@ipe.ac.cn
RI Wang, Wei/B-8494-2008
OI Wang, Wei/0000-0002-8290-1579
FU CAS-TWASChinese Academy of Sciences; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [21576263,
   21625605, 91834302]; "Transformational Technologies for Clean Energy and
   Demonstration", Strategic Priority Research Program of the Chinese
   Academy of Sciences [XDA21030700]; Chinese Academy of SciencesChinese
   Academy of Sciences [XXH13506-301]; Youth Innovation Promotion
   Association of Chinese Academy of Sciences [2015033]
FX The first auhor acknowledges the financial assistance provided by
   CAS-TWAS. This work is financially supported by the National Natural
   Science Foundation of China under Grant nos. 21576263, 21625605 and
   91834302, the "Transformational Technologies for Clean Energy and
   Demonstration", Strategic Priority Research Program of the Chinese
   Academy of Sciences under Grant no. XDA21030700, the Chinese Academy of
   Sciences under Grant no. XXH13506-301 and the Youth Innovation Promotion
   Association of Chinese Academy of Sciences (no. 2015033).
CR Ahmad N, 2019, CHINESE J CHEM ENG, V27, P54, DOI 10.1016/j.cjche.2018.04.011
   Andrews MJ, 1996, INT J MULTIPHAS FLOW, V22, P379, DOI 10.1016/0301-9322(95)00072-0
   ANSYS I., 2013, ANSYS FLUENT THEOR G
   Beetstra R, 2007, AICHE J, V53, P489, DOI 10.1002/aic.11065
   Chao ZX, 2012, PARTICUOLOGY, V10, P62, DOI 10.1016/j.partic.2011.10.001
   Chew JW, 2012, CHEM ENG SCI, V68, P82, DOI 10.1016/j.ces.2011.09.011
   CHIBA S, 1980, POWDER TECHNOL, V26, P1, DOI 10.1016/0032-5910(80)85001-7
   Cooper S, 2005, POWDER TECHNOL, V151, P27, DOI 10.1016/j.powtec.2004.11.041
   Deen NG, 2007, CHEM ENG SCI, V62, P28, DOI 10.1016/j.ces.2006.08.014
   Formisani B, 2013, AICHE J, V59, P729, DOI 10.1002/aic.13876
   Formisani B, 2001, CHEM ENG SCI, V56, P109, DOI 10.1016/S0009-2509(00)00426-7
   Gan JG, 2012, POWDER TECHNOL, V218, P69, DOI 10.1016/j.powtec.2011.11.041
   Gauthier D, 1999, CHEM ENG J, V74, P181, DOI 10.1016/S1385-8947(99)00075-3
   Ge W, 2002, CHEM ENG SCI, V57, P3993, DOI 10.1016/S0009-2509(02)00234-8
   Ge W, 2017, REV CHEM ENG, V33, P551, DOI 10.1515/revce-2015-0079
   GELDART D, 1972, POWDER TECHNOL, V6, P201, DOI 10.1016/0032-5910(72)83014-6
   Geng SJ, 2016, POWDER TECHNOL, V302, P384, DOI 10.1016/j.powtec.2016.09.001
   Gidaspow D., 1986, APPL MECH REV, V39, P1, DOI DOI 10.1115/1.3143702
   Gidaspow D., 1994, MULTIPHASE FLOW FLUI
   GRACE JR, 1991, CAN J CHEM ENG, V69, P1126, DOI 10.1002/cjce.5450690512
   Hilligardt K., 1987, CHEM ENG TECHNOL, V10, P272
   HOFFMANN AC, 1993, CHEM ENG SCI, V48, P1583, DOI 10.1016/0009-2509(93)80118-A
   Hong K, 2014, POWDER TECHNOL, V266, P424, DOI 10.1016/j.powtec.2014.06.064
   Hong K, 2013, CHEM ENG SCI, V99, P191, DOI 10.1016/j.ces.2013.05.050
   HORIO M, 1987, AICHE J, V33, P1865, DOI 10.1002/aic.690331113
   Joseph GG, 2007, AICHE J, V53, P2804, DOI 10.1002/aic.11282
   Li J., 1994, PATICLE FLUID 2 PHAS
   Li TW, 2014, POWDER TECHNOL, V265, P13, DOI 10.1016/j.powtec.2014.04.007
   Lu BN, 2013, AICHE J, V59, P1108, DOI 10.1002/aic.13917
   Lu BN, 2009, CHEM ENG SCI, V64, P3437, DOI 10.1016/j.ces.2009.04.024
   Lu HL, 2003, POWDER TECHNOL, V134, P86, DOI 10.1016/S0032-5910(03)00126-8
   Marzocchella A, 2000, AICHE J, V46, P2175, DOI 10.1002/aic.690461110
   Mazzei L, 2010, CHEM ENG J, V156, P432, DOI 10.1016/j.cej.2009.11.003
   McKeen T, 2003, POWDER TECHNOL, V129, P139, DOI 10.1016/S0032-5910(02)00294-2
   Olivieri G, 2004, AICHE J, V50, P3095, DOI 10.1002/aic.10340
   Owoyemi O, 2007, AICHE J, V53, P1924, DOI 10.1002/aic.11227
   Rasul MG, 1999, POWDER TECHNOL, V103, P175, DOI 10.1016/S0032-5910(98)00230-7
   ROWE PN, 1976, POWDER TECHNOL, V15, P141, DOI 10.1016/0032-5910(76)80042-3
   Shi ZS, 2011, CHEM ENG SCI, V66, P5541, DOI 10.1016/j.ces.2011.07.020
   Snider DM, 2001, J COMPUT PHYS, V170, P523, DOI 10.1006/jcph.2001.6747
   Taghipour F, 2005, CHEM ENG SCI, V60, P6857, DOI 10.1016/j.ces.2005.05.044
   Tian YJ, 2017, CHEM ENG SCI, V171, P271, DOI 10.1016/j.ces.2017.05.037
   TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7
   van Wachem BGM, 2001, AICHE J, V47, P1292, DOI 10.1002/aic.690470607
   Wang HF, 2018, AICHE J, V64, P2364, DOI 10.1002/aic.16163
   Wang JW, 2008, CHEM ENG SCI, V63, P1553, DOI 10.1016/j.ces.2007.11.023
   Wang W., 2015, ADV CHEM ENG, V47, P193
   Wang W, 2007, CHEM ENG SCI, V62, P208, DOI 10.1016/j.ces.2006.08.017
   Wen C.Y., 1966, CHEM ENG PROGR S SER, V62, P100, DOI DOI 10.1016/S0032-0633(98)00014-2
   Yang N, 2003, CHEM ENG J, V96, P71, DOI 10.1016/j.cej.2003.08.006
   Zhong HB, 2014, POWDER TECHNOL, V254, P36, DOI 10.1016/j.powtec.2014.01.016
   Zhou Q, 2015, CHEM ENG SCI, V122, P637, DOI 10.1016/j.ces.2014.10.025
NR 52
TC 3
Z9 3
U1 2
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 257
EP 267
DI 10.1016/j.ces.2019.02.016
PG 11
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000023
DA 2020-05-12
ER

PT J
AU Hejazi, SAH
   Shah, S
   Pini, R
AF Hejazi, Sayed Alireza Hosseinzadeh
   Shah, Saurabh
   Pini, Ronny
TI Dynamic measurements of drainage capillary pressure curves in carbonate
   rocks
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Capillarity; Core analysis; Porous media; Multiphase flow
ID SCALE INTERFACIAL CURVATURE; FLOW BEHAVIOR; PORE-SCALE; MULTIPHASE FLOW;
   POROUS-MEDIA; RELATIVE PERMEABILITY; CO2/WATER SYSTEM; BEREA SANDSTONE;
   CO2; HETEROGENEITY
AB The heterogeneity of rocks represents a challenge for interpreting and using outcomes from multiphase-flow experiments carried out on laboratory samples. While the capillary pressure-saturation function, p(c)(S), is known to vary spatially and cause local saturation development during immiscible displacements, its variation remains difficult to measure. This is particularly challenging for rocks with complex fabrics, such as carbonates. Here, we present a workflow for the dynamic measurement of core-and subcore-scale drainage pcoS+ curves in heterogeneous porous media. Multi-rate, two-phase core-flooding tests are conducted on three carbonate rocks with direct observations of local saturation data. The interpretation of the experiments is done by fitting the parameters of the p(c)(S) curve, while describing both steady-state saturation and pressure profiles with a detailed one-dimensional model that accounts for the variation of subcore-scale properties in the direction of displacement. Workflow validation is achieved by means of synthetic data, thereby demonstrating the uniqueness of the solution of the resulting multi-objective optimisation problem. The model reproduces accurately experimental data on the three rocks and enables computing the effective core-scale p(c)(S) curve in the limit of zero velocity, as it would be expected during a porous-plate experiment. The output of the proposed technique is however much richer and includes the relative p(c)(S) curve that is universal and independent of the specific pattern of heterogeneity, in addition to a set of scaling factors. The latter describe the distribution of the p(c)(S) curves at the subcore-scale due to heterogeneity and form the statistical basis needed for upscaling studies. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hejazi, Sayed Alireza Hosseinzadeh; Shah, Saurabh; Pini, Ronny] Imperial Coll London, Dept Chem Engn, London, England.
   [Shah, Saurabh; Pini, Ronny] Imperial Coll London, Qatar Carbonates & Carbon Storage Res Ctr, London, England.
RP Hejazi, SAH (reprint author), Imperial Coll London, Dept Chem Engn, London, England.
EM a.hejazi@imperial.ac.uk
FU Qatar Petroleum; ShellRoyal Dutch Shell; Qatar Science and Technology
   Park; Natural Environment Research CouncilNERC Natural Environment
   Research Council [NE/N016173/1]
FX This work was carried out as part of the Qatar Carbonates and Carbon
   Storage Centre (QCCSRC). We gratefully acknowledge the funding of QCCSRC
   provided jointly by Qatar Petroleum, Shell, and the Qatar Science and
   Technology Park. SAHH and RP also acknowledge funding by the Natural
   Environment Research Council (grant NE/N016173/1). We also thank Dr. Ben
   Niu for the technical support during the core-floodong experiments and
   Joshua Momodu for carrying out routine characterisation of the rock
   plugs.
CR Al-Menhali A, 2015, WATER RESOUR RES, V51, P7895, DOI 10.1002/2015WR016947
   Alemu BL, 2013, GEOPHYS PROSPECT, V61, P235, DOI 10.1111/j.1365-2478.2012.01061.x
   ANDERSON WG, 1987, J PETROL TECHNOL, V39, P1283, DOI 10.2118/15271-PA
   Armstrong RT, 2014, GEOPHYS RES LETT, V41, P55, DOI 10.1002/2013GL058075
   Armstrong RT, 2012, ADV WATER RESOUR, V46, P55, DOI 10.1016/j.advwatres.2012.05.009
   Berg S, 2013, INT J GREENH GAS CON, V12, P478, DOI 10.1016/j.ijggc.2011.04.005
   Brooks R, 1964, HYDROL PAP, P1
   BROWN HW, 1951, T AM I MIN MET ENG, V192, P67
   Chang J, 1992, SPE RESERVOIR ENG, V7, P285, DOI DOI 10.2118/18798-PA
   CHAOUCHE M, 1994, CHEM ENG SCI, V49, P2447, DOI 10.1016/0009-2509(94)E0040-W
   Chardaire-Riviere C, 1992, SPE FORMATION EVAL, V7, P283, DOI DOI 10.2118/19680-PA
   CHRISTOFFERSEN KR, 1995, SPE FORMATION EVAL, V10, P153, DOI 10.2118/26673-PA
   Dale M, 1997, TRANSPORT POROUS MED, V26, P229, DOI 10.1023/A:1006536021302
   Dury O, 1999, WATER RESOUR RES, V35, P1481, DOI 10.1029/1999WR900019
   Egermann P, 2005, PETROPHYSICS, V46, P335
   Ehrenberg SN, 2007, AAPG BULL, V91, P835, DOI 10.1306/01090706093
   El-Maghraby RM, 2013, ENVIRON SCI TECHNOL, V47, P227, DOI 10.1021/es304166u
   FORDHAM EJ, 1993, AICHE J, V39, P1431, DOI 10.1002/aic.690390903
   Georgiadis A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.033002
   GRAUE A, 1994, SPE DRILL COMPLETION, V9, P57, DOI 10.2118/21101-PA
   Haghpanah R, 2013, IND ENG CHEM RES, V52, P4249, DOI 10.1021/ie302658y
   HASSANIZADEH SM, 1987, TRANSPORT POROUS MED, V2, P521
   Hejazi SAH, 2017, IND ENG CHEM RES, V56, P5679, DOI 10.1021/acs.iecr.7b00219
   Herring AL, 2017, ADV WATER RESOUR, V107, P460, DOI 10.1016/j.advwatres.2017.05.011
   Hilfer R, 1996, TRANSPORT POROUS MED, V22, P53, DOI 10.1007/BF00974311
   HOPMANS JW, 1987, J HYDROL, V93, P241, DOI 10.1016/0022-1694(87)90098-9
   Huang DD, 1998, J PETROL SCI ENG, V19, P103, DOI 10.1016/S0920-4105(97)00040-5
   HUANG Y, 1996, SPE J, V1, P451, DOI DOI 10.2118/30781-PA
   HUANG YD, 1995, SPE RESERVOIR ENG, V10, P287, DOI 10.2118/28942-PA
   Jackson SJ, 2018, WATER RESOUR RES, V54, P3139, DOI 10.1029/2017WR022282
   JENNINGS J, 1988, SPE FORMATION EVAL, V3, P322, DOI DOI 10.2118/14418-PA
   Joekar-Niasar V, 2010, J FLUID MECH, V655, P38, DOI 10.1017/S0022112010000704
   Joss L, 2017, J PHYS CHEM C, V121, P26903, DOI 10.1021/acs.jpcc.7b09836
   Krause M, 2011, SPE J, V16, P768, DOI 10.2118/126340-PA
   Krause M, 2013, TRANSPORT POROUS MED, V98, P565, DOI 10.1007/s11242-013-0161-y
   Krause MH, 2015, ADV WATER RESOUR, V83, P376, DOI 10.1016/j.advwatres.2015.07.009
   Krevor SCM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048239
   Kuo CW, 2015, ADV WATER RESOUR, V79, P1, DOI 10.1016/j.advwatres.2015.01.012
   Li BX, 2015, ADV WATER RESOUR, V83, P389, DOI 10.1016/j.advwatres.2015.07.010
   Lin QY, 2018, WATER RESOUR RES, V54, P7046, DOI [10.1029/2018WR023214, 10.1029/2018wr023214]
   Oh J, 2013, ADV WATER RESOUR, V62, P442, DOI 10.1016/j.advwatres.2013.03.007
   Olivier P, 2005, PETROPHYSICS, V46, P424
   Pentland CH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046683
   Perrin JC, 2010, TRANSPORT POROUS MED, V82, P93, DOI 10.1007/s11242-009-9426-x
   Pini R, 2017, ADV WATER RESOUR, V108, P277, DOI 10.1016/j.advwatres.2017.08.011
   Pini R, 2013, GEOPHYS RES LETT, V40, P3903, DOI 10.1002/grl.50756
   Pini R, 2013, WATER RESOUR RES, V49, P3516, DOI 10.1002/wrcr.20274
   Pini R, 2012, ADV WATER RESOUR, V38, P48, DOI 10.1016/j.advwatres.2011.12.007
   PURCELL WR, 1949, J PETROL TECHNOL, V186, P39, DOI DOI 10.2118/949039-G
   Raeesi B, 2014, VADOSE ZONE J, V13, DOI 10.2136/vzj2013.06.0097
   RAMAKRISHNAN TS, 1991, CHEM ENG SCI, V46, P1157, DOI 10.1016/0009-2509(91)85109-B
   Reynolds CA, 2015, WATER RESOUR RES, V51, P9464, DOI 10.1002/2015WR018046
   Ringrose PS, 1993, J PETROL SCI ENG, V9, P103, DOI 10.1016/0920-4105(93)90071-L
   Saadatpoor E, 2010, TRANSPORT POROUS MED, V82, P3, DOI 10.1007/s11242-009-9446-6
   Shi JQ, 2011, INT J GREENH GAS CON, V5, P75, DOI 10.1016/j.ijggc.2010.07.003
   Tokunaga TK, 2013, WATER RESOUR RES, V49, P4566, DOI 10.1002/wrcr.20316
   VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x
   Virnovsky GA, 2004, TRANSPORT POROUS MED, V54, P167, DOI 10.1023/A:1026363132351
   WARRICK AW, 1977, WATER RESOUR RES, V13, P355, DOI 10.1029/WR013i002p00355
   Wei N, 2014, GREENH GASES, V4, P400, DOI 10.1002/ghg.1407
   WILKINSON D, 1986, PHYS REV A, V34, P1380, DOI 10.1103/PhysRevA.34.1380
   Zhang DX, 2000, GEOPHYS RES LETT, V27, P1195, DOI 10.1029/1999GL011101
   Zhang Y, 2014, GEOPHYS J INT, V197, P1789, DOI 10.1093/gji/ggu089
NR 63
TC 5
Z9 4
U1 1
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 268
EP 284
DI 10.1016/j.ces.2019.02.002
PG 17
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000024
DA 2020-05-12
ER

PT J
AU Siddiqui, O
   Dincer, I
AF Siddiqui, O.
   Dincer, I
TI Development and performance evaluation of a direct ammonia fuel cell
   stack
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Direct ammonia; Fuel cell stack; Peak power density; Open circuit
   voltage; Efficiencies
ID ELECTROCHEMICAL OXIDATION; BINARY-ALLOYS; MOLTEN; SOFC; IR
AB In the present study, the experimental investigation and performance evaluation of a newly developed direct type ammonia fuel cell stack are performed. A solid anion exchange membrane electrolyte is also utilized. The performances of a single-cell and a 5-cell stack are investigated through thermodynamic efficiencies. The open circuit voltages for a single cell and 5-cell stack are obtained as 280 +/- 8 mV and 1249 +/- 37.5 mV respectively. Furthermore, the peak power densities are found as 6.4 +/- 0.2 W m(-2) and 13.4 +/- 0.4W m(-2) for a single-cell and a 5-cell stack respectively. Moreover, the effects of varying humidifier temperatures on their efficiencies are studied, and hence increasing humidifier temperatures are found to provide higher efficiencies. Both energetic and exergetic efficiencies at the peak power density are determined to be 52.4 +/- 1.6% and 49.3 +/- 1.6% respectively under the ambient conditions considered. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Siddiqui, O.; Dincer, I] Univ Ontario Inst Technol, Fac Engn & Appl Sci, Clean Energy Res Lab, 2000 Simcoe St North, Oshawa, ON L1H 7K4, Canada.
RP Siddiqui, O (reprint author), Univ Ontario Inst Technol, Fac Engn & Appl Sci, Clean Energy Res Lab, 2000 Simcoe St North, Oshawa, ON L1H 7K4, Canada.
EM osamah.siddiqui@uoit.net; ibrahim.dincer@uoit.net
RI Siddiqui, Osamah/AAI-2754-2020
CR Ahmed M, 2011, INT J ENERG RES, V35, P1213, DOI 10.1002/er.1889
   [Anonymous], AMI7001 MEMBR INT IN
   [Anonymous], PLAT VULC CARB PAP E
   Ay M, 2006, INT J EXERGY, V3, P16, DOI 10.1504/IJEX.2006.008324
   Bunce NJ, 2011, ELECTROCHIM ACTA, V56, P8085, DOI 10.1016/j.electacta.2011.07.078
   de Mishima BAL, 1998, ELECTROCHIM ACTA, V43, P395, DOI 10.1016/S0013-4686(97)00061-3
   de Vooys ACA, 2001, J ELECTROANAL CHEM, V506, P127, DOI 10.1016/S0022-0728(01)00491-0
   Demirel Y, 2013, ARAB J SCI ENG, V38, P221, DOI 10.1007/s13369-012-0450-8
   Endo K, 2004, ELECTROCHIM ACTA, V49, P2503, DOI 10.1016/j.electacta.2004.01.025
   Endo K, 2004, ELECTROCHIM ACTA, V49, P1635, DOI 10.1016/electacta.2003.11.024
   Fournier GGM, 2006, J POWER SOURCES, V162, P198, DOI 10.1016/j.jpowsour.2006.06.047
   Fuerte A, 2009, J POWER SOURCES, V192, P170, DOI 10.1016/j.jpowsour.2008.11.037
   Ganley JC, 2008, J POWER SOURCES, V178, P44, DOI 10.1016/j.jpowsour.2007.11.093
   Lan R, 2010, ELECTROCHEM SOLID ST, V13, pB83, DOI 10.1149/1.3428469
   Lee KR, 2014, RSC ADV, V4, P5638, DOI 10.1039/c3ra44057e
   Li YS, 2016, INT J HYDROGEN ENERG, V41, P20336, DOI 10.1016/j.ijhydene.2016.08.180
   Li YS, 2018, ACS SUSTAIN CHEM ENG, V6, P12827, DOI 10.1021/acssuschemeng.8b02084
   Li YS, 2017, ANGEW CHEM INT EDIT, V56, P5734, DOI 10.1002/anie.201701816
   Li YS, 2014, RSC ADV, V4, P16879, DOI 10.1039/c4ra01399a
   Lin Y, 2010, INT J HYDROGEN ENERG, V35, P2637, DOI 10.1016/j.ijhydene.2009.04.019
   Liu MF, 2008, J POWER SOURCES, V185, P188, DOI 10.1016/j.jpowsour.2008.06.076
   Ma QL, 2007, J POWER SOURCES, V164, P86, DOI 10.1016/j.jpowsour.2006.09.093
   Ma QL, 2006, ELECTROCHEM COMMUN, V8, P1791, DOI 10.1016/j.elecom.2006.08.012
   Ma QL, 2006, J POWER SOURCES, V161, P95, DOI 10.1016/j.jpowsour.2006.04.099
   Maffei N., 2008, Journal of Power Sources, V175, P221, DOI 10.1016/j.jpowsour.2007.09.040
   Maffei N, 2005, J POWER SOURCES, V140, P264, DOI 10.1016/j.jpowsour.2004.08.020
   McFarlan A, 2004, J ELECTROCHEM SOC, V151, pA930, DOI 10.1149/1.1738133
   Meng GY, 2007, J POWER SOURCES, V173, P189, DOI 10.1016/j.jpowsour.2007.05.002
   Okanishi T., 2017, FUEL CELLS, P1
   Pelletier L, 2005, J POWER SOURCES, V145, P262, DOI 10.1016/j.jpowsour.2005.02.040
   Schuth F, 2012, ENERG ENVIRON SCI, V5, P6278, DOI 10.1039/c2ee02865d
   Siddiqui O, 2019, ENERGY, V169, P914, DOI 10.1016/j.energy.2018.12.096
   Siddiqui O, 2018, FUEL CELLS, V18, P379, DOI 10.1002/fuce.201800052
   Suzuki S, 2012, J POWER SOURCES, V208, P257, DOI 10.1016/j.jpowsour.2012.02.043
   U. S. Energy Information Administration, 2016, MONTHL EN REV
   Worldbank, 2014, FOSS FUEL EN CONS TO
   Xie K, 2007, J POWER SOURCES, V170, P38, DOI 10.1016/j.jpowsour.2007.03.059
   Yang J, 2014, J POWER SOURCES, V245, P277, DOI 10.1016/j.jpowsour.2013.06.143
   Zhang LM, 2008, J POWER SOURCES, V179, P92, DOI 10.1016/j.jpowsour.2007.12.061
NR 39
TC 5
Z9 5
U1 17
U2 63
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 285
EP 293
DI 10.1016/j.ces.2019.01.059
PG 9
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000025
DA 2020-05-12
ER

PT J
AU McDonough, JR
   Law, R
   Reay, DA
   Zivkovic, V
AF McDonough, J. R.
   Law, R.
   Reay, D. A.
   Zivkovic, V
TI Fluidization in small-scale gas-solid 3D-printed fluidized beds
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Additive manufacturing; Micro-fluidized bed; Bubbling; Slugging;
   Turbulence
ID WALL FRICTION; PRESSURE FLUCTUATION; HORIZONTAL CHANNEL; FLOW;
   HYDRODYNAMICS; PARTICLES; ROUGHNESS; ONSET; DIAMETER; VELOCITY
AB Additive manufacturing could be used to facilitate the rapid fabrication and testing of small-scale fluidized beds for use in screening applications, such as adsorbent screening for carbon capture. In this work, experiments were performed in order to map the different flow regimes produced in small-scale (D-h = 3-15 mm) gas-solid fluidized beds that were fabricated using additive manufacturing using the stereolithography approach. Here, the effects of bed hydraulic diameter (D-h), static particle height (H-s), and particle type/size (D-p and rho(p)) were considered. Pressure drop data and high speed camera images were used to develop simple flow regime maps for these printed beds showing the operating windows for packed bed, bubbling, slugging and turbulence applicable to a wide range of bed size to particle diameter ratios (D-h/D-p = 20-200) and gas velocities (U-g = 1-400 mm/s) in both '2D' and '3D' bed aspect ratios. Fast Fourier transforms of the pressure drop signals were also used to study the evolution of bubbling/slugging behaviour as the gas velocity was increased by creating 2D colour maps of the frequency spectra. These allowed a new quantitative method to be proposed for the identification of slugging-the point where the dominant frequency in the power spectrum becomes constant as the gas velocity increases. It is concluded in this study that the rougher surfaces generated by additive manufacturing do not influence the fluidization characteristics nor modify the wall effects of small-scale beds. Macro-scale fluidization could also be achieved at smaller D-h/D-p ratios in these 3D printed beds compared to more conventional Plexiglas beds (D-h/D-p = 75 compared to D-h/D-p = 300). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [McDonough, J. R.; Law, R.; Reay, D. A.; Zivkovic, V] Newcastle Univ, Sch Engn, Merz Court, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RP McDonough, JR (reprint author), Newcastle Univ, Sch Engn, Merz Court, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM jonathan.mcdonough@ncl.ac.uk
FU EPSRCEngineering & Physical Sciences Research Council (EPSRC)
   [EP/N024540/1]
FX This work is part of a collaborative carbon capture project with Heriot
   Watt University and University of Sheffield funded by the EPSRC [Grant
   No. EP/N024540/1].
CR Agu CE, 2017, CHEM ENG J, V328, P997, DOI 10.1016/j.cej.2017.07.098
   BAEYENS J, 1974, CHEM ENG SCI, V29, P255, DOI 10.1016/0009-2509(74)85051-7
   Bi HT, 2000, CHEM ENG SCI, V55, P4789, DOI 10.1016/S0009-2509(00)00107-X
   BROADHURST TE, 1975, AICHE J, V21, P238, DOI 10.1002/aic.690210204
   DiMattia DG, 1997, CAN J CHEM ENG, V75, P452, DOI 10.1002/cjce.5450750220
   do Nascimento OL, 2016, POWDER TECHNOL, V304, P55, DOI 10.1016/j.powtec.2016.05.013
   FAN LT, 1983, AICHE J, V29, P33, DOI 10.1002/aic.690290105
   GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3
   Guardiola J, 1996, J ELECTROSTAT, V37, P1, DOI 10.1016/0304-3886(96)00002-2
   Guo QJ, 2009, CHEM ENG TECHNOL, V32, P1992, DOI 10.1002/ceat.200900092
   Guo YZ, 2016, ENERG FUEL, V30, P6021, DOI 10.1021/acs.energyfuels.6b00538
   Hang F, 2014, J SEMICOND, V35, DOI 10.1088/1674-4926/35/2/024005
   HO TC, 1983, POWDER TECHNOL, V35, P249, DOI 10.1016/0032-5910(83)87015-6
   Jafari D, 2018, RENEW SUST ENERG REV, V91, P420, DOI 10.1016/j.rser.2018.03.109
   Jaiboon OA, 2013, CHEM ENG J, V219, P262, DOI 10.1016/j.cej.2012.12.081
   Jaiboon OA, 2013, POWDER TECHNOL, V233, P215, DOI 10.1016/j.powtec.2012.09.014
   JOHNSON PC, 1987, J FLUID MECH, V176, P67, DOI 10.1017/S0022112087000570
   Khana MN, 2017, ENRGY PROCED, V105, P1998, DOI 10.1016/j.egypro.2017.03.573
   Kong WB, 2017, IND ENG CHEM RES, V56, P4136, DOI 10.1021/acs.iecr.6b04798
   Kuhar M, 2005, J PROSTHET DENT, V93, P76, DOI 10.1016/j.prosdent.2004.10.002
   Kussin J, 2002, EXP FLUIDS, V33, P143, DOI 10.1007/s00348-002-0485-9
   Lain S, 2008, POWDER TECHNOL, V184, P76, DOI 10.1016/j.powtec.2007.08.013
   Leu LP, 2009, KOREAN J CHEM ENG, V26, P513, DOI 10.1007/s11814-009-0087-9
   Leva M., 1951, FLUID FLOW PACKED FL, P58
   Li TW, 2012, AICHE J, V58, P2058, DOI 10.1002/aic.12728
   Liu XH, 2008, CHEM ENG J, V137, P302, DOI 10.1016/j.cej.2007.04.035
   Loezos PN, 2002, CHEM ENG SCI, V57, P5123, DOI 10.1016/S0009-2509(02)00421-9
   Mabrouk R, 2008, POWDER TECHNOL, V186, P80, DOI 10.1016/j.powtec.2007.11.009
   Macdonald NP, 2017, ANAL CHEM, V89, P3858, DOI 10.1021/acs.analchem.7b00136
   McDonough Jonathan R., 2018, Thermal Science and Engineering Progress, V8, P17, DOI 10.1016/j.tsep.2018.07.012
   Mehrani P, 2005, J ELECTROSTAT, V63, P165, DOI 10.1016/j.elstat.2004.10.003
   NOORDERGRAAF IW, 1987, POWDER TECHNOL, V52, P59, DOI 10.1016/0032-5910(87)80007-4
   Norouzi HR, 2011, CHEM ENG RES DES, V89, P817, DOI 10.1016/j.cherd.2010.10.014
   Odeleye AOO, 2018, CHEM ENG RES DES, V140, P194, DOI 10.1016/j.cherd.2018.09.042
   Okafor O, 2017, REACT CHEM ENG, V2, P129, DOI 10.1039/c6re00210b
   Parra-Cabrera C, 2018, CHEM SOC REV, V47, P209, DOI 10.1039/c7cs00631d
   Potic B, 2005, CHEM ENG SCI, V60, P5982, DOI 10.1016/j.ces.2005.04.047
   Rao A, 2010, AICHE J, V56, P2304, DOI 10.1002/aic.12161
   ROJO V, 1986, CHEM ENG SCI, V41, P2171, DOI 10.1016/0009-2509(86)87133-0
   Sanchez-Delgado S, 2011, POWDER TECHNOL, V207, P145, DOI 10.1016/j.powtec.2010.10.020
   SAXENA SC, 1983, POWDER TECHNOL, V36, P61, DOI 10.1016/0032-5910(83)80009-6
   Shen LH, 2004, CHEM ENG SCI, V59, P2607, DOI 10.1016/j.ces.2004.01.063
   Shende P, 2018, BIOMED PHARMACOTHER, V107, P146, DOI 10.1016/j.biopha.2018.07.167
   Sommerfeld M, 2004, POWDER TECHNOL, V142, P180, DOI 10.1016/j.powtec.2004.05.002
   Srivastava A, 2002, POWDER TECHNOL, V124, P45, DOI 10.1016/S0032-5910(01)00471-5
   TSINONTIDES SC, 1993, J FLUID MECH, V255, P237, DOI 10.1017/S0022112093002472
   Vakhshouri K, 2010, PARTICUOLOGY, V8, P2, DOI 10.1016/j.partic.2009.05.005
   Wang F, 2011, IND ENG CHEM RES, V50, P4741, DOI 10.1021/ie102245m
   Wang HY, 2017, CHEM ENG PROCESS, V118, P78, DOI 10.1016/j.cep.2017.04.007
   Wang JW, 2011, CHEM ENG SCI, V66, P2001, DOI 10.1016/j.ces.2011.02.003
   Wilson R, 2017, POWDER TECHNOL, V312, P321, DOI 10.1016/j.powtec.2017.01.080
   YERUSHALMI J, 1979, POWDER TECHNOL, V24, P187, DOI 10.1016/0032-5910(79)87036-9
   Yu JA, 2010, AICHE J, V56, P2905, DOI 10.1002/aic.12205
   Zhou J, 1996, AICHE J, V42, P1153, DOI 10.1002/aic.690420427
   Zhu HY, 2008, CAN J CHEM ENG, V86, P553, DOI 10.1002/cjce.20059
   Zivkovic V, 2015, CHEM ENG SCI, V126, P143, DOI 10.1016/j.ces.2014.12.023
   Zivkovic V, 2013, AICHE J, V59, P361, DOI 10.1002/aic.13961
NR 57
TC 1
Z9 1
U1 0
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 294
EP 309
DI 10.1016/j.ces.2019.01.048
PG 16
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000026
DA 2020-05-12
ER

PT J
AU Hoffmann, AC
   Skorpen, A
   Chang, YF
AF Hoffmann, Alex C.
   Skorpen, Ashild
   Chang, Yu-Fen
TI Positron emission particle tracking and CFD investigation of
   hydrocyclones acting on liquids of varying viscosity
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hydrocyclones; Viscous liquids; Liquid and particle flow; Positron
   emission particle tracking; CFD; Large Eddy simulations
ID FLOW PATTERN; MOTION; SEPARATION; SIMULATION; MEDIA
AB Cyclone separators are widely used for separation of solids or droplets from gases or liquid fluids. They represent an elegant and robust separation technology involving low capital and maintenance costs. It is therefore interesting, to extend cyclone technology to new applications, particularly in the oil and gas industry where separation duties are becoming ever more demanding and diverse, and separation processes are moving to more remote installations, such as sub-sea or even down-hole installations. The objective of this paper is to elucidate the working of hydrocyclones including ones acting on liquids of elevated viscosity using state-of-the-art experimental and analysis techniques, namely positron emission particle tracking (PEPT) and computational fluid dynamics (CFD) with large-eddy simulation of turbulence effects. The results show a number of interesting and anomalous features of the liquid and particle flow, such as unexpected excursions of particles to the inner vortex and the effect of the vortex end on the particle flow. It is shown that it is possible to determine the axis of the hydrocyclone very precisely by a minimization technique and thus convert the output from the tracking algorithm in Cartesian coordinates to cylindrical coordinates with the cyclone as axis. This throws additional light on the results. Tracks of different particles, some of which are eventually captured and some which are lost, are shown both in 3-D Cartesian and 2-D cylindrical coordinates and the effects of the fluid and particle properties are discussed. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hoffmann, Alex C.; Skorpen, Ashild; Chang, Yu-Fen] Univ Bergen, Dept Phys & Technol, Bergen, Norway.
RP Hoffmann, AC (reprint author), Univ Bergen, Dept Phys & Technol, Bergen, Norway.
EM alex.hoffmann@uib.no
RI Chang, Yu-Fen/L-3254-2018; Chang, Yu-Fen/U-9485-2019
OI Chang, Yu-Fen/0000-0002-9147-9162; Chang, Yu-Fen/0000-0002-9147-9162
CR Agar G. E., 1966, AIMS T, V235, P145
   Chan CW, 2009, POWDER TECHNOL, V194, P58, DOI 10.1016/j.powtec.2009.03.032
   Chan CW, 2009, POWDER TECHNOL, V193, P137, DOI 10.1016/j.powtec.2009.02.016
   Chan CW, 2009, IND ENG CHEM RES, V48, P253, DOI 10.1021/ie800213g
   Chang YF, 2011, CHEM ENG SCI, V66, P4203, DOI 10.1016/j.ces.2011.06.001
   Chang Y.-F., 2012, P 6 INT S PROC TOM C
   Chang YF, 2011, AIP CONF PROC, V1389, DOI 10.1063/1.3636698
   Derksen JJ, 2006, POWDER TECHNOL, V163, P59, DOI 10.1016/j.powtec.2006.01.006
   Derksen JJ, 2005, COMPUT FLUIDS, V34, P301, DOI 10.1016/j.compfluid.2004.06.001
   Derksen JJ, 2003, AICHE J, V49, P1359, DOI 10.1002/aic.690490603
   Ding YL, 2002, INT J MULTIPHAS FLOW, V28, P635, DOI 10.1016/S0301-9322(01)00081-7
   Emami S, 2010, J FOOD PROCESS ENG, V33, P728, DOI 10.1111/j.1745-4530.2008.00300.x
   Fonnes D. G., 2011, INVESTIGATION PARTIC
   Guo J, 2006, PROCEEDINGS OF THE CONFERENCE OF GLOBAL CHINESE SCHOLARS ON HYDRODYNAMICS, P394
   Hoffmann A.C., 2007, GAS CYCLONES SWIRL T
   Hoffmann AC, 2005, MEAS SCI TECHNOL, V16, P851, DOI 10.1088/0957-0233/16/3/029
   IOZIA DL, 1989, AEROSOL SCI TECH, V10, P491, DOI 10.1080/02786828908959289
   ISRAEL R, 1983, AEROSOL SCI TECH, V2, P45
   Kawatra SK, 1996, MINER ENG, V9, P881, DOI 10.1016/0892-6875(96)00079-9
   Leonard A., 1975, ADV GEOPHYSICS     A, P237, DOI [DOI 10.1016/S0065-2687(08)60464-1, 10.1016/S0065-2687(08)60464-1]
   Marthinussen SA, 2014, CHEM ENG SCI, V108, P169, DOI 10.1016/j.ces.2014.01.008
   Middha P, 2013, POWDER TECHNOL, V237, P87, DOI 10.1016/j.powtec.2013.01.024
   Peng W, 2002, POWDER TECHNOL, V127, P212, DOI 10.1016/S0032-5910(02)00148-1
   Pisarev GI, 2012, POWDER TECHNOL, V222, P101, DOI 10.1016/j.powtec.2012.02.006
   Pisarev GI, 2012, AICHE J, V58, P1371, DOI 10.1002/aic.12695
   Pisarev GI, 2011, APPL MATH COMPUT, V217, P5016, DOI 10.1016/j.amc.2010.07.050
   Ren LC, 2007, PETROL SCI, V4, P81
   Snieders FF, 1999, POWDER TECHNOL, V101, P229, DOI 10.1016/S0032-5910(98)00152-1
   Sovechles JM, 2017, MEAS SCI TECHNOL, V28, DOI 10.1088/1361-6501/aa7dce
   Stein M, 2000, CHEM ENG SCI, V55, P5291, DOI 10.1016/S0009-2509(00)00177-9
   Svarovsky L., 2000, SOLID LIQUID SEPARAT
   Trinh T., 1976, 77 NASA STI REC
   Wang LY, 2006, PROCEEDINGS OF THE CONFERENCE OF GLOBAL CHINESE SCHOLARS ON HYDRODYNAMICS, P400
NR 33
TC 1
Z9 1
U1 5
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 310
EP 319
DI 10.1016/j.ces.2019.01.061
PG 10
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000027
DA 2020-05-12
ER

PT J
AU Hua, LN
   Zhao, H
   Li, J
   Zhu, QS
   Wang, JW
AF Hua, Leina
   Zhao, Hu
   Li, Jun
   Zhu, Qingshan
   Wang, Junwu
TI Solid residence time distribution in a cross-flow dense fluidized bed
   with baffles
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Cross-flow dense fluidized bed; Baffle; Non-spherical particle; Solid
   residence time distribution; Solid dispersion coefficient;
   Eulerian-Eulerian model
ID CFD SIMULATION; BULK SOLIDS; GAS; PARTICLES; DISPERSION; FUEL; REACTOR;
   RISER; QUANTIFICATION; COEFFICIENT
AB The residence time distribution (RTD) of particles in a gas-solid dense fluidized bed with a continuous solid flow operation and baffles needs much more focus for the purpose of the wide industrial applications. The available models of solid RTD are not adequate in this case due to the additional convective diffusion induced by the cross-flow of the solid feeding and the complex geometry caused by the baffles. To address this problem, this work applied a two-phase Eulerian-Eulerian model combined with the species transport equation to predict solid RTD in a dense fluidized bed. The effects of the continuous solid feeding and baffles were considered. The solid dispersion coefficient Ds in the species transport equation was calculated by an analytical solution from kinetic theory of granular flow. Ds only needs the value at a molecular level due to the fact that the computational fluid dynamics (CFD) model is able to reproduce the RTD procedure exactly same as the practical experiments. To validate the established CFD model, a series of 3D lab-scale cold flow experiments were conducted in the free and baffled beds for the bed material with various severe non-spherical shapes. The measurement included the solid hydrodynamic characteristics at the outlet of the outflow pipe and solid RTD of the system. The reasonable agreement between the CFD prediction and experimental data demonstrated the good performance of the CFD model. 1D plug flow with dispersion model and the tanks-in-series model were further used to fit the calculated RTD curves. The estimated lateral dispersion coefficient of solids locates in a rational range compared with the data collected extensively from the literature. The results showed that the lateral dispersion coefficient of solids decreases when the baffles are installed. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hua, Leina; Zhao, Hu; Li, Jun; Zhu, Qingshan; Wang, Junwu] Chinese Acad Sci, State Key Lab Multiphase Complex Syst, Inst Proc Engn, Beijing 100190, Peoples R China.
   [Zhao, Hu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Hua, LN (reprint author), Chinese Acad Sci, State Key Lab Multiphase Complex Syst, Inst Proc Engn, Beijing 100190, Peoples R China.
EM lnhua@ipe.ac.cn
RI Li, Jun/B-6583-2015; Wang, Junwu/P-5040-2019; Wang, Junwu/C-6591-2009
OI Li, Jun/0000-0002-6703-3275; Wang, Junwu/0000-0003-3988-1477; Wang,
   Junwu/0000-0003-3988-1477
FU National Natural Science Foundation of China, ChinaNational Natural
   Science Foundation of China [21306202]; State Key Laboratory of
   Multiphase Complex Systems, Institute of Process Engineering, Chinese
   Academy of Sciences, China [MPCS-2012-A-02]; National Key R&D Program of
   China, China [2017YFE0106500]
FX This work was financially supported by the National Natural Science
   Foundation of China, China [grant number 21306202], the State Key
   Laboratory of Multiphase Complex Systems, Institute of Process
   Engineering, Chinese Academy of Sciences, China [grant number
   MPCS-2012-A-02], and the National Key R&D Program of China, China [grant
   number 2017YFE0106500].
CR Almuttahar A, 2008, POWDER TECHNOL, V185, P11, DOI 10.1016/j.powtec.2007.09.010
   BELLGARDT D, 1986, POWDER TECHNOL, V48, P173, DOI 10.1016/0032-5910(86)80076-6
   BERRUTI F, 1986, CAN J CHEM ENG, V64, P48, DOI 10.1002/cjce.5450640107
   Bhusarapu S, 2004, CHEM ENG SCI, V59, P5381, DOI 10.1016/j.ces.2004.07.052
   BI J, 1995, CHEM ENG RES DES, V73, P162
   Bi XTT, 2004, INT J CHEM REACT ENG, V2
   Borodulya V. A., 1982, Journal of Engineering Physics, V42, P528, DOI 10.1007/BF00824945
   Breault RW, 2006, POWDER TECHNOL, V163, P9, DOI 10.1016/j.powtec.2006.01.009
   BRENNER H, 1962, CHEM ENG SCI, V17, P229, DOI 10.1016/0009-2509(62)85002-7
   Cui HP, 2006, CHEM ENG SCI, V61, P388, DOI 10.1016/j.ces.2005.06.014
   Davidson J.F., 1971, FLUIDIZATION
   Deza M, 2009, J FLUID ENG-T ASME, V131, DOI 10.1115/1.4000257
   Du B, 2002, AICHE J, V48, P1896, DOI 10.1002/aic.690480907
   FAN LT, 1986, CHEM ENG SCI, V41, P117, DOI 10.1016/0009-2509(86)85204-6
   Fotovat F, 2015, CHEM ENG SCI, V126, P543, DOI 10.1016/j.ces.2014.12.022
   Gao YJ, 2012, POWDER TECHNOL, V228, P416, DOI 10.1016/j.powtec.2012.05.060
   Gel'perin N. I., 1970, THEOR FOUND CHEM ENG, V4, P572
   Geldart D, 1986, GAS FLUIDIZATION TEC
   Geng SJ, 2017, POWDER TECHNOL, V320, P555, DOI 10.1016/j.powtec.2017.07.085
   Gidaspow D., 1994, MULTIPHASE FLOW FLUI
   Grasa G, 2002, CHEM ENG SCI, V57, P2791, DOI 10.1016/S0009-2509(02)00146-X
   Guio-Perez DC, 2014, CHEM ENG RES DES, V92, P1107, DOI 10.1016/j.cherd.2013.10.018
   Guio-Perez DC, 2013, CHEM ENG SCI, V104, P269, DOI 10.1016/j.ces.2013.08.047
   Guio-Perez DC, 2013, IND ENG CHEM RES, V52, P10732, DOI 10.1021/ie400211h
   Harris AT, 2003, CHEM ENG SCI, V58, P2181, DOI 10.1016/S0009-2509(03)00082-4
   Heertjes P. M., 1967, P INT S FLUIDIZATION, P476
   HSIAU SS, 1993, J HEAT TRANS-T ASME, V115, P541, DOI 10.1115/1.2910720
   Hua LN, 2018, CHEM ENG SCI, V186, P168, DOI 10.1016/j.ces.2018.04.027
   [华蕾娜 Hua Leina], 2016, [化工学报, CIESC Journal], V67, P3251
   Hua LN, 2015, POWDER TECHNOL, V284, P299, DOI 10.1016/j.powtec.2015.06.057
   Hua LN, 2014, CHEM ENG SCI, V117, P264, DOI 10.1016/j.ces.2014.05.055
   JOHNSON PC, 1987, J FLUID MECH, V176, P67, DOI 10.1017/S0022112087000570
   Jung JW, 2006, CHEM ENG COMMUN, V193, P946, DOI 10.1080/00986440500351982
   Kashyap M, 2011, IND ENG CHEM RES, V50, P7549, DOI 10.1021/ie1012079
   KATO K, 1985, J CHEM ENG JPN, V18, P254, DOI 10.1252/jcej.18.254
   Khongprom P, 2012, CHEM ENG SCI, V73, P8, DOI 10.1016/j.ces.2012.01.020
   Kong WB, 2018, CHEM ENG SCI, V187, P213, DOI 10.1016/j.ces.2018.04.073
   Kunii D., 1991, FLUIDIZATION ENG
   Lan XY, 2013, IND ENG CHEM RES, V52, P11888, DOI 10.1021/ie3034448
   Levenspiel O., 2012, TRACER TECHNOLOGY
   Li TW, 2012, AICHE J, V58, P756, DOI 10.1002/aic.12619
   Li TW, 2009, CHEM ENG RES DES, V87, P1451, DOI 10.1016/j.cherd.2009.04.012
   Lim KS, 1995, INT J MULTIPHAS FLOW, V21, P141, DOI 10.1016/0301-9322(95)00038-Y
   Liu DY, 2012, AICHE J, V58, P745, DOI 10.1002/aic.12627
   Liu DY, 2011, AICHE J, V57, P1459, DOI 10.1002/aic.12376
   Liu YJ, 2012, AICHE J, V58, P1119, DOI 10.1002/aic.12646
   MAY WG, 1959, CHEM ENGNG PROG, V55, P49
   Mostoufi N, 2001, POWDER TECHNOL, V114, P23, DOI 10.1016/S0032-5910(00)00258-8
   Nauman EB, 2008, IND ENG CHEM RES, V47, P3752, DOI 10.1021/ie071635a
   Niemi T., 2013, 14 INT C FLUID FROM
   Niklasson F, 2002, IND ENG CHEM RES, V41, P4663, DOI 10.1021/ie020173s
   Pallares D, 2006, CHEM ENG SCI, V61, P2710, DOI 10.1016/j.ces.2005.11.030
   Peirano E, 2001, CHEM ENG SCI, V56, P4787, DOI 10.1016/S0009-2509(01)00141-5
   RAMAMOORTHY S, 1981, CHEM ENG J BIOCH ENG, V22, P237, DOI 10.1016/0300-9467(81)80019-6
   Sanchez-Prieto J, 2017, CHEM ENG J, V307, P113, DOI 10.1016/j.cej.2016.08.075
   SAVAGE SB, 1993, MECH MATER, V16, P225, DOI 10.1016/0167-6636(93)90047-U
   Schlichthaerle P, 2001, POWDER TECHNOL, V120, P21, DOI 10.1016/S0032-5910(01)00342-4
   Sette E, 2016, APPL ENERG, V163, P304, DOI 10.1016/j.apenergy.2015.11.024
   Sette E, 2015, FUEL PROCESS TECHNOL, V140, P245, DOI 10.1016/j.fuproc.2015.09.017
   Sette E, 2014, APPL ENERG, V136, P671, DOI 10.1016/j.apenergy.2014.09.075
   Sette E, 2014, POWDER TECHNOL, V263, P74, DOI 10.1016/j.powtec.2014.04.091
   SHEN LH, 1995, POWDER TECHNOL, V84, P207, DOI 10.1016/0032-5910(95)02994-D
   Sheoran M, 2018, CHEM ENG COMMUN, V205, P739, DOI 10.1080/00986445.2017.1410478
   Shi XG, 2015, POWDER TECHNOL, V271, P16, DOI 10.1016/j.powtec.2014.11.011
   SHI YF, 1984, IND ENG CHEM PROC DD, V23, P337, DOI 10.1021/i200025a026
   SHI YF, 1985, POWDER TECHNOL, V41, P23, DOI 10.1016/0032-5910(85)85070-1
   Simonin O., 1996, KARMAN I FLUID DYNAM
   Sivashanmugam P, 2000, POWDER TECHNOL, V107, P256, DOI 10.1016/S0032-5910(99)00250-8
   Smolders K, 2000, CHEM ENG SCI, V55, P4101, DOI 10.1016/S0009-2509(00)00084-1
   SUBBARAO D, 1985, CHEM ENG SCI, V40, P1988, DOI 10.1016/0009-2509(85)80142-1
   Sun QQ, 2005, FUEL, V84, P1739, DOI 10.1016/j.fuel.2004.09.026
   van Wachem BGM, 2001, AICHE J, V47, P1035, DOI 10.1002/aic.690470510
   VANDEEMTER JJ, 1967, P INT S FLUID
   Vollmari K, 2018, POWDER TECHNOL, V338, P625, DOI 10.1016/j.powtec.2018.07.061
   Winaya INS, 2007, POWDER TECHNOL, V178, P173, DOI 10.1016/j.powtec.2007.05.005
   Xiao P., 1998, J THERM SCI, V7, P78
   Yang HR, 2002, CHINESE J CHEM ENG, V10, P490
   Younis BA, 2005, P ROY SOC A-MATH PHY, V461, P575, DOI 10.1098/rspa.2004.1380
   Zhang JW, 2015, PARTICUOLOGY, V19, P155, DOI 10.1016/j.partic.2014.04.019
   Zhao YZ, 2010, PARTICUOLOGY, V8, P44, DOI 10.1016/j.partic.2009.11.002
   Zou Z, 2017, CHINESE J CHEM ENG, V25, P1706, DOI 10.1016/j.cjche.2017.02.010
   Zou Z, 2017, CHEM ENG J, V321, P184, DOI 10.1016/j.cej.2017.03.110
NR 82
TC 2
Z9 2
U1 5
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 8
PY 2019
VL 200
BP 320
EP 335
DI 10.1016/j.ces.2019.01.054
PG 16
WC Engineering, Chemical
SC Engineering
GA HP1HR
UT WOS:000461418000028
DA 2020-05-12
ER

PT J
AU Ratnapriya, S
   Keerti
   Sahasrabuddhe, AA
   Dube, A
AF Ratnapriya, Sneha
   Keerti
   Sahasrabuddhe, Amogh A.
   Dube, Anuradha
TI Visceral leishmaniasis: An overview of vaccine adjuvants and their
   applications
SO VACCINE
LA English
DT Review
DE Visceral leishmaniasis; Vaccines; Adjuvant
ID PRIME-BOOST VACCINATION; LONG-LASTING PROTECTION; EFFICACY FIELD TRIAL;
   PROTEINASES TYPE-I; MAJOR PLUS BCG; 78 KDA ANTIGEN; BALB/C MICE;
   HYPOTHETICAL PROTEIN; INTERFERON-GAMMA; DNA VACCINE
AB Although there has been an extensive research on vaccine development over the last decade and some vaccines have been commercialized for canine visceral leishmaniasis (CVL), but as yet no effective vaccine is available for anthroponotic VL which may partly be due to the absence of an appropriate adjuvant system. Vaccines alone yield poor immunity hence requiring an adjuvant which can boost the immunosuppressed state of VL infected individuals by eliciting adaptive immune responses to achieve required immunological enhancement. Recent studies have documented the continuous efforts that are being made in the field of adjuvants research in an attempt to render vaccines more effective. This review article focuses on adjuvants, particularly particulate and non-particulate ones, which have been assessed with VL vaccine candidates in several preclinical and clinical trials outlining the induction of immune responses obtained from these studies. Moreover, we have emphasized the applicability of multiple adjuvants combination for an improvement in the potential of a VL vaccine. (C) 2019 Published by Elsevier Ltd.
C1 [Ratnapriya, Sneha; Keerti; Sahasrabuddhe, Amogh A.] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
   [Dube, Anuradha] Cent Drug Res Inst, CSIR, Div Parasitol, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
RP Dube, A (reprint author), Cent Drug Res Inst, CSIR, Div Parasitol, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
EM anuradhadube@gmail.com
OI Dube, Anuradha/0000-0002-5122-400X
CR Afrin F, 2000, J PARASITOL, V86, P730, DOI 10.1645/0022-3395(2000)086[0730:IOPPAL]2.0.CO;2
   Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002
   Aguiar-Soares RDDO, 2014, PARASITE VECTOR, V7, P1, DOI [10.1186/1756-1305-7-61, DOI 10.1186/1756-1305-7-61]
   Ali KM, 1995, RECOMBINANT LEISHMAN, V63, P2062
   Ananias RZ, 2007, SCAND J IMMUNOL, V65, P538, DOI 10.1111/j.1365-3083.2007.01939.x
   Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017
   Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588
   Atmar RL, 2009, CURR TOP MICROBIOL, V333, P323, DOI 10.1007/978-3-540-92165-3_16
   Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111
   BADARO R, 1994, EUR J CLIN MICROBIOL, V13, pS23, DOI 10.1007/BF01973598
   Badaro R, 2001, Braz J Infect Dis, V5, P223
   Badiee A, 2013, VACCINE, V31, P735, DOI 10.1016/j.vaccine.2012.11.068
   Baharia RK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003557
   Barati M, 2015, IRAN J PARASITOL, V10, P351
   Bhandari V, 2012, PLOS NEGLECT TROP D, V6, P1, DOI [10.1371/journalpntd0001657, DOI 10.1371/JOURNALPNTD0001657]
   Bhardwaj S, 2009, EXP PARASITOL, V121, P29, DOI 10.1016/j.exppara.2008.09.019
   Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07
   Bliss J, 1996, J IMMUNOL, V156, P887
   Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3
   Borja-Cabrera GP, 2008, VACCINE, V26, P4991, DOI 10.1016/j.vaccine.2008.07.029
   Borja-Cabrera GP, 2004, VACCINE, V22, P2234, DOI 10.1016/j.vaccine.2003.11.039
   Bourdoiseau G, 2009, VET IMMUNOL IMMUNOP, V128, P71, DOI 10.1016/j.vetimm.2008.10.309
   Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1
   Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042
   Cecilio P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005951
   Chakravarty J, 2011, VACCINE, V29, P3531, DOI 10.1016/j.vaccine.2011.02.096
   Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
   Chavez-Fumagalli MA, 2010, MICROBES INFECT, V12, P967, DOI 10.1016/j.micinf.2010.06.008
   Choudhury R, 2013, IMMUNOBIOLOGY, V218, P114, DOI 10.1016/j.imbio.2012.02.008
   Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07
   Coler RN, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.6
   Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333
   Das A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003091
   Datta N, 2003, EUR J IMMUNOL, V33, P1508, DOI 10.1002/eji.200323671
   de Sousa CBP, 2004, VACCINE, V22, P2470, DOI 10.1016/j.vaccine.2004.01.072
   de Souza EP, 2001, VACCINE, V19, P3104, DOI 10.1016/S0264-410X(01)00031-7
   Dias DS, 2018, PARASITOLOGY, V145, P740, DOI [10.1017/S0031182017001731, 10.1017/s0031182017001731]
   Dias DS, 2017, MOL IMMUNOL, V91, P272, DOI 10.1016/j.molimm.2017.09.017
   Dole VS, 2000, VACCINE, V19, P423, DOI 10.1016/S0264-410X(00)00207-3
   Duarte MC, 2016, MOL IMMUNOL, V76, P70, DOI 10.1016/j.molimm.2016.06.014
   Durando P, 2010, EXPERT OPIN BIOL TH, V10, P639, DOI 10.1517/14712591003724662
   Duthie MS, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0025-5
   Duthie MS, 2016, VACCINE, V34, P2779, DOI 10.1016/j.vaccine.2016.04.067
   El Fadili A, 2004, J BIOL CHEM, V279, P18575, DOI 10.1074/jbc.M400652200
   Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095
   Ferreira JFL, 2008, VACCINE, V26, P677, DOI 10.1016/j.vaccine.2007.11.044
   Fiuza JA, 2016, PLOS NEGLECT TROP D, V10, P1, DOI [10.1371/journal.pm-d.004122, DOI 10.1371/JOURNAL.PM-D.004122]
   Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033
   Gamboa-Leon R, 2006, VACCINE, V24, P4863, DOI 10.1016/j.vaccine.2006.03.005
   Garcon N, 2011, EXPERT OPIN BIOL TH, V11, P667, DOI 10.1517/14712598.2011.573624
   Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401
   Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461
   Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X
   GHOSH AK, 1995, CLIN DIAGN LAB IMMUN, V2, P291, DOI 10.1128/CDLI.2.3.291-296.1995
   Giunchetti RC, 2008, VACCINE, V26, P623, DOI 10.1016/j.vaccine.2007.11.057
   Goto Y, 2007, VACCINE, V25, P7450, DOI 10.1016/j.vaccine.2007.08.001
   Goto Y, 2011, CLIN VACCINE IMMUNOL, V18, P1118, DOI 10.1128/CVI.05024-11
   Gradoni L, 2005, VACCINE, V23, P5245, DOI 10.1016/j.vaccine.2005.07.001
   Grimaldi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185438
   Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853
   Guha R, 2013, VACCINE, V31, P1905, DOI 10.1016/j.vaccine.2013.02.025
   Gupta R, 2012, INT J PARASITOL, V42, P429, DOI 10.1016/j.ijpara.2012.02.013
   GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9
   Jaiswal AK, 2015, PARASITOLOGY, V142, P728, DOI 10.1017/S003118201400184X
   Joshi J, 2014, PARASITE IMMUNOL, V36, P3, DOI 10.1111/pim.12071
   Joshi J, 2014, PARASITOLOGY, V141, P554, DOI 10.1017/S0031182013001959
   Kanagavelu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090100
   Kaushal H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0653-6
   Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881
   Khalil EAG, 2006, ANN TROP PAEDIATR, V26, P357, DOI 10.1179/146532806X152890
   Khare P, 2016, CLIN EXP IMMUNOL, V185, P165, DOI 10.1111/cei.12780
   Khare P, 2014, PARASITOL RES, V113, P851, DOI 10.1007/s00436-013-3716-5
   Khoshgoo N, 2008, VACCINE, V26, P5822, DOI 10.1016/j.vaccine.2008.08.065
   Kool M, 2018, ALUM ADJUVANT SOME T, P927, DOI [10.1099/imm.0.038943-0, DOI 10.1099/IMM.0.038943-0]
   Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202
   Kumari S, 2008, VACCINE, V26, P5700, DOI 10.1016/j.vaccine.2008.08.021
   Lage DP, 2015, PARASITE IMMUNOL, V37, P646, DOI 10.1111/pim.12287
   Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51
   Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083
   Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061
   Ferreira JHL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002729
   Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531
   Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111
   Margaroni M, 2017, INT J NANOMED, V12, P6169, DOI 10.2147/IJN.S141069
   Marques-da-Silva EA, 2005, PARASITOL RES, V98, P67, DOI 10.1007/s00436-005-0008-8
   Martins VT, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0964-5
   Martins VT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002148
   Martins VT, 2016, ACTA TROP, V154, P73, DOI 10.1016/j.actatropica.2015.11.006
   Martins VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137683
   Masih S, 2011, EXP PARASITOL, V129, P55, DOI 10.1016/j.exppara.2011.05.014
   Mazumder S, 2007, VACCINE, V25, P8771, DOI 10.1016/j.vaccine.2007.10.028
   Mazumder S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001429
   Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644
   McQuarrie S, 2015, CAN J INFECT DIS MED, V26, P325, DOI 10.1155/2015/176545
   Miret J, 2008, VACCINE, V26, P1585, DOI 10.1016/j.vaccine.2008.01.026
   Misra A, 2001, VACCINE, V19, P3485, DOI 10.1016/S0264-410X(01)00058-5
   Mohebali M, 2004, VACCINE, V22, P4097, DOI 10.1016/j.vaccine.2004.03.058
   Moreno J, 2007, VACCINE, V25, P5290, DOI 10.1016/j.vaccine.2007.05.010
   Mutiso JM, 2012, SCAND J IMMUNOL, V76, P471, DOI 10.1111/j.1365-3083.2012.02764.x
   Mutiso JM, 2010, J BIOMED RES, V24, P16, DOI 10.1016/S1674-8301(10)60004-8
   Nagill R, 2015, ASIAN PAC J TROP MED, V8, P511, DOI 10.1016/j.apjtm.2015.06.008
   Nagill R, 2010, VACCINE, V28, P4002, DOI 10.1016/j.vaccine.2010.01.015
   Nico D, 2014, PROCEDIA VACCINOL, V8, P58, DOI 10.1016/j.provac.2014.07.010
   Nico D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000866
   Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004
   O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/erv.12.140, 10.1586/ERV.12.140]
   Ogawa Chikako, 2011, Curr Bioact Compd, V7, P180
   Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007
   Oliveira-Freitas E, 2006, VACCINE, V24, P3909, DOI 10.1016/j.vaccine.2006.02.034
   Parody N, 2004, PARASITE IMMUNOL, V26, P283, DOI 10.1111/j.0141-9838.2004.00711.x
   Pinto AR, 2000, INT J PARASITOL, V30, P599, DOI 10.1016/S0020-7519(00)00037-0
   Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813
   Poot J, 2006, VACCINE, V24, P2460, DOI 10.1016/j.vaccine.2005.12.039
   Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011
   Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009
   Rafati S, 2008, EXP PARASITOL, V118, P393, DOI 10.1016/j.exppara.2007.10.004
   Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551
   Raman VS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00144
   Ramesh V, 2015, PLOS NEGLECT TROP D, V9, P1
   Ramirez L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-3
   Ravindran R, 2012, MOL PHARMACEUT, V9, P59, DOI 10.1021/mp2002494
   Ravindran R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-181
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
   Resende LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161169
   Roatt BM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00217
   Ryan JR, 2002, J CLIN MICROBIOL, V40, P1037, DOI 10.1128/JCM.40.3.1037-1043.2002
   Salk J, 1977, SCIENCE, DOI [10.1126/science:320661, DOI 10.1126/SCIENCE:320661]
   Santos FN, 2007, VACCINE, V25, P6176, DOI 10.1016/j.vaccine.2007.06.005
   Santos TTO, 2017, ACTA TROP, V171, P8, DOI 10.1016/j.actatropica.2017.03.008
   Santos WR, 1999, VACCINE, V17, P2554, DOI 10.1016/S0264-410X(99)00058-4
   Santos WR, 2002, VACCINE, V21, P30, DOI 10.1016/S0264-410X(02)00444-9
   Santos WR, 2003, VACCINE
   Satti IN, 2001, VACCINE, V19, P2100, DOI 10.1016/S0264-410X(00)00401-1
   Schwendener Reto A, 2014, Ther Adv Vaccines, V2, P159, DOI 10.1177/2051013614541440
   Sharma A, 2009, J IMMUNOL, V183, P7719, DOI 10.4049/jimmunol.0900132
   Sharma SK, 2006, VACCINE, V24, P1800, DOI 10.1016/j.vaccine.2005.10.025
   Shivahare R, 2014, PLOS NEGLECT TROP D, V9, P1
   Silva-Barrios S, 2016, CELL REP, V15, P2427, DOI 10.1016/j.celrep.2016.05.028
   SOUZA AE, 1994, MOL BIOCHEM PARASIT, V63, P213, DOI 10.1016/0166-6851(94)90057-4
   Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978
   Srivastava JK, 2003, PARASITOLOGY, V127, P107, DOI 10.1017/S0031182003003457
   Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064
   Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091
   Sundar S, 1997, J INFECT DIS, V176, P1117, DOI 10.1086/516526
   Tandon R, 2018, PARASITOLOGY, V145, P508, DOI 10.1017/S0031182017001160
   Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348
   Tewary P, 2004, FEMS IMMUNOL MED MIC, V42, P241, DOI 10.1016/j.femsim.2004.05.008
   Tewary P, 2004, VACCINE, V22, P3053, DOI 10.1016/j.vaccine.2004.02.007
   Thakur A, 2015, MED MICROBIOL IMMUN, V204, P539, DOI 10.1007/s00430-014-0367-9
   Thakur A, 2015, IMMUNOBIOLOGY, V220, P1031, DOI 10.1016/j.imbio.2015.05.014
   Thakur A, 2015, PARASITOL INT, V64, P70, DOI 10.1016/j.parint.2014.10.003
   Trigo J, 2010, VACCINE, V28, P3333, DOI 10.1016/j.vaccine.2010.02.089
   Tripathi P, 2008, SCAND J IMMUNOL, V68, P492, DOI 10.1111/j.1365-3083.2008.02171.x
NR 154
TC 4
Z9 4
U1 6
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3505
EP 3519
DI 10.1016/j.vaccine.2019.04.092
PG 15
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600001
PM 31103364
DA 2020-05-12
ER

PT J
AU Kaddar, M
   Saxenian, H
   Senouci, K
   Mohsni, E
   Sadr-Azodi, N
AF Kaddar, Miloud
   Saxenian, Helen
   Senouci, Kamel
   Mohsni, Ezzeddine
   Sadr-Azodi, Nahad
TI Vaccine procurement in the Middle East and North Africa region:
   Challenges and ways of improving program efficiency and fiscal space
SO VACCINE
LA English
DT Review
DE Vaccine supply and procurement; Immunization financing and fiscal space;
   Vaccine market and regulation; Pooled procurement; New vaccines; Middle
   East and North Africa
AB Improving vaccine procurement performance has been a priority concern of national health authorities in the Middle East and North Africa (MENA) region for years particularly in terms of its role in accessing new vaccines and assuring a steady supply of quality vaccines at affordable prices. This article reviews the vaccine procurement mechanisms in the MENA region; analyzes the factors and drivers affecting demand for and supply of vaccines; discusses the main challenges; and suggests measures which can increase efficiency gains and generate the budgetary room to introduce life-saving vaccines. Based on in-depth analysis of available data and interviews with key informants at the regional and country level, this paper explains why most of the current strategies do not sufficiently recognize the specific characteristics of vaccine markets and best practices in procurement given these markets. The paper suggests potential efficiency gains for governments and global partners from pooling demand and moving from transaction-based purchasing to strategic purchasing in order to strengthen immunization services and introduce more life-saving vaccines. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Kaddar, Miloud] MK Int Consulting, 17 Villa Bruyeres, F-94800 Villejuif, France.
   [Senouci, Kamel; Sadr-Azodi, Nahad] UNICEF MENA Reg Off, Hlth & Nutr Sect, Abdulqader Al Abed St,Bldg 15 Tlaa Al Ali, Amman, Jordan.
   [Mohsni, Ezzeddine] Global Hlth Dev, Abdallah Ben Abbas St,Bldg 42, Amman, Jordan.
RP Sadr-Azodi, N (reprint author), UNICEF MENA Reg Off, Hlth & Nutr Sect, Abdulqader Al Abed St,Bldg 15 Tlaa Al Ali, Amman, Jordan.
EM nsadrazodi@unicef.org
OI Sadr-Azodi, Nahad/0000-0002-9489-9971; Kaddar,
   Miloud/0000-0001-5332-5640
FU Gavi, the Vaccine Alliance
FX This work was partly funded by Gavi, the Vaccine Alliance. The authors
   are grateful to Heather Deehan, UNICEF Supply Division for providing
   data and updates, and to Daniel Ngemera, UNICEF Regional Office for MENA
   reviewing the manuscript. Senior government health officials and other
   experts and individuals from international organizations took time out
   of their busy schedules to be interviewed. The authors alone are
   responsible for the views expressed in this publication and they do not
   necessarily represent the decisions, policy or views of UNICEF.
CR Adjagba A, 2017, VACCINE, V35, P3007, DOI 10.1016/j.vaccine.2017.04.039
   Andrus J, 2017, REV PANAM SALUD PUBL, V41
   [Anonymous], 2015, SHOT BRING BARR BARR
   Brenzel L, 2015, VACCINE S1, V33
   DeRoeck D, 2006, INT J HEALTH PLAN M, V21, P23, DOI 10.1002/hpm.822
   Gavi the Vaccine Alliance, 2016, MARK SHAP
   Giersing BK, 2017, VACCINE, V35, P6793, DOI 10.1016/j.vaccine.2017.04.063
   Haidari LA, 2017, VACCINE, V35, P199, DOI 10.1016/j.vaccine.2016.11.025
   Hinsch M, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-34
   Holmgren J, 2017, VACCINE, V35, P3355, DOI 10.1016/j.vaccine.2017.05.005
   Kaddar M, 2013, VACCINE S2, V31
   Levin A, 2011, HEALTH POLICY PLANN, V26, pi4, DOI 10.1093/heapol/czr037
   Makinen M, 2012, HLTH POLICY PLANN S2, V27
   Milstien J, 2010, VACCINE, V28
   Offit P., 2005, HLTH AFF, V24
   Pagliusi S, 2013, VACCINE S2, V31
   Pagliusi S, 2016, VACCINE, V34, P3562, DOI 10.1016/j.vaccine.2016.02.067
   Sadr-Azodi N, 2018, VACCINE, V36, P4425, DOI 10.1016/j.vaccine.2018.05.088
   UNICEF, 2018, VACC PRIC DAT
   UNICEF Supply Division, 2015, VACC PROC MIDDL INC
   USAID's Center for Accelerating Innovation and Impact, 2014, HLTH MARK GLOB HLTH
   World Health Organization, 2017, BYNCSA CC WHO
   World Health Organization, 2014, WHO V3P 2014 FACT CO
   World Health Organization, 2015, FIN DRAFT CONS WHO R
   Wyman O., 2006, STRUCTURAL SHIFT PRO
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3520
EP 3528
DI 10.1016/j.vaccine.2019.04.029
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600002
PM 31130259
OA Other Gold
DA 2020-05-12
ER

PT J
AU Schellenbacher, C
   Huber, B
   Skoll, M
   Shafti-Keramat, S
   Roden, RBS
   Kirnbauer, R
AF Schellenbacher, C.
   Huber, B.
   Skoll, M.
   Shafti-Keramat, S.
   Roden, R. B. S.
   Kirnbauer, R.
TI Incorporation of RG1 epitope into HPV16L1-VLP does not compromise
   L1-specific immunity
SO VACCINE
LA English
DT Article
ID (HPV)-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS;
   HPV-6/11/16/18 VACCINE; L1 PROTEIN; IN-VIVO; HPV; IMMUNOGENICITY;
   INFECTION; L2; EXPRESSION
AB The candidate pan-Human Papillomavirus (HPV) vaccine RG1-VLP are HPV16 major capsid protein L1 virus-like-particles (VLP) comprising a type-common epitope of HPV16 minor capsid protein L2 (RG1; aa17-36). Vaccinations have previously demonstrated efficacy against genital high-risk (hr), low-risk (1r) and cutaneous HPV.
   To compare RG1-VLP to licensed vaccines, rabbits (n = 3) were immunized thrice with 1 mu g, 5 mu g, 25 mu g, or 125 mu g of RG1-VLP or a 1/4 dose of Cervarix (R). 5 mu g of RG1-VLP or 16L1-VLP (Cervarix) induced comparable HPV16 capsid-reactive and neutralizing antibodies titers (62,500/12,500-62,500 or 1000/10,000). 25 mu g RG1-VLP induced robust cross-neutralization titers (50-1000) against hrHPV18/31/33/45/52/58/26/70. To mimic reduced immunization schedules in adolescents, mice (n = 10) were immunized twice with RG1-VLP (5 mu g) plus 18L1-VLP (5 mu g). HPV16 neutralization (titers of 10,000) similar to Cervarix and Gardasil and cross-protection against hrHPV58 vaginal challenge was observed.
   RG1-VLP vaccination induces hrHPV16 neutralization comparable to similar doses of licensed vaccines, plus cross-neutralization to heterologous hrHPV even when combined with HPV18L1-VLP. (C) 2019 Published by Elsevier Ltd.
C1 [Schellenbacher, C.; Huber, B.; Skoll, M.; Shafti-Keramat, S.; Kirnbauer, R.] Med Univ Vienna MUW, Dept Dermatol, Vienna, Austria.
   [Roden, R. B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA.
RP Schellenbacher, C (reprint author), Med Univ Vienna, Dept Dermatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM christina.schellenbacher@meduniwien.ac.at
FU National Cancer Institute of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA118790,
   P50CA098252, R01CA233486]; EUEuropean Union (EU)
FX This publication was supported in part by US Public Health Service
   grants (grants.nih.gov) from the National Cancer Institute of the
   National Institutes of Health under awards numbered R01CA118790,
   P50CA098252, and R01CA233486 to RBSR. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. Further support was
   provided by EU-funded InfectEra: HPV-MOTIVA to RK.
CR Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004
   CHANDRACHUD LM, 1995, VIROLOGY, V211, P204, DOI 10.1006/viro.1995.1392
   Chengt N, 1992, MED SCI, V89, P12180, DOI [10.1073/pnas.89.24.12180, DOI 10.1073/PNAS.89.24.12180]
   Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12
   Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003
   Einstein MH, 2014, HUM VACC IMMUNOTHER, V10, P3455, DOI 10.4161/hv.36117
   Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282
   Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055
   Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07
   HAGENSEE ME, 1993, J VIROL, V67, P315, DOI 10.1128/JVI.67.1.315-322.1993
   Harro CD, 2001, JNCI-J NATL CANCER I, DOI [10.1093/jnci934.284, DOI 10.1093/JNCI934.284]
   Huber A, 2017, NUCL MATER ENERGY, V12, P100, DOI 10.1016/j.nme.2017.01.005
   Huh WK, 2017, LANCET, V390, P2143, DOI 10.1016/S0140-6736(17)31821-4
   Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044
   Leung TF, 2018, VACCINE, V36, P98, DOI 10.1016/j.vaccine.2017.11.034
   Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598
   ROSE RC, 1993, J VIROL, V67, P1936, DOI 10.1128/JVI.67.4.1936-1944.1993
   Schellenbacher C, 2017, VIRUS RES, V231, P166, DOI 10.1016/j.virusres.2016.11.020
   Schellenbacher C, 2013, J INVEST DERMATOL, V133, P2706, DOI 10.1038/jid.2013.253
   Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09
   Schwarz TF, 2008, GYNECOL ONCOL, DOI [10.1016/jygyno2008.05.036, DOI 10.1016/JYGYNO2008.05.036]
   Wang JW, 2018, J VIROL, V92, DOI 10.1128/JVI.00572-18
NR 22
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3529
EP 3534
DI 10.1016/j.vaccine.2019.05.011
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600003
PM 31147274
DA 2020-05-12
ER

PT J
AU Forro, B
   Marton, S
   Kecskemeti, S
   Hornyak, A
   Banyai, K
AF Forro, Barbara
   Marton, Szilvia
   Kecskemeti, Sandor
   Hornyak, Akos
   Banyai, Krisztian
TI Vaccine-associated rabies in red fox, Hungary
SO VACCINE
LA English
DT Article
DE Rabies; Vaccination; Wildlife; Hungary
ID VULPES-VULPES; AGE-DETERMINATION; ORAL VACCINATION; VIRUS-VACCINE;
   WILDLIFE; STRAIN; PATHOGENICITY; GLYCOPROTEIN; ELIMINATION; GERMANY
AB Rabies vaccine strain was isolated from a red fox (Vulpes vulpes) with signs of neurological disorder during an oral vaccination campaign in 2015, Hungary. The whole genome sequence of the isolated strain shared >99.9% nucleotide sequence identity to the whole genomes of vaccines strains recently used in Hungarian oral vaccination campaigns. The neuroinvasive potential of rabies vaccines that leads to development of clinical manifestations is rarely seen among wild animals; however, the observed residual pathogenicity needs awareness of field experts and requires close monitoring of rabies cases in areas where elimination programs are implemented. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Forro, Barbara; Marton, Szilvia; Banyai, Krisztian] Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, POB 18, H-1581 Budapest, Hungary.
   [Kecskemeti, Sandor] Vet Diagnost Directorate, Natl Food Chain Safety Off, Debrecen, Hungary.
   [Hornyak, Akos] Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary.
RP Banyai, K (reprint author), Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, POB 18, H-1581 Budapest, Hungary.
EM bkrota@hotmail.com
OI Banyai, Krisztian/0000-0002-6270-1772
FU Momentum program; Bolyai scholarhip
FX Authors at the Institute for Veterinary Medical Research were supported
   by the Momentum program. SM was a recipient of the Bolyai scholarhip.
CR ARTOIS M, 1992, VACCINE, V10, P524, DOI 10.1016/0264-410X(92)90351-J
   BINGHAM J, 1992, VET REC, V131, P55, DOI 10.1136/vr.131.3.55
   Cliquet F, 2013, ANTIVIR RES, V100, P84, DOI 10.1016/j.antiviral.2013.07.012
   *EUR COMM, 2002, OR VACC FOX RAB REP
   European Commission. Survey Program for Rabies Hungary, 2012, SURV PROGR RAB HUNG
   Feher E, 2017, ACTA MICROBIOL IMM H, V64, P373, DOI 10.1556/030.64.2017.038
   Fehiner-Gardiner C, 2008, J WILDLIFE DIS, V44, P71
   FENJE P, 1960, CAN J MICROBIOL, V6, P480, DOI 10.1139/m60-055
   Feyssaguet M, 2007, VACCINE, V25, P2244, DOI 10.1016/j.vaccine.2006.12.012
   Fooks AR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000530
   Freuling CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0142
   HARRIS S, 1978, J ZOOL, V184, P91, DOI 10.1111/j.1469-7998.1978.tb03268.x
   Hoper D, 2015, VACCINE, V33, P5829, DOI 10.1016/j.vaccine.2015.08.091
   Homonnay ZG, 2014, AVIAN PATHOL, V43, P552, DOI 10.1080/03079457.2014.973832
   Hornyak A, 2018, TRANSBOUND EMERG DIS, V65, pe14, DOI 10.1111/tbed.12658
   Hostnik P, 2014, J WILDLIFE DIS, V50, P397, DOI 10.7589/2013-07-183
   JOHNSTON DH, 1982, COMP IMMUNOL MICROB, V5, P185, DOI 10.1016/0147-9571(82)90035-2
   King Arthur, 2004, HIST PERSPECTIVE RAB
   Mahl P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0077-8
   Muller T, 2012, BERL MUNCH TIERARZTL, V125, P178, DOI 10.2376/0005-9366-125-178
   Muller T, 2009, ARCH VIROL, V154, P1081, DOI 10.1007/s00705-009-0408-7
   Muller TF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003953
   Pfaff F, 2019, VACCINE, V37, P4758, DOI 10.1016/j.vaccine.2018.01.083
   Picard-Meyer E, 2004, VACCINE, V22, P1921, DOI 10.1016/j.vaccine.2003.11.015
   Robardet E, 2016, PLOS NEGLECT TROP D, P10, DOI [10.1371/journal.pntd.0004432e0004432, DOI 10.1371/JOURNAL.PNTD.0004432E0004432]
   Roulichova J, 2007, FOLIA ZOOL, V56, P440
   Sato G, 2004, J VET MED SCI, V66, P747, DOI 10.1292/jvms.66.747
   Vitasek J, 2004, VET MED-CZECH, V49, P171, DOI 10.17221/5692-VETMED
   Vos A, 1999, EPIDEMIOL INFECT, V123, P165, DOI 10.1017/S0950268899002666
   Vuta V, 2016, VACCINE, V34, P5021, DOI 10.1016/j.vaccine.2016.08.013
   Wakeley PR, 2005, J CLIN MICROBIOL, V43, P2786, DOI 10.1128/JCM.43.6.2786-2792.2005
   WANDELER AI, 1988, REV INFECT DIS, V10, pS649
   WHO, 2013, 2 WHO
NR 33
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3535
EP 3538
DI 10.1016/j.vaccine.2019.05.014
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600004
PM 31109719
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Festjens, N
   Vandewalle, K
   Houthuys, E
   Plets, E
   Vanderschaeghe, D
   Borgers, K
   Van Hecke, A
   Tiels, P
   Callewaert, N
AF Festjens, Nele
   Vandewalle, Kristof
   Houthuys, Erica
   Plets, Evelyn
   Vanderschaeghe, Dieter
   Borgers, Katlyn
   Van Hecke, Annelies
   Tiels, Petra
   Callewaert, Nico
TI SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and
   preclinical safety characterization
SO VACCINE
LA English
DT Article
DE Tuberculosis; Vaccine; SapM; Immunomodulation
ID GUINEA-PIG MODEL; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE IMMUNITY;
   IN-VITRO; METAANALYSIS; MENINGITIS; CHALLENGE; RESPONSES; EFFICACY;
   STRAINS
AB The Mycobacterium bovis Bacille Calmette Guerin (BCG) vaccine shows variable efficacy in protection against adult tuberculosis (TB). Earlier, we have described a BCG mutant vaccine with a transposon insertion in the gene coding for the secreted acid phosphatase SapM, which led to enhanced long-term survival of vaccinated mice challenged with TB infection, To facilitate development of this mutation as part of a future improved live attenuated TB vaccine, we have now characterized the genome and transcriptome of this sapM::Tn mutant versus parental BCG Pasteur. Furthermore, we show that the sapM::Tn mutant had an equal low pathogenicity as WT BCG upon intravenous administration to immunocompromised SCID mice, passing this important safety test. Subsequently, we investigated the clearance of this improved vaccine strain following vaccination and found a more effective innate immune control over the sapM::Tn vaccine bacteria as compared to WT BCG. This leads to a fast contraction of IFN gamma producing Th1 and Tc1 cells after sapM::Tn BCG vaccination. These findings corroborate that a live attenuated vaccine that affords improved long-term survival upon TB infection can be obtained by a mutation that further attenuates BCG. These findings suggest that an analysis of the effectiveness of innate immune control of the vaccine bacteria could be instructive also for other live attenuated TB vaccines that are currently under development, and encourage further studies of SapM mutation as a strategy in developing a more protective live attenuated TB vaccine. (C) 2019 Elsevier Ltd. All rights reserved.
C1 Univ Ghent, VIB Ctr Med Biotechnol, Unit Med Biotechnol, Ghent, Belgium.
   Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium.
   [Vandewalle, Kristof] Inbiose, Technol Pk Zwijnaarde 90,Bus 41, B-9052 Zwijnaarde, Belgium.
   [Houthuys, Erica] iTeos Therapeut, Rue Freres Wright 29, B-6041 Gosselies, Belgium.
   [Vanderschaeghe, Dieter] NLO, AA Tower,Technol Pk Zwijnaarde 122, B-9052 Zwijnaarde, Belgium.
RP Festjens, N; Callewaert, N (reprint author), Technol Pk Zwijnaarde 71, B-9052 Zwijnaarde, Belgium.
EM Nele.Festjens@vib-ugent.be; Nico.Callewaert@vib-ugent.be
OI Festjens, Nele/0000-0002-3429-5463
FU ERC Consolidator grant [616966]; GOA grant
FX This work was supported by an ERC Consolidator grant to N.C.
   (GlycoTarget; 616966) and a GOA grant. N.F. and D.V. were post-doctoral
   fellows and K.V. and K.B. were predoctoral fellows of FWO. We thank Dr.
   Peter Sander (Institute for Medical Microbiology, Faculty of Medicine,
   University of Zurich) for providing us with the M. bovis BCG strain 1721
   (RpsL, K43R), Dr. S. Alonso (Dept, Microbiology, National University of
   Singapore) for providing us the optimal protocol for electroporation of
   M. bovis BCG and Dr. K. Huygen (WIV, Brussels) for providing us the PPD.
   We thank Prof. Dr. E. Rubin (Dept, Immunology and Infectious diseases,
   Harvard School of Public Health, Boston) for providing us the pMV261Hyg
   vector and Prof. W.R. Jacobs Jr (Albert Einstein College of Medicine,
   New York) for providing us the pMV306Kan vector. We thank the VIB
   Nucleomics core (www.nucleomics.be) and Genomics Core (UZ -K.U. Leuven,
   gc.uzleuven.be) facilities for the Illumina MiSeq and HiSeq sequencing
   services. We thank Jannick Leoen from the VIB Protein Core facility
   (https://corefacilities.vib.be/psf) for purification of SapM protein.
   The following reagent was obtained through BEI Resources, NIAID, NIH:
   Ag85 Complex, Purified Native Protein from Mycobacterium tuberculosis,
   Strain H37Rv, NR-14855.
CR Arbues A, 2013, VACCINE, V31, P4867, DOI 10.1016/j.vaccine.2013.07.051
   Bahal RK, 2018, BIOL OPEN, V7, DOI 10.1242/bio.029546
   Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31
   Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094
   Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004
   Brighenti S, UNDERST TUBERC ANAL, DOI [10.5772/29651, DOI 10.5772/29651]
   Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104
   Chen JM, 2007, VACCINE, V25, P8114, DOI 10.1016/j.vaccine.2007.09.041
   Chin KL, 2017, J IMMUNOL RES, DOI 10.1155/2017/5212910
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698
   Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13
   Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689
   Dietrich G, 2000, FEMS MICROBIOL LETT, V186, P177, DOI 10.1111/j.1574-6968.2000.tb09100.x
   Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725
   Ernst JD, 2018, CELL HOST MICROBE, V24, P34, DOI 10.1016/j.chom.2018.06.004
   Festjens N, 2011, EMBO MOL MED, V3, P222, DOI 10.1002/emmm.201000125
   Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052
   Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017
   Hatherill M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0015-2016
   Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003
   Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005
   Infante E, 2005, CLIN EXP IMMUNOL, V141, P21, DOI 10.1111/j.1365-2249.2005.02832.x
   Kalia V, 2010, ADV EXP MED BIOL, V684, P79
   Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413
   Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017
   Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003
   Miller BK, 2019, ELIFE, V8, DOI 10.7554/eLife.40063
   Naka T, 2011, J BIOL CHEM, V286, P44153, DOI 10.1074/jbc.M111.310037
   Nieuwenhuizen NE, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu2018.00121, DOI 10.3389/FIMMU2018.00121]
   Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230
   Orme IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00461
   Orr MT, 2015, VACCINE, V33, P6570, DOI 10.1016/j.vaccine.2015.10.115
   Orr MT, 2015, J INFECT DIS, V212, P495, DOI 10.1093/infdis/jiv055
   Puri RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070514
   Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652
   RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154
   Saikolappan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036198
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   Sallin MA, 2018, NAT MICROBIOL, V3, P1198, DOI 10.1038/s41564-018-0231-6
   Sander P, 2015, VACCINE, V33, P1353, DOI 10.1016/j.vaccine.2015.01.058
   Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x
   Sellers RS, 2012, VET PATHOL, V49, P32, DOI 10.1177/0300985811429314
   Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048
   Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07
   Triccas James A, 2016, PNEUMONIA, V8, DOI [10.1186/541479-016-0020-z, DOI 10.1186/541479-016-0020-Z]
   Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3
   Vandewalle K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8106
   WHO, GLOB TUB REP 2018
   Zulauf KE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007011
NR 49
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3539
EP 3551
DI 10.1016/j.vaccine.2019.05.022
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600005
PM 31122861
DA 2020-05-12
ER

PT J
AU Stanton, SE
   Gad, E
   Corulli, LR
   Lu, HL
   Disis, ML
AF Stanton, Sasha E.
   Gad, Ekram
   Corulli, Lauren R.
   Lu, Hailing
   Disis, Mary L.
TI Tumor-associated antigens identified early in mouse mammary tumor
   development can be effective vaccine targets
SO VACCINE
LA English
DT Article
DE Breast cancer prevention; Vaccine antigens; Th1; DNA vaccines; Mouse
   mammary tumor models
ID COMPREHENSIVE MOLECULAR PORTRAITS; HUMAN BREAST-CANCER; IGF-IR;
   EXPRESSION; METASTASIS; GROWTH; INVASION; IMMUNITY; MICE; NEU
AB Breast cancer vaccines composed of antigens identified by serological analysis of cDNA expression libraries (SEREX) induce antigen specific immune responses in patients but have had disappointing clinical benefits. While many attempts to modify the adjuvants and vaccine method have been tried, one issue not addressed was whether the SEREX tumor-associated antigens identified from late stages of disease were ideal targets. We questioned in the transgenic TgMMTV-neu mouse model whether the antigen repertoire is distinct between early and late stage breast cancer and whether the antigens identified via SEREX from transgenic mice with early or late stage tumors would elicit differential anti-tumor effects to address this question.
   Three early stage antigens, Pdhx, Stk39, and Otud6B, were identified from a SEREX screen of mice prior to development of palpable lesions. Formulated into a vaccine, each early antigen inhibited tumor growth (p < 0.0001). The antigens identified from mice with late stage tumors (Swap70, Gsn, and Arhgef2) were unable to inhibit tumor growth when used as vaccines (for example Gsn p = 0.26). Each of the three early stage antigens were essential for tumor survival in syngeneic mouse tumor cells and in human breast cancer cell lines across breast cancer subtypes. Silencing protein expression of the early antigens increased apoptosis (p < 0.0001 for all antigens in mouse and p < 0.05 for all antigens in human triple negative breast cancer) and decreased survival (p < 0.0001 for all antigens in mouse and human triple negative and HER2 positive breast cancer). Overexpression of the early stage antigens in women with breast cancer predicted worse prognosis (p = 0.03) while overexpression of late stage antigens did not impact prognosis (p = 0.09). These data suggest that antigens expressed earlier in breast tumor development and functionally relevant to breast tumor growth may be more effective targets for therapeutic breast cancer vaccines than antigens identified in later disease. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Stanton, Sasha E.; Gad, Ekram; Corulli, Lauren R.; Lu, Hailing; Disis, Mary L.] Univ Washington, Canc Vaccine Inst, 850 Republican St,Box 358050, Seattle, WA 98109 USA.
   [Lu, Hailing] Immune Design, 1616 Eastlake Ave E Suite 3, Seattle, WA 98102 USA.
RP Stanton, SE (reprint author), Univ Washington, Canc Vaccine Inst, 850 Republican St,Box 358050, Seattle, WA 98109 USA.
EM sestant2@uw.edu
OI Stanton, Sasha/0000-0002-4300-551X
FU American Cancer SocietyAmerican Cancer Society;  [5R01CA129417-4]; 
   [U01CA141539]
FX The research was funded by 5R01CA129417-4 United States, For Mary Disis
   the Athena Distinguished Professor of Breast cancer Research is United
   States, The American Cancer Society is United States, The U01CA141539 is
   United States, And for Sasha Stanton Both the NIH T32 and ITHS NIH KL2
   are United States.
CR Balatoni CE, 2009, AM J PATHOL, V175, P1653, DOI 10.2353/ajpath.2009.090091
   Buonaguro L, 2011, CLIN VACCINE IMMUNOL, V18, P23, DOI 10.1128/CVI.00286-10
   Cecil DL, 2013, BREAST CANCER RES TR, V139, P657, DOI 10.1007/s10549-013-2577-z
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   Chen B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-443
   Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012
   Chen ZY, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0197-0
   Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239
   Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033
   Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7
   Curigliano G, 2006, ANN ONCOL, V17, P750, DOI 10.1093/annonc/mdj083
   Curigliano G, 2011, ANN ONCOL, V22, P98, DOI 10.1093/annonc/mdq325
   Davis Ian D, 2017, Immunotherapy, V9, P249, DOI 10.2217/imt-2016-0132
   Disis ML, 2013, CANCER PREV RES, V6, P1273, DOI 10.1158/1940-6207.CAPR-13-0182
   Eastlack SC, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0851-8
   Finn OJ, 2003, J EXP MED, V198, P1623, DOI 10.1084/jem.20031787
   Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088
   GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954
   Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hartung F, 2017, ONCOTARGET, V8, P102161, DOI 10.18632/oncotarget.22240
   Heemskerk B, 2013, EMBO J, V32, P194, DOI 10.1038/emboj.2012.333
   Huang YT, 2009, J CLIN ONCOL, V27, P2660, DOI 10.1200/JCO.2008.18.7906
   Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784
   Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Kostianets O, 2017, BIOMARKERS, V22, P149, DOI 10.1080/1354750X.2016.1252952
   Li P, 2009, INT IMMUNOPHARMACOL, V9, P1002, DOI 10.1016/j.intimp.2009.04.008
   Liao YC, 2012, ONCOGENE, V31, P3086, DOI 10.1038/onc.2011.476
   Lollini PL, 2003, TRENDS IMMUNOL, V24, P62, DOI 10.1016/S1471-4906(02)00030-3
   Lu HL, 2006, CANCER RES, V66, P9754, DOI 10.1158/0008-5472.CAN-06-1083
   Mao JN, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-121
   Maskey N, 2017, ONCOL LETT, V14, P2261, DOI 10.3892/ol.2017.6439
   Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111
   Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101
   Obata, 1999, Breast Cancer, V6, P305, DOI 10.1007/BF02966445
   Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046
   Park KH, 2008, CANCER RES, V68, P8400, DOI 10.1158/0008-5472.CAN-07-5891
   Park YH, 2010, BIOCHEM BIOPH RES CO, V395, P416, DOI 10.1016/j.bbrc.2010.04.038
   Parmiani G, 2007, ANN ONCOL, V18, P226, DOI 10.1093/annonc/mdl158
   Parmigiani RB, 2006, P NATL ACAD SCI USA, V103, P18066, DOI 10.1073/pnas.0608853103
   Rajendran BK, 2017, ONCOTARGET, V8, P50252, DOI 10.18632/oncotarget.17225
   Scanlan MJ, 2001, BREAST CANCER RES, V3, P95, DOI 10.1186/bcr278
   Sobol A, 2017, MOL CANCER RES, V15, P117, DOI 10.1158/1541-7786.MCR-16-0281-T
   Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105
   Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082
NR 46
TC 3
Z9 3
U1 3
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3552
EP 3561
DI 10.1016/j.vaccine.2019.05.024
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600006
PM 31126858
OA Bronze
DA 2020-05-12
ER

PT J
AU Tashani, M
   Badandah, A
   Alfelali, M
   Barasheed, O
   Alqahtani, AS
   Heron, L
   Wong, M
   Louth, J
   Rashid, H
   Borrow, R
   Booy, R
AF Tashani, Mohamed
   Badandah, Al-Mamoon
   Alfelali, Mohammad
   Barasheed, Osamah
   Alqahtani, Amani S.
   Heron, Leon
   Wong, Melanie
   Louth, Jennifer
   Rashid, Harunor
   Borrow, Ray
   Booy, Robert
TI Effect on meningococcal serogroup W immunogenicity when Tdap was
   administered prior, concurrent or subsequent to the quadrivalent (ACWY)
   meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A
   randomised controlled trial
SO VACCINE
LA English
DT Article
DE Meningococcal conjugate vaccine; Carrier protein; Vaccine interaction;
   Diphtheria, tetanus, acellular pertussis vaccine; Serum bactericidal
   antibody
ID INFLUENZAE TYPE-B; TOXOID CONJUGATE VACCINE; GLYCOCONJUGATE VACCINE;
   ANTIBODY-RESPONSE; CHILDREN YOUNGER; CARRIER PROTEIN; MENACWY-CRM;
   TETANUS; IMMUNIZATION; DIPHTHERIA
AB Immune responses to the capsular polysaccharide administered in the polysaccharide-protein conjugate vaccines can be either improved or suppressed by the pre-existence of immunity to the carrier protein. Receiving multiple vaccinations is essential for travellers such as Hajj pilgrims, and the use of conjugated vaccines is recommended.
   We studied the immune response to meningococcal serogroup W upon prior, concurrent and sequential administration of a quadrivalent meningococcal conjugate vaccine (MCV4) conjugated to CRM197 (coadministered with 13 valent pneumococcal vaccine conjugate CRM197 [PCV13]), and tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Australian adults before attending the Hajj pilgrimage in 2014.
   Participants were randomly assigned, by computer-generated numbers, to three study arms by 1:1:1 ratio. Group A received Tdap followed by MCV4-CRM197 (+PCV13) 3-4 weeks later. Group B received all three vaccines in a single visit. Group C received MCV4-CRM197 (+PCVI3) followed by Tdap 3-4 weeks later. Blood samples obtained prior to and 3-4 weeks after immunisation with MCV4-CRM197 were tested for meningococcal serogroup W-specific serum bactericidal antibody responses using baby rabbit complement (rSBA).
   One hundred and seven participants aged between 18 and 64 (median 40) years completed the study. No significant difference in meningococcal serogroup W rSBA geometric mean titre (GMT) was observed between the study arms post vaccination with MCV-CRM197 but Group A tended to have a slightly lower GMT (A = 404, B = 984 and C = 1235, p = 0.15). No statistical difference was noticed between the groups in proportions of subjects achieving a >= 4-fold rise in rSBA titres or achieving rSBA titre >= 8 post vaccination.
   In conclusion, receipt of MCV4-CRM197 vaccine prior, concurrent or subsequent to Tdap has similar immunologic response, and hence concurrent administration is both immunogenic and practical. However, further investigation into whether carrier induced suppression is a public health issue is suggested. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Tashani, Mohamed; Badandah, Al-Mamoon; Alfelali, Mohammad; Rashid, Harunor; Booy, Robert] Univ Sydney, Fac Med & Hlth, Clin Sch, Discipline Child & Adolescent Hlth,Childrens Hosp, Sydney, NSW, Australia.
   [Tashani, Mohamed] Univ Tripoli, Fac Med, Tripoli, Libya.
   [Badandah, Al-Mamoon; Alfelali, Mohammad; Heron, Leon; Rashid, Harunor; Booy, Robert] Childrens Hosp Westmead, NCIRS, Cnr Hawkesbury Rd & Hainsworth St,Locked Bag 4001, Westmead, NSW 2145, Australia.
   [Badandah, Al-Mamoon; Alfelali, Mohammad] King Abdulaziz Univ, Fac Med Rabigh, Dept Family & Community Med, Jeddah, Saudi Arabia.
   [Barasheed, Osamah] KAMC HC, Execut Adm Res & Innovat, Mecca 24246, Saudi Arabia.
   [Alqahtani, Amani S.] Saudi Food & Drug Author, Riyadh 13312, Saudi Arabia.
   [Wong, Melanie] Childrens Hosp Westmead, Immunol Dept, Westmead, NSW 2145, Australia.
   [Rashid, Harunor; Booy, Robert] Univ Sydney, Sch Biol Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2145, Australia.
   [Rashid, Harunor; Booy, Robert] Univ Sydney, Sydney Med Sch, Sydney, NSW 2145, Australia.
   [Louth, Jennifer; Borrow, Ray] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England.
   [Booy, Robert] Flinders Univ S Australia, WHO Collaborating Ctr Mass Gatherings & High Cons, Adelaide, SA 5001, Australia.
RP Badandah, A (reprint author), Childrens Hosp Westmead, NCIRS, Cnr Hawkesbury Rd & Hainsworth St,Locked Bag 4001, Westmead, NSW 2145, Australia.
EM almamoon.badahdah@health.nsw.gov.au
OI Tashani, Mohamed/0000-0003-1669-1494; Rashid,
   Harunor/0000-0003-2286-5139; S Alqahtani, Amani/0000-0002-6320-118X
FU Islamic Development Bank (IsDB)
FX Richard Pryce-Williams, PHE Manchester, UK for laboratory work. Mohamed
   Tashani would like to acknowledge the Islamic Development Bank (IsDB)
   for providing financial support.
CR Aguilera JF, 2002, EMERG INFECT DIS, V8, P761, DOI 10.3201/eid0808.010422
   Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8
   Alberer M, 2015, J TRAVEL MED, V22, P105, DOI 10.1111/jtm.12180
   Alberer M, 2015, J TRAVEL MED, V22, P48, DOI 10.1111/jtm.12164
   Alotaibi BM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw087
   Alqahtani AS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay068
   Alqahtani AS, 2016, INT J INFECT DIS, V47, P53, DOI 10.1016/j.ijid.2016.02.005
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P331
   Arguedas A, 2010, VACCINE, V28, P3171, DOI 10.1016/j.vaccine.2010.02.045
   Australian Technical Advisory Group on Immunisation (ATAGI), 2015, AUSTR IMM HDB
   Avci FY, 2013, CURR TOP MED CHEM, V13, P2535, DOI 10.2174/15680266113136660180
   Badandah AM, 2018, J TRAVEL MED, V25
   BARINGTON T, 1993, INFECT IMMUN, V61, P432, DOI 10.1128/IAI.61.2.432-438.1993
   Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Broderick MP, 2016, CLIN VACCINE IMMUNOL, V23, P672, DOI 10.1128/CVI.00267-16
   Burrage M, 2002, INFECT IMMUN, V70, P4946, DOI 10.1128/IAI.70.9.4946-4954.2002
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P833
   Ceyhan M, 2013, CLIN VACCINE IMMUNOL, V20, P66, DOI 10.1128/CVI.00314-12
   Dagan R, 2008, EXPERT REV VACCINES, V7, P97, DOI 10.1586/14760584.7.1.97
   Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026
   Delves P. J., 2017, ESSENTIAL IMMUNOLOGY
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307
   Hahne SJM, 2002, LANCET, V359, P582, DOI 10.1016/S0140-6736(02)07716-4
   Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006
   Hedari CP, 2014, INFECT DRUG RESIST, V7, P85, DOI 10.2147/IDR.S36243
   Kim HW, 2016, YONSEI MED J, V57, P1511, DOI 10.3349/ymj.2016.57.6.1511
   Knuf M, 2011, VACCINE, V29, P4881, DOI 10.1016/j.vaccine.2011.04.053
   Lucero MG, 2004, J INFECT DIS, V189, P2077, DOI 10.1086/420849
   Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1
   Mulholland K, 1996, JAMA-J AM MED ASSOC, V275, P1182, DOI 10.1001/jama.275.15.1182
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   PEETERS CCAM, 1991, INFECT IMMUN, V59, P3504, DOI 10.1128/IAI.59.10.3504-3510.1991
   Pobre K, 2014, VACCINE, V32, P1423, DOI 10.1016/j.vaccine.2014.01.047
   Pollabauer EM, 2009, VACCINE, V27, P1674, DOI 10.1016/j.vaccine.2009.01.005
   Rashid H, 2013, TRAVEL MED INFECT DI, V11, P288, DOI 10.1016/j.tmaid.2013.06.001
   Sanofi Pasteur Inc, 2018, MEN FULL PRESCR INF
   Shelly MA, 2001, SCAND J INFECT DIS, V33, P542, DOI 10.1080/00365540110026502
   Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052
   Tashani M, 2018, VACCINE, V36, P4375, DOI 10.1016/j.vaccine.2018.04.033
   Tashani M, 2016, VACCINE, V34, P5929, DOI 10.1016/j.vaccine.2016.10.020
   Tashani M, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax006
   Tashani Mohamed, 2016, World J Clin Pediatr, V5, P311, DOI 10.5409/wjcp.v5.i3.311
   Tejedor JC, 2008, PEDIATR INFECT DIS J, V27, P579, DOI 10.1097/INF.0b013e31816b4561
   Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1
   Vipond C, 2012, VACCINE, V30, pB10, DOI 10.1016/j.vaccine.2011.12.060
   Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4
   Weston WM, 2011, VACCINE, V29, P1017, DOI 10.1016/j.vaccine.2010.11.057
   Wilder-Smith A, 2007, CURR OPIN INFECT DIS, V20, P454, DOI 10.1097/QCO.0b013e3282a64700
   Wong CA, 2013, J ADOLESCENT HEALTH, V53, P492, DOI 10.1016/j.jadohealth.2013.05.009
   Yezli S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay070
NR 50
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3562
EP 3567
DI 10.1016/j.vaccine.2019.05.025
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600007
PM 31128875
DA 2020-05-12
ER

PT J
AU Levin, A
   Munthali, S
   Vodungbo, V
   Rukhadze, N
   Maitra, K
   Ashagari, T
   Brenzel, L
AF Levin, Ann
   Munthali, Spy
   Vodungbo, Venance
   Rukhadze, Natia
   Maitra, Kuhu
   Ashagari, Tesfaye
   Brenzel, Logan
TI Scope and magnitude of private sector financing and provision of
   immunization in Benin, Malawi and Georgia
SO VACCINE
LA English
DT Article
DE Vaccination; Private sector; Financing; Expenditures
ID HEALTH
AB Background: Little is known about the role of private sector providers in providing and financing immunization. To fill this gap, the authors conducted a study in Benin, Malawi, and Georgia to estimate (1) the proportion of vaccinations taking place through the private sector; (2) private expenditures for vaccination; and (3) the extent of regulation.
   Methods: In each country, the authors surveyed a stratified random sample of 50 private providers (private for-profit and not-for-profit) using a standardized, pre-tested questionnaire administered by trained enumerators. In addition, the authors conducted 300 or more client exit interviews in each country.
   Results: The three countries had different models of private service provision of vaccination. In Malawi, 44% of private facilities, predominantly faith-based organizations, administered an estimated 27% of all vaccinations. In Benin, 18% of private for-profit and not-for-profit facilities provided vaccinations, accounting for 8% of total vaccinations. In Georgia, all sample facilities were privately managed, and conducted 100% of private vaccinations. In all three countries, the Ministries of Health (MoHs) supplied vaccines and other support to private facilities. The study found that 6-76% of clients paid nominal fees for vaccination cards and services, and a small percentage (2-26%) chose to pay higher fees for vaccines not within their countries' national schedules. The percentage of private expenditure on vaccination was less than 1% of national health expenditures. The case studies revealed that service quality at private facilities was mixed, a finding that is similar to those of other studies on private sector vaccination. The three countries varied in how well the MoHs managed and supervised private sector services.
   Discussion/Conclusion: The private sector plays a growing role in lower-income countries and is expanding access to services. Governments' ability to regulate and monitor immunization services and promote quality and affordable services in the private sector should be a priority. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Levin, Ann] Levin & Morgan LLC, Washington, DC 20009 USA.
   [Munthali, Spy] Univ Malawi, Zomba, Malawi.
   [Vodungbo, Venance] MoH Benin, Benin, Benin.
   [Rukhadze, Natia] ACT Global, Tbilisi, Georgia.
   [Maitra, Kuhu; Ashagari, Tesfaye] Abt Associates Inc, Cambridge, MA USA.
   [Brenzel, Logan] BMGF, Seattle, WA USA.
RP Levin, A (reprint author), Levin & Morgan LLC, Washington, DC 20009 USA.
EM ann@levinmorgan.com
RI Brenzel, Logan/AAH-2824-2020
OI Brenzel, Logan/0000-0002-7506-7686
FU Bill and Melinda Gates FoundationGates Foundation [OPP1129338]
FX The authors acknowledge support for this work under Investment ID
   OPP1129338 to Abt Associates, Inc. by the Bill and Melinda Gates
   Foundation.
CR Amarasinghe A, 2018, VACCINE, V36, P4958, DOI 10.1016/j.vaccine.2018.01.008
   Balabanova D, 2008, 9 ROCK FDN RES DEV I
   Carmona A, 2014, BENIN PRIVATE HLTH S
   Carmona A., 2013, MALAWI PRIVATE HLTH
   Howard DH, 2004, HEALTH SERV RES, V39, P2013, DOI 10.1111/j.1475-6773.2004.00330.x
   Lagomarsino G, 2009, PUBLIC STEWARDSHIP P
   Levin A, 2017, METHODOLOGY NOTE EFF
   Levin A, 2011, HEALTH POLICY PLANN, V26, pi4, DOI 10.1093/heapol/czr037
   Ministry of Health (MoH) [Malawi] and ICF International, 2014, MAL SERV PROV ASS MS
   Mitrovich R, 2017, REV PRIVATE SECTORS
   Olorunsaiye C, 2017, PAN AFR MED J S3, P27
   Peters DH, 2004, HEALTH POLICY PLANN, V19, pI5, DOI 10.1093/heapol/czh041
   Soeung SC, 2008, J HEALTH POPUL NUTR, V26, P95
   UNICEF, 2010, COV EV SURV
   Waters H, 2003, HEALTH POLICY PLANN, V18, P127, DOI 10.1093/heapol/czg017
   Watkins R, 2018, BIOARCHAEOL SOC THEO, P27, DOI 10.1007/978-3-319-71114-0_3
   WHO, 2017, ENG PRIV NONG HLTH P
   World Bank, 2013, PRIV HLTH POL TOOLK
NR 18
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3568
EP 3575
DI 10.1016/j.vaccine.2019.05.023
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600008
PM 31122855
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Ortiz-Brizuela, E
   Leal-Vega, F
   Cuellar-Rodriguez, J
   Bobadilla-del-Valle, M
   Ponce-de-Leon, A
AF Ortiz-Brizuela, Edgar
   Leal-Vega, Francisco
   Cuellar-Rodriguez, Jennifer
   Bobadilla-del-Valle, Miriam
   Ponce-de-Leon, Alfredo
TI Vaccine-derived varicella zoster infection in a kidney transplant
   recipient after zoster vaccine live administration
SO VACCINE
LA English
DT Article
DE Zoster vaccine; Herpes zoster; Shingles; Kidney transplantation; Solid
   organ transplantation; Shingrix; Zostavax
ID SAFETY; VIRUS
AB A 49-year-old kidney transplant recipient, presented with a skin rash, and interstitial infiltrates three weeks after receiving a live attenuated varicella-zoster vaccine. Varicella-zoster Oka-vaccine strain was detected in plasma by polymerase chain reaction and sequencing analysis targeting open reading frame 62 (ORF 62). She was treated successfully with intravenous acyclovir. Our case report supports the current contraindication of live attenuated varicella-zoster vaccine in the solid-organ transplant recipients. Recombinant subunit varicella-zoster vaccine may be the vaccine of choice in these patients; nevertheless, further information is required to establish its safety, efficacy, and optimal timing. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ortiz-Brizuela, Edgar; Leal-Vega, Francisco; Bobadilla-del-Valle, Miriam; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Clin Microbiol, Ave Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.
   [Ortiz-Brizuela, Edgar; Cuellar-Rodriguez, Jennifer; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Ave Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.
RP Ponce-de-Leon, A (reprint author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Lab Clin Microbiol, Ave Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.
EM luis.ponceg@incmnsz.mx
RI Ortiz-Brizuela, Edgar/U-6302-2019; Bobadilla-del-Valle,
   Miriam/AAD-6418-2020
OI Ortiz-Brizuela, Edgar/0000-0001-7169-8459; BOBADILLA-DEL VALLE,
   MIRIAM/0000-0003-1184-827X; Ponce-de-Leon, Alfredo/0000-0003-2640-2916
CR Costa E, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2015-212688
   Croce E, 2017, VACCINE, V35, P1216, DOI 10.1016/j.vaccine.2017.01.048
   Cunningham AL, 2018, J INFECT DIS, V218, pS127, DOI 10.1093/infdis/jiy382
   Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5
   Kwak BO, 2017, ARCH VIROL, V162, P1725, DOI 10.1007/s00705-017-3276-6
   Miller G, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12874
   Pergam SA, 2013, AM J TRANSPLANT, V13, P138, DOI 10.1111/ajt.12107
   Rubin LG, 2014, CLIN INFECT DIS, V58, P309, DOI 10.1093/cid/cit816
   Russell AF, 2015, VACCINE, V33, P3129, DOI 10.1016/j.vaccine.2015.04.090
   Wang L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01632
   Willis ED, 2017, VACCINE, V35, P7231, DOI 10.1016/j.vaccine.2017.11.013
   Winston DJ, 2018, LANCET, V391, P2116, DOI [10.1016/S0140-6736(18)30631-7, 10.1016/s0140-6736(18)30631-7]
NR 12
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3576
EP 3579
DI 10.1016/j.vaccine.2019.05.017
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600009
PM 31109718
DA 2020-05-12
ER

PT J
AU Trauchessec, M
   Lambert, O
   Bonnafous, P
   Berard, Y
   Barriere, F
   Huillet, C
   Marco, S
   Sirohi, D
   Hedrick, V
   Kuhn, R
   Guy, B
   Ronzon, F
   Manin, C
AF Trauchessec, Mathieu
   Lambert, Olivier
   Bonnafous, Pierre
   Berard, Yves
   Barriere, Fabienne
   Huillet, Celine
   Marco, Sergio
   Sirohi, Devika
   Hedrick, Victoria
   Kuhn, Richard
   Guy, Bruno
   Ronzon, Frederic
   Manin, Catherine
TI Complementary use of mass spectrometry and cryo-electron microscopy to
   assess the maturity of live attenuated dengue vaccine viruses
SO VACCINE
LA English
DT Article
DE Dengue vaccine; Virus maturity; Mass spectrometry; Cryo-electron
   microscopy
ID ABSOLUTE QUANTIFICATION; MATURATION; PROTEOMICS; BURDEN
AB Dengue virus (DENV) infection is a global health threat with the potential to affect at least 3.6 billion people living in areas of risk. No specific curative treatments against dengue disease are available and vaccines are currently the only way to prevent the disease. The tetravalent dengue vaccine developed by Sanofi Pasteur has demonstrated significant efficacy in phase III studies and is now licensed in several countries for the prevention of disease in dengue-seropositives over 9 years of age. The vaccine is composed of four recombinant, live, attenuated vaccines (CYD 1-4) based on a yellow fever vaccine 17D (YFV 17D) backbone, each expressing the pre-membrane (prM) and envelope (E) genes of one of the four DENV serotypes. Virus maturity could impact the biological activity of the vaccine viruses. To address this question, the maturity of the four vaccine viruses used in phase III clinical studies was assessed by two complementary techniques: mass spectrometry (MS) and cryo-electron microscopy (cryoEM). MS assessed viral maturity at the molecular level by quantifying specifically the prM, and M proteins. CryoEM provided information at the particle level, allowing visualizing the different phenotypes of viral particles: spiky (immature), smooth/bumpy (mature), and mixed (partially mature). Results of the two assays used in this study show that all four CYD dengue vaccine viruses present in lots used in phase III efficacy trials, display in the majority a mature phenotype. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Trauchessec, Mathieu; Berard, Yves; Barriere, Fabienne; Huillet, Celine; Marco, Sergio; Guy, Bruno; Ronzon, Frederic; Manin, Catherine] Sanofi Pasteur, Analyt Sci Dept, 1541 Av Marcel Merieux, F-69280 Marcy Letoile, France.
   [Lambert, Olivier; Bonnafous, Pierre] Bordeaux Univ, CBMN, UMR CNRS 5248, Bordeaux Inst Natl Polytech, 14 Allee Geoffroy St Hilaire, F-33600 Pessac, France.
   [Sirohi, Devika; Kuhn, Richard] Purdue Univ, Dept Biol Sci, Purdue Inst Inflammat Immunol & Infect Dis, 240 S Martin Jischke Dr, W Lafayette, IN 47907 USA.
   [Hedrick, Victoria] Purdue Univ, Bindley Biosci Ctr, 1203 W State St, W Lafayette, IN 47907 USA.
   [Bonnafous, Pierre] Bordeaux Univ, INSERM, U1212, CNRS,UMR 5320,ARNA Lab, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
   [Bonnafous, Pierre] Bordeaux Univ, Inst Europeen Chim & Biol, 2 Rue Robert Escarpit, F-33607 Pessac, France.
   [Trauchessec, Mathieu] ANAQUANT, 5 Rue Doua, F-69100 Villeurbanne, France.
RP Manin, C (reprint author), Sanofi Pasteur, Analyt Sci Dept, 1541 Av Marcel Merieux, F-69280 Marcy Letoile, France.
EM catherine.manin@sanofi.com
OI Sirohi, Devika/0000-0001-8601-6211
FU Sanofi Pasteur
FX Sanofi Pasteur funded this research.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Byers Anthony M, 2015, Open Forum Infect Dis, V2, pofv172, DOI 10.1093/ofid/ofv172
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Choi H, 2011, B KOREAN CHEM SOC, V32, P599, DOI 10.5012/bkcs.2011.32.2.599
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P785, DOI 10.1038/ni0715-785a
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Guy B, 2017, EXPERT REV VACCINES, V16, P671, DOI 10.1080/14760584.2017.1335201
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Kuhn RJ, 2013, US, Patent No. [2013/0059291 Al, 20130059291]
   Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61
   Lecouturier V, 2019, VACCINE, V37, P4601, DOI 10.1016/j.vaccine.2018.04.065
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Olszowy PP, 2013, ANAL BIOCHEM, V438, P67, DOI 10.1016/j.ab.2013.03.023
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Rodenhuis-Zybert IA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003564
   Rougemont B, 2015, PROTEOMICS, V15, P3320, DOI 10.1002/pmic.201500101
   Trauchessec M, 2014, MOL CELL PROTEOMICS, V13, P954, DOI 10.1074/mcp.M113.032672
   Tsai W-Y, 2018, J VIROL, P92, DOI [10.1128/JVI.005.56-18, DOI 10.1128/JVI.005.56-18]
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   World Health Organization Special Programme for Research Training in Tropical Diseases World Health Organization. Department of Control of Neglected Tropical Diseases World Health Organization, 2009, DENG GUID DIAGN TREA
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, CURR OPIN VIROL, V12, P109, DOI 10.1016/j.coviro.2015.04.006
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 36
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3580
EP 3587
DI 10.1016/j.vaccine.2019.05.012
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600010
PM 31122859
DA 2020-05-12
ER

PT J
AU Hoshi, SL
   Seposo, X
   Shono, A
   Okubo, I
   Kondo, M
AF Hoshi, Shu-ling
   Seposo, Xerxes
   Shono, Aiko
   Okubo, Ichiro
   Kondo, Masahide
TI Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella
   Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia
   among adults aged 65 and over in Japan
SO VACCINE
LA English
DT Article
DE Cost-effectiveness; Economic evaluation; Herpes zoster; Varicella
   vaccine; Vaccination; Quality-adjusted life year
ID SUBUNIT VACCINE; OLDER-ADULTS; LONG-TERM; EFFICACY; IMMUNIZATION;
   EPIDEMIOLOGY; SHINGLES
AB Background: The approval of the extended use of 1-dose varicella vaccine (VVL) in adults aged 50 and older against herpes zoster (HZ) in 2016 and the 2-dose recombinant zoster vaccine (RZV) in 2018 raised the need to evaluate the value for money between these two vaccines.
   Methods: We conducted a cost-effectiveness analysis with Markov modelling to evaluate the efficiency of the immunisation programmes from payer's perspective. Eight strategies with different ages to receive VVL or RZV were set, namely: 65-84 year old (y.o.), 70-84 y.o., 75-84 y.o., and 80-84 y.o. VVL- or RZV-strategy. Incremental cost-effectiveness ratios (ICERs) compared with curative care scenario were calculated. The health statuses following the target cohort were as follows: acute HZ followed by recovery, post-herpetic neuralgia followed by recovery, post HZ/PHN, recurrence of HZ, and general death.
   Results: At the vaccination cost (sic)8000 (US$73) for 1-dose ZVL and (sic)30,000 (US$273) for 2-dose RZV, ICERs ranged from (sic)2,633,587/US$23,942 (age 80-84 y.o.) to (sic)3,434,267 or US$31,221 (age 65-84 y.o.)/QALY gained for WL-strategies: from (sic)5,262,227 or US$47,838 (age 80-84 y.o.) to (sic)6,278,557 or US$57,078/QALY gained (age 65-84 y.o.) for RZV-strategies. Cost-effectiveness acceptability curves derived from probabilistic sensitivity analyses showed that if the cost-effective threshold was at (sic)3,000,000 or US$27,273/QALY, the acceptability was 90.7% and 8.8% for 65-84 VVL-strategy and 65-84 RZV-strategy, respectively; if at (sic)5,000,000 or US$45,455/QALY, 56.2% and 43.8%, and if at (sic)10,000,000 or US$90,909/QALY 11.9% and 88.1%, respectively.
   Conclusion: Vaccinating individuals aged 65-84 y.o., 70-84 y.o., 75-84 y.o., 80-84 y.o. with VVL or RZV to prevent HZ-associated disease in Japan can be cost-effective from payer's perspective, with vaccination costs at (sic)8,000 per shot for VVL, (sic)30,000 for 2-dose RZV. While the results suggesting that only 65-84 VVL-strategy and 65-84 RZV strategy should be considered when introducing HZ immunisation programme. The optimal strategy varies depending on the willingness-to-pay threshold. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hoshi, Shu-ling; Kondo, Masahide] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.
   [Seposo, Xerxes] Kyoto Univ, Dept Environm Engn, Environm Hlth Div, Nishikyo Ku, Kyoto 6158246, Japan.
   [Shono, Aiko] Meiji Pharmaceut Univ, Fac Pharmaceut Sci, Dept Publ Hlth & Epidemiol, 2-522-1 Noshio, Tokyo 2048588, Japan.
   [Okubo, Ichiro] Yokohama City Inst Publ Hlth, Kanazawa Ku, 7-1,Tomiokahigashi 2 Chom, Yokohama, Kanagawa 2360051, Japan.
RP Hoshi, SL (reprint author), Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.
EM hoshi@hcs.tsukuba.ac.jp
FU Ministry of Health, Labour and Welfare, JapanMinistry of Health, Labour
   and Welfare, Japan [H29-SHINKOGYOSEI-SHITEI-003]
FX This study was supported by a research grant for Research on Emerging
   and Re-emerging Infectious Diseases, Health and Labour Sciences Research
   Grants from the Ministry of Health, Labour and Welfare, Japan
   (H29-SHINKOGYOSEI-SHITEI-003). The authors declare no conflict of
   interest associated with this manuscript.
CR [Anonymous], 2017, P COMM COST EFF CENT
   [Anonymous], TREEAGE PRO 2015 R1
   [Anonymous], 2016, P COMM IMM VACC HLTH
   [Anonymous], 2017, P COMM IMM VACC HLTH
   Baxter R, 2018, AM J EPIDEMIOL, V187, P161, DOI 10.1093/aje/kwx245
   Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800
   Curran D, 2018, VACCINE, V36, P5037, DOI 10.1016/j.vaccine.2018.07.005
   Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5
   Drummond Michael F., 2015, METHODS EC EVALUATIO
   Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5
   Ekeroth S, 2019, J NANOPART RES, V21, DOI 10.1007/s11051-019-4479-4
   HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106
   Hoshi SL, 2017, VACCINE, V35, P3264, DOI 10.1016/j.vaccine.2017.04.046
   Igarashi A., 2017, Journal of the National Institute of Public Health, V66, P41
   Kamiya Hitoshi, 2011, Kansenshogaku Zasshi, V85, P161
   Kawashima M, 2017, J DERMATOL, V44, P1219, DOI 10.1111/1346-8138.13948
   Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184
   Le P, 2018, JAMA INTERN MED, V178, P248, DOI 10.1001/jamainternmed.2017.7431
   Ministry of Health Labour and Welfare, VIT STAT JAP 2015
   Ministry of Internal Affairs and Communications, 2002, POP EST JAP
   Miyachi M, 2016, J DERMATOL, V43, P1184, DOI 10.1111/1346-8138.13334
   Mizukami A, 2018, CLIN DRUG INVEST, V38, P29, DOI 10.1007/s40261-017-0581-5
   Murakami Y, 2018, JAP J PUBLIC HLTH, V65, P20
   Nakamura Hiroyuki, 2017, Drugs Real World Outcomes, V4, P187, DOI 10.1007/s40801-017-0119-4
   NICE, 2013, GUID METH TECHN APPR
   Ogunjimi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066485
   Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016
   Prosser LA, 2017, EC EVALUATION VACCIN
   Sato K, 2017, J DERMATOL, V44, P414, DOI 10.1111/1346-8138.13639
   Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638
   Shiraki K, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx007
   Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481
   Takao Y, 2015, J EPIDEMIOL, V25, P617, DOI 10.2188/jea.JE20140210
   Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599
   Tseng HF, 2016, J INFECT DIS, V213, P1872, DOI 10.1093/infdis/jiw047
   Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983
   Varicella and Herpes Zoster vaccines, 2014, WKLY EPIDEMIOL REC, V89, P265
   Watanabe D., 2018, SINKI TAIJOUHOUSIN S, P142
   Watanabe D, 2018, DERMATOLOGY THER, V8, P269, DOI 10.1007/s13555-018-0236-3
   Whitley RJ, 2015, PRINCIPLES PRACTICE, P1731
   York Health Economics Consortium, 2016, NET MON BEN
   Yoshikawa T, 2016, VACCINE, V34, P1965, DOI 10.1016/j.vaccine.2016.02.058
NR 42
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3588
EP 3597
DI 10.1016/j.vaccine.2019.05.006
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600011
PM 31153691
DA 2020-05-12
ER

PT J
AU Lim, SI
   Choe, S
   Kim, KS
   Jeoung, HY
   Cha, RM
   Park, GS
   Shin, J
   Park, GN
   Cho, IS
   Song, JY
   Hyun, BH
   Park, BK
   An, DJ
AF Lim, Seong-in
   Choe, SeEun
   Kim, Ki-Sun
   Jeoung, Hye-Young
   Cha, Ra Mi
   Park, Gil-Soon
   Shin, Jihye
   Park, Gyu-Nam
   Cho, In-Soo
   Song, Jae-Young
   Hyun, Bang-Hun
   Park, Bong-Kyun
   An, Dong-Jun
TI Assessment of the efficacy of an attenuated live marker classical swine
   fever vaccine (Flc-LOM-BErns) in pregnant sows
SO VACCINE
LA English
DT Article
DE Classical swine fever virus; Flc-LOM-BErns; Transplacental transmission;
   Pregnant sow; E-rns ELSIA
ID HOG-CHOLERA VIRUS; TRANS-PLACENTAL TRANSMISSION; NEWCASTLE-DISEASE
   VIRUS; STRAIN; CP7-E2ALF; PIGS; CANDIDATES
AB Here, we constructed an attenuated live marker classical swine fever (CSF) vaccine (Flc-LOM-BErns) to eradicate CSF. This was done by taking infectious clone Flc-LOM, which is based on an attenuated live CSF vaccine virus (LOM strain), and removing the full-length classical swine fever virus (CSFV) E-rns sequences and the 3' end (52 base pairs) of the CSFV capsid. These regions were substituted with the full-length bovine viral diarrhoea virus (BVDV) E-rns gene sequence and the 3' end (52 base pairs) of the BVDV capsid gene. Sows were vaccinated with the Flc-LOM-BErns vaccine 3 weeks before insemination and then challenged with virulent CSFV at the early, mid- or late stages of pregnancy. We then examined transplacental transmission to the foetuses. Piglets born to sows vaccinated with Flc-LOM-BErns did not show vertical infection, regardless of challenge time. In addition, CSFV challenge did not affect the delivery date, weight or length of the foetus. Pregnant sows inoculated with the Flc-LOM-BErns vaccine were anti-CSF E-rns antibody-negative and anti-BVDV E-rns antibody-positive. Challenge of pregnant sows with virulent CSFV resulted in anti-CSF E-rns antibody positivity. These results strongly indicate that differential diagnosis can be conducted between the Flc-LOM-BErns vaccinated animal and virulent CSFV affected animal by detecting antibody against BVDV E-rns or CSF E-rns gene. Therefore, the Flc-LOM-BErns vaccine may fulfil the function of differential diagnosis which required for DIVA vaccine. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Lim, Seong-in; Choe, SeEun; Kim, Ki-Sun; Jeoung, Hye-Young; Cha, Ra Mi; Park, Gil-Soon; Shin, Jihye; Park, Gyu-Nam; Cho, In-Soo; Song, Jae-Young; Hyun, Bang-Hun; Park, Bong-Kyun; An, Dong-Jun] Anim & Plant Quarantine Agcy, Virus Dis Div, Gimchen 39660, Gyeongbuk Do, South Korea.
   [Park, Bong-Kyun] Seoul Univ, Coll Vet Med, Seoul 08826, South Korea.
RP An, DJ (reprint author), Anim & Plant Quarantine Agcy, Virus Dis Div, Gimchen 39660, Gyeongbuk Do, South Korea.
EM andj67@korea.kr
FU Animal and Plant Quarantine Agency (QIA), Republic of Korea
   [B-1543083-2017-18-02, B-1543083-2019-20-01]
FX This project was supported by a grant (Project Code nos.
   B-1543083-2017-18-02 and B-1543083-2019-20-01) from the Animal and Plant
   Quarantine Agency (QIA), Republic of Korea, 2017-2019.
CR Ahrens U, 2000, VET MICROBIOL, V77, P83, DOI 10.1016/S0378-1135(00)00265-0
   Aoki H, 2004, J VET MED SCI, V66, P161, DOI 10.1292/jvms.66.161
   Blome S, 2017, VET RES, V48, DOI 10.1186/s13567-017-0457-y
   Blome S, 2013, BERL MUNCH TIERARZTL, V126, P481, DOI 10.2376/0005-9366-126-481
   Blome S, 2012, VET MICROBIOL, V158, P42, DOI 10.1016/j.vetmic.2012.02.015
   de Smit AJ, 2000, VET QUART, V22, P150, DOI 10.1080/01652176.2000.9695045
   Depner KR, 2001, VET MICROBIOL, V83, P107, DOI 10.1016/S0378-1135(01)00410-2
   Drew T., 2008, OIE MANUAL DIAGNOSTI, P1092
   Eble PL, 2013, VET MICROBIOL, V162, P437, DOI 10.1016/j.vetmic.2012.10.030
   Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3
   FREY HR, 1980, ZBL VET MED B, V27, P154
   Goller KV, 2015, ARCH VIROL, V160, P3121, DOI 10.1007/s00705-015-2611-z
   Greiser-Wilke Irene, 2004, Animal Health Research Reviews, V5, P223, DOI 10.1079/AHR200472
   Henke J, 2018, VACCINE, V36, P4181, DOI 10.1016/j.vaccine.2018.06.014
   Kang BJ, 1971, RES REPT RURAL DEV A, V17, P27
   Kim B, 2008, VET REC, V162, P12, DOI 10.1136/vr.162.1.12
   Koenig P, 2007, VACCINE, V25, P3391, DOI 10.1016/j.vaccine.2006.12.052
   Konig P, 2011, VACCINE, V30, P5, DOI 10.1016/j.vaccine.2011.10.064
   Kozasa T, 2015, J VET MED SCI, V77, P511, DOI 10.1292/jvms.14-0420
   KUMAGAI T, 1958, SCIENCE, V128, P366, DOI 10.1126/science.128.3320.366
   Lindenbach BD, FIELDS VIROLOGY
   Mayer H, 1980, ZBL VET MED B, V27, P659
   Munoz-Gonzalez S, 2018, VET MICROBIOL, V213, P143, DOI 10.1016/j.vetmic.2017.10.014
   Pannhorst K, 2015, J VET DIAGN INVEST, V27, P449, DOI 10.1177/1040638715592446
   Park GS, 2012, J VET SCI, V13, P81, DOI 10.4142/jvs.2012.13.1.81
   Reimann Ilona, 2016, Methods Mol Biol, V1349, P239, DOI 10.1007/978-1-4939-3008-1_15
   van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008
   VONBENTEN K, 1980, ZBL VET MED B, V27, P714
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3598
EP 3604
DI 10.1016/j.vaccine.2019.04.076
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600012
PM 31151802
DA 2020-05-12
ER

PT J
AU Choi, WS
   Choi, JH
   Jung, DS
   Choi, HJ
   Kim, YS
   Lee, J
   Jang, HC
   Shin, EC
   Park, JS
   Kim, H
   Cheong, AHJ
AF Choi, Won Suk
   Choi, Jung Hyun
   Jung, Dong Sik
   Choi, Hee Jung
   Kim, Yeon-Sook
   Lee, Jacob
   Jang, Hee-Chang
   Shin, Eui-Cheol
   Park, Jun-Sik
   Kim, Hun
   Cheong, Hee Jin A.
TI Immunogenicity and safety of a new live attenuated herpes zoster vaccine
   (NBP608) compared to Zostavax (R) in healthy adults aged 50 years and
   older
SO VACCINE
LA English
DT Article
DE Herpes zoster vaccine; Prevention of herpes zoster; Attenuated vaccine;
   Immunogenicity; Safety; Clinical trial
ID IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; SUBUNIT VACCINE; EFFICACY;
   RECOMMENDATIONS
AB A multi-centre, randomised, double-blinded, active-controlled, parallel-group clinical trial was carried out to assess the immunogenicity and safety of NBP608-a newly developed live-attenuated zoster vaccine in Korea-relative to Zostavax (R) in healthy adults aged 50 years or older. Immune responses to the vaccine were evaluated by glycoprotein enzyme-linked immunosorbent assay (gpELISA) and enzyme-linked immunosorbent spot (ELISPOT) assays using the interferon (IFN)-gamma and interleukin (IL)-2 FluoroSpot kit 6 weeks after vaccination. Safety was monitored for 26 weeks based on subjects' diaries, spontaneous reports from subjects, and history taking by the investigators. A total of 845 subjects participated in the screening, and 823 received the vaccination (413 in the NBP608 group and 411 in the comparator group). The gpELISA-determined geometric mean fold rise from baseline to post NBP608 vaccination was 2.75 [95% confidence interval, CI (2.57, 2.94)]. The gpELISA-determined adjusted geometric mean titers (GMTs) of NBP608 and the comparator were 1346.37 [95% CI (1273.99, 1422.87)] and 1674.94 [95% CI (1585.35, 1769.58)], respectively. The adjusted GMT ratio of NBP608 to the comparator was 0.80 [95% CI (0.75, 0.87)]. There was no statistically significant difference between two groups in terms of the geometric mean spot numbers determined by IFN-gamma and IL-2 ELISPOT assays at 6 weeks post vaccination (P = 0.7232, 0.3844). The incidence of adverse events (AEs) within 6 weeks post vaccination was 49.82% overall (410/823, 941 cases), 50.73% (209/412, 474 cases) in the NBP608 group, and 48.91% (201/411, 467 cases) in the comparator group. The difference in AE rate between the two groups was not statistically significant (P = 0.6010). Most AEs were mild, with a rate of 83.12% in the NBP608 group and 75.37% in the comparator group. Thus, NBP608 is non-inferior to Zostavax (R) in terms of inducing the immune response and can be safely administered to adults aged 50 years or older. (C) 2019 Published by Elsevier Ltd.
C1 [Choi, Won Suk; Cheong, Hee Jin A.] Korea Univ, Dept Internal Med, Div Infect Dis, Coll Med, Seoul, South Korea.
   [Choi, Jung Hyun] Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Div Infect Dis, Incheon, South Korea.
   [Jung, Dong Sik] Dong A Univ Hosp, Dept Internal Med, Div Infect Dis, Busan, South Korea.
   [Choi, Hee Jung] Ewha Womans Univ, Dept Internal Med, Div Infect Dis, Mokdong Hosp, Seoul, South Korea.
   [Kim, Yeon-Sook] Chungnam Natl Univ, Dept Internal Med, Div Infect Dis, Sch Med, Daejon, South Korea.
   [Lee, Jacob] Hallym Univ, Dept Internal Med, Div Infect Dis, Coll Med, Chunchon, South Korea.
   [Jang, Hee-Chang] Chonnam Natl Univ, Dept Infect Dis, Med Sch, Gwangju, South Korea.
   [Shin, Eui-Cheol; Park, Jun-Sik] Korea Adv Inst Sci & Technol, Lab Immunol & Infect Dis, Grad Sch Med Sci & Engn, Daejeon, South Korea.
   [Kim, Hun] SK Biosci, Life Sci Res Inst, Seongnam, Gyeonggi Do, South Korea.
RP Cheong, AHJ (reprint author), Korea Univ, Guro Hosp, Div Infect Dis, Dept Internal Med,Coll Med, 148 Gurodong Ro, Seoul 08308, South Korea.
EM heejinmd@korea.ac.kr
RI Shin, Eui-Cheol/C-1690-2011
OI Shin, Eui-Cheol/0000-0002-6308-9503; Kim, Yeon-Sook/0000-0003-1142-5488;
   Lee, Jacob/0000-0002-7041-065X
FU SK bioscience Co., Ltd.
FX This study was supported by SK bioscience Co., Ltd. The study was
   designed, executed, and analysed by the sponsor. Although the sponsor
   reviewed a draft of the manuscript, the opinions expressed in this
   article do not necessarily reflect those of the sponsor.
CR Chen SY, 2014, INFECTION, V42, P325, DOI 10.1007/s15010-013-0550-8
   Choi WS, 2014, J MED VIROL, V86, P525, DOI 10.1002/jmv.23830
   Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800
   DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605
   Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5
   Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674
   Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1
   Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0
   Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184
   Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029
   Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016
   Sauerbrei A, 2006, J CLIN MICROBIOL, V44, P3094, DOI 10.1128/JCM.00719-06
   Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970
   Schroder C, 2017, J INFECTION, V75, P207, DOI 10.1016/j.jinf.2017.06.010
   SCIENTIFIC DISCUSSION: EPAR, 2007, EMEAHC000674II0003
   World Health Organization, 2017, WHO EXP COMM BIOL ST
NR 16
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3605
EP 3610
DI 10.1016/j.vaccine.2019.04.046
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600013
PM 31122860
DA 2020-05-12
ER

PT J
AU Li, J
   Zhang, Y
   Yang, Y
   Liang, ZC
   Tian, Y
   Liu, BW
   Gao, ZY
   Jia, L
   Chen, LJ
   Wang, QY
AF Li, Jie
   Zhang, Yi
   Yang, Yang
   Liang, Zhichao
   Tian, Yi
   Liu, Baiwei
   Gao, Zhiyong
   Jia, Lei
   Chen, Lijuan
   Wang, Quanyi
TI Effectiveness of Lanzhou lamb rotavirus vaccine in preventing
   gastroenteritis among children younger than 5 years of age
SO VACCINE
LA English
DT Article
DE Rotavirus; Vaccine; Effectiveness; Case-control design
ID DISEASE; BURDEN; EFFICACY; DIARRHEA; INFANTS; PCR
AB Background: Lanzhou Lamb rotavirus (LLR) vaccine was licensed in China in 2000. It was the only vaccine available in private market before 2018. However, the data about the post-marketing effectiveness is very limited. To assess the vaccine effectiveness (VE), we conducted a case-control study based on the hospital surveillance system in Beijing from 2015 to 2017.
   Methods: Seven hospitals located in seven districts in Beijing, from October 1, 2015, to March 31, 2017, were included. The VE of LLR vaccine was assessed in laboratory-confirmed rotavirus infection among children younger than five years old through a case-control design, using rotavirus-negative cases as controls. LLR vaccination was documented from a vaccination registry. VE was estimated adjusting for age group, gender, study site, the month of illness onset and interval days between illness onset to sampling through a logistic regression model.
   Results: A total of 598 cases and 1766 controls were included in this study. The vaccine average coverage rate during 2015-2017 among children younger than five years old was 10.8% in Beijing. The adjusted VE for LLR vaccine of 1 dose versus 0 dose was 34.9% (95%CI, 5.3-55.3). We also obtained the adjusted VE of 87.7% (95%CI, 32.7-97.8) for patients with the severity score >= 11, 36.2% (95%CI, 4.7-57.3) for children of 2-35 months age group and 40.8% (95%CI, 7.8-61.9) against G9 rotavirus infection. Vaccinated cases were less likely to have watery stool (OR = 0.42) and have diarrhea longer than 5 days (OR = 0.47) than unvaccinated cases.
   Discussion: LLR vaccine conferred protection against rotavirus disease. Children who were vaccinated presented with less severe clinical manifestations. An immunization schedule of receiving all three doses in the first year should be preferred. (C) 2019 Published by Elsevier Ltd.
C1 Beijing Ctr Dis Prevent & Control, 16 Hepingli Middle Rd, Beijing 100013, Peoples R China.
   Res Ctr Prevent Med Beijing, 16 Hepingli Middle Rd, Beijing 100013, Peoples R China.
RP Wang, QY (reprint author), Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, 16 He Pingli Middle St, Beijing 100013, Peoples R China.
EM bjcdcxm@126.com
FU Beijing Municipal Natural Science FoundationBeijing Natural Science
   Foundation [7164240]
FX This work was supported by the grant from Beijing Municipal Natural
   Science Foundation to JL (7164240).
CR Burnett E, 2018, PEDIATR DRUGS, V20, P223, DOI 10.1007/s40272-018-0283-3
   Clarke E, 2015, MUCOSAL IMMUNOL, V8, P1, DOI 10.1038/mi.2014.114
   Cunliffe NA, 2002, J INFECTION, V45, P1, DOI 10.1053/jinf.2002.1012
   Fu CX, 2007, VACCINE, V25, P8756, DOI 10.1016/j.vaccine.2007.10.036
   Fu CX, 2012, VACCINE, V31, P154, DOI 10.1016/j.vaccine.2012.10.078
   Kheyami AM, 2008, J CLIN MICROBIOL, V46, P1185, DOI 10.1128/JCM.02244-07
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Lewis K., 2011, VESIKARI CLIN SEVERI
   Li RC, 2014, HUM VACC IMMUNOTHER, V10, P11, DOI 10.4161/hv.26319
   Liu N, 2014, VACCINE, V32, P4369, DOI 10.1016/j.vaccine.2014.06.018
   NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Tian Y, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3411-3
   Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960
   Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006
   VESIKARI T, 1984, LANCET, V1, P977
   Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x
   Vesikari T, 2010, EUR J PEDIATR, V169, P1379, DOI 10.1007/s00431-010-1242-3
   Wu D, 2016, PEDIATR INFECT DIS J, V35, pE392, DOI 10.1097/INF.0000000000001327
   Xu WH, 2000, J CLIN MICROBIOL, V38, P4114, DOI 10.1128/JCM.38.11.4114-4120.2000
   Yanling Z, 2004, VACCINOLOGY
   Zhen SS, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.64
   Zuccotti G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-218
NR 23
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3611
EP 3616
DI 10.1016/j.vaccine.2019.03.069
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600014
PM 31122857
DA 2020-05-12
ER

PT J
AU Wei, LH
   Xie, X
   Liu, JH
   Zhao, Y
   Chen, W
   Zhao, C
   Wang, SM
   Liao, XY
   Shou, Q
   Qiu, YZ
   Qiao, YL
   Saah, AJ
AF Wei, Lihui
   Xie, Xing
   Liu, Jihong
   Zhao, Yun
   Chen, Wen
   Zhao, Chao
   Wang, Shaoming
   Liao, Xueyan
   Shou, Qiong
   Qiu, Yuanzheng
   Qiao, Youlin
   Saah, Alfred J.
TI Efficacy of quadrivalent human papillomavirus vaccine against persistent
   infection and genital disease in Chinese women: A randomized,
   placebo-controlled trial with 78-month follow-up
SO VACCINE
LA English
DT Article
DE Efficacy; Genital diseases; Persistent infection; Quadrivalent human
   papillomavirus vaccine; Randomized controlled trial
ID COST-EFFECTIVENESS; POOLED ANALYSIS; PREVALENCE; STATISTICS; COUNTRIES;
   NEOPLASIA; CANCER; IMPACT; LEVEL
AB Background: A quadrivalent human papillomavirus vaccine (qHPV; HPV6/11/16/18) has demonstrated efficacy and effectiveness worldwide. We report qHPV vaccine efficacy for up to 6.5 years after first administration among Chinese women 20-45 years of age.
   Methods: In this randomized, double-blind, placebo-controlled, multicenter, Phase 3 study (NCT00834106), women were randomized 1:1 to receive 3 doses of qHPV vaccine or placebo (Day 1, Month 2, Month 6). Endo-ecto-cervical and external genital swabs were collected for HPV testing and gynecologic examinations, and cervical cytology testing were performed at Day 1 and Months 7, 12, 18, 24, 30, 42, 54, 66, and 78. Any abnormality in cytology testing would trigger colposcopy examination and cervical biopsy, if necessary. Efficacy against genital disease, persistent infection, and the composite endpoint was assessed. Primary efficacy analyses were conducted in the per-protocol efficacy (PPE) population.
   Results: Of 3006 participants randomized, 2759 (91.8%) and 2374 (79%) completed the Month 30 and Month 78 visits, respectively. At Month 78, efficacy among women aged 20-45 years was 100% (95% CI: 32.3, 100; 0 vs 7 cases) and 100% (95% CI: 70.9, 100; 0 vs 14 cases) against HPV16/18-related cervical intraepithelial neoplasia Grade 2 or 3, adenocarcinoma in situ, and cervical cancer (CIN 2+) and HPV6/11/16/18-related CIN 1+, respectively, in the PPE population. The efficacy against cervical 6-month and 12-month persistent infection was 91.6% (95% CI: 66.0, 99.0) and 97.5% (95% CI: 85.1, 99.9) at Month 30 and Month 78, respectively, in the PPE population. The vaccine also reduced the rate of cervical cytology abnormalities associated with HPV6/11/16/18, with an efficacy of 94.0% (95% CI: 81.5, 98.8). The vaccine was generally well tolerated (reported separately).
   Conclusion: The qHPV vaccine is efficacious against endpoints of persistent infection and genital precancerous lesions in Chinese women aged 20-45 years. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Wei, Lihui; Zhao, Yun; Zhao, Chao] Peking Univ, Peoples Hosp, Dept Obstet & Gynecol, 11 Xizhimen South St, Beijing 100044, Peoples R China.
   [Xie, Xing] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynecol Oncol, 1 Xueshi Rd, Hangzhou 310006, Zhejiang, Peoples R China.
   [Liu, Jihong] Sun Yat Sen Univ, Canc Ctr, Dept Gynecol Oncol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.
   [Chen, Wen; Wang, Shaoming; Qiao, Youlin] Chinese Acad Med Sci, Canc Hosp, Dept Canc Epidemiol, 17 South Panjiayuan Lane, Beijing 100021, Peoples R China.
   [Chen, Wen; Wang, Shaoming; Qiao, Youlin] Peking Union Med Coll, 17 South Panjiayuan Lane, Beijing 100021, Peoples R China.
   [Liao, Xueyan; Shou, Qiong; Qiu, Yuanzheng] MSD R&D China, 21 Rongda Rd, Beijing 100012, Peoples R China.
   [Saah, Alfred J.] Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.
RP Saah, AJ (reprint author), Merck & Co Inc, 351 N Sumneytown Pike, N Wales, PA 19454 USA.; Qiao, YL (reprint author), 17 South Panjiayuan Lane, Beijing 100021, Peoples R China.
EM qiaoy@cicams.ac.cn; Alfred_saah@merck.com
RI Qiao, You-Lin/B-4139-2012
OI Qiao, You-Lin/0000-0001-6380-0871
FU Merck Sharp Dohme CorpMerck & Company; Merck & Co., Inc., Kenilworth,
   NJ, USA
FX Funding for this study was provided by Merck Sharp & Dohme Corp, a
   subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
CR [Anonymous], 2012, GLOBOCAN 2012 EST CA
   Bruni L, 2017, HUMAN PAPILLOMAVIRUS
   Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7
   Castellsague X, 2016, PAPILLOMAVIRUS RES, V2, P61, DOI 10.1016/j.pvr.2016.03.002
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Chen W, 2009, CANCER CAUSE CONTROL, V20, P1705, DOI 10.1007/s10552-009-9422-z
   de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716
   de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8
   Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168
   Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4
   Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060
   FUTURE I and II Study Group, 2010, BMJ-BRIT MED J, V340, pc3493
   Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760
   Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354
   Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071
   Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2
   Kavanagh K, 2017, LANCET INFECT DIS, V17, P1293, DOI 10.1016/S1473-3099(17)30468-1
   Kim SY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-174
   Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031
   Koutsky Laura, 1997, American Journal of Medicine, V102, P3
   Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1
   Merck & Co. Inc. Kenilworth NJ USA, 2015, GARD US PRESCR INF
   Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7
   Pitisuttithum P, 2015, EXPERT REV VACCINES, V14, P1405, DOI 10.1586/14760584.2015.1089174
   Radley D, 2016, HUM VACC IMMUNOTHER, V12, P768, DOI 10.1080/21645515.2015.1088616
   Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741
   Wang H, 2008, INT J STD AIDS, V19, P680, DOI 10.1258/ijsa.2008.008040
   World Health Organization (WHO), 2016, REC ASS QUAL SAF EFF
   Zhao FH, 2012, INT J CANCER, V131, P2929, DOI 10.1002/ijc.27571
NR 31
TC 6
Z9 10
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2019
VL 37
IS 27
BP 3617
EP 3624
DI 10.1016/j.vaccine.2018.08.009
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IH2LF
UT WOS:000474325600015
PM 30122646
DA 2020-05-12
ER

PT J
AU Cabrera, G
   Marcipar, I
AF Cabrera, Gabriel
   Marcipar, Ivan
TI Vaccines and the regulatory arm of the immune system. An overview from
   the Trypanosoma cruzi infection model
SO VACCINE
LA English
DT Review
DE Trypanosoma cruzi; Vaccine; Myeloid-derived suppressor cells;
   Foxp3+regulatory T cells; Trans-sialidase
ID SUPPRESSOR-CELLS MEDIATE; HUMAN CHAGAS-DISEASE; T-CELLS;
   TRANS-SIALIDASE; DENDRITIC CELLS; LIMITED ROLE; VACCINATION; INDUCTION;
   RESPONSES; EXPRESSION
AB The knowledge that the immune system is composed of a regulatory/suppressor arm added a new point of view to better understand the nature of several pathologies including cancer, transplants, infections and autoimmune diseases. The striking discoveries concerning molecules and cells involved in this kind of regulation were followed by the elucidation of equally notable mechanisms used by several pathogens to manipulate the host immune system. Vaccines against pathogens are an invaluable tool developed to help the immune system cope with a potential infection or prevent disease pathology. Nowadays, there is accumulated evidence indicating that the powerful stimulation capacity of vaccines influences not only the effector arm of the immune system but also cells with regulatory/suppressor capacity, such as myeloid derived suppressor cells (MDSCs) and Foxp3+ regulatory T cells (Tregs).
   Trypanosoma cruzi (T. cruzi) is a protozoan parasite with a complex life cycle that has evolved several strategies to influence the regulatory immune response. Although diverse vaccine formulations have been able to stimulate the effector response, achieving non-sterilizing protection against T. cruzi, the influence of the vaccine candidates on the regulatory machinery has scarcely been assessed. This fact may not only reveal important information concerning how vaccines may influence cells with regulatory/suppressor capacity but also open the possibility to analyze whether vaccines are able to disrupt the mechanisms used by some pathogens to manipulate the host regulatory circuits. The aim of this review is to summarize and discuss available data related to the role of cellular components, like MDSCs and Foxp3+ Tregs, during T. cruzi infection, and the potential utility of those populations as additional targets for the rational design of vaccines. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cabrera, Gabriel] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, Santa Fe, Argentina.
   Univ Nacl Litoral, Fac Ciencias Med, Santa Fe, Argentina.
RP Cabrera, G (reprint author), Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, Santa Fe, Argentina.
EM galt132000@yahoo.com.ar
FU ANPCyT (Argentine National Agency for the Promotion of Science and
   Technology)ANPCyT [PICT2014-620, PICT 2015-2544]; SECTeI (Secretary of
   State for Science, Technology and Innovation of the province of Santa
   Fe) [SECTeI 2016: 2010-099-16]
FX Gabriel Cabrera and Ivan Marcipar are research career members of
   CONICET. The work of the authors related to this review was supported by
   ANPCyT (Argentine National Agency for the Promotion of Science and
   Technology) (PICT2014-620 and PICT 2015-2544) and SECTeI (Secretary of
   State for Science, Technology and Innovation of the province of Santa
   Fe) SECTeI 2016: 2010-099-16.
CR ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955
   Akkina R, 2013, CURR OPIN IMMUNOL, V25, P403, DOI 10.1016/j.coi.2013.03.009
   Almeida MS, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12650
   Furlan CLA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02555
   Arce-Fonseca M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0738-0
   Arocena AR, 2014, EUR J IMMUNOL, V44, P184, DOI 10.1002/eji.201343606
   Batista-Duharte A, 2018, PHARMACOL RES, V129, P237, DOI 10.1016/j.phrs.2017.11.026
   Bayry Jagadeesh, 2014, VirusDisease, V25, P18, DOI 10.1007/s13337-013-0187-3
   Gonzalez FB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004285
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   BENNETT JA, 1978, P NATL ACAD SCI USA, V75, P5142, DOI 10.1073/pnas.75.10.5142
   Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021
   Berod L, 2012, MICROB BIOTECHNOL, V5, P260, DOI 10.1111/j.1751-7915.2011.00299.x
   Bertona D, 2017, J PHARM PHARMACOL, V69, P1293, DOI 10.1111/jphp.12768
   Beswick EJ, 2011, INFECT IMMUN, V79, P2737, DOI 10.1128/IAI.01146-10
   Boer MC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00217
   Bonney KM, 2015, PARASITOL RES, V114, P1167, DOI 10.1007/s00436-014-4300-3
   Bontempi I, 2017, IMMUNOTHERAPY-UK, V9, P555, DOI 10.2217/imt-2017-0009
   Bontempi IA, 2015, VACCINE, V33, P1274, DOI 10.1016/j.vaccine.2015.01.044
   Brezar V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004752
   Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150
   Cabrera G, 2008, J VIROL, V82, P7422, DOI 10.1128/JVI.00102-08
   Cardillo F, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv082
   Cazorla SI, 2009, EXPERT REV VACCINES, V8, P921, DOI [10.1586/erv.09.45, 10.1586/ERV.09.45]
   Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928
   de Araujo FF, 2012, IMMUNOBIOLOGY, V217, P768, DOI 10.1016/j.imbio.2012.04.008
   de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992
   de Araujo FF, 2011, HUM PATHOL, V42, P299, DOI 10.1016/j.humpath.2010.10.002
   Braz SCD, 2014, J CLIN IMMUNOL, V34, P991, DOI 10.1007/s10875-014-0092-6
   DOSREIS GA, 1995, PARASITOL TODAY, V11, P390
   Dumonteil E, 2012, EXPERT REV VACCINES, V11, P1043, DOI [10.1586/ERV.12.85, 10.1586/erv.12.85]
   DUWE AK, 1979, CELL IMMUNOL, V43, P362, DOI 10.1016/0008-8749(79)90180-1
   Ersching J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005698
   Fedatto PF, 2012, IMMUNOLOGY, V137, P239, DOI 10.1111/imm.12006
   Flores-Garcia Y, 2013, BIOMED RES INT, DOI 10.1155/2013/632436
   Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
   Freire-de-Lima L, 2015, GLYCOBIOLOGY, V25, P1142, DOI 10.1093/glycob/cwv057
   Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506
   Garg A, 2014, J INFECT DIS, V209, P441, DOI 10.1093/infdis/jit469
   GERSHON RK, 1970, IMMUNOLOGY, V18, P723
   Goni O, 2002, INT IMMUNOL, V14, P1125, DOI 10.1093/intimm/dxf076
   Gonzalez FB, 2015, BRAIN BEHAV IMMUN, V45, P219, DOI 10.1016/j.bbi.2014.11.016
   Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074
   Gupta N, 2014, EUR J IMMUNOL, V44, P1363, DOI 10.1002/eji.201343701
   Hall CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012154
   Heithoff DM, 2001, INFECT IMMUN, V69, P6725, DOI 10.1128/IAI.69.11.6725-6730.2001
   Heithoff DM, 2008, INFECT IMMUN, V76, P5191, DOI 10.1128/IAI.00759-08
   Hisaeda H, 2008, J IMMUNOL, V180, P2496, DOI 10.4049/jimmunol.180.4.2496
   Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490
   Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299
   Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909
   Knuschke T, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0258-9
   Kong XH, 2014, J IMMUNOL, V193, P1645, DOI 10.4049/jimmunol.1303432
   Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06
   Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006
   Lin PH, 2018, MUCOSAL IMMUNOL, V11, P1239, DOI 10.1038/s41385-018-0004-9
   Luan Y, 2013, AM J TRANSPLANT, V13, P3123, DOI 10.1111/ajt.12461
   Mariano FS, 2008, MICROBES INFECT, V10, P825, DOI 10.1016/j.micinf.2008.04.009
   Martino A, 2010, J IMMUNOL, V184, P2038, DOI 10.4049/jimmunol.0903348
   Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399
   Nardy AFFR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00348
   Nardy AF, 2015, J IMMUNOL RES, DOI 10.1155/2015/178947
   Ndure J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00477
   Nihei J, 2014, EUR J MICROBIOL IMMU, V4, P128, DOI 10.1556/EuJMI.4.2014.2.6
   Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193
   Poncini CV, 2015, J IMMUNOL, V195, P3311, DOI 10.4049/jimmunol.1403019
   Poncini CV, 2008, INFECT IMMUN, V76, P2633, DOI 10.1128/IAI.01298-07
   Prochetto E, 2017, ONCOTARGET, V8, P58003, DOI 10.18632/oncotarget.18217
   Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12
   Ren JP, 2016, IMMUNOLOGY, V148, P377, DOI 10.1111/imm.12616
   Rodriguez-Morales O, 2015, J IMMUNOL RES, DOI 10.1155/2015/489758
   Rodriguez-Perea AL, 2016, CLIN EXP IMMUNOL, V185, P281, DOI 10.1111/cei.12804
   Diaz PR, 2015, INFECT IMMUN, V83, P2099, DOI 10.1128/IAI.00031-15
   SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
   Sales-Junior PA, 2008, MICROBES INFECT, V10, P680, DOI 10.1016/j.micinf.2008.03.008
   Sanoja C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065820, 10.1371/journal.pone.006]
   Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018
   Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160
   Bezerra IPS, 2018, VACCINE, V36, P2480, DOI 10.1016/j.vaccine.2018.03.020
   Sui YJ, 2014, J CLIN INVEST, V124, P2538, DOI 10.1172/JCI73518
   Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700
   Tang CL, 2017, PARASITOL RES, V116, P2727, DOI 10.1007/s00436-017-5581-0
   TARLETON RL, 1988, J IMMUNOL, V140, P2769
   Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658
   Trinath J, 2012, J INFECT DIS, V205, P694, DOI 10.1093/infdis/jir820
   Van Overtvelt L, 1999, INFECT IMMUN, V67, P4033, DOI 10.1128/IAI.67.8.4033-4040.1999
   Vasconcelos JF, 2013, FASEB J, V27, P4691, DOI 10.1096/fj.13-229351
   Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x
   Wang J, 2017, ONCOTARGET, V8, P17050, DOI 10.18632/oncotarget.14991
   Wang SM, 2012, HUM VACC IMMUNOTHER, V8, P1243, DOI 10.4161/hv.21117
   Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110
   Wen ZY, 2017, MICROBES INFECT, V19, P626, DOI 10.1016/j.micinf.2017.08.013
   Zhao Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1004983
   Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547
NR 94
TC 2
Z9 2
U1 5
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3628
EP 3637
DI 10.1016/j.vaccine.2019.05.015
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100002
PM 31155420
DA 2020-05-12
ER

PT J
AU Yakubogullari, N
   Genc, R
   Coven, F
   Nalbantsoy, A
   Bedir, E
AF Yakubogullari, Nilgun
   Genc, Rukan
   Coven, Fethiye
   Nalbantsoy, Ayse
   Bedir, Erdal
TI Development of adjuvant nanocarrier systems for seasonal influenza A
   (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS)
SO VACCINE
LA English
DT Article
DE Gum tragacanth; Astragaloside VII; Astragalus; Adjuvant; Nanocarrier;
   Influenza
ID MEDIATED IMMUNE-RESPONSES; AERIAL PARTS; SAPONINS; MICE; IMMUNOGENICITY;
   IMMUNIZATION; PROTECTION; EMULSION; ANTIBODY; CELLS
AB Adjuvants are chemical/biological substances that are used in vaccines to increase the immunogenicity of antigens. A few adjuvants have been developed for use in human vaccines because of their limitations including lack of efficacy, unacceptable local or systemic toxicity, the difficulty of manufacturing, poor stability, and high cost. For that reasons, novel adjuvants/adjuvant systems are under search. Astragaloside VII (AST-VII), isolated from Astragalus trojanus, exhibited significant cellular and humoral immune responses. The polysaccharides (APS) obtained from the roots of Astragalus species have been used in traditional Chinese medicine and possess strong immunomodulatory properties. In the present study, the immunomodulatory effects of a newly developed nanocarrier system (APNS: APS containing carrier) and its AST-VII containing formulation (ANS: AST-VII + APNS), on seasonal influenza A (H3N2) vaccine were investigated. Inactivated H3N2 alone or its combinations with test compounds/formulations were intramuscularly injected into Swiss albino mice. Four weeks after immunization, the immune responses were evaluated in terms of antibody and cytokine responses as well as splenocyte proliferation. APNS demonstrated Th2 mediated response by increasing IgG1 antibody titers, whereas ANS showed response towards Th1/Th2 balance and Th17 by producing of IFN-gamma, IL-17A and IgG2a. Based on these results, we propose that APNS and ANS are good candidates to be utilized in seasonal influenza A vaccines as adjuvants/carrier systems. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yakubogullari, Nilgun; Bedir, Erdal] Izmir Inst Technol, Fac Engn, Dept Bioengn, TR-35433 Izmir, Turkey.
   [Genc, Rukan] Mersin Univ, Fac Engn, Dept Chem Engn, TR-33343 Mersin, Turkey.
   [Coven, Fethiye] Bornova Vet Control & Res Inst, TR-35100 Izmir, Turkey.
   [Nalbantsoy, Ayse] Ege Univ, Fac Engn, Dept Bioengn, TR-35100 Izmir, Turkey.
RP Bedir, E (reprint author), Izmir Inst Technol, Fac Engn, Dept Bioengn, TR-35433 Izmir, Turkey.; Nalbantsoy, A (reprint author), Ege Univ, Fac Engn, Dept Bioengn, TR-35100 Izmir, Turkey.
EM ayse.nalbantsoy@ege.edu.tr; erdalbedir@iyte.edu.tr
OI Bedir, Erdal/0000-0003-1262-063X; Yakubogullari,
   Nilgun/0000-0002-5621-0221
FU Scientific and Technological Research Council of Turkey (TUBITAK)Turkiye
   Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [215S544]
FX We would like to extend our thanks to AREL (Research and Education
   Laboratory, Ege University School of Medicine) for providing laboratory
   facilities to perform in vitro studies. This project was financially
   supported by The Scientific and Technological Research Council of Turkey
   (TUBITAK, Project No: 215S544).
CR ALLAN WH, 1978, FAO ANIMAL PRODUCTIO, V10
   Barr IG, 1998, ADV DRUG DELIVER REV, V32, P247, DOI 10.1016/S0169-409X(98)00013-1
   Bedir E, 2001, CHEM PHARM BULL, V49, P1482, DOI 10.1248/cpb.49.1482
   Bedir E, 1999, J NAT PROD, V62, P563, DOI 10.1021/np980399t
   Bedir E, 1999, PHYTOCHEMISTRY, V51, P1017, DOI 10.1016/S0031-9422(99)00035-7
   Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292
   Broadbent AJ, 2011, CURR OPIN VIROL, V1, P254, DOI 10.1016/j.coviro.2011.08.002
   Cargnelutti DE, 2012, J MICROBIOL BIOTECHN, V22, P416, DOI 10.4014/jmb.1106.06021
   Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109
   Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042
   Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x
   Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320
   FROLOV AF, 1985, VOP VIRUSOL+, P50
   Gopal R, 2014, AM J PATHOL, V184, P55, DOI 10.1016/j.ajpath.2013.09.012
   Gorji SG, 2014, FOOD HYDROCOLLOID, V34, P161, DOI 10.1016/j.foodhyd.2012.10.019
   Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814
   Hayward AC, 2015, AM J RESP CRIT CARE, V191, P1422, DOI 10.1164/rccm.201411-1988OC
   HIERHOLZER JC, 1969, APPL MICROBIOL, V18, P824, DOI 10.1128/AEM.18.5.824-833.1969
   Hou YC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/826319
   Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349
   KOHN R, 1978, CHEM ZVESTI, V32, P478
   Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009
   Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052135
   LOVGREN K, 1988, SCAND J IMMUNOL, V27, P241, DOI 10.1111/j.1365-3083.1988.tb02343.x
   Madhun AS, 2009, VACCINE, V27, P7367, DOI 10.1016/j.vaccine.2009.09.044
   Mbawuike I, 2007, VACCINE, V25, P3263, DOI 10.1016/j.vaccine.2007.01.073
   Minutello M, 1999, VACCINE, V17, P99, DOI 10.1016/S0264-410X(98)00185-6
   Nalbantsoy A, 2012, J ETHNOPHARMACOL, V139, P574, DOI 10.1016/j.jep.2011.11.053
   Nalbantsoy A, 2011, J ETHNOPHARMACOL, V134, P897, DOI 10.1016/j.jep.2011.01.054
   Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0
   Reimer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041451
   Rimmelzwaan GF, 2000, VACCINE, V19, P1180, DOI 10.1016/S0264-410X(00)00310-8
   Romanini D, 2013, APPL CALORIMETRIC TE, DOI [10.5772/54260, DOI 10.5772/54260]
   Rosenkrands I, 2011, VACCINE, V29, P6283, DOI 10.1016/j.vaccine.2011.06.040
   Sivakumar SM, 2011, SAUDI PHARM J, V19, P197, DOI 10.1016/j.jsps.2011.06.003
   Sjolander A, 2001, VACCINE, V19, P2661, DOI 10.1016/S0264-410X(00)00497-7
   Soema PC, 2015, EUR J PHARM BIOPHARM, V94, P251, DOI 10.1016/j.ejpb.2015.05.023
   Spitaels J, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040033
   VALENSI JPM, 1994, J IMMUNOL, V153, P4029
   Vogel FR, 1998, DEV BIOL STAND, V92, P241
   Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054
   Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38
   Wu CY, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0487-6
   Wyde PR, 2001, INT CONGR SER, V1219, P999, DOI 10.1016/S0531-5131(01)00411-3
   Yam KK, 2017, HUM VACC IMMUNOTHER, V13, P561, DOI 10.1080/21645515.2016.1241360
   Yam KK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00207
   Yang ZG, 2005, VACCINE, V23, P5196, DOI 10.1016/j.vaccine.2005.06.016
   Yesilada E, 2005, J ETHNOPHARMACOL, V96, P71, DOI 10.1016/j.jep.2004.08.036
NR 48
TC 1
Z9 1
U1 3
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3638
EP 3645
DI 10.1016/j.vaccine.2019.05.038
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100003
PM 31155418
DA 2020-05-12
ER

PT J
AU Ba-Nguz, A
   Shah, A
   Bresee, JS
   Lafond, KE
   Cavallaro, K
   Shefer, A
   Donadel, M
   Seward, JF
AF Ba-Nguz, Antoinette
   Shah, Adeel
   Bresee, Joseph S.
   Lafond, Kathryn E.
   Cavallaro, Kathy
   Shefer, Abigail
   Donadel, Morgane
   Seward, Jane F.
TI Supporting national immunization technical advisory groups (NITAGs) in
   resource-constrained settings. New strategies and lessons learned from
   the Task Force for Global Health's Partnership for influenza vaccine
   introduction
SO VACCINE
LA English
DT Article
DE NITAG; Evidence-based; Vaccine; Policy; Resource-constrained;
   Immunization; Recommendations; Lessons
ID ESTABLISHMENT; COMMITTEE; RECOMMENDATIONS; COUNTRIES; CAPACITY; AMERICA;
   POLICY; MODEL
AB National Immunization Technical Advisory Groups (NITAGs) are multidisciplinary national experts who provide independent, evidence-informed vaccine policy recommendations to national health authorities. An essential NITAG function is to ensure that these decisions are grounded in the best available evidence generated through a systematic, transparent process. However, in many low- and middle-income countries (LMICs), experience with this decision making method is limited. The Task Force for Global Health manages the Partnership for Influenza Vaccine Introduction (PIVI) program in collaboration with the Centers for Disease Control and Prevention, Ministries of Health, corporate partners and others. During 2017, PIVI worked with its country partners and the World Health Organization regional and local offices to assess NITAG strengthening needs and to provide technical assistance in 7 LMIC countries (Laos Peoples Democratic Republic, Mongolia, Vietnam, Armenia, Cote d'Ivoire; Moldova and the Republic of Georgia). Our workshops supported general NITAG capacity building and the evidence-based review process using vaccines of interest to the country. For NITAGs reviewing evidence on seasonal influenza, we developed an influenza resource package to support their review and provide country-relevant information in an easy to use format. Of the seven NITAGs trained, six have applied some of the concepts learnt: revision or development of formal transparent, systematic procedures for their operations; preparation of recommendations on seasonal influenza vaccination using quality-assessed data from systematic searches and local data; and have applied the principles learned for making other new vaccine recommendations. Our experience confirms that LMIC NITAGs are considerably under-resourced without adequate technical support or access to global peer-reviewed literature. Ongoing support from NITAG partners must be secured and creative approaches might be needed to help countries achieve the GVAP 2020 target and support development of sustainable vaccine policies and programs. (C) 2019 Published by Elsevier Ltd.
C1 [Ba-Nguz, Antoinette; Shah, Adeel; Bresee, Joseph S.; Seward, Jane F.] Task Force Global Hlth, Atlanta, GA USA.
   [Bresee, Joseph S.; Lafond, Kathryn E.; Cavallaro, Kathy; Shefer, Abigail; Donadel, Morgane] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Bresee, JS (reprint author), Task Force Global Hlth, Atlanta, GA USA.
EM jsb6@cdc.gov
RI Donadel, Morgane/AAB-8954-2020
CR Adjagba A, 2017, VACCINE, V35, P3007, DOI 10.1016/j.vaccine.2017.04.039
   Adjagba A, 2015, VACCINE, V33, P588, DOI 10.1016/j.vaccine.2014.12.026
   Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811
   Andrus JK, 2011, HEALTH AFFAIR, V30, P1104, DOI 10.1377/hlthaff.2011.0361
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P301
   [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
   Blau J, 2013, VACCINE, V31, P2653, DOI 10.1016/j.vaccine.2013.01.047
   Blau J, 2012, VACCINE, V30, P2588, DOI 10.1016/j.vaccine.2012.01.066
   Duclos P, 2012, VACCINE, V30, P7147, DOI 10.1016/j.vaccine.2012.04.015
   Duclos P, 2010, VACCINE, V28, pA18, DOI 10.1016/j.vaccine.2010.02.027
   Hall AJ, 2010, VACCINE, V28, pA54, DOI 10.1016/j.vaccine.2010.02.034
   Howard N, 2018, HUM VACCIN IMMUNOTHE
   International Vaccine Access Center Johns Hopkins University Bloomberg School of Public Health, 2017, TECHN INF NAT LEV RO
   International Vaccine Access Center Johns Hopkins University Bloomberg School of Public Health, 2017, TECHN INF NAT LEV PC
   Ismail SJ, 2010, VACCINE, V28, pA58, DOI 10.1016/j.vaccine.2010.02.035
   Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P619
   MacDonald NE, 2017, VACCINE, V35, P6925, DOI 10.1016/j.vaccine.2017.10.048
   Matysiak-Klose Dorothea, 2012, Vaccine, V30, P2399, DOI 10.1016/j.vaccine.2011.12.004
   Nolan TM, 2010, VACCINE, V28, pA76, DOI 10.1016/j.vaccine.2010.02.038
   Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103
   Smith JC, 2010, VACCINE, V28, pA68, DOI 10.1016/j.vaccine.2010.02.037
   Tapia-Conyer R, 2013, VACCINE, V31, P3826, DOI 10.1016/j.vaccine.2012.12.062
   Task Force for Global Health, PARTN INFL VACC INTR
   WHO, 2018, SUMM ASS, P1
   World Health Organization, NAT ADV COMM IMM 201
   World Health Organization, 2013, GLOB VACC ACT PLAN 2
   World Health Organization, ASS REP GLOB VACC AC
NR 27
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3646
EP 3653
DI 10.1016/j.vaccine.2019.05.046
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100004
PM 31130258
DA 2020-05-12
ER

PT J
AU Jina, A
   Wang, TL
   Seyferth, ER
   Cohen, A
   Bernstein, HH
AF Jina, Asmita
   Wang, Tiffany L.
   Seyferth, Elisabeth R.
   Cohen, Amy
   Bernstein, Henry H.
TI Increasing antepartum Tdap vaccine administration: A quality improvement
   initiative
SO VACCINE
LA English
DT Article
DE Vaccine/immunization; Infectious diseases; Quality improvement;
   Administration/practice management
ID ADVISORY-COMMITTEE; RECOMMENDATIONS; PERTUSSIS
AB The Centers for Disease Control and Prevention (CDC) recommends antepartum Tdap vaccination for women with each pregnancy to protect themselves and their vulnerable infants through transplacental transfer of maternal antibodies. Our aim was to increase the rate of antepartum Tdap vaccine administration by 20%. Obstetricians were surveyed to identify their present approaches and barriers to antepartum Tdap vaccine administration to help guide the development of our intervention. Limited staff training, lack of vaccine on site, and cost were the most commonly identified barriers. Using these survey responses, existing literature, and brainstorming conversations with colleagues, an interdisciplinary workgroup then created a fishbone analysis and developed a 5-step intervention to address these barriers: (1) educate providers and patients on Tdap and pertussis; (2) increase Tdap availability to all pregnant women; (3) remind staff of the established Tdap standing order to facilitate administration; (4) encourage obstetricians to offer Tdap; (5) transfer documentation of Tdap administration from office to hospital. To monitor changes in the process over 15 months of pre- and post-intervention, data were collected from monthly chart audits and a two-phase control chart was created. The main outcome measure was proportion of eligible women who received Tdap during current pregnancy. In the pre-intervention period, 362 of 636 eligible women (56.9%) received Tdap during their current pregnancy; in the post-intervention period, 457 of 708 eligible women (64.5%) received Tdap during their current pregnancy. This absolute difference of 7.6% (64.5% vs. 56.9%, p < 0.01) represents a 13.4% relative increase (64.5%/56.9%) in the proportion of clinically eligible pregnant women who received Tdap. This represents a clinically and statistically significant increase in the rate of antepartum Tdap immunization. More research is needed to further understand obstetric barriers and maternal refusal of antepartum Tdap administration. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Jina, Asmita; Wang, Tiffany L.; Seyferth, Elisabeth R.; Bernstein, Henry H.] Cohen Childrens Med Ctr, Gen Pediat, New Hyde Pk, NY USA.
   [Cohen, Amy; Bernstein, Henry H.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Bernstein, Henry H.] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA.
RP Bernstein, HH (reprint author), 410 Lakeville Rd,Suite 311, New Hyde Pk, NY 11042 USA.
EM hbernstein@northwell.edu
FU Northwell Health Walk/Internal Clinical Care Innovation Grant
FX This work was supported by the Northwell Health Walk/Internal Clinical
   Care Innovation Grant.
CR Bernstein HH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-0607
   Centers for Disease Control and Prevention (CDC), 2017, PREN WOM FLU VACC
   Centers for Disease Control and Prevention (CDC), 2016, PREGN WOM TDAP VACC
   Centers for Disease Control and Prevention (CDC), 2017 PROV PERT SURV
   Centers for Disease Control and Prevention (CDC), 2018, INFL TDAP VACC COV P
   Freedman JL, 2015, PEDIATRICS, V135, pE540, DOI 10.1542/peds.2014-0943
   Fu LY, 2012, PEDIATRICS, V129, pE496, DOI 10.1542/peds.2010-3610
   Hoppe KK, 2011, INFECT DIS OBSTET GY, V2011
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Schillie S, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6701a1
   Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d
   Zolotor AL, 2014, AM FAM PHYSICIAN, V89, P199
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3654
EP 3659
DI 10.1016/j.vaccine.2019.05.045
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100005
PM 31122862
DA 2020-05-12
ER

PT J
AU Bezerra, IPS
   Costa-Souza, BLS
   Carneiro, G
   Ferreira, LAM
   Guedes, HLD
   Rossi-Bergmann, B
AF Bezerra, Izabella P. S.
   Costa-Souza, Beatriz L. S.
   Carneiro, Guilherme
   Miranda Ferreira, Lucas Antonio
   de Matos Guedes, Herbert Leonel
   Rossi-Bergmann, Bartira
TI Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for
   intranasal vaccination against cutaneous leishmaniasis
SO VACCINE
LA English
DT Article
DE Leishmaniasis; Mucosal vaccine; Retinoic acid; Immune tolerance
ID REGULATORY T-CELLS; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; B-CELLS;
   ANTIGEN; BALB/C; MICE; GUT; SUSCEPTIBILITY; IMMUNIZATION
AB Mucosal, but not peripheral, vaccination with whole Leishmania amazonensis antigen (LaAg) effectively protects mice against leishmaniasis, likely through a tolerogenic mechanism. Given the crucial role of retinoic acid (RA) in CD4(+) Foxp3(+) regulatory T cell (T-reg) differentiation and mucosal tolerance, here we evaluated the capacity of RA to improve intranasal (i.n.) vaccination with LaAg. To prevent degradation and possible mucosa irritation, RA was encapsulated in solid lipid nanoparticles (RA-SLN). Thus, BALB/c mice were given two i.n. doses of LaAg alone or in association with RA-SLN (LaAg/RA-SLN) prior to challenge with L. amazonensis. No histological sign of irritation or inflammation was produced in the nasal mucosa after RA-SLN administration. LaAg/RA-SLN vaccine was more effective in delaying lesion growth and reducing parasite burdens than LaAg alone (96% and 61% reduction, respectively). At two months after challenge, both vaccinated groups displayed similar T helper (Th) 1-skewed in situ cytokine responses, different from early infection where both Th1 and Th2 responses were suppressed, except for transforming growth factor (TGF)-beta mRNA, that was higher in mice given RA-SLN. At the mucosa, RA-SLN promoted enhanced expression of interleukin (IL)-10 and CD4(+) Foxp3(+) T-reg population. In sum, these data show that RA-SLN is an effective and safe tolerogenic adjuvant for i.n. vaccination against leishmaniasis. (C) 2019 Published by Elsevier Ltd.
C1 [Bezerra, Izabella P. S.; Costa-Souza, Beatriz L. S.; de Matos Guedes, Herbert Leonel; Rossi-Bergmann, Bartira] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Carneiro, Guilherme] Univ Fed Vales Jequitinhonha & Mucuri, Dept Farm, Diamantina, MG, Brazil.
   [Miranda Ferreira, Lucas Antonio] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
RP Rossi-Bergmann, B (reprint author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM bartira@biof.ufrj.br
RI Carneiro, Guilherme/AAK-9472-2020; de Matos Guedes, Herbert
   L/K-6191-2014
OI Carneiro, Guilherme/0000-0002-0367-8170; de Matos Guedes, Herbert
   L/0000-0002-3819-3069; Ferreira, Lucas/0000-0003-2474-5536
FU Conselho Nacional de Desenvolvimento Cientffico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq) [486611/2011-6]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [400894/2014-9]
FX This work was supported by Grant #486611/2011-6 from Conselho Nacional
   de Desenvolvimento Cientffico e TecnolOgico (CNPq, Brazil). Bezerra IPS
   was the recipient of a postdoctoral fellowship #400894/2014-9 from CNPq.
CR Bailey F, 2017, PLOS NEGLECT TROP D, V11, DOI [10.1371/journal.pntd.005739e005739, DOI 10.1371/JOURNAL.PNTD.005739E005739]
   Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971
   Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2
   Campos-Neto A, 2005, BRAZ J MED BIOL RES, V38, P979, DOI 10.1590/S0100-879X2005000700001
   Carvalho AK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7068287
   Castro GA, 2009, INT J PHARMACEUT, V381, P77, DOI 10.1016/j.ijpharm.2009.07.025
   Cirelli E, 2015, J VACCINES VACCIN, V6, P265, DOI [10.4172/2157-7560.1000265, DOI 10.4172/2157-7560.1000265]
   Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590
   DaSilva-Couto L, 2015, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd.9797103111, DOI 10.1371/JOURNAL.PNTD.9797103111]
   Guedes HLD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-448
   Gomes DCD, 2007, VACCINE, V25, P2168, DOI 10.1016/j.vaccine.2006.11.060
   Gomes DCD, 2012, PARASITOLOGY, V139, P1562, DOI 10.1017/S0031182012000868
   Gomes DCD, 2011, PARASITOLOGY, V138, P1892, DOI 10.1017/S0031182011001417
   Duthie MS, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00108-17
   Erkelens MN, 2017, TRENDS IMMUNOL, V38, P168, DOI 10.1016/j.it.2016.12.006
   FISHER GJ, 1991, J INVEST DERMATOL, V96, P699, DOI 10.1111/1523-1747.ep12470632
   Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262
   Iborra S, 2018, EXPERT REV VACCINES, V17, P323, DOI 10.1080/14760584.2018.1459191
   Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011
   Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147
   Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421
   Kenney RT, 1999, J IMMUNOL, V163, P4481
   Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193
   Lamichhane A, 2014, VACCINE, V32, P6711, DOI 10.1016/j.vaccine.2014.08.089
   Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8
   Leal JM, 2015, PARASITOLOGY, V142, P1640, DOI 10.1017/S0031182015001250
   Marzochi KB, MEM I O CRUZ, V93, P205
   McSorley SJ, 1998, EUR J IMMUNOL, V28, P424, DOI 10.1002/(SICI)1521-4141(199802)28:02<424::AID-IMMU424>3.0.CO;2-U
   Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742
   Mwanza-Lisulo M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0145
   Pinheiro RO, 2005, MICROBES INFECT, V7, P1317, DOI 10.1016/j.micinf.2005.04.016
   Pinheiro RO, 2007, VACCINE, V25, P2716, DOI 10.1016/j.vaccine.2006.05.093
   Pinheiro RO, 2007, MEM I OSWALDO CRUZ, V102, P79, DOI 10.1590/S0074-02762007000100013
   Pinto EF, 2004, INFECT IMMUN, V72, P4521, DOI 10.1128/IAI.72.8.4521-4527.2004
   Pinto EF, 2003, VACCINE, V21, P3534, DOI 10.1016/S0264-410X(03)00427-4
   Ponte-Sucre A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006052
   Rudraraju R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086554
   Sakamoto H, 2015, INT ARCH ALLERGY IMM, V167, P167, DOI 10.1159/000437326
   Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72
   Bezerra IPS, 2018, VACCINE, V36, P2480, DOI 10.1016/j.vaccine.2018.03.020
   Pratti JES, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1822-9
   Tan XF, 2011, J VIROL, V85, P8316, DOI 10.1128/JVI.00781-11
   Torres-Santos EC, 1999, ANTIMICROB AGENTS CH, V43, P1776, DOI 10.1128/AAC.43.7.1776
   Velez ID, 2005, T ROY SOC TROP MED H, V99, P593, DOI 10.1016/j.trstmh.2005.04.002
   Wu JH, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-28
NR 45
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3660
EP 3667
DI 10.1016/j.vaccine.2019.05.043
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100006
PM 31133469
DA 2020-05-12
ER

PT J
AU Grandesso, F
   Kasambara, W
   Page, AL
   Debes, AK
   M'bang'ombe, M
   Palomares, A
   Lechevalier, P
   Pezzoli, L
   Alley, I
   Salumu, L
   Msyamboza, K
   Sack, D
   Cohuet, S
   Luquero, FJ
AF Grandesso, Francesco
   Kasambara, Watipaso
   Page, Anne-Laure
   Debes, Amanda K.
   M'bang'ombe, Maurice
   Palomares, Adriana
   Lechevalier, Pauline
   Pezzoli, Lorenzo
   Alley, Ian
   Salumu, Leon
   Msyamboza, Kelias
   Sack, David
   Cohuet, Sandra
   Luquero, Francisco Javier
TI Effectiveness of oral cholera vaccine in preventing cholera among
   fishermen in Lake Chilwa, Malawi: A case-control study
SO VACCINE
LA English
DT Article
DE Cholera; Vaccine; Thermostability; Effectiveness; Hard-to-reach
   populations; Malawi
ID VIBRIO-CHOLERAE; PROTECTION; EFFICACY; IMMUNOGENICITY; CHALLENGES;
   OUTBREAK; KOLKATA; FIELD
AB Background: In response to a cholera outbreak among mobile, difficult-to-reach fishermen on Lake Chilwa, Malawi in 2016, a novel vaccine distribution strategy exploited the proven vaccine thermostability. Fishermen, while taking the first vaccine dose under supervision, received the second dose in a sealed bag, and were told to drink it two weeks later. This study assessed short-term vaccine protection of this strategy.
   Methods: Patients with diarrhoea admitted to health facilities around lake were interviewed and a stool sample collected for PCR testing. Vaccine effectiveness was assessed in a case-control test-negative design by comparing cases (PCR-positive for V. cholerae O1) and controls (patients with diarrhoea but PCR-negative) and with the screening method that compared the proportions of vaccinated among cholera cases versus the general fishermen population.
   Results: Of 145 study participants, 120 were fishermen living on the lake. Vaccine effectiveness at three-months was 90.0% [95% CI: 38.8; 98.4] among fishermen and 83.3% [95% CI: 20.8; 96.5] among all participants in the case-control test-negative design, and 97.5% [95% CI: 90.9; 99.3] with the screening method.
   Conclusion: This strategy was effective in providing short-term protection in fishermen against cholera. Further research is needed to determine the adding value of the second dose and to identify the optimal vaccination strategies for different contexts. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Grandesso, Francesco; Page, Anne-Laure; Alley, Ian; Cohuet, Sandra; Luquero, Francisco Javier] Epicentre, 8 Rue St Sabin, F-75011 Paris, France.
   [Kasambara, Watipaso; M'bang'ombe, Maurice] Minist Hlth Malawi, Lilongwe, Malawi.
   [Debes, Amanda K.; Sack, David] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Palomares, Adriana; Lechevalier, Pauline; Salumu, Leon] Med Sans Frontieres, 8 Rue St Sabin, F-75011 Paris, France.
   [Pezzoli, Lorenzo] WHO, Geneva, Switzerland.
   [Msyamboza, Kelias] WHO, Lilongwe, Malawi.
RP Grandesso, F (reprint author), Epicentre, 8 Rue St Sabin, F-75011 Paris, France.
EM Francesco.GRANDESSO@epicentre.msf.org
RI Pezzoli, Lorenzo/AAA-9894-2019
OI Grandesso, Francesco/0000-0001-9909-0285
FU Medecins Sans Frontieres (MSF), Operational Centre Paris; MSF
FX This work was funded by Medecins Sans Frontieres (MSF), Operational
   Centre Paris. MSF national and international personnel collaborated and
   supported the implementation of the study.
CR AHMED ZU, 1994, MICROBIOL IMMUNOL, V38, P837, DOI 10.1111/j.1348-0421.1994.tb02135.x
   Ali M, 2016, VACCINE, V34, P479, DOI 10.1016/j.vaccine.2015.12.004
   Ali M, 2013, CLIN INFECT DIS, V56, P1123, DOI 10.1093/cid/cit009
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P477
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P437
   Azman AS, 2016, LANCET GLOB HEALTH, V4, pE856, DOI 10.1016/s2214-109x(16)30211-x
   Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1
   Bi QF, 2017, LANCET INFECT DIS, V17, P1080, DOI [10.1016/s1473-3099(17)30359-6, 10.1016/S1473-3099(17)30359-6]
   Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512
   Debes AK, 2016, AM J TROP MED HYG, V94, P537, DOI 10.4269/ajtmh.15-0496
   Desai SN, 2017, HUM VACC IMMUNOTHER, V13, P579, DOI 10.1080/21645515.2016.1245250
   FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742
   Grandesso F, 2018, B WORLD HEALTH ORGAN, V96, P817, DOI 10.2471/BLT.17.206417
   Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x
   Ivers LC, 2015, LANCET GLOB HEALTH, V3, pE162, DOI 10.1016/S2214-109X(14)70368-7
   Kanungo S, 2009, VACCINE, V27, P6887, DOI 10.1016/j.vaccine.2009.09.008
   Khonje A, 2012, MALAWI MED J, V24, P29
   Lopez AL, 2018, CLIN INFECT DIS, V66, P1960, DOI 10.1093/cid/cix1039
   Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323
   Luquero FJ, 2014, NEW ENGL J MED, V370, P2111, DOI 10.1056/NEJMoa1312680
   Msyamboza KP, 2014, J INFECT DEV COUNTR, V8, P720, DOI 10.3855/jidc.3506
   Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000
   ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023
   ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055
   Parker LA, 2017, LANCET INFECT DIS, V17, pE123, DOI 10.1016/S1473-3099(16)30472-8
   Poncin M, 2018, B WORLD HEALTH ORGAN, V96, P86, DOI 10.2471/BLT.16.189241
   Qadri F, 2018, LANCET INFECT DIS, V18, P666, DOI 10.1016/S1473-3099(18)30108-7
   Qadri F, 2016, NEW ENGL J MED, V374, P1723, DOI 10.1056/NEJMoa1510330
   Saha A, 2016, VACCINE, V34, P1551, DOI 10.1016/j.vaccine.2016.02.020
   SPAN Arkay Healthcare, CRYST VC TEST PROC
   Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010
   Vilcu AM, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.003
   Wierzba TF, 2015, VACCINE, V33, P2463, DOI 10.1016/j.vaccine.2015.03.073
   World Health Organization, WHO PREQ VACC CHOL I
   World Health Organization, 2018, VAR TEXT PACK INS AP
NR 35
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3668
EP 3676
DI 10.1016/j.vaccine.2019.05.044
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100007
PM 31133470
OA Other Gold
DA 2020-05-12
ER

PT J
AU Gaultier, GN
   McCready, W
   Ulanova, M
AF Gaultier, Gabrielle Nicole
   McCready, William
   Ulanova, Marina
TI Natural immunity against Haemophilus influenzae type a and B-cell
   subpopulations in adult patients with severe chronic kidney disease
SO VACCINE
LA English
DT Article
DE B cells; Haemophilus influenzae type a; Severe chronic kidney disease;
   Flow cytometry analysis; Serum bactericidal assay; ELISA
ID STAGE RENAL-DISEASE; EPIDEMIOLOGY; VACCINATION; LYMPHOCYTES; SEROTYPE;
   IMPACT
AB Individuals suffering from severe chronic kidney disease (CKD) are immunocompromised and therefore highly susceptible to various infections including Haemophilus influenzae type a (Hia), an emerging pathogen in North American Indigenous populations. Immunocompromised Indigenous adults are considered a target for a new Hia vaccine under development. In an attempt to foresee their response to Hia immunization, we studied natural immunity against Hia and B-cell subpopulations in sixty patients with CKD residing in a geographic region with noticeable presence of Hia invasive disease. Serum bactericidal activity (SBA) against Hia, concentrations of IgG and IgM antibodies specific to Hia capsular polysaccharide, and B-cell subpopulations were studied in patients with CKD and 35 healthy controls of the same age. Of the patients with CKD, proportions and absolute numbers of B-cell subpopulations were determined for 28 patients. The patients had lower SBA titres compared to controls. Although no significant differences in anti-Hia IgG or IgM antibody concentrations between control and CKD groups were found, IgM antibody concentrations were higher in Indigenous than non-Indigenous patients. Patients with CKD had a higher proportion of B cells (CD19+), class switched memory B cells (CD19+CD27+IgM-) and a lower proportion of CD19+CD27-IgM- B cells compared to healthy controls. Non-Indigenous patients with CKD had significantly higher proportions of IgM memory B cells and CD19+CD27-IgM- B cells compared to Indigenous patients with no significant difference in absolute numbers. Because 72% of CKD patients had detectable SBA titres and 100% had detectable IgG and IgM antibodies it is possible that a portion of IgM memory B cells and class switched memory B cells are specific for Hia resulting from a natural exposure to the pathogen. The data suggest that a Hia-conjugate vaccine may be immunogenic in adult patients with CKD as it will potentially induce re-activation of immunological memory against Hia. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Gaultier, Gabrielle Nicole; Ulanova, Marina] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada.
   [McCready, William; Ulanova, Marina] Northern Ontario Sch Med, Thunder Bay, ON, Canada.
RP Ulanova, M (reprint author), Lakehead Univ, Northern Ontario Sch Med, Div Med Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.
EM gngaulti@lakeheadu.ca; wmccready@nosm.ca; mulanova@nosm.ca
FU Northern Ontario Academic Medicine Association (AFP Innovation Fund
   Project) [A-15-05]; Canadian Immunization Research Network [CT20ON31]
FX We would like to thank all the study participants for donating blood for
   our study, as well as the nurses at the Renal Services (TBRHSC) for
   collecting samples from patients and Hanan Alsarmi for collecting
   healthy control samples. We thank Eli Nix, Angele Desbiens-Forget
   (Northern Ontario School of Medicine) and Lori Moon (Clinical Trials
   Department, TBRHSC) for assistance with patient recruitment and Twyla
   Biluk (Thunder Bay 55 Plus Center) for assistance with recruitment of
   healthy controls. We thank Victoria Domonkos for collecting patient
   medical histories. We thank Dr. Andrew Cox (National Research Council
   Canada) for providing the Hia antigen for ELISA and Dr. Karen Rudolph
   (Arctic Investigation Program CDC) for donating the reference serum. We
   thank Eli Nix and Kylie Williams for helping with development of
   methodology, and Brenda Huska for performing some ELISA assays. Funding
   was provided by the Northern Ontario Academic Medicine Association (AFP
   Innovation Fund Project #A-15-05) and the Canadian Immunization Research
   Network (CT20ON31).
CR [Anonymous], 2016, CENSUS PROFILE 2016
   Brown VM, 2009, CLIN INFECT DIS, V49, P1240, DOI 10.1086/605671
   Bulati M, 2011, AGEING RES REV, V10, P274, DOI 10.1016/j.arr.2010.12.002
   Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003
   Cox A D, 2017, Can Commun Dis Rep, V43, P89
   Dyck RF, 1998, CLIN INVEST MED, V21, P33
   Eton V, 2017, INT J INFECT DIS, V65, P27, DOI 10.1016/j.ijid.2017.09.016
   Ferguson TW, 2017, KIDNEY INT, V92, P192, DOI 10.1016/j.kint.2017.02.022
   Grzegorzewska AE, 2014, EXPERT REV VACCINES, V13, P1317, DOI 10.1586/14760584.2014.944508
   Hara Y, 2015, MOL IMMUNOL, V68, P617, DOI 10.1016/j.molimm.2015.10.003
   Hawdon N, 2012, CLIN VACCINE IMMUNOL, V19, P967, DOI 10.1128/CVI.00101-12
   Inoue T, 2018, IMMUNOL REV, V283, P138, DOI 10.1111/imr.12640
   Kelly L, 2011, J MED MICROBIOL, V60, P384, DOI 10.1099/jmm.0.026914-0
   Khaskhely N, 2012, J IMMUNOL, V188, P2455, DOI 10.4049/jimmunol.1102809
   Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020
   Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802
   Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351
   Liakopoulos V, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3081856
   Mahmoodi M, 2009, EUR CYTOKINE NETW, V20, P69, DOI 10.1684/ecn.2009.0153
   Martorana A, 2014, IMMUNOL LETT, V162, P303, DOI 10.1016/j.imlet.2014.06.003
   Mihai S, 2018, J IMMUNOL RES, DOI 10.1155/2018/2180373
   Miyagaki T, 2015, INT IMMUNOL, V27, P495, DOI 10.1093/intimm/dxv026
   Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x
   Muriach M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/102158
   Naqvi SB, 2006, ADV CHRONIC KIDNEY D, V13, P199, DOI 10.1053/j.ackd.2006.04.004
   Nix EB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201282
   Nix EB, 2015, EMERG INFECT DIS, V21, P273, DOI 10.3201/eid2102.140722
   Pahl MV, 2010, NEPHROL DIAL TRANSPL, V25, P205, DOI 10.1093/ndt/gfp397
   Polverino F, 2016, AM J PHYSIOL-LUNG C, V311, pL687, DOI 10.1152/ajplung.00304.2016
   Qian Q, 2017, CONTRIB NEPHROL, V191, P72, DOI 10.1159/000479257
   Qin L, 2016, AGING-US, V8, P848, DOI 10.18632/aging.100894
   Rouphael NG, 2011, CLIN VACCINE IMMUNOL, V18, P243, DOI 10.1128/CVI.00219-10
   Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730
   Seifert M, 2016, LEUKEMIA, V30, P2283, DOI 10.1038/leu.2016.226
   Tsang RSW, 2017, VACCINE, V35, P4270, DOI 10.1016/j.vaccine.2017.06.001
   Ulanova M, 2014, LANCET INFECT DIS, V14, P70, DOI 10.1016/S1473-3099(13)70170-1
   Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020
   Veneri D, 2009, BLOOD TRANSFUS-ITALY, V7, P29, DOI 10.2450/2008.0007-08
   Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5
   Wenger JD, 1998, PEDIATR INFECT DIS J, V17, pS132, DOI 10.1097/00006454-199809001-00008
   William-Mendenhall RB, 2014, INTRO PROBABILITY ST
   Xiang FF, 2016, RENAL FAILURE, V38, P7, DOI 10.3109/0886022X.2015.1106871
NR 42
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3677
EP 3684
DI 10.1016/j.vaccine.2019.05.036
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100008
PM 31122854
DA 2020-05-12
ER

PT J
AU Laestadius, A
   Ingelman-Sundberg, HM
   Myrberg, IH
   Verme, A
   Sundberg, E
   Schweiger, B
   Saghafian-Hedengren, S
   Nilsson, A
AF Laestadius, Asa
   Ingelman-Sundberg, Hanna M.
   Myrberg, Ida Hed
   Verme, Anna
   Sundberg, Erik
   Schweiger, Brunhilde
   Saghafian-Hedengren, Shanie
   Nilsson, Anna
TI Altered proportions of circulating CXCR5+helper T cells do not dampen
   influenza vaccine responses in children with rheumatic disease
SO VACCINE
LA English
DT Article
DE Influenza vaccination; Pediatric rheumatic disease; Biological therapy;
   Follicular helper T cells; CXCL13
ID JUVENILE IDIOPATHIC ARTHRITIS; B-CELLS; SAFETY; EFFICACY; METHOTREXATE;
   ANTIBODY; THERAPY; SERUM
AB Biological therapy options for the treatment of rheumatic disease target molecules that can affect the cross-talk between innate and adaptive immune responses upon vaccination. Influenza vaccination in children with rheumatic disease has been recommended, but there are only sparse data on the quality of vaccine responses from pediatric patients treated with biological therapy.
   We conducted an influenza vaccine study over 3 consecutive seasons where the antibody response to TIV was evaluated in children with PRD (n = 78), including both non-treated (n = 17) and treated (with methotrexate, TNF-inhibitors with or without methotrexate, or IL-inhibitors, n = 61) children as well as healthy age-matched controls (n = 24). Peripheral B cells, T and NK cell populations, as well as CXCR5+ (follicular) helper T cells (T-FH) and chemokines involved in antibody responses were assessed prior to immunization in the same cohort. Data on disease duration, therapy and data on previous influenza vaccinations were retrieved.
   The proportion of circulating T-FH cells were significantly lower in non-treated children with PRD compared to treated patients and healthy controls. The significantly lower proportion of T-FH cells was mirrored by a marked significant increase in CXCL13 serum level, the ligand for CXCR5, with higher levels in non-treated children with PRD compared to treated patients and healthy controls. However, the proportion of T-FH cells or CXCL13 level at the time of vaccination was not a predictor of the antibody response to TIV in this cohort of children. Children with PRD had an overall similar response to TIV as healthy children. Although not significant, children treated with TNF-inhibitors differed as a few children remained seronegative towards H3N2- and influenza B viruses after immunization.
   Our data show that children with PRD respond to TIV as healthy children. Furthermore, plasma CXCL13 levels did not correlate to the proportion of T-FH cells in blood prior to immunisation, or to antibody responses following immunization. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Laestadius, Asa; Ingelman-Sundberg, Hanna M.] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.
   [Myrberg, Ida Hed; Saghafian-Hedengren, Shanie; Nilsson, Anna] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Tomtebodav 18, S-17176 Stockholm, Sweden.
   [Verme, Anna; Sundberg, Erik] Astrid Lindgren Childrens Hosp, Paediat Rheumatol Unit, Stockholm, Sweden.
   [Schweiger, Brunhilde] Robert Koch Inst, Div Influenza & Other Resp Viruses, Natl Reference Ctr Influenza, Berlin, Germany.
   [Saghafian-Hedengren, Shanie] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.
RP Nilsson, A (reprint author), Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Tomtebodav 18, S-17176 Stockholm, Sweden.
EM anna.nilsson.1@ki.se
OI Nilsson, Anna/0000-0001-5885-7101
FU Stiftelsen Frimurarna Barnahuset; Pfizer Incorporated; Stockholm County
   through the ALF agreement
FX This work was funded by Stiftelsen Frimurarna Barnahuset, an
   unconditional grant from Pfizer Incorporated, and the Stockholm County
   through the ALF agreement. The work was completed independent of the
   funders.
CR Bentebibel SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26494
   Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191
   Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024
   Camacho-Lovillo MS, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0190-0
   D'Orlando O, 2007, J BIOL REG HOMEOS AG, V21, P49
   Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739
   Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736
   Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113
   Heijstek MW, 2011, ANN RHEUM DIS, V70, P1704, DOI 10.1136/ard.2011.150193
   Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503
   Ingelman-Sundberg HM, 2016, VACCINE, V34, P1304, DOI 10.1016/j.vaccine.2016.01.027
   Kang SM, 2009, MOL CELLS, V27, P5, DOI 10.1007/s10059-009-0015-1
   Kessler EA, 2014, BEST PRACT RES CL RH, V28, P293, DOI 10.1016/j.berh.2014.03.005
   Lee J, 2015, INT J RHEUM DIS, V18, P200, DOI 10.1111/1756-185X.12432
   Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012
   Mourao AF, 2016, RHEUMATOLOGY, V55, P697, DOI 10.1093/rheumatology/kev398
   Ogimi C, 2011, PEDIATR INFECT DIS J, V30, P208, DOI 10.1097/INF.0b013e3181f7ce44
   Pritchard GH, 2018, J LEUKOCYTE BIOL, V103, P269, DOI 10.1002/JLB.4MR0517-215R
   Rasmussen TK, 2016, DAN MED J, V63
   Ringold S, 2014, ARTHRIT CARE RES, V66, P1063, DOI 10.1002/acr.22259
   Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999
   Saghafian-Hedengren S, 2018, BLOOD REV, V32, P71, DOI 10.1016/j.blre.2017.08.009
   Salinas GF, 2013, ANN RHEUM DIS, V72, P1037, DOI 10.1136/annrheumdis-2011-201270
   Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006
   Schmeling H, 2014, ARTHRITIS RHEUMATOL, V66, P2580, DOI 10.1002/art.38741
   Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002
   Sim JH, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0687-1
   Tarp S, 2016, RHEUMATOLOGY, V55, P669, DOI 10.1093/rheumatology/kev382
   Toplak N, 2012, CLIN EXP RHEUMATOL, V30, P436
   Waalen K, 2010, EURO SURVEILL, V15
   Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251
NR 31
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3685
EP 3693
DI 10.1016/j.vaccine.2019.05.037
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100009
PM 31126860
DA 2020-05-12
ER

PT J
AU Shah, SFA
   Ginossar, T
   Weiss, D
AF Shah, Sayyed Fawad Ali
   Ginossar, Tamar
   Weiss, David
TI "This is a Pakhtun disease": Pakhtun health journalists' perceptions of
   the barriers and facilitators to polio vaccine acceptance among the
   high-risk Pakhtun community in Pakistan
SO VACCINE
LA English
DT Article
DE Health journalists; Polio eradication; Polio vaccine; Vaccine
   acceptance; Vaccine hesitancy, vaccination campaigns
ID IMMUNIZATION; ERADICATION; OPINIONS; BOYCOTT; WORKERS
AB Introduction: Pakistan is one of only three poliomyelitis-endemic countries in the world. Twelve wild poliovirus (WPV) cases were recorded in the country in 2018. Even though resistance to oral polio vaccine (OPV) has decreased over time, there are still pockets of communities, mostly ethnic Pakhtun living in the Khyber Pakhtunkhwa (KP) province, that resist OPV. Although local journalists may be important sources of health information, past studies have overlooked their role in this context. The purpose of this study was to examine Pakhtun health journalists' beliefs regarding OPV and their views of the barriers and facilitators that influence OPV acceptance or hesitancy in their communities.
   Methods: We recruited and interviewed 33 Pakhtun journalists covering health issues for diverse media outlets in high-risk districts for WPV of the KP province. The semi-structured interviews were translated, transcribed, and analyzed for themes.
   Results: The participants strongly supported OPV and advocated that children in their own families and communities get vaccinated against polio. At the same time, they felt that their communities faced more urgent health needs that were not addressed by the government. They identified barriers at the media organizational level operating against accurate coverage of OPV, including financial and time constraints, a lack of checks and balances, and limited health literacy. They regarded press releases issued by the officials associated with OPV campaigns as the main facilitators in the coverage of OPV. The participants perceived lack of community trust in the government, security concerns, and community members' religious beliefs as the major impediments to increase in uptake of OPV.
   Conclusion: Pakhtun health journalists have the potential to be important partners in national polio eradication initiatives. They should receive culturally sensitive training in local languages at appropriate literacy levels. We also suggest direct involvement of journalists in community mobilization efforts. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Shah, Sayyed Fawad Ali] Jacksonville State Univ, Dept Commun, 700 Pelham RD N, Jacksonville, AL 36265 USA.
   [Ginossar, Tamar; Weiss, David] Univ New Mexico, Dept Commun & Journalism, MSC 03 2240,1 Univ New Mexico, Albuquerque, NM 87131 USA.
RP Shah, SFA (reprint author), Jacksonville State Univ, Dept Commun, 700 Pelham RD N, Jacksonville, AL 36265 USA.
EM shah@jsu.edu
CR Abimbola S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001529
   Adoghe A., 2011, LINKING POLICY TECHN
   Charmaz K., 2014, CONSTRUCTING GROUNDE
   Closser S, 2015, GLOBAL HLTH COMMUN, V1, P1
   Closser S, 2015, MED ANTHR Q
   Closser S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001528
   Closser Svea, 2010, CHASING POLIO PAKIST
   Ghinai I, 2013, GLOB PUBLIC HEALTH, V8, P1138, DOI 10.1080/17441692.2013.859720
   Hinnant A, 2011, HEALTH EDUC RES, V26, P937, DOI 10.1093/her/cyr086
   infoasaid, 2012, PAK MED TEL LANDSC G, P1
   Jan F, 2015, REPRESENTING SELF OT
   Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073
   Kaufmann JR, 2009, HEALTH AFFAIR, V28, P1091, DOI 10.1377/hlthaff.28.4.1091
   Khan A., 2011, NEW MEDIA JOURNALISM
   Khan TM, 2016, VACCINE, V34, P2074, DOI 10.1016/j.vaccine.2016.03.008
   Khan T, 2013, J EPIDEMIOL COMMUN H, V67, P696, DOI 10.1136/jech-2012-202162
   Khowaja AR, 2012, B WORLD HEALTH ORGAN, V90, P822, DOI 10.2471/BLT.12.106260
   Lariscy RW, 2010, J PUBLIC RELAT RES, V22, P113, DOI 10.1080/10627260802640708
   MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401
   Mezzera M, 2010, MEDIA GOVERNANCE PAK, P1
   Mills J., 2006, INT J QUAL METH, V5, P1, DOI DOI 10.1177/160940690600500103
   Mills Jane, 2006, Int J Nurs Pract, V12, P8, DOI 10.1111/j.1440-172X.2006.00543.x
   Mishler EG., SOCIAL CONTEXTS HLTH, P1
   Naeem M, 2011, J POSTGRADUATE MED I, V26
   Naqvi LJ, 2019, NEWS, P16
   Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P159, DOI 10.2471/BLT.09.066480
   Nutbeam D, 2010, THEORY NUTSHELL PRAC
   Nyambe A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3802-6
   Obregon R, 2010, J HEALTH COMMUN, V15, P25, DOI 10.1080/10810731003695367
   Oshinsky D. M., 2005, POLIO AM STORY
   Pintak L, 2013, MEDIA CULT SOC, V35, P640, DOI 10.1177/0163443713483654
   Polio Abraham T, 2018, ODYSSEY ERADICATION
   Privitera GJ., 2013, RES METHODS BEHAV SC
   Renne E.P., 2010, POLITICS POLIO NO NI
   Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025
   Reporter A, 2018, DAWN
   Riaz H, 2013, LANCET INFECT DIS, V13, P120, DOI 10.1016/S1473-3099(12)70344-4
   Ricchiardi S., CHALLENGES INDEPENDE
   Shah M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-457
   Siddiqi K, 2016, EXPRESS TRIBUNE
   Sirajuddin, 2018, DAWN
   Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585
   The Emergency Operations Center, 2018, EOC COMM UPD NO 167
   The Emergency Operations Center, 2018, EOC COMM UPD NO 164
   UNICEF, 2016, POL COMM GLOB GUID M
   Voss M, 2002, AM J PUBLIC HEALTH, V92, P1158, DOI 10.2105/AJPH.92.7.1158
   Warigon C, 2016, J INFECT DIS, V213, pS86, DOI 10.1093/infdis/jiv545
   WHO, 2007, HLTH SYST PROF PAK, P93
   Yahya M, 2007, AFR AFFAIRS, V106, P185, DOI 10.1093/afraf/adm016
   Yusufzai A, 2018, DAWN
NR 50
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3694
EP 3703
DI 10.1016/j.vaccine.2019.05.029
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100010
PM 31155417
DA 2020-05-12
ER

PT J
AU Bartsch, SM
   Bottazzi, ME
   Asti, L
   Strych, U
   Meymandi, S
   Falcon-Lezama, JA
   Randall, S
   Hotez, PJ
   Lee, BY
AF Bartsch, Sarah M.
   Bottazzi, Maria Elena
   Asti, Lindsey
   Strych, Ulrich
   Meymandi, Sheba
   Abelardo Falcon-Lezama, Jorge
   Randall, Samuel
   Hotez, Peter J.
   Lee, Bruce Y.
TI Economic value of a therapeutic Chagas vaccine for indeterminate and
   Chagasic cardiomyopathy patients
SO VACCINE
LA English
DT Article
ID TRYPANOSOMA-CRUZI; COST-EFFECTIVENESS; DISEASE; BENZNIDAZOLE;
   PREDICTORS; BURDEN
AB Background: Therapeutic vaccines to prevent Chagas disease progression to cardiomyopathy are under development because the only available medications (benznidazole and nifurtimox) are limited by their efficacy, long treatment course, and side effects. Better understanding the potential clinical and economic value of such vaccines can help guide development and implementation.
   Methods: We developed a computational Chagas Markov model to evaluate the clinical and economic value of a therapeutic vaccine given in conjunction with benznidazole in indeterminate and chronic Chagas patients. Scenarios explored the vaccine's impact on reducing drug treatment dosage, duration, and adverse events, and risk of disease progression.
   Results: When administering standard-of-care benznidazole to 1000 indeterminate patients, 148 discontinued treatment and 219 progressed to chronic disease, resulting in 119 Chagas-related deaths and 2293 DALYs, costing $18.9 million in lifetime societal costs. Compared to benznidazole-only, therapeutic vaccination administered with benznidazole (25-75% reduction in standard dose and duration), resulted in 37-111 more patients (of 1000) completing treatment, preventing 11-219 patients from progressing, 6-120 deaths, and 108-2229 DALYs (5-100% progression risk reduction), saving <=$16,171 per patient. When vaccinating determinate Kuschnir class 1 Chagas patients, 10-197 fewer patients further progressed compared to benznidazole-only, averting 11-228 deaths and 144-3037 DALYs (5-100% progression risk reduction), saving <=$34,059 per person. When vaccinating Kuschnir class 2 patients, 13-279 fewer progressed (279 with benznidazole-only), averting 13-692 deaths and 283-10,785 DALYs (5-100% progression risk reduction), saving <=$89,759. Therapeutic vaccination was dominant (saved costs and provided health benefits) with >= 5% progression risk reduction, except when only reducing drug treatment regimen and adverse events, but remained cost-effective when costing <$200.
   Conclusions: Our study helps outline the thresholds at which a therapeutic Chagas vaccine may be costeffective (e.g., <5% reduction in preventing cardiac progression, 25% reduction in benznidazole treatment doses and duration) and cost-saving (e.g., >= 5% and 25%, respectively). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Bartsch, Sarah M.; Asti, Lindsey; Randall, Samuel; Lee, Bruce Y.] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Computat & Operat Res PHICOR, 615 N Wolfe St, Baltimore, MD 21205 USA.
   [Bartsch, Sarah M.; Asti, Lindsey; Randall, Samuel; Lee, Bruce Y.] Johns Hopkins Bloomberg Sch Publ Hlth, GOPC, 615 N Wolfe St,Room W3501, Baltimore, MD 21205 USA.
   [Bottazzi, Maria Elena; Strych, Ulrich; Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, One Baylor Plaza,BCM113, Houston, TX 77030 USA.
   [Bottazzi, Maria Elena; Strych, Ulrich; Hotez, Peter J.] Baylor Coll Med, Dept Pediat, One Baylor Plaza,BCM113, Houston, TX 77030 USA.
   [Bottazzi, Maria Elena; Strych, Ulrich; Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza,BCM113, Houston, TX 77030 USA.
   [Meymandi, Sheba] Olive View UCLA Med Ctr, Ctr Excellence Chagas Dis, 14445 Olive View Dr, Sylmar, CA 91342 USA.
   [Abelardo Falcon-Lezama, Jorge] Carlos Slim Fdn, Lago Zurich 245,Piso 20 Ampliac Granada, Mexico City 11529, DF, Mexico.
RP Lee, BY (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, GOPC, 615 N Wolfe St,Room W3501, Baltimore, MD 21205 USA.; Lee, BY (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, IVAC, 615 N Wolfe St,Room W3501, Baltimore, MD 21205 USA.
EM brucelee@jhu.edu
OI Bottazzi, Maria Elena/0000-0002-8429-0476; , Jorge
   Abelardo/0000-0001-9081-4064
FU Carlos Slim Foundation, Mexico Agency for Healthcare Research and
   Quality (AHRQ) [R01HS023317]; National Institute of General Medical
   Sciences (NIGMS) via MIDAS [U24GM110707]; United States Agency for
   International Development (USAID)United States Agency for International
   Development (USAID) [AID-OAA-A-15-00064]
FX This work was supported by the Carlos Slim Foundation, Mexico Agency for
   Healthcare Research and Quality (AHRQ) via grant R01HS023317, the
   National Institute of General Medical Sciences (NIGMS) via MIDAS grant
   U24GM110707, and the United States Agency for International Development
   (USAID) under agreement number AID-OAA-A-15-00064. The funders had no
   role in the design and conduct of the study; collection, management,
   analysis, and interpretation of the data; and preparation, review, or
   approval of the manuscript.
CR Abuhab A, 2013, INT J CARDIOL, V168, P2375, DOI 10.1016/j.ijcard.2013.01.262
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Barbosa AP, 2011, ARQ BRAS CARDIOL, V97, P517, DOI 10.1590/S0066-782X2011005000112
   Barry MA, 2016, HUM VACC IMMUNOTHER, V12, P976, DOI 10.1080/21645515.2015.1119346
   Basombrio MA, 1998, T ROY SOC TROP MED H, V92, P137, DOI 10.1016/S0035-9203(98)90720-9
   Beaumier CM, 2016, VACCINE, V34, P2996, DOI 10.1016/j.vaccine.2016.03.074
   Bern C, 2011, ADV PARASITROL
   Bertocchi GL, 2013, T ROY SOC TROP MED H, V107, P372, DOI 10.1093/trstmh/trt029
   Bestetti RB, 2015, NEW ENGL J MED, V373, P1881, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]
   Biter AB, 2018, J PHARM SCI-US, V107, P1468, DOI 10.1016/j.xphs.2017.12.014
   Bloomberg Markets, 2018, USDMXN SPOT EXCH RAT
   Castillo-Riquelme M, 2008, J HEALTH ECON, V27, P405, DOI 10.1016/j.jhealeco.2007.04.005
   de la Cruz JJ, 2018, HIST NATURELLE ANIMA, P1
   Diez-Domingo J, 2015, VACCINE, V33, P789, DOI 10.1016/j.vaccine.2014.12.024
   Drugs for Neglected Diseases initiative (DNDi), CHAG DIS
   Dumonteil E, 2012, EXPERT REV VACCINES, V11, P1043, DOI [10.1586/ERV.12.85, 10.1586/erv.12.85]
   Gessner BD, 2017, VACCINE, V35, P6255, DOI 10.1016/j.vaccine.2017.09.048
   Gonzalez J, 2012, REV ARGENT CARDIOL, V80, P240
   Hotez PJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004744
   Quintana-Carrillo RH, 2013, INT J STROKE, V8, pE23, DOI 10.1111/ijs.12121
   Instituto Nacional de Estadistica y Geografia, 2016, ENC NAC INGR GAST HO
   IQVIA Institute for Human Data Science, 2018, UNL EC POT HLTH SECT
   Carod-Artal FJ, 2010, LANCET NEUROL, V9, P533, DOI 10.1016/S1474-4422(10)70042-9
   Jones K, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00876-17, 10.1128/iai.00876-17]
   Konduri V, 2017, INFECT IMMUN, V85, DOI [10.1128/iai.00127-17, 10.1128/IAI.00127-17]
   KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249
   Laurell A, 2018, GLOBAL PUBLIC HLTH
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005457
   Lee BY, 2017, VACCINE, V35, pA36, DOI 10.1016/j.vaccine.2016.11.033
   Lee BY, 2012, HUM VACC IMMUNOTHER, V8, P1293, DOI 10.4161/hv.20966
   Lee BY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000916
   Lee BY, 2010, VACCINE, V28, P2806, DOI 10.1016/j.vaccine.2009.09.047
   Management Sciences for Health, 2016, INT MED PROD PRIC GU
   Manne JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002488
   Manzullo EC, 1999, MEM I OSWALDO CRUZ, V94, P317, DOI 10.1590/S0074-02761999000700060
   Marti Sebastian Garcia, 2013, Cost Eff Resour Alloc, V11, P21, DOI 10.1186/1478-7547-11-21
   Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574
   National Institute of Medical Sciences and Nutrition, 2010, OFF TAB COSTS 2010
   OECD, 2017, HLTH GLANC 2017 OECD
   Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4
   Pinheiro E, 2017, REV SOC BRAS MED TRO, V50, P296, DOI 10.1590/0037-8682-0433-2016
   Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2
   Ramsey JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002776
   Rassi A Jr, 2001, Arq Bras Cardiol, V76, P75
   Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Sari T, 2014, TRAVEL MED INFECT DI, V12, P659, DOI 10.1016/j.tmaid.2014.03.004
   Secretaria de Salud Instituto Nacional de Cardiologia Ignacio Chavez, 2016, PUBL CONTR NAT I CAR
   Seid CA, 2017, HUM VACC IMMUNOTHER, V13, P621, DOI 10.1080/21645515.2016.1242540
   The World Bank, 2017, PPP CONV FACT GCP LC
   VIOTTI R, 1994, AM HEART J, V127, P151, DOI 10.1016/0002-8703(94)90521-5
   Viotti R, 2005, REV ESP CARDIOL, V58, P1037, DOI 10.1016/S1885-5857(06)60436-2
   Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960
   Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006
   Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157
   WORLD BANK, 2016, WORLD DEV IND 1960 2
   World Health Organization, 2013, GLOB HLTH OBS COUNTR
   Zeng W, 2018, VACCINE, V36, P413, DOI 10.1016/j.vaccine.2017.11.064
NR 59
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3704
EP 3714
DI 10.1016/j.vaccine.2019.05.028
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100011
PM 31104883
DA 2020-05-12
ER

PT J
AU Nieminen, H
   Rinta-Kokko, H
   Jokinen, J
   Puumalainen, T
   Moreira, M
   Borys, D
   Schuerman, L
   Palmu, AA
AF Nieminen, H.
   Rinta-Kokko, H.
   Jokinen, J.
   Puumalainen, T.
   Moreira, M.
   Borys, D.
   Schuerman, L.
   Palmu, A. A.
TI Effectiveness of the 10-valent pneumococcal conjugate vaccine among
   girls, boys, preterm and low-birth-weight infants - Results from a
   randomized, double-blind vaccine trial
SO VACCINE
LA English
DT Article
DE Pneumococcal conjugate vaccine; Invasive pneumococcal disease;
   Pneumonia; Otitis; Sex; Preterm infant; Low-birth-weight infant
ID SEX-DIFFERENCES; RISK-FACTORS; DISEASE; IMMUNOGENICITY; PHID-CV10;
   SAFETY; TOLERABILITY; CHILDHOOD; PNEUMONIA; EFFICACY
AB Background: Several studies have shown differences in susceptibility to infections and immune response to vaccines by sex. Prematurely born infants are at higher risk for pneumococcal diseases, with lower effectiveness for some vaccines compared to term infants. We have reported the effectiveness of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on several endpoints in the Finnish Invasive Pneumococcal disease (FinIP) vaccine trial. Now, we present the results of a post-hoc analysis evaluating PHiD-CV10 effectiveness in subgroups by sex, gestational age, and birth weight.
   Methods: The FinIP trial was a phase III/IV cluster-randomized, double-blind trial. Infants enrolled < 7 - months of age received PHiD-CV10 in two thirds of clusters (3 + 1 or 2 + 1 schedule) and hepatitis B vaccine as control in remaining third. Outcome data included invasive pneumococcal disease, pneumonia, tympanostomy tube placements, and antimicrobial purchases collected through national, routinely used health registers. Negative binomial model was used in the incidence and vaccine effectiveness estimation, and differences in incidences between subgroups were tested among control children.
   Results: Of the 30,527 infants enrolled 51% were boys. The incidences of hospital-diagnosed pneumonia and otitis-related outcomes were higher among boys in control groups. There were no significant sex differences in the vaccine effectiveness estimates.
   Altogether, 1519 (5%) infants were born before 37th gestational week. The incidences of pneumonia outcomes were higher among premature infants when compared to term infants.
   The vaccine effectiveness estimates among preterm infants were not statistically significant except for antimicrobial purchases, but all point estimates were at the same level among preterm infants as among term infants. There was no significant difference between 2 + 1 and 3 + 1 schedules in any of the subgroups analysed.
   Conclusion: PHiD-CV10 had a similar effectiveness in both sexes, and seemed to be protective in preterm infants. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Nieminen, H.; Palmu, A. A.] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, FinnMedi 1,Biokatu 6, FI-33520 Tampere, Finland.
   [Rinta-Kokko, H.; Jokinen, J.] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, POB 30, FI-00271 Helsinki, Finland.
   [Puumalainen, T.] Natl Inst Hlth & Welf, Dept Hlth Secur, POB 30, FI-00271 Helsinki, Finland.
   [Moreira, M.; Borys, D.; Schuerman, L.] GSK, Ave Fleming 20, B-1300 Wavre, Belgium.
RP Nieminen, H (reprint author), Natl Inst Hlth & Welf, Dept Publ Hlth Solut, FinnMedi 1,Biokatu 6, FI-33520 Tampere, Finland.
EM heta.nieminen@thl.fi
FU GlaxoSmithKline Biologicals SA, BelgiumGlaxoSmithKline; National
   Institute for Health and Welfare (THL), Finland
FX GlaxoSmithKline Biologicals SA, Belgium and National Institute for
   Health and Welfare (THL), Finland
CR Baraibar R, 1997, CLIN MICROBIAL IN S3, V3
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   de St Maurice A, 2016, J INFECT DIS, V214, P792, DOI 10.1093/infdis/jiw222
   Esposito S, 2005, VACCINE, V23, P1703, DOI 10.1016/j.vaccine.2004.09.029
   Esposito S, 2012, EXPERT REV VACCINES, V11, P1199, DOI [10.1586/ERV.12.93, 10.1586/erv.12.93]
   Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006
   Haukka J, 2007, EUR J CLIN PHARMACOL, V63, P1069, DOI 10.1007/s00228-007-0349-6
   Jakobsson M, 2008, BJOG-INT J OBSTET GY, V115, P38, DOI 10.1111/j.1471-0528.2007.01565.x
   Kent A, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3945
   Kilpi TM, 2018, VACCINE, V36, P5891, DOI 10.1016/j.vaccine.2018.08.020
   Knoll MD, 2014, PEDIATR INFECT DIS J, V33, pS119, DOI 10.1097/INF.0000000000000079
   MacIntyre EA, 2010, PAED CHILD HEALT-CAN, V15, P437, DOI 10.1093/pch/15.7.437
   Mahon BE, 2007, PEDIATRICS, V119, pE804, DOI 10.1542/peds.2006-2094
   Martinon-Torres F, 2015, PEDIATRICS, V135, pE876, DOI 10.1542/peds.2014-2941
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Palmu AA, 2014, LANCET RESP MED, V2, P717, DOI 10.1016/S2213-2600(14)70139-0
   Palmu AA, 2018, VACCINE, V36, P1816, DOI 10.1016/j.vaccine.2018.02.088
   Palmu AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172690
   Palmu AA, 2015, PEDIATR INFECT DIS J, V34, P1230, DOI 10.1097/INF.0000000000000857
   Palmu AA, 2014, LANCET INFECT DIS, V14, P205, DOI [10.1016, 10.1016/S1473-3099(13)70338-4]
   Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6
   Rinta-Kokko H, 2018, VACCINE, V36, P1934, DOI 10.1016/j.vaccine.2018.03.001
   Ruckinger S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-12
   Ruggeberg JU, 2007, VACCINE, V25, P264, DOI 10.1016/j.vaccine.2006.07.036
   Sawyer MH, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0975
   Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007
   Shinefield H, 2002, PEDIATR INFECT DIS J, V21, P182, DOI 10.1097/00006454-200203000-00003
   Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637
   Voysey M, 2016, VACCINE, V34, P1657, DOI 10.1016/j.vaccine.2016.02.036
   WASHBURN TC, 1965, PEDIATRICS, V35, P57
NR 30
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3715
EP 3721
DI 10.1016/j.vaccine.2019.05.033
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100012
PM 31122856
OA Other Gold
DA 2020-05-12
ER

PT J
AU Nicolodi, C
   Groiss, F
   Kiselev, O
   Wolschek, M
   Seipelt, J
   Muster, T
AF Nicolodi, Christina
   Groiss, Franz
   Kiselev, Oleg
   Wolschek, Markus
   Seipelt, Joachim
   Muster, Thomas
TI Safety and immunogenicity of a replication-deficient H5N1 influenza
   virus vaccine lacking NS1
SO VACCINE
LA English
DT Article
DE Influenza; NS1; Intranasal; H5N1; Live attenuated;
   Replication-deficient; Reverse genetics
ID CANDIDATE VACCINE; REVERSE GENETICS; A VIRUSES; LIVE; INFECTION;
   REASSORTMENT; CELLS
AB Background: Traditional inactivated influenza vaccines are the type of vaccines that were most frequently developed for immunization against the highly pathogenic avian H5N1 influenza virus. However, clinical trials with inactivated influenza vaccines for H5N1 indicated that high doses and at least two immunizations are required for an effective immune response (Nicholson et al., 2001; Treanor, Campbell et al., 2006; Treanor, Schiff et al., 2006; Ehrlich et al., 2008). We investigated the safety and immunogenicity of a live attenuated H5N1 vaccine (delNS1-H5N1) lacking the interferon antagonist nonstructural protein 1 (NS1).
   Methods: We conducted a double-blind, placebo-controlled, phase 1 study in healthy adult participants who were randomly assigned at a 2:1 ratio to receive two immunizations of delNS1-H5N1 vaccine at 6.8 log10 50% tissue culture infectious doses (TCID50)/subject or 7.5 log10 TCID50/subject, or placebo.
   Results: Intranasal vaccination with the live attenuated delNS1-H5N1 vaccine was safe and well tolerated. The most common adverse events identified were symptoms associated with mild influenza infections, such as increased body temperature (>37.0 degrees C), pharyngeal erythema, rhinitis and throat irritation, and were reported within 7 days after the first immunization. delNS1-H5N1 was able to induce significant vaccine specific serum antibody titers even at the lower dose level of 6.8 log10 TCID50/subject. Seroconversion occurred in 75% of study participants after only one immunization with 7.5 log10 TCID50/subject. Vaccine-specific local IgA responses were observed in 41.7% of individuals that showed serum antibody responses after 2nd immunization.
   Conclusions: We show that vaccination with a live attenuated H5N1 influenza vaccine lacking NS1 is safe and induces significant levels of vaccine-specific antibodies even after one immunization. The safety and immunogenicity data indicate that delNS1-H5N1 has the potential to fulfil the unmet need for an effective influenza vaccine in pandemic situations. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Nicolodi, Christina; Groiss, Franz; Wolschek, Markus; Seipelt, Joachim; Muster, Thomas] AVIR Green Hills Biotechnol, A-1200 Vienna, Austria.
   [Kiselev, Oleg] Russian Acad Med Sci, Res Inst Influenza, St Petersburg, Russia.
   [Wolschek, Markus; Seipelt, Joachim] BlueSky Vaccines GmbH, A-1060 Vienna, Austria.
   [Muster, Thomas] Vivaldi Biosci Inc, Ft Collins, CO 80523 USA.
RP Nicolodi, C (reprint author), AVIR Green Hills Biotechnol Res Dev Trade AG, Forsthausgasse 11, A-1220 Vienna, Austria.
EM nicolodi.christina@gmail.com
OI Seipelt, Joachim/0000-0001-9865-814X
FU AVIR Green Hills Biotechnology Research Development AG, Austria; EU
   grant FLUVACC [518281]
FX The clinical study was sponsored by AVIR Green Hills Biotechnology
   Research Development AG, Austria and by the EU grant FLUVACC contract
   nr. 518281.
CR Ambrose CS, 2012, VACCINE, V30, P6794, DOI 10.1016/j.vaccine.2012.09.018
   BEARE AS, 1975, LANCET, V2, P729
   Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368
   Bergen R, 2004, PEDIATR RES, DOI [10.1097/01inf.0000109392.96411.4f, DOI 10.1097/01INF.0000109392.96411.4F]
   Block SL, 2007, ANTIMICROB AGENTS CH, V51, P4001, DOI 10.1128/AAC.00517-07
   Boyce TG, 1999, VACCINE, V18, P82, DOI 10.1016/S0264-410X(99)00183-8
   Clements ML, 1986, J CLIN MICROBIOL, DOI [10.1016/S1364-6613(00)01601-6, DOI 10.1016/S1364-6613(00)01601-6]
   Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783
   Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998
   FLORENT G, 1979, J BIOL STAND, V7, P361, DOI 10.1016/S0092-1157(79)80010-4
   Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508
   Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697
   Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09
   Jovanovic D, 1977, Dev Biol Stand, V39, P105
   Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930
   Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099
   Louisirirotchanakul S, 2007, J CLIN MICROBIOL, V45, P2284, DOI 10.1128/JCM.00921-07
   Mossler C, 2013, VACCINE, V31, P6194, DOI 10.1016/j.vaccine.2013.10.061
   Nakowitsch S, 2011, VACCINE, V29, P3517, DOI 10.1016/j.vaccine.2011.02.100
   Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054
   Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850
   Organizacidn Mundial de la Salud, 2006, WHOIVB0613 ORG MUND
   Parks CL, 2007, VIROLOGY, V367, P275, DOI 10.1016/j.virol.2007.05.004
   Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rudenko L, 2008, INFLUENZA OTHER RESP, DOI [10.1111/j.1750-2659.2008.00056.x, DOI 10.1111/J.1750-2659.2008.00056.X]
   Rudenko L, 2015, VACCINE, V33, P5110, DOI 10.1016/j.vaccine.2015.08.019
   Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393
   Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778
   Trombetta C M, 2018, J Prev Med Hyg, V59, pE1, DOI 10.15167/2421-4248/jpmh2018.59.1.870
   Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021
   Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428
   Wang H, 2008, LANCET, DOI [10.1016/S0140-6716(02)60491-6, DOI 10.1016/S0140-6716(02)60491-6]
   WHO, 2017, CUM NUMB CONF HUM CA
   WHO, 2015, WKLY EPIDEMIOL REC, V90, P261, DOI [10.1111/irv.12324/epdf, DOI 10.1111/IRV.12324/EPDF]
   Wong SS, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0017-5
   World Health Organization [WHO], 2002, WHO AN INFL MAN
   YOUNGNER JS, 1994, J CLIN MICROBIOL, V32, P750, DOI 10.1128/JCM.32.3.750-754.1994
   Zaman M, 2014, J INFECT DEV COUNTR, V8, P202, DOI 10.3855/jidc.3329
   Zangwill KM, 2008, J INFECT DIS, V197, P580, DOI 10.1086/526537
NR 40
TC 2
Z9 2
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3722
EP 3729
DI 10.1016/j.vaccine.2019.05.013
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100013
PM 31155415
DA 2020-05-12
ER

PT J
AU Moro, PL
   Arana, J
   Marquez, PL
   Ng, C
   Barash, F
   Hibbs, BF
   Cano, M
AF Moro, Pedro L.
   Arana, Jorge
   Marquez, Paige L.
   Ng, Carmen
   Barash, Faith
   Hibbs, Beth F.
   Cano, Maria
TI Is there any harm in administering extra-doses of vaccine to a person?
   Excess doses of vaccine reported to the Vaccine Adverse Event Reporting
   System (VAERS), 2007-2017
SO VACCINE
LA English
DT Article
DE Adverse event; Epidemiology; Excess dose; Extra dose; Surveillance;
   Vaccination errors; Vaccine safety
ID ACELLULAR PERTUSSIS VACCINES; YELLOW-FEVER VACCINE; ADVISORY-COMMITTEE;
   UNITED-STATES; PREVENTING TETANUS; DIPHTHERIA; SAFETY; TDAP;
   RECOMMENDATIONS; IMMUNOGENICITY
AB Background: The administration of an extra dose of a vaccine may occur due to a programmatic error (e.g., vaccination error) when there is need to provide one of the antigens of a combination vaccine not readily available as a single antigen, or when there is need to provide immunization in a person with uncertain vaccination histories (e.g., refugees). There is little data available on the safety of an extra dose of vaccine.
   Objective: To assess for the presence of adverse events (AEs) most commonly reported following the administration of excess doses of vaccine in the Vaccine Adverse Event Reporting System (VAERS).
   Methods: We searched VAERS for US reports where an excess dose of vaccine was administered to a person received from 1/1/2007 through 1/26/2018. We reviewed medical records for all serious reports and a random sample of non-serious reports. The most common AEs among reports of excess dose of vaccine administered were compared with the corresponding AEs for all vaccines reported to VAERS during the same period.
   Results: Out of 366,815 total VAERS reports received, 5067 (1.4%) reported an excess dose of vaccine was administered; 3898 (76.9%) did not describe an adverse health event (AHE). The most common vaccines reported were trivalent inactivated influenza (15.4%), varicella (13.9%), hepatitis A (11.4%), and measles, mumps, rubella, varicella (11.1%). Among reports where only AHEs were reported, the most common were pyrexia (12.8%), injection site erythema (9.7%), injection site pain (8.9%), and headache (6.6%). The percentage of AHEs among these reports was comparable to all reports submitted to VAERS during the same study period.
   Conclusion: More than three-fourths of reports of an excess dose of vaccine did not describe an AHE. Among reports where an AHE event was reported, we did not observe any unexpected conditions or clustering of AEs. Published by Elsevier Ltd.
C1 [Moro, Pedro L.; Arana, Jorge; Marquez, Paige L.; Ng, Carmen; Hibbs, Beth F.; Cano, Maria] Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, NCEZID, 1600 Clifton Rd,MS D26, Atlanta, GA 30333 USA.
   [Barash, Faith] US FDA, CBER, Rockville, MD 20857 USA.
RP Moro, PL (reprint author), Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, NCEZID, 1600 Clifton Rd,MS D26, Atlanta, GA 30333 USA.
EM pmoro@cdc.gov
FU CDC budget; FDA budget
FX The study was implemented by the Centers for Disease Control and
   Prevention (CDC) and Food and Drug Administration (FDA). The only funds
   used were from CDC and FDA budgets. This study had no external sponsors.
CR [Anonymous], 1997, MMWR Recomm Rep, V46, P1
   Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Carneiro M, 2011, REV SOC BRAS MED TRO, V44, P252, DOI 10.1590/S0037-86822011000200025
   DESTEFANO F, 1982, JAMA-J AM MED ASSOC, V247, P2551, DOI 10.1001/jama.1982.03320430055032
   Food and Drug Administration, 1997, FED REGISTER, V62, P52252
   Halperin SA, 2006, PEDIATR INFECT DIS J, V25, P195, DOI 10.1097/01.inf.0000202082.56403.c4
   Hibbs BF, 2015, VACCINE, V33, P3171, DOI 10.1016/j.vaccine.2015.05.006
   Jackson LA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-165
   Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Kroger AT, GEN BEST PRACTICE GU
   Liang JL, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6702a1
   McNeil MM, 2018, MMWR-MORBID MORTAL W, V67, P109, DOI 10.15585/mmwr.mm6703a6
   Midthun K, 1998, Dev Biol Stand, V95, P245
   Moro PL, 2016, VACCINE, V34, P2349, DOI 10.1016/j.vaccine.2016.03.049
   Nishioka Sérgio de Andrade, 2002, Rev. Soc. Bras. Med. Trop., V35, P541, DOI 10.1590/S0037-86822002000500022
   Pichichero ME, 2002, PEDIATR INFECT DIS J, V21, P854, DOI 10.1097/00006454-200209000-00014
   Pichichero ME, 1997, PEDIATRICS, V100, P772, DOI 10.1542/peds.100.5.772
   Pichichero ME, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e11
   Rabello Ana, 2002, Rev. Soc. Bras. Med. Trop., V35, P177, DOI 10.1590/S0037-86822002000200008
   Shimabukuro TT, 2015, VACCINE, V33, P4398, DOI 10.1016/j.vaccine.2015.07.035
   Sukumaran L, 2015, JAMA-J AM MED ASSOC, V314, P1581, DOI 10.1001/jama.2015.12790
   Talbot EA, 2010, VACCINE, V28, P8001, DOI 10.1016/j.vaccine.2010.09.034
NR 22
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3730
EP 3734
DI 10.1016/j.vaccine.2019.04.088
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100014
PM 31155414
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Zimmermann, P
   Donath, S
   Perrett, KP
   Messina, NL
   Ritz, N
   Netea, MG
   Flanagan, KL
   van der Klis, FRM
   Curtis, N
   Abruzzo, V
   Allen, K
   Casalaz, D
   Freyne, B
   Gardiner, K
   Germano, S
   Morrison, C
   Ponsonby, AL
   Robins-Browne, R
   Shann, F
   Vuillermin, P
AF Zimmermann, Petra
   Donath, Susan
   Perrett, Kirsten P.
   Messina, Nicole L.
   Ritz, Nicole
   Netea, Mihai G.
   Flanagan, Katie L.
   van der Klis, Fiona R. M.
   Curtis, Nigel
   Abruzzo, Veronica
   Allen, Katie
   Casalaz, Dan
   Freyne, Bridget
   Gardiner, Kaya
   Germano, Susie
   Morrison, Care
   Ponsonby, Anne Louise
   Robins-Browne, Roy
   Shann, Frank
   Vuillermin, Peter
CA MIS BAIR Grp
TI The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on
   heterologous vaccine responses in infants
SO VACCINE
LA English
DT Article
DE Vaccination; Antibodies; Humoral; Immunoglobulin; Non-specific;
   Seroprotection; Titre
ID MULTIPLEX IMMUNOASSAY; IMMUNE-RESPONSE; RESPIRATORY-INFECTION; ALLERGIC
   DISEASE; SERUM ANTIBODIES; TUBERCULOSIS; PROTECTION; DIPHTHERIA;
   CHILDHOOD; IMMUNOGENICITY
AB Introduction: Bacillus Calmette-Guerin vaccine (BCG), one of the most widely used vaccines, does not only provide protection against tuberculosis and other mycobacterial infections, but also has nonspecific (heterologous) immunomodulatory effects. In participants in a randomised trial, we investigated the effect of neonatal BCG immunisation on antibody responses to routine infant vaccines given in the first year of life.
   Methods: Antibodies against antigens in the diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), and the 13-valent pneumococcal conjugate vaccines were measured in 91 (45 BCG-vaccinated, 46 BCG-naive) infants one month after, and in 310 (169 BCG-vaccinated, 141 BCG-naive) infants seven months after immunisation at 6 weeks, 4 and 6 months of age. In addition, antibodies against meningococcus C, Hib, measles, mumps, and rubella were measured in 147 (78 BCG-vaccinated, 69 BCG-naive) infants one month after immunisation at 12 months of age. The seroprotection rates for each vaccine and the geometric mean concentrations (GMC) of antibodies were compared in BCG-vaccinated and BCG-naive infants.
   Results: At 7 months of age, seroprotection rates were high in both BCG-vaccinated and BCG-naive infants. At 13 months of age, seroprotection rates were lower than at 7 months of age, particularly for pertussis and a number of pneumococcal antigens, with generally higher rates for the latter in BCG-vaccinated infants. Although not statistically significant, antibody responses in BCG-vaccinated infants were consistently higher against diphtheria, tetanus, and pneumococcal antigens at both 7 and 13 months of age, and against measles and mumps at 13 months of age, but were lower against Hib one month after immunisation at both 7 and 13 months of age.
   Conclusion: The immunomodulatory effect of BCG on antibody responses to heterologous vaccines adds to the evidence that BCG immunisation at birth has broad heterologous effects on the infant immune system. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zimmermann, Petra; Donath, Susan; Messina, Nicole L.; Ritz, Nicole; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.
   [Zimmermann, Petra; Messina, Nicole L.; Curtis, Nigel] Murdoch Childrens Res Inst, Infect Dis Res Grp, Parkville, Vic, Australia.
   [Zimmermann, Petra; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia.
   [Zimmermann, Petra] Univ Fribourg, Dept Pediat, Fribourg Hosp HFR, Fribourg, Switzerland.
   [Zimmermann, Petra] Univ Fribourg, Fac Sci & Med, Fribourg, Switzerland.
   [Perrett, Kirsten P.] Murdoch Childrens Res Inst, Food Allergy Res Grp, Melbourne, Vic, Australia.
   [Perrett, Kirsten P.] Murdoch Childrens Res Inst, Melbourne Childrens Trial Ctr, Melbourne, Vic, Australia.
   [Perrett, Kirsten P.] Royal Childrens Hosp, Dept Allergy & Immunol, Melbourne, Vic, Australia.
   [Perrett, Kirsten P.] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia.
   [Perrett, Kirsten P.] Univ Melbourne, Sch Populat & Global Hlth, Parkville, Vic, Australia.
   [Ritz, Nicole] Univ Basel, Childrens Hosp, Infect Dis Unit, Basel, Switzerland.
   [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Internal Med, Nijmegen, Netherlands.
   [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.
   [Flanagan, Katie L.] Univ Tasmania, Launceston, Tas, Australia.
   [Flanagan, Katie L.] Monash Univ, Clayton, Vic, Australia.
   [van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis, Bilthoven, Netherlands.
   [Donath, Susan] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic, Australia.
RP Curtis, N (reprint author), Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia.
EM nigel.curtis@rch.org.au
RI Netea, Mihai/N-5155-2014; Zimmermann, Petra/I-4670-2019; Ponsonby,
   Anne-Louise/AAE-4351-2019; Ritz, Nicole/G-2924-2015; perrett,
   kirsten/P-8813-2019
OI Zimmermann, Petra/0000-0002-2388-4318; Messina,
   Nicole/0000-0001-8404-4462; Ritz, Nicole/0000-0002-1498-1685; perrett,
   kirsten/0000-0002-5683-996X
FU Australian National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [GNT1051228,
   GNT1099680]; University of MelbourneUniversity of Melbourne; European
   Society of Paediatric Infectious Diseases; Spinoza grant of the
   Netherlands Organization for Scientific Research
FX This work was supported by the Australian National Health and Medical
   Research Council (NHMRC) (grants GNT1051228 and GNT1099680), the
   University of Melbourne (International Research Scholarship to PZ), and
   the European Society of Paediatric Infectious Diseases (Fellowship to
   PZ). MGN was supported by a Spinoza grant of the Netherlands
   Organization for Scientific Research. We thank Rhian Bonnici for help
   with processing of blood samples, Hannah Elborough and Judith Spotswood
   for collection of blood samples, and Casey Goodall for help with data
   entry. We also thank Prof Andrew Pollard for his helpful comments on the
   manuscript.
CR Aaby P, 2012, ARCH DIS CHILD, V97, P685, DOI 10.1136/archdischild-2011-300646
   Anderson EJ, 2012, VACCINE, V30, P2083, DOI 10.1016/j.vaccine.2012.01.053
   Butkeviciute E, 2018, FUTURE MICROBIOL, V13, P1193, DOI 10.2217/fmb-2018-0026
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698
   Curtsinger JM, 1950, J IMMUNOL, V2005, P4465
   de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07
   de Voer RM, 2009, CLIN VACCINE IMMUNOL, V16, P433, DOI 10.1128/CVI.00364-08
   Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620
   Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09
   Faustman DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041756
   Favorov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032567
   Freidl GS, 2018, VACCINE, V36, P1664, DOI 10.1016/j.vaccine.2018.01.079
   Freyne B, 2018, J INFECT DIS, V217, P1798, DOI 10.1093/infdis/jiy069
   Freyne B, 2014, ARCH DIS CHILD, V99, P182, DOI 10.1136/archdischild-2013-305655
   Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43
   Grange JM, 2003, J ROY SOC MED, V96, P389, DOI 10.1258/jrsm.96.8.389
   Hemdan T, 2014, J UROLOGY, V191, P1244, DOI 10.1016/j.juro.2013.11.005
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hollm-Delgado MG, 2014, PEDIATRICS, V133, pE73, DOI 10.1542/peds.2013-2218
   de Castro MJ, 2015, CLIN INFECT DIS, V60, P1611, DOI 10.1093/cid/civ144
   Kandasamy R, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5225
   Kleinnijenhuis J, 2015, T ROY SOC TROP MED H, V109, P29, DOI 10.1093/trstmh/tru168
   Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628
   Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109
   Leentjens J, 2015, J INFECT DIS, V212, P1930, DOI 10.1093/infdis/jiv332
   Libraty Daniel H, 2014, Trials Vaccinol, V3, P1, DOI 10.1016/j.trivac.2013.11.004
   Nissen TN, 2017, VACCINE, V35, P2084, DOI 10.1016/j.vaccine.2017.02.048
   Ota MO, 1950, J IMMUNOL, V2002, P919
   Pfahlberg A, 2002, J INVEST DERMATOL, V119, P570, DOI 10.1046/j.1523-1747.2002.00643.x
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Pollard AJ, 2017, ARCH DIS CHILD
   Ristori G, 2014, NEUROLOGY, V82, P41, DOI 10.1212/01.wnl.0000438216.93319.ab
   Ritz N, 2013, VACCINE, V31, P3098, DOI 10.1016/j.vaccine.2013.03.059
   Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC
   Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671
   Schepp RM, 2017, J VIROL METHODS, V241, P15, DOI 10.1016/j.jviromet.2016.12.006
   Shann F, 2005, BRIT MED J, V330, P844, DOI 10.1136/bmj.330.7495.844
   Shann F, 2012, LANCET, V379, P26, DOI 10.1016/S0140-6736(12)60016-6
   Shann F, 2011, J INFECT DIS, V204, P182, DOI 10.1093/infdis/jir244
   Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537
   Simondon F, 1999, EUR J CLIN MICROBIOL, V18, P23, DOI 10.1007/s100960050221
   Smits GP, 2012, CLIN VACCINE IMMUNOL, V19, P396, DOI 10.1128/CVI.05537-11
   Steenhuis TJ, 2008, CLIN EXP ALLERGY, V38, P79, DOI 10.1111/j.1365-2222.2007.02859.x
   Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3
   van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018
   Zimmermann P, 2018, EXPERT REV VACC
   Zimmermann P, 2018, J INFECT DIS
   ZYKOV M P, 1981, Zeitschrift fuer Erkrankungen der Atmungsorgane, V156, P203
   ZYKOV MP, 1985, ACTA VIROL, V29, P403
NR 49
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 19
PY 2019
VL 37
IS 28
BP 3735
EP 3744
DI 10.1016/j.vaccine.2019.03.016
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IE9PI
UT WOS:000472706100015
PM 31153688
DA 2020-05-12
ER

PT J
AU Vipond, C
   Sutherland, J
   Nordgren, K
   Kemp, G
   Heath, A
   Care, R
   Studholme, L
AF Vipond, Caroline
   Sutherland, Janet
   Nordgren, Karin
   Kemp, George
   Heath, Alan
   Care, Rory
   Studholme, Lucy
TI Development and validation of a monocyte activation test for the
   control/safety testing of an OMV-based meningococcal B vaccine
SO VACCINE
LA English
DT Article
DE Bexsero; Outer membrane vesicles; Monocyte activation test; Pyrogenicity
ID MEMBRANE VESICLE VACCINE; PYROGEN TEST; WHOLE-BLOOD; DISEASE;
   IMMUNOGENICITY; POLYSACCHARIDE; IMMUNIZATION; PROTEIN; SAFETY
AB It is imperative to ensure biological products are free of contaminating pyrogenic material prior to administration to patients. Historically the rabbit pyrogen test (RPT) was used to screen for such contamination in medicines for intravenous delivery. This test was adapted for use to screen vaccines. However, some, including meningococcal vaccines containing outer membrane vesicles, are intrinsically pyrogenic. Indeed, this is the case for Bexsero which contains relatively high levels of endotoxin and other potential pyrogens such as lipoproteins and porins. The RPT proved a difficult method for measuring the pyrogenic content of Bexsero and differences between laboratories in different countries made repeat testing at the control laboratories problematic resulting in batches being wrongly identified as unsafe. At NIBSC a monocyte activation test (MAT) was adapted and validated as an alternative. This required setting of a specification in-house and deciding on a decisional procedure using multiple donors, allowing batches equally pyrogenic or less, than those batches shown to be safe in a clinical trial, to be certified as safe. The resulting format was a reference comparison method with an upper limit of 1.8 relative pyrogen units (RPU). The batch passed if an initial four donors had a response equal to or less than 1.8 RPU, if one donor is above this limit the batch was tested in a further four donors and seven of the eight must be equal to or below 1.8 RPU. If two donors have a response greater than 1.8 the batch failed. Crown Copyright (C) 2018 Published by Elsevier Ltd.
C1 [Vipond, Caroline; Kemp, George; Care, Rory] Natl Inst Biol Stand & Controls, Dept Bacteriol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Sutherland, Janet; Nordgren, Karin; Studholme, Lucy] Natl Inst Biol Stand & Controls, Dept Biotherapeut, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Heath, Alan] Natl Inst Biol Stand & Controls, Dept Biostat, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
RP Vipond, C (reprint author), Natl Inst Biol Stand & Controls, Dept Bacteriol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
EM caroline.vipond@nibsc.org
CR BANG FB, 1956, B JOHNS HOPKINS HOSP, V98, P325
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999
   BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S
   Bryan P, 2018, LANCET CHILD ADOLESC, V2, P395, DOI 10.1016/S2352-4642(18)30103-2
   Das REG, 2004, J IMMUNOL METHODS, V288, P165, DOI 10.1016/j.jim.2004.03.002
   DEMORAES JC, 1992, LANCET, V340, P1074
   DINARELLO CA, 1984, J CLIN MICROBIOL, V20, P323, DOI 10.1128/JCM.20.3.323-329.1984
   Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164
   Findlay L, 2010, J IMMUNOL METHODS, V352, P1, DOI 10.1016/j.jim.2009.10.013
   Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73
   FRASCH CE, 1982, INFECT IMMUN, V37, P271, DOI 10.1128/IAI.37.1.271-280.1982
   GEIER MR, 1978, APPL ENVIRON MICROB, V36, P445, DOI 10.1128/AEM.36.3.445-449.1978
   Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85
   Hasiwa N, 2013, ALTEX-ALTERN ANIM EX, V30, P169, DOI 10.14573/altex.2013.2.169
   Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010
   Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513
   Nordgren IK, 2016, J IMMUNOL METHODS, V428, P42, DOI 10.1016/j.jim.2015.12.001
   Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063
   POOLE S, 1988, LANCET, V1, P130
   Poole S, 2003, J IMMUNOL METHODS, V274, P209, DOI 10.1016/S0022-1759(02)00519-7
   Rosenqvist E, 1998, DEV BIOL STAND, V92, P323
   Schindler S, 2004, J IMMUNOL METHODS, V294, P89, DOI 10.1016/j.jim.2004.08.019
   SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195
   TAKTAK YS, 1991, J PHARM PHARMACOL, V43, P578, DOI 10.1111/j.2042-7158.1991.tb03540.x
   Vesikari T, 2013, LANCET
   Vipond C, 2006, PROTEOMICS, V6, P3400, DOI 10.1002/pmic.200500821
   Vipond C, 2016, ALTEX-ALTERN ANIM EX, V33, P47, DOI 10.14573/altex.1509291
   Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x
   ZOLLINGER WD, 1978, J INFECT DIS, V137, P728, DOI 10.1093/infdis/137.6.728
NR 29
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3747
EP 3753
DI 10.1016/j.vaccine.2018.06.038
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900002
PM 31202503
OA Bronze
DA 2020-05-12
ER

PT J
AU Valentini, S
   Santoro, G
   Baffetta, F
   Franceschi, S
   Paludi, M
   Brandini, E
   Gherardini, L
   Serruto, D
   Capecchi, B
AF Valentini, Sara
   Santoro, Giovanna
   Baffetta, Federica
   Franceschi, Sara
   Paludi, Marilena
   Brandini, Elisa
   Gherardini, Leonardo
   Serruto, Davide
   Capecchi, Barbara
TI Monocyte-activation test to reliably measure the pyrogenic content of a
   vaccine: An in vitro pyrogen test to overcome in vivo limitations
SO VACCINE
LA English
DT Article
DE Bexsero; Outer Membrane Vesicles; Monocyte Activation Test; Pyrogenicity
ID CYTOKINE PRODUCTION; ENDOTOXIC ACTIVITY; LIMULUS TEST; FACTOR-H;
   PROTEIN; RABBIT; LIPOPOLYSACCHARIDES; EVOLUTION; APPROVAL; IMMUNITY
AB Pyrogen content is one of the critical quality attributes impacting the safety of a product, and there is an increasing need for assays that can reliably measure this attribute in vaccines. The Limulus amebocyte lysate (LAL) assay and the rabbit pyrogen test (RPT) are the canonical animal-based pyrogen tests currently used to release vaccines; however, there are several drawbacks associated with these tests when applied to Bexsero, intrinsically pyrogenic product, containing a meningococcal Outer Membrane Vesicle component. While the RPT, as applied to Bexsero at its given dilution, ensures safe vaccine, it is highly variable and prone to false positive results. On the other hand, the LAL assay although quantitative, can detect only endotoxin pyrogens and is not sufficient for monitoring the safety of Bexsero, which contains both LPS and non-endotoxin pyrogens. Being aware of these limitations of the RPT and LAL when applied to Bexsero, the Monocyte Activation Test (MAT) which is sensitive to both endotoxin and non-endotoxin based pyrogens has been developed as an alternative pyrogen test. Here, the development and the validation of a MAT assay adapted from the European pharmacopoeia for Bexsero, is described. The MAT assay is then used for monitoring the safety and consistency of Bexsero vaccines at release, providing great advantages in terms of reduced variability with respect to RPT, reduction of animal use, in line with the 3Rs principle concerning the protection of animals and faster time to market. In addition the correlation of the MAT to the RPT has been demonstrated supporting the replacement of the in vivo method and the potential application of the assay to other intrinsically pyrogenic vaccines. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Valentini, Sara; Santoro, Giovanna; Baffetta, Federica; Paludi, Marilena; Brandini, Elisa; Gherardini, Leonardo; Serruto, Davide; Capecchi, Barbara] GSK Srl, Via Fiorentina 1, I-53100 Siena, Italy.
   [Franceschi, Sara] Univ Calabria, I-87036 Cosenza, Italy.
   [Franceschi, Sara] Univ Calabria, Dept Econ Stat & Finance, Cubo 0-C, I-87036 Cosenza, Italy.
RP Capecchi, B (reprint author), GSK Srl, Via Fiorentina 1, I-53100 Siena, Italy.
EM barbara.x.capecchi@gsk.com
FU GSK Vaccines srl
FX This study was sponsored by Novartis Vaccines, now acquired by the GSK
   Vaccines srl. GSK took responsibility for all costs incurred in
   publishing and was involved in all stages of the study conduct and
   analysis.
CR Acevedo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00121
   BANG FB, 1956, B JOHNS HOPKINS HOSP, V98, P325
   Beken S, 2016, ADV EXP MED BIOL, V856, P33, DOI 10.1007/978-3-319-33826-2_3
   Brandenburg K, 2009, CURR MED CHEM, V16, P2653, DOI 10.2174/092986709788682001
   Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x
   Das REG, 2004, J IMMUNOL METHODS, V288, P165, DOI 10.1016/j.jim.2004.03.002
   Davis RL, 2004, VACCINE, V22, P536, DOI 10.1016/j.vaccine.2003.06.001
   De Mattia Fabrizio, 2011, Biologicals, V39, P59, DOI 10.1016/j.biologicals.2010.12.001
   Dehus O, 2006, J ENDOTOXIN RES, V12, P171, DOI 10.1179/096805106X102156
   European Directorate for the Quality of Medicines, 2017, MON ACT TEST EUR PHA
   Fennrich S, 1999, Dev Biol Stand, V101, P131
   Fennrich S, 2016, ATLA-ALTERN LAB ANIM, V44, P239, DOI 10.1177/026119291604400305
   Findlay L, 2015, Pharmeur Bio Sci Notes, V2015, P73
   Findlay L, 2019, VACCINE, V37, P3761
   Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103
   Gohil Kunj, 2015, P T, V40, P362
   GREISMAN SE, 1969, P SOC EXP BIOL MED, V131, P1154, DOI 10.3181/00379727-131-34059
   Gutsmann T, 2010, INNATE IMMUN-LONDON, V16, P39, DOI 10.1177/1753425909106447
   Hartung T, 2001, ATLA-ALTERN LAB ANIM, V29, P99, DOI 10.1177/026119290102900203
   Hartung T, 2015, ALTEX-ALTERN ANIM EX, V32, P79, DOI 10.14573/altex.1503241
   Hendriksen CF, 2002, ILAR J S, V43, P543
   Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010
   Hort EC, 1912, J HYG-CAMBRIDGE, V12, P361, DOI 10.1017/S0022172400005052
   KANEGASAKI S, 1986, J BIOCHEM-TOKYO, V99, P1203, DOI 10.1093/oxfordjournals.jbchem.a135583
   Kulpa-Eddy J, 2011, PROCEDIA VACCINOL, V5, P232, DOI 10.1016/j.provac.2011.10.024
   Luo Y, 2016, AAPS J, V18, P1562, DOI 10.1208/s12248-016-9979-x
   Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501
   MARTIN WJ, 1964, APPL MICROBIOL, V12, P483, DOI 10.1128/AEM.12.6.483-486.1964
   Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533
   Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067
   Parikh SR, 2016, LANCET, V388, P2775, DOI 10.1016/S0140-6736(16)31921-3
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Poole S, 1989, PHARMEUROPA, V1, P17
   POOLE S, 1989, PHARMEUROPA, V1, P238
   Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102
   Roberts KJ, 2007, ENDOTOXINS PYROGENS, P261
   ROBINSON A, 1992, VACCINE, V10, P139, DOI 10.1016/0264-410X(92)90001-Z
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107
   Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d
   TAKTAK YS, 1991, J PHARM PHARMACOL, V43, P578, DOI 10.1111/j.2042-7158.1991.tb03540.x
   TRUMENBA1, 2015, TRUMENBA MEN GROUP B
   United States Pharmacopeial Convention, 2016, 39NF34 USP
   Vipond C, 2006, PROTEOMICS, V6, P3400, DOI 10.1002/pmic.200500821
   Vipond C, 2018, VACCINE
   Vipond C, 2016, ALTEX-ALTERN ANIM EX, V33, P47, DOI 10.14573/altex.1509291
   Williams KL, 2007, ENDOTOXINS PYROGENS, P27
NR 48
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3754
EP 3760
DI 10.1016/j.vaccine.2018.10.082
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900003
PM 30448065
DA 2020-05-12
ER

PT J
AU Studholme, L
   Sutherland, J
   Desai, T
   Hockley, J
   Care, R
   Nordgren, IK
   Vipond, C
AF Studholme, Lucy
   Sutherland, Janet
   Desai, Trusha
   Hockley, Jason
   Care, Rory
   Nordgren, Ida Karin
   Vipond, Caroline
CA Collaborative Study Grp
TI Evaluation of the monocyte activation test for the safety testing of
   meningococcal B vaccine Bexsero: A collaborative study
SO VACCINE
LA English
DT Article
DE Monocyte activation test; Pyrogens; Bexsero; Outer membrane vesicles;
   Rabbit pyrogen test; Meningococcal vaccine
ID RABBIT PYROGEN TEST; CYTOKINE PRODUCTION; IMMUNOGENICITY; RECOMBINANT;
   UNIVERSITY; ROUTINE; FEVER
AB The aim of this collaborative study was to evaluate the robustness of the monocyte activation test (MAT) for quantifying the pyrogenic content in the outer membrane vesicle (OMV)-containing vaccine Bexsero: the first meningococcal B vaccine to be licenced. We analysed datasets from 9 laboratories covering 15 test systems for 3 batches of Bexsero with higher, equivalent and lower activity relative to a reference lot in the MAT. Activity was measured in terms of relative pyrogen units (RPU) based on European Pharmacopoeia (Ph. Eur.) MAT Chapter 2.6.30 Method C: Reference Lot Comparison Test. We report that all 15 test systems were consistent in that they showed sample A to be the most active in the MAT; that 13 of 15 test systems had an accuracy of more than 80% and an overall geometric mean RPU of 1.03 with lower and upper 95% confidence limits of 0.97 and 1.09 respectively fora sample with an expected value of 1.00 RPU. We also report larger variability in the results for test systems involving cells from individual blood donations for sample A suggesting that there could be donor to donor differences in sensitivity to the vaccine constituents responsible for the higher activity of this batch. Overall, the consistency and accuracy of the MAT was remarkable given the range of test systems used by participants, all of which are permitted by the Ph. Eur. General MAT Chapter. This is important given the limitations of the rabbit pyrogen test for the control of pyrogenicity in general and particularly with products with intrinsic pyrogenicity such as Bexsero. (C) 2018 Elsevier Ltd.
C1 [Studholme, Lucy; Sutherland, Janet; Desai, Trusha; Hockley, Jason; Care, Rory; Nordgren, Ida Karin; Vipond, Caroline; Collaborative Study Grp] Natl Inst Biol Stand & Controls, Med & Healthcare Regulatory Agcy, Potters Bar EN6 3QG, Herts, England.
RP Nordgren, IK (reprint author), Natl Inst Biol Stand & Controls, Med & Healthcare Regulatory Agcy, Potters Bar EN6 3QG, Herts, England.
EM karin.nordgren@nibsc.org
CR Biswas HH, 2016, MMWR-MORBID MORTAL W, V65, P520, DOI 10.15585/mmwr.mm6520a3
   da Silva CC, 2016, TOXICOL IN VITRO, V32, P70, DOI 10.1016/j.tiv.2015.12.004
   Das REG, 2004, J IMMUNOL METHODS, V288, P165, DOI 10.1016/j.jim.2004.03.002
   DINARELLO CA, 1984, J CLIN MICROBIOL, V20, P323, DOI 10.1128/JCM.20.3.323-329.1984
   Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129
   EDQM-Council of Europe, 2017, COMBISTATS V5 0
   European Medicines Agency, 2013, BEXS MEN GROUP B VAC
   Findlay L, 2015, Pharmeur Bio Sci Notes, V2015, P73
   Findlay L, 2010, J IMMUNOL METHODS, V352, P1, DOI 10.1016/j.jim.2009.10.013
   Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73
   Foley NM, 2015, MILITARY MED RES, V2, pCP10, DOI 10.1186/s40779-014-0029-7
   Gianchecchi E, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4020020
   Gimenes I, 2015, REGUL TOXICOL PHARM, V73, P356, DOI 10.1016/j.yrtph.2015.07.025
   HALVORSEN H, 1993, J LEUKOCYTE BIOL, V54, P275
   Hartung T, 2001, ATLA-ALTERN LAB ANIM, V29, P99, DOI 10.1177/026119290102900203
   Hasiwa N, 2013, ALTEX-ALTERN ANIM EX, V30, P169, DOI 10.14573/altex.2013.2.169
   Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010
   Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017
   Kikkert R, 2007, J ENDOTOXIN RES, V13, P140, DOI 10.1177/0968051907080024
   Koryakina A, 2014, J IMMUNOL METHODS, V405, P181, DOI 10.1016/j.jim.2014.01.005
   McNamara LA, 2015, PEDIATRICS, V135, P798, DOI 10.1542/peds.2014-4015
   Nordgren IK, 2016, J IMMUNOL METHODS, V428, P42, DOI 10.1016/j.jim.2015.12.001
   POOLE S, 1988, LANCET, V1, P130
   Poole S, 1988, Dev Biol Stand, V69, P121
   Poole S, 2003, J IMMUNOL METHODS, V274, P209, DOI 10.1016/S0022-1759(02)00519-7
   RAFFERTY B, 1991, J IMMUNOL METHODS, V144, P69, DOI 10.1016/0022-1759(91)90232-5
   Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d
   Solati S, 2015, INNATE IMMUN-LONDON, V21, P677, DOI 10.1177/1753425915583365
   Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09
   TAKTAK YS, 1991, J PHARM PHARMACOL, V43, P578, DOI 10.1111/j.2042-7158.1991.tb03540.x
   Troelstra A, 1999, J IMMUNOL, V162, P4220
   van der Pol L, 2015, BIOTECHNOL J, V10, P1689, DOI 10.1002/biot.201400395
   Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8
   Vipond C, 2016, ALTEX-ALTERN ANIM EX, V33, P47, DOI 10.14573/altex.1509291
   Yoon H, 2016, J MICROBIOL BIOTECHN, V26, P1343, DOI 10.4014/jmb.1604.04080
NR 35
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3761
EP 3769
DI 10.1016/j.vaccine.2018.05.073
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900004
PM 31202504
OA Bronze
DA 2020-05-12
ER

PT J
AU Awasthi, S
   Hook, LM
   Swaminathan, G
   Cairns, TM
   Brooks, B
   Smith, JS
   Ditto, NT
   Gindy, ME
   Bett, AJ
   Espeseth, AS
   Cohen, GH
   Friedman, HM
AF Awasthi, Sita
   Hook, Lauren M.
   Swaminathan, Gokul
   Cairns, Tina M.
   Brooks, Benjamin
   Smith, Jeffrey S.
   Ditto, Noah T.
   Gindy, Marian E.
   Bett, Andrew J.
   Espeseth, Amy S.
   Cohen, Gary H.
   Friedman, Harvey M.
TI Antibody responses to crucial functional epitopes as a novel approach to
   assess immunogenicity of vaccine adjuvants
SO VACCINE
LA English
DT Article
DE Adjuvants; Herpes simplex virus; Vaccines; Epitopes; Antibodies;
   Biosensor
ID HERPES-SIMPLEX-VIRUS; CATIONIC LIPID NANOCARRIERS; SUBUNIT ANTIGEN
   VACCINE; HSV-2 GLYCOPROTEIN C; CPG OLIGONUCLEOTIDES; SYSTEMIC DELIVERY;
   EPITHELIAL-CELLS; B-CELL; SPREAD; NANOPARTICLES
AB We are interested in developing a vaccine that prevents genital herpes. Adjuvants have a major impact on vaccine immunogenicity. We compared two adjuvants, an experimental Merck Sharp & Dohme lipid nanoparticle (LNP) adjuvant, LNP-2, with CpG oligonucleotide combined with alum for immunogenicity in mice when administered with herpes simplex virus type 2 (HSV-2) glycoproteins C, D and E (gC2, gD2, gE2). The immunogens are intended to produce neutralizing antibodies to gC2 and gD2, antibodies to gD2 and gE2 that block cell-to-cell spread, and antibodies to gE2 and gC2 that block immune evasion from antibody and complement, respectively. Overall, CpG/alum was better at producing serum and vaginal IgG binding antibodies, neutralizing antibodies, antibodies that block virus spread from cell-to-cell, and antibodies that block immune evasion domains on gC2. We used a novel high throughput biosensor assay to further assess differences in immunogenicity by mapping antibody responses to seven crucial epitopes on gD2 involved in virus entry or cell-to-cell spread. We found striking differences between CpG/alum and LNP-2. Mice immunized with gD2 CpG/alum produced higher titers of antibodies than LNP-2 to six of seven crucial epitopes and produced antibodies to more crucial epitopes than LNP-2. Measuring epitope-specific antibodies helped to define mechanisms by which CpG/alum outperformed LNP-2 and is a valuable technique to compare adjuvants. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Awasthi, Sita; Hook, Lauren M.; Friedman, Harvey M.] Univ Penn, Dept Med, Infect Dis Div, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Swaminathan, Gokul; Smith, Jeffrey S.; Gindy, Marian E.; Bett, Andrew J.; Espeseth, Amy S.] Merck & Co Inc, Kenilworth, NJ USA.
   [Cairns, Tina M.; Cohen, Gary H.] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Brooks, Benjamin; Ditto, Noah T.] Carterra Inc, Salt Lake City, UT USA.
RP Awasthi, S (reprint author), Univ Penn, Dept Med, Infect Dis Div, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM sawasthi@pennmedicine.upenn.edu; lhook@-pennmedicine.upenn.edu;
   tmcairns@dental.upenn.edu; benjamin.d.brooks@ndsu.edu;
   jeffrey.smith@merck.com; nditto@carterra-bio.com;
   marian_gindy@merck.com; andrew_bett@merck.com; amy_espeseth@merck.com;
   ghc@dental.upenn.edu; hfriedma@pennmedicine.upenn.edu
OI Hook, Lauren/0000-0002-5540-2459
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI105959
   (Awasthi), RO1AI104854, RO1AI18289]
FX This work was supported by the National Institutes of Health grants
   number R21AI105959 (Awasthi and Friedman co-PI), RO1AI104854 (Friedman
   PI) and RO1AI18289 (Cohen PI). The funding source had no role in the
   study design, collection of data, analysis or interpretation of data, in
   writing the manuscript, or in the decision to submit the article for
   publication.
CR Atanasiu D, 2018, J VIROL, V92, DOI 10.1128/JVI.01694-18
   Awasthi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006141
   Awasthi S, 2014, J VIROL, V88, P8421, DOI 10.1128/JVI.01130-14
   Awasthi S, 2014, J VIROL, V88, P2000, DOI 10.1128/JVI.03163-13
   Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11
   Batista-Duharte A, 2018, BIOMED PHARMACOTHER, V105, P616, DOI 10.1016/j.biopha.2018.06.026
   Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bershteyn A, 2012, J CONTROL RELEASE, V157, P354, DOI 10.1016/j.jconrel.2011.07.029
   Cairns TM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006430
   Chen Z, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.75
   Cocchi F, 2000, J VIROL, V74, P3909, DOI 10.1128/JVI.74.8.3909-3917.2000
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   du Plessis LH, 2014, CURR PHARM BIOTECHNO, V15, P659
   Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800
   Fox CB, 2013, EXPERT REV VACCINES, V12, P747, DOI 10.1586/14760584.2013.811188
   Gindy ME, 2014, MOL PHARMACEUT, V11, P4143, DOI 10.1021/mp500367k
   Hook LM, 2019, VACCINE, V37, P664, DOI 10.1016/j.vaccine.2018.11.076
   Hook LM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007095
   Huber MT, 2001, J VIROL, V75, P10309, DOI 10.1128/JVI.75.21.10309-10318.2001
   Iwasaki A, 2016, ANNU REV IMMUNOL, V34, P575, DOI 10.1146/annurev-immunol-032414-112315
   Kensil C R, 1998, Expert Opin Investig Drugs, V7, P1475, DOI 10.1517/13543784.7.9.1475
   Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012
   Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0
   Lecrenier N, 2018, EXPERT REV VACCINES, V17, P619, DOI 10.1080/14760584.2018.1495565
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Lin QY, 2014, NANOMEDICINE-UK, V9, P105, DOI 10.2217/nnm.13.192
   Lonez C, 2015, CELL MOL LIFE SCI, V72, P3971, DOI 10.1007/s00018-015-1915-1
   Lonez C, 2014, NANOMED-NANOTECHNOL, V10, P775, DOI 10.1016/j.nano.2013.12.003
   Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963
   McGraw HM, 2009, J VIROL, V83, P4791, DOI 10.1128/JVI.02341-08
   Mirotti LC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00047
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145
   Moyle PM, 2013, NANOMED-NANOTECHNOL, V9, P935, DOI 10.1016/j.nano.2013.01.009
   Nelson CS, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0074-4
   Nicola AV, 1998, J VIROL, V72, P3595, DOI 10.1128/JVI.72.5.3595-3601.1998
   O'Hagan DT, 2015, VACCINE, V33, pB14, DOI 10.1016/j.vaccine.2015.01.088
   Pardi N, 2018, J EXP MED
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007
   Rappuoli R, 2018, SEMIN IMMUNOL
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Schillie S, 2018, MMWR-MORBID MORTAL W, V67, P455, DOI 10.15585/mmwr.mm6715a5
   Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12
   Skwarczynski M, 2014, NANOMEDICINE-UK, V9, P2657, DOI [10.2217/NNM.14.187, 10.2217/nnm.14.187]
   Sulczewski FB, 2018, ARCH VIROL, V163, P2313, DOI 10.1007/s00705-018-3856-0
   Swaminathan G, 2016, SCI REP-UK, V6, DOI 10.1038/srep34215
   Swaminathan G, 2016, VACCINE, V34, P110, DOI 10.1016/j.vaccine.2015.10.132
   Thoryk EA, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040047
   Tross D, 2008, J IMMUNOL, V181, P5785, DOI 10.4049/jimmunol.181.8.5785
   Wang F, 2010, VIROLOGY, V405, P269, DOI 10.1016/j.virol.2010.06.006
   Whitbeck JC, 2014, J VIROL
   Wilson HL, 2006, INT REV IMMUNOL, V25, P183, DOI 10.1080/08830180600785868
   Xu Y, 2014, MOL PHARMACEUT, V11, P1424, DOI 10.1021/mp400584h
NR 54
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3770
EP 3778
DI 10.1016/j.vaccine.2019.05.068
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900005
PM 31153687
OA Other Gold
DA 2020-05-12
ER

PT J
AU Haugnes, H
   Flem, E
   Wisloff, T
AF Haugnes, Havard
   Flem, Elmira
   Wisloff, Torbjorn
TI Healthcare costs associated with varicella and herpes zoster in Norway
SO VACCINE
LA English
DT Article
DE Cost of illness; Varicella; Herpes zoster
ID MORTALITY
AB Background: Norway does not implement routine vaccination against varicella or herpes zoster. Despite substantial health burden associated with both diseases, their economic impact is not well described. The aim of the present study was to document the healthcare costs associated with both conditions in a Norwegian setting.
   Methods: We used registry data about patients' contacts with primary and specialized healthcare services from 2008 to 2014 to estimate the costs associated with varicella and herpes zoster in the primary and hospital care sector. We calculated the individual costs by treatment facility (general practitioner and emergency primary care clinic) in primary care and by treatment level (inpatient, outpatient or ambulatory treatment) at hospitals.
   Results: We estimate that the annual healthcare cost of patients with varicella and herpes zoster are NOK 85 million (approximately (sic) 9 million). Of the annual costs, 73% are associated with herpes zoster and 27% are due to varicella. The majority (54%) of the total annual cost is represented by patients with herpes zoster treated in hospital.
   Conclusion: Varicella and herpes zoster impose a substantial financial burden on the national healthcare services in Norway. Most of the costs are incurred by herpes zoster, which could be prevented by vaccination. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Haugnes, Havard; Flem, Elmira; Wisloff, Torbjorn] Norwegian Inst Publ Hlth, Dept Infect Diasease Epidemiol & Modelling, Oslo, Norway.
   [Haugnes, Havard] Boehringer Ingelheim GmbH & Co KG, Oslo, Norway.
   [Wisloff, Torbjorn] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.
RP Wisloff, T (reprint author), Norwegian Inst Publ Hlth, Dept Infect Diesease Epidemiol & Modelling, Postboks 222 Skoyen, N-0213 Oslo, Norway.
EM elmira.flem@fhi.no; torbjorn.wisloff@fhi.no
OI Wisloff, Torbjorn/0000-0002-7539-082X
CR [Anonymous], 2017, SHINGL HERP ZOST VAC
   [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P265
   Bilde L, 2016, NORDIC J HLTH EC, V5, P7, DOI DOI 10.5617/NJHE.1792
   Bricout H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1753-y
   European Medicines Agency, 2018, SHINGR EUR PUBL ASS
   Gater A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1514-y
   Hope-Simpson RE, 1975, J R COLL GEN PRACT, V25
   HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106
   Marchetti S, 2018, VACCINE, V36, P1116, DOI 10.1016/j.vaccine.2018.01.038
   Mirinaviciute G, 2017, PEDIATR INFECT DIS J, V36, P1032, DOI [10.1097/INF.0000000000001656, 10.1097/inf.0000000000001656]
   Nilsson J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0951-7
   Norwegian Directorate of Health, 2012, SOC AN HLTH CAR SECT
   Norwegian Medicines Agency, 2018, GUID SUBM DOC SINGL
   Oxman MN, 2005, N ENGL J MED, V352, p[2271, 2365]
   Rimseliene G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1581-4
   Statistics Norway, 2017, HLTH ACC
   Statistics Norway, 2018, BIRTHS STAT NORW
   Statistics Norway, 2016, MAIN EC IND 2004 201
   US Food & Drug Administration, 2017, BIOL LIC APPL APPR
NR 19
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3779
EP 3784
DI 10.1016/j.vaccine.2019.05.063
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900006
PM 31151798
DA 2020-05-12
ER

PT J
AU Liu, X
   Adams, LJ
   Zeng, XM
   Lin, J
AF Liu, Xiang
   Adams, Lindsay Jones
   Zeng, Ximin
   Lin, Jun
TI Evaluation of in ovo vaccination of DNA vaccines for Campylobacter
   control in broiler chickens
SO VACCINE
LA English
DT Article
DE Campylobacter jejuni; DNA vaccine; In ovo vaccination; Poultry; Kozak
   sequence
ID MULTIDRUG EFFLUX PUMP; PROTECTIVE IMMUNITY; CONFERS PROTECTION;
   NEWCASTLE-DISEASE; CMEABC; POULTRY; PROTEIN; IMMUNIZATION; ENHANCEMENT;
   EXPRESSION
AB Campylobacter is the leading bacterial cause of human enteritis in developed countries. Chicken is a major natural host of Campylobacter. Thus, on-farm control of Campylobacter load in poultry would reduce the risk of human exposure to this pathogen. Vaccination is an attractive intervention measure to mitigate Campylobacter in poultry. Our previous studies have demonstrated that Campylobacter outer membrane proteins CmeC (a component of multidrug efflux pump) and CfrA (ferric enterobactin receptor) are feasible and promising candidates for vaccine development. In this study, by targeting these two attractive vaccine candidates, we explored and evaluated a new vaccination strategy, which combines the in ovo vaccination route and novel DNA vaccine formulation, for Campylobacter control in broilers. We observed that direct cloning of cfrA or cmeC gene into the eukaryotic expression vector pCAGGS did not lead to sufficient level of production of the target proteins in the eukaryotic HEK-293 cell line. However, introduction of the Kozak consensus sequence (ACCATGG) in the cloned bacterial genes greatly enhanced production of inserted gene in eukaryotic cells, creating desired DNA vaccines. Subsequently, the validated DNA vaccines were prepared and used for two independent in ovo vaccination trials to evaluate their immune response and protective efficacy. However, single in ovo injection of specific DNA vaccine at 18th day of embryonation, regardless using neutral lipid-protected vector or not, failed to trigger significant IgG and IgA immune responses and did not confer protection against C. jejuni colonization in the intestine of chickens. In conclusion, this study demonstrates that the Kozak sequence is critically important for construction of the DNA vaccine expressing prokaryotic gene. The optimal regimen for in ovo vaccination of DNA vaccine for Campylobacter control in poultry needs to be determined in future studies. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Liu, Xiang; Adams, Lindsay Jones; Zeng, Ximin; Lin, Jun] Univ Tennessee, Dept Anim Sci, 2506 River Dr, Knoxville, TN 37996 USA.
RP Lin, J (reprint author), Univ Tennessee, Dept Anim Sci, 2506 River Dr, Knoxville, TN 37996 USA.
EM jlin6@utk.edu
FU Agriculture and Food Research Initiative (AFRI) [2012-68003-19679]
FX This work was supported by the Agriculture and Food Research Initiative
   (AFRI) Competitive Grants No. 2012-68003-19679.
CR Barjesteh N, 2015, VIRAL IMMUNOL
   Batz BM, 2011, RANKING RISKS 10 PAT, P1
   Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780
   Bu ZG, 2003, VIROLOGY, V309, P272, DOI 10.1016/S0042-6822(03)00066-7
   Bu ZG, 2003, AIDS RES HUM RETROV, V19, P409, DOI 10.1089/088922203765551755
   Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005
   Ding XC, 2005, VACCINE, V23, P3733, DOI 10.1016/j.vaccine.2005.01.144
   Ding XC, 2004, INFECT IMMUN, V72, P6939, DOI 10.1128/IAI.72.12.6939-6944.2004
   Ge JY, 2014, VACCINE, V32, P1514, DOI 10.1016/j.vaccine.2014.01.020
   Han TK, 2007, J MED MICROBIOL, V56, P675, DOI 10.1099/jmm.0.47020-0
   Jagusztyn-Krynicka EK, 2009, EXPERT REV VACCINES, V8, P625, DOI 10.1586/ERV.09.21
   Johnston PA, 1997, POULTRY SCI, V76, P165, DOI 10.1093/ps/76.1.165
   KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125
   Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1
   Leitner WW, 1999, VACCINE, V18, P765, DOI 10.1016/S0264-410X(99)00271-6
   Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002
   Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005
   Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003
   Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Makanya AN, 2015, METHODS MOL BIOL, V1214, P185, DOI 10.1007/978-1-4939-1462-3_11
   Martinez A, 2006, FOODBORNE PATHOG DIS, V3, P393, DOI 10.1089/fpd.2006.3.393
   Mawla N. N., 2014, DELTA MED COLL J, V2, P28
   Meunier M, 2018, VACCINE, V36, P2119, DOI 10.1016/j.vaccine.2018.03.004
   Meunier M, 2016, VACCINE, V34, P202, DOI 10.1016/j.vaccine.2015.11.043
   NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
   Oshop GL, 2003, VACCINE, V21, P1275, DOI 10.1016/S0264-410X(02)00624-2
   Pradhan SN, 2014, VET MICROBIOL, V171, P13, DOI 10.1016/j.vetmic.2014.02.019
   Restifo Nicholas P., 1999, Current Opinion in Oncology, V11, P50, DOI 10.1097/00001622-199901000-00012
   Ricks CA, 1999, ADV VET MED-ACAD PR, V41, P495
   Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244
   Sakaguchi M, 1996, VACCINE, V14, P747, DOI 10.1016/0264-410X(95)00254-X
   Salahi A, 2011, 18 EUR S POULTR NUTR
   Sawant PM, 2015, VACCINE, V33, P333, DOI 10.1016/j.vaccine.2014.11.020
   Shah MAA, 2014, WORLD POULTRY SCI J, V70, P315, DOI 10.1017/S0043933914000336
   ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302
   Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002
   Wahren B, 2014, VACCINES-BASEL, V2, P785, DOI 10.3390/vaccines2040785
   Zeng X, 2010, J VACCINES VACCIN, V1, P112, DOI DOI 10.4172/2157-7560.1000112
   Zeng XM, 2009, INFECT IMMUN, V77, P5437, DOI 10.1128/IAI.00666-09
NR 40
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3785
EP 3792
DI 10.1016/j.vaccine.2019.05.082
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900007
PM 31171394
DA 2020-05-12
ER

PT J
AU Cawlfield, A
   Genito, CJ
   Beck, Z
   Bergmann-Leitner, ES
   Bitzer, AA
   Soto, K
   Zou, XY
   Hadiwidjojo, SH
   Gerbasi, RV
   Mullins, AB
   Noe, A
   Waters, NC
   Alving, CR
   Matyas, GR
   Dutta, S
AF Cawlfield, Alicia
   Genito, Christopher J.
   Beck, Zoltan
   Bergmann-Leitner, Elke S.
   Bitzer, Alexis A.
   Soto, Kimberly
   Zou, Xiaoyan
   Hadiwidjojo, Sri H.
   Gerbasi, Robert V.
   Mullins, Anna B.
   Noe, Amy
   Waters, Norman C.
   Alving, Carl R.
   Matyas, Gary R.
   Dutta, Sheetij
TI Safety, toxicity and immunogenicity of a malaria vaccine based on the
   circumsporozoite protein (FMP013) with the adjuvant army liposome
   formulation containing QS21 (ALFQ)
SO VACCINE
LA English
DT Article
DE Malaria; Vaccine; Circumsporozoite protein; FMP013; ALFQ; Rhesus
ID MONOPHOSPHORYL-LIPID-A; IMMUNE-RESPONSES; PRECLINICAL EVALUATION; RHESUS
   MACAQUES; FALCIPARUM; EFFICACY; TRIAL; RTS,S/AS01B; QS-21; INFECTION
AB Antibodies to Circumsporozoite protein (CSP) confer protection against controlled human malaria infection (CHMI) caused by the parasite Plasmodium falciparum. Although CSP is highly immunogenic, it does not induce long lasting protection and efforts to improve CSP-specific immunological memory and duration of protection are underway. We have previously reported that the clinical grade CSP vaccine FMP013 was immunogenic and protective against malaria challenge in mice when combined with the Army Liposomal Formulation adjuvant containing immune modulators 3D-PHAD (TM) and QS21 (ALFQ). To move forward with clinical evaluation, we now report the safety, toxicity and immunogenicity of clinical grade FMP013 and ALFQ in Rhesus macaques. Three groups of Rhesus (n = 6) received half or full human dose of FMP013 + ALFQ on a 0-1-2 month schedule, which showed mild local site reactions with no hematologic derangements in red blood cell homeostasis, liver function or kidney function. Immunization induced a transient systemic inflammatory response, including elevated white blood cell counts, mild fever, and a few incidences of elevated creatine kinase, receding to normal range by day 7 post vaccination. Optimal immunogenicity in Rhesus was observed using a 1 mL ALFQ+ 20 mu g FMP013 dose. Doubling the FMP013 antigen dose to 40 mu g had no effect while halving the ALFQ adjuvant dose to 0.5 mL lowered immunogenicity. Similar to data generated in mice, FMP013 + ALFQ induced serum antibodies that reacted to all regions of the CSP molecule and a Th1-biased cytokine response in Rhesus. Rhesus antibody response to FMP013 + ALFQ was found to be non-inferior to historical benchmarks including that of RTS,S + AS01 in humans. A four-dose GLP toxicity study in rabbits confirmed no local site reactions and transient systemic inflammation associated with ALFQ adjuvant administration. These safety and immunogenicity data support the clinical progression and testing of FMP013 + ALFQ in a CHMI trial in the near future. (C) 2019 The Author(s). Published by Elsevier Ltd.
C1 [Cawlfield, Alicia; Mullins, Anna B.] Walter Reed Army Inst Res, Dept Vet Med, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   [Genito, Christopher J.; Bitzer, Alexis A.; Soto, Kimberly; Dutta, Sheetij] Walter Reed Army Inst Res, Struct Vaccinol Lab, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   [Beck, Zoltan; Alving, Carl R.; Matyas, Gary R.] Walter Reed Army Inst Res, Mil HIV Res Program, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   [Beck, Zoltan] Henry M Jackson Fdn Adv Mil Med, 6720A Rockledge Dr, Bethesda, MD 20817 USA.
   [Bergmann-Leitner, Elke S.] Walter Reed Army Inst Res, Malaria Vaccine Branch, Flow Cytometer Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   [Zou, Xiaoyan; Hadiwidjojo, Sri H.] Naval Med Res Ctr, Malaria Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   [Noe, Amy] Leidos Life Sci, 5202 Presidents Court,Suite 110, Frederick, MD 21703 USA.
   [Waters, Norman C.] Walter Reed Army Inst Res, Malaria Vaccine Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
RP Dutta, S (reprint author), Walter Reed Army Inst Res, Struct Vaccinol Lab, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
EM sheetij.dutta.civ@mail.mil
RI Bergmann-Leitner, Elke/I-5431-2019
OI Bergmann-Leitner, Elke/0000-0002-8571-8956; Noe,
   Amy/0000-0002-5230-9742; Genito, Christopher/0000-0002-9044-964X
FU USAID Malaria Vaccine Development ProgramUnited States Agency for
   International Development (USAID); Department of the Army; Henry M.
   Jackson Foundation for the Advancement of Military Medicine
   [W81XWH-07-2-067]; U.S. Army Medical Research and Materiel Command
   (MRMC)U.S. Army Medical Research & Materiel Command (USAMRMC)
   [W81XWH-07-2-067]
FX The funding for this work was provided by the USAID Malaria Vaccine
   Development Program and the Department of the Army. The work of ZB, CRA
   and GRM was supported through a Cooperative Agreement Award (no.
   W81XWH-07-2-067) between the Henry M. Jackson Foundation for the
   Advancement of Military Medicine and the U.S. Army Medical Research and
   Materiel Command (MRMC). The funding bodies had no role in the design of
   the study and collection, analysis, and interpretation of data and in
   writing the manuscript.
CR Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524
   Ashley EA, 2018, LANCET, V391, P1608, DOI 10.1016/S0140-6736(18)30324-6
   Beck Z, 2015, VACCINE, V33, P5578, DOI 10.1016/j.vaccine.2015.09.001
   Beck Z, 2015, BBA-BIOMEMBRANES, V1848, P775, DOI 10.1016/j.bbamem.2014.12.005
   Bergmann-Leitner ES, 2005, INT IMMUNOL, V17, P245, DOI 10.1093/intimm/dxh205
   Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097
   Coccia M, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0027-3
   Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677
   Dendouga N, 2012, VACCINE, V30, P3126, DOI 10.1016/j.vaccine.2012.01.088
   Espinosa DA, 2015, J INFECT DIS
   FRIES LF, 1992, INFECT IMMUN, V60, P1834, DOI 10.1128/IAI.60.5.1834-1839.1992
   Genito CJ, 2017, VACCINE, V35, P3865, DOI 10.1016/j.vaccine.2017.05.070
   Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547
   Harris DT, 1999, SEMIN ONCOL, V26, P439
   Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304
   Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477
   Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120
   Khan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142035
   Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512
   Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40
   Lal H, 2018, VACCINE, V36, P148, DOI 10.1016/j.vaccine.2017.11.019
   Long CA, 2016, CURR OPIN MICROBIOL, V32, P96, DOI 10.1016/j.mib.2016.04.006
   Marty-Roix R, 2016, J BIOL CHEM, V291, P1123, DOI 10.1074/jbc.M115.683011
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819
   Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571
   Phares TW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1766-3
   Pichyangkul S, 2008, INFECT IMMUN, V76, P229, DOI 10.1128/IAI.00977-07
   Pichyangkul S, 2009, VACCINE, V28, P452, DOI 10.1016/j.vaccine.2009.10.022
   Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465
   Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13
   Regules JA, 2016, J INFECT DIS, V214, P762, DOI 10.1093/infdis/jiw237
   Schwenk R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111020
   Shen CJ, 2014, VACCINE, V32, P5337, DOI 10.1016/j.vaccine.2014.07.036
   Sherwood JA, 1996, VACCINE, V14, P817, DOI 10.1016/0264-410X(95)00221-L
   Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06
   Stewart VA, 2006, VACCINE, V24, P6493, DOI 10.1016/j.vaccine.2006.06.035
   Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033
   Walsh DS, 2006, VACCINE, V24, P4167, DOI 10.1016/j.vaccine.2006.02.041
   Walsh DS, 2004, AM J TROP MED HYG, V70, P499, DOI 10.4269/ajtmh.2004.70.499
   Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247
   White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395
   Zou XY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-394
NR 43
TC 4
Z9 4
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3793
EP 3803
DI 10.1016/j.vaccine.2019.05.059
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900008
PM 31151801
OA Other Gold
DA 2020-05-12
ER

PT J
AU Ma, R
   Lu, L
   Suo, LD
   Zhangzhu, JZ
   Chen, M
   Pang, XH
AF Ma, Rui
   Lu, Li
   Suo, Luodan
   Zhangzhu, Jiazi
   Chen, Meng
   Pang, Xinghuo
TI Evaluation of the adequacy of measles laboratory diagnostic tests in the
   era of accelerating measles elimination in Beijing, China
SO VACCINE
LA English
DT Article
DE Measles; Laboratory tests; Sensitivity
ID INFECTION
AB Background: Measles-containing vaccine (MCV) was introduced in 1965 in Beijing and given to the children aged 8m-14y. In population-based surveillance system, real-time polymerase chain reaction (RT-PCR) and immunoglobulin M(IgM) serology tests have been conducted for each suspected case since 2013. We used the surveillance data to evaluate the adequacy of the tests for laboratory confirmation during 2014-2016.
   Methods: Informations on IgM tests, RT-PCR, age, vaccination history for confirmed cases were from the surveillance system. Laboratory confirmed cases were defined as cases with positive IgM serology and/or positive RT-PCR. All tests were conducted in the laboratories accredited by Beijing CDC or Beijing CDC laboratory.
   Results: Totally 4600 cases were confirmed. Sensitivities of IgM tests within 0-3 days post rash, IgM tests within 4-28 days post rash and RT-PCR within 0-3 days post rash were 56.53%, 82.06% and 94.39%, respectively. The combined sensitivity of IgM tests and RT-PCR decreased by the interval between rash onset and collection of virologic specimen. MCV immunization history lowered sensitivity of IgM tests and RT-PCR. Among the cases aged >= 15 years, around 95% had no written immunization records. The sensitivity of IgM tests within 0-3 days post rash was less than 60%. Around 60% had unknown immunization histories. Compared with unvaccinated cases based on written records, unvaccinated cases based on recollection had no significantly different sensitivity of laboratory tests. But unknown immunization history significantly lowered sensitivity of RT-PCR within 0-3 days post rash.
   Conclusions: Neither IgM tests nor RT-PCR reached 100% sensitive for confirmed cases. Virologic specimen should be collected as early as possible to achieve maxim sensitivity. Cases with unknown immunization history could not be treated as unvaccinated. Combination of the two tests and further laboratory assays were needed especially for vaccinated cases or cases aged >= 15 years. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ma, Rui; Lu, Li; Suo, Luodan; Zhangzhu, Jiazi; Chen, Meng; Pang, Xinghuo] Beijing Ctr Dis Control & Prevent, EPI Dept, He Ping Li Zhong Jie 16, Beijing 100013, Peoples R China.
RP Ma, R (reprint author), Beijing Ctr Dis Control & Prevent, EPI Dept, He Ping Li Zhong Jie 16, Beijing 100013, Peoples R China.
EM bjjm@bjcdc.org
CR [Anonymous], 2014, NAT MEASL SURV GUID
   Benamar T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147154
   Hubschen JM, 2017, CLIN MICROBIOL INFEC, V23, P511, DOI 10.1016/j.cmi.2017.04.009
   Hyde TB, 2009, B WORLD HEALTH ORGAN, V87, P93, DOI 10.2471/BLT.07.045484
   Ma R, 2017, VACCINE, V35, P1117, DOI 10.1016/j.vaccine.2017.01.021
   Michel Y, 2013, J MED VIROL, V85, P723, DOI 10.1002/jmv.23515
   National Health and Family Planning Commission of the People's Republic of China, DIAGN CRIT MEASL WS2
   Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3
   US Centers for Disease Control and Prevention, MANUAL SURVEILLANCE
   WHO, 2007, MAN LAB DIAGN MEASL
   WHO, 2003, WHO REC STAND SURV S
   Woo GKS, 2010, J MED VIROL, V82, P1773, DOI 10.1002/jmv.21888
   Zhang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134681
NR 13
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3804
EP 3809
DI 10.1016/j.vaccine.2019.05.058
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900009
PM 31153690
DA 2020-05-12
ER

PT J
AU Liu, SQ
   Zhang, SH
   Duan, YQ
   Niu, Y
   Gu, HJ
   Zhao, ZP
   Zhang, SG
   Yang, Y
   Wang, XL
   Gao, YH
   Yang, PH
AF Liu, Siqi
   Zhang, Suohui
   Duan, Yueqiang
   Niu, Yan
   Gu, Hongjing
   Zhao, Zhongpeng
   Zhang, Shaogeng
   Yang, Ying
   Wang, Xiliang
   Gao, Yunhua
   Yang, Penghui
TI Transcutaneous immunization of recombinant Staphylococcal enterotoxin B
   protein using a dissolving microneedle provides potent protection
   against lethal enterotoxin challenge
SO VACCINE
LA English
DT Article
DE Dissolving microneedle; Transcutaneous immunization; rSEB
ID VACCINE; DELIVERY; SEB
AB Staphylococcal enterotoxin B (SEB) produced by the Staphylococcus aureus bacteriumis most commonly associated with food poisoning and is known to also cause toxic shock syndrome. Currently, no approved vaccine or specific drug is available to treat SEB intoxication. In this study, we fabricated dissolving microneedles (MNs) loaded with recombinant SEB (rSEB) protein, and evaluated its characteristics, including dissolution profile, protein particle size, insertion depth, antigen retention time in vivo, and skin irritation. Our results showed that rSEB protein-loaded dissolving MNs made of chondroitin sulfate (2%) and trehalose (0.8%) could easily penetrate into the mouse skin within 5 min. The rSEB particle size was unchanged before and after MN fabrication. The skin penetration depth of the MNs was 260 mu m. Moreover, the MNs also significantly extended the antigen retention time in vivo. rSEB protein-loaded dissolving MNs also triggered slight erythema at the beginning of administration, but this erythema disappeared within a few hours. More importantly, we investigated the immunogenicity and protective efficacy of rSEB protein-loaded dissolving MNs. Challenge studies in mice revealed that mice in full-dose MN group had a high level of SEB specific antibody response thatprovided100% protection against a lethal SEB toxin challenge. However, there was only 60% protection observed in mice that were in the half-dose MN (dose sparing) group. We also determined the pathological alterations in the tissues of the immunized mice. Taken together, these dissolving MNs may present a promising transcutaneous immunization strategy for treating SEB intoxication. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Liu, Siqi; Zhang, Shaogeng; Yang, Penghui] Chinese PIA Gen Hosp, Med Ctr 5, Beijing 302 Hosp, Beijing 100039, Peoples R China.
   [Liu, Siqi; Niu, Yan; Yang, Ying] Inner Mongolia Med Univ, Coll Basic Med, Hohhot 010110, Peoples R China.
   [Zhang, Suohui; Gao, Yunhua] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photo Chem Convers & Optoelect Mat, Beijing, Peoples R China.
   [Duan, Yueqiang; Niu, Yan; Gu, Hongjing; Wang, Xiliang; Yang, Penghui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing 100071, Peoples R China.
RP Wang, XL; Gao, YH; Yang, PH (reprint author), 100 West 4th Ring Rd, Beijing, Peoples R China.
EM xiliangw@126.com; yhgao@mail.ipc.ac.cn; ypenghuiamms@hotmail.com
FU National Key Research and Development Plan of China [2016YFC1000902]
FX This work was supported by the National Key Research and Development
   Plan of China (No. 2016YFC1000902).
CR Boles JW, 2003, CLIN IMMUNOL, V108, P51, DOI 10.1016/S1521-6616(03)00066-4
   Chen BL, 2018, IEEE INT WORKSH COMP, P1, DOI 10.1080/00207160.2018.1478415
   Chen WH, 2016, CLIN VACCINE IMMUNOL, V23, P918, DOI 10.1128/CVI.00399-16
   Choi JY, 2017, TOXICON, V131, P68, DOI 10.1016/j.toxicon.2017.03.012
   de Groot AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01789
   Donnelly RF, 2010, DRUG DELIV, V17, P187, DOI 10.3109/10717541003667798
   Dutta K, 2015, J BIOL CHEM, V290, P6715, DOI 10.1074/jbc.M114.630715
   Edens C, 2015, VACCINE, V33, P4683, DOI 10.1016/j.vaccine.2015.01.089
   He ML, 2018, J PHARM SCI-US, V107, P1037, DOI 10.1016/j.xphs.2017.11.013
   Higgs BW, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-48
   Hutton ARJ, 2018, INT J PHARMACEUT, V541, P56, DOI 10.1016/j.ijpharm.2018.02.031
   Inskeep TK, 2010, CLIN VACCINE IMMUNOL, V17, P1163, DOI 10.1128/CVI.00078-10
   Jin X, 2018, ADV DRUG DELIV REV
   Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075
   Kim NW, 2018, ACS NANO, V12, P9702, DOI 10.1021/acsnano.8b04146
   Krakauer T, 2013, VIRULENCE, V4, P759, DOI 10.4161/viru.23905
   Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095
   LeClaire RD, 1996, TOXICOL PATHOL, V24, P619, DOI 10.1177/019262339602400513
   LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002
   Ono A, 2017, PHARMACEUTICS, V9
   Pamornpathomkul B, 2018, EUR J PHARM SCI OFF
   Rejinold NS, 2016, EXPERT OPIN DRUG DEL, V13, P109, DOI 10.1517/17425247.2016.1115835
   Rodgers AM, 2018, EXPERT OPIN DRUG DEL, V15, P1039, DOI 10.1080/17425247.2018.1522301
   Rouphael NG, 2017, LANCET, V390, P649, DOI 10.1016/S0140-6736(17)30575-5
   Spaulding AR, 2014, J INFECT DIS, V209, P1955, DOI 10.1093/infdis/jit823
   Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182
   Varshney AK, 2014, MBIO, V5, DOI 10.1128/mBio.01007-14
   Wang SX, 2008, IMMUNOL LETT, V121, P167, DOI 10.1016/j.imlet.2008.10.007
   Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106
   Zhu ZZ, 2016, J CONTROL RELEASE, V243, P291, DOI 10.1016/j.jconrel.2016.10.019
NR 30
TC 2
Z9 2
U1 4
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3810
EP 3819
DI 10.1016/j.vaccine.2019.05.055
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900010
PM 31147275
OA Other Gold
DA 2020-05-12
ER

PT J
AU Kang, CK
   Kim, NH
   Kim, CJ
   Rhie, GE
   Jo, SK
   Ahn, M
   Kang, J
   Choe, PG
   Park, WB
   Kim, NJ
   Oh, MD
AF Kang, Chang Kyung
   Kim, Nak-Hyun
   Kim, Chung-Jong
   Rhie, Gi-eun
   Jo, Su Kyoung
   Ahn, Misun
   Kang, Jieun
   Choe, Pyoeng Gyun
   Park, Wan Beom
   Kim, Nam-Joong
   Oh, Myoung-don
TI Immunogenicity and safety of a novel recombinant protective antigen
   anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled
   phase II clinical study
SO VACCINE
LA English
DT Article
DE Bacillus anthracis; Recombinant protective antigen anthrax vaccine;
   Immunogenicity; Safety
ID RECOMMENDATIONS
AB Background: The demand on effective and safe anthrax vaccine is increasing as a part of the preparedness for possible bioterrorism in the future. We performed a randomized, single-blind, placebo controlled phase 11 clinical study to evaluate the immunogenicity and safety of a novel recombinant protective antigen (rPA) anthrax vaccine, GC1109, in healthy adult volunteers.
   Methods: Participants were randomized to experiment groups (0.3 mL, 0.5 mL, and 1.0 mL of GC1109) or placebo group (normal saline 0.5 mL) in 2:2:2:1 ratio. They received respective vaccines intramuscularly at 0, 4 and 8 weeks. Immunogenicity was evaluated by seroconversion rate and geometric mean titer (GMT) of lethal toxin neutralizing assay (TNA) and anti-PA IgG by ELISA. Safety was assessed by laboratory tests, and solicited and unsolicited adverse events on diary cards.
   Results: 30, 29, 30 participants were randomized to 0.3, 0.5, and 1.0 mL of GC1109 groups, respectively, while 15 to placebo group. 92 participants received all three doses. In per-protocol analysis, TNA GMTs at week 12 were 296.5, 285.2, and 433.2 in the three groups, respectively. Seroconversion rates measured by ELISA were 100% at week 12 in the three groups. Local and systemic vaccine-related adverse events were frequent; however, most of them were mild, and no serious events were observed.
   Conclusions: A new rPA anthrax vaccine GC1109 was immunogenic after three doses of intramuscular administration, and was well-tolerated. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kang, Chang Kyung; Kim, Nak-Hyun; Kim, Chung-Jong; Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Nam-Joong; Oh, Myoung-don] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kang, Chang Kyung; Kim, Nak-Hyun; Kim, Chung-Jong; Choe, Pyoeng Gyun; Park, Wan Beom; Kim, Nam-Joong; Oh, Myoung-don] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Rhie, Gi-eun; Jo, Su Kyoung] Korea Ctr Dis Control & Prevent, Ctr Lab Control Infect Dis, Div High Risk Pathogens, Chungju, South Korea.
   [Ahn, Misun; Kang, Jieun] GC Pharma Cent Res Ctr, Yongin, South Korea.
RP Oh, MD (reprint author), 101 Daehak Ro, Seoul 03080, South Korea.
EM mdohmd@snu.ac.kr
FU GC Pharma (Yongin, Republic of Korea); Korea Centers for Disease Control
   and Prevention [4840-302-260]
FX This study was supported by GC Pharma (Yongin, Republic of Korea) and by
   the Research Program funded by the Korea Centers for Disease Control and
   Prevention (No. 4840-302-260).
CR [Anonymous], 2002, ASSESSMENT CDC ANTHR
   Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459
   Chen LG, 2014, CLIN VACCINE IMMUNOL, V21, P1512, DOI 10.1128/CVI.00469-14
   Fay MP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004073
   Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044
   Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003
   Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236
   JOELLENBECK LM, 2002, ANTHRAX VACCINE IS I
   Leppla SH, 2002, J CLIN INVEST, V110, P141, DOI [10.1172/JCI200216204, 10.1172/JCI0216204]
   Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004
   Niu M, 2009, VACCINE, V27, P6654, DOI 10.1016/j.vaccine.2009.08.027
   Schiffer JM, 2016, EXPERT REV VACCINES, V15, P1151, DOI 10.1586/14760584.2016.1162104
   Schiffer JM, 2015, VACCINE, V33, P3709, DOI 10.1016/j.vaccine.2015.05.091
   Tozzi AE, 2013, VACCINE, V31, P5041, DOI 10.1016/j.vaccine.2013.08.087
   U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research 2007, 2007, GUID IND TOX GRAD SC
   Wright Jennifer Gordon, 2010, Morbidity and Mortality Weekly Report, V59, P1
NR 16
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3820
EP 3824
DI 10.1016/j.vaccine.2019.05.057
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900011
PM 31151800
DA 2020-05-12
ER

PT J
AU Kim, H
   Kim, AY
   Kim, JS
   Lee, JM
   Lee, HY
   Cheong, KM
   Kim, B
   Park, CK
   Ko, YJ
AF Kim, Hyejin
   Kim, Ah-Young
   Kim, Jae-Seok
   Lee, Jung-Min
   Lee, Hye-Young
   Cheong, Kwang-Myun
   Kim, Byounghan
   Park, Choi-Kyu
   Ko, Young-Joon
TI A simple and rapid assay to evaluate purity of foot-and-mouth disease
   vaccine before animal experimentation
SO VACCINE
LA English
DT Article
DE Assay; Foot-and-mouth disease; Nonstructural proteins; Purity; Vaccine
ID GENOME-LINKED PROTEIN; NONSTRUCTURAL PROTEINS; VIRUS; ELISA; 3ABC; VPG
AB Currently, foot-and-mouth disease (FMD) vaccine purity is tested in cattle to detect antibodies against the non-structural protein (NSP) after repeated immunization with the final vaccine product. In case of vaccine failure, the manufacturing company would suffer significant economic loss. To prevent such unfortunate losses with the final vaccine product, in vitro testing is required to quantitate an NSP antigen during the manufacturing process prior to animal experiments. A novel lateral-flow assay device was developed using a monoclonal antibody (MAb) against the 3B NSP. To determine the minimal amount of NSP required to elicit antibodies in livestock, goats were immunized several times with various concentrations of either the recombinant 3AB (rec.3AB) protein or FMD virus culture supernatant. Antibodies against 3AB were elicited after a second immunization with 10.6 ng to 42.5 ng of rec.3AB and a third immunization with a 10-fold diluted FMD virus culture supernatant in goats. The lateral-flow assay device detected the minimal amount of rec.3AB and native NSP in FMD virus culture supernatant required to induce NSP antibodies in goats. The in vitro assay device is simple and economical, provides rapid results, and should be useful for FMD vaccine-manufacturing companies prior to conducting animal experiments to test the vaccine purity. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Kim, Hyejin; Kim, Ah-Young; Kim, Jae-Seok; Lee, Jung-Min; Kim, Byounghan; Ko, Young-Joon] Anim & Plant Quarantine Agcy, Gimcheon 39660, Gyeonsangbuk Do, South Korea.
   [Lee, Hye-Young; Cheong, Kwang-Myun] Median Diagnost, Chunchon 24399, Kangwon Do, South Korea.
   [Kim, Hyejin; Park, Choi-Kyu] Kyungpook Natl Univ, Coll Vet Med, Daegu 41566, South Korea.
   [Kim, Hyejin; Park, Choi-Kyu] Kyungpook Natl Univ, Anim Dis Intervent Ctr, Daegu 41566, South Korea.
RP Park, CK (reprint author), Kyungpook Natl Univ, Coll Vet Med, Daegu 41566, South Korea.; Park, CK (reprint author), Kyungpook Natl Univ, Anim Dis Intervent Ctr, Daegu 41566, South Korea.; Ko, YJ (reprint author), Anim & Plant Quarantine Agcy, Ctr FMD Vaccine Res, Gimcheon 39660, Gyeonsangbuk Do, South Korea.
EM parkck@knu.ac.kr; koyoungjoon@korea.kr
FU Animal and Plant Quarantine Agency, Republic of Korea
   [B-1543386-2018-19-01]
FX This work was supported by the Animal and Plant Quarantine Agency,
   Republic of Korea [grant number B-1543386-2018-19-01].
CR Bergmann IE, 2006, DEV BIOLOGICALS, V126, P241
   BINAGRI-SISLEGIS, 2008, INSTR NORM 50 2008
   Colling A, 2014, AUST VET J, V92, P192, DOI 10.1111/avj.12190
   CRAWFORD NM, 1983, P NATL ACAD SCI-BIOL, V80, P7452, DOI 10.1073/pnas.80.24.7452
   Duffy S, 2018, USE SEROLOGICAL TEST
   FALK MM, 1992, J VIROL, V66, P2251, DOI 10.1128/JVI.66.4.2251-2260.1992
   Fenwick N, 2009, CAN VET J, V50, P523
   Frew PM, 2010, OPEN ACCESS J CLIN T, V2, P149, DOI 10.2147/OAJCT.S11915
   Gao Y, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0561-z
   Garcia-Briones M, 2006, VIROLOGY, V349, P409, DOI 10.1016/j.virol.2006.02.042
   Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004
   International Committee Biological Standards Commission International Office of Epizootics, 2012, MAN DIAGN TESTS VACC
   International Committee Biological Standards Commission International Office of Epizootics, 2017, MAN DIAGN TESTS VACC
   Kim AY, 2017, J VET MED SCI, V79, P1822, DOI 10.1292/jvms.17-0338
   Kim EJ, 2016, BIOMACROMOLECULES, V17, P4, DOI 10.1021/acs.biomac.5b01566
   Liu ZZ, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00153-17, 10.1128/cvi.00153-17]
   Maradei E, 2008, VACCINE, V26, P6577, DOI 10.1016/j.vaccine.2008.09.033
   Oem JK, 2007, J VIROL METHODS, V142, P174, DOI 10.1016/j.jviromet.2007.01.025
   Pacheco JM, 2010, VIROLOGY, V405, P149, DOI 10.1016/j.virol.2010.05.036
   RUECKERT RR, 1984, J VIROL, V50, P957, DOI 10.1128/JVI.50.3.957-959.1984
   SANGAR DV, 1981, J VIROL, V39, P67, DOI 10.1128/JVI.39.1.67-74.1981
   Sharma GK, 2014, J VIROL METHODS, V207, P22, DOI 10.1016/j.jviromet.2014.06.022
   Sorensen KJ, 1998, ARCH VIROL, V143, P1461, DOI 10.1007/s007050050390
   Capozzo AV, 2010, VACCINE, V28, P6647, DOI 10.1016/j.vaccine.2010.05.049
NR 24
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3825
EP 3831
DI 10.1016/j.vaccine.2019.05.053
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900012
PM 31138453
DA 2020-05-12
ER

PT J
AU Jiang, JJ
   Ramos, SJ
   Bangalore, P
   Fisher, P
   Germar, K
   Lee, BK
   Williamson, D
   Kemme, A
   Schade, E
   McCoy, J
   Muthumani, K
   Weiner, DB
   Humeau, LM
   Broderick, KE
AF Jiang, Jingjing
   Ramos, Stephanie J.
   Bangalore, Preeti
   Fisher, Paul
   Germar, Kristine
   Lee, Brian K.
   Williamson, Dan
   Kemme, Andrea
   Schade, Eric
   McCoy, Jay
   Muthumani, Kar
   Weiner, David B.
   Humeau, Laurent M.
   Broderick, Kate E.
TI Integration of needle-free jet injection with advanced electroporation
   delivery enhances the magnitude, kinetics, and persistence of engineered
   DNA vaccine induced immune responses
SO VACCINE
LA English
DT Article
DE DNA vaccine; Needle-free injection; Electroporation; Immunogenicity
ID GENE DELIVERY; IMMUNOGENICITY; SAFETY; COMBINATION; DEVICE
AB The combination of optimized DNA constructs, improved formulations and advanced in vivo electroporation (EP) has been shown to generate potent and efficacious immune responses in the clinic. Needle-free jet injection has also been reported to improve DNA vaccine delivery over standard needle and syringe in clinical trials. Here we investigated the impact of combined jet injection and EP (Jet-EP) delivery on muscle transfection efficiency and DNA vaccine immunogenicity in rabbits and nonhuman primates (NHPs) compared to jet injection alone. Our results show that the addition of EP significantly enhanced in vivo DNA transfection efficiency of rabbit muscle over jet injection alone. Jet-EP delivery augmented the rate and magnitude of DNA vaccine induced humoral and cellular responses over jet injection alone in both rabbits and NHPs. Jet-EP delivery also resulted in higher proportions of polyfunctional antigen specific T cells producing IFN gamma, IL-2, and/or TNF alpha. Elevated antibody levels were sustained nine months post immunization in NHPs immunized with a DNA vaccine using Jet-EP delivery, far outperforming jet delivery alone. Our results provide proof-of-concept that addition of advanced EP to needle-free jet injection delivery improves in vivo DNA transfection efficiency, increasing the magnitude, rate and duration of cellular and humoral immune responses to DNA vaccines. This combination likely has significant advantages in important vaccine and immunotherapy settings. (C) 2019 Inovio Pharmaceuticals Inc. Published by Elsevier Ltd.
C1 [Jiang, Jingjing; Ramos, Stephanie J.; Bangalore, Preeti; Fisher, Paul; Germar, Kristine; Lee, Brian K.; Williamson, Dan; Kemme, Andrea; Schade, Eric; McCoy, Jay; Humeau, Laurent M.; Broderick, Kate E.] Inovio Pharmaceut Inc, Plymouth Meeting, PA USA.
   [Muthumani, Kar; Weiner, David B.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
RP Ramos, SJ (reprint author), 10480 Wateridge Circle, San Diego, CA 92121 USA.
EM sramos@inovio.com
OI Ramos, Stephanie/0000-0002-5326-4937
CR Ake JA, 2017, J INFECT DIS, V216, P1080, DOI 10.1093/infdis/jix456
   Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y
   Babiuk S, 2003, MOL THER, V8, P992, DOI 10.1016/j.ymthe.2003.09.008
   Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414
   Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005
   Broderick KE, 2015, EXPERT REV VACCINES, V14, P195, DOI 10.1586/14760584.2015.990890
   Frelin L, 2010, DRUG NEWS PERSPECT, V23, P647, DOI 10.1358/dnp.2010.23.10.1513492
   Gaudinski MR, 2017, LANCET
   Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hallengard David, 2012, Genet Vaccines Ther, V10, P5, DOI 10.1186/1479-0556-10-5
   Jones CH, 2015, DISCOV MED, V19, P447
   Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236
   Li JW, 2017, CURR MED CHEM, V24, P2413, DOI 10.2174/0929867324666170526124053
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Low L, 2009, HUM GENE THER, V20, P1269, DOI 10.1089/hum.2009.067
   Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847
   Mir LM, 1998, CR HEBD ACAD SCI, VIII, P893
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Nilsson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131748
   Patel A, 2018, J INFECT DIS
   Raviprakash Kanakatte, 2006, V127, P83
   Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008
   Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6
   Tebas P, 2017, N ENGL J MED
   Tomizawa Minoru, 2013, World J Methodol, V3, P39, DOI 10.5662/wjm.v3.i4.39
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   Tsang C, 2007, VACCINE, V25, P5485, DOI 10.1016/j.vaccine.2007.03.009
   Ugen KE, 1998, VACCINE, V16, P1818, DOI 10.1016/S0264-410X(98)00180-7
   Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252
   Weiland O, 2013, MOL THER, V21, P1796, DOI 10.1038/mt.2013.119
   Yin JM, 2011, VACCINE, V29, P6763, DOI 10.1016/j.vaccine.2010.12.055
   Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79
NR 34
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3832
EP 3839
DI 10.1016/j.vaccine.2019.05.054
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900013
PM 31174938
OA Other Gold
DA 2020-05-12
ER

PT J
AU Espana, PP
   Uranga, A
   Ruiz, LA
   Quintana, JM
   Bilbao, A
   Aramburu, A
   Serrano, L
   Ayarza, R
   Martinez, AP
   Zalacain, R
AF Espana, Pedro P.
   Uranga, Ane
   Alberto Ruiz, Luis
   Maria Quintana, Jose
   Bilbao, Amaia
   Aramburu, Amaia
   Serrano, Leyre
   Ayarza, Rafael
   Patricia Martinez, Ana
   Zalacain, Rafael
TI Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the
   period 2001-2014, after introduction of the pneumococcal conjugate
   vaccine in bizkaia (spain)
SO VACCINE
LA English
DT Article
DE Bacteremic pneumococcal pneumonia; Pneumococcal conjugate vaccine;
   Pneumococcal serotypes; Comorbidities; Clinical outcomes
ID COMMUNITY-ACQUIRED PNEUMONIA; DISEASE; RISK; CHILDREN; SMOKING; IMPACT
AB The introduction of pneumococcal conjugate vaccines (PCV7 and PCV13) in children has led to a change in the pattern of pneumococcal serotypes causing pneumococcal disease in adults. The aim of this study is to analyze the distribution of pneumococcal serotypes in adults with bacteremic pneumococcal community-acquired pneumonia (BPP) after the introduction of PCVs in childhood, and the impact of age and comorbidity on this distribution. We conducted an observational study of all adults hospitalized with BPP between 2001 and 2014, in two tertiary hospitals. Overall, we identified 451 cases of BPP (2001-2005: 194, 2006-2010: 134, 2011-2014: 123). The rate of appearance of new cases decreased over the study period. In 70% of the cases, the serotypes found were among those included in PCV13. The most prevalent serotypes were 3 (23.1%), 7F (14.6%), 19A (8.4%) and 1 (7.5%). There was a significant trend to decrease in the percentage of BPP cases due to PCV7 from period 2001-2005 to 2011-2014 (p = 0.0166) and a significant trend to increase in the six serotypes added to form PCV 13 (p = 0.0003). Serotype 3 was the most frequent in patients who developed complications during hospitalization. We did not detect a significant increase in cases caused by non-PCV13 serotypes. The most frequent non-PCV13 serotype was 22F. In conclusion, a significant proportion of adults continue to develop BPP with vaccine serotypes despite infant pneumococcal vaccination. There is a need for further strategies to reduce the current burden of this disease on adults. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Espana, Pedro P.; Uranga, Ane; Bilbao, Amaia] Galdakao Usansolo Hosp, Dept Resp Med, Bizkaia, Spain.
   [Alberto Ruiz, Luis; Serrano, Leyre; Zalacain, Rafael] Cruces Univ Hosp, Dept Resp Med, Bizkaia, Spain.
   [Maria Quintana, Jose] Galdakao Usansolo Hosp, Hlth Serv Res Chron Patients Network REDISSEC, Res Unit, Bizkaia, Spain.
   [Bilbao, Amaia] Basurto Hosp, Hlth Serv Res Chron Patients Network REDISSEC, Res Unit, Bizkaia, Spain.
   [Ayarza, Rafael; Patricia Martinez, Ana] Galdakao Usansolo Hosp, Dept Microbiol, Bizkaia, Spain.
RP Espana, PP (reprint author), Galdakao Usansolo Hosp, Dept Resp Med, Bizkaia, Spain.
EM pedropablo.espanayandiola@osakidetza.eus
OI Serrano Fernandez, Leyre/0000-0002-3149-0693
CR Aliberti S, 2014, CLIN MICROBIOL INFEC, V20, P52, DOI 10.1111/1469-0691.12518
   Ardanuy C, 2012, PLOS ONE, V7
   Azzari C, 2016, HUM VACC IMMUNOTHER, V12, P344, DOI 10.1080/21645515.2015.1102811
   Bewick T, 2013, EUR RESPIR J, V42, P733, DOI 10.1183/09031936.00144712
   Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544
   Brunkard Joan M., 2012, Morbidity and Mortality Weekly Report, V61, P309
   Burgos J, 2013, CLIN MICROBIOL INFEC, V19, P385, DOI 10.1111/j.1469-0691.2012.03895.x
   Capelastegui A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-128
   Chalmers JD, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0242-0
   Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402
   Galanis I, 2016, EUR RESPIR J, V47, P1208, DOI 10.1183/13993003.01451-2015
   Gervaix A, 2014, CLIN THER, V36, P802, DOI 10.1016/j.clinthera.2014.03.001
   Gonzalez-Romo F, 2017, REV ESP QUIM, V30, P142
   Grau I, 2014, INT J INFECT DIS, V25, P59, DOI 10.1016/j.ijid.2013.12.013
   Guevara M, 2014, VACCINE, V32, P2553, DOI 10.1016/j.vaccine.2014.03.054
   Kalin M, 2000, J INFECT DIS, V182, P840, DOI 10.1086/315760
   Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999
   Marimon JM, 2016, J CLIN MICROBIOL, V54, P2197, DOI 10.1128/JCM.01156-16
   Menendez R, 2010, ARCH BRONCONEUMOL, V46, P543, DOI 10.1016/j.arbres.2010.06.014
   Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3
   Moreira M, 2017, HUM VACC IMMUNOTHER, V13, P1242, DOI 10.1080/21645515.2016.1263409
   Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593
   Pletz MW, 2016, VACCINE, V34, P2342, DOI 10.1016/j.vaccine.2016.03.052
   Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273
   Torres A, 2013, EUR RESP SOC ERS ANN
   Torres A, 2015, THORAX, V70, P984, DOI 10.1136/thoraxjnl-2015-206780
   van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017
   Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7
   Webber C, 2017, VACCINE, V35, P1266, DOI 10.1016/j.vaccine.2017.01.032
   Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828
   Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502
NR 31
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3840
EP 3848
DI 10.1016/j.vaccine.2019.05.052
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900014
PM 31153692
DA 2020-05-12
ER

PT J
AU Petrie, JG
   Martin, ET
   Zhu, YW
   Wyatt, DG
   Kaniclides, A
   Ferdinands, JM
   Monto, AS
   Trabue, C
   Talbot, HK
AF Petrie, Joshua G.
   Martin, Emily T.
   Zhu, Yuwei
   Wyatt, Dayna G.
   Kaniclides, Anne
   Ferdinands, Jill M.
   Monto, Arnold S.
   Trabue, Christopher
   Talbot, H. Keipp
TI Comparison of a frailty short interview to a validated frailty index in
   adults hospitalized for acute respiratory illness
SO VACCINE
LA English
DT Article
DE Influenza; Influenza vaccination; Frailty; Hospitalization; Adults
ID INFLUENZA VACCINE EFFECTIVENESS; OLDER-ADULTS; FUNCTIONAL STATUS;
   SEX-DIFFERENCES; PREVALENCE; INFECTION
AB Background: Frailty is an important physiologic factor in studies of influenza and influenza vaccines carried out in older adults and hospitalized populations. Unfortunately, comprehensive assessments of frailty requiring physical assessments and extensive medical record review are not often feasible in time- and resource-limited settings common to studies of influenza and influenza vaccines.
   Methods: We developed a 5-question frailty short interview, and implemented it in a multicenter, hospital-based study of influenza over two years. Frailty status defined by the frailty short interview was compared to a validated frailty index based on medical record review of 59 parameters. Agreement between the two frailty measures was assessed, and multivariable linear regression models were used to explore differences between the measures. The association between each frailty measure and likelihood of influenza vaccination was also assessed.
   Results: During the 2015-2016 and 2016-2017 influenza seasons, 2070 adult patients hospitalized with acute respiratory illness were enrolled and included in analyses. Frailty was frequently identified in the study population; 43% of participants were defined as frail by the frailty short interview and 32% by frailty index. Responses to the frailty short interview were only moderately correlated with the frailty index, and agreement between the two frailty measures was low. Women were more likely to be defined as frail by the frailty short interview than men. White individuals were more likely than other races to be defined as frail by the frailty index. Increasing frailty index was associated with increased likelihood of influenza vaccination, but the frailty short interview was not associated with vaccination.
   Conclusions: The frailty short interview provided a feasible and consistent measure of frailty across study hospitals and study years. However, its modest correlation with the frailty index and differential association with likelihood of influenza vaccination highlight differences in the conceptualization of frailty. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Petrie, Joshua G.; Martin, Emily T.; Kaniclides, Anne; Monto, Arnold S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Zhu, Yuwei] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA.
   [Wyatt, Dayna G.; Talbot, H. Keipp] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA.
   [Ferdinands, Jill M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.
   [Trabue, Christopher] Univ Tennessee, Hlth Sci Ctr, St Thomas Hlth, Dept Med, Nashville, TN USA.
   [Talbot, H. Keipp] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA.
RP Petrie, JG (reprint author), Univ Michigan, Sch Publ Hlth, 1415 Washington Hts, Ann Arbor, MI 48109 USA.
EM jpetrie@umich.edu
OI Petrie, Joshua/0000-0002-5696-965X
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01 IP000974-01, U01 IP000979-01]
FX This work was supported by the Centers for Disease Control and
   Prevention (grant numbers U01 IP000974-01 and U01 IP000979-01).
CR Aguayo GA, 2017, AM J EPIDEMIOL, V186, P420, DOI 10.1093/aje/kwx061
   Alexandre TD, 2018, J AGING HEALTH, V30, P190, DOI 10.1177/0898264316671228
   Andrew MK, 2017, J INFECT DIS, V216, P405, DOI 10.1093/infdis/jix282
   Bagshaw M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1338-x
   Barker WH, 1998, ARCH INTERN MED, V158, P645, DOI 10.1001/archinte.158.6.645
   Bouillon K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-64
   Centers for Disease Control and Prevention (CDC), 2014, NHIS QUEST AD
   de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2
   Gordon EH, 2017, EXP GERONTOL, V89, P30, DOI 10.1016/j.exger.2016.12.021
   Hak E, 2004, J INFECT DIS, V189, P450, DOI 10.1086/381165
   Haq K, 2014, IMMUNOL LETT, V162, P323, DOI 10.1016/j.imlet.2014.06.009
   Hoover M, 2013, HEALTH REP, V24, P10
   Hubbard RE, 2015, INTERD T GERONT GERI, V41, P41, DOI 10.1159/000381161
   Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274
   Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275
   Kehler DS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0423-6
   McElhaney JE, 2017, VACCINE, V35, P6269, DOI 10.1016/j.vaccine.2017.09.084
   McElhaney JE, 2012, VACCINE, V30, P2060, DOI 10.1016/j.vaccine.2012.01.015
   Mitnitski A B, 2001, ScientificWorldJournal, V1, P323
   Petrie JG, 2016, CLIN INFECT DIS, V63, P1017, DOI 10.1093/cid/ciw432
   Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722
   Romero-Ortuno R, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-57
   Skowronski DM, 2018, J INFECT DIS, V217, P168, DOI 10.1093/infdis/jix548
   Smart R, 2017, J FRALITY AGING, V6, P219, DOI 10.14283/jfa.2017.28
   Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x
   Sullivan SG, 2016, VACCINE, V34, P4645, DOI 10.1016/j.vaccine.2016.08.003
   Talbot HK, 2016, VACCINE, V34, P1806, DOI 10.1016/j.vaccine.2016.02.037
   Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420
   Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009
   Yao X, 2011, VACCINE, V29, P5015, DOI 10.1016/j.vaccine.2011.04.077
NR 32
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3849
EP 3855
DI 10.1016/j.vaccine.2019.05.051
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900015
PM 31113675
DA 2020-05-12
ER

PT J
AU Perez-Vilar, S
   Wernecke, M
   Arya, D
   Lo, AC
   Lufkin, B
   Hu, M
   Chu, S
   MaCurdy, TE
   Kelman, J
   Forshee, RA
AF Perez-Vilar, Silvia
   Wernecke, Michael
   Arya, Deepa
   Lo, An-Chi
   Lufkin, Bradley
   Hu, Mao
   Chu, Steve
   MaCurdy, Thomas E.
   Kelman, Jeffrey
   Forshee, Richard A.
TI Surveillance for Guillain-Barre syndrome after influenza vaccination
   among US Medicare beneficiaries during the 2017-2018 season
SO VACCINE
LA English
DT Article
DE Influenza vaccines; Guillain-Barre syndrome; Near real-time
   surveillance; Sequential tests; Self-controlled risk interval; Vaccine
   safety
ID A H1N1; UNITED-STATES; ASSOCIATION; POPULATION; VACCINES; SAFETY; RISK;
   RECEIPT
AB Background: The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services have been actively monitoring the risk of Guillain-Barre syndrome (GBS) following influenza vaccination among Fee-for-Service (FFS) Medicare beneficiaries every season since 2008. We present our evaluation of the GBS risk following influenza vaccinations during the 2017-2018 season.
   Methods: We implemented a multilayered approach to active safety surveillance that included near real-time surveillance early in the season, comparing GBS rates post-vaccination during the 2017-2018 season with rates from five prior seasons using the Updating Sequential Probability Ratio Test (USPRT), and end-of-season self-controlled risk interval (SCRI) analyses.
   Results: We identified approximately 16 million influenza vaccinations. The near real-time surveillance did not signal for a potential 2.5-fold increased GBS risk either in days 8-21 or 1-42 post-influenza vaccination. In the SCRI analyses, we did not detect statistically significant increased GBS risks among influenza-vaccinated Medicare beneficiaries >= 65 years for either the 8-21 or 1-42-day risk windows for all seasonal vaccines combined, high-dose vaccine, or standard-dose vaccines; we did detect an increased GBS risk in days 8-21 post-vaccination for individuals vaccinated with the adjuvanted vaccine (OR: 3.75; 95% CI: 1.01, 13.96), although this finding was not statistically significant after multiplicity adjustment (p = 0.146).
   Conclusions: Our multilayered surveillance approach-which allows for early detection of elevated GBS risk and provides reliable end-of-season SCRI estimates of effect size-did not identify an increased GBS risk following 2017-2018 influenza vaccinations. The slightly increased GBS risk with the adjuvanted vaccine, which was not statistically significant following multiplicity adjustment, is consistent with the package inserts of all U.S.-licensed influenza vaccines, which warn of a potential low increased GBS risk. The benefits of influenza vaccines in preventing morbidity and mortality heavily outweigh this potential risk. Published by Elsevier Ltd.
C1 [Perez-Vilar, Silvia; Arya, Deepa; Forshee, Richard A.] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,Bldg 71,Room 1334, Silver Spring, MD 20993 USA.
   [Wernecke, Michael; Lo, An-Chi; Lufkin, Bradley; Hu, Mao; MaCurdy, Thomas E.] Acumen LLC, Burlingame, CA USA.
   [Chu, Steve; Kelman, Jeffrey] Ctr Medicare & Medicaid Serv, Baltimore, MD USA.
   [MaCurdy, Thomas E.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA.
   [MaCurdy, Thomas E.] Stanford Univ, Hoover Inst, Stanford, CA 94305 USA.
RP Perez-Vilar, S (reprint author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,Bldg 71,Room 1334, Silver Spring, MD 20993 USA.
EM silvia.perezvilar@fda.hhs.gov; mwernecke@acumenllc.com;
   deepa.arya@fda.hhs.gov; alo@sphereinsti-tute.com; blufkin@acumenllc.com;
   mhu@acumenllc.com; steve.chu@cms.hhs.gov; tmac@acumenllc.com;
   jeffrey.kelman@cms.hhs.gov; richard.forshee@fda.hhs.gov
RI Perez-Vilar, Silvia/H-4372-2016
OI Perez-Vilar, Silvia/0000-0003-1272-1502
FU U.S. Food and Drug Administration [244-18-1067S]; Centers for Medicare &
   Medicaid Services [244-18-1067S]
FX This study was funded through an inter-agency agreement between the U.S.
   Food and Drug Administration and the Centers for Medicare & Medicaid
   Services (IAA number: 244-18-1067S).
CR Arya D, 2019, SURVEILLANCE G UNPUB
   Bardage C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5956
   Baxter R, 2013, CLIN INFECT DIS, V57, P197, DOI 10.1093/cid/cit222
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Burwen DR, 2012, AM J PUBLIC HEALTH, V102, P1921, DOI 10.2105/AJPH.2011.300510
   Burwen DR, 2010, AM J PREV MED, V39, P296, DOI 10.1016/j.amepre.2010.05.022
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2018, NAT REG STAT LEV OUT
   [Centers for Disease Control and Prevention June 2018 Advisory Committee on Immunization Practices (ACIP)], 2018, END OF SEAS UPD 2017
   De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342
   Dodd CN, 2013, VACCINE, V31, P4448, DOI 10.1016/j.vaccine.2013.06.032
   Forshee RA, PHARMACOEPIDEMIOL DR
   Franks R, 2014, STAT ANAL DATA MIN, V7, P368, DOI 10.1002/sam.11234
   Gilca V, 2011, VACCINE, V30, P35, DOI 10.1016/j.vaccine.2011.10.062
   Greene SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067185
   Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195
   Haber P, 2019, VACCINE, V37, P1516, DOI 10.1016/j.vaccine.2019.01.052
   Hu M, 2019, 35 ANN INT C PHARM T
   HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601
   Izurieta HS, 2015, LANCET INFECT DIS, V15, P293, DOI 10.1016/S1473-3099(14)71087-4
   Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217
   KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698
   LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809
   LANGMUIR AD, 1979, J ROY SOC MED, V72, P660, DOI 10.1177/014107687907200908
   Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501
   Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7
   Lochner KA, 2015, AM J PREV MED, V48, P384, DOI 10.1016/j.amepre.2014.10.016
   MaCurdy T, 1320, ASA BIOPH SECT STAT
   Polakowski LL, 2013, AM J EPIDEMIOL, V178, P962, DOI 10.1093/aje/kwt051
   Romio S, 2009, PLOS ONE, V2014
   Romio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082222
   ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974
   RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225
   Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8
   Sandhu SK, 2017, VACCINE, V35, P2986, DOI 10.1016/j.vaccine.2017.03.087
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Seqirus I, 2018, FLUAD
   Shay DK, 2017, J INFECT DIS, V215, P510, DOI 10.1093/infdis/jiw641
   Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220
   U.S. Food and Drug Administration, 2018, VACC LIC US US
   U.S. Food and Drug Administration, 2015, APPR LETT FLUAD 2015
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196
   Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197
NR 49
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3856
EP 3865
DI 10.1016/j.vaccine.2019.05.041
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900016
PM 31122853
DA 2020-05-12
ER

PT J
AU Hitri, K
   Kuttel, MM
   De Benedetto, G
   Lockyer, K
   Gao, F
   Hansal, P
   Rudd, TR
   Beamish, E
   Rijpkema, S
   Ravenscroft, N
   Bolgiano, B
AF Hitri, Krisztina
   Kuttel, Michelle M.
   De Benedetto, Gianluigi
   Lockyer, Kay
   Gao, Fang
   Hansal, Peter
   Rudd, Timothy R.
   Beamish, Emma
   Rijpkema, Sjoerd
   Ravenscroft, Neil
   Bolgiano, Barbara
TI O-acetylation of typhoid capsular polysaccharide confers polysaccharide
   rigidity and immunodominance by masking additional epitopes
SO VACCINE
LA English
DT Article
DE Enteric; Glycoconjugate; Molecular modelling; Nuclear magnetic
   resonance; Vaccine; Vi polysaccharide
ID VI-ANTIGEN; SALMONELLA-TYPHI; CONJUGATE VACCINE; IMMUNOGENICITY;
   PREVENTION; EFFICACY; FEVER
AB In this work, we explore the effects of O-acetylation on the physical and immunological characteristics of the WHO International Standards of Vi polysaccharide (Vi) from both Citrobacter freundii and Salmonella enterica serovar Typhi. We find that, although structurally identical according to NMR, the two Vi standards have differences with respect to susceptibility to de-O-acetylation and viscosity in water. Vi standards from both species have equivalent mass and O-acetylation-dependent binding to a mouse monoclonal antibody and to anti-Vi polyclonal antisera, including the WHO International Standard for human anti-typhoid capsular Vi PS IgG. This study also confirms that human anti-Vi sera binds to completely de-O-acetylated Vi. Molecular dynamics simulations provide conformational rationales for the known effect of de-O-acetylation both on the viscosity and antigenicity of the Vi, demonstrating that de-O-acetylation has a very marked effect on the conformation and dynamic behavior of the Vi, changing the capsular polysaccharide from a rigid helix into a more flexible coil, as well as enhancing the strong interaction of the polysaccharide with sodium ions. Partial de-O-acetylation of Vi revealed hidden epitopes that were recognized by human and sheep anti-Vi PS immune sera. These findings have significance for the manufacture and evaluation of Vi vaccines. (C) 2019 Published by Elsevier Ltd.
C1 [Hitri, Krisztina; De Benedetto, Gianluigi; Lockyer, Kay; Gao, Fang; Hansal, Peter; Beamish, Emma; Rijpkema, Sjoerd; Bolgiano, Barbara] NIBSC, Div Bacteriol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Kuttel, Michelle M.] Univ Cape Town, Dept Comp Sci, Private Bag X3, ZA-7701 Cape Town, South Africa.
   [Rudd, Timothy R.] NIBSC, Lab Mol Struct Analyt & Biol Sci, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
   [Ravenscroft, Neil] Univ Cape Town, Dept Chem, Private Bag X3, ZA-7701 Cape Town, South Africa.
RP Bolgiano, B (reprint author), NIBSC, Div Bacteriol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.
EM Barbara.Bolgiano@nibsc.org
RI Rudd, Tim/M-6129-2019
OI Rudd, Tim/0000-0003-4434-0333; Kuttel, Michelle/0000-0003-0554-4632;
   Beamish, Emma/0000-0002-7000-7641
FU Coalition Against Typhoid of the Sabin Vaccine Institute; World Health
   OrganizationWorld Health Organization; South African National Research
   FoundationNational Research Foundation - South Africa [103805]; Bill &
   Melinda Gates FoundationGates Foundation [OPP 1145952]
FX Funding for assay development and optimization was given by the
   Coalition Against Typhoid of the Sabin Vaccine Institute to SR which
   funded PH, and by the World Health Organization to FG. The South African
   National Research Foundation (Grant no: 103805) provided funding for the
   molecular modelling component of this work. KH and EB were supported by
   the Bill & Melinda Gates Foundation (OPP 1145952).
CR Abdelhameed AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35588
   Arcuri M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189100
   Berti F, 2018, MOLECULES, V23, DOI 10.3390/molecules23061340
   BYSTRICKY S, 1994, BIOPHYS CHEM, V51, P1, DOI 10.1016/0301-4622(94)00002-6
   CLARK WR, 1958, J BIOL CHEM, V230, P81
   DANIELS EM, 1989, INFECT IMMUN, V57, P3159, DOI 10.1128/IAI.57.10.3159-3164.1989
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Felix A, 1934, LANCET, V2, P186
   Gao F, 2019, BIOLOGICALS, V57, P34, DOI 10.1016/j.biologicals.2018.11.004
   Giannelli C, 2017, J PHARMACEUT BIOMED, V139, P143, DOI 10.1016/j.jpba.2017.02.042
   Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004
   Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e
   Hadidi M, 2016, CARBOHYD POLYM, V152, P12, DOI 10.1016/j.carbpol.2016.06.095
   HESTRIN S, 1949, J BIOL CHEM, V180, P249
   Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106
   HEYNS K., 1967, CARBOHYD RES, V3, P340, DOI 10.1016/S0008-6215(00)82210-7
   Hlozek J, 2018, CARBOHYD RES, V465, P44, DOI 10.1016/j.carres.2018.06.007
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JARVIS FG, 1967, J BACTERIOL, V94, P1406, DOI 10.1128/JB.94.5.1406-1410.1967
   Jin C, 2017, LANCET, V390, P2472, DOI 10.1016/S0140-6736(17)32149-9
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kuttel M, P 7 IEEE INT C E SCI, P395
   Kuttel MM, 2016, J COMPUT CHEM, V37, P2098, DOI 10.1002/jcc.24428
   LANDY M, 1961, AM J HYG, V73, P55, DOI 10.1093/oxfordjournals.aje.a120165
   Landy M, 1954, AM J PUBLIC HEALTH N, V44, P1572
   Legnani L, ORGANIC BIOMOLECULAR, V9, P5554
   Lemercinier X, 2000, BIOLOGICALS, V28, P17, DOI 10.1006/biol.1999.0238
   Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   QADRI A, 1990, J IMMUNOASSAY, V11, P235, DOI 10.1080/01971529008053271
   Rijpkema S, 2004, BIOLOGICALS, V32, P11, DOI 10.1016/j.biologicals.2003.09.002
   Rijpkema S, 2018, BIOLOGICALS, V56, P29, DOI 10.1016/j.biologicals.2018.09.001
   ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436
   STONE AL, 1988, J CLIN MICROBIOL, V26, P719, DOI 10.1128/JCM.26.4.719-725.1988
   Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829
   SZEWCZYK B, 1980, INFECT IMMUN, V29, P539
   SZU SC, 1991, INFECT IMMUN, V59, P4555, DOI 10.1128/IAI.59.12.4555-4561.1991
   SZU SC, 1987, J EXP MED, V166, P1510, DOI 10.1084/jem.166.5.1510
   Szu SC, 2013, EXPERT REV VACCINES, V12, P1273, DOI 10.1586/14760584.2013.845529
   Vipond C, 2017, BIOLOGICALS, V47, P33, DOI 10.1016/j.biologicals.2017.03.001
   Vipond C, 2012, BIOLOGICALS, V40, P353, DOI 10.1016/j.biologicals.2012.03.003
   WHO, 2017, EXP COMM BIOL STAND
   WHO, 1994, WHO TECHN REP SER, V840, P14
   World Hlth Org, 2014, WHO TECH REP SER, V987, P101
NR 44
TC 2
Z9 2
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3866
EP 3875
DI 10.1016/j.vaccine.2019.05.050
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900017
PM 31160100
OA Other Gold, Green Published
DA 2020-05-12
ER

PT J
AU Crooke, SN
   Haralambieva, LH
   Grill, DE
   Ovsyannikova, IG
   Kennedy, RB
   Poland, GA
AF Crooke, Stephen N.
   Haralambieva, Lana H.
   Grill, Diane E.
   Ovsyannikova, Inna G.
   Kennedy, Richard B.
   Poland, Gregory A.
TI Seroprevalence and durability of rubella virus antibodies in a highly
   immunized population
SO VACCINE
LA English
DT Article
DE Rubella; Measles-mumps-rubella; MMR; Antibodies; Titer; Demographics;
   Seroepidemiology
ID PERSONALIZED VACCINES; WANING IMMUNITY; UNITED-STATES; MEASLES; MUMPS;
   RESPONSES; PERSISTENCE; VARICELLA; INFECTION; CHILDREN
AB Background: Although the administration of the measles-mumps-rubella (MMR) vaccine has been widespread in the United States for decades, gaps in vaccine coverage still persist for various reasons. The maintenance of herd immunity against rubella virus (RV) is important to controlling the spread and resurgence of rubella and congenital rubella syndrome.
   Methods: In this study, we sought to assess the seroprevalence of RV-specific antibodies in an adult population from a defined geographic area in Olmsted County, MN, and the surrounding municipalities, with relatively high vaccine coverage and no documented evidence of circulating RV in the past 24 years. Rubella-specific IgG antibodies were measured by ELISA in a large set of serum samples (n = 1393) obtained from the Mayo Clinic Biobank. This cohort was 80.2% female and ranged from 20 to 44 years of age.
   Results: In total, 97.8% of subjects were seropositive for rubella-specific IgG antibodies, with a median titer of 40.56 IU/mL, suggesting a high degree of immunization; however, 2.2% of subjects were found to be seronegative. Interestingly, 25.1% of subjects were seropositive but had titers lower than 25 IU/mL, indicating either a population of low responders or individuals that could potentially be at risk of waning immunity. No significant associations or differences were found between RV-specific titers and demographic variables such as age, sex, or body mass index (BMI).
   Conclusions: A high rate of seropositivity for rubella was found among this young adult cohort, but a significant percent of the cohort had lower titers that may indicate poor initial vaccine response and potential risk if their antibody titers decline. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Crooke, Stephen N.; Haralambieva, Lana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Guggenheim Bldg 611C,200 First St SW, Rochester, MN 55905 USA.
   [Grill, Diane E.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA.
RP Poland, GA (reprint author), Mayo Clin, Vaccine Res Grp, Guggenheim Bldg 611C,200 First St SW, Rochester, MN 55905 USA.
EM poland.gregory@mayo.edu
OI Crooke, Stephen/0000-0002-4711-5767
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R37AI048793]; Mayo
   Clinic Center for Individualized Medicine
FX We would like to thank the staff of the Mayo Clinic Vaccine Research
   Group and all of the participants in this study. We would also like to
   thank Caroline L. Vitse for editorial assistance with the preparation of
   this manuscript. The work reported was funded by the National Institutes
   of Health under Award Number R37AI048793. The Mayo Clinic Biobank was
   supported by funding from the Mayo Clinic Center for Individualized
   Medicine.
CR Aboudy Y, 1997, J INFECTION, V34, P273, DOI 10.1016/S0163-4453(97)94507-2
   ALFORD CA, 1964, NEW ENGL J MED, V271, P1275, DOI 10.1056/NEJM196412172712501
   Almuneef MA, 2006, INFECT CONT HOSP EP, V27, P1178, DOI 10.1086/508826
   Alsibiani SA, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/659838
   [Anonymous], MINN STAT 2018 SECT
   Barlinn R, 2014, J MED VIROL, V86, P820, DOI 10.1002/jmv.23757
   Borras E, 2014, HUM VACC IMMUNOTHER, V10, P686, DOI 10.4161/hv.27498
   Byrne L, 2012, VACCINE, V30, P161, DOI 10.1016/j.vaccine.2011.11.045
   Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993
   Del Giudice G, 2017, NPJ AGING MECH DIS, V4, DOI 10.1038/s41514-017-0020-0
   Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513
   FANG JWS, 1994, J TROP PEDIATRICS, V40, P104, DOI 10.1093/tropej/40.2.104
   Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588
   Grubeck-Loebenstein B, 2009, AGING CLIN EXP RES, V21, P201, DOI 10.1007/BF03324904
   Hamami D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00233
   He HQ, 2013, VACCINE, V31, P533, DOI 10.1016/j.vaccine.2012.11.014
   Hill HA, 2017, MMWR-MORBID MORTAL W, V66, P1171, DOI 10.15585/mmwr.mm6643a3
   Hui SYA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183630
   Hyde TB, 2006, CLIN INFECT DIS, V43, pS146, DOI 10.1086/505947
   Kennedy RB, 2014, IMMUNOGENETICS, V66, P493, DOI 10.1007/s00251-014-0776-3
   Kennedy RB, 2014, EXPERT REV VACCINES, V13, P657, DOI 10.1586/14760584.2014.905744
   Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086
   Klein SL, 2015, T ROY SOC TROP MED H, V109, P9, DOI 10.1093/trstmh/tru167
   Klein SL, 2013, VACCINE, V31, P2599, DOI 10.1016/j.vaccine.2013.02.070
   Lambert ND, 2015, J INFECT DIS, V211, P898, DOI 10.1093/infdis/jiu553
   Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13
   Lambert ND, 2014, IMMUNOL RES, V58, P1, DOI 10.1007/s12026-013-8475-y
   LeBaron CW, 2009, J INFECT DIS, V200, P888, DOI 10.1086/605410
   Lebo EJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv006
   Leung J, 2017, EXPERT REV VACCINES, V16, P391, DOI 10.1080/14760584.2017.1294069
   Lievano F, 2012, VACCINE, V30, P6918, DOI 10.1016/j.vaccine.2012.08.057
   Liu YB, 2018, EXPERT REV VACCINES, V17, P445, DOI 10.1080/14760584.2018.1445529
   MILLER E, 1982, LANCET, V2, P781
   Minakami H, 2014, J INFECTION, V68, P99, DOI 10.1016/j.jinf.2013.09.002
   Minnesota Department of Health, RUB DIS STAT
   Mitchell LA, 1999, J MED MICROBIOL, V48, P1075, DOI 10.1099/00222615-48-12-1075
   Mou J, 2010, VACCINE, V28, P7844, DOI 10.1016/j.vaccine.2010.09.082
   Oberg AL, 2015, VACCINE
   Olson JE, 2013, MAYO CLIN PROC, V88, P952, DOI 10.1016/j.mayocp.2013.06.006
   Onakewhor JU, 2011, NIGER J CLIN PRACT, V14, P140, DOI 10.4103/1119-3077.84002
   Ovsyannikova IG, 2015, IMMUNOGENETICS, V67, P547, DOI 10.1007/s00251-015-0864-z
   Ovsyannikova IG, 2014, VACCINE, V32, P4206, DOI 10.1016/j.vaccine.2014.04.091
   Painter SD, 2015, VACCINE, V33, P4422, DOI 10.1016/j.vaccine.2015.06.101
   Paradowska-Stankiewicz I, 2013, EURO SURVEILL, V18
   Pera A, 2015, MATURITAS
   Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1
   Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI 10.1517/14712598.8.11.1659 
   Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344
   Robertson Susan E., 2003, Rev Panam Salud Publica, V14, P306, DOI 10.1590/S1020-49892003001000005
   ROBINSON J, 1994, PEDIATR INFECT DIS J, V13, P812, DOI 10.1097/00006454-199409000-00013
   Rota JS, 2011, J INFECT DIS, V204, pS559, DOI 10.1093/infdis/jir098
   Seagle EE, 2018, VACCINE, V36, P818, DOI 10.1016/j.vaccine.2017.12.075
   Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208
   Siberry GK, 2015, CLIN INFECT DIS, V61, P988, DOI 10.1093/cid/civ440
   Smits G, 2014, VACCINE, V32, P1890, DOI 10.1016/j.vaccine.2014.01.066
   Sydnor E, 2014, VACCINE, V32, P4814, DOI 10.1016/j.vaccine.2014.03.097
   Vesikari L, 2012, VACCINE, V30, P3082, DOI 10.1016/j.vaccine.2012.02.062
   Voigt EA, 2018, J INFECT DIS, V217, P560, DOI 10.1093/infdis/jix538
   Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089948
NR 59
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3876
EP 3882
DI 10.1016/j.vaccine.2019.05.049
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900018
PM 31126859
DA 2020-05-12
ER

PT J
AU Goldstein, ND
   LeVasseur, MT
   Tran, NK
   Purtle, J
   Welles, SL
   Eppes, SC
AF Goldstein, Neal D.
   LeVasseur, Michael T.
   Tran, Nguyen K.
   Purtle, Jonathan
   Welles, Seth L.
   Eppes, Stephen C.
TI Modeling HPV vaccination scale-up among urban young men who have sex
   with men in the context of HIV
SO VACCINE
LA English
DT Article
DE Disease modeling; Epidemiology; Sexual and gender minority; Sexually
   transmitted diseases; Human papillomavirus
ID HUMAN-PAPILLOMAVIRUS VACCINATION; POPULATION-LEVEL IMPACT;
   UNITED-STATES; INFECTION; RISK; PREVALENCE; GAY; TRANSMISSION;
   CLEARANCE; BEHAVIORS
AB Introduction: Young men who have sex with men (YMSM) are at high risk to contract human papillomavirus (HPV). While an effective vaccination exists, its use among YMSM is markedly lower compared to non-MSM and women. This study compares scaling up HPV vaccination in conjunction with other prevention strategies.
   Methods: An agent-based model of urban YMSM (<= 26 years of age) reflective of the demography of Philadelphia, PA, simulated for up to ten years of follow-up to examine anal and oral transmission of the HPV genotypes covered in the nonavalent (9v) vaccine: 6, 11, 16, 18, 31, 33, 45, 52, 58. Starting HPV prevalences ranged from a high of 18% (type 6) to a low of 6% (type 31); overall 65% of individuals carried any HPV genotype. Simulated levels of vaccination were ranged from 0% to 13% (present-day level), 25%, 50%, 80% (Healthy People 2020 target), and 100% in conjunction with condom use and HIV seroadaptive practices. The primary outcome was the relative reduction in HPV infection.
   Results: Compared to present-day vaccination levels (13%), scaling-up vaccination led to expected declines in 10-year post-simulation HPV prevalence. Anal HPV (any 9v types) declined by 9%, 27%, 46%, and 58% at vaccination levels of 25%, 50%, 80%, and 100%, respectively. Similarly, oral HPV (any 9v types) declined by 11%, 33%, 57%, and 71% across the same levels of vaccine uptake. Comparing the prevention strategies, condoms blocked the greatest number of anal transmissions when vaccination was at or below present-day levels. For oral transmission, vaccination was superior to condom use at all levels of coverage.
   Conclusions: Public health HPV preventions strategies should continue to emphasize the complementary roles of condoms and vaccination, especially for preventing oral infection. Improving vaccination coverage will ultimately have the greatest impact on reducing HPV infection among YMSM. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Goldstein, Neal D.; Eppes, Stephen C.] Christiana Care Hlth Syst, Dept Pediat, 4745 Ogletown Stanton Rd,MAP 1,Suite 116, Newark, DE 19713 USA.
   [Goldstein, Neal D.; LeVasseur, Michael T.; Tran, Nguyen K.; Welles, Seth L.] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, 3215 Market St, Philadelphia, PA 19104 USA.
   [Purtle, Jonathan] Drexel Univ, Dornsife Sch Publ Hlth, Dept Hlth Management & Policy, 3215 Market St, Philadelphia, PA 19104 USA.
RP Goldstein, ND (reprint author), 3215 Market St, Philadelphia, PA 19104 USA.
EM ng338@drexel.edu
OI Tran, Nguyen Khai/0000-0002-5093-4499
FU Merck Sharp Dohme CorpMerck & Company
FX This work was supported by a grant from Merck Sharp & Dohme Corp (to NDG
   and MTL).
CR Beachler DC, 2016, J INFECT DIS, V213, P1444, DOI 10.1093/infdis/jiv753
   Beavis AL, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00019
   Bianchi Carlo, 2007, Computational Economics, V30, P245, DOI 10.1007/s10614-007-9097-z
   Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524
   Bogenschneider K, 2011, EVIDENCE-BASED POLICYMAKING: INSIGHTS FROM POLICY-MINDED RESEARCHERS AND RESEARCH-MINDED POLICYMAKERS, P1
   Chesson HW, 2018, VACCINE, V36, P4362, DOI 10.1016/j.vaccine.2018.04.071
   Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125
   Cornelisse VJ, 2018, SEX TRANSM INFECT
   Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438
   Fisher KA, 2016, TRANSL CANCER RES, V5, pS1000, DOI 10.21037/tcr.2016.10.66
   Gerend MA, 2016, SEX TRANSM DIS, V43, P185, DOI 10.1097/OLQ.0000000000000408
   Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101
   Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365
   Grey JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129877
   Hamel L., 2014, HIV AIDS LIVES GAY B
   Hariri S, 2013, J INFECT DIS, V208, P367, DOI 10.1093/infdis/jit193
   Hernandez-Romieu AC, 2015, SEX TRANSM DIS, V42, P505, DOI 10.1097/OLQ.0000000000000332
   Hirth JM, 2017, VACCINE, V35, P3446, DOI 10.1016/j.vaccine.2017.05.025
   Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454
   Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006
   Ingles DJ, 2015, PAPILLOMAVIRUS RES, V1, P126, DOI 10.1016/j.pvr.2015.09.001
   Jenness SM, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i08
   Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X
   King EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157976
   Koester KA, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00250
   Larke N, 2011, J INFECT DIS, V204, P1375, DOI 10.1093/infdis/jir523
   Lessler J, 2016, AM J EPIDEMIOL
   LeVasseur MT, 2017, J ACQUIR IMMUNE DEFI, V25
   Lin A, 2017, CLIN INFECT DIS, V64, P580, DOI 10.1093/cid/ciw845
   Liu G, 2018, AIDS, V32, P795, DOI [10.1097/QAD.0000000000001765, 10.1097/qad.0000000000001765]
   Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160
   Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3
   Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968
   McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8
   Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5
   Meites E, 2016, J INFECT DIS, V214, P689, DOI 10.1093/infdis/jiw232
   Miksis S, 2008, JOGNN-J OBST GYN NEO, V37, P329, DOI 10.1111/j.1552-6909.2008.00236.x
   Mooij SH, 2016, AIDS, V30, P121, DOI 10.1097/QAD.0000000000000909
   Mooij SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098955
   Nelson KE, 2014, INFECT DIS EPIDEMIOL
   Nyitray AG, 2016, CLIN INFECT DIS, V62, P1367, DOI 10.1093/cid/ciw140
   Omori R, 2015, SEX TRANSM INFECT, V91, P451, DOI 10.1136/sextrans-2014-051925
   Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971
   Phang CW, 2008, SEX TRANSM INFECT, V84, P217, DOI 10.1136/sti.2007.028787
   Poynten IM, 2012, SEX TRANSM DIS, V39, P726, DOI 10.1097/OLQ.0b013e31825d5cb8
   Punyacharoensin N, 2015, AIDS, V29, P339, DOI 10.1097/QAD.0000000000000525
   Ranganathan Priya, 2016, Perspect Clin Res, V7, P144, DOI 10.4103/2229-3485.184823
   Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6
   Reagan-Steiner S, 2015, MMWR-MORBID MORTAL W, V64, P784, DOI 10.15585/mmwr.mm6429a3
   Reiter PL, 2015, AM J PUBLIC HEALTH, V105, P96, DOI 10.2105/AJPH.2014.302095
   Rosenberger JG, 2011, J SEX MED, V8, P3040, DOI 10.1111/j.1743-6109.2011.02438.x
   Singh S, 2014, MMWR-MORBID MORTAL W, V63, P829
   Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201
   Snowden JM, 2014, SEX TRANSM INFECT, V90, P498, DOI 10.1136/sextrans-2013-051368
   Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182
   U. S. Department of Health and Human Services, HEALTHY PEOPLE 2020
   US Food & Drug Administration, FDA APPR EXP US GARD
   van Aar F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0668-z
   Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395
   Van de Ven P, 1997, J SEX RES, V34, P349, DOI 10.1080/00224499709551903
   Wall KM, 2013, J HOMOSEXUAL, V60, P1520, DOI 10.1080/00918369.2013.819256
   Welling CAH, 2015, SEX TRANSM DIS, V42, P297, DOI 10.1097/OLQ.0000000000000278
   Zhang L, 2017, VACCINE, V35, P4923, DOI 10.1016/j.vaccine.2017.07.078
   Zou HC, 2015, LANCET INFECT DIS, V15, P65, DOI 10.1016/S1473-3099(14)70994-6
   Zou HC, 2014, J INFECT DIS, V209, P642, DOI 10.1093/infdis/jit626
NR 65
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3883
EP 3891
DI 10.1016/j.vaccine.2019.05.047
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900019
PM 31155416
DA 2020-05-12
ER

PT J
AU Cole, LE
   Li, L
   Jetley, U
   Zhang, JR
   Pacheco, K
   Ma, FQ
   Zhang, JX
   Mundle, S
   Yan, YH
   Barone, L
   Rogers, C
   Beltraminelli, N
   Quemeneur, L
   Kleanthous, H
   Anderson, SF
   Anosova, NG
AF Cole, Leah E.
   Li, Lu
   Jetley, Utsav
   Zhang, Jinrong
   Pacheco, Kristl
   Ma, Fuqin
   Zhang, Jianxin
   Mundle, Sophia
   Yan, Yanhua
   Barone, Lucianna
   Rogers, Christopher
   Beltraminelli, Nicola
   Quemeneur, Laurence
   Kleanthous, Harry
   Anderson, Stephen F.
   Anosova, Natalie G.
TI Deciphering the domain specificity of C. difficile toxin neutralizing
   antibodies
SO VACCINE
LA English
DT Article
DE C. difficile; Toxoid; Vaccine; Neutralizing; Antibody
ID CLOSTRIDIUM-DIFFICILE; TOXOID VACCINE; TCDB TOXIN; PROTECTION;
   INFECTION; RECEPTOR; IMMUNIZATION; MECHANISM; MODEL; IDENTIFICATION
AB Clostridium difficile infection (CDI) is the principal cause of nosocomial diarrhea and pseudomembranous colitis associated with antibiotic therapy. The pathological effects of CDI are primarily attributed to toxins A (TcdA) and B (TcdB). Adequate toxin-specific antibody responses are associated with asymptomatic carriage, whereas insufficient humoral responses are associated with recurrent CDI. While the data supporting the importance of anti-toxin antibodies are substantial, clarity about the toxin domain specificity of these antibodies is more limited. To investigate this matter, combinations of human mAbs targeting multiple domains of TcdB were assessed using toxin neutralization assays. These data revealed that a combination of mAbs specific to all major toxin domains had improved neutralizing potency when compared to equivalent concentrations of a single mAb or a combination of mAbs against one or two domains. The function and toxin domain binding specificity of serum antibodies elicited by immunization of hamsters with a toxoid vaccine candidate was also assessed. Immunization with a toxoid vaccine candidate provoked toxin neutralizing antibodies specific to multiple domains of both TcdA and TcdB. When assessed in a toxin neutralization assay, polyclonal sera displayed greater activity against elevated concentrations of toxins than equivalent concentrations of individual mAbs. These data suggest a potential benefit of any antibody based therapeutic or prophylactic treatment that targets multiple toxin domains. (C) 2019 The Authors. Published by Elsevier Ltd.
C1 [Cole, Leah E.; Li, Lu; Jetley, Utsav; Zhang, Jinrong; Pacheco, Kristl; Ma, Fuqin; Zhang, Jianxin; Mundle, Sophia; Yan, Yanhua; Barone, Lucianna; Rogers, Christopher; Kleanthous, Harry; Anderson, Stephen F.; Anosova, Natalie G.] Sanofi Pasteur, Res North Amer, 38 Sidney St, Cambridge, MA 02139 USA.
   [Jetley, Utsav] Momenta Pharmaceut INC, Res, 675 W Kendall St, Cambridge, MA 02142 USA.
   [Barone, Lucianna] Harvard Vanguard Med Associates, 230 Worcester St, Wellesley, MA 02481 USA.
   [Rogers, Christopher] Maine Med Ctr, Dept Pediat, 22 Bramhall St, Portland, ME 04102 USA.
   [Beltraminelli, Nicola] BliNK Biomed SAS, R&D, Gerland Plaza Techsud,70,Rue St Jean Dieu, F-69007 Lyon, France.
   [Quemeneur, Laurence] Sanofi Pasteur, Res Europe, 1541 Ave Marcel Merieux, F-68280 Marcy Letoile, France.
   [Anderson, Stephen F.] Anokion US Inc, Dev & Analyt, 50 Hampshire St, Cambridge, MA 02139 USA.
RP Anosova, NG (reprint author), Sanofi Pasteur, Res North Amer, 38 Sidney St, Cambridge, MA 02139 USA.
EM natalie.anosova@sanofi.com
CR Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14
   Anosova NG, 2013, J MED MICROBIOL, V62, P1394, DOI 10.1099/jmm.0.056796-0
   ARONSSON B, 1985, INFECTION, V13, P97, DOI 10.1007/BF01642866
   Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06
   BACON AE, 1994, DIAGN MICR INFEC DIS, V18, P205, DOI 10.1016/0732-8893(94)90021-3
   de Bruyn G, 2016, VACCINE, V34, P2170, DOI 10.1016/j.vaccine.2016.03.028
   Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220
   Di Bella S, 2016, TOXINS, V8, DOI 10.3390/toxins8050134
   Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056
   Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107
   Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x
   Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0
   Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030
   Goy SD, 2015, CELL MICROBIOL, V17, P893, DOI 10.1111/cmi.12410
   Gupta P, 2017, J BIOL CHEM, V292, P17290, DOI 10.1074/jbc.M117.806687
   Gupta SB, 2016, CLIN INFECT DIS, V63, P730, DOI 10.1093/cid/ciw364
   Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010
   KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987
   Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998
   Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604
   Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3
   LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112
   Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144
   Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772
   Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416
   Olling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017623
   Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748
   Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x
   Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10
   Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8
   Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111
   Sougioultzis S, 2005, GASTROENTEROLOGY, V128, P764, DOI 10.1053/j.gastro.2004.11.004
   Sun XM, 2011, INFECT IMMUN, V79, P2856, DOI 10.1128/IAI.01336-10
   Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799
   TORRES JF, 1995, INFECT IMMUN, V63, P4619, DOI 10.1128/IAI.63.12.4619-4627.1995
   TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991
   Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005
   Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12
   Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615
   Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169
NR 40
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3892
EP 3901
DI 10.1016/j.vaccine.2019.05.040
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900020
PM 31122858
OA Other Gold
DA 2020-05-12
ER

PT J
AU Sunay, MME
   Martins, KAO
   Steffens, JT
   Gregory, M
   Vantongeren, SA
   Van Hoeven, N
   Games, PG
   Bavari, S
AF Sunay, Melek M. E.
   Martins, Karen A. O.
   Steffens, Jesse T.
   Gregory, Melissa
   Vantongeren, Sean A.
   Van Hoeven, Neal
   Games, Preston G.
   Bavari, Sina
TI Glucopyranosyl lipid adjuvant enhances immune response to Ebola
   virus-like particle vaccine in mice
SO VACCINE
LA English
DT Article
DE Vaccine; Adjuvant; TLR agonist; Protection; Ebola virus
ID T-CELLS; HUMAN-PAPILLOMAVIRUS; MARBURG; EFFICACY; PROTECT;
   IMMUNOGENICITY; INFLAMMASOME; ACTIVATION; INFLUENZA; EMULSION
AB The identification of adjuvants that promote lasting antigen-specific immunity and augment vaccine efficacy are integral to the development of new protein-based vaccines. The Ebola virus-like particle (VLP) vaccine expressing Ebola virus glycoprotein (GP) and matrix protein (VP40) was used in this study to evaluate the ability of TLR4 agonist glucopyranosyl lipid adjuvant (GLA) formulated in a stable emulsion (SE) to enhance immunogenicity and promote durable protection against mouse-adapted Ebola virus (ma-EBOV). Antibody responses and Ebola-specific T cell responses were evaluated post vaccination. Survival analysis after lethal ma-EBOV challenge was performed 4 weeks and 22 weeks following final vaccination. GLA-SE enhanced EBOV-specific immunity and resulted in long-term protection against challenge with ma-EBOV infection in a mouse model. Specifically, GIA-SE elicited Th1-skewed antibodies and promoted the generation of EBOV GP-specific polyfunctional T cells. These results provide further support for the utility of TLR4 activating GLA-SE-adjuvanted vaccines. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sunay, Melek M. E.; Martins, Karen A. O.; Steffens, Jesse T.; Gregory, Melissa; Vantongeren, Sean A.; Bavari, Sina] US Army, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.
   [Van Hoeven, Neal; Games, Preston G.] Infect Dis Res Inst, 1616 Eastlake Ave E,Suite 400, Seattle, WA 98102 USA.
RP Bavari, S (reprint author), US Army, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.
EM sina.bavari.civ@mail.mil
OI Bavari, Sina/0000-0001-8424-5635
FU Department of Defense Threat Reduction Agency (DTRA) [CB2630]
FX This work was supported with funding from the Department of Defense
   Threat Reduction Agency (DTRA) project number CB2630. This research was
   also supported in part by an appointment to the Postgraduate Research
   Participation Program at the U.S. Army Medical Research Institute of
   Infectious Diseases administered by the Oak Ridge Institute for Science
   and Education through an interagency agreement between the U.S.
   Department of Energy and USAMRMC. Opinions, interpretations, conclusions
   and recommendations are those of the authors and are not necessarily
   endorsed by the United States Army.
CR Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386
   Brunner R, 2010, IMMUNOL LETT, V128, P29, DOI 10.1016/j.imlet.2009.10.005
   Coates T, 2001, CLIN THER, V23, P392, DOI 10.1016/S0149-2918(01)80044-8
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Coler RN, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.6
   Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333
   Cooper CL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.31
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Fox CB, 2012, CLIN VACCINE IMMUNOL, V19, P1633, DOI 10.1128/CVI.00235-12
   Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760
   Ilyinskii PO, 2014, VACCINE, V32, P2882, DOI 10.1016/j.vaccine.2014.02.027
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007
   Kaisho T, 2003, CURR MOL MED, V3, P373, DOI 10.2174/1566524033479726
   Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07
   Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6
   Ma CY, 2015, J IMMUNOL, V194, P1905, DOI 10.4049/jimmunol.1400923
   Martins KAO, 2016, EBIOMEDICINE, V3, P67, DOI 10.1016/j.ebiom.2015.11.041
   Martins KAO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089735
   Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110
   McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689
   Mendoza D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003195
   Monaci E, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00439
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Morefield GL, 2007, CLIN VACCINE IMMUNOL, V14, P1499, DOI 10.1128/CVI.00153-07
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Nymo S, 2016, J IMMUNOL, V196, P2293, DOI 10.4049/jimmunol.1502220
   Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005
   Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5
   Rappuoli R, 2018, SEMIN IMMUNOL
   Reed SG, 2016, CURR OPIN IMMUNOL, V41, P85, DOI 10.1016/j.coi.2016.06.007
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI 10.1586/ERV.10.115
   Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61
   Swenson DL, 2005, VACCINE, V23, P3033, DOI 10.1016/j.vaccine.2004.11.070
   Swenson DL, 2004, FEMS IMMUNOL MED MIC, V40, P27, DOI 10.1016/S0928-8244(03)00273-6
   Treanor JJ, 2013, VACCINE, V31, P5760, DOI 10.1016/j.vaccine.2013.08.064
   Underhill DM, 2003, EUR J IMMUNOL, V33, P1767, DOI 10.1002/eji.200324037
   Vono M, 2013, P NATL ACAD SCI USA, V110, P21095, DOI 10.1073/pnas.1319784110
   Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583
   Warfield KL, 2005, EXPERT REV VACCINES, V4, P429, DOI 10.1586/14760584.4.3.429
   Warfield KL, 2004, VACCINE, V22, P3495, DOI 10.1016/j.vaccine.2004.01.063
   Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100
   Wilson NS, 2014, J IMMUNOL, V192, P3259, DOI 10.4049/jimmunol.1302011
NR 46
TC 3
Z9 3
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3902
EP 3910
DI 10.1016/j.vaccine.2019.05.026
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900021
PM 31174937
DA 2020-05-12
ER

PT J
AU Andrasik, M
   Grove, D
   Broder, G
   Scott, H
   Allen, M
   Karuna, S
AF Andrasik, Michele
   Grove, Doug
   Broder, Gail
   Scott, Hyman
   Allen, Mary
   Karuna, Shelly
TI A descriptive analysis of transgender participants in phase 1-2a trials
   of the HIV Vaccine Trials Network (HVTN) in the United States and Peru
SO VACCINE
LA English
DT Article
DE Transgender; HIV prevention; HIV/AIDS; Vaccine clinical trials;
   Biomedical interventions
ID WOMEN; INFECTION; BARRIERS; HEALTH; FACILITATORS; PREVALENCE; PEOPLE;
   BURDEN; CARE
AB Background: HIV disproportionately impacts transgender populations globally, creating challenges to inclusion in trials requiring low HIV risk profiles (LHRP) for acquisition. Our knowledge of transgender individuals with LHRP is limited. We conducted an analysis of transgender and cisgender individuals in HVTN trials enrolling individuals with LHRP.
   Methods: We analyzed data from 694 participants enrolled in the phase 1-2a HVTN trials in the US and Peru from 2009 to 2014 that included individuals who reported gender identity (GI) differing from assigned birth sex (transgender [TG]), and compared them with those who reported a congruent GI (cisgender [CG]).
   Results: 681 participants (98%) were CG and 13 (2%) were TG. Mean age was 25 years. 16% were Hispanic and most (69%) were White. Reasons for enrolling included to help find an effective vaccine (TG 100%; CG 98%) and help their community (TG 100%; CG 96%). Significant differences by GI were observed in reported pre-existing conditions (p = 0.004); however, approximately 10% of pre-existing conditions reported by TG were GI-related (e.g., gender dysphoria). Significant differences were observed in hormone therapy use (p < 0.001) and mental health medications (p = 0.007). Retention was excellent with 2.1% missed visits and no discontinuations of vaccination for TG and 3% missed visits and 7.1% discontinuations among CG. There was no statistically significant difference in HIV incidence.
   Conclusions: Primary reasons for participation were altruistic for all participants. Comparable to CG counterparts, TG participants maintained LHRP, followed trial procedures, and had high retention, facilitating meaningful early phase HIV preventive vaccine trial contributions. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Andrasik, Michele; Broder, Gail; Karuna, Shelly] Fred Hutch HIV Vaccine Trials Network, Seattle, WA 98104 USA.
   [Grove, Doug] Stat Ctr HIV AIDS Res & Prevent, Fred Hutch, Seattle, WA USA.
   [Scott, Hyman] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA.
   [Allen, Mary] NIAID, NIH, Baltimore, MD USA.
RP Andrasik, M (reprint author), Fred Hutch HIV Vaccine Trials Network, Seattle, WA 98104 USA.
EM mandrasik@fredhutch.org; dgrove@scharp.org; gbroder@fredhutch.org;
   hyman.scott@sfdph.org; MAllen@niaid.nih.gov; mkaruna@fredhutch.org
FU US National Institute of Allergies and Infectious Diseases (NIAID)
   [5UM1A1068614]
FX Many thanks to all of the participants who generously contribute to our
   clinical trials and advance this important work. This publication
   resulted from research for the Leadership Group for a Global HIV Vaccine
   Clinical Trials Network supported by the US National Institute of
   Allergies and Infectious Diseases (NIAID) grant number 5UM1A1068614. We
   would like to sincerely thank the HIV Vaccine Trials Network US-and
   Peru-based Clinical Research Site (CRS) staff who collected the data.
   Clinical Research Sites include: Alabama Vaccine Research Clinic at
   University of Alabama, Birmingham, AL; Asociacion Civil Selva Amazonica,
   Iquitos, Peru; Bridge HIV at the San Francisco Department of Public
   Health, San Francisco, CA; Brigham and Women's Hospital, Boston, MA;
   Columbia Research Unit at Columbia University Medical Center, New York,
   NY; The Hope Clinic Emory Vaccine Center at Emory University, Atlanta,
   GA; lmpacta-Barranco, Lima, Peru; Project Achieve at the New York Blood
   Center, New York, NY; Project WISH at University of Illinois, Chicago,
   IL; Rochester Victory Alliance at University of Rochester Medical
   Center, Rochester, NY; Seattle Vaccine Trials Unit of the Fred
   Hutchinson Cancer Research Center and the University of Washington,
   Seattle, WA; HIV Prevention Research Division at University of
   Pennsylvania, Philadelphia, PA; and the Vanderbilt HIV Vaccine Program
   at Vanderbilt University, Nashville, TN.
CR Andrasik MP, 2014, PREV SCI, V15, P268, DOI 10.1007/s11121-013-0371-0
   Ayala DV, 2017, AM J PUBLIC HEALTH, V107, pE9, DOI 10.2105/AJPH.2017.303776
   Baral S, 2012, J INT AIDS SOC, V15, P98
   Castillo R, 2015, JAIDS-J ACQ IMM DEF, V69, P567, DOI 10.1097/QAI.0000000000000667
   Deutsch MB, 2015, LANCET HIV, V2, pE512, DOI 10.1016/S2352-3018(15)00206-4
   Glen F., 2012, TECHNICAL NOTE MEASU
   Grant J, 2011, INJUSTICE EVERY TURN
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566
   Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3
   Hodder SL, 2013, ANN INTERN MED, V158, P10, DOI 10.7326/0003-4819-158-1-201301010-00004
   Institute of Medicine (IOM), 2011, HLTH LESB GAY BISEX
   James SE, 2016, REPORT 2015 US TRANS
   Kuyper L, 2014, ARCH SEX BEHAV, V43, P377, DOI 10.1007/s10508-013-0140-y
   Mayer KH, 2016, JAIDS-J ACQ IMM DEF, V72, pS207, DOI 10.1097/QAI.0000000000001086
   Murad MH, 2010, CLIN ENDOCRINOL, V72, P214, DOI 10.1111/j.1365-2265.2009.03625.x
   Poteat T, 2016, JAIDS-J ACQ IMM DEF, V72, pS210, DOI 10.1097/QAI.0000000000001087
   Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X
   Reisner SL, 2016, JAIDS-J ACQ IMM DEF, V72, pS235, DOI 10.1097/QAI.0000000000001088
   Reisner SL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1224
   Salazar X, 2013, SALUD SEXUAL REPROD
   Salazar X, 2010, PERSONAS T EPIDEMIA
   Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8
   Thomas R, 2017, B WORLD HEALTH ORGAN, V95, P154, DOI [10.2471/blt.16.183913, 10.2471/BLT.16.183913]
   Van Caenegem E, 2015, ARCH SEX BEHAV, V44, P1281, DOI 10.1007/s10508-014-0452-6
   Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8
NR 26
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3911
EP 3917
DI 10.1016/j.vaccine.2019.05.016
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900022
PM 31176538
DA 2020-05-12
ER

PT J
AU Markowitz, LE
   Naleway, AL
   Lewis, RM
   Crane, B
   Querec, TD
   Weinmann, S
   Steinau, M
   Unger, ER
AF Markowitz, Lauri E.
   Naleway, Allison L.
   Lewis, Rayleen M.
   Crane, Bradley
   Querec, Troy D.
   Weinmann, Sheila
   Steinau, Martin
   Unger, Elizabeth R.
TI Declines in HPV vaccine type prevalence in women screened for cervical
   cancer in the United States: Evidence of direct and herd effects of
   vaccination
SO VACCINE
LA English
DT Article
DE Human papillomavirus; HPV vaccine; HPV prevalence; Herd effects; Vaccine
   impact
ID HUMAN-PAPILLOMAVIRUS VACCINATION; NUTRITION EXAMINATION SURVEY;
   CARE-DELIVERY SYSTEM; NATIONAL-HEALTH; ADVISORY-COMMITTEE;
   RECOMMENDATIONS; PROTECTION; REDUCTION; AUSTRALIA; PROGRAMS
AB Background: Human papillomavirus (HPV) vaccine has been recommended in the United States since 2006 for routine vaccination of girls at age 11-12 years and through age 26 years for women not previously vaccinated. Changes in vaccine-type HPV (VT) prevalence can be used to evaluate vaccine impact, including herd effects.
   Methods: We determined type-specific HPV in cytology specimens from women aged 20-29 years screened for cervical cancer at Kaiser Permanente Northwest in 2007 and in two vaccine era periods: 2012-2013 and 2015-2016. Detection and typing used Ll consensus PCR with hybridization for 37 types, including quadrivalent vaccine types (HPV 6/11/16/18).
   Results: Among 20-24 year-olds in 2012-2013 and 2015-2016, 44% and 64% had a history of >= 1-dose vaccination. VT prevalence decreased from 13.1% in 2007 to 2.9% in 2015-2016 (prevalence ratio [PR] = 0.22; 95% confidence interval [CI] 0.17-0.29). HPV 31 prevalence was also lower in the vaccine periods compared with 2007. VT prevalence in 2015-2016 among 20-24 year-olds was lower in both vaccinated, 1.3% (PR = 0.10; 95% CI 0.06-0.16), and unvaccinated women, 5.8% (PR = 0.45; 95% CI 0.33-0.61). Among 25-29 year-olds, 21% and 32% had a history of >= 1-dose vaccination. VT prevalence decreased from 8.1% in 2007 to 5.0% in 2015-2016 (PR = 0.62; 95% CI 0.50-0.78). Non-VT high risk prevalence was higher in the vaccine periods compared with the pre-vaccine era in both age groups, however, not in 2015-2016 compared with 2012-2013.
   Conclusion: Within 9-10 years of vaccine introduction, VT prevalence decreased 78% among 20-24 year-olds and 38% in 25-29 year-olds. There were declines in both vaccinated and unvaccinated women, showing evidence of direct and herd protection. Published by Elsevier Ltd.
C1 [Markowitz, Lauri E.; Lewis, Rayleen M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd, Atlanta, GA 30329 USA.
   [Naleway, Allison L.; Crane, Bradley; Weinmann, Sheila] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97227 USA.
   [Lewis, Rayleen M.] Synergy Amer Inc, Duluth, GA 30097 USA.
   [Querec, Troy D.; Steinau, Martin; Unger, Elizabeth R.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA.
   [Steinau, Martin] Ctr Dis Control & Prevent, Natl Ctr Global Hlth, Atlanta, GA 30329 USA.
RP Markowitz, LE (reprint author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd, Atlanta, GA 30329 USA.
EM LEM2@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX This work was supported by the Centers for Disease Control and
   Prevention.
CR Benard VB, 2017, JAMA ONCOL, V3, P833, DOI 10.1001/jamaoncol.2016.3609
   Drolet M, 2017, J INFECT DIS, V216, P1205, DOI 10.1093/infdis/jix476
   Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4
   Dunne EF, 2015, J INFECT DIS, V212, P1970, DOI 10.1093/infdis/jiv342
   Dunne EF, 2013, CANCER CAUSE CONTROL, V24, P403, DOI 10.1007/s10552-012-0085-9
   Flagg EW, 2016, AM J PUBLIC HEALTH, V106, P2211, DOI 10.2105/AJPH.2016.303472
   Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341
   Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587
   Kavanagh K, 2017, LANCET INFECT DIS, V17, P1293, DOI 10.1016/S1473-3099(17)30468-1
   Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968
   Markowitz LE, 2014, MMWR RECOMM REP, V63, P1
   Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192
   Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5
   Mesher D, 2018, J INFECT DIS, V218, P911, DOI 10.1093/infdis/jiy249
   Mesher D, 2016, EMERG INFECT DIS, V22, P1732, DOI 10.3201/eid2210.160675
   Murray Horwitz Mara E, 2018, Am J Public Health, V108, pS336, DOI [10.2105/ajph.2018.304556, 10.2105/AJPH.2018.304556]
   Oliver SE, 2017, J INFECT DIS, V216, P594, DOI 10.1093/infdis/jix244
   Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI 10.1309/AJCPTGD94EVRSJCG
   Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2
   Walker TY, 2017, MMWR-MORBID MORTAL W, V66, P874, DOI 10.15585/mmwr.mm6633a2
NR 20
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3918
EP 3924
DI 10.1016/j.vaccine.2019.04.099
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900023
PM 31160099
DA 2020-05-12
ER

PT J
AU Ng, YX
   Nandar, K
   Chua, LAV
   Mak, TM
   Foo, K
   Muhammad, IR
   Low, CKK
   Ma, S
   Ooi, SPL
   Lin, RTP
   James, L
   Lee, VJM
AF Ng, Yixiang
   Nandar, Khine
   Chua, Lily Ai Vee
   Mak, Tze Minn
   Foo, Kelly
   Muhammad, Imran Roshan
   Low, Constance Khia Ki
   Ma, Stefan
   Ooi, Steven Peng-Lim
   Lin, Raymond Tzer Pin
   James, Lyn
   Lee, Vernon Jian Ming
TI Evaluating the effectiveness of the influenza vaccine during respiratory
   outbreaks in Singapore's long term care facilities, 2017
SO VACCINE
LA English
DT Article
DE Influenza vaccine; Effectiveness; 2017; Test-negative design; Tropics;
   Outbreak investigation
ID PROTECTION; DESIGN
AB Influenza outbreaks occur periodically in Long Term Care Facilities (LTCFs) and vaccination is critical in preventing influenza infections. We evaluated the influenza vaccine effectiveness (VE) during respiratory outbreaks in LTCFs reported to the Ministry of Health, Singapore in 2017.
   A test-negative design was used to estimate the ratio of the odds of testing positive for influenza among vaccinated individuals to the odds among unvaccinated individuals. The VE was calculated as (1-odds ratio) x 100%. For adjusted VE, the estimates were derived using logistic regression adjusted for age group, gender, month of illness, and number of days from date of illness onset till to swab collection date. Estimates by influenza subtypes and post-vaccination time periods (15-180 days & 181-365 days) were also calculated using stratified data.
   264 individuals, with 118 laboratory-confirmed influenza cases [32 A(H1N1)pdm09, 75 A(H3N2), 11 A (untypable)], were included in the analysis. No one was identified to be infected with influenza B. The overall adjusted VE estimate was 40.5% (95% CI: -12.2-68.5%), while the subtype-specific adjusted VE estimates were -43.4% (95% CI: -312.4-50.2%) against A(H1N1)pdm09 and 57.1% (95% CI: 5.7-80.5%) against A(H3N2). At 15-180 days post-vaccination period, the adjusted VEs were 59.3% (95% CI: 18.0-79.8%) against all influenza, 35.4% (95% CI: -123.5-81.3%) against A(H1N1)pdm09 and 67.9% (95% CI: 22.5-86.7%) against A(H3N2). Estimates were not significant at 181-365 days post-vaccination.
   The influenza vaccine showed varying effectiveness among individuals in Singapore's LTCFs in 2017, with a higher effectiveness among those who were more recently vaccinated. It remains an important tool in preventing influenza infections, especially for those who are at high risk of influenza-related complications. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ng, Yixiang; Chua, Lily Ai Vee; Ma, Stefan; James, Lyn] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore.
   [Nandar, Khine; Foo, Kelly; Muhammad, Imran Roshan; Low, Constance Khia Ki; Ooi, Steven Peng-Lim; Lee, Vernon Jian Ming] Minist Hlth, Communicable Dis Div, Singapore, Singapore.
   [Mak, Tze Minn; Lin, Raymond Tzer Pin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore.
RP Ng, YX (reprint author), Minist Hlth Singapore, Epidemiol & Dis Control Div, Coll Med Bldg,16 Coll Rd, Singapore 169854, Singapore.
EM NG_yixiang@moh.gov.sg
OI Ng, Yixiang/0000-0003-4490-9374; Mak, Tze Minn/0000-0002-8249-8353
CR Ambrose C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081215
   Ang LW, 2016, J MED VIROL, V88, P2069, DOI 10.1002/jmv.24566
   Bond HS, 2016, EPIDEMIOL INFECT, V144, P1601, DOI 10.1017/S095026881500309X
   Castilla J, 2013, EUROSURVEILLANCE, V18, P17
   Doern CD, 2013, J CLIN MICROBIOL, V51, P4036, DOI 10.1128/JCM.02546-13
   Flannery B, 2017, MMWR-MORBID MORTAL W, V66, P167, DOI 10.15585/mmwr.mm6606a3
   Foppa IM, 2016, INT J EPIDEMIOL, V45, P2052, DOI 10.1093/ije/dyw022
   Fukushima W, 2017, VACCINE, V35, P4796, DOI 10.1016/j.vaccine.2017.07.003
   Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003
   Lewnard JA, 2018, AM J EPIDEMIOL, V187, P2686, DOI 10.1093/aje/kwy163
   Ministry of Health Singapore, 2017, INT LONG TERM CAR SE
   Ministry of Health. Singapore, 2018, SEAS INFL VACC 2018
   Ministry of Health Singapore, 2018, COMM DIS SURV SING 2
   Ministry of Health Singapore, 2017, MOH EST NAT AD IMM S
   Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736
   Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X
   Public Health England, 2017, INFL VACC EFF AD CHI
   R Core Team, 2016, R LANG ENV STAT COMP
   Radin JM, 2016, VACCINE, V34, P3907, DOI 10.1016/j.vaccine.2016.05.034
   Sullivan SG, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.43.17-00707
   Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958
   WHO, 2017, EV INFL VACC EFF GUI
   World Health Organization, 2017, INFL WHICH VACC FORM
   World Health Organization, 2018, INFL SEAS FACT SHEET
   World Health Organization (WHO), 2016, REC COMP INFL VIR VA
   Young B, 2018, J INFECT DIS, V217, P731, DOI 10.1093/infdis/jix632
   Young B, 2017, VACCINE, V35, P212, DOI 10.1016/j.vaccine.2016.11.013
NR 27
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 27
PY 2019
VL 37
IS 29
BP 3925
EP 3931
DI 10.1016/j.vaccine.2019.03.054
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IF3MM
UT WOS:000472984900024
PM 31160102
DA 2020-05-12
ER

PT J
AU Zeng, LL
   Liu, Q
   Luo, L
   Liu, L
   Tang, KW
AF Zeng, Lelin
   Liu, Qian
   Luo, Li
   Liu, Lian
   Tang, Kewen
TI Enhancement mechanism of an improved liquid membrane using selective
   permeation retardant for heavy metal ions separation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Enhancement mechanism; Liquid membrane; Selective permeation retardant;
   Metal ions separation; Supported liquid membrane
ID SOLVENT-EXTRACTION; P-NITROPHENOL; RARE-EARTHS; TRANSPORT; EQUILIBRIUM;
   EFFICIENT; RECOVERY; SYSTEM; ACID; OIL
AB Liquid membrane (LM) separation is a kinetic process that can be enhanced by increasing the difference between the permeation rates of the components. The addition of H(3)Cit/Na(3)Cit as a selective permeation retardant can enlarge the difference between the permeation rates of Cu(II) and Cd(II) ions when P507 was used as the extractant. This retardant is analogous to a masking agent employed in liquid-liquid extraction (LLE). However, the retardant mainly affects the LM's kinetics, while the masking agent impacts the LLE's equilibrium. It was found that the separation coefficient of the H(3)Cit/Na(3)Cit LM system could be much greater than that of the H(3)Cit/Na(3)Cit LLE system owing to the LM's kinetic effect. Following the addition of H(3)Cit/Na(3)Cit, the Cu(II) ion permeation rate was selectively retarded, and the LM selectivity of Cd(II)/Cu(II) was significantly enhanced in comparison with a control LM system. To reveal this enhancement mechanism, a new LM kinetic model was established in which the interfacial chemical reactions and mass transfer resistance in the middle connection zone of a H-type device were considered. The model's predictions agreed well with the experimental data. According to the model' quantitative analysis, the retardant affected the apparent reaction rate constants of Cd(II) and Cu(II) ions differently, and this is key to the enhancement mechanism. Aside from concentration, the LM model also predicted the variations in separation coefficient, purity, and yield with time. An optimal LM extraction time zone was defined to obtain high yield and high purity simultaneously. Finally, the enhanced LM was further verified and applied on a preliminary basis in a supported liquid membrane with strip dispersion, which is a LM technology with potential for industrial application. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zeng, Lelin; Liu, Qian; Luo, Li; Liu, Lian; Tang, Kewen] Hunan Inst Sci & Technol, Dept Chem & Chem Engn, Yueyang 414000, Hunan, Peoples R China.
RP Zeng, LL; Tang, KW (reprint author), Hunan Inst Sci & Technol, Dept Chem & Chem Engn, Yueyang 414000, Hunan, Peoples R China.
EM zenglelin2013@126.com; tangkewenhnist@sina.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21706059]; Provincial Natural Science Foundation Of
   China's Hunan Province [2018JJ3206]
FX This work was supported by the National Natural Science Foundation of
   China (No. 21706059) and the Provincial Natural Science Foundation Of
   China's Hunan Province (No. 2018JJ3206).
CR Abdelrahim MYM, 2017, J MEMBRANE SCI, V528, P225, DOI 10.1016/j.memsci.2017.01.033
   Akin I, 2012, J HAZARD MATER, V223, P24, DOI 10.1016/j.jhazmat.2012.03.043
   Anitha M, 2008, DESALINATION, V232, P59, DOI 10.1016/j.desal.2007.10.037
   Chang SH, 2011, CHEM ENG J, V173, P352, DOI 10.1016/j.cej.2011.07.062
   Chaudhury S, 2018, J MEMBRANE SCI, V545, P75, DOI 10.1016/j.memsci.2017.09.060
   Chen YC, 2015, IND ENG CHEM RES, V54, P3828, DOI 10.1021/ie503922f
   Guimaraes AS, 2018, HYDROMETALLURGY, V175, P250, DOI 10.1016/j.hydromet.2017.12.001
   Hao ZS, 2014, J MEMBRANE SCI, V468, P90, DOI 10.1016/j.memsci.2014.05.052
   Jagdale YD, 2013, DESALINATION, V325, P104, DOI 10.1016/j.desal.2013.06.014
   Jebur M, 2018, J MEMBRANE SCI, V556, P1, DOI 10.1016/j.memsci.2018.03.064
   Jiang B, 2017, J MEMBRANE SCI, V536, P123, DOI 10.1016/j.memsci.2017.05.004
   Jiao HP, 2013, DESALINATION, V313, P36, DOI 10.1016/j.desal.2012.12.002
   Koter S, 2013, SEP PURIF TECHNOL, V107, P135, DOI 10.1016/j.seppur.2013.01.032
   Kumar V, 2018, J IND ENG CHEM, V67, P109, DOI 10.1016/j.jiec.2018.06.021
   Ma M, 2004, J MEMBRANE SCI, V234, P101, DOI 10.1016/j.memsci.2004.01.014
   MA RJ, 2009, EXTRACTIVE METALLURG
   Madaeni SS, 2011, SEP PURIF TECHNOL, V81, P116, DOI 10.1016/j.seppur.2011.07.004
   Mahdavi HR, 2016, CHEM ENG PROCESS, V106, P50, DOI 10.1016/j.cep.2016.05.004
   Mason LR, 2013, MICROFLUID NANOFLUID, V14, P197, DOI 10.1007/s10404-012-1038-z
   Nathsarma KC, 2006, HYDROMETALLURGY, V84, P149, DOI 10.1016/j.hydromet.2006.05.004
   Pont L, 2016, J CHROMATOGR A, V1444, P145, DOI 10.1016/j.chroma.2016.03.052
   Rynkowska E., 2018, REV CHEM ENG, V341
   Sadyrbaeva TZ, 2015, DESALINATION, V365, P167, DOI 10.1016/j.desal.2015.02.036
   Shi QH, 2017, SEP PURIF TECHNOL, V181, P1, DOI 10.1016/j.seppur.2017.03.010
   Song N, 2018, DESALINATION, V437, P59, DOI 10.1016/j.desal.2018.02.024
   Sousa CS, 2010, HYDROMETALLURGY, V103, P114, DOI 10.1016/j.hydromet.2010.03.005
   Szczepanski P, 2018, CHEM ENG SCI, V185, P141, DOI 10.1016/j.ces.2018.04.007
   Szczepanski P, 2014, SEP PURIF TECHNOL, V132, P616, DOI 10.1016/j.seppur.2014.06.016
   Szczepanski P, 2013, J MEMBRANE SCI, V435, P1, DOI 10.1016/j.memsci.2013.02.004
   Tang KW, 2013, AICHE J, V59, P2594, DOI 10.1002/aic.14004
   Thakur NV, 1998, HYDROMETALLURGY, V48, P125, DOI 10.1016/S0304-386X(97)00061-3
   Tsai HH, 2011, J TAIWAN INST CHEM E, V42, P486, DOI 10.1016/j.jtice.2010.09.009
   Vilt ME, 2011, J MEMBRANE SCI, V367, P71, DOI 10.1016/j.memsci.2010.10.044
   Walkowlak W, 2009, DESALINATION, V240, P186, DOI 10.1016/j.desal.2007.12.041
   Wang WR, 2019, AICHE J, V65, P259, DOI 10.1002/aic.16419
   Ward TJ, 2012, ANAL CHEM, V84, P626, DOI 10.1021/ac202892w
   WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222
   Xie F, 2014, MINER ENG, V56, P10, DOI 10.1016/j.mineng.2013.10.021
   Zaheri P, 2015, CHEM ENG RES DES, V100, P81, DOI 10.1016/j.cherd.2015.05.016
   Zeng LL, 2018, CHEM ENG RES DES, V140, P261, DOI 10.1016/j.cherd.2018.10.036
   Zeng LL, 2015, IND ENG CHEM RES, V54, P9832, DOI 10.1021/acs.iecr.5b02788
NR 41
TC 3
Z9 3
U1 6
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 1
EP 14
DI 10.1016/j.ces.2019.02.017
PG 14
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900001
DA 2020-05-12
ER

PT J
AU Wang, TD
   Shan, JX
   Wang, L
   Zhang, XW
   Li, GZ
AF Wang, Tengda
   Shan, Jianxing
   Wang, Li
   Zhang, Xiangwen
   Li, Guozhu
TI On the kinetics of catalytic hydrogenation over Pd nanoparticles
   regulated by various nucleosides
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Nucleoside; Kinetics; L-H model; Catalytic hydrogenation; Turnover
   frequency; Linear free energy relationships
ID DNA; REDUCTION; 4-NITROPHENOL; SUPPORT; NANOSTRUCTURES; NANOCOMPOSITE;
   NANOCRYSTALS; NITROPHENOLS; NANOWIRES; REACTOR
AB Aqueous-phase hydrogenation of 4-nitrophenol (4-NIP) by H-2 has been investigated in the presence of Pd nanoparticles (NPs) regulated by small biological molecules. Nucleosides and their derivatives were employed as capping agents of Pd NPs, and their effect on Pd activity was evaluated. All four kinds of nucleosides exhibited obvious promoting effect on the activity of Pd NPs in comparison to that without any capping agent. The general promoting effect sequence of nucleosides and their derivatives on the activity of Pd NPs was nucleoside >= nucleotide > deoxynucleoside > base > deoxynucleotide. The quantitative correlation between the activity promoting effect and the structure of nucleosides and their derivatives were also studied using the method based on poly-parameter linear free energy relationships. Moreover, the kinetic behaviors of 4-NIP hydrogenation over Pd NPs regulated by different nucleosides (adenosine, guanosine, cytidine, and beta-thymidine) were studied systematically and different kinetic models were developed to fit the data. The obtained kinetic data fitted well to the Langmuir-Hinshelwood (L-H) model, where the surface reaction is the rate-controlling step. The apparent activation energy, adsorption enthalpy of 4-NIP, and dissociated adsorption enthalpy of hydrogen were calculated and compared for a better understanding of the mechanism. Pd NPs regulated by cytidine showed the lowest apparent activation energy of 43.66 kJ mol(-1). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Tengda; Shan, Jianxing; Wang, Li; Zhang, Xiangwen; Li, Guozhu] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Green Chem Technol, Minist Educ, Tianjin 300072, Peoples R China.
   [Wang, Li; Zhang, Xiangwen; Li, Guozhu] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.
RP Li, GZ (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Key Lab Green Chem Technol, Minist Educ, Tianjin 300072, Peoples R China.
EM gzli@tju.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21306132]
FX This work was supported by the research fund of the National Natural
   Science Foundation of China (21306132).
CR ABRAHAM MH, 1993, CHEM SOC REV, V22, P73, DOI 10.1039/cs9932200073
   ABRAHAM MH, 1994, J PHYS ORG CHEM, V7, P672, DOI 10.1002/poc.610071205
   Abraham MH, 2010, J PHARM SCI-US, V99, P1500, DOI 10.1002/jps.21922
   Antonels NC, 2013, LANGMUIR, V29, P13433, DOI 10.1021/la402885k
   Bawane SP, 2005, APPL CATAL A-GEN, V293, P162, DOI 10.1016/j.apcata.2005.07.004
   Bhandari R, 2012, CATAL SCI TECHNOL, V2, P256, DOI 10.1039/c1cy00350j
   Byun S, 2016, ACS APPL MATER INTER, V8, P14637, DOI 10.1021/acsami.6b05229
   Chiou JR, 2013, J HAZARD MATER, V248, P394, DOI 10.1016/j.jhazmat.2013.01.030
   Chiu CY, 2013, CHEM SOC REV, V42, P2512, DOI 10.1039/c2cs35347d
   Crespo-Quesada M, 2011, J AM CHEM SOC, V133, P12787, DOI 10.1021/ja204557m
   Fang C, 2007, SENSOR ACTUAT B-CHEM, V126, P684, DOI 10.1016/j.snb.2007.04.031
   Fu P, 2018, CHEMISTRYSELECT, V3, P3351, DOI 10.1002/slct.201800106
   Gao WP, 2018, NANO LETT, V18, P7004, DOI 10.1021/acs.nanolett.8b02953
   Geng YL, 2011, J MATER CHEM, V21, P12126, DOI 10.1039/c1jm11932j
   Ghosh S, 2018, DALTON T, V47, P17401, DOI 10.1039/c8dt03854f
   Gu Q, 2008, MATER LETT, V62, P3047, DOI 10.1016/j.matlet.2008.01.131
   Gu Q, 2006, PHYSICA E, V33, P92, DOI 10.1016/j.physe.2005.11.010
   Huang HW, 2017, ACS APPL MATER INTER, V9, P31203, DOI 10.1021/acsami.7b12018
   Jadbabaei N, 2017, APPL CATAL A-GEN, V543, P209, DOI 10.1016/j.apcata.2017.06.023
   Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901
   Kalekar AM, 2016, RSC ADV, V6, P11911, DOI 10.1039/c5ra23138h
   Karim AM, 2015, J PHYS CHEM C, V119, P13257, DOI 10.1021/acs.jpcc.5b01681
   Kundu S, 2017, DALTON T, V46, P9678, DOI 10.1039/c7dt01474k
   Li XD, 2014, CATAL SCI TECHNOL, V4, P3290, DOI 10.1039/c4cy00580e
   Li XX, 2018, CATAL LETT, V148, P3325, DOI 10.1007/s10562-018-2554-6
   Liu YH, 2016, LANGMUIR, V32, P13675, DOI 10.1021/acs.langmuir.6b03340
   Mallikarjuna K, 2017, COLLOID SURFACE A, V535, P194, DOI 10.1016/j.colsurfa.2017.09.045
   Narayanan RK, 2015, IND ENG CHEM RES, V54, P1197, DOI 10.1021/ie5038352
   Niu ZQ, 2014, CHEM MATER, V26, P72, DOI 10.1021/cm4022479
   Noh JH, 2014, APPL SURF SCI, V320, P400, DOI 10.1016/j.apsusc.2014.09.058
   Ohara S, 2011, ADV POWDER TECHNOL, V22, P559, DOI 10.1016/j.apt.2011.05.006
   Rode CV, 2001, CHEM ENG SCI, V56, P1299, DOI 10.1016/S0009-2509(00)00352-3
   Rusling DA, 2014, ANGEW CHEM INT EDIT, V53, P3979, DOI 10.1002/anie.201309914
   Saha S, 2010, LANGMUIR, V26, P2885, DOI 10.1021/la902950x
   Sakaguchi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01442-8
   Satyavolu NSR, 2016, J AM CHEM SOC, V138, P16542, DOI 10.1021/jacs.6b10983
   Song TJ, 2015, ANGEW CHEM INT EDIT, V54, P8114, DOI 10.1002/anie.201500838
   Vaidya MJ, 2003, ORG PROCESS RES DEV, V7, P202, DOI 10.1021/op025589w
   Vincent T, 2003, LANGMUIR, V19, P8475, DOI 10.1021/la034364r
   Wang W, 2017, CHEM SCI, V8, P3310, DOI 10.1039/c7sc00069c
   Wunder S, 2011, ACS CATAL, V1, P908, DOI 10.1021/cs200208a
   Xia JW, 2016, APPL CATAL B-ENVIRON, V180, P408, DOI 10.1016/j.apcatb.2015.06.043
   YAO HC, 1959, J AM CHEM SOC, V81, P4125, DOI 10.1021/ja01525a001
   Yeh CC, 2014, APPL CATAL B-ENVIRON, V150, P298, DOI 10.1016/j.apcatb.2013.12.040
   Yun S, 2016, ACS CATAL, V6, P2435, DOI 10.1021/acscatal.5b02613
   Zang WT, 2015, CATAL SCI TECHNOL, V5, P2532, DOI 10.1039/c4cy01619j
   Zhang F, 2014, J AM CHEM SOC, V136, P11198, DOI 10.1021/ja505101a
   Zheng JS, 2018, J ELECTROANAL CHEM, V816, P189, DOI 10.1016/j.jelechem.2018.03.056
   Zong Z, 2018, J CATAL, V361, P168, DOI 10.1016/j.jcat.2018.02.020
NR 49
TC 1
Z9 1
U1 5
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 15
EP 24
DI 10.1016/j.ces.2019.02.014
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900002
DA 2020-05-12
ER

PT J
AU Guo, YL
   Zhao, ZK
AF Guo, Yongle
   Zhao, Zhongkui
TI Hierarchical H beta zeolite as a highly efficient solid acid catalyst
   for alkenylation of p-xylene with phenylacetylene
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hierarchical beta zeolite; Steam-assisted conversion; Modulation and
   optimization; Heterogeneous catalysis; Alkenylation
ID FRIEDEL-CRAFTS ALKENYLATION; DIVERSE AROMATICS; ARENES; ACTIVATION;
   LA2O3-ZRO2; CARBON
AB In this work, using phenylacetylene as alkenylating agent, the alkenylation of p-xylene on a series of hierarchical H beta (Hier-H beta) zeolites prepared by a modified steam-assisted conversion (SAC) method under different preparation conditions was firstly investigated. Various characterization techniques including X-ray diffraction (XRD), X-ray fluorescence (XRF), argon adsorption-desorption, ammonia temperature-programmed desorption (NH3-TPD), pyridine-IR (Py-IR), and thermogravimetric Analysis (TGA) were adopted to discover the relationship of structure-performance in alkenylation. The results demonstrate that the optimized Hier-H beta zeolite exhibits an outstanding alkenylation catalytic performance, which is much better than the traditional microporous H beta zeolite. It can be found that the alkenylation catalytic properties of the as-prepared Hier-H beta zeolites are dramatically affected by their properties of acidic sites and textural properties, which are significantly dependent on the preparation process parameters for SAC process. Moreover, the spent Hier-H beta zeolite catalyst can be completely refreshed by a simple calcination method. In a word, the optimized Hier-H beta catalyst prepared by a modified SAC approach demonstrates great potential to promote alkenylation of aromatics with alkynes to their corresponding alkylaromatics. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Guo, Yongle; Zhao, Zhongkui] Dalian Univ Technol, Sch Chem Engn, Dept Catalysis Chem & Engn, State Key Lab Fine Chem, 2 Linggong Rd, Dalian 116024, Peoples R China.
RP Zhao, ZK (reprint author), Dalian Univ Technol, Sch Chem Engn, Dept Catalysis Chem & Engn, State Key Lab Fine Chem, 2 Linggong Rd, Dalian 116024, Peoples R China.
EM zkzhao@dlut.edu.cn
RI Zhao, Zhongkui/J-5669-2015
OI Zhao, Zhongkui/0000-0001-6529-5020
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21276041, U1610104]; Chinese Ministry of Education
   via the Program for New Century Excellent Talents in University
   [NCET-12-0079]
FX This work is financially supported by the National Natural Science
   Foundation of China (Grant nos. 21276041 and U1610104) and the Chinese
   Ministry of Education via the Program for New Century Excellent Talents
   in University (Grant no. NCET-12-0079).
CR Bohstrom Z, 2013, J MOL CATAL A-CHEM, V366, P64, DOI 10.1016/j.molcata.2012.09.009
   Boyarskiy VP, 2016, CHEM REV, V116, P5894, DOI 10.1021/acs.chemrev.5b00514
   Choi DS, 2007, CHEM COMMUN, P3482, DOI 10.1039/b705719a
   Egeblad K, 2008, CHEM MATER, V20, P946, DOI 10.1021/cm702224p
   Jia CG, 2000, SCIENCE, V287, P1992, DOI 10.1126/science.287.5460.1992
   Kostrab G, 2008, APPL CATAL A-GEN, V335, P74, DOI 10.1016/j.apcata.2007.11.019
   Kowalska-Kus J, 2017, J MOL CATAL A-CHEM, V426, P205, DOI 10.1016/j.molcata.2016.11.018
   Li RS, 2007, ORG LETT, V9, P2219, DOI 10.1021/ol070737u
   Liu ZH, 2015, ACS CATAL, V5, P5837, DOI 10.1021/acscatal.5b01350
   Loenders R, 1998, J CATAL, V176, P545, DOI 10.1006/jcat.1998.2045
   Lucas N, 2009, APPL CATAL A-GEN, V352, P74, DOI 10.1016/j.apcata.2008.09.032
   Majano G, 2005, MICROPOR MESOPOR MAT, V80, P227, DOI 10.1016/j.micromeso.2004.12.019
   Matsukata M, 2002, MICROPOR MESOPOR MAT, V56, P1, DOI 10.1016/S1387-1811(02)00412-2
   Moller K, 2011, CHEM MATER, V23, P4301, DOI 10.1021/cm103533e
   Moller K, 2011, J AM CHEM SOC, V133, P5284, DOI 10.1021/ja108698s
   Ranirez J. P., 2008, CHEM SOC REV, V37, P2530
   Ryabukhin DS, 2014, TETRAHEDRON, V70, P6428, DOI 10.1016/j.tet.2014.07.028
   SARTORI G, 1995, TETRAHEDRON LETT, V36, P9177, DOI 10.1016/0040-4039(95)01934-A
   Serrano DP, 2013, CHEM SOC REV, V42, P4004, DOI 10.1039/c2cs35330j
   Shchukin AO, 2010, RUSS J ORG CHEM+, V46, P82, DOI 10.1134/S1070428010010082
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Tang S, 2015, CHEM SOC REV, V44, P1070, DOI 10.1039/c4cs00347k
   Tian QW, 2016, ADV FUNCT MATER, V26, P1881, DOI 10.1002/adfm.201504888
   Tischler O, 2017, J MOL CATAL A-CHEM, V426, P444, DOI 10.1016/j.molcata.2016.09.018
   Tsuchimoto T, 2000, CHEM COMMUN, P1573, DOI 10.1039/b003702h
   Verboekend D, 2011, CATAL SCI TECHNOL, V1, P879, DOI 10.1039/c1cy00150g
   Yang H, 2016, CHEM ENG J, V299, P112, DOI 10.1016/j.cej.2016.04.009
   Zhang JL, 2016, CHEM ENG J, V291, P82, DOI 10.1016/j.cej.2016.01.088
   Zhao Z, 2013, ENERG SOURCE PART A, V35, P1761, DOI 10.1080/15567036.2010.531503
   Zhao ZK, 2017, CATAL COMMUN, V93, P53, DOI 10.1016/j.catcom.2017.02.001
   Zhao ZK, 2016, APPL CATAL A-GEN, V526, P139, DOI 10.1016/j.apcata.2016.08.028
   Zhao ZK, 2016, CHINESE J CATAL, V37, P1303, DOI 10.1016/S1872-2067(15)61118-4
   Zhao ZK, 2016, RSC ADV, V6, P9072, DOI 10.1039/c5ra26432d
   Zhao ZK, 2015, APPL CATAL A-GEN, V503, P103, DOI 10.1016/j.apcata.2015.07.007
   Zhao ZK, 2015, APPL CATAL A-GEN, V503, P77, DOI 10.1016/j.apcata.2015.01.023
   Zhao ZK, 2012, J CATAL, V288, P44, DOI 10.1016/j.jcat.2011.12.024
NR 36
TC 2
Z9 2
U1 11
U2 86
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 25
EP 33
DI 10.1016/j.ces.2019.02.023
PG 9
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900003
DA 2020-05-12
ER

PT J
AU Tang, M
   Zhang, SF
   Wang, DW
   Liu, Y
   Zhang, YS
   Wang, LS
   Liu, C
AF Tang, Meng
   Zhang, Shaofeng
   Wang, Dewu
   Liu, Yan
   Zhang, Yishuo
   Wang, Lusha
   Liu, Chen
TI CFD simulation of gas flow field distribution and design optimization of
   the tridimensional rotational flow sieve tray with different structural
   parameters
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE TRST; CFD simulation; Gas flow field distribution; Structure
   optimization; Rotational flow; Flow through perforations
ID MASS-TRANSFER; PRESSURE-DROP; HYDRODYNAMICS; DISTILLATION; HYDRAULICS;
   TURBULENCE; HEAT
AB Using CFD simulation, we first investigated the flow field distribution of the tridimensional rotational flow sieve tray (TRST) under different structural parameters (i.e. number of the blades, twist angle of the blades, tray height and sieve hole diameter) and installation methods (forward and backward) when gas flows downward through the TRST. Secondly, we carried out a comparative study of three modified structures of the tray, i.e. no supporting ring, a closed internal cylinder and no sieve holes present. Finally, we studied the transformed situations of the rotational flow and propose a dimensionless correlation to evaluate the performance of the tray. The results show that, apart from the tray with a smaller twist angle of the blade, the gas flow field distributions for all the other types of trays are similar. When two trays are installed, the gas flow field of the second tray in a forward installation is obviously different to that of a backward installation. The transformed position of the rotational flow for most types of trays is about half the depth of the tray. After comprehensive evaluation, the optimized tray structures are identified as a configuration with 8 blades, a 90 degrees twist angle of the blades, a tray height of 40 mm, and sieve holes of 5 mm diameter. In addition, the tray should have open internal cylinder without a supporting ring. When a multi-tray is installed, the backward installation method should be adopted. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Tang, Meng; Zhang, Shaofeng; Wang, Dewu; Liu, Yan; Zhang, Yishuo; Wang, Lusha; Liu, Chen] Hebei Univ Technol, Chem Engn Inst, Tianjin 300401, Peoples R China.
RP Zhang, SF (reprint author), Hebei Univ Technol, Chem Engn Inst, Tianjin 300401, Peoples R China.
EM 1986037@hebut.edu.cn
FU Chinese National Natural Science FoundationNational Natural Science
   Foundation of China [21776055]; Graduate Innovation Project of Hebei
   Province, China [CXZZBS2017030]
FX This work was supported by the Chinese National Natural Science
   Foundation [grant number 21776055]; and the Graduate Innovation Project
   of Hebei Province, China [grant number CXZZBS2017030].
CR Besbes S, 2015, CHEM ENG SCI, V126, P560, DOI 10.1016/j.ces.2014.12.046
   Brahem R, 2013, CHEM ENG SCI, V100, P23, DOI 10.1016/j.ces.2013.03.030
   Fluent I. E, 2012, FLUENT 14 5 US GUID
   Gesit G, 2003, AICHE J, V49, P910, DOI 10.1002/aic.690490410
   KESTIN J, 1971, J HEAT TRANSF, V93, P321, DOI 10.1115/1.3449823
   Kolhe NS, 2011, CHEM ENG RES DES, V89, P1909, DOI 10.1016/j.cherd.2011.01.020
   KONDJOYAN A, 1995, INT J HEAT MASS TRAN, V38, P1735, DOI 10.1016/0017-9310(94)00338-V
   Krishna R, 1999, CHEM ENG RES DES, V77, P639, DOI 10.1205/026387699526575
   Larachi F, 2003, IND ENG CHEM RES, V42, P222, DOI 10.1021/ie020416g
   Li H, 2016, CHEM ENG TECHNOL, V39, P815, DOI 10.1002/ceat.201500656
   Li QS, 2016, CHEM ENG SCI, V143, P23, DOI 10.1016/j.ces.2015.12.014
   Mayer FD, 2014, IND ENG CHEM RES, V53, P8323, DOI 10.1021/ie5010543
   Olujic Z, 2009, CHEM ENG PROCESS, V48, P1089, DOI 10.1016/j.cep.2009.03.004
   Rahimi R, 2012, CHEM ENG SCI, V76, P90, DOI 10.1016/j.ces.2012.01.006
   Said W, 2011, CHEM ENG SCI, V66, P2107, DOI 10.1016/j.ces.2011.02.011
   Shi WD, 2016, CHEM ENG SCI, V143, P206, DOI 10.1016/j.ces.2016.01.005
   Springer PAM, 2003, CHEM ENG RES DES, V81, P413, DOI 10.1205/026387603765173682
   Tang M, 2018, CHEM ENG SCI, V191, P383, DOI 10.1016/j.ces.2018.06.080
   Tang M, 2017, CHEM ENG RES DES, V126, P241, DOI 10.1016/j.cherd.2017.08.026
   van Baten JM, 2000, CHEM ENG J, V77, P143, DOI 10.1016/S1385-8947(99)00164-3
   Wang HH, 2017, CHEM ENG PROCESS, V112, P38, DOI 10.1016/j.cep.2017.01.002
   [许晓平 XU Xiao-ping], 2009, [飞行力学, Flight Dynamics], V27, P87
   Zarei A, 2013, CHEM ENG RES DES, V91, P2333, DOI 10.1016/j.cherd.2013.03.006
   Zarei A, 2013, J TAIWAN INST CHEM E, V44, P27, DOI 10.1016/j.jtice.2012.10.004
   Zarei T, 2017, KOREAN J CHEM ENG, V34, P969, DOI 10.1007/s11814-017-0004-6
   Zarei T, 2017, KOREAN J CHEM ENG, V34, P150, DOI 10.1007/s11814-016-0250-z
   Zhang M, 2017, CHEM ENG PROCESS, V120, P330, DOI 10.1016/j.cep.2017.07.022
NR 27
TC 0
Z9 0
U1 3
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 34
EP 49
DI 10.1016/j.ces.2019.01.049
PG 16
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900004
DA 2020-05-12
ER

PT J
AU Zhang, HY
   Liu, CJ
   Chen, L
   Dai, B
AF Zhang, Haiyan
   Liu, Chunjie
   Chen, Liang
   Dai, Bin
TI Control of ice crystal growth and its effect on porous structure of
   chitosan cryogels
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Crystal growth; Cryogels; Morphology; Pore size; Chitosan
ID CRYSTALLIZATION; SEPARATION; SCAFFOLDS; AFFINITY; BIOREACTOR; SLURRIES;
   NETWORK; MASS
AB We presented an improved preparation method to generate cryogels with controllable pore size. It included 5 stages: pre-cooling, pre-crystallization, crystal growth, freezing, and thawing (PPCFT); crystal growth was the key step. Chitosan (CS) cryogels with uniform and honeycomb-like structures were prepared with the method, and then the properties of these cryogels were studied. The results demonstrated that the mean pore diameters of CS cryogels were successfully controlled in a wide range (approximately 60-240 mu m, by scanning electron microscope) by simply varying the temperature and time of crystal growth. The crystal growth law of this process was described by an empirical equation based on the classical theory for Ostwald ripening by Lifshitz, Slyozov, and Wagner (LSW). Furthermore, the hydrodynamics performance (permeability and column efficiency) of CS cryogel columns clearly varied with crystal growth conditions, while both the accessible porosity and water absorption ratio remained at a high level. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhang, Haiyan; Liu, Chunjie; Chen, Liang; Dai, Bin] Shihezi Univ, Sch Chem & Chem Engn, Key Lab Green Proc Chem Engn Xinjiang Bingtuan, Shihezi 832000, Peoples R China.
RP Chen, L; Dai, B (reprint author), Shihezi Univ, Sch Chem & Chem Engn, Key Lab Green Proc Chem Engn Xinjiang Bingtuan, Shihezi 832000, Peoples R China.
EM chliang@shzu.edu.cn; db_tea@shzu.edu.cn
OI Chen, Liang/0000-0001-8279-9212; liu, chunjie/0000-0001-9148-5274
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [21206094]
FX This work was supported by the Natural Science Foundation of China [No.
   21206094].
CR Akyurt M, 2002, ENERG CONVERS MANAGE, V43, P1773, DOI 10.1016/S0196-8904(01)00129-7
   Andac M, 2016, J CHROMATOGR B, V1021, P69, DOI 10.1016/j.jchromb.2015.09.034
   Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004
   Ayel V, 2005, INT J THERM SCI, V44, P11, DOI 10.1016/j.ijthermalsci.2004.04.012
   Bansal V, 2006, J MOL RECOGNIT, V19, P332, DOI 10.1002/jmr.785
   Brito ABN, 2007, CRYST RES TECHNOL, V42, P583, DOI 10.1002/crat.200610867
   Chabanon E, 2016, J MEMBRANE SCI, V509, P57, DOI 10.1016/j.memsci.2016.02.051
   Chang KH, 2013, ACTA BIOMATER, V9, P9012, DOI 10.1016/j.actbio.2013.06.046
   Choudhury S, 2015, ANAL METHODS-UK, V7, P6967, DOI 10.1039/c5ay01193k
   Dainiak MB, 2010, BIOMATERIALS, V31, P67, DOI 10.1016/j.biomaterials.2009.09.029
   Damania A, 2018, J BIOMED MATER RES B, V106, P259, DOI 10.1002/jbm.b.33851
   Delgado AE, 2001, J FOOD ENG, V47, P157, DOI 10.1016/S0260-8774(00)00112-6
   Dinu MV, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0285-3
   Dragan ES, 2014, CHEM ENG J, V243, P572, DOI 10.1016/j.cej.2014.01.065
   Elowsson L, 2012, J MATER SCI-MATER M, V23, P2489, DOI 10.1007/s10856-012-4713-4
   Erturk G, 2014, J CHROMATOGR A, V1357, P24, DOI 10.1016/j.chroma.2014.05.055
   Gun'ko VM, 2013, ADV COLLOID INTERFAC, V187, P1, DOI 10.1016/j.cis.2012.11.001
   Gutierrez MC, 2007, ADV FUNCT MATER, V17, P3505, DOI 10.1002/adfm.200700093
   He XJ, 2007, CHEM ENG SCI, V62, P1334, DOI 10.1016/j.ces.2006.11.027
   Hixon KR, 2017, ACTA BIOMATER, V62, P29, DOI 10.1016/j.actbio.2017.08.033
   Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010
   HUIGE NJJ, 1971, J CRYST GROWTH, V13, P483, DOI 10.1016/0022-0248(72)90285-0
   JONES AG, 1974, CHEM ENG SCI, V29, P105, DOI 10.1016/0009-2509(74)85036-0
   Kiani H, 2011, TRENDS FOOD SCI TECH, V22, P407, DOI 10.1016/j.tifs.2011.04.011
   Kim S, 2005, ORG PROCESS RES DEV, V9, P894, DOI 10.1021/op050091q
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Kirsebom H, 2007, J BIOACT COMPAT POL, V22, P621, DOI 10.1177/0883911507084293
   Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9
   Kumari J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41551
   LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3
   Lottin O, 2001, INT J REFRIG, V24, P455, DOI 10.1016/S0140-7007(00)00077-3
   LOZINSKY VI, 1982, COLLOID POLYM SCI, V260, P776, DOI 10.1007/BF01452068
   LOZINSKY VI, 2002, RUSS CHEM REV, V71, P489, DOI DOI 10.1070/RC2002V071N06ABEH000720
   Mohameed HA, 2002, CHEM ENG PROCESS, V41, P297, DOI 10.1016/S0255-2701(01)00145-3
   MULLIN JW, 1971, CHEM ENG SCI, V26, P369, DOI 10.1016/0009-2509(71)83012-9
   Nagy ZK, 2012, ANNU REV CHEM BIOMOL, V3, P55, DOI 10.1146/annurev-chembioeng-062011-081043
   Nikonorov VV, 2010, POLYM SCI SER A+, V52, P828, DOI 10.1134/S0965545X10080092
   Okawa S, 2002, INT J REFRIG, V25, P514, DOI 10.1016/S0140-7007(01)00038-X
   Pan MM, 2015, SEP PURIF TECHNOL, V147, P132, DOI 10.1016/j.seppur.2015.04.026
   Park J, 2010, J APPL POLYM SCI, V115, P3434, DOI 10.1002/app.30632
   Persson P, 2004, BIOTECHNOL BIOENG, V88, P224, DOI 10.1002/bit.20236
   Plieva F, 2006, J MATER CHEM, V16, P4065, DOI 10.1039/b606734d
   Plieva FM, 2005, SOFT MATTER, V1, P303, DOI 10.1039/b510010k
   Podorozhko EA, 2016, COLLOID J+, V78, P90, DOI 10.1134/S1061933X16010130
   Pronk P, 2005, INT J REFRIG, V28, P27, DOI 10.1016/j.ijrefrig.2004.07.011
   Qian L, 2009, J MATER CHEM, V19, P5212, DOI 10.1039/b903461g
   Rudt M, 2015, J CHROMATOGR A, V1413, P68, DOI 10.1016/j.chroma.2015.08.025
   Sahiner N, 2018, POLYM ADVAN TECHNOL, V29, P2184, DOI 10.1002/pat.4326
   Shoji M, 2011, J CHEM ENG JPN, V44, P191, DOI 10.1252/jcej.10we251
   Singh A, 2019, BIOMACROMOLECULES, V20, P662, DOI 10.1021/acs.biomac.8b01308
   Suner SS, 2018, POLYM ADVAN TECHNOL, V29, P151, DOI 10.1002/pat.4097
   Takiyama H, 2002, J CHEM ENG JPN, V35, P1072, DOI 10.1252/jcej.35.1072
   WAGNER C, 1961, Z ELEKTROCHEM, V65, P581
   Wey J.S., 2002, HDB IND CRYSTALLIZAT, P231
   Wu JJ, 2012, SOFT MATTER, V8, P3620, DOI 10.1039/c2sm07411g
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Yao KJ, 2006, CHEM ENG SCI, V61, P6701, DOI 10.1016/j.ces.2006.06.022
   Yao KJ, 2006, J CHROMATOGR A, V1109, P103, DOI 10.1016/j.chroma.2006.01.014
   Yu ZQ, 2007, CHEM ENG RES DES, V85, P893, DOI 10.1205/cherd06234
   Zarrintaj P, 2018, CARBOHYD POLYM, V187, P66, DOI 10.1016/j.carbpol.2018.01.060
NR 61
TC 8
Z9 8
U1 8
U2 55
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 50
EP 57
DI 10.1016/j.ces.2019.02.026
PG 8
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900005
DA 2020-05-12
ER

PT J
AU Sardina, G
   Jareteg, K
   Strom, H
   Sasic, S
AF Sardina, Gaetano
   Jareteg, Klas
   Strom, Henrik
   Sasic, Srdjan
TI Assessing the ability of the Eulerian-Eulerian and the
   Eulerian-Lagrangian frameworks to capture meso-scale dynamics in bubbly
   flows
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Bubbly flows; Eulerian-Lagrangian framework; Eulerian-Eulerian
   framework; Two-fluid model
ID DIRECT NUMERICAL SIMULATIONS; POINT PARTICLE METHOD; 2-FLUID MODEL; LIFT
   FORCE; TURBULENCE MODULATION; SCALE SIMULATIONS; DRAG REDUCTION;
   STABILITY; LADEN; BEHAVIOR
AB Bubbly flows are characterised by instabilities that appear in the form of elongated meso-scale structures aligned along the direction of gravity. The instabilities result in a non-homogeneous distribution of the gas fraction in the system where high-cluster and high-voidage regions coexist. The correct prediction of the meso-scale dynamics is fundamental to formulate more accurate closure models for coarsegrained simulations applied to design systems of industrial scale. Two different frameworks are compared to test their capability of capturing the characteristic meso-scale structures (understood as hetereogeneities in the gas fraction distribution with dimensions larger than the bubble size and smaller than the typical lengths of the system): the Eulerian-Eulerian two-fluid model and a Eulerian-Lagrangian approach. This kind of benchmark has been already applied to gas-particle flows, but based to the best of our knowledge, this is the first time when the comparison between different frameworks is used to investigate the meso-scale flow structures of bubbly suspensions. We show that the Eulerian-Eulerian simulations are affected at low bubble loadings by unphysical numerical instabilities appearing due to the lack of hyperbolicity of the governing equation system. Unfortunately, the occurrence of the numerical instabilities cannot be predicted a priori, but when they are not present in the solution, the two frameworks are able to predict the same meso-scale dynamics. Our analysis suggests that, concerning meso-scale simulations, the Eulerian-Lagrangian approach produces physically faithful results and represents an ideal framework to formulate new closure models. The well-known limit of this methodology to extract parameter-independent Eulerian statistics has been addressed linking the post-processing technique to physical phenomenologies. In particular, we show that a characteristic post-processing length scale smaller than two bubble diameters is needed to correctly capture the phenomenologies associated with bubble small-scale clusters. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Sardina, Gaetano; Strom, Henrik; Sasic, Srdjan] Chalmers Univ Technol, Dept Mech & Maritime Sci, Div Fluid Dynam, Gothenburg, Sweden.
   [Jareteg, Klas] Fraunhofer Chalmers Res Ctr Ind Math, Chalmers Sci Pk, Gothenburg, Sweden.
RP Sardina, G (reprint author), Chalmers Univ Technol, Dept Mech & Maritime Sci, Div Fluid Dynam, Gothenburg, Sweden.
EM sardina@chalmers.se
RI Sardina, Gaetano/X-9234-2019; /H-4779-2011
OI Sardina, Gaetano/0000-0002-9172-6311; /0000-0002-8581-5174
FU Swedish Research Council (Vetenskapsrdet)Swedish Research Council [VR
   2017-05031]
FX This research was conducted with funding from the Swedish Research
   Council (Vetenskapsrdet), grant VR 2017-05031. The computations were
   performed on resources at Chalmers Centre for Computational Science and
   Engineering (C3SE) provided by the Swedish National Infrastructure for
   Computing (SNIC).
CR Agrawal K, 2001, J FLUID MECH, V445, P151, DOI 10.1017/S0022112001005663
   Ali BA, 2011, INT J MULTIPHAS FLOW, V37, P268, DOI 10.1016/j.ijmultiphaseflow.2010.10.002
   Annaland MV, 2005, CHEM ENG SCI, V60, P2999, DOI 10.1016/j.ces.2005.01.031
   BATCHELOR GK, 1988, J FLUID MECH, V193, P75, DOI 10.1017/S002211208800206X
   Battista F, 2018, INT J MULTIPHAS FLOW, V101, P113, DOI 10.1016/j.ijmultiphaseflow.2018.01.006
   Becker S, 1994, CHEM ENG SCI, V49, P5747, DOI 10.1016/0009-2509(94)00290-8
   Bunner B, 1999, PHYS FLUIDS, V11, P1967, DOI 10.1063/1.870105
   Burns A. D., 2004, EULERIAN MULTIPHASE, V4, P1
   Capecelatro J, 2014, J FLUID MECH, V747, DOI 10.1017/jfm.2014.194
   Capecelatro J, 2013, J COMPUT PHYS, V238, P1, DOI 10.1016/j.jcp.2012.12.015
   Cano-Lozano JC, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.053604
   CHEN RC, 1992, CHEM ENG SCI, V47, P3615, DOI 10.1016/0009-2509(92)85077-O
   Climent E, 1999, PHYS REV LETT, V82, P4827, DOI 10.1103/PhysRevLett.82.4827
   CROWE CT, 1977, J FLUID ENG-T ASME, V99, P325, DOI 10.1115/1.3448756
   Daitche A, 2015, J FLUID MECH, V782, P567, DOI 10.1017/jfm.2015.551
   Delnoij E, 1999, CHEM ENG SCI, V54, P2217, DOI 10.1016/S0009-2509(98)00362-5
   Dijkhuizen W, 2010, CHEM ENG SCI, V65, P1427, DOI 10.1016/j.ces.2009.10.022
   Dinh T.N., 2003, P 10 INT TOP M NUCL
   Druzhinin OA, 1998, PHYS FLUIDS, V10, P685, DOI 10.1063/1.869594
   Ferrante A, 2004, J FLUID MECH, V503, P345, DOI 10.1017/S0022112004007943
   Fox RO, 2014, J FLUID MECH, V742, P368, DOI 10.1017/jfm.2014.21
   Garg R, 2007, INT J MULTIPHAS FLOW, V33, P1337, DOI 10.1016/j.ijmultiphaseflow.2007.06.002
   Gualtieri P, 2015, J FLUID MECH, V773, P520, DOI 10.1017/jfm.2015.258
   Gualtieri P, 2013, J FLUID MECH, V715, P134, DOI 10.1017/jfm.2012.503
   Harteveld W, 2005, THESIS
   Igci Y, 2008, AICHE J, V54, P1431, DOI 10.1002/aic.11481
   Igci Y, 2011, IND ENG CHEM RES, V50, P13190, DOI 10.1021/ie200190q
   Igci Y, 2011, AICHE J, V57, P2691, DOI 10.1002/aic.12486
   Ireland PJ, 2017, J COMPUT PHYS, V338, P405, DOI 10.1016/j.jcp.2017.02.070
   Ishii M., 1975, A75 NASA STI REC
   ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9
   Jackson R., 1963, T I CHEM ENG-LOND, V41, P13
   Jareteg K., 2015, M C 2015
   Jareteg K., 2017, THESIS
   Jareteg K, 2017, CHEM ENG SCI, V170, P184, DOI 10.1016/j.ces.2017.03.063
   Lahey R. T.  Jr., 1988, Advances in nuclear science and technology. Vol.20, P1
   LAHEY RT, 1980, INT J MULTIPHAS FLOW, V6, P281, DOI 10.1016/0301-9322(80)90021-X
   Lakkaraju R, 2013, P NATL ACAD SCI USA, V110, P9237, DOI 10.1073/pnas.1217546110
   Lee SJ, 1998, INT J MULTIPHAS FLOW, V24, P855, DOI 10.1016/S0301-9322(97)00089-X
   Lhuillier D, 2013, J FLUID MECH, V731, DOI 10.1017/jfm.2013.380
   Lucas D, 2005, CHEM ENG SCI, V60, P3609, DOI 10.1016/j.ces.2005.02.032
   Lucas D, 2011, INT J MULTIPHAS FLOW, V37, P1178, DOI 10.1016/j.ijmultiphaseflow.2011.05.009
   Lucas D, 2006, CHEM ENG TECHNOL, V29, P1066, DOI 10.1002/ceat.200600150
   Maxey M. R., 1994, APPL MECH REC, V47, P70, DOI DOI 10.1115/1.3124443
   Maxey MR, 2001, INT J MULTIPHAS FLOW, V27, P1603, DOI 10.1016/S0301-9322(01)00014-3
   Mazzitelli IM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066317
   Molin D, 2012, INT J MULTIPHAS FLOW, V42, P80, DOI 10.1016/j.ijmultiphaseflow.2012.01.010
   Monahan SM, 2007, CHEM ENG SCI, V62, P3159, DOI 10.1016/j.ces.2007.03.021
   Monahan SM, 2005, AICHE J, V51, P1897, DOI 10.1002/aic.10425
   Mudde RF, 2005, ANNU REV FLUID MECH, V37, P393, DOI 10.1146/annurev.fluid.37.061903.175803
   Mudde RF, 1999, CHEM ENG SCI, V54, P5061, DOI 10.1016/S0009-2509(99)00234-1
   Niceno B, 2008, CHEM ENG SCI, V63, P3923, DOI 10.1016/j.ces.2008.04.050
   Pai MG, 2009, J FLUID MECH, V628, P181, DOI 10.1017/S002211200900617X
   Panicker N, 2018, APPL MATH MODEL, V57, P432, DOI 10.1016/j.apm.2018.01.011
   Patel RG, 2017, AICHE J, V63, P5396, DOI 10.1002/aic.15949
   Pokharna H, 1997, J COMPUT PHYS, V134, P282, DOI 10.1006/jcph.1997.5695
   Pope S.B., 2001, TURBULENT FLOWS
   Prosperetti A., 1990, 2 PHASE FLOWS WAVES, P98
   Prosperetti A, 2009, COMPUTATIONAL METHOD
   RAMSHAW JD, 1978, NUCL SCI ENG, V66, P93, DOI 10.13182/NSE78-A15191
   RANSOM VH, 1984, J COMPUT PHYS, V53, P124, DOI 10.1016/0021-9991(84)90056-1
   RIETEMA K, 1970, TRANS INST CHEM ENG, V48, pT54
   Risso F, 2018, ANNU REV FLUID MECH, V50, P25, DOI 10.1146/annurev-fluid-122316-045003
   Rogallo RS, 1981, NASA STI RECON TECHN, V81, P31508
   Roghair I, 2011, INT J MULTIPHAS FLOW, V37, P1093, DOI 10.1016/j.ijmultiphaseflow.2011.07.004
   Rzehak R, 2017, CHEM ENG SCI, V157, P147, DOI 10.1016/j.ces.2016.04.056
   Sankaranarayanan K, 2002, CHEM ENG SCI, V57, P3521, DOI 10.1016/S0009-2509(02)00269-5
   Sardina G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.184501
   Schiller L., 1935, Z VER DTSCH ING, V77, P318
   Schneiderbauer S, 2014, AICHE J, V60, P839, DOI 10.1002/aic.14321
   Sokolichin A, 1997, CHEM ENG SCI, V52, P611, DOI 10.1016/S0009-2509(96)00425-3
   Spandan V, 2016, J FLUID MECH, V798, P411, DOI 10.1017/jfm.2016.316
   Strom H, 2015, INT J CHEM REACT ENG, V13, P449, DOI 10.1515/ijcre-2014-0171
   Tripathi MK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7268
   Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744
   Yang N, 2010, CHEM ENG SCI, V65, P517, DOI 10.1016/j.ces.2009.06.014
   ZUN I, 1980, INT J MULTIPHAS FLOW, V6, P583, DOI 10.1016/0301-9322(80)90053-1
NR 77
TC 2
Z9 2
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 58
EP 73
DI 10.1016/j.ces.2019.02.022
PG 16
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900006
DA 2020-05-12
ER

PT J
AU Hamidi, M
   Bayon, A
   Wheeler, VM
   Kreider, P
   Wallace, MA
   Tsuzuki, T
   Catchpole, K
   Weimer, AW
AF Hamidi, Marziyeh
   Bayon, Alicia
   Wheeler, Vincent M.
   Kreider, Peter
   Wallace, Mark A.
   Tsuzuki, Takuya
   Catchpole, Kylie
   Weimer, Alan W.
TI Reduction kinetics for large spherical 2:1 iron-manganese oxide redox
   materials for thermochemical energy storage
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Thermochemical energy storage; Iron-manganese oxide; Redox reaction;
   Reaction kinetic modelling; Shrinking core model; Non-linear regression
ID HIGH-TEMPERATURE; HEAT-STORAGE; METAL-OXIDES; CYCLES; MN; FE; SYSTEMS;
   EXPLOITATION; COUPLE
AB Spherical 0.5-1 mm iron-manganese oxide with the Fe/Mn molar ratio of 2:1 (Fe67) was studied for thermochemical energy storage (TCES) system. Iron and manganese oxide are abundant, low-cost, and nontoxic; three ideal materials characteristics for TCES applications. Fe67 was reduced in both argon and air environments. A thermogravimetric analyser (TGA) and differential scanning calorimeter (DSC) were used to investigate reaction kinetics and the enthalpy of reduction. A shrinking core model fit the non-isothermal kinetic data obtained from four heating rates. It is hypothesized that thermal reduction of Fe67 is controlled by oxygen internal diffusion for an inert atmosphere, while oxygen internal diffusion followed by oxygen external diffusion control the process in an air environment. A reduction reaction rate expression was derived and is useful for reactor design. This is the first kinetics investigation for Fe67 active redox material and its first consideration for TCES applications.Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.
C1 [Hamidi, Marziyeh; Wheeler, Vincent M.; Kreider, Peter; Tsuzuki, Takuya; Catchpole, Kylie; Weimer, Alan W.] Australian Natl Univ, Res Sch Engn, Acton, ACT 2401, Australia.
   [Bayon, Alicia] CSIRO Energy, POB 330, Newcastle, NSW 2300, Australia.
   [Wallace, Mark A.; Weimer, Alan W.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
RP Weimer, AW (reprint author), Australian Natl Univ, Res Sch Engn, Acton, ACT 2401, Australia.; Bayon, A (reprint author), CSIRO Energy, POB 330, Newcastle, NSW 2300, Australia.
RI Catchpole, Kylie/AAE-5973-2019; Kreider, Peter/O-3583-2019
OI Catchpole, Kylie/0000-0003-4858-1820; Bayon, Alicia/0000-0002-6422-0884;
   WEIMER, ALAN/0000-0002-2471-349X; Wheeler, Vincent/0000-0002-2331-4905;
   Hamidi, Marziyeh/0000-0002-1144-1085
FU Australian Renewable Energy Agency (ARENA)Australian Renewable Energy
   Agency (ARENA);  [2014/RND005]
FX The authors gratefully acknowledge the Australian Renewable Energy
   Agency (ARENA) for sponsoring this research. The work was supported via
   Grant 2014/RND005. This work was a collaboration between the Australian
   National University, the University of Colorado Boulder and the
   Commonwealth Scientific and Industrial Research Organisation (CSIRO).
   The authors would like to thank Prof. Wojciech Lipinski for the use of
   his laboratories. The authors also thank Dr. John Pye and Dr.
   Charles-Alexis Asselineau for their valuable advice, Dr. Xiang Gao for
   BET surface area measurement and Linda McMorrow for ICP analysis. The
   authors acknowledge the facilities, and the scientific and technical
   assistance of the Australian Microscopy & Microanalysis Research
   Facility at the Centre of Advanced Microscopy, the Australian National
   University.
CR Agrafiotis C, 2016, SOL ENERGY, V139, P695, DOI 10.1016/j.solener.2016.04.034
   Agrafiotis C, 2015, SOL ENERGY, V114, P440, DOI 10.1016/j.solener.2014.12.036
   Agrafiotis C, 2015, SOL ENERGY, V114, P459, DOI 10.1016/j.solener.2014.12.037
   Agrafiotis C, 2014, SOL ENERGY, V102, P189, DOI 10.1016/j.solener.2013.12.032
   Alonso E, 2015, SOL ENERGY, V115, P297, DOI 10.1016/j.solener.2015.03.005
   Amiri A, 2015, CHEM ENG COMMUN, V202, P1161, DOI 10.1080/00986445.2014.910771
   Andre L, 2017, J SOLID STATE CHEM, V253, P6, DOI 10.1016/j.jssc.2017.05.015
   Azimi G, 2011, ENRGY PROCED, V4, P370, DOI 10.1016/j.egypro.2011.01.064
   Babiniec SM, 2016, INT J ENERG RES, V40, P280, DOI 10.1002/er.3467
   Babiniec SM, 2015, SOL ENERGY, V118, P451, DOI 10.1016/j.solener.2015.05.040
   Bale C, 2002, CALPHAD, V26, P189, DOI 10.1016/S0364-5916(02)00035-4
   Bayon A, 2018, ENERGY, V149, P473, DOI 10.1016/j.energy.2017.11.084
   Block T, 2016, SOL ENERGY, V126, P195, DOI 10.1016/j.solener.2015.12.032
   Block T, 2014, THERMOCHIM ACTA, V577, P25, DOI 10.1016/j.tca.2013.11.025
   Botas JA, 2012, INT J HYDROGEN ENERG, V37, P18661, DOI 10.1016/j.ijhydene.2012.09.114
   Carrillo AJ, 2016, PHYS CHEM CHEM PHYS, V18, P8039, DOI 10.1039/c5cp07777j
   Carrillo AJ, 2016, J PHYS CHEM C, V120, P27800, DOI 10.1021/acs.jpcc.6b08708
   Carrillo AJ, 2016, J ENERGY STORAGE, V5, P169, DOI 10.1016/j.est.2015.12.005
   Carrillo AJ, 2015, CHEMSUSCHEM, V8, P1947, DOI 10.1002/cssc.201500148
   Carrillo AJ, 2014, J MATER CHEM A, V2, P19435, DOI 10.1039/c4ta03409k
   Carrillo AJ, 2014, SOL ENERG MAT SOL C, V123, P47, DOI 10.1016/j.solmat.2013.12.018
   Chase Jr M.W., 1998, NIST JANAF THERMOCHE
   Droege P., 2015, ENERGY P, V73, P263
   FAHIM MA, 1983, CHEM ENG J BIOCH ENG, V27, P21, DOI 10.1016/0300-9467(83)80042-2
   Go KS, 2008, INT J HYDROGEN ENERG, V33, P5986, DOI 10.1016/j.ijhydene.2008.05.039
   Imponenti L, 2016, ECS TRANSACTIONS, V72, P11, DOI 10.1149/07207.0011ecst
   Karagiannakis G, 2014, ENRGY PROCED, V49, P820, DOI 10.1016/j.egypro.2014.03.089
   Karagiannakis G, 2016, SOL ENERGY, V133, P394, DOI 10.1016/j.solener.2016.04.032
   Khawam A, 2006, J PHYS CHEM B, V110, P17315, DOI 10.1021/jp062746a
   LEVENSPIEL O, 1999, CHEM REACTION ENG
   Pagkoura C, 2014, SOL ENERGY, V108, P146, DOI 10.1016/j.solener.2014.06.034
   Powell KM, 2012, CHEM ENG SCI, V71, P138, DOI 10.1016/j.ces.2011.12.009
   Prieto C, 2016, RENEW SUST ENERG REV, V60, P909, DOI 10.1016/j.rser.2015.12.364
   Ryden M, 2014, APPL ENERG, V113, P1924, DOI 10.1016/j.apenergy.2013.06.016
   Schrader AJ, 2015, SOL ENERGY, V118, P485, DOI 10.1016/j.solener.2015.05.045
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   Wokon M, 2017, SOL ENERGY, V153, P471, DOI 10.1016/j.solener.2017.05.045
   Wokon M, 2017, SOL ENERGY, V153, P200, DOI 10.1016/j.solener.2017.05.034
   Wong B., 2011, THERMOCHEMICAL HEAT
   Zhang ZK, 2016, SOL ENERGY, V134, P494, DOI 10.1016/j.solener.2016.05.031
   Zhu Y, 2018, CHEM ENG SCI, V177, P132, DOI 10.1016/j.ces.2017.11.001
NR 41
TC 2
Z9 2
U1 2
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 74
EP 81
DI 10.1016/j.ces.2019.02.012
PG 8
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900007
DA 2020-05-12
ER

PT J
AU Don, MG
   Khan, F
AF Don, Mihiran Galagedarage
   Khan, Faisal
TI Dynamic process fault detection and diagnosis based on a combined
   approach of hidden Markov and Bayesian network model
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Process fault diagnosis; Hidden Markov model; Bayesian network; Process
   fault detection
ID SPEED-DOWN PROCESS; COMPONENT ANALYSIS; RECOGNITION METHOD; SYSTEM
AB The present study introduces a novel methodology for fault detection and diagnosis (FDD), based on a combined approach of data and process knowledge driven techniques. The Hidden Markov Model (HMM) detects the abnormalities based on process history while the Bayesian Network (BN) diagnoses the root causes of faults. An HMM is trained with standard operating condition data while the structure of BN is developed based on process knowledge. The log-likelihoods (LL) of process historical data strings are used to establish the conditional probability tables of the BN. HMM identifies the abnormal behaviour of the system. The time of detection of abnormality, respective log-likelihood value, and the probabilities of being in the process condition at the time of detection are used as evidence to BN. The updated BN is then used to diagnose the root cause by considering the respective changes in the probabilities. Performance of the new technique is tested and validated with published data of Tennessee Eastman Process. Eight of the ten selected faults were successfully detected and diagnosed. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Don, Mihiran Galagedarage; Khan, Faisal] Mem Univ Newfoundland, Fac Engn & Appl Sci, C RISE, St John, NF A1B 3X5, Canada.
RP Khan, F (reprint author), Mem Univ Newfoundland, Fac Engn & Appl Sci, C RISE, St John, NF A1B 3X5, Canada.
EM fikhan@mun.ca
OI Khan, Faisal/0000-0002-5638-4299
FU Natural Science and Engineering Council of CanadaNatural Sciences and
   Engineering Research Council of Canada; Canada Research Chair (CRC) Tier
   I Program in offshore safety and risk engineering
FX The authors thankfully acknowledge the financial support provided by the
   Natural Science and Engineering Council of Canada and the Canada
   Research Chair (CRC) Tier I Program in offshore safety and risk
   engineering.
CR Amin MT, 2018, CHEM ENG SCI, V189, P191, DOI 10.1016/j.ces.2018.05.045
   Boyraz Pinar, 2007, Proceedings of the 2007 IEEE Intelligent Vehicles Symposium, P987
   Cai BP, 2017, IEEE T IND INFORM, V13, P2227, DOI 10.1109/TII.2017.2695583
   Cao Y, 2015, IEEE T NEUR NET LEAR, V26, P318, DOI 10.1109/TNNLS.2014.2315042
   Chan A, 2008, J OPER RES SOC, V59, P423, DOI 10.1057/palgrave.jors.2602388
   Chen ZS, 2012, J VIB ACOUST, V134, DOI 10.1115/1.4005830
   Choi CK, 2014, INT J PRECIS ENG MAN, V15, P1667, DOI 10.1007/s12541-014-0517-4
   de Almeida G. M, 2008, IFAC P VOLUMES, V41, DOI [10.3182/20080706-5-KR-1001.02102, DOI 10.3182/20080706-5-KR-1001.02102]
   Ding SX, 2014, ADV IND CONTROL, P1, DOI 10.1007/978-1-4471-6410-4
   dos Santos EB, 2014, RISK ANAL, V34, P485, DOI 10.1111/risa.12112
   DOWNS JJ, 1993, COMPUT CHEM ENG, V17, P245, DOI 10.1016/0098-1354(93)80018-I
   Gharahbagheri H, 2017, IND ENG CHEM RES, V56, P2054, DOI 10.1021/acs.iecr.6b01916
   Harman M, 2012, IEEE INT CONF AUTOM, P1, DOI 10.1145/2351676.2351678
   Hassan MR, 2009, NEUROCOMPUTING, V72, P3439, DOI 10.1016/j.neucom.2008.09.029
   Huang JS, 2009, ICICTA: 2009 SECOND INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTATION TECHNOLOGY AND AUTOMATION, VOL II, PROCEEDINGS, P513, DOI 10.1109/ICICTA.2009.358
   IEEE, 2013, IEEE SYMP INDUST EL, P75, DOI 10.1109/ISIEA.2013.6738971
   Jin S, 2017, INT J ADV MANUF TECH, V88, P663, DOI 10.1007/s00170-016-8795-x
   Kang JS, 2011, 2011 INTERNATIONAL CONFERENCE ON QUALITY, RELIABILITY, RISK, MAINTENANCE, AND SAFETY ENGINEERING (ICQR2MSE), P486
   Lee YK, 2010, J ENG GAS TURB POWER, V132, DOI 10.1115/1.3204508
   Li ZF, 2014, EXPERT SYST APPL, V41, P744, DOI 10.1016/j.eswa.2013.07.098
   Li ZN, 2006, J SOUND VIB, V291, P60, DOI 10.1016/j.jsv.2005.05.020
   Li ZN, 2005, MECH SYST SIGNAL PR, V19, P329, DOI 10.1016/j.ymssp.2004.01.001
   Liu KB, 2014, IEEE T AUTOM SCI ENG, V11, P452, DOI 10.1109/TASE.2013.2287101
   Mallick M. R, 2013, HYBRID METHOD PROCES
   Mu FP, 2003, COMP AID CH, V14, P803
   Murphy K, 2005, HIDDEN MARKOV MODEL
   Nelwamondo FV, 2006, INT J INNOV COMPUT I, V2, P1281
   Onel M, 2018, COMPUT CHEM ENG, V115, P46, DOI 10.1016/j.compchemeng.2018.03.025
   Qi F, 2011, AUTOMATICA, V47, P1349, DOI 10.1016/j.automatica.2011.02.015
   Rabiner L. R., 1986, IEEE ASSP Magazine, V3, P4, DOI 10.1109/MASSP.1986.1165342
   RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626
   Ragab A, 2018, EXPERT SYST APPL, V95, P368, DOI 10.1016/j.eswa.2017.11.045
   Rato TJ, 2013, CHEMOMETR INTELL LAB, V125, P101, DOI 10.1016/j.chemolab.2013.04.002
   Ren X, 2017, IND ENG CHEM RES, V56, P11545, DOI 10.1021/acs.iecr.7b02419
   Ren-Wu Y., 2009, P IEEE CIRC SYST INT, P1, DOI DOI 10.1109/CAS-ICTD.2009.4960787
   Sadhu A, 2017, J VIB CONTROL, V23, P3175, DOI 10.1177/1077546315627934
   Soualhi A, 2012, 2012 XXTH INTERNATIONAL CONFERENCE ON ELECTRICAL MACHINES (ICEM), P1693, DOI 10.1109/ICElMach.2012.6350108
   Tobon-Mejia Diego A, 2010, 2010 IEEE International Conference on Automation Science and Engineering (CASE 2010), P338, DOI 10.1109/COASE.2010.5584759
   Venkatasubramanian V, 2003, COMPUT CHEM ENG, V27, P327, DOI 10.1016/S0098-1354(02)00162-X
   Venkatasubramanian V, 2003, COMPUT CHEM ENG, V27, P313, DOI 10.1016/S0098-1354(02)00161-8
   Verron S, 2010, ENG APPL ARTIF INTEL, V23, P1229, DOI 10.1016/j.engappai.2010.05.002
   Wang DB, 2009, ADV DIFFER EQU-NY, DOI 10.1155/2009/830247
   Wang F, 2016, IND ENG CHEM RES, V55, P4613, DOI 10.1021/acs.iecr.5b04777
   Wang L, 2015, J PHYS CONF SER, V659, DOI 10.1088/1742-6596/659/1/012047
   Wei Xiao, 2016, International Journal of Prognostics and Health Management, V7, P1
   Wong Wee Chin, 2009, IFAC P, V42, P291, DOI [10.3182/20090712-4-TR-2008.00045, DOI 10.3182/20090712-4-TR-2008.00045]
   Wu B, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P5697
   Xie SY, 2013, PROCEEDINGS OF THE 2013 8TH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE & EDUCATION (ICCSE 2013), P1004
   Yu HY, 2015, IND ENG CHEM RES, V54, P2724, DOI 10.1021/ie503530v
   Yu HY, 2014, IND ENG CHEM RES, V53, P8831, DOI 10.1021/ie500815a
   Yuwono M, 2016, ENG APPL ARTIF INTEL, V47, P88, DOI 10.1016/j.engappai.2015.03.007
   Zadakbar O, 2013, IND ENG CHEM RES, V52, P809, DOI 10.1021/ie202880w
   Zhou HT, 2016, MECH SYST SIGNAL PR, V66-67, P568, DOI 10.1016/j.ymssp.2015.04.037
NR 53
TC 7
Z9 7
U1 13
U2 101
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 82
EP 96
DI 10.1016/j.ces.2019.01.060
PG 15
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900008
DA 2020-05-12
ER

PT J
AU Trampuz, M
   Teslic, D
   Likozar, B
AF Trampuz, Marko
   Teslic, Dusan
   Likozar, Blaz
TI Crystallization of fesoterodine fumarate active pharmaceutical
   ingredient: Modelling of thermodynamic equilibrium, nucleation, growth,
   agglomeration and dissolution kinetics and temperature cycling
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fesoterodine fumarate ingredient; Crystallization; Dissolution;
   Consecutive temperature cycling; Mathematical process modelling;
   Population balance equation
ID METASTABLE ZONE WIDTH; ANTISOLVENT CRYSTALLIZATION; POPULATION BALANCE;
   SCALE-UP; CRYSTAL
AB The crystallization of active pharmaceutical ingredients (API) is an important, but complex unit operation in drug manufacturing industry, due to the diverse chemical nature of medicinal formulation compounds, several physicochemical phenomena that take place during particle formation process, and multi-phase governing resistances. This research paper presents a combined experimental-modelling approach to understanding fesoterodine fumarate crystallization and dissolution in 2-butanone. A rigorous in-house mechanistic model algorithm that includes calibration, thermodynamic equilibrium description, energy, mass and population balance equations, heat transfer limitations, and ordering, agglomeration and detachment step kinetics was developed. On the basis of experimentally-determined saturated solubility, a specified initial number of designed dissolution and cooling crystallization experiments was performed, monitored by attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy, focused beam reflectance measurement (FBRM) technique and microscopy. The estimated kinetic parameters of transport, nucleation, crystal lattice growth, agglomeration and dissolution were evaluated by fitting the measured/simulated concentration curves with crystallite size distributions. Correlation was validated with additional trial results, observing a rather good agreement. The behaviour of the component during validations' temperature cycling was thoroughly examined by simulations to achieve a solid final insight into mechanisms, which may aid further production development, optimization, as well as scale-up. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Trampuz, Marko; Likozar, Blaz] Natl Inst Chem, Dept Catalysis & Chem React Engn, Hajdrihova 19, Ljubljana 1001, Slovenia.
   [Trampuz, Marko] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana 1000, Slovenia.
   [Teslic, Dusan] Lek Pharmaceut Dd, Sandoz Dev Ctr Slovenia, Kolodvorska 27, Menges 1234, Slovenia.
RP Trampuz, M; Likozar, B (reprint author), Natl Inst Chem, Dept Catalysis & Chem React Engn, Hajdrihova 19, Ljubljana 1001, Slovenia.
EM marko.trampuz@ki.si; blaz.likozar@ki.si
RI Trampuz, Marko/D-7382-2019
OI Trampuz, Marko/0000-0002-1335-6474
FU Slovenian Research AgencySlovenian Research Agency - Slovenia [P2-0152];
   Lek Pharmaceuticals d.d.
FX The authors gratefully acknowledge dr. Vesna Stergar and Pavel Drnovsek
   from Lek Pharmaceuticals d.d., for their support of this work. The
   financial support for conducting the research and preparation of the
   article was provided by Slovenian Research Agency (grant program number
   P2-0152) and Lek Pharmaceuticals d.d.
CR Abbas A, 2007, SEP PURIF TECHNOL, V53, P153, DOI 10.1016/j.seppur.2006.06.027
   ABEGG CF, 1968, AICHE J, V14, P118, DOI 10.1002/aic.690140121
   Alvarez AJ, 2011, CRYST GROWTH DES, V11, P4392, DOI 10.1021/cg200546g
   Bonnin-Paris J, 2011, CHEM ENG COMMUN, V198, P1004, DOI 10.1080/00986445.2011.545301
   Ciambecchini U., 2011, Solid Forms of Fesoterodine Fumarate, Patent No. [US008049031B2, 008049031]
   David R, 2003, POWDER TECHNOL, V130, P338, DOI 10.1016/S0032-5910(02)00213-9
   Ennis S. C., 2011, Synthesis of Phenolic Esters of Hydroxymethyl Phenols, Patent No. [US007985873B2, 007985873]
   Gao ZG, 2017, ENGINEERING-PRC, V3, P343, DOI 10.1016/J.ENG.2017.03.022
   GARSIDE J, 1971, CHEM ENG SCI, V26, P1425, DOI 10.1016/0009-2509(71)80062-3
   Kerekes P., 2012, Patent No. [US 20120220655A1, 20120220655]
   Li JC, 2017, CRYST GROWTH DES, V17, P1000, DOI 10.1021/acs.cgd.6b01212
   Luo YH, 2013, J CHEM ENG DATA, V58, P588, DOI 10.1021/je3011997
   MARCHAL P, 1988, CHEM ENG SCI, V43, P59, DOI 10.1016/0009-2509(88)87126-4
   Mersmann A., 2001, CRYSTALLIZATION TECH
   Michel MC, 2008, EXPERT OPIN PHARMACO, V9, P1787, DOI [10.1517/14656566.9.10.1787, 10.1517/14656566.9.10.1787 ]
   Mullin J. W., 2001, CRYSTALLIZATION, DOI [10.1002/0471238961.0318251918152119.a01.pub3, DOI 10.1002/0471238961.0318251918152119.A01.PUB3]
   Myerson A. S., 2001, HDB IND CRYSTALLIZAT, DOI [10.1016/B978-075067012-8/50014-8, DOI 10.1016/B978-075067012-8/50014-8]
   Nagy ZK, 2008, J PROCESS CONTR, V18, P856, DOI 10.1016/j.jprocont.2008.06.002
   Nagy ZK, 2013, CHEM ENG RES DES, V91, P1903, DOI 10.1016/j.cherd.2013.07.018
   NOYES AA, 1897, J AM CHEM SOC, V19, P930, DOI DOI 10.1021/JA02086A003
   Paul E.L., 2004, HDB IND MIXING SCI P
   Perry R., 2007, PERRYS CHEM ENG HDB, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Pohar A, 2014, IND ENG CHEM RES, V53, P10762, DOI 10.1021/ie501572h
   Quon JL, 2012, CRYST GROWTH DES, V12, P3036, DOI 10.1021/cg300253a
   Randolph A.D., 1988, THEORY PARTICULATE P
   Ridder BJ, 2014, IND ENG CHEM RES, V53, P4387, DOI 10.1021/ie402806n
   Saleemi A, 2012, CRYSTENGCOMM, V14, P2196, DOI 10.1039/c2ce06288g
   Schmidt B, 2004, ORG PROCESS RES DEV, V8, P998, DOI 10.1021/op040013n
   TAVARE NS, 1987, CHEM ENG COMMUN, V61, P259, DOI 10.1080/00986448708912042
   Togkalidou T, 2001, J CRYST GROWTH, V231, P534, DOI 10.1016/S0022-0248(01)01518-4
   Tung H. H., 2009, CRYSTALLIZATION ORGA, DOI [10.1002/9780470447796, DOI 10.1002/9780470447796]
   Tung HH, 2013, ORG PROCESS RES DEV, V17, P445, DOI 10.1021/op3002323
   Welty J. R., 1970, FUNDAMENTALS MOMENTU, V13, DOI [10.1016/0017-9310(70)90063-3, DOI 10.1016/0017-9310(70)90063-3]
   Wu ZH, 2016, CRYSTENGCOMM, V18, P2222, DOI 10.1039/c5ce02522b
   Yu LX, 2004, ADV DRUG DELIVER REV, V56, P349, DOI 10.1016/j.addr.2003.10.012
   Yu ZQ, 2007, CHEM ENG RES DES, V85, P893, DOI 10.1205/cherd06234
   Zhang Y, 2015, CHEM ENG RES DES, V95, P187, DOI 10.1016/j.cherd.2014.10.018
NR 37
TC 3
Z9 3
U1 6
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 97
EP 111
DI 10.1016/j.ces.2019.02.019
PG 15
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900009
DA 2020-05-12
ER

PT J
AU Nurlilasari, P
   Widiyastuti, W
   Setyawan, H
   Faizal, F
   Wada, M
   Lenggoro, IW
AF Nurlilasari, Puspita
   Widiyastuti, Widiyastuti
   Setyawan, Heru
   Faizal, Ferry
   Wada, Mitsuki
   Lenggoro, I. Wuled
TI High-throughput production of magnetite nanoparticles prepared by the
   monopolar arrangement of iron electrodes in water
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Magnetite nanoparticle; Electrosynthesis; Electrochemical performance;
   Energy storage materials; Electrocatalyst
ID FE3O4 NANOPARTICLES; STEP SYNTHESIS
AB Magnetite nanoparticles have been successfully produced by the electro-oxidation of iron in water using a monopolar arrangement of iron electrodes. Two types of monopolar configurations were used: conventional monopolar (CM) and alternating monopolar (AM). The production rate of the magnetite nanoparticles could be increased significantly (similar to 30 times higher) by using the AM electrode arrangement compared to the production rate of one-pair of electrodes in the same system. The particle sizes ranged from 28 to 88 nm for the CM and from 20 to 25 nm for the AM arrangements. The performance of the AM arrangement was superior that of the CM arrangement in regard to production rate, particle size, and product purity. A numerical simulation showed distinguishable electric fields between the AM and CM arrangements. The magnetite particles produced using the CM arrangement contained impurities in the form of FeOOH and Fe2O3. On the other hand, only magnetite was identified in the particles prepared using the AM arrangement. In addition, particle morphologies other than spherical could also be produced using the AM arrangement by changing the operating condition. The magnetite nanoparticles exhibited ferromagnetic properties. They can be used as a promising catalyst for oxygen reduction reactions in alkaline media. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Nurlilasari, Puspita; Widiyastuti, Widiyastuti; Setyawan, Heru] Sepuluh Nopember Inst Technol, Fac Ind Technol, Dept Chem Engn, Kampus ITS Sukolilo, Surabaya 60111, Indonesia.
   [Faizal, Ferry; Wada, Mitsuki; Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, 2-24-16 Nakacho, Koganei, Tokyo 1848588, Japan.
RP Setyawan, H (reprint author), Sepuluh Nopember Inst Technol, Fac Ind Technol, Dept Chem Engn, Kampus ITS Sukolilo, Surabaya 60111, Indonesia.
EM sheru@chem-eng.its.ac.id
RI Lenggoro, Wuled/P-1286-2019; Lenggoro, Wuled/B-8629-2009; Setyawan,
   Heru/J-2800-2015
OI Lenggoro, Wuled/0000-0002-0048-8486; Lenggoro,
   Wuled/0000-0002-0048-8486; Setyawan, Heru/0000-0002-2158-6819;
   Widiyastuti, W./0000-0002-2805-2836
FU PMDSU research grant by the Ministry of Research, Technology and Higher
   Education, Indonesia [77188/IT2.VII/HK.00.02/2017,
   15300/IT2.11/HK.00.02/2016, 091533/IT2.VII/HK.00.02/2018]; JSPS
   KAKENHIMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [JP17K06903, JP18H02203, JP18H05342];
   Ministry of Research, Technology and Higher Education, Indonesia through
   PMDSU
FX This work was supported by a PMDSU research grant (Contract No.
   77188/IT2.VII/HK.00.02/2017, Grant numbers 15300/IT2.11/HK.00.02/2016,
   77188/IT2.VII/HK.00.02/2017, 091533/IT2.VII/HK.00.02/2018) provided by
   the Ministry of Research, Technology and Higher Education, Indonesia and
   JSPS KAKENHI, Grant Numbers JP17K06903, JP18H02203, JP18H05342. One of
   the authors (P.N.) would like to thank the Ministry of Research,
   Technology and Higher Education, Indonesia for a doctoral scholarship
   through PMDSU. We also thank Ms. Dewi L. Kartika for her assistance with
   the electrochemical measurements.
CR Barros WRP, 2015, ELECTROCHIM ACTA, V162, P263, DOI 10.1016/j.electacta.2015.02.175
   Cabrera LI, 2011, J NANOPART RES, V13, P6931, DOI 10.1007/s11051-011-0602-x
   Cheng JP, 2012, APPL PHYS A-MATER, V106, P837, DOI 10.1007/s00339-012-6786-9
   Fajaroh F, 2012, ADV POWDER TECHNOL, V23, P328, DOI 10.1016/j.apt.2011.04.007
   Franger S, 2004, J SOLID STATE ELECTR, V8, P218, DOI 10.1007/s10008-003-0469-6
   Gopi D, 2016, ARAB J CHEM, V9, pS829, DOI 10.1016/j.arabjc.2011.08.005
   Hofmann-Amtenbrink  M., 2009, ADV DRUG DELIV, DOI [10.1016/j.addr.2012.10.008, DOI 10.1016/J.ADDR.2012.10.008]
   Karimzadeh I, 2017, J MAGN MAGN MATER, V433, P148, DOI 10.1016/j.jmmm.2017.02.048
   Liu J, 2013, IONICS, V19, P1255, DOI 10.1007/s11581-013-0857-6
   Manrique-Julio J, 2016, J MAGN MAGN MATER, V401, P81, DOI 10.1016/j.jmmm.2015.10.018
   Marques RFC, 2008, J MAGN MAGN MATER, V320, P2311, DOI 10.1016/j.jmmm.2008.04.165
   Munoz M, 2015, APPL CATAL B-ENVIRON, V176, P249, DOI 10.1016/j.apcatb.2015.04.003
   Nur A, 2016, J CHEM ENG JPN, V49, P144, DOI 10.1252/jcej.15we130
   Petcharoen K, 2012, MATER SCI ENG B-ADV, V177, P421, DOI 10.1016/j.mseb.2012.01.003
   Roca AG, 2007, J PHYS CHEM C, V111, P18577, DOI 10.1021/jp075133m
   Sahoo Y, 2005, J PHYS CHEM B, V109, P3879, DOI 10.1021/jp045402y
   Setyawan H, 2019, KONA POWDER PART J, P145, DOI 10.14356/kona.2019011
   Setyawan H, 2014, ASIA-PAC J CHEM ENG, V9, P768, DOI 10.1002/apj.1828
   Setyawan H, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0807-7
   Usman M, 2012, APPL CATAL B-ENVIRON, V117, P10, DOI 10.1016/j.apcatb.2012.01.007
   Ying TY, 2002, J DISPER SCI TECHNOL, V23, P569, DOI 10.1081/DIS-120014025
NR 21
TC 0
Z9 0
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 112
EP 120
DI 10.1016/j.ces.2019.02.027
PG 9
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900010
DA 2020-05-12
ER

PT J
AU Liu, MY
   Huan, RL
   Li, CX
   Che, MD
   Su, RX
   Li, SZ
   Yu, J
   Qi, W
   He, ZM
AF Liu, Mingyue
   Huan, Renliang
   Li, Chuanxi
   Che, Mingda
   Su, Rongxin
   Li, Shuzhou
   Yu, Jing
   Qi, Wei
   He, Zhimin
TI Continuous rapid dechlorination of p-chlorophenol by Fe-Pd nanoparticles
   promoted by procyanidin
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Zero-valent iron; Dechlorination; p-Chlorophenol; Reaction rate;
   Procyanidin; Procyanidin-iron complex
ID ZERO-VALENT IRON; GREEN SYNTHESIS; HEXAVALENT CHROMIUM; CATALYTIC
   DECHLORINATION; AQUEOUS-SOLUTION; WATER-TREATMENT; PLANT-EXTRACTS;
   WASTE-WATER; NZVI; REMOVAL
AB Nanoscale zero-valent iron has been widely applied in environmental remediation and toxic waste treatment, especially for the degradation of persistent organic pollutants (POPs). However, the dechlorination activity of Fe nanoparticles (Fe NPs) can be suppressed by the precipitation of iron oxides generated from the corrosion of Fe-Pd NPs under alkaline conditions, leading to a decreased dechlorination efficiency. Faced with this challenge, we report a highly effective dechlorination system that functions over a broad pH range and especially well under alkaline conditions in this work. Procyanidin (PROC), a natural polyphenol, was utilized as a stabilizer to manipulate the size distribution of Fe-Pd NPs and, more importantly, as a scavenger of Fe ions to prevent iron oxide precipitation. Experiments and theoretical calculations reveal that the generated Fe ions was mainly present in the form of bis- and tris-PROC-Fe complexes in the reaction solution. Compared with pristine Fe-Pd NPs, the PROC-modified Fe-Pd NPs had a dechlorination efficiency that was increased 20-fold (pH 9.0). Notably, a normalized rate constant was enhanced by more than 2 orders of magnitude compared to the previously reported dechlorination systems. The PROC-modified Fe-Pd NPs showed excellent dechlorination efficiency over a wide pH range (2.3-13.0). (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Liu, Mingyue; Li, Chuanxi; Che, Mingda; Su, Rongxin; Qi, Wei; He, Zhimin] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin Key Lab Membrane Sci & Desalinat Technol, Tianjin 300072, Peoples R China.
   [Huan, Renliang] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
   [Su, Rongxin; Qi, Wei] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.
   [Li, Shuzhou; Yu, Jing] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
RP Su, RX (reprint author), Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin Key Lab Membrane Sci & Desalinat Technol, Tianjin 300072, Peoples R China.; Yu, J (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
EM surx@tju.edu.cn; yujing@ntu.edu.sg
RI Li, Shuzhou/E-3146-2010; Yu, Jing/C-4138-2017; Rongxin, Su/B-6634-2014
OI Li, Shuzhou/0000-0002-2159-2602; Yu, Jing/0000-0002-4288-951X; Rongxin,
   Su/0000-0001-9778-9113
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21621004, 51473115, 21776212]; Tianjin Municipal
   Science and Technology Bureau, China [16JCZDJC37900, 18YFHBZC00010,
   18YFZCSF00590]; Ministry of Education [NCET-11-0372]; NTUNational Taiwan
   UniversityNanyang Technological University [M4082049.070]
FX This work was supported by the National Natural Science Foundation of
   China (21621004, 51473115, 21776212), Tianjin Municipal Science and
   Technology Bureau, China (16JCZDJC37900, 18YFHBZC00010, 18YFZCSF00590),
   and the Ministry of Education (grant No. NCET-11-0372). JY thanks to a
   start-up grant of NTU, M4082049.070.
CR Alharbi OML, 2018, J MOL LIQ, V263, P442, DOI 10.1016/j.molliq.2018.05.029
   Arvanitoyannis IS, 2006, INT J FOOD SCI TECH, V41, P475, DOI 10.1111/j.1365-2621.2005.01111.x
   Chekli L, 2016, ANAL CHIM ACTA, V903, P13, DOI 10.1016/j.aca.2015.10.040
   Chen HC, 2015, CHEM ENG SCI, V138, P510, DOI 10.1016/j.ces.2015.08.033
   Cheng R, 2007, J HAZARD MATER, V144, P334, DOI 10.1016/j.jhazmat.2006.10.032
   Chrysochoou M, 2017, B ENVIRON CONTAM TOX, V98, P353, DOI 10.1007/s00128-016-1901-9
   Contreras-Dominguez M, 2006, BIOCHIMIE, V88, P1899, DOI 10.1016/j.biochi.2006.07.011
   Crane RA, 2012, J HAZARD MATER, V211, P112, DOI 10.1016/j.jhazmat.2011.11.073
   Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b
   Deng DH, 2013, ANGEW CHEM INT EDIT, V52, P371, DOI 10.1002/anie.201204958
   Dong HR, 2018, WATER RES, V129, P51, DOI 10.1016/j.watres.2017.11.002
   Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265
   Emiroglu O, 2010, B ENVIRON CONTAM TOX, V84, P427, DOI 10.1007/s00128-010-9961-8
   Filippidi E, 2017, SCIENCE, V358, P502, DOI 10.1126/science.aao0350
   Fu FL, 2014, J HAZARD MATER, V267, P194, DOI 10.1016/j.jhazmat.2013.12.062
   Gao JJ, 2014, DALTON T, V43, P7964, DOI 10.1039/c4dt00118d
   Ghasemi J, 2007, J CHEM ENG DATA, V52, P1171, DOI 10.1021/je060325g
   He F, 2007, ENVIRON SCI TECHNOL, V41, P6216, DOI 10.1021/es0705543
   He F, 2008, APPL CATAL B-ENVIRON, V84, P533, DOI 10.1016/j.apcatb.2008.05.008
   Hoag GE, 2009, J MATER CHEM, V19, P8671, DOI 10.1039/b909148c
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Huang LL, 2014, SPECTROCHIM ACTA A, V130, P295, DOI 10.1016/j.saa.2014.04.037
   Huang X, 2010, GREEN CHEM, V12, P395, DOI 10.1039/b918176h
   Hwang Y, 2014, CHEM ENG SCI, V119, P310, DOI 10.1016/j.ces.2014.08.002
   Khorsandi H, 2017, DESALIN WATER TREAT, V70, P284, DOI 10.5004/dwt.2017.20505
   Kocur CM, 2013, J CONTAM HYDROL, V145, P17, DOI 10.1016/j.jconhyd.2012.11.001
   Liang M, 2014, ACS APPL MATER INTER, V6, P4638, DOI 10.1021/am500665p
   Lin CH, 2015, CHEM ENG J, V262, P59, DOI 10.1016/j.cej.2014.09.038
   Liu A, 2017, J HAZARD MATER, V322, P129, DOI 10.1016/j.jhazmat.2015.12.070
   Liu AR, 2015, CHEMOSPHERE, V119, P1068, DOI 10.1016/j.chemosphere.2014.09.026
   Liu TX, 2013, ENVIRON SCI TECHNOL, V47, P13712, DOI 10.1021/es403709v
   Liu YH, 2001, WATER RES, V35, P1887, DOI 10.1016/S0043-1354(00)00463-2
   Ma BW, 2015, WATER RES, V71, P140, DOI 10.1016/j.watres.2014.12.034
   Ma JM, 2011, NAT CLIM CHANGE, V1, P255, DOI 10.1038/NCLIMATE1167
   Markova Z, 2014, ACS SUSTAIN CHEM ENG, V2, P1674, DOI 10.1021/sc5001435
   Mystrioti C, 2016, SCI TOTAL ENVIRON, V539, P105, DOI 10.1016/j.scitotenv.2015.08.091
   Phenrat T, 2009, ENVIRON SCI TECHNOL, V43, P5079, DOI 10.1021/es900171v
   Pullin H, 2017, CHEM ENG J, V308, P568, DOI 10.1016/j.cej.2016.09.088
   Rahim MA, 2017, ADV MATER, V29, DOI 10.1002/adma.201606717
   Rao H, 2017, NATURE, V548, P74, DOI 10.1038/nature23016
   Roadcap GS, 2005, GROUND WATER, V43, P806, DOI 10.1111/j.1745-6584.2005.00060.x
   Shahwan T, 2011, CHEM ENG J, V172, P258, DOI 10.1016/j.cej.2011.05.103
   Shen JY, 2016, J MATER CHEM C, V4, P7614, DOI 10.1039/c6tc01912a
   Shen Y, 2017, NAT NANOTECHNOL, V12, P642, DOI [10.1038/nnano.2017.58, 10.1038/NNANO.2017.58]
   Shi W, 2017, WATER RES, V113, P22, DOI 10.1016/j.watres.2017.01.059
   Soliemanzadeh A, 2017, MICROPOR MESOPOR MAT, V239, P60, DOI 10.1016/j.micromeso.2016.09.050
   Stefaniuk M, 2016, CHEM ENG J, V287, P618, DOI 10.1016/j.cej.2015.11.046
   Su J, 2011, DESALINATION, V280, P167, DOI 10.1016/j.desal.2011.06.067
   Sun YG, 2017, SCIENCE, V356, P302, DOI 10.1126/science.aaf6792
   Tsakiroglou CD, 2017, CHEM ENG SCI, V167, P191, DOI 10.1016/j.ces.2017.04.007
   Wang XY, 2013, SCI TOTAL ENVIRON, V449, P157, DOI 10.1016/j.scitotenv.2013.01.008
   Wang ZQ, 2014, ACS SUSTAIN CHEM ENG, V2, P1022, DOI 10.1021/sc500021n
   Weng XL, 2017, CHEM ENG J, V308, P904, DOI 10.1016/j.cej.2016.09.134
   Xu FY, 2012, ENVIRON SCI TECHNOL, V46, P4576, DOI 10.1021/es203876e
   Xu J, 2013, CHEM ENG J, V231, P26, DOI 10.1016/j.cej.2013.07.018
   Yan T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6602
   Yi YQ, 2019, MATER LETT, V234, P388, DOI 10.1016/j.matlet.2018.09.137
   Yoo HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11923
   Yoshikawa E, 2012, J HAZARD MATER, V237, P277, DOI 10.1016/j.jhazmat.2012.08.045
   Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107
   Zhu F, 2018, J CLEAN PROD, V174, P184, DOI 10.1016/j.jclepro.2017.10.302
   Zou YD, 2016, ENVIRON SCI TECHNOL, V50, P7290, DOI 10.1021/acs.est.6b01897
NR 62
TC 5
Z9 5
U1 31
U2 107
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 121
EP 131
DI 10.1016/j.ces.2019.02.024
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900011
DA 2020-05-12
ER

PT J
AU Janiga, G
AF Janiga, Gabor
TI Large-eddy simulation and 3D proper orthogonal decomposition of the
   hydrodynamics in a stirred tank
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Stirred tank; Computational fluid dynamics; Large-eddy simulation;
   Macro-instability; Proper orthogonal decomposition; Coherent flow
   structures
ID MACRO-INSTABILITIES; TURBULENT-FLOW; CFD SIMULATION; VESSEL; FREQUENCY;
   LES; DYNAMICS
AB The present study attempts to characterize the time-dependent three-dimensional hydrodynamics in a stirred tank reactor using computational fluid dynamics (CFD). The rotating propellers produce a complex, unsteady, three-dimensional turbulent flow field. This results in efficient mixing and is therefore widely used in various process engineering applications. The time-dependent turbulent single-phase flow is computed using large eddy simulation, relying on the sliding mesh approach. The unresolved subgrid scales are treated using the Smagorinsky-Lilly model. The dominant coherent flow structures are characterized in the entire three-dimensional computational domain using the 3D proper orthogonal decomposition (POD) technique. The design of the propeller is evaluated in a separate POD analysis in a rotating frame which encloses the propeller. The most energetic POD modes characterize the organized large scale structures, the so-called coherent flow structures, while the higher modes correspond to the small-scale disorganized turbulence. It was found that the dynamics of the main flow structures can be reconstructed using only 3 modes corresponding to 98% of the overall energy in the entire 3D inner rotating domain and 21 modes are necessary for the same amount of energy in the outer stationary region.
   Furthermore, the macro instability (MI) was characterized by monitoring the velocity in more than 1 million computational cells, as well as using FFT analyses of the three-dimensional POD temporal coefficients. In the outer stationary domain, both approaches showed characteristic frequencies around one-eighth and one-fifth of the blade passage frequency. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Janiga, Gabor] Univ Magdeburg Otto von Guericke, Lab Fluid Dynam & Tech Flows, Magdeburg, Germany.
RP Janiga, G (reprint author), Univ Magdeburg Otto von Guericke, Lab Fluid Dynam & Tech Flows, Magdeburg, Germany.
EM janiga@ovgu.de
FU German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)German
   Research Foundation (DFG) [TRR63]
FX This work is part of the Collaborative Research Center "Integrated
   Chemical Processes in Liquid Multiphase Systems" (Subproject B8).
   Financial support of the German Research Foundation (Deutsche
   Forschungsgemeinschaft, DFG) is gratefully acknowledged (TRR63).
CR Abdelsamie A, 2016, COMPUT FLUIDS, V131, P123, DOI 10.1016/j.compfluid.2016.03.017
   Aranyi P, 2013, INT J HEAT FLUID FL, V43, P204, DOI 10.1016/j.ijheatfluidflow.2013.07.001
   de Souza LM, 2017, PROG COMPUT FLUID DY, V17, P90
   Delafosse A, 2008, CHEM ENG RES DES, V86, P1322, DOI 10.1016/j.cherd.2008.07.008
   Doulgerakis Z, 2011, AICHE J, V57, P2941, DOI 10.1002/aic.12519
   Eng M, 2015, CHEM ENG J, V259, P900, DOI 10.1016/j.cej.2014.08.056
   Fluent A., 2011, ANSYS FLUENT THEOR G
   Geurts B., 2004, ELEMENTS DIRECT LARG
   Hartmann H, 2004, CHEM ENG SCI, V59, P2419, DOI 10.1016/j.ces.2004.01.065
   Hasal P, 2000, CHEM ENG SCI, V55, P391, DOI 10.1016/S0009-2509(99)00334-6
   Hasal P, 2008, PHILOS T R SOC A, V366, P409, DOI 10.1098/rsta.2007.2098
   Holmes P. J., 1996, TURBULENCE COHERENT, P384, DOI [10.1016/S0370-1573(97)00017-3, DOI 10.1016/S0370-1573(97)00017-3]
   Holmes PJ, 1997, PHYS REP, V287, P337, DOI 10.1016/S0370-1573(97)00017-3
   Janiga G, 2017, CHEM ENG TECHNOL, V40, P1370, DOI 10.1002/ceat.201700067
   JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462
   Joshi JB, 2011, CAN J CHEM ENG, V89, P754, DOI 10.1002/cjce.20465
   Joshi JB, 2011, CAN J CHEM ENG, V89, P23, DOI 10.1002/cjce.20446
   Lehwald A, 2012, CHEM ENG SCI, V79, P8, DOI 10.1016/j.ces.2012.05.026
   Line A, 2013, CHEM ENG RES DES, V91, P2073, DOI 10.1016/j.cherd.2013.05.002
   Lumley J. L., 1981, TRANSITION TURBULENC, P215, DOI DOI 10.1016/B978-0-12-493240-1.50017-X
   Mangold M, 2015, J COMPUT APPL MATH, V289, P253, DOI 10.1016/j.cam.2015.01.028
   Menter F.R., 2015, BEST PRACTICE SCALE
   Moin P, 2002, INT J HEAT FLUID FL, V23, P710, DOI 10.1016/S0142-727X(02)00167-4
   Murthy BN, 2008, CHEM ENG SCI, V63, P5468, DOI 10.1016/j.ces.2008.06.019
   Nikiforaki L, 2003, CHEM ENG SCI, V58, P2937, DOI 10.1016/S0009-2509(03)00152-0
   Pope S. B., 2000, TURBULENT FLOWS
   Revstedt J, 1998, CHEM ENG SCI, V53, P4041, DOI 10.1016/S0009-2509(98)00203-6
   RIESZ F, 1955, FUNCTIONAL ANAL
   Roussinova V, 2003, CHEM ENG SCI, V58, P2297, DOI 10.1016/S0009-2509(03)00097-6
   Sagaut P., 2006, LARGE EDDY SIMULATIO
   SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462
   Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)091, 10.1175/1520-0493(1963)091<less than>0099:GCEWTP<greater than>2.3.CO;2]
   Sommerfeld M, 2004, CHEM ENG TECHNOL, V27, P215, DOI 10.1002/ceat.200402007
   Tabib MV, 2008, CHEM ENG SCI, V63, P3695, DOI 10.1016/j.ces.2008.04.046
   Wilcox DC, 1998, TURBULENCE MODELING
   Yeoh SL, 2004, CHEM ENG RES DES, V82, P834, DOI 10.1205/0263876041596751
   Zhao Qiuyue, 2012, Advanced Materials Research, V499, P218, DOI 10.4028/www.scientific.net/AMR.499.218
NR 37
TC 0
Z9 0
U1 1
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 132
EP 144
DI 10.1016/j.ces.2019.01.058
PG 13
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900012
DA 2020-05-12
ER

PT J
AU Feng, S
   Cui, C
   Li, KY
   Zhang, LZ
   Shi, Q
   Zhao, SQ
   Xu, CM
AF Feng, Song
   Cui, Chen
   Li, Kaiyu
   Zhang, Linzhou
   Shi, Quan
   Zhao, Suoqi
   Xu, Chunming
TI Molecular composition modelling of petroleum fractions based on a hybrid
   structural unit and bond-electron matrix (SU-BEM) framework
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Petroleum; Compositional model; Molecular management; Group
   contribution; Diesel; Slurry oil
ID COMPLEX-REACTION SYSTEMS; MONTE-CARLO; HEAVY PETROLEUM;
   GAS-CHROMATOGRAPHY; KINETIC-MODEL; REPRESENTATION; RESOLUTION;
   RECONSTRUCTION; IDENTIFICATION; RESIDUE
AB In this paper, we developed a method to represent petroleum molecules and reconstruct the molecular composition of petroleum fractions. A hybrid framework combining structural units and a bond-electron matrix (SU-BEM) was proposed to represent petroleum molecules in a convenient way and retain all the detailed atomic information. The structural units and bond-electron matrix represent the basic structural components and the atom connectivity of petroleum molecules, respectively. The group contribution method was implemented in the framework to predict the physical and chemical properties of petroleum molecules based on their chemical structures. Good agreement was observed for the property calculations of pure low-carbon number components. A flexible probability density function (PDF) sequence module was developed and used in the sampling procedure to obtain the molecular quantities used in the compositional models. The PDF parameters, as well as molecular compositions, were optimized by minimizing the differences between predicted and experimental properties. The method was validated for applications involving diesel, vacuum gas oil, and fluid catalytic cracking slurry oil. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Feng, Song; Cui, Chen; Li, Kaiyu; Zhang, Linzhou; Shi, Quan; Zhao, Suoqi; Xu, Chunming] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
RP Zhang, LZ (reprint author), China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
EM lzz@cup.edu.cn
OI Zhang, Linzhou/0000-0002-8354-784X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21506254]; Science Foundation of China University
   of Petroleum, Beijing [2462014YJRC020, 2462018BJC003]
FX This work was supported by the National Natural Science Foundation of
   China (No. 21506254) and the Science Foundation of China University of
   Petroleum, Beijing (Nos. 2462014YJRC020 and 2462018BJC003).
CR Ahmad MI, 2011, CHEM ENG RES DES, V89, P410, DOI 10.1016/j.cherd.2010.07.016
   Alvarez-Majmutov A, 2016, ENERG FUEL, V30, P138, DOI [10.1021/acs.energyfuels.5b02084, 10.1021/acs.energyfuels.5b02082]
   Alvarez-Majmutov A, 2014, ENERG FUEL, V28, P7385, DOI 10.1021/ef5018169
   Aye MMS, 2005, CHEM ENG SCI, V60, P6702, DOI 10.1016/j.ces.2005.05.033
   Beens J, 2000, TRAC-TREND ANAL CHEM, V19, P260, DOI 10.1016/S0165-9936(99)00205-8
   Cai GQ, 2018, ENERG FUEL, V32, P3290, DOI 10.1021/acs.energyfuels.7b04075
   Campbell DM, 1997, APPL CATAL A-GEN, V160, P41, DOI 10.1016/S0926-860X(97)00123-3
   Chen J, 2017, METHODS
   CONSTANTINOU L, 1994, AICHE J, V40, P1697, DOI 10.1002/aic.690401011
   de Oliveira LP, 2013, ENERG FUEL, V27, P3622, DOI 10.1021/ef300768u
   Hu SY, 2001, APPL THERM ENG, V21, P1331, DOI 10.1016/S1359-4311(01)00011-4
   Hudebine D, 2004, CHEM ENG SCI, V59, P4755, DOI 10.1016/j.ces.2004.09.019
   Hudebine D, 2009, OIL GAS SCI TECHNOL
   Hukkerikar AS, 2012, FLUID PHASE EQUILIBR, V321, P25, DOI 10.1016/j.fluid.2012.02.010
   Jaffe SB, 2005, IND ENG CHEM RES, V44, P9840, DOI 10.1021/ie058048e
   Kaminski M, 2005, CRIT REV ANAL CHEM, V35, P193, DOI 10.1080/10408340500304024
   Klein MT, 2005, MOL MODELING HEAVY H
   Marshall AG, 2004, ACCOUNTS CHEM RES, V37, P53, DOI 10.1021/ar020177t
   Mei H, 2017, IND ENG CHEM RES, V56, P14865, DOI 10.1021/acs.iecr.7b02905
   Mei H, 2017, CHEM ENG SCI, V164, P81, DOI 10.1016/j.ces.2017.02.005
   NEUROCK M, 1990, CHEM ENG SCI, V45, P2083, DOI 10.1016/0009-2509(90)80080-X
   NEUROCK M, 1994, CHEM ENG SCI, V49, P4153
   Nguyen TTH, 2017, ENERG FUEL, V31, P5673, DOI 10.1021/acs.energyfuels.7b00360
   Peng, 1999, MOL MODELLING PETROL
   PETTI TF, 1994, ENERG FUEL, V8, P570, DOI 10.1021/ef00045a009
   Phillips JB, 1999, J CHROMATOGR A, V856, P331, DOI 10.1016/S0021-9673(99)00815-8
   Pyl SP, 2011, IND ENG CHEM RES, V50, P10850, DOI 10.1021/ie200583t
   Qian K, 2001, ENERG FUEL, V15, P492, DOI 10.1021/ef000255y
   Qian KN, 2002, ANAL CHEM, V74, P3977, DOI 10.1021/ac020166d
   Qian KN, 2001, ENERG FUEL, V15, P1505, DOI 10.1021/ef010111z
   Qian K, 2007, INT J MASS SPECTROM, V265, P230, DOI 10.1016/j.ijms.2007.02.012
   QUANN RJ, 1992, IND ENG CHEM RES, V31, P2483, DOI 10.1021/ie00011a013
   Quann RJ, 1996, CHEM ENG SCI, V51, P1615, DOI 10.1016/0009-2509(96)00023-1
   Shi Q, 2010, ENERG FUEL, V24, P2545, DOI 10.1021/ef901564e
   Tian LD, 2012, IND ENG CHEM RES, V51, P3923, DOI 10.1021/ie2025272
   Tian LD, 2010, ENERG FUEL, V24, P4380, DOI 10.1021/ef100534e
   TRAUTH DM, 1994, ENERG FUEL, V8, P576, DOI 10.1021/ef00045a010
   Verstraete JJ, 2010, CHEM ENG SCI, V65, P304, DOI 10.1016/j.ces.2009.08.033
   Wei W, 2008, FUEL PROCESS TECHNOL, V89, P350, DOI 10.1016/j.fuproc.2007.11.015
   WHITSON CH, 1990, CHEM ENG COMMUN, V96, P259, DOI 10.1080/00986449008911495
   Wu Y, 2009, CHEM ENG T, V18
   Wu YW, 2010, IND ENG CHEM RES, V49, P12773, DOI 10.1021/ie101647d
   Zhang, 1999, MOL APPROACH CHARACT
   Zhang LZ, 2014, ENERG FUEL, V28, P1736, DOI 10.1021/ef402081x
   Zhang LZ, 2012, ENERG FUEL, V26, P5795, DOI 10.1021/ef3009663
NR 45
TC 0
Z9 0
U1 2
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 145
EP 156
DI 10.1016/j.ces.2019.01.050
PG 12
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900013
DA 2020-05-12
ER

PT J
AU Cheng, P
   Tatarchuk, BJ
AF Cheng, Peng
   Tatarchuk, Bruce J.
TI Kinetic study of SO2 adsorption on microfibrous entrapped sorbents for
   solid oxide fuel cell cathode protection
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Breakthrough curve; Sulfur dioxide; Axial dispersion; Microfibrous
   entrapped sorbent; Mathematical model; SOFC power system
ID FLUE-GAS DESULFURIZATION; SIMULTANEOUS REMOVAL; DRY DESULFURIZATION;
   CATALYST STRUCTURES; LOW-TEMPERATURE; CARBON-DIOXIDE; COPPER-OXIDE;
   METAL-OXIDES; BED REACTOR; MODEL
AB The kinetics of the non-catalytic gas-solid reaction between MnOx/gamma-Al(2)O(3 )and SO2 were investigated. A mathematical model based on axial dispersion, external and internal diffusion resistance, as well as a depletion mechanism for the sorbent has been established in this study. It predicted the breakthrough curves of packed bed (PB) and microfibrous entrapped sorbent (MFES) with acceptable deviations. This model consists of two predetermined parameters: the initial sorption rate constant (k(o)) and the depletion rate constant (k(d)), which can be determined by fitting the model to experimental data at various temperatures. Due to the uniform flow pattern and minimized bed channeling, MFES outperformed conventional PB consisting of the same sorbent particle size in terms of the reduction in SO2 concentration. The MFES surpassed PB significantly during the in situ regeneration in anode exhaust gas (AEG). Furthermore, MFES maintained its high breakthrough capacity up to five adsorption/regeneration cycles. Therefore, the MFES is a superior approach to remove the potential SO2 from the fuel cell cathode air stream for practical applications. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cheng, Peng; Tatarchuk, Bruce J.] Auburn Univ, Ctr Microfibrous Mat, Dept Chem Engn, 212 Ross Hall, Auburn, AL 36849 USA.
RP Tatarchuk, BJ (reprint author), Auburn Univ, Ctr Microfibrous Mat, Dept Chem Engn, 212 Ross Hall, Auburn, AL 36849 USA.
EM tatarbj@auburn.edu
FU Office of Naval ResearchOffice of Naval Research [N00014-09-C-0208]
FX The authors acknowledge the financial support by Office of Naval
   Research under the contract at Auburn University (N00014-09-C-0208). The
   authors also thank Dr. Donald Cahela for helpful suggestions.
CR Arcibar-Orozco JA, 2013, J HAZARD MATER, V246, P300, DOI 10.1016/j.jhazmat.2012.12.001
   Bahrami R, 2014, IND ENG CHEM RES, V53, P16285, DOI 10.1021/ie502581n
   Bausach M, 2005, AICHE J, V51, P1455, DOI 10.1002/aic.10403
   Cahela DR, 2014, IND ENG CHEM RES, V53, P6509, DOI 10.1021/ie404222d
   Centi G, 1997, IND ENG CHEM RES, V36, P2945, DOI 10.1021/ie9604886
   CENTI G, 1992, IND ENG CHEM RES, V31, P1956, DOI 10.1021/ie00008a017
   dos Santos RP, 2012, APPL CATAL A-GEN, V449, P23, DOI 10.1016/j.apcata.2012.09.026
   DWIVEDI PN, 1977, IND ENG CHEM PROC DD, V16, P157, DOI 10.1021/i260062a001
   EDWARDS MF, 1968, CHEM ENG SCI, V23, P109, DOI 10.1016/0009-2509(68)87056-3
   Fernandez I, 1998, CHEM ENG SCI, V53, P1869, DOI 10.1016/S0009-2509(98)00029-3
   Ferriz RM, 2002, CATAL LETT, V82, P123, DOI 10.1023/A:1020512713021
   Ficicilar B, 2006, CATAL TODAY, V115, P274, DOI 10.1016/j.cattod.2006.02.058
   Fogler H.S., 1992, ELEMENTS CHEM REACTI
   Fu RJ, 2014, J POWER SOURCES, V261, P120, DOI 10.1016/j.jpowsour.2014.03.045
   FULLER EN, 1966, IND ENG CHEM, V58, P19, DOI 10.1021/ie50677a007
   Garces HF, 2010, MICROPOR MESOPOR MAT, V127, P190, DOI 10.1016/j.micromeso.2009.07.022
   Garea A, 2001, CHEM ENG SCI, V56, P1387, DOI 10.1016/S0009-2509(00)00362-6
   Gavaskar VS, 2007, IND ENG CHEM RES, V46, P1161, DOI 10.1021/ie061363w
   Gavaskar VS, 2006, IND ENG CHEM RES, V45, P5859, DOI 10.1021/ie060123d
   Gu Q, 2016, IND ENG CHEM RES, V55, P8025, DOI 10.1021/acs.iecr.5b04247
   Gu Q, 2015, ENG APPL COMP FLUID, V9, P567, DOI 10.1080/19942060.2015.1094415
   Jeong SM, 1997, IND ENG CHEM RES, V36, P5425, DOI 10.1021/ie970206h
   Kalluri RR, 2008, SEP PURIF TECHNOL, V62, P304, DOI 10.1016/j.seppur.2008.01.021
   Kalluri RR, 2009, APPL CATAL B-ENVIRON, V90, P507, DOI 10.1016/j.apcatb.2009.04.015
   Karatepe N, 2004, CHEM ENG SCI, V59, P3883, DOI 10.1016/j.ces.2004.04.013
   KIANG KD, 1976, ENVIRON SCI TECHNOL, V10, P886, DOI 10.1021/es60120a014
   Koballa Thomas E, 1978, AICHE S SER, V73, P199
   Levenspiel O., 1962, CHEM REACTION ENG
   Li YR, 2007, FUEL, V86, P785, DOI 10.1016/j.fuel.2006.09.011
   Liu YJ, 2015, ENERG FUEL, V29, P1931, DOI 10.1021/ef502655k
   LOWELL PS, 1971, IND ENG CHEM PROC DD, V10, P384, DOI 10.1021/i260039a018
   Qu YF, 2013, APPL SURF SCI, V282, P425, DOI 10.1016/j.apsusc.2013.05.146
   Rutheven D. M., 1984, PRINCIPLES ADSORPTIO
   Sheng M, 2012, APPL CATAL A-GEN, V445, P143, DOI 10.1016/j.apcata.2012.08.012
   Sheng M, 2011, J CATAL, V281, P254, DOI 10.1016/j.jcat.2011.05.006
   Shih SM, 2011, IND ENG CHEM RES, V50, P12409, DOI 10.1021/ie2009668
   Song CS, 2002, CATAL TODAY, V77, P17, DOI 10.1016/S0920-5861(02)00231-6
   Sumathi S, 2010, CHEM ENG J, V162, P51, DOI 10.1016/j.cej.2010.04.056
   Suyadal Y, 2005, FUEL, V84, P1705, DOI 10.1016/j.fuel.2005.03.003
   Suyadal Y, 1999, IND ENG CHEM RES, V38, P2932, DOI 10.1021/ie9805077
   Suzuki M., 1972, Chemical Engineering Journal, V3, P256, DOI 10.1016/0300-9467(72)85029-9
   Tatarchuk B., 2009, Patent No. [US 7501012B2, 7501012B2]
   Tikhomirov K, 2006, APPL CATAL B-ENVIRON, V67, P160, DOI 10.1016/j.apcatb.2006.03.025
   UYSAL BZ, 1988, IND ENG CHEM RES, V27, P434, DOI 10.1021/ie00075a012
   VOGEL RF, 1974, ENVIRON SCI TECHNOL, V8, P432, DOI 10.1021/es60090a004
   Wang F, 2013, FUEL CELLS, V13, P520, DOI 10.1002/fuce.201200172
   Wang F, 2014, ENVIRON SCI TECHNOL, V48, P12427, DOI 10.1021/es503603w
   Yang HY, 2008, CHEM ENG SCI, V63, P2707, DOI 10.1016/j.ces.2008.02.025
   Yang H, 2007, J POWER SOURCES, V174, P302, DOI 10.1016/j.jpowsour.2007.08.031
   Yang HY, 2010, AICHE J, V56, P2898, DOI 10.1002/aic.12201
   Yang JH, 2012, IND ENG CHEM RES, V51, P2553, DOI 10.1021/ie202665a
   Yang R. T., 1987, GAS SEPARATION ADSOR
   Yasyerli S, 2001, IND ENG CHEM RES, V40, P5206, DOI 10.1021/ie0010621
   Yasyerli S., 2010, CHEM ENG COMMUN, V190, P1055
   Ye Q, 2012, ENERG FUEL, V26, P2497, DOI 10.1021/ef201699w
   YOO KS, 1994, IND ENG CHEM RES, V33, P1786, DOI 10.1021/ie00031a018
NR 56
TC 1
Z9 1
U1 4
U2 55
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 157
EP 166
DI 10.1016/j.ces.2019.02.011
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900014
DA 2020-05-12
ER

PT J
AU Hou, JQ
   Liu, YH
   Liu, YZ
   Wu, L
   Yang, ZJ
   Xu, TW
AF Hou, Jianqiu
   Liu, Yahua
   Liu, Yazhi
   Wu, Liang
   Yang, Zhengjin
   Xu, Tongwen
TI Self-healing anion exchange membrane for pH 7 redox flow batteries
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Anion exchange membrane; Self-healing; Diels-Alder reaction; Dynamic
   covalent bond; Organic aqueous redox flow battery
ID CROSS-LINKING; POLYMERS; CELLS
AB Anion exchange membranes (AEMs) separate the redox active electrolytes and transfer the charge carriers in redox flow batteries. During the long-term operation of a redox flow battery, the formation and propagation of cracks in AEMs are detrimental, resulting in capacity loss and self-discharge, while replacing the cracked membranes would increase the cost. Here we incorporate self-healing to an AEM through reversible and temperature-controlled Diels-Alder (DA) reaction. We first synthesized a block copolymer from vinylbenzyl chloride and 2-((4-vinylbenzyloxy) methyl) furan by RAFT polymerization. The benzylic chloride moiety was quaternized with trimethylamine to conduct anions, while bismaleimide was added to dynamically connect the furan moieties via DA reaction. By solution casting and reacting at 80 degrees C, an AEM with dynamic network was prepared. When evaluated for practical application, we found the AEM has a Cl conductivity of 32.7 mS cm( 1) at 80 degrees C and man-made cracks on the membrane can be self-healed. We then tested its performance in a pH 7 aqueous organic redox flow battery, where it delivered stable cycling performances over 100 consecutive charge/discharge cycles, with a coulombic efficiency of >97% and an energy efficiency of >79%. This membrane is promising for practical applications and what we report here is a useful strategy in rendering conventional AEMs with self-healing property. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hou, Jianqiu; Liu, Yahua; Liu, Yazhi; Wu, Liang; Yang, Zhengjin; Xu, Tongwen] Univ Sci & Technol China, Collaborat Innovat Ctr Chem Energy Mat, Sch Chem & Mat Sci, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
RP Yang, ZJ; Xu, TW (reprint author), Univ Sci & Technol China, Collaborat Innovat Ctr Chem Energy Mat, Sch Chem & Mat Sci, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.
EM yangzj09@ustc.edu.cn; twxu@ustc.edu.cn
RI Xu, Tongwen/F-6000-2010; Wu, Liang/E-8180-2016
OI Xu, Tongwen/0000-0002-9221-5126; Wu, Liang/0000-0002-8377-5834
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21720102003, 91534203, 21878281, 21506201];
   International Partnership Program of Chinese Academy of Sciences
   [21134ky5b20170010]; K.C. Wong Education Foundation [2016-11];
   Changjiang Scholars Program Funding (2014)
FX This project has been supported by the National Natural Science
   Foundation of China (Nos. 21720102003, 91534203, 21878281, 21506201),
   International Partnership Program of Chinese Academy of Sciences (No.
   21134ky5b20170010), K.C. Wong Education Foundation (2016-11) and
   Changjiang Scholars Program Funding (2014). The numerical calculations
   were performed on the supercomputing system in the Supercomputing Center
   at the University of Science and Technology of China.
CR Amel A, 2016, J MEMBRANE SCI, V514, P125, DOI 10.1016/j.memsci.2016.04.027
   An QF, 2005, J POLYM SCI POL CHEM, V43, P1973, DOI 10.1002/pola.20622
   Beh ES, 2017, ACS ENERGY LETT, V2, P639, DOI 10.1021/acsenergylett.7b00019
   Cao Y, 2017, ADV MATER, V29, DOI 10.1002/adma.201605099
   Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879
   Fuhrmann A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13623
   HAAS HC, 1973, J POLYM SCI POL CHEM, V11, P327, DOI 10.1002/pol.1973.170110202
   He YB, 2016, J MEMBRANE SCI, V504, P47, DOI 10.1016/j.memsci.2016.01.008
   Hou JQ, 2018, J POWER SOURCES, V375, P404, DOI 10.1016/j.jpowsour.2017.06.073
   Jo YY, 2017, POLYMER, V108, P58, DOI 10.1016/j.polymer.2016.11.040
   Kavitha AA, 2009, ACS APPL MATER INTER, V1, P1427, DOI 10.1021/am900124c
   Kuhl N, 2012, ANGEW CHEM INT EDIT, V51, P8230, DOI 10.1002/anie.201203792
   Kwasny MT, 2018, J AM CHEM SOC, V140, P7961, DOI 10.1021/jacs.8b03979
   Lai JC, 2016, ADV MATER, V28, P8277, DOI 10.1002/adma.201602332
   Li H, 2016, POLYMER, V85, P106, DOI 10.1016/j.polymer.2016.01.050
   Li YX, 2018, ADV MATER, V30, DOI 10.1002/adma.201707146
   Lin CX, 2017, J MEMBRANE SCI, V539, P24, DOI 10.1016/j.memsci.2017.05.063
   Liu TB, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201501449
   Mehmood A, 2015, J POWER SOURCES, V297, P224, DOI 10.1016/j.jpowsour.2015.07.094
   Ran J, 2017, J MEMBRANE SCI, V522, P267, DOI 10.1016/j.memsci.2016.09.033
   Rottger M, 2017, SCIENCE, V356, P62, DOI 10.1126/science.aah5281
   SATA T, 1995, J PHYS CHEM-US, V99, P12875, DOI 10.1021/j100034a028
   Sumerlin BS, 2018, SCIENCE, V362, P150, DOI 10.1126/science.aau6453
   Tang SKY, 2017, SCIENCE, V356, P1022, DOI 10.1126/science.aam6496
   Taylor DL, 2016, ADV MATER, V28, P9060, DOI 10.1002/adma.201601613
   Tee BCK, 2012, NAT NANOTECHNOL, V7, P825, DOI [10.1038/nnano.2012.192, 10.1038/NNANO.2012.192]
   Trovatti E, 2015, ADV MATER, V27, P2242, DOI 10.1002/adma.201405801
   Wang LZ, 2014, POLYM CHEM-UK, V5, P2928, DOI 10.1039/c3py01490h
   Wang YM, 2018, CHEM MATER, V30, P4289, DOI 10.1021/acs.chemmater.8b01260
   Wu J, 2017, ADV MAT, V29
   Yang ZJ, 2015, MACROMOL RAPID COMM, V36, P1362, DOI 10.1002/marc.201500116
   Zhang GG, 2016, ACS MACRO LETT, V5, P805, DOI 10.1021/acsmacrolett.6b00357
   Zhang HW, 2015, FUEL CELLS, V15, P761, DOI 10.1002/fuce.201500039
   Zhu L, 2016, POLYM CHEM-UK, V7, P2464, DOI 10.1039/c5py01911g
NR 34
TC 0
Z9 0
U1 23
U2 133
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 167
EP 174
DI 10.1016/j.ces.2019.02.033
PG 8
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900015
DA 2020-05-12
ER

PT J
AU Maaref, S
   Kantzas, A
   Bryant, SL
AF Maaref, Sepideh
   Kantzas, Apostolos
   Bryant, Steven L.
TI The effect of silanization assisted nanoparticle hydrophobicity on
   emulsion stability through droplet size distribution analysis
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Nanoparticle synthesis; Nanoparticle wettability; Emulsion stability;
   Droplet size distribution; Distribution functions
ID IN-WATER EMULSIONS; SILICA NANOPARTICLES; INTERFACIAL BEHAVIOR;
   SURFACTANT; STABILIZATION; PARTICLES; ADSORPTION; MIXTURE;
   HEXAMETHYLDISILAZANE; MECHANISM
AB There has been great recent interest in the potential use of Nanoparticles as modifiers or alternatives to surfactants for stabilizing emulsions, among which silica NPs have been commonly used as the most cost effective option. Since silica NPs are hydrophilic with a tendency toward the aqueous phase, their surface should be activated either by the aid of a surfactant or by chemical treatment. The aim of the present work is to assess the effect of two chemically activated silica NPs on stability of dodecane-water emulsions through optical microscopy. Therefore, hydrophilic silica NPs are firstly synthesized with sodium silicate solution and are subsequently silanized with hexamethyldisilazane (HMDS) into different extents to synthesize two different NPs with different wettability states, namely as HSNP1 and HSNP2. The degree of Nanoparticle wettability is quantified by the variation of the silanol group density of bare silica NPs, which has reduced by 49% for HSNP1, resulting in partially hydrophobic silica NPs and by 60% for HSNP2, resulting in hydrophobic silica NPs. The emulsion stability prepared by HSNP1 and HSNP2 has been assessed via both bottle tests and droplet size distribution analysis, which is tracked by fitting proper distribution functions on the experimental data. The log-normal and the bimodal (a mixture of two log-normal distribution) distribution functions are respectively fitted on the droplet size distribution of emulsions stabilized by HSNP1 and HSNP2. This revealed minor changes in the droplet size distribution of emulsions stabilized by partially hydrophobic silica NPs (HSNP1) over a month, while a significant alteration in droplet size distribution of emulsions stabilized by hydrophobic silica NPs (HSNP2) has been observed after a week. Higher emulsion stability stabilized by HSNP1 is also confirmed by higher zeta potential value and higher surface coverage of partially hydrophobic silica NPs (HSNP1) compared to that of hydrophobic silica NPs (HSNP2). The partially hydrophobic silica NPs, wetted to the same extent by both liquid phases has been found to be suitable for stabilizing emulsions for Enhanced Oil Recovery (EOR) applications. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Maaref, Sepideh; Kantzas, Apostolos; Bryant, Steven L.] Univ Calgary, Dept Chem & Petr Engn, Calgary, AB, Canada.
RP Maaref, S (reprint author), Univ Calgary, Dept Chem & Petr Engn, Calgary, AB, Canada.
EM sepideh.maaref@ucalgary.ca
FU Canada Excellence Research Chair (CERC) program in Materials
   Engineering; Schulich School of Engineering, University of Calgary
FX The authors would like to gratefully acknowledge the support from the
   Canada Excellence Research Chair (CERC) program in Materials Engineering
   for Unconventional Reservoirs, as well as the Schulich School of
   Engineering, University of Calgary.
CR Ahualli S, 2011, LANGMUIR, V27, P9182, DOI 10.1021/la201242d
   Aminzadeh-goharrizi B, 2012, SPE IMPR OIL REC S S
   Arab D, 2018, J PETROL SCI ENG, V163, P217, DOI 10.1016/j.petrol.2017.12.091
   Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6
   Binks B. P., 2006, COLLOIDAL PARTICLES
   Binks BP, 2007, PHYS CHEM CHEM PHYS, V9, P6391, DOI 10.1039/b711174f
   Binks BP, 2007, LANGMUIR, V23, P7436, DOI 10.1021/la700597k
   Binks BP, 2007, LANGMUIR, V23, P3626, DOI 10.1021/la0634600
   Binks BP, 2007, LANGMUIR, V23, P1098, DOI 10.1021/la062510y
   Binks BP, 2016, LANGMUIR, V32, P3110, DOI 10.1021/acs.langmuir.6b00140
   Binks BP, 2016, SOFT MATTER, V12, P876, DOI 10.1039/c5sm02438b
   Binks BP, 2009, COLLOID SURFACE A, V345, P195, DOI 10.1016/j.colsurfa.2009.05.001
   Binks BP, 2005, LANGMUIR, V21, P3296, DOI 10.1021/la046915z
   Binks BP, 2000, LANGMUIR, V16, P8622, DOI 10.1021/la000189s
   Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0
   Biswal NR, 2016, J PHYS CHEM B, V120, P7265, DOI 10.1021/acs.jpcb.6b03763
   Bresme F, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/413101
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cui ZG, 2008, COLLOID SURFACE A, V329, P67, DOI 10.1016/j.colsurfa.2008.06.049
   DiCarlo D. A., 2011, GEOPHYS RES LETT, V38, P24
   Dickson JL, 2004, LANGMUIR, V20, P7976, DOI 10.1021/la0488102
   El Rassy H, 2005, J NON-CRYST SOLIDS, V351, P1603, DOI 10.1016/j.jnoncrysol.2005.03.048
   Essien ER, 2011, J MET MATER MINER, V21, P7
   Fernandez-Toledano JC, 2006, THEORY INTERACTIONS, P108
   Griffith C, 2018, J COLLOID INTERF SCI, V509, P132, DOI 10.1016/j.jcis.2017.08.100
   Gun'ko VM, 2000, J COLLOID INTERF SCI, V228, P157, DOI 10.1006/jcis.2000.6934
   HERTL W, 1971, J PHYS CHEM-US, V75, P2181
   Horozov T.S., 2006, ANGEW CHEM INT EDIT, V118, P787, DOI DOI 10.1002/ange.200503131
   Horozov TS, 2007, PHYS CHEM CHEM PHYS, V9, P6398, DOI 10.1039/b709807n
   Innocenzi P, 2003, J PHYS CHEM B, V107, P4711, DOI 10.1021/jp026609z
   Jiang L, 2016, COLLOID SURFACE A, V488, P20, DOI 10.1016/j.colsurfa.2015.10.007
   Katepalli H, 2014, LANGMUIR, V30, P12736, DOI 10.1021/la502291q
   Kim I., 2017, IOR 2017 19 EUR S IM
   KORETSKY AF, 1971, IZV SIB OTD AKAD NAU, V2, P139
   Lan Q, 2007, COLLOID SURFACE A, V302, P126, DOI 10.1016/j.colsurfa.2007.02.010
   Lin Y, 2005, LANGMUIR, V21, P191, DOI 10.1021/la048000q
   Liu KH, 2017, LANGMUIR, V33, P2296, DOI 10.1021/acs.langmuir.6b04459
   Maaref S, 2018, J DISPER SCI TECHNOL, V39, P721, DOI 10.1080/01932691.2017.1386569
   Moghadam TF, 2014, COLLOID SURFACE A, V457, P333, DOI 10.1016/j.colsurfa.2014.06.009
   Moradi M, 2011, ENERG FUEL, V25, P260, DOI 10.1021/ef101236h
   Paunov VN, 2002, LANGMUIR, V18, P6946, DOI 10.1021/la0203584
   Pilapil BK, 2016, LANGMUIR, V32, P7109, DOI 10.1021/acs.langmuir.6b00873
   Reincke F, 2006, PHYS CHEM CHEM PHYS, V8, P3828, DOI 10.1039/b604535a
   Safouane M, 2007, LANGMUIR, V23, P11546, DOI 10.1021/la700800a
   Schlomach J, 2004, J COLLOID INTERF SCI, V277, P316, DOI 10.1016/j.jcis.2004.04.051
   SEARS GW, 1956, ANAL CHEM, V28, P1981, DOI 10.1021/ac60120a048
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Sun Q, 2014, ENERG FUEL, V28, P2384, DOI 10.1021/ef402453b
   TAMBE DE, 1994, ADV COLLOID INTERFAC, V52, P1, DOI 10.1016/0001-8686(94)80039-1
   Tyowua AT, 2017, J COLLOID INTERF SCI, V488, P127, DOI 10.1016/j.jcis.2016.10.089
   Weichold O, 2008, J COLLOID INTERF SCI, V324, P105, DOI 10.1016/j.jcis.2008.04.060
   Whitby CP, 2011, J COLLOID INTERF SCI, V361, P170, DOI 10.1016/j.jcis.2011.05.046
   Worthen AJ, 2013, AICHE J, V59, P3490, DOI 10.1002/aic.14124
   Yang WP, 2017, ENERG FUEL, V31, P4721, DOI 10.1021/acs.energyfuels.6b03217
   Zawrah MF, 2009, J OVONIC RES, V5, P129
   Zhang T, 2010, SPE IMPR OIL REC S S
   Zhang T., 2009, SPE INT S OILF CHEM
   Zhao MW, 2017, J SURFACTANTS DETERG, V20, P873, DOI 10.1007/s11743-017-1966-4
   Zhu Y, 2015, LANGMUIR, V31, P3301, DOI 10.1021/acs.langmuir.5b00295
   Zulfiqar U, 2016, J ASIAN CERAM SOC, V4, P91, DOI 10.1016/j.jascer.2015.12.001
   Zulfiqar U, 2016, J SOL-GEL SCI TECHN, V77, P753, DOI 10.1007/s10971-015-3950-7
NR 61
TC 4
Z9 4
U1 15
U2 54
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 175
EP 190
DI 10.1016/j.ces.2019.02.034
PG 16
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900016
DA 2020-05-12
ER

PT J
AU Wang, T
   Zhang, YL
   Shi, XP
   Wu, LG
   Zhang, XY
   Zhang, SQ
AF Wang, Ting
   Zhang, Yan-ling
   Shi, Xiao-ping
   Wu, Li-guang
   Zhang, Xue-yang
   Zhang, Shan-qi
TI Polyurethane hybrid membranes with confined mass transfer channels: The
   effect of functionalized multi-walled carbon nanotubes on permeation
   properties
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hhybrid membranes; Pervaporation; Multi-walled carbon nanotubes;
   Confined mass transfer channels
ID MIXED MATRIX MEMBRANES; GRAPHENE OXIDE; BENZENE/CYCLOHEXANE MIXTURES;
   PERVAPORATION PERFORMANCE; COMPOSITE MEMBRANES; CO2 SEPARATION;
   CHITOSAN; SURFACE; NANOPARTICLES; DIFFUSION
AB Aiming to prepare pervaporation membranes with confined mass transfer channels, multi-walled carbon nanotubes (MWCNTs) with and without functionalization were incorporated into polyurethane (PU) polymer matrices. Scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS), transmission electron microscopy (TEM), high-resolution TEM (HRTEM), X-ray diffraction (XRD), Fourier-transform infrared (FTIR), and Raman spectroscopy were employed to explore the effect of functionalization on the morphologies of MWCNTs. The changes in the morphologies of the resulting PU hybrid membrane were then characterized by SEM, TEM, and XRD. Swelling-sorption and pervaporation experiments of benzene and cyclohexane were employed to evaluate the separation performances of various hybrid membranes. The results showed that the introduction of many oxygenated functional groups onto the MWCNT surfaces through functionalization not only efficiently inhibited the MWCNT aggregation but also improved the distributions of the MWCNTs in solvents and polymer materials. Due to the 1D tube structures of the MWCNTs with conjugated pi bonds, the addition of well-distributed MWCNTs into the hybrid membranes not only increased the benzene sorption abilities of the membranes but also enhanced the benzene diffusion selectivities due to the strong driving force for the molecules in the confined mass transfer channels. A higher content of well-distributed MWCNTs in the membrane yielded a higher separation performance for benzene. Additionally, increasing the operating temperature in the pervaporation experiments accelerated the molecular motion and weakened the affinity between the benzene molecules and the walls of the MWCNTs, increasing the permeation fluxes of the membranes while decreasing the benzene separation factors. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Ting; Zhang, Yan-ling; Shi, Xiao-ping; Wu, Li-guang; Zhang, Xue-yang; Zhang, Shan-qi] Zhejiang Gongshang Univ, Sch Environm Sci & Engn, Hangzhou 310018, Zhejiang, Peoples R China.
RP Wu, LG (reprint author), Zhejiang Gongshang Univ, Sch Environm Sci & Engn, Hangzhou 310018, Zhejiang, Peoples R China.
EM wulg64@hotmail.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21776250, 21376218]; Natural Science Foundation of
   Zhejiang ProvinceNatural Science Foundation of Zhejiang Province
   [LY14B060001]
FX The authors gratefully acknowledge the financial support from the
   National Natural Science Foundation of China Grants (Contracts 21776250
   and 21376218) and the Natural Science Foundation of Zhejiang Province
   (Contracts LY14B060001). We thank LetPub (www.letpub.com) for its
   linguistic assistance during the preparation of this manuscript.
CR Baheri B, 2017, SEP PURIF TECHNOL, V185, P112, DOI 10.1016/j.seppur.2017.05.026
   Baker RW, 2010, J MEMBRANE SCI, V348, P346, DOI 10.1016/j.memsci.2009.11.022
   Boffa V, 2016, MICROPOR MESOPOR MAT, V221, P81, DOI 10.1016/j.micromeso.2015.09.017
   Castel C, 2018, CHEM ENG SCI, V183, P136, DOI 10.1016/j.ces.2018.03.013
   Chang H, 2018, CHEM ENG SCI, V192, P85, DOI 10.1016/j.ces.2018.07.027
   Chen HL, 2000, CHEM ENG J, V78, P159, DOI 10.1016/S1385-8947(00)00154-6
   Cheng C, 2019, CHEM ENG SCI, V196, P265, DOI 10.1016/j.ces.2018.11.019
   Cong HL, 2007, J MEMBRANE SCI, V294, P178, DOI 10.1016/j.memsci.2007.02.035
   Cuello NI, 2017, MAT SCI ENG C-MATER, V78, P674, DOI 10.1016/j.msec.2017.02.010
   Cui ZL, 2018, DESALINATION, V440, P68, DOI 10.1016/j.desal.2017.12.038
   Dai SQ, 2016, J COLLOID INTERF SCI, V478, P145, DOI 10.1016/j.jcis.2016.06.009
   Eastoe J, 2006, ADV COLLOID INTERFAC, V128, P5, DOI 10.1016/j.cis.2006.11.009
   Ekambaram K, 2017, CARBOHYD POLYM, V173, P431, DOI 10.1016/j.carbpol.2017.06.017
   Grossi N, 2001, SEP PURIF TECHNOL, V22-3, P255, DOI 10.1016/S1383-5866(00)00126-X
   Hoang VT, 2013, CHEM REV, V113, P4980, DOI 10.1021/cr3003888
   Hong SH, 2010, COLLOID POLYM SCI, V288, P1013, DOI 10.1007/s00396-010-2229-3
   Hu YX, 2016, ANGEW CHEM INT EDIT, V55, P2048, DOI 10.1002/anie.201509213
   Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711
   Kang YS, 2007, ADV MATER, V19, P475, DOI 10.1002/adma.200601009
   Kao ST, 2002, DESALINATION, V149, P35, DOI 10.1016/S0011-9164(02)00688-4
   Khazaei A, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.45853
   Kim HJ, 2014, ACS APPL MATER INTER, V6, P17877, DOI 10.1021/am504581j
   Kumarasinghe AR, 2013, J PHYS CHEM C, V117, P9507, DOI 10.1021/jp402428j
   Li WB, 2015, CHEM ENG SCI, V135, P232, DOI 10.1016/j.ces.2015.04.011
   Li WD, 2017, CHINESE J CHEM ENG, V25, P1563, DOI 10.1016/j.cjche.2017.04.015
   Li YF, 2013, J MATER CHEM A, V1, P10058, DOI 10.1039/c3ta01652h
   Liu HX, 2018, CHINESE J CHEM ENG, V26, P1, DOI 10.1016/j.cjche.2017.03.006
   Luis P, 2015, SEP PURIF TECHNOL, V148, P94, DOI 10.1016/j.seppur.2015.05.006
   Mawhinney DB, 2000, J AM CHEM SOC, V122, P2383, DOI 10.1021/ja994094s
   McHale R, 2012, NAT CHEM, V4, P491, DOI [10.1038/nchem.1331, 10.1038/NCHEM.1331]
   Novita FJ, 2018, CHEM ENG SCI, V190, P297, DOI 10.1016/j.ces.2018.06.024
   Park CH, 2016, J MEMBRANE SCI, V514, P195, DOI 10.1016/j.memsci.2016.04.011
   Peng FB, 2007, J MEMBRANE SCI, V300, P13, DOI 10.1016/j.memsci.2007.06.008
   Qiu S, 2010, IND ENG CHEM RES, V49, P11667, DOI 10.1021/ie101223k
   Shen JN, 2014, J MEMBRANE SCI, V462, P160, DOI 10.1016/j.memsci.2014.03.040
   Sheng JL, 2017, ACS APPL MATER INTER, V9, P15139, DOI 10.1021/acsami.7b02594
   Swaidan R, 2015, J MEMBRANE SCI, V475, P571, DOI 10.1016/j.memsci.2014.10.046
   Wang J, 2018, CHEM ENG SCI, V181, P237, DOI 10.1016/j.ces.2018.02.009
   Wang T, 2017, ENVIRON SCI TECHNOL, V51, P6202, DOI 10.1021/acs.est.7b01563
   Wang T, 2016, IND ENG CHEM RES, V55, P1043, DOI 10.1021/acs.iecr.5b04074
   Wang T, 2014, J MEMBRANE SCI, V466, P338, DOI 10.1016/j.memsci.2014.04.054
   Wu LG, 2018, APPL SURF SCI, V440, P1063, DOI 10.1016/j.apsusc.2018.01.261
   Ye H, 2017, J POLYM ENG, V37, P449, DOI 10.1515/polyeng-2016-0155
   Yue XJ, 2018, IND ENG CHEM RES, V57, P10439, DOI 10.1021/acs.iecr.8b02577
   Zhang WF, 2015, ADV MATER, V27, P7349, DOI 10.1002/adma.201502695
NR 45
TC 3
Z9 3
U1 9
U2 102
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 191
EP 200
DI 10.1016/j.ces.2019.02.037
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900017
DA 2020-05-12
ER

PT J
AU Wang, GC
   Wan, DD
   Peng, C
   Liu, K
   Wang, LP
AF Wang, Guichao
   Wan, Dongdong
   Peng, Cheng
   Liu, Ke
   Wang, Lian-Ping
TI LBM study of aggregation of monosized spherical particles in homogeneous
   isotropic turbulence
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Lattice Boltzmann method; Mono-sized spherical particles; Aggregation;
   Turbulence
ID LATTICE BOLTZMANN SIMULATION; DIRECT NUMERICAL SIMULATIONS; PARTICULATE
   SUSPENSIONS; WATER-TREATMENT; DEM SIMULATION; FLOCCULATION; FLOTATION;
   BREAKUP; DYNAMICS; EQUATION
AB Direct numerical simulations of an aggregation system composed of monosized spherical particles in homogeneous isotropic turbulence have been performed using Lattice Boltzmann method (LBM). The effects of hydrodynamics on the aggregation process were considered by directly resolving the disturbance flows around finite-size solid particles using an interpolated bounce-back scheme. A nonuniform time-dependent large-scale stochastic forcing scheme was implemented within the mesoscopic multiple-relaxation-time LBM approach to maintain turbulence intensity at targeted levels. To simulate particle interactions, the non-contact surface force and the contact force were taken into account using the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory and the soft-sphere model, respectively. This interface-resolved direct numerical simulation (IR-DNS) combined with the well-known DLVO theory was employed to obtain an insight into the aggregation process of micron-size particles. Specifically, the model was used to study the effects of solid volume fraction on aggregate growth. Aggregates of larger sizes formed in local regions of higher concentration of particles due to higher encountering probability between particles. The effects of aggregating particles of different volume fractions on the statistically stationary homogeneous isotropic turbulent flow were investigated. It was found that the presence of particles attenuated the turbulent kinetic energy at large scales and augmented the kinetic energy at the small scales. This effect is more apparent with increasing volume concentration of particles. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Guichao; Liu, Ke] Southern Univ Sci & Technol, SUSTech Acad Adv Interdisciplinary Studies, Shenzhen 518055, Peoples R China.
   [Wan, Dongdong] Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Manufacture, Jinan 250061, Shandong, Peoples R China.
   [Peng, Cheng; Wang, Lian-Ping] Univ Delaware, Spencer Lab 126, Dept Mech Engn, Newark, DE 19716 USA.
   [Wang, Lian-Ping] Southern Univ Sci & Technol, Dept Mech & Aerosp Engn, Shenzhen 518055, Peoples R China.
RP Wang, LP (reprint author), Univ Delaware, Spencer Lab 126, Dept Mech Engn, Newark, DE 19716 USA.
EM wanglp@sustc.edu.cn
RI Wang, Lian-Ping/N-7516-2016; Peng, Cheng/T-8915-2019
OI Wang, Lian-Ping/0000-0003-4276-0051; 
FU Grand Research Project of National Natural Science Foundation of China
   [91852205]
FX We gratefully acknowledge that this work was supported by Grand Research
   Project of National Natural Science Foundation of China "91852205".
CR Abdelsamie AH, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3678332
   Babler MU, 2015, J FLUID MECH, V766, DOI 10.1017/jfm.2015.13
   Babler MU, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.025301
   Bratby J, 2006, COAGULATION AND FLOCCULATION IN WATER AND WASTEWATER TREATMENT, 2ND EDITION, P1
   Bridgeman J, 2009, ENG APPL COMP FLUID, V3, P220, DOI 10.1080/19942060.2009.11015267
   Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329
   Chouippe A, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4936274
   de Motta JCB, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4817382
   Derksen JJ, 2012, AICHE J, V58, P2589, DOI 10.1002/aic.12761
   Ernst M, 2013, ACTA MECH, V224, P2425, DOI 10.1007/s00707-013-0923-1
   ESWARAN V, 1988, COMPUT FLUIDS, V16, P257, DOI 10.1016/0045-7930(88)90013-8
   Gao H, 2013, COMPUT MATH APPL, V65, P194, DOI 10.1016/j.camwa.2011.06.028
   Gao Y, 2017, COLLOID SURFACE A, V529, P876, DOI 10.1016/j.colsurfa.2017.06.082
   Higashitani K, 2001, CHEM ENG SCI, V56, P2927, DOI 10.1016/S0009-2509(00)00477-2
   Hunter R. J., 2001, FDN COLLOID SCI
   Jameson GJ, 2010, MINER ENG, V23, P835, DOI 10.1016/j.mineng.2010.04.001
   Karpinska AM, 2016, WATER RES, V88, P861, DOI 10.1016/j.watres.2015.11.008
   Kromkamp J, 2006, CHEM ENG SCI, V61, P858, DOI 10.1016/j.ces.2005.08.011
   LADD AJC, 1994, J FLUID MECH, V271, P311, DOI 10.1017/S0022112094001783
   LADD AJC, 1994, J FLUID MECH, V271, P285, DOI 10.1017/S0022112094001771
   Ladd AJC, 2001, J STAT PHYS, V104, P1191, DOI 10.1023/A:1010414013942
   Lallemand P, 2003, J COMPUT PHYS, V184, P406, DOI 10.1016/S0021-9991(02)00022-0
   Liang Y, 2007, ADV COLLOID INTERFAC, V134-35, P151, DOI 10.1016/j.cis.2007.04.003
   Nguyen NQ, 2005, J FLUID MECH, V525, P73, DOI 10.1017/S0022112004002563
   Nguyen NQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046708
   Peng ZB, 2012, ADV POWDER TECHNOL, V23, P437, DOI 10.1016/j.apt.2012.03.009
   Peng ZB, 2012, POWDER TECHNOL, V223, P3, DOI 10.1016/j.powtec.2011.11.001
   Peng ZB, 2010, POWDER TECHNOL, V204, P91, DOI 10.1016/j.powtec.2010.07.023
   Rubio J, 2002, MINER ENG, V15, P139, DOI 10.1016/S0892-6875(01)00216-3
   Saha D, 2016, LANGMUIR, V32, P55, DOI 10.1021/acs.langmuir.5b03804
   Samaras K, 2010, CHEM ENG J, V162, P208, DOI 10.1016/j.cej.2010.05.032
   Schneiders L, 2017, J FLUID MECH, V819, P188, DOI 10.1017/jfm.2017.171
   Sun R, 2018, ADV WATER RESOUR, V111, P406, DOI 10.1016/j.advwatres.2017.11.012
   Ten Cate A, 2004, J FLUID MECH, V519, P233, DOI [10.1017/S0022112004001326, 10.1017/s0022112004001326]
   Thomas DN, 1999, WATER RES, V33, P1579, DOI 10.1016/S0043-1354(98)00392-3
   Vadasarukkai YS, 2011, J AM WATER WORKS ASS, V103, P66
   van Vliet E, 2005, AICHE J, V51, P725, DOI 10.1002/aic.10365
   Vandamme D, 2013, TRENDS BIOTECHNOL, V31, P233, DOI 10.1016/j.tibtech.2012.12.005
   Vreman AW, 2016, J FLUID MECH, V796, DOI 10.1017/jfm.2016.228
   Wang C, 2014, MINER ENG, V58, P113, DOI 10.1016/j.mineng.2014.01.018
   Wang GC, 2018, MINER ENG, V127, P153, DOI 10.1016/j.mineng.2018.08.019
   Wang GC, 2018, FUEL PROCESS TECHNOL, V178, P104, DOI 10.1016/j.fuproc.2018.04.035
   Wang LP, 2014, COMPUT MATH APPL, V67, P363, DOI 10.1016/j.camwa.2013.04.001
   Zhang JF, 2013, OCEAN DYNAM, V63, P1123, DOI 10.1007/s10236-013-0646-9
   Zhang JF, 2011, CONT SHELF RES, V31, pS94, DOI 10.1016/j.csr.2010.03.009
   Zhang Q.-H., 2008, P MAR SCI, P227, DOI DOI 10.1016/S1568-2692(08)80018-6
   Zhou K, 2017, CHEM ENG SCI, V167, P288, DOI 10.1016/j.ces.2017.04.026
NR 47
TC 3
Z9 3
U1 14
U2 49
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 201
EP 211
DI 10.1016/j.ces.2019.03.004
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900018
DA 2020-05-12
ER

PT J
AU Zhou, HD
   Zhang, QS
   Dai, CL
   Li, YY
   Lv, WJ
   Wu, YN
   Cheng, R
   Zhao, MW
AF Zhou, Hongda
   Zhang, Qingsheng
   Dai, Caili
   Li, Yuyang
   Lv, Wenjiao
   Wu, Yining
   Cheng, Rui
   Zhao, Mingwei
TI Experimental investigation of spontaneous imbibition process of
   nanofluid in ultralow permeable reservoir with nuclear magnetic
   resonance
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Spontaneous imbibition; Nuclear magnetic resonance; Nanofluid;
   Interfacial activity; Enhanced oil recovery
ID ENHANCED OIL-RECOVERY; PORE STRUCTURE; WETTABILITY ALTERATION;
   INTERFACIAL PROPERTIES; SURFACTANT SOLUTION; ROCK WETTABILITY; WET
   CAPILLARY; NANOPARTICLES; WATER; NMR
AB Spontaneous imbibition of nanofluid has attracted much interest in enhanced oil recovery (EOR) in ultralow permeable reservoirs. However, the oil distribution in ultralow permeable cores during the spontaneous imbibition using nanofluids has not been discussed in detail. In this study, imbibition experiment and nuclear magnetic resonance (NMR) measurement were used to monitor the migration rule of nanofluid and oil distribution in the imbibition. The results show that 70.82-71.98 wt% of the oil was distributed in mesopores (50 nm < pore size < 3000 nm). The final oil recoveries of cores immersed in different concentrations of nanofluids (0.1 wt%, 0.05 wt%, 0.01 wt%, and 0.005 wt%) and brine were 32.5%, 26.9%, 20.5%, 15.1%, and 8.3%, respectively. The NMR spectra and imaging show that the nanoparticles seeped into the core. Significant insight into the oil distribution during the imbibition of nanofluid is provided. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zhou, Hongda; Zhang, Qingsheng; Dai, Caili; Li, Yuyang; Lv, Wenjiao; Wu, Yining; Cheng, Rui; Zhao, Mingwei] China Univ Petr East China, Sch Petr Engn, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China.
RP Dai, CL; Zhao, MW (reprint author), China Univ Petr East China, Sch Petr Engn, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China.
EM Daicaili@upc.edu.cn; zhaomingwei@upc.edu.cn
OI Dai, Cai li/0000-0002-7477-8865
FU National Key Basic Research ProgramNational Basic Research Program of
   China [2015CB250904]; National Science Fund [U1663206, 51425406]; Chang
   Jiang Scholars ProgramProgram for Changjiang Scholars & Innovative
   Research Team in University (PCSIRT) [T2014152]; Climb Taishan Scholar
   Program in Shandong Province [tspd20161004]
FX This work was financially supported by the National Key Basic Research
   Program (No. 2015CB250904), National Science Fund (U1663206, 51425406),
   Chang Jiang Scholars Program (T2014152), and Climb Taishan Scholar
   Program in Shandong Province (tspd20161004).
CR Al-Mahrooqi SH, 2003, J PETROL SCI ENG, V39, P389, DOI 10.1016/S0920-4105(03)00077-9
   Bayat AE, 2014, ENERG FUEL, V28, P6255, DOI 10.1021/ef5013616
   Bourbiaux B.J., 1990, SPE RESERVOIR ENG, V5, P361, DOI DOI 10.2118/18283-PA
   Brown R.J.S., 1956, FALL M PETR BRANCH A
   Cai JC, 2010, CHEM ENG SCI, V65, P5178, DOI 10.1016/j.ces.2010.06.013
   Chengara A, 2004, J COLLOID INTERF SCI, V280, P192, DOI 10.1016/j.jcis.2004.07.005
   Dillinger A, 2014, MAR PETROL GEOL, V57, P455, DOI 10.1016/j.marpetgeo.2014.06.010
   Ehtesabi H, 2014, ENERG FUEL, V28, P423, DOI 10.1021/ef401338c
   El-hoshoudy AN, 2016, FUEL, V170, P161, DOI 10.1016/j.fuel.2015.12.036
   Franco CA, 2013, ENERG FUEL, V27, P2899, DOI 10.1021/ef4000825
   Giri A, 2012, J APPL GEOPHYS, V87, P40, DOI 10.1016/j.jappgeo.2012.09.002
   Guo F, 2016, FUEL, V186, P430, DOI 10.1016/j.fuel.2016.08.058
   Hammond PS, 2011, LANGMUIR, V27, P4412, DOI 10.1021/la1048503
   Hammond PS, 2010, LANGMUIR, V26, P6206, DOI 10.1021/la903924m
   Hammond PS, 2009, LANGMUIR, V25, P12591, DOI 10.1021/la901781a
   Hashemi R, 2014, APPL ENERG, V133, P374, DOI 10.1016/j.apenergy.2014.07.069
   Hendraningrat L, 2013, SPE RES CHAR SIM C E
   Hendraningrat L, 2014, ENERG FUEL, V28, P6228, DOI 10.1021/ef5014049
   Karimi A, 2012, ENERG FUEL, V26, P1028, DOI 10.1021/ef201475u
   Kondiparty K, 2011, LANGMUIR, V27, P3324, DOI 10.1021/la104204b
   Kondiparty K, 2012, LANGMUIR, V28, P14618, DOI 10.1021/la3027013
   Lai F., 2016, ENERGY FUELS
   Lai J, 2016, ENERGY FUELS, V30
   Lai J, 2018, MAR PETROL GEOL, V91, P179, DOI 10.1016/j.marpetgeo.2017.12.024
   Li KW, 2010, J PETROL SCI ENG, V73, P20, DOI 10.1016/j.petrol.2010.05.002
   Li KW, 2006, GEOTHERMICS, V35, P198, DOI 10.1016/j.geothermics.2006.02.001
   Li Y., 2017, ENERGY FUELS
   Liang B., 2017, INVESTIGATION OIL SA
   Hun L, 2016, ENERG FUEL, V30, P9097, DOI 10.1021/acs.energyfuels.6b01739
   Liu KL, 2012, LANGMUIR, V28, P16274, DOI 10.1021/la302702g
   Maas M, 2010, LANGMUIR, V26, P17867, DOI 10.1021/la103492a
   Meng MM, 2016, J PETROL SCI ENG, V137, P63, DOI 10.1016/j.petrol.2015.11.012
   Monfared A. D., 2016, ENERGY FUELS, V30
   Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001
   Perino A, 2013, ENERG FUEL, V27, P2399, DOI 10.1021/ef301627e
   Rahmatmand B, 2016, J CHEM ENG DATA, V61, P1378, DOI 10.1021/acs.jced.5b00442
   Saidian M, 2015, FUEL, V161, P197, DOI 10.1016/j.fuel.2015.08.014
   Sharma T, 2016, IND ENG CHEM RES, V55, P12387, DOI 10.1021/acs.iecr.6b03299
   Suleimanov BA, 2011, J PETROL SCI ENG, V78, P431, DOI 10.1016/j.petrol.2011.06.014
   Tinni A., 2015, SPE RESERVOIR EVAL E, V18
   Wang XZ, 2018, FUEL, V224, P280, DOI 10.1016/j.fuel.2018.03.104
   Wang Z., 2018, ENERGY FUELS
   Wasan DT, 2003, NATURE, V423, P156, DOI 10.1038/nature01591
   Wei B., 2016, ENERGY FUELS, V30
   Wong K. V., 2010, ADV MECH ENG, V2010, P1652
   Yang L, 2016, J NAT GAS SCI ENG, V34, P1461, DOI 10.1016/j.jngse.2016.01.002
   Zargartalebi M, 2015, FUEL, V143, P21, DOI 10.1016/j.fuel.2014.11.040
   Zhang G. Q., 2000, BIOCHIM BIOPHYS ACTA, V1445, P86
   Zhang H, 2014, ENERG FUEL, V28, P3002, DOI 10.1021/ef500272r
   Zhang ZY, 2014, GEOPHYSICS, V79, pD377, DOI 10.1190/GEO2014-0143.1
   Zhao PQ, 2017, MAR PETROL GEOL, V86, P1067, DOI 10.1016/j.marpetgeo.2017.07.011
   Zhou L, 2016, J NAT GAS SCI ENG, V35, P860, DOI 10.1016/j.jngse.2016.09.030
NR 52
TC 2
Z9 2
U1 21
U2 52
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 212
EP 221
DI 10.1016/j.ces.2019.02.036
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900019
DA 2020-05-12
ER

PT J
AU Niskanen, I
   Forsberg, V
   Zakrisson, D
   Reza, S
   Hummelgard, M
   Andres, B
   Fedorov, I
   Suopajarvi, T
   Liimatainen, H
   Thungstrom, G
AF Niskanen, Ilpo
   Forsberg, Viviane
   Zakrisson, Daniel
   Reza, Salim
   Hummelgard, Magnus
   Andres, Britta
   Fedorov, Igor
   Suopajarvi, Terhi
   Liimatainen, Henrikki
   Thungstrom, Goran
TI Determination of nanoparticle size using Rayleigh approximation and Mie
   theory
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Nanoparticles; Size; Rayleigh approximation; Mie theory;
   Spectrophotometer; Nanocellulose
ID DYNAMIC LIGHT-SCATTERING; DISPERSION; CELLULOSE; DIFFRACTION;
   MICROSCOPY; REFRACTION; PARTICLES
AB Accurate determination of the size of nanoparticles has an important role in many different scientific and industrial purposes, such as in material, medical and environment sciences, colloidal chemistry and astrophysics. We describe an effective optical method to determine the size of nanoparticles by analysis of transmission and scattering of visible spectral range data from a designed UV-Vis multi-spectrophotometer. The size of the nanoparticles was calculated from the extinction cross section of the particles using Rayleigh approximation and Mie theory. We validated the method using polystyrene nanospheres, cellulose nanofibrils, and cellulose nanocrystals. A good agreement was achieved through graphical analysis between measured extinction cross section values and theoretical Rayleigh approximation and Mie theory predictions for the sizes of polystyrene nanospheres at wavelength range 450-750 nm. Provided that Rayleigh approximation's forward scattering (FS)/back scattering (BS) ratio was smaller than 1.3 and Mie theory's FS/BS ratio was smaller than 1.8. A good fit for the hydrodynamic diameter of nanocellulose was achieved using the Mie theory and Rayleigh approximation. However, due to the high aspect ratio of nanocellulose, the obtained results do not directly reflect the actual cross-sectional diameters of the nanocellulose. Overall, the method is a fast, relatively easy, and simple technique to determine the size of a particle by a spectrophotometer. Consequently, the method can be utilized for example in production and quality control purposes as well as for research and development applications. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Niskanen, Ilpo] Univ Oulu, Fac Technol Struct & Construct Technol, POB 7300, FI-90014 Oulu, Finland.
   [Niskanen, Ilpo; Zakrisson, Daniel; Reza, Salim; Fedorov, Igor; Thungstrom, Goran] Mid Sweden Univ, Dept Elect Design, Holmgatan 10, SE-85170 Sundsvall, Sweden.
   [Forsberg, Viviane; Hummelgard, Magnus; Andres, Britta] Mid Sweden Univ, Dept Nat Sci, Holmgatan 10, SE-85170 Sundsvall, Sweden.
   [Forsberg, Viviane] KTH Royal Inst Technol, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
   [Suopajarvi, Terhi; Liimatainen, Henrikki] Univ Oulu, Fac Technol Fibre & Particle Engn, POB 4300, FI-90014 Oulu, Finland.
RP Niskanen, I (reprint author), Univ Oulu, Fac Technol Struct & Construct Technol, POB 7300, FI-90014 Oulu, Finland.
EM ilpo.niskanen@oulu.fi
OI Andres, Britta/0000-0002-2393-3378; Fedorov, Igor/0000-0002-7235-4823
FU Knowledge Foundation of Sweden [2150361]
FX We gratefully acknowledge funding from the Knowledge Foundation of
   Sweden (2150361).
CR Amendola V, 2009, J PHYS CHEM C, V113, P4277, DOI 10.1021/jp8082425
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Bijeon JL, 2004, EUR PHYS J-APPL PHYS, V26, P45, DOI 10.1051/epjap:2004021
   Blott SJ, 2006, SEDIMENTOLOGY, V53, P671, DOI 10.1111/j.1365-3091.2006.00786.x
   CHAMPION JV, 1979, J COLLOID INTERF SCI, V72, P471, DOI 10.1016/0021-9797(79)90348-5
   Charitidis CA, 2014, MANUF REV, V1, DOI 10.1051/mfreview/2014009
   Chinga-Carrasco G, 2011, NANOCOMPOSITES AND POLYMERS WITH ANALYTICAL METHODS, P243
   Cox AJ, 2002, AM J PHYS, V70, P620, DOI 10.1119/1.1466815
   Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P7277, DOI 10.1021/es900249m
   Forsberg V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154522
   Gasparyan V, 2013, NANOTECHNOL DEV, V3, P1, DOI [10.4081/nd.2013.e2, DOI 10.4081/ND.2013.E2]
   George J, 2015, NANOTECHNOL SCI APPL, V8, P45, DOI 10.2147/NSA.S64386
   Gwaze P, 2007, ATMOS RES, V86, P93, DOI 10.1016/j.atmosres.2007.02.009
   Halaka FG, 2003, P NATL ACAD SCI USA, V100, P10164, DOI 10.1073/pnas.1233790100
   HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555
   HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780
   Hirvonen LM, 2009, EUR BIOPHYS J BIOPHY, V38, P807, DOI 10.1007/s00249-009-0501-6
   Huang P.M., 2011, HDB SOIL SCI PROPERT
   Hulst H. C. V. D., 1957, LIGHT SCATTERING SMA
   Jillavenkatesa A., 2001, SPECIAL PUBLICATION, V960-1, DOI [10.6028/NBS.SP.960-1, DOI 10.6028/NBS.SP.960-1]
   Jones SH, 2013, PHYS CHEM CHEM PHYS, V15, P20735, DOI 10.1039/c3cp53498g
   Kim H.-J., 2015, PROCESS PERFORMANCE, P395
   Klemm D, 1998, COMPREHENSIVE CELLUL, V1
   Lee JY, 2005, J NANOSCI NANOTECHNO, V5, P1045, DOI 10.1166/jnn.2005.160
   Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Malvern, 2018, DYNAMIC LIGHT SCATTE
   Meeten GH, 1997, OPT COMMUN, V134, P233, DOI 10.1016/S0030-4018(96)00577-9
   Mohan A.C., 2016, J MAT SCI ENG, V5, DOI 10.4172/2169-0022.1000291
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240
   Nawa Y, 2012, OPT EXPRESS, V20, P5629, DOI 10.1364/OE.20.005629
   Niskanen I, 2016, TALANTA, V149, P225, DOI 10.1016/j.talanta.2015.11.051
   Osong SH, 2016, CELLULOSE, V23, P93, DOI 10.1007/s10570-015-0798-5
   Peiponen KE, 1999, DISPERSION COMPLEX A
   Peng YC, 2012, CELLULOSE, V19, P91, DOI 10.1007/s10570-011-9630-z
   Rauscher H, 2015, REV EC RECOMMENDAT 3, DOI [10.2788/678452, DOI 10.2788/678452]
   Saito T, 2009, BIOMACROMOLECULES, V10, P1992, DOI 10.1021/bm900414t
   Sekhon BS, 2014, NANOTECHNOL SCI APPL, V7, P31, DOI 10.2147/NSA.S39406
   Sultanova N, 2009, ACTA PHYS POL A, V116, P585, DOI 10.12693/APhysPolA.116.585
   Washenfelder RA, 2013, ATMOS MEAS TECH, V6, P861, DOI 10.5194/amt-6-861-2013
   Xu JQ, 2015, ACS NANO, V9, P2917, DOI 10.1021/nn506952g
   Yamanaka M, 2011, BIOMED OPT EXPRESS, V2, P1946, DOI 10.1364/BOE.2.001946
   Zakharov P, 2009, S-P B ENVIRON SCI, P433, DOI 10.1007/978-3-540-74276-0_8
NR 44
TC 2
Z9 2
U1 7
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 222
EP 229
DI 10.1016/j.ces.2019.02.020
PG 8
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900020
DA 2020-05-12
ER

PT J
AU Hoskins, AL
   Gossett, TA
   Musgrave, CB
   Weimer, AW
AF Hoskins, Amanda L.
   Gossett, Tyler A.
   Musgrave, Charles B.
   Weimer, Alan W.
TI The effect of ultrathin ALD films on the oxidation kinetics of SiC in
   high-temperature steam
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Oxidation/corrosion; Silicon carbide; Environmental barrier coatings;
   Atomic layer deposition
ID ATOMIC LAYER DEPOSITION; ENVIRONMENTAL BARRIER COATINGS;
   SILICON-CARBIDE; WATER-VAPOR; FLUIDIZED-BED; MULLITE; NANOPARTICLES;
   PROTECTION; PARTICLES; CORROSION
AB Ultra-thin, oxidation-resistant, pinhole-free alumina coatings were deposited on silicon carbide (SiC) particles using atomic layer deposition (ALD), and investigated as environmental barrier coatings (EBCs) for high-temperature steam oxidation. The uncoated and alumina coated SiC particles were exposed to high temperature steam for 20 hat temperatures ranging from 1050 degrees C to 1150 degrees C to assess oxidation rates. The kinetic triplet (activation energy, rate constant, and pre-exponential factor) for each sample was determined using the D4 kinetic model (representing 3-dimensional diffusion) which was demonstrated to be accurate via the isothermal isoconversional method. Activation energies for oxidation of 247.4 +/- 0.1 kJ/mol, 250.6 +/- 0.5 kJ/mol, and 253.0 +/- 1.0 kJ/mol were calculated for uncoated SiC, SiC coated with a 5 nm alumina film, and SiC coated with a 10 nm alumina film, respectively. Reaction rate data for the oxidation reaction of uncoated SiC and SiC coated with a 10 nm film indicate that the ALD coating reduces the rate of oxidation of SiC by up to a factor of 5 for steam oxidation at temperatures between 1050 degrees C and 1150 degrees C. This is the first investigation of steam oxidation kinetics for SiC coated with an ALD deposited EBC. The results of this study indicate that ultra-thin alumina films deposited by ALD act as effective EBCs with oxidation resistance comparable to CVD films that are orders of magnitude thicker. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Hoskins, Amanda L.; Gossett, Tyler A.; Musgrave, Charles B.; Weimer, Alan W.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Musgrave, Charles B.] Univ Colorado, Dept Chem, Boulder, CO 80309 USA.
   [Musgrave, Charles B.] Univ Colorado, Mat Sci & Engn Program, Boulder, CO 80309 USA.
   [Musgrave, Charles B.] Natl Renewable Energy Lab, Golden, CO 80401 USA.
RP Weimer, AW (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM alan.weimer@colorado.edu
RI MUSGRAVE, CHARLES B/Y-2966-2018
OI MUSGRAVE, CHARLES B/0000-0002-5732-3180; WEIMER,
   ALAN/0000-0002-2471-349X
FU DOE EERE grant [DE-EE0006671]
FX This work was funded through DOE EERE grant DE-EE0006671 "Flowing
   Particle Bed Solarthermal Redox Process to Split Water".
CR Agrafiotis CC, 2007, SOL ENERG MAT SOL C, V91, P474, DOI 10.1016/j.solmat.2006.10.021
   Bhaskar Chandra M, 2011, J PHYS D, V44
   COSTELLO JA, 1981, J AM CERAM SOC, V64, P327, DOI 10.1111/j.1151-2916.1981.tb10297.x
   DEAL BE, 1965, J APPL PHYS, V36, P3770, DOI 10.1063/1.1713945
   Eaton HE, 2002, J EUR CERAM SOC, V22, P2741, DOI 10.1016/S0955-2219(02)00141-3
   Ehrhart BD, 2016, INT J HYDROGEN ENERG, V41, P19894, DOI 10.1016/j.ijhydene.2016.07.110
   Elam JW, 2003, CHEM MATER, V15, P3507, DOI 10.1021/cm0303080
   Feng FJ, 2016, CERAM INT, V42, P15203, DOI 10.1016/j.ceramint.2016.06.149
   Ferguson JD, 2000, THIN SOLID FILMS, V371, P95, DOI 10.1016/S0040-6090(00)00973-1
   George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b
   Hakim LF, 2005, NANOTECHNOLOGY, V16, pS375, DOI 10.1088/0957-4484/16/7/010
   Hakim LF, 2005, CHEM VAPOR DEPOS, V11, P420, DOI 10.1002/cvde.200506392
   Haynes JA, 2000, J AM CERAM SOC, V83, P657
   Hoskins AL, 2018, J AM CERAM SOC, V101, P2493, DOI 10.1111/jace.15408
   JACOBSON NS, 1993, J AM CERAM SOC, V76, P3, DOI 10.1111/j.1151-2916.1993.tb03684.x
   JORGENSEN PJ, 1959, J AM CERAM SOC, V42, P613, DOI 10.1111/j.1151-2916.1959.tb13582.x
   JORGENSEN PJ, 1961, J AM CERAM SOC, V44, P258, DOI 10.1111/j.1151-2916.1961.tb15374.x
   Khawam A, 2006, J PHARM SCI-US, V95, P472, DOI 10.1002/jps.20559
   Khawam A, 2006, J PHYS CHEM B, V110, P17315, DOI 10.1021/jp062746a
   King DM, 2007, SURF COAT TECH, V201, P9163, DOI 10.1016/j.surfcoat.2007.05.002
   Krishnamurthy R, 2005, J AM CERAM SOC, V88, P1099, DOI 10.1111/j.1551-2916.2005.00169.x
   Lee KN, 2015, CERAMIC MATRIX COMPOSITES: MATERIALS, MODELING AND TECHNOLOGY, P430
   Lee KN, 2005, J EUR CERAM SOC, V25, P1705, DOI 10.1016/j.jeurceramsoc.2004.12.013
   LEE KN, 1995, J AM CERAM SOC, V78, P705, DOI 10.1111/j.1151-2916.1995.tb08236.x
   LI J, 1990, WERKST KORROS, V41, P716
   MAEDA M, 1988, J MATER SCI, V23, P3933, DOI 10.1007/BF01106816
   Munro RG, 1997, J PHYS CHEM REF DATA, V26, P1195, DOI 10.1063/1.556000
   NARUSHIMA T, 1989, J AM CERAM SOC, V72, P1386, DOI 10.1111/j.1151-2916.1989.tb07658.x
   NARUSHIMA T, 1990, J AM CERAM SOC, V73, P3580, DOI 10.1111/j.1151-2916.1990.tb04261.x
   OGBUJI LUJT, 1995, J ELECTROCHEM SOC, V142, P925, DOI 10.1149/1.2048559
   Opila EJ, 1999, J AM CERAM SOC, V82, P625
   OPILA EJ, 1994, J AM CERAM SOC, V77, P730, DOI 10.1111/j.1151-2916.1994.tb05357.x
   Opila EJ, 1997, J AM CERAM SOC, V80, P197, DOI 10.1111/j.1151-2916.1997.tb02810.x
   Park DJ, 2014, CORROS SCI, V88, P416, DOI 10.1016/j.corsci.2014.07.052
   Puurunen RL, 2003, CHEM VAPOR DEPOS, V9, P327, DOI 10.1002/cvde.200306266
   Ramberg C. E, 1996, J AM CERAM SOC, V77, P730
   Richards B. T, 2015, J AM CERAM SOC
   Richards BT, 2016, ACTA MATER, V106, P1, DOI 10.1016/j.actamat.2015.12.053
   SINGHAL SC, 1976, J MATER SCI, V11, P1246, DOI 10.1007/BF00545142
   Terrani KA, 2014, J AM CERAM SOC, V97, P2331, DOI 10.1111/jace.13094
   Tortorelli PF, 2003, J AM CERAM SOC, V86, P1249, DOI 10.1111/j.1151-2916.2003.tb03460.x
   Vyazovkin S, 1999, THERMOCHIM ACTA, V520, P1
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   Wank J. R, 2004, FLUIDIZATION 11 PRES
   Wank JR, 2004, POWDER TECHNOL, V142, P59, DOI 10.1016/j.powtec.2004.03.010
   Weimer AW, 2019, J NANOPART RES, V21, DOI 10.1007/s11051-018-4442-9
   Xu Y, 2017, CERAM INT, V43, P5847, DOI 10.1016/j.ceramint.2017.01.153
   Zemskova SM, 2001, J PHYS IV, V11, P861, DOI 10.1051/jp4:20013107
   ZHENG Z, 1990, J ELECTROCHEM SOC, V137, P2812, DOI 10.1149/1.2087080
NR 49
TC 0
Z9 0
U1 7
U2 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 230
EP 236
DI 10.1016/j.ces.2019.02.044
PG 7
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900021
DA 2020-05-12
ER

PT J
AU Frederix, EMA
   Cox, TLW
   Kuerten, JGM
   Komen, EMJ
AF Frederix, E. M. A.
   Cox, T. L. W.
   Kuerten, J. G. M.
   Komen, E. M. J.
TI Poly-dispersed modeling of bubbly flow using the log-normal size
   distribution
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Bubbly flow; Moment modeling; Two-fluid model; Size distribution;
   Log-normal; Population balance
ID POPULATION BALANCE-EQUATIONS; QUADRATURE METHOD; VERTICAL PIPE;
   SIMULATION; DISCRETIZATION; DYNAMICS; FRACTION; VELOCITY
AB The bubble size distribution plays an important role in interfacial mass, momentum and energy transfer between bubbles and their carrier liquid in bubbly flow. Accurate modeling of the size distribution is therefore key. A Log-Normal presumed Number Density Function (LNpNDF) approach is proposed, which is embedded into the two-fluid model. Two additional moment transport equations are formulated which are shown to be consistent with the two-fluid model. From the moments, the size distribution can be fully reconstructed using the assumption that its underlying shape is log-normal. This methodology offers closure for the modeling of processes such as bubble coalescence, break-up and bubble poly-celerity. Special attention is paid to the concept of poly-celerity, which is shown to play an important role in the evolution of finite-width size distributions. A new average diameter, which is based on the fifth and third moment of the size distribution, is proposed, and it is shown that this diameter is a more suitable quadrature node for the modeling of bubble-liquid Stokes-like drag. The paper lays the mathematical foundation for a pragmatic, computationally efficient and effective poly-dipsersed method for the modeling of dispersed two-phase flow. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Frederix, E. M. A.; Cox, T. L. W.; Komen, E. M. J.] Nucl Res & Consultancy Grp NRG, POB 25, NL-1755 ZG Petten, Netherlands.
   [Cox, T. L. W.; Kuerten, J. G. M.] Eindhoven Univ Technol, Mech Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.
RP Frederix, EMA (reprint author), Nucl Res & Consultancy Grp NRG, POB 25, NL-1755 ZG Petten, Netherlands.
EM frederix@nrg.eu
CR Burns A. D., 2004, EULERIAN MULTIPHASE, V4, P1
   FRIEDLANDER SK, 1983, ANN NY ACAD SCI, V404, P354, DOI 10.1111/j.1749-6632.1983.tb19497.x
   GELBARD F, 1980, J COLLOID INTERF SCI, V78, P485, DOI 10.1016/0021-9797(80)90587-1
   Hansch S, 2012, INT J MULTIPHAS FLOW, V47, P171, DOI 10.1016/j.ijmultiphaseflow.2012.07.007
   Hinds W., 2012, AEROSOL TECHNOLOGY P
   Ishii M., 2010, THERMOFLUID DYNAMICS
   ISHII MAMORU, 2005, Nuclear Engineering and Technology, V37, P525
   Krepper E, 2005, NUCL ENG DES, V235, P597, DOI 10.1016/j.nucengdes.2004.09.006
   Krepper E, 2008, NUCL ENG DES, V238, P1690, DOI 10.1016/j.nucengdes.2008.01.004
   Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2
   Kumar S, 1996, CHEM ENG SCI, V51, P1333, DOI 10.1016/0009-2509(95)00355-X
   Lahey RT, 2005, NUCL ENG DES, V235, P1043, DOI 10.1016/j.nucengdes.2005.02.020
   LEE KW, 1984, AEROSOL SCI TECH, V3, P53, DOI 10.1080/02786828408958993
   Liao Y., 2018, INT J NUMER METH FLU
   Liao YX, 2015, CHEM ENG SCI, V122, P336, DOI 10.1016/j.ces.2014.09.042
   LIU TJ, 1993, INT J HEAT MASS TRAN, V36, P1049, DOI 10.1016/S0017-9310(05)80289-3
   LIU TJ, 1993, INT J HEAT MASS TRAN, V36, P1061, DOI 10.1016/S0017-9310(05)80290-X
   Ma T, 2017, PHYS REV FLUIDS, V2, DOI 10.1103/PhysRevFluids.2.034301
   Marchisio D.L, 2013, COMPUTATIONAL MODELS
   Marchisio DL, 2005, J AEROSOL SCI, V36, P43, DOI 10.1016/j.jaerosci.2004.07.009
   McGraw R, 1997, AEROSOL SCI TECH, V27, P255, DOI 10.1080/02786829708965471
   Rzehak R, 2013, INT J MULTIPHAS FLOW, V55, P138, DOI 10.1016/j.ijmultiphaseflow.2013.04.007
   SHAVER D. R., 2015, P AM NUCL SOC WINT M
   Sugrue R, 2017, ANN NUCL ENERGY, V110, P79, DOI 10.1016/j.anucene.2017.05.059
   Tomiyama A, 1998, JSME INT J B-FLUID T, V41, P472, DOI 10.1299/jsmeb.41.472
NR 25
TC 1
Z9 1
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 237
EP 246
DI 10.1016/j.ces.2019.02.013
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900022
DA 2020-05-12
ER

PT J
AU Alsabery, AI
   Mohebbi, R
   Chamkha, AJ
   Hashim, I
AF Alsabery, Ammar, I
   Mohebbi, Rasul
   Chamkha, Ali J.
   Hashim, Ishak
TI Effect of local thermal non-equilibrium model on natural convection in a
   nanofluid-filled wavy-walled porous cavity containing inner solid
   cylinder
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Natural convection; Heat transfer mechanism; Wavy porous cavity;
   Forchheimer model; Local thermal non-equilibrium
ID CU-WATER NANOFLUID; HEAT-TRANSFER; ENTROPY GENERATION; MIXED CONVECTION;
   SIMULATION; CHANNEL; MEDIA; FLOW
AB In the current work, the impacts of local thermal non-equilibrium model and Al2O3-water nanofluid on natural convection heat transfer in a porous cavity consisting of a bottom heated wavy wall and an inner solid cylinder are investigated. The Galerkin weighted residual finite element method is utilized to simulate the dimensionless governing equations of the fluid flow and heat transfer. The effects of different parameters including Darcy number (10(-6) <= Da <= 10(-2) ), nanoparticle volume fraction (0 <= phi <= 0.04), modified conductivity ratio (0.01 <= gamma <= 1000), number of undulations (1 <= N <= 4) and the porosity of the medium (0.2 <= epsilon <= 0.8) on the field of the flow and the heat transfer mechanisms are described. The Forchheimer-Brinkman-extended Darcy model along with the Boussinesq approximation are assumed to hold. A comprehensive validation of the present code is obtained by comparing the results with those of previous studies. The results show that all the mentioned parameters have significant impacts on the fluid flow and the temperature distributions. In addition, increasing the thermal conductivity of the nanoparticles leads to an increase in the rate of heat transfer for the nanofluid condition and reaches its maximum value at phi = 0.04. Considering high values of epsilon, the average Nusselt number increases by the augmentation of phi, while at low values of the porosity, the average Nusselt number decreases after reaching a peak. The results of this study are very useful for designing a porous heat exchanger. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Alsabery, Ammar, I] Islamic Univ, Coll Tech Engn, Refrigerat & Air Conditioning Tech Engn Dept, Najaf, Iraq.
   [Alsabery, Ammar, I; Hashim, Ishak] Univ Kebangsaan Malaysia, Fac Sci & Technol, Ctr Modelling & Data Sci, Ukm Bangi 43600, Selangor, Malaysia.
   [Mohebbi, Rasul] Damghan Univ, Sch Engn, POB 3671641167, Damghan, Iran.
   [Chamkha, Ali J.] Prince Mohammad Bin Fand Univ, Prince Mohammad Endowment Nanosci & Technol, Dept Mech Engn, Al Khobar 31952, Saudi Arabia.
   [Chamkha, Ali J.] Amer Univ Ras Al Khaimah, RAK Res & Innovat Ctr, POB 10021, Ras Al Khaymah, U Arab Emirates.
RP Alsabery, AI (reprint author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Ctr Modelling & Data Sci, Ukm Bangi 43600, Selangor, Malaysia.
EM ammar_e_2011@yahoo.com
RI Alsabery, Ammar/G-2574-2017
OI Alsabery, Ammar/0000-0002-2970-6600
FU Universiti Kebangsaan Malaysia (UKM) research grant [DIP-2017-010]
FX The work was supported by the Universiti Kebangsaan Malaysia (UKM)
   research grant DIP-2017-010.
CR Al-Rashed AAAA, 2018, INT J MECH SCI, V135, P362, DOI 10.1016/j.ijmecsci.2017.11.033
   Alsabery AI, 2017, J HEAT TRANS-T ASME, V139, DOI 10.1115/1.4037087
   Alsabery AI, 2019, COMPUT METHOD APPL M, V346, P952, DOI 10.1016/j.cma.2018.09.041
   Alsabery AI, 2018, INT COMMUN HEAT MASS, V95, P197, DOI 10.1016/j.icheatmasstransfer.2018.05.003
   Alsabery AI, 2017, INT J NUMER METHOD H, V27, P1365, DOI 10.1108/HFF-11-2015-0488
   Bergman TL, 2011, INTRO HEAT TRANSFER
   Bondareva NS, 2016, INT J HEAT MASS TRAN, V99, P872, DOI 10.1016/j.ijheatmasstransfer.2016.04.055
   Calcagni B, 2005, APPL THERM ENG, V25, P2522, DOI 10.1016/j.applthermaleng.2004.11.032
   Choi S., 1995, ASME FED, V231, P99, DOI DOI 10.1115/1.1532008
   Chon CH, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2093936
   Corcione M, 2013, INT J THERM SCI, V71, P182, DOI 10.1016/j.ijthermalsci.2013.04.005
   Corcione M, 2011, ENERG CONVERS MANAGE, V52, P789, DOI 10.1016/j.enconman.2010.06.072
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   Ghasemi K, 2017, J MOL LIQ, V233, P415, DOI 10.1016/j.molliq.2017.03.016
   Ho CJ, 2010, INT J THERM SCI, V49, P1345, DOI 10.1016/j.ijthermalsci.2010.02.013
   Izadi M, 2018, INT J NUMER METHOD H, V28, P1930, DOI 10.1108/HFF-03-2018-0110
   Izadi M, 2018, J MOL LIQ, V261, P357, DOI 10.1016/j.molliq.2018.04.063
   Javaheri M, 2010, TRANSPORT POROUS MED, V84, P441, DOI 10.1007/s11242-009-9513-z
   Khanafer K, 2009, INT J HEAT MASS TRAN, V52, P1887, DOI 10.1016/j.ijheatmasstransfer.2008.08.040
   Kolsi L, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18060232
   Ma Y, 2019, INT J HEAT MASS TRAN, V130, P123, DOI 10.1016/j.ijheatmasstransfer.2018.10.072
   Mahian O, 2019, PHYS REP, V790, P1, DOI 10.1016/j.physrep.2018.11.004
   Mahian O, 2019, PHYS REP, V791, P1, DOI 10.1016/j.physrep.2018.11.003
   Nguyen MT, 2015, NUMER HEAT TR A-APPL, V67, P224, DOI 10.1080/10407782.2014.923225
   Misirlioglu A, 2006, TRANSPORT POROUS MED, V64, P229, DOI 10.1007/s11242-005-2857-0
   Mohebbi R, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4993866
   Mohebbi R, 2018, INT J HEAT MASS TRAN, V117, P425, DOI 10.1016/j.ijheatmasstransfer.2017.10.043
   Mohebbi R, 2018, INT J HEAT MASS TRAN, V117, P1291, DOI 10.1016/j.ijheatmasstransfer.2017.10.063
   Mohebbi R, 2017, J TAIWAN INST CHEM E, V72, P70, DOI 10.1016/j.jtice.2017.01.006
   Nazridoust K, 2007, CHEM ENG SCI, V62, P6155, DOI 10.1016/j.ces.2007.06.038
   Oztop HF, 2008, INT J HEAT FLUID FL, V29, P1326, DOI 10.1016/j.ijheatfluidflow.2008.04.009
   Oztop HF, 2011, INT J THERM SCI, V50, P502, DOI 10.1016/j.ijthermalsci.2010.10.015
   Rahimi A, 2018, COMPUT MATH APPL, V75, P1795, DOI 10.1016/j.camwa.2017.11.037
   Saguy IS, 2005, TRENDS FOOD SCI TECH, V16, P495, DOI 10.1016/j.tifs.2005.07.006
   Selimefendigil F, 2016, INT COMMUN HEAT MASS, V71, P9, DOI 10.1016/j.icheatmasstransfer.2015.12.007
   Sheikholeslami M, 2017, J MOL LIQ, V233, P499, DOI 10.1016/j.molliq.2017.03.050
   Sheremet MA, 2017, APPL THERM ENG, V113, P413, DOI 10.1016/j.applthermaleng.2016.11.033
   Siavashi M, 2015, ENERGY, V93, P2451, DOI 10.1016/j.energy.2015.10.100
   Sivasankaran S, 2011, TRANSPORT POROUS MED, V86, P291, DOI 10.1007/s11242-010-9620-x
   Xu HT, 2017, INT COMMUN HEAT MASS, V81, P104, DOI 10.1016/j.icheatmasstransfer.2016.12.001
   Zhao FY, 2009, CHEM ENG SCI, V64, P1390, DOI 10.1016/j.ces.2008.12.005
NR 41
TC 19
Z9 19
U1 10
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 247
EP 263
DI 10.1016/j.ces.2019.03.006
PG 17
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900023
DA 2020-05-12
ER

PT J
AU Yin, YR
   Zhu, CY
   Fu, TT
   Ma, YG
   Wang, K
   Luo, GS
AF Yin, Yaran
   Zhu, Chunying
   Fu, Taotao
   Ma, Youguang
   Wang, Kai
   Luo, Guangsheng
TI Enhancement effect and mechanism of gas-liquid mass transfer by baffles
   embedded in the microchannel
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Mass transfer enhancement; Microchannel; Gas-liquid two-phase; Baffle;
   Enhancement factor
ID CO2 ABSORPTION; CARBON-DIOXIDE; AQUEOUS-SOLUTIONS; HEAT-TRANSFER; TAYLOR
   FLOW; SLUG FLOW; CAPTURE; MONOETHANOLAMINE; PERFORMANCE; REACTORS
AB The enhancement of gas-liquid mass transfer by baffles embedded in a microchannel was investigated experimentally for CO2 absorption into monoethanolamine/1-butyl-3-methylimidazolium tetrafluoroborate (MEA/Bmim][BF4]) aqueous solutions. The influences of baffle size on mass transfer rate and pressure drop were studied through varying the MEA/[Bmim][BE4] concentration ratio, gas-liquid flow rate and blockage ratio. Experimental results showed that the proper baffle configuration could improve effectively gas-liquid mass transfer performance. Although the pressure drop of the baffled microchannel has slight increase (the maximum growth 0.3 kPa, or 20% in relative term) in comparison with the unobstructed microchannel, it is acceptable for industrial application. Under lower MEA/[Bmim][BE4] concentration ratios, higher two-phase flow rates and blockage ratios, the mass transfer enhancement is more pronounced and the enhancement factor could reach to 1.5. A new empirical correlation of enhancement factor is proposed with good predictive performance. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yin, Yaran; Zhu, Chunying; Fu, Taotao; Ma, Youguang] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China.
   [Wang, Kai; Luo, Guangsheng] Tsinghua Univ, Dept Chem Engn, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
RP Zhu, CY; Ma, YG (reprint author), Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Tianjin 300072, Peoples R China.
EM zhchy971@tju.edu.cn; ygma@tju.edu.cn
OI Fu, Taotao/0000-0003-1881-1509; Wang, Kai/0000-0002-0873-6421
FU National Nature Science Foundation of ChinaNational Natural Science
   Foundation of China [21776200, 21576186, 91634105, 91434204]; aid of
   Opening Project of State Key Laboratory of Chemical Engineering
   [SKL-ChE-17B02, SKL-ChE-16B03]
FX This study was supported by the National Nature Science Foundation of
   China (No. 21776200, 21576186, 91634105, 91434204), the aid of Opening
   Project of State Key Laboratory of Chemical Engineering (No.
   SKL-ChE-17B02, SKL-ChE-16B03).
CR Abiev RS, 2013, CHEM ENG J, V227, P66, DOI 10.1016/j.cej.2012.10.009
   Ahmady A, 2011, FLUID PHASE EQUILIBR, V309, P76, DOI 10.1016/j.fluid.2011.06.029
   Alam A, 2014, CHEM ENG RES DES, V92, P423, DOI 10.1016/j.cherd.2013.09.008
   Chen P, 2016, J LOSS PREVENT PROC, V41, P48, DOI 10.1016/j.jlp.2016.02.020
   Dong ZY, 2015, LAB CHIP, V15, P1145, DOI 10.1039/c4lc01431f
   Ehrich H, 2002, CHIMIA, V56, P647, DOI 10.2533/000942902777680063
   Feng TF, 2018, CHEM ENG SCI, V177, P270, DOI 10.1016/j.ces.2017.11.029
   Ganapathy H, 2014, APPL ENERG, V119, P43, DOI 10.1016/j.apenergy.2013.12.047
   Ganapathy H, 2016, APPL ENERG, V162, P416, DOI 10.1016/j.apenergy.2015.10.010
   Inoue T, 2007, IND ENG CHEM RES, V46, P1153, DOI 10.1021/ie061277w
   Jahnisch K, 2000, J FLUORINE CHEM, V105, P117, DOI 10.1016/S0022-1139(00)00300-6
   Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j
   Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956
   Kockmann N, 2013, HEAT TRANSFER ENG, V34, P169, DOI 10.1080/01457632.2013.703508
   Kreutzer MT, 2005, CHEM ENG SCI, V60, P5895, DOI 10.1016/j.ces.2005.03.022
   Last W, 2002, CHEM ENG TECHNOL, V25, P385, DOI 10.1002/1521-4125(200204)25:4<385::AID-CEAT385>3.3.CO;2-C
   Li CF, 2014, INT J HEAT MASS TRAN, V78, P1055, DOI 10.1016/j.ijheatmasstransfer.2014.07.071
   Liao Sl, 2018, LANGMUIR, V34, P11655, DOI 10.1021/acs.langmuir.8b01067
   Losey MW, 2001, IND ENG CHEM RES, V40, P2555, DOI 10.1021/ie000523f
   Lu BH, 2012, INT J GREENH GAS CON, V11, P152, DOI 10.1016/j.ijggc.2012.08.007
   Lu BH, 2013, ENERG FUEL, V27, P6002, DOI 10.1021/ef400976j
   Maira AJ, 2001, APPL CATAL B-ENVIRON, V29, P327, DOI 10.1016/S0926-3373(00)00211-3
   Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01
   Nieves-Remacha MJ, 2013, IND ENG CHEM RES, V52, P8996, DOI 10.1021/ie4011707
   Niu HN, 2009, IND ENG CHEM RES, V48, P1621, DOI 10.1021/ie801095a
   Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336
   Pan MQ, 2015, APPL ENERG, V154, P416, DOI 10.1016/j.apenergy.2015.05.021
   Pirouz MM, 2011, SCI IRAN, V18, P213, DOI 10.1016/j.scient.2011.03.016
   Rao AB, 2002, ENVIRON SCI TECHNOL, V36, P4467, DOI 10.1021/es0158861
   Sahu PK, 2013, MICROSYST TECHNOL, V19, P493, DOI 10.1007/s00542-012-1617-7
   Seo HS, 2012, MATER RES BULL, V47, P2948, DOI 10.1016/j.materresbull.2012.04.138
   Shao N, 2010, CHEM ENG J, V160, P873, DOI 10.1016/j.cej.2010.02.049
   Sreedhar I, 2017, RENEW SUST ENERG REV, V76, P1080, DOI 10.1016/j.rser.2017.03.109
   Tai CH, 2006, ELECTROPHORESIS, V27, P4982, DOI 10.1002/elps.200500900
   Taib MM, 2012, CHEM ENG J, V181, P56, DOI 10.1016/j.cej.2011.09.048
   Tan J, 2012, CHEM ENG J, V185, P314, DOI 10.1016/j.cej.2012.01.054
   Teufel R, 2015, J AM CHEM SOC, V137, P8078, DOI 10.1021/jacs.5b03983
   Wang K, 2017, CHEM ENG SCI, V169, P18, DOI 10.1016/j.ces.2016.10.025
   Wang W, 2011, CHEM SOC REV, V40, P3703, DOI 10.1039/c1cs15008a
   Whitman W.G., 1923, Chemical and Metallurgical Engineering, V29, P146
   Wu YN, 2014, MICROFLUID NANOFLUID, V16, P275, DOI 10.1007/s10404-013-1211-z
   Xia GD, 2017, INT J THERM SCI, V119, P9, DOI 10.1016/j.ijthermalsci.2017.05.015
   Xu JH, 2008, CHEM ENG J, V141, P242, DOI 10.1016/j.cej.2007.12.030
   Xu QB, 2009, SMALL, V5, P1575, DOI 10.1002/smll.200801855
   Yang J, 2014, IND ENG CHEM RES, V53, P2790, DOI 10.1021/ie4040658
   Yang L, 2014, CHEM ENG SCI, V109, P306, DOI 10.1016/j.ces.2014.02.004
   Yao CQ, 2017, CHEM ENG J, V319, P179, DOI 10.1016/j.cej.2017.03.003
   Yao CQ, 2015, CHEM ENG SCI, V123, P137, DOI 10.1016/j.ces.2014.11.005
   Yao CQ, 2014, CHEM ENG SCI, V112, P15, DOI 10.1016/j.ces.2014.03.016
   Yao XJ, 2015, RENEW SUST ENERG REV, V47, P519, DOI 10.1016/j.rser.2015.03.078
   Yu CH, 2012, AEROSOL AIR QUAL RES, V12, P745, DOI 10.4209/aaqr.2012.05.0132
   Yu GR, 2016, INT J GREENH GAS CON, V44, P52, DOI 10.1016/j.ijggc.2015.11.008
   Yue J, 2007, CHEM ENG SCI, V62, P2096, DOI 10.1016/j.ces.2006.12.057
   Zaloha P, 2012, CHEM ENG SCI, V68, P640, DOI 10.1016/j.ces.2011.10.036
   Zhang JS, 2018, AICHE J, V64, P564, DOI 10.1002/aic.15941
   Zhang P, 2018, CHEM ENG SCI, V182, P17, DOI 10.1016/j.ces.2018.02.018
NR 56
TC 2
Z9 2
U1 13
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 264
EP 273
DI 10.1016/j.ces.2019.02.039
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900024
DA 2020-05-12
ER

PT J
AU Tang, JG
   Sun, LC
   Wu, D
   Du, M
   Xie, G
   Yang, K
AF Tang, Jiguo
   Sun, Licheng
   Wu, Dan
   Du, Min
   Xie, Guo
   Yang, Kai
TI Effects of ultrasonic waves on subcooled pool boiling on a small plain
   heating surface
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Subcooled pool boiling; Ultrasonic waves; Acoustic streaming; Capillary
   waves
ID NATURAL-CONVECTION; VAPOR BUBBLES; ENHANCEMENT; EMISSION; TERRESTRIAL;
   SIMULATION; VIBRATION; MOTION; WIRE; GAS
AB Experiments were conducted to investigate the effects of ultrasonic waves on subcooled pool boiling on a small plain heating surface. Ultrasonic waves with different amplitudes (0-10 mu m) were applied for both nucleate boiling and transition boiling modes with the liquid subcooling and heat flux covering 15-60 K and 0.15-8 MW/m(2) , respectively. The results show that the acoustic streaming induced by high amplitude ultrasound has an obvious enhancement effect on nucleate boiling at low heat flux, but the augmentation will be restricted with increase in heat flux and decrease in ultrasonic amplitude. In transition boiling region, the ultrasound makes different impact. At liquid subcooling of 15 K under which microbubble emission boiling (MEB) would not occur normally, the strong acoustic streaming triggers MEB, thereby heat transfer is significantly enhanced. At subcooling of 21-40 K, the transition boiling is in the mode of stable MEB, the ultrasound barely affects the heat transfer and bubble behaviors. With the subcooling increasing to 50-60 K, the heat transfer of MEB is enhanced by the 10 mu m amplitude ultrasound but deteriorated by the 5 um amplitude ultrasound. The opposite results depend on the different effects arising from the ultrasound on the collapse and oscillation of the vapor film on the heating surface. (C)2019 Elsevier Ltd. All rights reserved.
C1 [Tang, Jiguo; Sun, Licheng; Du, Min; Xie, Guo; Yang, Kai] Sichuan Univ, Coll Water Resource & Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Sichuan, Peoples R China.
   [Wu, Dan] Nucl Power Inst China, Sci & Technol Reactor Syst Design Technol Lab, Chengdu 610200, Sichuan, Peoples R China.
RP Sun, LC; Du, M (reprint author), Sichuan Univ, Coll Water Resource & Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu 610065, Sichuan, Peoples R China.
EM tangjiguo@sina.cn; leechengsun@sohu.com; dmscu.2009@scu.edu.cn
RI sun, licheng/AAD-7245-2020
OI sun, licheng/0000-0002-5312-2525
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51706149, 51606130]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2018M643474]; Operating
   foundation for Key Laboratory of nuclear reactor thermal hydraulic
   technology in CNNC
FX The authors are profoundly grateful to the financial supports of the
   National Natural Science Foundation of China (Grant Nos. 51706149 and
   51606130), the project funded by China Postdoctoral Science Foundation
   (2018M643474), and the Operating foundation for Key Laboratory of
   nuclear reactor thermal hydraulic technology in CNNC.
CR Ando J, 2016, INT J HEAT MASS TRAN, V101, P240, DOI 10.1016/j.ijheatmasstransfer.2016.05.050
   Baffigi F, 2012, EXP THERM FLUID SCI, V36, P12, DOI 10.1016/j.expthermflusci.2011.07.012
   Bartoli C, 2012, APPL THERM ENG, V47, P95, DOI 10.1016/j.applthermaleng.2012.02.009
   Bartoli C, 2011, EXP THERM FLUID SCI, V35, P423, DOI 10.1016/j.expthermflusci.2010.11.002
   Boziuk TR, 2017, INT J HEAT MASS TRAN, V108, P181, DOI 10.1016/j.ijheatmasstransfer.2016.11.071
   Cardenas R, 2012, INT J HEAT MASS TRAN, V55, P4217, DOI 10.1016/j.ijheatmasstransfer.2012.03.063
   Carey VP, 2007, LIQUID VAPOR PHASE C
   Chen SW, 2018, APPL THERM ENG, V143, P639, DOI 10.1016/j.applthermaleng.2018.07.133
   Chicharro R, 2014, EXP THERM FLUID SCI, V55, P221, DOI 10.1016/j.expthermflusci.2014.03.011
   Dehbani M, 2014, HEAT MASS TRANSFER, V50, P1319, DOI 10.1007/s00231-014-1346-9
   Douglas Z, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4721669
   Hao Y, 1999, PHYS FLUIDS, V11, P2008, DOI 10.1063/1.870064
   Hao Y, 2001, PHYS FLUIDS, V13, P1167, DOI 10.1063/1.1359746
   Hetsroni G, 2014, INT J MULTIPHAS FLOW, V67, P13, DOI 10.1016/j.ijmultiphaseflow.2014.05.016
   Holt RG, 1996, PHYS REV LETT, V77, P1274, DOI 10.1103/PhysRevLett.77.1274
   IIDA Y, 1992, EXP THERM FLUID SCI, V5, P108, DOI 10.1016/0894-1777(92)90059-E
   Inada S., 1981, T JSME, V47, P2021
   Jeong JH, 2006, HEAT MASS TRANSFER, V42, P1155, DOI 10.1007/s00231-005-0079-1
   Kim HY, 2004, INT J HEAT MASS TRAN, V47, P2831, DOI 10.1016/j.ijheatmasstransfer.2003.11.033
   Krishnan S, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4025641
   Kumagai S, 2000, JSME INT J B-FLUID T, V43, P206, DOI 10.1299/jsmeb.43.206
   Kumar A, 2006, CHEM ENG SCI, V61, P7410, DOI 10.1016/j.ces.2006.08.038
   Legay M, 2011, INT J CHEM ENG, DOI 10.1155/2011/670108
   Li B, 2016, APPL THERM ENG, V92, P93, DOI 10.1016/j.applthermaleng.2015.09.069
   Li C. D, 2016, ENERGY CONSERV TECHN, V34, P527
   Louisnard O, 2017, ULTRASON SONOCHEM, V35, P518, DOI 10.1016/j.ultsonch.2016.09.013
   Minocha N, 2016, CHEM ENG SCI, V145, P245, DOI 10.1016/j.ces.2016.02.015
   Moehrle RE, 2016, INT J HEAT MASS TRAN, V93, P322, DOI 10.1016/j.ijheatmasstransfer.2015.09.030
   O'Sullivan JJ, 2018, ULTRASON SONOCHEM, V48, P218, DOI 10.1016/j.ultsonch.2018.05.037
   PARK KA, 1988, INT J HEAT MASS TRAN, V31, P664, DOI 10.1016/0017-9310(88)90049-X
   Prosperetti A, 2017, ANNU REV FLUID MECH, V49, P221, DOI 10.1146/annurev-fluid-010816-060221
   Sitter JS, 1998, INT J HEAT MASS TRAN, V41, P2143, DOI 10.1016/S0017-9310(97)00344-X
   Suzuki K, 2005, EXP THERM FLUID SCI, V29, P827, DOI 10.1016/j.expthermflusci.2005.03.009
   Suzuki K, 2011, HEAT TRANSFER ENG, V32, P673, DOI 10.1080/01457632.2010.509771
   Tang JG, 2018, CHEM ENG SCI, V188, P179, DOI 10.1016/j.ces.2018.05.002
   Tang JG, 2017, EXP THERM FLUID SCI, V80, P40, DOI 10.1016/j.expthermflusci.2016.08.011
   Tang JG, 2015, INT J HEAT MASS TRAN, V88, P597, DOI 10.1016/j.ijheatmasstransfer.2015.04.090
   Tang JG, 2015, EXP THERM FLUID SCI, V61, P210, DOI 10.1016/j.expthermflusci.2014.11.009
   Ueno I, 2015, EUR PHYS J-SPEC TOP, V224, P415, DOI 10.1140/epjst/e2015-02370-6
   Zhang CY, 2016, INT J HEAT MASS TRAN, V101, P1331, DOI 10.1016/j.ijheatmasstransfer.2016.05.036
   Zhao SN, 2018, CHEM ENG SCI, V186, P122, DOI 10.1016/j.ces.2018.04.042
   Zhou DW, 2002, EXP THERM FLUID SCI, V26, P931, DOI 10.1016/S0894-1777(02)00201-7
NR 42
TC 0
Z9 0
U1 7
U2 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 274
EP 287
DI 10.1016/j.ces.2019.03.009
PG 14
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900025
DA 2020-05-12
ER

PT J
AU Wu, YF
   Song, XH
   Zhang, JH
   Xu, SQ
   Gao, LJ
   Zhang, J
   Xiao, GM
AF Wu, Yuanfeng
   Song, Xianghai
   Zhang, Jiahui
   Xu, Siquan
   Gao, Lijing
   Zhang, Jin
   Xiao, Guomin
TI Mn-based MOFs as efficient catalysts for catalytic conversion of carbon
   dioxide into cyclic carbonates and DFT studies
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE CO2; Cycloaddition; Allyl-glycidyl ether; Epoxides; DFT
ID METAL-ORGANIC FRAMEWORKS; CHEMICAL FIXATION; FORMIC-ACID; CO2; EPOXIDES;
   TEMPERATURE; HYDROGENATION; BEHAVIOR; METHANOL; COMPLEX
AB The present work is aimed to investigate the catalytic activities of various Mn-based MOFs for carbon dioxide coupling with epoxides. The metal organic frameworks, [(CH3NH3][Mn(COOH)(3)] (MA-MnF), [(CH3CH2NH3][Mn(COOH)(3)] (EA-MnF), and [C3H5N2][Mn(COOH)(3)] (Im-MnF) were studied via several characterizations such as XRD, FT-IR, XPS, N-2-adsorption, TG-DSC, CO2 -adsorption and NH3-TPD. Interestingly, Im-MnF compound was observed to possess the highest catalytic activity among the studied compounds, which is associated not only with the amounts of basic sites, but also related to the nitrogen-containing species. 97.27% conversion of allyl-glycidyl ether (AGE, TOF: 36.78 h(-1)) and 97.66% selectivity to allyl-glycidyl carbonate (AGC) were obtained under the explored optimized conditions (100 degrees C, 15 bar, 6 h, 1.0 wt% of AGE). In addition, only a slight downward in catalytic activity was found when the sample was reused twice. Furthermore, coupling reactions of CO2 with various epoxides were also performed, of which, the yield of the cyclic carbonates followed the order: Epichlorohydrin > Allyl glycidyl ether > Styrene oxide > Cyclohexene oxide > Propylene oxide. Finally, a mechanism was proposed, which is in good agreement with the DFT calculation. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wu, Yuanfeng; Song, Xianghai; Zhang, Jiahui; Xu, Siquan; Gao, Lijing; Zhang, Jin; Xiao, Guomin] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.
RP Xiao, GM (reprint author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.
EM xiaogm426@gmail.com
RI Wu, Yuanfeng/O-4599-2016
OI Wu, Yuanfeng/0000-0002-8634-7931
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21676054, 21406034]; Natural Science foundation of
   JiangsuNatural Science Foundation of Jiangsu Province [BK20161415];
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2242018K40041]
FX This work was financially supported by National Natural Science
   Foundation of China (Nos. 21676054, 21406034), Natural Science
   foundation of Jiangsu (No. BK20161415), Fundamental Research Funds for
   the Central Universities (No. 2242018K40041). Also, we are very grateful
   to Dr. Qi for providing DFT calculation.
CR Bai DS, 2012, APPL ORGANOMET CHEM, V26, P600, DOI 10.1002/aoc.2906
   Chang T, 2015, CHINESE J CATAL, V36, P408, DOI 10.1016/S1872-2067(14)60227-8
   Chiang CL, 2018, J CLEAN PROD, V172, P1957, DOI 10.1016/j.jclepro.2017.11.229
   Chizallet C, 2010, J AM CHEM SOC, V132, P12365, DOI 10.1021/ja103365s
   Fan GZ, 2015, J MOL CATAL A-CHEM, V404, P92, DOI 10.1016/j.molcata.2015.04.017
   Fan GZ, 2011, CATAL SCI TECHNOL, V1, P1138, DOI 10.1039/c1cy00208b
   Gao WY, 2016, ANGEW CHEM INT EDIT, V55, P5472, DOI 10.1002/anie.201511484
   Han L, 2011, J MOL CATAL A-CHEM, V338, P58, DOI 10.1016/j.molcata.2011.02.001
   He HM, 2016, SMALL, V12, P6309, DOI 10.1002/smll.201602711
   Jayakumar S, 2017, CHEM-ASIAN J, V12, P577, DOI 10.1002/asia.201601676
   Jeong GS, 2018, CHINESE J CATAL, V39, P63, DOI 10.1016/S1872-2067(17)62916-4
   Jeong HM, 2018, KOREAN J CHEM ENG, V35, P438, DOI 10.1007/s11814-017-0294-8
   Jia RL, 2018, J CHEM ENG DATA, V63, P3874, DOI 10.1021/acs.jced.8b00516
   Kovvali AS, 2002, IND ENG CHEM RES, V41, P2287, DOI 10.1021/ie010757e
   Kumar P, 2017, POWDER TECHNOL, V309, P13, DOI 10.1016/j.powtec.2016.12.016
   Kurisingal JF, 2018, CATAL SCI TECHNOL, V8, P591, DOI 10.1039/c7cy02063e
   Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f
   Li W, 2018, CHEM ENG SCI, V189, P65, DOI 10.1016/j.ces.2018.05.042
   Liu JW, 2014, CHEM SOC REV, V43, P6011, DOI 10.1039/c4cs00094c
   Xamena FXLI, 2012, MICROPOR MESOPOR MAT, V157, P112, DOI 10.1016/j.micromeso.2011.12.058
   Lyszczek R, 2008, J THERM ANAL CALORIM, V91, P595, DOI 10.1007/s10973-007-8471-3
   Malik MI, 2016, CHEM ENG SCI, V152, P468, DOI 10.1016/j.ces.2016.06.035
   Maspoch D, 2007, CHEM SOC REV, V36, P770, DOI 10.1039/b501600m
   Milani JLS, 2018, CHINESE J CATAL, V39, P245, DOI 10.1016/S1872-2067(17)62992-9
   Morris RE, 2008, ANGEW CHEM INT EDIT, V47, P4966, DOI 10.1002/anie.200703934
   Nagabhushana GP, 2015, J AM CHEM SOC, V137, P10351, DOI 10.1021/jacs.5b06146
   Opelt S, 2012, MICROPOR MESOPOR MAT, V147, P327, DOI 10.1016/j.micromeso.2011.07.003
   Pato-Doldan B, 2012, PHYS CHEM CHEM PHYS, V14, P8498, DOI 10.1039/c2cp40564d
   Rodenas T, 2015, NAT MATER, V14, P48, DOI [10.1038/NMAT4113, 10.1038/nmat4113]
   Senthilkumar S, 2018, DALTON T, V47, P418, DOI 10.1039/c7dt03754f
   Song JL, 2009, GREEN CHEM, V11, P1031, DOI 10.1039/b902550b
   Song LL, 2017, MICROPOR MESOPOR MAT, V241, P36, DOI 10.1016/j.micromeso.2016.12.009
   Sun KK, 2017, J COLLOID INTERF SCI, V486, P128, DOI 10.1016/j.jcis.2016.09.068
   Sun ZH, 2008, OPT MATER, V30, P1001, DOI 10.1016/j.optmat.2007.05.028
   Szczesniak B, 2018, J COLLOID INTERF SCI, V514, P801, DOI 10.1016/j.jcis.2017.11.049
   Szymborska-Malek K, 2016, SPECTROCHIM ACTA A, V159, P35, DOI 10.1016/j.saa.2016.01.031
   Tamura M, 2013, J CATAL, V305, P191, DOI 10.1016/j.jcat.2013.05.013
   Tian DW, 2012, J IND ENG CHEM, V18, P1332, DOI 10.1016/j.jiec.2012.01.034
   Tu XF, 2017, APPL SURF SCI, V400, P329, DOI 10.1016/j.apsusc.2016.12.220
   Wang FF, 2015, J MATER CHEM C, V3, P6350, DOI 10.1039/c5tc01004g
   Wang PC, 2017, APPL SURF SCI, V392, P562, DOI 10.1016/j.apsusc.2016.09.083
   Wang ZM, 2004, DALTON T, P2209, DOI 10.1039/b404466e
   Wu SS, 2008, APPL CATAL A-GEN, V341, P106, DOI 10.1016/j.apcata.2008.02.021
   Wu YF, 2018, J IND ENG CHEM, V58, P296, DOI 10.1016/j.jiec.2017.09.040
   Zanon A, 2017, J CO2 UTIL, V20, P282, DOI 10.1016/j.jcou.2017.05.026
   Zeng GJ, 2016, ELECTROCHIM ACTA, V222, P773, DOI 10.1016/j.electacta.2016.11.035
   Zeng YP, 2018, CHEM ENG SCI, V192, P94, DOI 10.1016/j.ces.2018.07.025
   Zhang S, 2018, ACS SUSTAIN CHEM ENG, V6, P4204, DOI 10.1021/acssuschemeng.7b04600
   Zhang XL, 2018, MICROPOR MESOPOR MAT, V258, P55, DOI 10.1016/j.micromeso.2017.08.013
   Zhou XH, 2016, CHEM ENG SCI, V153, P10, DOI 10.1016/j.ces.2016.07.007
NR 50
TC 5
Z9 5
U1 30
U2 193
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 288
EP 297
DI 10.1016/j.ces.2019.02.032
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900026
DA 2020-05-12
ER

PT J
AU Li, BB
   Xin, F
   Zhu, GR
   Tan, W
AF Li, Bingbing
   Xin, Feng
   Zhu, Guorui
   Tan, Wei
TI Asymmetric coalescence-induced droplet jumping on hydrophobic fibers
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Asymmetric coalescence; Theoretical model; Hydrophobic fiber;
   Capillary-inertial scaling law; Critical jumping radius ratio
ID SUPERHYDROPHOBIC SURFACES; CONDENSATION; COATINGS; ENERGY
AB Coalescence of two unequal-sized droplets on hydrophobic fibers is more common in nature. To elucidate the mechanism of merged droplets jumping on hydrophobic fibers, a new theoretical model for two unequal-sized droplets coalescence was first developed, which considered the effects of contact angle hysteresis and droplet-fiber contact area. Then, the influences of Ohnesorge number (Oh), droplet radius ratio (n), droplet-fiber radius ratio (k) and contact angle (CA) on the dimensionless jumping velocity (U/v(ci)) were studied theoretically. The value of U/v(ci) increased with the increase of n, k and CA but decreased as Oh increased. The dimensionless jumping velocity for two unequal-sized droplets coalescence on hydrophobic fibers still followed the capillary-inertial scaling law with U/v(ci) approximate to 0.45 when n = 0.5. In addition, the effects of k and CA on the critical jumping radius ratio were the critical jumping radius ratio being reduced as k and CA increased, and the minimal critical jumping radius ratio was approximately 0.1. These findings will help to characterize coalescence-induced droplet jumping on hydrophobic fibers. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Li, Bingbing; Xin, Feng; Zhu, Guorui; Tan, Wei] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300350, Peoples R China.
   [Li, Bingbing] Tianjin Univ, Dept Chem Engn, Renai Coll, Tianjin 301636, Peoples R China.
RP Zhu, GR; Tan, W (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300350, Peoples R China.
EM zhuguorui@tju.edu.cn; wtan@tju.edu.cn
OI Xin, Feng/0000-0003-0877-8434
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21606164]
FX This work is supported by the National Natural Science Foundation of
   China (NO. 21606164).
CR Agranovski IE, 1998, AICHE J, V44, P2775, DOI 10.1002/aic.690441218
   Boreyko JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.184501
   Cha H, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.064102
   Chen X, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.148101
   Chen XM, 2017, ACS OMEGA, V2, P2883, DOI 10.1021/acsomega.7b00225
   Chen XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18649
   Cheng YP, 2016, INT J HEAT MASS TRAN, V95, P506, DOI 10.1016/j.ijheatmasstransfer.2015.11.074
   Enright R, 2014, ACS NANO, V8, P10352, DOI 10.1021/nn503643m
   Gao S, 2018, J PHYS CHEM LETT, V9, P13, DOI 10.1021/acs.jpclett.7b02939
   Haynes WM, 2014, CRC HDB CHEM PHYS
   He M, 2012, SOFT MATTER, V8, P6680, DOI 10.1039/c2sm25828e
   Kim MK, 2015, LANGMUIR, V31, P13452, DOI 10.1021/acs.langmuir.5b03778
   Li BB, 2018, IND ENG CHEM RES, V57, P8299, DOI 10.1021/acs.iecr.8b00716
   Li HX, 2017, LANGMUIR, V33, P8574, DOI 10.1021/acs.langmuir.7b02146
   Li JQ, 2005, SEP PURIF TECHNOL, V42, P1, DOI 10.1016/j.seppur.2004.05.006
   Liu FJ, 2014, J FLUID MECH, V752, P39, DOI 10.1017/jfm.2014.320
   Liu TQ, 2012, COLLOID SURFACE A, V414, P366, DOI 10.1016/j.colsurfa.2012.08.063
   Liu XL, 2015, INT COMMUN HEAT MASS, V64, P7, DOI 10.1016/j.icheatmasstransfer.2015.03.002
   Lv CJ, 2015, LANGMUIR, V31, P2414, DOI 10.1021/la504638y
   Lv CJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4812976
   Miljkovic N, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4886798
   Miljkovic N, 2013, NANO LETT, V13, P179, DOI 10.1021/nl303835d
   Mulroe MD, 2017, ACS NANO, V11, P8499, DOI 10.1021/acsnano.7b04481
   Peng BL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799650
   Rykaczewski K, 2013, LANGMUIR, V29, P881, DOI 10.1021/la304264g
   Sarkar MK, 2011, APPL SURF SCI, V257, P7003, DOI 10.1016/j.apsusc.2011.03.057
   Shi Y, 2015, INT J HEAT MASS TRAN, V88, P445, DOI 10.1016/j.ijheatmasstransfer.2015.04.085
   Shin C, 2004, AICHE J, V50, P343, DOI 10.1002/aic.10031
   Sokolovic RS, 2009, J HAZARD MATER, V162, P410, DOI 10.1016/j.jhazmat.2008.05.054
   Tadmor R, 2004, LANGMUIR, V20, P7659, DOI 10.1021/la049410h
   Tian J, 2014, J PHYS CHEM LETT, V5, P2084, DOI 10.1021/jz500798m
   Wang FC, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3553782
   Wang K, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.4998443
   Wang K, 2016, RSC ADV, V6, P99314, DOI 10.1039/c6ra22421k
   WANG YH, 2018, AIP ADV, V8
   Wasserfall J, 2017, PHYS REV FLUIDS, V2, DOI 10.1103/PhysRevFluids.2.123601
   Xie FF, 2018, LANGMUIR, V34, P2734, DOI 10.1021/acs.langmuir.7b04360
   Xu Q, 2014, ACS APPL MATER INTER, V6, P8976, DOI 10.1021/am502607e
   Yanagisawa K, 2014, APPL SURF SCI, V315, P212, DOI 10.1016/j.apsusc.2014.07.120
   Zhang KG, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.074502
   Zhang QL, 2013, CHEM COMMUN, V49, P4516, DOI 10.1039/c3cc40592c
   Zhu J, 2015, ACS APPL MATER INTER, V7, P10660, DOI 10.1021/acsami.5b02376
   Zielecka M, 2006, PROG ORG COAT, V55, P160, DOI 10.1016/j.porgcoat.2005.09.012
NR 43
TC 2
Z9 2
U1 11
U2 51
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 298
EP 308
DI 10.1016/j.ces.2019.02.041
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900027
DA 2020-05-12
ER

PT J
AU Star, AG
   Fuller, TF
AF Star, Andrew G.
   Fuller, Thomas F.
TI Combining tomographic imaging and in silico computation for rapid
   effective PEMFC cathode transport characterization
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fuel cells; Transport phenomena; Porous media; Tomography; Computation;
   Characterization
ID FUEL-CELL ELECTRODES; CATALYST LAYER; DIFFUSION; TORTUOSITY; MEDIA;
   MICROSTRUCTURE; MORPHOLOGY; RECONSTRUCTION; PERFORMANCE
AB An approach for determination of effective oxygen diffusivity within a polymer electrolyte membrane fuel cell cathode catalyst layer by combining tomography and geometric calculations is presented. Accurate determination of effective oxygen diffusivity is critical for modeling and characterization of cathode design architectures. In silico geometric characterization methods exploit the increasing availability, capability, and decreasing cost of tomographic imaging and high-performance computing. Geometric methods can be made simple and fast and could accelerate efforts to iteratively improve cathode design. The method described herein relied on mathematically exact and statistically significant definitions of geometric tortuosity and geometric constrictivity, in addition to porosity. To demonstrate generality and robustness, a correlation for obstruction factor underpinned by these parameters was statistically induced from hundreds of instantiations of stochastic cathode microstructures generated by a simulated annealing method and validated versus the obstruction factor of real cathode microstructures obtained separately by Star and Fuller in a previous publication and Ziegler et al. at the University of Freiburg. This work demonstrated the utility and viability of adopting a combined tomography/geomet ric-computational approach for determination of the effective diffusivity of reactant in the cathode catalyst layer and its underlying transport properties. This analysis was based on a conventional cathode microstructure with platinum catalyst, carbon black support, and perfluorosulfonic acid ionomer. However, the method could easily be extended to platinum group metal-free cathodes in which accurate characterization may be of even greater importance due to the thicker cathode layers required in these systems. This approach could be widely adopted and relied upon for characterization as the materials and processing conditions of cathode layers are iteratively tested and optimized. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Star, Andrew G.; Fuller, Thomas F.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
RP Star, AG (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
EM andrew.star@nrel.gov
FU Toyota Motor Engineering & Manufacturing North America
FX We acknowledge Eric Woods at the Georgia Tech Institute for Electronics
   and Nanotechnology for help collecting FIB-SEM data. Toyota Motor
   Engineering & Manufacturing North America supported this work.
CR Atkinson RW, 2018, ACS APPL ENERG MATER, V1, P191, DOI 10.1021/acsaem.7b00077
   Bazylak A, 2009, INT J HYDROGEN ENERG, V34, P3845, DOI 10.1016/j.ijhydene.2009.02.084
   Bird R. B., 2002, TRANSPORT PHENOMENA
   Blunt MJ, 2013, ADV WATER RESOUR, V51, P197, DOI 10.1016/j.advwatres.2012.03.003
   Borup R. L., 2018, ECS M, P1591
   Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l
   Carman P.C., 1937, T I CHEM ENG-LOND, V15, P17, DOI [10.1016/S0263-8762(97)80003-2, DOI 10.1016/S0263-8762(97)80003-2]
   Cetinbas FC, 2017, J ELECTROCHEM SOC, V164, pF1596, DOI 10.1149/2.1111714jes
   Cetinbas FC, 2017, J POWER SOURCES, V344, P62, DOI 10.1016/j.jpowsour.2017.01.104
   Chapman S., 1995, MATH THEORY NONUNIFO
   Clennell MB, 1997, GEOL SOC SP, P299, DOI 10.1144/GSL.SP.1997.122.01.18
   CUNNINGHAM RE, 1980, DIFFUSION GASES PORO
   Curtis A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03445-z
   Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390
   Epting WK, 2012, ADV FUNCT MATER, V22, P555, DOI 10.1002/adfm.201101525
   Ferrando-May E, 2016, MICROSC RES TECHNIQ, V79, P463, DOI 10.1002/jemt.22648
   Garcia-Salaberri PA, 2018, INT J HEAT MASS TRAN, V127, P687, DOI 10.1016/j.ijheatmasstransfer.2018.07.030
   Groger O, 2015, J ELECTROCHEM SOC, V162, pA2605, DOI 10.1149/2.0211514jes
   I. C. B. Association, 2016, CARB BLACK US GUID, P36
   Ichikawa Y., 2012, TRANSPORT PHENOMENA
   Inoue G, 2016, J POWER SOURCES, V327, P1, DOI 10.1016/j.jpowsour.2016.07.037
   Kim SH, 2009, J ELECTROCHEM SOC, V156, pB673, DOI 10.1149/1.3106136
   Kongkanand A, 2016, J PHYS CHEM LETT, V7, P1127, DOI 10.1021/acs.jpclett.6b00216
   Kusoglu A, 2017, CHEM REV, V117, P987, DOI 10.1021/acs.chemrev.6b00159
   Litster S, 2013, FUEL CELLS, V13, P935, DOI 10.1002/fuce.201300008
   Liu ZY, 2010, J ELECTROCHEM SOC, V157, pB906, DOI 10.1149/1.3391737
   Mench M. M., 2008, FUEL CELL ENGINES, P1
   More K., 2016, ECS C ORR 3 NOBL MET
   Mukherjee PP, 2006, J ELECTROCHEM SOC, V153, pA840, DOI 10.1149/1.2179303
   Padgett E, 2018, J ELECTROCHEM SOC, V165, pF173, DOI 10.1149/2.0541803jes
   Pant LM, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.023306
   Papageorgopoulos D., 2016, 2016 ANN MER REV PEE
   Poling B. E., 2001, PROPERTIES GASES LIQ
   POLLARD WG, 1948, PHYS REV, V73, P762, DOI 10.1103/PhysRev.73.762
   Putz A. M. V., 2016, ECS M
   Sabharwal M, 2016, FUEL CELLS, V16, P734, DOI 10.1002/fuce.201600008
   Silin D, 2006, PHYSICA A, V371, P336, DOI 10.1016/j.physa.2006.04.048
   Sinha PK, 2006, ELECTROCHEM SOLID ST, V9, pA344, DOI 10.1149/1.2203307
   Star AG, 2017, J ELECTROCHEM SOC, V164, pF901, DOI 10.1149/2.0321709jes
   SUMAN R, 1993, TRANSPORT POROUS MED, V12, P185, DOI 10.1007/BF00616979
   Tjaden B, 2018, INT MATER REV, V63, P47, DOI 10.1080/09506608.2016.1249995
   Tjaden B, 2016, CURR OPIN CHEM ENG, V12, P44, DOI 10.1016/j.coche.2016.02.006
   Torquato S., 2002, RANDOM HETEROGENEOUS
   Vafai K., 2005, HDB POROUS MEDIA
   VANBRAKEL J, 1974, INT J HEAT MASS TRAN, V17, P1093, DOI 10.1016/0017-9310(74)90190-2
   Weber AZ, 2014, J ELECTROCHEM SOC, V161, pF1254, DOI 10.1149/2.0751412jes
   Wu HR, 2017, PHYSCS PROC, V88, P184, DOI 10.1016/j.phpro.2017.06.025
   Yang FF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10635
   Yeong CLY, 1998, PHYS REV E, V58, P224, DOI 10.1103/PhysRevE.58.224
   Zalc JM, 2004, CHEM ENG SCI, V59, P2947, DOI 10.1016/j.ces.2004.04.028
   Zenyuk IV, 2016, J POWER SOURCES, V328, P364, DOI 10.1016/j.jpowsour.2016.08.020
   Ziegler C, 2011, J POWER SOURCES, V196, P2094, DOI 10.1016/j.jpowsour.2010.09.044
NR 52
TC 0
Z9 0
U1 2
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 309
EP 318
DI 10.1016/j.ces.2019.02.018
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900028
DA 2020-05-12
ER

PT J
AU Nagai, Y
   Sugime, H
   Noda, S
AF Nagai, Yukuya
   Sugime, Hisashi
   Noda, Suguru
TI 1.5 Minute-synthesis of continuous graphene films by chemical vapor
   deposition on Cu foils rolled in three dimensions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Graphene; Chemical vapor deposition; Ethylene; Three-dimensional
   reaction field; Short reaction time; Productivity
ID ALIGNED SINGLE-WALL; LARGE-AREA GRAPHENE; HIGH-PERFORMANCE;
   HIGH-QUALITY; GROWTH; COPPER; TRANSPARENT; CVD; DELAMINATION; METAL
AB We report a high-productivity chemical vapor deposition (CVD) process of graphene by extending the reaction field to three dimensions (3D) and shortening the CVD time to a few minutes. A large Cu foil (5 x 30 cm(2)) is rolled up and set in a small reactor (3.4 cm in diameter), and a continuous graphene film is obtained uniformly in a short time (1.5 min) by using C2H4 as a more reactive carbon source than the popular CH4. The graphene transferred onto a quartz glass showed optical transmittances of 94.8-96.7% (550 nm) with sheet resistances of 0.78-1.68 K Omega sq(1) (without doping) and 0.3 K Omega sq(1) (with doping by HNO3 vapor). Compared with the previous reports for fast and/or large-scale CVD, our method realized similarly high productivity of 100 cm(2) min (1) based on the CVD time despite of the small reactor, and higher productivity of 0.03 cm(2)-graphene per cm(3) -reactor per minute based on the reactor volume and total time for high temperature processing (15 min for heating, 1 min for annealing, and 1.5 min for CVD). The knowledge obtained here on the CVD conditions and packing ratio of Cu foils (0.55 cm(2) per cm(3)-reactor) is reusable for designing large-scale graphene production processes. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Nagai, Yukuya; Noda, Suguru] Waseda Univ, Dept Appl Chem, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
   [Sugime, Hisashi] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.
   [Noda, Suguru] Waseda Univ, Waseda Res Inst Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
RP Noda, S (reprint author), Waseda Univ, Dept Appl Chem, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
EM noda@waseda.jp
RI Sugime, Hisashi/G-5678-2015; Noda, Suguru/C-1365-2008
OI Sugime, Hisashi/0000-0003-0247-3445; Noda, Suguru/0000-0002-7305-5307
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP25107002]
FX This work is financially supported by JSPS KAKENHI [grant number
   JP25107002], Japan.
CR Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]
   Chandrashekar BN, 2015, ADV MATER, V27, P5210, DOI 10.1002/adma.201502560
   Chen H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.186101
   de la Rosa CJL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4775583
   Deng B, 2015, NANO LETT, V15, P4206, DOI 10.1021/acs.nanolett.5b01531
   Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130
   Eres G, 2005, J PHYS CHEM B, V109, P16684, DOI 10.1021/jp051531i
   Gao LB, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3512865
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gupta P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03882
   Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962
   Hesjedal T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573866
   Jung W, 2014, ADV MATER, V26, P6394, DOI 10.1002/adma.201400773
   Kang J, 2012, ACS NANO, V6, P5360, DOI 10.1021/nn301207d
   Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Kim SM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365602
   Kobayashi T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4776707
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675
   Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Lisi N, 2014, THIN SOLID FILMS, V571, P139, DOI 10.1016/j.tsf.2014.09.040
   Mas'ud FA, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/20/205504
   Noda S, 2007, JPN J APPL PHYS 2, V46, pL399, DOI 10.1143/JJAP.46.L399
   Polat EO, 2015, SCI REP-UK, V5, DOI 10.1038/srep16744
   Polsen ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep10257
   Sagar RR, 2014, MATER RES INNOV, V18, P706, DOI 10.1179/1432891714Z.000000000771
   Shi LJ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145704
   Sugime H, 2012, CARBON, V50, P2953, DOI 10.1016/j.carbon.2012.02.065
   Sugime H, 2009, CARBON, V47, P234, DOI 10.1016/j.carbon.2008.10.001
   Vlassiouk I., 2012, CARBON N Y, V54, P58
   Wang DY, 2013, ADV MATER, V25, P4521, DOI 10.1002/adma.201301152
   Wang H, 2016, ADV MATER, V28, P8968, DOI 10.1002/adma.201603579
   Wang XH, 2014, SMALL, V10, P694, DOI 10.1002/smll.201301892
   Wang XX, 2017, SMALL, V13, DOI 10.1002/smll.201603369
   Wang Y, 2011, ACS NANO, V5, P9927, DOI 10.1021/nn203700w
   Weatherup RS, 2012, ACS NANO, V6, P9996, DOI 10.1021/nn303674g
   Yamada T, 2012, CARBON, V50, P2615, DOI 10.1016/j.carbon.2012.02.020
   Zhong GF, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4967010
NR 40
TC 0
Z9 0
U1 7
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 319
EP 324
DI 10.1016/j.ces.2019.02.038
PG 6
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900029
DA 2020-05-12
ER

PT J
AU Wang, ZY
   Lou, WQ
   Sun, BJ
   Pan, SW
   Zhao, XX
   Liu, H
AF Wang, Zhiyuan
   Lou, Wenqiang
   Sun, Baojiang
   Pan, Shaowei
   Zhao, Xinxin
   Liu, Hui
TI A model for predicting bubble velocity in yield stress fluid at low
   Reynolds number
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Yield stress fluid; Rising velocity; Low Reynolds number; Predicting
   model; Velocity field
ID COUETTE-POISEUILLE FLOW; VISCOPLASTIC FLUIDS; DRAG COEFFICIENT;
   GAS-BUBBLES; DYNAMICS; MOTION; LIQUIDS; RISE
AB Currently, studies on bubble velocity in yield stress fluids with low Reynolds numbers are lacking. In most engineering applications, such value is often calculated using predictive models developed for viscous fluids. However, these models are only applicable to yield stress fluids in limited conditions because the bubble rise velocity is affected by the yield stress in these fluids significantly. In this study, a velocity field model around a bubble is first developed by performing an infinitesimal analysis of the velocity field in the equatorial plane of the bubble and combining the continuity equation with the constitutive equation of yield stress fluids. Next, a new model is proposed for predicting bubble velocity in yield stress fluids at a low transport rate by integrating the model of velocity field around the bubble with energy conservation equations. Finally, experimental studies are performed to analyze the bubble transport behavior in yield stress fluids at low Reynolds numbers. The experimental results showed that under a low Reynolds number, the bubble rise velocity is dominated by the yield stress of the fluid. Hence, we further validated the proposed bubble velocity prediction model with experimental measurements, which match closely with each other. We conclude that for a Reynolds number less than 0.4, the model developed in this study can be used to predict the bubble velocity in yield stress fluids with high accuracy. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Zhiyuan; Lou, Wenqiang; Sun, Baojiang; Pan, Shaowei; Zhao, Xinxin; Liu, Hui] China Univ Petr East China, Offshore Petr Engn Res Ctr, Sch Petr Engn, Qingdao 266580, Peoples R China.
RP Wang, ZY (reprint author), China Univ Petr East China, Offshore Petr Engn Res Ctr, Sch Petr Engn, Qingdao 266580, Peoples R China.
EM wangzy1209@126.com
FU National Natural Science Foundation-Outstanding Youth Foundation
   [51622405]; Shandong Natural Science funds for Distinguished Young
   Scholar [JQ201716]; Changjiang Scholars ProgramProgram for Changjiang
   Scholars & Innovative Research Team in University (PCSIRT) [Q2016135];
   Construction Project of Taishan Scholars; Program for Changjiang
   Scholars and Innovative Research Team in UniversityProgram for
   Changjiang Scholars & Innovative Research Team in University (PCSIRT)
   [IRT_14R58]
FX The work was supported by the National Natural Science
   Foundation-Outstanding Youth Foundation (51622405), the Shandong Natural
   Science funds for Distinguished Young Scholar (JQ201716), the Changjiang
   Scholars Program (Q2016135), the Construction Project of Taishan
   Scholars, and the Program for Changjiang Scholars and Innovative
   Research Team in University (IRT_14R58).
CR Ahonguio F, 2014, J NON-NEWTON FLUID, V206, P57, DOI 10.1016/j.jnnfm.2014.03.002
   ASTARITA G, 1965, AICHE J, V11, P815, DOI 10.1002/aic.690110514
   BERIS AN, 1985, J FLUID MECH, V158, P219, DOI 10.1017/S0022112085002622
   Bingham E.C., 1922, FLUIDITY PLASTICITY, V2
   Chhabra R.P., 2006, BUBBLES DROPS PARTIC
   Curran SJ, 2002, J FOOD SCI, V67, P176, DOI 10.1111/j.1365-2621.2002.tb11379.x
   Dhiman AK, 2007, NUMER HEAT TR A-APPL, V52, P185, DOI 10.1080/10407780601149870
   Dijkhuizen W, 2010, CHEM ENG SCI, V65, P1415, DOI 10.1016/j.ces.2009.10.021
   Dimakopoulos Y, 2013, J NON-NEWTON FLUID, V200, P34, DOI 10.1016/j.jnnfm.2012.10.012
   Duangsuwan W, 2011, AICHE J, V57, P897, DOI 10.1002/aic.12324
   Duangsuwan W, 2010, AICHE J, V56, P3274, DOI 10.1002/aic.12208
   Duangsuwan W, 2009, CHEM ENG SCI, V64, P3147, DOI 10.1016/j.ces.2009.02.053
   Dubash N, 2007, J NON-NEWTON FLUID, V142, P123, DOI 10.1016/j.jnnfm.2006.06.006
   Dubash N, 2004, PHYS FLUIDS, V16, P4319, DOI 10.1063/1.1803391
   Filip P, 2003, J PETROL SCI ENG, V40, P111, DOI 10.1016/S0920-4105(03)00107-4
   Herschel WH, 1926, KOLLOID Z, V39, P291, DOI 10.1007/BF01432034
   Hutter K, 2016, ADV GEOPHYS ENV MECH, P1, DOI 10.1007/978-3-319-33636-7_11
   Islam MT, 2015, RSC ADV, V5, P7819, DOI 10.1039/c4ra15728a
   Liu YQ, 2010, J NON-NEWTON FLUID, V165, P1494, DOI 10.1016/j.jnnfm.2010.07.013
   Lopez WF, 2018, J RHEOL, V62, P209, DOI 10.1122/1.4995348
   Mirzaagha S, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4998740
   Mitsoulis E, 2017, RHEOL ACTA, V56, P231, DOI 10.1007/s00397-016-0981-0
   Mougin N, 2012, J NON-NEWTON FLUID, V171, P42, DOI 10.1016/j.jnnfm.2012.01.003
   Nogueira S, 2006, CHEM ENG SCI, V61, P845, DOI 10.1016/j.ces.2005.07.038
   Ohta M, 2011, INT J MULTIPHAS FLOW, V37, P1059, DOI 10.1016/j.ijmultiphaseflow.2011.05.012
   Papanastasiou T, 1999, VISCOUS FLUID FLOW
   PEEBLES FN, 1953, CHEM ENG PROG, V49, P88
   Piau JM, 2007, J NON-NEWTON FLUID, V144, P1, DOI 10.1016/j.jnnfm.2007.02.011
   Pinto G. H. V. P, 2012, BRAZ J PETROL GAS, V6
   Premlata AR, 2017, J NON-NEWTON FLUID, V239, P53, DOI 10.1016/j.jnnfm.2016.12.003
   Rodrigue D, 1999, CAN J CHEM ENG, V77, P766, DOI 10.1002/cjce.5450770419
   Samson G, 2017, RHEOL ACTA, V56, P431, DOI 10.1007/s00397-017-1007-2
   Santos O. L, 1997, LATIN AM CAR PETR EN
   Shu SL, 2013, IND ENG CHEM RES, V52, P11391, DOI 10.1021/ie303486y
   Sikorski D, 2009, J NON-NEWTON FLUID, V159, P10, DOI 10.1016/j.jnnfm.2008.11.011
   Sousa RG, 2005, CHEM ENG SCI, V60, P1859, DOI 10.1016/j.ces.2004.11.035
   Sun BJ, 2015, J NAT GAS SCI ENG, V26, P867, DOI 10.1016/j.jngse.2015.07.020
   Terasaka K, 2003, CHEM ENG SCI, V58, P5331, DOI 10.1016/j.ces.2003.09.011
   Terasaka K, 2001, CHEM ENG SCI, V56, P3237, DOI 10.1016/S0009-2509(01)00002-1
   Tripathi MK, 2015, J NON-NEWTON FLUID, V222, P217, DOI 10.1016/j.jnnfm.2014.12.003
   Tsamopoulos J, 2008, J FLUID MECH, V601, P123, DOI 10.1017/S0022112008000517
   van Hout R, 2002, INT J MULTIPHAS FLOW, V28, P579, DOI 10.1016/S0301-9322(01)00082-9
   White FM, 2006, VISCOUS FLUID FLOW
   [尹浚羽 Yin Junyu], 2016, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University. Science & Technology Edition], V38, P135
   Yu Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046708
   Zenit R, 2018, ANNU REV FLUID MECH, V50, P505, DOI 10.1146/annurev-fluid-122316-045114
   Zhang J, 2018, GSTF J MATH STAT OPE, V2
   Zhang JY, 2012, INT J NUMER METH FL, V69, P731, DOI 10.1002/fld.2609
NR 48
TC 2
Z9 2
U1 4
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 325
EP 338
DI 10.1016/j.ces.2019.02.035
PG 14
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900030
DA 2020-05-12
ER

PT J
AU Wang, K
   Chen, JH
   Song, ZH
AF Wang, Kai
   Chen, Junghui
   Song, Zhihuan
TI Using multivariate pattern segmentation to assess process performance
   and mine good operation conditions for dynamic chemical industry
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Dynamic feature extraction; Interval halving; Performance assessment;
   Process data mining; Subspace gap; Time sequence segmentation
ID MUTUAL INFORMATION; COMPONENT ANALYSIS; FAULT-DETECTION; DISSIMILARITY;
   DIAGNOSIS; IDENTIFICATION; FRAMEWORK
AB Before performing any in-depth analytics, an important issue in dealing with historical dynamic data is to extract data segments from the operation data. The raw data always involve different kinds of patterns over a long series of sequences because of the operation changes or some faults. Conventional methods for identifying the patterns are based on variance or covariance, but the indices designed from variance or covariance are not necessarily able to cover the process dynamics completely, so the precision degradation of segmentations will be induced. This paper designs a new dissimilarity index based on the auto-correlation function to deal with dynamic data. And a fast and high-efficient segmentation algorithm using interval halving and the moving window is proposed to locate the change points of data patterns. Moreover, a new dynamic performance assessment index is designed to find the optimal segment in the dataset. Two case studies, including a numerical example and a distillation column benchmark, validate the advantages of the proposed scheme over the conventional variance-based methods. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wang, Kai; Song, Zhihuan] Zhejiang Univ, State Key Lab Ind Control Technol, Hangzhou 310027, Zhejiang, Peoples R China.
   [Chen, Junghui] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 32023, Taiwan.
   [Chen, Junghui] Chung Yuan Christian Univ, Res Ctr Circular Econ, Taoyuan 32023, Taiwan.
   [Chen, Junghui] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 32023, Taiwan.
RP Chen, JH; Song, ZH (reprint author), Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 32023, Taiwan.; Chen, JH; Song, ZH (reprint author), Chung Yuan Christian Univ, Res Ctr Circular Econ, Taoyuan 32023, Taiwan.
EM jason@wavenet.cycu.edu.tw; songzhihuan@zju.edu.cn
RI Chen, Junghui/A-9496-2015
OI Chen, Junghui/0000-0002-9994-839X
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [61573308]; Ministry of Science and Technology,
   Taiwan, R.O.C.Ministry of Science and Technology, Taiwan [MOST
   106-2221-E-033-060-MY3]
FX The authors would like to thank sponsor and financial support from the
   National Natural Science Foundation of China (61573308) and Ministry of
   Science and Technology, Taiwan, R.O.C. (MOST 106-2221-E-033-060-MY3).
CR Bauer M, 2016, J PROCESS CONTR, V38, P1, DOI 10.1016/j.jprocont.2015.11.002
   Bengio Y, 2004, J MACH LEARN RES, V5, P1089
   Chen ZW, 2017, J FRANKLIN I, V354, P556, DOI 10.1016/j.jfranklin.2016.10.031
   Das L, 2017, AICHE J, V63, P3311, DOI 10.1002/aic.15689
   Das L, 2016, IEEE T CONTR SYST T, V24, P1067, DOI 10.1109/TCST.2015.2468087
   Das L, 2016, AICHE J, V62, P146, DOI 10.1002/aic.15042
   Dash S, 2004, AICHE J, V50, P149, DOI 10.1002/aic.10014
   Dobos L, 2012, CHEM ENG SCI, V75, P96, DOI 10.1016/j.ces.2012.02.022
   Fearnhead P, 2005, IEEE T SIGNAL PROCES, V53, P2160, DOI 10.1109/TSP.2005.847844
   FUKUNAGA K, 1970, IEEE T COMPUT, VC 19, P311, DOI 10.1109/T-C.1970.222918
   Ge Z., 2018, IND ENG CHEM RES
   Ge ZQ, 2017, IEEE ACCESS, V5, P20590, DOI 10.1109/ACCESS.2017.2756872
   Haghani A, 2014, IEEE T IND ELECTRON, V61, P6446, DOI 10.1109/TIE.2014.2311409
   Jelali M, 2006, CONTROL ENG PRACT, V14, P441, DOI 10.1016/j.conengprac.2005.11.005
   Jiang QC, 2014, ISA T, V53, P1516, DOI 10.1016/j.isatra.2014.05.031
   Kano M, 2002, AICHE J, V48, P1231, DOI 10.1002/aic.690480610
   Katayama T., 2006, SUBSPACE METHODS SYS
   Kruger U, 2004, J PROCESS CONTR, V14, P879, DOI 10.1016/j.jprocont.2004.02.002
   Ku WF, 1995, CHEMOMETR INTELL LAB, V30, P179, DOI 10.1016/0169-7439(95)00076-3
   Li C, 2014, IND ENG CHEM RES, V53, P18226, DOI 10.1021/ie503641c
   Liu Y, 2015, CHEM ENG SCI, V137, P106, DOI 10.1016/j.ces.2015.06.016
   Meyer CD, 2000, MATRIX ANAL APPL LIN
   Punskaya E, 2002, IEEE T SIGNAL PROCES, V50, P747, DOI 10.1109/78.984776
   Qin SJ, 2003, J CHEMOMETR, V17, P480, DOI 10.1002/cem.800
   Qin SJ, 1998, COMPUT CHEM ENG, V23, P173, DOI 10.1016/S0098-1354(98)00259-2
   Rashid MM, 2012, CHEMOMETR INTELL LAB, V115, P44, DOI 10.1016/j.chemolab.2012.04.008
   Shah S. L, 2002, AICHE S SERIES, P190
   Srinivasan B, 2012, AUTOMATICA, V48, P1359, DOI 10.1016/j.automatica.2012.04.003
   Touretzky CR, 2017, AICHE J, V63, P1959, DOI 10.1002/aic.15564
   Wan YM, 2012, J PROCESS CONTR, V22, P26, DOI 10.1016/j.jprocont.2011.10.013
   Wang K, 2017, J PROCESS CONTR, V54, P152, DOI 10.1016/j.jprocont.2017.03.001
   Yu J, 2008, AICHE J, V54, P1811, DOI 10.1002/aic.11515
   Yu J, 2008, J PROCESS CONTR, V18, P277, DOI 10.1016/j.jprocont.2007.06.002
   Zhao CH, 2017, CONTROL ENG PRACT, V65, P70, DOI 10.1016/j.conengprac.2017.05.005
   Zhao CH, 2009, CONTROL ENG PRACT, V17, P221, DOI 10.1016/j.conengprac.2008.07.001
NR 35
TC 1
Z9 1
U1 3
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 339
EP 348
DI 10.1016/j.ces.2019.01.057
PG 10
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900031
DA 2020-05-12
ER

PT J
AU Yu, X
   Zhou, H
   Jing, S
   Lan, WJ
   Li, SW
AF Yu, Xiong
   Zhou, Han
   Jing, Shan
   Lan, Wenjie
   Li, Shaowei
TI CFD-PBM simulation of two-phase flow in a pulsed disc and doughnut
   column with directly measured breakup kernel functions
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Pulsed disc and doughnut column; Computational fluid dynamics;
   Population balance model; Droplet size distribution; Hydraulic
   performance
ID POPULATION BALANCE-EQUATIONS; LIQUID-LIQUID-EXTRACTION;
   SOLVENT-EXTRACTION; QUADRATURE METHOD; DROP SIZE; SIEVE-PLATE; DISPERSED
   PHASE; PIPE-FLOW; COALESCENCE; DYNAMICS
AB The pulsed disc and doughnut column (PDDC) is a widely used type of liquid-liquid extraction equipment. Both the research and design of this type of equipment require in-depth knowledge of the dispersed phase droplet size distribution (DSD). The coupling of computational fluid dynamics (CFD) and population balance model (PBM) has exhibited a significant potential for predicting the DSD by considering droplet breakage and coalescence. In the present work, the CFD-PBM simulation is adopted to predict the DSD, and to investigate local liquid-liquid flow behaviors in a square-sectioned PDDC. The empirical correlations of the breakup kernels, which are based on our previous work [Hao Zhou et al., Direct measurement of droplet breakage in a pulsed disc and doughnut column. AIChE Journal, 2017, 63(9), 4188-4200], are implemented in the CFD code. For comparison, the kernel functions obtained by Coulaloglou and Tavlarides [Coulaloglou and Tavlarides. Description of interaction processes in agitated liquid-liquid dispersions. Chemical Engineering Science, 1977, 32, 1289-1297] are also tested. The class method with the fixed pivot technique is utilized to solve the population balance equations. The droplet size distribution predicted by the CFD-PBM simulation combined with the kernel functions that we have previously determined experimentally are observed to be more precise than those of Coulaloglou and Tavlarides. Accordingly, the CFD-PBM simulation results with the kernel functions of our proposed correlations are used to investigate the liquid-liquid flow behaviors in the PDDC. The influences of droplet size range and initial droplet size distribution at the dispersed phase inlet in the predicted DSD are discussed. The hydraulic performance of simulation results agrees well with experimental data. Local flow behaviors are illustrated to depict the typical flow characteristics of PDDC. The simulation results suggest that CFD-PBM method with the proposed PBM kernel functions is a promising approach for the simulation of liquid-liquid flow in the PDDC. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Yu, Xiong; Zhou, Han; Jing, Shan; Li, Shaowei] Tsinghua Univ, Collaborat Innovat Ctr Adv Nucl Energy Technol, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.
   [Lan, Wenjie] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
   [Li, Shaowei] Tsinghua Univ, State Key Lab Chem Engn, Beijing 100084, Peoples R China.
RP Jing, S; Li, SW (reprint author), Tsinghua Univ, Collaborat Innovat Ctr Adv Nucl Energy Technol, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.
EM s-jiag@tsinghua.edu.cn; lsw@tsinghua.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [21776151, 21576147, 21376132]
FX We gratefully acknowledge the support of the National Natural Science
   Foundation of China (21776151, 21576147, 21376132) to this research.
CR Alzyod S, 2016, COMPUT-AIDED CHEM EN, V38A, P427, DOI 10.1016/B978-0-444-63428-3.50076-X
   Amokrane A, 2016, CHEM ENG J, V296, P366, DOI 10.1016/j.cej.2016.03.089
   Amokrane A, 2014, CAN J CHEM ENG, V92, P220, DOI 10.1002/cjce.21933
   Angelov G, 1998, CHEM ENG J, V71, P1, DOI 10.1016/S1385-8947(98)00111-9
   Bhole MR, 2008, CHEM ENG SCI, V63, P2267, DOI 10.1016/j.ces.2008.01.013
   BILLERBECK CJ, 1956, IND ENG CHEM, V48, P183, DOI 10.1021/ie50554a012
   COULALOGLOU CA, 1977, CHEM ENG SCI, V32, P1289, DOI 10.1016/0009-2509(77)85023-9
   Drumm C., 2010, THESIS
   Drumm C, 2009, CHEM ENG SCI, V64, P721, DOI 10.1016/j.ces.2008.05.041
   Ebrahimzadeh H, 2007, ANAL CHIM ACTA, V594, P93, DOI 10.1016/j.aca.2007.05.013
   Galinat S, 2007, AICHE J, V53, P56, DOI 10.1002/aic.11055
   Galinat S, 2005, CHEM ENG SCI, V60, P6511, DOI 10.1016/j.ces.2005.05.012
   Galinat S, 2007, J FLUID MECH, V578, P85, DOI 10.1017/S0022112007005186
   HANDLOS AE, 1957, AICHE J, V3, P127, DOI 10.1002/aic.690030121
   HSIA MA, 1983, CHEM ENG J BIOCH ENG, V26, P189, DOI 10.1016/0300-9467(83)80014-8
   ISHII M, 1979, AICHE J, V25, P843, DOI 10.1002/aic.690250513
   Jahya A.B., 2002, PERFORMANCE PULSED D
   Jaradat M, 2011, IND ENG CHEM RES, V50, P14121, DOI 10.1021/ie201041q
   Jildeh HB, 2012, PROCEDIA ENGINEER, V42, P1692, DOI 10.1016/j.proeng.2012.07.562
   Kumar A, 1996, IND ENG CHEM RES, V35, P2682, DOI 10.1021/ie950674w
   KUMAR A, 1985, CAN J CHEM ENG, V63, P368, DOI 10.1002/cjce.5450630303
   Kumar S, 1996, CHEM ENG SCI, V51, P1311, DOI 10.1016/0009-2509(96)88489-2
   Liu HQ, 2016, IND ENG CHEM RES, V55, P2242, DOI 10.1021/acs.iecr.5b04661
   Liu JQ, 2015, SOLVENT EXTR ION EXC, V33, P385, DOI 10.1080/07366299.2015.1010891
   Luo H, 1996, AICHE J, V42, P1225, DOI 10.1002/aic.690420505
   Marchisio DL, 2005, J AEROSOL SCI, V36, P43, DOI 10.1016/j.jaerosci.2004.07.009
   Marchisio DL, 2003, J COLLOID INTERF SCI, V258, P322, DOI 10.1016/S0021-9797(02)00054-1
   McGraw R, 1997, AEROSOL SCI TECH, V27, P255, DOI 10.1080/02786829708965471
   MILOT JF, 1990, CHEM ENG J BIOCH ENG, V45, P111, DOI 10.1016/0300-9467(90)80033-9
   Mirzaie M, 2016, SOLVENT EXTR ION EXC, V34, P643, DOI 10.1080/07366299.2016.1236542
   Nabli MA, 1997, CHEM ENG SCI, V52, P2353
   NOH SH, 1984, AICHE J, V30, P120, DOI 10.1002/aic.690300117
   PRINCE MJ, 1990, AICHE J, V36, P1485, DOI 10.1002/aic.690361004
   Retieb S, 2007, CHEM ENG SCI, V62, P4558, DOI 10.1016/j.ces.2007.04.043
   Saini RK, 2014, ENRGY PROCED, V54, P796, DOI 10.1016/j.egypro.2014.07.323
   Sarkar S, 2017, CHEM ENG PROCESS, V118, P131, DOI 10.1016/j.cep.2017.04.016
   Sen N, 2018, SOLVENT EXTR ION EXC, V36, P66, DOI 10.1080/07366299.2017.1415672
   SOLE KC, 1995, HYDROMETALLURGY, V37, P129, DOI 10.1016/0304-386X(94)00023-V
   Solsvik J, 2016, IND ENG CHEM RES, V55, P2872, DOI 10.1021/acs.iecr.6b00591
   Srilatha C, 2010, CHEM ENG SCI, V65, P3409, DOI 10.1016/j.ces.2010.02.035
   Torab-Mostaedi M, 2011, CHEM ENG RES DES, V89, P2742, DOI 10.1016/j.cherd.2011.06.006
   TSOURIS C, 1994, AICHE J, V40, P395, DOI 10.1002/aic.690400303
   van Delden ML, 2006, SOLVENT EXTR ION EXC, V24, P539, DOI 10.1080/07366290600760664
   van Delden ML, 2006, SOLVENT EXTR ION EXC, V24, P519, DOI 10.1080/07366290600760649
   Vanni M, 2000, J COLLOID INTERF SCI, V221, P143, DOI 10.1006/jcis.1999.6571
   Wang TF, 2003, CHEM ENG SCI, V58, P4629, DOI 10.1016/j.ces.2003.07.009
   Wang Y, 2016, CHEM ENG RES DES, V109, P667, DOI 10.1016/j.cherd.2016.03.016
   Wardle KE, 2008, AICHE J, V54, P74, DOI 10.1002/aic.11381
   Zhou H, 2017, AICHE J, V63, P4188, DOI 10.1002/aic.15742
NR 49
TC 0
Z9 0
U1 11
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 349
EP 361
DI 10.1016/j.ces.2019.03.010
PG 13
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900032
DA 2020-05-12
ER

PT J
AU Arabiourrutia, M
   Lopez, G
   Aguado, R
   Bilbao, J
   Olazar, M
AF Arabiourrutia, M.
   Lopez, G.
   Aguado, R.
   Bilbao, J.
   Olazar, M.
TI Coupling gas flow pattern and kinetics for tyre pyrolysis modelling
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Gas flow pattern; Residence time distribution; Flow dispersion;
   Kinetics; Tyre pyrolysis
ID WASTE TIRE; CATALYTIC PYROLYSIS; RESIDENCE TIME; SCRAP TIRES; BED
   REACTOR; TG-FTIR; RUBBER; OIL; FUELS; CHAR
AB A novel strategy has been proposed for the rigorous kinetic modeling of tyre pyrolysis in a conical spouted bed reactor. A kinetic model coupled with a gas flow model was used in the fitting of experimental results obtained in a bench scale unit in the 425-610 degrees C range. A gas flow model should be incorporated to account for the delay and mixing phenomena observed in tracer experiments, as these phenomena cause remarkable deviations in the assessment of the kinetic parameters. The gas flow pattern from the reactor to the measuring device was modeled using two different approaches based on ideal flow reactors. Furthermore, two kinetic schemes considering lumped products have been proposed; the first one is based on four parallel independent reactions accounting for the volatile products (gas, liquid, aromatics and tar). The second one considers an additional secondary reaction of aromatic formation from the liquid. The strategy proposed for coupling the kinetics and the flow model led to a suitable fitting of the experimental results, with the performance of the model considering a secondary reaction being slightly better than the simple one. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Arabiourrutia, M.; Lopez, G.; Aguado, R.; Bilbao, J.; Olazar, M.] Univ Basque Country, UPV EHU, Chem Engn Dept, POB 644-48080, Bilbao, Spain.
RP Arabiourrutia, M (reprint author), Univ Basque Country, UPV EHU, Chem Engn Dept, POB 644-48080, Bilbao, Spain.
EM miriam.arbiourrutia@ehu.eus
RI Aguado, Roberto/G-4849-2011; Olazar, Martin/AAA-2334-2019; Lopez,
   Gartzen/F-2486-2011
OI Aguado, Roberto/0000-0001-8743-5696; Olazar, Martin/0000-0002-5740-727X;
   Lopez, Gartzen/0000-0002-0560-7376; BILBAO ELORRIAGA,
   JAVIER/0000-0001-7084-9665
FU Ministry of Economy and Competitiveness of the Spanish Government
   [CTQ2016-75535-R]; Basque GovernmentBasque Government [IT748-13]
FX This work was carried out with the financial support from the Ministry
   of Economy and Competitiveness of the Spanish Government
   (CTQ2016-75535-R (AEI/FEDER, UE)) and the Basque Government (IT748-13).
CR Al-Salem SM, 2009, J HAZARD MATER, V172, P1690, DOI 10.1016/j.jhazmat.2009.07.127
   Alvarez J, 2017, ENERGY, V128, P463, DOI 10.1016/j.energy.2017.03.163
   Antoniou N, 2014, RENEW SUST ENERG REV, V39, P1053, DOI 10.1016/j.rser.2014.07.143
   Antoniou N, 2013, RENEW SUST ENERG REV, V20, P539, DOI 10.1016/j.rser.2012.12.005
   Antoniou N, 2015, J CLEAN PROD, V101, P323, DOI 10.1016/j.jclepro.2015.03.101
   Arabiourrutia M, 2007, CHEM ENG SCI, V62, P5271, DOI 10.1016/j.ces.2006.12.026
   Arabiourrutia M, 2008, IND ENG CHEM RES, V47, P7600, DOI 10.1021/ie800376d
   Ayanoglu A, 2016, ENERGY, V103, P456, DOI 10.1016/j.energy.2016.02.155
   Aylon E, 2008, IND ENG CHEM RES, V47, P4029, DOI 10.1021/ie071573o
   Aylon E, 2005, J ANAL APPL PYROL, V74, P259, DOI 10.1016/j.jaap.2004.09.006
   Aylon E, 2010, WASTE MANAGE, V30, P2530, DOI 10.1016/j.wasman.2010.04.018
   Bittante A, 2014, CHEM ENG J, V250, P99, DOI 10.1016/j.cej.2014.03.062
   Choi GG, 2017, ENERGY, V141, P2234, DOI 10.1016/j.energy.2017.12.015
   Choi GG, 2016, ENERGY, V114, P457, DOI 10.1016/j.energy.2016.08.020
   Cunliffe AM, 1998, J ANAL APPL PYROL, V44, P131, DOI 10.1016/S0165-2370(97)00085-5
   Czajczynska D, 2017, ENERGY, V134, P1121, DOI 10.1016/j.energy.2017.05.042
   Dai XW, 2001, ENERGY, V26, P385, DOI 10.1016/S0360-5442(01)00003-2
   Martinez JD, 2013, RENEW SUST ENERG REV, V23, P179, DOI 10.1016/j.rser.2013.02.038
   Danon B, 2015, J ANAL APPL PYROL, V112, P1, DOI 10.1016/j.jaap.2014.12.025
   Danon B, 2015, THERMOCHIM ACTA, V621, P56, DOI 10.1016/j.tca.2015.10.008
   Faulkner BP, 2001, MINER METALL PROC, V18, P215, DOI 10.1007/BF03403253
   Froment G.F., 1990, CHEM REACTOR ANAL DE
   Galvagno S, 2007, J THERM ANAL CALORIM, V88, P507, DOI 10.1007/s10973-006-8409-1
   Garcia-Nunez JA, 2017, ENERG FUEL, V31, P5751, DOI 10.1021/acs.energyfuels.7b00641
   Helleur R, 2001, J ANAL APPL PYROL, V58, P813, DOI 10.1016/S0165-2370(00)00207-2
   Ismail HY, 2017, WASTE MANAGE, V60, P482, DOI 10.1016/j.wasman.2016.10.024
   Kaminsky W, 2001, J ANAL APPL PYROL, V58, P803, DOI 10.1016/S0165-2370(00)00129-7
   Kaminsky W, 2009, J ANAL APPL PYROL, V85, P334, DOI 10.1016/j.jaap.2008.11.012
   Kan T, 2017, FUEL, V191, P403, DOI 10.1016/j.fuel.2016.11.100
   Lah B, 2013, CHEM ENG SCI, V87, P1, DOI 10.1016/j.ces.2012.10.003
   Larsen MB, 2006, FUEL, V85, P1335, DOI 10.1016/j.fuel.2005.12.014
   Li SQ, 2004, IND ENG CHEM RES, V43, P5133, DOI 10.1021/ie030115m
   Lopez G, 2017, ENERG CONVERS MANAGE, V142, P523, DOI 10.1016/j.enconman.2017.03.051
   Lopez G, 2017, RENEW SUST ENERG REV, V73, P346, DOI 10.1016/j.rser.2017.01.142
   Lopez G, 2016, ENERGY, V107, P493, DOI 10.1016/j.energy.2016.04.040
   Lopez G, 2010, FUEL, V89, P1946, DOI 10.1016/j.fuel.2010.03.029
   Lopez G, 2009, WASTE MANAGE, V29, P2649, DOI 10.1016/j.wasman.2009.06.005
   Luo SY, 2017, ENERG CONVERS MANAGE, V136, P27, DOI 10.1016/j.enconman.2016.12.076
   Makibar J, 2011, CHEM ENG PROCESS, V50, P790, DOI 10.1016/j.cep.2011.05.013
   Mazloom G, 2009, J ANAL APPL PYROL, V84, P157, DOI 10.1016/j.jaap.2009.01.006
   Miranda M, 2013, FUEL, V103, P542, DOI 10.1016/j.fuel.2012.06.114
   Mkhize NM, 2016, J ANAL APPL PYROL, V120, P314, DOI 10.1016/j.jaap.2016.04.019
   Moliner C, 2017, ENERGIES, V10, DOI 10.3390/en10111729
   Olazar M, 2008, J ANAL APPL PYROL, V82, P199, DOI 10.1016/j.jaap.2008.03.006
   Olazar M, 2008, J ANAL APPL PYROL, V81, P127, DOI 10.1016/j.jaap.2007.09.011
   Perkins G, 2018, RENEW SUST ENERG REV, V90, P292, DOI 10.1016/j.rser.2018.03.048
   Quek A, 2012, J ANAL APPL PYROL, V95, P1, DOI 10.1016/j.jaap.2012.01.012
   Saldarriaga JF, 2018, FUEL, V227, P256, DOI 10.1016/j.fuel.2018.04.060
   Saravanathamizhan R, 2008, CHEM ENG J, V142, P209, DOI 10.1016/j.cej.2008.02.017
   Seidelt S, 2006, J ANAL APPL PYROL, V75, P11, DOI 10.1016/j.jaap.2005.03.002
   Stanciulescu M, 2006, J ANAL APPL PYROL, V75, P217, DOI 10.1016/j.jaap.2005.06.003
   Thomas BS, 2016, RENEW SUST ENERG REV, V54, P1323, DOI 10.1016/j.rser.2015.10.092
   Wibel W, 2013, CHEM ENG J, V215, P449, DOI 10.1016/j.cej.2012.10.011
   Williams PT, 2013, WASTE MANAGE, V33, P1714, DOI 10.1016/j.wasman.2013.05.003
   Williams PT, 2003, J ANAL APPL PYROL, V67, P143, DOI 10.1016/S0165-2370(02)00059-1
   Xu FF, 2018, ENERG CONVERS MANAGE, V175, P288, DOI 10.1016/j.enconman.2018.09.013
NR 56
TC 3
Z9 3
U1 1
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 362
EP 372
DI 10.1016/j.ces.2019.02.025
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900033
DA 2020-05-12
ER

PT J
AU Cortes-Reyes, M
   Larrubia, MA
   Herrera, C
   Alemany, LJ
AF Cortes-Reyes, Marina
   Angeles Larrubia, M.
   Herrera, Concepcion
   Alemany, Luis J.
TI Influence of CO2 and H2O co-feeding in the NOx abatement by SCR over an
   efficient Cu-CHA catalyst
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Cu-CHA catalyst; Copper species; Hydrothermal stability; SCR-DeNO(x);
   Real conditions; CO2 and H2O co-adsorption
ID HYDROTHERMAL STABILITY; CU/SAPO-34 CATALYSTS; CU-SAPO-34 CATALYSTS;
   NH3-SCR CATALYSTS; ZEOLITE CATALYSTS; MOLECULAR-SIEVES; COMBINED NSR;
   SITU-DRIFTS; REDUCTION; ADSORPTION
AB Cu-SAPO-34 materials with 2 wt% of copper synthesized in one pot with all the copper inside the framework are hydrothermally stable. Copper oxide species were not detected by XRD after thermal and hydrothermal aging at 750 degrees C. CO2 and H2O molecules are retained on Cu-SAPO catalyst and are related to CO2 adsorption aided by water involving the Cu-species. Copper species coordination is modified by the reaction atmosphere and the species are directly involved in the SCR-process. A decrease in the ammonia storage capacity in the presence of water has been justified due to the cooperative competition between the ammonia and water adsorption and/or CO2 carbonation over the same sites. Higher coordinated Cu species localized inside of CHA-framework, up to a loading close to 4% with this methodology, are highly efficient in the removal of NOx by reaction with ammonia, in the presence of oxygen, water (1.5%) and CO2 (0.3%) as reaction atmosphere. The SCR mechanism is essentially the same as in dry conditions because the Cu2+/Cu+ ions, in equilibrium with H2O + CO2, are the active species in the SCR-reaction. Hydrated-carbonated Cu(II) and hydrated-carbonated Cu(I) species are associated with the redox-chemistry of NOx abatement as responsible for the improvement in the standard SCR; favoring the hindering of ammonia oxidation and nitrate decomposition. In the SCR temperature range, the conversion values registered for this catalyst are higher than 80% with total selectivity to N-2. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cortes-Reyes, Marina; Angeles Larrubia, M.; Herrera, Concepcion; Alemany, Luis J.] Univ Malaga, Fac Ciencias, Dept Ingn Quim, Campus Teatinos, E-29071 Malaga, Spain.
RP Alemany, LJ (reprint author), Univ Malaga, Fac Ciencias, Dept Ingn Quim, Campus Teatinos, E-29071 Malaga, Spain.
EM luijo@uma.es
RI ; Herrera, Concepcion/F-2318-2016
OI Alemany, Luis J./0000-0002-7428-4718; Herrera,
   Concepcion/0000-0002-7330-094X
FU Spanish Ministry of Education, Culture and Sport [FPU12/03826]; CTQ
   Project [2013-47853R]
FX MCR acknowledges the Spanish Ministry of Education, Culture and Sport
   (FPU12/03826) for the FPU grant and Universidad de Malaga. Campus de
   Excelencia Internacional Andalucia Tech. The authors want to thank the
   financial support of the CTQ 2013-47853R Project. Special thanks to Prof
   Luca Lietti and the LCCP Research Group from Politecnico di Milano for
   the replication of the catalytic activity experiments in their
   facilities.
CR Alvaro-Munoz T, 2012, CATAL TODAY, V179, P27, DOI 10.1016/j.cattod.2011.07.038
   Bates SA, 2014, J CATAL, V312, P87, DOI 10.1016/j.jcat.2014.01.004
   Blakeman PG, 2014, CATAL TODAY, V231, P56, DOI 10.1016/j.cattod.2013.10.047
   Bonaccorsi L, 2013, MICROPOR MESOPOR MAT, V167, P30, DOI 10.1016/j.micromeso.2012.06.006
   Bonzi R, 2010, CATAL TODAY, V151, P376, DOI 10.1016/j.cattod.2010.02.003
   Bordiga S, 2005, J PHYS CHEM B, V109, P7724, DOI 10.1021/jp044324b
   Brandenberger S, 2008, CATAL REV, V50, P492, DOI 10.1080/01614940802480122
   Busca G, 1998, APPL CATAL B-ENVIRON, V18, P1, DOI 10.1016/S0926-3373(98)00040-X
   Can F, 2015, CATAL TODAY, V257, P41, DOI 10.1016/j.cattod.2015.03.024
   Cao Y, 2015, J MOL CATAL A-CHEM, V398, P304, DOI 10.1016/j.molcata.2014.12.020
   Chen PR, 2016, CATAL SCI TECHNOL, V6, P3362, DOI 10.1039/c6cy00452k
   Cheng XX, 2014, PARTICUOLOGY, V16, P1, DOI 10.1016/j.partic.2014.01.006
   Colombo M, 2012, CATAL TODAY, V197, P243, DOI 10.1016/j.cattod.2012.09.002
   Colombo M, 2012, APPL CATAL B-ENVIRON, V111, P433, DOI 10.1016/j.apcatb.2011.10.031
   Colombo M, 2010, CATAL TODAY, V151, P223, DOI 10.1016/j.cattod.2010.01.010
   Cortes-Reyes M, 2016, INT J INNOV RES SCI, V5, P5540, DOI [10.15680/IJIRSET.2016.0504189, DOI 10.15680/IJIRSET.2016.0504189]
   Cortes-Reyes M, 2017, MICROPOR MESOPOR MAT, V241, P258, DOI 10.1016/j.micromeso.2016.11.032
   Cui Y, 2013, PARTICUOLOGY, V11, P468, DOI 10.1016/j.partic.2012.12.009
   Dang TTH, 2009, MICROPOR MESOPOR MAT, V123, P209, DOI 10.1016/j.micromeso.2009.04.003
   Danon A, 2011, J PHYS CHEM C, V115, P11540, DOI 10.1021/jp200914v
   De la Torre U, 2016, CATAL TODAY, V273, P72, DOI 10.1016/j.cattod.2016.02.054
   De La Torre U, 2012, CHEM ENG J, V207, P10, DOI 10.1016/j.cej.2012.06.092
   De-La-Torre U, 2016, APPL CATAL B-ENVIRON, V187, P419, DOI 10.1016/j.apcatb.2016.01.020
   Fan SK, 2013, CATAL SCI TECHNOL, V3, P2357, DOI 10.1039/c3cy00267e
   Gao F, 2017, J AM CHEM SOC, V139, P4935, DOI 10.1021/jacs.7b01128
   Gao F, 2015, APPL CATAL B-ENVIRON, V162, P501, DOI 10.1016/j.apcatb.2014.07.029
   Gao F, 2013, TOP CATAL, V56, P1441, DOI 10.1007/s11244-013-0145-8
   Godiksen A, 2014, J PHYS CHEM C, V118, P23126, DOI 10.1021/jp5065616
   Grossale A, 2009, J CATAL, V265, P141, DOI 10.1016/j.jcat.2009.04.014
   Hee I, 2011, MICROPOR MESOPOR MAT, V141, P8, DOI 10.1016/j.micromeso.2010.02.005
   Kim YJ, 2014, J CATAL, V311, P447, DOI 10.1016/j.jcat.2013.12.012
   Kim YJ, 2012, APPL CATAL B-ENVIRON, V126, P9, DOI 10.1016/j.apcatb.2012.06.010
   Kock EM, 2013, J PHYS CHEM C, V117, P17666, DOI 10.1021/jp405625x
   Kwak JH, 2012, CHEM COMMUN, V48, P4758, DOI 10.1039/c2cc31184d
   Leistner K, 2015, APPL CATAL B-ENVIRON, V165, P192, DOI 10.1016/j.apcatb.2014.09.067
   Lindholm A, 2010, APPL CATAL B-ENVIRON, V98, P112, DOI 10.1016/j.apcatb.2010.05.019
   Liu XS, 2017, CATAL TODAY, V281, P596, DOI 10.1016/j.cattod.2016.05.021
   Ma L, 2014, APPL CATAL B-ENVIRON, V156, P428, DOI 10.1016/j.apcatb.2014.03.048
   Martinez-Franco R, 2014, J CATAL, V314, P73, DOI 10.1016/j.jcat.2014.03.018
   Martinez-Franco R, 2012, APPL CATAL B-ENVIRON, V127, P273, DOI 10.1016/j.apcatb.2012.08.034
   Martini A, 2017, CHEM SCI, V8, P6836, DOI 10.1039/c7sc02266b
   Mihai O, 2014, J CATAL, V311, P170, DOI 10.1016/j.jcat.2013.11.016
   Montanari T, 2008, VIB SPECTROSC, V46, P45, DOI 10.1016/j.vibspec.2007.09.001
   Mrad R, 2015, APPL CATAL A-GEN, V504, P542, DOI 10.1016/j.apcata.2014.10.021
   Niu C, 2016, CHEM ENG J, V294, P254, DOI 10.1016/j.cej.2016.02.086
   Palella BI, 2003, J CATAL, V217, P100, DOI 10.1016/S0021-9517(03)00033-2
   Paolucci C, 2017, SCIENCE, V357, P898, DOI 10.1126/science.aan5630
   Petitto C, 2015, CHEM ENG J, V264, P404, DOI 10.1016/j.cej.2014.11.111
   Regli L, 2005, STUD SURF SCI CATAL, V155, P471
   Rutkowska M, 2015, MICROPOR MESOPOR MAT, V209, P54, DOI 10.1016/j.micromeso.2014.10.011
   Shen MQ, 2015, CATAL SCI TECHNOL, V5, P1741, DOI 10.1039/c4cy01129e
   Shwan S, 2012, CATAL TODAY, V197, P24, DOI 10.1016/j.cattod.2012.06.014
   Su WK, 2015, PHYS CHEM CHEM PHYS, V17, P29142, DOI 10.1039/c5cp05128b
   Turco M, 2004, J CATAL, V228, P43, DOI 10.1016/j.jcat.2004.08.026
   Villarreal A, 2017, J CO2 UTIL, V19, P266, DOI 10.1016/j.jcou.2017.03.021
   Wang D, 2015, APPL CATAL B-ENVIRON, V165, P438, DOI 10.1016/j.apcatb.2014.10.020
   Wang D, 2014, CATAL TODAY, V231, P64, DOI 10.1016/j.cattod.2013.11.040
   Wang D, 2013, ACS CATAL, V3, P871, DOI 10.1021/cs300843k
   Wang J, 2015, J CATAL, V322, P84, DOI 10.1016/j.jcat.2014.11.010
   Wang J, 2014, CATAL SCI TECHNOL, V4, P3004, DOI 10.1039/c4cy00451e
   Wang J, 2012, APPL CATAL B-ENVIRON, V127, P137, DOI 10.1016/j.apcatb.2012.08.016
   Wang L, 2013, J CATAL, V306, P68, DOI 10.1016/j.jcat.2013.06.010
   Westermann A, 2017, CATAL TODAY, V283, P74, DOI 10.1016/j.cattod.2016.02.031
   Westermann A, 2015, APPL CATAL B-ENVIRON, V174, P120, DOI 10.1016/j.apcatb.2015.02.026
   Xiang X, 2016, RSC ADV, V6, P12544, DOI 10.1039/c5ra22868a
   Yu T, 2015, CHEM ENG J, V264, P845, DOI 10.1016/j.cej.2014.12.017
   Yu T, 2014, J PHYS CHEM C, V118, P6565, DOI 10.1021/jp4114199
   Yu T, 2013, CATAL SCI TECHNOL, V3, P3234, DOI 10.1039/c3cy00453h
   Zabilskiy M, 2015, APPL CATAL B-ENVIRON, V163, P113, DOI 10.1016/j.apcatb.2014.07.057
NR 69
TC 3
Z9 3
U1 10
U2 76
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 373
EP 381
DI 10.1016/j.ces.2019.02.031
PG 9
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900034
DA 2020-05-12
ER

PT J
AU Mansour, M
   Thevenin, D
   Nigam, KDP
   Zahringer, K
AF Mansour, Michael
   Thevenin, Dominique
   Nigam, Krishna D. P.
   Zaehringer, Katharina
TI Generally-valid optimal Reynolds and Dean numbers for efficient
   liquid-liquid mixing in helical pipes
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Liquid-liquid mixing; Optimal Reynolds number; Optimal Dean number;
   Helical pipes; Geometrical parameters; CFD
ID HEAT-TRANSFER
AB This work documents optimal flow conditions in terms of Reynolds number Re (and Dean number De) for mixing of two miscible liquids in helical pipes. Extending our previous investigations (Mansour et al., 2017, 2018), many more configurations have been considered with widely different dimensions; as a consequence, generally-valid values for Re-opt and De(opt) have been obtained. A full-factorial design of experiment (DOE) has been carried out by considering all possible combinations of geometrical parameters studied in Mansour et al. (2018). This leads to a total of 27 different coiled configurations with a wide variety of curvature ratio (0.033-0.214) and dimensionless pitch (0.034-0.273). Additionally, 47 different values of the Reynolds number have been considered within the laminar range of 5-4000, which corresponds to a Dean number range of De = 2-1850. This study involves at the end 1269 distinct numerical simulations. The results reveal that the mixing efficiency as function of the Reynolds number always exhibits two peaks at nearly similar Reynolds numbers. Average values of the two optimal ranges of Reynolds number and Dean number have been deduced from all simulations, leading to Re-opt,Re-1 approximate to 35 (De(opt,1) approximate to 10), and Re-opt,Re-2 approximate to 650 (De(opt,2) approximate to 185). Those can be used to get excellent mixing within any coiled configuration. The first optimal value leads to a much lower pressure drop and a slightly better mixing efficiency, and is therefore recommended to get optimal mixing and power consumption. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Mansour, Michael; Thevenin, Dominique; Zaehringer, Katharina] Univ Magdeburg Otto von Guericke, Lab Fluid Dynam & Tech Flows, Magdeburg, Germany.
   [Mansour, Michael] Helwan Univ, Fac Engn Mattaria, Mech Power Engn Dept, Cairo, Egypt.
   [Nigam, Krishna D. P.] Indian Inst Technol Delhi, New Delhi, India.
RP Mansour, M (reprint author), Univ Magdeburg Otto von Guericke, Lab Fluid Dynam & Tech Flows, Magdeburg, Germany.
EM michael.mansour@ovgu.de
OI Mansour, Michael/0000-0002-6404-9546
FU German Research Foundation (DFG)German Research Foundation (DFG) [SFB/TR
   63]; Egyptian government
FX This work is part of the Collaborative Research Center "Integrated
   Chemical Processes in Liquid Multiphase Systems" coordinated by the
   Technische Universitat Berlin. Financial support by the German Research
   Foundation (DFG) is gratefully acknowledged (SFB/TR 63). The Ph.D. work
   of Mr. Mansour was partially supported by a scholarship from the
   Egyptian government.
CR Jokiel M, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.09.221
   Jokiel M, 2017, CHEM ENG SCI, V170, P410, DOI 10.1016/j.ces.2017.01.027
   Kumar V, 2008, CHEM ENG J, V139, P284, DOI 10.1016/j.cej.2007.07.101
   Mansour M, 2018, CHEM ENG SCI, V177, P369, DOI 10.1016/j.ces.2017.11.031
   Mansour M, 2017, CHEM ENG SCI, V172, P250, DOI 10.1016/j.ces.2017.06.015
   Mansour M, 2020, CHEM ENG SCI, V214, DOI 10.1016/j.ces.2018.09.046
   Nigam K.D.P., 1986, ENCVCL FLUID MECH, V1, P675
   SCHMIDT EF, 1967, CHEM-ING-TECH, V39, P781, DOI 10.1002/cite.330391302
   Srinivasan P., 1968, CHEM ENG, V218, pCE113
NR 9
TC 4
Z9 4
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 382
EP 385
DI 10.1016/j.ces.2019.03.003
PG 4
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900035
DA 2020-05-12
ER

PT J
AU Wu, GW
   Cao, EH
   Ellis, P
   Constantinou, A
   Kuhn, S
   Gavriilidis, A
AF Wu, Gaowei
   Cao, Enhong
   Ellis, Peter
   Constantinou, Achilleas
   Kuhn, Simon
   Gavriilidis, Asterios
TI Continuous flow aerobic oxidation of benzyl alcohol on Ru/Al2O3 catalyst
   in a flat membrane microchannel reactor: An experimental and modelling
   study
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Ruthenium catalyst; Alcohol aerobic oxidation; Teflon AF-2400 membrane;
   Membrane reactor modelling
ID GAS-LIQUID; SELECTIVE OXIDATION; MOLECULAR-OXYGEN; MICROREACTORS;
   CHEMISTRY; TRANSPORT; AF
AB A flat Teflon AF-2400 membrane microchannel reactor was experimentally and theoretically investigated for aerobic oxidation of benzyl alcohol on a 5 wt% Ru/Al2O3 catalyst. The reactor consisted of gas and liquid channels (75 mm (L) x 3 mm (W) x 1 mm (D)), separated by a 0.07 mm thick semipermeable Teflon AF-2400 flat membrane, which allowed continuous supply of oxygen during the reaction and simultaneously avoided direct mixing of gaseous oxygen with organic reactants. A catalyst stability test was first carried out, and the experimental data obtained were used to estimate the kinetics of benzyl alcohol oxidation with a 2D reactor model. Using these kinetics, predictions from the 2D reactor model agreed well with the experimental data obtained at different liquid flow rates and oxygen pressures. The mass transfer and catalytic reaction in the membrane microchannel reactor were then theoretically studied by changing the membrane thickness, the liquid channel depth, and the reaction rate coefficient. Oxygen transverse mass transport in the catalyst bed was found to be the controlling process for the system investigated, and decreasing the liquid channel depth is suggested to improve the oxygen supply and enhance the benzyl alcohol conversion in the membrane reactor. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Wu, Gaowei; Cao, Enhong; Constantinou, Achilleas; Kuhn, Simon; Gavriilidis, Asterios] UCL, Dept Chem Engn, Torrington Pl, London WC1E 7JE, England.
   [Ellis, Peter] Johnson Matthey Technol Ctr, Reading RG4 9NH, Berks, England.
   [Constantinou, Achilleas] London South Bank Univ, Sch Engn, Div Chem & Petr Engn, 103 Borough Rd, London SE1 0AA, England.
   [Kuhn, Simon] Katholieke Univ Leuven, Dept Chem Engn, Celestijnenlaan 200F, B-3001 Leuven, Belgium.
RP Gavriilidis, A (reprint author), UCL, Dept Chem Engn, Torrington Pl, London WC1E 7JE, England.
EM a.gavriilidis@ucl.ac.uk
RI Wu, Gaowei/B-6877-2016; Kuhn, Simon/C-6177-2015; Gavriilidis,
   Asterios/G-7353-2011
OI Wu, Gaowei/0000-0001-7958-7323; Kuhn, Simon/0000-0002-2816-0060;
   Gavriilidis, Asterios/0000-0003-3508-5043; Constantinou,
   Achilleas/0000-0002-7763-9481
FU EPSRC, UKEngineering & Physical Sciences Research Council (EPSRC)
   [EP/L003279/1, EP/K038656/1]
FX Financial support by EPSRC, UK (grant EP/L003279/1) is gratefully
   acknowledged. The assistance of Matthew Rose (Johnson Matthey) with ICP
   analysis is appreciated. We thank Dr. Han Wu and the EPSRC CNIE research
   facility service (grant EP/K038656/1) at University College London for
   catalyst particle characterisation.
CR Aran HC, 2011, J MEMBRANE SCI, V381, P244, DOI 10.1016/j.memsci.2011.07.037
   Aran HC, 2011, CHEM ENG J, V169, P239, DOI 10.1016/j.cej.2010.11.005
   Bavykin DV, 2005, APPL CATAL A-GEN, V288, P175, DOI 10.1016/j.apcata.2005.04.042
   Brazier JB, 2017, REACT CHEM ENG, V2, P60, DOI 10.1039/c6re00208k
   Brzozowski M, 2015, ACCOUNTS CHEM RES, V48, P349, DOI 10.1021/ar500359m
   Constantinou A, 2015, ORG PROCESS RES DEV, V19, P1973, DOI 10.1021/acs.oprd.5b00220
   Davis SE, 2013, GREEN CHEM, V15, P17, DOI 10.1039/c2gc36441g
   Delgado JMPQ, 2006, HEAT MASS TRANSFER, V42, P279, DOI 10.1007/s00231-005-0019-0
   Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/NCHEM.1753, 10.1038/nchem.1753]
   Froment G.F., 2010, CHEM REACTOR ANAL DE
   Frossling N., 1938, GERL BEITR GEOPHYS, V52, P170
   Gavriilidis A, 2016, REACT CHEM ENG, V1, P595, DOI 10.1039/c6re00155f
   Gemoets HPL, 2016, CHEM SOC REV, V45, P83, DOI 10.1039/c5cs00447k
   Goethals M, 1999, J HAZARD MATER, V70, P93, DOI 10.1016/S0304-3894(99)00164-8
   Greene JF, 2015, ORG PROCESS RES DEV, V19, P858, DOI 10.1021/acs.oprd.5b00125
   Gutmann B, 2015, ANGEW CHEM INT EDIT, V54, P6688, DOI 10.1002/anie.201409318
   HAYDUK W, 1972, CHEM ENG SCI, V27, P1997, DOI 10.1016/0009-2509(72)87058-1
   Hessel V, 2005, IND ENG CHEM RES, V44, P9750, DOI 10.1021/ie0503139
   Hogg SR, 2012, ACS APPL MATER INTER, V4, P1440, DOI 10.1021/am201693e
   Hone CA, 2017, CHEMSUSCHEM, V10, P32, DOI 10.1002/cssc.201601321
   Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577
   Liu M, 2016, CHEM ENG J, V301, P35, DOI 10.1016/j.cej.2016.04.116
   Mallat T, 2004, CHEM REV, V104, P3037, DOI 10.1021/cr0200116
   Mallia CJ, 2016, ORG PROCESS RES DEV, V20, P327, DOI 10.1021/acs.oprd.5b00222
   Mannel DS, 2014, ORG PROCESS RES DEV, V18, P1503, DOI 10.1021/op5002676
   Mo YM, 2018, GREEN CHEM, V20, P3867, DOI 10.1039/c8gc01917g
   NAYAR S, 1973, J CHEM ENG DATA, V18, P356, DOI 10.1021/je60059a007
   Noel T, 2013, CHEMSUSCHEM, V6, P405, DOI 10.1002/cssc.201200913
   Pieber B, 2016, TOP ORGANOMETAL CHEM, V57, P97, DOI 10.1007/3418_2015_133
   Polyakov AM, 2003, J MEMBRANE SCI, V216, P241, DOI 10.1016/S0376-7388(03)00077-2
   REDDY KA, 1967, IND ENG CHEM FUND, V6, P77, DOI 10.1021/i160021a012
   Richardson J. F., 2002, CHEM ENG PARTICLE TE, P191
   Selinsek M, 2016, CATAL TODAY, V268, P85, DOI 10.1016/j.cattod.2016.02.003
   Tan XY, 2013, J CHEM TECHNOL BIOT, V88, P1771, DOI 10.1002/jctb.4155
   WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222
   Wu GW, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.10.023
   Wu GW, 2017, CHEM ENG TECHNOL, V40, P2346, DOI 10.1002/ceat.201700196
   Wu GW, 2015, IND ENG CHEM RES, V54, P4183, DOI 10.1021/ie5041176
   Yamaguchi K, 2003, CHEM-EUR J, V9, P4353, DOI 10.1002/chem.200304916
   Yamaguchi K, 2002, ANGEW CHEM INT EDIT, V41, P4538, DOI 10.1002/1521-3773(20021202)41:23<4538::AID-ANIE4538>3.0.CO;2-6
   Yang L, 2013, ORG PROCESS RES DEV, V17, P927, DOI 10.1021/op400085a
   Yang ZW, 2015, CATAL COMMUN, V65, P34, DOI 10.1016/j.catcom.2015.02.021
   Yaws C. L., 2014, TRANSPORT PROPERTIES, P131
   Zhang H, 2012, TOP CURR CHEM, V308, P307, DOI 10.1007/128_2011_249
   Zotova N, 2010, GREEN CHEM, V12, P2157, DOI 10.1039/c0gc00493f
NR 45
TC 5
Z9 5
U1 23
U2 99
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 386
EP 396
DI 10.1016/j.ces.2019.02.015
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900036
DA 2020-05-12
ER

PT J
AU Jorge, P
   Mendes, MAA
   Werzner, E
   Pereira, JMC
AF Jorge, Pedro
   Mendes, Miguel A. A.
   Werzner, Eric
   Pereira, Jose M. C.
TI Characterization of laminar flow in periodic open-cell porous structures
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Porous media; Periodic porous structures; CFD; Permeability correlation;
   Darcy-Forchheimer law
ID PRESSURE-DROP CORRELATION; FLUID-FLOW; NUMERICAL-SIMULATION; CIRCULAR
   CYLINDER; TURBULENT-FLOW; HEAT-TRANSFER; POROSITY; MEDIA; FOAMS;
   HYDRODYNAMICS
AB The present work deals with the numerical simulations of 3D incompressible flow through periodic porous structures, consisting of cubic cells with different strut geometry and structure tilting with respect to the flow direction. Simulation results are obtained for different porosities, while covering a range of Reynolds numbers from laminar-steady flow (Darcy regime) up to the transition to laminar-unsteady flow (moderate Forchheimer regime). These results are post-processed in order to characterize the influence of the periodic porous structures on the flow statistics related to the Darcy-Forchheimer law. Based on this analysis, along with 3D simulation results previously obtained for different random foams, correlations for the Darcy and Forchheimmer permeability coefficients are developed from a theoretical background, being expressed only as functions of the cell geometrical parameters and tortuosity estimation. However, the influences of flow tortuosity and cell orientation on the Darcy coefficient are found to cancel each other. The proposed correlation for the Darcy coefficient performs very well for both periodic and random porous structures, when compared with recent correlations available in the literature. The performance of the correlation proposed for the Forchheimmer coefficient is found to be satisfactory, however, different correlation constants were found for periodic and random structures. The proposed correlation for the Forchheimer permeability coefficient depends on the flow tortuosity inside the porous structure, which must be estimated either through 3D fluid flow simulations or using tortuosity correlations. In this respect, a correlation is proposed for predicting the flow tortuosity inside porous structures, as an alternative for avoiding 3D simulations. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Jorge, Pedro; Mendes, Miguel A. A.; Pereira, Jose M. C.] Univ Lisbon, Inst Super Tecn, IDMEC, Av Rovisco Pais 1, P-1049001 Lisbon, Portugal.
   [Werzner, Eric] Tech Univ Bergakad Freiberg, Inst Thermal Engn, Gustav Zeuner Str 7, D-09596 Freiberg, Germany.
RP Mendes, MAA; Pereira, JMC (reprint author), Univ Lisbon, Inst Super Tecn, IDMEC, Av Rovisco Pais 1, P-1049001 Lisbon, Portugal.
EM miguel.mendes@tecnico.ulisboa.pt; jose.chaves@tecnico.ulisboa.pt
RI Mendes, Miguel A. A./L-8372-2016
OI Mendes, Miguel A. A./0000-0001-9817-2334
FU FCT, through IDMEC, under LAETA [UID/EMS/50022/2019]; German Research
   Foundation (DFG)German Research Foundation (DFG)
FX This work was supported by FCT, through IDMEC, under LAETA, project
   UID/EMS/50022/2019. The third author thanks the German Research
   Foundation (DFG) for the financial support in the subproject B02 of the
   Collaborative Research Center 920.
CR Abendroth M, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700080
   Ahmed J, 2011, CHEM ENG SCI, V66, P4771, DOI 10.1016/j.ces.2011.06.040
   Alomar OR, 2014, INT J THERM SCI, V86, P408, DOI 10.1016/j.ijthermalsci.2014.08.003
   Bhattacharya A, 2002, INT J HEAT MASS TRAN, V45, P1017, DOI 10.1016/S0017-9310(01)00220-4
   Calado Andre, 2016, THESIS
   Darcy H.R.P.G., 1856, FONTAINES PUBLIQUES
   DENNIS SCR, 1970, J FLUID MECH, V42, P471, DOI 10.1017/S0022112070001428
   Dietrich B, 2012, CHEM ENG SCI, V74, P192, DOI 10.1016/j.ces.2012.02.047
   Duda A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036319
   Dukhan N, 2014, EXP THERM FLUID SCI, V57, P425, DOI 10.1016/j.expthermflusci.2014.06.011
   DUPLESSIS P, 1994, CHEM ENG SCI, V49, P3545, DOI 10.1016/0009-2509(94)00170-7
   Dybbs A, 1984, FUNDAMENTALS TRANSPO, P199, DOI [10.1007/978-94-009-6175-3_4, DOI 10.1007/978-94-009-6175-3_4]
   Edouard D, 2008, CHEM ENG J, V144, P299, DOI 10.1016/j.cej.2008.06.007
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   FORNBERG B, 1980, J FLUID MECH, V98, P819, DOI 10.1017/S0022112080000419
   Fourie JG, 2002, CHEM ENG SCI, V57, P2781
   Habisreuther P, 2009, CHEM ENG SCI, V64, P4943, DOI 10.1016/j.ces.2009.07.033
   HSU CT, 1990, INT J HEAT MASS TRAN, V33, P1587, DOI 10.1016/0017-9310(90)90015-M
   Inayat A, 2016, CHEM ENG J, V287, P704, DOI 10.1016/j.cej.2015.11.050
   JACKSON CP, 1987, J FLUID MECH, V182, P23, DOI 10.1017/S0022112087002234
   Jorge P, 2017, THESIS
   Kaviany M., 2012, MECH ENG SERIES
   Kevlahan NKR, 2001, EUR J MECH B-FLUID, V20, P333, DOI 10.1016/S0997-7546(00)01121-3
   Klumpp M, 2014, CHEM ENG J, V242, P364, DOI 10.1016/j.cej.2013.12.060
   Kumar P, 2014, TRANSPORT POROUS MED, V105, P57, DOI 10.1007/s11242-014-0358-8
   Kumar Prashant, 2017, J FLUIDS ENG, V139
   Kundu P, 2016, APPL MATH MODEL, V40, P9848, DOI 10.1016/j.apm.2016.06.043
   Kundu P, 2016, POWDER TECHNOL, V303, P278, DOI 10.1016/j.powtec.2016.09.037
   Kuwahara F, 2006, INT COMMUN HEAT MASS, V33, P411, DOI 10.1016/j.icheatmasstransfer.2005.12.011
   Lacroix M, 2007, CHEM ENG SCI, V62, P3259, DOI 10.1016/j.ces.2007.03.027
   Linnick MN, 2005, J COMPUT PHYS, V204, P157, DOI 10.1016/j.jcp.2004.09.017
   Lu TJ, 1998, ACTA MATER, V46, P3619, DOI 10.1016/S1359-6454(98)00031-7
   MACDONALD IF, 1979, IND ENG CHEM FUND, V18, P199, DOI 10.1021/i160071a001
   Mancin S, 2010, INT J HEAT MASS TRAN, V53, P3121, DOI 10.1016/j.ijheatmasstransfer.2010.03.015
   Matyka M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026306
   Nie ZW, 2017, INT J HEAT MASS TRAN, V113, P819, DOI 10.1016/j.ijheatmasstransfer.2017.05.119
   Ortona A., 2017, DESIGN ADDITIVE MANU
   Parthasarathy P, 2016, CHEM ENG SCI, V147, P91, DOI 10.1016/j.ces.2016.03.015
   Pereira JMC, 2010, FUEL, V89, P1928, DOI 10.1016/j.fuel.2010.01.011
   PRICE SJ, 1995, J SOUND VIB, V181, P85, DOI 10.1006/jsvi.1995.0127
   Regulski W, 2015, CHEM ENG SCI, V137, P320, DOI 10.1016/j.ces.2015.06.043
   Schlichting H., 1960, MCGRAW HILL SERIES M
   Tabor G, 2008, INT J MOD PHYS C, V19, P703, DOI 10.1142/S0129183108012509
   TRITTON DJ, 1959, J FLUID MECH, V6, P547, DOI 10.1017/S0022112059000829
   Voss S, 2013, P COMBUST INST, V34, P3335, DOI 10.1016/j.proci.2012.06.044
   Werzner E, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700240
   Woudberg S, 2016, CHEM ENG SCI, V148, P44, DOI 10.1016/j.ces.2016.03.013
   Ziada S., 1992, J FLUIDS STRUCT, V6
NR 48
TC 2
Z9 2
U1 2
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 397
EP 412
DI 10.1016/j.ces.2019.02.010
PG 16
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900037
DA 2020-05-12
ER

PT J
AU Deka, H
   Tsai, PH
   Biswas, G
   Dalal, A
   Ray, B
   Wang, AB
AF Deka, Hiranya
   Tsai, Pei-Hsun
   Biswas, Gautam
   Dalal, Amaresh
   Ray, Bahni
   Wang, An-Bang
TI Dynamics of formation and oscillation of non-spherical drops
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Drop; Pinch-off; Surface tension; Aspect ratio; Oscillation
ID COUPLED LEVEL SET; SURFACE-TENSION; LIQUID-DROPS; BREAKUP; FLUID; SHAPE;
   DEFORMATION; VOLUME; STABILITY; WEIGHT
AB Present study focuses on the shape of a drop during pinch-off and how the shape of a drop is affected by the flow parameters and different physical properties of the fluids. Both experimental and numerical investigations are performed to unveil the mechanism of non-spherical drop formation and the oscillatory motion of a drop after pinch-off. Numerical simulations are performed over a wide range of density ratios (0.001-0.9) and viscosity ratios (0.01-10) ranging from a gas-liquid system to a liquid-liquid system. The deformation of a drop at the incipience of pinch-off depends on the internal stress distribution within the drop. A larger velocity gradient inside the drop culminates in a stronger shear force within the drop leading to a non-spherical drop during pinch-off. We reveal that the shape of a drop remains either in prolate or in spherical form during pinch-off. A drop undergoes prolate-oblate-prolate oscillation while falling through the surrounding medium. The oscillatory motion is generated due to the local capillary pressure that develops across the drop surface because of the deformed shape of the drop after pinch-off. Present investigation reveals that the deformation of the drop because of the downward pull generated near the pinching region makes the drop shape non-spherical after pinch-off and initiates the oscillatory motion of the drop. The oscillation of a drop reduces substantially at higher relative strength of the viscous force. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Deka, Hiranya; Biswas, Gautam; Dalal, Amaresh] Indian Inst Technol Guwahati, Dept Mech Engn, Gauhati 781039, India.
   [Tsai, Pei-Hsun; Wang, An-Bang] Natl Taiwan Univ, Inst Appl Mech, Taipei 10617, Taiwan.
   [Ray, Bahni] Indian Inst Technol Delhi, Dept Mech Engn, Delhi 110016, India.
RP Biswas, G (reprint author), Indian Inst Technol Guwahati, Dept Mech Engn, Gauhati 781039, India.
EM gtm@iitg.ac.in
RI Ray, Bahni/X-6287-2019; RAY, BAHNI/N-3979-2015
CR Agrawal M, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.033111
   Ambravaneswaran B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.034501
   Ambravaneswaran B, 2000, PHYS REV LETT, V85, P5332, DOI 10.1103/PhysRevLett.85.5332
   Beale JC, 1999, ATOMIZATION SPRAY, V9, P623
   BECKER E, 1991, J FLUID MECH, V231, P189, DOI 10.1017/S0022112091003361
   Castrejon-Pita JR, 2015, P NATL ACAD SCI USA, V112, P4582, DOI 10.1073/pnas.1418541112
   Chakraborty I, 2016, INT J MULTIPHAS FLOW, V84, P54, DOI 10.1016/j.ijmultiphaseflow.2016.04.002
   Chen AU, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174501
   Clanet C, 1999, J FLUID MECH, V383, P307, DOI 10.1017/S0022112098004066
   Deka H, 2016, ASME INT MECH ENG C, V7
   Deka H, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5064516
   Deka H, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5022374
   Deka H, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4992124
   EGGERS J, 1994, J FLUID MECH, V262, P205, DOI 10.1017/S0022112094000480
   Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601
   Fakhari A, 2011, COMPUT FLUIDS, V40, P156, DOI 10.1016/j.compfluid.2010.08.020
   Feng JQ, 2011, ATMOS RES, V101, P480, DOI 10.1016/j.atmosres.2011.04.012
   Gallino G, 2016, J FLUID MECH, V786, DOI 10.1017/jfm.2015.650
   Gerlach D, 2006, INT J HEAT MASS TRAN, V49, P740, DOI 10.1016/j.ijheatmasstransfer.2005.07.045
   GOEDDE EF, 1970, J FLUID MECH, V40, P495, DOI 10.1017/S0022112070000289
   HADAMARD J., 1911, CR HEBD ACAD SCI, V152, P1735
   Han J, 1999, PHYS FLUIDS, V11, P3650, DOI 10.1063/1.870229
   Harkins WD, 1919, J AM CHEM SOC, V41, P499, DOI 10.1021/ja01461a003
   HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178
   HEIDEGER WJ, 1986, AICHE J, V32, P1372, DOI 10.1002/aic.690320815
   KOH CJ, 1989, PHYS FLUIDS A-FLUID, V1, P1309, DOI 10.1063/1.857359
   KOH CJ, 1990, PHYS FLUIDS A-FLUID, V2, P2103, DOI 10.1063/1.857796
   KOJIMA M, 1984, PHYS FLUIDS, V27, P19, DOI 10.1063/1.864511
   Lamb H, 1932, HYDRODYNAMICS
   Loth E, 2008, INT J MULTIPHAS FLOW, V34, P523, DOI 10.1016/j.ijmultiphaseflow.2007.08.010
   MICHAEL DH, 1981, ANNU REV FLUID MECH, V13, P189, DOI 10.1146/annurev.fl.13.010181.001201
   Pan Y, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2194936
   Ramaswamy S, 1999, J NON-NEWTON FLUID, V85, P127, DOI 10.1016/S0377-0257(98)00212-2
   Ray B, 2010, J FLUID MECH, V655, P72, DOI 10.1017/S0022112010000662
   Ray B, 2015, J FLUID MECH, V768, DOI 10.1017/jfm.2015.108
   Rayleigh L., 1899, LONDON EDINBURGH DUB, V48, P321, DOI [DOI 10.1080/14786449908621342, 10.1080/14786449908621342]
   RAYLEIGH L, 1879, P R SOC LONDON, V29, P71, DOI DOI 10.1098/RSPL.1879.0015
   RICHARDS JR, 1994, PHYS FLUIDS, V6, P2640, DOI 10.1063/1.868154
   RODRIGUEZ F, 1988, J COLLOID INTERF SCI, V121, P121, DOI 10.1016/0021-9797(88)90414-6
   Rybczyn ski W., 1911, Bulletin de l'Academie des Sciences de Cracovie, P40
   SCHULKES RMSM, 1994, J FLUID MECH, V278, P83, DOI 10.1017/S0022112094003629
   SHIELD TW, 1987, IBM J RES DEV, V31, P96, DOI 10.1147/rd.311.0096
   Sostarecz MC, 2003, J FLUID MECH, V497, P235, DOI 10.1017/S0022112003006621
   SQUIRE HB, 1953, BRIT J APPL PHYS, V4, P167, DOI 10.1088/0508-3443/4/6/302
   STERLING AM, 1975, J FLUID MECH, V68, P477, DOI 10.1017/S0022112075001772
   STONE HA, 1990, J FLUID MECH, V220, P161, DOI 10.1017/S0022112090003226
   Subramani HJ, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2185111
   Sussman M, 2000, J COMPUT PHYS, V162, P301, DOI 10.1006/jcph.2000.6537
   Tate T., 1864, PHILOS MAG, V27, P176, DOI DOI 10.1080/14786446408643645
   TAYLOR TD, 1964, J FLUID MECH, V18, P466, DOI 10.1017/S0022112064000349
   Thoraval MJ, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.033128
   Tomotika S., 1935, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V150, P322, DOI 10.1098/rspa.1935.0104
   Utada AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.094502
   Wanchoo RK, 2003, CHEM ENG PROCESS, V42, P387, DOI 10.1016/S0255-2701(02)00059-4
   Wang AB, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4822483
   WELLEK RM, 1966, AICHE J, V12, P854, DOI 10.1002/aic.690120506
   WILSON SDR, 1988, J FLUID MECH, V190, P561, DOI 10.1017/S0022112088001454
   Wilson WC, 2003, ANAT REC PART A, V272A, P491, DOI 10.1002/ar.a.10057
   Yildirim OE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1938227
   Zhang DF, 1997, PHYS FLUIDS, V9, P2234, DOI 10.1063/1.869346
   ZHANG XG, 1995, PHYS FLUIDS, V7, P1184, DOI 10.1063/1.868577
   Zou J, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3703674
NR 62
TC 2
Z9 2
U1 3
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 413
EP 423
DI 10.1016/j.ces.2019.03.008
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900038
DA 2020-05-12
ER

PT J
AU Zenner, A
   Fiaty, K
   Belliere-Baca, V
   Rocha, C
   Gauthier, G
   Edouard, D
AF Zenner, A.
   Fiaty, K.
   Belliere-Baca, V
   Rocha, C.
   Gauthier, G.
   Edouard, D.
TI Effective heat transfers in packed bed: Experimental and model
   investigation
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Fixed bed reactor; Heat transfer; Thermal conductivity;
   Pseudo-homogeneous model; Catalyst supports; Particle shapes
ID RADIAL THERMAL-CONDUCTIVITY; GAS-FLOW; EXPERIMENTAL VALIDATION;
   POROUS-MEDIA; REACTOR; PACKINGS; WALL; TUBES
AB In industry, many heterogeneous solid/gas reactions are exothermic. Consequently, the radial heat transfer properties can be an important key for the process optimization. In this context, thermal tests were conducted in an innovative laboratory pilot. Radial temperature profiles are measured between a central hot-wire and the cooling jacket of the tube. Two models were presented in order to estimate the heat transfer coefficients from the experimental data. The results are discussed and compared with the main literature correlations. The influence of the particle shapes on heat transfers and the pressure drop is investigated. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Zenner, A.; Fiaty, K.; Edouard, D.] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, LAGEPP UMR 5007, 43 Blvd 11 Novembre 1918, F-69100 Villeurbanne, France.
   [Zenner, A.; Belliere-Baca, V] ADISSEO France SAS, Antony Parc 2-10, Antony, France.
   [Rocha, C.; Gauthier, G.] SOLVAY, Res & Innovat, Brussels, Belgium.
RP Edouard, D (reprint author), Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, LAGEPP UMR 5007, 43 Blvd 11 Novembre 1918, F-69100 Villeurbanne, France.
EM david.edouard@univ-lyon1.fr
FU Adisseo
FX The authors gratefully acknowledge J.P. Valour (LAGEP), S. Urbaniak
   (LAGEP) and F. Bornette (LGPC) who helped for the building and the
   understanding of the pilot. The authors would like to thanks Sicat and
   NorPro for providing samples, and Adisseo for scientific and financial
   support.
CR Bartholomew CH, 2001, APPL CATAL A-GEN, V212, P17, DOI 10.1016/S0926-860X(00)00843-7
   BAUER R, 1978, INT CHEM ENG, V18, P181
   Bey O, 2001, INT J THERM SCI, V40, P152, DOI 10.1016/S1290-0729(00)01204-7
   BHATTACHARYYA D, 1975, CHEM ENG SCI, V30, P293, DOI 10.1016/0009-2509(75)80079-0
   Bianchi E, 2012, CHEM ENG J, V198, P512, DOI 10.1016/j.cej.2012.05.045
   BUNNELL DG, 1949, IND ENG CHEM, V41, P1977, DOI 10.1021/ie50477a033
   Calverley EM, 2013, CHEM ENG SCI, V90, P170, DOI 10.1016/j.ces.2012.12.017
   Chueh CC, 2014, INT J HEAT MASS TRAN, V71, P183, DOI 10.1016/j.ijheatmasstransfer.2013.12.041
   De Wasch A. P., 1971, Chemical Engineering Science, V26, P629, DOI 10.1016/0009-2509(71)86006-2
   DIXON AG, 1988, CAN J CHEM ENG, V66, P705, DOI 10.1002/cjce.5450660501
   Dixon AG, 2008, CHEM ENG SCI, V63, P2219, DOI 10.1016/j.ces.2008.01.017
   Dixon AG, 2012, CHEM ENG J, V200, P344, DOI 10.1016/j.cej.2012.06.065
   Dixon AG, 2012, CAN J CHEM ENG, V90, P507, DOI 10.1002/cjce.21630
   Edouard D, 2010, INT J HEAT MASS TRAN, V53, P3807, DOI 10.1016/j.ijheatmasstransfer.2010.04.033
   Eisfeld B., 2001, CHEM ENG SCI, V42, P2163
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   Forzatti P, 1999, CATAL TODAY, V52, P165, DOI 10.1016/S0920-5861(99)00074-7
   GLASER MB, 1958, AICHE J, V4, P63, DOI 10.1002/aic.690040113
   Gunn D. J., 1987, RADIAL HEAT TRANSFER
   Guo XY, 2014, CHEM ENG SCI, V107, P266, DOI 10.1016/j.ces.2013.12.032
   HENNECKE FW, 1973, CHEM-ING-TECH, V45, P277, DOI 10.1002/cite.330450510
   MACDONALD IF, 1979, IND ENG CHEM FUND, V18, P199, DOI 10.1021/i160071a001
   Nemec D, 2005, CHEM ENG SCI, V60, P6947, DOI 10.1016/j.ces.2005.05.068
   Pangarkar K, 2009, CATAL TODAY, V147, pS2, DOI 10.1016/j.cattod.2009.07.035
   Romkes SJP, 2003, CHEM ENG J, V96, P3, DOI 10.1016/j.cej.2003.08.026
   Saber M., 2012, FOAM CATALYST, P15011
   Sadeghi E, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/12/125406
   Smirnov EI, 2004, CHEM ENG RES DES, V82, P293, DOI 10.1205/026387604772992891
   Stasiek J, 1996, INT J HEAT MASS TRAN, V39, P149, DOI 10.1016/S0017-9310(96)85013-7
   van Antwerpen W, 2010, NUCL ENG DES, V240, P1803, DOI 10.1016/j.nucengdes.2010.03.009
   Vatcha SR, 1998, COLLOID SURFACE A, V133, P99, DOI 10.1016/S0927-7757(97)00123-4
   Wen DS, 2006, CHEM ENG SCI, V61, P3532, DOI 10.1016/j.ces.2005.12.027
   XU YR, 1992, J AM CERAM SOC, V75, P325, DOI 10.1111/j.1151-2916.1992.tb08182.x
   YAGI S, 1960, AICHE J, V6, P97, DOI 10.1002/aic.690060119
   YAGI S, 1957, AICHE J, V3, P373, DOI 10.1002/aic.690030317
   ZEHNER P, 1970, CHEM-ING-TECH, V42, P933, DOI 10.1002/cite.330421408
   Zhu XW, 2014, CHEM ENG J, V247, P75, DOI 10.1016/j.cej.2014.02.089
   Zhu XW, 2010, IND ENG CHEM RES, V49, P10682, DOI 10.1021/ie1004527
NR 38
TC 0
Z9 0
U1 3
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 424
EP 436
DI 10.1016/j.ces.2019.02.028
PG 13
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900039
DA 2020-05-12
ER

PT J
AU Cheng, WK
   Ye, Y
   Jiang, SX
   Wang, JJ
   Gu, XP
   Feng, LF
AF Cheng, Wenkai
   Ye, Yang
   Jiang, Shuxian
   Wang, Jiajun
   Gu, Xueping
   Feng, Lianfang
TI Mixing intensification in a horizontal self-cleaning twin-shaft kneader
   with a highly viscous Newtonian fluid
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Computational fluid dynamics (CFD); Mixing; Finite element method (FEM);
   Kneader; Particle tracking
ID NUMERICAL-SIMULATION; FLOW
AB Mixing process of a highly viscous Newtonian fluid in a horizontal self-cleaning twin-shaft kneader was simulated by means of finite element method combined with mesh superposition technique. Particle tracking technique was carried out based on the velocity profiles to evaluate the mixing performance. There exists a strong intermeshing interaction between the kneading bars mounted on the rotating shafts in the overlapping zone, which can disrupt the cluster and promote the material exchange in the angular position. The intermeshing kneading bars allow the infinitesimal lines associated with the material points to reorient and continue to stretch. The periodic intermeshing leads to self-cleaning and chaotic mixing characteristics. The horizontal twin-shaft kneader is efficient for mixing highly viscous fluids due to the intermeshing of kneading bars. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Cheng, Wenkai; Ye, Yang; Jiang, Shuxian; Wang, Jiajun; Gu, Xueping; Feng, Lianfang] Zhejiang Univ, Coll Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China.
RP Wang, JJ (reprint author), Zhejiang Univ, Coll Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China.
EM jiajunwang@zju.edu.cn
FU National Key R&D Program of China [2017YFB0307702]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [21276222]; State Key Laboratory of Chemical Engineering [SKL-ChE-16D02]
FX This work was supported financially by the National Key R&D Program of
   China (2017YFB0307702), the National Natural Science Foundation of China
   (21276222), and the State Key Laboratory of Chemical Engineering
   (SKL-ChE-16D02). The authors gratefully acknowledge Prof. Jean-Pierre
   Corriou (Lorraine Universite, France) for his suggestions to improve
   this paper.
CR Avalosse T, 1996, MACROMOL SYMP, V112, P91, DOI 10.1002/masy.19961120114
   Belkhiria S., 2008, U. S. Patent, Patent No. [7,398,606, 7398606]
   Connelly RK, 2007, J FOOD ENG, V79, P956, DOI 10.1016/j.jfoodeng.2006.03.017
   Connelly RK, 2006, ADV POLYM TECH, V25, P182, DOI 10.1002/adv.20071
   Connelly RK, 2006, AICHE J, V52, P3383, DOI 10.1002/aic.10960
   DANCKWERTS PV, 1952, APPL SCI RES, V3, P279, DOI 10.1007/BF03184936
   Dotsch W., 1995, U. S. Patent, Patent No. [5,407,266, 5407266]
   Eitzlmayr A, 2017, AICHE J, V63, P2451, DOI 10.1002/aic.15607
   Eitzlmayr A, 2015, CHEM ENG SCI, V134, P861, DOI 10.1016/j.ces.2015.04.055
   Eitzlmayr A, 2015, CHEM ENG SCI, V134, P880, DOI 10.1016/j.ces.2015.05.035
   Fleury P., 2014, U. S. Patent, Patent No. [8,678,641, 8678641]
   Fleury P., 2013, U. S. Patent, Patent No. [8,376,607, 8376607]
   Jongen T, 2000, AICHE J, V46, P2140, DOI 10.1002/aic.690461107
   Ottino J.M., 1989, KINEMATICS MIXING ST
   Palmer D., 2000, U. S. Patent, Patent No. [6,039,469, 6039469]
   Robinson M, 2012, CHEM ENG SCI, V84, P382, DOI 10.1016/j.ces.2012.08.044
   Salahudeen SA, 2011, CHEM ENG SCI, V66, P2502, DOI 10.1016/j.ces.2011.02.017
   Schebesta K., 1997, U. S. Patent, Patent No. [5,658,075, 5658075]
   Schebesta K., 1997, U. S. Patent, Patent No. [5,669,710, 5669710]
   Seck O, 2010, MACROMOL SYMP, V289, P155, DOI 10.1002/masy.200900020
   Stueven U., 2011, U. S. Patent, Patent No. [8,070,351, 8070351]
   Wittek P, 2018, CHEM ENG SCI, V187, P256, DOI 10.1016/j.ces.2018.05.007
NR 22
TC 1
Z9 1
U1 7
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 437
EP 447
DI 10.1016/j.ces.2019.03.005
PG 11
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900040
DA 2020-05-12
ER

PT J
AU Shrestha, S
   Kuang, SB
   Yu, AB
   Zhou, ZY
AF Shrestha, Siddhartha
   Kuang, Shibo
   Yu, Aibing
   Zhou, Zongyan
TI Particle shape effect on bubble dynamics in central air jet pseudo-2D
   fluidized beds: A CFD-DEM study
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Bubble properties; Ellipsoids; Fluidization; Single jet; CFD-DEM
ID PARTICULATE SYSTEMS; GAS FLUIDIZATION; SINGLE ORIFICE; THEORETICAL
   DEVELOPMENTS; NONSPHERICAL PARTICLES; DRAG COEFFICIENT; HEAT-TRANSFER;
   2-PHASE FLOW; SIMULATION; BEHAVIOR
AB Bubbles considerably influence the characteristics of gas-solid fluidized bed, hence play an important role in determining process performance. This paper presents a CFD-DEM study on the effect of particle shape on the bed microstructure and bubble properties in a pseudo-2D bubbling gas-solid fluidized bed, operated with a continuous central jet. The bubble formation process is successfully generated, where bubbles rise through the bed and burst at the top of the bed. The numerical results show that ellipsoids have slightly different flow patterns from those of spheres. However, the mechanisms of bubble splitting and coalescence are found strongly dependent on particle shape. For spheres, the bubble trajectories mainly follow the bed centreline, whereas the bubbles for ellipsoids are widely distributed on both sides of the bed centreline. This result suggests that the lateral drift of bubbles is high for ellipsoids because such particles prefer to orient their longest major axis in the direction of the fluid flow. At the lower part of the bed, both gas and particle velocity profiles are found axially similar to a Gaussian distribution. In contrast, at the upper part of the bed, their peaks become flatter and broader for ellipsoids. Additionally, the bubble equivalent diameters are higher for ellipsoids while bubbles become more circular for spheres. Both bubble frequency and bubble velocity for ellipsoids are lower than spheres. The results obtained from this study can improve the understanding of bubble dynamics in the fluidization of non-spherical particles. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Shrestha, Siddhartha; Kuang, Shibo; Yu, Aibing; Zhou, Zongyan] Monash Univ, Lab Simulat & Modelling Particulate Syst, Dept Chem Engn, Clayton, Vic 3800, Australia.
RP Zhou, ZY (reprint author), Monash Univ, Lab Simulat & Modelling Particulate Syst, Dept Chem Engn, Clayton, Vic 3800, Australia.
EM zongyan.zhou@monash.edu
RI Kuang, Shibo/H-4935-2013; Yu, Aibing/A-6054-2008
OI Kuang, Shibo/0000-0002-2969-9420; Yu, Aibing/0000-0002-5139-0657; Zhou,
   Zongyan/0000-0002-0480-7173
FU Australian Research Council Industrial Transformation Research Hubs
   SchemeAustralian Research Council [IH140100035]; Australian
   GovernmentAustralian Government
FX The authors are grateful for the financial support from Australian
   Research Council Industrial Transformation Research Hubs Scheme (Project
   Number IH140100035). This research was undertaken with the assistance of
   resources from the National Computational Infrastructure (NCI), which is
   supported by the Australian Government.
CR Amiri Z, 2017, POWDER TECHNOL, V305, P739, DOI 10.1016/j.powtec.2016.10.055
   Amiri Z, 2016, AICHE J, V62, P1430, DOI 10.1002/aic.15150
   ANDERSON TB, 1967, IND ENG CHEM FUND, V6, P527, DOI 10.1021/i160024a007
   Boer L, 2018, POWDER TECHNOL, V329, P332, DOI 10.1016/j.powtec.2018.01.083
   Busciglio A, 2008, CHEM ENG J, V140, P398, DOI 10.1016/j.cej.2007.11.015
   Busciglio A, 2009, CHEM ENG J, V148, P145, DOI 10.1016/j.cej.2008.11.010
   Caicedo GR, 2003, CHEM ENG PROCESS, V42, P9, DOI 10.1016/S0255-2701(02)00039-9
   CARAM HS, 1986, CHEM ENG SCI, V41, P1445, DOI 10.1016/0009-2509(86)85230-7
   CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47
   Davidson Harrison, 1963, FLUIDIZED PARTICLES
   Davidson J., 1960, T I CHEM ENGRS, V38, P335
   Davidson J. F., 1961, T I CHEM ENG-LOND, V39, P223
   Dziugys A, 2001, GRANUL MATTER, V3, P231, DOI 10.1007/PL00010918
   Enwald H, 1996, INT J MULTIPHAS FLOW, V22, P21, DOI 10.1016/S0301-9322(96)90004-X
   ERGUN S, 1952, CHEM ENG PROG, V48, P89
   EVANS DJ, 1977, MOL PHYS, V34, P327, DOI 10.1080/00268977700101761
   Fabich HT, 2017, CHEM ENG SCI, V172, P476, DOI 10.1016/j.ces.2017.07.003
   Feng YQ, 2004, IND ENG CHEM RES, V43, P8378, DOI 10.1021/ie049387v
   Feng YQ, 2004, AICHE J, V50, P1713, DOI 10.1002/aic.10169
   FILLA M, 1983, CAN J CHEM ENG, V61, P370, DOI 10.1002/cjce.5450610317
   Gan JQ, 2017, CHEM ENG SCI, V163, P11, DOI 10.1016/j.ces.2017.01.020
   Gan JQ, 2016, CHEM ENG SCI, V156, P64, DOI 10.1016/j.ces.2016.09.017
   Gan JQ, 2016, AICHE J, V62, P62, DOI 10.1002/aic.15050
   GANSER GH, 1993, POWDER TECHNOL, V77, P143, DOI 10.1016/0032-5910(93)80051-B
   Gidaspow D., 1994, MULTIPHASE FLOW FLUI
   Gil M, 2014, FUEL, V116, P328, DOI 10.1016/j.fuel.2013.08.011
   Goldstein H, 1980, CLASSICAL MECH, P426
   HAIDER A, 1989, POWDER TECHNOL, V58, P63, DOI 10.1016/0032-5910(89)80008-7
   HALOW JS, 1992, POWDER TECHNOL, V69, P255, DOI 10.1016/0032-5910(92)80017-Q
   Harrison D, 1961, CHEM ENG RES DES, V39, P409
   He YR, 2016, POWDER TECHNOL, V287, P264, DOI 10.1016/j.powtec.2015.10.012
   Hilton JE, 2010, CHEM ENG SCI, V65, P1584, DOI 10.1016/j.ces.2009.10.028
   Holzer A, 2008, POWDER TECHNOL, V184, P361, DOI 10.1016/j.powtec.2007.08.021
   Hou QF, 2012, CHEM ENG SCI, V84, P449, DOI 10.1016/j.ces.2012.08.051
   Hou QF, 2012, AICHE J, V58, P1422, DOI 10.1002/aic.12700
   Huang JK, 2018, CHEM ENG RES DES, V136, P687, DOI 10.1016/j.cherd.2018.04.028
   Kruggel-Emden H, 2016, PARTICUOLOGY, V29, P1, DOI 10.1016/j.partic.2016.01.004
   Kuang SB, 2008, IND ENG CHEM RES, V47, P470, DOI 10.1021/ie070991q
   KUIPERS JAM, 1991, CHEM ENG SCI, V46, P2881, DOI 10.1016/0009-2509(91)85157-S
   Kunii D., 1991, FLUIDIZATION ENG
   Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, P269, DOI 10.1016/0045-7825(74)90029-2
   Li TW, 2012, PARTICUOLOGY, V10, P532, DOI 10.1016/j.partic.2012.02.006
   Lim KS, 1995, INT J MULTIPHAS FLOW, V21, P141, DOI 10.1016/0301-9322(95)00038-Y
   LIN XS, 1995, INT J NUMER ANAL MET, V19, P653, DOI 10.1002/nag.1610190905
   Lu G, 2015, CHEM ENG SCI, V127, P425, DOI 10.1016/j.ces.2014.11.050
   Lu YJ, 2015, CHEM ENG J, V274, P123, DOI 10.1016/j.cej.2015.03.117
   Lungu M, 2015, POWDER TECHNOL, V269, P139, DOI 10.1016/j.powtec.2014.08.067
   Muller CR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154504
   NGUYEN XT, 1972, CHEM ENG SCI, V27, P1748, DOI 10.1016/0009-2509(72)80089-7
   Nieuwland JJ, 1996, CHEM ENG SCI, V51, P4087, DOI 10.1016/0009-2509(96)00260-6
   Nosrati K, 2017, POWDER TECHNOL, V305, P620, DOI 10.1016/j.powtec.2016.10.051
   Olaofe OO, 2011, CHEM ENG SCI, V66, P2764, DOI 10.1016/j.ces.2011.03.030
   Oschmann T, 2014, POWDER TECHNOL, V258, P304, DOI 10.1016/j.powtec.2014.03.046
   Pandit JK, 2007, CHEM ENG SCI, V62, P159, DOI 10.1016/j.ces.2006.08.013
   Rangarajan D, 2013, POWDER TECHNOL, V242, P74, DOI 10.1016/j.powtec.2013.01.014
   Rong LW, 2012, ADV POWDER TECHNOL, V23, P398, DOI 10.1016/j.apt.2011.05.008
   ROWE PN, 1979, T I CHEM ENG-LOND, V57, P194
   Shrestha S, 2018, POWDER TECHNOL, V339, P70, DOI 10.1016/j.powtec.2018.08.001
   Shrestha Siddhartha, 2017, EPJ Web of Conferences, V140, DOI 10.1051/epjconf/201714015026
   Singh R, 2006, SOL ENERGY, V80, P760, DOI 10.1016/j.solener.2005.07.001
   Sommerfeld M., 2008, TRANSPORT CHARACTERI
   Tan LH, 2017, PARTICUOLOGY, V33, P80, DOI 10.1016/j.partic.2016.09.008
   Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016
   TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7
   TSUKADA M, 1990, POWDER TECHNOL, V63, P69, DOI 10.1016/0032-5910(90)80008-M
   Utikar RP, 2007, CHEM ENG SCI, V62, P167, DOI 10.1016/j.ces.2006.08.037
   Verma V, 2014, CHEM ENG J, V245, P217, DOI 10.1016/j.cej.2014.02.026
   Wang JW, 2009, IND ENG CHEM RES, V48, P5567, DOI 10.1021/ie900247t
   Wang TY, 2016, POWDER TECHNOL, V301, P927, DOI 10.1016/j.powtec.2016.07.005
   Xu BH, 1997, CHEM ENG SCI, V52, P2785, DOI 10.1016/S0009-2509(97)00081-X
   Yang WJ, 2014, IND ENG CHEM RES, V53, P8245, DOI 10.1021/ie404158e
   Zhang K, 2012, CHEM ENG SCI, V68, P108, DOI 10.1016/j.ces.2011.09.018
   Zhong WQ, 2016, POWDER TECHNOL, V302, P108, DOI 10.1016/j.powtec.2016.07.010
   Zhou Z., 2009, P 7 INT C CFD MIN PR
   Zhou ZY, 2011, CHEM ENG SCI, V66, P6128, DOI 10.1016/j.ces.2011.08.041
   Zhou ZY, 2009, AICHE J, V55, P868, DOI 10.1002/aic.11823
   Zhou ZY, 2011, IND ENG CHEM RES, V50, P9787, DOI 10.1021/ie200862n
   Zhu HP, 2007, CHEM ENG SCI, V62, P3378, DOI 10.1016/j.ces.2006.12.089
   Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006
NR 79
TC 8
Z9 8
U1 11
U2 57
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 448
EP 466
DI 10.1016/j.ces.2019.02.030
PG 19
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900041
DA 2020-05-12
ER

PT J
AU Zhang, J
   Dong, KJ
   Luo, WM
AF Zhang, Jun
   Dong, Kaijun
   Luo, Weimin
TI PdCl2-catalyzed hydrodeoxygenation of 5-hydroxymethylfurfural into
   2,5-dimethylfuran at room-temperature using polymethylhydrosiloxane as
   the hydrogen donor
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE 5-hydroxymethylfurfural; Polymethylhydrosiloxane; Room temperature;
   2,5-dimethylfuran
ID CATALYTIC TRANSFER HYDROGENATION; HIGH-YIELD PRODUCTION; ONE-POT;
   EFFICIENT; DIMETHYLFURAN; ISOMERIZATION; CONVERSION; REDUCTION;
   RUTHENIUM; OXIDATION
AB A facile and mild method for the catalytic production of 2,5-dimethylfuran (DMF) from 5-hydroxymethylfurfural (HMF) was developed, which utilized commercial PdCl2 as the catalyst together with the green, non-toxic and low-cost hydride source, polymethylhydrosiloxane (PMHS). A synergistic effect among hydrogen donor, in situ generated metallic Pd-0 species and acid site HCl in the reaction played a key role in DMF formation. Gratifyingly, the desirable yield of hydrodeoxygenation product DMF as high as 89.7% from HMF was attained at room temperature (298 K) in 0.5 h. Meanwhile, biomass derived sugars also could be converted into DMF in relative high efficiency via a one-pot reaction in the present system. A plausible pathway for the hydrodeoxygenation of HMF into DMF in the present system was also proposed. The study thus highlights a new perspective for a simple, green, and efficient hydrodeoxygenation of biomass derivatives under milder conditions, employing a readily available, inexpensive and practical catalytic system of PdCl2-PMHS-ethanol, but without any external hydrogen supplies and pre-reduction treatments. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Dong, Kaijun] Chinese Acad Sci, Guangzhou Inst Energy Convers, Guangzhou 510640, Guangdong, Peoples R China.
   CAS Key Lab Renewable Energy, Guangzhou 510640, Guangdong, Peoples R China.
   Guangdong Prov Key Lab New & Renewable Energy Res, Guangzhou 510640, Guangdong, Peoples R China.
RP Dong, KJ (reprint author), Chinese Acad Sci, Guangzhou Inst Energy Convers, Guangzhou 510640, Guangdong, Peoples R China.
EM dongkj@ms.giec.ac.cn
FU Natural Science Foundation of Guangdong Province, ChinaNational Natural
   Science Foundation of Guangdong Province [2018A030313856,
   2016A030313173]; Science and Technology Planning Project of Guangdong
   Province, China [2017A050501044]
FX This work was supported by Natural Science Foundation of Guangdong
   Province, China (2018A030313856, 2016A030313173), and Science and
   Technology Planning Project of Guangdong Province, China
   (2017A050501044).
CR Boukherroub R, 1996, ORGANOMETALLICS, V15, P1508, DOI 10.1021/om950514k
   Drabo P, 2018, CATAL COMMUN, V107, P24, DOI 10.1016/j.catcom.2018.01.011
   Friberg I, 2018, APPL CATAL B-ENVIRON, V231, P242, DOI 10.1016/j.apcatb.2018.03.003
   Gilkey MJ, 2016, ACS CATAL, V6, P1420, DOI 10.1021/acscatal.5b02171
   Goto H, 2017, APPL CATAL A-GEN, V548, P122, DOI 10.1016/j.apcata.2017.06.041
   Guo B, 2017, CHINESE J CHEM, V35, P1529, DOI 10.1002/cjoc.201700084
   Gyngazova MS, 2017, CHEM ENG SCI, V173, P455, DOI 10.1016/j.ces.2017.07.045
   Hao WW, 2016, GREEN CHEM, V18, P1080, DOI 10.1039/c5gc01221j
   Huang YB, 2014, CHEMSUSCHEM, V7, P1068, DOI 10.1002/cssc.201301356
   Jae J, 2013, CHEMSUSCHEM, V6, P1158, DOI 10.1002/cssc.201300288
   Kong X, 2017, ACS SUSTAIN CHEM ENG, V5, P11280, DOI 10.1021/acssuschemeng.7b01813
   Kong X, 2015, ACS CATAL, V5, P5914, DOI 10.1021/acscatal.5b01080
   Kong X, 2015, GREEN CHEM, V17, P2504, DOI 10.1039/c5gc00062a
   Kumalaputri AJ, 2014, CHEMSUSCHEM, V7, P2266, DOI 10.1002/cssc.201402095
   Li H, 2017, APPL CATAL B-ENVIRON, V215, P18, DOI 10.1016/j.apcatb.2017.05.039
   Li H, 2017, GREEN CHEM, V19, P2101, DOI 10.1039/c7gc00580f
   Li RD, 2017, FUEL PROCESS TECHNOL, V167, P363, DOI 10.1016/j.fuproc.2017.07.013
   Liu XL, 2017, ENERG FUEL, V31, P12108, DOI 10.1021/acs.energyfuels.7b01622
   Nie GK, 2018, CHEM ENG SCI, V180, P64, DOI 10.1016/j.ces.2018.01.024
   Nishimura S, 2014, CATAL TODAY, V232, P89, DOI 10.1016/j.cattod.2013.10.012
   Oozeerally R, 2018, CHEMCATCHEM, V10, P706, DOI 10.1002/cctc.201701825
   Pasini T, 2014, J CATAL, V317, P206, DOI 10.1016/j.jcat.2014.06.023
   Priecel P, 2018, IND ENG CHEM RES, V57, P1991, DOI 10.1021/acs.iecr.7b04715
   Rahaim RJ, 2011, ORG LETT, V13, P584, DOI 10.1021/ol102757v
   Roman-Leshkov Y, 2007, NATURE, V447, P982, DOI 10.1038/nature05923
   Scholz D, 2014, CHEMSUSCHEM, V7, P268, DOI 10.1002/cssc.201300774
   Siddiqui N, 2018, SUSTAIN ENERG FUELS, V2, P191, DOI 10.1039/c7se00363c
   Thananatthanachon T, 2010, ANGEW CHEM INT EDIT, V49, P6616, DOI 10.1002/anie.201002267
   Tran LS, 2017, COMBUST FLAME, V181, P251, DOI 10.1016/j.combustflame.2017.03.030
   Valentini F, 2018, CHEMCATCHEM, V10, P1277, DOI 10.1002/cctc.201701922
   Venezia A. M, 2011, APPL CATAL A-GEN, V211, P167
   Volkov A, 2015, ANGEW CHEM INT EDIT, V54, P5122, DOI 10.1002/anie.201411059
   Wang BW, 2017, J ENERGY CHEM, V26, P799, DOI 10.1016/j.jechem.2017.04.008
   Wang LY, 2017, J BIOBASED MATER BIO, V11, P562, DOI 10.1166/jbmb.2017.1714
   Xiao HL, 2017, FUEL, V192, P53, DOI 10.1016/j.fuel.2016.12.007
   Yang PP, 2016, J ENERGY CHEM, V25, P1015, DOI 10.1016/j.jechem.2016.08.008
   Yang PP, 2015, CATAL COMMUN, V66, P55, DOI 10.1016/j.catcom.2015.02.014
   Zhang J, 2018, FUEL, V234, P664, DOI 10.1016/j.fuel.2018.07.060
   Zhang J, 2017, ACS SUSTAIN CHEM ENG, V5, P5982, DOI 10.1021/acssuschemeng.7b00778
   Zhang J, 2012, CHEMCATCHEM, V4, P1230, DOI 10.1002/cctc.201200113
   Zhu YF, 2015, CATAL SCI TECHNOL, V5, P4208, DOI 10.1039/c5cy00700c
NR 41
TC 2
Z9 2
U1 14
U2 93
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 467
EP 474
DI 10.1016/j.ces.2019.03.011
PG 8
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900042
DA 2020-05-12
ER

PT J
AU Williams, YO
   Roas-Escalona, N
   Rodriguez-Lopez, G
   Villa-Torrealba, A
   Toro-Mendoza, J
AF O'Neil Williams, Yhan
   Roas-Escalona, Nelmary
   Rodriguez-Lopez, Gieberth
   Villa-Torrealba, Andrea
   Toro-Mendoza, Jhoan
TI Modeling droplet coalescence kinetics in microfluidic devices using
   population balances
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE O/W emulsion; Coalescence kinetics; Coalescence time; Population balance
   model
ID HUMAN BLOOD-PLATELETS; DISAGGREGATION KINETICS; QUADRATURE METHOD; FLOW;
   AGGREGATION; DISPERSIONS; DYNAMICS; EQUATION; BREAKUP
AB The coalescence kinetics of oil-in-water emulsions in a wide range of properties and flow microfluidic conditions is quantified. The conditions were chosen in order to mimic situations found in industrial processes involving liquid-liquid dispersions. With that aim, a numerical scheme based on population balance equations is proposed, applied, and validated by comparison to microfluidic experiments reported in the literature. A coalescence efficiency model accounting for colloidal and hydrodynamic interactions, and interface mobility is incorporated using the Smoluchowski collision kernel. The latter assures the accurate estimation of the droplet size evolution which governs the interfacial area and rate of mass transfer. Besides, the combined effect of interfacial tension and oil viscosity on the coalescence kinetics is properly quantified with one single fitting parameter. From the kinetics, the estimated coalescence time increases as the shear rate and volume fraction of the dispersed phase diminish. The close agreement of our results with the experimental findings substantiates the accuracy and wider application of the methodology here described as a diagnostic tool beneficial to industrial process design and control. (C) 2019 Published by Elsevier Ltd.
C1 [O'Neil Williams, Yhan; Roas-Escalona, Nelmary; Rodriguez-Lopez, Gieberth; Villa-Torrealba, Andrea; Toro-Mendoza, Jhoan] Inst Venezolano Invest Cient, CEIF, Lab Dispers & Interfases, Caracas 1020A, Venezuela.
RP Williams, YO; Toro-Mendoza, J (reprint author), Inst Venezolano Invest Cient, CEIF, Lab Dispers & Interfases, Caracas 1020A, Venezuela.
EM yhanwilliams@gmail.com; jhoantoro@gmail.com
OI Toro-Mendoza, Jhoan/0000-0003-4916-7445; Roas Escalona,
   Nelmary/0000-0002-6406-9053
FU  [IVIC-1013]
FX Thanks are given to Ph.D. Yeni Sanchez for helpful discussions and
   criticisms. This research was financially supported by project
   IVIC-1013.
CR Abdurahman N.H., 2013, IJESIT, V2
   Bhutani G, 2016, COMPUT CHEM ENG, V87, P208, DOI 10.1016/j.compchemeng.2016.01.011
   Bremond N, 2012, SOFT MATTER, V8, P10549, DOI 10.1039/c2sm25923k
   CHESTERS AK, 1991, CHEM ENG RES DES, V69, P259
   Christopher GF, 2009, LAB CHIP, V9, P1102, DOI 10.1039/b813062k
   DAVIS RH, 1989, PHYS FLUIDS A-FLUID, V1, P77, DOI 10.1063/1.857525
   Fu TT, 2012, CHEM ENG SCI, V84, P207, DOI 10.1016/j.ces.2012.08.039
   Gu H, 2011, INT J MOL SCI, V12, P2572, DOI 10.3390/ijms12042572
   Hu YT, 2000, PHYS FLUIDS, V12, P484, DOI 10.1063/1.870254
   HUANG PY, 1993, BIOPHYS J, V65, P334, DOI 10.1016/S0006-3495(93)81078-6
   HUANG PY, 1993, BIOPHYS J, V65, P344, DOI 10.1016/S0006-3495(93)81079-8
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Ivanov IB, 1999, COLLOID SURFACE A, V152, P161, DOI 10.1016/S0927-7757(98)00620-7
   Klink IM, 2011, J COLLOID INTERF SCI, V353, P467, DOI 10.1016/j.jcis.2010.09.059
   Krebs T, 2013, FUEL, V106, P327, DOI 10.1016/j.fuel.2012.10.067
   Krebs T., 2012, ADV FLUID MECH, V74, P427
   Krebs T, 2012, SOFT MATTER, V8, P10650, DOI 10.1039/c2sm26122g
   Krebs T, 2012, LAB CHIP, V12, P1060, DOI 10.1039/c2lc20930f
   Lazzari S, 2018, LANGMUIR, V34, P3307, DOI 10.1021/acs.langmuir.8b00076
   Leal LG, 2004, PHYS FLUIDS, V16, P1833, DOI 10.1063/1.1701892
   Liao YX, 2010, CHEM ENG SCI, V65, P2851, DOI 10.1016/j.ces.2010.02.020
   Marchisio DL, 2003, AICHE J, V49, P1266, DOI 10.1002/aic.690490517
   Marchisio DL, 2005, J AEROSOL SCI, V36, P43, DOI 10.1016/j.jaerosci.2004.07.009
   McCoy BJ, 2003, CHEM ENG SCI, V58, P3049, DOI 10.1016/S0009-2509(03)00159-3
   Muijlwijk K, 2017, FOOD HYDROCOLLOID, V70, P96, DOI 10.1016/j.foodhyd.2017.03.031
   Podgorska W, 2005, CHEM ENG SCI, V60, P2115, DOI 10.1016/j.ces.2004.10.035
   PRINCE MJ, 1990, AICHE J, V36, P1425, DOI 10.1002/aic.690360915
   PRINCE MJ, 1990, AICHE J, V36, P1485, DOI 10.1002/aic.690361004
   RAMKRISHNA D, 2000, POPULATION BALANCES
   Sajjadi B, 2013, REV CHEM ENG, V29, P131, DOI 10.1515/revce-2012-0014
   Shardt O, 2013, LANGMUIR, V29, P6201, DOI 10.1021/la304919p
   Silva LFLR, 2008, COMPUT CHEM ENG, V32, P2933, DOI 10.1016/j.compchemeng.2008.03.007
   Tandon P, 1997, BIOPHYS J, V73, P2819, DOI 10.1016/S0006-3495(97)78311-5
   Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g
   TSOURIS C, 1994, AICHE J, V40, P395, DOI 10.1002/aic.690400303
   VANDEVEN TGM, 1989, COLLOIDAL HYDRODYNAM
   Xu B., 2011, MICRONANOSYST, V3, P131, DOI DOI 10.2174/1876402911103020131
   Yang H, 2001, PHYS FLUIDS, V13, P1087, DOI 10.1063/1.1358873
NR 38
TC 6
Z9 6
U1 5
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD JUN 29
PY 2019
VL 201
BP 475
EP 483
DI 10.1016/j.ces.2019.02.040
PG 9
WC Engineering, Chemical
SC Engineering
GA HP9TC
UT WOS:000462034900043
DA 2020-05-12
ER

PT J
AU Mahmoudi, S
   Huda, N
   Alavi, Z
   Islam, MT
   Behnia, M
AF Mahmoudi, Sajjad
   Huda, Nazmul
   Alavi, Zahraossadat
   Islam, Md Tasbirul
   Behnia, Masud
TI End-of-life photovoltaic modules: A systematic quantitative literature
   review
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE EoL PV modules; Recycling; Recovery; PV waste management; Forecasting;
   Reverse logistics
ID PANEL WASTE GLASS; EQUIPMENT WEEE MANAGEMENT; SILICON SOLAR-CELLS;
   CADMIUM-TELLURIDE; CHEMICAL TREATMENT; AMORPHOUS-SILICON; REVERSE
   LOGISTICS; RECYCLING PROCESS; CYCLE ASSESSMENT; CDTE
AB PV modules which are installed worldwide have a defined lifetime for useful service after which the panels become End-of-Life (EoL) products. An enormous amount of obsolete solar PV modules will be added to the waste stream in the near future. Hence, the EoL photovoltaic waste stream could cause an appalling problem in the future if a holistic management strategy is not considered. Despite the vast research on photovoltaic technology, little is known about the perspective of how the EoL PV modules will be handled. The current study systematically investigates global research on EoL PV modules to identify gaps for further exploration. The review reveals that most of the research concentrates on the recovery and recycling of PV panels. Also, the vast majority of the research is mostly carried out in laboratory-scale. The geographical distribution of the studies was concentrated on 15 countries including the USA, Italy, and Taiwan, the latter of which has produced the most publications. Life-cycle-assessment and reverse logistics (RL) are two critical aspects of PV waste management and have only recently received attention from researchers, with 11 and six papers respectively. There are still many countries which have not attempted to forecast their EoL solar-panel waste stream and develop recycling infrastructure. Based on review findings, the future research must be focused on forecasting the PV waste streams, development of recycling technologies, reverse logistics and the policies of individual PV consumer countries. Finally, this study develops a foundation for future research on Photovoltaic waste management to build upon.
C1 [Mahmoudi, Sajjad; Huda, Nazmul; Alavi, Zahraossadat; Islam, Md Tasbirul] Macquarie Univ, Sch Engn, N Ryde, NSW 2109, Australia.
   [Behnia, Masud] Macquarie Univ, Macquarie Grad Sch Management, N Ryde, NSW 2109, Australia.
RP Huda, N (reprint author), Macquarie Univ, Sch Engn, N Ryde, NSW 2109, Australia.
EM nazmul.huda@mq.edu.au
RI Mahmoudi, Sajjad/M-9426-2019; Huda, Nazmul/AAI-4807-2020
OI Huda, Nazmul/0000-0002-2349-7019; Behnia, Masud/0000-0003-3493-3100;
   Islam, Md Tasbirul/0000-0002-6323-2795
FU Macquarie University under the International Macquarie University
   Research Training Program scholarship (IMQRTP)
FX The first author acknowledges funding support from Macquarie University
   under the International Macquarie University Research Training Program
   scholarship (IMQRTP).
CR Berger W, 2010, RESOUR CONSERV RECY, V54, P711, DOI 10.1016/j.resconrec.2009.12.001
   Celik I, 2018, J CLEAN PROD, V186, P632, DOI 10.1016/j.jclepro.2018.03.063
   Chen HH, 2010, KNOWL-BASED SYST, V23, P924, DOI 10.1016/j.knosys.2010.06.008
   Cheng A, 2014, MATER RES INNOV, V18, P344, DOI 10.1179/1432891714Z.000000000428
   Choi JK, 2014, J CLEAN PROD, V66, P443, DOI 10.1016/j.jclepro.2013.11.022
   Choi JK, 2010, J IND ECOL, V14, P947, DOI 10.1111/j.1530-9290.2010.00289.x
   Choi JK, 2010, ENVIRON SCI TECHNOL, V44, P8678, DOI 10.1021/es101710g
   Collins MK, 2017, INT J SUSTAIN ENERGY, V36, P531, DOI 10.1080/14786451.2015.1053392
   Corcelli F, 2017, J CLEAN PROD, V161, P1129, DOI 10.1016/j.jclepro.2017.05.031
   Cucchiella F, 2015, RENEW SUST ENERG REV, V47, P552, DOI 10.1016/j.rser.2015.03.076
   Cyrs WD, 2014, ENERG POLICY, V68, P524, DOI 10.1016/j.enpol.2014.01.025
   D'Adamo I, 2017, INT J PHOTOENERGY, DOI 10.1155/2017/4184676
   Dias P, 2018, J CLEAN PROD, V197, P750, DOI 10.1016/j.jclepro.2018.06.161
   Dias P, 2018, J CLEAN PROD, V174, P7, DOI 10.1016/j.jclepro.2017.10.219
   Dias P, 2017, WASTE MANAGE, V60, P716, DOI 10.1016/j.wasman.2016.08.036
   Dias P, 2016, WASTE MANAGE, V57, P220, DOI 10.1016/j.wasman.2016.03.016
   Doi T, 2001, SOL ENERG MAT SOL C, V67, P397, DOI 10.1016/S0927-0248(00)00308-1
   Dominguez A, 2017, RESOUR CONSERV RECY, V127, P29, DOI 10.1016/j.resconrec.2017.08.013
   Dytrych P, 2017, IND ENG CHEM RES, V56, P12864, DOI 10.1021/acs.iecr.7b01156
   Fthenakis VM, 2000, ENERG POLICY, V28, P1051, DOI 10.1016/S0301-4215(00)00091-4
   Fthenakis VM, 2006, PROG PHOTOVOLTAICS, V14, P363, DOI 10.1002/pip.676
   Giacchetta G, 2013, J CLEAN PROD, V51, P214, DOI 10.1016/j.jclepro.2013.01.022
   Goe M, 2016, SOL ENERG MAT SOL C, V156, P27, DOI 10.1016/j.solmat.2016.04.025
   Granata G, 2014, SOL ENERG MAT SOL C, V123, P239, DOI 10.1016/j.solmat.2014.01.012
   Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
   Hao H, 2015, ENVIRON ENG MANAG J, V14, P79
   Hao HC, 2013, ENVIRON PROG SUSTAIN, V32, P797, DOI 10.1002/ep.11693
   Hsueh JT, 2015, CLEAN TECHNOL ENVIR, V17, P155, DOI 10.1007/s10098-014-0770-3
   Huang BJ, 2017, SOL ENERGY, V143, P132, DOI 10.1016/j.solener.2016.12.038
   Huang TY, 2016, ACS SUSTAIN CHEM ENG, V4, P5769, DOI 10.1021/acssuschemeng.6b01749
   IEA, 2018, IEA PVPS TRENDS 2018
   Islam MT, 2018, RESOUR CONSERV RECY, V137, P48, DOI 10.1016/j.resconrec.2018.05.026
   Kang S, 2012, RENEW ENERG, V47, P152, DOI 10.1016/j.renene.2012.04.030
   Kim S, 2016, SUSTAINABILITY, V8, P17
   Kim Y, 2012, SOL ENERG MAT SOL C, V98, P317, DOI 10.1016/j.solmat.2011.11.022
   Klugmann-Radziemska E, 2010, SOL ENERG MAT SOL C, V94, P2275, DOI 10.1016/j.solmat.2010.07.025
   Kreiger MA, 2013, RESOUR CONSERV RECY, V70, P44, DOI 10.1016/j.resconrec.2012.10.002
   Kuroiwa K, 2014, MINER ENG, V55, P181, DOI 10.1016/j.mineng.2013.10.002
   Latunussa CEL, 2016, SOL ENERG MAT SOL C, V156, P101, DOI 10.1016/j.solmat.2016.03.020
   Lee JK, 2017, SOL ENERG MAT SOL C, V160, P301, DOI 10.1016/j.solmat.2016.10.034
   Lin CY, 2013, J TEST EVAL, V41, P386, DOI 10.1520/JTE20120104
   Lin KL, 2015, J MATER CYCLES WASTE, V17, P194, DOI 10.1007/s10163-014-0240-3
   Lin KL, 2013, ENVIRON TECHNOL, V34, P15, DOI 10.1080/09593330.2012.679693
   Lin KL, 2012, ENVIRON PROG SUSTAIN, V31, P612, DOI 10.1002/ep.10587
   Lu B, 2017, CHEMISTRYSELECT, V2, P3479, DOI 10.1002/slct.201700607
   Ma CM, 2013, APPL CLAY SCI, V80-81, P196, DOI 10.1016/j.clay.2013.03.017
   MALANDRINO O, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9040481
   Marwede M, 2014, J IND ECOL, V18, P254, DOI 10.1111/jiec.12108
   Marwede M, 2013, RENEW ENERG, V55, P220, DOI 10.1016/j.renene.2012.12.038
   Marwede M, 2012, RESOUR CONSERV RECY, V69, P35, DOI 10.1016/j.resconrec.2012.09.003
   McDonald NC, 2010, ENERG POLICY, V38, P7041, DOI 10.1016/j.enpol.2010.07.023
   Menezes S, 2001, THIN SOLID FILMS, V387, P175, DOI 10.1016/S0040-6090(00)01704-1
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Pagnanelli F, 2016, T I MIN METALL C, V125, P221, DOI 10.1080/03719553.2016.1200764
   Pagnanelli F, 2017, WASTE MANAGE, V59, P422, DOI 10.1016/j.wasman.2016.11.011
   Paiano A, 2015, RENEW SUST ENERG REV, V41, P99, DOI 10.1016/j.rser.2014.07.208
   Park J, 2014, RSC ADV, V4, P34823, DOI 10.1039/c4ra03895a
   Peeters JR, 2017, RESOUR CONSERV RECY, V120, P14, DOI 10.1016/j.resconrec.2017.01.001
   Petticrew M, 2006, SYSTEMATIC REVIEWS IN THE SOCIAL SCIENCES: A PRACTICAL GUIDE, P1, DOI 10.1002/9780470754887
   Pickering C, 2015, STUD HIGH EDUC, V40, P1756, DOI 10.1080/03075079.2014.914907
   Pickering C, 2014, HIGH EDUC RES DEV, V33, P534, DOI 10.1080/07294360.2013.841651
   Quercia G, 2013, CEMENT CONCRETE RES, V54, P161, DOI 10.1016/j.cemconres.2013.08.010
   Radziemska E, 2010, ECOL CHEM ENG S, V17, P385
   Radziemska E, 2009, ECOL CHEM ENG S, V16, P379
   Raugei M, 2012, INT J LIFE CYCLE ASS, V17, P192, DOI 10.1007/s11367-011-0348-9
   Ravikumar D, 2016, PROG PHOTOVOLTAICS, V24, P735, DOI 10.1002/pip.2711
   Redlinger M, 2015, SOL ENERG MAT SOL C, V138, P58, DOI 10.1016/j.solmat.2015.02.027
   Rocchetti L, 2015, J CLEAN PROD, V89, P59, DOI 10.1016/j.jclepro.2014.11.009
   Savvilotidou V, 2017, WASTE MANAGE, V59, P394, DOI 10.1016/j.wasman.2016.10.003
   Segebade C, 2008, J RADIOANAL NUCL CH, V276, P29, DOI 10.1007/s10967-007-0405-9
   Shin J, 2017, SOL ENERG MAT SOL C, V162, P1, DOI 10.1016/j.solmat.2016.12.038
   Sica D, 2018, RENEW SUST ENERG REV, V82, P2934, DOI 10.1016/j.rser.2017.10.039
   Sinha P, 2008, ENERG POLICY, V36, P381, DOI 10.1016/j.enpol.2007.09.017
   Smith YR, 2017, MINERAL MET MAT SER, P379, DOI 10.1007/978-3-319-52192-3_37
   Solangi KH, 2011, RENEW SUST ENERG REV, V15, P2149, DOI 10.1016/j.rser.2011.01.007
   Stephanie Weckend I, 2016, END OF LIFE MANAGEME
   Tammaro M, 2015, RENEW ENERG, V81, P103, DOI 10.1016/j.renene.2015.03.014
   Tao J, 2015, SOL ENERG MAT SOL C, V141, P108, DOI 10.1016/j.solmat.2015.05.005
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Vellini M, 2017, ENERGY, V138, P1099, DOI 10.1016/j.energy.2017.07.031
   Xu L, 2018, J CLEAN PROD, V170, P310, DOI 10.1016/j.jclepro.2017.09.129
   Yi YK, 2014, J AIR WASTE MANAGE, V64, P797, DOI 10.1080/10962247.2014.891540
   Zeng DW, 2004, J ENVIRON SCI-CHINA, V16, P889
   Zeng XL, 2017, SCI TOTAL ENVIRON, V575, P1, DOI 10.1016/j.scitotenv.2016.09.078
   Zhang M, 2016, 2016 INTERNATIONAL CONFERENCE ON MANAGEMENT, ECONOMICS AND SOCIAL DEVELOPMENT (ICMESD 2016), P186
   Zhang T, 2014, J HAZARD MATER, V279, P597, DOI 10.1016/j.jhazmat.2014.07.024
   Zhang Y, 2017, J HAZARD MATER, V329, P22, DOI 10.1016/j.jhazmat.2017.01.023
   Zhang ZS, 2017, MOD PHYS LETT B, V31, DOI 10.1142/S0217984917500877
   Zimmermann YS, 2014, ENVIRON SCI TECHNOL, V48, P13412, DOI 10.1021/es502695k
   Zimmermann YS, 2013, ENVIRON SCI TECHNOL, V47, P13151, DOI 10.1021/es402969c
NR 90
TC 5
Z9 5
U1 20
U2 47
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 1
EP 16
DI 10.1016/j.resconrec.2019.03.018
PG 16
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900001
DA 2020-05-12
ER

PT J
AU Niu, BZ
   Mu, ZH
   Chen, L
   Lee, CKM
AF Niu, Baozhuang
   Mu, Zihao
   Chen, Lei
   Lee, Carman K. M.
TI Coordinate the economic and environmental sustainability via procurement
   outsourcing in a co-opetitive supply chain
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Sustainable efforts; Contract manufacturing; Co-opetition; Procurement
   outsourcing; Sustainability
ID RESOURCE; CONTRACT; STRATEGIES; MANAGEMENT; INNOVATION; IMPACTS; CHINA;
   MODEL; TAX
AB The increasing concern about sustainability prompts the original equipment manufacturers (OEMs) to make efforts for sustainable technology innovations, thereby attracting customer demand. However, the increased demand results in more resource consumption and hurts the environmental sustainability deterioration. In this paper, we coordinate the economic sustainability (because of the increased demand and profits) and the environmental sustainability (because of the reduced demand and resource consumption) through procurement outsourcing. We develop a co-opetitive supply chain consisting of an OEM and a competitive contract manufacturer (CM), where the OEM faces the strategic decisions of procurement outsourcing to the CM. In the sense of economic sustainability, we derive three interactive effects that make the OEM prefer procurement outsourcing when its market potential is either low or high. The main reason is that the OEM could drag down the competitive CM with a high component/material wholesale price. In the sense of environmental sustainability, we find that there exists incentive conflict between the economic and environmental sustainability because of the OEM's priority of achieving economic sustainability. We further identify the "sustainable-effort-dilemma" to show that the coordination of economic and environmental sustainability is attainable when the OEM chooses procurement outsourcing.
C1 [Niu, Baozhuang; Mu, Zihao; Chen, Lei] South China Univ Technol, Sch Business Adm, Guangzhou 510640, Guangdong, Peoples R China.
   [Lee, Carman K. M.] Hong Kong Polytech Univ, Dept Ind & Syst Engn, Hong Kong, Peoples R China.
RP Chen, L (reprint author), South China Univ Technol, Sch Business Adm, Guangzhou 510640, Guangdong, Peoples R China.
EM bmniubz@scut.edu.cn; mzhscut@sina.com; jayden_business@foxmail.com;
   ckm.lee@polyu.edu.hk
OI Lee, Carman/0000-0001-8577-4547
FU NSFC Excellent Young Scientists Fund [71822202]; NSFCNational Natural
   Science Foundation of China [71571194]; Chang Jiang Scholars
   ProgramProgram for Changjiang Scholars & Innovative Research Team in
   University (PCSIRT); GDUPS; Chinese Mainland University from HKPolyU;
   Taiwan University from HKPolyU; Macao University from HKPolyU; RGC of
   the Hong Kong Special Administrative Region, ChinaHong Kong Research
   Grants Council [G-SBOT]; ITF Project [K-45-35-ZM25]
FX The authors are grateful to the editors and reviewers for their helpful
   comments. The first author's work was supported by NSFC Excellent Young
   Scientists Fund (No. 71822202), NSFC (No. 71571194), Chang Jiang
   Scholars Program (Niu Baozhuang 2017), GDUPS (Niu Baozhuang 2017). Zihao
   Mu is the co-first author. The corresponding author, Lei Chen' work was
   supported by the Joint Supervision Scheme with the Chinese
   Mainland,Taiwan and Macao Universities from HKPolyU and RGC of the Hong
   Kong Special Administrative Region, China (No. G-SBOT). Carman Lee was
   supported by ITF Project (No. K-45-35-ZM25).
CR Aileron, 2011, FORBES
   Appelbaum R, 2006, WORKING PAPER
   Arya A, 2007, MARKET SCI, V26, P651, DOI 10.1287/mksc.1070.0280
   Ayodele TR, 2018, RESOUR CONSERV RECY, V134, P165, DOI 10.1016/j.resconrec.2018.03.017
   Bai CG, 2019, INT J PROD RES, V57, P1037, DOI 10.1080/00207543.2018.1498986
   Berger PD, 2004, OMEGA-INT J MANAGE S, V32, P9, DOI 10.1016/j.omega.2003.09.001
   Bolandifar E, 2016, PROD OPER MANAG, V25, P1528, DOI 10.1111/poms.12566
   Chen YJ, 2012, PROD OPER MANAG, V21, P907, DOI 10.1111/j.1937-5956.2012.01325.x
   Chiang WYK, 2003, MANAGE SCI, V49, P1, DOI 10.1287/mnsc.49.1.1.12749
   Choi TM, 2012, INT J PROD ECON, V135, P552, DOI 10.1016/j.ijpe.2010.10.004
   D'Alessandro Simone, 2010, Journal of Cleaner Production, V18, P291, DOI 10.1016/j.jclepro.2009.10.015
   Deshpande V, 2011, PROD OPER MANAG, V20, P165, DOI 10.1111/j.1937-5956.2010.01188.x
   Domberger S, 1998, CONTRACTING ORG STRA
   Dong CW, 2016, ANN OPER RES, V240, P509, DOI 10.1007/s10479-013-1514-1
   Elliot S, 2011, MIS QUART, V35, P197
   Guo PF, 2010, INT J PROD ECON, V128, P175, DOI 10.1016/j.ijpe.2010.06.017
   Harvard Business Review, 2010, HARVARD BUSINESS REV
   Hong ZF, 2019, OMEGA-INT J MANAGE S, V83, P155, DOI 10.1016/j.omega.2018.02.010
   Hsu VN, 2017, M&SOM-MANUF SERV OP, V19, P72, DOI 10.1287/msom.2016.0592
   Hu B, 2018, WORKING PAPER
   Hua GW, 2010, EUR J OPER RES, V205, P113, DOI 10.1016/j.ejor.2009.12.012
   Jia XP, 2017, RESOUR CONSERV RECY, V119, P1, DOI 10.1016/j.resconrec.2016.11.004
   Krass D, 2013, PROD OPER MANAG, V22, P1035, DOI 10.1111/poms.12023
   Li G, 2017, INT J PROD EC
   Li WY, 2015, RESOUR CONSERV RECY, V104, P348, DOI 10.1016/j.resconrec.2014.08.005
   Liang HW, 2017, RESOUR CONSERV RECY, V123, P11, DOI 10.1016/j.resconrec.2016.04.001
   Liu Z, 2018, RESOUR CONSERV RECY, V128, P417, DOI 10.1016/j.resconrec.2016.06.012
   Martinico-Perez MFG, 2018, RESOUR CONSERV RECY, V138, P74, DOI 10.1016/j.resconrec.2018.07.003
   Melville NP, 2010, MIS QUART, V34, P1
   Meng XY, 2019, RESOUR CONSERV RECY, V140, P224, DOI 10.1016/j.resconrec.2018.09.021
   Niu BZ, 2019, J CLEAN PROD, V208, P1281, DOI 10.1016/j.jclepro.2018.10.162
   Niu BZ, 2017, TRANSPORT RES E-LOG, V107, P81, DOI 10.1016/j.tre.2017.09.010
   Ruiz-Torres AJ, 2006, INT J PROD ECON, V103, P755, DOI 10.1016/j.ijpe.2005.09.008
   Schelling T. C., 1960, STRATEGY CONFLICT
   Shen B., 2016, US SUSTAINABILITY, V8, P31
   Shen B, 2015, SUSTAINABILITY-BASEL, V7, P1172, DOI 10.3390/su7021172
   Sodhi MS, 2013, INT J PROD ECON, V146, P14, DOI 10.1016/j.ijpe.2012.10.014
   Song ML, 2018, RESOUR CONSERV RECY, V128, P197, DOI 10.1016/j.resconrec.2016.08.015
   Song ML, 2012, RENEW SUST ENERG REV, V16, P4465, DOI 10.1016/j.rser.2012.04.052
   SPIEGEL Y, 1993, RAND J ECON, V24, P570, DOI 10.2307/2555746
   Tang L, 2017, RESOUR CONSERV RECY, V117, P34, DOI 10.1016/j.resconrec.2015.08.016
   United Nations, 2018, SUST DEV GOALS REP
   Wang JC, 2013, COMPUT IND ENG, V64, P235, DOI 10.1016/j.cie.2012.09.009
   Wang JQ, 2015, PROD OPER MANAG, V24, P134, DOI 10.1111/poms.12218
   Wang YL, 2014, PROD OPER MANAG, V23, P610, DOI 10.1111/poms.12025
   Wang YL, 2013, PROD OPER MANAG, V22, P104, DOI 10.1111/j.1937-5956.2012.01336.x
   WSJ, 2015, WALL STREET J
   Xu JY, 2018, PROD OPER MANAG, V27, P251, DOI 10.1111/poms.12798
   Ye F, 2018, RESOUR CONSERV RECY, V128, P306, DOI 10.1016/j.resconrec.2016.11.023
   Zhang T., 2018, ANN OPER RES, P1, DOI [10.1007/s10479-018-3084-8, DOI 10.1007/S10479-018-3084-8]
   Zheng XF, 2016, ACSR ADV COMPUT, V66, P1
NR 51
TC 5
Z9 5
U1 17
U2 42
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 17
EP 27
DI 10.1016/j.resconrec.2019.03.007
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900002
DA 2020-05-12
ER

PT J
AU Li, D
   Zhao, LM
   Ma, S
   Shao, S
   Zhang, LX
AF Li, Ding
   Zhao, Luman
   Ma, Shuang
   Shao, Shuai
   Zhang, Lixiao
TI What influences an individual's pro-environmental behavior? A literature
   review
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Pro-environmental behavior; Determinant; External factor; Internal
   factor
ID PREDICTING RECYCLING BEHAVIOR; PLANNED BEHAVIOR; WASTE MANAGEMENT;
   PROENVIRONMENTAL BEHAVIOR; REVERSE LOGISTICS; CIRCULAR ECONOMY; PLACE
   ATTACHMENT; POLICY MEASURES; EXTENDED THEORY; SOCIAL NORMS
AB This review paper discusses determinants of pro-environmental behavior on Resources Conservation and Recycling from 1987 to 2017. The main factors which influence pro-environmental behavior include both external and internal factors-specifically, demographic variables and psychological factors. The main purpose of this work is to review the literature (i.e., published studies) regarding the impact, relations, and mutual effects on pro-environmental behavior of each group of factors. Identifying the determinants of pro-environmental behavior is helpful when formulating the most appropriate and effective policies for improving the public's behavior toward protecting the natural environment.
C1 [Li, Ding] Southwestern Univ Finance & Econ, Inst Dev Studies, Chengdu, Sichuan, Peoples R China.
   [Li, Ding; Ma, Shuang] Southwestern Univ Finance & Econ, Survey & Res Ctr China Household Finance, Chengdu, Sichuan, Peoples R China.
   [Zhao, Luman] Southwestern Univ Finance & Econ, Sch Econ, Chengdu, Sichuan, Peoples R China.
   [Ma, Shuang] Guangzhou Univ, Sch Econ & Stat, Guangzhou, Guangdong, Peoples R China.
   [Shao, Shuai] Shanghai Univ Finance & Econ, Inst Finance & Econ Res, Sch Urban & Reg Sci, Shanghai, Peoples R China.
   [Zhang, Lixiao] Beijing Normal Univ, Sch Environm, Beijing, Peoples R China.
RP Ma, S (reprint author), Guang Zhou Univ, Guangzhou Higher Educ Mega Ctr, 312 Room,Adm Bldg,230 Wai Huan Xi Rd, Guangzhou 510006, Guangdong, Peoples R China.
EM shuangma@swufe.edu.cn
RI , 李丁/AAF-9031-2020
FU "Innovation and introducing talents for universities plan" (111 Project)
   [B16040]; Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71373153, 71773075]
FX This study is Supported by the "Innovation and introducing talents for
   universities plan" (111 Project B16040) undertaken at the Survey and
   Research Center for China Household Finance, Southwestern University of
   Finance and Economics (SWUFE). This study was also funded by Natural
   Science Foundation of China (Nos. 71373153 and 71773075)
CR Aizawa H, 2008, RESOUR CONSERV RECY, V52, P1399, DOI 10.1016/j.resconrec.2008.07.013
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 1980, UNDERSTANDING ATTITU
   Ajzen I, 2007, PREDICTION CHANGE HL
   Allen JB, 1999, ENVIRON BEHAV, V31, P338, DOI 10.1177/00139169921972137
   Amutenya N, 2009, RESOUR CONSERV RECY, V53, P237, DOI 10.1016/j.resconrec.2008.12.001
   Barr S, 2005, RESOUR CONSERV RECY, V45, P172, DOI 10.1016/j.resconrec.2004.12.007
   Barr S, 2003, LOCAL ENVIRON, V8, P407, DOI DOI 10.1080/13549830306667
   Barr S, 2011, J ENVIRON PLANN MAN, V54, P1331, DOI 10.1080/09640568.2011.574996
   Begum RA, 2009, RESOUR CONSERV RECY, V53, P321, DOI 10.1016/j.resconrec.2009.01.005
   Berardi U, 2017, RESOUR CONSERV RECY, V123, P230, DOI 10.1016/j.resconrec.2016.03.014
   Bertoldo R, 2016, RESOUR CONSERV RECY, V112, P45, DOI 10.1016/j.resconrec.2016.03.020
   BORDEN RJ, 1977, PERS SOC PSYCHOL B, V3, P407, DOI 10.1177/014616727700300309
   Botetzagias I, 2015, RESOUR CONSERV RECY, V95, P58, DOI 10.1016/j.resconrec.2014.12.004
   Brecard D, 2009, ECOL ECON, V69, P115, DOI 10.1016/j.ecolecon.2009.07.017
   Byrne S, 2014, RESOUR CONSERV RECY, V87, P89, DOI 10.1016/j.resconrec.2014.03.001
   Lobato NCC, 2015, RESOUR CONSERV RECY, V102, P49, DOI 10.1016/j.resconrec.2015.05.025
   Chen H, 2017, RESOUR CONSERV RECY, V125, P25, DOI 10.1016/j.resconrec.2017.05.013
   Cheung SF, 1999, ENVIRON BEHAV, V31, P587, DOI 10.1177/00139169921972254
   Coleman J., 1990, FDN SOCIAL THEORY
   Corral-Verdugo V, 2006, ENVIRON BEHAV, V38, P406, DOI 10.1177/0013916505282272
   CRAIK KH, 1973, ANNU REV PSYCHOL, V24, P403, DOI 10.1146/annurev.ps.24.020173.002155
   DANIELSON L, 1995, APPL ECON, V27, P1253, DOI 10.1080/00036849500000108
   DAVIES J, 2002, MARKETING THEORY, V2, P29, DOI DOI 10.1177/1470593102002001645
   Davis G, 2006, RESOUR CONSERV RECY, V46, P115, DOI 10.1016/j.resconrec.2005.07.001
   Dixit S, 2016, RESOUR CONSERV RECY, V107, P115, DOI 10.1016/j.resconrec.2015.11.021
   Domina T, 2002, ENVIRON BEHAV, V34, P216, DOI 10.1177/0013916502034002004
   Dupont DP, 2004, ECOL ECON, V49, P273, DOI 10.1016/j.ecolecon.2004.01.013
   Eagly A.H., 1993, PSYCHOL ATTITUDES
   ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99
   Eriksson L, 2008, TRANSPORT RES A-POL, V42, P1117, DOI 10.1016/j.tra.2008.03.006
   Fan CH, 2018, RESOUR CONSERV RECY, V128, P167, DOI 10.1016/j.resconrec.2016.09.006
   Fan LX, 2013, RESOUR CONSERV RECY, V74, P45, DOI 10.1016/j.resconrec.2013.02.017
   Fielding KS, 2016, RESOUR CONSERV RECY, V106, P90, DOI 10.1016/j.resconrec.2015.11.009
   Fu XK, 2017, RESOUR CONSERV RECY, V122, P219, DOI 10.1016/j.resconrec.2017.02.012
   Graham-Rowe E, 2015, RESOUR CONSERV RECY, V101, P194, DOI 10.1016/j.resconrec.2015.05.020
   Graham-Rowe E, 2014, RESOUR CONSERV RECY, V84, P15, DOI 10.1016/j.resconrec.2013.12.005
   Hage O, 2009, RESOUR CONSERV RECY, V53, P155, DOI 10.1016/j.resconrec.2008.11.003
   Halvorsen B, 2012, RESOUR CONSERV RECY, V67, P18, DOI 10.1016/j.resconrec.2012.06.008
   Hansmann R, 2006, RESOUR CONSERV RECY, V47, P133, DOI 10.1016/j.resconrec.2005.10.006
   Hines J., 1987, J ENVIRON EDUC, V18, P1, DOI DOI 10.1080/00958964.1987.9943482
   Hungerford H. R., 1990, J ENVIRON EDUC, V21, P8, DOI DOI 10.1080/00958964.1990.10753743
   Hynes N, 2016, TECHNOL FORECAST SOC, V111, P349, DOI 10.1016/j.techfore.2016.06.034
   Kinnaman TC, 2014, RESOUR CONSERV RECY, V85, P5, DOI 10.1016/j.resconrec.2013.11.002
   Klockner CA, 2011, RESOUR CONSERV RECY, V55, P463, DOI 10.1016/j.resconrec.2010.12.009
   Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI DOI 10.1080/13504620220145401
   Lakhan C, 2015, RESOUR CONSERV RECY, V97, P31, DOI 10.1016/j.resconrec.2015.02.006
   Lange F, 2014, RESOUR CONSERV RECY, V92, P246, DOI 10.1016/j.resconrec.2014.07.008
   Lim JS, 2016, J PUBLIC AFF, V16, P231, DOI 10.1002/pa.1583
   LINKE RD, 1981, J ENVIRON EDUC, V12, P20
   Liu YL, 2017, RESOUR CONSERV RECY, V125, P98, DOI 10.1016/j.resconrec.2017.06.005
   Liu Y, 2014, RESOUR CONSERV RECY, V87, P145, DOI 10.1016/j.resconrec.2014.04.002
   Lizin S, 2017, RESOUR CONSERV RECY, V122, P66, DOI 10.1016/j.resconrec.2017.02.003
   Lopez-Mosquera N, 2015, RESOUR CONSERV RECY, V99, P29, DOI 10.1016/j.resconrec.2015.03.007
   Lu H, 2017, RESOUR CONSERV RECY, V120, P166, DOI 10.1016/j.resconrec.2016.12.008
   Martinho G, 2015, RESOUR CONSERV RECY, V103, P58, DOI 10.1016/j.resconrec.2015.07.012
   Miafodzyeva S, 2013, WASTE BIOMASS VALORI, V4, P221, DOI 10.1007/s12649-012-9144-4
   Miliute-Plepiene J, 2016, RESOUR CONSERV RECY, V113, P40, DOI 10.1016/j.resconrec.2016.05.008
   Missimer M, 2017, J CLEAN PROD, V140, P32, DOI 10.1016/j.jclepro.2016.03.170
   Ohtomo S, 2014, RESOUR CONSERV RECY, V84, P57, DOI 10.1016/j.resconrec.2013.12.014
   OSKAMP S, 1991, ENVIRON BEHAV, V23, P494, DOI 10.1177/0013916591234005
   Perrin D, 2001, RESOUR CONSERV RECY, V33, P61, DOI 10.1016/S0921-3449(01)00075-1
   Poldnurk J, 2015, RESOUR CONSERV RECY, V97, P55, DOI 10.1016/j.resconrec.2015.02.003
   Prestin A, 2010, RESOUR CONSERV RECY, V54, P1017, DOI 10.1016/j.resconrec.2010.02.009
   Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847
   Putnam Robert D, 1993, MAKING DEMOCRACY WOR
   Ramayah T, 2010, RESOUR CONSERV RECY, V54, P1419, DOI 10.1016/j.resconrec.2010.06.007
   Ramkissoon H, 2018, J SUSTAIN TOUR, V26, P341, DOI 10.1080/09669582.2017.1354866
   Ramkissoon H, 2017, TOUR ANAL, V22, P59, DOI [10.3727/108354217x14828625279735, 10.3727/108354217X14828625279735]
   Ramkissoon H, 2013, J SUSTAIN TOUR, V21, P434, DOI 10.1080/09669582.2012.708042
   Rigamonti L, 2014, RESOUR CONSERV RECY, V85, P42, DOI 10.1016/j.resconrec.2013.12.012
   Russell SV, 2017, RESOUR CONSERV RECY, V125, P107, DOI 10.1016/j.resconrec.2017.06.007
   Saphores JDM, 2012, RESOUR CONSERV RECY, V60, P49, DOI 10.1016/j.resconrec.2011.12.003
   Sasaki S, 2014, RESOUR CONSERV RECY, V89, P11, DOI 10.1016/j.resconrec.2014.05.006
   SCHWARTZ SH, 1968, J PERS SOC PSYCHOL, V10, P232, DOI 10.1037/h0026569
   Schwartz SH, 1977, ADV EXPT SOCIAL PSYC, V10, P221, DOI DOI 10.1016/S0065-2601(08)60358-5
   SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170
   Shih LH, 2001, RESOUR CONSERV RECY, V32, P55, DOI 10.1016/S0921-3449(00)00098-7
   Sia A. P., 1985, J ENVIRON EDUC, V17, P31, DOI [10.1080/00958964.1986.9941408, DOI 10.1080/00958964.1986.9941408]
   Sidique SF, 2010, RESOUR CONSERV RECY, V54, P163, DOI 10.1016/j.resconrec.2009.07.012
   Singh MP, 2018, RESOUR CONSERV RECY, V135, P313, DOI 10.1016/j.resconrec.2017.07.015
   Staats H, 2004, ENVIRON BEHAV, V36, P341, DOI 10.1177/0013916503260163
   Stern P.C., 1999, HUMAN ECOLOGY REV, V6, P81
   Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175
   Sun Y., 2012, CHINESE J MANAGE, V9, P144
   Tadesse T, 2009, RESOUR CONSERV RECY, V53, P183, DOI 10.1016/j.resconrec.2008.11.009
   Tester J. W., 1992, RESOUR CONSERV RECY, V6, P171, DOI [10.1016/0921-3449(92)90047-6, DOI 10.1016/0921-3449(92)90047-6]
   Thogersen J, 2009, BASIC APPL SOC PSYCH, V31, P348, DOI 10.1080/01973530903317144
   Timlett RE, 2009, RESOUR CONSERV RECY, V53, P498, DOI 10.1016/j.resconrec.2009.03.010
   Tonglet M, 2004, RESOUR CONSERV RECY, V42, P27, DOI 10.1016/j.resconrec.2004.02.001
   Tonglet M, 2004, RESOUR CONSERV RECY, V41, P191, DOI 10.1016/j.resconrec.2003.11.001
   Torgler B., 2005, ECOL ECON, V63, P536
   Tudor T. L., 2006, CONSERV RECYCLING, V51, P1, DOI DOI 10.1016/J.RESC0NREC.2006.06.009.ISSN
   Van der Werff E, 2014, ENVIRON BEHAV, V46, P626, DOI 10.1177/0013916512475209
   Van Liere K. D., 1981, ENVIRON BEHAV, V13, P651, DOI DOI 10.1177/0013916581136001
   VINING J, 1992, J APPL SOC PSYCHOL, V22, P1580, DOI 10.1111/j.1559-1816.1992.tb01758.x
   Wan C, 2014, RESOUR CONSERV RECY, V83, P141, DOI 10.1016/j.resconrec.2013.12.009
   Webb TL, 2009, BRIT J SOC PSYCHOL, V48, P507, DOI 10.1348/014466608X370591
   Welsch H, 2010, J ECON PSYCHOL, V31, P405, DOI 10.1016/j.joep.2010.01.009
   Zhang SP, 2016, RESOUR CONSERV RECY, V109, P176, DOI 10.1016/j.resconrec.2016.02.008
NR 100
TC 7
Z9 7
U1 22
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 28
EP 34
DI 10.1016/j.resconrec.2019.03.024
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900003
DA 2020-05-12
ER

PT J
AU Chen, JJ
   Wang, ZH
   Wu, YF
   Li, LQ
   Li, B
   Pan, DA
   Zuo, TY
AF Chen Jingling
   Wang Zhaohui
   Wu Yufeng
   Li Liquan
   Li Bin
   Pan De'an
   Zuo Tieyong
TI Environmental benefits of secondary copper from primary copper based on
   life cycle assessment in China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Refined copper; Life cycle assessment; Environmental impact; Primary
   copper; Secondary copper
ID IMPACT ASSESSMENT METHODS; RECOVERY; SCRAP; EMISSIONS
AB China is the largest producer and consumer of refined copper in the world. The large amount of copper consumption not only creates added pressure surrounding resource availability but also causes prominent environmental problems. Although copper can be recycled to alleviate resource pressure, there are significant differences between mining primary copper and recycling scrap copper in view of resources, energy consumption, and pollution emissions. These factors were analyzed to better understand the total environmental effects of refined copper from extracting primary ore and recycling scrap copper. The results of this analysis showed that the most serious environmental impacts of refined copper were human toxicity, abiotic depletion potential, and global warming potential. The environmental impacts were mainly caused by the mining and smelting of primary copper by pyrometallurgy. For secondary copper, refining and electrolysis were the main factors. Thus, these main processes, which cause major environmental impacts, should be promoted technologically. According to the results, the total environmental impact of secondary copper was only 1/8 that of the primary copper production process, which indicates that regeneration has better environmental benefits. Furthermore, the sensitive analysis showed that electricity was the most sensitive factor of both technologies. By optimizing the energy structure and increasing the proportion of regeneration, can also reduce the environmental impact. It was suggested that energy structure should be improved and secondary copper should be given more attention and be developed vigorously. Finally, ways to reduce the environmental impact of primary copper and secondary copper industries were recommended.
C1 [Chen Jingling; Wang Zhaohui; Wu Yufeng; Li Bin; Pan De'an; Zuo Tieyong] Beijing Univ Technol, Beijing 100124, Peoples R China.
   [Li Liquan] State Informat Ctr, Beijing 100045, Peoples R China.
RP Li, B (reprint author), Beijing Univ Technol, Beijing 100124, Peoples R China.
EM thlibin@sina.com
RI yufeng, wu/AAK-8528-2020; Yufeng, Wu/AAI-6904-2020
FU National Key R&D Program of China [2018YFC1902803, 2018YFC1902504];
   Beijing Natural Science FoundationBeijing Natural Science Foundation
   [2174065]
FX The authors are grateful to the National Key R&D Program of China [grant
   numbers 2018YFC1902803, 2018YFC1902504] and Beijing Natural Science
   Foundation [grant numbers 2174065].
CR Beylot A, 2017, J CLEAN PROD, V153, P139, DOI 10.1016/j.jclepro.2017.03.129
   Bonnin M, 2015, RESOUR CONSERV RECY, V99, P48, DOI 10.1016/j.resconrec.2015.03.013
   Chen XJ, 2018, RESOUR CONSERV RECY, V137, P316, DOI 10.1016/j.resconrec.2018.06.011
   China Association of Circular Economy (CACE), 2017, REP DEV CIRC EC CHIN
   CMRA, 2016, REP DEV CHIN REC IND
   Esnouf A, 2018, SCI TOTAL ENVIRON, V621, P1264, DOI 10.1016/j.scitotenv.2017.10.102
   Fogarasi S, 2014, J HAZARD MATER, V273, P215, DOI 10.1016/j.jhazmat.2014.03.043
   Fogarasi S, 2013, J CLEAN PROD, V54, P264, DOI 10.1016/j.jclepro.2013.04.044
   Gomez F, 2007, RESOUR POLICY, V32, P183, DOI 10.1016/j.resourpol.2007.08.002
   Coelho LMG, 2018, RESOUR CONSERV RECY, V128, P438, DOI 10.1016/j.resconrec.2016.09.026
   Gyurov S, 2017, INT J MINER PROCESS, V158, P1, DOI 10.1016/j.minpro.2016.11.008
   Han M., 2009, ENV SCI MANAG, V34, P40
   Hong JL, 2015, WASTE MANAGE, V38, P357, DOI 10.1016/j.wasman.2014.12.022
   Hongtao Wang, 2015, Materials Science Forum, V814, P559, DOI 10.4028/www.scientific.net/MSF.814.559
   Hung PC, 2015, CHEMOSPHERE, V118, P148, DOI 10.1016/j.chemosphere.2014.07.064
   Iannicelli-Zubiani EM, 2017, J CLEAN PROD, V140, P1204, DOI 10.1016/j.jclepro.2016.10.040
   ICSG, 2016, ICSG WORLD COPP FACT
   [姜金龙 Jiang Jinlong], 2006, [兰州理工大学学报, Journal of Lanzhou University of Technology], V32, P19
   [姜金龙 JIANG linlong], 2006, [兰州理工大学学报, Journal of Lanzhou University of Technology], V32, P4
   Lasvaux S, 2016, ECOL INDIC, V67, P174, DOI 10.1016/j.ecolind.2016.01.056
   Li LQ, 2017, RESOUR CONSERV RECY, V127, P1, DOI 10.1016/j.resconrec.2017.07.046
   Miah JH, 2017, J CLEAN PROD, V168, P846, DOI 10.1016/j.jclepro.2017.08.187
   Nie ZQ, 2012, ATMOS ENVIRON, V57, P109, DOI 10.1016/j.atmosenv.2012.04.048
   Norgate T, 2010, MINER ENG, V23, P65, DOI 10.1016/j.mineng.2009.10.002
   Northey S, 2013, J CLEAN PROD, V40, P118, DOI 10.1016/j.jclepro.2012.09.027
   Peng YL, 2012, HYDROMETALLURGY, V129, P156, DOI 10.1016/j.hydromet.2012.06.009
   RUAN Ren-Man, 2010, CHINA NONFERROUS MET, V4, P30
   Sarfo P, 2017, WASTE MANAGE, V70, P272, DOI 10.1016/j.wasman.2017.09.024
   Shuva MAH, 2016, J CLEAN PROD, V131, P795, DOI 10.1016/j.jclepro.2016.04.061
   Song XL, 2014, FRONT ENV SCI ENG, V8, P580, DOI 10.1007/s11783-013-0599-8
   Swart P, 2013, ENVIRON SCI TECHNOL, V47, P13917, DOI 10.1021/es4030518
   Wang MX, 2017, RESOUR POLICY, V52, P235, DOI 10.1016/j.resourpol.2016.12.009
   Yang X., 2014, TMS ANN M
   Yu X, 2014, MATH PROBL ENG, DOI 10.1155/2014/918795
   Zeng G Y, 2012, CHINA POPULATION RES, V22, p46 
   Zhang LG, 2016, J CLEAN PROD, V127, P19, DOI 10.1016/j.jclepro.2016.04.004
NR 36
TC 5
Z9 5
U1 10
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 35
EP 44
DI 10.1016/j.resconrec.2019.03.020
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900004
DA 2020-05-12
ER

PT J
AU Guo, J
   Miatto, A
   Shi, F
   Tanikawa, H
AF Guo, Jing
   Miatto, Alessio
   Shi, Feng
   Tanikawa, Hiroki
TI Spatially explicit material stock analysis of buildings in Eastern China
   metropoles
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Building material stock; GIS; Material intensity; Eastern China; Spatial
   distribution
ID DEMOLITION WASTE MANAGEMENT; MATERIAL FLOWS; RESIDENTIAL BUILDINGS;
   MATERIALS DEMAND; CONSTRUCTION; ACCUMULATION; DYNAMICS; SOCIETY; ENERGY;
   STEEL
AB China is experiencing a period of rapid urbanization and fervent construction activities, which are responsible for the accumulation of large amount of material stocks (MS). Fundamental in every society, buildings not only shape material flows before and during construction, but also during maintenance and demolition, inducing the extraction of resources and the production of construction waste. It is thus imperative to understand the amount, composition, and location of current building MS as a first step to design appropriate management strategies for an environmentally sustainable society. This research uses the latest GIS dataset of buildings in 14 representative Eastern China metropoles to quantify the current status of building MS by employing a bottom-up method. The selection of the study areas relies on the law of the primate" city, which permits to quickly target the most important urban areas of a region. We review and discuss existing material intensity (MI) coefficients for Chinese buildings, and produce a new set of MIs manipulating those available in the literature. We then calculate the total MS, MS density, and per capita MS for each city. Results find that in 14 cities 7.9 Gt of building materials are currently stored in a total area of 3790 km(2), resulting on an average density of 2.1 Mt/km(2). The per capita building MS results being 283 t/cap, and this value correlates with a growth of the per capita GDP. We conclude the research with a hotspot analysis of the spatial distribution of the MS, identifying the MS clusters.
C1 [Guo, Jing; Tanikawa, Hiroki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi, Japan.
   [Miatto, Alessio] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT USA.
   [Shi, Feng] Shandong Acad Sci, Jinan, Shandong, Peoples R China.
RP Guo, J (reprint author), Chikusa Ku,Furou Cho,D2-1 510, Nagoya, Aichi 4648601, Japan.
EM guo.jing@i.mbox.nagoya-u.ac.jp
RI Miatto, Alessio/R-9972-2019
OI Miatto, Alessio/0000-0001-7541-9330
FU Environment Research and Technology Development Fund of the Ministry of
   the Environment, JapanMinistry of the Environment, Japan [2-1711]; China
   Scholarship Council of the Ministry of Education (CSC); Environmental
   Restoration and Conservation Agency
FX This research was supported by the Environment Research and Technology
   Development Fund (2-1711) of the Ministry of the Environment, Japan, the
   Environmental Restoration and Conservation Agency, and the China
   Scholarship Council of the Ministry of Education (CSC).
CR Beijing Municipal Bureau of Statistics, 2017, COMM NAT EC SOC DEV
   Cai WJ, 2015, ENVIRON SCI TECHNOL, V49, P13921, DOI 10.1021/acs.est.5b02333
   Cao Z, 2018, J IND ECOL, V22, P377, DOI 10.1111/jiec.12579
   Chen C., 2016, UNIVERSAL J MAT SCI, V4, P40, DOI DOI 10.13189/UJMS.2016.040204
   Chen ZX, 2017, ADV SOC SCI EDUC HUM, V121, P334
   Duan HB, 2016, WASTE MANAGE RES, V34, P397, DOI 10.1177/0734242X16647603
   EUROSTAT, 2013, EC WID MAT FLOW ACC
   Fernandez JE, 2007, J IND ECOL, V11, P99, DOI 10.1162/jie.2007.1199
   Fishman T, 2015, ECOL ECON, V113, P76, DOI 10.1016/j.ecolecon.2015.03.001
   Gonti P, 2018, RESOUR CONSERV RECY, V130, P228, DOI 10.1016/j.resconrec.2017.11.022
   Gu C., 1992, CHINAS URBAN SYSTEM
   Gu L, 2009, STUDIES ENV IMPACT B
   Han J, 2013, SUSTAIN SCI, V8, P553, DOI 10.1007/s11625-012-0196-y
   Hong LX, 2016, ENERG POLICY, V94, P47, DOI 10.1016/j.enpol.2016.03.024
   Hu D, 2010, RESOUR CONSERV RECY, V54, P1177, DOI 10.1016/j.resconrec.2010.03.011
   Hu MM, 2010, J IND ECOL, V14, P440, DOI 10.1111/j.1530-9290.2010.00245.x
   Hu MM, 2010, RESOUR CONSERV RECY, V54, P591, DOI 10.1016/j.resconrec.2009.10.016
   Huang BJ, 2018, RESOUR CONSERV RECY, V129, P36, DOI 10.1016/j.resconrec.2017.09.029
   Huang C, 2017, RESOUR CONSERV RECY, V123, P47, DOI 10.1016/j.resconrec.2016.06.014
   Huang SL, 2003, LANDSCAPE URBAN PLAN, V63, P61, DOI 10.1016/S0169-2046(02)00152-4
   Huang T, 2013, RESOUR CONSERV RECY, V72, P91, DOI 10.1016/j.resconrec.2012.12.013
   Ichinose T, 2018, SUSTAIN CITIES SOC, V38, P560, DOI 10.1016/j.scs.2018.01.009
   JEFFERSON M, 1989, GEOGR REV, V79, P226, DOI 10.2307/215528
   Kennedy CA, 2015, P NATL ACAD SCI USA, V112, P5985, DOI 10.1073/pnas.1504315112
   Kleemann F, 2017, J IND ECOL, V21, P368, DOI 10.1111/jiec.12446
   Krausmann F, 2017, P NATL ACAD SCI USA, V114, P1880, DOI 10.1073/pnas.1613773114
   Lee S.-I., 2017, ENCY GIS, P360, DOI DOI 10.1007/978-3-319-23519-6_1524-1
   [冷炳荣 Leng Bingrong], 2011, [地理学报, Acta Geographica Sinica], V66, P199
   [刘天星 LIU TianXing], 2006, [中国科学院研究生院学报, Journal of the Graduate School of the Academy of Sciences], V23, P231
   Marcellus-Zamora KA, 2016, J IND ECOL, V20, P1025, DOI 10.1111/jiec.12327
   Miatto A, 2019, RESOUR CONSERV RECY, V142, P245, DOI 10.1016/j.resconrec.2018.12.011
   Miatto A, 2017, RESOUR CONSERV RECY, V127, P168, DOI 10.1016/j.resconrec.2017.08.024
   Miatto A, 2017, J IND ECOL, V21, P924, DOI 10.1111/jiec.12471
   Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025
   National Bureau of Statistics of China, 2017, 2017 NAT EC SOC DEV
   National Bureau of Statistics of China, 2017, CHIN STAT YB 1999 20
   Ortlepp R, 2018, BUILD RES INF, V46, P164, DOI 10.1080/09613218.2016.1264121
   Ortlepp R, 2016, BUILD RES INF, V44, P840, DOI 10.1080/09613218.2016.1112096
   Osmani M, 2008, WASTE MANAGE, V28, P1147, DOI 10.1016/j.wasman.2007.05.011
   Schandl H, 2018, J IND ECOL, V22, P827, DOI 10.1111/jiec.12626
   Shanghai Municipal Bureau of Statistics, 2017, COMM NAT EC SOC DEV
   Shi F, 2012, J IND ECOL, V16, P493, DOI 10.1111/j.1530-9290.2012.00523.x
   Song C, 2005, HOUSING SCI, V290, P287
   Stephan A, 2018, RESOUR CONSERV RECY, V129, P248, DOI 10.1016/j.resconrec.2017.09.022
   Tanikawa H, 2015, J IND ECOL, V19, P778, DOI 10.1111/jiec.12284
   Tanikawa H, 2009, BUILD RES INF, V37, P483, DOI 10.1080/09613210903169394
   Torres A, 2017, SCIENCE, V357, P970, DOI 10.1126/science.aao0503
   Wang T, 2015, RESOUR CONSERV RECY, V103, P205, DOI 10.1016/j.resconrec.2015.07.021
   Wiedenhofer D, 2015, J IND ECOL, V19, P538, DOI 10.1111/jiec.12216
   Wu J., 2015, EVALUATING RISK CHIN
   Xiao YX, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6110358
   Xiong X, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-41
   Yu H., 1999, CONSTRUCTION PROJECT
   Yue Y, 2017, INT J GEOGR INF SCI, V31, P658, DOI 10.1080/13658816.2016.1220561
   Zeng C, 2015, CITIES, V43, P92, DOI 10.1016/j.cities.2014.11.009
   Zhang Y, 2015, W FORUM, V25, P60
NR 56
TC 0
Z9 0
U1 9
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 45
EP 54
DI 10.1016/j.resconrec.2019.03.031
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900005
DA 2020-05-12
ER

PT J
AU Yang, XS
   Weber, A
AF Yang, Xisi
   Weber, Anja
TI Who can improve the environment-Me or the powerful others? An
   integrative approach to locus of control and pro-environmental behavior
   in China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Internal locus of control; External locus of control; Pro-environmental
   behavior; China; Cross-cultural comparison
ID GENERALIZED SELF-EFFICACY; SUSTAINABLE CONSUMPTION; RECYCLING BEHAVIOR;
   GREEN; POLICY; MANAGEMENT; INTENTION; ATTITUDES; RELIGION; BELIEFS
AB Many people think that only powerful institutions are effective to combat environmental problems, especially in government-guided countries such as China. This study contrasts people's beliefs in their own abilities to improve the environment to their perceptions of other powers (e.g. government, corporations, higher powers, and earth-cycles). Previous research explored the impact of internal and external control beliefs on individuals' pro environmental behavior mostly separately in developed Western countries. Since China's cultural and sociopolitical environment significantly differs from that of Western countries, we develop and test an integrated model of environmental locus of control (ELOC) to enlighten possible interactions and simultaneous effects in China. As expected, results indicate that internal ELOC generates positive effects on Chinese people's behaviors. But contrary to our predictions, external ELOC is positively correlated with internal factors and also positively influences behaviors. The belief in one's own abilities outperforms the belief in others to translate the confidence into reported behaviors. Nevertheless, Chinese perceive a higher level of governmental and corporate responsibility relative to their own environmental impacts which is driven by Confucian values (i.e. group orientation, belief in hierarchy). Compared to relatively consistent internal ELOC, the perceptions of most external ELOC factors significantly differ among provinces by levels of GDP per capita. Promotional programs should stress the individual's significance through daily behaviors in specific ways such as green purchase, activism, advocate (e.g. persuasion of friends), and recycling. Communicating the impact of powerful institutions might not necessarily trigger responsibility diffusion, but seems to promote the sense of shared responsibility.
C1 [Yang, Xisi; Weber, Anja] HHL Leipzig Grad Sch Management, Jahnallee 59, D-04109 Leipzig, Germany.
RP Yang, XS (reprint author), HHL Leipzig Grad Sch Management, Jahnallee 59, D-04109 Leipzig, Germany.
EM xisi.yang@hhl.de
OI Weber, Anja/0000-0002-5896-748X
CR Ackerman D, 2009, J BUS ETHICS, V88, P473, DOI 10.1007/s10551-009-0304-9
   Agan Y, 2016, J CLEAN PROD, V112, P1872, DOI 10.1016/j.jclepro.2014.08.090
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Allen JB, 1999, ENVIRON BEHAV, V31, P338, DOI 10.1177/00139169921972137
   Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002
   Baxter J, 2016, RESOUR CONSERV RECY, V109, P96, DOI 10.1016/j.resconrec.2016.02.012
   Biel A, 2005, AMBIO, V34, P360, DOI 10.1639/0044-7447(2005)034[0360:HAVPB]2.0.CO;2
   Bodur M, 2005, ENVIRON BEHAV, V37, P487, DOI 10.1177/0013916504269666
   Borick C., ISSUES ENERGY ENV PO
   Bradburn N. M., 1980, OXFORD J
   Bradley G. L., 2002, J SERV RES-US, V4, P312, DOI DOI 10.1177/
   Busseri MA, 1998, J APPL SOC PSYCHOL, V28, P1067, DOI 10.1111/j.1559-1816.1998.tb01668.x
   Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003
   Chan R.Y.K, 2000, BUS HORIZONS, P55, DOI DOI 10.1016/50007-6813(00)88561-4
   Cho YN, 2013, J BUS RES, V66, P1052, DOI 10.1016/j.jbusres.2012.08.020
   Cleveland M, 2005, J CONSUM MARK, V22, P198, DOI 10.1108/07363760510605317
   Cleveland M, 2012, PSYCHOL MARKET, V29, P293, DOI 10.1002/mar.20522
   Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297
   DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589
   Dasgupta S, 2001, ECOL ECON, V36, P487, DOI 10.1016/S0921-8009(00)00249-4
   Dendler L, 2016, J CLEAN PROD, V134, P239, DOI 10.1016/j.jclepro.2016.02.141
   Dono J, 2010, J ENVIRON PSYCHOL, V30, P178, DOI 10.1016/j.jenvp.2009.11.006
   Douglas SP, 2007, J INT MARKETING, V15, P30, DOI 10.1509/jimk.15.1.030
   Fielding KS, 2012, ENVIRON EDUC RES, V18, P171, DOI 10.1080/13504622.2011.592936
   Fielding KS, 2008, J ENVIRON PSYCHOL, V28, P318, DOI 10.1016/j.jenvp.2008.03.003
   Fornell C., 1981, STRUCTURAL EQUATION
   Forsyth DR, 2002, PERS SOC PSYCHOL B, V28, P54, DOI 10.1177/0146167202281005
   Fryxell GE, 2004, J ENVIRON MANAGE, V71, P45, DOI 10.1016/j.jenvman.2004.01.005
   GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815
   GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227
   Grinstein A, 2015, J INT BUS STUD, V46, P694, DOI 10.1057/jibs.2015.1
   Groening C, 2018, J CLEAN PROD, V172, P1848, DOI 10.1016/j.jclepro.2017.12.002
   Grunert KG, 2005, EUR REV AGRIC ECON, V32, P369, DOI 10.1093/eurrag/jbi011
   GUAGNANO GA, 1995, POPUL ENVIRON, V17, P63, DOI 10.1007/BF02208278
   Hadler M, 2011, INT SOCIOL, V26, P315, DOI 10.1177/0268580910392258
   Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202
   HALLAL JC, 1982, NURS RES, V31, P137
   Hanss D, 2016, SUSTAIN DEV, V24, P357, DOI 10.1002/sd.1615
   Harman H. H., 1961, J AM STAT ASSOC, V56, P444, DOI [10.2307/2282293, DOI 10.2307/2282293]
   Harris PG, 2006, ENVIRON BEHAV, V38, P5, DOI 10.1177/0013916505280087
   Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928
   Hew JJ, 2015, IND MANAGE DATA SYST, V115, P1269, DOI 10.1108/IMDS-01-2015-0028
   Hines J., 1987, J ENVIRON EDUC, V18, P1, DOI DOI 10.1080/00958964.1987.9943482
   Hoffman DL, 2003, J PUBLIC POLICY MARK, V22, P41, DOI 10.1509/jppm.22.1.41.17628
   Huebner RB, 1981, BASIC APPL SOC PSYCH, V2, P45, DOI 10.1207/s15324834basp0201_4
   Jenkins W, 2011, ANNU REV ENV RESOUR, V36, P441, DOI 10.1146/annurev-environ-042610-103728
   Jin YN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121219
   Johnson T, 2005, J CROSS CULT PSYCHOL, V36, P264, DOI 10.1177/0022022104272905
   Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693
   Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80
   Kalamas M, 2014, J BUS RES, V67, P12, DOI 10.1016/j.jbusres.2013.03.007
   Kaplan H. R., 1987, J GAMBLING BEHAV, V3, P168, DOI DOI 10.1007/BF01367438
   Kim Bryan K, 2005, Cultur Divers Ethnic Minor Psychol, V11, P187, DOI 10.1037/1099-9809.11.3.187
   Klockner CA, 2013, GLOBAL ENVIRON CHANG, V23, P1028, DOI 10.1016/j.gloenvcha.2013.05.014
   Knight J., 1999, OUP CATALOGUE
   Koo DM, 2009, COMPUT HUM BEHAV, V25, P466, DOI 10.1016/j.chb.2008.10.010
   Larson LR, 2015, J ENVIRON PSYCHOL, V43, P112, DOI 10.1016/j.jenvp.2015.06.004
   Le Monkhouse L, 2013, ASIA PAC BUS REV, V19, P320, DOI 10.1080/13602381.2012.732388
   Lee N, 2013, J BUS RES, V66, P242, DOI 10.1016/j.jbusres.2012.08.004
   Lee Z, 2011, EUR J MARKETING, V45, P703, DOI 10.1108/03090561111119994
   Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x
   Liu XB, 2010, J ENVIRON MANAGE, V91, P1707, DOI 10.1016/j.jenvman.2010.03.011
   Lo CWH, 2005, J DEV STUD, V41, P558, DOI 10.1080/00220380500092655
   lyer E. S., 2007, J CONSUM BEHAV, V6, P32, DOI [DOI 10.1002/CB.206, 10.1002/cb]
   McCarty JA, 2001, J PUBLIC POLICY MARK, V20, P93, DOI 10.1509/jppm.20.1.93.17291
   McDonald S, 2006, PSYCHOL MARKET, V23, P515, DOI 10.1002/mar.20132
   Milfont TL, 2006, ENVIRON BEHAV, V38, P745, DOI 10.1177/0013916505285933
   Miliute-Plepiene J, 2016, RESOUR CONSERV RECY, V113, P40, DOI 10.1016/j.resconrec.2016.05.008
   Ministry of Agriculture, 2015, NAT RUR SUST DEV PLA
   Morren M, 2016, J ENVIRON PSYCHOL, V47, P91, DOI 10.1016/j.jenvp.2016.05.003
   Muldavin J, 2000, ECON GEOGR, V76, P244, DOI 10.2307/144292
   National Bureau of Statistics of China, 2017, CHIN STAT YB 2017
   National Bureau of Statistics of China, 2016, NAT DAT ED
   Ng M., 2015, ASIAN J BUS RES, V5, P1, DOI DOI 10.1016/J.INPA.2015.05.001
   Noronha C, 2013, CORP SOC RESP ENV MA, V20, P29, DOI 10.1002/csr.1276
   Overmyer DL, 2003, CHINA QUART, P307, DOI 10.1017/S0009443903000196
   PARKES KR, 1984, J PERS SOC PSYCHOL, V46, P655, DOI 10.1037/0022-3514.46.3.655
   Pavalache-Ilie M, 2012, PROCD SOC BEHV, V33, P198, DOI 10.1016/j.sbspro.2012.01.111
   PEW-TEMPLETON, 2018, CHIN REL DEM AFF
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879
   Ramayah T, 2010, RESOUR CONSERV RECY, V54, P1419, DOI 10.1016/j.resconrec.2010.06.007
   Rauwald KS, 2002, ENVIRON BEHAV, V34, P709, DOI 10.1177/001391602237243
   ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976
   Rural Development Institute Chinese Academy of Social Sciences (RDICASS), 2016 2017 RUR EC CHI
   Schroeder P, 2014, J CLEAN PROD, V63, P64, DOI 10.1016/j.jclepro.2013.05.039
   Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255
   SCHWEPKER CH, 1991, J PUBLIC POLICY MARK, V10, P77, DOI 10.1177/074391569101000205
   Shao M, 2006, FRONT ECOL ENVIRON, V4, P353, DOI 10.1890/1540-9295(2006)004[0353:CCICAA]2.0.CO;2
   Shu CL, 2016, J BUS ETHICS, V133, P471, DOI 10.1007/s10551-014-2401-7
   State Council of China (SCC), 2016, FULL TEXT REP WORK G
   Stern P.C., 1999, HUMAN ECOLOGY REVIEW, V6, P81, DOI DOI 10.2307/2083693
   Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005
   Thogersen J, 2012, J MARKET MANAG-UK, V28, P313, DOI 10.1080/0267257X.2012.658834
   Thomas C, 2013, RESOUR CONSERV RECY, V79, P11, DOI 10.1016/j.resconrec.2013.04.010
   Trivedi RH, 2015, MARK INTELL PLAN, V33, P67, DOI 10.1108/MIP-03-2012-0028
   WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107
   Wan C, 2014, RESOUR CONSERV RECY, V83, P141, DOI 10.1016/j.resconrec.2013.12.009
   Wang P, 2014, J CLEAN PROD, V63, P152, DOI 10.1016/j.jclepro.2013.05.007
   Wang Y., 2016, RESOURCES CONSERVATI, V128, P187
   WANG Y, 2003, ENVIRON IMPACT ASSES, V23, P543, DOI DOI 10.1016/S0195-9255(03)00071-4
   Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014
   Xiuzhen C., 2002, ENVIRON IMPACT ASSES, V22, P101
   Zhan XY, 2013, PUBLIC ADMIN, V91, P381, DOI 10.1111/j.1467-9299.2011.02011.x
   Zhang B, 2008, J CLEAN PROD, V16, P1036, DOI 10.1016/j.jclepro.2007.06.016
   Zhang XP, 2009, ECOL ECON, V68, P2706, DOI 10.1016/j.ecolecon.2009.05.011
   Zhu QH, 2005, INT J OPER PROD MAN, V25, P449, DOI 10.1108/01443570510593148
   Zhu QY, 2016, INT J PROD ECON, V181, P289, DOI 10.1016/j.ijpe.2016.06.006
   ZUO JP, 1991, SOCIOL ANAL, V52, P99, DOI 10.2307/3710718
NR 109
TC 3
Z9 3
U1 8
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 55
EP 67
DI 10.1016/j.resconrec.2019.03.005
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900006
DA 2020-05-12
ER

PT J
AU Ioannidou, D
   Pommier, R
   Habert, G
   Sonnemann, G
AF Ioannidou, Dimitra
   Pommier, Regis
   Habert, Guillaume
   Sonnemann, Guido
TI Evaluating the risks in the construction wood product system through a
   criticality assessment framework
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Criticality; Wood; Biotic resources; Supply risk
ID ECOSYSTEM SERVICES; CLIMATE-CHANGE; FOREST CERTIFICATION; CHANGE
   IMPACTS; RESOURCES; BENEFITS; DEFORESTATION; BIODIVERSITY; MANAGEMENT;
   TIMBER
AB The increasing use of wood in product eco-design focuses on the environmental merits of wood. Nevertheless, forest cover loss and other threats may hamper the supply of certain wood species, hence significantly impacting the economic sector. Supply risk has been intensively studied in the field of mineral resources; this has led to the emergence of the criticality concept, which evaluates the supply risks and main impacts of limited accessibility. In the case of biotic, renewable resources, lack of sustainable management can result in supply shortage. We developed here a criticality framework for wood to assess the risk of supply shortage of different wood species in different regions. Our motivation to look at wood is that it is the biotic resource most used in construction. The indicators used in the framework express all factors that can disturb the forest growth, such as fire and diseases, the sustainable supply of harvested wood, such as trade barriers and country governance, as well as the impacts of the aforementioned factors on the construction wood product system. The value of the framework and of the observations that can be derived thereof is shown through application to four different wood species. Such a criticality assessment can help define points of intervention at different geographic scales.
C1 [Ioannidou, Dimitra; Sonnemann, Guido] Univ Bordeaux, ISM, UMR 5255, F-33400 Talence, France.
   [Ioannidou, Dimitra; Sonnemann, Guido] CNRS, UMR 5255, ISM, F-33400 Talence, France.
   [Pommier, Regis] Univ Bordeaux, CNRS, UMR 5295, I2M, Talence, France.
   [Habert, Guillaume] Swiss Fed Inst Technol, Chair Sustainable Construct, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland.
RP Sonnemann, G (reprint author), Univ Bordeaux, ISM, UMR 5255, F-33400 Talence, France.
EM guido.sonnemann@u-bordeaux.fr
RI , Habert/Q-3853-2019; Ioannidou, Dimitra/C-4558-2017
OI , Habert/0000-0003-3533-7896; pommier, regis/0000-0002-9854-2961;
   Ioannidou, Dimitra/0000-0001-5461-1139
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [P2EZP2_175297]
FX D.I. thanks the Swiss National Science Foundation (project
   P2EZP2_175297). We thank S. Cahoon, G. Christensen, C. Barnett and C.
   Toney from U.S. Forest Service for provision of data on spruce. The
   authors thank the reviewers for their valuable feedback to an earlier
   draft of the manuscript.
CR Achzet B, 2013, RESOUR POLICY, V38, P435, DOI 10.1016/j.resourpol.2013.06.003
   Agrawal A., 2013, 1 UN FOR FOR
   [Anonymous], 2006, 14040 ISO, DOI [10.1016/j.ecolind.2011.01.007, DOI 10.1016/J.ECOLIND.2011.01.007]
   Arbellay E, 2017, TREE PHYSIOL, V37, P1611, DOI 10.1093/treephys/tpx102
   Bach V, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010137
   Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947
   Bare JC, 2000, INT J LIFE CYCLE ASS, V5, P319, DOI 10.1007/BF02978665
   Bellassen V, 2014, NATURE, V506, P153, DOI 10.1038/506153a
   Blackman A, 2017, INT FOREST REV, V19, P247, DOI 10.1505/146554817821865072
   Blackman A, 2015, DOES ECOCERTIFICATIO
   Blaser J., 2007, INITIAL ANAL MITIGAT
   Blengini GA., 2017, ASSESSMENT METHODOLO, DOI [10.2760/73303, DOI 10.2760/73303]
   Bosch M, 2015, RESOUR CONSERV RECY, V94, P99, DOI 10.1016/j.resconrec.2014.11.014
   Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773
   Bradshaw Alex M., 2013, Green, V3, P93, DOI 10.1515/green-2013-0014
   Bradshaw CJA, 2012, J PLANT ECOL, V5, P109, DOI 10.1093/jpe/rtr038
   Brander JA, 1998, AM ECON REV, V88, P119
   Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x
   Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002
   Cuaresma JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40678
   DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756
   European Commission, 2018, REP CRIT RAW MAT CIR, DOI [10.1097/PPO.0b013e3181b9c5d5, DOI 10.1097/PPO.0B013E3181B9C5D5]
   European Commission, 2010, EUCOM, V39, P1, DOI [10.1002/eji.200839120.1L-17-Producing, DOI 10.1002/EJI.200839120.IL-17-PRODUCING]
   European Commission, 2014, REP CRIT RAW MAT EU
   FAO, 2001, FAO FOR PLANT THEM P
   FAO, 2016, STAT WORLDS FOR 2016
   FAO, 2014, STAT WORLDS FOR ENH, DOI [10.1103/PhysRevLett.74.2694, DOI 10.1103/PHYSREVLETT.74.2694]
   Food and Agriculture Organization, 2015, FAO COUNTR REP 2015, V2015
   Food and Agriculture Organization UNECE, 2018, FOR PROD ANN MARK RE
   Gonzalez-Garcia S, 2011, INT J LIFE CYCLE ASS, V16, P224, DOI 10.1007/s11367-011-0261-2
   Graedel TE, 2016, J IND ECOL, V20, P692, DOI 10.1111/jiec.12305
   Graedel TE, 2015, P NATL ACAD SCI USA, V112, P4257, DOI 10.1073/pnas.1500415112
   Graedel TE, 2012, ENVIRON SCI TECHNOL, V46, P1063, DOI 10.1021/es203534z
   Gustavsson L, 2006, BUILD ENVIRON, V41, P940, DOI 10.1016/j.buildenv.2005.04.008
   Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]
   Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693
   Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012
   Hlasny T, 2017, REG ENVIRON CHANGE, V17, P65, DOI 10.1007/s10113-015-0894-y
   Hofstede G, 2011, ONLINE READ PSYCHOL, DOI [10.9707/2307-0919.1014, DOI 10.9707/2307-0919.1014]
   Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009
   Howard J. L., 2017, FPLRN0348
   International Union for Conservation of Nature and Natural Resources, 2000, IUCN RED LIST CAT CR
   Ioannidou D., 2019, J IND ECOL, P1
   Ioannidou D, 2017, RESOUR CONSERV RECY, V126, P25, DOI 10.1016/j.resconrec.2017.07.016
   Kates RW, 2011, P NATL ACAD SCI USA, V108, P19449, DOI 10.1073/pnas.1116097108
   Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014
   Kirilenko AP, 2007, P NATL ACAD SCI USA, V104, P19697, DOI 10.1073/pnas.0701424104
   Kissinger G., 2012, DRIVERS DEFORESTATIO
   Kopnina H, 2017, ENVIRON CONSERV, V44, P24, DOI 10.1017/S0376892916000436
   Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111
   Lissouck RO, 2016, J TROP FOR SCI, V28, P4
   Lopatin E, 2016, FORESTS, V7, DOI 10.3390/f7040085
   Lukumbuzya K., 2017, OVERVIEW TIMBER TRAD
   McDermott CL, 2015, FOREST POLICY ECON, V50, P134, DOI 10.1016/j.forpol.2014.05.011
   Nabuurs GJ, 2002, GLOBAL CHANGE BIOL, V8, P304, DOI 10.1046/j.1354-1013.2001.00470.x
   Nassar NT, 2012, ENVIRON SCI TECHNOL, V46, P1071, DOI 10.1021/es203535w
   National Research Council, 2008, MIN CRIT MIN US EC, DOI [10.17226/12034, DOI 10.17226/12034]
   Nuss P, 2014, ENVIRON SCI TECHNOL, V48, P4171, DOI 10.1021/es405044w
   Ojea E, 2016, WORLD DEV, V78, P246, DOI 10.1016/j.worlddev.2015.10.002
   Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295
   Pommier R, 2016, INT J LIFE CYCLE ASS, V21, P265, DOI 10.1007/s11367-015-1009-1
   Pretzsch H., 2010, FOREST DYNAMICS GROW, DOI [10.1007/978-3.540-88307-4, DOI 10.1007/978-3.540-88307-4]
   Ramage MH, 2017, RENEW SUST ENERG REV, V68, P333, DOI 10.1016/j.rser.2016.09.107
   Rowe R, 2013, BBC
   Salomon RL, 2016, CAN J FOREST RES, V46, P1059, DOI 10.1139/cjfr-2016-0121
   Seidl R, 2011, CLIMATIC CHANGE, V106, P225, DOI 10.1007/s10584-010-9899-1
   Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036
   Sonderegger T, 2015, ENVIRON SCI TECHNOL, V49, P12315, DOI 10.1021/acs.est.5b02982
   Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x
   Suter F, 2017, J IND ECOL, V21, P874, DOI 10.1111/jiec.12486
   Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193
   Uhde B, 2015, ENVIRON MANAGE, V56, P373, DOI 10.1007/s00267-015-0503-3
   UNEP, 2017, CONV INT TRAD END SP
   Vangansbeke P, 2017, BIODIVERS CONSERV, V26, P3213, DOI 10.1007/s10531-016-1135-5
NR 74
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 68
EP 76
DI 10.1016/j.resconrec.2019.03.021
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900007
DA 2020-05-12
ER

PT J
AU Hang, Y
   Wang, QW
   Zhou, DQ
   Zhang, L
AF Hang, Ye
   Wang, Qunwei
   Zhou, Dequn
   Zhang, Lu
TI Factors influencing the progress in decoupling economic growth from
   carbon dioxide emissions in China's manufacturing industry
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Manufacturing industry; Decoupling analysis; PDA-IDA method;
   Technological progress
ID INDEX DECOMPOSITION ANALYSIS; ENERGY-CONSUMPTION; CO2 EMISSIONS;
   PRODUCTIVITY GROWTH; MALMQUIST INDEXES; DISTANCE FUNCTION; INTENSITY
   CHANGE; ATTRIBUTION; PERFORMANCE; DRIVERS
AB Manufacturing industry occupies an important position in China's national economy, and its decoupling from carbon dioxide emissions largely determines the realization of China's transition to a green economy. This paper uses the Tapio decoupling indicator to explore the decoupling status between manufacturing value added and carbon dioxide emissions in China from 1995 to 2015. Then, the improved production-theoretical decomposition analysis-index decomposition analysis (PDA-IDA) method is proposed to analyze the factors influencing changes in decoupling status, with the technology heterogeneity of manufacturing sub-sectors considered. The results show that China's manufacturing industry experiences a decoupling development trend from 1995 to 2015. The potential energy intensity is the dominant factor in promoting the decoupling development of manufacturing industry, while the output scale effect is the main inhibitory factor. In addition, industrial restructuring and adjustment in carbon density are far from achieving the expected emission reduction effects, while the effects of technological progress and technical efficiency on the decoupling are relatively small.
C1 [Hang, Ye; Wang, Qunwei; Zhou, Dequn; Zhang, Lu] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, 29 Jiangjun Ave, Nanjing 211106, Jiangsu, Peoples R China.
   [Hang, Ye; Wang, Qunwei; Zhou, Dequn; Zhang, Lu] Nanjing Univ Aeronaut & Astronaut, Res Ctr Soft Energy Sci, 29 Jiangjun Ave, Nanjing 211106, Jiangsu, Peoples R China.
RP Wang, QW (reprint author), Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, 29 Jiangjun Ave, Nanjing 211106, Jiangsu, Peoples R China.
EM wqw0305@126.com
OI Wang, Qunwei/0000-0002-3878-2832
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71573186, 71834003]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities [NE2017005, NW2018002]; Six Talents Peak Project of Jiangsu
   Province [JY-032]
FX Authors are grateful to the financial support from the National Natural
   Science Foundation of China (nos. 71573186 & 71834003), the Fundamental
   Research Funds for the Central Universities (nos. NE2017005 &
   NW2018002), and Six Talents Peak Project of Jiangsu Province (no.
   JY-032).
CR Afsharian M, 2015, ANN OPER RES, V226, P1, DOI 10.1007/s10479-014-1668-5
   Ang BW, 2015, ENERG ECON, V51, P67, DOI 10.1016/j.eneco.2015.06.004
   Ang BW, 2015, ENERG POLICY, V86, P233, DOI 10.1016/j.enpol.2015.07.007
   Ang BW, 2015, ENERG ECON, V47, P68, DOI 10.1016/j.eneco.2014.10.011
   Ang BW, 2004, ENERG POLICY, V32, P1131, DOI 10.1016/S0301-4215(03)00076-4
   [Anonymous], 2016, CHIN STAT YB
   Chen B, 2017, RENEW SUST ENERG REV, V67, P662, DOI 10.1016/j.rser.2016.09.027
   Chen JD, 2019, ENERG ECON, V78, P589, DOI 10.1016/j.eneco.2018.12.011
   Chen SY, 2013, ENERG POLICY, V57, P52, DOI 10.1016/j.enpol.2012.08.060
   Dong B, 2016, ENERG POLICY, V97, P414, DOI 10.1016/j.enpol.2016.07.054
   Dong F, 2018, RESOUR CONSERV RECY, V129, P187, DOI 10.1016/j.resconrec.2017.10.035
   Eggleston H.S., 2006, 2006 IPCC GUIDELINES
   Fare R, 2007, ENERGY, V32, P1055, DOI 10.1016/j.energy.2006.09.005
   Hammond GP, 2012, ENERGY, V41, P220, DOI 10.1016/j.energy.2011.06.035
   Ji Q, 2019, J CLEAN PROD, V208, P1178, DOI 10.1016/j.jclepro.2018.10.167
   Ji Q, 2018, J CLEAN PROD, V198, P972, DOI 10.1016/j.jclepro.2018.07.126
   Kathuria V, 2012, PRODUCTIVITY MEASURE
   Li G, 2019, ANIMAL, V13, P2060, DOI [10.1017/S1751731118003440, 10.1017/s1751731118003440]
   Li G, 2019, ENVIRON TECHNOL, V40, P2620, DOI 10.1080/09593330.2018.1454513
   Li L, 2018, TECHNOL FORECAST SOC, V135, P66, DOI 10.1016/j.techfore.2017.05.028
   Liang S, 2014, ENVIRON SCI TECHNOL, V48, P1103, DOI 10.1021/es4042429
   Lin BQ, 2014, ENERGY, V76, P830, DOI 10.1016/j.energy.2014.08.082
   Lin BQ, 2014, APPL ENERG, V129, P158, DOI 10.1016/j.apenergy.2014.04.101
   [刘志迎 Liu Zhiying], 2013, [系统工程, Systems Engineering], V31, P14
   Macpherson AJ, 2013, ECOL INDIC, V34, P296, DOI 10.1016/j.ecolind.2013.05.009
   National Bureau of Statistics of China (NBSC), 1996, 1996 2016B CHIN STAT
   National Bureau of Statistics of China (NBSC), 1996, 1996 2016C CHIN IND
   National Bureau of Statistics of China (NBSC), 1996, 1996 2016A CHIN EN S
   OECD (Organization for Economic Co-operation and Development), 2002, IND MEAS DEC ENV PRE
   Pastor J. T., 2011, SOCIO-ECON PLAN SCI, V45, P10, DOI DOI 10.1016/J.SEPS.2010.09.001
   Pastor JT, 2005, ECON LETT, V88, P266, DOI 10.1016/j.econlet.2005.02.013
   Ren SG, 2014, ENVIRON DEV, V9, P61, DOI 10.1016/j.envdev.2013.11.003
   Ren SG, 2012, ENERG POLICY, V43, P407, DOI 10.1016/j.enpol.2012.01.021
   Shao S., 2017, CHINA IND EC, V3, P44
   Shestalova V, 2003, J PROD ANAL, V19, P211, DOI 10.1023/A:1022857501478
   State Council, 2015, NOT STAT COUNC PRINT
   Su B, 2014, ENERGY, V69, P778, DOI 10.1016/j.energy.2014.03.074
   Sun JS, 2018, J CLEAN PROD, V175, P561, DOI 10.1016/j.jclepro.2017.12.042
   Tapio P, 2005, TRANSP POLICY, V12, P137, DOI 10.1016/j.tranpol.2005.01.001
   Wang CH, 2007, ENERGY, V32, P1326, DOI 10.1016/j.energy.2006.10.001
   Wang CH, 2011, RESOUR ENERGY ECON, V33, P279, DOI 10.1016/j.reseneeco.2010.06.005
   Wang QW, 2018, ENERG ECON, V70, P12, DOI 10.1016/j.eneco.2017.12.014
   Wang QW, 2016, ENERGY, V113, P728, DOI 10.1016/j.energy.2016.07.108
   Wang QW, 2016, ENERG ECON, V56, P475, DOI 10.1016/j.eneco.2016.04.005
   Wang WW, 2017, ENERGY, V128, P11, DOI 10.1016/j.energy.2017.04.004
   Xu B, 2017, J CLEAN PROD, V166, P628, DOI 10.1016/j.jclepro.2017.08.052
   Xu B, 2016, J CLEAN PROD, V131, P594, DOI 10.1016/j.jclepro.2016.04.129
   Xu XY, 2014, APPL ENERG, V113, P342, DOI 10.1016/j.apenergy.2013.07.052
   Yang L, 2018, ENERGY, V160, P796, DOI 10.1016/j.energy.2018.06.186
   Zhang M, 2018, RESOUR CONSERV RECY, V129, P454, DOI 10.1016/j.resconrec.2016.06.021
   Zhang ZX, 2000, WORLD DEV, V28, P739, DOI 10.1016/S0305-750X(99)00154-0
   Zhao X, 2017, J CLEAN PROD, V142, P3500, DOI 10.1016/j.jclepro.2016.10.117
   Zhou P, 2008, ENERG ECON, V30, P1054, DOI 10.1016/j.eneco.2007.10.005
NR 53
TC 11
Z9 11
U1 12
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 77
EP 88
DI 10.1016/j.resconrec.2019.03.034
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900008
DA 2020-05-12
ER

PT J
AU Strangl, M
   Ortner, E
   Buettner, A
AF Strangl, Miriam
   Ortner, Eva
   Buettner, Andrea
TI Evaluation of the efficiency of odor removal from recycled HDPE using a
   modified recycling process
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Gas chromatography; Odor; Olfactometry; Plastic; Pollution; Stable
   isotope dilution analysis
ID THERMAL-OXIDATION; IDENTIFICATION; BOTTLES; WASTE; WATER
AB A series of recent global and local policymaking procecws is promoting or demanding developments in the recycling of post-consumer plastic packaging waste. After successfully clearing most hurdles in the PET bottle sector to promote a successful market launch of the recycled PET products, it is now important to take measures to meet the challenges associated with the recycling of polyolefins such as HDPE. In this respect, the need to further improve recycling technologies is currently prevalent because the quality parameters of the recycled materials do not yet meet the strict industrial requirements. In this context, apart from optical or mechanical properties, there is increasing awareness of odorous contaminants in the recycled products. Therefore, in this study, a modified HDPE recycling method was evaluated for its ability to reduce odors. For the aim of mapping and understanding the odor of recycled HDPE pellets with different residence times in a special decontamination reactor a combinatory sensory and instrumental-olfactometric approach was applied. Furthermore, based on the characterization of the causative odorants by gas chromatography-olfactometry and two-dimensional gas chromatography-mass spectrometry/olfactometry, quantitative determination of selected odorants was carried out over time using stable isotope dilution analysis. With regard to the decontamination efficacy of the evaluated decontamination process, we observed that the decrease in the concentration profiles of the monitored odorants went along with a sensorially relevant overall odor minimization of the recycled HDPE. The results of the study are aiding the adaptation of technological procedures for smell reduction or complete decontamination.
C1 [Strangl, Miriam; Buettner, Andrea] Friedrich Alexander Univ Erlangen Nurnberg, Chair Aroma & Smell Res, Emil Fischer Ctr, Henkestr 9, D-91054 Erlangen, Germany.
   [Strangl, Miriam; Ortner, Eva; Buettner, Andrea] Fraunhofer Inst Proc Engn & Packaging IVV, Giggenhauser Str 35, D-85354 Freising Weihenstephan, Germany.
RP Buettner, A (reprint author), Friedrich Alexander Univ Erlangen Nurnberg, Chair Aroma & Smell Res, Emil Fischer Ctr, Henkestr 9, D-91054 Erlangen, Germany.; Buettner, A (reprint author), Fraunhofer Inst Proc Engn & Packaging IVV, Giggenhauser Str 35, D-85354 Freising Weihenstephan, Germany.
EM miriam.strangl@ivv.fraunhofer.de; eva.ortner@ivv.fraunhofer.de;
   andrea.buettner@ivv.fraunhofer.de
RI Buettner, Andrea/E-2510-2011
OI Buettner, Andrea/0000-0002-6205-5125
FU Studienstiftung des Deutschen Volkes; Deutsche Gesellschaft fiir
   Abfallwirtschaft [13</SUP>C<INF>2]
FX Miriam Strangl has been supported by a PhD grant provided by the
   Studienstiftung des Deutschen Volkes. Furthermore, we are especially
   grateful to the Deutsche Gesellschaft fiir Abfallwirtschaft for the
   financial support regarding the isotopically labeled odorants
   [<SUP>2</SUP>H<INF>7</INF>]-methoxynaphthalene and
   [<SUP>13</SUP>C<INF>2</INF>]-verdyl acetate and to Der Gruner
   Punkt-Duales System Deutschland GmbH for supplying the sample materials.
CR AMOORE JE, 1978, CHEM SENS FLAV, V3, P57, DOI 10.1093/chemse/3.1.57
   Anouar BS, 2015, J SUPERCRIT FLUID, V98, P25, DOI 10.1016/j.supflu.2014.12.022
   Barczak RJ, 2018, WATER SCI TECHNOL, V77, P759, DOI 10.2166/wst.2017.569
   Bemelmans J. M. H., 1979, APPL SCI, P79
   BRAVO A, 1992, J AGR FOOD CHEM, V40, P1881, DOI 10.1021/jf00022a031
   BRAVO A, 1993, J APPL POLYM SCI, V47, P1741, DOI 10.1002/app.1993.070471004
   Buettner A., 2001, ACS SYM SER, V782, P33, DOI DOI 10.1021/BK-2001-0782.CH004
   BUTTERY RG, 1973, J AGR FOOD CHEM, V21, P198, DOI 10.1021/jf60186a029
   Camacho W, 2001, POLYM DEGRAD STABIL, V71, P123
   Consultic Marketing & Industrieberatung GmbH, 2016, PROD VER VERW KUNSTS
   Devlieghere F, 1998, FOOD ADDIT CONTAM, V15, P336, DOI 10.1080/02652039809374649
   Engel W, 1999, EUR FOOD RES TECHNOL, V209, P237, DOI 10.1007/s002170050486
   European Comission, 2018, COS EUR COMM DAT INF
   European Commission & Secretariat-General, 2018, COMM COMM EUR PARL C
   Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533
   Hallaji K., 2015, PROCESS PRODUCING PC
   Hopewell J, 2009, PHILOS T R SOC B, V364, P2115, DOI 10.1098/rstb.2008.0311
   IK Industrievereinigung Kunststoffverpackungen e. V, 2017, VERW REC KUNSTST DUR
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Landbell AG, 2018, VERP INF DE
   Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w
   Project MainStream Ellen Mac Arthur Foundation World Economic Forum & McKinsey Company, 2016, NEW PLAST EC RETH FU
   Scarola L S., 1998, PROCESS REMOVING VOL
   STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162
   Strangl M, 2018, J CLEAN PROD, V181, P599, DOI 10.1016/j.jclepro.2018.01.137
   Strangl M, 2017, J SEP SCI, V40, P1500, DOI 10.1002/jssc.201601077
   TUDOS F, 1988, ACTA POLYM, V39, P19, DOI 10.1002/actp.1988.010390105
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Welle F., 2005, DEV FOOD GRADE HDPE
   Widen H, 2005, FOOD ADDIT CONTAM, V22, P681, DOI 10.1080/02652030500159987
NR 30
TC 3
Z9 3
U1 6
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 89
EP 97
DI 10.1016/j.resconrec.2019.03.009
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900009
DA 2020-05-12
ER

PT J
AU Wu, BB
   Li, TX
   Balezentis, T
   Streimikiene, D
AF Wu, Beibei
   Li, Tianxiang
   Balezentis, Tomas
   Streimikiene, Dalia
TI Impacts of income growth on air pollution-related health risk:
   Exploiting objective and subjective measures
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Gaseous pollutant; Particulate matter; Household income; Health risk;
   China
ID SELF-RATED HEALTH; CO2 EMISSIONS; MORTALITY; EXPOSURE; STROKE;
   ASSOCIATION
AB China's remarkable economic growth during the past four decades has resulted in a number of environmental problems. However, very few studies have addressed the interactive impact of both income and air pollution on public health. Thus, an innovative contribution of this paper is to test whether household income growth (HIG) can mitigate the health risks resulting from air pollution in China. More specifically, using pooled data from the China Health and Retirement Longitudinal Study and official statistical data, we try to estimate the interactive impact of HIG and air pollution-related health risks by employing an ordered logistic regression model, and compare these effects across different levels of pollution and education attainment. Our results indicate that HIG can significantly reduce the health risks of air pollution, especially those health risks caused by gaseous pollutants (SO2 and NOx). However, HIG fails to offset the adverse health effect induced by particulate matter (PM). Further, heterogeneity analysis shows that the health benefits from incomes vary greatly among different regions. HIG can mitigate the health risks of NOx to people in heavily polluted regions. In terms of education level, HIG can significantly raise the self-rated health level for groups with different educational backgrounds, but HIG of the highly educated group can significantly offset the health losses due to air pollution.
C1 [Wu, Beibei; Li, Tianxiang] Nanjing Agr Univ, Coll Econ & Management, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China.
   [Wu, Beibei; Li, Tianxiang] Nanjing Agr Univ, China Ctr Food Secur Studies, Nanjing 210095, Jiangsu, Peoples R China.
   [Balezentis, Tomas; Streimikiene, Dalia] Lithuanian Inst Agr Econ, Kudirkos 18-2, LT-03105 Vilnius, Lithuania.
RP Li, TX (reprint author), Nanjing Agr Univ, Coll Econ & Management, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China.
EM babewu@foxmail.com; txl0428@njau.edu.cn; tomas@laei.lt;
   dalia@mail.lei.lt
RI Balezentis, Tomas/D-8609-2015; Streimikiene, Dalia/AAD-7762-2020
OI Balezentis, Tomas/0000-0002-3906-1711; 
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71803085, 71703071, 71703072, 71773051, 71673142];
   China Postdoctoral Science FoundationChina Postdoctoral Science
   Foundation [2017M621766]; Postdoctoral Research Funding Scheme of
   Jiangsu Province [2018K066B]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [SKCX2017002]; Social Science Foundation of Jiangsu Province [15JD018];
   Priority Academic Program Development (PAPD) of Jiangsu Higher Education
   Institutions; Jiangsu Center for Food Security Studies; Collaborative
   Innovation Center of Modern Grain Circulation Safety
FX Supported by the National Natural Science Foundation of China (71803085,
   71703071, 71703072, 71773051 and 71673142), the China Postdoctoral
   Science Foundation (2017M621766), the Postdoctoral Research Funding
   Scheme of Jiangsu Province (2018K066B), and the Fundamental Research
   Funds for the Central Universities (SKCX2017002). The base project of
   the Social Science Foundation of Jiangsu Province (15JD018) is also
   acknowledged. The authors are also grateful for the support from
   Priority Academic Program Development (PAPD) of Jiangsu Higher Education
   Institutions, Jiangsu Center for Food Security Studies, and the
   Collaborative Innovation Center of Modern Grain Circulation& Safety. The
   usual disclaimers apply.
CR Alberini A, 1997, J ENVIRON ECON MANAG, V34, P107, DOI 10.1006/jeem.1997.1007
   Atkociuniene V, 2017, TRANSFORM BUS ECON, V16, P73
   Auffhammer M, 2008, J ENVIRON ECON MANAG, V55, P229, DOI 10.1016/j.jeem.2007.10.002
   Barker T, 2000, OECD ANCILLARY BENEF, P413
   BATES DV, 1992, ENVIRON RES, V59, P336, DOI 10.1016/S0013-9351(05)80040-4
   Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3
   Bickel Peter, 2005, EXTERNE EXTERNALITIE
   Chay KY, 2003, Q J ECON, V118, P1121, DOI 10.1162/00335530360698513
   Chen JD, 2018, TRANSFORM BUS ECON, V17, P112
   Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425
   Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110
   Currie J, 2015, AM ECON REV, V105, P678, DOI 10.1257/aer.20121656
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Duvaljouve M. J., 2003, B SOCIA TA BOT FR, V16, P381
   Ebenstein A, 2012, REV ECON STAT, V94, P186, DOI 10.1162/REST_a_00150
   Fang ST, 2018, MANAG ENVIRON QUAL, V29, P240, DOI 10.1108/MEQ-07-2017-0063
   Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2
   Halkos GE, 2013, ECOL ECON, V91, P48, DOI 10.1016/j.ecolecon.2013.04.002
   Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43
   Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B
   Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187
   Huang DS, 2012, ENVIRON SCI POLICY, V15, P38, DOI 10.1016/j.envsci.2011.09.007
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359
   Kabir Z, 2007, Ir Med J, V100, P367
   Kan HD, 2004, SCI TOTAL ENVIRON, V322, P71, DOI 10.1016/j.scitotenv.2003.09.010
   Li H. B., 2008, J COMP COMP EC, V34, P668
   Lin YL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030438
   LIU R, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/su10051613
   Liu XY, 2012, J CLEAN PROD, V23, P113, DOI 10.1016/j.jclepro.2011.09.027
   Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182
   Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Rohde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135749
   Rupasingha A, 2004, PAP REG SCI, V83, P407, DOI 10.1111/j.1435-5597.2004.tb01915.x
   Samoli E, 2008, ENVIRON HEALTH PERSP, V116, P1480, DOI 10.1289/ehp.11345
   Scasny M, 2015, ENVIRON RESOUR ECON, V62, P383, DOI 10.1007/s10640-015-9969-y
   Smith JP, 2007, J HUM RESOUR, V42, P739
   Song ML, 2018, RESOUR CONSERV RECY, V128, P197, DOI 10.1016/j.resconrec.2016.08.015
   Spadaro J. V, 2002, INT J RISK ASSESS MA, V3, P1
   Suder A, 2018, TECHNOL ECON DEV ECO, V24, P844, DOI 10.3846/20294913.2016.1216905
   Sun C, 2017, ECOL ECON, V131, P468, DOI 10.1016/j.ecolecon.2016.06.030
   Sun D, 2018, RESOUR CONSERV RECY, V129, P416, DOI 10.1016/j.resconrec.2016.09.021
   [涂正革 Tu Zhengge], 2018, [中国人口·资源与环境, China Population Resources and Environment], V28, P130
   Wang R, 2015, INT J ENV RES PUB HE, V12, P1834, DOI 10.3390/ijerph120201834
   Wang WD, 2018, CHIN J POPUL RESOUR, V16, P120, DOI 10.1080/10042857.2018.1480689
   WANG Y, 2018, SUSTAINABILITY-BASEL, V10, DOI [DOI 10.3390/SU10082865, DOI 10.3390/su10082865]
   Warlenius R, 2015, GLOBAL ENVIRON CHANG, V30, P21, DOI 10.1016/j.gloenvcha.2014.10.014
   Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47
   Xiao YY, 2018, RESOUR CONSERV RECY, V129, P1, DOI 10.1016/j.resconrec.2017.10.002
   Xu B, 2015, J CLEAN PROD, V101, P311, DOI 10.1016/j.jclepro.2015.03.088
   Zhang X, 2018, P NATL ACAD SCI USA, V115, P9193, DOI 10.1073/pnas.1809474115
   Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203
   Zheng XS, 2018, TRANSFORM BUS ECON, V17, P507
   ZHOU Q, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9101741
NR 55
TC 3
Z9 3
U1 7
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 98
EP 105
DI 10.1016/j.resconrec.2019.03.037
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900010
DA 2020-05-12
ER

PT J
AU Phonphoton, N
   Pharino, C
AF Phonphoton, Nuchcha
   Pharino, Chanathip
TI Multi-criteria decision analysis to mitigate the impact of municipal
   solid waste management services during floods
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Analytic hierarchy process (AHP); Bangkok Metropolitan Administration
   (BMA); Flood; Municipal solid waste management (MSWM); Multi-criteria
   decision analysis (MCDA)
ID ANALYTICAL HIERARCHY PROCESS; STAKEHOLDERS; GIS
AB The efficiency of municipal solid waste management (MSWM) services indicates the sustainability of a city. Sustainable development goals (SDGs) are defined as sustainable global agenda covering normal and disaster situations as per goal#11, to make sustainable cities and communities with holistic disaster risk management. Local governments are among the target groups to adopt and implement local disaster risk reduction strategies. Mitigation plans are highly important, especially during crises such as flooding that have the potential to disrupt regular waste management services in cities.
   This study aims to identify practical approaches for impact mitigation and preparedness of MSWM services during floods. In this study, Multi-Criteria Decision Analysis (MCDA) is applied, using a panel of responsible providers and waste management and town planning specialists to assess appropriate impact mitigation alternatives. Flood impacts on MSWM in cities are classified into three situations: 1) Cannot collect waste from sources (CNC), 2) Cannot transfer waste for final disposal (CNT), and 3) Cannot collect and transfer waste for final disposal (CNC and CNT). The decision support system is designed based on the principles of sustainable development, and considers impacting criteria, namely environment, society and economic factors.
   The results show that modifying waste-hauling trucks is the most appropriate alternative for all situations to prepare for mitigating flood impact on MSWM services. The findings can help develop an appropriate mitigation management plan for waste management systems during floods that challenges practice to develop cities and communities sustainably and achieve the SDGs.
C1 [Phonphoton, Nuchcha] Chulalongkorn Univ, Grad Sch, Interdisciplinary Program Environm Sci, Bangkok 10330, Thailand.
   [Pharino, Chanathip] Chulalongkorn Univ, Fac Engn, Dept Environm Engn, Bangkok 10330, Thailand.
RP Pharino, C (reprint author), Chulalongkorn Univ, Fac Engn, Dept Environm Engn, Bangkok 10330, Thailand.
EM Nuchcha.ph@student.chula.ac.th; Chanathip.p@chula.ac.t
OI Challcharoenwattana, Amornchai/0000-0002-2313-1682
FU Ratchadaphiseksomphot Endowment Fund of Chulalongkorn
   UniversityChulalongkorn University; Thesis Grant of Interdisciplinary
   Program in Environmental Science, Graduate School, Chulalongkorn
   University
FX This study was supported by Ratchadaphiseksomphot Endowment Fund of
   Chulalongkorn University and the Thesis Grant of Interdisciplinary
   Program in Environmental Science, Graduate School, Chulalongkorn
   University. The authors would like to thank all experts in MSWM and
   flood experts for their time and contribution during interviews. Also,
   many thanks to MSWM authorities for their valuable inputs and supporting
   data.
CR Aragones-Beltran P, 2010, J ENVIRON MANAGE, V91, P1071, DOI 10.1016/j.jenvman.2009.12.007
   BMA, 2015, BANGK SOL WAST MAN P
   BMA, 2015, ACT PLAN CORR PREV F
   Brown C, 2011, WASTE MANAGE, V31, P1085, DOI 10.1016/j.wasman.2011.01.027
   Coban A, 2018, J CLEAN PROD, V180, P159, DOI 10.1016/j.jclepro.2018.01.130
   Contreras F, 2008, RESOUR CONSERV RECY, V52, P979, DOI 10.1016/j.resconrec.2008.03.003
   De Feo G, 2014, WASTE MANAGE, V34, P2225, DOI 10.1016/j.wasman.2014.05.028
   De Feo G, 2010, WASTE MANAGE, V30, P2370, DOI 10.1016/j.wasman.2010.04.010
   Melare AVD, 2017, WASTE MANAGE, V59, P567, DOI 10.1016/j.wasman.2016.10.045
   Garfi M, 2009, WASTE MANAGE, V29, P2729, DOI 10.1016/j.wasman.2009.05.019
   Guha-Sapir D, 2011, NAT HAZARDS, V58, P845, DOI 10.1007/s11069-011-9775-y
   Hanan D, 2013, WASTE MANAGE, V33, P566, DOI 10.1016/j.wasman.2012.06.007
   He F, 2016, EUR J OPER RES, V252, P246, DOI 10.1016/j.ejor.2015.12.048
   Hung ML, 2007, WASTE MANAGE, V27, P209, DOI 10.1016/j.wasman.2006.01.008
   Josimovic B, 2015, WASTE MANAGE, V36, P331, DOI 10.1016/j.wasman.2014.11.003
   Khanh NT, 2017, WASTE MANAGE, V59, P14, DOI 10.1016/j.wasman.2016.10.048
   Korucu MK, 2012, WASTE MANAGE, V32, P2315, DOI 10.1016/j.wasman.2012.07.003
   Kubota R, 2015, FLOOD WASTE MANAGEME
   Moeinaddini M, 2010, WASTE MANAGE, V30, P912, DOI 10.1016/j.wasman.2010.01.015
   Nations T. U, 2015, 2030 AG SUST DEV GOA
   Phonphoton N, 2019, WASTE MANAGE, V87, P525, DOI 10.1016/j.wasman.2019.02.036
   Saaty T. L, 2013, ANAL NETWORK PROCESS, V195
   Saaty TL, 1980, ANAL HIERARCHY PROCE
   Soltani A, 2015, WASTE MANAGE, V35, P318, DOI 10.1016/j.wasman.2014.09.010
   Tabata T, 2017, WASTE MANAGE, V61, P386, DOI 10.1016/j.wasman.2016.12.020
NR 25
TC 3
Z9 3
U1 3
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 106
EP 113
DI 10.1016/j.resconrec.2019.03.044
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900011
DA 2020-05-12
ER

PT J
AU Fraccascia, L
   Giannoccaro, I
   Albino, V
AF Fraccascia, Luca
   Giannoccaro, Ilaria
   Albino, Vito
TI Business models for industrial symbiosis: A taxonomy focused on the form
   of governance
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Industrial symbiosis; Sustainable business models; Taxonomy; Governance;
   Centralization; Circular economy
ID CIRCULAR ECONOMY; SUSTAINABLE DEVELOPMENT; QUANTITATIVE ASSESSMENT;
   VALUE CREATION; NETWORKS; PARKS; MANAGEMENT; PERSPECTIVE; INNOVATION;
   EVOLUTION
AB The aim of this paper is to propose a taxonomy of industrial symbiosis (IS) business models. Rather than to adopt a firm perspective, we take a system perspective and focus on the governance of the system made up of the firms implementing IS, being the latter considered an important factor influencing firm's competitive advantage. Four extreme IS business models are identified, characterized on the basis of two governance features: (1) need for coordination and (2) centralization of control. For each model, the main characteristics are presented and the main factors influencing firm value creation and value capture discussed. In doing so, our study contributes to clarify how and why firms applying IS practice can gain competitive advantage, a major gap in the current literature. Consequently, we contribute to the practical development of IS, which appears to be still not fully exploited by firms, despite its relevance.
C1 [Fraccascia, Luca] Sapienza Univ Rome, Dept Comp Control & Management Engn Antonio Ruber, Rome, Italy.
   [Fraccascia, Luca] Univ Twente, Dept Ind Engn & Business Informat Syst, Enschede, Netherlands.
   [Giannoccaro, Ilaria; Albino, Vito] Polytech Univ Bari, Dept Mech Math & Management, Bari, Italy.
RP Giannoccaro, I (reprint author), Polytech Univ Bari, Dept Mech Math & Management, Bari, Italy.
EM ilaria.giannoccaro@poliba.it
RI Giannoccaro, Ilaria/H-6875-2013; Londe, Pedro/AAG-2267-2019; FRACCASCIA,
   Luca/I-8078-2019
OI FRACCASCIA, Luca/0000-0002-6841-9823
CR Afshari H, 2018, RESOUR CONSERV RECY, V139, P315, DOI 10.1016/j.resconrec.2018.09.002
   Aid G, 2017, RESOUR CONSERV RECY, V124, P85, DOI 10.1016/j.resconrec.2017.04.007
   Albino V., 2015, P ENV SCI ENG MANAG, V2, P217
   Albino V, 2016, J CLEAN PROD, V112, P4353, DOI 10.1016/j.jclepro.2015.06.070
   Alfaro J, 2014, J IND ECOL, V18, P145, DOI 10.1111/jiec.12077
   Amit R, 2001, STRATEGIC MANAGE J, V22, P493, DOI 10.1002/smj.187
   Arikan AT, 2011, J MANAGE STUD, V48, P772, DOI 10.1111/j.1467-6486.2010.00951.x
   Ashton W, 2008, J IND ECOL, V12, P34, DOI 10.1111/j.1530-9290.2008.00002.x
   Ashton WS, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9040605
   Ashton WS, 2011, BUS STRATEG ENVIRON, V20, P297, DOI 10.1002/bse.696
   Aviso KB, 2014, PROCESS SAF ENVIRON, V92, P160, DOI 10.1016/j.psep.2012.12.001
   Aviso KB, 2010, CLEAN TECHNOL ENVIR, V12, P353, DOI 10.1007/s10098-009-0252-1
   Baas LW, 2004, J CLEAN PROD, V12, P1073, DOI 10.1016/j.jclepro.2004.02.005
   Bansal P, 2009, J SUPPLY CHAIN MANAG, V45, P26, DOI 10.1111/j.1745-493X.2009.03174.x
   Behera SK, 2012, J CLEAN PROD, V29-30, P103, DOI 10.1016/j.jclepro.2012.02.009
   Bocken NMP, 2014, J CLEAN PROD, V65, P42, DOI 10.1016/j.jclepro.2013.11.039
   Boix M, 2015, J CLEAN PROD, V87, P303, DOI 10.1016/j.jclepro.2014.09.032
   Boons F, 2017, J IND ECOL, V21, P938, DOI 10.1111/jiec.12468
   Boons F, 2013, J CLEAN PROD, V45, P9, DOI 10.1016/j.jclepro.2012.07.007
   Casadesus-Masanell R, 2010, LONG RANGE PLANN, V43, P195, DOI 10.1016/j.lrp.2010.01.004
   Chertow M, 2012, J IND ECOL, V16, P13, DOI 10.1111/j.1530-9290.2011.00450.x
   Chertow MR, 2007, J IND ECOL, V11, P11, DOI 10.1162/jiec.2007.1110
   Chertow MR, 2000, ANNU REV ENERG ENV, V25, P313, DOI 10.1146/annurev.energy.25.1.313
   Chopra SS, 2014, J ENVIRON MANAGE, V141, P86, DOI 10.1016/j.jenvman.2013.12.038
   Desrochers P, 2004, J CLEAN PROD, V12, P1099, DOI 10.1016/j.jclepro.2004.02.008
   Doganova L, 2009, RES POLICY, V38, P1559, DOI 10.1016/j.respol.2009.08.002
   Domenech T, 2019, ECOL ECON, V155, P7, DOI 10.1016/j.ecolecon.2017.11.001
   Domenech T, 2011, BUS STRATEG ENVIRON, V20, P281, DOI 10.1002/bse.695
   Dong L, 2017, ECOL MODEL, V361, P164, DOI 10.1016/j.ecolmodel.2017.07.032
   Ehrenfeld J.R., 1997, J IND ECOL, V1, P67, DOI DOI 10.1162/JIEC.1997.1.1.67
   Eilering J.A.M., 2004, PROGR IND ECOLOGY, V1, P245, DOI DOI 10.1504/PIE.2004.004681
   Eisenhardt KM, 2007, ACAD MANAGE J, V50, P25, DOI 10.5465/AMJ.2007.24160888
   Esty Daniel C., 1998, J IND ECOL, V2, P35, DOI DOI 10.1162/JIEC.1998.2.1.35
   European Commission, 2015, CLOS LOOP EU ACT PLA
   Evans S, 2017, BUS STRATEG ENVIRON, V26, P597, DOI 10.1002/bse.1939
   Farel R, 2016, J MANUF SCI E-T ASME, V138, DOI 10.1115/1.4034438
   Fichtner W., 2005, Progress in Industrial Ecology, V2, P73, DOI 10.1504/PIE.2005.006778
   Fraccascia L, 2018, RESOUR CONSERV RECY, V136, P473, DOI 10.1016/j.resconrec.2018.03.009
   Fraccascia L, 2017, ECOL ECON, V137, P148, DOI 10.1016/j.ecolecon.2017.02.026
   FROSCH RA, 1989, SCI AM, V261, P144, DOI 10.1038/scientificamerican0989-144
   Geng Y, 2007, INT J SUST DEV WORLD, V14, P329, DOI 10.1080/13504500709469733
   Geng Y, 2010, J CLEAN PROD, V18, P993, DOI 10.1016/j.jclepro.2010.03.003
   Gereffi G, 2005, REV INT POLIT ECON, V12, P78, DOI 10.1080/09692290500049805
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Gibbs D., 2003, LOCAL EC, V18, P222, DOI DOI 10.1080/0269094032000114595
   Gibbs D, 2007, J CLEAN PROD, V15, P1683, DOI 10.1016/j.jclepro.2007.02.003
   Golev A, 2015, J IND ECOL, V19, P141, DOI 10.1111/jiec.12159
   Hamel G., 2000, LEADING REVOLUTION
   Han F, 2017, J CLEAN PROD, V168, P1289, DOI 10.1016/j.jclepro.2017.09.115
   Hashimoto S, 2010, RESOUR CONSERV RECY, V54, P704, DOI 10.1016/j.resconrec.2009.11.013
   Hein A. M., 2017, AUTOMATIZED GENERATI, P691, DOI [10.1007/978-981-10-3518-0_60, DOI 10.1007/978-981-10-3518-060, 10.1007/978-981-10-3518-060]
   Hein AM, 2017, J CLEAN PROD, V148, P923, DOI 10.1016/j.jclepro.2017.01.136
   Herczeg G, 2018, J CLEAN PROD, V171, P1058, DOI 10.1016/j.jclepro.2017.10.046
   Hewes AK, 2008, REG STUD, V42, P1329, DOI 10.1080/00343400701654079
   Hurt S., 2008, INT J BUS RES, V3
   Jacobsen NB, 2006, J IND ECOL, V10, P239, DOI 10.1162/108819806775545411
   Jensen PD, 2016, RESOUR CONSERV RECY, V107, P92, DOI 10.1016/j.resconrec.2015.11.018
   Jensen PD, 2011, RESOUR CONSERV RECY, V55, P703, DOI 10.1016/j.resconrec.2011.02.003
   Korhonen J, 2018, ECOL ECON, V143, P37, DOI 10.1016/j.ecolecon.2017.06.041
   Krones JS, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050806
   Lambert AJD, 2002, TECHNOVATION, V22, P471, DOI 10.1016/S0166-4972(01)00040-2
   Lebre E, 2017, J IND ECOL, V21, P662, DOI 10.1111/jiec.12596
   Lewandowski M, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010043
   Liideke-Freund F., 2010, CONCEPTUAL FRAMEWORK
   Liu Z, 2018, RESOUR CONSERV RECY, V128, P417, DOI 10.1016/j.resconrec.2016.06.012
   Liu Z, 2017, ENERG POLICY, V102, P88, DOI 10.1016/j.enpol.2016.12.013
   Liwarska-Bizukojc E, 2009, J CLEAN PROD, V17, P732, DOI 10.1016/j.jclepro.2008.11.004
   Lombardi DR, 2012, J IND ECOL, V16, P28, DOI 10.1111/j.1530-9290.2011.00444.x
   LOWE EA, 1997, J CLEAN PROD, V5, P57, DOI DOI 10.1016/S0959-6526(97)00017-6
   Ludeke-Freund F., 2018, J IND ECOL, DOI [10.1111/jiec, DOI 10.1111/JIEC]
   Ludeke-Freund F, 2018, SUSTAIN PROD CONSUMP, V15, P145, DOI 10.1016/j.spc.2018.06.004
   Lyons DI, 2007, J IND ECOL, V11, P43, DOI 10.1162/jiec.2007.1029
   Manninen K, 2018, J CLEAN PROD, V171, P413, DOI 10.1016/j.jclepro.2017.10.003
   Martin M, 2011, BIOMASS BIOENERG, V35, P1747, DOI 10.1016/j.biombioe.2011.01.016
   Mason KJ, 2008, J MANAGE STUD, V45, P774, DOI 10.1111/j.1467-6486.2008.00769.x
   Mirata M, 2005, J CLEAN PROD, V13, P993, DOI 10.1016/j.jclepro.2004.12.010
   Nair A, 2009, DECISION SCI, V40, P783, DOI 10.1111/j.1540-5915.2009.00251.x
   Ohnishi S, 2012, J CLEAN PROD, V33, P217, DOI 10.1016/j.jclepro.2012.03.027
   Osterwalder, 2004, BUSINESS MODEL ONTOL
   Park HS, 2008, J ENVIRON MANAGE, V87, P1, DOI 10.1016/j.jenvman.2006.12.045
   Park JM, 2016, J CLEAN PROD, V114, P33, DOI 10.1016/j.jclepro.2015.08.115
   Pfeffer J., 2003, EXTERNAL CONTROL ORG
   Richardson J, 2008, STRATEG CHANG, V17, P133, DOI 10.1002/jsc.821
   Sakr D, 2011, J CLEAN PROD, V19, P1158, DOI 10.1016/j.jclepro.2011.01.001
   Schaltegger S, 2016, ORGAN ENVIRON, V29, P264, DOI 10.1177/1086026616633272
   Sgarbossa F, 2017, INT J PROD ECON, V183, P596, DOI 10.1016/j.ijpe.2016.07.022
   Shi H, 2012, J IND ECOL, V16, P290, DOI 10.1111/j.1530-9290.2012.00505.x
   Shi H, 2010, J CLEAN PROD, V18, P191, DOI 10.1016/j.jclepro.2009.10.002
   Shi L, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9071085
   Short SW, 2014, J IND ECOL, V18, P603, DOI 10.1111/jiec.12171
   Simchi-Levi D., 2000, DESIGNING MANAGING S
   Simon H. A., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.2307/985254
   Sokka L, 2011, J IND ECOL, V15, P137, DOI 10.1111/j.1530-9290.2010.00276.x
   Sperandio G., 2017, CHEM ENG T, V58, P487, DOI DOI 10.3303/CET1758082
   Sterr T, 2004, J CLEAN PROD, V12, P947, DOI 10.1016/j.jclepro.2004.02.029
   SUN L, 2017, [No title captured], V9, DOI DOI 10.3390/SU9040549
   Sun L, 2017, RESOUR CONSERV RECY, V119, P78, DOI 10.1016/j.resconrec.2016.06.007
   Taddeo R, 2017, ECOL ECON, V139, P55, DOI 10.1016/j.ecolecon.2017.04.006
   Tapscott D., 2000, DIGITAL CAPITAL
   Thompson J.D., 1967, ORG ACTION SOCIAL SC
   Tingley DD, 2017, J CLEAN PROD, V148, P642, DOI 10.1016/j.jclepro.2017.02.006
   Tsvetkova A., 2012, J CLEAN PROD, P29, DOI [10.1016/J.JCLEPRO.2012.01.017.246-254, DOI 10.1016/J.JCLEPRO.2012.01.017.246-254]
   Tudor T, 2007, ECOL ECON, V61, P199, DOI 10.1016/j.ecolecon.2006.10.010
   Ubando AT, 2015, CHEM ENGINEER TRANS, V45, P355, DOI 10.3303/CET1545060
   Urbinati A, 2017, J CLEAN PROD, V168, P487, DOI 10.1016/j.jclepro.2017.09.047
   Valero A, 2013, ENERGY, V62, P62, DOI 10.1016/j.energy.2013.07.014
   van Beers D, 2007, J IND ECOL, V11, P55
   Van Behkel R, 2009, ENVIRON SCI TECHNOL, V43, P1271, DOI 10.1021/es803319r
   Van Berkel R, 2009, J ENVIRON MANAGE, V90, P1544, DOI 10.1016/j.jenvman.2008.11.010
   Wicks AC, 1999, ACAD MANAGE REV, V24, P99, DOI 10.2307/259039
   Wirtz B.W., 2011, BUSINESS MODEL MANAG
   Yang SL, 2008, RESOUR CONSERV RECY, V52, P813, DOI 10.1016/j.resconrec.2007.11.008
   Yazan DM, 2012, WOODHEAD PUBL SER EN, P254
   Yazan DM, 2016, J CLEAN PROD, V129, P537, DOI 10.1016/j.jclepro.2016.03.160
   Yazdanpanah M, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7010008
   Yu C, 2015, J IND ECOL, V19, P441, DOI 10.1111/jiec.12185
   Yu C, 2014, J CLEAN PROD, V64, P464, DOI 10.1016/j.jclepro.2013.09.002
   Yuan ZW, 2009, J CLEAN PROD, V17, P1295, DOI 10.1016/j.jclepro.2009.03.016
   Zabaniotou A, 2015, ENVIRON DEV, V14, P22, DOI 10.1016/j.envdev.2014.12.002
   Zaman A.U., 2011, CITY CULTURE SOC, V2, P177, DOI DOI 10.1016/J.CCS.2011.11.007
   Zaman AU, 2013, J CLEAN PROD, V50, P123, DOI 10.1016/j.jclepro.2012.11.041
   Zhang L, 2010, J CLEAN PROD, V18, P504, DOI 10.1016/j.jclepro.2009.11.018
   Zhang Y, 2016, FRONT EARTH SCI-PRC, V10, P352, DOI 10.1007/s11707-015-0520-9
   Zhu JM, 2014, COMPUT ENVIRON URBAN, V44, P37, DOI 10.1016/j.compenvurbsys.2013.11.001
   Zhu QH, 2004, J CLEAN PROD, V12, P1025, DOI 10.1016/j.jclepro.2004.02.030
   Zhu QH, 2007, J IND ECOL, V11, P31, DOI 10.1162/jiec.2007.929
   Zott C., 2009, NETWORK CHALLENGE, P259
   Zott C, 2011, J MANAGE, V37, P1019, DOI 10.1177/0149206311406265
   Zott C, 2010, LONG RANGE PLANN, V43, P216, DOI 10.1016/j.lrp.2009.07.004
   Zucchella A, 2019, BUS STRATEG ENVIRON, V28, P274, DOI 10.1002/bse.2216
NR 130
TC 4
Z9 4
U1 4
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 114
EP 126
DI 10.1016/j.resconrec.2019.03.016
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900012
DA 2020-05-12
ER

PT J
AU Munir, MJ
   Wu, YF
   Kazmi, SMS
   Patnaikuni, I
   Zhou, YW
   Xing, F
AF Munir, Muhammad Junaid
   Wu, Yu-Fei
   Kazmi, Syed Minhaj Saleem
   Patnaikuni, Indubhushan
   Zhou, Yingwu
   Xing, Feng
TI Stress-strain behavior of spirally confined recycled aggregate concrete:
   An approach towards sustainable design
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Recycled aggregates; Recycled aggregate concrete; Confinement; Spiral
   reinforcement; Axial stress-strain behavior
ID MECHANICAL-PROPERTIES; COMPRESSIVE BEHAVIOR; REINFORCED-CONCRETE;
   COLUMNS; MODEL
AB Application of recycled aggregate concrete (RAC) in the concrete structures is very limited due to inferior performance. Moreover, design of concrete structures ignores the role of transverse reinforcement in the strength enhancement of compression members. This study aims to utilize pre-existing transverse reinforcement to improve the performance of RAC. For this purpose, spirally confined concrete specimens were examined under axial compression, with the variation of three recycled aggregates (RA) replacement ratios (i.e., 0, 50 and 100%) and three pitches of spiral reinforcement (i.e., 20, 30 and 40 mm). The results show that increase of RA will cause a reduction of peak strength and peak strain. However, improved strength and ductility of RAC are observed with the increase in confinement pressure. A comparative study of the existing models for stress-strain behavior of steel confined normal aggregate concrete (NAC) with the test results indicates that the stress-strain characteristics of steel confined RAC cannot be well predicted using these existing models. Based on the test results, a model is developed in this work by modifying the parameters of best performing stress-strain model for steel confined NAC to incorporate the influence of RA replacement ratio. The proposed model can estimate the stress strain characteristics of both NAC and RAC confined by steel spiral, which may be helpful in designing the sustainable RAC compression members. Moreover, an equation is presented to estimate the amount of RA for the given confinement level which can be recycled without compromising the design strength of spirally confined concrete compression members.
C1 [Munir, Muhammad Junaid; Zhou, Yingwu; Xing, Feng] Shenzhen Univ, Guangdong Prov Key Lab Durabil Marine Civil Engn, Shenzhen 518060, Peoples R China.
   [Munir, Muhammad Junaid; Wu, Yu-Fei; Kazmi, Syed Minhaj Saleem; Patnaikuni, Indubhushan] RMIT Univ, Sch Engn, 376-392 Swanston St, Melbourne, Vic 3001, Australia.
RP Wu, YF (reprint author), RMIT Univ, Sch Engn, 376-392 Swanston St, Melbourne, Vic 3001, Australia.
EM yufei.wu@rmit.edu.au
RI Munir, Muhammad/AAC-3696-2019; Wu, Yu-Fei/D-1929-2013; kazmi, Syed
   Minhaj Saleem/AAC-3695-2019
OI Munir, Muhammad/0000-0003-4060-5576; Wu, Yu-Fei/0000-0002-3970-3999;
   kazmi, Syed Minhaj Saleem/0000-0002-7913-4065
FU RMIT University
FX Authors also acknowledge the scholarships provided by RMIT University to
   the student authors.
CR AHMAD SH, 1982, J AM CONCRETE I, V79, P484
   [Anonymous], 2014, 275812014 AS STAND A
   [Anonymous], 2016, C1922016 ASTM
   [Anonymous], 2010, 39722010 AS STAND AU
   Assa B, 2001, J STRUCT ENG-ASCE, V127, P743, DOI 10.1061/(ASCE)0733-9445(2001)127:7(743)
   Bing L, 2001, ACI STRUCT J, V98, P395
   Carneiro JA, 2014, CEMENT CONCRETE COMP, V46, P65, DOI 10.1016/j.cemconcomp.2013.11.006
   Common Wealth Scientific Industrial Research Organization, 2002, GUID SPEC REC CONCR
   Counto U.J., 1964, MAGAZINE CONCRETE RE, V16, P129, DOI DOI 10.1680/MACR.1964.16.48.129
   de Brito J, 2016, J BUILD ENG, V6, P1, DOI 10.1016/j.jobe.2016.02.003
   ELDASH KM, 1995, MAG CONCRETE RES, V47, P177, DOI 10.1680/macr.1995.47.171.177
   Hoshikuma J, 1997, J STRUCT ENG-ASCE, V123, P624, DOI 10.1061/(ASCE)0733-9445(1997)123:5(624)
   Kim YJ, 2017, ACI STRUCT J, V114, P775, DOI 10.14359/51689464
   Kou SC, 2007, J MATER CIVIL ENG, V19, P709, DOI 10.1061/(ASCE)0899-1561(2007)19:9(709)
   Kou SC, 2013, CEMENT CONCRETE COMP, V37, P12, DOI 10.1016/j.cemconcomp.2012.12.011
   Kou SC, 2011, CEMENT CONCRETE COMP, V33, P286, DOI 10.1016/j.cemconcomp.2010.10.003
   Li LG, 2017, CONSTR BUILD MATER, V157, P757, DOI 10.1016/j.conbuildmat.2017.09.097
   Liu YZ, 2016, CONSTR BUILD MATER, V129, P37, DOI 10.1016/j.conbuildmat.2016.11.006
   Ma CK, 2017, CONSTR BUILD MATER, V133, P502, DOI 10.1016/j.conbuildmat.2016.12.100
   MANDER JB, 1988, J STRUCT ENG-ASCE, V114, P1827, DOI 10.1061/(ASCE)0733-9445(1988)114:8(1827)
   MANDER JB, 1988, J STRUCT ENG-ASCE, V114, P1804, DOI 10.1061/(ASCE)0733-9445(1988)114:8(1804)
   Nematzadeh M, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002125
   Oikonomou ND, 2005, CEMENT CONCRETE COMP, V27, P315, DOI 10.1016/j.cemconcomp.2004.02.020
   Omary S, 2018, INT J CIV ENG, V16, P973, DOI 10.1007/s40999-017-0247-y
   Omary S, 2016, CONSTR BUILD MATER, V108, P163, DOI 10.1016/j.conbuildmat.2016.01.042
   Poon CS, 2007, CONSTR BUILD MATER, V21, P164, DOI 10.1016/j.conbuildmat.2005.06.031
   Poon CS, 2004, CEMENT CONCRETE RES, V34, P2215, DOI 10.1016/j.cemconres.2004.02.011
   Popovics S, 1973, CEMENT CONCRETE RES, V3, P583, DOI DOI 10.1016/0008-8846(73)90096-3
   Priestley M.N., 1996, SEISMIC DESIGN RETRO
   Productivity Commission Australia, 2006, WAST MAN PROD COMM D
   Razvi S, 1999, J STRUCT ENG-ASCE, V125, P281, DOI 10.1061/(ASCE)0733-9445(1999)125:3(281)
   Ren XD, 2017, CONSTR BUILD MATER, V154, P10, DOI 10.1016/j.conbuildmat.2017.07.174
   Richart F., 1929, ENG EXPT STATION B, V190
   Richart F., 1928, ENG EXPT STATION B, V185
   Rosado LP, 2017, J CLEAN PROD, V151, P634, DOI 10.1016/j.jclepro.2017.03.068
   del Bosque IFS, 2017, CEMENT CONCRETE COMP, V81, P25, DOI 10.1016/j.cemconcomp.2017.04.011
   Scott B.D., 1982, ACI STRUCT J, V79, P13, DOI DOI 10.14359/10875
   SHAH SP, 1983, J STRUCT ENG-ASCE, V109, P1695, DOI 10.1061/(ASCE)0733-9445(1983)109:7(1695)
   SHEIKH SA, 1993, ACI STRUCT J, V90, P542
   Shi CJ, 2016, J CLEAN PROD, V112, P466, DOI 10.1016/j.jclepro.2015.08.057
   Sohu Company, 2019, HEAV JAN 1 2019 SHAN
   Tam VWY, 2009, J CLEAN PROD, V17, P688, DOI 10.1016/j.jclepro.2008.11.015
   Teng JG, 2016, J COMPOS CONSTR, V20, DOI 10.1061/(ASCE)CC.1943-5614.0000602
   TOPCU IB, 1995, CEMENT CONCRETE RES, V25, P1385, DOI 10.1016/0008-8846(95)00131-U
   Wang L, 2017, CONSTR BUILD MATER, V144, P432, DOI 10.1016/j.conbuildmat.2017.03.191
   Wang WL, 2017, CONSTR BUILD MATER, V154, P496, DOI 10.1016/j.conbuildmat.2017.07.179
   Wardeh G, 2015, INT J CONCR STRUCT M, V9, P1, DOI 10.1007/s40069-014-0087-y
   Wei Y, 2014, CONSTR BUILD MATER, V54, P443, DOI 10.1016/j.conbuildmat.2013.12.083
   Wu YF, 2010, J COMPOS CONSTR, V14, P175, DOI 10.1061/(ASCE)CC.1943-5614.0000062
   Xiao JZ, 2018, J CLEAN PROD, V181, P753, DOI 10.1016/j.jclepro.2018.01.247
   Xiao JZ, 2012, SCI CHINA TECHNOL SC, V55, P1463, DOI 10.1007/s11431-012-4786-9
   Xiao JZ, 2012, CONSTR BUILD MATER, V31, P364, DOI 10.1016/j.conbuildmat.2011.12.074
   Xiao JZ, 2012, CONSTR BUILD MATER, V26, P591, DOI 10.1016/j.conbuildmat.2011.06.062
   Xiao JZ, 2005, CEMENT CONCRETE RES, V35, P1187, DOI 10.1016/j.cemconres.2004.09.020
   Xu JJ, 2017, COMPOS STRUCT, V174, P277, DOI 10.1016/j.compstruct.2017.04.034
   Xuan DX, 2017, CEMENT CONCRETE COMP, V84, P214, DOI 10.1016/j.cemconcomp.2017.09.015
   Yang YF, 2006, J CONSTR STEEL RES, V62, P1310, DOI 10.1016/j.jcsr.2006.02.010
   Zhao JL, 2015, J COMPOS CONSTR, V19, DOI 10.1061/(ASCE)CC.1943-5614.0000513
NR 58
TC 2
Z9 2
U1 7
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 127
EP 139
DI 10.1016/j.resconrec.2019.03.043
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900013
DA 2020-05-12
ER

PT J
AU Pana, DA
   Li, LL
   Tian, X
   Wu, YF
   Cheng, N
   Yu, HL
AF Pana, De'an
   Li, Lili
   Tian, Xi
   Wu, Yufeng
   Cheng, Na
   Yu, Hailiang
TI A review on lead slag generation, characteristics, and utilization
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Lead slag; Recovery of metals; Utilization; Toxic elements
ID PB/ZN SMELTING SLAG; SECONDARY LEAD; FLY-ASH; BLAST-FURNACE;
   METALLURGICAL SLAGS; CHEMICAL-STABILITY; FINE AGGREGATE; ZINC SLAG; BOF
   SLAG; PB
AB Lead slag is produced by the primary and secondary lead industry. The large amount of lead slag discharge causes environmental problems. Reducing the toxicity and increasing utilization of lead slag are important measures to solve the negative impact of lead slag on the environment. Here, we review the lead slag physical and chemical characteristics, as well as environmental impacts. This review focuses on the utilization of lead slag: recovery of metals and used for construction materials. Various processes for metal recovery including pyrometallurgical, hydrometallurgical, and bioleaching methods are summarized. Coal-based direct reduction is a typical pyrometallurgical technology for recovering metals from lead slag, which has the characteristics of high recovery efficiency, high energy consumption and suitable for industrial production. Chloride, acetic acid, and HNO3-based leaching systems are mainly used in hydrometallurgy of lead slag. The waste reagents and residues produced in hydrometallurgy process inevitably increase the environmental risk. Bioleaching is an environmentally friendly technology, but it is currently limited to laboratory scale. We also discuss the utilization of lead slag in construction materials. The use of lead slag in road construction and concrete will cause environmental risk of leaching toxic elements. The utilization rate of lead slag in cement clinker is extremely low. Geopolymers and glass-ceramics have good stabilization effect on toxic elements. However, the extensive use of alkaline activators limits the large-scale application of geopolymers. High energy consumption of glass-ceramics should be considered. Finally, the limitations and prospects for future research of lead slag utilization are also considered.
C1 [Pana, De'an; Li, Lili; Tian, Xi; Wu, Yufeng] Beijing Univ Technol, Inst Circular Econ, Beijing 100124, Peoples R China.
   [Cheng, Na] Shenyang Zhongke Ecol Environm Assessment Co Ltd, Shenyang, Liaoning, Peoples R China.
   [Yu, Hailiang] Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha 410083, Peoples R China.
RP Wu, YF (reprint author), Beijing Univ Technol, Inst Circular Econ, Beijing 100124, Peoples R China.
EM wuyufeng3r@126.com
RI Yufeng, Wu/AAI-6904-2020; yufeng, wu/AAK-8528-2020; Yu,
   Hailiang/B-5977-2009
OI Yu, Hailiang/0000-0001-7959-0717
FU Guangdong Province Science and Technology Project [2017B020238001]
FX This work is supported by the Guangdong Province Science and Technology
   Project (2017B020238001). We also thank the Key Laboratory of Solid
   Waste Reuse for Building Materials (SWR-2016-006) for their assistance
   in this study.
CR Albitar M, 2015, CONSTR BUILD MATER, V83, P128, DOI 10.1016/j.conbuildmat.2015.03.009
   Alwaeli M, 2017, J CLEAN PROD, V166, P157, DOI 10.1016/j.jclepro.2017.07.203
   Alwaeli M, 2013, RADIAT PHYS CHEM, V83, P54, DOI 10.1016/j.radphyschem.2012.09.024
   Atzeni C, 1996, CEMENT CONCRETE RES, V26, P1381, DOI 10.1016/0008-8846(96)00121-4
   Barna R, 2004, WASTE MANAGE, V24, P945, DOI 10.1016/j.wasman.2004.07.014
   Brito J. D, 2013, GREEN ENERGY TECHNOL, V54, P115
   Buzatu T, 2015, J MATER CYCLES WASTE, V17, P707, DOI 10.1007/s10163-014-0297-z
   Cardoso C, 2018, RESOUR CONSERV RECY, V138, P130, DOI 10.1016/j.resconrec.2018.05.020
   Carvalho SZ, 2017, RESOUR CONSERV RECY, V127, P216, DOI 10.1016/j.resconrec.2017.08.021
   Chai LY, 2015, T NONFERR METAL SOC, V25, P3429, DOI 10.1016/S1003-6326(15)63978-4
   Chen HY, 2009, J POWER SOURCES, V191, P22, DOI 10.1016/j.jpowsour.2008.12.140
   Cheng Y, 2009, BIORESOURCE TECHNOL, V100, P2737, DOI 10.1016/j.biortech.2008.12.038
   Cioffi R, 2000, WASTE MAT CONSTRUCTI, P741
   da Silva WR, 2017, ECOTOX ENVIRON SAFE, V144, P522, DOI 10.1016/j.ecoenv.2017.06.068
   Dai W, 2010, MIN RES DEV, P58
   Lima LRPD, 2013, ENVIRON EARTH SCI, V68, P1033, DOI 10.1007/s12665-012-1805-x
   Lima LRPD, 2011, J HAZARD MATER, V189, P692, DOI 10.1016/j.jhazmat.2011.02.091
   De Angelis G, 2002, WASTE MANAGE, V22, P925, DOI 10.1016/S0956-053X(02)00082-X
   [邓新辉 Deng Xinhui], 2015, [生态环境学报, Ecology and Environmental Sciences], V24, P1534
   Dong B. S, 2001, CHIN ENV PROT IND, V5, P20
   Ellis TW, 2010, J POWER SOURCES, V195, P4525, DOI 10.1016/j.jpowsour.2009.12.118
   Ettler V, 2004, CHEMOSPHERE, V57, P567, DOI 10.1016/j.chemosphere.2004.07.022
   Ettler V, 2003, CR GEOSCI, V335, P1005, DOI 10.1016/j.crte.2003.09.005
   Ettler V, 2001, CAN MINERAL, V39, P873, DOI 10.2113/gscanmin.39.3.873
   Ettler V, 2014, APPL GEOCHEM, V40, P97, DOI 10.1016/j.apgeochem.2013.11.001
   Ettler V, 2009, APPL GEOCHEM, V24, P1, DOI 10.1016/j.apgeochem.2008.10.003
   European Committee for Standardization, 2002, 124572 EN EUR COMM S
   Gomes GMF, 2011, J CLEAN PROD, V19, P1096, DOI 10.1016/j.jclepro.2011.01.006
   Forte F, 2017, RSC ADV, V7, P49999, DOI 10.1039/c7ra09150h
   Francis AA, 2004, J EUR CERAM SOC, V24, P2819, DOI 10.1016/j.jeurceramsoc.2003.08.019
   Gok O, 2013, HYDROMETALLURGY, V134, P40, DOI 10.1016/j.hydromet.2013.01.021
   Golpayegani MH, 2017, T NONFERR METAL SOC, V27, P2704, DOI 10.1016/S1003-6326(17)60299-1
   Gregurek D, 2015, J EUR CERAM SOC, V35, P1683, DOI 10.1016/j.jeurceramsoc.2014.12.011
   Gulson BL, 2004, ENVIRON HEALTH PERSP, V112, P52, DOI 10.1289/ehp.6465
   Guo B, 2017, CONSTR BUILD MATER, V134, P123, DOI 10.1016/j.conbuildmat.2016.12.139
   Guo H, 2018, RESOUR CONSERV RECY, V129, P209, DOI 10.1016/j.resconrec.2017.10.027
   Guo Zhao-hui, 2008, Chinese Journal of Nonferrous Metals, V18, P923
   Guo ZH, 2010, HYDROMETALLURGY, V104, P25, DOI 10.1016/j.hydromet.2010.04.006
   Halinen AK, 2009, HYDROMETALLURGY, V98, P92, DOI 10.1016/j.hydromet.2009.04.005
   Hilts SR, 2003, SCI TOTAL ENVIRON, V303, P51, DOI 10.1016/S0048-9697(02)00357-1
   Hou X., 2011, YUNNAN METALL, V40, P42
   Kim E, 2017, HYDROMETALLURGY, V169, P372, DOI 10.1016/j.hydromet.2017.02.027
   Kim E, 2017, HYDROMETALLURGY, V169, P589, DOI 10.1016/j.hydromet.2017.04.002
   Knezevic M, 2010, METALL MATER ENG-ASS, V16, P195
   Kreusch MA, 2007, RESOUR CONSERV RECY, V52, P368, DOI 10.1016/j.resconrec.2007.05.004
   Kritikaki A, 2016, WASTE BIOMASS VALORI, V7, P885, DOI 10.1007/s12649-016-9480-x
   Lan M. Z, 2004, CEMENT, V6, P7
   Lassin A, 2007, J HAZARD MATER, V139, P430, DOI 10.1016/j.jhazmat.2006.02.055
   Li H. W, 2016, ENV ENG, V34, P661
   Li K. M, 2012, CHINA NONFERROUS MET, P70
   Li M, 2012, J HAZARD MATER, V237, P323, DOI 10.1016/j.jhazmat.2012.08.052
   Li W. L, 2004, HENAN BUILD MAT, V1, P15
   Li YC, 2017, T NONFERR METAL SOC, V27, P1862, DOI 10.1016/S1003-6326(17)60210-3
   Li YC, 2017, J CLEAN PROD, V143, P311, DOI 10.1016/j.jclepro.2016.12.108
   Li YP, 2017, RESOUR CONSERV RECY, V117, P1, DOI 10.1016/j.resconrec.2015.11.005
   Lin B, 2000, CEMENT ENG, V5, P30
   Medici F., 2012, J SOLID WASTE TECHNO, V38, P117
   Meng YZ, 2018, RESOUR CONSERV RECY, V138, P298, DOI 10.1016/j.resconrec.2018.07.029
   Morachevskii AG, 2001, RUSS J APPL CHEM+, V74, P1103, DOI 10.1023/A:1013050414173
   Mosavinezhad SHG, 2012, KSCE J CIV ENG, V16, P989, DOI 10.1007/s12205-012-1240-2
   Ogundiran MB, 2013, J HAZARD MATER, V248, P29, DOI 10.1016/j.jhazmat.2012.12.040
   Onisei S, 2012, J HAZARD MATER, V205, P101, DOI 10.1016/j.jhazmat.2011.12.039
   Pan D. A, 2015, CN, Patent No. [104773958A, 104773958]
   Pan DA, 2018, J CLEAN PROD, V175, P251, DOI 10.1016/j.jclepro.2017.12.030
   Pan HY, 2019, RESOUR CONSERV RECY, V140, P13, DOI 10.1016/j.resconrec.2018.09.012
   Panda S, 2015, KOREAN J CHEM ENG, V32, P667, DOI 10.1007/s11814-014-0298-6
   Pelino M, 2000, WASTE MANAGE, V20, P561, DOI 10.1016/S0956-053X(00)00002-7
   Penpolcharoen M, 2005, CEMENT CONCRETE RES, V35, P1050, DOI 10.1016/j.cemconres.2004.11.001
   Piatak NM, 2015, APPL GEOCHEM, V57, P236, DOI 10.1016/j.apgeochem.2014.04.009
   Pisciella P, 2001, WASTE MANAGE, V21, P1, DOI 10.1016/S0956-053X(00)00077-5
   Pollmann K, 2018, BIOTECHNOL ADV, V36, P1048, DOI 10.1016/j.biotechadv.2018.03.006
   Potysz A, 2018, J ENVIRON MANAGE, V219, P138, DOI 10.1016/j.jenvman.2018.04.083
   Saikia N, 2008, J HAZARD MATER, V154, P766, DOI 10.1016/j.jhazmat.2007.10.093
   Saikia N, 2012, J MATER CYCLES WASTE, V14, P102, DOI 10.1007/s10163-012-0043-3
   Seignez N, 2007, J HAZARD MATER, V149, P418, DOI 10.1016/j.jhazmat.2007.04.007
   Seignez N, 2006, WIT TRANS ECOL ENVIR, V92, P31, DOI 10.2495/WM060041
   Seignez N, 2008, APPL GEOCHEM, V23, P3699, DOI 10.1016/j.apgeochem.2008.09.009
   Shirinbayan M, 2014, RUSS J NON-FERR MET+, V55, P538, DOI 10.3103/S1067821214060236
   Shoaib MM, 2001, CEMENT CONCRETE RES, V31, P1533, DOI 10.1016/S0008-8846(01)00561-0
   Shu YH, 2015, J POWER SOURCES, V281, P219, DOI 10.1016/j.jpowsour.2015.01.181
   Sinclair R. J, 2009, EXTRACTIVE METALLURG, P10
   Smaniotto A, 2009, J HAZARD MATER, V172, P1677, DOI 10.1016/j.jhazmat.2009.07.026
   Sobanska S, 2016, APPL GEOCHEM, V64, P107, DOI 10.1016/j.apgeochem.2015.09.011
   Sohn H. Y., 2014, TREATISE PROCESS MET, V3, P671, DOI DOI 10.1016/B978-0-08-096988-6.0025-0
   Stulovic M, 2013, ENVIRON PROT ENG, V39, P149, DOI 10.5277/epe130311
   Sun Z, 2017, WASTE MANAGE, V64, P190, DOI 10.1016/j.wasman.2017.03.007
   Toniolo N, 2017, CERAM INT, V43, P14545, DOI 10.1016/j.ceramint.2017.07.221
   Tukker A, 2006, RESOUR CONSERV RECY, V49, P89, DOI 10.1016/j.resconrec.2006.03.005
   *USEPA, 2008, SW846 USEPA
   van Jaarsveld JGS, 1999, CEMENT CONCRETE RES, V29, P1189, DOI 10.1016/S0008-8846(99)00032-0
   Wang CL, 2017, ISIJ INT, V57, P996, DOI 10.2355/isijinternational.ISIJINT-2016-683
   Wang CL, 2014, ADV MATER RES-SWITZ, V878, P254, DOI 10.4028/www.scientific.net/AMR.878.254
   Wang J, 2015, J ENVIRON MANAGE, V159, P11, DOI 10.1016/j.jenvman.2015.05.013
   Yang X.L, 2014, TERRITORY NAT RESOUR, V1, P42
   Yin NH, 2016, J ENVIRON MANAGE, V180, P310, DOI 10.1016/j.jenvman.2016.05.052
   Yousef RI, 2009, J HAZARD MATER, V165, P379, DOI 10.1016/j.jhazmat.2008.10.004
   Yu W, 2015, ISIJ INT, V55, P329, DOI 10.2355/isijinternational.55.329
   Yu Xianjin, 2011, 2011 International Conference on Materials for Renewable Energy & Environment, P1104, DOI 10.1109/ICMREE.2011.5930533
   Zhang S. G, 2015, CN, Patent No. [104445944A, 104445944]
   Zhang W, 2016, RENEW SUST ENERG REV, V61, P108, DOI 10.1016/j.rser.2016.03.046
   Zhang W, 2016, J CHEM TECHNOL BIOT, V91, P672, DOI 10.1002/jctb.4620
   Zheng L, 2015, FRONT ENV SCI ENG, V9, P642, DOI 10.1007/s11783-014-0707-4
   Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750
   Zhou D. N, 1992, GUANGXI METALL, V2, P46
NR 104
TC 2
Z9 2
U1 29
U2 51
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 140
EP 155
DI 10.1016/j.resconrec.2019.03.036
PG 16
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900014
DA 2020-05-12
ER

PT J
AU Bhandari, D
   Singh, RK
   Garg, SK
AF Bhandari, Dimple
   Singh, Rajesh Kr
   Garg, Suresh K.
TI Prioritisation and evaluation of barriers intensity for implementation
   of cleaner technologies: Framework for sustainable production
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Cleaner technologies; Sustainability; Analytic hierarchy process; Graph
   theory approach; Barriers intensity
ID SUPPLY CHAIN MANAGEMENT; ENERGY-EFFICIENCY; RENEWABLE ENERGY; INDUSTRY;
   INNOVATION; LOGISTICS; ADOPTION; INVESTMENT; STRATEGIES; DECISION
AB In the era of circular economy, the economic growth of a country is highly dependent on the sustainable performance of its manufacturing sector. Therefore, it is mandatory to develop technology with maximum efficiency and minimum pollution to make manufacturing sector sustainable and competitive. Hence cleaner technology is an ingenious option to maintain potential for increasing effectiveness of manufacturing processes. Cleaner technologies application is the modem integrated approach in manipulating pollutants and wastes in industries. "Cleaner Technology" is all about less and more systematic energy and materials use. For manufacturing organisations to be globally competitive and sustainable, it is necessary to implement cleaner technologies in different functions. Organisations face number of barriers while implementing cleaner technologies. It becomes indispensable to measure the influence of these barriers for formulating strategic approach to implement cleaner technologies. On the basis of literature review and experts' opinion, four categories of barriers, namely technical information barriers, operational and strategic barriers, financial and economic barriers and human barriers are identified. In this study, hybrid approach comprising of analytic hierarchy process (AHP) and graph theoretic approach (GTA) has been used. First prioritisation of different categories of barriers by AHP has been done and second, GTA has been applied for finding the barriers intensity index. Based on this study, finance and economic barriers have emerged as major hurdle in implementing cleaner technologies. Proposed framework will help organisations in quantifying barriers in implementing cleaner technologies in different processes thereby developing effective strategies for sustainable production.
C1 [Singh, Rajesh Kr] Management Dev Inst, Gurgaon, India.
   [Bhandari, Dimple; Garg, Suresh K.] Delhi Technol Univ, Delhi, India.
RP Singh, RK (reprint author), Management Dev Inst, Gurgaon, India.
EM rajesh.singh@mdi.ac.in
CR Agrawal S, 2016, J CLEAN PROD, V137, P93, DOI 10.1016/j.jclepro.2016.07.045
   Agrawal S, 2016, RESOUR CONSERV RECY, V108, P41, DOI 10.1016/j.resconrec.2016.01.004
   Ahuja IPS, 2008, J QUAL MAINT ENG, V14, P123, DOI 10.1108/13552510810877647
   Alkaya E, 2013, RESOUR CONSERV RECY, V77, P89, DOI 10.1016/j.resconrec.2013.06.004
   Anand G, 2012, PROD PLAN CONTROL, V23, P801, DOI 10.1080/09537287.2011.642164
   Anand G, 2010, International Journal of Human Resources Development and Management, V10, P63, DOI 10.1504/IJHRDM.2010.029447
   Anbanandam R, 2011, INT J PRODUCT PERFOR, V60, P82, DOI 10.1108/17410401111101449
   [Anonymous], 1998, HUMAN DEV REPORT, P66
   Attri R, 2013, INT J SYST ASSUR ENG, V4, P365, DOI 10.1007/s13198-012-0122-9
   Baas L, 2007, J CLEAN PROD, V15, P1205, DOI 10.1016/j.jclepro.2006.07.017
   Baglee D, 2010, CONTROL CYBERN, V39, P275
   Barve A, 2009, EUR J IND ENG, V3, P2, DOI 10.1504/EJIE.2009.021582
   Buyukbay B, 2010, RESOUR CONSERV RECY, V54, P744, DOI 10.1016/j.resconrec.2009.12.004
   Vargas JRC, 2018, RESOUR CONSERV RECY, V139, P237, DOI 10.1016/j.resconrec.2018.08.018
   Chhabra D, 2017, J CLEAN PROD, V167, P962, DOI 10.1016/j.jclepro.2017.02.158
   Jabbour CJC, 2008, J CLEAN PROD, V16, P51, DOI 10.1016/j.jclepro.2006.07.025
   de Groot HLF, 2001, ENERG ECON, V23, P717, DOI 10.1016/S0140-9883(01)00083-4
   DeCanio SJ, 1998, REV ECON STAT, V80, P95, DOI 10.1162/003465398557366
   Demirel P, 2015, TECHNOL ANAL STRATEG, V27, P782, DOI 10.1080/09537325.2015.1019849
   Dubey R, 2017, J CLEAN PROD, V142, P1119, DOI 10.1016/j.jclepro.2016.03.117
   Dubey R, 2016, RESOUR CONSERV RECY, V106, P78, DOI 10.1016/j.resconrec.2015.11.008
   Eisenack K., 2002, 16 WORKSH QUAL REAS, P53
   Faisal MN, 2006, IND MANAGE DATA SYST, V106, P878, DOI 10.1108/02635570610671533
   Foxon TJ, 2005, ENERG POLICY, V33, P2123, DOI 10.1016/j.enpol.2004.04.011
   GANDHI OP, 1992, RELIAB ENG SYST SAFE, V35, P147, DOI 10.1016/0951-8320(92)90034-I
   Gandhi OP, 1996, J PRESS VESS-T ASME, V118, P434, DOI 10.1115/1.2842210
   Ghadimi P, 2019, RESOUR CONSERV RECY, V140, P72, DOI 10.1016/j.resconrec.2018.09.005
   Govindarajulu N, 2004, IND MANAGE DATA SYST, V104, P364, DOI 10.1108/02635570410530775
   Griffiths A, 2001, INT J OPER PROD MAN, V21, P1573, DOI 10.1108/01443570110410919
   Grimal L, 2003, PERSPECT IND ECOL, V291, P291
   Grover S, 2006, BENCHMARKING, V13, P447, DOI 10.1108/14635770610676290
   Gunasekaran A, 2012, INT J PROD ECON, V140, P35, DOI 10.1016/j.ijpe.2011.05.011
   GUNNINGHAM N, 1997, [No title captured]
   Hafez S, 1994, UNEP IND ENV, V17, P75
   Hamed MM, 2004, J CLEAN PROD, V12, P327, DOI 10.1016/S0959-6526(03)00037-4
   Harris J, 2000, ENERG POLICY, V28, P867, DOI 10.1016/S0301-4215(00)00075-6
   Hartmann J, 2014, J OPER MANAG, V32, P281, DOI 10.1016/j.jom.2014.01.005
   Hilson G, 2000, MINER ENG, V13, P699, DOI 10.1016/S0892-6875(00)00055-8
   Jacobsson S, 2013, ENERG POLICY, V63, P1182, DOI 10.1016/j.enpol.2013.08.077
   JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4
   Ji GJ, 2014, INT J PROD ECON, V147, P211, DOI 10.1016/j.ijpe.2013.04.012
   JURKAT WB, 1966, J ALGEBRA, V3, P1, DOI 10.1016/0021-8693(66)90016-0
   Kablan MM, 2003, ENERGY, V28, P1533, DOI [10.1016/S0360-5442(03)00129-4, 10.1016/s0360-5442(03)00129-4]
   Kaur A., 2006, International Journal of Logistics Systems and Management, V2, P321
   Khalili NR, 2015, J CLEAN PROD, V96, P30, DOI 10.1016/j.jclepro.2014.01.099
   Kiran C. Phaneendra, 2012, International Journal of Industrial and Systems Engineering, V12, P1, DOI 10.1504/IJISE.2012.048283
   Koefoed M, 2008, J CLEAN PROD, V16, pS78, DOI 10.1016/j.jclepro.2007.10.023
   Kulkarni S., 2005, TQM MAGAZINE, V17, P509, DOI [10.1108/09544780510627615, DOI 10.1108/09544780510627615]
   Kumar Abhishek, 2011, International Journal of Industrial and Systems Engineering, V9, P350, DOI 10.1504/IJISE.2011.043143
   Kumar Abhishek, 2011, International Journal of Productivity and Quality Management, V8, P85, DOI 10.1504/IJPQM.2011.041099
   Leete S, 2013, ENERG POLICY, V60, P866, DOI 10.1016/j.enpol.2013.05.011
   Liu SF, 2011, INT J SUSTAIN ENG, V4, P236, DOI 10.1080/19397038.2011.574744
   Liu Y, 2014, ENERG POLICY, V67, P412, DOI 10.1016/j.enpol.2013.12.022
   Jabbour ABLD, 2015, RESOUR CONSERV RECY, V104, P366, DOI 10.1016/j.resconrec.2015.07.017
   Silva DAL, 2013, J CLEAN PROD, V47, P174, DOI 10.1016/j.jclepro.2012.10.026
   Luo ZW, 2018, COMPUT ECON, V52, P1257, DOI 10.1007/s10614-017-9688-2
   Luthra S, 2018, RESOUR CONSERV RECY, V138, P194, DOI 10.1016/j.resconrec.2018.07.005
   Luthra S, 2017, RESOUR CONSERV RECY, V125, P198, DOI 10.1016/j.resconrec.2017.02.018
   Mathivathanan D, 2018, RESOUR CONSERV RECY, V128, P284, DOI 10.1016/j.resconrec.2017.01.003
   Mitchell CL, 2006, J CLEAN PROD, V14, P1576, DOI 10.1016/j.jclepro.2005.04.010
   Mittel V.K., 2013, REENG MAN SUST P 20
   Mohan M, 2003, P I MECH ENG A-J POW, V217, P259, DOI 10.1243/095765003322066493
   Moors EHM, 2005, J CLEAN PROD, V13, P657, DOI 10.1016/j.jclepro.2003.12.010
   Mudgal R.K., 2010, INT J LOGIST SYST MA, V7, P81, DOI DOI 10.1504/IJLSM.2010.033891
   Muduli K, 2013, RESOUR CONSERV RECY, V76, P50, DOI 10.1016/j.resconrec.2013.03.006
   Muduli K, 2013, J CLEAN PROD, V47, P335, DOI 10.1016/j.jclepro.2012.10.030
   Murillo-Luna JL, 2011, J CLEAN PROD, V19, P1417, DOI 10.1016/j.jclepro.2011.05.005
   O. E. C. D, 2001, REP CLEAN PROD
   Plambeck E, 2012, MIT SLOAN MANAGE REV, V53, P43
   Polzin F, 2016, TECHNOL FORECAST SOC, V103, P34, DOI 10.1016/j.techfore.2015.10.001
   Qureshi MN, 2009, INT J SERV TECHNOL M, V12, P35, DOI 10.1504/IJSTM.2009.025035
   Raj T, 2010, J MANUF TECHNOL MANA, V21, P160, DOI 10.1108/17410381011014350
   Rao RV, 2002, INT J MACH TOOL MANU, V42, P321
   SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I
   Sarkis J, 2018, RESOUR CONSERV RECY, V134, pA1, DOI 10.1016/j.resconrec.2017.12.022
   Sehgal R, 2000, RELIAB ENG SYST SAFE, V68, P39, DOI 10.1016/S0951-8320(99)00081-2
   Sellitto MA, 2019, RESOUR CONSERV RECY, V145, P1, DOI 10.1016/j.resconrec.2019.02.013
   Shi H, 2008, J CLEAN PROD, V16, P842, DOI 10.1016/j.jclepro.2007.05.002
   Shi H, 2006, ENVIRON POLIT, V15, P271, DOI 10.1080/09644010600562567
   Shi H., 2003, CLEANER PRODUCTION C, P63
   Shi Z., 2004, ENV PROTECT, P4
   Song ML, 2018, MANAGE DECIS, V56, P188, DOI 10.1108/MD-04-2017-0375
   Song ML, 2017, ENVIRON SCI POLLUT R, V24, P1648, DOI 10.1007/s11356-016-7925-1
   Song ML, 2015, ANN OPER RES, V228, P47, DOI 10.1007/s10479-013-1442-0
   Song ML, 2013, J CLEAN PROD, V42, P42, DOI 10.1016/j.jclepro.2012.11.010
   Song ML, 2012, SUPPLY CHAIN MANAG, V17, P5, DOI 10.1108/13598541211212168
   Stock T, 2016, PROC CIRP, V40, P536, DOI 10.1016/j.procir.2016.01.129
   Thakkar J, 2007, J MANUF TECHNOL MANA, V19, P92, DOI 10.1108/17410380810843471
   Tonn B, 2000, ENERG POLICY, V28, P831, DOI 10.1016/S0301-4215(00)00068-9
   Trianni A, 2012, ENERGY, V37, P494, DOI 10.1016/j.energy.2011.11.005
   UNEP (United Nation Environment Programme), 1993, CLEAN PROD WORLD WID
   UNEP (United Nation Environment Programme) UNIDO (United Nation Development Programme), 2004, EST OP CLEAN PROD CT
   Unnikrishnan S, 2007, RESOUR CONSERV RECY, V50, P427, DOI 10.1016/j.resconrec.2006.07.003
   Van Berkel R., 2006, J CLEAN PROD, V20, P1
   Vickers I, 1999, TECHNOL ANAL STRATEG, V11, P75, DOI 10.1080/095373299107591
   Vietnam Cleaner Production Centre (VNCPC), 2002, VIETN CLEAN PROD CTR
   Wang SH, 2017, SCI TOTAL ENVIRON, V595, P201, DOI 10.1016/j.scitotenv.2017.03.243
   Weber L, 1997, ENERG POLICY, V25, P833, DOI 10.1016/S0301-4215(97)00084-0
   Wu ZH, 2011, J OPER MANAG, V29, P577, DOI 10.1016/j.jom.2010.10.001
   Yongqiang J., 1995, UNEP IND ENV, V18, P23
   Zhang YL, 2015, COMPUT ECON, V46, P1, DOI 10.1007/s10614-014-9447-6
   Zilahy G, 2004, J CLEAN PROD, V12, P311, DOI 10.1016/S0959-6526(03)00016-7
NR 102
TC 3
Z9 3
U1 7
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 156
EP 167
DI 10.1016/j.resconrec.2019.02.038
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900015
DA 2020-05-12
ER

PT J
AU Uwizeye, A
   Gerber, PJ
   Opio, CI
   Tempio, G
   Mottet, A
   Makkar, HPS
   Falcucci, A
   Steinfeld, H
   de Boer, IJM
AF Uwizeye, Aimable
   Gerber, Pierre J.
   Opio, Carolyn I.
   Tempio, Giuseppe
   Mottet, Anne
   Makkar, Harinder P. S.
   Falcucci, Alessandra
   Steinfeld, Henning
   de Boer, Imke J. M.
TI Nitrogen flows in global pork supply chains and potential improvement
   from feeding swill to pigs
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Animal production; Nitrogen use efficiency; Livestock; Food wastes; Life
   cycle
ID LIFE-CYCLE ASSESSMENT; FOOD WASTE; ANIMAL PRODUCTION; ENVIRONMENTAL
   ASSESSMENT; MANURE MANAGEMENT; NUTRIENT USE; LIVESTOCK; CHINA;
   SUSTAINABILITY; EMISSIONS
AB The global pork sector contributes to food security and supports livelihoods for millions of households but also causes nitrogen (N) pollution. Here we assess N flows, losses, and N use indicators for global pork supply chains, from "cradle-to-primary-processing-gate" and for three production systems: the backyard, intermediate and industrial systems. Subsequently, we evaluate the effects of feeding swill to industrial pigs on N flows and land use. To produce 3.5 Tg N of pork globally, 14.7 Tg N are lost into the environment, of which 68% is lost to watercourses in the form of nitrates and organic N and the reminder emitted to the atmosphere as N-gas (e.g., NH3, NOx and N2O). We found that the efficiency of N use, hotspot and magnitude of N losses per unit of area depend chiefly on the region (agro-ecological and economic context), origin of feed, and manure management systems. Swill feeding increases N use efficiency and reduces N losses at the feed production stage. It achieves a saving of 31 Mt of soybeans and 20 Mt of grains on dry matter basis, equivalent to 16 M ha of land used. Its adoption would require innovative policies to preserve food safety and public health. Future research may explore the feasibility and requirements to adopt swill feeding at a country level and may investigate potential impacts on other sustainability objectives.
C1 [Uwizeye, Aimable; Gerber, Pierre J.; Opio, Carolyn I.; Tempio, Giuseppe; Mottet, Anne; Makkar, Harinder P. S.; Falcucci, Alessandra; Steinfeld, Henning] UN, Food & Agr Org, Anim Prod & Hlth Div, Viale Terme Caracalla, I-00153 Rome, Italy.
   [Uwizeye, Aimable; Gerber, Pierre J.; de Boer, Imke J. M.] Wageningen Univ & Res, Anim Prod Syst Grp, POB 338, NL-6700 AH Wageningen, Netherlands.
   [Uwizeye, Aimable] TEAGASC, Crops Environm & Land Use Programme, Wexford Y35 Y521, Ireland.
   [Gerber, Pierre J.] World Bank Grp, 1818 H St NW, Washington, DC 20433 USA.
RP Uwizeye, A (reprint author), UN, Food & Agr Org, Anim Prod & Hlth Div, Viale Terme Caracalla, I-00153 Rome, Italy.
EM aimable.uwizeye@fao.org
RI de Boer, Imke/P-7107-2014; Mottet, Anne/AAG-7082-2020
OI de Boer, Imke/0000-0002-0675-7528; Mottet, Anne/0000-0003-4142-5171;
   Uwizeye, Aimable/0000-0002-0646-1292
FU Teagasc Walsh Fellowship Scheme [2012230]; Livestock Environmental
   Assessment Performance (LEAP) Partnership [GCP/GLO/369/MUL]; Livestock
   Information, Sector Analysis and Policy Branch (AGAL) of Food and
   Agriculture Organization of United Nations (FAO)
FX This work is supported by the Teagasc Walsh Fellowship Scheme (Ref:
   2012230), the Livestock Environmental Assessment Performance (LEAP)
   Partnership (GCP/GLO/369/MUL) and the Livestock Information, Sector
   Analysis and Policy Branch (AGAL) of Food and Agriculture Organization
   of United Nations (FAO). We would like to thank Rogier Schulte for his
   advice on the design of this research.
CR Bai ZH, 2014, ENVIRON SCI TECHNOL, V48, P12742, DOI 10.1021/es502160v
   Bai ZH, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8534
   Beausang C, 2017, RESOUR CONSERV RECY, V126, P177, DOI 10.1016/j.resconrec.2017.07.042
   Bittman S., 2014, OPTIONS AMMONIA MITI
   Bodirsky BL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4858
   Brancoli P, 2017, RESOUR CONSERV RECY, V118, P39, DOI 10.1016/j.resconrec.2016.11.024
   Chen MP, 2016, RESOUR CONSERV RECY, V111, P10, DOI 10.1016/j.resconrec.2016.03.026
   Corbala-Robles L, 2018, RESOUR CONSERV RECY, V131, P86, DOI 10.1016/j.resconrec.2017.12.010
   Costanza JK, 2008, SCI TOTAL ENVIRON, V398, P76, DOI 10.1016/j.scitotenv.2008.02.024
   Cu TTT, 2012, J CLEAN PROD, V27, P64, DOI 10.1016/j.jclepro.2012.01.006
   Dentener F.J., 2006, GLOBAL MAPS ATMOSPHE
   Ermgassen EKHJZ, 2016, FOOD POLICY, V58, P35, DOI 10.1016/j.foodpol.2015.11.001
   FAO, 2011, GLOBAL FOOD LOSSES F
   FAO, 2011, WORLD LIV LIV FOOD S
   FAO, 2018, GLOB LIV ENV ASS MOD
   FAOSTAT, 2018, STAT DAT, pxxii + 634
   Gale F., 2014, USDA ERS EC INFORM B, V136
   Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2
   Garrone P, 2016, J CLEAN PROD, V137, P1076, DOI 10.1016/j.jclepro.2016.07.145
   Gerber P., 2010, LIVESTOCK CHANGING L, P51
   Gerber PJ, 2014, CURR OPIN ENV SUST, V9-10, P122, DOI 10.1016/j.cosust.2014.09.007
   Gerber PJ, 2013, TACKLING CLIMATE CHA
   Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181
   Hamilton HA, 2018, NAT SUSTAIN, V1, P314, DOI 10.1038/s41893-018-0079-z
   Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960
   Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3
   HLPE, 2014, FOOD LOSS WAST CONT
   Horst HS, 1997, REV SCI TECH OIE, V16, P207, DOI 10.20506/rst.16.1.1004
   Huang WM, 2016, CHINA AGR ECON REV, V8, P22, DOI 10.1108/CAER-10-2014-0100
   Intergovernmental Panel on Climate Change IPCC, 2006, GUID NAT GREENH GAS
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Lassaletta L., 2016, P 2016 INT NITR IN C
   Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011
   Leip A, 2014, J AGR SCI-CAMBRIDGE, V152, pS20, DOI 10.1017/S0021859613000786
   Liu C, 2016, J CLEAN PROD, V133, P557, DOI 10.1016/j.jclepro.2016.06.026
   Liu Q, 2017, SOIL RES, V55, P451, DOI 10.1071/SR17031
   Macleod M., 2013, GREENHOUSE GAS EMISS
   MacLeod MJ, 2018, ANIMAL, V12, P383, DOI 10.1017/S1751731117001847
   Mottet A, 2017, GLOB FOOD SECUR-AGR, V14, P1, DOI 10.1016/j.gfs.2017.01.001
   OECD-FAO, 2015, OECD FAO AGR OUTL 20, DOI 10.1787/agr_outlook-2015-en
   Oenema O, 2005, SCI CHINA SER C, V48, P871, DOI 10.1360/062005-279
   Oenema O, 2005, NUTR CYCL AGROECOSYS, V72, P51, DOI 10.1007/s10705-004-7354-2
   Papargyropoulou E, 2014, J CLEAN PROD, V76, P106, DOI 10.1016/j.jclepro.2014.04.020
   Peoples MB, 2009, SYMBIOSIS, V48, P1, DOI 10.1007/BF03179980
   Philippe FX, 2011, AGR ECOSYST ENVIRON, V141, P245, DOI 10.1016/j.agee.2011.03.012
   Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216
   R Core Team, 2013, R LANG ENV STAT COMP
   Schaffner M, 2010, CLEAN TECHNOL ENVIR, V12, P407, DOI 10.1007/s10098-009-0255-y
   Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855
   Strokal M, 2014, MAR POLLUT BULL, V85, P123, DOI 10.1016/j.marpolbul.2014.06.011
   Sugiura K, 2009, VET ITAL, V45, P397
   Takata M, 2012, SCI TOTAL ENVIRON, V432, P309, DOI 10.1016/j.scitotenv.2012.05.049
   Thieme O, 2017, ANIM PROD SCI, V57, P601, DOI 10.1071/AN16183
   Uwizeye A, 2017, ENVIRON MODELL SOFTW, V96, P58, DOI 10.1016/j.envsoft.2017.06.041
   Uwizeye A, 2016, J CLEAN PROD, V129, P647, DOI 10.1016/j.jclepro.2016.03.108
   Van Zanten HHE, 2018, GLOBAL CHANGE BIOL, V24, P4185, DOI 10.1111/gcb.14321
   Vu TKV, 2007, LIVEST SCI, V112, P288, DOI 10.1016/j.livsci.2007.09.008
   Westendorf ML, 1998, J ANIM SCI, V76, P2976
   Yamaji K, 2004, ATMOS ENVIRON, V38, P7111, DOI 10.1016/j.atmosenv.2004.06.045
   Zu XH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191626
NR 60
TC 3
Z9 3
U1 9
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 168
EP 179
DI 10.1016/j.resconrec.2019.03.032
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900016
DA 2020-05-12
ER

PT J
AU Luo, H
   Kou, ZY
   Zhao, F
   Cai, H
AF Luo, Hao
   Kou, Zhaoyu
   Zhao, Fu
   Cai, Hua
TI Comparative life cycle assessment of station-based and dock-less bike
   sharing systems
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Bike sharing; Life cycle assessment; Station-based; Dock-less
ID US; IMPACT
AB Bike sharing system (BSS) is growing worldwide. Although bike sharing is viewed as a sustainable transportation mode, it still has environmental footprints from its operation (e.g., bike rebalancing using automobiles) and upstream impacts (e.g., bike manufacturing). Thus, evaluating the environmental impacts of BSS from the life cycle perspective is vital to inform decision making for the system design and operation. In this study, we conducted a comparative life cycle assessment (LCA) of station-based and dock-less BSS in the U.S. The results show that dock-less BSS has a greenhouse gas (GHG) emissions factor of 118 g CO2.eq/bike-km in the base scenario, which is 82% higher than the station-based system. Bike rebalancing is the main source of GHG emissions, accounting for 36% and 73% of the station-based and dock-less systems, respectively. However, station-based BSS has 54% higher total normalized environmental impacts (TNEI), compared to dock-less BSS. The dock manufacturing dominants the TNEI (61%) of station-based BSS and the bike manufacturing contributes 52% of TNEI in dock-less BSS. BSS can also bring environmental benefits through substituting different transportation modes. Car trip replacement rate is the most important factor. The results suggest four key approaches to improve BSS environmental performance: 1) optimizing the bike distribution and rebalancing route or repositioning bikes using more sustainable approaches, 2) incentivizing more private car users to switch to using BSSs, 3) prolonging lifespans of docking infrastructure to significantly reduce the TNEI of station-based systems, and 4) increasing the bike utilization efficiency to improve the environmental performance of dock-less systems.
C1 [Luo, Hao; Zhao, Fu; Cai, Hua] Purdue Univ, Environm & Ecol Engn, W Lafayette, IN 47907 USA.
   [Kou, Zhaoyu; Cai, Hua] Purdue Univ, Ind Engn, W Lafayette, IN 47907 USA.
   [Zhao, Fu] Purdue Univ, Mech Engn, W Lafayette, IN 47907 USA.
RP Cai, H (reprint author), 315 N Grant St, W Lafayette, IN 47907 USA.
EM huacai@purdue.edu
RI ; Cai, Hua/B-2011-2014
OI Luo, Hao/0000-0002-5115-7353; Cai, Hua/0000-0002-5895-1664; Zhao,
   Fu/0000-0001-5195-868X
CR Amaya J, 2014, J ENG DESIGN, V25, P280, DOI 10.1080/09544828.2014.974523
   Bachand-Marleau J, 2012, TRANSPORT RES REC, P66, DOI 10.3141/2314-09
   Benjamin H, 2017, CHINESE BIKE SHARE G
   BERKHOUT F, 2001, IMPACTS INFORM COMMU
   Bernstein M, 2013, UNDERSTANDING LIFE L
   Chester MV, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024008
   Chrisafis A, 2018, WHEELS COME PARIS BI
   Coelho MC, 2015, TRANSP RES PROC, V10, P443, DOI 10.1016/j.trpro.2015.09.094
   Davis L. S., 2014, PLANNING, V80, P11
   EPA, 2012, TOOL RED ASS CHEM O
   Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018
   Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036
   Fishman E, 2014, TRANSPORT RES D-TR E, V31, P13, DOI 10.1016/j.trd.2014.05.013
   Haupt M, 2018, DATA BRIEF, V19, P1441, DOI 10.1016/j.dib.2018.05.067
   ISO, 2006, ENV MAN LIF CYCL ASS
   Kou ZY, 2019, PHYSICA A, V515, P785, DOI 10.1016/j.physa.2018.09.123
   Lazo L, 2019, BIKE SHARE DEBACLE I
   Leuenberger M, 2010, LIFE CYCLE ASSESSMEN
   Liu JM, 2015, IEEE DATA MINING, P883, DOI 10.1109/ICDM.2015.99
   Lloyd S. A, 2018, DID SEATTLES BIKE SH
   Lucas K, 2018, DOCKLESS DC DISTRICT
   Martin EW, 2014, J TRANSP GEOGR, V41, P315, DOI 10.1016/j.jtrangeo.2014.06.026
   Maus J, 2016, PORTLAND NOW USING P
   Meddin R, 2018, BIKE SHARING WORLD M
   NACTO, 2017, BIK SHAR US 2017
   Nieuwesteeg T, 2018, DOCKLESS BIKES PROMI
   O'Kane S, 2018, DOCKLESS BIKE SHARE
   Otero I, 2018, ENVIRON INT, V115, P387, DOI 10.1016/j.envint.2018.04.014
   Pennington DW, 2004, ENVIRON INT, V30, P721, DOI 10.1016/j.envint.2003.12.009
   Qiu LY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10041145
   Rebitzer G, 2004, ENVIRON INT, V30, P701, DOI 10.1016/j.envint.2003.11.005
   Ryberg M, 2014, CLEAN TECHNOL ENVIR, V16, P329, DOI 10.1007/s10098-013-0629-z
   Shaheen SA, 2013, TRANSPORT RES REC, P83, DOI 10.3141/2387-10
   Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20
   Shui CS, 2018, TRANSPORT RES D-TR E, V60, P119, DOI 10.1016/j.trd.2017.06.023
   Texas Instruments, 2018, SMART LOCK REF DES E
   The International Standards Organisation, 2006, 14044 ISO, V2006, P652, DOI [10.1007/s11367-011-0297-3, DOI 10.1007/S11367-011-0297-3]
   Wang MS, 2017, J TRANSP GEOGR, V65, P147, DOI 10.1016/j.jtrangeo.2017.10.022
   Wernet G, 2016, INT J LIFE CYCLE ASS, V21, P1218, DOI 10.1007/s11367-016-1087-8
   Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425
   Zhang YP, 2018, APPL ENERG, V220, P296, DOI 10.1016/j.apenergy.2018.03.101
NR 41
TC 8
Z9 8
U1 8
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 180
EP 189
DI 10.1016/j.resconrec.2019.03.003
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900017
DA 2020-05-12
ER

PT J
AU Mahmoudi, S
   Huda, N
   Behnia, M
AF Mahmoudi, Sajjad
   Huda, Nazmul
   Behnia, Masud
TI Photovoltaic waste assessment: Forecasting and screening of emerging
   waste in Australia
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE EoL PV modules; PV waste management; Forecasting; Recycling; Circular
   economy
ID CADMIUM-TELLURIDE; MANAGEMENT; SILICON; PANELS; TECHNOLOGIES; GALLIUM;
   INDIUM
AB Australia has to meet the challenges of End-of-Life treatment of photovoltaic modules in coming years due to rapid growth of photovoltaic capacity during the last decades. This paper contributes towards the sustainable management of decommissioned solar panels through the estimation of PV waste flow between the years 2031-2047 based on the actual installation of the PV modules from 2001 to 2018, and the provision of a forecasting model applying on four major scenarios to project the waste generated from 2048-2060. Assuming three forecasting schemes, and consistent annual-growth-rate of PV installation for each scenario, the future PV waste was quantified. Considering the PV installation from 2001 to 2018, the cumulative waste is estimated to be 0.8 million tonnes until 2047. The mainstream of the waste is estimated to be glass and aluminium with 541,209 and 116,483 tonnes respectively, followed by 8375 tonnes of copper and 71,329 tonnes of steel. The PV waste includes various valuable substances which, if appropriately recycled, can bring significant economic benefit. With regards to all PV penetration scenarios in the electricity generation market until 2030, Australia is estimated to face around 1-8 million tonnes of decommissioned PV until 2060. The recovery of the EoL PV raw materials can lead to value creation of nearly 1.2 billion dollars. These findings can shed light on the possibility of a circular economy and suggest an active contribution of all parties and a very well-planned coordinated approach prevent the potential environmental impacts and maximize resource efficiency.
C1 [Mahmoudi, Sajjad; Huda, Nazmul] Macquarie Univ, Sch Engn, N Ryde, NSW 2109, Australia.
   [Behnia, Masud] Macquarie Univ, Macquarie Grad Sch Management, N Ryde, NSW 2109, Australia.
RP Huda, N (reprint author), Macquarie Univ, Sch Engn, N Ryde, NSW 2109, Australia.
EM nazmul.huda@mq.edu.au
RI Huda, Nazmul/AAI-4807-2020; Mahmoudi, Sajjad/M-9426-2019
OI Huda, Nazmul/0000-0002-2349-7019; Behnia, Masud/0000-0003-3493-3100
FU Macquarie University under the International Macquarie University
   Research Training Pathway scholarship program (iMQRTP)
FX The first author acknowledges funding support from Macquarie University
   under the International Macquarie University Research Training Pathway
   scholarship program (iMQRTP).
CR ALSEMA EA, 2006, 21 EUR PHOT SOL EN C
   Anctil A, 2013, PROG PHOTOVOLTAICS, V21, P1253, DOI [10.1002/pip.2226, 10.1002/pip.2308]
   ARENA AREA., 2017, ADV SOL AUSTR RD D I
   Azeumo MF, 2019, SOL ENERG MAT SOL C, V193, P314, DOI 10.1016/j.solmat.2019.01.035
   Berger W, 2010, RESOUR CONSERV RECY, V54, P711, DOI 10.1016/j.resconrec.2009.12.001
   BIO, 2011, STUD PHOT PAN SUPPL
   Chine W, 2014, RENEW ENERG, V66, P99, DOI 10.1016/j.renene.2013.11.073
   Choi JK, 2014, J CLEAN PROD, V66, P443, DOI 10.1016/j.jclepro.2013.11.022
   Choi JK, 2010, J IND ECOL, V14, P947, DOI 10.1111/j.1530-9290.2010.00289.x
   Choi JK, 2010, ENVIRON SCI TECHNOL, V44, P8678, DOI 10.1021/es101710g
   Coalition S. V. T., 2009, JUST SUST SOL EN IND
   Corcelli F, 2018, ECOL INDIC, V94, P37, DOI 10.1016/j.ecolind.2016.03.028
   Cyrs WD, 2014, ENERG POLICY, V68, P524, DOI 10.1016/j.enpol.2014.01.025
   D'Adamo I, 2017, INT J PHOTOENERGY, DOI 10.1155/2017/4184676
   DeGraaff D., 2011, NREL 2011 PHOT MOD R
   Dias P., 2019, EC POLITICAL PRESSUR
   Dias P, 2019, J CLEAN PROD, V209, P846, DOI 10.1016/j.jclepro.2018.10.306
   Dias P, 2018, J CLEAN PROD, V197, P750, DOI 10.1016/j.jclepro.2018.06.161
   Dominguez A, 2017, RESOUR CONSERV RECY, V127, P29, DOI 10.1016/j.resconrec.2017.08.013
   Duflou JR, 2018, CIRP ANN-MANUF TECHN, V67, P29, DOI 10.1016/j.cirp.2018.04.053
   Faircloth CC, 2019, RESOUR CONSERV RECY, V143, P260, DOI 10.1016/j.resconrec.2019.01.008
   Fraunhofer, 2018, PHOT REP
   Gaustad G, 2018, RESOUR CONSERV RECY, V135, P24, DOI 10.1016/j.resconrec.2017.08.002
   Geyer R., 2018, PHOTOVOLTAIC WASTE A
   Goe M, 2014, APPL ENERG, V120, P41, DOI 10.1016/j.apenergy.2014.01.036
   Goverment A., 2018, M ENV MIN MEM
   Held M, 2011, PROG PHOTOVOLTAICS, V19, P614, DOI 10.1002/pip.1068
   Hunt L. P., 1976, 12 PHOT SPEC C
   IEA-PVPS, 2014, T1252014 IEAPVPS
   Islam MT, 2018, RESOUR CONSERV RECY, V137, P48, DOI 10.1016/j.resconrec.2018.05.026
   Islam MT., 2019, COMP E WASTE MANAGEM
   Kang S, 2012, RENEW ENERG, V47, P152, DOI 10.1016/j.renene.2012.04.030
   Katsigiannis Y., 2015, SOL CELLS, V3
   Latunussa CEL, 2016, SOL ENERG MAT SOL C, V156, P101, DOI 10.1016/j.solmat.2016.03.020
   Lopion P, 2018, RENEW SUST ENERG REV, V96, P156, DOI 10.1016/j.rser.2018.07.045
   Mahmoudi S., 2018, DESTECH T ENV EN EAR
   MALANDRINO O, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9040481
   Marwede M, 2014, J IND ECOL, V18, P254, DOI 10.1111/jiec.12108
   Marwede M, 2013, RENEW ENERG, V55, P220, DOI 10.1016/j.renene.2012.12.038
   Marwede M, 2012, RESOUR CONSERV RECY, V69, P35, DOI 10.1016/j.resconrec.2012.09.003
   McDonald NC, 2010, ENERG POLICY, V38, P7041, DOI 10.1016/j.enpol.2010.07.023
   Monier V., 2011, ENV G, V4, P6
   Moreno-Garcia IM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060770
   Osborne M, 2016, INS FORECASTS GLOBAL
   Padlewski S., 2014, DEC SELECTING RIGHT
   Paiano A, 2015, RENEW SUST ENERG REV, V41, P99, DOI 10.1016/j.rser.2014.07.208
   Paiano A, 2013, RESOUR CONSERV RECY, V73, P162, DOI 10.1016/j.resconrec.2013.02.008
   Peeters JR, 2017, RESOUR CONSERV RECY, V120, P14, DOI 10.1016/j.resconrec.2017.01.001
   Radziemska E, 2010, ECOL CHEM ENG S, V17, P385
   Redlinger M, 2015, SOL ENERG MAT SOL C, V138, P58, DOI 10.1016/j.solmat.2015.02.027
   Research G, 2016, GLOB PV DEM OUTL 201
   Sander K, 2007, STUDY DEV TAKE BACK
   Sibley S. F., 2011, OVERVIEW FLOW STUDIE
   Sica D, 2018, RENEW SUST ENERG REV, V82, P2934, DOI 10.1016/j.rser.2017.10.039
   Sinha P, 2008, ENERG POLICY, V36, P381, DOI 10.1016/j.enpol.2007.09.017
   Spence A, 2016, SOLAR PANEL RECYCLER
   Stephanie Weckend A. W., 2016, END OF LIFE MANGEMEN
   Syed A., 2011, AUSTR ENERGY PROJECT
   Syed A., 2014, AUSTR ENERGY PROJECT
   Syed A., 2012, AUSTR ENERGY PROJECT
   Tao J, 2015, SOL ENERG MAT SOL C, V141, P108, DOI 10.1016/j.solmat.2015.05.005
   Trading-Economics, 2017, AUSTR IMP
   Vodermeyer C., 2013, PHOTOVOLTAICS LONG T
   Weckend S., 2016, END OF LIFE MANAGEME
   Winneker C, 2013, GLOBAL MARKET OUTLOO
   Xu Y, 2018, WASTE MANAGE, V75, P450, DOI 10.1016/j.wasman.2018.01.036
   Yi YK, 2014, J AIR WASTE MANAGE, V64, P797, DOI 10.1080/10962247.2014.891540
   Zhang J., 2008, FDN TECHNOL, V12
NR 68
TC 2
Z9 2
U1 6
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 192
EP 205
DI 10.1016/j.resconrec.2019.03.039
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900019
DA 2020-05-12
ER

PT J
AU Severis, RM
   da Silva, FA
   Wahrlich, J
   Skoronski, E
   Simioni, FJ
AF Severis, Roni M.
   da Silva, Flavia Arcari
   Wahrlich, Julia
   Skoronski, Everton
   Simioni, Flavio J.
TI Economic analysis and risk-based assessment of the financial losses of
   domestic rainwater harvesting systems
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE RWH; Economic indicators; Risk probability; Sensitivity analysis; Water
   supply
ID POTABLE WATER SAVINGS; ENVIRONMENTAL-ANALYSIS; FEASIBILITY; RELIABILITY;
   OPERATION; DESIGN; CITIES
AB The considerable potential for rainwater harvesting (RWH) opens the door for the study of economic viability and risk indicators in this kind of system. The aim of this paper was to present economic and risk analyses of three RWH systems intended for water supply to single-family residences. The systems were analyzed based on water demand, degree of treatment and distribution arrangement. Economic, sensitivity and risk analyses were performed. The system with the basic treatment of rainwater and distribution by pressure (BX Pressure) was the most economically viable. The Net Present Value and the Intern Return Rate of the BX Pressure system was 480.36 USD and 6.85%, respectively. In the sensitivity analysis, both basic treatment systems were viable at any considered discount rate (0.00%-10.00%) and at a water price ranging from 1.58 USD to 2.72 USD for BX Pressure. In the risk analysis, BX Pressure was also the most viable system, presenting a risk probability of viability of 95.9% at current water prices. Water price, demand, lower discount rates and initial investment costs determined the greater economic viability and lower economic risk associated with domestic RWH systems.
C1 [Severis, Roni M.; da Silva, Flavia Arcari; Wahrlich, Julia; Simioni, Flavio J.] Santa Catarina State Univ, Lab Environm Management, Environm & Sanit Dept, Ave Luis de Camoes 2090, BR-88520000 Lages, SC, Brazil.
   [Skoronski, Everton] Santa Catarina State Univ, Lab Water & Waste Treatment, Environm & Sanit Dept, Ave Luis de Camoes 2090, BR-88520000 Lages, SC, Brazil.
RP Simioni, FJ (reprint author), Santa Catarina State Univ, Lab Environm Management, Environm & Sanit Dept, Ave Luis de Camoes 2090, BR-88520000 Lages, SC, Brazil.
EM eng.severis@hotmail.com; flarcari@hotmail.com; julia.wahrlich@gmail.com;
   everton.skoronski@udesc.br; flavio.simioni@udesc.br
RI skoronski, everton/N-9318-2014
OI skoronski, everton/0000-0002-8554-8272; Arcari da Silva,
   Flavia/0000-0002-6669-5197
FU State of Santa Catarina Research and Innovation Support Foundation
   (FAPESC); Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Santa Catarina State University Graduate Education Program
   of Teaching Assistance Scholarship (UDESC/PROMOP)
FX This study was funded by the State of Santa Catarina Research and
   Innovation Support Foundation (FAPESC), the Coordination for the
   Improvement of Higher Education Personnel (CAPES) and the Santa Catarina
   State University Graduate Education Program of Teaching Assistance
   Scholarship (UDESC/PROMOP).
CR ABIDES-Brazilian Association of Integration and Sustainable Development, 2015, MUCH WAT DO YOU CONS
   ABNT-Brazilian National Standards Organization, 1989, 108441989 ABNT NBR B
   ABNT-Brazilian National Standards Organization, 2017, 122182017 ABNT NBR B
   Akter A, 2015, J HYDROL, V528, P84, DOI 10.1016/j.jhydrol.2015.06.017
   Amos CC, 2018, J CLEAN PROD, V172, P196, DOI 10.1016/j.jclepro.2017.10.114
   Amos CC, 2016, WATER-SUI, V8, DOI 10.3390/w8040149
   ANA-National Water Agency, 2009, WAT FACTS TEND
   Bashar MZI, 2018, RESOUR CONSERV RECY, V133, P146, DOI 10.1016/j.resconrec.2018.01.025
   BCB-Central Bank of Brazil, 2018, BCB INT RAT HIST SER
   Campisano A, 2014, PROCEDIA ENGINEER, V89, P1507, DOI 10.1016/j.proeng.2014.11.441
   Campisano A, 2017, URBAN WATER J, V14, P883, DOI 10.1080/1573062X.2017.1279192
   Campisano A, 2017, WATER RES, V115, P195, DOI 10.1016/j.watres.2017.02.056
   Casarotto Filho N., 2010, ANALISE INVESTIMENTO, P432
   Castonguay AC, 2018, ENVIRON MODELL SOFTW, V105, P270, DOI 10.1016/j.envsoft.2018.05.001
   Pacheco PRD, 2017, J CLEAN PROD, V141, P290, DOI 10.1016/j.jclepro.2016.09.097
   Dias I. C. S., 2007, REV EC NORDESTE, V38, P542
   dos Santos SM, 2017, J CLEAN PROD, V164, P1007, DOI 10.1016/j.jclepro.2017.06.251
   Farreny R, 2011, RESOUR CONSERV RECY, V55, P686, DOI 10.1016/j.resconrec.2011.01.008
   Fernandes LFS, 2015, SCI TOTAL ENVIRON, V529, P91, DOI 10.1016/j.scitotenv.2015.05.061
   Carvalho CRF, 2014, CIENC RURAL, V44, P2293, DOI 10.1590/0103-8478cr20131570
   Ghimire SR, 2017, J CLEAN PROD, V151, P74, DOI 10.1016/j.jclepro.2017.02.025
   Ghisi E, 2006, BUILD ENVIRON, V41, P204, DOI 10.1016/j.buildenv.2005.01.014
   Ghisi E, 2007, BUILD ENVIRON, V42, P1654, DOI 10.1016/j.buildenv.2006.02.007
   Ghisi E, 2013, WATER RESOUR MANAG, V27, P2555, DOI 10.1007/s11269-013-0303-6
   Ghisi E, 2010, WATER RESOUR MANAG, V24, P2381, DOI 10.1007/s11269-009-9557-4
   Gitman L. J., 2010, PRINCIPIOS ADM FINAN, P800
   Gomez YD, 2017, RESOUR CONSERV RECY, V127, P56, DOI 10.1016/j.resconrec.2017.08.015
   Guo R, 2018, J HYDROL, V562, P30, DOI 10.1016/j.jhydrol.2018.04.062
   Haque MM, 2016, J CLEAN PROD, V137, P60, DOI 10.1016/j.jclepro.2016.07.038
   IBGE-Brazilian Institute of Geography and Statistics, 2016, PESQ NAC AM DOM SINT, P108
   INMET-National Institute of Meteorology, 2016, MET DAT TEACH RES BD
   Jing XE, 2017, RESOUR CONSERV RECY, V126, P74, DOI 10.1016/j.resconrec.2017.07.027
   Karim MR, 2015, RESOUR CONSERV RECY, V104, P61, DOI 10.1016/j.resconrec.2015.09.010
   Lopes VAR, 2017, J CLEAN PROD, V148, P304, DOI 10.1016/j.jclepro.2017.01.132
   Moniruzzaman M, 2017, RESOUR CONSERV RECY, V125, P139, DOI 10.1016/j.resconrec.2017.06.001
   Morales JA, 2017, ING AGUA, V21, P179, DOI 10.4995/Ia.2017.6939
   Morales-Pinzon T., 2014, SCI TOTAL ENVIRON, P470, DOI [10.1016/j.scitotenv.2013.10.101.1257-1271, DOI 10.1016/J.SCITOTENV.2013.10.101.1257-1271]
   Morales-Pinzon T, 2015, J CLEAN PROD, V87, P613, DOI 10.1016/j.jclepro.2014.10.021
   Morales-Pinzon T, 2012, RESOUR CONSERV RECY, V69, P130, DOI 10.1016/j.resconrec.2012.09.014
   Mugume SN, 2017, P I CIVIL ENG-WAT M, V170, P115, DOI 10.1680/jwama.15.00078
   Mwinuka L, 2017, AGREKON, V56, P274, DOI 10.1080/03031853.2017.1343154
   Okoye CO, 2015, RESOUR CONSERV RECY, V104, P131, DOI 10.1016/j.resconrec.2015.08.015
   Oliveira AC, 2017, FLORESTA AMBIENTE, V24, DOI 10.1590/2179-8087.026516
   Oviedo-ocana E. R., 2018, FINANCIAL FEASIBILIT, P19200, DOI [10.1007/s11356-017-8710-5, DOI 10.1007/S11356-017-8710-5]
   Palla A, 2017, J ENVIRON MANAGE, V191, P297, DOI 10.1016/j.jenvman.2017.01.025
   Palla A, 2011, J HYDROL, V401, P65, DOI 10.1016/j.jhydrol.2011.02.009
   Partzsch L, 2009, J CLEAN PROD, V17, P985, DOI 10.1016/j.jclepro.2009.01.009
   Pavolova H, 2019, J CLEAN PROD, V209, P1119, DOI 10.1016/j.jclepro.2018.10.308
   Pietrucha-Urbanik K, 2018, WATER-SUI, V10, DOI 10.3390/w10111679
   Ramos D. M., 2011, REV BRAS BIOCIENCIAS, V9, P156
   Rippl W., 1883, MINUTES P I CIVIL EN, V71, P270, DOI DOI 10.1680/IMOTP.1883.21797
   Fonseca CR, 2017, J CLEAN PROD, V145, P323, DOI 10.1016/j.jclepro.2017.01.057
   Samanez C. P., 2009, ENGENHARIA EC, P210
   Sample DJ, 2014, J CLEAN PROD, V75, P174, DOI 10.1016/j.jclepro.2014.03.075
   Sanepar-Parana Sanitation Company, 2017, RESP CONS
   Silva CM, 2015, RESOUR CONSERV RECY, V94, P21, DOI 10.1016/j.resconrec.2014.11.004
   SNIS-Sanitation National Information System, 2018, SNIS HIST SER
   SNIS-Sanitation National Information System, 2016, WAT SEW SERV DIAGN I
   Steffen J, 2013, J AM WATER RESOUR AS, V49, P810, DOI 10.1111/jawr.12038
   Su MD, 2009, RESOUR CONSERV RECY, V53, P393, DOI 10.1016/j.resconrec.2009.03.005
   TESTON A, 2018, WATER-SUI, V10, DOI DOI 10.3390/w10040471
NR 61
TC 1
Z9 1
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 206
EP 217
DI 10.1016/j.resconrec.2019.03.040
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900020
DA 2020-05-12
ER

PT J
AU He-Lambert, L
   Shylo, O
   English, BC
   Eash, NS
   Zahn, JA
   Lambert, DM
AF He-Lambert, Lixia
   Shylo, Oleg
   English, Burton C.
   Eash, Neal S.
   Zahn, James A.
   Lambert, Dayton M.
TI Supply chain and logistic optimization of industrial Spent Microbial
   Biomass distribution as a soil amendment for field crop production
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Bioeconomy; Bioprocessing; Coproducts; Spent Microbial Biomass (SMB);
   Closed-loop supply chain (CLSC)
ID NETWORK DESIGN; FERTILIZER; RESIDUES; MODEL; GRAIN
AB Advancement of a sustainable bioeconomy requires strategic planning and development of new markets for coproducts. This research develops a least cost transportation model to deliver Spent Microbial Biomass (SMB) to farm fields as a soil amendment and fertilizer substitute. SMB is a coproduct resulting from the production of Bio-PDO (TM) a certified biobased 1,3-propanediol made from corn glucose. SMB is bulky, but high in organic matter and other important plant nutrients. Distribution of SMB requires storage sites and truck transportation. The location of storage sites and serviceable coverage area are important factors determining supply logistic costs. This case study focuses on a Bio-PDO (TM) processing facility in East Tennessee. Stochastic programming and Monte Carlo simulation were used to evaluate the least-cost distribution of SMB under uncertain farmer demand. Farmer interest and participation rates affect the number and location of storage facilities, the systems total storage capacity and costs, and transportation costs. The results suggest that on-farm storage of SMB minimizes material transport and storage costs.
C1 [He-Lambert, Lixia] Oklahoma State Univ, Dept Agr Econ, 321 Agr Hall, Stillwater, OK 74078 USA.
   [Shylo, Oleg] Univ Tennessee, Dept Ind & Syst Engn, 523 John D Tickle Bldg, Knoxville, TN 37996 USA.
   [English, Burton C.] Univ Tennessee, Dept Agr & Resource Econ, 308 Morgan Hall, Knoxville, TN 37996 USA.
   [Eash, Neal S.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, 110 Biosyst Engn Soil Sci Off, Knoxville, TN 37996 USA.
   [Zahn, James A.] DuPont Tate & Lyle Bio Prod, 198 Blair Bend Rd, Loudon, TN 37774 USA.
   [Lambert, Dayton M.] Oklahoma State Univ, Dept Agr Econ, 411 Agr Hall, Stillwater, OK 74078 USA.
RP He-Lambert, L (reprint author), Oklahoma State Univ, Dept Agr Econ, 321 Agr Hall, Stillwater, OK 74078 USA.
EM lixia.lambert@okstate.edu; oshylo@utk.edu; benglish@utk.edu;
   eash@utk.edu; James.A.Zahn@dupont.com; dayton.lambert@okstate.edu
OI Eash, Neal/0000-0001-9141-4302
FU DuPont Tate and Lyle Bio Products; University of Tennessee Agricultural
   Experiment Station; Oklahoma Agricultural Experimental Station
FX This research was supported by DuPont Tate and Lyle Bio Products. The
   authors would like to thank Mr. Bradley Wilson for technical suggestions
   and Dr. Aaron Smith for helpful discussions. The authors also
   acknowledge support from the University of Tennessee Agricultural
   Experiment Station and Oklahoma Agricultural Experimental Station.
CR Aboukila E. F., 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P390, DOI 10.1016/j.jssas.2016.09.005
   Ahmed S, 2002, SIAM J OPTIMIZ, V12, P479, DOI DOI 10.1137/S1052623499363220
   Andersen JT, 2001, RES MICROBIOL, V152, P823, DOI 10.1016/S0923-2508(01)01266-9
   BARKER TW, 1983, J SCI FOOD AGR, V34, P638, DOI 10.1002/jsfa.2740340615
   Batidzirai B, 2016, BIOMASS BIOENERG, V92, P106, DOI 10.1016/j.biombioe.2016.06.010
   Ben-Hamed U, 2010, ASP APPL BIOL, V105, P267
   BEN-HAMED U., 2011, WORLD ACAD SCI ENG T, V50, P695
   Bovo F, 2015, BRAZ J MICROBIOL, V46, P577, DOI 10.1590/S1517-838246220130400
   Brook A, 1988, GAMS USER GUIDE
   Buffington J., 2014, ADV CHEM ENG SCI, V4, P308, DOI DOI 10.4236/ACES.2014.43034
   Chopra S., 2015, SUPPLY CHAIN MANAGEM
   Clomburg JM, 2017, SCIENCE, V355, DOI 10.1126/science.aag0804
   Conway R, 2008, 720166 USDA
   Dessalew G, 2017, J CLEAN PROD, V157, P22, DOI 10.1016/j.jclepro.2017.04.116
   FAO, 2016, 63 FAO ENV NAT RES M
   Fleischmann M, 2001, PROD OPER MANAG, V10, P156
   German Bioeconomy Council, 2018, BIOEC POL 3
   Golden J, 2016, C US
   Gonsalves GD, 2017, J CLEAN PROD, V168, P908, DOI 10.1016/j.jclepro.2017.09.089
   Guide VDR, 2002, QUANTITATIVE APPROAC, P47
   Halter MC, 2017, J IND MICROBIOL BIOT, V44, P213, DOI 10.1007/s10295-016-1876-x
   Hardgrove SJ, 2016, URBAN FOR URBAN GREE, V18, P1, DOI 10.1016/j.ufug.2016.02.015
   Hijbeek R, 2018, NUTR CYCL AGROECOSYS, V110, P105, DOI 10.1007/s10705-017-9875-5
   Kleywegt AJ, 2001, SIAM J OPTIMIZ, V12, P479, DOI 10.1137/S1052623499363220
   Lokko Y, 2018, NEW BIOTECHNOL, V40, P5, DOI 10.1016/j.nbt.2017.06.005
   Mahajan J., 2016, VIKALPA, V41, P197, DOI [10.1177/0256090916659029, DOI 10.1177/0256090916659029]
   Melo MT, 2009, EUR J OPER RES, V196, P401, DOI 10.1016/j.ejor.2008.05.007
   Mussatto S.I., 2016, BIOMASS FRACTIONATIO, P1
   Mussatto SI, 2006, J CEREAL SCI, V43, P1, DOI 10.1016/j.jcs.2005.06.001
   Novozymes, 2006, NEIGHB INV LOC ENV
   Novozymes, 2016, 7 4 WAST ENV DAT
   Novozymes, 2006, SUST PARTN BIOM NOV
   OLAJIRE AA, 2012, J CLEAN PROD, V30, P1, DOI [DOI 10.1016/JJDEPR0.2012.03.003, DOI 10.1016/J.JCLEPR0.2012.03.003]
   Pinna R, 2012, REVERSE LOGISTICS RO, DOI [10.5772/33047, DOI 10.5772/33047]
   Rashid N, 2013, BIOCHEM ENG J, V75, P101, DOI 10.1016/j.bej.2013.04.001
   Rogers D.S., 1999, GOING BACKWARDS REVE, V2
   Roni MS, 2014, TRANSPORT RES E-LOG, V61, P115, DOI 10.1016/j.tre.2013.10.007
   Santoso T, 2005, EUR J OPER RES, V167, P96, DOI 10.1016/j.ejor.2004.01.046
   Sgarbossa F, 2017, INT J PROD ECON, V183, P596, DOI 10.1016/j.ijpe.2016.07.022
   Stindt D, 2014, FLEX SERV MANUF J, V26, P268, DOI 10.1007/s10696-012-9137-4
   Sullivan CT, 2017, AGRON J, V109, P1870, DOI 10.2134/agronj2016.12.0742
   Szmelter A, 2016, LOGISTYKA ODZYSKU, V3, P8286
   Taheripour F, 2010, BIOMASS BIOENERG, V34, P278, DOI 10.1016/j.biombioe.2009.10.017
   United State Department of Agriculture (USDA), 2013, CROPSC CROPL DAT LAY
   Wortmann C. S, 2015, RES IDENTIFIES ATTRI
   Zhang JS, 2016, J CLEAN PROD, V112, P3927, DOI 10.1016/j.jclepro.2015.07.096
   Zuorro A, 2012, J CLEAN PROD, V34, P49, DOI 10.1016/j.jclepro.2011.12.003
NR 47
TC 0
Z9 0
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 218
EP 231
DI 10.1016/j.resconrec.2019.03.028
PG 14
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900021
DA 2020-05-12
ER

PT J
AU Moreno-Brieva, F
   Marin, R
AF Moreno-Brieva, Fernando
   Marin, Raquel
TI Technology generation and international collaboration in the Global
   Value Chain of Lithium Batteries
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Global Value Chain; Lithium batteries; Knowledge generation; Patents;
   International connectivity; Competitiveness
ID INNOVATION CAPABILITIES; AVAILABILITY; FUTURE; PATENTS; GOVERNANCE;
   STATE; FLOW
AB The Global Value Chain (GVC) literature generally highlights the opportunities for developing economies to be found in technological upgrading although the generation of technology tends to be associated with the highest added-value stages, what could be a limiting aspect in those chains based primarily on natural resources. The case of lithium batteries allows analysis of the trade-off between technology generation and international collaboration, as well as any potential asymmetries between producers of natural resources and end-use products within the same GVC. Lithium is a relevant component, currently seen as a valuable player in the reduction of fossil fuel emissions, given the potential of lithium batteries for energy storage, in final applications ranging from consumer electronics to electric vehicles. Our findings show a divergent relationship between lithium producers and related technologies at the country level, across the different stages of the Global Value Chain for Lithium Batteries (GVCLB), and this suggests that upgrading throughout the value chain could foster imbalances. Empirical analysis has been conducted using data from patent applications made to the European Patent Office, and the findings reveal wide international divergence and numerous interactions within the GVCLB, defining a complex international pattern of collaboration, with technology generation concentrated into very few economies.
C1 [Moreno-Brieva, Fernando; Marin, Raquel] Univ Complutense Madrid, Inst Complutense Estudios Int, Finca Mas Ferre, Edif A,Campus Somosaguas, Madrid 28223, Spain.
   [Moreno-Brieva, Fernando] Univ Talca, Inst Innovac Basada Ciencia, 2 Norte 685, Talca, Chile.
   [Marin, Raquel] Univ Complutense Madrid, Dept Econ Anal, Finca Mas Ferre, Edif A Campus Somosaguas, Madrid 28223, Spain.
RP Marin, R (reprint author), Univ Complutense Madrid, Inst Complutense Estudios Int, Finca Mas Ferre, Edif A,Campus Somosaguas, Madrid 28223, Spain.; Marin, R (reprint author), Univ Complutense Madrid, Dept Econ Anal, Finca Mas Ferre, Edif A Campus Somosaguas, Madrid 28223, Spain.
EM fernmo01@ucm.es; rmarinsa@ucm.es
RI Marin, Raquel/L-3543-2014
OI Marin, Raquel/0000-0002-1304-4817; Moreno-Brieva,
   Fernando/0000-0002-0588-7267
CR Almeida P, 2004, STRATEGIC MANAGE J, V25, P847, DOI 10.1002/smj.388
   Alvarez I, 2015, J EC BUS MANAG, V3, P619, DOI [10.7763/JOEBM.2015.V3.255, DOI 10.7763/JOEBM.2015.V3.255]
   ARCHIBUGI D, 1992, SCI PUBL POLICY, V19, P357, DOI DOI 10.1093/SPP/19.6.357
   BASBERG BL, 1987, RES POLICY, V16, P131, DOI 10.1016/0048-7333(87)90027-8
   Cano-Kollmann M, 2016, J INT BUS STUD, V47, P255, DOI 10.1057/jibs.2016.8
   Cantwell J A, 2002, J INT MANAG, V8, P69, DOI DOI 10.1016/S1075-4253(01)00056-4
   Cantwell JA, 2011, GLOB STRATEG J, V1, P206, DOI 10.1002/gsj.24
   Comision Chilena del Cobre, 2009, ANT POL PUBL MIN EST
   Ebensperger A, 2005, RESOUR POLICY, V30, P218, DOI 10.1016/j.resourpol.2005.09.001
   Egbue O, 2012, EMJ-ENG MANAG J, V24, P52, DOI 10.1080/10429247.2012.11431947
   European Patent Office, 2016, ESP PAT SEARCH
   Fan X, 2017, SCIENTOMETRICS, V111, P117, DOI 10.1007/s11192-017-2274-5
   Gereffi G, 2005, REV INT POLIT ECON, V12, P78, DOI 10.1080/09692290500049805
   Gereffi G, 1995, GLOBAL CHANGE REGION, P95
   Glanzel W, 2003, SCIENTOMETRICS, V58, P415, DOI 10.1023/A:1026248929668
   GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301
   Grosjean C, 2012, RENEW SUST ENERG REV, V16, P1735, DOI 10.1016/j.rser.2011.11.023
   Gruber PW, 2011, J IND ECOL, V15, P760, DOI 10.1111/j.1530-9290.2011.00359.x
   Humphrey J., 2000, GOVERNANCE UPGRADING, V120
   JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401
   KOGUT B, 1984, J INT BUS STUD, V15, P151, DOI 10.1057/palgrave.jibs.8490488
   KOGUT B, 1985, SLOAN MANAGE REV, V26, P15
   Laurens P, 2015, RES POLICY, V44, P765, DOI 10.1016/j.respol.2014.11.001
   Lebedeva N, 2017, 28534 EUR EN, DOI [10.2760/6060, DOI 10.2760/6060]
   Lema R, 2018, EUR J DEV RES, V30, P345, DOI 10.1057/s41287-018-0149-0
   Lema R, 2015, RES POLICY, V44, P1376, DOI 10.1016/j.respol.2015.03.005
   Lowe M, 2010, TECH REP, DOI [10.13140/RG.2.1.1421.0324, DOI 10.13140/RG.2.1.1421.0324]
   Meyer M, 2000, RES POLICY, V29, P409, DOI 10.1016/S0048-7333(99)00040-2
   Moreno-Brieva F. J, 2015, CADENA VALOR GLOBAL
   Motohashi K, 2016, INT J TECHNOL MANAGE, V72, P5, DOI 10.1504/IJTM.2016.080539
   Mudambi R, 2008, J ECON GEOGR, V8, P699, DOI 10.1093/jeg/lbn024
   Narins TP, 2017, EXTRACT IND SOC, V4, P321, DOI 10.1016/j.exis.2017.01.013
   Naumov AV, 2010, RUSS J NON-FERR MET+, V51, P324, DOI 10.3103/S1067821210040127
   [OECD OECD], 2009, OECD PAT STAT MAN
   Pavitt K., 1988, HDB QUANTITATIVE STU, P509, DOI DOI 10.1016/B978-0-444-70537-2.50021-0
   Peiro LT, 2013, JOM-US, V65, P986, DOI 10.1007/s11837-013-0666-4
   Prior T, 2013, SCI TOTAL ENVIRON, V461, P785, DOI 10.1016/j.scitotenv.2013.05.042
   Santangelo G. D., 2006, Structural Change and Economic Dynamics, V17, P174, DOI 10.1016/j.strueco.2005.06.001
   Schmitz Hubert, 2009, International Journal of Technological Learning, Innovation, and Development, V2, P231
   Schroeder P, 2018, RESOUR CONSERV RECY, V136, P77, DOI 10.1016/j.resconrec.2018.04.003
   SOETE L, 1987, RES POLICY, V16, P101, DOI 10.1016/0048-7333(87)90026-6
   Speirs J, 2014, RENEW SUST ENERG REV, V35, P183, DOI 10.1016/j.rser.2014.04.018
   Stephan A, 2017, RES POLICY, V46, P709, DOI 10.1016/j.respol.2017.01.009
   Sturgeon TJ, 2001, IDS BULL-I DEV STUD, V32, P9, DOI 10.1111/j.1759-5436.2001.mp32003002.x
   Sun X, 2017, RESOUR CONSERV RECY, V124, P50, DOI 10.1016/j.resconrec.2017.04.012
   U.S.G.S, 2012, 1371 USGS, P1
   U.S.G.S, 2017, USGS DAT SER
   Vikstrom H, 2013, APPL ENERG, V110, P252, DOI 10.1016/j.apenergy.2013.04.005
   Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k
   Yaksic A, 2009, RESOUR POLICY, V34, P185, DOI 10.1016/j.resourpol.2009.05.002
   Ziemann S, 2012, RESOUR CONSERV RECY, V63, P26, DOI 10.1016/j.resconrec.2012.04.002
   Zubi G, 2018, RENEW SUST ENERG REV, V89, P292, DOI 10.1016/j.rser.2018.03.002
NR 52
TC 0
Z9 0
U1 6
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 232
EP 243
DI 10.1016/j.resconrec.2019.03.026
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900022
DA 2020-05-12
ER

PT J
AU Fisher, LV
   Barron, AR
AF Fisher, Lucy V.
   Barron, Andrew R.
TI The recycling and reuse of steelmaking slags - A review
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Steelmaking slag; Cement; Coral reef; CO2 sequestration; Seaweed;
   Phytoplankton
ID BASIC OXYGEN FURNACE; STEEL-MAKING SLAG; BOF SLAG; MAGNETIC SEPARATION;
   PHOSPHORUS REMOVAL; BLAST-FURNACE; AGGREGATE; RECOVERY; SULFIDE; WATER
AB Large volumes of slags are formed as by-products during the refinement of pig iron by basic oxygen steelmaking or electric arc furnace steelmaking. In order to lower the environmental impact of the steel industry and ensure its economic sustainability, there have been significant studies finding the ways to recycle by-products. The formation, composition and physical properties of steel making slag are discussed with regard to the problems associated with its reuse. The volume instability caused by free lime exposure to moisture means that the reuse of steelmaking slag is often limited as many potential applications, and the leaching behavior of steelmaking slag is important for environmental considerations. Land-based applications that have been demonstrated include replacing natural sand as aggregate in cement, which may be combined with the CO2 sequestration properties. Steel slag shows use as a liming material (when spread over acidic soils to help to raise the pH to a more neutral level) and to enhance the physical properties of soft soils. Potential benefits to the marine environment is due to high porosity and large surface area, making slags ideal for coral reef repair (e.g., overcoming coral bleaching) and replacement (e.g., artificial reef to promote growth of green marine plants and seagrass), as well as a growth promoter for seaweed and phytoplankton that are microscopic organisms that are an essential component of ecosystems in oceans around the world. The chemistry of steelmaking slag also makes it a contender for adsorption of H2S and metalloids from marine environments.
C1 [Fisher, Lucy V.; Barron, Andrew R.] Swansea Univ Bay Campus, Energy Safety Res Inst, Swansea SA1 8EN, W Glam, Wales.
   [Barron, Andrew R.] Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.
   [Barron, Andrew R.] Rice Univ, Dept Mat Sci & Nanoengn, Houston, TX 77005 USA.
RP Barron, AR (reprint author), Swansea Univ Bay Campus, Energy Safety Res Inst, Swansea SA1 8EN, W Glam, Wales.
EM a.r.barron@swansea.ac.uk
RI ; Barron, Andrew/L-9869-2016
OI Fisher, Lucy/0000-0001-8971-8518; Barron, Andrew/0000-0002-2018-8288
FU Materials and Manufacturing Academy (M2A) from the European Social Fund
   via the Welsh Government; Materials and Manufacturing Academy (M2A) from
   the European Social Fund via the Engineering and Physical Sciences
   Research Council (EPSRC); Materials and Manufacturing Academy (M2A) from
   the European Social Fund via the Tata Steel; Welsh Government Ser Cymru
   Chair Program; Robert A. Welch FoundationThe Welch Foundation [C-0002]
FX Financial support was provided by Materials and Manufacturing Academy
   (M2A) that has been made possible through funding from the European
   Social Fund via the Welsh Government, the Engineering and Physical
   Sciences Research Council (EPSRC) and Tata Steel, the Welsh Government
   Ser Cymru Chair Program, and the Robert A. Welch Foundation (C-0002).
CR Alanyali H, 2006, WASTE MANAGE, V26, P1133, DOI 10.1016/j.wasman.2006.01.017
   Asaoka S, 2013, CHEM ENG J, V228, P843, DOI 10.1016/j.cej.2013.05.065
   Barca C, 2013, ENVIRON SCI TECHNOL, V47, P549, DOI 10.1021/es303778t
   Barker K. J., 1998, STEEL REFINING VOLUM, P431
   Biswas A., 1966, PRINCIPLES STEELMAKI
   Blanco I, 2016, WATER RES, V89, P355, DOI 10.1016/j.watres.2015.11.064
   Bodor M, 2016, CEMENT CONCRETE COMP, V65, P55, DOI 10.1016/j.cemconcomp.2015.10.002
   Bolukbasi OS, 2014, SCI SINTER, V46, P331, DOI 10.2298/SOS1403331B
   Bowden LI, 2009, ENVIRON SCI TECHNOL, V43, P2476, DOI 10.1021/es801626d
   Branca TA, 2014, METALL RES TECHNOL, V111, P155, DOI 10.1051/metal/2014022
   Brandt D.A., 2005, METALLURGY FUNDAMENT
   Carleton Ray G., 2014, MARINE CONSERVATION, P15
   Carvalho SZ, 2017, RESOUR CONSERV RECY, V127, P216, DOI 10.1016/j.resconrec.2017.08.021
   Chakraborty A, 2014, WATER ENVIRON RES, V86, P524, DOI 10.2175/106143014X13975035524907
   Chang EE, 2012, J HAZARD MATER, V227, P97, DOI 10.1016/j.jhazmat.2012.05.021
   Chazarenc F., 2014, 26412 EUR, DOI [10.2777/59366, DOI 10.2777/59366]
   Chen KW, 2016, J CLEAN PROD, V124, P350, DOI 10.1016/j.jclepro.2016.02.072
   COLLINS K. J., 1995, CHEM ECOL, V10, P205
   Coudurier L., 1978, FUNDAMENTALS METALLU, DOI [10.1016/C2013-0-03773-5, DOI 10.1016/C2013-0-03773-5]
   Devi VS, 2014, PROCEDIA ENGINEER, V97, P95, DOI 10.1016/j.proeng.2014.12.229
   El-Moshley K. H. M, 2012, INT J ENV PROTECTION, V2, P1
   European Environment Agency, 2015, NUTR FRESHW
   FILLOS J, 1972, J WATER POLLUT CON F, V44, P644
   FREEMAN JS, 1981, J SOIL SCI, V32, P75, DOI 10.1111/j.1365-2389.1981.tb01687.x
   Fujimoto ICI., 2012, NIPPON STEEL TECHNIC, V101, P208
   Futatsuka T, 2004, ISIJ INT, V44, P753, DOI 10.2355/isijinternational.44.753
   Gao CH, 2014, IEEE T FUZZY SYST, V22, P586, DOI 10.1109/TFUZZ.2013.2269145
   Gao X., 2015, UTILIZATION STEELMAK
   Garside J. E., 1957, GRIFFIN, P76
   Gautier M, 2013, INT J MINER PROCESS, V123, P94, DOI 10.1016/j.minpro.2013.05.002
   GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779
   Gomez-Caminero A, 2001, ENV HLTH CRITERIA
   Guo H, 2018, RESOUR CONSERV RECY, V129, P209, DOI 10.1016/j.resconrec.2017.10.027
   Han C, 2016, J ENVIRON SCI-CHINA, V46, P63, DOI 10.1016/j.jes.2015.09.024
   Haraguchi K, 2003, ISIJ INT, V43, P1461, DOI 10.2355/isijinternational.43.1461
   Hayashi A, 2014, ISIJ INT, V54, P1741, DOI 10.2355/isijinternational.54.1741
   Hayashi A, 2013, ISIJ INT, V53, P1894, DOI 10.2355/isijinternational.53.1894
   Horii K., 2013, NIPPON STEEL TECHNIC
   Huang XY, 2016, CONSTR BUILD MATER, V112, P241, DOI 10.1016/j.conbuildmat.2016.02.088
   Huijgen W. J. J., 2005, CARBON DIOXIDE STORA
   Jafer HM, 2018, J CLEAN PROD, V172, P516, DOI 10.1016/j.jclepro.2017.10.233
   Joulazadeh MH, 2010, ARCH METALL MATER, V55, P1137, DOI 10.2478/v10172-010-0017-1
   Juneja A., 2015, JPN GEOTECH SOC SPEC, V3, P86, DOI [10.3208/jgssp.v03.i06, DOI 10.3208/JGSSP.V03.I06]
   Kim K, 2012, ENVIRON SCI TECHNOL, V46, P10169, DOI 10.1021/es301575u
   Lee A. R., 1974, BLAST FURNACE STEEL, P38
   Lee MO, 2018, OCEAN COAST MANAGE, V154, P55, DOI 10.1016/j.ocecoaman.2018.01.010
   Liu CW, 2017, METALL MATER TRANS B, V48, P1602, DOI 10.1007/s11663-017-0966-0
   Liu CW, 2016, METALL MATER TRANS B, V47, P3237, DOI 10.1007/s11663-016-0809-4
   Liu XL, 2019, IRONMAK STEELMAK, V46, P953, DOI 10.1080/03019233.2018.1464107
   Lupu C, 2007, IND ENG CHEM RES, V46, P8018, DOI 10.1021/ie0709279
   Lupu C, 2006, ADV ENG MATER, V8, P576, DOI 10.1002/adem.200500280
   Ma NY, 2014, J CLEAN PROD, V82, P221, DOI 10.1016/j.jclepro.2014.06.092
   Malhotra V., 1996, SP, P1
   Matino I, 2017, WASTE BIOMASS VALORI, V8, P2569, DOI 10.1007/s12649-016-9768-x
   Mehta P. K., 1989, 3 INT C P FLY ASH SI, V144, P1
   MIKHAIL SA, 1995, THERMOCHIM ACTA, V263, P87, DOI 10.1016/0040-6031(94)02413-I
   Miyata Y., 2018, JFE TECHNICAL REPORT, V23, P69
   Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006
   Montemor MF, 2014, SURF COAT TECH, V258, P17, DOI 10.1016/j.surfcoat.2014.06.031
   MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387
   Motz H, 2001, WASTE MANAGE, V21, P285, DOI 10.1016/S0956-053X(00)00102-1
   Nakamura Y, 1998, ISIJ INT, V38, P390, DOI 10.2355/isijinternational.38.390
   Nanukuttan SV, 2015, CONSTR BUILD MATER, V93, P831, DOI 10.1016/j.conbuildmat.2015.05.083
   Pang B, 2015, CONSTR BUILD MATER, V84, P454, DOI 10.1016/j.conbuildmat.2015.03.008
   Park D, 2008, HYDROMETALLURGY, V93, P72, DOI 10.1016/j.hydromet.2008.03.003
   Park T, 2017, CHEMOSPHERE, V167, P91, DOI 10.1016/j.chemosphere.2016.09.150
   Peters A. T., 1982, FERROUS PRODUCTION M
   Pistocchi C, 2017, J ENVIRON MANAGE, V203, P896, DOI 10.1016/j.jenvman.2017.05.007
   Poh HY, 2006, J MATER CIVIL ENG, V18, P229, DOI 10.1061/(ASCE)0899-1561(2006)18:2(229)
   Proctor DM, 2000, ENVIRON SCI TECHNOL, V34, P1576, DOI 10.1021/es9906002
   Quaghebeur M, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2015.00052
   Rehackova L, 2015, METALURGIJA, V54, P455
   Risso-de Faverney C, 2010, MAR ENVIRON RES, V70, P87, DOI 10.1016/j.marenvres.2010.03.007
   Santos RM, 2012, CHEM ENG J, V203, P239, DOI 10.1016/j.cej.2012.06.155
   Scrivener KL, 2004, INTERFACE SCI, V12, P411, DOI 10.1023/B:INTS.0000042339.92990.4c
   Shen HT, 2003, WASTE MANAGE, V23, P933, DOI 10.1016/S0956-053X(02)00164-2
   Shi CJ, 2004, J MATER CIVIL ENG, V16, P230, DOI 10.1061/(ASCE)0899-1561(2004)16:3(230)
   Shokry M., 2009, OPEN ENV ENG J, V2, P37
   Singh R., 2012, APPL WELDING ENG PRO, DOI [10.1016/B978-0-12-391916-8.00005-4, DOI 10.1016/B978-0-12-391916-8.00005-4]
   Sipila J., 2008, 20081 AB AK U FAC TE
   SMITH RW, 1978, J WATER POLLUT CON F, V50, P2189
   Tabassum MR, 2018, ENERG CONVERS MANAGE, V174, P855, DOI 10.1016/j.enconman.2018.08.084
   Takahashi T., 2002, NKK TECH REV, V87, P38
   Taneez M, 2018, ENVIRON POLLUT, V239, P714, DOI 10.1016/j.envpol.2018.04.089
   Thomas Michael, 2016, Key Engineering Materials, V711, DOI 10.4028/www.scientific.net/KEM.711.390
   Thuy N., 2016, PROG ORG COAT, V101, P331, DOI [10.1016/j.porgcoat.2016.08.021, DOI 10.1016/J.PORGCOAT.2016.08.021]
   Uemura R., 2015, NIPPON STEEL TECHNIC, V109, P96
   Walker R. D., 1986, MODERN IRONMAKING ME
   Wang DY, 2012, STEEL RES INT, V83, P189, DOI 10.1002/srin.201100216
   Wang G, 2010, J HAZARD MATER, V184, P555, DOI 10.1016/j.jhazmat.2010.08.071
   Wu W, 2010, MATER DESIGN, V31, P2878, DOI 10.1016/j.matdes.2009.12.037
   YAMADA H, 1986, WATER RES, V20, P547, DOI 10.1016/0043-1354(86)90018-7
   Yamamoto T, 2016, ISIJ INT, V56, P708, DOI 10.2355/isijinternational.ISIJINT-2015-341
   Yi H, 2012, PROCEDIA ENVIRON SCI, V16, P791, DOI 10.1016/j.proenv.2012.10.108
   Yildirim IZ, 2011, ADV CIV ENG, DOI 10.1155/2011/463638
   Zhang GH, 2015, J IRON STEEL RES INT, V22, P905, DOI 10.1016/S1006-706X(15)30088-1
   Zhang W, 2016, PROCESSES, V4, DOI 10.3390/pr4040036
   Zhou WZ, 2016, BIORESOURCE TECHNOL, V214, P534, DOI 10.1016/j.biortech.2016.05.008
NR 98
TC 6
Z9 6
U1 21
U2 83
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 244
EP 255
DI 10.1016/j.resconrec.2019.03.010
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900023
DA 2020-05-12
ER

PT J
AU Romano, G
   Rapposelli, A
   Marrucci, L
AF Romano, Giulia
   Rapposelli, Agnese
   Marrucci, Lorenzo
TI Improving waste production and recycling through zero-waste strategy and
   privatization: An empirical investigation
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Waste; Urban waste management; Recycling; Separate collection; Local
   government policy; Ownership
ID COLLECTION SERVICES; COST EFFICIENCY; MANAGEMENT; PERFORMANCE;
   SEPARATION; FORMS; WATER
AB Using a large 2012-2015 cross-sectional dataset for all 279 municipalities in Tuscany, Italy (the location of the first municipality in Europe to adopt a zero-waste strategy in 2007), this study investigates whether and how municipal waste production and re-cycling activities are related to two waste management policies of municipalities: the adoption of a zero-waste strategy and ownership type of the entity entrusted with urban waste management services. Population density, the municipal average age of inhabitants, municipality area, and the average taxable income of individuals per capita are considered as control variables in the panel data regression models. The study demonstrates the relevance of municipal policies on waste management performance. Specifically, the results show that municipal waste production is higher when urban waste services are managed by privately owned companies, as well as when the average taxable income of individuals per capita is lower. The adoption of a zero-waste strategy by municipalities significantly improves the separate collection rate in Tuscan municipalities. Municipalities that have entrusted solid waste collection and disposal services to mixed-owned firms have lower rates of separate collection than do municipalities that directly manage the service or entrust it to publicly owned firms. Furthermore, the separate collection rate is higher where population density and the average taxable income of individuals per capita are higher. The analysis helps policy and decision makers to identify policies with higher probabilities of reducing waste production and improving the separate collection rate, thereby reaching high standards of waste reduction and recycling.
C1 [Romano, Giulia; Marrucci, Lorenzo] Univ Pisa, Dept Econ & Management, Via Ridolfi 10, I-56124 Pisa, Italy.
   [Rapposelli, Agnese] Univ G dAnnunzio, Dept Econ Aziendale, Chieti, Italy.
RP Romano, G (reprint author), Univ Pisa, Dept Econ & Management, Via Ridolfi 10, I-56124 Pisa, Italy.
EM giulia.romano@unipi.it
RI Romano, Giulia/AAB-4915-2020
OI Romano, Giulia/0000-0002-9770-3831
FU University of Pisa, PRA 2018
FX We acknowledge support for data collection and checks from ARRR Spa and
   ATO Costa. Giulia Romano acknowledges financial support from the
   University of Pisa, PRA 2018.
CR Abbott A, 2011, ECOL ECON, V70, P2214, DOI 10.1016/j.ecolecon.2011.06.028
   Bel G, 2008, J ECON POLICY REFORM, V11, P45, DOI 10.1080/17487870802134884
   Callan SJ, 2006, E ECON J, V32, P221
   Cecere G, 2014, ECOL ECON, V107, P163, DOI 10.1016/j.ecolecon.2014.07.007
   Chifari R, 2017, WASTE MANAGE, V60, P32, DOI 10.1016/j.wasman.2017.01.015
   Connet P., 2013, ZERO WASTE SOLUTION
   Czajkowski M, 2017, ENVIRON RESOUR ECON, V66, P647, DOI 10.1007/s10640-015-9964-3
   Fageda X., 2006, URBAN PUBLIC EC REV, V6, P13
   Gaeta GL, 2017, LETT SPAT RESOUR SCI, V10, P337, DOI 10.1007/s12076-017-0188-8
   Guerrini A, 2017, J CLEAN PROD, V147, P431, DOI 10.1016/j.jclepro.2017.01.079
   Hage O, 2018, LETT SPAT RESOUR SCI, V11, P245, DOI 10.1007/s12076-017-0200-3
   HOOD C, 1991, PUBLIC ADMIN, V69, P3, DOI 10.1111/j.1467-9299.1991.tb00779.x
   Hoornweg D., 2012, WHAT WASTE GLOBAL RE
   ISPRA, 2012, RAPP RIF URB
   Kinnaman TC, 2000, J URBAN ECON, V48, P419, DOI 10.1006/juec.2000.2174
   Kinnaman TC, 2005, TOPICS EC ANAL POLIC, V5, P1, DOI DOI 10.1515/1538-0653.1294
   Lakhan C, 2014, RESOUR CONSERV RECY, V92, P222, DOI 10.1016/j.resconrec.2014.07.006
   Lombrano A, 2009, RESOUR CONSERV RECY, V53, P601, DOI 10.1016/j.resconrec.2009.04.017
   Zafra-Gomez JL, 2013, PUBLIC ADMIN, V91, P51, DOI 10.1111/j.1467-9299.2011.02012.x
   Plata-Diaz AM, 2014, WASTE MANAGE, V34, P1967, DOI 10.1016/j.wasman.2014.07.003
   Mazzanti M, 2011, APPL ECON, V43, P3299, DOI 10.1080/00036840903559612
   Perez-Lopez G, 2016, EUR J OPER RES, V255, P583, DOI 10.1016/j.ejor.2016.05.034
   Petersen OH, 2018, SOC POLICY ADMIN, V52, P130, DOI 10.1111/spol.12297
   Ruiz-Villaverde A, 2018, URBAN WATER J, V15, P138, DOI 10.1080/1573062X.2017.1414860
   Sidique SF, 2010, RESOUR CONSERV RECY, V54, P242, DOI 10.1016/j.resconrec.2009.08.006
   Simoes P, 2012, J CLEAN PROD, V29-30, P214, DOI 10.1016/j.jclepro.2012.01.027
   Simoes P, 2012, J ENVIRON MANAGE, V106, P40, DOI 10.1016/j.jenvman.2012.04.005
   Starr J, 2015, RESOUR CONSERV RECY, V99, P7, DOI 10.1016/j.resconrec.2015.03.009
   Stoeva K, 2017, WASTE MANAGE, V68, P732, DOI 10.1016/j.wasman.2017.06.005
   Struk M, 2017, RESOUR CONSERV RECY, V122, P155, DOI 10.1016/j.resconrec.2017.01.023
   Tantau AD, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072141
   Villalonga B, 2000, J ECON BEHAV ORGAN, V42, P43, DOI 10.1016/S0167-2681(00)00074-3
   Zaman A.U., 2011, CITY CULTURE SOC, V2, P177, DOI DOI 10.1016/J.CCS.2011.11.007
   Zero Waste International Alliance (ZWIA), 2018, DEF GLOB PRINC
NR 34
TC 3
Z9 3
U1 7
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 256
EP 263
DI 10.1016/j.resconrec.2019.03.030
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900024
DA 2020-05-12
ER

PT J
AU Yang, JS
   Wang, HF
   Zhang, GW
   Bai, XJ
   Zhao, XL
   He, YQ
AF Yang, Jinshan
   Wang, Haifeng
   Zhang, Guangwen
   Bai, Xuejie
   Zhao, Xiaolu
   He, Yaqun
TI Recycling organics from non-metallic fraction of waste printed circuit
   boards by a novel conical surface triboelectric separator
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Waste printed circuit board; Nonmetallic fraction; Triboelectric
   separation; Organic materials
ID ELECTRONIC EQUIPMENT; MOBILE PHONES; METALS; PARTICLES; RECOVERY;
   COMBUSTION; CU
AB The nonmetallic fractions (NMFs) from waste printed circuit boards mainly comprise organic materials (OMs) and inorganic materials, taking up a large proportion of E-waste. The NMFs can be used as fillers for composite materials by decreasing the content of inorganic materials. In this study, a novel conical surface triboelectric separator based on the tribocharge difference of organics and inorganics was used to concentrate OM and remove inorganics to improve the usability of NMFs. The X-ray fluorescence (XRF) analysis showed that the content of OM in the raw samples was up to 73.03%, and Si, Al, Br, and Ca were the main inorganic elements in the NMFs. The experimental results demonstrated that the organic particles were negatively charged while the inorganic particles were positively charged in the process of particle friction and collision. The effects of feed rate, rotation speed, and voltage on the triboelectric separation of NMFs were investigated, and the optimum separation was achieved at 12.96 kg/h feed rate, 500 r/min rotation speed and 50 kV voltage. The OM content in the positive plate product increased to 85.12% with a yield of 28.81%, while that in the negative plate product decreased to 59.22% with a yield of 36.45%. The test results demonstrated that the novel conical surface triboelectric separator can effectively recycle OM from the NMFs and facilitate the subsequent reutilization of NMFs.
C1 [Yang, Jinshan; Wang, Haifeng; Zhang, Guangwen; Bai, Xuejie; Zhao, Xiaolu; He, Yaqun] China Univ Min & Technol, Key Lab Coal Proc & Efficient Utilizat, Xuzhou 221116, Jiangsu, Peoples R China.
   [Yang, Jinshan; Wang, Haifeng; Zhang, Guangwen; Bai, Xuejie; Zhao, Xiaolu; He, Yaqun] China Univ Min & Technol, Sch Chem Engn & Technol, Xuzhou 221116, Jiangsu, Peoples R China.
   [He, Yaqun] China Univ Min & Technol, Adv Anal & Computat Ctr, Xuzhou 221116, Jiangsu, Peoples R China.
RP Wang, HF (reprint author), China Univ Min & Technol, Sch Chem Engn & Technol, Xuzhou 221116, Jiangsu, Peoples R China.
EM whfcumt@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [51674257]; Fundamental Research Funds for the
   Central UniversitiesFundamental Research Funds for the Central
   Universities [2018XKQYMS06]; National Science Foundation of Jiangsu
   Province of China [BK20180647]
FX This work is supported by the National Natural Science Foundation of
   China (No. 51674257), the Fundamental Research Funds for the Central
   Universities (2018XKQYMS06) and the National Science Foundation of
   Jiangsu Province of China (No. BK20180647). The authors would like to
   thank Advanced Analysis and Computation Center of China University of
   Mining and Technology for their technical support.
CR Arshadi M, 2018, RESOUR CONSERV RECY, V139, P298, DOI 10.1016/j.resconrec.2018.08.013
   Awasthi AK, 2016, ENVIRON SCI POLLUT R, V23, P21141, DOI 10.1007/s11356-016-7529-9
   Balde C.P., 2017, GLOBAL E WASTE MONIT
   Guanghan S., 2016, PROCEDIA ENV SCI, V31, P935, DOI DOI 10.1016/J.PR0ENV.2016.02.114
   Guo J, 2010, J HAZARD MATER, V179, P203, DOI 10.1016/j.jhazmat.2010.02.080
   Guo JY, 2009, J HAZARD MATER, V168, P567, DOI 10.1016/j.jhazmat.2009.02.104
   Habib M, 2013, WASTE MANAGE, V33, P722, DOI 10.1016/j.wasman.2012.11.017
   Hall WJ, 2007, RESOUR CONSERV RECY, V51, P691, DOI 10.1016/j.resconrec.2006.11.010
   Hino T, 2009, J MATER CYCLES WASTE, V11, P42, DOI 10.1007/s10163-008-0218-0
   Holgersson S, 2018, RESOUR CONSERV RECY, V133, P300, DOI 10.1016/j.resconrec.2017.02.011
   Huang K, 2009, J HAZARD MATER, V164, P399, DOI 10.1016/j.jhazmat.2008.08.051
   Kovacevic T, 2017, COMPOS PART B-ENG, V127, P1, DOI 10.1016/j.compositesb.2017.06.020
   LaDou J, 2006, INT J HYG ENVIR HEAL, V209, P211, DOI 10.1016/j.ijheh.2006.02.001
   Li J, 2007, J ELECTROSTAT, V65, P233, DOI 10.1016/j.elstat.2006.08.004
   Li J, 2015, WASTE MANAGE, V35, P36, DOI 10.1016/j.wasman.2014.10.001
   Li JZ, 2004, IEEE T ELECTRON PACK, V27, P33, DOI 10.1109/TEPM.2004.830501
   Matsumoto Y, 2014, J SUPERCRIT FLUID, V95, P462, DOI 10.1016/j.supflu.2014.10.020
   Menad N, 1998, RESOUR CONSERV RECY, V24, P65, DOI 10.1016/S0921-3449(98)00040-8
   Miandad R, 2016, WASTE MANAGE, V58, P250, DOI 10.1016/j.wasman.2016.09.023
   Silvas FPC, 2015, WASTE MANAGE, V46, P503, DOI 10.1016/j.wasman.2015.08.030
   Sun ZX, 2015, ENVIRON TECHNOL, V36, P160, DOI 10.1080/09593330.2014.940399
   Tao YJ, 2017, INT J MIN SCI TECHNO, V27, P1037, DOI 10.1016/j.ijmst.2017.06.004
   Tuncuk A, 2012, MINER ENG, V25, P28, DOI 10.1016/j.mineng.2011.09.019
   Turner A, 2017, SCI TOTAL ENVIRON, V601, P374, DOI 10.1016/j.scitotenv.2017.05.173
   Wang HD, 2017, RESOUR CONSERV RECY, V126, P209, DOI 10.1016/j.resconrec.2017.08.001
   Wu CC, 2016, ENVIRON SCI TECHNOL, V50, P6599, DOI 10.1021/acs.est.5b05952
   Xia MC, 2018, RESOUR CONSERV RECY, V136, P267, DOI 10.1016/j.resconrec.2018.05.001
   Xue MQ, 2015, ENVIRON SCI TECHNOL, V49, P940, DOI 10.1021/es504750q
   Xue MQ, 2012, ENVIRON SCI TECHNOL, V46, P494, DOI 10.1021/es202513b
   Yamane LH, 2011, WASTE MANAGE, V31, P2553, DOI 10.1016/j.wasman.2011.07.006
   Zhang GW, 2018, J CLEAN PROD, V187, P1036, DOI 10.1016/j.jclepro.2018.03.282
   Zhang GG, 2017, J CLEAN PROD, V142, P1911, DOI 10.1016/j.jclepro.2016.11.093
   Zhang GW, 2016, WASTE MANAGE, V49, P230, DOI 10.1016/j.wasman.2015.12.022
   Zheng YH, 2010, J APPL POLYM SCI, V118, P2914, DOI 10.1002/app.32589
   Zheng YH, 2009, J HAZARD MATER, V163, P600, DOI 10.1016/j.jhazmat.2008.07.008
NR 35
TC 2
Z9 2
U1 7
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 264
EP 269
DI 10.1016/j.resconrec.2019.03.008
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900025
DA 2020-05-12
ER

PT J
AU Clavier, KA
   Watts, B
   Liu, YL
   Ferraro, CC
   Townsend, TG
AF Clavier, Kyle A.
   Watts, Benjamin
   Liu, Yalan
   Ferraro, Christopher C.
   Townsend, Timothy G.
TI Risk and performance assessment of cement made using municipal solid
   waste incinerator bottom ash as a cement kiln feed
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Bottom ash; Cement; Recycling; Waste incineration; Kiln feed; Clinker
ID FLY-ASH; RAW-MATERIALS; MSWI BOTTOM
AB To assess the feasibility of incorporating municipal solid waste incineration (MSWI) bottom ash (BA) as a replacement for traditional raw materials in cement kiln feed, an industrial-scale kiln trial was performed. Leach testing and chemical and physical characterization data from a cement product made at a replacement percentage of 2.8% by mass of kiln feed were comparable to results from ordinary portland cement. The concentrations of constituents of concern in leach tests were generally below risk-based screening levels or of similar or lower magnitude than leachate from control products. Ash-amended cement exhibited greater early age reactivity, and this was reflected in initial mortar compressive strength results; ultimate compressive strength results were higher in the control mortar. The ash-amended and control cements were similar in characteristic, but quantitative x-ray diffraction results reveal differences in alite and aluminate formation during the clinker formation process.
C1 [Clavier, Kyle A.; Liu, Yalan; Townsend, Timothy G.] Univ Florida, Dept Environm Engn Sci, POB 116450, Gainesville, FL 32611 USA.
   [Watts, Benjamin] US Army, Corp Engineers Cold Reg Res & Engn Lab, Hanover, NH 03755 USA.
   [Watts, Benjamin; Ferraro, Christopher C.] Univ Florida, Dept Civil & Coastal Engn, POB 116580, Gainesville, FL 32611 USA.
RP Townsend, TG (reprint author), Univ Florida, Dept Environm Engn Sci, POB 116450, Gainesville, FL 32611 USA.
EM ttown@ufl.edu
RI Ferraro, Christopher/K-6172-2017
OI Ferraro, Christopher/0000-0001-5639-8247; Clavier,
   Kyle/0000-0003-2840-5336
FU Miami-Dade County; Hinkley Center for Solid and Hazardous Waste
   Management
FX This study was funded through a research grant with Miami-Dade County in
   collaboration with The Hinkley Center for Solid and Hazardous Waste
   Management. The authors thank the industry partners involved in this
   study, including the MSWI facility and cement kiln facility operators.
   The authors also extend their appreciation to Dr. Jerry Paris and Eduard
   Tora for assisting in laboratory experiments.
CR American Society for Testing and Materials (ASTM), 2017, DES C403 403M 16 STA, DOI [10.1520/C0403C0403M-16, DOI 10.1520/C0403_C0403M-16]
   American Society for Testing and Materials (ASTM), 2016, DES C109 C109M 16A S, DOI [10.1520/C0109_C0109M-16A, DOI 10.1520/C0109_C0109M-16A]
   American Society for Testing and Materials (ASTM), 2017, DES C1702 17 STAND T, DOI [10.1520/C1702-17, DOI 10.1520/C1702-17]
   American Society for Testing and Materials (ASTM), 2014, DES C305 14 STAND PR, DOI [10.1520/C0305-14, DOI 10.1520/C0305-14]
   American Society for Testing and Materials (ASTM), 2018, DES C150 C150M 18 ST, DOI [10.1520/C0150M.18, DOI 10.1520/C0150M.18]
   American Society for Testing and Materials (ASTM), 2016, DES C192 C192M 16A S, DOI [10.1520/C0192C0192M-16A, DOI 10.1520/C0192_C0192M-16A]
   American Society for Testing and Materials (ASTM), 2018, DES C1365 18 STAND T, DOI [10.1520/C1365-18, DOI 10.1520/C1365-18]
   Ampadu KO, 2002, CEMENT CONCRETE RES, V32, P893, DOI 10.1016/S0008-8846(02)00721-4
   Carrasquillo P. M, 1994, TECHNIQUES PROCEDURE, P124
   Chen IA, 2009, J MATER SCI, V44, P2617, DOI 10.1007/s10853-009-3342-x
   Doebelin N, 2015, J APPL CRYSTALLOGR, V48, P1573, DOI 10.1107/S1600576715014685
   Dou XM, 2017, RENEW SUST ENERG REV, V79, P24, DOI 10.1016/j.rser.2017.05.044
   Florida Administrative Code (FAC), 2005, CTLS DEV CLEAN TARG
   Forteza R, 2004, WASTE MANAGE, V24, P899, DOI 10.1016/j.wasman.2004.07.004
   Guo XL, 2016, MATER STRUCT, V49, P2383, DOI 10.1617/s11527-015-0655-x
   Hanehara S, 2001, JCI KCI INT JOINT SE
   Ibanez R, 2019, J HAZARD MATER, V79, P215
   Jones KB, 2012, INT J COAL GEOL, V94, P337, DOI 10.1016/j.coal.2011.10.007
   Kikuchi R, 2001, RESOUR CONSERV RECY, V31, P137, DOI 10.1016/S0921-3449(00)00077-X
   Kirchheim AP, 2009, J MATER SCI, V44, P2038, DOI 10.1007/s10853-009-3292-3
   Krammart P, 2004, CONSTR BUILD MATER, V18, P579, DOI 10.1016/j.conbuildmat.2004.04.014
   Lam CHK, 2010, CHEM ENGINEER TRANS, V21, P757, DOI 10.3303/CET1021127
   Lam CHK, 2011, CLEAN TECHNOL ENVIR, V13, P607, DOI 10.1007/s10098-011-0367-z
   Oehmig WN, 2015, ENVIRON SCI POLICY, V51, P304, DOI 10.1016/j.envsci.2015.04.024
   Olmo IF, 2001, CEMENT CONCRETE RES, V31, P1213
   Pan JR, 2008, WASTE MANAGE, V28, P1113, DOI 10.1016/j.wasman.2007.04.009
   Paris JM, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002381
   Portland Cement Association (PCA), 2017, US CEM CONCR IND
   Saikia N, 2007, WASTE MANAGE, V27, P1178, DOI 10.1016/j.wasman.2006.06.004
   Schafer ML, 2019, WASTE BIOMASS VALORI, V10, P2733, DOI 10.1007/s12649-018-0296-8
   Shih PH, 2003, CEMENT CONCRETE RES, V33, P1831, DOI 10.1016/S0008-8846(03)00206-0
   Sosa P. Y, 2017, THESIS, P112
   Taylor H., 2004, CEMENT CHEM
   Tsuyumoto I, 2002, J CERAM SOC JPN, V110, P535, DOI 10.2109/jcersj.110.535
   United States Environmental Protection Agency (USEPA), 2015, EPA PUBL
   United States Environmental Protection Agency (USEPA), 2018, NAT OV FACTS FIG MAT
   Uwasu M, 2014, ENVIRON DEV, V10, P36, DOI 10.1016/j.envdev.2014.02.005
   Wang L, 2010, RESOUR CONSERV RECY, V54, P1428, DOI 10.1016/j.resconrec.2010.06.006
   Watts BE, 2017, CEMENT CONCRETE COMP, V78, P63, DOI 10.1016/j.cemconcomp.2016.11.002
   Wu K, 2011, WASTE MANAGE, V31, P2001, DOI 10.1016/j.wasman.2011.04.022
   Yan DH, 2018, WASTE MANAGE, V76, P106, DOI 10.1016/j.wasman.2018.03.006
NR 41
TC 5
Z9 5
U1 14
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 270
EP 279
DI 10.1016/j.resconrec.2019.03.047
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900026
DA 2020-05-12
ER

PT J
AU Daxini, A
   Ryan, M
   O'Donoghue, C
   Barnes, AP
   Buckley, C
AF Daxini, Amar
   Ryan, Mary
   O'Donoghue, Cathal
   Barnes, Andrew P.
   Buckley, Cathal
TI Using a typology to understand farmers' intentions towards following a
   nutrient management plan
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Nutrient management plan; Farmer decision making; Theory of planned
   behaviour; Intentions; Latent class analysis
ID LATENT CLASS ANALYSIS; ENVIRONMENTAL BEHAVIOR; PSYCHOLOGICAL-FACTORS;
   PRACTICE ADOPTION; DAIRY FARMERS; POLICY; AGRICULTURE; PHOSPHORUS;
   ATTITUDES; RISK
AB Optimising resource use efficiency is high on many national policy agendas. Inappropriate management in agricultural production can result in increased risk of nutrient loss to the environment. Best practice in nutrient management can help to mitigate this. However, policy initiatives aimed at encouraging farmers to follow a nutrient management plan (NMP) appear to be limited in their success. We employ a typology to classify farms/farmers based on a number of policy relevant farm and farmer characteristics. The theory of planned behaviour is applied to understand the variables which influence farmers' intentions to follow a NMP across the Republic of Ireland. The typology resulted in a total of three classes of farmers, namely 'traditional', 'supplementary income' and 'business-orientated'. The findings from the regression analysis reveal that attitude towards the outcomes of following a NMP is a weak predictor of intentions whereas subjective norm (social pressure) and perceived behavioural control (ease/difficulty) are strong predictors of intentions across the classes. Furthermore, contact with agricultural extension (a combination of one-to-one and group based extension) is found to be critical in determining the intentions of both traditional and supplementary income classes of farmers. The results also indicate that policy, which requires certain farmers in Ireland to develop a NMP on a mandatory basis, has consistent but mixed levels of influence on intentions. Initiatives designed to further encourage farmers to follow a NMP must account for the diversity that exists among the farming population and how different groups of farmers may respond to such initiatives.
C1 [Daxini, Amar; Ryan, Mary; Buckley, Cathal] Mellows Campus, Teagasc Rural Econ & Dev Programme, Athenry, Galway, Ireland.
   [Daxini, Amar; Barnes, Andrew P.] Scotlands Rural Coll SRUC, West Mains Rd,Kings Bldg, Edinburgh EH9 3JG, Midlothian, Scotland.
   [Daxini, Amar] Univ Edinburgh, Sch Geosci, Kings Bldg, Edinburgh, Midlothian, Scotland.
   [O'Donoghue, Cathal] Natl Univ Ireland, NUIG Policy Lab, Galway, Ireland.
RP Daxini, A (reprint author), Scotlands Rural Coll SRUC, West Mains Rd,Kings Bldg, Edinburgh EH9 3JG, Midlothian, Scotland.
EM Amar.Daxini@sruc.ac.uk
FU Teagasc Walsh Fellowship Programme; SRUC; Dept of Agriculture, Food and
   Marine HARMONY project; Science Foundation Ireland BEACON projectScience
   Foundation Ireland
FX The authors are grateful for funding provided by a joint stewardship
   between the Teagasc Walsh Fellowship Programme and SRUC. The authors
   also acknowledge support from the Dept of Agriculture, Food and Marine
   HARMONY project and the Science Foundation Ireland BEACON project.
CR Adnan N, 2018, LAND USE POLICY, V79, P575, DOI 10.1016/j.landusepol.2018.08.033
   Adnan N, 2017, LAND USE POLICY, V68, P372, DOI 10.1016/j.landusepol.2017.07.046
   Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 2002, CONSTRUCTING TPB QUE
   Ajzen I, 1985, ACTION CONTROL COGNI, P11, DOI DOI 10.1007/978-3-642-69746-3_2
   Amon-Armah F, 2013, ENVIRON MANAGE, V52, P1177, DOI 10.1007/s00267-013-0148-z
   Areal FJ, 2012, FOOD POLICY, V37, P401, DOI 10.1016/j.foodpol.2012.04.003
   Barnes AP, 2013, J RURAL STUD, V32, P448, DOI 10.1016/j.jrurstud.2012.09.006
   Barnes AP, 2013, APPL GEOGR, V41, P105, DOI 10.1016/j.apgeog.2013.03.011
   Barnes AP, 2011, J ENVIRON PLANN MAN, V54, P477, DOI 10.1080/09640568.2010.515880
   Baumgart-Getz A, 2012, J ENVIRON MANAGE, V96, P17, DOI 10.1016/j.jenvman.2011.10.006
   Beegle DB, 2000, J ENVIRON QUAL, V29, P72, DOI 10.2134/jeq2000.00472425002900010009x
   Blackstock KL, 2010, SCI TOTAL ENVIRON, V408, P5631, DOI 10.1016/j.scitotenv.2009.04.029
   Borges JAR, 2016, J ENVIRON PSYCHOL, V45, P89, DOI 10.1016/j.jenvp.2015.12.001
   Borges JAR, 2014, LIVEST SCI, V169, P163, DOI 10.1016/j.livsci.2014.09.014
   Brown P, 2019, J ENVIRON MANAGE, V231, P110, DOI 10.1016/j.jenvman.2018.10.018
   Buckley C, 2015, INT J AGR MANAG, V4, P152, DOI DOI 10.5836/IJAM/2015-04-152
   Buckley C, 2013, ENVIRON SCI POLICY, V25, P118, DOI 10.1016/j.envsci.2012.10.002
   Buckley C, 2012, ECOL ECON, V78, P29, DOI 10.1016/j.ecolecon.2012.02.031
   Buckwell A., 2016, NUTR RECOVERY REUSE
   Burton RJF, 2004, J RURAL STUD, V20, P359, DOI 10.1016/j.jrurstud.2003.12.001
   Burton RJF, 2014, J ENVIRON MANAGE, V135, P19, DOI 10.1016/j.jenvman.2013.12.005
   Chikowo R, 2014, NUTR CYCL AGROECOSYS, V100, P1, DOI 10.1007/s10705-014-9632-y
   Chinedu O., 2018, FOOD POLICY
   CSO, 2016, ENV IND IR 2016
   CSO, 2018, FARM STRUC SURV 2016
   DAFF, 2010, FOOD HARV 2020 VIS I
   DAFM, 2015, FOOD WIS 2025 A 10
   DAFM, 2019, PUBL CONS 2019 NITR
   Daloglu I, 2014, AGR SYST, V129, P93, DOI 10.1016/j.agsy.2014.05.007
   Daxini A, 2018, J ENVIRON MANAGE, V224, P350, DOI 10.1016/j.jenvman.2018.07.059
   Dean N, 2010, ANN I STAT MATH, V62, P11, DOI 10.1007/s10463-009-0258-9
   Dillon E., 2017, TEAGASC NATL FARM SU
   Dillon E., 2018, TEAGASC NATL FARM SU
   Easton ZM, 2017, J ENVIRON QUAL, V46, P1257, DOI 10.2134/jeq2016.09.0377
   Emtage N, 2007, ENVIRON MANAGE, V40, P481, DOI 10.1007/s00267-005-0359-z
   Field A., 2009, DISCOVERING STAT USI
   Fishbein M., 2010, PREDICTING CHANGING
   Flett R, 2004, AGR SYST, V80, P199, DOI 10.1016/j.agsy.2003.08.002
   Floress K, 2018, LAND USE POLICY, V70, P414, DOI 10.1016/j.landusepol.2017.11.030
   Floress K, 2017, J ENVIRON PSYCHOL, V53, P73, DOI 10.1016/j.jenvp.2017.06.009
   Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284
   Francis JJ, 2004, MAN HLTH SERV RES, V2010, P2
   Martinez-Garcia CG, 2013, LIVEST SCI, V152, P228, DOI 10.1016/j.livsci.2012.10.007
   Genskow KD, 2012, J SOIL WATER CONSERV, V67, P51, DOI 10.2489/jswc.67.1.51
   Gorton M, 2008, J RURAL STUD, V24, P322, DOI 10.1016/j.jrurstud.2007.10.001
   Guillem EE, 2012, J ENVIRON MANAGE, V110, P226, DOI 10.1016/j.jenvman.2012.06.020
   Hair J.F., 2010, MULTIVARIATE DATA AN
   Hammond J, 2017, AGR SYST, V154, P1, DOI 10.1016/j.agsy.2017.02.009
   Hansson H, 2012, J AGR ECON, V63, P465, DOI 10.1111/j.1477-9552.2012.00344.x
   Howley P, 2015, ECOL ECON, V109, P186, DOI 10.1016/j.ecolecon.2014.11.015
   Howley P, 2013, J ENVIRON MANAGE, V123, P105, DOI 10.1016/j.jenvman.2013.03.013
   Image M, 2016, CPAE002 ADAS UK LTD
   Jiang LL, 2018, J CLEAN PROD, V189, P797, DOI 10.1016/j.jclepro.2018.04.040
   Jolliffe I., 2002, ENCY STAT BEHAV SCI
   KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575
   Kamau JW, 2018, J RURAL STUD, V57, P171, DOI 10.1016/j.jrurstud.2017.12.014
   Kania J., 2014, WP3 AKIS EU INVENTOR
   Ketterings QM, 2017, J ENVIRON QUAL, V46, P1372, DOI 10.2134/jeq2016.05.0185
   Knowler D, 2007, FOOD POLICY, V32, P25, DOI 10.1016/j.foodpol.2006.01.003
   Lapple D, 2015, FOOD POLICY, V51, P1, DOI 10.1016/j.foodpol.2014.11.003
   Lapple D, 2013, ECOL ECON, V88, P11, DOI 10.1016/j.ecolecon.2012.12.025
   Laforge JML, 2018, GEOFORUM, V96, P256, DOI 10.1016/j.geoforum.2018.07.022
   Lawley C, 2009, LAND ECON, V85, P186, DOI 10.3368/le.85.1.186
   McDonald NT, 2019, AGR ECOSYST ENVIRON, V274, P14, DOI 10.1016/j.agee.2018.12.014
   McGlynn D., 2018, RESOURCE EFFICIENCY
   McGuire J, 2013, AGR HUM VALUES, V30, P57, DOI 10.1007/s10460-012-9381-y
   Micha E, 2018, ENVIRON SCI POLICY, V84, P41, DOI 10.1016/j.envsci.2018.02.014
   Micha E, 2015, LAND USE POLICY, V48, P144, DOI 10.1016/j.landusepol.2015.05.016
   Montemurro F, 2016, AGRONOMY-BASEL, V6, DOI 10.3390/agronomy6020031
   Morais M, 2018, LAND USE POLICY, V71, P445, DOI 10.1016/j.landusepol.2017.11.002
   Morey E, 2008, ECOL ECON, V68, P536, DOI 10.1016/j.ecolecon.2008.05.015
   Nunnally J.C., 1978, PSYCHOMETRIC THEORY
   Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396
   Oenema O, 2002, AMBIO, V31, P159, DOI 10.1639/0044-7447(2002)031[0159:NMIFPA]2.0.CO;2
   Osmond DL, 2015, J ENVIRON QUAL, V44, P382, DOI 10.2134/jeq2014.02.0091
   Perez MR, 2015, J ENVIRON QUAL, V44, P402, DOI 10.2134/jeq2014.07.0304
   Peth D, 2018, ECOL ECON, V152, P310, DOI 10.1016/j.ecolecon.2018.06.007
   Prager K, 2017, J RURAL STUD, V56, P1, DOI 10.1016/j.jrurstud.2017.09.002
   Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38
   Prokopy LS, 2008, J SOIL WATER CONSERV, V63, P300, DOI 10.2489/63.5.300
   Reimer AP, 2018, ENVIRON MANAGE, V62, P694, DOI 10.1007/s00267-018-1083-9
   Reimer AP, 2012, J RURAL STUD, V28, P118, DOI 10.1016/j.jrurstud.2011.09.005
   Reimer AP, 2012, AGR HUM VALUES, V29, P29, DOI 10.1007/s10460-011-9308-z
   Rezaei R, 2018, J RURAL STUD, V60, P152, DOI 10.1016/j.jrurstud.2018.04.005
   Rhead R, 2018, SOC SCI RES, V74, P210, DOI 10.1016/j.ssresearch.2018.06.001
   Ribaudo MO, 2007, REV AGR ECON, V29, P689, DOI 10.1111/j.1467-9353.2007.00381.x
   Roberts WM, 2017, SCI TOTAL ENVIRON, V589, P25, DOI 10.1016/j.scitotenv.2017.02.201
   Rohila A. K., 2017, ASIAN J MICROBIOL BI, V19, P145
   Savage JA, 2013, J ENVIRON MANAGE, V129, P143, DOI 10.1016/j.jenvman.2013.06.039
   Schreiber JB, 2017, RES SOC ADMIN PHARM, V13, P1196, DOI 10.1016/j.sapharm.2016.11.011
   Schulte R. P. O., 2009, Tearmann, V7, P211
   Sharot T., 2011, CURR BIOL
   Shepard R, 2005, J SOIL WATER CONVSER, V60, P251
   Stojcheska AM, 2016, LAND USE POLICY, V59, P71, DOI 10.1016/j.landusepol.2016.08.019
   Stuart D, 2018, LAND USE POLICY, V70, P289, DOI 10.1016/j.landusepol.2017.10.047
   Sutton M.A., 2013, OUR NUTR WORLD
   Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a
   Tao HY, 2016, J EXT, V54
   Thomas MA, 2007, APPL ENG AGRIC, V23, P747
   Ulbricht CM, 2018, PSYCHIAT RES, V266, P228, DOI 10.1016/j.psychres.2018.03.003
   Ulrich-Schad JD, 2017, J SOIL WATER CONSERV, V72, P506, DOI 10.2489/jswc.72.5.506
   Valbuena D, 2008, AGR ECOSYST ENVIRON, V128, P27, DOI 10.1016/j.agee.2008.04.015
   Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025
   Walder P, 2018, ECOL ECON, V143, P55, DOI 10.1016/j.ecolecon.2017.06.018
   Walters DF, 2014, CAN GEOGR-GEOGR CAN, V58, P203, DOI 10.1111/j.1541-0064.2013.12058.x
   Wang YD, 2018, SCI TOTAL ENVIRON, V633, P1126, DOI 10.1016/j.scitotenv.2018.03.273
   Wauters E, 2010, LAND USE POLICY, V27, P86, DOI 10.1016/j.landusepol.2009.02.009
   WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806
   Welch Eric W., 2001, Lake and Reservoir Management, V17, P233
   Wilson RS, 2018, WATER RES, V139, P38, DOI 10.1016/j.watres.2018.03.065
   Wilson RS, 2014, WATER RESOUR RES, V50, P6735, DOI 10.1002/2013WR015200
   Yazdanpanah M, 2015, J CLEAN PROD, V107, P342, DOI 10.1016/j.jclepro.2015.02.071
   Yoshida Y, 2018, J ENVIRON PLANN MAN, V61, P1033, DOI 10.1080/09640568.2017.1327423
   Zhang WD, 2016, J GREAT LAKES RES, V42, P1343, DOI 10.1016/j.jglr.2016.08.007
NR 116
TC 2
Z9 2
U1 5
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 280
EP 290
DI 10.1016/j.resconrec.2019.03.027
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900027
DA 2020-05-12
ER

PT J
AU Unal, E
   Urbinati, A
   Chiaroni, D
   Manzini, R
AF Unal, Enes
   Urbinati, Andrea
   Chiaroni, Davide
   Manzini, Raffaella
TI Value Creation in Circular Business Models: The case of a US small
   medium enterprise in the building sector
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Circular business model; Value creation; Contextual
   factors; Building sector; Sustainability
ID SUPPLY CHAINS; ECONOMY; INNOVATION; SUSTAINABILITY; SMES; COLLABORATION;
   INDUSTRY; IMPLEMENTATION; TAXONOMY; SUPPORT
AB A circular business model represents a holistic system of co-evolving managerial practices for collective value creation, delivery and capture, which provide solutions for sustainable development. Previous research on circular business models aimed to understand value creation mostly in terms of a single managerial practice or in a relatively isolated manner. In particular, little is known regarding the system of managerial practices that creates value. Accordingly, this study proposes a theoretical framework characterized by a set of managerial practices in connection with relevant internal and external contextual factors for creating value within a circular business model. The framework was used in a specific case of a small medium-sized enterprise (SME) operating in building sector, which can be considered a great example of circular economy put into practice. Therefore, the explorative nature of the case allows for deep probing that helps consolidating the framework. Among the main results, essential outcomes included configuring and adapting the company's business model to particular internal and external contextual factors; valorization of local waste by harmonizing managerial practices, and socio-cultural and socio-economic settings, as well as sustainable behaviours among the actors of supply chain. This study contributes to the field of circular business models research by adopting a broader, interdisciplinary approach toward the concept of value creation. Further, it provides managers with a roadmap for creating value by enhancing the degree of circularity within a given context.
C1 [Unal, Enes; Urbinati, Andrea; Chiaroni, Davide] Politecn Milan, Sch Management, Milan, Italy.
   [Unal, Enes] KTH Royal Inst Technol, Dept Ind Econ & Management, Stockholm, Sweden.
   [Urbinati, Andrea; Manzini, Raffaella] LIUC Univ Cattaneo, Sch Ind Engn, Castellanza, Italy.
RP Unal, E (reprint author), Via Lambruschini 4B,Bldg 26B, I-20156 Milan, Italy.
EM enes.unal@polimi.it
CR Amit R, 2001, STRATEGIC MANAGE J, V22, P493, DOI 10.1002/smj.187
   Bocken NMP, 2018, ENVIRON INNOV SOC TR, V28, P79, DOI 10.1016/j.eist.2018.02.001
   Bougrain F, 2002, RES POLICY, V31, P735, DOI 10.1016/S0048-7333(01)00144-5
   Bourguignon D, 2016, CLOSING LOOP NEW CIR, V9, DOI [10.1111/j.1742-1241.2010.02575.x, DOI 10.1111/J.1742-1241.2010.02575.X]
   Bouwman H., 2008, MOBILE SERVICE INNOV, P31, DOI DOI 10.1007/978-3-540-79238-3
   Bouwman H, 2018, DIGIT POLICY REGUL G, V20, P105, DOI 10.1108/DPRG-07-2017-0039
   Chesbrough H. W., 1999, IND CORP CHANGE, V8, P447, DOI DOI 10.1093/ICC/8.3.447
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   D'Amato A, 2009, CORP GOV-INT J BUS S, V9, P421, DOI 10.1108/14720700910984972
   De los Rios IC, 2017, J CLEAN PROD, V160, P109, DOI 10.1016/j.jclepro.2016.10.130
   Doz Y, 2008, CALIF MANAGE REV, V50, P95, DOI 10.2307/41166447
   European Commission, 2018, REP CRIT RAW MAT CIR
   Foss NJ, 2018, LONG RANGE PLANN, V51, P9, DOI 10.1016/j.lrp.2017.07.006
   Foss NJ, 2017, J MANAGE, V43, P200, DOI 10.1177/0149206316675927
   Fritscher B, 2010, LECT NOTES COMPUTER, DOI [10.1007/978-3-642-11797-8_3, DOI 10.1007/978-3-642-11797-8_3]
   Geissdoerfer M, 2018, J CLEAN PROD, V198, P401, DOI 10.1016/j.jclepro.2018.06.240
   Geissdoerfer M, 2018, J CLEAN PROD, V190, P712, DOI 10.1016/j.jclepro.2018.04.159
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Glaser B. G., 1967, DISCOVERY GROUNDED T
   Go TF, 2011, J CLEAN PROD, V19, P1536, DOI 10.1016/j.jclepro.2011.05.003
   Goldsworthy K, 2013, MAK FUTURE, V3
   Gregson N, 2015, ECON SOC, V44, P218, DOI 10.1080/03085147.2015.1013353
   Guba E. G, 1994, HDB QUAL RES
   Haaker T, 2017, FUTURES, V89, P14, DOI 10.1016/j.futures.2017.04.003
   Hueske AK, 2015, J ENG TECHNOL MANAGE, V35, P45, DOI 10.1016/j.jengtecman.2014.10.001
   Ingrao C, 2016, J CLEAN PROD, V124, P283, DOI 10.1016/j.jclepro.2016.02.112
   Intini F, 2011, INT J LIFE CYCLE ASS, V16, P306, DOI 10.1007/s11367-011-0267-9
   Karakaya E, 2015, RENEW SUST ENERG REV, V43, P1090, DOI 10.1016/j.rser.2014.11.077
   Kendall J, 1999, WESTERN J NURS RES, V21, P743, DOI 10.1177/019394599902100603
   Khasreen Mohamad Monkiz, 2009, Sustainability, V1, P674, DOI 10.3390/su1030674
   Kiesler C.A., 1971, PSYCHOL COMMITMENT E
   Klein KJ, 1996, ACAD MANAGE REV, V21, P1055, DOI 10.2307/259164
   Korhonen J, 2018, J CLEAN PROD, V175, P544, DOI 10.1016/j.jclepro.2017.12.111
   Kucuksayrac E, 2015, J CLEAN PROD, V101, P38, DOI 10.1016/j.jclepro.2015.03.078
   Lamsa, 2000, LEADERSHIP ORG DEV J, V21, P297, DOI [10.1108/01437730010372822, DOI 10.1108/01437730010372822]
   Lapko Y, 2019, J IND ECOL, V23, P182, DOI 10.1111/jiec.12741
   Lee S, 2010, RES POLICY, V39, P290, DOI 10.1016/j.respol.2009.12.009
   Leising E, 2018, J CLEAN PROD, V176, P976, DOI 10.1016/j.jclepro.2017.12.010
   Lewandowski M, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010043
   Li HQ, 2010, ENERGY, V35, P4273, DOI 10.1016/j.energy.2009.04.021
   Lieder M, 2016, J CLEAN PROD, DOI [10.1016/j.clepro.2015.12.042, DOI 10.1016/J.CLEPRO.2015.12.042]
   Linder M, 2017, BUS STRATEG ENVIRON, V26, P182, DOI 10.1002/bse.1906
   Lindgren P, 2013, ED NEXT, DOI [10.1145/2228360.2228567, DOI 10.1145/2228360.2228567]
   Mang P, 2015, BUILD RES INF, V43, P7, DOI 10.1080/09613218.2014.911565
   Manninen K, 2018, J CLEAN PROD, V171, P413, DOI 10.1016/j.jclepro.2017.10.003
   Martins LL, 2015, STRATEG ENTREP J, V9, P99, DOI 10.1002/sej.1191
   Massa L, 2013, OXFORD HDB INNOV MAN, DOI [10.1002/9781118466421.ch4, DOI 10.1002/9781118466421.CH4]
   Mayyas A, 2012, RENEW SUST ENERG REV, V16, P1845, DOI 10.1016/j.rser.2012.01.012
   McDonough W, 2002, CHEM ENG NEWS, V193, DOI [DOI 10.1177/0276146704264148, 10.1177/0276146704264148]
   Merli R, 2018, J CLEAN PROD, V178, P703, DOI 10.1016/j.jclepro.2017.12.112
   Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842
   Miles R E, 1978, Acad Manage Rev, V3, P546, DOI 10.2307/257544
   Moreno M, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8090937
   Morris M, 2005, J BUS RES, V58, P726, DOI 10.1016/j.jbusres.2003.11.001
   Morse J, 1998, HDB QUALITATIVE RES, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183
   Mowday R. T, 1983, AM J SOCIOL, DOI [10.2307/2068333, DOI 10.2307/2068333]
   Murray A., 2015, J BUS ETHICS, P1, DOI [10.1007/s10551-015-2693-2, DOI 10.1007/S10551-015-2693-2]
   Narula R, 2004, TECHNOVATION, V24, P153, DOI 10.1016/S0166-4972(02)00045-7
   Osterwalder A, 2010, BUSINESS MODEL GENER, DOI [10.1523/JNEUROSCI.0307-10.2010, DOI 10.1523/JNEUROSCI.0307-10.2010]
   Osterwalder A., 2004, BUSINESS, P1, DOI [10.1111/j.1467-9310.2010.00605.x, DOI 10.1111/J.1467-9310.2010.00605.X, 10.1017/CB09781107415324.004]
   Parkinson HJ, 2003, P I MECH ENG E-J PRO, V217, P243, DOI 10.1243/095440803322328890
   Peck D, 2016, CRITICAL MAT PRODUCT, DOI [10.4233/uuid:a6a69144-c7f3d-4feb-8df7-51d1c20434ea, DOI 10.4233/UUID:A6A69144-C7F3D-4FEB-8DF7-51D1C20434EA]
   PHILLIPS CF, 1971, BELL J ECON, V2, P683, DOI 10.2307/3003013
   Pomponi F, 2017, J CLEAN PROD, V143, P710, DOI 10.1016/j.jclepro.2016.12.055
   PORTER ME, 1979, HARVARD BUS REV, V57, P137
   Porter ME, 2011, HARVARD BUS REV, V89, P62
   Ramus CA, 2000, ACAD MANAGE J, V43, P605, DOI 10.2307/1556357
   Reed B, 2007, BUILD RES INF, V35, P674, DOI 10.1080/09613210701475753
   REICHERS AE, 1985, ACAD MANAGE REV, V10, P465, DOI 10.2307/258128
   Reijnders L, 2008, J CLEAN PROD, V16, P1138, DOI 10.1016/j.jclepro.2008.02.003
   Rizos V, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8111212
   Salancik G. R, 1977, NEW DIR ORG BEHAV
   SCHERER FM, 1990, IND MARKET STRUCTURE
   Schneider S, 2013, INT J INNOV MANAG, V17, DOI 10.1142/S136391961340001X
   Shao J, 2019, J CLEAN PROD, V209, P1473, DOI 10.1016/j.jclepro.2018.11.022
   Singh J, 2016, J CLEAN PROD, V134, P342, DOI 10.1016/j.jclepro.2015.12.020
   Solaimani S, 2018, EUR MANAG REV, V15, P79, DOI 10.1111/emre.12124
   STAHEL WR, 1994, GREENING OF INDUSTRIAL ECOSYSTEMS, P178
   Susur E, 2019, RESOUR CONSERV RECY, V140, P338, DOI 10.1016/j.resconrec.2018.06.002
   Teece DJ, 2018, LONG RANGE PLANN, V51, P40, DOI 10.1016/j.lrp.2017.06.007
   Tellis W., 1997, QUALITATIVE REPORT, V3, P3
   Terziovski M, 2010, STRATEGIC MANAGE J, V31, P892, DOI 10.1002/smj.841
   Tongur S, 2014, TECHNOVATION, V34, P525, DOI 10.1016/j.technovation.2014.02.006
   Tukker A, 2015, J CLEAN PROD, V97, P76, DOI 10.1016/j.jclepro.2013.11.049
   Unal E, 2019, J CLEAN PROD, V212, P754, DOI 10.1016/j.jclepro.2018.11.291
   Unal E, 2019, J MANUF TECHNOL MANA, V30, P561, DOI 10.1108/JMTM-02-2018-0061
   Urbinati A, 2018, INT J INNOV TECHNOL, V15, DOI 10.1142/S0219877018500244
   Urbinati A, 2017, J CLEAN PROD, V168, P487, DOI 10.1016/j.jclepro.2017.09.047
   van Heerde HJ, 2013, J MARKETING RES, V50, P177, DOI 10.1509/jmr.10.0414
   Vermeulen WJV, 2015, BUS STRATEG ENVIRON, V24, P73, DOI 10.1002/bse.1804
   Visnjic I, 2018, TECHNOVATION, V72-73, P46, DOI 10.1016/j.technovation.2018.02.003
   Weber R. P., 1990, BASIC CONTENT ANAL, DOI [10.2307/2289192, DOI 10.2307/2289192]
   Williams A, 2007, J CLEAN PROD, V15, P1093, DOI 10.1016/j.jclepro.2006.05.034
   Wirtz BW, 2016, LONG RANGE PLANN, V49, P36, DOI 10.1016/j.lrp.2015.04.001
   Yin R. K., 1994, CASE STUDY RES DESIG
   Yin R. K., 2013, CASE STUDY RES DESIG, DOI [10.1097/FCH.0b013e31822dda9e, DOI 10.1097/FCH.0B013E31822DDA9E]
   Yu D, 2010, INT J MANAG REV, V12, P435, DOI 10.1111/j.1468-2370.2009.00272.x
   Zhu QH, 2011, J IND ECOL, V15, P405, DOI 10.1111/j.1530-9290.2011.00329.x
   Zhu QH, 2010, J ENVIRON MANAGE, V91, P1324, DOI 10.1016/j.jenvman.2010.02.013
   Zink T, 2017, J IND ECOL, V21, P593, DOI 10.1111/jiec.12545
   Zott C, 2010, LONG RANGE PLANN, V43, P216, DOI 10.1016/j.lrp.2009.07.004
NR 102
TC 8
Z9 8
U1 11
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 291
EP 307
DI 10.1016/j.resconrec.2018.12.034
PG 17
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900028
DA 2020-05-12
ER

PT J
AU Bi, RS
   Chen, C
   Tang, J
   Jia, XP
   Xiang, SG
AF Bi, Rongshan
   Chen, Chen
   Tang, Jiao
   Jia, Xiaoping
   Xiang, Shuguang
TI Two-level optimization model for water consumption based on water prices
   in eco-industrial parks
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE EIP; Water resource; Optimization model
ID OPTIMAL-DESIGN; MANAGEMENT; NETWORKS; LP; MINIMIZATION; PERFORMANCE;
   INTEGRATION; TECHNOLOGY; SCARCITY; SYSTEMS
AB The eco-industrial park (EIP) is universally acknowledged as an important way to achieve resources sustain ability by the plant cooperation. As an essential public resource in an EIP, the water resource is a primary research focus for minimizing the water consumption in Ell's. Commonly, the water price was adopted to adjust the plant water consumption; however, this method was relatively single. In this paper, a two-level optimization method was proposed based on the relationship between the water supplier and industrial plants and the interrelationship among plants in the EIP. Two cases were investigated based on the proposed method, and the results of different water prices and profit allocation ratios were presented in detail. Compared to the traditional method, the two-level optimization could produce more effective guide on industrial plants for applying water saving and new technologies.
C1 [Bi, Rongshan; Chen, Chen; Tang, Jiao; Xiang, Shuguang] Qingdao Univ Sci & Technol, Coll Chem Engn, Qingdao 266042, Shandong, Peoples R China.
   [Jia, Xiaoping] Qingdao Univ Sci & Technol, Coll Environm & Safety Engn, Qingdao 266042, Shandong, Peoples R China.
RP Bi, RS; Xiang, SG (reprint author), Qingdao Univ Sci & Technol, Coll Chem Engn, Qingdao 266042, Shandong, Peoples R China.
EM birongshan@163.com; psechen@163.com; tangjiao64@163.com;
   jiaxp@qust.edu.cn; xsg@qust.edu.cn
OI JIA, Xiaoping/0000-0002-1338-7545; Chen, Chen/0000-0002-6862-8457; Bi,
   Rongshan/0000-0003-1230-6165
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [41771575]
FX The authors would like to thank the financial support provided by the
   National Natural Science Foundation of China (41771575).
CR Ahmetovic E, 2014, APPL ENERG, V135, P791, DOI 10.1016/j.apenergy.2014.04.063
   Alva-Argaez A, 2007, CHEM ENG J, V128, P33, DOI 10.1016/j.cej.2006.10.001
   Blanke A, 2007, AGR WATER MANAGE, V87, P139, DOI 10.1016/j.agwat.2006.06.025
   Boix M, 2015, J CLEAN PROD, V87, P303, DOI 10.1016/j.jclepro.2014.09.032
   Boix M, 2012, APPL THERM ENG, V36, P442, DOI 10.1016/j.applthermaleng.2011.10.062
   Boix M, 2012, J CLEAN PROD, V22, P85, DOI 10.1016/j.jclepro.2011.09.011
   Castro PM, 2007, RESOUR CONSERV RECY, V50, P158, DOI 10.1016/j.resconrec.2006.06.013
   Cavaliere A, 2017, WATER RESOUR ECON, V18, P1, DOI 10.1016/j.wre.2017.04.001
   Chen X, 2012, SEP PURIF TECHNOL, V98, P516, DOI 10.1016/j.seppur.2012.06.039
   Chew IML, 2009, J CLEAN PROD, V17, P1611, DOI 10.1016/j.jclepro.2009.08.005
   Cuviella-Suarez C, 2019, J CLEAN PROD, V213, P1322, DOI 10.1016/j.jclepro.2018.12.269
   Fan XY, 2018, J CLEAN PROD, V197, P1394, DOI 10.1016/j.jclepro.2018.06.277
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Hong XD, 2017, APPL ENERG, V197, P254, DOI 10.1016/j.apenergy.2017.04.003
   Huang BJ, 2019, RESOUR CONSERV RECY, V140, P137, DOI 10.1016/j.resconrec.2018.09.013
   Hussain T, 2018, J CLEAN PROD, V198, P806, DOI 10.1016/j.jclepro.2018.07.051
   Jia XP, 2015, CHEM ENGINEER TRANS, V45, P139, DOI 10.3303/CET1545024
   Karthick R, 2010, RESOUR CONSERV RECY, V54, P783, DOI 10.1016/j.resconrec.2009.12.008
   Kucukmehmetoglu M, 2012, J HYDROL, V450, P308, DOI 10.1016/j.jhydrol.2012.04.036
   Lavric V, 2007, RESOUR CONSERV RECY, V50, P186, DOI 10.1016/j.resconrec.2006.06.015
   Liu Z, 2019, RESOUR CONSERV RECY, V143, P111, DOI 10.1016/j.resconrec.2018.12.027
   Ma JZ, 2018, ENERGY, V150, P797, DOI 10.1016/j.energy.2018.03.029
   Martinez-Patino J, 2011, ENERGY, V36, P3888, DOI 10.1016/j.energy.2010.12.042
   Matijasevic L, 2010, RESOUR CONSERV RECY, V54, P1362, DOI 10.1016/j.resconrec.2010.05.011
   Montastruc L, 2013, J CLEAN PROD, V43, P1, DOI 10.1016/j.jclepro.2012.12.039
   Mughees W, 2015, COMPUT CHEM ENG, V73, P34, DOI 10.1016/j.compchemeng.2014.11.004
   Nguyen MT, 2014, J CLEAN PROD, V84, P639, DOI 10.1016/j.jclepro.2014.04.004
   Oliver P, 2008, J CLEAN PROD, V16, P1275, DOI 10.1016/j.jclepro.2007.06.012
   Priya GSK, 2017, RESOUR CONSERV RECY, V119, P128, DOI 10.1016/j.resconrec.2016.02.005
   Ramos M, 2016, COMPUT-AIDED CHEM EN, V38A, P1177, DOI 10.1016/B978-0-444-63428-3.50201-0
   Sahin O, 2016, ENVIRON MODELL SOFTW, V75, P348, DOI 10.1016/j.envsoft.2014.05.018
   Silori GK, 2018, CHEM ENG RES DES, V136, P417, DOI 10.1016/j.cherd.2018.06.001
   Skouteris G, 2018, J CLEAN PROD, V172, P786, DOI 10.1016/j.jclepro.2017.10.213
   Sujak S, 2017, J CLEAN PROD, V146, P194, DOI 10.1016/j.jclepro.2016.06.182
   Tang JJ, 2013, J ENVIRON MANAGE, V126, P55, DOI 10.1016/j.jenvman.2013.03.051
   Taskhiri MS, 2011, RESOUR CONSERV RECY, V55, P730, DOI 10.1016/j.resconrec.2011.03.001
   Teles J, 2008, CHEM ENG SCI, V63, P376, DOI 10.1016/j.ces.2007.09.033
   Thevendiraraj S, 2003, RESOUR CONSERV RECY, V37, P227, DOI 10.1016/S0921-3449(02)00102-7
   Tiu BTC, 2017, RESOUR CONSERV RECY, V119, P89, DOI 10.1016/j.resconrec.2016.06.005
   Tokos H, 2009, J CLEAN PROD, V17, P1465, DOI 10.1016/j.jclepro.2009.06.009
   WANG YP, 1994, CHEM ENG SCI, V49, P981, DOI 10.1016/0009-2509(94)80006-5
   Wang ZF, 2012, CHEM ENG SCI, V69, P565, DOI 10.1016/j.ces.2011.11.015
   Weber O, 2018, J CLEAN PROD, V195, P963, DOI 10.1016/j.jclepro.2018.05.269
   Xu XY, 2015, RESOUR CONSERV RECY, V101, P96, DOI 10.1016/j.resconrec.2015.05.019
   Yan FY, 2016, CHEM ENG SCI, V140, P76, DOI 10.1016/j.ces.2015.09.036
NR 45
TC 2
Z9 2
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 308
EP 315
DI 10.1016/j.resconrec.2019.04.004
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900029
DA 2020-05-12
ER

PT J
AU Li, BL
   Bicknell, KB
   Renwick, A
AF Li, Binlin
   Bicknell, K. B.
   Renwick, Alan
TI Peak phosphorus, demand trends and implications for the sustainable
   management of phosphorus in China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Peak phosphorus; Resources; Demand; Sustainability
ID WORLD OIL PRODUCTION; FOOD SECURITY; FARMING SYSTEMS; RESOURCES;
   RECOVERY; HISTORY; AGRICULTURE; STRATEGIES; DEPLETION; MINERALS
AB An increasing number of studies have suggested that global phosphate rock (PR) extraction will reach a peak in the coming decades, with subsequent implications for food security. This paper focuses on peak phosphorus in China, which serves as an "early warning indicator" for phosphorus security. The results indicate that China's production of PR is likely to peak sometime between 2035 and 2045. This result was derived using Chinese data, which differs from the U.S. Geological Survey (USGS) data, upon which estimates are more commonly based. Drivers of Chinese phosphorus consumption were also identified, and trends in phosphate use from six developed countries were analysed to form an overall assessment of the current demand for phosphorus in China. This analysis indicates that the demand for Chinese PR has reached a plateau. Combining the forecasts of both extraction and demand, the study explores potential challenges for sustainable phosphorus management. The study concludes with a range of policies that may help ensure a sustainable supply of Chinese PR.
C1 [Li, Binlin] Yunnan Agr Univ, Coll Econ & Management, Kunming, Yunnan, Peoples R China.
   [Bicknell, K. B.; Renwick, Alan] Lincoln Univ, Dept Global Value Chains & Trade, Lincoln, New Zealand.
RP Li, BL (reprint author), Yunnan Agr Univ, Coll Econ & Management, Kunming, Yunnan, Peoples R China.
EM 2398660134@qq.com; Kathryn.Bicknell@lincoln.ac.nz;
   Alan.Renwick@lincoln.ac.nz
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71763034]; Yunnan Agricultural University Natural
   Science Foundation for Young Scientists [2016ZR01]
FX Many thanks to three anonymous reviewers for helpful suggestions. This
   study was conducted with the support of two projects. Project 71763034
   supported by National Natural Science Foundation of China, Project
   2016ZR01 supported by Yunnan Agricultural University Natural Science
   Foundation for Young Scientists.
CR Aleklett K., 2009, C CAMPBELL 100 MONTH
   Bai ZH, 2016, NUTR CYCL AGROECOSYS, V104, P361, DOI 10.1007/s10705-015-9737-y
   Bartlett AA, 2000, MATH GEOL, V32, P1, DOI 10.1023/A:1007587132700
   Bentley RW, 2016, LECT N ENERG, V34, P57, DOI 10.1007/978-3-319-26372-4_3
   Bleischwitz Raimund, 2009, ECO INNOVATION PUTTI
   Bradford-Hartke Z, 2015, ENVIRON SCI TECHNOL, V49, P8611, DOI 10.1021/es505102v
   Campbell C. J., 1999, IMMINENT PEAK WORLD
   Chapman I, 2014, ENERG POLICY, V64, P93, DOI 10.1016/j.enpol.2013.05.010
   Chen MP, 2015, J CLEAN PROD, V91, P337, DOI 10.1016/j.jclepro.2014.12.042
   Chengxin, 2017, ANN REP CHENGX GROUP
   Chowdhury RB, 2017, J CLEAN PROD, V140, P945, DOI 10.1016/j.jclepro.2016.07.012
   CICC, 2012, SUGG INV OPP PHOSPH
   Conijn JG, 2018, AGR ECOSYST ENVIRON, V251, P244, DOI 10.1016/j.agee.2017.06.001
   Cooper J, 2013, RESOUR CONSERV RECY, V74, P82, DOI 10.1016/j.resconrec.2013.03.001
   Cordell D, 2015, FOOD SECUR, V7, P337, DOI 10.1007/s12571-015-0442-0
   Cordell D, 2014, ANNU REV ENV RESOUR, V39, P161, DOI 10.1146/annurev-environ-010213-113300
   Cordell D, 2013, AGRONOMY-BASEL, V3, P86, DOI 10.3390/agronomy3010086
   Cordell D, 2011, SUSTAINABILITY-BASEL, V3, P2027, DOI 10.3390/su3102027
   Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009
   Dory P., 2007, PEAK PHOSPHORUS
   Edixhoven JD, 2014, EARTH SYST DYNAM, V5, P491, DOI DOI 10.5194/ESD-5-491-2014
   Feng Muhua, 2008, Hupo Kexue, V20, P766
   Gao L., 2015, PHOSPHATE COMP FERTI, V43, P9, DOI [10.3969/jAssn.1007-6220.2015.09.015, DOI 10.3969/JASSN.1007-6220.2015.09.015]
   George TS, 2016, PLANT SOIL, V401, P1, DOI 10.1007/s11104-016-2846-9
   Hall C, 2016, SCIENCE, V352, P155, DOI 10.1126/science.aaf2220
   He B., 2015, PHOSPHATE COMP FERTI, V30, P28, DOI [10.3969/j.issn.1007-6220.2015.08.010, DOI 10.3969/J.ISSN.1007-6220.2015.08.010]
   Heckenmiiller M., 2014, GLOBAL AVAILABILITY
   Heppell J, 2016, PLANT SOIL, V401, P135, DOI 10.1007/s11104-015-2543-0
   Hirsch RL, 2006, AICHE J, V52, P2, DOI 10.1002/aic.10747
   Holland S.P., 2013, ENCY ENERGY NATURAL, V1, P146, DOI [10.1016/6978-0-12-375067-9.00124-8, DOI 10.1016/B978-0-12-375067-9.00124-8]
   Hook M., 2011, NAT RESOUR RES, V20, P103, DOI DOI 10.1007/S11053-011-9139-Z
   Huang J, 2017, J CLEAN PROD, V159, P171, DOI 10.1016/j.jclepro.2017.05.008
   Hubbert MK, 1959, 44 ANN M AM ASS PETR
   IFA, 2017, PROD INT TRAD STAT
   IndexMundi, 2017, ROCK PHOSPH MONTHL P
   Jasinski S.M., 2011, PHOSPHATE ROCK MINER
   Jasinski S. M., 2017, PHOSPHATE ROCK MINER
   Jiang J., 2014, MULTIPURPOSE UTILIZA, V4, P16, DOI [10.3969/j.issn.1000-6532.2014.04.004, DOI 10.3969/J.ISSN.1000-6532.2014.04.004]
   Jin L., 2016, CHINA POPUL RESOUR E, V26, P417
   Karunanithi R, 2015, ADV AGRON, V131, P173, DOI 10.1016/bs.agron.2014.12.005
   Le Corre KS, 2009, CRIT REV ENV SCI TEC, V39, P433, DOI 10.1080/10643380701640573
   Leinweber P, 2018, AMBIO, V47, P3, DOI 10.1007/s13280-017-0968-9
   Li G., 2014, RURAL HIST, V5, P4
   Li GH, 2016, AGR SYST, V144, P87, DOI 10.1016/j.agsy.2016.01.006
   Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5
   Li J., 2014, GUIZHOU J ANIM HUSB, V38, P10, DOI [10.3969/j.issn.1007-1474.2014.06.004, DOI 10.3969/J.ISSN.1007-1474.2014.06.004]
   Li W., 2015, CHINA MIN MAG, V6, P6, DOI [DOI 10.3969/J.ISSN.1004-4051.2015.06.003, 10.3969/j.issn.1004-4051.2015.06.003]
   Linderholm K, 2012, RESOUR CONSERV RECY, V66, P27, DOI 10.1016/j.resconrec.2012.04.006
   Liu YJ, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/2/023001
   Lun F, 2018, EARTH SYST SCI DATA, V10, P1, DOI 10.5194/essd-10-1-2018
   Luo ZB, 2017, RESOUR CONSERV RECY, V126, P186, DOI 10.1016/j.resconrec.2017.07.018
   Lwin CM, 2017, RESOUR CONSERV RECY, V122, P94, DOI 10.1016/j.resconrec.2017.01.017
   March MD, 2016, ECOL INDIC, V69, P667, DOI 10.1016/j.ecolind.2016.05.022
   Mason L, 2011, J CLEAN PROD, V19, P958, DOI 10.1016/j.jclepro.2010.12.006
   Mayer BK, 2016, ENVIRON SCI TECHNOL, V50, P6606, DOI 10.1021/acs.est.6b01239
   Mew MC, 2016, SCI TOTAL ENVIRON, V542, P1008, DOI 10.1016/j.scitotenv.2015.08.045
   MLR, 2015, 2015 CHIN MIN RES
   MLR, 2012, 3 IND REAS EXPL UT P
   MOFCOM, 2016, COND APPL PHOSPH ROC
   Mohr S. H., 2013, PROJECTIONS FUTURE P
   Mudd GM, 2010, RESOUR POLICY, V35, P98, DOI 10.1016/j.resourpol.2009.12.001
   NBS, 2017, NBS RAT URB IS 57 35
   Neset TS, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00047
   NOTHOLT AJG, 1989, PHOSPHATE DEPOSITS W, V2
   Nziguheba G, 2016, NUTR CYCL AGROECOSYS, V104, P321, DOI 10.1007/s10705-015-9729-y
   Okullo SJ, 2015, RESOUR ENERGY ECON, V40, P36, DOI 10.1016/j.reseneeco.2015.01.002
   Pearce BJ, 2015, J CLEAN PROD, V109, P203, DOI 10.1016/j.jclepro.2015.08.111
   Prior T, 2012, GLOBAL ENVIRON CHANG, V22, P577, DOI 10.1016/j.gloenvcha.2011.08.009
   Pufahl PK, 2017, ECON GEOL, V112, P483
   Reardon T, 2014, GLOB FOOD SECUR-AGR, V3, P108, DOI 10.1016/j.gfs.2014.02.001
   Rhodes C., 2015, CHEAP OIL DOES NOT M
   Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a
   Rowe H, 2016, NUTR CYCL AGROECOSYS, V104, P393, DOI 10.1007/s10705-015-9726-1
   Roy ED, 2017, ECOL ENG, V98, P213, DOI 10.1016/j.ecoleng.2016.10.076
   Sattari SZ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054003
   Scholz RW, 2016, EARTH SYST DYNAM, V7, P103, DOI 10.5194/esd-7-103-2016
   Scholz R. W., 2014, SUSTAINABLE PHOSPHOR, DOI [10.1007/978-94-007-7250-2_1, DOI 10.1007/978-94-007-7250-2_1]
   Scholz RW, 2015, RESOUR CONSERV RECY, V105, P259, DOI 10.1016/j.resconrec.2015.10.003
   Scholz RW, 2013, SCI TOTAL ENVIRON, V461, P799, DOI 10.1016/j.scitotenv.2013.05.043
   Scholz RW, 2013, GLOBAL ENVIRON CHANG, V23, P11, DOI 10.1016/j.gloenvcha.2012.10.013
   Schroder J.J., 2010, B1ETU20090025 PLANT
   Springer NP, 2017, SCI TOTAL ENVIRON, V577, P319, DOI 10.1016/j.scitotenv.2016.10.190
   Steen L., 1998, PHOSPHORUS AVAILABIL
   Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855
   [孙小虹 Sun Xiaohong], 2015, [地球学报, Acta Geoscientia Sinica], V36, P213
   Tang Y., 2014, IND MIN PROCESS, V43, P51
   Tilton JE, 2018, RESOUR CONSERV RECY, V139, P280, DOI 10.1016/j.resconrec.2018.08.026
   Toth G, 2014, EUR J AGRON, V55, P42, DOI 10.1016/j.eja.2013.12.008
   Tunney H, 2003, J PLANT NUTR SOIL SC, V166, P438, DOI 10.1002/jpln.200321153
   Ulrich AE, 2014, SCI TOTAL ENVIRON, V490, P694, DOI 10.1016/j.scitotenv.2014.04.050
   Ulrich AE, 2013, SUSTAINABILITY-BASEL, V5, P4523, DOI 10.3390/su5114523
   UN (United Nations), 2014, WORLD POP PROSP 2014
   Van der Hoeven D., 2017, GEOPOLITICS PHOSPHAT
   Van Kauwenbergh S.J., 2010, WORLD PHOSPHATE ROCK
   Van Vuuren DP, 2010, GLOBAL ENVIRON CHANG, V20, P428, DOI 10.1016/j.gloenvcha.2010.04.004
   Walan P, 2014, RESOUR CONSERV RECY, V93, P178, DOI 10.1016/j.resconrec.2014.10.011
   Weikard HP, 2016, FOOD SECUR, V8, P405, DOI 10.1007/s12571-016-0551-4
   Wellmer FW, 2017, MINER ECON, V30, P73, DOI 10.1007/s13563-016-0094-3
   Wen J, 2011, THESIS
   White S., 2010, PEAK PHOSPHORUS SEQU
   Xia XH, 2011, J WUHAN I TECH, V33, P6, DOI DOI 10.3969/J.ISSN.1674-2869.2011.02.002
   Yan Z. H., 2011, MIN METALL, V20, P21
   Yen W., 2014, THESIS
   Yun T., 2017, ANN REPORT YUNTIANHU
   Zhang S J, 2014, CHINA MIN MAG, V23, P8
   Zhang T., 2016, CHINA AGR PROD NEWS, V13, P3
   Zhang X., 2016, T SOC MIN METALL EXP, V7, P214, DOI [10.3969/j.issn.1674-7801.2016.01.028, DOI 10.3969/J.ISSN.1674-7801.2016.01.028]
   Zhao X., 2014, SCI TECHNOL CHEM IND, V22, P65, DOI [10.3969/j.issn.1008-0511.2014.02.017, DOI 10.3969/J.ISSN.1008-0511.2014.02.017]
   ZHONGLINEX, 2015, 2015 PHOSPH DISTR CU
NR 109
TC 0
Z9 0
U1 8
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 316
EP 328
DI 10.1016/j.resconrec.2019.03.033
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900030
DA 2020-05-12
ER

PT J
AU Kumar, A
   Kuppusamy, VK
   Holuszko, M
   Song, SL
   Loschiavo, A
AF Kumar, Amit
   Kuppusamy, Vinoth Kumar
   Holuszko, Maria
   Song, Shulei
   Loschiavo, Antonio
TI LED lamps waste in Canada: Generation and characterization
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE LED lamps; Recycling; Waste generation; Metal content; TOP; Test
ID POTENTIAL ENVIRONMENTAL IMPACTS; PRODUCTS; RESOURCES; METALS; FLOWS;
   CFL; US
AB Lamps and lighting products are the most commonly used electrical products around the globe. With the improvement in lamp technologies, products have grown complex and hence require an improved recycling process. Light emitting diode (LED) lamps consist of various valuable and hazardous metals such as copper, aluminum, iron, zinc, lead, arsenic, and antimony.
   This paper provides an estimation of the waste LED lamps generation in Canada. It shows that the cumulative waste from LED lamps is expected to reach 12 kT by 2021. A characterization of LED lamps was also conducted to estimate the metal concentration and landfill leachate toxicity characteristics, which have not yet been studied with a bulk sample. The results showed that aluminum is the major metal present in LED lamps with a concentration of over 22%, followed by iron, copper, and zinc. It also showed the presence of heavy metals such as lead, arsenic, and antimony. On the contrary to the previous study, the landfill leachate concentration for waste LED lamps was found to be lower than the British Columbia (BC) landfill limits for all metals.
C1 [Kumar, Amit; Kuppusamy, Vinoth Kumar; Holuszko, Maria] Univ British Columbia, NBK Inst Min Engn, Vancouver, BC V6T 1Z4, Canada.
   [Song, Shulei] China Univ Min & Technol, Sch Chem Engn & Technol, 1 Daxue Rd, Xuzhou 221116, Jiangsu, Peoples R China.
   [Loschiavo, Antonio] Contact Environm Inc, 5-7965 Alexander Rd, Delta, BC V4G 1C6, Canada.
RP Kumar, A (reprint author), Univ British Columbia, NBK Inst Min Engn, Vancouver, BC V6T 1Z4, Canada.
EM amit9937@mail.ubc.ca
RI Holuszko, Maria/AAG-8872-2020
FU MITACS Inc.; Contact Environmental Inc.
FX The author would like to acknowledge the financial support provided by
   GOE2 industry donations, MITACS Inc. and academic grants provided by Dr.
   Maria Holuszko, at the University of British of Columbia. The author
   also acknowledges Contact Environmental Inc. for their financial support
   as well as for providing samples, expert advice, and other necessary
   technical details.
CR Abbasi G, 2015, ENVIRON SCI TECHNOL, V49, P1521, DOI 10.1021/es504007v
   Aman MM, 2013, ENERG POLICY, V52, P482, DOI 10.1016/j.enpol.2012.09.068
   ASTM International, 2016, D537316 ASTM INT, DOI [10.1520/D5373-16, DOI 10.1520/D5373-16]
   Balde C. P, 2015, E WASTE STAT GUIDELI
   Balde C.P., 2017, GLOBAL E WASTE MONIT
   Balde K., 2015, GLOBAL E WASTE MONIT
   Buchert M, 2012, RECYCLING CRITICAL R
   CEC, 2016, QUANT CHAR DOM TRANS
   Centers for Disease Control and Prevention, 2016, NIOSH POCK GUID CHEM
   Cheung M., 2017, BC LAMPS LIGHTING EQ
   Cheung M, 2016, BC LAMPS LIGHTING EQ
   Department of Energy, 2012, US LEDS THEIR BEST A
   Department of Energy, 2013, LIF CYCL ASS EN ENV
   Department of Energy, 2006, LIF WHIT LEDS
   Department of Energy, 2015, LED BAS
   Department of Energy, 2012, LIF CYCL ASS EN ENV
   Tran PH, 2016, ENVIRON SCI TECHNOL, V50, P2424, DOI 10.1021/acs.est.5b01388
   Humphreys CJ, 2008, MRS BULL, V33, P459, DOI 10.1557/mrs2008.91
   ISRI, 2018, OV IND FACT SHEET
   Kumar A., 2018, RECYCLING, V3
   Kumar A, 2018, WASTE MANAGE, V75, P94, DOI 10.1016/j.wasman.2018.02.010
   Kumar A, 2016, RESOURCES-BASEL, V5, DOI 10.3390/resources5040035
   Kumar A, 2017, RESOUR CONSERV RECY, V122, P32, DOI 10.1016/j.resconrec.2017.01.018
   Kyle B., 2013, NEW RES SHOWS CFLS L
   Lazenby H., 2017, UBC RES DEV FLOWSHEE
   Li J, 2007, ENVIRON SCI TECHNOL, V41, P1995, DOI 10.1021/es0618245
   Liggett B, 2011, STUDY FINDS LED LIGH
   Lim SR, 2013, ENVIRON SCI TECHNOL, V47, P1040, DOI 10.1021/es302886m
   Lim SR, 2011, ENVIRON SCI TECHNOL, V45, P320, DOI 10.1021/es101052q
   Martin T. D., 1994, ENVIRONMENTAL MONITO
   McKinsey & Company, 2012, LIGHTN WAY PERSP GLO
   Miller TR, 2016, ENVIRON SCI TECHNOL, V50, P5711, DOI 10.1021/acs.est.6b00079
   Nagy S, 2017, ARCH METALL MATER, V62, P1161, DOI 10.1515/amm-2017-0170
   Natural Resources Canada, 2016, EN FACT BOOK 2016 20
   Parajuly K, 2016, J CLEAN PROD, V137, P652, DOI 10.1016/j.jclepro.2016.07.142
   Penning J., 2016, ENERGY SAVINGS FOREC
   Principi P, 2014, J CLEAN PROD, V83, P96, DOI 10.1016/j.jclepro.2014.07.031
   Rahman SMM, 2017, RESOUR CONSERV RECY, V127, P256, DOI 10.1016/j.resconrec.2017.04.013
   RecycFluo, 2013, MEET FAM
   Reuter MA, 2015, J SUSTAIN METALL, V1, P4, DOI 10.1007/s40831-014-0006-0
   Sarkar A, 2013, TOTAL QUAL MANAG BUS, V24, P641, DOI 10.1080/14783363.2012.704265
   Smallwood P, 2014, LED LIGHTING GLOBAL
   Thomas G. P., 2012, RECYCLING LED LIGHTS
   Tuenge Jason R., 2013, LIFE CYCLE ASSESSM 3, DOI [10.2172/1074312, DOI 10.2172/1074312]
   USEPA, 1992, 1311 USEPA
   VanSchaik A., 2014, PRODUCT CENTRIC DESI
   Veit Hugo Marcelo, 2014, Rem: Rev. Esc. Minas, V67, P73, DOI 10.1590/S0370-44672014000100011
   Wilburn David R, 2012, BYPRODUCT METALS RAR
   Willick F., 2017, CANADIANS WILL SOON
   Yu H., 2015, GLOBAL LED LIGHTING
   Zhang LG, 2016, J CLEAN PROD, V127, P19, DOI 10.1016/j.jclepro.2016.04.004
NR 51
TC 6
Z9 6
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 329
EP 336
DI 10.1016/j.resconrec.2019.04.006
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900031
DA 2020-05-12
ER

PT J
AU Sun, JS
   Li, G
   Wang, ZH
AF Sun, Jiasen
   Li, Guo
   Wang, Zhaohua
TI Technology heterogeneity and efficiency of China's circular economic
   systems: A game meta-frontier DEA approach
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Game theory; Meta-frontier; Pollution treatment and
   waste disposal
ID DATA ENVELOPMENT ANALYSIS; ENVIRONMENTAL EFFICIENCY; PERFORMANCE
   EVALUATION; ENERGY-CONSUMPTION; EMISSION PERMITS; EMPIRICAL-RESEARCH;
   CO2 EMISSIONS; SUPPLY CHAIN; FIXED COST; ENTERPRISES
AB China is vigorously developing a circular economy to alleviate environmental degradation and resource shortages. In a circular economic system, resource recovery and pollutant treatment are core subsystems. To improve resource utilization efficiencies and reduce pollutant emissions in the circular economic system, this study first proposes a comprehensive model using game theory and a data envelopment analysis (DEA) method. Then, to identify the technology gaps between circular economic systems, the study proposes a game meta frontier DEA model. The proposed models are then applied to evaluate the circular economic systems in China's different provinces from 2007 to 2016. The results show a continuing conflict between economic growth, environmental protection, and resource recycling in China. In addition, the efficiency of pollution treatment and waste disposal (PTWD) and the production efficiency of the circular economic systems differ when different frontiers are applied. The improvement direction and potential efficiencies also differ. The production technology and PTWD technology in Eastern China are the highest, while the technology levels in Western China are the lowest. Based on management potential and technological potential, the circular economic systems in China are divided into four categories. For each category, this study provides the specific recommendations for improving production/PTWD efficiency.
C1 [Sun, Jiasen] Soochow Univ, Business Sch, Res Ctr Smarter Supply Chain, Suzhou, Peoples R China.
   [Li, Guo; Wang, Zhaohua] Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China.
   [Li, Guo; Wang, Zhaohua] Beijing Inst Technol, Ctr Energy & Environm Policy Res, Beijing, Peoples R China.
   [Li, Guo; Wang, Zhaohua] Sustainable Dev Res Inst Econ & Soc Beijing, Beijing 100081, Peoples R China.
RP Li, G (reprint author), Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China.
EM liguo@bit.edu.cn
OI Li, Guo/0000-0002-7127-1102
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71501139, 71871153, 91746110, 71372019, 91746208,
   71521002, 71642004, 71625003]; Joint Development Program of Beijing
   Municipal Commission of Education; Natural Science Funds of Jiangsu
   ProvinceNatural Science Foundation of Jiangsu Province [BK20150307];
   Research Project of Philosophy and Social Sciences in Universities of
   Jiangsu [2018SJA1299]; Jiangsu Overseas Visiting Scholar Program for
   University Prominent Young & Middle-aged Teachers and Presidents
FX This research is partially supported by the National Natural Science
   Foundation of China under the grant nos. 71501139, 71871153. 91746110,
   71372019, 91746208, 71521002, 71642004 and 71625003, the Joint
   Development Program of Beijing Municipal Commission of Education;
   Natural Science Funds of Jiangsu Province (No. BK20150307); Research
   Project of Philosophy and Social Sciences in Universities of Jiangsu
   (2018SJA1299). Jiasen Sun thanks the sponsorship of Jiangsu Overseas
   Visiting Scholar Program for University Prominent Young & Middle-aged
   Teachers and Presidents.
CR Babbitt CW, 2018, RESOUR CONSERV RECY, V135, P1, DOI 10.1016/j.resconrec.2018.04.012
   Battese GE, 2004, J PROD ANAL, V21, P91, DOI 10.1023/B:PROD.0000012454.06094.29
   Bi WJ, 2016, IEEE T IND INFORM, V12, P1270, DOI 10.1109/TII.2016.2547584
   Chiu CR, 2012, ENERG ECON, V34, P1392, DOI 10.1016/j.eneco.2012.06.003
   Cook WD, 2010, EUR J OPER RES, V207, P1122, DOI 10.1016/j.ejor.2010.05.006
   Cook WD, 2010, OMEGA-INT J MANAGE S, V38, P423, DOI 10.1016/j.omega.2009.12.001
   Du J, 2014, EUR J OPER RES, V235, P206, DOI 10.1016/j.ejor.2013.10.002
   Fare R, 1996, ECON LETT, V50, P65, DOI 10.1016/0165-1765(95)00729-6
   Fare R., 2007, MODELING DATA IRREGU, P209, DOI DOI 10.1007/978-0-387-71607-7_12
   Feng YL, 2018, INT J PROD RES, V56, P7405, DOI 10.1080/00207543.2018.1471237
   Fukuyama H, 2017, EUR J OPER RES, V259, P721, DOI 10.1016/j.ejor.2016.10.044
   Geng Y, 2016, SCIENCE S, V6278, P73
   Geng Y, 2008, INT J SUST DEV WORLD, V15, P231, DOI 10.3843/SusDev.15.3:6
   Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Golini R, 2017, INT J PROD RES, V55, P1183, DOI 10.1080/00207543.2016.1234724
   Guo C, 2017, EUR J OPER RES, V257, P896, DOI 10.1016/j.ejor.2016.08.002
   He Q, 2018, J CLEAN PROD, V176, P1091, DOI 10.1016/j.jclepro.2017.11.220
   Ji X, 2019, ANN OPER RES, V278, P281, DOI 10.1007/s10479-018-2855-6
   Ji X, 2017, APPL ENERG, V204, P607, DOI 10.1016/j.apenergy.2017.07.033
   Ji X, 2017, ENERG POLICY, V108, P163, DOI 10.1016/j.enpol.2017.05.035
   Kao C, 2010, DECIS SUPPORT SYST, V48, P437, DOI 10.1016/j.dss.2009.06.002
   Li G, 2018, ENERG EFFIC, V12, P1007, DOI 10.1007/s12053-018-9743-4
   Li G, 2018, J CLEAN PROD, V197, P124, DOI 10.1016/j.jclepro.2018.06.177
   Li G, 2017, ANN OPER RES, V255, P507, DOI 10.1007/s10479-016-2202-8
   Li G, 2016, TRANSPORT RES E-LOG, V90, P25, DOI 10.1016/j.tre.2015.09.008
   Li JL, 2019, RESOUR CONSERV RECY, V145, P349, DOI 10.1016/j.resconrec.2019.01.036
   Li MJ, 2018, J CLEAN PROD, V192, P252, DOI 10.1016/j.jclepro.2018.05.015
   Li YJ, 2013, OMEGA-INT J MANAGE S, V41, P55, DOI 10.1016/j.omega.2011.02.008
   Li YJ, 2012, OMEGA-INT J MANAGE S, V40, P611, DOI 10.1016/j.omega.2011.11.007
   Liang L, 2008, OPER RES, V56, P1278, DOI 10.1287/opre.1070.0487
   Lins MPE, 2003, EUR J OPER RES, V148, P312, DOI 10.1016/S0377-2217(02)00687-2
   Liu JG, 2012, SCIENCE, V337, P649, DOI 10.1126/science.1219471
   Liu JS, 2013, OMEGA-INT J MANAGE S, V41, P893, DOI 10.1016/j.omega.2012.11.004
   Liu Q, 2009, J CLEAN PROD, V17, P265, DOI 10.1016/j.jclepro.2008.06.003
   Liu Y, 2014, RESOUR CONSERV RECY, V87, P145, DOI 10.1016/j.resconrec.2014.04.002
   Lozano S, 2009, EUR J OPER RES, V193, P752, DOI 10.1016/j.ejor.2007.07.029
   McDowall W, 2017, J IND ECOL, V21, P651, DOI 10.1111/jiec.12597
   Mi ZF, 2015, J CLEAN PROD, V103, P455, DOI 10.1016/j.jclepro.2014.06.011
   Mi ZF, 2018, GEOPHYS RES LETT, V45, P4309, DOI 10.1029/2018GL077915
   Mi ZF, 2017, J CLEAN PROD, V142, P2227, DOI 10.1016/j.jclepro.2016.11.055
   Nakabayashi K, 2006, OMEGA-INT J MANAGE S, V34, P135, DOI 10.1016/j.omega.2004.08.003
   Oh DH, 2010, ENERG ECON, V32, P146, DOI 10.1016/j.eneco.2009.07.006
   Omrani H, 2019, ANN OPER RES, V274, P471, DOI 10.1007/s10479-018-2803-5
   Pearce D. W., 1990, EC NATURAL RESOURCES
   Shephard R.W, 1980, DYNAMIC THEORY PRODU, V50
   Simon B, 2019, RESOUR CONSERV RECY, V141, P299, DOI 10.1016/j.resconrec.2018.10.044
   Song ML, 2018, RESOUR CONSERV RECY, V129, P333, DOI 10.1016/j.resconrec.2016.08.005
   Song ML, 2018, RESOUR CONSERV RECY, V128, P197, DOI 10.1016/j.resconrec.2016.08.015
   Song ML, 2018, EUR J OPER RES, V269, P51, DOI 10.1016/j.ejor.2017.03.073
   Song ML, 2017, RESOUR CONSERV RECY, V122, P261, DOI 10.1016/j.resconrec.2017.03.001
   Song ML, 2018, ANN OPER RES, V268, P425, DOI 10.1007/s10479-016-2307-0
   Song ML, 2015, J CLEAN PROD, V104, P374, DOI 10.1016/j.jclepro.2014.02.028
   Song ML, 2013, J CLEAN PROD, V42, P42, DOI 10.1016/j.jclepro.2012.11.010
   Song ML, 2012, RENEW SUST ENERG REV, V16, P4465, DOI 10.1016/j.rser.2012.04.052
   Su B, 2013, J CLEAN PROD, V42, P215, DOI 10.1016/j.jclepro.2012.11.020
   Sun JS, 2018, STRUCT CHANGE ECON D, V47, P57, DOI 10.1016/j.strueco.2018.07.007
   Sun JS, 2018, J CLEAN PROD, V175, P561, DOI 10.1016/j.jclepro.2017.12.042
   Sun JS, 2017, TRANSPORT POLICY, V60, P75, DOI 10.1016/j.tranpol.2017.09.001
   Sun JS, 2017, COMPUT IND ENG, V113, P891, DOI 10.1016/j.cie.2017.05.028
   Sun JS, 2014, INT J PROD RES, V52, P419, DOI 10.1080/00207543.2013.829592
   Tone K, 2014, OMEGA-INT J MANAGE S, V42, P124, DOI 10.1016/j.omega.2013.04.002
   Wang N, 2018, J CLEAN PROD, V180, P876, DOI 10.1016/j.jclepro.2018.01.089
   Wang ZH, 2015, APPL ENERG, V147, P617, DOI 10.1016/j.apenergy.2015.01.108
   Wu HQ, 2014, RESOUR CONSERV RECY, V83, P163, DOI 10.1016/j.resconrec.2013.10.003
   Wu HQ, 2013, MATH COMPUT MODEL, V58, P1095, DOI 10.1016/j.mcm.2012.03.008
   Wu J, 2016, INT J PROD RES, V54, P5990, DOI 10.1080/00207543.2016.1148278
   Wu J, 2016, EUR J OPER RES, V254, P1047, DOI 10.1016/j.ejor.2016.04.034
   Wu J, 2009, EXPERT SYST APPL, V36, P4357, DOI 10.1016/j.eswa.2008.05.001
   Wu J, 2009, OMEGA-INT J MANAGE S, V37, P909, DOI 10.1016/j.omega.2008.07.001
   Zhang LL, 2018, RESOUR CONSERV RECY, V136, P248, DOI 10.1016/j.resconrec.2018.04.032
   Zhou P, 2014, ENERG ECON, V45, P99, DOI 10.1016/j.eneco.2014.06.019
NR 72
TC 9
Z9 9
U1 20
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 337
EP 347
DI 10.1016/j.resconrec.2019.03.046
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900032
DA 2020-05-12
ER

PT J
AU Chen, YD
   Cui, ZJ
   Cui, XW
   Liu, W
   Wang, XL
   Li, XX
   Li, SX
AF Chen, Yuedong
   Cui, Zhaojie
   Cui, Xiaowei
   Liu, Wei
   Wang, Xinlei
   Li, XinXin
   Li, Shouxiu
TI Life cycle assessment of end-of-life treatments of waste plastics in
   China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Waste plastics; Life cycle assessment; Mechanical recycling;
   Incineration; Landfilling
ID PVC; MANAGEMENT; POLLUTION; RECOVERY; CONCRETE
AB As the world's largest producer and consumer of plastics, China is also the largest producer and recycler of waste plastics. It is necessary to explore the environmental impacts of actual end-of-life (EOL) treatments of waste plastics in China. In this study, a life cycle assessment (LCA) was conducted to evaluate the environmental impacts of mechanical recycling of waste plastics as well as incineration and landfilling with municipal solid waste in China. The results indicate the environmental benefits of current EOL treatments of waste plastics in China. Mechanical recycling was a negative and decisive contributor, with a minimum impact on terrestrial acidification potential (-83.4%) and a maximum impact on global warming potential (-165.8%). Incineration had negative contributions to 8 of the 12 environmental indicators, and landfilling was a positive contributor to all environmental impacts. Scenarios of treatment pattern, recycling technologies and import policy were set to analyze the potential reduction in environmental impacts of future EOL treatments of waste plastics. Increasing the proportion of mechanical recycling would reduce all environmental impacts, including up to 51.8% on particulate matter formation potential. Energy conservation and emission reduction in atmospheric pollutants would effectively reduce the environmental impacts of mechanical recycling. Banning waste plastics imports would decrease the transportation distances of waste plastics, thereby reducing the related environmental impacts, most notably a reduction of 84.8% for marine ecotoxicity potential. This study provides robust references for waste plastics management in China.
C1 [Chen, Yuedong; Cui, Zhaojie; Liu, Wei; Wang, Xinlei; Li, XinXin; Li, Shouxiu] Shandong Univ, Sch Environm Sci & Engn, Qingdao 266237, Shandong, Peoples R China.
   [Cui, Xiaowei] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China.
RP Liu, W (reprint author), Shandong Univ, Sch Environm Sci & Engn, Qingdao 266237, Shandong, Peoples R China.
EM wliu@sdu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [41701619]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2017M622208]
FX We appreciate the funding from the National Natural Science Foundation
   of China (Grant No.41701619) and the China Postdoctoral Science
   Foundation (Grant No.2017M622208). We are grateful to the management
   committee and enterprises in ZEDA for their support and assistance in
   the questionnaire survey, interview, and data collection.
CR Al-Maaded M, 2012, J POLYM ENVIRON, V20, P186, DOI 10.1007/s10924-011-0332-2
   [Anonymous], 2017, CHIN PLAST IND YB
   [Anonymous], 2016, CHIN PLAST IND YB
   [Anonymous], 2018, GUARDIAN
   [Anonymous], 2017, ZHONGH ENV REP
   Dodbiba G, 2008, J CLEAN PROD, V16, P458, DOI 10.1016/j.jclepro.2006.08.029
   Dormer A, 2013, J CLEAN PROD, V51, P133, DOI 10.1016/j.jclepro.2013.01.014
   Gu F, 2017, SCI TOTAL ENVIRON, V601, P1192, DOI 10.1016/j.scitotenv.2017.05.278
   Gu L, 2016, WASTE MANAGE, V51, P19, DOI 10.1016/j.wasman.2016.03.005
   Hamad K, 2013, POLYM DEGRAD STABIL, V98, P2801, DOI 10.1016/j.polymdegradstab.2013.09.025
   Heijungs R, 2010, INT J LIFE CYCLE ASS, V15, P511, DOI 10.1007/s11367-010-0158-5
   Hu S, 2012, RECYCLABLE RESOURCES, V5, P24
   Hu Z, 2012, ENV SCI MANAGE, V37, P93
   ISO (International Organization for Standardization), 2006, ISO14040
   Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352
   Lazarevic D, 2010, RESOUR CONSERV RECY, V55, P246, DOI 10.1016/j.resconrec.2010.09.014
   Li WC, 2016, SCI TOTAL ENVIRON, V566, P333, DOI 10.1016/j.scitotenv.2016.05.084
   Liu W, 2015, J CLEAN PROD, V108, P1149, DOI 10.1016/j.jclepro.2015.07.026
   MILT, 2016, GREEN IND DEV PLANN
   Muise I, 2016, RESOUR CONSERV RECY, V109, P137, DOI 10.1016/j.resconrec.2016.02.011
   Nana Njobet L, 2012, EVAL REP UTENRIKSDEP, V25, P126
   National Academy of Development and Strategy, 2015, SUGG MAN OBJ MOD MUN
   National Bureau of Statistics of the People's Republic of China, 2017, CHIN STAT YB
   NDRC, 2016, 13 5 YEAR PLAN MUN S
   NDRC, 2012, NOT POL IMPR POW GEN
   Ness B, 2007, ECOL ECON, V60, P498, DOI 10.1016/j.ecolecon.2006.07.023
   Ozkan K, 2015, WASTE MANAGE, V35, P29, DOI 10.1016/j.wasman.2014.09.030
   Pacheco EBAV, 2012, RESOUR CONSERV RECY, V60, P140, DOI 10.1016/j.resconrec.2011.12.010
   Perugini F, 2005, ENVIRON PROG, V24, P137, DOI 10.1002/ep.10078
   PlasticsEurope, 2017, PLAST FACTS AN EUR P
   Possatto FE, 2011, MAR POLLUT BULL, V62, P1098, DOI 10.1016/j.marpolbul.2011.01.036
   PWMI, 2018, PLAST PROD PLAST WAS
   Rahim R, 2017, J CLEAN PROD, V141, P1067, DOI 10.1016/j.jclepro.2016.09.023
   Rajendran S, 2013, PLAST RUBBER COMPOS, V42, P1, DOI 10.1179/1743289812Y.0000000002
   Rigamonti L, 2014, RESOUR CONSERV RECY, V85, P42, DOI 10.1016/j.resconrec.2013.12.012
   Seike T, 2018, RESOUR CONSERV RECY, V131, P41, DOI 10.1016/j.resconrec.2017.12.003
   Shen L, 2010, RESOUR CONSERV RECY, V55, P34, DOI 10.1016/j.resconrec.2010.06.014
   Shuyuan Li, 2015, Applied Mechanics and Materials, V768, P240, DOI 10.4028/www.scientific.net/AMM.768.240
   Sommerhuber PF, 2017, RESOUR CONSERV RECY, V117, P235, DOI 10.1016/j.resconrec.2016.10.012
   Stichnothe H, 2013, RESOUR CONSERV RECY, V71, P40, DOI 10.1016/j.resconrec.2012.12.005
   Tsai CJ, 2009, CHEMOSPHERE, V74, P1104, DOI 10.1016/j.chemosphere.2008.10.041
   Vantsi O, 2015, RESOUR CONSERV RECY, V104, P38, DOI 10.1016/j.resconrec.2015.09.009
   Wager PA, 2015, SCI TOTAL ENVIRON, V529, P158, DOI 10.1016/j.scitotenv.2015.05.043
   Wilcox C, 2015, P NATL ACAD SCI USA, V112, P11899, DOI 10.1073/pnas.1502108112
   Wu Y. P., 2013, THESIS
   [谢明辉 Xie Minghui], 2010, [环境科学研究, Research of Environmental Sciences], V23, P1284
   Yin S, 2016, J CLEAN PROD, V112, P2231, DOI 10.1016/j.jclepro.2015.09.073
   Zhang B, 2013, LIFE CYCLE ASSESSMEN
   Zhou YC, 2013, RESOUR CONSERV RECY, V73, P33, DOI 10.1016/j.resconrec.2012.12.016
   Zhu Run-ye, 2013, Huanjing Kexue, V34, P4689
   Zhu YQ, 2016, NATURE, V540, P354, DOI 10.1038/nature21001
NR 51
TC 4
Z9 4
U1 42
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 348
EP 357
DI 10.1016/j.resconrec.2019.03.011
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900033
DA 2020-05-12
ER

PT J
AU Zhou, JZ
   Zhu, NW
   Liu, HR
   Wu, PX
   Zhang, XP
   Zhong, ZQ
AF Zhou, Jiazhi
   Zhu, Nengwu
   Liu, Huangrui
   Wu, Pingxiao
   Zhang, Xiaoping
   Zhong, Zuqi
TI Recovery of gallium from waste light emitting diodes by oxalic acidic
   leaching
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Light emitting diodes; Gallium; Leaching; Organic acid; Optimum
   conditions
ID LITHIUM-ION BATTERIES; PRINTED-CIRCUIT BOARDS; VALUABLE METALS;
   ORGANIC-ACIDS; ELECTRONIC WASTE; PROCESS OPTIMIZATION; LED INDUSTRY;
   WEEE; COBALT; MANAGEMENT
AB Recovery of gallium from light emitting diodes (LEDs) is receiving great attention due to both high content of gallium and potential risk of environmental pollution. In this study, a novel environment-friendly route was proposed for efficient recovery of gallium from surface mounted device (SMD) of LEDs by using organic acid. Reduction of non-metallic components, selection of lixiviants, optimization of leaching parameters, and possible mechanism of gallium were investigated. Results showed that pyrolysis could reduce non-metallic components effectively, and 22% weight loss was achieved at 733 K. Selection of lixiviant experiments indicated that 83.42% gallium could be extracted from SMD LEDs by oxalic acid, which was much higher than that of 79.89% by hydrochloric acid, 70.62% by citric acid, and 71.69% by DL-malic acid. Further investigation revealed that 90 degrees C of leaching temperature, 10 g L-1 of pulp density, 0.7 M of oxalic acid and 48-75 mu m of particle size were the optimum conditions for effective gallium leaching by oxalic acid. After optimization, the gallium recovery efficiency reached as high as 90.36% in 60 min. Such efficient gallium leaching came from the higher dissociation constant of oxalic acid and the formation of ferrous oxalate which would promote the generation and maintenance of H+ Hence, oxalic acid could be a promising lixiviant for efficient recovery of gallium from SMD LEDs.
C1 [Zhou, Jiazhi; Zhu, Nengwu; Liu, Huangrui; Wu, Pingxiao; Zhang, Xiaoping; Zhong, Zuqi] South China Univ Technol, Sch Environm & Energy, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhu, Nengwu; Wu, Pingxiao; Zhang, Xiaoping] Minist Educ, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhu, Nengwu; Wu, Pingxiao; Zhang, Xiaoping] Guangdong Environm Protect Key Lab Solid Waste Tr, Guangzhou 510006, Guangdong, Peoples R China.
RP Zhu, NW (reprint author), South China Univ Technol, Sch Environm & Energy, Guangzhou 510006, Guangdong, Peoples R China.
EM nwzhu@scut.edu.cn
RI ZHU, NENGWU/A-9977-2012
OI ZHU, NENGWU/0000-0002-5414-884X
FU National Key R&D Plan Project of China [2016YFC0400702-2]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [51178191]; Guangdong Science and Technology Project
   [2017A020216013]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [2017PY012]; Guangzhou Science and Technology Project [201604020055]
FX This work was supported by the National Key R&D Plan Project of China
   (2016YFC0400702-2), National Natural Science Foundation of China
   (51178191), Guangdong Science and Technology Project (2017A020216013),
   the Fundamental Research Funds for the Central Universities (2017PY012),
   and Guangzhou Science and Technology Project (201604020055) for
   financial support.
CR Afroz R, 2013, J CLEAN PROD, V52, P185, DOI 10.1016/j.jclepro.2013.02.004
   Bahaloo-Horeh N, 2017, WASTE MANAGE, V60, P666, DOI 10.1016/j.wasman.2016.10.034
   Chan JKY, 2007, ENVIRON SCI TECHNOL, V41, P7668, DOI 10.1021/es071492j
   Chandraprabha MN, 2002, MINER ENG, V15, P751, DOI 10.1016/S0892-6875(02)00129-2
   Cucchiella F, 2015, RENEW SUST ENERG REV, V51, P263, DOI 10.1016/j.rser.2015.06.010
   Cui JY, 2019, ACS SUSTAIN CHEM ENG, V7, P3849, DOI 10.1021/acssuschemeng.8b04756
   Cui JR, 2003, J HAZARD MATER, V99, P243, DOI 10.1016/S0304-3894(03)00061-X
   Font O, 2007, J HAZARD MATER, V139, P413, DOI 10.1016/j.jhazmat.2006.02.041
   Frohlich P, 2017, ANGEW CHEM INT EDIT, V56, P2544, DOI 10.1002/anie.201605417
   Golmohammadzadeh R, 2018, RESOUR CONSERV RECY, V136, P418, DOI 10.1016/j.resconrec.2018.04.024
   Golmohammadzadeh R, 2017, WASTE MANAGE, V64, P244, DOI 10.1016/j.wasman.2017.03.037
   Horeh NB, 2016, J POWER SOURCES, V320, P257, DOI 10.1016/j.jpowsour.2016.04.104
   Innocenti V, 2017, J TAIWAN INST CHEM E, V80, P769, DOI 10.1016/j.jtice.2017.09.019
   Isildar A, 2018, RESOUR CONSERV RECY, V135, P296, DOI 10.1016/j.resconrec.2017.07.031
   Kim JK, 2008, OPT EXPRESS, V16, P21835, DOI 10.1364/OE.16.021835
   Kumar A, 2017, RESOUR CONSERV RECY, V122, P32, DOI 10.1016/j.resconrec.2017.01.018
   Li L, 2015, J POWER SOURCES, V282, P544, DOI 10.1016/j.jpowsour.2015.02.073
   Li L, 2013, J POWER SOURCES, V233, P180, DOI 10.1016/j.jpowsour.2012.12.089
   Li L, 2012, J POWER SOURCES, V218, P21, DOI 10.1016/j.jpowsour.2012.06.068
   Lim SR, 2011, ENVIRON SCI TECHNOL, V45, P320, DOI 10.1021/es101052q
   Poledniok J, 2008, CHEMOSPHERE, V73, P572, DOI 10.1016/j.chemosphere.2008.06.012
   Rahman SMM, 2017, RESOUR CONSERV RECY, V127, P256, DOI 10.1016/j.resconrec.2017.04.013
   Rocchetti L, 2013, ENVIRON SCI TECHNOL, V47, P1581, DOI 10.1021/es302192t
   Ruiz-Mercado GJ, 2017, RESOUR CONSERV RECY, V126, P42, DOI 10.1016/j.resconrec.2017.07.009
   Sun CH, 2018, WASTE MANAGE RES, V36, P113, DOI 10.1177/0734242X17744273
   Sun Z, 2017, ACS SUSTAIN CHEM ENG, V5, P21, DOI 10.1021/acssuschemeng.6b00841
   Swain B, 2015, ENVIRON RES, V138, P401, DOI 10.1016/j.envres.2015.02.027
   Swain B, 2015, J POWER SOURCES, V281, P265, DOI 10.1016/j.jpowsour.2015.01.189
   Tipre DR, 2004, HYDROMETALLURGY, V75, P37, DOI 10.1016/j.hydromet.2004.06.002
   Torres R, 2018, WASTE MANAGE, V71, P420, DOI 10.1016/j.wasman.2017.10.029
   Ueberschaar M, 2017, WASTE MANAGE, V60, P534, DOI 10.1016/j.wasman.2016.12.035
   Van Eygen E, 2016, RESOUR CONSERV RECY, V107, P53, DOI 10.1016/j.resconrec.2015.10.032
   Wang RX, 2014, WASTE MANAGE, V34, P1455, DOI 10.1016/j.wasman.2014.03.004
   Xiang Y, 2010, J HAZARD MATER, V184, P812, DOI 10.1016/j.jhazmat.2010.08.113
   Xu K, 2007, HYDROMETALLURGY, V86, P172, DOI 10.1016/j.hydromet.2006.11.013
   Yazici EY, 2013, HYDROMETALLURGY, V139, P30, DOI 10.1016/j.hydromet.2013.06.018
   Zhan L, 2015, J HAZARD MATER, V299, P388, DOI 10.1016/j.jhazmat.2015.06.029
   Zhu NW, 2011, J HAZARD MATER, V192, P614, DOI 10.1016/j.jhazmat.2011.05.062
NR 38
TC 2
Z9 2
U1 10
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 366
EP 372
DI 10.1016/j.resconrec.2019.04.002
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900035
DA 2020-05-12
ER

PT J
AU Wakiyama, T
   Lenzen, M
   Faturay, F
   Geschke, A
   Malik, A
   Fry, J
   Nansai, K
AF Wakiyama, Takako
   Lenzen, Manfred
   Faturay, Futu
   Geschke, Arne
   Malik, Arunima
   Fry, Jacob
   Nansai, Keisuke
TI Responsibility for food loss from a regional supply-chain perspective
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Food loss; Consumers' responsibility; Multi-regional input output;
   Agricultural crops; Footprint analysis; Supply chain; Field disposal;
   Vegetables
ID INPUT-OUTPUT; WATER FOOTPRINT; CONSTRUCTION; IMPACTS
AB Reducing food waste and food loss generated through the whole food supply chain has, in actuality, become a global requirement. A Sustainable Development Goal (SDG) aims to ensure sustainable consumption and production patterns. The government in a nation strives efforts to reduce the amount of the wasted edible food to achieve the SDG target. This paper examines edible food loss at the stage of vegetable production in Japan. Vegetables are not delivered to a market, but are instead discarded in the field. As described herein, we identify the amount of food loss at the regional level in Japan, and elucidate relations between production and consumption by examining multi-regional trading within Japan. Using a footprint analysis particularly addressing vegetables that are discarded in fields, we identify where food loss occurs and where agricultural products that are discarded in fields are presumed to be delivered and consumed. Clarifying the linkage of the food loss from production sites to intended consumers by prefecture helps farmers to make a crop production and distribution plan and to cooperate with other farmers to reduce annual food losses. Our food loss footprint analysis can provide opportunities for consumers to realize their own responsibilities and to raise awareness about food loss. Furthermore, it identifies environmental burdens by producing the crops discarded in a field. The findings from our analysis can facilitate producer-consumer communication to avoid overproduction and to highlight alternative destinations for overproduced agricultural products to markets with a shortage of agricultural crops.
C1 [Wakiyama, Takako; Lenzen, Manfred; Faturay, Futu; Geschke, Arne; Malik, Arunima; Fry, Jacob; Nansai, Keisuke] Univ Sydney, Sch Phys A28, ISA, Sydney, NSW 2006, Australia.
   [Wakiyama, Takako] IGES, Hayama, Kanagawa, Japan.
   [Malik, Arunima] Univ Sydney, Sydney Business Sch, Discipline Accounting, Sydney, NSW 2006, Australia.
   [Nansai, Keisuke] Natl Inst Environm Studies, Ctr Waste Management & Mat Cycles Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
RP Wakiyama, T (reprint author), Univ Sydney, Sch Phys A28, ISA, Sydney, NSW 2006, Australia.
EM twak0938@uni.sydney.edu.au
RI Nansai, Keisuke/C-2516-2008
OI Fry, Jacob/0000-0002-2349-6745; Malik, Arunima/0000-0002-4630-9869;
   Faturay, Futu/0000-0001-5636-1794; /0000-0002-2449-1874
FU Japan Society for the Promotion of Science (JSPS)Ministry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [JP 16K21703]; Environment Research and
   Technology Development Fund of the Environmental Restoration and
   Conservation Agency of Japan [1-1703, 2-1801]; National eResearch
   Collaboration Tools and Resources project (NeCTAR) through its
   Industrial Ecology Virtual Laboratory [VL201]; Australian Research
   Council (ARC)Australian Research Council [DP0985522, DP130101293,
   LE160100066]
FX This study was financially supported by the Japan Society for the
   Promotion of Science (JSPS) JP 16K21703, by the Environment Research and
   Technology Development Fund (1-1703, 2-1801) of the Environmental
   Restoration and Conservation Agency of Japan, by the National eResearch
   Collaboration Tools and Resources project (NeCTAR) through its
   Industrial Ecology Virtual Laboratory VL201, and by the Australian
   Research Council (ARC) through its Discovery Projects DP0985522 and
   DP130101293, and through IELab infrastructure funding LE160100066.
CR ALIC, 2018, SUPPL DEM DAT POT
   ALIC, 2017, ACT STAB PROD SHIPM
   Australian Government, 2017, NAT FOOD WAST STRAT
   Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1
   Buzby JC, 2012, FOOD POLICY, V37, P561, DOI 10.1016/j.foodpol.2012.06.002
   Campbell BM, 2016, GLOB FOOD SECUR-AGR, V11, P34, DOI 10.1016/j.gfs.2016.06.002
   Clapp J, 2017, FOOD POLICY, V66, P88, DOI 10.1016/j.foodpol.2016.12.001
   Cucek L, 2012, J CLEAN PROD, V34, P9, DOI 10.1016/j.jclepro.2012.02.036
   Dejuan O, 2018, ROUTL EXPLOR ENVIRON, P1
   Dixie G, 2005, HORTICULTURAL MARKET
   Engstrom R, 2004, FOOD POLICY, V29, P203, DOI 10.1016/j.foodpol.2004.03.004
   Field C B, 2012, MANAGING RISKS EXTRE, P1, DOI DOI 10.1017/CB09781139177245
   Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592
   Grunert KG, 2014, FOOD POLICY, V44, P177, DOI 10.1016/j.foodpol.2013.12.001
   Gustaysson J., 2013, METHODOLOGY FAO STUD
   Hagiwara T., 2012, KOBE U EC REV, V58
   Harris Farm, 2018, 15 MILL KIL IMP PICK
   Hasegawa Ryoji, 2011, CASE STUDY, DOI [10.1186/s40008-015-0015-6, DOI 10.1186/S40008-015-0015-6]
   Hitomi K., 2008, Y07035 JPN CENTR RES
   Hobbs J.E., 2000, SUPPLY CHAIN MANAG, V5, P131, DOI DOI 10.1108/13598540010338884
   Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365
   Hokkaido Government, 2018, AGR HOKK JAP
   Johnson LK, 2018, RESOUR CONSERV RECY, V137, P243, DOI 10.1016/j.resconrec.2018.05.017
   Kimura M., 2013, MECH OCCURRENCE FOOD
   Kodera Masaya, 2016, RES PRODUCTION WASTE
   Kronenberg T, 2009, INT REGIONAL SCI REV, V32, P40, DOI 10.1177/0160017608322555
   Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092
   Kurasaka H., 2010, STABLE SUPPLY VEGETA
   LENZEN M, 2004, ECON SYST RES, V16, P391, DOI DOI 10.1080/0953531042000304272
   Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018
   Lenzen M, 2018, NAT CLIM CHANGE, V8, P522, DOI 10.1038/s41558-018-0141-x
   Lenzen M, 2017, ECON SYST RES, V29, P275, DOI 10.1080/09535314.2017.1315331
   Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938
   Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x
   Lenzen Manfred, 2014, COMPILING USING INPU, DOI [10.1016/j.scitotenv.2014.03.062, DOI 10.1016/J.SCITOTENV.2014.03.062]
   Lenzen Manfred, 2013, UNIFYING GLOBAL APPR
   LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294
   Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]
   MAFF, 2015, FRUIT VEG WHOL MARK
   MAFF, 2016, PREF FERT STAND
   MAFF, 2015, SURV VEG PROD
   MAFF, 2007, POSS RESP DIV NEEDS
   MAFF, 2015, SURV LOC SPEC VEG PR
   MAFF, 2007, COMM EM SUPPL DEM AD
   MAFF, 2007, COMM REP EM SUPPL DE
   MAFF, 2015, SURV FRUITS PROD
   Mattsson Kristin, 2014, WHY DO WE THROW AWAY
   Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011
   METI, 2014, STAT CHARTS IND
   MIC, 2015, 2011 INP OUTP TABL
   Miyagi Toshihiko, 2003, DOBOKU KEIKAKU KENKY, V20, P87
   MOE, 2017, US FOOD WAST FY2014
   NIES, 2018, EMB EN EM INT DAT JA
   Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216
   Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767
   Sargento ALM, 2012, ECON SYST RES, V24, P173, DOI 10.1080/09535314.2011.574609
   Seminar K. B., 2016, Journal of Developments in Sustainable Agriculture, V11, P17
   Stat, 2014, EC CENS BUS ACT
   Stat, 2014, POPULATION
   Tamura Yuka, 2015, J KYOTO SEIKA U, V47
   Tobben J, 2015, ECON SYST RES, V27, P487, DOI 10.1080/09535314.2015.1091765
   Tsuruta Hiromi, 2007, RES DEV FOOD MAT UTI
   United Nations, 2015, TRANSF OUR WORLD 203, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2, 10.1007/ s13398-014-0173-7.2]
   Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003
   Wiedmann T, 2018, NAT GEOSCI, V11, P314, DOI 10.1038/s41561-018-0113-9
   Wu WJ, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8060512
   Yamada M., 2015, EC STRUCTURES, V4, P11, DOI [10.1186/s40008-015-0022-7, DOI 10.1186/S40008-015-0022-7]
   Zaks DPM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044010
   Zhang C, 2014, ECOL ECON, V100, P159, DOI 10.1016/j.ecolecon.2014.02.006
NR 69
TC 3
Z9 3
U1 12
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 373
EP 383
DI 10.1016/j.resconrec.2019.04.003
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900036
DA 2020-05-12
ER

PT J
AU Kuo, TC
   Chiu, MC
   Hsu, CW
   Tseng, ML
AF Kuo, Tsai-Chi
   Chiu, Ming-Chuan
   Hsu, Chia-Wei
   Tseng, Ming-Lang
TI Supporting sustainable product service systems: A product selling and
   leasing design model
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Sustainable product service system; Servitization; Life-cycle cost
   analysis; Design for environment; Product selling and leasing model
   design
ID PREVENTIVE-MAINTENANCE; LEASED PRODUCTS; BUSINESS MODEL; DURABLE-GOODS;
   MANAGEMENT; PERFORMANCE; INNOVATION; BEHAVIOR; FOSTER; TAX
AB Prior studies are lacking on a combined product selling and leasing model design and absent on the life cycle cost analysis and the product design model. To address these shortcomings, this study analyzes a leasing model on the profit and cost variables in comparison to a selling model to evaluate a proposed sustainable product-service system. The trade-off is the cost of additional durability and residual value of the product at end of the lease period. To increase the performance of sustainable supply chain management, this study is essential to comply with customer requirements and to align the product design and to track both product design integration and life-cycle cost analysis when developing an analytical model to effectively implement the sustainable product service system. Multiple regression is utilized to screen the variables that influence both product design and the firm's profits. A heat-pump water heater case study is conducted and analyzed using the proposed method to generate product selling and leasing model design suggestions that facilitate sustainable product-service systems servitization with development considerations. The method proposed in this study could be a reference decision making model for different business model based on different decision strategies.
C1 [Kuo, Tsai-Chi] Chung Yuan Christian Univ, Dept Ind & Syst Engn, Taoyuan, Taiwan.
   [Kuo, Tsai-Chi] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan, Taiwan.
   [Chiu, Ming-Chuan] Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu, Taiwan.
   [Hsu, Chia-Wei] Tung Nan Univ, Dept Tourism, New Taipei, Taiwan.
   [Tseng, Ming-Lang] Asia Univ, Inst Innovat & Circular Econ, Taichung, Taiwan.
   [Tseng, Ming-Lang] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.
RP Chiu, MC (reprint author), Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu, Taiwan.
EM tckuo@cycu.edu.tw; mcchiu@ie.nthu.edu.tw; jcwhsu@gmail.com;
   tsengminglang@asia.edu.tw
RI Kuo, Tsai Chi/U-5547-2019; Tseng, Ming Lang/M-9051-2014
OI Kuo, Tsai Chi/0000-0002-4661-5276; Tseng, Ming Lang/0000-0002-2702-3590
FU Ministry of Science Technology of the Republic of China, Taiwan [NSC
   96-2621-Z-033-003-MY3, MOST 106-2221-E-007-073-MY3]
FX This work was supported by the Ministry of Science Technology of the
   Republic of China, Taiwan, under contracts NSC 96-2621-Z-033-003-MY3 and
   MOST 106-2221-E-007-073-MY3, for which the authors are most grateful.
CR Ahmad S, 2018, RESOUR CONSERV RECY, V132, P49, DOI 10.1016/j.resconrec.2018.01.020
   Annarelli A, 2016, J CLEAN PROD, V139, P1011, DOI 10.1016/j.jclepro.2016.08.061
   Aras N, 2011, INT J PROD ECON, V133, P262, DOI 10.1016/j.ijpe.2010.01.024
   Attanasio OP, 2000, REV ECON STUD, V67, P667
   Bell TJ, 2013, ECON LETT, V120, P338, DOI 10.1016/j.econlet.2013.05.005
   Barquet APB, 2013, IND MARKET MANAG, V42, P693, DOI 10.1016/j.indmarman.2013.05.003
   Bhaskaran SR, 2005, MANAGE SCI, V51, P1278, DOI 10.1287/mnsc.1050.0421
   Bhaskaran SR, 2009, MARKET SCI, V28, P918, DOI 10.1287/mksc.1080.0458
   Bras B, 1999, ROBOT CIM-INT MANUF, V15, P167, DOI 10.1016/S0736-5845(99)00021-6
   Chou CJ, 2015, J CLEAN PROD, V86, P277, DOI 10.1016/j.jclepro.2014.08.059
   Chou Y.-W., 2013, STUDY LEASING SERVIC, P86
   Cui L, 2017, J CLEAN PROD, V161, P1308, DOI 10.1016/j.jclepro.2017.03.056
   Darghouth MN, 2017, RELIAB ENG SYST SAFE, V165, P197, DOI 10.1016/j.ress.2017.03.033
   Dress K, 2018, INT J FORECASTING, V34, P551, DOI 10.1016/j.ijforecast.2018.01.008
   Eisfeldt AL, 2009, REV FINANC STUD, V22, P1621, DOI 10.1093/rfs/hhn026
   Geng XL, 2012, EXPERT SYST APPL, V39, P1492, DOI 10.1016/j.eswa.2011.08.038
   GITS CW, 1992, INT J PROD ECON, V24, P217, DOI 10.1016/0925-5273(92)90133-R
   Gremyr I, 2014, J CLEAN PROD, V79, P231, DOI 10.1016/j.jclepro.2014.05.018
   Guo LL, 2017, J CLEAN PROD, V162, P894, DOI 10.1016/j.jclepro.2017.05.210
   Hatcher GD, 2011, J CLEAN PROD, V19, P2004, DOI 10.1016/j.jclepro.2011.06.019
   Hsu CC, 2013, INT J OPER PROD MAN, V33, P656, DOI 10.1108/IJOPM-10-2011-0401
   Ijomah WL, 2007, ROBOT CIM-INT MANUF, V23, P712, DOI 10.1016/j.rcim.2007.02.017
   Iskandar BP, 2017, COMPUT IND ENG, V113, P693, DOI 10.1016/j.cie.2017.09.028
   Kim JC, 2014, INT REV ECON FINANC, V29, P132, DOI 10.1016/j.iref.2013.05.009
   Kuijken B, 2017, IND MARKET MANAG, V60, P33, DOI 10.1016/j.indmarman.2016.04.013
   Kuo TC, 2001, COMPUT IND ENG, V41, P241, DOI 10.1016/S0360-8352(01)00045-6
   Kuo TC, 2000, INT J PROD RES, V38, P993, DOI 10.1080/002075400188988
   Kuo TC, 2013, COMPUT IND ENG, V65, P54, DOI 10.1016/j.cie.2011.12.029
   Kuo TC, 2019, RESOUR CONSERV RECY, V145, P31, DOI 10.1016/j.resconrec.2019.02.005
   Li KJ, 2015, OMEGA-INT J MANAGE S, V54, P134, DOI 10.1016/j.omega.2015.01.018
   Lin C. W. R., 2018, MANAG ENV QUAL INT J, V30, P329
   Liu X, 2014, RENEW ENERG, V66, P770, DOI 10.1016/j.renene.2014.01.026
   Markeset T., 2003, Journal of Quality in Maintenance Engineering, V9, P376, DOI 10.1108/13552510310503231
   Ming-Chuan Chiu, 2011, International Journal of Product Development, V13, P132, DOI 10.1504/IJPD.2011.038869
   Mol JM, 2005, J MANAGE STUD, V42, P251, DOI 10.1111/j.1467-6486.2005.00496.x
   Mont O, 2004, THESIS
   Mont O., 2004, PRODUCT SERVICE SYST
   Mont O, 2006, J CLEAN PROD, V14, P1509, DOI 10.1016/j.jclepro.2006.01.024
   Muto K, 2016, PROC CIRP, V47, P537, DOI 10.1016/j.procir.2016.03.053
   Muto K, 2015, PROC CIRP, V30, P60, DOI 10.1016/j.procir.2015.02.188
   Qu M, 2016, COMPUT IND, V77, P1, DOI 10.1016/j.compind.2015.12.004
   Reim W, 2015, J CLEAN PROD, V97, P61, DOI 10.1016/j.jclepro.2014.07.003
   Roy R, 2000, FUTURES, V32, P289, DOI 10.1016/S0016-3287(99)00098-1
   Salhieh SM, 1999, ROBOT CIM-INT MANUF, V15, P319, DOI 10.1016/S0736-5845(99)00008-3
   Sarkis J, 1998, EUR J OPER RES, V107, P159, DOI 10.1016/S0377-2217(97)00160-4
   Sassanelli C, 2016, PROC CIRP, V47, P192, DOI 10.1016/j.procir.2016.03.233
   Shoda Y., 2011, OVERVIEW JAPANS ENV
   Smith S, 2016, J CLEAN PROD, V139, P729, DOI 10.1016/j.jclepro.2016.08.095
   Smith S, 2010, ROBOT CIM-INT MANUF, V26, P790, DOI 10.1016/j.rcim.2010.05.006
   Song WY, 2017, COMPUT IND, V85, P11, DOI 10.1016/j.compind.2016.11.005
   Steeneck DW, 2018, INT J PROD ECON, V202, P132, DOI 10.1016/j.ijpe.2018.04.025
   Sundin E, 2005, J CLEAN PROD, V13, P913, DOI 10.1016/j.jclepro.2004.04.006
   Swan KS, 2005, J PROD INNOVAT MANAG, V22, P144, DOI 10.1111/j.0737-6782.2005.00111.x
   Tseng ML, 2018, INT J PROD ECON, V203, P414, DOI 10.1016/j.ijpe.2018.07.020
   Tseng ML, 2017, J CLEAN PROD, V142, P727, DOI 10.1016/j.jclepro.2016.05.062
   Tseng ML, 2016, INT J PROD ECON, V181, P257, DOI 10.1016/j.ijpe.2016.09.016
   Tseng ML, 2015, IND MANAGE DATA SYST, V115, P436, DOI 10.1108/IMDS-10-2014-0319
   Tukker A, 2015, J CLEAN PROD, V97, P76, DOI 10.1016/j.jclepro.2013.11.049
   UN Global Compact WBCSD, 2015, SDG 12 ENS SUST CONS
   Vezzoli C, 2015, J CLEAN PROD, V97, P1, DOI 10.1016/j.jclepro.2015.02.061
   Wang PP, 2011, INT J PROD RES, V49, P6863, DOI 10.1080/00207543.2010.535862
   Wu KJ, 2016, IND MANAGE DATA SYST, V116, P777, DOI 10.1108/IMDS-08-2015-0327
   Wu WW, 2010, KNOWL-BASED SYST, V23, P397, DOI 10.1016/j.knosys.2010.01.014
   Xiong Y, 2012, EUR J OPER RES, V217, P75, DOI 10.1016/j.ejor.2011.08.012
   Yeh RH, 2011, EXPERT SYST APPL, V38, P3558, DOI 10.1016/j.eswa.2010.08.144
   Zhang D, 1995, MANUF SCI ENG, P2
NR 66
TC 1
Z9 1
U1 16
U2 29
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 384
EP 394
DI 10.1016/j.resconrec.2019.04.007
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900037
DA 2020-05-12
ER

PT J
AU Montemayor, E
   Bonmati, A
   Torrellas, M
   Camps, F
   Ortiz, C
   Domingo, F
   Riau, V
   Anton, A
AF Montemayor, Erica
   Bonmati, August
   Torrellas, Marta
   Camps, Francesc
   Ortiz, Carlos
   Domingo, Francesc
   Riau, Victor
   Anton, Assumpci
TI Environmental accounting of closed-loop maize production scenarios:
   Manure as fertilizer and inclusion of catch crops
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Life cycle assessment (LCA); Maize; Catch crop rotation; Manure
   fertilization; Emissions; Anaerobic co-digestion
ID LIFE-CYCLE ASSESSMENT; CROPPING SYSTEMS; PERFORMANCE; MANAGEMENT;
   SLURRY; SOIL
AB The agri-food sector has moved towards a more linear production economy, partly caused by worldwide food demand. One clear example is the intensification of livestock production, with consequent manure-management and feed-production challenges, the effects of which have led to large environmental problems. Currently, efforts are being made to move the agricultural sector towards closed-loop alternatives. To ensure high environmental performance of these alternatives, realistic quantification of environmental impacts is needed. Thus, using Life Cycle Assessment (LCA) tools, we analyzed the environmental profile of six closed-loop maize scenarios focusing on different combinations of mineral fertilizer, digested organic fertilizer (digestate) from a manure co-digestion biogas plant, and rotation with (or without) catch crops (CCs) as a strategy to prevent nitrate leaching to groundwater and as a co-substrate in the biogas plant.
   Results demonstrated that replacing a large portion of the mineral fertilizers with digestate could help offset much of the total potential impact of global warming (by 25-35 %), resource depletion (by 94-96%), photochemical ozone formation (by 17-22 %), ozone depletion (by 96-99%) or even avoid it entirely as in freshwater eutrophication. However, digestate production and application contributed greatly to acidification (51%) and particulate matter (51-52%) categories, with minor differences depending on the species of CC used. An optimal combination of both digestate and mineral fertilizers is recommended. The incorporation of CCs in a maize rotation can reduce freshwater eutrophication impacts but increase global warming potential. Conclusions were drawn suggesting better management strategies to decrease environmental impacts of maize production.
C1 [Montemayor, Erica; Bonmati, August; Torrellas, Marta; Riau, Victor; Anton, Assumpci] Inst Res & Technol Food & Agr IRTA, Barcelona 08140, Spain.
   [Camps, Francesc; Domingo, Francesc] Fundacio Mas Badia, La Tallada Demporda 17134, Girona, Spain.
   [Domingo, Francesc] Dept Agr Ramaderia Pesca & Alimentacio, 191 Rovira Roure, E-25198 Lleida, Spain.
RP Montemayor, E; Anton, A (reprint author), Inst Res & Technol Food & Agr IRTA, Barcelona 08140, Spain.
EM erica.montemayor@irta.cat
RI Riau, Victor/K-1005-2016; Bonmati, August/G-2764-2015
OI Riau, Victor/0000-0001-8466-5381; Bonmati, August/0000-0002-1848-6438;
   Montemayor, Erica/0000-0003-4619-8457
FU European Commission's Life<SUP>+</SUP> Program [LIFE12 ENV/ES/000647];
   CERCA Programme/Generalitat de Catalunya
FX This work forms a part of the Futur Agrari research project, "Farms for
   the future: Innovation for sustainable manure management from farm to
   soil" (LIFE12 ENV/ES/000647), co-funded by the European Commission's
   Life<SUP>+</SUP> Program. The authors would like to thank the "CERCA
   Programme/Generalitat de Catalunya" for their support, and the editor,
   and reviewers for their valuable suggestions to improve this article.
CR ACA Catalan Water Agency, 2016, TECHN REP EV PROBL C
   ANFFE, 2017, NAT ASS FERT MAN SEC
   [Anonymous], CALC DELS CONST UT M
   [Anonymous], 2006, 14040 ISO
   Bacenetti J, 2016, EUR J AGRON, V79, P107, DOI 10.1016/j.eja.2016.05.015
   Bittman S., 2014, OPTIONS AMMONIA MITI
   Bjornsson L., 2013, IMPACT BIOGAS ENERGY
   Bockstaller C, 2009, AGRON SUSTAIN DEV, V29, P223, DOI 10.1051/agro:2008058
   Bos U., 2016, LANCA CHARACTERISATI
   Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002
   Christian T, 2003, ACTA HYDROCH HYDROB, V31, P36, DOI 10.1002/aheh.200390014
   Client Earth, 2013, RED PART MATT EM DIE
   EC-JRC, 2010, INT REF LIF CYCL DAT
   EC-JRC, 2012, 25167 ECJRC EUR PUBL
   EEA, 2013, 122013 EEA
   Ekvall T, 1997, INT J LIFE CYCLE ASS, V2, P155, DOI 10.1007/BF02978810
   Futur agrari, 2018, FARMS FUT LIFE 12 EN
   Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000
   Gomes R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005078
   IPCC, 2006, AGR FOR OTH LAND US, V2
   IPCC, 2006, GUID NAT GREENH GAS
   Janulevicius A, 2013, ENERG CONVERS MANAGE, V75, P498, DOI 10.1016/j.enconman.2013.06.052
   Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7
   Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004
   Koch P., 2016, AGRIBALYSE RAPPORT M, P262
   Lebacq T, 2013, AGRON SUSTAIN DEV, V33, P311, DOI 10.1007/s13593-012-0121-x
   LIFE ES-WAMAR, 2011, LIFE06ENVE000044ESWA
   Lijo L, 2014, RENEW ENERG, V68, P625, DOI 10.1016/j.renene.2014.03.005
   MAGRAMA Ministry of agriculture food and environment, 2008, CALC COSTS US IMPL A
   McDonough W., 2002, CRADLE CRADLE REMAKI
   Nemecek T., 2007, LIFE CYCLE INVENTORI, V2.0
   Nemecek T, 2014, METHODOLOGICAL GUIDE
   Nkoa R, 2014, AGRON SUSTAIN DEV, V34, P473, DOI 10.1007/s13593-013-0196-z
   Oberholzer HR, 2012, AGRON SUSTAIN DEV, V32, P639, DOI 10.1007/s13593-011-0072-7
   Prashun V., 2006, SALCA PHOSPHOR ERFAS
   Pre Consultants, 2017, SIMAPRO 8 5 2 0
   Prechsl UE, 2017, AGR SYST, V157, P39, DOI 10.1016/j.agsy.2017.06.011
   Rinaldi M., 2002, 577 FAT SWISS FED RE
   Robledo de Pedro F., 1981, APPL PLASTICS AGR ED, V37
   SAEFL, 2000, SAEFL HDB OFFR DAT
   Sogaard HT, 2002, ATMOS ENVIRON, V36, P3309, DOI 10.1016/S1352-2310(02)00300-X
   Tidaker P, 2014, AGR SYST, V129, P133, DOI 10.1016/j.agsy.2014.05.015
   Torrellas M, 2018, ATMOS ENVIRON, V177, P203, DOI 10.1016/j.atmosenv.2018.01.023
   Wernet G, 2016, INT J LIFE CYCLE ASS, V21, P1218, DOI 10.1007/s11367-016-1087-8
   Wilke B., 1996, Mitteilungen der Deutschen Bodenkundlichen Gesellschaft, V79, P435
NR 45
TC 1
Z9 1
U1 11
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 395
EP 404
DI 10.1016/j.resconrec.2019.03.013
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900038
DA 2020-05-12
ER

PT J
AU Song, XG
   Zhou, YX
   Jia, W
AF Song, Xuguang
   Zhou, Yuanxiang
   Jia, Wei
TI How do Economic Openness and R&D Investment Affect Green Economic
   Growth?-Evidence from China
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE economic growth; Economic openness; Research and development investment;
   Heterogeneous areas
ID CO2 EMISSIONS; TRADE; TECHNOLOGY; SYSTEM
AB The increased concern on green economic growth has facilitated the shift of many countries from simply pursuing economic growth to a green economy growth mode for the protection of resources and the environment. Under this background, we calculate China's green GDP and its growth rate and study the impact of economic openness and R&D investment on green economic growth. We apply the established open economic endogenous growth model to the green economic growth and China's provincial panel data to test the relationship among three factors. Results show that economic openness and green economic growth have a nonlinear negative U-shaped relationship. Although R&D investment scale is not conducive to green economic growth in the short term, it has a positive impact on green economic growth. We also need to pay attention to the increased pollution caused by economic openness in heterogeneous areas in China. The impact of economic openness on green economic growth has different performance: insignificant (eastern region), positive U-shaped (central region), and negative U-shaped (western region). The impact of R&D scale on green economic growth is positive for a long time, but the impact is negative in the eastern and western regions in the current period. Therefore, economic openness and R&D investment must be increased while focusing on coordinating regional development to achieve green economic growth.
C1 [Song, Xuguang; Zhou, Yuanxiang; Jia, Wei] Beijing Normal Univ, Sch Stat, Beijing 100875, Peoples R China.
RP Jia, W (reprint author), Beijing Normal Univ, Sch Stat, Beijing 100875, Peoples R China.
EM jiaweibnu@mail.bnu.edu.cn
FU Humanity and Social Sciences Foundation of the Ministry of Education in
   China [17YJA910001]
FX Xuguang Song thanks the support of the Humanity and Social Sciences
   Foundation of the Ministry of Education in China (17YJA910001).
CR Acemoglu D, 2012, AM ECON REV, V102, P131, DOI 10.1257/aer.102.1.131
   Andrea M. B., 2012, MEASURING PROGR INCL
   Bao Q., 2008, J WORLD EC, P3, DOI [10.3969/j.issn.1002-9621.2008.09.001, DOI 10.3969/J.ISSN.1002-9621.2008.09.001]
   Dinda Soumyananda, 2014, International Journal of Green Economics, V8, P177, DOI 10.1504/IJGE.2014.065851
   Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379
   GGGI, 2013, MOV COMM APPR GREEN
   Grimaud A, 2003, J ENVIRON ECON MANAG, V45, P433, DOI 10.1016/S0095-0696(02)00049-9
   Grover RB, 2013, ENERGY STRATEG REV, V1, P255, DOI 10.1016/j.esr.2012.12.010
   Guo LL, 2018, RESOUR CONSERV RECY, V128, P143, DOI 10.1016/j.resconrec.2016.09.035
   Hallegatte S., 2012, GROWTH GREEN GROWTH
   Hart R, 2008, J ENVIRON ECON MANAG, V55, P194, DOI 10.1016/j.jeem.2007.06.004
   Jacobs M., 2012, GREEN GROWTH EC THEO
   James D. E., 1978, EC APPROACHES ENV PR
   Jin Y., 2014, AREAL RES DEV, V33, P131, DOI [10.3969/j.issn.1003-2363.2014.04.024, DOI 10.3969/J.ISSN.1003-2363.2014.04.024]
   JONES CI, 1995, J POLIT ECON, V103, P759, DOI 10.1086/262002
   Jouvet PA, 2013, INT EC, V134, P29, DOI DOI 10.1016/J.INTEC0.2013.05.003
   Kim SE, 2014, FUTURES, V63, P37, DOI 10.1016/j.futures.2014.08.002
   Lai MY, 2006, CHINA ECON REV, V17, P300, DOI 10.1016/j.chieco.2006.04.005
   Li J, 2018, EC RES J, V9, P151
   Li N, 2017, RESOUR CONSERV RECY, V121, P11, DOI 10.1016/j.resconrec.2016.03.016
   Lorek S, 2014, J CLEAN PROD, V63, P33, DOI 10.1016/j.jclepro.2013.08.045
   Martinelli A, 2010, CORP GOV-INT J BUS S, V10, P6, DOI 10.1108/14720701011021076
   Menyah K, 2014, ECON MODEL, V37, P386, DOI 10.1016/j.econmod.2013.11.044
   Noguer M, 2005, J INT ECON, V65, P447, DOI 10.1016/j.jinteco.2003.11.006
   OECD, 2010, INT REP GREEN GROWTH
   OECD, 2017, GREEN GROWTH IND 201, DOI [10.1787/9789264268586-en, DOI 10.1787/9789264268586-EN]
   OECD, 2014, GREEN GROWTH IND 201, DOI [10.1787/9789264202030-en, DOI 10.1787/9789264202030-EN]
   Organisation for Economic Cooperation and Development (OECD), 2011, GREEN GROWTH MON PRO
   Padilla-Perez R, 2014, RES POLICY, V43, P749, DOI 10.1016/j.respol.2013.10.011
   Pan W, 2019, J CLEAN PROD, V209, P680, DOI 10.1016/j.jclepro.2018.10.267
   Pang Z. Q, 2008, J STAT RES IRAN, V25, P47, DOI [10.3969/j.issn.1002-4565.2008.01.011, DOI 10.3969/J.ISSN.1002-4565.2008.01.011]
   Papageorgiou C, 2002, ECON LETT, V77, P85, DOI 10.1016/S0165-1765(02)00114-3
   Pearce D.W., 1989, BLUEPRINT GREEN EC
   Quaas MF, 2018, ENVIRON RESOUR ECON, V71, P529, DOI 10.1007/s10640-017-0172-1
   Ramsey FP, 1928, ECON J, V38, P543, DOI 10.2307/2224098
   Reilly JM, 2012, ENERG ECON, V34, pS85, DOI 10.1016/j.eneco.2012.08.033
   Rozkrut D., 2014, FOLIA OECONOMICA STE, V14, P137, DOI DOI 10.2478/F0LI-2014-0110
   Song ML, 2018, EUR J OPER RES, V269, P51, DOI 10.1016/j.ejor.2017.03.073
   Stokey NL, 1998, INT ECON REV, V39, P1, DOI 10.2307/2527228
   Talberth J, 2006, ECOL ECON, V58, P743, DOI 10.1016/j.ecolecon.2005.09.002
   van der Ploeg R, 2013, ENVIRON INNOV SOC TR, V6, P116, DOI 10.1016/j.eist.2012.11.003
   [王金南 WANG Jinnan], 2006, [中国人口·资源与环境, China Population·Resources and Environment], V16, P11
   Yi HT, 2015, GLOBAL ENVIRON CHANG, V31, P11, DOI 10.1016/j.gloenvcha.2014.12.001
   Zeng M, 2013, RENEW SUST ENERG REV, V20, P36, DOI 10.1016/j.rser.2012.11.048
   Zsyman J., 2012, INTERECONOMICS, V47, P140, DOI DOI 10.1007/s10272-012-0415-x
NR 45
TC 7
Z9 7
U1 12
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 405
EP 415
DI 10.1016/j.resconrec.2019.03.050
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900039
DA 2020-05-12
ER

PT J
AU Miller, SA
   Cunningham, PR
   Harvey, JT
AF Miller, Sabbie A.
   Cunningham, Patrick R.
   Harvey, John T.
TI Rice-based ash in concrete: A review of past work and potential
   environmental sustainability
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Review
DE Rice hull ash; Rice straw ash; Biomass ash; Pozzolans; Concrete;
   Supplementary cementitious materials
ID HUSK ASH; STRENGTH DEVELOPMENT; COMPRESSIVE STRENGTH;
   MECHANICAL-BEHAVIOR; CEMENT REPLACEMENT; SILICA FUME; RHA; COMBUSTION;
   DURABILITY; STRAW
AB The demand for concrete continues to grow with increases in population and increased urbanization. This demand, in turn, increases the need to reduce the environmental impacts of concrete while continuing to provide the same or better performance. Increasing population also creates growing demand for food and energy resources. The cultivation of rice, the staple food of over half the world's inhabitants, results in the production of additional biomass. Rice biomass, such as hulls and straw, can be combusted as a renewable energy source and, under specific combustion conditions, the resulting ash can be used as a supplementary cementitious material or beneficial filler in the production of concrete, which can potentially lead to reduced environmental impacts in concrete.
   This paper reviews rice-based ash and its influence on concrete properties to address current understanding of these ashes as an alternative mineral admixture. The review of the literature shows that under proper combustion conditions as well as through use of pre- and post-combustion treatments, highly pozzolanic (reactive) ash can be produced from rice hulls. These reactive ashes have the ability to improve several properties of concrete when used as a partial replacement for cement. Additionally, the production of rice-based ash can offer a lower greenhouse gas emitting pozzolan than portland cement and some conventional supplementary cementitious materials. Further research into the utilization of rice-straw ash, durability properties, and high performance concrete could lead to the production of rice ash as a cost- and environmentally-competitive alternative in the production of concrete.
C1 [Miller, Sabbie A.; Cunningham, Patrick R.; Harvey, John T.] Univ Calif Davis, Dept Civil & Environm Engn, 2001 Ghausi Hall,One Shields Ave, Davis, CA 95616 USA.
   [Harvey, John T.] Univ Calif Davis, UC Pavement Res Ctr, 3301 Apiary Dr,One Shields Ave, Davis, CA 95616 USA.
RP Miller, SA (reprint author), Univ Calif Davis, Dept Civil & Environm Engn, 2001 Ghausi Hall,One Shields Ave, Davis, CA 95616 USA.
EM sabmil@ucdavis.edu
FU California Rice Research Board [CARRB RU-14]
FX The authors would like to thank Bryan Jenkins, Alissa Kendall, and Peter
   Thy, at the University of California Davis, and Zachary McCaffery, at
   the Western Regional Center of the United States Department of
   Agriculture, for their insights and conversations. This work was
   supported by the California Rice Research Board grant number CARRB
   RU-14. This work represents the views of the authors, not necessarily
   those of the sponsor.
CR Abu Bakar R, 2016, PROCEDIA CHEM, V19, P189, DOI 10.1016/j.proche.2016.03.092
   Alex J, 2016, CONSTR BUILD MATER, V127, P353, DOI 10.1016/j.conbuildmat.2016.09.150
   Ambedkar B, 2017, CONSTR BUILD MATER, V148, P167, DOI 10.1016/j.conbuildmat.2017.05.022
   [Anonymous], 2018, TECHN ROADM LOW CARB
   Antiohos SK, 2014, CEMENT CONCRETE RES, V61-62, P20, DOI 10.1016/j.cemconres.2014.04.001
   Antiohos SK, 2013, CONSTR BUILD MATER, V49, P455, DOI 10.1016/j.conbuildmat.2013.08.046
   Aprianti E, 2015, CONSTR BUILD MATER, V74, P176, DOI 10.1016/j.conbuildmat.2014.10.010
   Arel HS, 2018, ACI MATER J, V115, P55, DOI 10.14359/51700991
   Bakker RR, 2002, ENERG FUEL, V16, P356, DOI 10.1021/ef010197w
   BEA, 2018, REG DAT GROSS DOM PR
   Bie RS, 2015, CEMENT CONCRETE COMP, V55, P162, DOI 10.1016/j.cemconcomp.2014.09.008
   Binod P, 2010, BIORESOURCE TECHNOL, V101, P4767, DOI 10.1016/j.biortech.2009.10.079
   BOATENG AA, 1990, CEMENT CONCRETE RES, V20, P795, DOI 10.1016/0008-8846(90)90013-N
   Brodt S, 2014, FIELD CROP RES, V169, P89, DOI 10.1016/j.fcr.2014.09.007
   Caltrans, 2016, FLY ASH CURR FUT SUP
   CARB, 2017, CAL GREENH GAS EM IN
   Chao-Lung H, 2011, CONSTR BUILD MATER, V25, P3768, DOI 10.1016/j.conbuildmat.2011.04.009
   Coutinho JS, 2003, CEMENT CONCRETE COMP, V25, P51
   de Sensale GR, 2008, CEMENT CONCRETE COMP, V30, P892, DOI 10.1016/j.cemconcomp.2008.06.014
   de Sensale GR, 2006, CEMENT CONCRETE COMP, V28, P158, DOI 10.1016/j.cemconcomp.2005.09.005
   Esteves TC, 2012, CONSTR BUILD MATER, V26, P687, DOI 10.1016/j.conbuildmat.2011.06.075
   Fernandes IJ, 2016, FUEL, V165, P351, DOI 10.1016/j.fuel.2015.10.086
   Ferraro C. C, 2017, EVALUATION ALTERNATI
   FHWA, 2012, US GUID WAST BYPR MA
   Gastaldini ALG, 2014, CONSTR BUILD MATER, V54, P369, DOI 10.1016/j.conbuildmat.2013.12.044
   Givi AN, 2010, CONSTR BUILD MATER, V24, P2145, DOI 10.1016/j.conbuildmat.2010.04.045
   Gowda MR, 2011, J MATER CIVIL ENG, V23, P526, DOI 10.1061/(ASCE)MT.1943-5533.0000202
   Gursel AP, 2016, J CLEAN PROD, V112, P823, DOI 10.1016/j.jclepro.2015.06.029
   Le HT, 2015, CONSTR BUILD MATER, V80, P225, DOI 10.1016/j.conbuildmat.2015.01.079
   Habeeb GA, 2009, AUST J BASIC APPL SC, V3, P1616, DOI DOI 10.22587/AJBAS.2017.11.13.2
   HAMAD MA, 1981, THERMOCHIM ACTA, V48, P343, DOI 10.1016/0040-6031(81)80255-9
   Harish KV, 2010, TRANSPORT RES REC, P26, DOI 10.3141/2164-04
   Hasparyk NP, 2000, ACI MATER J, V97, P486
   He ZH, 2017, CEMENT CONCRETE COMP, V80, P190, DOI 10.1016/j.cemconcomp.2017.03.014
   Huang HH, 2017, CONSTR BUILD MATER, V149, P621, DOI 10.1016/j.conbuildmat.2017.05.155
   [International Energy Agency (IEA) www.iea.org/publications/freepublications/publication/WEO2015SpecialReportonEnergyandClimateChange.pdf], 2015, EN CLIM CHANG
   International Energy Agency (IEA), 2015, KEY WORLD EN STAT
   Jamil M, 2013, CONSTR BUILD MATER, V47, P588, DOI 10.1016/j.conbuildmat.2013.05.088
   Jenkins BM, 1998, FUEL PROCESS TECHNOL, V54, P17, DOI 10.1016/S0378-3820(97)00059-3
   Khan R, 2012, CONSTR BUILD MATER, V30, P360, DOI 10.1016/j.conbuildmat.2011.11.028
   Khan W, 2018, CONSTR BUILD MATER, V176, P89, DOI 10.1016/j.conbuildmat.2018.04.213
   Liu HP, 2013, BIOMASS BIOENERG, V49, P22, DOI 10.1016/j.biombioe.2012.12.024
   Mahmud HB, 2005, ACI, P189
   Matalkah F, 2016, CONSTR BUILD MATER, V121, P491, DOI 10.1016/j.conbuildmat.2016.06.023
   Mehta P.K., 2006, CONCRETE MICROSTRUCT
   MEHTA PK, 1995, AMER CONC I, V154, P531
   MEHTA PK, 1977, J AM CONCRETE I, V74, P440
   MEHTA PK, 1978, J AM CONCRETE I, V75, P60
   Moraes CAM, 2010, RESOUR CONSERV RECY, V54, P1170, DOI 10.1016/j.resconrec.2010.03.012
   Miller SA, 2018, NAT SUSTAIN, V1, P69, DOI 10.1038/s41893-017-0009-5
   Miller SA, 2018, CEMENT CONCRETE RES, V114, P115, DOI 10.1016/j.cemconres.2017.08.026
   Miller SA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074029
   Monteiro PJM, 2017, NAT MATER, V16, P698, DOI 10.1038/nmat4930
   Munshi Surajit, 2013, International Journal of Engineering and Technology, V5, P603, DOI 10.7763/IJET.2013.V5.626
   Nair DG, 2008, CEMENT CONCRETE RES, V38, P861, DOI 10.1016/j.cemconres.2007.10.004
   National Geographic Education Staff, 2014, STAPL FOOD CROPS WOR
   Nguyen V. T, 2010, INT RILEM C US SUP P
   Hung NV, 2018, RENEW ENERG, V115, P969, DOI 10.1016/j.renene.2017.09.012
   Tuan NV, 2011, CEMENT CONCRETE RES, V41, P1104, DOI 10.1016/j.cemconres.2011.06.009
   Park KB, 2016, CONSTR BUILD MATER, V105, P196, DOI 10.1016/j.conbuildmat.2015.12.086
   Parvez AM, 2016, ENERGY, V94, P579, DOI 10.1016/j.energy.2015.11.022
   Patel YJ, 2018, CONSTR BUILD MATER, V171, P654, DOI 10.1016/j.conbuildmat.2018.03.166
   Prasara-A J, 2017, J CLEAN PROD, V167, P1020, DOI 10.1016/j.jclepro.2016.11.042
   Prasara-A J, 2011, INT J LIFE CYCLE ASS, V16, P493, DOI 10.1007/s11367-011-0293-7
   Prasittisopin L, 2017, ADV CIV ENG MATER, V6, P17, DOI 10.1520/ACEM20160001
   Provis JL, 2018, CEMENT CONCRETE RES, V114, P40, DOI 10.1016/j.cemconres.2017.02.009
   Rajamma R, 2009, J HAZARD MATER, V172, P1049, DOI 10.1016/j.jhazmat.2009.07.109
   Ramezanianpour AA, 2011, CONSTR BUILD MATER, V25, P2472, DOI 10.1016/j.conbuildmat.2010.11.069
   Rego JHS, 2015, CONSTR BUILD MATER, V80, P56, DOI 10.1016/j.conbuildmat.2014.12.059
   de Sensale GR, 2018, CONSTR BUILD MATER, V166, P873, DOI 10.1016/j.conbuildmat.2018.01.113
   de Sensale GR, 2010, CEMENT CONCRETE COMP, V32, P718, DOI 10.1016/j.cemconcomp.2010.07.008
   Rosello J, 2017, IND CROP PROD, V103, P39, DOI 10.1016/j.indcrop.2017.03.030
   Rozenberg J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095006
   Salas A, 2009, CEMENT CONCRETE RES, V39, P773, DOI 10.1016/j.cemconres.2009.05.006
   Sandhu RK, 2017, CONSTR BUILD MATER, V153, P751, DOI 10.1016/j.conbuildmat.2017.07.165
   Santos S, 1999, ACI SPEC PUBL, V186, P715
   Scrivener K.L., 2017, ECOEFFICIENT CEMENTS
   Shafie SM, 2012, ENRGY PROCED, V14, P499, DOI 10.1016/j.egypro.2011.12.965
   Shatat MR, 2016, ARAB J CHEM, V9, pS1869, DOI 10.1016/j.arabjc.2013.12.006
   Shen YF, 2017, RENEW SUST ENERG REV, V80, P453, DOI 10.1016/j.rser.2017.05.115
   Silalertruksa T, 2013, APPL ENERG, V112, P560, DOI 10.1016/j.apenergy.2013.06.028
   Soltani N, 2015, CHEM ENG J, V264, P899, DOI 10.1016/j.cej.2014.11.056
   Stein B, 2015, WORLD COAL ASH WOCA
   Sugita S, 1999, ACISP1722, V172, P29
   Taylor P.C., 2007, INTEGRATED MAT CONST
   Thomas M., 2007, OPTIMIZING USE FLY A
   Thy P, 2006, FUEL PROCESS TECHNOL, V87, P383, DOI 10.1016/j.fuproc.2005.08.015
   Thy P, 2005, ENERG FUEL, V19, P2571, DOI 10.1021/ef050042e
   Thy P, 2013, ENERG FUEL, V27, P3969, DOI 10.1021/ef400660u
   USEPA, 2017, US GREENH GAS INV RE
   van Oss H. G, 2018, MINERALS YB CEMENT 2
   Venkatanarayanan HK, 2015, CEMENT CONCRETE COMP, V55, P348, DOI 10.1016/j.cemconcomp.2014.09.021
   Vigneshwari M, 2018, J CLEAN PROD, V188, P264, DOI 10.1016/j.jclepro.2018.04.008
   Villaquiran-Caicedo MA, 2015, APPL CLAY SCI, V118, P276, DOI 10.1016/j.clay.2015.10.005
   WBCSD IEA Cement Technology Roadmap, 2009, CEM TECHN ROADM 2009
   Xu WT, 2015, CONSTR BUILD MATER, V89, P90, DOI 10.1016/j.conbuildmat.2015.04.030
   Xu WT, 2012, CONSTR BUILD MATER, V29, P541, DOI 10.1016/j.conbuildmat.2011.11.005
   Yi ST, 2006, NUCL ENG DES, V236, P115, DOI 10.1016/j.nucengdes.2005.08.004
   Yin K, 2018, WASTE MANAGE, V78, P401, DOI 10.1016/j.wasman.2018.06.012
   Zain MFM, 2011, CONSTR BUILD MATER, V25, P798, DOI 10.1016/j.conbuildmat.2010.07.003
   Zareei Seyed Alireza, 2017, Case Studies in Construction Materials, V7, P73, DOI 10.1016/j.cscm.2017.05.001
   Zerbino R, 2012, CONSTR BUILD MATER, V36, P796, DOI 10.1016/j.conbuildmat.2012.04.049
   Zunino F, 2017, CONSTR BUILD MATER, V149, P869, DOI 10.1016/j.conbuildmat.2017.05.187
NR 103
TC 0
Z9 0
U1 4
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 416
EP 430
DI 10.1016/j.resconrec.2019.03.041
PG 15
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900040
DA 2020-05-12
ER

PT J
AU Jiang, MH
   An, HZ
   Gao, XY
   Liu, SY
   Xi, X
AF Jiang, Meihui
   An, Haizhong
   Gao, Xiangyun
   Liu, Siyao
   Xi, Xian
TI Factors driving global carbon emissions: A complex network perspective
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Carbon emissions; Factors; Multi-regional input-output analysis; Complex
   network; Panel regression analysis
ID INPUT-OUTPUT-ANALYSIS; STRUCTURAL DECOMPOSITION ANALYSIS; CHINA-US
   TRADE; CO2 EMISSIONS; INTERNATIONAL-TRADE; INDUSTRIAL SECTORS;
   CLIMATE-CHANGE; ENERGY; EVOLUTION; FLOW
AB Carbon emission is one of the most important topics in the environmental and economic issues. Although previous studies have largely revealed the drivers of carbon emissions, there is still a big challenge to uncover the impacts of the positions of countries in the global supply chains. This paper combined multi-regional input-output analysis, complex network and panel regression analysis to quantify the influence of the roles of countries in the global carbon emissions embodied in trade (EET) transfer networks on their direct carbon emissions. The results showed the network structures had significant evolutionary characteristics. Countries played different roles in the embodied carbon emission transfers, and their roles changed over time. Furthermore, we found the direct carbon emissions of countries were significantly determined by some roles in the networks, including import universality, import strength, media capability and the importance of transfer partners. Our work demonstrated the import of embodied carbon emissions significantly decreased countries' direct carbon emissions. For the global emission reduction, these important importing countries should reduce their domestic consumptions, and take the responsibility to help their import sources reduce the environmental pressure. It also indicated developing the trade relations with some important countries would help reduce the unnecessary carbon emissions in the domestic productions. Moreover, our work indicated reducing carbon emissions should consider both direct and indirect influence from the entire supply chains. One country's carbon emission reduction would need the improvement of the trade structures of all the direct and indirect importer and exporters in the same supply chain.
C1 [Jiang, Meihui; An, Haizhong; Gao, Xiangyun; Liu, Siyao; Xi, Xian] China Univ Geosci, Sch Econ & Management, Beijing 100083, Peoples R China.
   [Jiang, Meihui; An, Haizhong; Gao, Xiangyun; Liu, Siyao; Xi, Xian] Minist Nat Resources, Key Lab Carrying Capac Assessment Resource & Envi, Beijing 100083, Peoples R China.
RP An, HZ (reprint author), China Univ Geosci, Sch Econ & Management, Beijing 100083, Peoples R China.
EM ahz369@163.com
RI ; Gao, Xiangyun/R-6133-2016
OI An, Haizhong/0000-0002-6141-5619; Gao, Xiangyun/0000-0003-2101-1609
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [41871202,71771022]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities [292018252, 265208247]; Beijing Natural Science
   FoundationBeijing Natural Science Foundation [9174041]; Humanities and
   Social Sciences planning funds project under the Ministry of Education
   of the PRC [17YJCZH047]
FX This research is supported by grants from the National Natural Science
   Foundation of China (Grant No.41871202,71771022), the Fundamental
   Research Funds for the Central Universities (Grant No. 292018252,
   265208247), Beijing Natural Science Foundation (Grant No. 9174041)and
   the Humanities and Social Sciences planning funds project under the
   Ministry of Education of the PRC (Grant No. 17YJCZH047).
CR An F, 2016, PHYSICA A, V447, P276, DOI 10.1016/j.physa.2015.12.050
   Arto I, 2014, ENVIRON SCI TECHNOL, V48, P5388, DOI 10.1021/es5005347
   Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249
   Cerina F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134025
   Chang N., 2016, ECON SYST RES, V28, P1, DOI DOI 10.1080/09535314.2016.1172476
   Chen B, 2018, APPL ENERG, V210, P98, DOI 10.1016/j.apenergy.2017.10.113
   Chen GQ, 2013, COMMUN NONLINEAR SCI, V18, P2493, DOI 10.1016/j.cnsns.2012.12.029
   Chen GQ, 2010, COMMUN NONLINEAR SCI, V15, P3647, DOI 10.1016/j.cnsns.2009.12.024
   Chen WQ, 2016, ENVIRON SCI TECHNOL, V50, P3905, DOI 10.1021/acs.est.5b05095
   Chen WD, 2017, RESOUR CONSERV RECY, V117, P264, DOI 10.1016/j.resconrec.2016.10.008
   Chen ZM, 2011, ENERG POLICY, V39, P2899, DOI 10.1016/j.enpol.2011.02.068
   Deng GY, 2017, ENERGY, V137, P140, DOI 10.1016/j.energy.2017.07.064
   Du HB, 2011, ENERG POLICY, V39, P5980, DOI 10.1016/j.enpol.2011.06.060
   Du Q, 2018, ENVIRON SCI POLLUT R, V25, P24469, DOI 10.1007/s11356-018-2533-x
   Du RJ, 2017, APPL ENERG, V196, P142, DOI 10.1016/j.apenergy.2016.12.042
   Duan CC, 2018, APPL ENERG, V227, P342, DOI 10.1016/j.apenergy.2018.01.028
   Duan YW, 2018, J CLEAN PROD, V194, P499, DOI 10.1016/j.jclepro.2018.05.133
   Feng KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8714
   Forkel M, 2016, SCIENCE, V351, P696, DOI 10.1126/science.aac4971
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gao CX, 2018, APPL ENERG, V215, P792, DOI 10.1016/j.apenergy.2018.02.075
   Gao XY, 2017, APPL ENERG, V192, P201, DOI 10.1016/j.apenergy.2017.02.014
   Ge JP, 2016, RESOUR POLICY, V50, P119, DOI 10.1016/j.resourpol.2016.09.002
   Guan J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197575
   Islam M, 2016, J IND ECOL, V20, P494, DOI 10.1111/jiec.12455
   Jiang M., 2018, RESOUR POLICY
   Jiang MH, 2019, J CLEAN PROD, V208, P426, DOI 10.1016/j.jclepro.2018.10.127
   Jiborn M, 2018, GLOBAL ENVIRON CHANG, V49, P27, DOI 10.1016/j.gloenvcha.2017.12.006
   Kagawa S, 2015, GLOBAL ENVIRON CHANG, V35, P486, DOI 10.1016/j.gloenvcha.2015.04.003
   Lan J, 2016, APPL ENERG, V163, P436, DOI 10.1016/j.apenergy.2015.10.178
   Lee A, 2018, J CHEMINFORMATICS, V10, DOI 10.1186/s13321-018-0274-y
   Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938
   Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x
   Li HJ, 2016, PHYSICA A, V449, P224, DOI 10.1016/j.physa.2016.01.009
   Li W, 2017, RESOUR CONSERV RECY, V126, P162, DOI 10.1016/j.resconrec.2017.07.043
   Li YL, 2018, J CLEAN PROD, V192, P950, DOI 10.1016/j.jclepro.2018.04.230
   Liang S, 2016, PHYSICA A, V452, P311, DOI 10.1016/j.physa.2016.01.090
   Liang S, 2015, J IND ECOL, V19, P307, DOI 10.1111/jiec.12242
   Liu H. G., 2017, SUSTAINABILITY, V9, P18
   Long RY, 2018, J ENVIRON MANAGE, V209, P371, DOI 10.1016/j.jenvman.2017.12.067
   McKenzie NR, 2016, SCIENCE, V352, P444, DOI 10.1126/science.aad5787
   Meng J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04337-y
   Nuss P., 2016, ENV SCI TECHNOL, V50
   Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338
   Sheng ZL, 2016, J SCI IND RES INDIA, V75, P529
   Steinmann ZJ, 2018, J IND ECOL, V22, P565, DOI 10.1111/jiec.12694
   Su B, 2016, ENERG ECON, V59, P414, DOI 10.1016/j.eneco.2016.09.006
   Su B, 2014, APPL ENERG, V114, P377, DOI 10.1016/j.apenergy.2013.09.036
   Su B, 2010, ENERG ECON, V32, P166, DOI 10.1016/j.eneco.2009.07.010
   Sun XQ, 2016, ENERGY, V94, P195, DOI 10.1016/j.energy.2015.10.102
   Sun XD, 2017, APPL ENERG, V196, P118, DOI 10.1016/j.apenergy.2016.12.088
   Tang X, 2017, J CLEAN PROD, V161, P1094, DOI 10.1016/j.jclepro.2017.05.069
   Tang X, 2013, ENERG POLICY, V57, P418, DOI 10.1016/j.enpol.2013.02.009
   Tian YS, 2018, J CLEAN PROD, V193, P563, DOI 10.1016/j.jclepro.2018.05.047
   Tsekeris T., 2017, J ECON INTERACT COOR, V12, P1
   Tukker A, 2018, J IND ECOL, V22, P482, DOI 10.1111/jiec.12767
   Tukker A, 2018, J IND ECOL, V22, P489, DOI 10.1111/jiec.12736
   Tukker A, 2018, J IND ECOL, V22, P585, DOI 10.1111/jiec.12716
   Wang XB, 2017, RESOUR CONSERV RECY, V125, P363, DOI 10.1016/j.resconrec.2017.07.006
   Wiedmann T, 2018, NAT GEOSCI, V11, P314, DOI 10.1038/s41561-018-0113-9
   Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110
   Yang LX, 2018, J CLEAN PROD, V180, P595, DOI 10.1016/j.jclepro.2018.01.116
   Yin J., 2016, CHINA WATER, V8, P18
   Zha N, 2018, RESOUR CONSERV RECY, V134, P329, DOI 10.1016/j.resconrec.2017.09.009
   Zhang Q, 2015, SUSTAINABILITY-BASEL, V7, P8223, DOI 10.3390/su7078223
   Zhang S, 2017, ENVIRON SCI POLLUT R, V24, P17616, DOI 10.1007/s11356-017-9392-8
   Zhang Y, 2019, APPL ENERG, V233, P576, DOI 10.1016/j.apenergy.2018.10.051
   Zhang YJ, 2015, RENEW SUST ENERG REV, V41, P1255, DOI 10.1016/j.rser.2014.09.021
   Zhang ZY, 2016, ECON SYST RES, V28, P362, DOI 10.1080/09535314.2016.1165651
   Zhao YH, 2016, J CLEAN PROD, V131, P678, DOI 10.1016/j.jclepro.2016.04.114
   Zhong WQ, 2016, APPL ENERG, V165, P868, DOI 10.1016/j.apenergy.2015.12.083
   Zhong ZQ, 2018, ENERGY, V147, P858, DOI 10.1016/j.energy.2018.01.008
   Zhu BZ, 2018, APPL ENERG, V230, P1545, DOI 10.1016/j.apenergy.2018.09.026
   Zhu YB, 2018, ECOL ECON, V146, P574, DOI 10.1016/j.ecolecon.2017.12.020
NR 75
TC 4
Z9 4
U1 32
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 431
EP 440
DI 10.1016/j.resconrec.2019.04.012
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900041
DA 2020-05-12
ER

PT J
AU Ma, L
   Long, HL
   Chen, KQ
   Tu, SS
   Zhang, YN
   Liao, LW
AF Ma, Li
   Long, Hualou
   Chen, Kunqiu
   Tu, Shuangshuang
   Zhang, Yingnan
   Liao, Liuwen
TI Green growth efficiency of Chinese cities and its spatio-temporal
   pattern
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Green growth efficiency; SBM model; Spatial autocorrelation analysis;
   Spatio-temporal pattern; Industrialization and urbanization; Sustainable
   development; Gravity center analysis
ID SPATIAL-TEMPORAL DISPARITIES; GAS EMISSION REDUCTION; SLACKS-BASED
   MEASURE; LAND-USE; ECONOMIC-DEVELOPMENT; NATURAL-RESOURCES; INDUSTRIAL
   LAND; ENVIRONMENT; INDICATORS; MANAGEMENT
AB Based on the panel data of 285 Chinese cities at prefecture level from 2005 to 2016, remote sensing data and socio-economic data were used to establish a green growth efficiency analysis database. Additionally, the TOPSIS model, super-efficient SBM model, and exploratory spatial analysis method supported by the entropy technology were applied to test and analyze the input-output index, comprehensive evaluation index, spatio-temporal pattern of green growth efficiency, spatial correlation effect, and the shift of the barycenter of green growth of Chinese cities. The following results were obtained: (1) There are obvious spatial differences between Chinese cities in terms of resources investment, socio-economic benefits, and environmental impact index of green growth; the efficiency of urban resource conversion is low, and there is much scope for improvement. (2) In 2005, 2010, and 2016, the comprehensive evaluation index of green growth of Chinese cities increased first and then decreased, and the regional gap was small but was gradually expanding. The green growth efficiency decreased first and then increased with significant spatial differences. (3) In 2005, 2010, and 2016, the Moran's I of China's green growth efficiency was 0.1888, 0.0745, and 0.0584, respectively. There was a positive correlation but a weakening trend spatially, featuring "small agglomeration and large dispersion." (4) From 2005 to 2016, the center of gravity of China's green growth efficiency moved toward the southwest-the moving track was from Suiping County to Biyang County, and to Suizhou City. The research results could improve China's green growth efficiency and provide scientific support and a practical reference for narrowing the imbalance of green growth between the regions.
C1 [Ma, Li; Long, Hualou; Chen, Kunqiu; Tu, Shuangshuang; Zhang, Yingnan; Liao, Liuwen] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.
   [Ma, Li; Long, Hualou; Chen, Kunqiu; Zhang, Yingnan; Liao, Liuwen] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
   [Ma, Li; Long, Hualou; Chen, Kunqiu; Zhang, Yingnan; Liao, Liuwen] Chinese Acad Sci, Key Lab Reg Sustainable Dev Modeling, Beijing 100101, Peoples R China.
   [Tu, Shuangshuang] Nanning Normal Univ, Key Lab Environm Change & Resources Use Beibu Gul, Minist Educ, Nanning 530001, Peoples R China.
RP Long, HL; Tu, SS (reprint author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.; Tu, SS (reprint author), Nanning Normal Univ, Key Lab Environm Change & Resources Use Beibu Gul, Minist Educ, Nanning 530001, Peoples R China.
EM longhl@igsnrr.ac.cn; tuss@nnnu.edu.cn
RI LONG, Hualou/AAE-9250-2019
OI Long, Hualou/0000-0002-9146-2467
FU Key Program of National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [41731286]; Postdoctoral Science
   Foundation of ChinaChina Postdoctoral Science Foundation [2018M630197];
   Bagui Scholars Program of Guangxi Zhuang Autonomous Region; Natural
   Science Foundation of Guangxi Zhuang Autonomous RegionNational Natural
   Science Foundation of Guangxi Province [2018GXNSFAA138055]
FX This work was supported by the Key Program of National Natural Science
   Foundation of China (Grant No. 41731286), the Postdoctoral Science
   Foundation of China (Grant No. 2018M630197), the Bagui Scholars Program
   of Guangxi Zhuang Autonomous Region, and Natural Science Foundation of
   Guangxi Zhuang Autonomous Region (Grant No. 2018GXNSFAA138055).
CR Bai Y, 2018, J CLEAN PROD, V188, P49, DOI 10.1016/j.jclepro.2018.03.312
   Balezentis T, 2019, RESOUR CONSERV RECY, V142, P225, DOI 10.1016/j.resconrec.2018.12.019
   Bank A. D.  Institute A. D. B., 2013, LOW CARB GREEN GROWT
   Barnes P, 1998, AGROFOREST SYST, V42, P25, DOI 10.1023/A:1006191709168
   Cao YG, 2018, LAND USE POLICY, V74, P97, DOI 10.1016/j.landusepol.2017.09.003
   Cao YG, 2015, J URBAN PLAN DEV, V141, DOI 10.1061/(ASCE)UP.1943-5444.0000204
   Casadio Tarabusi E, 2018, ECOL INDIC, V84, P515, DOI 10.1016/j.ecolind.2017.07.061
   Chen X., 2018, PALGRAVE COMMUNICATI, V4, P1
   Choi Y, 2016, TECHNOL FORECAST SOC, V112, P134, DOI 10.1016/j.techfore.2016.05.021
   Colby M., 1989, EVOLUTION PARADIGMS
   Ertugrul I, 2009, EXPERT SYST APPL, V36, P702, DOI 10.1016/j.eswa.2007.10.014
   Fan WG, 2017, RESOUR CONSERV RECY, V126, P174, DOI 10.1016/j.resconrec.2017.07.041
   Geddes JA, 2016, ENVIRON HEALTH PERSP, V124, P281, DOI 10.1289/ehp.1409567
   Goodstein E, 1996, ENVIRON MANAGE, V20, P313, DOI 10.1007/BF01203840
   Gu J, 2018, ENERG POLICY, V120, P675, DOI 10.1016/j.enpol.2018.05.028
   Gunderson R, 2017, J CLEAN PROD, V144, P239, DOI 10.1016/j.jclepro.2017.01.006
   Guo LL, 2017, J CLEAN PROD, V162, P894, DOI 10.1016/j.jclepro.2017.05.210
   Guo LL, 2018, RESOUR CONSERV RECY, V128, P143, DOI 10.1016/j.resconrec.2016.09.035
   Han J., 2013, COMP EC SOC SYST, V5, P100
   Hou LL, 2019, J CLEAN PROD, V208, P178, DOI 10.1016/j.jclepro.2018.10.047
   Hwang CL, 1981, MULTIPLE ATTRIBUTES
   Islam M, 2019, RESOUR CONSERV RECY, V145, P126, DOI 10.1016/j.resconrec.2019.02.027
   Jakob M., 2015, OXF REV EC POLICY, V30, P447
   [金贵 Jin Gui], 2018, [地理学报, Acta Geographica Sinica], V73, P1242
   Kunapatarawong R, 2016, RES POLICY, V45, P1218, DOI 10.1016/j.respol.2016.03.013
   Li X, 2015, J CENT U FINANCE EC, V1, P92
   Li YF, 2018, RESOUR CONSERV RECY, V132, P291, DOI 10.1016/j.resconrec.2017.03.009
   Li YR, 2015, J RURAL STUD, V38, P12, DOI 10.1016/j.jrurstud.2015.01.004
   Liu D, 2019, RESOUR CONSERV RECY, V143, P114, DOI 10.1016/j.resconrec.2018.12.015
   [刘彦随 Liu Yansui], 2016, [中国科学院院刊, Bulletin of the Chinese Academy of Sciences], V31, P269
   Long H, 2016, ECON GEOGR, V36, P1
   Long HL, 2012, J GEOGR SCI, V22, P548, DOI 10.1007/s11442-012-0946-x
   Ma L, 2019, J GEOGR SCI, V29, P163, DOI 10.1007/s11442-019-1590-5
   Merino-Saum A, 2018, RESOUR CONSERV RECY, V139, P90, DOI 10.1016/j.resconrec.2018.07.007
   Miao CL, 2017, RESOUR CONSERV RECY, V126, P153, DOI 10.1016/j.resconrec.2017.07.019
   Miao Z, 2018, APPL GEOGR, V98, P184, DOI 10.1016/j.apgeog.2018.07.020
   Nielsen M, 2014, MAR POLICY, V46, P43, DOI 10.1016/j.marpol.2014.01.003
   OECD, 2009, OECD M COUNC
   Reilly JM, 2012, ENERG ECON, V34, pS85, DOI 10.1016/j.eneco.2012.08.033
   Bolivar MPR, 2016, LOCAL GOV STUD, V42, P29, DOI 10.1080/03003930.2015.1061506
   Shen ZY, 2018, CHINA ECON REV, V51, P83, DOI 10.1016/j.chieco.2018.04.014
   Shu C, 2018, LAND USE POLICY, V77, P107, DOI 10.1016/j.landusepol.2018.05.031
   Song M, 2013, EC RES J, V48, P122
   Song ML, 2018, MANAGE DECIS, V56, P188, DOI 10.1108/MD-04-2017-0375
   Song ML, 2018, RESOUR CONSERV RECY, V128, P197, DOI 10.1016/j.resconrec.2016.08.015
   [宋马林 Song Malin], 2010, [中国软科学, China Soft Science], P143
   Talen E, 2016, LANDSCAPE URBAN PLAN, V152, P27, DOI 10.1016/j.landurbplan.2016.04.002
   Tan MH, 2018, APPL GEOGR, V90, P239, DOI 10.1016/j.apgeog.2017.12.012
   Tan MH, 2017, LAND USE POLICY, V66, P72, DOI 10.1016/j.landusepol.2017.04.032
   Tone K, 2002, EUR J OPER RES, V143, P32, DOI 10.1016/S0377-2217(01)00324-1
   Tone K, 2001, EUR J OPER RES, V130, P498, DOI 10.1016/S0377-2217(99)00407-5
   Tseng ML, 2018, RESOUR CONSERV RECY, V131, P146, DOI 10.1016/j.resconrec.2017.12.028
   Tseng ML, 2018, RESOUR CONSERV RECY, V128, P118, DOI 10.1016/j.resconrec.2017.02.014
   van der Ploeg R, 2013, ENVIRON INNOV SOC TR, V6, P116, DOI 10.1016/j.eist.2012.11.003
   van Donkelaar A, 2016, ENVIRON SCI TECHNOL, V50, P3762, DOI 10.1021/acs.est.5b05833
   Vazquez-Brust D, 2014, FUTURES, V64, P38, DOI 10.1016/j.futures.2014.10.005
   Xie HL, 2019, J CLEAN PROD, V207, P1047, DOI 10.1016/j.jclepro.2018.10.087
   Xie HL, 2018, TECHNOL FORECAST SOC, V133, P15, DOI 10.1016/j.techfore.2018.03.015
   Xie HL, 2018, LAND USE POLICY, V75, P518, DOI 10.1016/j.landusepol.2018.04.027
   Xiong LC, 2018, RESOUR CONSERV RECY, V130, P12, DOI 10.1016/j.resconrec.2017.11.009
   Zhang ZY, 2018, RESOUR CONSERV RECY, V133, P242, DOI 10.1016/j.resconrec.2018.02.017
   Zhao T, 2017, RENEW SUST ENERG REV, V80, P481, DOI 10.1016/j.rser.2017.05.142
   单豪杰, 2008, [数量经济技术经济研究, Quantitative & Technical Economics], V25, P17
NR 63
TC 8
Z9 8
U1 18
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 441
EP 451
DI 10.1016/j.resconrec.2019.03.049
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900042
DA 2020-05-12
ER

PT J
AU Moraga, G
   Huysveld, S
   Mathieux, F
   Blengini, GA
   Alaerts, L
   Van Acker, K
   de Meester, S
   Dewulf, J
AF Moraga, Gustavo
   Huysveld, Sophie
   Mathieux, Fabrice
   Blengini, Gian Andrea
   Alaerts, Luc
   Van Acker, Karel
   de Meester, Steven
   Dewulf, Jo
TI Circular economy indicators: What do they measure?
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; indicators; Sustainability; Life cycle thinking
ID LIFE-CYCLE ASSESSMENT; RESOURCE EFFICIENCY; CHINA; PRODUCTS; SYSTEM;
   LOOP
AB Circular Economy (CE) is a growing topic, especially in the European Union, that promotes the responsible and cyclical use of resources possibly contributing to sustainable development. CE is an umbrella concept incorporating different meanings. Despite the unclear concept, CE is turned into defined action plans supported by specific indicators. To understand what indicators used in CE measure specifically, we propose a classification framework to categorise indicators according to reasoning on what (CE strategies) and how (measurement scope), Despite different types, CE strategies can be grouped according to their attempt to preserve functions, products, components, materials, or embodied energy; additionally, indicators can measure the linear economy as a reference scenario. The measurement scope shows how indicators account for technological cycles with or without a Life Cycle Thinking (LCT) approach; or their effects on environmental, social, or economic dimensions.
   To illustrate the classification framework, we selected quantitative micro scale indicators from literature and macro scale indicators from the European Union 'CE monitoring framework'. The framework illustration shows that most of the indicators focus on the preservation of materials, with strategies such as recycling. However, micro scale indicators can also focus on other CE strategies considering LCT approach, while the European indicators mostly account for materials often without taking LCT into account. Furthermore, none of the available indicators can assess the preservation of functions instead of products, with strategies such as sharing platforms, schemes for product redundancy, or multifunctionality. Finally, the framework illustration suggests that a set of indicators should be used to assess CE instead of a single indicator.
C1 [Moraga, Gustavo; Huysveld, Sophie; Dewulf, Jo] Univ Ghent, Dept Green Chem & Technol, Coupure Links 653, B-9000 Ghent, Belgium.
   [de Meester, Steven] Univ Ghent, Dept Green Chem & Technol, Graaf Karel Goedelaan 5, B-8500 Kortrijk, Belgium.
   [Mathieux, Fabrice; Blengini, Gian Andrea] European Commiss, Sustainable Resources Directorate, Joint Res Ctr, Via E Fermi 2749, I-21027 Ispra, Italy.
   [Alaerts, Luc; Van Acker, Karel] Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44, B-3001 Leuven, Belgium.
RP Mathieux, F (reprint author), European Commiss, Sustainable Resources Directorate, Joint Res Ctr, Via E Fermi 2749, I-21027 Ispra, Italy.
EM fabrice.mathieux@ec.europa.eu
RI Van Acker, Karel/E-6481-2011
OI Van Acker, Karel/0000-0002-5320-8839; Blengini, Gian
   Andrea/0000-0002-7977-1363; Alaerts, Luc/0000-0002-6640-6287; Moraga,
   Gustavo/0000-0001-6775-1456
FU Flemish administration of Belgium via the Steunpunt Circulaire Economie
   (Policy Research Centre Circular Economy)
FX The authors are very grateful for full financial support received from
   the Flemish administration of Belgium via the Steunpunt Circulaire
   Economie (Policy Research Centre Circular Economy). We also would like
   to thank Arturo De La Fuente Nuno and Maria Nyberg (European Commission)
   for their feedback on the paper.
CR Adibi N, 2017, J CLEAN PROD, V165, P1517, DOI 10.1016/j.jclepro.2017.07.226
   Allwood J.M, 2014, HDB RECYCLING, DOI [10.1016/b978-0-12-396459-5.00030-1, DOI 10.1016/B978-0-12-396459-5.00030-1]
   Ardente F, 2014, J CLEAN PROD, V83, P126, DOI 10.1016/j.jclepro.2014.07.058
   ARNSPERGER C, 2016, REV OFCE, V145, P91, DOI DOI 10.3917/RE0F.145.0091
   Azevedo SG, 2017, RESOURCES-BASEL, V6, DOI 10.3390/resources6040063
   Beukering P., 2001, RECYCLING INT TRADE, DOI [10.1016/13978-0-12-396459-5.00030-1, DOI 10.1016/13978-0-12-396459-5.00030-1]
   Beukering P., 2014, HDB RECYCLING, P479, DOI [10.1016/8978-0-12-396459-5.00031-3, DOI 10.1016/8978-0-12-396459-5.00031-3]
   Blomsma F, 2017, J IND ECOL, V21, P603, DOI 10.1111/jiec.12603
   Bobba S, 2018, J ENERGY STORAGE, V19, P213, DOI 10.1016/j.est.2018.07.008
   Bocken NMP, 2016, J IND PROD ENG, V33, P308, DOI 10.1080/21681015.2016.1172124
   CIRAIG (International Reference Center for the Life Cycle of Products Processes and Services), 2015, CIRC EC CRIT LIT REV
   Cullen JM, 2017, J IND ECOL, V21, P483, DOI 10.1111/jiec.12599
   Dewulf J, 2015, J IND ECOL, V19, P963, DOI 10.1111/jiec.12289
   Di Maio F., 2015, J ENV PROT, V06, P1095, DOI DOI 10.4236/JEP.2015.610096
   Di Maio F, 2017, RESOUR CONSERV RECY, V122, P163, DOI 10.1016/j.resconrec.2017.02.009
   EASAC, 2016, IND CIRC CIRC EC
   EC, 2015, COM2015614 EC
   EC, 2016, EU RES EFF SCOR 2015
   EC, 2003, COM2003302 EC, P302
   EC, 2018, SWD201816 EC
   EC, 2011, COM2011571 EC
   EC (European Commission), 2018, SWD201817 EC
   EEA, 2016, 3 EEA, DOI [10.2800/51444, DOI 10.2800/51444]
   EEA, 2017, 62017 EEA, DOI [10.2800/860754, DOI 10.2800/860754]
   EESC, 2018, EESC OP MON FRAM CIR
   Elia V, 2017, J CLEAN PROD, V142, P2741, DOI 10.1016/j.jclepro.2016.10.196
   Ellen MacArthur Foundation (EMF), 2015, DEL CIRC EC TOOLK PO
   EMF, 2013, CIRCULAR EC
   EMF-Ellen MacArthur Foundation, 2015, METHODOLOGY, V23, DOI [10.1016/j.giq.2006.04.004, DOI 10.1016/J.GIQ.2006.04.004]
   Franklin-Johnson E, 2016, J CLEAN PROD, V133, P589, DOI 10.1016/j.jclepro.2016.05.023
   Gallopin G, 1996, ENVIRON MODEL ASSESS, V1, P101, DOI DOI 10.1007/BF01874899
   Geissdoerfer M, 2017, J CLEAN PROD, V143, P757, DOI 10.1016/j.jclepro.2016.12.048
   Geng Y, 2008, INT J SUST DEV WORLD, V15, P231, DOI 10.3843/SusDev.15.3:6
   Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059
   Geng Y, 2012, J CLEAN PROD, V23, P216, DOI 10.1016/j.jclepro.2011.07.005
   Georgescu-Roegen N., 1973, ENTROPY LAW EC PROCE
   Geyer R, 2016, J IND ECOL, V20, P1010, DOI 10.1111/jiec.12355
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x
   Graedel T. E., 2014, HDB RECYCLING, P17, DOI 10.1016/8978-0-12-396459-5.00003-9
   Homrich AS, 2018, J CLEAN PROD, V175, P525, DOI 10.1016/j.jclepro.2017.11.064
   Huysman S, 2017, RESOUR CONSERV RECY, V120, P46, DOI 10.1016/j.resconrec.2017.01.013
   Huysman S, 2015, RESOUR CONSERV RECY, V101, P53, DOI 10.1016/j.resconrec.2015.05.014
   Iacovidou E, 2017, J CLEAN PROD, V166, P910, DOI 10.1016/j.jclepro.2017.07.100
   JRC-EC, 2016, RAW MAT SCOR EUR INN, DOI [10.2873/85546, DOI 10.2873/85546]
   Kalmykova Y, 2018, RESOUR CONSERV RECY, V135, P190, DOI 10.1016/j.resconrec.2017.10.034
   Ketels C., 2017, PRIORITY SECTOR REPO
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Kjaer LL, 2019, J IND ECOL, V23, P22, DOI 10.1111/jiec.12747
   Korhonen J, 2018, J CLEAN PROD, V175, P544, DOI 10.1016/j.jclepro.2017.12.111
   Linder M, 2017, J IND ECOL, V21, P545, DOI 10.1111/jiec.12552
   Lonca G, 2018, J CLEAN PROD, V183, P424, DOI 10.1016/j.jclepro.2018.02.108
   Magnier C, 2017, 10 KEY INDICATORS MO
   Matsuno Y, 2007, INT J LIFE CYCLE ASS, V12, P34, DOI 10.1065/lca2006.05.246.2
   McDowall W, 2017, J IND ECOL, V21, P651, DOI 10.1111/jiec.12597
   Moldan B, 2012, ECOL INDIC, V17, P4, DOI 10.1016/j.ecolind.2011.04.033
   Moriguchi Y, 2007, J MATER CYCLES WASTE, V9, P112, DOI 10.1007/s10163-007-0182-0
   Murray A, 2017, J BUS ETHICS, V140, P369, DOI 10.1007/s10551-015-2693-2
   Pauliuk S, 2018, RESOUR CONSERV RECY, V129, P81, DOI 10.1016/j.resconrec.2017.10.019
   Potting J, 2017, CIRCULAR EC MEASURIN
   Potting J., 2018, CIRCULAR EC WHAT WE
   Prieto-Sandoval V, 2018, J CLEAN PROD, V179, P605, DOI 10.1016/j.jclepro.2017.12.224
   Reap J, 2008, INT J LIFE CYCLE ASS, V13, P290, DOI 10.1007/s11367-008-0008-x
   Reike D., 2017, RESOUR CONSERV RECY, P1, DOI [10.1016/jsesconrec.2017.08.027, DOI 10.1016/JSESCONREC.2017.08.027]
   Sala S, 2013, INT J LIFE CYCLE ASS, V18, P1686, DOI 10.1007/s11367-012-0509-5
   Scheepens AE, 2016, J CLEAN PROD, V114, P257, DOI 10.1016/j.jclepro.2015.05.075
   Smol M, 2017, CLEAN TECHNOL ENVIR, V19, P669, DOI 10.1007/s10098-016-1323-8
   Tukker A, 2015, J CLEAN PROD, V97, P76, DOI 10.1016/j.jclepro.2013.11.049
   UNEP, 2013, MERC TIM TO ACT, P2013
   UNEP, 2005, LIF CYCL APPR ROAD A
   United Nations, 2015, TRANSF OUR WORLD 203
   Vanegas P, 2018, RESOUR CONSERV RECY, V135, P323, DOI 10.1016/j.resconrec.2017.06.022
   Waas T, 2014, SUSTAINABILITY-BASEL, V6, P5512, DOI 10.3390/su6095512
   Wit M., 2019, CIRCLE EC
   Zink T, 2017, J IND ECOL, V21, P593, DOI 10.1111/jiec.12545
   Zink T, 2016, J IND ECOL, V20, P719, DOI 10.1111/jiec.12317
NR 76
TC 21
Z9 21
U1 12
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 452
EP 461
DI 10.1016/j.resconrec.2019.03.045
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900043
PM 31274959
OA Green Published, Other Gold
HC Y
HP Y
DA 2020-05-12
ER

PT J
AU Bakchan, A
   Faust, KM
   Leite, F
AF Bakchan, Amal
   Faust, Kasey M.
   Leite, Fernanda
TI Seven-dimensional automated construction waste quantification and
   management framework: Integration with project and site planning
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Construction waste; Automated quantification; Reuse; Recycling; Disposal
   planning
ID DEMOLITION WASTE; ECONOMIC-FEASIBILITY; DEBRIS GENERATION; MODEL;
   MINIMIZATION; SYSTEM; IMPACT
AB The large proportions of waste generated from the construction industry have led to adverse environmental and economic impacts. Consequentially, there is a need for effective construction waste management (CWM) at construction sites. This study seeks to define Building Information Modeling (BIM) dimensions and respective conceptual interactions that shape the integration of CWM with construction management. A multi-dimensional framework is proposed that leverages BIM-based automated construction waste (CW) estimation capabilities to provide guidance on CWM applications, specifically, CW disposal scheduling, disposal cost estimation, onsite reuse, and allocation of waste bins. The framework presents interactions between these CWM applications and construction management fields-scheduling, estimation, sustainability, and site planning-to enable a strategic alignment between conventional project objectives and CWM. To demonstrate the framework, a real-world pilot project is employed for the case of concrete waste. Data used are documented and tracked from the project and interviews. The results reveal a 5.3% difference between estimated and actual concrete waste quantities. Accordingly, the expected dates for scheduling concrete waste pick-up are estimated for proposed integration into the project schedule. The study estimates savings of over $35,000 from reuse and recycling. Construction activities related to a retaining wall-requiring backfill-are identified from the project schedule as opportunities for reuse. Findings reveal that waste bins could be dedicated to waste streams with high generation rates at each construction stage. Findings from this study would serve as a guide for construction practitioners in assessing key benefits of CWM in improving the scheduling, cost, and sustainability performance of construction projects.
C1 [Bakchan, Amal] Univ Texas Austin, Dept Civil Architectural & Environm Engn, 301 E Dean Keeton St,C1752, Austin, TX 78712 USA.
   [Faust, Kasey M.; Leite, Fernanda] Univ Texas Austin, Dept Civil Architectural & Environm Engn, Construct Engn & Project Management Program, 301 E Dean Keeton St,C1752, Austin, TX 78712 USA.
RP Bakchan, A (reprint author), Univ Texas Austin, Dept Civil Architectural & Environm Engn, 301 E Dean Keeton St,C1752, Austin, TX 78712 USA.
EM bakchan@utexas.edu; faustk@utexas.edu; Fernanda.leite@utexas.edu
OI Bakchan, Amal/0000-0002-1709-5937
CR Ajayi SO, 2017, WASTE MANAGE, V59, P330, DOI 10.1016/j.wasman.2016.10.040
   Akinade O.O., 2017, BIM BASED SOFTWARE C
   Aldhaheri M, 2018, ENG CONSTR ARCHIT MA, V25, P1226, DOI 10.1108/ECAM-07-2017-0130
   [Anonymous], 2014, 31814 ACI
   Bakchan A, 2019, WASTE MANAGE, V87, P301, DOI 10.1016/j.wasman.2019.02.024
   Bakshan A, 2017, RESOUR CONSERV RECY, V117, P274, DOI 10.1016/j.resconrec.2016.10.006
   Bakshan A, 2015, RESOUR CONSERV RECY, V100, P70, DOI 10.1016/j.resconrec.2015.04.002
   Begum RA, 2006, RESOUR CONSERV RECY, V48, P86, DOI 10.1016/j.resconrec.2006.01.004
   Begum RA, 2009, RESOUR CONSERV RECY, V53, P321, DOI 10.1016/j.resconrec.2009.01.005
   Bergsdal H, 2007, J IND ECOL, V11, P27, DOI 10.1162/jiec.2007.1149
   BRE, 2008, UK BUILD RES EST SMA
   Chen X, 2017, J CLEAN PROD, V141, P799, DOI 10.1016/j.jclepro.2016.09.164
   Cheng JCP, 2013, WASTE MANAGE, V33, P1539, DOI 10.1016/j.wasman.2013.01.001
   Cochran KM, 2010, WASTE MANAGE, V30, P2247, DOI 10.1016/j.wasman.2010.04.008
   Cochran K, 2007, WASTE MANAGE, V27, P921, DOI 10.1016/j.wasman.2006.03.023
   Crawford RH, 2017, PROCEDIA ENGINEER, V196, P830, DOI 10.1016/j.proeng.2017.08.014
   Doan DT, 2016, J CONSTR ENG M, V142, DOI 10.1061/(ASCE)CO.1943-7862.0001188
   EPA, 2018, SUST MAN CONSTR DEM
   EPA, 2018, US EPA EPA MAK STRID
   EPA, 1998, EPA530R98010
   Esa MR, 2017, RESOUR CONSERV RECY, V120, P219, DOI 10.1016/j.resconrec.2016.12.014
   Esin T, 2007, BUILD ENVIRON, V42, P1667, DOI 10.1016/j.buildenv.2006.02.008
   GhaffarianHoseini A, 2017, RENEW SUST ENERG REV, V72, P935, DOI 10.1016/j.rser.2016.12.061
   Hossain MU, 2017, WASTE MANAGE, V69, P325, DOI 10.1016/j.wasman.2017.07.043
   Jain M., 2012, INT J SCI RES PUBL, V2, P2250
   Jalali S., 2007, 6 INT TECHN C WAST V
   Jin RY, 2017, RESOUR CONSERV RECY, V126, P86, DOI 10.1016/j.resconrec.2017.07.034
   Kern AP, 2015, WASTE MANAGE, V39, P35, DOI 10.1016/j.wasman.2015.01.043
   Kofoworola OF, 2009, WASTE MANAGE, V29, P731, DOI 10.1016/j.wasman.2008.07.004
   Lau HH, 2008, INT J ENVIRON RES, V2, P261
   Li JR, 2013, RESOUR CONSERV RECY, V74, P20, DOI 10.1016/j.resconrec.2013.02.015
   Llatas C, 2011, WASTE MANAGE, V31, P1261, DOI 10.1016/j.wasman.2011.01.023
   Lockrey S, 2016, J CLEAN PROD, V133, P757, DOI 10.1016/j.jclepro.2016.05.175
   Long J., 2018, INSIGHT, V21
   Lu WS, 2017, RENEW SUST ENERG REV, V68, P587, DOI 10.1016/j.rser.2016.10.029
   Lu WS, 2010, RESOUR CONSERV RECY, V55, P201, DOI 10.1016/j.resconrec.2010.09.010
   Manowong E, 2012, WASTE MANAGE RES, V30, P56, DOI 10.1177/0734242X10387012
   Marrero M, 2017, RESOUR CONSERV RECY, V117, P160, DOI 10.1016/j.resconrec.2016.10.020
   Patanakul P, 2012, PROJ MANAG J, V43, P4, DOI 10.1002/pmj.20282
   Poon C., 2001, GUIDE MANAGING MINIM
   Poon CS, 2007, WASTE MANAGE, V27, P1715, DOI 10.1016/j.wasman.2007.08.013
   Poon CS, 2013, J CONSTR ENG M, V139, P466, DOI 10.1061/(ASCE)CO.1943-7862.0000631
   Poon CS, 2001, RESOUR CONSERV RECY, V32, P157, DOI 10.1016/S0921-3449(01)00052-0
   Rosenbaum S, 2014, J CONSTR ENG M, V140, DOI 10.1061/(ASCE)CO.1943-7862.0000793
   Sandler K, 2003, BIOCYCLE, V44, P51
   Tam VWY, 2008, RESOUR CONSERV RECY, V52, P821, DOI 10.1016/j.resconrec.2007.12.001
   Thamhain HJ, 2014, MANAGING TECHNOLOGY-BASED PROJECTS: TOOLS, TECHNIQUES, PEOPLE AND BUSINESS PROCESSES, P1, DOI 10.1002/9781118849958
   Tserng HP, 2004, AUTOMAT CONSTR, V13, P781, DOI 10.1016/j.autcon.2004.05.003
   Udawatta N, 2015, RESOUR CONSERV RECY, V101, P73, DOI 10.1016/j.resconrec.2015.05.003
   USGBC, 2009, US GREEN BUILD COUNC
   Saez PV, 2013, RESOUR CONSERV RECY, V75, P52, DOI 10.1016/j.resconrec.2013.03.009
   Wang JY, 2014, RESOUR CONSERV RECY, V82, P1, DOI 10.1016/j.resconrec.2013.11.003
   Wetzel EM, 2015, AUTOMAT CONSTR, V60, P12, DOI 10.1016/j.autcon.2015.09.004
   Won J, 2017, AUTOMAT CONSTR, V79, P3, DOI 10.1016/j.autcon.2017.02.002
   Won J, 2016, WASTE MANAGE, V49, P170, DOI 10.1016/j.wasman.2015.12.026
   Yates JK, 2014, J CONSTR ENG M, V140, DOI 10.1061/(ASCE)CO.1943-7862.0000673
   Zhao W, 2010, RESOUR CONSERV RECY, V54, P377, DOI 10.1016/j.resconrec.2009.09.003
NR 57
TC 4
Z9 4
U1 10
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 462
EP 474
DI 10.1016/j.resconrec.2019.02.020
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900044
DA 2020-05-12
ER

PT J
AU Yue, SJ
   Shen, YC
   Yuan, JH
AF Yue, Shujing
   Shen, Yongchang
   Yuan, Jianhong
TI Sustainable total factor productivity growth for 55 states: An
   application of the new malmquist index considering ecological footprint
   and human development index
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Ecological footprint; Human development index; Sustainable total factor
   productivity; The Malmquist index; Data envelopment analysis
ID FACTOR ENERGY EFFICIENCY; ENVIRONMENTAL EFFICIENCY; INDUSTRIAL SECTORS;
   CHINA; REGIONS; IMPACT; RESOURCE
AB Expanding the total factor productivity framework has a profound theoretical and practical value for sustainable growth. This paper proposes a new indicator called the "Sustainable Total Factor Productivity". The new indicator simultaneously incorporates two comprehensive indicators, ecological footprint, which reflects human ecological consumption; and, human development index, which measures human well-being levels, into the traditional total factor productivity framework to measure sustainable growth. The sustainable total factor productivity indicator considers ecological inputs such as energy consumption, built-up land usage and biological resources occupation, while taking into account the comprehensive outputs of economic growth, life expectancy and education levels. This new indicator can better measure a state's sustainable growth. The Data Envelopment Analysis-Malmquist method and the convergence test are employed to estimate its changes and test its convergence for 55 nations for the period 1994 to 2014. The primary results indicate that: (1) the average sustainable total factor productivity growth for these nations shows a downward trend suggesting that most states placed less emphasis on sustainable growth. The downward trend resulted primarily from the slow growth of sustainable technical progress. (2) 19 of the 55 states had positive, sustainable total factor productivity growth and achieved sustainable growth. (3) Fifty-five states and four subgroup states converged towards steady-state levels.
C1 [Yue, Shujing; Shen, Yongchang] Southeast Univ, Sch Econ & Management, Nanjing 211189, Jiangsu, Peoples R China.
   [Yuan, Jianhong] Southeast Univ, Sch Marxism, Nanjing 211189, Jiangsu, Peoples R China.
   [Yue, Shujing; Yuan, Jianhong] Southeast Univ, Inst Socialist Dev Chinese Characterist, Nanjing 211189, Jiangsu, Peoples R China.
RP Yue, SJ (reprint author), Southeast Univ, Sch Econ & Management, Nanjing 211189, Jiangsu, Peoples R China.; Yue, SJ (reprint author), Southeast Univ, Inst Socialist Dev Chinese Characterist, Nanjing 211189, Jiangsu, Peoples R China.
EM yueshujing@seu.edu.cn
OI shujing, Yue/0000-0003-3488-170X
FU Social Science Fund of Jiangsu Province [17GLB008]; Fundamental Research
   Funds for the Central UniversitiesFundamental Research Funds for the
   Central Universities [2242018S10034, 2242019S30044]
FX This study was supported by the Social Science Fund of Jiangsu Province
   [grant number 17GLB008] and Fundamental Research Funds for the Central
   Universities [grant number 2242018S10034, 2242019S30044]. The authors
   are grateful to the Editor, as well as the anonymous referees for
   valuable suggestions and comments that helped us improve our paper
   significantly.
CR AmartyaSen, 2000, DEV FREEDOM
   Barbier LB., 2012, 6232 WORLD BANK
   Bernard A., 1996, EMPIR ECON, V21, P113, DOI DOI 10.1007/BF01205496
   Biggeri M, 2018, ECOL INDIC, V91, P220, DOI 10.1016/j.ecolind.2018.03.045
   CAVES DW, 1982, ECONOMETRICA, V50, P1393, DOI 10.2307/1913388
   Charfeddine L, 2017, RENEW SUST ENERG REV, V76, P138, DOI 10.1016/j.rser.2017.03.031
   Choi Y, 2016, TECHNOL FORECAST SOC, V112, P134, DOI 10.1016/j.techfore.2016.05.021
   Costanza R, 2016, ECOL ECON, V130, P350, DOI 10.1016/j.ecolecon.2016.07.009
   Du MZ, 2014, SUSTAINABILITY-BASEL, V6, P5983, DOI 10.3390/su6095983
   FARE R, 1994, AM ECON REV, V84, P66
   Folke C, 1997, AMBIO, V26, P167
   Fu W, 2015, ECOL INDIC, V48, P464, DOI 10.1016/j.ecolind.2014.09.023
   He J, 2016, ECOL INDIC, V70, P23, DOI 10.1016/j.ecolind.2016.05.042
   Hu JL, 2006, ENERG POLICY, V34, P3206, DOI 10.1016/j.enpol.2005.06.015
   Hu JL, 2018, MANAG ENVIRON QUAL, V29, P34, DOI 10.1108/MEQ-07-2016-0053
   Islam M, 2019, RESOUR CONSERV RECY, V145, P126, DOI 10.1016/j.resconrec.2019.02.027
   Klugman J, 2011, J ECON INEQUAL, V9, P249, DOI 10.1007/s10888-011-9178-z
   Koch M, 2017, ECOL ECON, V138, P74, DOI 10.1016/j.ecolecon.2017.03.035
   Kumar S, 2006, ECOL ECON, V56, P280, DOI 10.1016/j.ecolecon.2005.02.004
   Lasso de La Vega M. C., 2001, ENVIRON DEV SUSTAIN, V3, P199
   Li K, 2015, CHINA ECON REV, V36, P279, DOI 10.1016/j.chieco.2015.09.008
   Liu W, 2018, RESOUR CONSERV RECY, V139, P50, DOI 10.1016/j.resconrec.2018.07.017
   Malmquist S, 1953, TRABAJOS ESTADISTICA, V4, P209, DOI DOI 10.1007/BF03006863
   Miller SM, 2002, J MACROECON, V24, P267, DOI 10.1016/S0164-0704(02)00022-8
   Neumayer E, 2001, ECOL ECON, V39, P101, DOI 10.1016/S0921-8009(01)00201-4
   Pelenc J, 2015, ECOL ECON, V112, P36, DOI 10.1016/j.ecolecon.2015.02.006
   Ramathan B., 1999, INDIAN SOC SCI REV, V1, P193
   Rees W. E., 1992, ENVIRON URBAN, V4, P121, DOI DOI 10.1177/095624789200400212
   Rusiawan W, 2015, PROCEDIA ENVIRON SCI, V28, P493, DOI 10.1016/j.proenv.2015.07.059
   Shang CW, 2019, RESOUR CONSERV RECY, V141, P243, DOI 10.1016/j.resconrec.2018.10.032
   Shen ZY, 2017, INT J PROD ECON, V189, P30, DOI 10.1016/j.ijpe.2017.04.007
   Song ML, 2019, PROCESS SAF ENVIRON, V121, P281, DOI 10.1016/j.psep.2018.10.023
   Song ML, 2018, INT J PROD ECON, V205, P359, DOI 10.1016/j.ijpe.2018.09.019
   Song ML, 2018, RESOUR CONSERV RECY, V128, P197, DOI 10.1016/j.resconrec.2016.08.015
   Togtokh C., 2010, HUMAN SUSTAINABLE DE
   UNDP, 2010, HUM DEV REP 2010
   van Vuuren DP, 2000, ECOL ECON, V34, P115, DOI 10.1016/S0921-8009(00)00155-5
   Wackemagel M., 1996, OUR ECOLOGICAL FOOTP
   Wackernagel M, 1999, ECOL ECON, V29, P375, DOI 10.1016/S0921-8009(98)90063-5
   Wang ZH, 2015, APPL ENERG, V147, P617, DOI 10.1016/j.apenergy.2015.01.108
   World Bank, 2012, INCL SUST GROWTH PAT
   Yue SJ, 2017, ECOL INDIC, V73, P284, DOI 10.1016/j.ecolind.2016.09.047
   YUE SJ, 2016, SUSTAINABILITY-BASEL, V8, DOI DOI 10.3390/SU8111129
   Zhang N, 2015, ENERG ECON, V51, P88, DOI 10.1016/j.eneco.2015.06.003
   Zhang N, 2015, ECOL INDIC, V51, P165, DOI 10.1016/j.ecolind.2014.07.041
NR 45
TC 3
Z9 3
U1 11
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 475
EP 483
DI 10.1016/j.resconrec.2019.03.035
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900045
DA 2020-05-12
ER

PT J
AU Vreys, K
   Lizin, S
   Van Dael, M
   Tharakan, J
   Malina, R
AF Vreys, Kim
   Lizin, Sebastien
   Van Dael, Miet
   Tharakan, Joe
   Malina, Robert
TI Exploring the future of carbon capture and utilisation by combining an
   international Delphi study with local scenario development
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Technological foresight; Futures study; CCU; CDU; Delphi method;
   Scenario development
ID INFORMATION-SYSTEMS MANAGEMENT; LIFE-CYCLE ASSESSMENT; DIOXIDE
   UTILIZATION; CO2 CAPTURE; KEY ISSUES; ENERGY; TECHNOLOGIES; TOOL;
   STORAGE; PERCEPTIONS
AB This article identifies the factors that, according to international experts, will have substantial effects on the future development and commercialisation of carbon capture and utilisation (CCU) technologies. A two-round online Delphi study with 15 international experts in the field of CCU enabled us to explore the main items within five impact categories: (1) benefits, (2) risks, (3) future developments, (4) demand, and (5) supply constraints. Based on the results of the Delphi study, we constructed 4 future scenarios that represent how the CCU sector could develop within 10 years, using a local scenario development workshop with 9 experts from within Flanders (Belgium) and the Netherlands. We used a deductive, explorative scenario development method, which resulted in a two-by-two scenario matrix. We find that the local experts consider the role of the government and the development of CCU costs to be the most uncertain factors and could have the highest impact on the development of the sector within the next 10 years. Our insights can be instructive for facilitating the process of scenario planning for CCU development activities. Finally, although we work with a regionally specific case study, the same method could be implemented in other regions, using the general findings from our Delphi study as a starting point for the scenario development.
C1 [Vreys, Kim; Lizin, Sebastien; Van Dael, Miet; Malina, Robert] Hasselt Univ, Fac Business Econ, Ctr Environm Sci, Agoralaan Bldg D, B-3590 Diepenbeek, Belgium.
   [Vreys, Kim; Tharakan, Joe] Univ Liege, Dept Econ, HEC Liege, Bd Rectorat B31, B-4000 Liege, Belgium.
   [Van Dael, Miet] VITO, Unit Separat & Convers Technol, Boeretang 200, B-2400 Mol, Belgium.
RP Lizin, S (reprint author), Hasselt Univ, Fac Business Econ, Ctr Environm Sci, Agoralaan Bldg D, B-3590 Diepenbeek, Belgium.
EM kim.vreys@hotmail.com; sebastien.lizin@uhasselt.be;
   miet.vandael@vito.be; j.tharakan@ulg.ac.be; robert.malina@uhasselt.be
FU joint UHasselt-ULg special research grant; FWOFWO [12G5418N]; European
   Fund for Regional Development through the cross-border collaborative
   Interreg V program Flanders-the Netherlands (project EnOp)
FX We would like to thank the participants of both the Delphi study and the
   scenario workshop for their valuable insights. Miss Vreys would like to
   thank the joint UHasselt-ULg special research grant and Dr Lizin would
   like to thank FWO for the postdoctoral grant (12G5418N) for making this
   work possible. Furthermore, we acknowledge financial support from the
   European Fund for Regional Development through the cross-border
   collaborative Interreg V program Flanders-the Netherlands (project
   EnOp).
CR Abanades JC, 2017, ENERG ENVIRON SCI, V10, P2491, DOI 10.1039/c7ee02819a
   Al-Mamoori A, 2017, ENERGY TECHNOL
   ALWIN DF, 1985, PUBLIC OPIN QUART, V49, P535, DOI 10.1086/268949
   Amer M, 2013, FUTURES, V46, P23, DOI 10.1016/j.futures.2012.10.003
   Aresta M., 2013, CARBON DIOXIDE RECOV
   Aresta M, 2013, J CO2 UTIL, V3-4, P65, DOI 10.1016/j.jcou.2013.08.001
   Armstrong K, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2015.00008
   Artz J, 2017, CHEM REV
   Beckman EJ, 2004, J SUPERCRIT FLUID, V28, P121, DOI 10.1016/S0896-8446(03)00029-9
   Bishop P, 2007, FORESIGHT, V9, P5, DOI 10.1108/14636680710727516
   Blanken W, 2017, BIOTECHNOL BIOENG, V114, P769, DOI 10.1002/bit.26199
   Borjeson L, 2006, FUTURES, V38, P723, DOI 10.1016/j.futures.2005.12.002
   Brancheau JC, 1996, MIS QUART, V20, P225, DOI 10.2307/249479
   Bruhn T, 2016, ENVIRON SCI POLICY, V60, P38, DOI 10.1016/j.envsci.2016.03.001
   Copeman C, 2006, PICTURE THIS GUIDE S
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Cuellar-Franca RM, 2015, J CO2 UTIL, V9, P82, DOI 10.1016/j.jcou.2014.12.001
   DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458
   Dekleva S, 1996, INFORM MANAGE, V31, P1, DOI 10.1016/S0378-7206(96)01066-X
   Dimitriou I, 1789, ENERG ENVIRON SCI, V8, P1775
   Fraga ES, 2015, FARADAY DISCUSS, V183, P309, DOI 10.1039/c5fd00038f
   Gilbart E, 1998, AM J EPIDEMIOL, V148, P97, DOI 10.1093/oxfordjournals.aje.a009565
   Goeppert A, 2014, CHEM SOC REV, V43, P7995, DOI 10.1039/c4cs00122b
   GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148
   Gordon T, 2006, TECHNOL FORECAST SOC, V73, P321, DOI 10.1016/j.techfore.2005.09.005
   Gupta UG, 1996, TECHNOL FORECAST SOC, V53, P185, DOI 10.1016/S0040-1625(96)00094-7
   Hall JK, 2005, R&D MANAGE, V35, P273, DOI 10.1111/j.1467-9310.2005.00389.x
   Hasson F, 2011, TECHNOL FORECAST SOC, V78, P1695, DOI 10.1016/j.techfore.2011.04.005
   Hunt AJ, 2010, CHEMSUSCHEM, V3, P306, DOI 10.1002/cssc.200900169
   Jacobsson S, 2006, ENERG POLICY, V34, P256, DOI 10.1016/j.enpol.2004.08.029
   Jones CR, 2014, J CO2 UTIL, V7, P51, DOI 10.1016/j.jcou.2014.05.001
   Kang D, 2017, CHEM ENG J, V308, P1073, DOI 10.1016/j.cej.2016.09.120
   Karatayev M, 2016, RENEW SUST ENERG REV, V66, P120, DOI 10.1016/j.rser.2016.07.057
   Keil M, 2002, INFORM SYST J, V12, P103, DOI 10.1046/j.1365-2575.2002.00121.x
   Keith DW, 2009, SCIENCE, V325, P1654, DOI 10.1126/science.1175680
   Kendall MG, 1939, ANN MATH STAT, V10, P275, DOI 10.1214/aoms/1177732186
   Khoo HH, 2011, ENRGY PROCED, V4, P2494, DOI 10.1016/j.egypro.2011.02.145
   Kirchherr J, 2017, RESOUR CONSERV RECY, V127, P221, DOI 10.1016/j.resconrec.2017.09.005
   Kobus J, 2016, 9 IADIS INT C
   Kosow H., 2008, METHODS FUTURE SCENA
   Kunc M, 2017, TECHNOL FORECAST SOC, V124, P150, DOI 10.1016/j.techfore.2017.03.018
   Lainez-Aguirre J. M, 2017, COMPUT CHEM ENG
   Lehr T, 2017, TECHNOL FORECAST SOC, V124, P214, DOI 10.1016/j.techfore.2017.06.026
   Li L, 2013, FUEL, V108, P112, DOI 10.1016/j.fuel.2011.08.022
   Linstone H.A., 1975, DELPHI METHOD TECHNI, V29
   Loo R, 2002, POLICING, V25, P762, DOI 10.1108/13639510210450677
   Mac Dowell N, 2017, NAT CLIM CHANGE, V7, P243, DOI 10.1038/NCLIMATE3231
   Mahmoud M, 2009, ENVIRON MODELL SOFTW, V24, P798, DOI 10.1016/j.envsoft.2008.11.010
   Margolis R, 2006, NONTECHNICAL BARRIER
   Markewitz P, 2012, ENERG ENVIRON SCI, V5, P7281, DOI 10.1039/c2ee03403d
   Melander L, 2019, TECHNOL FORECAST SOC, V138, P178, DOI 10.1016/j.techfore.2018.08.019
   Mikkelsen M, 2010, ENERG ENVIRON SCI, V3, P43, DOI 10.1039/b912904a
   Muller K, 2014, CHEM-ING-TECH, V86, P497, DOI 10.1002/cite.201300152
   Mullen Penelope M, 2003, J Health Organ Manag, V17, P37, DOI 10.1108/14777260310469319
   Najera M, 2011, CHEM ENG RES DES, V89, P1533, DOI 10.1016/j.cherd.2010.12.017
   Negro SO, 2008, TECHNOL FORECAST SOC, V75, P57, DOI 10.1016/j.techfore.2006.08.006
   Nowack M, 2011, TECHNOL FORECAST SOC, V78, P1603, DOI 10.1016/j.techfore.2011.03.006
   Nygren NA, 2017, FUTURES, V93, P1, DOI 10.1016/j.futures.2017.08.004
   O'Brien FA, 2013, TECHNOL FORECAST SOC, V80, P643, DOI 10.1016/j.techfore.2012.06.006
   Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002
   Pare G, 2013, INFORM MANAGE-AMSTER, V50, P207, DOI 10.1016/j.im.2013.03.003
   Patricio J, 2017, J CO2 UTIL, V17, P50, DOI 10.1016/j.jcou.2016.10.002
   Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x
   Quadrelli EA, 2011, CHEMSUSCHEM, V4, P1194, DOI 10.1002/cssc.201100473
   Rahman FA, 2017, RENEW SUST ENERG REV, V71, P112, DOI 10.1016/j.rser.2017.01.011
   Reich MC, 2005, J CLEAN PROD, V13, P253, DOI 10.1016/j.jclepro.2004.02.015
   Riduan SN, 2010, DALTON T, V39, P3347, DOI 10.1039/b920163g
   ROWE EGP, 2001, SPRINGER MG MATH, P125
   Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7
   Sayre R, 2010, BIOSCIENCE, V60, P722, DOI 10.1525/bio.2010.60.9.9
   Schmidt R, 2001, J MANAGE INFORM SYST, V17, P5, DOI 10.1080/07421222.2001.11045662
   Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x
   SCHOEMAKER PJH, 1995, SLOAN MANAGE REV, V36, P25
   Schrag DP, 2009, SCIENCE, V325, P1658, DOI 10.1126/science.1175750
   Siebelink R, 2016, TECHNOL FORECAST SOC, V110, P226, DOI 10.1016/j.techfore.2016.01.030
   Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029
   Styring P., 2014, CARBON DIOXIDE UTILI
   Styring P, 2011, CARBON CAPTURE UTILI
   TGC Initiative, 2016, ROADMAP GLOBAL IMPLE
   The Ellen MacArthur Foundation, 2012, CIRC EC EC BUS RAT A
   The Royal Society, 2017, POT LIM US CARB DIOX
   Thomassen G, 2017, RENEW SUST ENERG REV, V68, P876, DOI 10.1016/j.rser.2016.02.015
   UNEP, 2002, GLOB ENV OUTL 3, P320
   Van der Heijden K., 2011, SCENARIOS ART STRATE
   van Heek J, 2017, ENERG POLICY, V105, P53, DOI 10.1016/j.enpol.2017.02.016
   van Notten PWF, 2003, FUTURES, V35, P423, DOI 10.1016/S0016-3287(02)00090-3
   von der Assen N, 2013, ENERG ENVIRON SCI, V6, P2721, DOI 10.1039/c3ee41151f
   von der Assen N, 2014, GREEN CHEM, V16, P3272, DOI 10.1039/c4gc00513a
   von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013
   von der Gracht HA, 2010, INT J PROD ECON, V127, P46, DOI 10.1016/j.ijpe.2010.04.013
   Wilson G, 2016, VISION SMART CO2 TRA
   Wulf T., 2010, SCENARIO BASED APPRO
   Yaqoot M, 2016, RENEW SUST ENERG REV, V58, P477, DOI 10.1016/j.rser.2015.12.224
   Yousuf M. I., 2007, PRACT ASSESS RES EVA, V12, P1
   Yu KMK, 2008, CHEMSUSCHEM, V1, P893, DOI 10.1002/cssc.200800169
   Zhang X, 2013, ENERG POLICY, V59, P536, DOI 10.1016/j.enpol.2013.04.005
NR 96
TC 2
Z9 2
U1 3
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 484
EP 501
DI 10.1016/j.resconrec.2019.01.027
PG 18
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900046
DA 2020-05-12
ER

PT J
AU Sen, B
   Ercan, T
   Tatari, O
   Zheng, QP
AF Sen, Burak
   Ercan, Tolga
   Tatari, Omer
   Zheng, Qipeng Phil
TI Robust Pareto optimal approach to sustainable heavy-duty truck fleet
   composition
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Fleet mix optimization; Heavy-duty truck robust optimization; Hybrid
   life cycle assessment; Alternative fuel adoption; Battery-electric
   heavy-duty truck; Robust Pareto optimal solutions
ID LIFE-CYCLE ASSESSMENT; CROSS-BORDER LOGISTICS; MULTIOBJECTIVE
   OPTIMIZATION; ENVIRONMENTAL OPTIMIZATION; EMISSIONS; IMPACTS; ENERGY;
   TOOL; PERFORMANCE; MANAGEMENT
AB Heavy-duty trucks are the main carrier of the most of freight in the United States today. The U.S. Department of Energy's projections show that, under the reference case, the truck vehicle-miles-travelled (VMT) on the national highway system will further increase in the near future. This outlook with regard to U.S. Class 8 Heavy-Duty Trucks (HDTs) raises concerns regarding environmental, economic, and social impacts of these vehicles and HDT fleets. However, the transition to sustainable trucking is a challenging task for which multiple sustainability objectives must be considered and addressed, such as minimizing the life-cycle costs (LCCs), life-cycle GHGs (LCGHGs), and life-cycle air pollution externality costs (LCAPECs) of trucks while composing a truck fleet. This study proposes a hybrid life-cycle assessment-based robust Pareto optimal approach to developing a HDT fleet mix, accounting for the sector-specific average payloads of 5 U.S. economic sectors. The results of this study indicate that battery-electric, hybrid, and diesel HDTs make up most of the fleet mixes in the studied sectors in order to optimize their environmental, economic, and social impacts. It is therefore concluded that, given the relevant objectives and constraints, the current techno-economic circumstances in the U.S. and current forms of electricity generation should both be improved in order for HDT fleet mixes to achieve greenhouse gas emission reductions of 30% or greater. The findings of the study will support decision-making processes by public and private organizations and help them to develop environmentally, economically, and socially optimized fleet mixes for their operations.
C1 [Sen, Burak; Ercan, Tolga; Tatari, Omer] Univ Cent Florida, Dept Civil Environm & Construct Engn, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
   [Zheng, Qipeng Phil] Univ Cent Florida, Dept Ind Engn & Management Syst, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
RP Tatari, O (reprint author), Univ Cent Florida, Dept Civil Environm & Construct Engn, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
EM tatari@ucf.edu
OI Ercan, Tolga/0000-0001-7074-4628; Tatari, Omer/0000-0002-8150-992X;
   Zheng, Qipeng/0000-0002-4597-3426
CR Ahmadi A, 2015, J CLEAN PROD, V100, P116, DOI 10.1016/j.jclepro.2015.03.045
   Antipova E, 2014, ENERG BUILDINGS, V82, P92, DOI 10.1016/j.enbuild.2014.07.001
   Askin AC, 2015, ENERG POLICY, V81, P1, DOI 10.1016/j.enpol.2015.02.005
   Bengtsson M., 2000, J IND ECOL, V4, P47, DOI DOI 10.1162/10881980052541945
   Bicer Y, 2018, RESOUR CONSERV RECY, V132, P141, DOI 10.1016/j.resconrec.2018.01.036
   Boriboonsomsin K., 2015, REDUCING CARBON FOOT
   Bureau of Transportation Statistics, 2018, TRANSP STAT ANN REP
   Burnham A., 2016, USER GUIDE AFLEET TO
   Burnham A., 2013, AFLEET TOOL 2013
   Burnham A., 2017, USER GUIDE AFLEET TO, P45
   California Air Resources Board, 2015, DRAFT TECHN ASS MED
   CALSTART, 2013, 1 710 PROJ ZER EM TR
   Cambero C, 2016, CHEM ENG RES DES, V107, P218, DOI 10.1016/j.cherd.2015.10.040
   Carnegie Mellon University Green Design Institute, 2008, EC INP OUTP LIF CYCL
   De Filippo G, 2014, APPL ENERG, V113, P1686, DOI 10.1016/j.apenergy.2013.09.011
   DiOrio N., 2015, TECHNOECONOMIC MODEL
   Ercan T, 2015, ENERGY, V93, P323, DOI 10.1016/j.energy.2015.09.018
   Ercan T, 2015, INT J LIFE CYCLE ASS, V20, P1213, DOI 10.1007/s11367-015-0927-2
   Executive Order 13693, 2015, FED REGISTER, V80, P15871
   Figliozzi M, 2020, TRANSPORT POLICY, V86, P60, DOI 10.1016/j.tranpol.2018.06.010
   Finnveden G, 1997, INT J LIFE CYCLE ASS, V2, P163, DOI 10.1007/BF02978812
   Gabrel V, 2014, EUR J OPER RES, V235, P471, DOI 10.1016/j.ejor.2013.09.036
   GAMS Development Corporation, 2013, GEN ALG MOD SYST GAM
   Gaspar-Cunha A, 2008, COMPUT OPTIM APPL, V39, P75, DOI 10.1007/s10589-007-9053-9
   Gore D., 2017, GUIDANCE FEDERAL AGE
   Gorissen BL, 2015, OMEGA-INT J MANAGE S, V53, P124, DOI 10.1016/j.omega.2014.12.006
   Guerrero SE, 2013, TRANSPORT RES E-LOG, V59, P85, DOI 10.1016/j.tre.2013.08.005
   Hendrickson CT, 1997, PROCEEDINGS OF THE 1997 IEEE INTERNATIONAL SYMPOSIUM ON ELECTRONICS AND THE ENVIRONMENT - ISEE-1997, P176, DOI 10.1109/ISEE.1997.605313
   Hu J, 2012, OPER RES, V60, P936, DOI 10.1287/opre.1120.1071
   Hummels D, 2007, J ECON PERSPECT, V21, P131, DOI 10.1257/jep.21.3.131
   Keeney RL, 1976, DECISIONS MULTIPLE O
   Kelly K., 2015, BATTERY OWNERSHIP MO
   Kempton W., 2001, VEHICLE TO GRID POWE
   Koc C, 2014, TRANSPORT RES B-METH, V70, P239, DOI 10.1016/j.trb.2014.09.008
   Kucukvar M, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010089
   Kucukvar M, 2015, J CLEAN PROD, V108, P395, DOI 10.1016/j.jclepro.2015.08.117
   Kucukvar M, 2014, WASTE MANAGE RES, V32, P500, DOI 10.1177/0734242X14536457
   Kucukvar M, 2014, INT J LIFE CYCLE ASS, V19, P1185, DOI 10.1007/s11367-014-0723-4
   Kucukvar M, 2014, AUTOMAT CONSTR, V40, P33, DOI 10.1016/j.autcon.2013.12.009
   Kucukvar M, 2013, INT J LIFE CYCLE ASS, V18, P958, DOI 10.1007/s11367-013-0545-9
   Leung SCH, 2002, MATH COMPUT MODEL, V36, P1221, DOI 10.1016/S0895-7177(02)00271-6
   Leung SCH, 2006, COMPUT IND ENG, V50, P263, DOI 10.1016/j.cie.2006.04.003
   Li Y, 2016, COMPUT OPER RES, V72, P107, DOI 10.1016/j.cor.2016.02.013
   List GF, 2003, TRANSPORT RES E-LOG, V39, P209, DOI 10.1016/S1366-5545(02)00026-1
   Mai T.T., 2018, ELECT FUTURES STUDY
   Mallon KR, 2017, ENERGIES, V10, DOI 10.3390/en10070943
   Mareev I, 2018, ENERGIES, V11, DOI 10.3390/en11010055
   Miettinen K., 1999, NONLINEAR MULTIOBJEC
   National Renewable Energy Laboratory, 2012, PLUG IN EL VEH HDB F
   Nealer R, 2012, TRANSPORT RES A-POL, V46, P588, DOI 10.1016/j.tra.2011.11.010
   Noori M, 2015, ENERGY, V89, P610, DOI 10.1016/j.energy.2015.05.152
   Noori M, 2015, INT J SUSTAIN ENERGY, V34, P629, DOI 10.1080/14786451.2013.854796
   Onat NC, 2015, INTEGRATED SUSTAINAB
   Onat NC., 2015, MACROLEVEL SUSTAINAB
   Onat NC, 2017, ENERGY, V121, P631, DOI 10.1016/j.energy.2017.01.035
   Onat NC, 2016, SUSTAIN PROD CONSUMP, V6, P12, DOI 10.1016/j.spc.2015.12.003
   Onat NC, 2016, J CLEAN PROD, V112, P291, DOI 10.1016/j.jclepro.2015.09.021
   Onat NC, 2014, SUSTAINABILITY-BASEL, V6, P9305, DOI 10.3390/su6129305
   Paez MA., 2016, ALTERNATIVE ENERGY S, P465
   Pell R, 2019, RESOUR CONSERV RECY, V142, P267, DOI 10.1016/j.resconrec.2018.11.022
   Pomponi F, 2018, J CLEAN PROD, V176, P210, DOI 10.1016/j.jclepro.2017.12.119
   Ranaiefar F, 2011, ELSEV INSIGHT, P333, DOI 10.1016/B978-0-12-385202-1.00016-5
   Rentizelas A, 2014, ENERG POLICY, V65, P134, DOI 10.1016/j.enpol.2013.10.023
   RobecoSAM AG, 2016, ROBECOSAM CORP SUST
   Roberts KP, 2018, J CLEAN PROD, V196, P547, DOI 10.1016/j.jclepro.2018.05.265
   Sen B, 2017, J CLEAN PROD, V141, P110, DOI 10.1016/j.jclepro.2016.09.046
   Seppala J., 2016, EXPERT PANEL WEIGHTI, DOI [10.1002/sd.1659, DOI 10.1002/SD.1659]
   Smith M., 2014, COSTS ASS COMPRESSED
   Suh S, 2004, ENVIRON SCI TECHNOL, V38, P657, DOI 10.1021/es0263745
   Tatari O, 2012, J CONSTR ENG M, V138, P918, DOI 10.1061/(ASCE)CO.1943-7862.0000509
   The Mathworks Inc, 2017, MATLAB
   Torrey W. F., 2016, ANAL OPERATIONAL COS
   Torrey W.F., 2015, ANAL OPERATIONAL COS
   TRB NRC, 2010, TECHN APPR RED FUEL
   U.S. Department of Energy, 2015, CLEAN CIT ALT FUEL P
   U. S. Department of Transportation, 2016, TRANSP STAT ANN REP
   U. S. EIA, 2017, GASOL DIESEL FUEL UP
   U. S. EIA, 2017, ELECT POWER MON
   U.S. Energy Information Administration, 2017, ANN EN OUTL 2017 PRO
   U.S. Energy Information Administration, 2019, ANN EN OUTL 2019 PRO
   U.S. Energy Information Administration, 2015, ANN EN OUTL 2015 PRO
   U. S. EPA, 2016, SMARTW PROGR
   U.S. EPA, 2019, INV US GREENH GAS EM
   von Winterfeldt D., 1986, DECISION ANAL BEHAV
   Vora AP, 2019, P I MECH ENG D-J AUT, V233, P1507, DOI 10.1177/0954407018802663
   Wang D, 2016, J POWER SOURCES, V332, P193, DOI 10.1016/j.jpowsour.2016.09.116
   Yue DJ, 2016, ENVIRON SCI TECHNOL, V50, P1501, DOI 10.1021/acs.est.5b04279
   Zhao Y, 2016, SUSTAIN PROD CONSUMP, V8, P18, DOI 10.1016/j.spc.2016.04.003
   Zhao Y, 2016, TRANSPORT RES D-TR E, V47, P195, DOI 10.1016/j.trd.2016.05.014
NR 89
TC 0
Z9 0
U1 4
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 502
EP 513
DI 10.1016/j.resconrec.2019.03.042
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900047
DA 2020-05-12
ER

PT J
AU Philippidis, G
   Sartori, M
   Ferrari, E
   M'Barek, R
AF Philippidis, George
   Sartori, Martina
   Ferrari, Emanuele
   M'Barek, Robert
TI Waste not, want not: A bio-economic impact assessment of household food
   waste reductions in the EU
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Food waste; CGE; EU; Households' food waste; Packaging; Costs of
   reducing food waste
ID LOSSES; TRADE; WATER; MODEL
AB Halving per capita food waste and reducing food losses along production and supply chains is one of the objectives fixed by the United Nations among the Sustainable Development Goals (SDGs). This study employs a system-wide modelling approach, to simulate economic impacts of households' food waste reduction in 2030, focusing on the European Union. The paper provides market, food security, biophysical and environmental indicators resulting from food commodity specific waste reductions by EU households. The scenarios explicitly account for associated costs paid by food manufacturers derived from adjustments in the packaging, labelling and logistics. The model shows, under a series of market assumptions, a possible increase in household savings, a fall in agri-food production and a minor negative macroeconomic impact due to household food waste reductions. On the other hand, the effects on environmental indicators such as land usage, GHG emissions and water abstraction are positive. Future research on several aspects of the food waste topic is needed to better integrate all economic aspects.
C1 [Philippidis, George; Sartori, Martina; Ferrari, Emanuele; M'Barek, Robert] European Commiss, JRC, Seville, Spain.
   [Philippidis, George] Govt Aragon, Agrifood Inst Aragon IA2, Aragonese Agcy Res & Dev ARAID, Ctr Agrofood Res & Technol CITA, Zaragoza, Spain.
RP Sartori, M (reprint author), European Commiss, JRC, Seville, Spain.
EM George.PHILIPPIDIS@ec.europa.eu; Martina.SARTORI@ec.europa.eu;
   Emanuele.FERRARI@ec.europa.eu; Robert.M'BAREK@ec.europa.eu
RI Ferrari, Emanuele/J-4954-2019
OI Ferrari, Emanuele/0000-0003-0031-7190; Sartori,
   Martina/0000-0002-2794-0532
CR Aguiar A, 2016, J GLOB ECON ANAL, V1, P181, DOI 10.21642/JGEA.010103AF
   [Anonymous], 2014, FOOD WAST FOOTPR IMP
   Bagherzadeh M., 2014, OECD FOOD AGR FISHER, V71, DOI [10.1787/5jxrcmftzj36-en, DOI 10.1787/18156797, 10.1787/18156797]
   Banse M, 2011, BIOMASS BIOENERG, V35, P2385, DOI 10.1016/j.biombioe.2010.09.001
   Bellemare MF, 2017, AM J AGR ECON, V99, P1148, DOI 10.1093/ajae/aax034
   Bio Intelligence Service, 2010, PREPARATORY STUDY FO, DOI [10.2779/85947, DOI 10.2779/85947]
   Boulanger P, 2015, FOOD POLICY, V51, P119, DOI 10.1016/j.foodpol.2015.01.004
   Britz W., 2014, EAAE 2014 C SLOV
   Burniaux J. M., 2002, 16 GTAP CTR GLOB TRA
   Campoy-Munoz P, 2017, RESOUR CONSERV RECY, V122, P202, DOI 10.1016/j.resconrec.2017.02.010
   Corong EL, 2017, J GLOB ECON ANAL, V2, P1
   Corrado S, 2019, GLOB FOOD SECUR-AGR, V20, P93, DOI 10.1016/j.gfs.2019.01.002
   Corrado S, 2018, WASTE MANAGE, V79, P120, DOI 10.1016/j.wasman.2018.07.032
   Cristobal J, 2018, WASTE MANAGE, V72, P3, DOI 10.1016/j.wasman.2017.11.007
   European Commission, 2018, SUST BIOEC EUR STREN
   European Commission, 2014, CIRC EC ZER WAST PRO
   European Court of Auditors, 2016, 34 EUR COURT AUD
   European Union, 2019, EU PLATF FOOD LOSS F
   FAO, 2013, FOOD WAST FOOTPR IMP
   Food and Agriculture Organization, 2011, GLOB FOOD LOSS FOOD
   Hanson C., 2017, CHAMPIONS, V12, P3
   Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092
   Lebersorger S, 2011, WASTE MANAGE, V31, P1924, DOI 10.1016/j.wasman.2011.05.023
   Lusk JL, 2017, APPL ECON LETT, V24, P1199, DOI 10.1080/13504851.2016.1265070
   Neff RA, 2019, WASTE MANAGE, V86, P123, DOI 10.1016/j.wasman.2019.01.023
   Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091
   Philippidis G., 2018, JRC TECHNICAL REPORT, DOI [10.2760/560977, DOI 10.2760/560977]
   ReFED, 2018, EC AN FOOD WAST SOL
   Rutten M., 2015, FOCUS FOOD PRICES PR
   Rutten M., 2013, REDUCING FOOD WASTE
   Rutten M., 2014, 2014035 LEI
   Rutten M. M., 2013, AGR FOOD SECURITY, V2, P1, DOI DOI 10.1186/2048-7010-2-13
   Rutten M, 2016, AFR J AGRIC RESOUR E, V11, P118
   Rutten M, 2013, FOOD POLICY, V38, P1, DOI 10.1016/j.foodpol.2012.09.002
   Schanes K, 2018, J CLEAN PROD, V182, P978, DOI 10.1016/j.jclepro.2018.02.030
   Scherhaufer S, 2018, WASTE MANAGE, V77, P98, DOI 10.1016/j.wasman.2018.04.038
   Schmitz C, 2014, AGR ECON-BLACKWELL, V45, P69, DOI 10.1111/agec.12090
   Schneider F, 2013, PROC INST CIV ENG-WA, V166, DOI 10.1680/warm.13.00016
   Segre A., 2014, BACKGROUND PAPER EC
   Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0
   Stenmarck A., ESTIMATES EUROPEAN F
   United Nations, 2015, TRANSF OUR WORLD 203
   Vanham D, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/084008
   Vanham D, 2018, NAT SUSTAIN, V1, P518, DOI 10.1038/s41893-018-0133-x
   Verghese K, 2015, PACKAG TECHNOL SCI, V28, P603, DOI 10.1002/pts.2127
   Williams H, 2012, J CLEAN PROD, V24, P141, DOI 10.1016/j.jclepro.2011.11.044
   Woltjer G. B., 2014, 14057 LEI WAG UR
NR 47
TC 3
Z9 3
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 514
EP 522
DI 10.1016/j.resconrec.2019.04.016
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900048
PM 31274960
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Bassi, F
   Dias, JG
AF Bassi, Francesca
   Dias, Jose G.
TI The use of circular economy practices in SMEs across the EU
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Circular economy; Small and medium-sized enterprises (SMEs);
   Cross-cultural research; Multilevel modeling; European Union
AB This study explores the circular economy (CE) practices of Small and Medium Enterprises (SMEs) in the 28 European Union (EU) member states. Five measures of CE are studied, namely Re-planning the way water is used to minimize usage and maximize re-usage, Using renewable energy, Re-planning energy usage to minimize consumption, Minimizing waste by recycling or reusing waste or selling it to another firm, and Redesigning products and services to minimize the use of materials or using recycled materials. Multilevel ordinal probit models that control within- and between-variability across European Union countries are estimated. Results show that CE measures across EU countries are very heterogeneous. At the firm level, we find that firm size (number of employees and total turnover in 2015) and percentage of firms' turnover invested in R&D in 2015 are significant in explaining within-country variations. The multilevel structure (between-country variability) accounts for 6.1%-15.1% of the total variability of CE measures. These results have implications for the design of framework policies at EU level given that the firms surveyed are SMEs, the segment in which these CE measures most need improved planning and implementation.
C1 [Bassi, Francesca] Univ Padua, Via C Battisti 241, I-35121 Padua, Italy.
   [Dias, Jose G.] Inst Univ Lisboa ISCTE IUL, Business Res Unit BRU IUL, Lisbon, Portugal.
RP Bassi, F (reprint author), Univ Padua, Via C Battisti 241, I-35121 Padua, Italy.
EM bassi@stat.unipd.it
RI Dias, Jose G./N-6217-2015
OI Bassi, Francesca/0000-0002-3257-7029
FU Portuguese Foundation for Science and TechnologyPortuguese Foundation
   for Science and Technology [UID/GES/00315/2013, UID/GES/00315/2019,
   BIRD162088/16]; University of Padua
FX The authors would like to thank the editor and one anonymous reviewer
   for his/her constructive comments, which helped us to improve the
   manuscript. This work was funded by the Portuguese Foundation for
   Science and Technology (Grant UID/GES/00315/2013 and UID/GES/00315/2019)
   and by grant BIRD162088/16 financed by the University of Padua for the
   project entitled "Advances in Multilevel and Longitudinal Modelling".
CR Cassells S, 2011, CORP SOC RESP ENV MA, V18, P186, DOI 10.1002/csr.269
   Dalhammar C, 2016, J CLEAN PROD, V123, P155, DOI 10.1016/j.jclepro.2015.12.035
   Del Rio G. P., 2005, BUSINESS STRATEGY EN, V14, P20, DOI DOI 10.1002/BSE.426
   Ellen MacArthur Foundation, 2015, CIRC EC EC BUS RAT A
   European Commission, 2014, CIRC EC ZER WAST PRO
   European Commission, 2016, EUR SMES CIRC EC FLA, V411
   European Commission, 2012, IMP ASS COMM BLUEPR
   European Commission, 2015, CLOS LOOP EU ACT PLA
   European Commission, 2003, COMM INT PROD POL BU
   European Commission Enterprise and Industry (ECEI), 2010, SMES ENV EUR UN
   Garetti M, 2012, PROD PLAN CONTROL, V23, P83, DOI 10.1080/09537287.2011.591619
   Ge XY, 2014, SAE INT J COMMER VEH, V7, P588, DOI 10.4271/2014-01-2410
   Ghisellini P, 2016, J CLEAN PROD, V114, P11, DOI 10.1016/j.jclepro.2015.09.007
   Hanyu K, 2000, RESOUR CONSERV RECY, V30, P177, DOI 10.1016/S0921-3449(00)00060-4
   HEDEKER D, 1994, BIOMETRICS, V50, P933, DOI 10.2307/2533433
   Hockerts K, 2010, J BUS VENTURING, V25, P481, DOI 10.1016/j.jbusvent.2009.07.005
   Hoogendoorn B, 2015, SMALL BUS ECON, V44, P759, DOI 10.1007/s11187-014-9618-9
   Hox J., 2002, QUANTITATIVE METHODO
   Huang PS, 2006, J CLEAN PROD, V14, P1635, DOI 10.1016/j.jclepro.2006.02.006
   Hughes R, 2017, PROC CIRP, V61, P10, DOI 10.1016/j.procir.2016.12.006
   Jansson J, 2010, J CONSUM MARK, V27, P358, DOI 10.1108/07363761011052396
   Kopnina H., 2018, HDB ENGAGED SUSTAINA, P809
   Lieder M, 2016, J CLEAN PROD, V115, P36, DOI 10.1016/j.jclepro.2015.12.042
   Liu LL, 2017, J MATER CYCLES WASTE, V19, P1314, DOI 10.1007/s10163-017-0606-4
   McDonald S, 2003, RESOUR CONSERV RECY, V39, P369, DOI 10.1016/S0921-3449(03)00020-X
   McDonough W., 2002, CRADLE CRADLE REMAKI
   Neubaum DO, 2004, J BUS ETHICS, V52, P335, DOI 10.1007/s10551-004-1532-7
   Ormazabal M, 2018, J CLEAN PROD, V185, P157, DOI 10.1016/j.jclepro.2018.03.031
   Pearce D. W., 1990, EC NATURAL RESOURCES
   Repo P, 2018, EUR J SUSTAIN DEV, V7, P249, DOI 10.14207/ejsd.2018.v7n1p249
   Rizos V, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8111212
   Schaltegger S, 2011, BUS STRATEG ENVIRON, V20, P222, DOI 10.1002/bse.682
   Snijders TAB, 2012, MULTILEVEL ANAL INTR
   Stahel W.R., 1976, POTENTIAL SUBSTITUTI
   Stahel WR, 2016, NATURE, V531, P435, DOI 10.1038/531435a
   WELSH JA, 1981, HARVARD BUS REV, V59, P18
   Yadav N, 2018, EUR J SUSTAIN DEV, V7, P531, DOI 10.14207/ejsd.2018.v7n4p531
NR 37
TC 3
Z9 3
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 523
EP 533
DI 10.1016/j.resconrec.2019.03.019
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900049
OA Green Accepted
DA 2020-05-12
ER

PT J
AU Ghimire, SR
   Johnston, JM
   Garland, J
   Edelen, A
   Ma, X
   Jahne, M
AF Ghimire, Santosh R.
   Johnston, John M.
   Garland, Jay
   Edelen, Ashley
   Ma, Xin (Cissy)
   Jahne, Michael
TI Life cycle assessment of a rainwater harvesting system compared with an
   AC condensate harvesting system
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Air-conditioning condensate water; Life cycle assessment; Rainwater
   harvesting; Water reuse
ID AIR; LCA
AB This study presents a life cycle assessment (LCA) of a rainwater harvesting (RWH) system and an air-conditioning condensate harvesting (ACH) system for non-potable water reuse. U.S. commercial buildings were reviewed to design rooftop RWH and ACH systems for one- to multi-story buildings' non-potable water demand. A life cycle inventory was compiled from the U.S. EPA's database. Nine scenarios were analyzed, including baseline RWH system, ACH system, and combinations of the two systems adapted to 4-story and 19-story commercial buildings in San Francisco and a 4-story building in Washington, DC. Normalization of 11 life cycle, impact assessment categories showed that RWH systems in 4-story buildings at both locations outperformed ACH systems (45-80% of ACH impacts) except equivalent in Evaporative Water Consumption. However, San Francisco's ACH system in 19-story building outperformed the RWH system (51-83% of RWH impacts) due to the larger volume of ACH collection, except equivalent in Evaporative Water Consumption. For all three buildings, the combined system preformed equivalently to the better-performing option (<= 4-8% impact difference compared to the maximum system). Sensitivity analysis of the volume of water supply and building occupancy showed impact-specific results. Local climatic conditions, rainfall, humidity, water collections and demands are important when designing building-scale RWH and ACH systems. LCA models are transferrable to other locations with variable climatic conditions for decision-making when developing and implementing on-site non-potable water systems.
C1 [Ghimire, Santosh R.] US EPA, Global Sustainabil & Life Cycle Consultant LLC, 960 Coll Stn Rd, Athens, GA 30605 USA.
   [Johnston, John M.] US EPA, Off Res & Dev, Computat Exposure Div, 960 Coll Stn Rd, Athens, GA 30605 USA.
   [Garland, Jay; Ma, Xin (Cissy); Jahne, Michael] US EPA, Off Res & Dev, 26 W Martin Luther King Dr, Cincinnati, OH 45268 USA.
   [Edelen, Ashley] US EPA, Oak Ridge Inst Sci & Educ Participant, 26 W Martin Luther King Dr, Cincinnati, OH 45268 USA.
   [Ghimire, Santosh R.] Global Sustainabil & Life Cycle Consultant LLC, POB 1008, Watkinsville, GA 30677 USA.
RP Ghimire, SR (reprint author), US EPA, Global Sustainabil & Life Cycle Consultant LLC, 960 Coll Stn Rd, Athens, GA 30605 USA.; Ghimire, SR (reprint author), Global Sustainabil & Life Cycle Consultant LLC, POB 1008, Watkinsville, GA 30677 USA.
EM sghimire02@gmail.com
OI Johnston, John/0000-0002-5886-7876
FU U.S. Environmental Protection Agency Office of Research and
   DevelopmentUnited States Environmental Protection Agency
   [EP-17-W-000114]
FX This research was supported in part by the U.S. Environmental Protection
   Agency Office of Research and Development through Contract Award Order
   No. EP-17-W-000114 to Global Sustainability and Life Cycle Consultant,
   LLC. Santosh R. Ghimire (SRG) is affiliated with the Global
   Sustainability and Life Cycle Consultant. SRG is also an Adjunct
   Assistant Professor in the Department of Environmental Science and
   Technology of University of Maryland, College Park (USA). The views
   expressed are those of the authors and do not necessarily reflect the
   views or policies of the EPA. Although this document has been reviewed
   in accordance with EPA policy and approved for publication, it may not
   necessarily reflect official Agency policy. The authors thank Fran
   Rauschenberg (Senior Service America, Inc.), Ranjani Theregowda
   (National Research Council Associate), and Briana Niblick (EPA) for
   technical editing and review that improved the manuscript. The authors
   also thank the three anonymous reviewers for their constructive comments
   which improved the manuscript. Preliminary results were presented at the
   2018 Water Research Foundation Conference in Atlanta, Georgia. Mention
   of trade names or commercial products does not constitute endorsement or
   recommendation for use.
CR [Anonymous], 2009, NASSAU COUNTY STORM
   [Anonymous], 2006, 14040 ISO
   [Anonymous], 2006, 14044 ISO
   AWE, 2018, COND WAT INTR
   Brauman KA, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000083
   Cashman S., 2014, ENV COST LIF CYCL AS
   Cook S, 2014, RESOUR CONSERV RECY, V89, P86, DOI 10.1016/j.resconrec.2014.05.003
   Domenech L, 2012, WATER ENVIRON J, V26, P465, DOI 10.1111/j.1747-6593.2011.00305.x
   Edelen A, 2016, GUIDANCE DATA QUALIT
   Eroksuz E, 2010, RESOUR CONSERV RECY, V54, P1449, DOI 10.1016/j.resconrec.2010.06.010
   ETA, 2016, 2012 CBECS SURV DAT
   Farreny R, 2011, RESOUR CONSERV RECY, V55, P686, DOI 10.1016/j.resconrec.2011.01.008
   Fathieh F, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3198
   Ghimire SR, 2012, WATER SCI TECH-W SUP, V12, P309, DOI 10.2166/ws.2011.135
   Ghimire SR, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.135
   Ghimire SR, 2017, J CLEAN PROD, V151, P74, DOI 10.1016/j.jclepro.2017.02.025
   Ghimire SR, 2015, WORLD ENVIRONMENTAL AND WATER RESOURCES CONGRESS 2015: FLOODS, DROUGHTS, AND ECOSYSTEMS, P182
   Ghimire SR, 2014, ENVIRON SCI TECHNOL, V48, P4069, DOI 10.1021/es500189f
   Ghimire Santosh R., 2013, Ecohydrology & Hydrobiology, V13, P159, DOI 10.1016/j.ecohyd.2013.03.007
   Glawe D. D., 2013, SAN ANTONIO CONDENSA
   GLEICK PH, 1993, WATER CRISIS GUIDE W
   Glendenning CJ, 2011, AGR WATER MANAGE, V98, P715, DOI 10.1016/j.agwat.2010.11.010
   Graham S, 2010, WATER CYCLE
   Guo M, 2012, SCI TOTAL ENVIRON, V435, P230, DOI 10.1016/j.scitotenv.2012.07.006
   Kim H, 2017, SCIENCE, V356, P430, DOI 10.1126/science.aam8743
   Lawrence T, 2010, ASHRAE J, V52, P48
   Lesage P., 2018, INT J LIFE CYCLE ASS, P1
   Licina D, 2012, ENERG BUILDINGS, V45, P257, DOI 10.1016/j.enbuild.2011.11.016
   Mahmood A, 2017, RESOUR CONSERV RECY, V125, P157, DOI 10.1016/j.resconrec.2017.06.013
   Mitchell K, 2008, RADICAL PHILOS, P54
   Mitchell VG, 2007, HYDROL PROCESS, V21, P2850, DOI 10.1002/hyp.6499
   Moniruzzaman M, 2017, RESOUR CONSERV RECY, V125, P139, DOI 10.1016/j.resconrec.2017.06.001
   Morelli B., COMMUNICATION
   National Academies of Sciences E. and Medicine, 2016, US GRAYW STORMW ENH
   NCEI, 2018, CLIM DAT ONL DAT TOO
   NIST, 2013, BUILD ENV EC SUST BE
   NREL, 2013, US LIF CYCL INV DAT
   OpenLCA, 2018, OPENLCA LIF CYCL SUS
   Painter F. L, 2009, ASHRAE T, V115
   Roebuck RM, 2011, WATER ENVIRON J, V25, P355, DOI 10.1111/j.1747-6593.2010.00230.x
   Ross S, 2002, INT J LIFE CYCLE ASS, V7, P47, DOI 10.1007/BF02978909
   RSES, 2009, SERV APPL MAN SAM
   Schoen M., 2015, SUSTAIN WATER QUAL E, V6, P75, DOI DOI 10.1016/j.swaqe.2015.05.001
   Sharvelle S., 2017, P WATER ENV FEDERATI, V8, P3799
   Shuster W, 2013, J HYDROL, V485, P177, DOI 10.1016/j.jhydrol.2012.10.043
   Siems R, 2016, J CLEAN PROD, V113, P251, DOI 10.1016/j.jclepro.2015.11.020
   TXWDB, 2005, TEX MAN RAINW HARV
   USEPA, 2018, LIF ASS PRINC PRACT
   USEPA, 2013, TOOL RED ASS CHEM OT
   USEPA, 2012, GUID WAT REUS
   Walsh TC, 2014, J HYDROL, V508, P240, DOI 10.1016/j.jhydrol.2013.10.038
   Wang RR, 2015, ENVIRON SCI TECHNOL, V49, P1768, DOI 10.1021/es5046887
   Ward S, 2012, WATER RES, V46, P5127, DOI 10.1016/j.watres.2012.06.043
   Welderufael W. A., 2011, HYDROL EARTH SYST SC, V8, P5051
   Zhang XQ, 2014, WATER RESOUR MANAG, V28, P671, DOI 10.1007/s11269-013-0507-9
NR 55
TC 1
Z9 1
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 536
EP 548
DI 10.1016/j.resconrec.2019.01.043
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900051
PM 31274961
OA Other Gold, Green Accepted
DA 2020-05-12
ER

PT J
AU Sheppard, P
   Rahimifard, S
AF Sheppard, Phil
   Rahimifard, Shahin
TI Embodied energy in preventable food manufacturing waste in the United
   Kingdom
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Food manufacturing; Food waste; Industrial energy efficiency; Embodied
   energy; Energy management
AB The food processing and manufacturing industry is the UK's largest manufacturing sector and consequently a large consumer of natural resources and source of environmental impacts. Considerable research effort has been made to quantify and characterise food waste and energy consumption from the industry, enabling the sector to set targets for reductions which contribute to national targets and the UN Sustainable Development Goal 12.3, and to identify improvement measures to meet the targets. A gap in this research is a detailed estimation of the energy consumption which could automatically be avoided through preventing food waste in food manufacturing. This paper reports research which estimates the energy embodied in preventable manufacturing food waste in the UK using available data for 2014. Whilst the estimate of 106 GW h per year is a tiny proportion of the industry's annual energy consumption, it is 1.75 percentage points of the main 20% energy efficiency improvement target and over half the contribution expected from energy management measures to improve energy efficiency. Preventing food waste in the factory could therefore also contribute significantly to energy efficiency and climate change targets with no extra effort.
C1 [Sheppard, Phil; Rahimifard, Shahin] Loughborough Univ, Wolfson Sch Mech Elect & Mfg Engn, Ctr Sustainable Mfg & Recycling Technol SMART, Loughborough LE11 3TU, Leics, England.
RP Rahimifard, S (reprint author), Loughborough Univ, Wolfson Sch Mech Elect & Mfg Engn, Ctr Sustainable Mfg & Recycling Technol SMART, Loughborough LE11 3TU, Leics, England.
EM p.sheppard@lboro.ac.uk; s.rahimifard@lboro.ac.uk
OI Sheppard, Phil/0000-0002-8540-1027
FU Engineering and Physical Sciences Research CouncilEngineering & Physical
   Sciences Research Council (EPSRC) [EP/K030957/1]; EPSRC Centre for
   Innovative Manufacturing in FoodEngineering & Physical Sciences Research
   Council (EPSRC)
FX This work was supported by the Engineering and Physical Sciences
   Research Council (grant number EP/K030957/1), the EPSRC Centre for
   Innovative Manufacturing in Food.
CR Alexander P, 2017, AGR SYST, V153, P190, DOI 10.1016/j.agsy.2017.01.014
   Cuellar AD, 2010, ENVIRON SCI TECHNOL, V44, P6464, DOI 10.1021/es100310d
   Department for Business Energy & Industrial Strategy Food & Drink Federation Dairy UK Scotch Whisky Association British Beer & Pub Association and Maltsters' Association of Great, 2017, FOOD DRINK JOINT IND
   Dorward LJ, 2012, FOOD POLICY, V37, P463, DOI 10.1016/j.foodpol.2012.04.006
   European Commission Joint Research Centre, 2015, EN US EU FOOD SECT S, DOI [10.2790/158316, DOI 10.2790/158316]
   Garcia-Garcia G, 2017, WASTE BIOMASS VALORI, V8, P2209, DOI 10.1007/s12649-016-9720-0
   Garrone P, 2016, J CLEAN PROD, V137, P1076, DOI 10.1016/j.jclepro.2016.07.145
   Gobel C, 2015, SUSTAINABILITY-BASEL, V7, P1429, DOI 10.3390/su7021429
   Gustaysson J., 2011, GLOBAL FOOD LOSSES F
   Office for National Statistics, 2015, PRODCOM INF PAP QUAL
   Office for National Statistics, 2018, GREENH GAS EM UK 190
   Office for National Statistics, 2015, PRODCOM TECHN REP SC
   Ostergen K., 2014, FUSIONS DEFINITIONAL
   Parry A., 2015, 76 OECD, P51, DOI [10.1787/18156797, DOI 10.1787/18156797]
   Ramirez CA, 2006, ENERG POLICY, V34, P1720, DOI 10.1016/j.enpol.2005.01.014
   Reeson S., 2015, STRATEGY APPROACHES
   Tonini D, 2018, WASTE MANAGE, V76, P744, DOI 10.1016/j.wasman.2018.03.032
   Vittuari M, 2016, ENERGIES, V9, DOI 10.3390/en9080660
   Wang L.J., 2008, ENERGY EFFICIENCY MA
   WRAP, 2013, EST WAST FOOD DRINK
   WRAP, 2013, PROD SUST FOR IMPR E
   WRAP, 2018, FOOD SURPL WAST UK K
   WRAP, 2014, UK FOOD WAST HIST CH
   WRAP, 2018, COURT 2025 SIGN DAT
   WRAP, 2016, QUANT FOOD SURPL WAS
   WRAP, COURT COMM 2025
   Zisopoulos FK, 2015, ENERGY, V82, P640, DOI 10.1016/j.energy.2015.01.073
NR 27
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 549
EP 559
DI 10.1016/j.resconrec.2019.03.002
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900052
OA Green Published, Other Gold
DA 2020-05-12
ER

PT J
AU Wu, KJ
   Gao, S
   Xia, L
   Tseng, ML
   Chiu, ASF
   Zhang, ZG
AF Wu, Kuo-Jui
   Gao, Shuo
   Xia, Li
   Tseng, Ming-Lang
   Chiu, Anthony S. F.
   Zhang, Zhigang
TI Enhancing corporate knowledge management and sustainable development: An
   inter-dependent hierarchical structure under linguistic preferences
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Knowledge management; Corporate sustainability performance; Fuzzy
   synthetic method; Analytical network process; Social media
ID SUPPLY CHAIN MANAGEMENT; FUZZY SYNTHETIC EVALUATION; SOCIAL MEDIA;
   INNOVATION PERFORMANCE; SYSTEM; FRAMEWORK; MODEL; COMPANIES; IMPACT;
   GREEN
AB With the United Nations' announcement of the 2030 sustainable development goals agenda, the electronic industry is striving to improve corporate sustainability performance. Studies have attempted to consider knowledge management to promote corporate sustainability performance. However, the possible linkages and potential benefits for bridging knowledge management and corporate sustainability performance are still lacking in previous discussions. To address this gap, this study proposes a hybrid method that integrates a fuzzy synthetic method with an analytical network process to develop an inter-dependent hierarchical framework. The results indicate that the relation, operation and economy aspects must align with the priority goal of achieving better corporate sustainability performance. Improvements of these aspects rely on the knowledge management of developing rigid external collaboration, adopting information technology-supported processes and expanding capital for developing knowledge management. This study contributes to (1) bridging knowledge management and corporate sustainability performance; (2) providing a hybrid method to develop a hierarchical framework; and (3) giving specific directions for guiding improvements. Theoretical and managerial implications are discussed.
C1 [Wu, Kuo-Jui; Gao, Shuo; Xia, Li] Dalian Univ Technol, Sch Business, Panjin 124221, Peoples R China.
   [Tseng, Ming-Lang] Asia Univ, Inst Innovat & Circular Econ, Taichung, Taiwan.
   [Tseng, Ming-Lang] China Med Univ, China Med Univ Hosp, Dept Med Res, Shenyang, Liaoning, Peoples R China.
   [Chiu, Anthony S. F.] De La Salle Univ, Dept Ind Engn, Manila 1004, Philippines.
   [Zhang, Zhigang] Dalian Univ Technol, Sch Intellectual Property, Panjin 124221, Peoples R China.
RP Tseng, ML (reprint author), Asia Univ, Inst Innovat & Circular Econ, Taichung, Taiwan.; Tseng, ML (reprint author), China Med Univ, China Med Univ Hosp, Dept Med Res, Shenyang, Liaoning, Peoples R China.
EM wukuojui@dlut.edu.cn; shuo.gao@foxmail.com; xiali1118@foxmail.com;
   tsengminglang@asia.edu.tw; anthony.chiu@dlsu.edu.ph; zhzhgang@163.com
RI Gao, Shuo/AAA-7641-2019; Xia, Li/AAE-1173-2019; Wu, Kuo-Jui/N-1926-2019
OI Wu, Kuo-Jui/0000-0002-6246-8245; Xia, Li/0000-0003-2465-9232; Chiu,
   Anthony Shun Fung/0000-0003-2411-7302; Gao, Shuo/0000-0003-2239-5982
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [71701029]; Liaoning Academy of Social Sciences Fund
   [L17BGL019]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [DUT18RC(4)002, DUT18RW510]
FX This study was funded by the National Natural Science Foundation of
   China (71701029), Liaoning Academy of Social Sciences Fund (L17BGL019)
   and Fundamental Research Funds for the Central Universities
   (DUT18RC(4)002; DUT18RW510).
CR Ahi P, 2013, J CLEAN PROD, V52, P329, DOI 10.1016/j.jclepro.2013.02.018
   Al-Mutawah K, 2009, J INTELL MANUF, V20, P593, DOI 10.1007/s10845-008-0142-0
   Alegre J, 2013, INT SMALL BUS J, V31, P454, DOI 10.1177/0266242611417472
   Amini M, 2014, J CLEAN PROD, V76, P12, DOI 10.1016/j.jclepro.2014.02.016
   Anand A, 2015, J KNOWL ECON, V6, P48, DOI 10.1007/s13132-012-0110-y
   Andreeva T, 2012, J KNOWL MANAG, V16, P617, DOI 10.1108/13673271211246185
   Arnold V, 2006, MIS QUART, V30, P79
   Baumgartner RJ, 2017, J CLEAN PROD, V140, P81, DOI 10.1016/j.jclepro.2016.04.146
   Blumenberg S, 2009, INT J INFORM MANAGE, V29, P342, DOI 10.1016/j.ijinfomgt.2008.11.004
   Bolis I, 2012, WORK, V41, P2713, DOI 10.3233/WOR-2012-0515-2713
   Buyukozkan G, 2011, EXPERT SYST APPL, V38, P13731, DOI 10.1016/j.eswa.2011.04.171
   Cao M, 2011, J OPER MANAG, V29, P163, DOI 10.1016/j.jom.2010.12.008
   Chan HK, 2016, PROD OPER MANAG, V25, P568, DOI 10.1111/poms.12390
   Chardine-Baumann E, 2014, COMPUT IND ENG, V76, P138, DOI 10.1016/j.cie.2014.07.029
   Chen F, 2000, MANAGE SCI, V46, P436, DOI 10.1287/mnsc.46.3.436.12069
   Chen YJ, 2012, EXPERT SYST APPL, V39, P13135, DOI 10.1016/j.eswa.2012.05.088
   Choi SY, 2010, MIS QUART, V34, P855
   Culnan MJ, 2010, MIS Q EXEC, V9, P243
   Dao V, 2011, J STRATEGIC INF SYST, V20, P63, DOI 10.1016/j.jsis.2011.01.002
   DING XW, 2017, WATER-SUI, V9, DOI DOI 10.3390/W9050329
   Docekalova MP, 2017, ECOL INDIC, V78, P108, DOI 10.1016/j.ecolind.2017.02.038
   Docekalova MP, 2016, ECOL INDIC, V61, P612, DOI 10.1016/j.ecolind.2015.10.012
   Duhon B., 1998, INFORM, V21, P8
   Eltayeb TK, 2011, RESOUR CONSERV RECY, V55, P495, DOI 10.1016/j.resconrec.2010.09.003
   Fiksel J., 1996, ENV QUAL MANAG, V5, P47, DOI DOI 10.1002/TQEM.3310050407
   Gautam H. C, 2018, RECENT DEV NEW DIREC, P605
   Gaziulusoy AI, 2013, J CLEAN PROD, V45, P104, DOI 10.1016/j.jclepro.2012.05.013
   Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669
   Gulati R, 2015, STRATEGIC MANAGEMENT, V20, P397
   Hart SL, 1997, HARVARD BUS REV, V75, P66
   Hu Y, 2016, J MANAGE ENG, V32, DOI 10.1061/(ASCE)ME.1943-5479.0000432
   Huang P, 2016, MIS QUART, V40, P785, DOI 10.25300/MISQ/2016/40.3.13
   Iacono MP, 2012, J KNOWL MANAG, V16, P604, DOI 10.1108/13673271211246176
   Inkinen HT, 2015, BALT J MANAG, V10, P432, DOI 10.1108/BJM-10-2014-0178
   Jasimuddin SM, 2011, INFORM SYST MANAGE, V28, P84, DOI 10.1080/10580530.2011.536117
   Johnson M, 2018, CORP SOC RESP ENV MA, V25, P659, DOI 10.1002/csr.1484
   Ko DG, 2005, MIS QUART, V29, P59
   Lai YL, 2014, J BUS RES, V67, P734, DOI 10.1016/j.jbusres.2013.11.036
   Li XN, 2018, J CLEAN PROD, V198, P1593, DOI 10.1016/j.jclepro.2018.07.036
   Liao SH, 2008, EXPERT SYST APPL, V34, P1763, DOI 10.1016/j.eswa.2007.01.036
   Lim MK, 2017, J CLEAN PROD, V162, P806, DOI 10.1016/j.jclepro.2017.06.056
   Linnenluecke MK, 2010, J WORLD BUS, V45, P357, DOI 10.1016/j.jwb.2009.08.006
   Liu SF, 2012, IND MARKET MANAG, V41, P581, DOI 10.1016/j.indmarman.2012.04.005
   Lozano R, 2012, J CLEAN PROD, V25, P14, DOI 10.1016/j.jclepro.2011.11.060
   Malhotra A, 2005, MIS QUART, V29, P145
   Mao N, 2016, APPL ENERG, V180, P536, DOI 10.1016/j.apenergy.2016.08.011
   Martinez-Conesa I, 2017, J KNOWL MANAG, V21, P553, DOI 10.1108/JKM-09-2016-0403
   Matos S, 2007, J OPER MANAG, V25, P1083, DOI 10.1016/j.jom.2007.01.013
   Ming-Lang Tseng, 2008, WSEAS Transactions on Environment and Development, V4, P487
   Nisar TM, 2019, J BUS RES, V94, P264, DOI 10.1016/j.jbusres.2018.05.005
   Noruzy A, 2013, INT J ADV MANUF TECH, V64, P1073, DOI 10.1007/s00170-012-4038-y
   Obeidat BY, 2016, MANAG RES REV, V39, P1214, DOI 10.1108/MRR-09-2015-0214
   Pang BH, 2013, J INTELL MANUF, V24, P163, DOI 10.1007/s10845-011-0551-3
   Patil SK, 2014, APPL SOFT COMPUT, V18, P126, DOI 10.1016/j.asoc.2014.01.027
   Robinson HS, 2006, BUS PROCESS MANAG J, V12, P793, DOI 10.1108/14637150610710936
   Ruhanen L, 2008, CURR ISSUES TOUR, V11, P429, DOI 10.1080/13683500802316030
   Seuring S, 2008, J CLEAN PROD, V16, P1699, DOI 10.1016/j.jclepro.2008.04.020
   Shi L, 2017, RESOUR CONSERV RECY, V119, P24, DOI 10.1016/j.resconrec.2016.08.014
   Sima V, 2009, KNOWLEDGE MANAGEMENT AND INNOVATION IN ADVANCING ECONOMIES-ANALYSES & SOLUTIONS, VOLS 1-3, P1344
   Stevenson M, 2007, INT J OPER PROD MAN, V27, P685, DOI 10.1108/01443570710756956
   Tahir AC, 2010, J CLEAN PROD, V18, P1598, DOI 10.1016/j.jclepro.2010.07.012
   Garcia-Alvarez MT, 2015, COMPUT HUM BEHAV, V51, P994, DOI 10.1016/j.chb.2014.10.007
   Tseng M. L, 2017, TECHNOLOGICAL FORECA
   Tseng ML, 2018, BUS STRATEG ENVIRON, V27, P1334, DOI 10.1002/bse.2182
   Tseng ML, 2017, J CLEAN PROD, V142, P727, DOI 10.1016/j.jclepro.2016.05.062
   Tseng ML, 2015, IND MANAGE DATA SYST, V115, P436, DOI 10.1108/IMDS-10-2014-0319
   Ulubeyli S, 2017, J BUS ECON MANAG, V18, P35, DOI 10.3846/16111699.2016.1218927
   Vickery SK, 2010, INT J PROD RES, V48, P7025, DOI 10.1080/00207540903348353
   Vildasen SS, 2017, ECOL ECON, V138, P40, DOI 10.1016/j.ecolecon.2017.03.029
   Wallin M.W, 2017, MANAGEMENT INFORMATI, V41
   Wolf J, 2014, J BUS ETHICS, V119, P317, DOI 10.1007/s10551-012-1603-0
   Wu KJ, 2018, J CLEAN PROD, V195, P908, DOI 10.1016/j.jclepro.2018.05.264
   Wu KJ, 2017, J CLEAN PROD, V142, P663, DOI 10.1016/j.jclepro.2016.04.040
   Wu KJ, 2016, IND MANAGE DATA SYST, V116, P777, DOI 10.1108/IMDS-08-2015-0327
   Wu WW, 2008, EXPERT SYST APPL, V35, P828, DOI 10.1016/j.eswa.2007.07.025
   Xu YZ, 2017, ENVIRON POLLUT, V223, P435, DOI 10.1016/j.envpol.2017.01.043
   Zailani S, 2012, INT J PROD ECON, V140, P330, DOI 10.1016/j.ijpe.2012.02.008
NR 77
TC 2
Z9 2
U1 4
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 560
EP 579
DI 10.1016/j.resconrec.2019.03.015
PG 20
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900053
DA 2020-05-12
ER

PT J
AU Wang, JB
   Ju, YY
   Wang, MX
   Li, X
AF Wang Junbo
   Ju Yiyi
   Wang Minxi
   Li Xin
TI Scenario analysis of the recycled copper supply in China considering the
   recycling efficiency rate and waste import regulations
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE In-use stock of refined copper; Secondary copper supply; Recycling
   efficiency rate; Material flow analysis; Waste import regulation
ID IN-USE STOCKS; MATERIAL FLOW-ANALYSIS; DYNAMIC-ANALYSIS; CYCLE;
   ALUMINUM; IRON; END
AB The rapid economic growth and industrialization in China has induced a large copper demand since 1990, of which only approximately 40% is met by domestic ore deposits. However, a high dependence on imported copper ores, refined copper, or copper scrap can pose great risks to the sustainable copper resource supply and economic development of one country. An assessment of the in-use stock of refined copper is essential to estimate the potential supply of recycled copper, especially for countries with a high external dependence, such as China. A scenario analysis may further evaluate such a supply under different development pathways in the context of the increasingly strict import regulation of copper-containing end-of-use products. We introduced Material Flow Analysis and the Weibull lifetime distribution to estimate the in-use stock of refined copper from 1990 to 2035 in China based on the time-series data for sectoral refined copper consumption. The results show that the amount of generated copper scrap has been increasing from 1990 and reached 3.67 Tg in 2016, with 34.4% from the home appliances sector (mainly air-conditioning) and 26.6% from the power infrastructure sector. In 2035, the total would reach 17.7 Tg, with 42.8% from the power infrastructure sector and 19.7% from the home appliances sector. A scenario analysis was conducted considering different consumption growth rates, waste import regulation standards, and domestic recycling efficiency growth rates. The results show that under both scenarios, a total ban and limited imports of metal-containing scraps, the growth of the domestic recycling efficiency may improve the refined copper supply, which would be 0.867 Tg (67.4%) and 1.04 Tg (80.9%), respectively. With an adequate in-use stock of refined copper and an increasing recycling efficiency rate, domestic recycled secondary copper can cover the shrinking import source of copper scrap and become an essential source to meet the needs of the booming refined copper consumption in China.
C1 [Wang Junbo; Wang Minxi; Li Xin] Chengdu Univ Technol, Coll Management Sci, Chengdu 610051, Sichuan, Peoples R China.
   [Ju Yiyi] Nagoya Univ, Grad Sch Int Dev, Nagoya, Aichi 4648601, Japan.
RP Li, X (reprint author), Chengdu Univ Technol, Coll Management Sci, Chengdu 610051, Sichuan, Peoples R China.
EM lixin2012@cdut.cn
OI li, xin/0000-0002-2939-4811; JU, Yiyi/0000-0003-4483-0332
FU National Social Science Foundation of China [17BGL147]; Key Program of
   Sichuan Mineral Resources Research Center [SCKCZY2018-ZD002]
FX This research is supported by Projects of the National Social Science
   Foundation of China (17BGL147), Key Program of Sichuan Mineral Resources
   Research Center [SCKCZY2018-ZD002].
CR Bonnin M, 2013, CHEM ENG RES DES, V91, P1390, DOI 10.1016/j.cherd.2013.03.016
   Brunner PH, 2004, PRACTICAL HDB MAT FL
   Chen WQ, 2012, ECOL ECON, V81, P92, DOI 10.1016/j.ecolecon.2012.06.008
   Davis J, 2007, RESOUR CONSERV RECY, V51, P118, DOI 10.1016/j.resconrec.2006.08.007
   Deng FL, 2016, CHINA MB MAG, V2, P143
   EFFACE (European Union Action to Fight Environmental Crime), 2015, ILL E WAST SHIPM EU
   Gloser S, 2013, ENVIRON SCI TECHNOL, V47, P6564, DOI 10.1021/es400069b
   Gordon RB, 2002, RESOUR CONSERV RECY, V36, P87, DOI 10.1016/S0921-3449(02)00019-8
   Graedel TE, 2002, ECOL ECON, V42, P9, DOI 10.1016/S0921-8009(02)00101-5
   Guo XY, 2008, RESOUR CONSERV RECY, V52, P874, DOI 10.1016/j.resconrec.2007.10.003
   Hatayama H, 2007, MATER TRANS, V48, P2518, DOI 10.2320/matertrans.MRA2007102
   Hatayama H, 2015, RESOUR POLICY, V44, P72, DOI 10.1016/j.resourpol.2015.02.004
   Huang C.IC, 2001, COPPER DEPOSIT CHINA
   Jamet C, 2009, 6 COMM GEN DEV DUR S
   Johansson J, 2009, J CLEAN PROD, V17, P26, DOI 10.1016/j.jclepro.2008.02.010
   Liu G, 2013, ENVIRON SCI TECHNOL, V47, P4882, DOI 10.1021/es305108p
   Liu Q. Y., 2014, CHINA MIN MAG, V23, P5
   McMillan CA, 2010, ECOL ECON, V69, P2606, DOI 10.1016/j.ecolecon.2010.08.005
   MOEEC (Ministry of Ecology and Environment of the People's Republic of China), 2018, ANN ADJ IMPR IMPR WA
   Park JA, 2011, RESOUR CONSERV RECY, V55, P456, DOI 10.1016/j.resconrec.2010.12.007
   Ruhrberg M, 2006, RESOUR CONSERV RECY, V48, P141, DOI 10.1016/j.resconrec.2006.01.003
   Soulier M, 2018, J CLEAN PROD, V195, P435, DOI 10.1016/j.jclepro.2018.04.243
   Soulier M, 2018, RESOUR CONSERV RECY, V129, P143, DOI 10.1016/j.resconrec.2017.10.013
   Spatari S, 2005, ECOL ECON, V54, P37, DOI 10.1016/j.ecolecon.2004.11.018
   Spatari S, 2002, ECOL ECON, V42, P27, DOI 10.1016/S0921-8009(02)00103-9
   Suhir E., 1997, APPL PROBABILITY ENG
   Sverdrup HU, 2014, RESOUR CONSERV RECY, V87, P158, DOI 10.1016/j.resconrec.2014.03.007
   Tanimoto AH, 2010, RESOUR CONSERV RECY, V55, P20, DOI 10.1016/j.resconrec.2010.03.007
   Wang H., 2008, EC TRADING, V4, P33
   Wang J., 2004, STUDIES TRACE ELEMEN, V21, P27
   Wang MX, 2017, RESOUR POLICY, V52, P235, DOI 10.1016/j.resourpol.2016.12.009
   Wang T, 2008, J MATER CYCLES WASTE, V10, P188, DOI 10.1007/s10163-008-0203-7
   Wang W., 2014, LAND RES INF, V11, P26
   Wen ZG, 2015, J IND ECOL, V19, P1091, DOI 10.1111/jiec.12271
   Wen Zongguo, 2013, Journal of Tsinghua University (Science and Technology), V53, P1283
   Yamane LH, 2011, WASTE MANAGE, V31, P2553, DOI 10.1016/j.wasman.2011.07.006
   Yan LY, 2013, RESOUR CONSERV RECY, V75, P23, DOI 10.1016/j.resconrec.2013.03.004
   Yue Q, 2009, RESOUR CONSERV RECY, V53, P680, DOI 10.1016/j.resconrec.2009.05.003
   Yue Q, 2006, MAT FLOW ANAL ECOLOG
   Yue Q, 2016, RESOUR POLICY, V49, P315, DOI 10.1016/j.resourpol.2016.07.001
   Yue Q, 2012, T NONFERR METAL SOC, V22, P1744, DOI 10.1016/S1003-6326(11)61382-4
   Zhang H., 2013, CHINA MIN MAG, V22, P7
   Zhang L, 2015, ENVIRON SCI TECHNOL, V49, P6430, DOI 10.1021/acs.est.5b00917
   Zhang L, 2014, SCI TOTAL ENVIRON, V478, P80, DOI 10.1016/j.scitotenv.2014.01.070
   Zhang L, 2012, J IND ECOL, V16, P191, DOI 10.1111/j.1530-9290.2011.00406.x
NR 45
TC 2
Z9 2
U1 14
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 580
EP 589
DI 10.1016/j.resconrec.2019.02.008
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900054
DA 2020-05-12
ER

PT J
AU Amato, A
   Gabrielli, F
   Spinozzi, F
   Galluzzi, LM
   Balducci, S
   Beolchini, F
AF Amato, Alessia
   Gabrielli, Francesco
   Spinozzi, Francesco
   Galluzzi, Lorenzo Magi
   Balducci, Susanna
   Beolchini, Francesca
TI Strategies of disaster waste management after an earthquake: A
   sustainability assessment
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Disaster waste management; Earthquake; Natural disaster; Life cycle
   assessment; Economic analysis
ID LIFE-CYCLE ASSESSMENT; DEMOLITION WASTE; ENVIRONMENTAL-IMPACT;
   CONSTRUCTION; SYSTEMS; LCA
AB One of the most significant effects of an earthquake is the production of a huge amount of waste. An incorrect management of the nibbles causes relevant environmental damages, economic losses and a psychological impact for the population. In this context, the present manuscript assesses different strategies of waste management, estimating the carbon footprint and the economic impact, in order to define the best choices. Overall, different management options can be applied, that have different costs and impacts on the environment: a temporary storage site could be used, nibbles can be treated through different technologies (either simple crushing or advanced refining), and the treatment can be carried out at different distances from the site of the event. The environmental impact assessment evidenced the importance of an in-situ pre-treatment of the nibbles and of an enhanced refining, addressed at the achievement of high quality inert. On the other hand, the economic analysis suggests that the best option is to transport everything to the treatment site, and to carry out a simple treatment of the rubbles. Consequently, our assessment resulted in conflicting conclusions, where an enhanced treatment of the nibbles is positive, from an environmental point of view, but negative, for the increase in the management costs. The economic criteria are currently pushing any decision taken by the emergency managers; however, the environmental load may have a long-term effect with even more significant economic consequences, and it cannot be neglected.
C1 [Amato, Alessia; Gabrielli, Francesco; Spinozzi, Francesco; Beolchini, Francesca] Marche Polytech Univ, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.
   [Galluzzi, Lorenzo Magi] Asa SRL, Landfill Tech Management, Azienda Serv Ambientali, Via S Vincenzo 18, I-60013 Corinaldo, An, Italy.
   [Balducci, Susanna] Special Planning Emergency & Operating Room, I-60125 Ancona, Italy.
RP Beolchini, F (reprint author), Marche Polytech Univ, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.
EM f.beolchini@univpm.it
OI Gabrielli, Francesco/0000-0002-0913-8458; Amato,
   Alessia/0000-0002-0840-1584
CR Allesch A, 2014, WASTE MANAGE RES, V32, P461, DOI 10.1177/0734242X14535653
   Amato A, 2017, ENVIRON ENG MANAG J, V16, P1651, DOI 10.30638/eemj.2017.180
   Amato A, 2016, PHYS STATUS SOLIDI C, V13, P979, DOI 10.1002/pssc.201600114
   Amato A, 2017, WASTE MANAGE, V59, P432, DOI 10.1016/j.wasman.2016.09.024
   Barrett E, 2007, MAINSTREAMING ENV HU
   Baycan F., 2004, INT C STUD COMP POST, V90, P1361
   Bellaera F., 2013, GESTIONE DEMOLIZIONI
   Brown C., 2010, P 14 EUR C EARTHQ EN, DOI [10.1016/j.rser.2015.06.021, DOI 10.1016/J.RSER.2015.06.021]
   Brown C, 2016, RESOUR CONSERV RECY, V106, P21, DOI 10.1016/j.resconrec.2015.10.021
   Brown C, 2011, WASTE MANAGE, V31, P1085, DOI 10.1016/j.wasman.2011.01.027
   Bueno G, 2015, RENEW SUST ENERG REV, V51, P449, DOI 10.1016/j.rser.2015.06.021
   Channell M., 2009, ENHANCED TOOLS TECHN, V46
   Cherubini F, 2009, ENERGY, V34, P2116, DOI 10.1016/j.energy.2008.08.023
   Coelho A, 2012, WASTE MANAGE, V32, P532, DOI 10.1016/j.wasman.2011.11.011
   Consiglio Nazionale Ricerche-Corpo Nazionale Vigili Del Fuoco, 2010, SISM ABR 6 APR 2009
   Dana B., 2013, LCA LIFE CYCLE ASSES
   de Azevedo A, 2017, J CLEAN PROD, V162, P1021, DOI 10.1016/j.jclepro.2017.06.141
   De Stefanis P., 2014, CERTIFICATI BIANCHI
   Eriksson O, 2005, J CLEAN PROD, V13, P241, DOI 10.1016/j.jclepro.2004.02.018
   Francesco G, 2018, WASTE MANAGE, V71, P542, DOI 10.1016/j.wasman.2017.10.012
   Gualtieri AF, 2013, WOOD PUBL SER CIVIL, P500, DOI 10.1533/9780857096906.4.500
   Hu ZH, 2013, TRANSPORT RES B-METH, V55, P118, DOI 10.1016/j.trb.2013.05.010
   Kartam N, 2004, WASTE MANAGE, V24, P1049, DOI 10.1016/j.wasman.2004.06.003
   Katsumi T., 2017, J JSCE, V5, P145, DOI [10.2208/journal4sce.5.1_145, DOI 10.2208/JOURNAL4SCE.5.1_145]
   Kawamoto K, 2016, INT J DISAST RISK RE, V18, P256, DOI 10.1016/j.ijdrr.2015.10.003
   Kunz N, 2017, INT J LOGIST-RES APP, V20, P85, DOI 10.1080/13675567.2015.1103845
   L'Abbate P, 2018, J CLEAN PROD, V172, P735, DOI 10.1016/j.jclepro.2017.10.045
   McCreanor P., 1999, DISASTER DEBRIS MANA, P1
   Pacheco-Torgal F, 2013, WOOD PUBL SER CIVIL, P1, DOI 10.1533/9780857096906.1
   PachecoTorgal F, 2013, WOOD PUBL SER CIVIL, P1, DOI 10.1533/9780857096906
   Pintilie L, 2016, J CLEAN PROD, V139, P1, DOI 10.1016/j.jclepro.2016.07.209
   Ranke U., 2016, NATURAL DISASTER RIS, P1, DOI [10.1007/978-3-319-20675-2_1, DOI 10.1007/978-3-319-20675-2_1]
   Reich MC, 2005, J CLEAN PROD, V13, P253, DOI 10.1016/j.jclepro.2004.02.015
   REV sr. 1, 2012, CRUSHER TRACK GCV 10
   REV sr.1, GRUPP VAGL SEM REV G
   Silva RV, 2017, J CLEAN PROD, V143, P598, DOI 10.1016/j.jclepro.2016.12.070
   UNEP, 1995, EARTHQ WAST S TP2
   United States Environmental Protection Agency, 2008, PLANN NAT DIS DEBR G
   Volvo Construction Equipment Group, 2000, VOLV EXC EC, P160
   Xiao J., 2018, SPRINGER TRACTS CIVI, DOI [10.1007/978-3-662-53987-3, DOI 10.1007/978-3-662-53987-3]
NR 40
TC 3
Z9 3
U1 2
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 590
EP 597
DI 10.1016/j.resconrec.2019.02.033
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900055
DA 2020-05-12
ER

PT J
AU Maier, JM
   Sowlati, T
   Salazar, J
AF Maier, Jan Moritz
   Sowlati, Taraneh
   Salazar, James
TI Life cycle assessment of forest-based biomass for bioenergy: A case
   study in British Columbia, Canada
SO RESOURCES CONSERVATION AND RECYCLING
LA English
DT Article
DE Bioenergy; Forest-based biomass; British Columbia; Environmental
   impacts; Life cycle assessment
ID METHODOLOGICAL CHOICES; SUPPLY CHAINS; KEY ISSUES; WOOD ASH; LCA;
   OPTIMIZATION; RESIDUES; BIOFUEL; ENERGY; CONSTRUCTION
AB Large quantities of residual forest-based biomass, including harvesting and sawmill residues, are available in British Columbia, Canada. They can be used to generate bioenergy. Currently, harvesting residues are burned to reduce fire hazard, and private and remote sawmills' residues are either burned or landfilled. While previous studies assessed the impact of bioenergy production from residual forest-based biomass on global warming, this life cycle assessment includes a comprehensive set of ten impact categories. Adopting a case study in a region in British Columbia, a life cycle model is applied to three locations considering four combustion and gasification technologies with different capacities (0.5 MW, 2 MW, 3 MW and 5 MW) and product outputs (electricity and/or heat). Most bioenergy supply chain scenarios showed improved environmental performance due to avoided uncontrolled combustion of residues and avoided fossil fuel combustion, particularly in the categories of acidification (+1% to -71%), eutrophication (-2% to -85%), fossil resource depletion (-2% to -84%), respiratory effects (0% to -96%), and photochemical ozone formation (+3% to -59%). Benefits were larger at locations dependent on fossil energy compared to locations dependent on hydropower. In contrast, ecotoxicity values increased in most scenarios (+460% to -11%), due to wood ash disposal. Results confirmed conversion efficiency and wood ash disposal as influencing factors in bioenergy supply chains for the investigated region, but showed a minor influence of the feedstock procurement distance. Moreover, the results emphasized the high contribution of uncontrolled bumings to the overall environmental impact of the forest biomass supply chains.
C1 [Maier, Jan Moritz; Sowlati, Taraneh] Univ British Columbia, Fac Forestry, Dept Wood Sci, Ind Engn Res Grp, 2931-2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.
   [Maier, Jan Moritz] Univ Hohenheim, Biobased Prod & Energy Crops, Fruwirthstr 23, D-70599 Stuttgart, Germany.
   [Salazar, James] Athena Sustainable Mat Inst, 119 Ross Ave,Suite 100, Ottawa, ON K1Y 0N6, Canada.
RP Sowlati, T (reprint author), Univ British Columbia, Fac Forestry, Dept Wood Sci, Ind Engn Res Grp, 2931-2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.
EM jmaier@mail.ubc.ca; taraneh.sowlati@ubc.ca
CR Achat DL, 2015, FOREST ECOL MANAG, V348, P124, DOI 10.1016/j.foreco.2015.03.042
   Ahlgren S, 2015, BIOFUEL BIOPROD BIOR, V9, P606, DOI 10.1002/bbb.1563
   Akhtari S, 2018, APPL ENERG, V213, P626, DOI 10.1016/j.apenergy.2017.10.017
   Athena Sustainable Materials Institute, 2018, CRADL TO GAT LIF CYC
   B. C. Ministry of Environment, 2011, SMOK MAN FRAM BRIT C
   B. C. Ministry of Forests Lands and Natural Resource Operations, 2014, WILL LAK TSA TIMB SU
   Barbosa R, 2013, FUEL PROCESS TECHNOL, V109, P124, DOI 10.1016/j.fuproc.2012.09.048
   Bare J, 2012, TOOL REDUCTION ASSES, DOI [10.2113/gselements.7.3.181, DOI 10.2113/GSELEMENTS.7.3.181]
   *BC MIN EN MIN PET, 2007, BC EN PLAN VIS CLEAN
   BC Ministry of Forests Mines and Lands, 2010, STAT BRIT COL FOR
   Bergman RD, 2012, RILEM PROC, V86, P318
   Saraiva AB, 2017, INT J ENVIRON SCI TE, V14, P435, DOI 10.1007/s13762-016-1138-5
   Boschiero M, 2016, J CLEAN PROD, V112, P2569, DOI 10.1016/j.jclepro.2015.09.094
   Brais S, 2015, FOREST ECOL MANAG, V348, P1, DOI 10.1016/j.foreco.2015.03.021
   Cambero C, 2016, APPL ENERG, V178, P721, DOI 10.1016/j.apenergy.2016.06.079
   Cambero C, 2016, CHEM ENG RES DES, V107, P218, DOI 10.1016/j.cherd.2015.10.040
   Cambero C, 2015, RESOUR CONSERV RECY, V105, P59, DOI 10.1016/j.resconrec.2015.10.014
   Cambero C, 2015, INT J ENERG RES, V39, P439, DOI 10.1002/er.3233
   Caro E, 2014, COMPUT EDUC, V76, P42, DOI 10.1016/j.compedu.2014.03.007
   Cherubini F, 2009, RESOUR CONSERV RECY, V53, P434, DOI 10.1016/j.resconrec.2009.03.013
   Cleary J, 2015, ENERGY, V88, P917, DOI 10.1016/j.energy.2015.07.045
   De Rosa M, 2018, INT J LIFE CYCLE ASS, V23, P147, DOI 10.1007/s11367-017-1312-0
   EC/JRC-IES, 2010, INT REF LIF CYCL DAT, DOI [10.2788/38479, DOI 10.2788/38479]
   Eero J, 2014, RENEW SUST ENERG REV, V29, P369, DOI 10.1016/j.rser.2013.08.101
   Forest Products Association of Canada, 2014, VISION2020 REP CARD
   Greendelta GmbH, 2018, OPENLCA 1 7
   Gu HM, 2017, WOOD FIBER SCI, V49, P177
   Guest G, 2011, J IND ECOL, V15, P908, DOI 10.1111/j.1530-9290.2011.00375.x
   Hope ES, 2017, CAN J FOREST RES, V47, P1222, DOI 10.1139/cjfr-2016-0524
   International Organisation for Standardization, 2006, 140402006 ISO
   ISO, 2006, 140442006 ISO
   Li R, 2016, BIORESOURCES, V11, P1919
   Microsoft, 2016, MICR OFF PROF PLUS 2
   Muench S, 2013, APPL ENERG, V112, P257, DOI 10.1016/j.apenergy.2013.06.001
   Muller S., 2011, RENEW ENERG, V72, DOI [10.1016/50960-1481(00)00187-7, DOI 10.1016/50960-1481(00)00187-7]
   Norstrom SH, 2012, GEODERMA, V187, P85, DOI 10.1016/j.geoderma.2012.04.011
   Oneil E, 2017, FOREST PROD J, V67, P316, DOI 10.13073/FPJ-D-17-00011
   Pawelzik P, 2013, RESOUR CONSERV RECY, V73, P211, DOI 10.1016/j.resconrec.2013.02.006
   Puettmann ME, 2017, FOREST PROD J, V67, P381, DOI [10.13073/fpj-d-16-00064, 10.13073/FPJ-D-16-00064]
   Puettmann ME, 2012, FOREST PROD J, V62, P273
   Pugliese S, 2014, CAN J SOIL SCI, V94, P621, DOI [10.4141/CJSS-2014-037, 10.4141/cjss-2014-037]
   Ralevic P., 2006, APPL BIOCHEM BIOTECH, P1
   Ranius T, 2018, J ENVIRON MANAGE, V209, P409, DOI 10.1016/j.jenvman.2017.12.048
   Reimann C, 2008, SCI TOTAL ENVIRON, V393, P191, DOI 10.1016/j.scitotenv.2008.01.015
   Richardson J., 2002, BIOENERGY SUSTAINABL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Rosillo-Calle F, 2000, P 3 ENC EN MEIO RUR, P1
   Steubing B, 2011, BIOMASS BIOENERG, V35, P2950, DOI 10.1016/j.biombioe.2011.03.036
   Tellnes LGF, 2017, IFOREST, V10, P815, DOI 10.3832/ifor2386-010
   Vassilev SV, 2013, FUEL, V105, P40, DOI 10.1016/j.fuel.2012.09.041
   Wagner M, 2017, GCB BIOENERGY, V9, P215, DOI 10.1111/gcbb.12372
   Wakelin T., 2014, BEILSTEIN J NANOTECH, V5, P1590
   Wernet G, 2016, INT J LIFE CYCLE ASS, V21, P1218, DOI 10.1007/s11367-016-1087-8
   Yemshanov D, 2014, BIOMASS BIOENERG, V69, P80, DOI 10.1016/j.biombioe.2014.07.002
NR 53
TC 2
Z9 2
U1 8
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-3449
EI 1879-0658
J9 RESOUR CONSERV RECY
JI Resour. Conserv. Recycl.
PD JUL
PY 2019
VL 146
BP 598
EP 609
DI 10.1016/j.resconrec.2019.02.035
PG 12
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA HZ2XU
UT WOS:000468712900056
DA 2020-05-12
ER

PT J
AU Chen, B
   Li, WC
   Wang, XD
   Chen, KX
   Hong, XY
AF Chen, Bo
   Li, Wenchen
   Wang, Xiaodan
   Chen, Kexin
   Hong, Xinyu
TI Cyst-Peritoneal Shunt for the Treatment of a Progressive Intracerebral
   Cyst Associated with ASNS Mutation: Case Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Asparagine synthetase deficiency; ASNS mutation; Cyst-peritoneal shunt;
   Intracerebral cyst
ID ASPARAGINE SYNTHETASE DEFICIENCY; SWISS-MODEL
AB BACKGROUND: Congenital microcephaly could result from a gene mutation. Asparagine synthetase deficiency, which is caused by the asparagine synthetase (ASNS) mutation, is a rare autosomal-recessive neurometabolic disorder. It is characterized by severe developmental delay, congenital microcephaly, and seizures.
   CASE DESCRIPTION: Here we present the first report on a progressive intracerebral cyst associated with ASNS mutation, which caused neurodevelopmental dysplasia. ASNS mutation was confirmed by whole-exome sequencing and is the most likely reason for the neurodevelopmental dysplasia, which results in microcephaly, refractory seizures, and congenital visual impairment. Antiepileptic drugs have limited therapeutic effect on these epileptic seizures.
   CONCLUSIONS: Although there is no cure for this disorder so far, the huge progressive intracerebral cyst can be cured by a cyst-peritoneal shunt.
C1 [Hong, Xinyu] Jilin Univ, Hosp 1, Dept Neurosurg Neurotumor, Changchun, Jilin, Peoples R China.
   [Chen, Bo; Li, Wenchen] Jilin Univ, Hosp 1, Dept Neurosurg Neurotrauma, Changchun, Jilin, Peoples R China.
   [Wang, Xiaodan; Chen, Kexin] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China.
   [Wang, Xiaodan; Chen, Kexin] Jilin Univ, Inst Immunol, Changchun, Jilin, Peoples R China.
RP Hong, XY (reprint author), Jilin Univ, Hosp 1, Dept Neurosurg Neurotumor, Changchun, Jilin, Peoples R China.
EM hongxy@jlu.edu.cn
RI Chen, KeXin/M-5657-2017
FU Finance Department of Jilin Province Foundation [2018SCZWSZX-014];
   Science & Technology Department of Jilin University Foundation
   [2017j046]; National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81501383]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2017M611330]
FX This study was supported by the Finance Department of Jilin Province
   Foundation (grant no. 2018SCZWSZX-014); the Science & Technology
   Department of Jilin University Foundation (grant no. 2017j046); the
   National Natural Science Foundation of China (grant no. 81701641); the
   National Natural Science Foundation of China (grant no. 81501383); and
   the China Postdoctoral Science Foundation (grant no. 2017M611330).
CR Alfadhel M, 2015, JIMD REP, V22, P11, DOI 10.1007/8904_2014_405
   Ben-Salem S, 2015, METAB BRAIN DIS, V30, P687, DOI 10.1007/s11011-014-9618-0
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132
   de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019
   Goumy C, 2016, BIRTH DEFECTS RES A, V106, P793, DOI 10.1002/bdra.23535
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Gupta N, 2017, METAB BRAIN DIS, V32, P1889, DOI 10.1007/s11011-017-0073-6
   Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-48
   Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768
   Lomelino CL, 2017, J BIOL CHEM, V292, P19952, DOI 10.1074/jbc.R117.819060
   Palmer EE, 2015, MOL GENET METAB, V116, P178, DOI 10.1016/j.ymgme.2015.08.007
   Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520
   Ruzzo EK, 2013, NEURON, V80, P429, DOI 10.1016/j.neuron.2013.08.013
   Sacharow SJ, 2018, MOL GENET METAB, V123, P317, DOI 10.1016/j.ymgme.2017.12.433
   Seidahmed MZ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0633-0
   Sun J, 2017, JIMD REPORTS, VOL 34, P1, DOI 10.1007/8904_2016_3
   van der Crabben SN, 2013, J INHERIT METAB DIS, V36, P613, DOI 10.1007/s10545-013-9592-4
   Wang GM, 2017, EXP THER MED, V14, P3413, DOI 10.3892/etm.2017.4926
   WANG J, 2016, INT J ENV RES PUBLIC, V13
   Yamamoto T, 2017, BRAIN DEV-JPN, V39, P236, DOI 10.1016/j.braindev.2016.09.010
NR 23
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 1
EP 7
DI 10.1016/j.wneu.2019.02.130
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300160
PM 30844524
DA 2020-05-12
ER

PT J
AU Asahi, T
   Taira, T
   Ikeda, K
   Horisawa, S
   Yamamoto, J
   Tsubono, H
   Sato, S
AF Asahi, Takashi
   Taira, Takaomi
   Ikeda, Kiyonobu
   Horisawa, Shiro
   Yamamoto, Jiro
   Tsubono, Hiroyuki
   Sato, Shuji
TI Improvement of Writer's Cramp from an Old Lesion in the Contralateral
   Hemisphere with Transient Gait Disturbance After Thalamotomy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous anomaly; Focal hand dystonia; Hypotonia; Thalamotomy;
   Ventro-oral nucleus; Writer's cramp
ID DYSTONIA; HEMIPARESIS
AB BACKGROUND: Stereotactic ventro-oral thalamotomy has been performed in cases of focal task-specific dystonia, including writer's cramp, with excellent outcomes. However, no reports have revealed the outcome of ventro-oral thalamotomy in a patient with a contralateral cerebral lesion. We describe a patient with left-hand writer's cramp with an old lesion in the left hemisphere and transient gait disturbance after right ventro-oral thalamotomy.
   CASE DESCRIPTION: A 43-year-old man had a hemorrhage in the left basal ganglia due to cerebral arteriovenous malformation at 22 years of age, and right hemiparesis remained as a sequela. He developed left-handed writing ability; however, he became aware of the stiffness of his left hand and difficulty in writing. Writer's cramp was diagnosed. Medical treatments were not effective, and right ventro-oral thalamotomy was performed. Although his writing ability improved, he could not walk. After performing rehabilitation, his walking completely improved, reaching the level before surgery, after 3 months, and his writer's cramp was completely cured.
   CONCLUSIONS: In patients with basal nucleus lesions, gait disturbance may appear transiently after contralateral thalamotomy. It is crucial to fully explain the potential complications, particularly in relation to temporal gait disturbances, and obtain informed consent.
C1 [Asahi, Takashi; Ikeda, Kiyonobu; Yamamoto, Jiro; Sato, Shuji] Kanazawa Neurosurg Hosp, Dept Neurosurg, Kanazawa, Ishikawa, Japan.
   [Tsubono, Hiroyuki] Kanazawa Neurosurg Hosp, Dept Med Engn, Kanazawa, Ishikawa, Japan.
   [Taira, Takaomi; Horisawa, Shiro] Tokyo Womens Hosp, Dept Neurosurg, Tokyo, Japan.
RP Asahi, T (reprint author), Kanazawa Neurosurg Hosp, Dept Neurosurg, Kanazawa, Ishikawa, Japan.
EM takashi-tym@umin.ac.jp
OI Asahi, Takashi/0000-0001-6266-3799
CR Alshaikh J, 2017, CLIN NEUROL NEUROSUR, V158, P103, DOI 10.1016/j.clineuro.2017.04.025
   Asahi T, 2018, ACTA NEUROCHIR, V160, P835, DOI 10.1007/s00701-018-3480-5
   Asahi T, 2017, WORLD NEUROSURG, V99, DOI 10.1016/j.wneu.2016.12.117
   Asahi T, 2014, STEREOT FUNCT NEUROS, V92, P405, DOI 10.1159/000366004
   Della Sala S, 2002, J NEUROL NEUROSUR PS, V72, P77, DOI 10.1136/jnnp.72.1.77
   Gorman MJ, 1998, STROKE, V29, P2549, DOI 10.1161/01.STR.29.12.2549
   Horisawa S, 2019, NEUROLOGY, V92, pE371, DOI 10.1212/WNL.0000000000006818
   Horisawa S, 2016, STEREOT FUNCT NEUROS, V94, P201, DOI 10.1159/000446612
   Horisawa S, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.05.017
   Horisawa S, 2013, ANN NEUROL, V74, P648, DOI 10.1002/ana.23877
   Ohye C, 2000, STEREOT FUNCT NEUROS, V75, P54, DOI 10.1159/000048384
   Shibata T, 2005, EUR NEUROL, V53, P38, DOI 10.1159/000084262
   Taira T, 2003, STEREOT FUNCT NEUROS, V80, P88, DOI 10.1159/000075165
   Yamamoto R, 2015, EUR NEUROL, V73, P106, DOI 10.1159/000369009
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 8
EP 10
DI 10.1016/j.wneu.2019.03.199
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300161
PM 30928593
DA 2020-05-12
ER

PT J
AU Kandregula, S
   Beniwal, M
   Srinivas, D
   Mhatre, R
AF Kandregula, Sandeep
   Beniwal, Manish
   Srinivas, Dwarakanath
   Mhatre, Radhika
TI Ganglioglioma with Cerebrospinal Fluid Rhinorrhea: A Rare Presentation
SO WORLD NEUROSURGERY
LA English
DT Article
DE CSF rhinorrhea; Erosion; Ganglioglioma; Seizures
ID TUMOR RECURRENCE; PROGRESSION
AB BACKGROUND: Gangliogliomas are low-grade gliomas, and patients generally present with seizures. Gangliogliomas commonly occur in the temporal lobe and predominantly occur in children. Malignant progression is rare.
   CASE DESCRIPTION: A 26-year-old woman presented with a history of seizures since childhood and cerebrospinal fluid rhinorrhea for the past 6 months. Generally, patients with gangliogliomas seek early medical attention, as they present with dramatic complex partial seizures. This patient experienced seizures for 10 years and never sought medical attention during this time. She did not present for medical evaluation until she developed cerebrospinal fluid rhinorrhea.
   CONCLUSIONS: This case gave us an opportunity to learn the natural history ganglioglioma, although clinical presentations vary according to tumor location. This is the first case report to our knowledge of a patient with ganglioglioma presenting with cerebrospinal fluid rhinorrhea.
C1 [Kandregula, Sandeep; Beniwal, Manish; Srinivas, Dwarakanath; Mhatre, Radhika] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India.
RP Beniwal, M (reprint author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India.
EM beniwal.m@gmail.com
RI ; Beniwal, Manish/Q-1469-2016
OI Kandregula, Sandeep/0000-0001-9392-3143; Beniwal,
   Manish/0000-0001-6037-3368
CR Bram R, 2018, PEDIATR NEUROSURG, V53, P43, DOI 10.1159/000479975
   Deb P, 2006, NEUROPATH APPL NEURO, V32, P461, DOI 10.1111/j.1365-2990.2006.00734.x
   El Khashab M, 2009, J NEUROSURG-PEDIATR, V3, P461, DOI 10.3171/2009.2.PEDS0861
   Gheyi V, 2004, AM J NEURORADIOL, V25, P1533
   Handzhiev DD, 2017, J CLIN NEUROSCI, V40, P84, DOI 10.1016/j.jocn.2017.02.002
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Luyken C, 2004, CANCER, V101, P146, DOI 10.1002/cncr.20332
   Luyken C, 2003, EPILEPSIA, V44, P822, DOI 10.1046/j.1528-1157.2003.56102.x
   Majores M, 2008, CANCER, V113, P3355, DOI 10.1002/cncr.23965
   Mesiwala AH, 2002, J NEUROSURG, V97, P190, DOI 10.3171/jns.2002.97.1.0190
   SHUANGSHOTI S, 1987, J SURG ONCOL, V36, P36, DOI 10.1002/jso.2930360109
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 11
EP 14
DI 10.1016/j.wneu.2019.03.156
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300162
PM 30922908
DA 2020-05-12
ER

PT J
AU Asmaro, K
   Abouelleil, M
   Haider, S
   Zakaria, HM
   Gradinaru, C
   Mukherjee, A
   Lee, I
AF Asmaro, Karam
   Abouelleil, Mohamed
   Haider, Sameah
   Zakaria, Hesham Mostafa
   Gradinaru, Ciprian
   Mukherjee, Abir
   Lee, Ian
TI Malignant Transformation of a Filum Terminale Dermoid Tumor into
   Adenocarcinoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Dermoid cyst; Filum terminale dermoid tumor; Intraspinal adenocarcinoma;
   Malignant intraspinal dermoid; Malignant transformation; Spinal benign
   cystic teratoma; Spinal mature teratoma
ID MATURE CYSTIC TERATOMA; NEURAL-TUBE; CLOSURE
AB BACKGROUND: Intraspinal dermoid tumors are usually rare benign growths that occur as a result of defects during neural tube formation. They make up less than 1% of tumors in the spine and are associated with spinal dysraphisms or sinus tracts. Although rare, malignant transformation into squamous cell carcinoma has been previously reported. Malignant transformation into adenocarcinoma, however, represents a novel phenotypic differentiation pattern that is hitherto undescribed.
   CASE DESCRIPTION: A 45-year-old woman presented with acute symptoms of equina syndrome. Imaging of the spine revealed a large intradural sacral mass. The lesion was surgically resected with pathology revealing a dermoid tumor with malignant transformation into adenocarcinoma. Metastatic workup revealed no other suspicious lesions. The patient had an uneventful postoperative course, gradually regaining micturition control.
   CONCLUSIONS: Dermoid tumors, also known as benign cystic teratoma or mature teratoma, are usually benign congenital tumors comprising epithelial cells that arise from displaced embryonic ectoderm and mesoderm during neural tube formation. Although extremely rare, malignant transformation into squamous cell carcinoma has been reported. This case represents the first report of an intraspinal dermoid tumor transforming into adenocarcinoma. A comprehensive histopathologic analysis is key to identifying the lesion and guiding postsurgical management.
C1 [Asmaro, Karam; Abouelleil, Mohamed; Haider, Sameah; Zakaria, Hesham Mostafa; Lee, Ian] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA.
   [Gradinaru, Ciprian] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI USA.
   [Mukherjee, Abir] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI USA.
RP Asmaro, K (reprint author), Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA.
EM kasmaro2@hfhs.org
OI Asmaro, Karam/0000-0002-2084-4863
CR Ahmad FU, 2009, SURG NEUROL, V71, P353, DOI 10.1016/j.surneu.2007.08.030
   Baruah D, 2015, CURR PROBL DIAGN RAD, V44, P256, DOI 10.1067/j.cpradiol.2014.12.004
   Black JD, 2015, INT J GYNECOL CANCER, V25, P792, DOI 10.1097/IGC.0000000000000431
   Bowen BC, 2008, SPINE IMAGING CASE R
   Bruyn GW, 1976, HDB CLIN NEUROLOGY, V20
   Fuller G, 2006, RUSSELL RUBINSTEINS, P583
   GREENFIELD JG, 1997, GREENFIELDS NEUROPAT
   GUPTA S, 1993, CLIN RADIOL, V48, P405, DOI 10.1016/S0009-9260(05)81110-9
   Hamlat A, 2005, J NEURO-ONCOL, V74, P187, DOI 10.1007/s11060-004-5175-4
   INO M, 1995, INT ORTHOP, V19, P185
   Kabbasch C, 2014, NEURORADIOL J, V27, P759, DOI 10.15274/NRJ-2014-10089
   Kandalaft PL, 2016, ARCH PATHOL LAB MED, V140, P508, DOI 10.5858/arpa.2015-0173-CP
   Kasai T, 2003, INT J UROL, V10, P505, DOI 10.1046/j.1442-2042.2003.00670.x
   Kudo N, 2007, J ORTHOP SCI, V12, P300, DOI 10.1007/s00776-007-1125-2
   LOMBARDI G, 1966, ACTA RADIOL DIAGN, V5, P1047, DOI 10.1177/02841851660050P249
   LUNARDI P, 1989, NEUROSURGERY, V25, P860, DOI 10.1227/00006123-198912000-00002
   Mhatre P, 2000, AM J ROENTGENOL, V174, P874, DOI 10.2214/ajr.174.3.1740874
   Nikolopoulou E, 2017, DEVELOPMENT, V144, P552, DOI 10.1242/dev.145904
   Patankar A P, 2012, Asian J Neurosurg, V7, P81, DOI 10.4103/1793-5482.98651
   Preece MT, 2006, AM J NEURORADIOL, V27, P1211
   SANDERS DGM, 1994, EUR J RADIOL, V18, P34, DOI 10.1016/0720-048X(94)90362-X
   Sanghera P., 2006, Archives of Gynecology and Obstetrics, V274, P178, DOI 10.1007/s00404-006-0139-x
   Tahir M, 2009, BMJ CASE REP, V2009
   Takai M, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-41
   Thompson DNP, 2013, CHILD NERV SYST, V29, P1647, DOI 10.1007/s00381-013-2147-z
   van Aalst J, 2009, PEDIATR NEUROSURG, V45, P281, DOI 10.1159/000235602
   Wong HH, 2012, J GASTROINTEST ONCOL, V3, P262, DOI 10.3978/j.issn.2078-6891.2012.019
NR 27
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 15
EP 19
DI 10.1016/j.wneu.2019.03.031
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300163
PM 30872204
DA 2020-05-12
ER

PT J
AU Mummareddy, N
   Legarreta, AD
   Yengo-Kahn, AM
   Bow, HC
   Solomon, GS
   Naftel, RP
   Zuckerman, SL
AF Mummareddy, Nishit
   Legarreta, Andrew D.
   Yengo-Kahn, Aaron M.
   Bow, Hansen C.
   Solomon, Gary S.
   Naftel, Robert P.
   Zuckerman, Scott L.
TI Sport-Related Structural Brain Injury in High School Soccer Epidural
   Hemorrhage After a "Header"
SO WORLD NEUROSURGERY
LA English
DT Article
DE Epidural hematoma; Soccer; Sport-related structural brain injury
ID ACUTE SUBDURAL-HEMATOMA; ARACHNOID CYST; 2ND IMPACT; PLAYER; CONCUSSION
AB BACKGROUND: Sports-related structural brain injury (SRSBI) is a rare, but potentially catastrophic, injury. Limited data exist outlining its epidemiology, pathophysiology, and outcomes. We have presented a case of an epidural hematoma (EDH) that occurred during a high school soccer game.
   CASE DESCRIPTION: A 16-year-old boy had experienced a head-to-ball collision and head-to-head collision with another player. He denied loss of consciousness, endorsed retrograde amnesia, and complained of a minor headache. On the sidelines, he subsequently passed brief orientation and physical exertion tests. However, on returning to play, he experienced blurry vision, along with headache and nausea/vomiting. At the local hospital, he was found to have a 2.6-cm right frontal EDH. After transfer to our institution, increasing somnolence was noted, prompting emergent evacuation of the EDH. His postoperative course was unremarkable, and he was discharged on postoperative day 2. At the 2-week and 3-month follow-up visits, he did not express any complaints or residual deficits and was cleared for full sporting activity.
   CONCLUSIONS: The present case highlights one of the few SRSBIs that have, occurred in soccer. Because of their rarity and severity, a concerted effort should be made to report these cases of SRSBIs regarding the mechanism, postcollision symptoms, and long-term outcomes.
C1 [Mummareddy, Nishit; Legarreta, Andrew D.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA.
   [Yengo-Kahn, Aaron M.; Bow, Hansen C.; Solomon, Gary S.; Naftel, Robert P.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37235 USA.
RP Zuckerman, SL (reprint author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA.; Zuckerman, SL (reprint author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37235 USA.
EM scott.zuckerman@vumc.org
CR Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239
   Bruzzone E, 2000, AM J SPORT MED, V28, P901, DOI 10.1177/03635465000280062201
   Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334
   DATTI R, 1995, BRIT J SPORT MED, V29, P95, DOI 10.1136/bjsm.29.2.95
   Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727
   Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710
   Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090
   Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452
   Ganz JC, 2013, J NEUROSURG, V118, P739, DOI 10.3171/2012.12.JNS121264
   HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563
   Keller TM, 1998, BRIT J SPORT MED, V32, P338, DOI 10.1136/bjsm.32.4.338
   Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025
   Kushi H, 2009, J TRAUMA, V66, P298, DOI 10.1097/TA.0b013e3181715dba
   Logan SM, 2001, J ATHL TRAINING, V36, P433
   Lutfi R, 2009, PEDIATR EMERG CARE, V25, P582, DOI 10.1097/PEC.0b013e3181b4f5f7
   Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a
   Mueller FO, 2001, J ATHL TRAINING, V36, P312
   Nemecek AN, 2005, PEDIATR NEUROSURG, V41, P170, DOI 10.1159/000085880
   Register-Mihalik JK, 2015, CLIN J SPORT MED, V25, P502, DOI 10.1097/JSM.0000000000000161
   SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538
   Stovitz SD, 2017, CURR SPORT MED REP, V16, P50, DOI 10.1249/JSR.0000000000000326
   Stump S., 2015, TODAY
   Tsuzuki N, 2003, NEUROSURGERY, V53, P242, DOI 10.1227/01.NEU.0000072303.16102.E1
   U. S. Youth Soccer, 2016, US YOUTH SOCC ANN RE
   Wang A, 2011, J NEUROSURG-PEDIATR, V7, P111, DOI 10.3171/2010.10.PEDS10283
   Yengo-Kahn AM, 2017, WORLD NEUROSURG, V106, DOI 10.1016/J.WNEU.2017.07.072
   Zeng T, 2011, CHIN J TRAUMATOL, V14, P174, DOI 10.3760/cma.j.issn.1008-1275.2011.03.010
   Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280
   Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593
   Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634
   Zuckerman SL, 2016, NEUROSURG FOCUS, V40, pE9
NR 31
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 20
EP 23
DI 10.1016/j.wneu.2019.03.198
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300164
PM 30928598
DA 2020-05-12
ER

PT J
AU Zhang, YW
   Deng, L
   Zhang, XX
   Yu, XL
   Ai, ZZ
   Mei, YX
   He, F
   Yu, H
   Zhang, L
   Xiao, X
   Xiao, Y
   Chen, X
   Zhang, SL
   Ge, HY
   Dong, XP
AF Zhang, Yuan-Wei
   Deng, Liang
   Zhang, Xiao-Xiang
   Yu, Xing-Liang
   Ai, Zi-Zheng
   Mei, Yu-Xiang
   He, Fei
   Yu, Huan
   Zhang, Liang
   Xiao, Xin
   Xiao, Yan
   Chen, Xi
   Zhang, Su-Li
   Ge, Hong-Yan
   Dong, Xie-Ping
TI Three-Dimensional Printing-Assisted Cervical Anterior Bilateral Pedicle
   Screw Fixation of Artificial Vertebral Body for Cervical Tuberculosis
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3D printing; Anterior; Artificial vertebral body; Bilateral pedicle
   screw fixation; Cervical tuberculosis
ID SPINAL TUBERCULOSIS; SURGICAL-MANAGEMENT; BONE; INSTRUMENTATION;
   ACCURACY; KYPHOSIS
AB BACKGROUND: Cervical tuberculosis accounts for only 4.2%-12% of the total incidence of spinal tuberculosis cases. Although antituberculosis drugs have been the mainstay treatment of cervical tuberculosis, they have been ineffective against the symptoms of existing spinal deformities and spinal cord compression, which often require surgical intervention. The conventional surgical methods have been anterior debridement and titanium mesh, cage bone graft fusion and internal fixation. However, all have certain deficiencies regarding the stability of fixation.
   CASE DESCRIPTION: We have presented the case of a 41-year-old Chinese man who had been experiencing neck pain and stiffness for 1 month. The symptoms had been accompanied by low-grade fever and repeated night sweats. The purified protein derivative test result was positive and the antituberculosis test result was negative. Imaging examination showed destruction of the C5 and C6 vertebral bodies and C5 andC6 intervertebral discs, with an intensive abscess at the C5-C6 vertebral level. After 3-dimensional printing-assisted anterior debridement and artificial vertebral body replacement, his preoperative symptoms of neck pain and stiffness had been alleviated. Also, his symptoms of numbness in both upper limbs had disappeared completely. At the last follow-up examination, he had recovered well and the tuberculosis focus had been completely cured.
   CONCLUSION: To the best of our knowledge, we have reported the first clinical application of 3-dimensional printing-assisted cervical anterior bilateral pedicle screw fixation of an artificial vertebral body. We accomplished ultrashort segment fixation, with excellent clinical outcomes obtained, which were maintained at the recent 2-year follow-up examination.
C1 [Zhang, Yuan-Wei; Deng, Liang; Zhang, Xiao-Xiang; Yu, Xing-Liang; Ai, Zi-Zheng; Mei, Yu-Xiang; He, Fei; Yu, Huan; Zhang, Liang; Dong, Xie-Ping] Nanchang Univ, Jiangxi Prov Peoples Hosp, Dept Orthoped, Nanchang, Jiangxi, Peoples R China.
   [Zhang, Yuan-Wei; Xiao, Xin; Xiao, Yan; Chen, Xi] Nanchang Univ, Grad Sch, Med Dept, Nanchang, Jiangxi, Peoples R China.
   [Zhang, Su-Li; Ge, Hong-Yan] Jiangsu Univ, Wujin Hosp, Dept Operating Room, Changzhou, Peoples R China.
RP Dong, XP (reprint author), Nanchang Univ, Jiangxi Prov Peoples Hosp, Dept Orthoped, Nanchang, Jiangxi, Peoples R China.
EM 13576030901@139.com
OI Deng, Liang/0000-0002-7221-9146
CR Bhandari A, 2014, SPINAL CORD, V52, P489, DOI 10.1038/sc.2014.49
   Dai LY, 2005, SPINE, V30, P2342, DOI 10.1097/01.brs.0000182109.36973.93
   GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004
   HSU LCS, 1984, J BONE JOINT SURG BR, V66, P1
   Jain AK, 2010, INDIAN J ORTHOP, V44, P127, DOI 10.4103/0019-5413.61893
   Koller H, 2008, EUR SPINE J, V17, P523, DOI 10.1007/s00586-007-0572-y
   Koller H, 2008, EUR SPINE J, V17, P539, DOI 10.1007/s00586-007-0573-x
   Koller H, 2010, EUR SPINE J, V19, P2137, DOI 10.1007/s00586-010-1503-x
   Kong LD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013480
   Koptan W, 2011, EUR SPINE J, V20, P308, DOI 10.1007/s00586-010-1537-0
   LOEMBE PM, 1994, ACTA NEUROCHIR, V131, P125, DOI 10.1007/BF01401462
   Miller LE, 2011, SPINE, V36, P2045, DOI 10.1097/BRS.0b013e3181ff37eb
   Miyazaki M, 2009, EUR SPINE J, V18, P783, DOI 10.1007/s00586-009-0924-x
   Ozdemir HM, 2003, SPINE, V28, P474, DOI 10.1097/00007632-200303010-00012
   Parthiban JKBC, 2002, NEUROL INDIA, V50, P17
   RAJASEKARAN S, 1989, J BONE JOINT SURG AM, V71A, P1314, DOI 10.2106/00004623-198971090-00006
   Rajasekaran S, 2018, GLOB SPINE J, V8, p96S, DOI 10.1177/2192568218769053
   Rathod AK, 2017, EUR SPINE J, V26, P3170, DOI 10.1007/s00586-017-5143-2
   Samartzis Dino, 2003, Spine J, V3, P451, DOI 10.1016/S1529-9430(03)00173-6
   Schlesinger N, 2005, JCR-J CLIN RHEUMATOL, V11, P17, DOI 10.1097/01.rhu.0000152144.91206.0c
   Turgut M, 2001, NEUROSURG REV, V24, P8, DOI 10.1007/PL00011973
   [吴晓宇 Wu Xiaoyu], 2018, [中国矫形外科杂志, Orthopedic Journal of China], V26, P538
   Zhu ZQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192581
NR 23
TC 4
Z9 4
U1 3
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 25
EP 30
DI 10.1016/J.WNEU.2019.03.238
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300166
PM 30947015
DA 2020-05-12
ER

PT J
AU Lu, VM
   Goyal, A
   Graffeo, CS
   Perry, A
   Burns, TC
   Parney, IF
   Quinones-Hinojosa, A
   Chaichana, KL
AF Lu, Victor M.
   Goyal, Anshit
   Graffeo, Christopher S.
   Perry, Avital
   Burns, Terry C.
   Parney, Ian F.
   Quinones-Hinojosa, Alfredo
   Chaichana, Kaisorn L.
TI Survival Benefit of Maximal Resection for Glioblastoma Reoperation in
   the Temozolomide Era: A Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Extent of resection; Glioblastoma; Gross total resection; Recurrence;
   Reoperation
ID RECURRENT GLIOBLASTOMA; SURGICAL RESECTION; TUMOR VOLUME; EXTENT;
   OUTCOMES; ASSOCIATION; MANAGEMENT; SURGERY; BIAS
AB BACKGROUND: Although reoperation likely confers survival benefit for glioblastoma, whether the extent of resection (EOR) of the reoperation affects survival outcome has yet to be thoroughly evaluated in the current temozolomide (TMZ) era. The aim of this meta-analysis was to pool the current literature and evaluate the prognostic significance of reoperation EOR for glioblastoma recurrence in the current TMZ era.
   METHODS: Searches of 7 electronic databases from inception to January 2019 were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. There were 1203 articles identified for screening. Prognostic hazard ratios (HRs) for overall survival (OS) derived from multivariate regression analysis were analyzed using meta-analysis of proportions.
   RESULTS: Nine individual studies satisfied all selection criteria, describing survival in 1507 patients with glioblastoma, including 1335 reoperations for recurrence (89%). When studies incorporated the EOR of index surgery into their analysis, maximal resection at reoperation was significantly prognostic for longer OS (HR, 0.59; 95% confidence interval [CI], 0.43-0.79; I-2 = 0%; P heterogeneity <0.01). When studies did not incorporate the EOR of index surgery into their analysis, maximal resection remained significantly prognostic for longer OS at reoperation (HR, 0.53; 95% CI, 0.45-0.64; I-2 = 5.2%; P heterogeneity <0.01). Based on EOR, radiographic gross total resection (GTR) was the most prognostic EOR definition at reoperation (HR, 0.52; 95% CI, 0.44-0.61; I-2 = 0%; P heterogeneity <0.01).
   CONCLUSIONS: In the current TMZ era, when reoperation is feasible for recurrent glioblastoma, maximal safe resection appears to confer a significant OS benefit based on the current literature. This benefit is most pronounced with radiographic GTR, and likely irrespective of EOR at index surgery.
C1 [Lu, Victor M.; Goyal, Anshit; Graffeo, Christopher S.; Perry, Avital; Burns, Terry C.; Parney, Ian F.] Mayo Clin, Dept Neurosurg, Rochester, MN USA.
   [Quinones-Hinojosa, Alfredo; Chaichana, Kaisorn L.] Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA.
RP Chaichana, KL (reprint author), Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA.
EM chaichana.kaisorn@mayo.edu
CR Almeida JP, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0517-x
   AMMIRATI M, 1987, NEUROSURGERY, V21, P607, DOI 10.1227/00006123-198711000-00001
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bloch O, 2012, J NEUROSURG, V117, P1032, DOI 10.3171/2012.9.JNS12504
   Brandes AA, 2017, ONCOLOGIST, V22, P432, DOI 10.1634/theoncologist.2016-0254
   Brandes AA, 2016, FUTURE ONCOL, V12, P1039, DOI 10.2217/fon.16.9
   Brown TJ, 2016, JAMA ONCOL, V2, P1460, DOI 10.1001/jamaoncol.2016.1373
   Chaichana KL, 2013, J NEUROSURG, V118, P812, DOI 10.3171/2012.9.JNS1277
   CHOUCAIR AK, 1986, J NEUROSURG, V65, P654, DOI 10.3171/jns.1986.65.5.0654
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eseonu CI, 2017, WORLD NEUROSURG, V103, P265, DOI 10.1016/j.wneu.2017.04.002
   Gan HK, 2015, J CLIN NEUROSCI, V22, P1462, DOI 10.1016/j.jocn.2015.03.029
   Goldman DA, 2018, J NEUROSURG, V129, P1231, DOI 10.3171/2017.6.JNS17393
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Lu VM, 2018, WORLD NEUROSURG, V115, P453, DOI 10.1016/j.wneu.2018.04.016
   Mallick S, 2016, J EGYPT NATL CANCER, V28, P199, DOI 10.1016/j.jnci.2016.07.001
   McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Oppenlander ME, 2014, J NEUROSURG, V120, P846, DOI 10.3171/2013.12.JNS13184
   Park CK, 2013, NEURO-ONCOLOGY, V15, P1096, DOI 10.1093/neuonc/not069
   Perrini P, 2017, J NEURO-ONCOL, V131, P585, DOI 10.1007/s11060-016-2330-7
   Pessina F, 2017, J NEURO-ONCOL, V131, P377, DOI 10.1007/s11060-016-2310-y
   Quick J, 2014, J NEURO-ONCOL, V117, P365, DOI 10.1007/s11060-014-1397-2
   Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998
   Sastry RA, 2018, J CLIN NEUROSCI, V53, P41, DOI 10.1016/j.jocn.2018.04.004
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Suchorska B, 2016, NEURO-ONCOLOGY, V18, P549, DOI 10.1093/neuonc/nov326
   Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135
   Yong RL, 2014, J NEUROSURG, V121, P802, DOI 10.3171/2014.6.JNS132038
NR 34
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 31
EP 37
DI 10.1016/j.wneu.2019.03.250
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300167
PM 30947000
DA 2020-05-12
ER

PT J
AU Yonezawa, N
   Murakami, H
   Demura, S
   Kato, S
   Yoshioka, K
   Takeuchi, A
   Shinmura, K
   Yokogawa, N
   Shimizu, T
   Oku, N
   Kitagawa, R
   Handa, M
   Tsuchiya, H
AF Yonezawa, Noritaka
   Murakami, Hideki
   Demura, Satoru
   Kato, Satoshi
   Yoshioka, Katsuhito
   Takeuchi, Akihiko
   Shinmura, Kazuya
   Yokogawa, Noriaki
   Shimizu, Takaki
   Oku, Norihiro
   Kitagawa, Ryo
   Handa, Makoto
   Tsuchiya, Hiroyuki
TI Morphologic Changes After Denosumab Therapy in Patients with Giant Cell
   Tumor of the Spine: Report of Four Cases and a Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Collapse; Denosumab; Giant cell tumor; RANKL; Shrinkage; Spine;
   Spondylectomy
ID EN-BLOC SPONDYLECTOMY; CERVICAL-SPINE; BONE; SYSTEM
AB OBJECTIVE: To evaluate the quantitative, radiologic, morphologic, and histo-logic effects of neoadjuvant denosumab treatment (DT) on 4 patients with spinal giant cell tumor of bone (GCTB) and determine the tumor shrinkage effects of DT for spinal GCTB.
   METHODS: The morphologic changes in the 4 patients with spinal GCTB who underwent total spondylectomy after neoadjuvant DT at our institution were retrospectively analyzed using computed tomography. Osteolytic tumor volume, vertebral body height, maximum anterior and transverse diameter, and mean area of the spinal canal occupied by the tumor were evaluated.
   RESULTS: In all patients, osteolytic tumor volume decreased by 81.2% and vertebral body height decreased by 87.4% on average following DT. In 3 of 4 patients with osteolytic lesions and a thin cortical rim, vertebral collapse had progressed after DT. Conversely, vertebral collapse was not observed in one patient with adequate anterior cortical bone. Two patients showed a mean decrease of 96.7% in the maximum transverse diameter, whereas 2 had a mean increase of 109% due to vertebral collapse. The mean area of the spinal canal occupied by the tumor reduced from 56.1% to 15.1%.
   CONCLUSIONS: In all patients, osteolytic tumor volume decreased after DT. This tumor shrinkage effect of DT may increase the mechanical stress on the thin cortical rim, leading to the acute collapse of the affected vertebral body if it consists mostly of osteolytic lesions. The presence of adequate anterior cortical bone could prevent acute vertebral collapse after DT.
C1 [Yonezawa, Noritaka; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Takeuchi, Akihiko; Shinmura, Kazuya; Yokogawa, Noriaki; Shimizu, Takaki; Oku, Norihiro; Kitagawa, Ryo; Handa, Makoto; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.
RP Murakami, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.
EM hmuraka@med.kanazawa-u.ac.jp
OI Shimizu, Takaki/0000-0001-7681-0593; Kato, Satoshi/0000-0003-4762-5932
CR Agarwal A, 2013, CASE REP ONCOL MED, DOI 10.1155/2013/496351
   Balke Maurice, 2012, Sarcoma, V2012, P410973, DOI 10.1155/2012/410973
   Boriani S, 2012, SPINE, V37, pE37, DOI 10.1097/BRS.0b013e3182233ccd
   Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578
   Chawla S, 2013, LANCET ONCOL, V14, P901, DOI 10.1016/S1470-2045(13)70277-8
   Cavalcante RAD, 2016, SPINE, V41, pE178, DOI 10.1097/BRS.0000000000001191
   Demura S, 2012, ORTHOPEDICS, V35, pE453, DOI 10.3928/01477447-20120222-42
   ENNEKING WF, 1986, CLIN ORTHOP RELAT R, P9
   Goldschlager T, 2015, J NEUROSURG-SPINE, V22, P526, DOI 10.3171/2014.10.SPINE13937
   Harrop JS, 2009, SPINE, V34, pS39, DOI 10.1097/BRS.0b013e3181ba0024
   Hart RA, 1997, SPINE, V22, P1773, DOI 10.1097/00007632-199708010-00018
   Inoue G, 2017, ONCOL LETT, V14, P4005, DOI 10.3892/ol.2017.6655
   Kajiwara D, 2016, ASIAN SPINE J, V10, P553, DOI 10.4184/asj.2016.10.3.553
   Kumar R, 2017, SPINE, V42, pE629, DOI 10.1097/BRS.0000000000001951
   Ma JM, 2008, SPINE, V33, P280, DOI 10.1097/BRS.0b013e318162454f
   Mattei TA, 2014, SPINE J, V14, pE15, DOI 10.1016/j.spinee.2014.02.019
   Nakazawa T, 2016, INT J SURG CASE REP, V24, P22, DOI 10.1016/j.ijscr.2016.05.008
   Oguro S, 2018, MAGN RESON MED SCI, V17, P325, DOI 10.2463/mrms.mp.2017-0072
   Randhawa SS, 2016, ASIAN SPINE J, V10, P945, DOI 10.4184/asj.2016.10.5.945
   Roux S, 2002, AM J CLIN PATHOL, V117, P210
   Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3
   TOMITA K, 1994, PARAPLEGIA, V32, P36, DOI 10.1038/sc.1994.7
   Wojcik J, 2016, AM J SURG PATHOL, V40, P72, DOI 10.1097/PAS.0000000000000506
   Yokogawa N, 2018, EUR SPINE J, V27, P3084, DOI 10.1007/s00586-018-5761-3
   Yonezawa N, 2017, EUR SPINE J, V26, pS236, DOI 10.1007/s00586-017-5086-7
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 38
EP 46
DI 10.1016/j.wneu.2019.03.185
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300168
PM 30926552
DA 2020-05-12
ER

PT J
AU Sumdani, H
   Shahbuddin, Z
   Harper, G
   Hamilton, L
AF Sumdani, Hasan
   Shahbuddin, Zanab
   Harper, Glenn
   Hamilton, Lesley
TI Case Report of Rarely Described Polymorphous Low-Grade Neuroepithelial
   Tumor of the Young and Comparison with Oligodendroglioma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Dysembryoplastic; Neoplasm; Neurosurgery; Oligodendroglioma; PLNTY;
   Polymorphous low-grade neuroepithelial tumor of the young; Seizure
AB BACKGROUND: Polymorphous low-grade neuroepithelial tumor of the young (PLANY) is a central nervous system tumor that shares many qualities with oligodendroglioma but is rarely and only very recently described as a distinct entity in the literature.
   CASE DESCRIPTION: A previously healthy, 19-year-old man presented with new onset of seizures. Imaging showed an intracranial mass, which was treated with surgical removal. Preoperative and postoperative magnetic resonance imaging, histopathologic examination, genetic testing, and immunohistochemical staining all supported a diagnosis of PLNTY.
   CONCLUSIONS: Diagnostic investigation of PLNTY shows many similarities with oligodendroglioma, and thus these entities can be mistaken for one another. Certain studies are needed to distinguish PLNTY and other dysembryoplastic neuroepithelial tumors, such as oligodendroglioma.
C1 [Harper, Glenn] Dept Neurosurg, Round Rock, TX USA.
   [Hamilton, Lesley] Dept Pathol, Round Rock, TX USA.
   [Sumdani, Hasan; Shahbuddin, Zanab] Seton Med Ctr Williamson, Round Rock, TX 78665 USA.
RP Sumdani, H (reprint author), Seton Med Ctr Williamson, Round Rock, TX 78665 USA.
EM hsumdani@medicine.tamhsc.edu
CR Bitar M, 2018, CLIN NEUROPATHOL, V37, P178, DOI 10.5414/NP301081
   Carneiro BA, 2015, GYNECOL ONCOL REP, V13, P53, DOI 10.1016/j.gore.2015.06.005
   Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782
   Huse JT, 2017, ACTA NEUROPATHOL, V133, P417, DOI 10.1007/s00401-016-1639-9
   Jenkinson MD, 2006, BRAIN, V129, P1884, DOI 10.1093/brain/awl108
   LEE YY, 1989, AM J ROENTGENOL, V152, P361, DOI 10.2214/ajr.152.2.361
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Mazzaferro V, 2019, BRIT J CANCER, V120, P165
   Smits M, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150857
   Vogelstein B, 2018, US patent, Patent No. 9873917
   Wesseling P, 2015, ACTA NEUROPATHOL, V129, P809, DOI 10.1007/s00401-015-1424-1
   Zavan B, 2015, INT J BIOL SCI, V11, P1127, DOI 10.7150/ijbs.11946
   Zhang K, 2018, AM J CLIN PATHOL S1, V150, P16, DOI 10.1093/ajcp/aqy090.040
NR 13
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 47
EP 51
DI 10.1016/j.wneu.2019.03.181
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300169
PM 30926558
DA 2020-05-12
ER

PT J
AU Sahyouni, R
   Goshtasbi, K
   Choi, E
   Mahboubi, H
   Le, R
   Khahera, AS
   Hanna, GK
   Hatefi, D
   Hsu, FP
   Bhandarkar, ND
   Kuan, EC
   Cadena, G
AF Sahyouni, Ronald
   Goshtasbi, Khodayar
   Choi, Edward
   Mahboubi, Hossein
   Le, Ryan
   Khahera, Anadjeet S.
   Hanna, George K.
   Hatefi, Dustin
   Hsu, Frank P.
   Bhandarkar, Naveen D.
   Kuan, Edward C.
   Cadena, Gilbert
TI Vision Outcomes in Early versus Late Surgical Intervention of Pituitary
   Apoplexy: Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Meta-analysis; Neurosurgery; Pituitary apoplexy; Timing; Vision
ID CONSERVATIVE MANAGEMENT; SURGERY; EXPERIENCE; ADENOMAS
AB BACKGROUND: Pituitary apoplexy (PA) is defined by hemorrhage and ne-crosis of the pituitary gland, often acute in onset, and frequently in the setting of an existing pituitary adenoma. Our objective was to conduct a meta-analysis of the available literature on vision outcomes following surgical intervention for PA on the basis of the timing from apoplexy to surgery (ATS).
   METHODS: A thorough literature search of the published English-language literature was performed in PubMed, Ovid, and Cochrane databases using the key words ("pituitary apoplexy") and ("surgery" or "vision") from database inception to August 2018 was conducted. The primary outcome variable evaluated using a binary random-effects model was vision recovery outcomes (metric: odds ratio).
   RESULTS: Of 234 articles found, 12 articles containing 200 patients met our eligibility criteria. The mean age was 46.1, with a male-to-female ratio of 2.9:1. A total of 86% of PA patients presented with visual deficits (ATS <7 days in 93 and >7 days in 79 patients). In patients with an ATS <7 days, 97.8% experienced visual recovery, compared with 84.8% with an ATS >7 days (odds ratio 2.6 [95% CI 0.94-7.31]; P value = 0.07).
   CONCLUSIONS: Despite readily accepted guidelines provided by the United Kingdom advocating for early surgical intervention in PA, the rates of vision outcomes we report demonstrate >80% recovery for patients in both the early and late surgical intervention group. As such, conservative management may be warranted for early stabilization before surgical intervention in PA patients with respect to vision outcomes.
C1 [Sahyouni, Ronald; Goshtasbi, Khodayar; Choi, Edward; Le, Ryan; Khahera, Anadjeet S.] UC Irvine, Sch Med, Orange, CA USA.
   [Mahboubi, Hossein; Bhandarkar, Naveen D.; Kuan, Edward C.] UC Irvine, Dept Otolaryngol Head & Neck Surg, Orange, CA USA.
   [Hanna, George K.; Hatefi, Dustin; Hsu, Frank P.; Cadena, Gilbert] UC Irvine, Dept Neurol Surg, Orange, CA 92868 USA.
RP Cadena, G (reprint author), UC Irvine, Dept Neurol Surg, Orange, CA 92868 USA.
EM gcadena@uci.edu
RI Kuan, Edward C/I-3715-2019
OI Kuan, Edward C/0000-0003-3475-0718; Sahyouni, Ronald/0000-0002-2124-0535
CR Agrawal D, 2005, SURG NEUROL, V63, P42, DOI 10.1016/j.surneu.2004.03.014
   Ayuk J, 2004, CLIN ENDOCRINOL, V61, P747, DOI 10.1111/j.1365-2265.2004.02162.x
   Bi WL, 2015, ENDOCRINE, V48, P69, DOI 10.1007/s12020-014-0359-y
   BILLS DC, 1993, NEUROSURGERY, V33, P602, DOI 10.1227/00006123-199310000-00007
   Briet C, 2015, ENDOCR REV, V36, P622, DOI 10.1210/er.2015-1042
   BROUGHAM M, 1950, J NEUROSURG, V7, P421, DOI 10.3171/jns.1950.7.5.0421
   Bujawansa S, 2014, CLIN ENDOCRINOL, V80, P419, DOI 10.1111/cen.12307
   CARDOSO ER, 1984, NEUROSURGERY, V14, P363, DOI 10.1227/00006123-198403000-00021
   Chuang CC, 2006, J NEURO-ONCOL, V80, P39, DOI 10.1007/s11060-006-9148-7
   EBERSOLD MJ, 1983, J NEUROSURG, V58, P315, DOI 10.3171/jns.1983.58.3.0315
   Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x
   Giritharan S, 2016, CLIN ENDOCRINOL, V85, P415, DOI 10.1111/cen.13075
   Glezer A, 2015, ARCH ENDOCRIN METAB, V59, P259, DOI 10.1590/2359-3997000000047
   Gruber A, 2006, BRIT J NEUROSURG, V20, P379, DOI 10.1080/02688690601046678
   Hage R, 2016, WORLD NEUROSURG, V94, P447, DOI 10.1016/j.wneu.2016.07.026
   Imboden PNE, 2005, MEDICINE, V84, P188, DOI 10.1097/01.md.0000164205.77287.9c
   Kim YH, 2018, WORLD NEUROSURG, V111, pE18, DOI 10.1016/j.wneu.2017.11.124
   Lee JH, 2007, J KOREAN NEUROSURG S, V42, P83
   Leyer C, 2011, J ENDOCRINOL INVEST, V34, P502, DOI 10.3275/7241
   Lubina A, 2005, ACTA NEUROCHIR, V147, P151, DOI 10.1007/s00701-004-0413-2
   MACCAGNAN P, 1995, J CLIN ENDOCR METAB, V80, P2190, DOI 10.1210/jc.80.7.2190
   MCFADZEAN RM, 1991, NEUROSURGERY, V29, P669, DOI 10.1227/00006123-199111000-00005
   Milazzo S, 1996, Eur J Ophthalmol, V6, P69
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Muthukumar N, 2008, J CLIN NEUROSCI, V15, P873, DOI 10.1016/j.jocn.2007.08.010
   ONESTI ST, 1990, NEUROSURGERY, V26, P980, DOI 10.1227/00006123-199006000-00010
   Raappana A, 2010, J CLIN ENDOCR METAB, V95, P4268, DOI 10.1210/jc.2010-0537
   Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x
   Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x
   REID RL, 1985, ARCH NEUROL-CHICAGO, V42, P712, DOI 10.1001/archneur.1985.04060070106028
   ROLIH CA, 1993, ENDOCRIN METAB CLIN, V22, P291, DOI 10.1016/S0889-8529(18)30167-1
   Semple PL, 2005, NEUROSURGERY, V56, P65, DOI 10.1227/01.NEU.0000144840.55247.38
   Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3
   Singh TD, 2015, J NEUROSURG, V122, P1450, DOI 10.3171/2014.10.JNS141204
   Takeda N, 2010, PITUITARY, V13, P154, DOI 10.1007/s11102-009-0216-9
   Woo HJ, 2010, J KOREAN NEUROSURG S, V48, P213, DOI 10.3340/jkns.2010.48.3.213
   Zayour DH, 2004, J CLIN ENDOCR METAB, V89, P5649, DOI 10.1210/jc.2004-0884
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 52
EP 57
DI 10.1016/j.wneu.2019.03.133
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300170
PM 30922898
DA 2020-05-12
ER

PT J
AU Bayley, VJC
   Goethe, EA
   Srinivasan, VM
   Klisch, TJ
   Mandel, JJ
   Patel, AJ
AF Bayley, James Cushing, V
   Goethe, Eric A.
   Srinivasan, Visish M.
   Klisch, Tiemo J.
   Mandel, Jacob J.
   Patel, Akash J.
TI Newly Diagnosed Optic Pathway Glioma During Pregnancy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Optic pathway glioma; Pilocytic astrocytoma; Pregnancy
ID NERVE GLIOMA
AB BACKGROUND: Optic pathway gliomas (OPGs) are relatively rare, and their presentation after the first decade of life is even less common. Although many treatment options exist, surgery is typically reserved for tumors significantly compressing surrounding structures. Pregnancy can complicate the management of these tumors, as fetal developmental considerations limit the ways in which they are imaged and treated.
   CASE DESCRIPTION: In this report we detail the case of a 27-year-old pregnant woman who was found to have an OPG during her third trimester. After a decline in this patient's vision and clinical status, a decision was made to induce labor at 31 weeks so that her disease could be more thoroughly addressed.
   CONCLUSIONS: While OPGs are typically benign tumors, pregnancy complicates their management significantly. Contrast media and anesthesia pose significant risks to the fetus, while pregnancy may contribute to increased rates of tumor growth and clinical deterioration. Managing OPGs in pregnant patients thus requires balancing the risks to the fetus and patient.
C1 [Bayley, James Cushing, V; Goethe, Eric A.; Srinivasan, Visish M.; Patel, Akash J.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.
   [Mandel, Jacob J.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.
   [Klisch, Tiemo J.; Patel, Akash J.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.
RP Patel, AJ (reprint author), Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.; Patel, AJ (reprint author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.
EM akash.patel@bcm.edu
OI Patel, Akash/0000-0002-1280-2989
CR BENES V, 1990, CHILD NERV SYST, V6, P75, DOI 10.1007/BF00307925
   Bunin GR, 1998, J NEUROSURG, V89, P547, DOI 10.3171/jns.1998.89.4.0547
   Byers WGM, 1901, PRIMARY INTRADURAL T
   DUTTON JJ, 1994, SURV OPHTHALMOL, V38, P427, DOI 10.1016/0039-6257(94)90173-2
   Herman A., 2017, NEJM J WATCH
   Lake MG, 2013, AM FAM PHYSICIAN, V88, P319
   Molitch ME, 2003, GROWTH HORM IGF RES, V13, pS38, DOI 10.1016/S1096-6374(03)00054-6
   Packer RJ, 1997, J NEUROSURG, V86, P747, DOI 10.3171/jns.1997.86.5.0747
   Pallud J, 2010, ANN NEUROL, V67, P398, DOI 10.1002/ana.21888
   Peeters S, 2018, J NEUROSURG, V128, P3, DOI 10.3171/2016.10.JNS16710
   Rasool N, 2017, CURR OPIN OPHTHALMOL, V28, P289, DOI 10.1097/ICU.0000000000000370
   Ray JG, 2016, JAMA-J AM MED ASSOC, V316, P952, DOI 10.1001/jama.2016.12126
   Strowd RE, 2016, AM J MED GENET A, V170, P1455, DOI 10.1002/ajmg.a.37622
   TOPLISS DJ, 1989, MED J AUSTRALIA, V150, P287, DOI 10.5694/j.1326-5377.1989.tb136478.x
   Wabbels B, 2004, GRAEF ARCH CLIN EXP, V242, P741, DOI 10.1007/s00417-004-0905-z
   Wang LP, 2008, ANESTH ANALG, V107, P193, DOI 10.1213/ane.0b013e31816c8888
   Witek P, 2013, MINERVA ENDOCRINOL, V38, P351
   WULC AE, 1989, ARCH OPHTHALMOL-CHIC, V107, P1013, DOI 10.1001/archopht.1989.01070020075033
   Yokoyama S, 2003, NEUROL MED-CHIR, V43, P559, DOI 10.2176/nmc.43.559
   Yust-Katz S, 2014, NEURO-ONCOLOGY, V16, P1289, DOI 10.1093/neuonc/nou019
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 58
EP 62
DI 10.1016/j.wneu.2019.02.207
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300171
PM 30878749
DA 2020-05-12
ER

PT J
AU Bohl, MA
   McBryan, S
   Spear, C
   Pais, D
   Preul, MC
   Wilhelmi, B
   Yeskel, A
   Turner, JD
   Kakarla, UK
   Nakaji, P
AF Bohl, Michael A.
   McBryan, Sarah
   Spear, Charlotte
   Pais, Danielle
   Preul, Mark C.
   Wilhelmi, Brian
   Yeskel, Ariya
   Turner, Jay D.
   Kakarla, U. Kumar
   Nakaji, Peter
TI Evaluation of a Novel Surgical Skills Training Course: Are Cadavers
   Still the Gold Standard for Surgical Skills Training?
SO WORLD NEUROSURGERY
LA English
DT Article
DE High-fidelity training models; Residency education; Surgical education;
   Training models
ID ANATOMY EDUCATION; SIMULATION; MODEL; CURRICULUM; KNOWLEDGE
AB BACKGROUND: An increasing body of literature describing use of high-fidelity surgical training models is challenging long-held dogma that cadavers provide the best medium for postgraduate surgical skills training. The purpose of this study was to describe a surgical skills course comprising entirely synthetic training models developed by resident and attending neurosurgeons and to evaluate their perceptions of the overall usefulness of this course and its usefulness compared with cadaveric courses.
   METHODS: Ten high-fidelity neurosurgical training models were developed. A neurosurgical skills course for residents was structured to include 7 spinal and 3 cranial learning stations, each with its own model and assigned attending expert. Resident and attending neurosurgeons were asked to complete surveys on their overall impressions of the course and models and on workload comparisons between models and real cases. Student t tests were used for statistical comparisons.
   RESULTS: Survey responses were collected from 9 of 16 participating residents (56.3%) and 3 of 10 attending neurosurgeons (30.0%). Both groups believed that the course was very helpful overall to resident education. Respondents furthermore believed that the course was more helpful overall than cadaveric courses. Task load index testing showed no significant workload difference between models and real cases (P >= 0.17), except in temporal demand (P < 0.001).
   CONCLUSIONS: Resident and attending neurosurgeons subjectively believe that high-fidelity synthetic models were superior to cadavers as a surgical skills teaching platform. This study raises the question of whether cadavers should remain the gold standard for surgical skills courses. Expanded use of these teaching models and further study are warranted.
C1 [Bohl, Michael A.; McBryan, Sarah; Spear, Charlotte; Pais, Danielle; Preul, Mark C.; Wilhelmi, Brian; Yeskel, Ariya; Turner, Jay D.; Kakarla, U. Kumar; Nakaji, Peter] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.
RP Nakaji, P (reprint author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.
EM Neuropub@barrowneuro.org
OI /0000-0001-6867-3568
CR Anastakis DJ, 1999, AM J SURG, V177, P167, DOI 10.1016/S0002-9610(98)00327-4
   Bohl MA, 2019, GLOB SPINE J, V9, P635, DOI 10.1177/2192568218824080
   Bohl Michael A, 2019, J Spine Surg, V5, P58, DOI 10.21037/jss.2019.01.05
   Bohl MA, 2019, CUREUS, V11, DOI 10.7759/cureus.3893
   Bohl Michael A, 2018, Cureus, V10, pe2142, DOI 10.7759/cureus.2142
   Bohl MA, 2018, CUREUS, V10, DOI 10.7759/cureus.2491
   Bohl MA, 2018, SPINE, V43, pE1368, DOI 10.1097/BRS.0000000000002715
   Cleary DR, 2018, J NEUROSURG, V128, P1553, DOI 10.3171/2016.12.JNS162165
   Ruiz-Rabelo JF, 2015, OBES SURG, V25, P2451, DOI 10.1007/s11695-015-1922-1
   Gilbody J, 2011, ANN ROY COLL SURG, V93, P347, DOI 10.1308/147870811X582954
   Gogalniceanu P, 2010, ANZ J SURG, V80, P6, DOI 10.1111/j.1445-2197.2009.05167.x
   Haffner M, 2018, ANN OTO RHINOL LARYN, V127, P338, DOI 10.1177/0003489418764987
   Harrop J, 2013, NEUROSURGERY, V73, P25, DOI 10.1227/NEU.0000000000000101
   Hart S. G., 1988, HUMAN MENTAL WORKLOA
   Hart S. G., 2006, P HUM FACT ERG SOC A, V50, P904, DOI DOI 10.1177/154193120605000909
   Holla SJ, 2009, ANAT SCI EDUC, V2, P179, DOI 10.1002/ase.79
   Law Katherine E, 2020, Ann Surg, V271, P906, DOI 10.1097/SLA.0000000000003173
   Lemole GM, 2007, NEUROSURGERY, V61, P142, DOI 10.1227/01.neu.0000279734.22931.21
   Leong SK, 1999, CLIN ANAT, V12, P422, DOI 10.1002/(SICI)1098-2353(1999)12:6<422::AID-CA4>3.0.CO;2-V
   Lobel DA, 2013, NEUROSURGERY, V73, P57, DOI 10.1227/NEU.0000000000000116
   Lowndes Bethany R, 2020, Ann Surg, V271, P686, DOI 10.1097/SLA.0000000000003058
   Mooney MA, 2019, OPER NEUROSURG
   Mowry SE, 2015, OTOL NEUROTOL, V36, P1562, DOI 10.1097/MAO.0000000000000848
   Patel KM, 2008, CLIN ANAT, V21, P182, DOI 10.1002/ca.20584
   Pavlidis I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38727-z
   Robinson WP, 2017, J VASC SURG, V65, P907, DOI 10.1016/j.jvs.2016.12.065
   Selden NR, 2013, NEUROSURGERY, V73, P15, DOI 10.1227/NEU.0000000000000058
   Selden NR, 2013, J NEUROSURG, V119, P796, DOI 10.3171/2013.3.JNS122114
   Stirling ERB, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0126-z
   Walters C, 2017, ASSOC OPER ROOM NURS, V106, P283, DOI 10.1016/j.aorn.2017.08.004
   Zheng JP, 2018, WORLD NEUROSURG, V111, pE773, DOI 10.1016/j.wneu.2017.12.169
NR 31
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 63
EP 71
DI 10.1016/j.wneu.2019.03.230
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300172
PM 30930320
DA 2020-05-12
ER

PT J
AU Plou, P
   Landriel, F
   Beltrame, S
   Hem, S
   Peralta, O
   Garcia-Monaco, R
   Yampolsky, C
AF Plou, Pedro
   Landriel, Federico
   Beltrame, Sofia
   Hem, Santiago
   Peralta, Oscar
   Garcia-Monaco, Ricardo
   Yampolsky, Claudio
TI Flow Diverter for the Treatment of Pseudoaneurysms of the Extracraneal
   Vertebral Artery: Report of Two Cases and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Spine flow diverter; Spine pseudoaneurysm; Vertebral artery
   pseudoaneurysm
ID PIPELINE EMBOLIZATION DEVICE; CEREBROVASCULAR-DISEASE; ENDOVASCULAR
   TREATMENT; HOSPITALIZED-PATIENTS; INCREASED PREVALENCE; ANEURYSMS;
   SURGERY; INJURY
AB BACKGROUND: Pseudoaneurysms (PAs) of the extracranial vertebral artery (VA) are rare lesions, representing less than 1% of all aneurysms. Although these lesions may resolve spontaneously, they present a high rupture rate, so early preventive treatment is advised.
   CASE DESCRIPTION: Case 1: A 48-year-old woman presented with pain and cervical rigidity. An angiotomography showed a PA of the left VA at the level of the C2 transverse foramen, with mural thrombosis and bone remodeling of the left lateral mass. The PA was treated with the endovascular placement of a flow diverter stent. The patient was discharged 3 days after the procedure without complications. The last vascular imaging follow-up was performed 6 years after the procedure showing a patent left VA, with complete resolution of the aneurysm. Case 2: A 57-year-old woman was admitted referring cervicalgia after a polytraumatism. An angiotomography revealed a fracture of the C1 posterior arch, lateral mass, and left transverse foramen, on top of a left VA thrombosis due to a vascular dissection. Eleven months after the trauma, a left VA V3 segment arteriovenous fistula developed. It was treated with hydrocoils, with no complications. One month after the embolization, a left VA V3 segment PA was observed and treated with a flow diverter stent. An angiographic follow-up 2 years after the procedure showed a patent left VA, with complete resolution of the PA.
   CONCLUSION: The use of flow diverters seems to be a safe and effective therapeutic option for the treatment of PAs of the extracranial VAs.
C1 [Plou, Pedro; Landriel, Federico; Beltrame, Sofia; Hem, Santiago; Yampolsky, Claudio] Hosp Italiano Buenos Aires, Neurosurg Dept, Buenos Aires, DF, Argentina.
   [Peralta, Oscar; Garcia-Monaco, Ricardo] Hosp Italiano Buenos Aires, Diagnost Imaging Dept, Buenos Aires, DF, Argentina.
RP Landriel, F (reprint author), Hosp Italiano Buenos Aires, Neurosurg Dept, Buenos Aires, DF, Argentina.
EM fedelandriel@gmail.com
CR Aihara M, 2018, J NEUROSURG, V129, P107, DOI 10.3171/2017.2.JNS162916
   Ambekar Sudheer, 2014, Case Rep Vasc Med, V2014, P341748, DOI 10.1155/2014/341748
   Antonov G I, 2015, Zh Vopr Neirokhir Im N N Burdenko, V79, P90, DOI 10.17116/neiro201579390-95
   Bernard G, 1987, VERTEBRAL ARTERY PAT
   Cohen JE, 2016, J CLIN NEUROSCI, V32, P77, DOI 10.1016/j.jocn.2016.03.023
   Faria MD, 2011, AM J NEURORADIOL, V32, P2192, DOI 10.3174/ajnr.A2671
   Dolati P, 2015, CUREUS, V7, DOI 10.7759/cureus.356
   Garcia-Monaco RD, 2012, CARDIOVASC INTER RAD, V35, P704, DOI 10.1007/s00270-011-0246-3
   Perez GCI, 2015, ANN VASC SURG, V29, DOI 10.1016/j.avsg.2015.01.022
   Kerolus M, 2018, BRIT J NEUROSURG, V32, P563, DOI 10.1080/02688697.2016.1265087
   Kim ST, 2018, J STROKE CEREBROVASC, V27, P296, DOI 10.1016/j.jstrokecerebrovasdis.2017.08.036
   Kim ST, 2017, J STROKE CEREBROVASC, V26, P1678, DOI 10.1016/j.jstrokecerebrovasdis.2017.03.025
   Leung GKK, 2012, CLIN NEURORADIOL, V22, P295, DOI 10.1007/s00062-012-0178-6
   Li F, 2014, ANN VASC SURG, V28, P489
   Lylyk P, 2001, J NEUROSURG, V94, P427, DOI 10.3171/jns.2001.94.3.0427
   Madawi AA, 1997, J NEUROSURG, V86, P961, DOI 10.3171/jns.1997.86.6.0961
   Morasch MD, 2013, ANN VASC SURG, V27, P418, DOI 10.1016/j.avsg.2012.08.002
   MORGAN MK, 1994, J NEUROSURG, V80, P237, DOI 10.3171/jns.1994.80.2.0237
   Nelson PK, 2011, AM J NEURORADIOL, V32, P34, DOI 10.3174/ajnr.A2421
   Neo M, 2008, SPINE, V33, P779, DOI 10.1097/BRS.0b013e31816957a7
   Rao S, 2015, MOD RHEUMATOL, V25, P476, DOI 10.3109/14397595.2013.843751
   Sancak T, 2008, KOREAN J RADIOL, V9, pS68, DOI 10.3348/kjr.2008.9.s.s68
   Schittek A, 1999, TEX HEART I J, V26, P90
   Shakir Hakeem J, 2016, Surg Neurol Int, V7, P104, DOI 10.4103/2152-7806.196235
   Shang EK, 2013, J VASC SURG, V58, P1391, DOI 10.1016/j.jvs.2013.01.040
   SHINTANI A, 1972, J NEUROSURG, V36, P447, DOI 10.3171/jns.1972.36.4.0447
   SUTTON LN, 1994, PEDIATR NEUROSURG, V21, P124, DOI 10.1159/000120874
   Tang S-J, 2009, SEMIN SPINE SURG, V21, P148
   Tekiner A, 2011, TURK NEUROSURG, V21, P90
   Yilmaz MB, 2015, TURK NEUROSURG, V25, P141, DOI 10.5137/1019-5149.JTN.8247-13.1
NR 30
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 72
EP 78
DI 10.1016/j.wneu.2019.03.098
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300173
PM 30898750
DA 2020-05-12
ER

PT J
AU Tokairin, K
   Osanai, T
   Kazumata, K
   Sawaya, R
   Houkin, K
AF Tokairin, Kikutaro
   Osanai, Toshiya
   Kazumata, Ken
   Sawaya, Ryosuke
   Houkin, Kiyohiro
TI Contrecoup Injury-Induced Middle Meningeal Arteriovenous Fistula
   Detected by Time-of-Flight Magnetic Resonance Angiography and Magnetic
   Resonance Arterial Spin Labeling: Case Report and Review of the
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Arterial spin labeling; Arteriovenous fistula; Contrecoup; Embolization;
   Middle meningeal artery; Time-of-flight magnetic resonance angiography;
   Trauma
ID SUBDURAL-HEMATOMA; CAVERNOUS SINUS; EMBOLIZATION; PSEUDOANEURYSM;
   LESIONS
AB BACKGROUND: Middle meningeal arteriovenous fistula (MM-AVF) is rare; however, it will sometimes be followed by intracranial hemorrhage or progressive symptoms caused by abnormal shunt flow. Radiological examination and endovascular treatment of this condition have recently advanced; thus, we have described the pathogenesis, clinical features, and appropriate diagnostic and therapeutic management of MM-AVF. We also reviewed the reported data of the past 35 years, including 30 cases of MM-AVF.
   CASE DESCRIPTION: We report the case of 24-year-old man who had presented with right tinnitus who had experienced previous head trauma on the opposite side to the tinnitus ear. Time-of-flight magnetic resonance angiography and magnetic resonance arterial spin labeling findings were suggestive of MM-AVF, and catheter angiography confirmed MM-AVF with shunt flow draining into the cavernous sinus. Endovascular transarterial embolization was performed, and the MM-AVF was embolized successfully using detachable coils and n-butyl-2-cyanoacrylate. The tinnitus disappeared completely immediately after the treatment.
   CONCLUSIONS: MM-AVF is caused, not only by coup injury, but also by contrecoup injury. Time-of-flight magnetic resonance angiography and magnetic resonance arterial spin labeling are useful for detecting MM-AVF. Endovascular transarterial embolization is an effective and safe treatment.
C1 [Tokairin, Kikutaro; Osanai, Toshiya; Kazumata, Ken; Sawaya, Ryosuke; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.
RP Tokairin, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.
EM k-tokairin@umin.ac.jp
RI Osanai, Toshiya/AAF-3011-2020
OI Kazumata, Ken/0000-0001-7409-9515; Tokairin,
   Kikutaro/0000-0002-0273-2585
CR Abla AA, 2011, NEUROSURGERY, V68, pE1750, DOI 10.1227/NEU.0b013e31821713fb
   Amukotuwa SA, 2018, AM J NEURORADIOL, V39, P669, DOI 10.3174/ajnr.A5570
   Andoh Shunpei, 2018, J Med Case Rep, V12, P166, DOI 10.1186/s13256-018-1676-1
   BERENSTEIN A, 1986, AM J NEURORADIOL, V7, P937
   Chandrashekar HS, 2007, INTERV NEURORADIOL, V13, P173, DOI 10.1177/159101990701300208
   de Andrade AF, 2008, NEUROSURGERY, V62, P416, DOI 10.1227/01.neu.0000316008.11388.f2
   FINCHER EF, 1951, ANN SURG, V133, P886, DOI 10.1097/00000658-195106000-00015
   FRECKMANN N, 1981, ACTA NEUROCHIR, V55, P273, DOI 10.1007/BF01808443
   INAGAWA T, 1984, J NEUROSURG, V60, P853, DOI 10.3171/jns.1984.60.4.0853
   Kawaguchi T, 2002, NEUROL MED-CHIR, V42, P221, DOI 10.2176/nmc.42.221
   Ko JH, 2014, INTERV NEURORADIOL, V20, P352, DOI 10.15274/NRJ-2014-10025
   KOMIYAMA M, 1994, SURG NEUROL, V42, P316, DOI 10.1016/0090-3019(94)90400-6
   Liu AH, 2008, SURG NEUROL, V70, P660, DOI 10.1016/j.surneu.2007.05.054
   Martinez M, 2018, CHILD NERV SYST, V34, P571, DOI 10.1007/s00381-017-3665-x
   Matsumoto K, 2001, SURG NEUROL, V55, P302, DOI 10.1016/S0090-3019(01)00328-7
   OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503
   PARK JW, 2017, KOREAN J NEUROTRAUMA, V13, P168, DOI DOI 10.12965/JER.1734948.474
   Peres CMA, 2018, J NEUROSURG, V128, P1044, DOI 10.3171/2016.11.JNS161398
   Sacho RH, 2014, J ORAL MAXIL SURG, V72, P1258, DOI 10.1016/j.joms.2014.03.007
   Sakata H, 2009, NEUROL MED-CHIR, V49, P462, DOI 10.2176/nmc.49.462
   Takeuchi S, 2008, NEUROL SURG TOKYO, V36, P907
   Takeuchi S, 2009, NEUROL SURG TOKYO, V37, P983
   Tanaka Jun, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2017-223512
   TOUHO H, 1995, NEURORADIOLOGY, V37, P65, DOI 10.1007/BF00588523
   Tsutsumi M, 2002, SURG NEUROL, V58, P325, DOI 10.1016/S0090-3019(02)00834-0
   Unterhofer C, 2009, ACTA NEUROCHIR, V151, P1301, DOI 10.1007/s00701-009-0251-3
   Vassilyadi M, 2009, CAN J NEUROL SCI, V36, P751, DOI 10.1017/S0317167100008386
   Yu JL, 2017, INTERV NEURORADIOL, V23, P90, DOI 10.1177/1591019916673584
NR 28
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 79
EP 84
DI 10.1016/j.wneu.2019.03.189
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300174
PM 30928586
DA 2020-05-12
ER

PT J
AU Telfeian, AE
   Doberstein, C
   Oyelese, AA
   Fridley, J
   Donahue, JE
   Gokaslan, Z
AF Telfeian, Albert E.
   Doberstein, Cody
   Oyelese, Adetokunbo A.
   Fridley, Jared
   Donahue, John E.
   Gokaslan, Ziya
TI A Transforaminal Endoscopic Approach for Treatment of a Lumbar
   Perineural Cyst: Technical Note
SO WORLD NEUROSURGERY
LA English
DT Article
DE Endoscopic spine surgery; Minimally invasive spine; Perineural cyst;
   Tarlov cyst; Transforaminal
ID TARLOV CYSTS; SURGICAL-TREATMENT; MANAGEMENT; PREVALENCE
AB OBJECTIVE: Perineural cysts are a benign spine pathology but, when they become symptomatic and require surgical treatment, represent a significant challenge to the spine surgeon. Here we describe our experience with a novel endoscopic approach to the biopsy, drainage, resection of the cyst wall, and direct cyst fenestration to the subarachnoid space.
   METHODS: A transforaminal endoscopic approach to a lumbar 2-3 perineural cyst is presented here in a 25-year-old patient. A step-by-step technique for the biopsy, drainage, and resection of the cyst wall is presented.
   RESULTS: The patient underwent cyst resection and fenestration into the subarachnoid space without complication, with immediate relief of his preoperative symptoms and after 1 year remains symptom-free.
   CONCLUSIONS: Surgical treatment of perineural cysts in the spine represent a significant challenge to the surgeon, principally due to the risk of spinal fluid leak in the post-operative period. Transforaminal endoscopic surgical access to this disease pathology is a novel minimally invasive surgical approach presented here that allows diagnosis and treatment of a perineural cyst and can be performed in an awake patient.
C1 [Telfeian, Albert E.; Doberstein, Cody; Oyelese, Adetokunbo A.; Fridley, Jared; Donahue, John E.; Gokaslan, Ziya] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
RP Telfeian, AE (reprint author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
EM albert.telfeian@nts-online.net
CR Acosta Jr FL, 2003, NEUROSURG FOCUS, V15, P15
   Cantore G, 2013, WORLD NEUROSURG, V79, P381, DOI 10.1016/j.wneu.2012.06.015
   Dowsett LE, 2018, CLIN SPINE SURG, V31, P377, DOI 10.1097/BSD.0000000000000582
   Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78
   Huang Y, 2018, WORLD NEUROSURG, V113, pE722, DOI 10.1016/j.wneu.2018.02.137
   Jiang W, 2017, PAIN PHYSICIAN, V20, pE653
   Kim SK, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0849-3
   Krings T, 2001, ACTA NEUROCHIR, V143, P227, DOI 10.1007/s007010170102
   Langdown AJ, 2005, J SPINAL DISORD TECH, V18, P29, DOI 10.1097/01.bsd.0000133495.78245.71
   Lee J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012412
   Lucantoni C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11221
   Mezzadri J, 2014, J NEUROL SURG PART A, V75, P462, DOI 10.1055/s-0033-1361836
   Mitra R, 2008, SPINE, V33, pE565, DOI 10.1097/BRS.0b013e31817e2cc9
   NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366
   Nayak Raghavendra, 2017, Asian J Neurosurg, V12, P321, DOI 10.4103/1793-5482.150004
   Neulen A, 2011, ACTA NEUROCHIR, V153, P1427, DOI 10.1007/s00701-011-1043-0
   PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293
   Seo DH, 2014, J KOREAN NEUROSURG S, V55, P110, DOI 10.3340/jkns.2014.55.2.110
   Sun JJ, 2013, SCI CHINA LIFE SCI, V56, P1007, DOI 10.1007/s11427-013-4536-7
   Tani S, 2013, NEUROL MED-CHIR, V53, P91, DOI 10.2176/nmc.53.91
   Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1067, DOI 10.1001/archneurpsyc.1938.02270120017001
   Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025
   Zhang B, 2018, WORLD NEUROSURG, V116, P390, DOI 10.1016/j.wneu.2018.05.177
NR 23
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 85
EP 91
DI 10.1016/j.wneu.2019.02.237
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300175
PM 30954752
DA 2020-05-12
ER

PT J
AU Wang, JH
   Zhu, CR
   Xia, H
AF Wang, JianHua
   Zhu, ChangRong
   Xia, Hong
TI Management of Unique Basilar Invagination Combined with C1 Prolapsing
   into the Foramen Magnum in Children: Report of 2 Cases
SO WORLD NEUROSURGERY
LA English
DT Article
DE 3D Printed; Atlantoaxial subluxation; Basilar invagination; Congenital
ID ATLANTOAXIAL JOINT DISTRACTION; CRANIOVERTEBRAL JUNCTION; DISLOCATION
AB BACKGROUND: Basilar invagination (BI) is a developmental anomaly and commonly presents with neurologic findings. The incidence of BI associated with other osseous anomalies of the craniovertebral junction is high, including incomplete ring of C1 with spreading of the lateral masses, atlanto-occipital assimilation, hypoplasia of the atlas, basiocciput hypoplasia, and occipital condylar hypoplasia. However, BI combined with C1 prolapsing into the foramen magnum (FM) is an extremely rare condition.
   CASE DESCRIPTION: A previously healthy 6-year-old girl (case 1) presented with extremities numbness and left limb weakness over a period of 3 months. Radiograph and computed tomography (CT) scan demonstrated basilar invagination with C1 and dens upward into the FM and C2-3 congenital fusion. Magnetic resonance imaging (MRI) showed ventral brainstem and medulla compression, and the medulla-cervical angle was about 100 degrees. The patient underwent transoral anterior decompression, reduction, and fusion by transoral atlantoaxial reduction plate surgery. The symptoms of extremities numbness and limb weakness were all alleviated after surgery. Postoperative MRI showed that the medulla-cervical angle improved from 100 degrees to 143 degrees. An 11-year-old boy (case 2) presented with a 2-month history of limbs numbness and weakness. CT scan and MRI demonstrated BI and compression of the spinal cord, with a crania-spinal angle of only 63 degrees. The 3-dimensional (3D) printed model showed that the anterior arch and lateral of C1 was 90 degrees flipping and vertically upward prolapsing into the FM together with the dens, and the width of the atlas was greater than the maximum diameter of the FM, which resulted in structural incarceration. The patient received posterior occipitocervical fixation and fusion surgery with hyperextension skull traction. Postoperative CT scan revealed the craniospinal angle increased to 102 degrees.
   CONCLUSIONS: We present 2 rare cases of BI combined with C1 prolapsing into the FM. We adopted different surgical strategies with satisfying outcome for these patients. We deem that the treatment of unique BI should be individualized according to the different image characteristics. The image-based modern rapid prototyping and 3D printed techniques can provide invaluable information in presurgical planning for complex craniovertebral junction anomalies.
C1 [Wang, JianHua; Zhu, ChangRong; Xia, Hong] Peoples Liberat Army, Southern Theater Gen Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.
RP Wang, JH (reprint author), Peoples Liberat Army, Southern Theater Gen Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.
EM 279716681@qq.com
CR Ai F, 2004, CHINESE J SURG, V9, P8
   Ai FZ, 2011, SPINE, V36, pE556, DOI 10.1097/BRS.0b013e3181f57191
   Chamberlain W E, 1939, Yale J Biol Med, V11, P487
   CHARNAS LR, 1993, NEUROLOGY, V43, P2603, DOI 10.1212/WNL.43.12.2603
   Goel A, 2004, J NEUROSURG-SPINE, V1, P281, DOI 10.3171/spi.2004.1.3.0281
   Goel A, 1998, J NEUROSURG, V88, P962, DOI 10.3171/jns.1998.88.6.0962
   Goel A, 2017, WORLD NEUROSURG, V99, P164, DOI 10.1016/j.wneu.2016.11.093
   Goel A, 2016, J NEUROSURG-SPINE, V25, P740, DOI 10.3171/2016.4.SPINE151268
   Goel A, 2009, J NEUROSURG-SPINE, V11, P9, DOI 10.3171/2009.3.SPINE08927
   Klimo P, 2007, NEUROSURG CLIN N AM, V18, P463, DOI 10.1016/j.nec.2007.04.005
   LEE BCP, 1985, AM J NEURORADIOL, V6, P209
   Lu S, 2009, SPINE, V34, pE959, DOI 10.1097/BRS.0b013e3181c09985
   Lu S, 2009, EUR SPINE J, V18, P1379, DOI 10.1007/s00586-009-1051-4
   Menezes AH, 1995, PEDIATR NEUROSURG, V23, P260, DOI 10.1159/000120969
   Menezes AH, 2008, CHILD NERV SYST, V24, P1109, DOI 10.1007/s00381-008-0600-1
   Smith JS, 2010, NEUROSURGERY, V66, pA39, DOI 10.1227/01.NEU.0000365770.10690.6F
   SMOKER WRK, 1994, RADIOGRAPHICS, V14, P255, DOI 10.1148/radiographics.14.2.8190952
   Sykes LM, 2004, INT J PROSTHODONT, V17, P454
   Xia H, 2014, EUR SPINE J, V23, P1648, DOI 10.1007/s00586-014-3378-8
   Yin QS, 2005, SPINE, V30, pE375, DOI 10.1097/01.brs.0000168374.84757.d5
   Zhang K, 2012, SPINE, V37, pE451, DOI 10.1097/BRS.0b013e31823735f5
NR 21
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 92
EP 96
DI 10.1016/j.wneu.2019.03.249
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300176
PM 30947013
DA 2020-05-12
ER

PT J
AU Kim, HS
   Damani, N
   Singh, R
   Adsul, NM
   Oh, SW
   Noh, JH
   Jang, IT
   Oh, SH
AF Kim, Hyeun Sung
   Damani, Neelesh
   Singh, Ravindra
   Adsul, Nitin Maruti
   Oh, Sung Woon
   Noh, Jung Hoon
   Jang, Il Tae
   Oh, Seong Hoon
TI Endoscopic Resection of Symptomatic Cervical Facet Cyst in Ankylosing
   Spondylitis
SO WORLD NEUROSURGERY
LA English
DT Article
DE Ankylosing spondylitis; Cervical facet cyst; Juxtafacetal cyst;
   Minimally invasive; Percutaneous endoscopic posterior cervical
   foraminotomy
ID SYNOVIAL CYST
AB BACKGROUND: Extradural benign cysts located in close proximity to the facet joints are called juxtafacetal cysts. Only about 3.5% of such cysts occur in the cervical spine. To our knowledge, there has been no published article on the endoscopic resection of a cervical facet cyst, and this is the first report.
   CASE DESCRIPTION: A 48-year-old male presented with a chief complaint of severe axial neck pain (visual analog scale score 9) and right scapular pain. The patient had no related radiculopathy or myelopathy, and neurologic status was intact. There was severe limitation of cervical spine movements. Plain radio-graphs indicated age-related degenerative changes with typical features of ankylosing spondylitis with a bamboo spine appearance and gross fusion of all the vertebrae. The only mobile cervical spinal level was C6-C7. Axial magnetic resonance imaging revealed a right-sided juxtafacetal lesion at C6-C7 level that was hyperintense on T2 and hypointense on T1 imaging. A percutaneous endoscopic posterior cervical foraminotomy at right-sided C7-T1 was performed tinder general anesthesia. The cyst was removed, and adequate decompression of the C7 root was achieved. Postoperative magnetic resonance imaging and computed tomography scan showed adequate foraminotomy and decompression of the neural structures. The patient had gross relief of neck pain (visual analog scale score 2).
   CONCLUSIONS: The findings suggest that ankylosing spondylitis may cause formation of a juxtafacetal cyst at the mobile levels in a relatively less mobile cervical spine. The endoscopic resection of such cysts is a minimally invasive novel procedure that can cure such patients successfully without unwanted fusion surgery.
C1 [Kim, Hyeun Sung; Damani, Neelesh; Singh, Ravindra; Adsul, Nitin Maruti; Oh, Sung Woon; Noh, Jung Hoon; Jang, Il Tae; Oh, Seong Hoon] Nanoori Hosp, Dept Neurosurg, Seoul, South Korea.
RP Kim, HS (reprint author), Nanoori Hosp, Dept Neurosurg, Seoul, South Korea.
EM neurospinekim@gmail.com
RI Kim, Hyeun-Sung/N-5816-2019
OI Kim, Hyeun-Sung/0000-0001-5361-5234
CR Bydon M, 2013, WORLD NEUROSURG, V79, P375, DOI 10.1016/j.wneu.2012.08.016
   Colen CB, 2006, J NEUROSURG-SPINE, V4, P186, DOI 10.3171/spi.2006.4.2.186
   EYSTER EF, 1989, NEUROSURGERY, V24, P112
   Ishii K, 2005, MINIM INVAS NEUROSUR, V48, P240, DOI 10.1055/s-2005-870927
   Jin HS, 2015, KOREAN J PAIN, V28, P275, DOI 10.3344/kjp.2015.28.4.275
   Jost SC, 2003, SPINE, V28, pE344, DOI 10.1097/01.BRS.0000090501.42188.2A
   KAO CC, 1974, J NEUROSURG, V41, P372, DOI 10.3171/jns.1974.41.3.0372
   Kim HS, 2011, J KOREAN NEUROSURG S, V50, P54, DOI 10.3340/jkns.2011.50.1.54
   Kostanian VJ, 2007, INTERV NEURORADIOL, V13, P295, DOI 10.1177/159101990701300310
   Kotilainen E, 1997, ACTA NEUROL SCAND, V96, P59
   김석원, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V37, P76
   Pikis S, 2013, J CLIN NEUROSCI, V20, P928, DOI 10.1016/j.jocn.2012.10.018
   Rahimizadeh A, 2016, WORLD SPINAL COLUMN, V3, P189
NR 13
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 99
EP 102
DI 10.1016/j.wneu.2019.03.220
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300178
PM 30930316
DA 2020-05-12
ER

PT J
AU Ding, C
   Chen, W
   Liu, FJ
   Xiong, ML
   Chen, J
AF Ding, Chang
   Chen, Wei
   Liu, Fujun
   Xiong, Moli
   Chen, Jing
TI Skull Base Chondrosarcoma Caused by Oilier Disease: A Case Report and
   Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Intracranial chondrosarcoma; Maffucci syndrome; Oilier disease
ID OLLIERS-DISEASE; MAFFUCCIS-SYNDROME; PATIENT
AB BACKGROUND: Oilier disease (OD) is a rare, nonhereditary bone disease that is characterized by the presence of multiple enchondromatosis (3 or more) with a typical asymmetric distribution which is mainly confined to the appendicular skeleton. OD's most serious complication is the transformation of an enchondroma into chondrosarcoma. The most common sites for chondrosarcoma are in the pelvic and shoulder bones, the superior metaphyseal and diaphyseal regions of the extremities. However, the cranium is an extremely rare site for chondrosarcoma because of OD.
   CASE DESCRIPTION: We report the case of a 27-year-old woman who was admitted to our hospital with paroxysmal headaches over 1 month and left ptosis for 2 weeks. Magnetic resonance imaging (MRI) scan revealed a mass was located at the left side of the parasellar area. The mass was surgically removed, and histopathologic examination confirmed chondrosarcoma grade I. During follow-up, more imaging examinations and pathologic examination confirmed the final diagnosis was OD.
   CONCLUSIONS: Intracranial chondrosarcoma caused by OD is extremely rare but should be considered in the differential diagnosis when primary chondrosarcoma is diagnosed. Preoperative diagnosis is challenging, and definitive diagnosis requires immunohistochemical examination and systematic examination of the body. Surgical resection is the most effective therapy for rapid relief of symptoms. For patients with OD with normal intracranial MRI, long-term follow-up is necessary.
C1 [Ding, Chang; Chen, Wei; Liu, Fujun; Xiong, Moli; Chen, Jing] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
RP Chen, J (reprint author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM chenjing6811@126.com
CR Balcer LJ, 1999, J NEURO-OPHTHALMOL, V19, P62
   Bovee JVMG, 2000, HUM PATHOL, V31, P1299, DOI 10.1053/hupa.2000.19308
   BRAZIER DJ, 1993, BRIT J OPHTHALMOL, V77, P599, DOI 10.1136/bjo.77.9.599
   CLIFTON AG, 1991, BRIT J RADIOL, V64, P633, DOI 10.1259/0007-1285-64-763-633
   D'Angelo L, 2009, CHILD NERV SYST, V25, P647, DOI 10.1007/s00381-009-0873-z
   Hughes Marion Alicia, 2014, Radiol Case Rep, V9, pe00031, DOI 10.2484/rcr.v9i1.889
   Jacobi CMC, 2015, HEAD NECK-J SCI SPEC, V37, pE30, DOI 10.1002/hed.23783
   Kumar A, 2015, ORTHOPEDICS, V38, pE497, DOI 10.3928/01477447-20150603-58
   Miyawaki T, 1997, ANN PLAS SURG, V38, P77, DOI 10.1097/00000637-199701000-00015
   Morris C. D., 2001, CHAPMANS ORTHOPAEDIC, P3402
   Noel G, 2004, ACTA ONCOL, V43, P705, DOI 10.1080/02841860410002770
   Ozisik YY, 1998, CANCER GENET CYTOGEN, V105, P128, DOI 10.1016/S0165-4608(98)00027-2
   PFLEIDERER AG, 1991, J LARYNGOL OTOL, V105, P148, DOI 10.1017/S002221510011521X
   REUTER K, 1981, NEURORADIOLOGY, V22, P151
   Silve C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-37
   Verdegaal SHM, 2011, ONCOLOGIST, V16, P1771, DOI 10.1634/theoncologist.2011-0200
NR 16
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 103
EP 108
DI 10.1016/j.wneu.2019.03.037
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300179
PM 30872199
DA 2020-05-12
ER

PT J
AU Alghamdi, MA
   Almubarak, AO
   Alsedrani, N
   Alshehri, WM
   Alturki, AY
AF Alghamdi, Majed Abdulrahman
   Almubarak, Abdulaziz Oqalaa
   Alsedrani, Nora
   Alshehri, Waleed M.
   Alturki, Abdulrahman Y.
TI Pretruncal Nonaneurysmal Subarachnoid Hemorrhage with Underlying
   Hemophilia C
SO WORLD NEUROSURGERY
LA English
DT Article
DE Hemophilia C; Perimesencephalic subarachnoid hemorrhage; Pretruncal
   nonaneurysmal subarachnoid hemorrhage
ID FACTOR-XI DEFICIENCY; RISK-FACTORS; MANAGEMENT; PATIENT; ARTERY
AB BACKGROUND: Pretruncal nonaneurysmal subarachnoid hemorrhage (PNSAH) accounts for 15%-12% of all case of subarachnoid hemorrhage. Its precise etiology is not yet established. Multiple theories and risk factors have been investigated to address the possible cause of this type of hemorrhage including basilar tip dissecting aneurysms, high spinal arteriovenous fistula, venous stenosis/hypertension or venous bleeding. Hereditary coagulopathies and hemophilias have rarely been reported in the literature as a potential cause of PNSAH.
   CASE DESCRIPTION: Here, we reported a rare case of PNSAH with negative angiogram and magnetic resonance imaging who was also found to have hemophilia C (factor XI deficiency) confirmed by laboratory investigation. We also included a literature review of hereditary coagulopathies and their role as a possible cause of PNSAH.
   CONCLUSIONS: Detailed medical history and physical examination of patients with PNSAH may lead to further hematologic evaluation for this group of patients, as in this case, and may reveal more cases of mild coagulopathy that require treatment.
C1 [Alghamdi, Majed Abdulrahman; Almubarak, Abdulaziz Oqalaa; Alsedrani, Nora; Alshehri, Waleed M.; Alturki, Abdulrahman Y.] King Fahad Med City, Natl Inst Neurosci, Riyadh, Saudi Arabia.
   [Almubarak, Abdulaziz Oqalaa] Prince Mohammed Med City, Aljouf, Saudi Arabia.
   [Alsedrani, Nora] Qassim Univ, Coll Med, Buraydah, Saudi Arabia.
RP Alturki, AY (reprint author), King Fahad Med City, Natl Inst Neurosci, Riyadh, Saudi Arabia.
EM dr.alturki.neurosurgery@gmail.com
CR Arboix A, 1999, CLIN NEUROL NEUROSUR, V101, P100, DOI 10.1016/S0303-8467(99)00026-8
   Backes D, 2016, STROKE, V47, P951, DOI 10.1161/STROKEAHA.115.012162
   Bolton-Maggs PHB, 2004, HAEMOPHILIA, V10, P593, DOI 10.1111/j.1365-2516.2004.00944.x
   Bolton-Maggs PHB, 2000, HAEMOPHILIA, V6, P100
   Cremers CHP, 2014, INT J STROKE, V9, P183, DOI 10.1111/ijs.12021
   Franchini M, 2006, HEMATOLOGY, V11, P307, DOI 10.1080/10245330600921964
   Gross BA, 2013, NEUROSURG REV, V36, P163, DOI 10.1007/s10143-012-0422-1
   Hashimoto H, 2000, J CLIN NEUROSCI, V7, P64, DOI 10.1054/jocn.1998.0145
   Mathews MS, 2008, NEUROLOGY, V70, P2410, DOI 10.1212/01.wnl.0000314688.26295.03
   Matsumaru Y, 2003, J NEUROSURG, V98, P426, DOI 10.3171/jns.2003.98.2.0426
   MATTLE H, 1989, J NEUROL NEUROSUR PS, V52, P829, DOI 10.1136/jnnp.52.7.829
   Nuss R, 2001, AM J HEMATOL, V68, P37, DOI 10.1002/ajh.1146
   Ogiichi Tsuneaki, 1997, Neurologia Medico-Chirurgica, V37, P612, DOI 10.2176/nmc.37.612
   PAPA ML, 1994, STROKE, V25, P508, DOI 10.1161/01.STR.25.2.508
   RINKEL GJE, 1991, LANCET, V338, P964, DOI 10.1016/0140-6736(91)91836-J
   Shad A, 2008, J CLIN NEUROSCI, V15, P839, DOI 10.1016/j.jocn.2007.03.024
   Siao D, 2008, CLIN APPL THROMB-HEM, V14, P108, DOI 10.1177/1076029607303963
   van der Schaaf IC, 2004, STROKE, V35, P1614, DOI 10.1161/01.STR.0000131657.08655.ce
   van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249
   Watanabe A, 2002, NEURORADIOLOGY, V44, P319, DOI 10.1007/s00234-001-0741-3
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 109
EP 112
DI 10.1016/j.wneu.2019.03.278
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300016
PM 30954739
DA 2020-05-12
ER

PT J
AU Maeda, T
   Mishima, K
   Imanishi, J
   Shirahata, M
   Suzuki, T
   Adachi, J
   Sasaki, A
   Nishikawa, R
AF Maeda, Takuma
   Mishima, Kazuhiko
   Imanishi, Jungo
   Shirahata, Mitsuaki
   Suzuki, Tomonari
   Adachi, Jun-ichi
   Sasaki, Atsushi
   Nishikawa, Ryo
TI An Epidermoid Cyst of the Thoracic Spine in an Elderly Patient
SO WORLD NEUROSURGERY
LA English
DT Article
DE Diffusion-weighted imaging; Elderly patient; Epidermoid cyst;
   Intradural; Thoracic spine
ID TUMOR
AB BACKGROUND: Spinal epidermoid cysts are very rare tumors, especially in thoracic spine; they represent 0.8% of all spinal epidermoids. In adult cases, they are often associated with surgical procedures such as lumbar puncture. We report a rare case of spinal epidermoid cyst in the thoracic spine of an elderly patient who had never undergone lumber puncture, thoracic spinal surgery, or trauma.
   CASE DESCRIPTION: A 78-year old woman presented with a 1-month history of rapidly progressive impairment of sensation in both the lower limbs, with gait disturbance. She had no history of spinal surgery, trauma, or lumbar puncture. Her past medical history was unremarkable. Magnetic resonance imaging of the whole spine revealed an intraspinalextramedullary tumor at the Th 1 .2 level. Diffusion-weighted imaging revealed significant homogeneous high intensity. We performed complete resection without damaging the spinal cord or nerve roots. The final histological examination indicated epidermoid cyst without malignancy. Her gait disturbance was completely resolved at 4-month follow-up.
   CONCLUSIONS: Epidermoid cysts must be considered among spinal tumors in .rly patients. Early detection by diffusion-weighted imaging and complete resection may lead to good neurological outcome.
C1 [Maeda, Takuma; Mishima, Kazuhiko; Shirahata, Mitsuaki; Suzuki, Tomonari; Adachi, Jun-ichi; Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Dept Neurosurg, Hidaka, Saitama, Japan.
   [Imanishi, Jungo] Saitama Med Univ, Int Med Ctr, Dept Orthopaed Oncol & Surg, Hidaka, Saitama, Japan.
   [Sasaki, Atsushi] Saitama Med Univ, Dept Pathol, Moroyama, Saitama, Japan.
RP Maeda, T (reprint author), Saitama Med Univ, Int Med Ctr, Dept Neurosurg, Hidaka, Saitama, Japan.
EM miyuki.yuming@gmail.com
CR Barbagallo GMV, 2017, WORLD NEUROSURG, V108, P54, DOI 10.1016/j.wneu.2017.08.078
   Cincu Rafael, 2007, Indian J Orthop, V41, P395, DOI 10.4103/0019-5413.37005
   Deogaonkar Milind, 1995, Neurologia Medico-Chirurgica, V35, P678, DOI 10.2176/nmc.35.678
   Kukreja K, 2007, PEDIATR RADIOL, V37, P556, DOI 10.1007/s00247-007-0463-8
   Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001
   Munshi A, 2009, J CANCER RES THER, V5, P290, DOI 10.4103/0973-1482.59913
   Per H, 2007, J CHILD NEUROL, V22, P332, DOI 10.1177/0883073807300531
   Scarrow AM, 2001, CLIN NEUROL NEUROSUR, V103, P220, DOI 10.1016/S0303-8467(01)00156-1
   Singh Kulwant, 2016, Surg Neurol Int, V7, pS67, DOI 10.4103/2152-7806.174890
   Singh K, 2015, INDIAN J OTOLARYNGOL, V67, P21, DOI 10.1007/s12070-014-0736-0
   Song KW, 2009, CLIN ORTHOP SURG, V1, P74, DOI 10.4055/cios.2009.1.2.74
   Yen CP, 2008, ACTA NEUROCHIR, V150, P305, DOI 10.1007/s00701-007-1398-4
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 113
EP 116
DI 10.1016/j.wneu.2019.03.262
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300180
PM 30951916
DA 2020-05-12
ER

PT J
AU Xu, F
   Sun, DD
   Zhu, L
   Sun, YZ
AF Xu, Feng
   Sun, Dongdong
   Zhu, Lun
   Sun, Yuanzhao
TI Pseudoaneurysm of Superficial Temporal Artery After Frontal Scalp
   Laceration Debridement
SO WORLD NEUROSURGERY
LA English
DT Article
DE Pseudoaneurysm; Scalp laceration; Superficial temporal artery
ID TRAUMATIC PSEUDOANEURYSM; BRANCH
AB BACKGROUND: Aneurysms of superficial temporal arteries (STAs) are rare. The majority of them are induced by blunt trauma. To our knowledge, a pseudoaneurysm of the STA induced by scalp laceration has never been reported.
   CASE DESCRIPTION: A 20-year-old man who complained of a pulsatile headache and had a lump on his right temple was admitted to our department. He had a history of frontal scalp laceration 2 weeks before the admission, and physical examination revealed 1 healed scar over the lump. On the basis of the characteristics of the headache and lump, surgical excision was taken and diagnosis was confirmed intraoperatively and by pathologic examination post-operatively. The postoperative course was uneventful.
   CONCLUSIONS: Despite the rarity of pseudoaneurysm of STA after scalp laceration, this case may warrant the potential complication of a pseudoaneurysm, especially if scalp laceration courses over the branches of the STA.
C1 [Xu, Feng] 1 Hosp Xuzhou City, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China.
   [Sun, Dongdong] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Sterilizat & Supply, Huaian City, Jiangsu, Peoples R China.
   [Zhu, Lun] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Pathol, Huaian City, Jiangsu, Peoples R China.
   [Sun, Yuanzhao] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Neurosurg, Huaian City, Jiangsu, Peoples R China.
RP Sun, YZ (reprint author), Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Neurosurg, Huaian City, Jiangsu, Peoples R China.
EM 15195505599@163.com
CR Ahn HS, 2010, CHILD NERV SYST, V26, P117, DOI 10.1007/s00381-009-0953-0
   Anania P, 2018, WORLD NEUROSURG, V111, P60, DOI 10.1016/j.wneu.2017.12.048
   Corvino A, 2016, J ULTRASOUND, V19, P197, DOI 10.1007/s40477-016-0211-8
   Grasso RF, 2007, CARDIOVASC INTER RAD, V30, P286, DOI 10.1007/s00270-005-0307-6
   Higashino T, 2005, NEUROL MED-CHIR, V45, P152, DOI 10.2176/nmc.45.152
   Hong JT, 2006, SURG NEUROL, V66, P86, DOI 10.1016/j.surneu.2005.10.022
   Hosseini M, 2013, TURK NEUROSURG, V23, P531, DOI 10.5137/1019-5149.JTN.5243-11.0
   Leal FSCB, 2005, ARQ NEURO-PSIQUIAT, V63, P859, DOI 10.1590/S0004-282X2005000500027
   Levisianos I, 2008, EMERG MED J, V25, P239, DOI 10.1136/emj.2007.055418
   Murphy M, 2006, BRIT J NEUROSURG, V20, P159, DOI 10.1080/02688690600777034
   Nelson M, 2016, J EMERG MED, V51, P572, DOI 10.1016/j.jemermed.2016.05.065
   Pourdanesh F, 2013, J CRANIOFAC SURG, V24, pE334, DOI 10.1097/SCS.0b013e31828a7ab0
   Prado A, 2007, PLAST RECONSTR SURG, V119, P2334, DOI 10.1097/01.prs.0000261095.07321.09
   Rancic Z, 2014, GEN THORAC CARDIOVAS, V62, P68, DOI 10.1007/s11748-013-0219-3
   Terterov Sergei, 2012, Surg Neurol Int, V3, P139, DOI 10.4103/2152-7806.103877
   Zhang DB, 2018, WORLD NEUROSURG, V115, P264, DOI 10.1016/j.wneu.2018.03.223
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 117
EP 120
DI 10.1016/j.wneu.2019.03.300
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300181
PM 30959251
DA 2020-05-12
ER

PT J
AU Granja, MF
   Agnoletto, GJ
   Monteiro, A
   Jaume, A
   Hanly, M
   Bit-Ivan, E
   Chmayssani, M
   Sauvageau, E
   Aghaebrahim, A
   Hanel, RA
AF Granja, Manuel F.
   Agnoletto, Guilherme Jose
   Monteiro, Andre
   Jaume, Alejandra
   Hanly, Mark
   Bit-Ivan, Esther
   Chmayssani, Mohammad
   Sauvageau, Eric
   Aghaebrahim, Amin
   Hanel, Ricardo A.
TI Cured from a Cardiac Myxoma? Brain Intraparenchymal Hemorrhage in a
   Patient with a 10-Year Successfully Resected Cardiac Myxorna
SO WORLD NEUROSURGERY
LA English
DT Article
DE Delayed neurologic myxoma complications; Echocardiogram; Hemorrhagic
   stroke; Left cardiac myxoma
ID NEUROLOGICAL MANIFESTATIONS; SURGICAL-TREATMENT; EXPERIENCE; SERIES
AB BACKGROUND: A cardiac myxoma (CM) is the most common primary tumor of the heart. This case report highlights that for metastatic CMs, even after a successful total resection, there is a small but real risk of recurrence that can manifest as late as 10 years after initial tumor resection.
   CASE DESCRIPTION: We present the case of a 53-year-old woman who visited the emergency room after a 4-day worsening right-sided weakness. The patient was diagnosed with a left CM 10 years previously, and a complete surgical resection was performed at that time. A noncontrast computed tomography of the head revealed a left parietal hematoma and a contrast computed tomography scan of the head revealed an enlarged left parieto-occipital vein that was subsequently shown to be part of an arteriovenous fistula. After embolization of the fistula was performed, postprocedure magnetic resonance imaging of the brain showed redemonstration of acute intra-parenchymal hemorrhage with vasogenic edema. The history of a previously resected CM and the multifocal distribution of brain lesions opened the possibility of slow-growing metastasis from the previous myxoma.
   CONCLUSIONS: Our case report demonstrates the metastatic nature of CMs to the central nervous system, even after successful gross total resection and no local relapsing mass in subsequent ultrasonographic follow-ups. A comprehensive evaluation on clinical and imagological grounds is mandatory to rule out the presence of myxomatous metastatic disease. Awareness and recognition of the potential neurologic manifestations of a metastatic CM will prevent unnecessary diagnostic workup and treatments.
C1 [Granja, Manuel F.; Agnoletto, Guilherme Jose; Monteiro, Andre; Chmayssani, Mohammad; Sauvageau, Eric; Aghaebrahim, Amin; Hanel, Ricardo A.] Lyerly Neurosurg, Jacksonville, FL 32207 USA.
   [Granja, Manuel F.; Agnoletto, Guilherme Jose; Monteiro, Andre; Hanly, Mark; Bit-Ivan, Esther; Chmayssani, Mohammad; Sauvageau, Eric; Aghaebrahim, Amin; Hanel, Ricardo A.] Baptist Neurol Inst, Jacksonville, FL 32207 USA.
   [Jaume, Alejandra] Maciel Hosp, Montevideo, Uruguay.
   [Jaume, Alejandra] Assesalud, Montevideo, Uruguay.
   [Hanly, Mark; Bit-Ivan, Esther] Southeastern Pathol Associates, Jacksonville, FL USA.
RP Hanel, RA (reprint author), Lyerly Neurosurg, Jacksonville, FL 32207 USA.; Hanel, RA (reprint author), Baptist Neurol Inst, Jacksonville, FL 32207 USA.
EM Ricardo.Hanel@bmcjax.com
CR Agrawal R, 2018, BMJ CASE REP, V2018
   Brinjikji W, 2015, CEREBROVASC DIS, V40, P35, DOI 10.1159/000381833
   CARNEY JA, 1995, SEMIN DERMATOL, V14, P90, DOI 10.1016/S1085-5629(05)80003-3
   Centofanti P, 1999, ANN THORAC SURG, V68, P1236, DOI 10.1016/S0003-4975(99)00700-6
   Ekinci EI, 2004, INTERN MED J, V34, P243, DOI 10.1111/j.1444-0903.2004.00563.x
   Flores PL, 2018, INTERV NEURORADIOL, V24, P277, DOI 10.1177/1591019917754070
   Garatti A, 2012, ANN THORAC SURG, V93, P825, DOI 10.1016/j.athoracsur.2011.11.009
   Guhathakurta S, 2000, TEX HEART I J, V27, P61
   Jain S, 2015, EXPERT REV CARDIOVAS, V13, P369, DOI 10.1586/14779072.2015.1024108
   KANDA T, 1994, INT J CARDIOL, V45, P144, DOI 10.1016/0167-5273(94)90272-0
   KNEPPER LE, 1988, STROKE, V19, P1435, DOI 10.1161/01.STR.19.11.1435
   Kuroczynski W, 2009, CARDIOL J, V16, P447
   Long YM, 2014, SCI WORLD J, DOI 10.1155/2014/718246
   MCCARTHY PM, 1989, J THORAC CARDIOV SUR, V98, P1083
   Andreu JP, 2013, NEUROLOGIA, V28, P529, DOI 10.1016/j.nrl.2013.03.006
   Pinede L, 2001, MEDICINE, V80, P159, DOI 10.1097/00005792-200105000-00002
   Rose D, 2016, J CARDIAC SURG, V31, P289, DOI 10.1111/jocs.12727
   Sabolek M, 2005, ACTA NEUROL SCAND, V111, P345, DOI 10.1111/j.1600-0404.2005.00413.x
   SAKAMOTO H, 1990, BIOCHEM BIOPH RES CO, V169, P462, DOI 10.1016/0006-291X(90)90354-P
   Scrofani Roberto, 2002, Ital Heart J Suppl, V3, P753
   Sveinsson O, 2015, BMJ CASE REP, V2015
   Wang ZJ, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0420-4
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 121
EP 125
DI 10.1016/j.wneu.2019.01.295
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300182
PM 30878747
DA 2020-05-12
ER

PT J
AU Ishida, T
   Endo, H
   Saito, R
   Kanamori, M
   Sato, K
   Matsumoto, Y
   Endo, T
   Fujimura, M
   Tominaga, T
AF Ishida, Tomohisa
   Endo, Hidenori
   Saito, Ryuta
   Kanamori, Masayuki
   Sato, Kenichi
   Matsumoto, Yasushi
   Endo, Toshiki
   Fujimura, Miki
   Tominaga, Teiji
TI Coexistence of Intracranial Germ Cell Tumor with Growing Arteriovenous
   Fistula
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous fistula; Embolization; Germ cell tumor; Growing teratoma
   syndrome
ID TERATOMA SYNDROME; MALFORMATION
AB BACKGROUND: A 26-year-old man was admitted with complaints of progressive depressive mood and general fatigue. Magnetic resonance imaging revealed diffuse enhanced lesions in the neurohypophyseal, pineal, and paraventricular regions and ventricular wall.
   CASE DESCRIPTION: Endoscopic biopsy confirmed the presence of germ cell tumor and chemoradiation therapy (CRT) was then performed. Most of the tumors disappeared after CRT except for the right paraventricular lesion. Follow-up magnetic resonance imaging performed 14 months after CRT showed enlargement of this residual lesion. In addition to tumor growth, coexistent flow void signals within the tumor increased. Angiographically, this vascular lesion mimicked arteriovenous malformation, which was mainly fed by the lenticulostriate artery and drained into the internal cerebral vein. Transarterial embolization was performed, resulting in effective flow reduction. Subsequently, the tumor was resected without complications. It was histopathologically diagnosed as a mature teratoma with an arteriovenous fistula (AVF). Arterial components were observed to directly connect to venous components within the tumor without any intermediate nidal components.
   CONCLUSIONS: To the best of our knowledge, this is the first reported case of an intracranial germ cell tumor coexistent with a growing AVF. AVF developed within a CRT-refractory teratomatous component, which was successfully treated with embolization followed by surgical resection.
C1 [Ishida, Tomohisa; Endo, Hidenori; Saito, Ryuta; Kanamori, Masayuki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan.
   [Ishida, Tomohisa; Endo, Toshiki; Fujimura, Miki] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi, Japan.
   [Sato, Kenichi; Matsumoto, Yasushi] Kohnan Hosp, Dept Neuroendovasc Therapy, Sendai, Miyagi, Japan.
RP Endo, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan.
EM hideendo@gmail.com
OI Endo, Hidenori/0000-0003-1472-6032
CR Andre F, 2000, EUR J CANCER, V36, P1389, DOI 10.1016/S0959-8049(00)00137-4
   Bulsara KR, 2002, NEUROSURGERY, V50, P1137, DOI 10.1097/00006123-200205000-00036
   Castillo M, 1998, NEURORADIOLOGY, V40, P574, DOI 10.1007/s002340050646
   Harris OA, 2000, NEUROL RES, V22, P473
   HONG WK, 1977, CANCER, V40, P2987, DOI 10.1002/1097-0142(197712)40:6<2987::AID-CNCR2820400634>3.0.CO;2-A
   JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155
   Kanamori M, 2018, J NEURO-ONCOL, V138, P601, DOI 10.1007/s11060-018-2827-3
   Kim CY, 2011, J NEURO-ONCOL, V101, P109, DOI 10.1007/s11060-010-0238-1
   Levin V, 2005, TXB MED ONCOLOGY, P415
   Liang L, 2002, NEURORADIOLOGY, V44, P382, DOI 10.1007/s00234-001-0752-0
   LOGOTHETIS CJ, 1982, CANCER, V50, P1629, DOI 10.1002/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1
   Mckinney JS, 2008, J NEUROSURG, V109, P1098, DOI 10.3171/JNS.2008.109.12.1098
   MEDVEDEV YA, 1991, J NEUROSURG, V75, P121, DOI 10.3171/jns.1991.75.1.0121
   Oya S, 2014, CHILD NERV SYST, V30, P1455, DOI 10.1007/s00381-014-2396-5
   Stevens J, 2009, AM J NEURORADIOL, V30, P111, DOI 10.3174/ajnr.A1255
   Yu JL, 2012, TURK NEUROSURG, V22, P510, DOI 10.5137/1019-5149.JTN.3961-10.1
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 126
EP 130
DI 10.1016/j.wneu.2019.04.015
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300183
PM 30965172
DA 2020-05-12
ER

PT J
AU Li, GW
   Lan, Q
AF Li Guowei
   Lan Qing
TI Microsurgical Management of Fourth Ventricle Astrocytoma via Median
   Suboccipital Keyhole Approach: Review of 12 Cases
SO WORLD NEUROSURGERY
LA English
DT Review
DE Astrocytoma; Fourth ventricle; Median suboccipital keyhole approach
ID POSTERIOR CRANIAL FOSSA; TRANSCEREBELLOMEDULLARY FISSURE APPROACH;
   TELOVELAR APPROACH; DIENCEPHALIC SYNDROME; TUMOR; EPENDYMOMAS; MUTISM;
   RESECTION; ANOREXIA; ANATOMY
AB OBJECTIVE: To investigate the clinical effect and surgical techniques of fourth ventricle astrocytoma resection through the median suboccipital keyhole approach.
   METHODS: Twelve patients received tumor resection -.Alga the median suboccipital keyhole approach in our department A 4-cm median suboccipital excision starting 1 cm under the foramen magnum region and directed vertically upward was applied. The fourth ventricle was exposed through a cerebellomedullary fissure approach within a bone hole approximate to 2.5 cm in diameter. All clinical data (including preoperative/postoperative symptoms, magnetic resonance imaging scan, intraoperative findings, tumor resection rate, and surgical complications) were collected and analyzed.
   RESULTS: In our treatment group, the mean maximum tumor diameter was 3.48 +/- 1.3 cm and the mean tumor volume was 34.79 +/- 20.70 cm(3) The complete resection rate was 92%. The average operative blood loss was 127.0 +/- 24.6 mL; the mean craniotomy time was 26.4 +/- 6.0 minutes; the mean tumor resection time was 190.3 +/- 31.2 minutes; the mean cranial closure time was 42.3 +/- 6.1 minutes; and the average hospitalization time was 13.6 +/- 2.4 days. The mean Glasgow Outcome Scale score before discharge was 4.92.
   CONCLUSIONS: If appropriate microneurosurgical techniques are used via the median suboccipital keyhole approach, the fourth ventricle astrocytoma may be accessed and resected safely with shorter surgery time, reduced hemorrhage during operation, low incidence of postoperative complications, good recovery, and shorter hospitalization time.
C1 [Li Guowei; Lan Qing] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.
RP Lan, Q (reprint author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.
EM szlq006@163.com
CR Brauner R, 2006, J CLIN ENDOCR METAB, V91, P2467, DOI 10.1210/jc.2006-0322
   Carmel P W, 1980, Clin Neurosurg, V27, P133
   Chen Duo, 2009, Clinical Oncology and Cancer Research, V6, P95, DOI 10.1007/s11805-009-0095-x
   DAILEY AT, 1995, J NEUROSURG, V83, P467, DOI 10.3171/jns.1995.83.3.0467
   FERRANTE L, 1994, ACTA NEUROCHIR, V131, P67, DOI 10.1007/BF01401455
   Gok A, 2004, NEUROSURG REV, V27, P50, DOI 10.1007/s10143-003-0286-5
   Han S, 2013, ACTA NEUROCHIR, V155, P1011, DOI 10.1007/s00701-013-1689-x
   Huber J, 2007, KLIN PADIATR, V219, P91, DOI 10.1055/s-2007-921559
   KAGAN H, 1958, ARCH DIS CHILD, V33, P257, DOI 10.1136/adc.33.169.257
   LEWIN K, 1972, BMJ-BRIT MED J, V2, P629, DOI 10.1136/bmj.2.5814.629
   MATSUSHIMA T, 1992, NEUROSURGERY, V30, P325, DOI 10.1227/00006123-199203000-00003
   Matsushima T, 2001, J NEUROSURG, V94, P257, DOI 10.3171/jns.2001.94.2.0257
   Matsushima T, 2014, WORLD NEUROSURG, V82, pE615, DOI 10.1016/j.wneu.2014.04.064
   Morris EB, 2009, J NEURO-ONCOL, V94, P391, DOI 10.1007/s11060-009-9866-8
   Murphy AM, 2006, CLIN DYSMORPHOL, V15, P253, DOI 10.1097/01.mcd.0000220622.80058.5b
   Mussi ACM, 2000, J NEUROSURG, V92, P812, DOI 10.3171/jns.2000.92.5.0812
   Parkinson D, 2001, NEUROSURGERY, V48, P1196, DOI 10.1097/00006123-200105000-00064
   POLLACK IF, 1995, NEUROSURGERY, V37, P885, DOI 10.1227/00006123-199511000-00006
   Rajesh BJ, 2007, CHILD NERV SYST, V23, P555, DOI 10.1007/s00381-006-0295-0
   Rhoton Jr AL, 2000, NEUROSURGERY S, V47, P7
   Shimoji K, 2009, CHILD NERV SYST, V25, P1221, DOI 10.1007/s00381-009-0835-5
   Spagnoli D, 2000, SURG NEUROL, V54, P19, DOI 10.1016/S0090-3019(00)00272-X
   Tomasello F, 2015, WORLD NEUROSURG, V83, P1141, DOI 10.1016/j.wneu.2015.01.039
   TORTORIDONATI P, 1995, NEURORADIOLOGY, V37, P238
   VANCALENBERGH F, 1995, NEUROSURGERY, V37, P894, DOI 10.1227/00006123-199511000-00007
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Zaheer SN, 2010, PEDIATR NEUROSURG, V46, P340, DOI 10.1159/000321539
NR 27
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 139
EP 145
DI 10.1016/j.wneu.2019.02.156
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300186
PM 30974274
DA 2020-05-12
ER

PT J
AU Ceraudo, M
   Anania, P
   Prior, A
   Rossi, DC
   Zona, G
AF Ceraudo, Marco
   Anania, Pasquale
   Prior, Alessandro
   Rossi, Diego Criminelli
   Zona, Gianluigi
TI Modified Endoscopic Diving Technique without the Traditional Irrigation
   System in Endoscopic Cranial Base Surgery: Technical Note
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cranial base surgery; Diving technique; Endoscopic surgery; Neurosurgery
AB BACKGROUND: We describe a modified endoscopic diving technique with an alternative irrigation system different than the one used by Locatelli et al. (CLEARVISION II, Karl Storz and Co., Tuttlingen, Germany).
   METHODS: From January 2016 to October 2018, our senior surgeon performed the modified endoscopic diving technique in 76 endoscopic surgical procedures. Diving surgery was performed in all procedures to check the completeness of tumor resection, thus allowing for the removal of any residual tumor tissue.
   RESULTS: In the modified endoscopic diving technique, the optic system and the irrigation source are separated into 2 independent tools, allowing surgeons to point the flow on a selected structure, whereas the endoscope can be pointed in the same direction or not. Moreover, the optic system and the irrigation source can be placed at different distances. Surgeons can control the infusion pressure and the entity of the flow.
   CONCLUSIONS: The use of the modified endoscopic --mg technique allows surgeons to have more settings that could be controlled and also bypasses any compatibility issues between different endoscopic systems. In addition, the reproducibility of this technique, together with the low cost of the instrumentation, could allow an easier application of the diving technique.
C1 [Ceraudo, Marco; Anania, Pasquale; Prior, Alessandro; Rossi, Diego Criminelli; Zona, Gianluigi] San Martino IST Univ Hosp IRCCS, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Div Neurosurg, Genoa, Italy.
RP Anania, P (reprint author), San Martino IST Univ Hosp IRCCS, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Div Neurosurg, Genoa, Italy.
EM pas.anania@gmail.com
RI Anania, Pasquale/AAF-7424-2019
OI Anania, Pasquale/0000-0001-8477-9629
CR Cappabianca P, 2015, NEUROSURG CLIN N AM, V26, P323, DOI 10.1016/j.nec.2015.03.007
   Castelnuovo P, 2006, RHINOLOGY, V44, P2
   de Divitiis E, 2002, NEUROSURGERY, V51, P699, DOI 10.1097/00006123-200209000-00016
   Gao HB, 2018, EXP THER MED, V15, P3815, DOI 10.3892/etm.2018.5922
   Locatelli D, 2006, NEUROSURGERY, V58, P246, DOI 10.1227/01.NEU.0000193924.65297.3F
   Locatelli Davide, 2010, Neurosurgery, V66, pE400, DOI 10.1227/01.NEU.0000363746.84763.A5
   Senior BA, 2005, AM J RHINOL, V19, P181, DOI 10.1177/194589240501900211
NR 7
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 146
EP 149
DI 10.1016/j.wneu.2019.03.276
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300187
PM 30954749
DA 2020-05-12
ER

PT J
AU Aloraidi, A
   Abbas, M
   Fallatah, B
   Alkhaibary, A
   Ahmed, ME
   Alassiri, AH
AF Aloraidi, Ahmed
   Abbas, Munzir
   Fallatah, Bassam
   Alkhaibary, Ali
   Ahmed, Muhammad Ejaz
   Alassiri, Ali H.
TI Meningioma Presenting with Spontaneous Subdural Hematoma: A Report of
   Two Cases and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Hemorrhagic; Hematoma; Meningioma; Spontaneous; Subdural
ID HEMORRHAGE; PATIENT; TUMORS; BRAIN
AB BACKGROUND: Although meningiomas are considered benign, encapsulated brain tumors, their distinct intracranial location can lead to devastating complications. Although a highly vascularized tumor, a rarely reported complication of meningioma is hemorrhage. To the best of our knowledge, only 19 cases of meningioma presenting with a subdural hematoma have been reported.
   CASE DESCRIPTION: We have outlined the clinical presentation, radiological findings, and outcomes of 2 female patients with a diagnosis of a spontaneous subdural hematoma associated with meningioma. The coagulation profile was within normal limits for both patients. The postoperative histopathologic examination results showed an angiomatous/microcystic subtype of meningioma (patient 1) and meningothelial meningioma (patient 2). Both patients underwent right frontal craniotomy, resection of the dural-based tumor, and evacuation of the subdural hematoma.
   CONCLUSIONS: We comprehensively reviewed the pertinent data for mediomas presenting as subdural hematomas. The mechanism of hemorrhage in meningiomas remains unclear. Therefore, further studies are required to investigate the possible mechanisms of bleeding in such tumors.
C1 [Aloraidi, Ahmed; Abbas, Munzir] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Dept Neurosurg,King Abdulaziz Med City, Riyadh, Saudi Arabia.
   [Fallatah, Bassam] King Fahad Med City, Natl Neurosci Inst, Riyadh, Saudi Arabia.
   [Alkhaibary, Ali] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.
   [Ahmed, Muhammad Ejaz] Minist Natl Guard, King Abdulaziz Med City, Med Imaging Dept, Riyadh, Saudi Arabia.
   [Alassiri, Ali H.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, King Abdulaziz Med City, Dept Pathol & Lab Med, Riyadh, Saudi Arabia.
RP Alkhaibary, A (reprint author), King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia.
EM AlkhaibaryA@hotmail.com
CR CHASKIS C, 1992, CLIN NEUROL NEUROSUR, V94, P269, DOI 10.1016/0303-8467(92)90103-A
   Chonan Masashi, 2013, No Shinkei Geka, V41, P235
   Di Rocco F, 2006, ACTA NEUROCHIR, V148, P1097, DOI 10.1007/s00701-006-0861-y
   Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218
   Goyal A, 2003, NEUROL INDIA, V51, P419
   Hambra Di Vitantonio, 2014, Surg Neurol Int, V5, pS469, DOI 10.4103/2152-7806.143724
   Kashimura H, 2008, NEUROL MED-CHIR, V48, P466, DOI 10.2176/nmc.48.466
   KONDZIOLKA D, 1987, J NEUROSURG, V67, P852, DOI 10.3171/jns.1987.67.6.0852
   Lefranc F, 2001, ACTA NEUROCHIR, V143, P977, DOI 10.1007/s007010170002
   Levine AB, 2014, CAN J NEUROL SCI, V41, P506, DOI 10.1017/S0317167100018576
   Mitsuhara T, 2006, NEUROL SURG TOKYO, V34, P827
   NIIKAWA S, 1990, Neurologia Medico-Chirurgica, V30, P169, DOI 10.2176/nmc.30.169
   Niiro M, 2003, ACTA NEUROCHIR, V145, P767, DOI 10.1007/s00701-003-0089-z
   Okuno S, 1999, SURG NEUROL, V52, P180, DOI 10.1016/S0090-3019(97)00028-1
   Prasad GL, 2010, NEUROL INDIA, V58, P179, DOI 10.4103/0028-3886.73769
   RUSSELL NA, 1993, ANN SAUDI MED, V13, P369, DOI 10.5144/0256-4947.1993.369
   SATO K, 1989, Neurological Surgery, V17, P687
   SPEKTOR S, 1995, ACTA NEUROCHIR, V134, P51, DOI 10.1007/BF01428502
   Sunada I, 1998, Radiat Med, V16, P483
   TOKUNAGA T, 1988, Neurological Surgery, V16, P1389
   Ueno Masami, 1993, Neurologia Medico-Chirurgica, V33, P36, DOI 10.2176/nmc.33.36
   Vij M, 2012, J CANCER RES THER, V8, P145, DOI 10.4103/0973-1482.95198
   Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3
   Worm PV, 2009, ARQ NEURO-PSIQUIAT, V67, P308, DOI 10.1590/S0004-282X2009000200028
NR 24
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 150
EP 154
DI 10.1016/j.wneu.2019.03.248
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300188
PM 30947005
DA 2020-05-12
ER

PT J
AU Briggs, RG
   Jones, RG
   Conner, AK
   Allan, PG
   Homburg, HB
   Maxwell, BD
   Fung, KM
   Sughrue, ME
AF Briggs, Robert G.
   Jones, Ryan G.
   Conner, Andrew K.
   Allan, Parker G.
   Homburg, Hannah B.
   Maxwell, B. David
   Fung, Kar-Ming
   Sughrue, Michael E.
TI Hemangioblastoma of Cerebral Aqueduct Removed via Sitting,
   Supracerebellar Intracollicular Approach
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cerebral aqueduct; Colliculus; Hemangioblastoma
ID BRAIN-STEM HEMANGIOBLASTOMAS; CENTRAL-NERVOUS-SYSTEM;
   SURGICAL-MANAGEMENT; TUMORS; EXPERIENCE; DIAGNOSIS; RESECTION; REGION
AB BACKGROUND: Tumors protruding into the cerebral aqueduct are rare, and tumors arising from within the cerebral aqueduct are rarer still.
   CASE DESCRIPTION: In this report, we discuss the presentation and clinical outcome of a 65-year-old man who presented to us with symptoms of hydrocephalus. Prior imaging had revealed a small enhancing nodule within the cerebral aqueduct. In the 6 months between initial imaging and our seeing the patient, the tumor demonstrated substantial interval growth, so the patient was offered resection. The tumor was accessed using a sitting, supracerebellar, intracollicular approach, which allowed for gross total resection of the mass without complication. Histopathology later revealed the lesion to be a heman-gioblastoma. Two years after surgery, the patient was doing well with no neurologic deficits.
   CONCLUSION'S: We report the first case of an aqueductal hemangioblastoma describe our use of a sitting, supracerebellar, intracollicular approach to access tumors occupying this cerebrospinal fluid space.
C1 [Briggs, Robert G.; Jones, Ryan G.; Conner, Andrew K.; Allan, Parker G.; Homburg, Hannah B.; Maxwell, B. David] Univ Oklahoma, Hlth Sci Ctr, Dept Neurosurg, Oklahoma City, OK USA.
   [Fung, Kar-Ming] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.
   [Sughrue, Michael E.] Prince Wales Private Hosp, Ctr Minimally Invas Neurosurg, Sydney, NSW, Australia.
RP Sughrue, ME (reprint author), Prince Wales Private Hosp, Ctr Minimally Invas Neurosurg, Sydney, NSW, Australia.
EM sughruevs@gmail.com
OI Allan, Parker/0000-0002-6302-4793
CR Cavalheiro S, 2015, CHILD NERV SYST, V31, P1815, DOI 10.1007/s00381-015-2799-y
   Chen LF, 2013, J CLIN NEUROSCI, V20, P1727, DOI 10.1016/j.jocn.2013.01.027
   Choudhri O, 2016, NEUROSURG FOCUS S1, V40
   Feletti A, 2017, WORLD NEUROSURG, V98, DOI 10.1016/j.wneu.2016.11.096
   HO KL, 1982, CANCER, V49, P154, DOI 10.1002/1097-0142(19820101)49:1<154::AID-CNCR2820490131>3.0.CO;2-9
   Howng S L, 1991, Gaoxiong Yi Xue Ke Xue Za Zhi, V7, P609
   Jagannathan J, 2008, J NEUROSURG, V108, P210, DOI 10.3171/JNS/2008/108/2/0210
   Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005527
   Kaku Y, 1999, NEUROSURGERY, V44, P338, DOI 10.1097/00006123-199902000-00052
   KANNO H, 1994, CANCER RES, V54, P4845
   LABORDE G, 1992, ACTA NEUROCHIR, V114, P135, DOI 10.1007/BF01400602
   Liebenow B, 2019, J NEURO-ONCOL, V142, P471, DOI 10.1007/s11060-019-03118-x
   Ma DX, 2015, WORLD NEUROSURG, V84, P1030, DOI 10.1016/j.wneu.2015.05.030
   Mai JC, 2013, WORLD NEUROSURG, V79, P691, DOI 10.1016/j.wneu.2012.04.030
   NAZZARO JM, 1992, J NEUROSURG, V76, P746, DOI 10.3171/jns.1992.76.5.0746
   NEUMANN HPH, 1989, J NEUROSURG, V70, P24, DOI 10.3171/jns.1989.70.1.0024
   Pavesi G, 2010, ACTA NEUROCHIR, V152, P287, DOI 10.1007/s00701-009-0512-1
   Roth J, 2015, ACTA NEUROCHIR, V157, P169, DOI 10.1007/s00701-014-2264-9
   SANFORD RA, 1982, J NEUROSURG, V57, P690, DOI 10.3171/jns.1982.57.5.0690
   Sanli AM, 2012, J NEUROSURG-PEDIATR, V10, P186, DOI 10.3171/2012.6.PEDS11562
   Schroeder HWS, 2013, WORLD NEUROSURG, V79
   Shankar GM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0167-x
   Tamura R, 2017, J CLIN NEUROSCI, V44, P260, DOI 10.1016/j.jocn.2017.06.059
   Weil RJ, 2003, J NEUROSURG, V98, P95, DOI 10.3171/jns.2003.98.1.0095
   Wind JJ, 2011, J NEUROSURG, V114, P1312, DOI 10.3171/2010.9.JNS10839
   Yin LX, 2014, J CLIN NEUROSCI, V21, P250, DOI 10.1016/j.jocn.2013.03.037
   Zhou LF, 2005, SURG NEUROL, V63, P307, DOI 10.1016/j.surneu.2004.07.038
NR 27
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 155
EP 159
DI 10.1016/j.wneu.2019.03.206
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300189
PM 30928590
DA 2020-05-12
ER

PT J
AU Fujimori, T
   Shindo, A
   Ogawa, D
   Okada, M
   Hatakeyama, T
   Okauchi, M
   Kawanishi, M
   Miyake, K
   Tamiya, T
AF Fujimori, Takeshi
   Shindo, Atsushi
   Ogawa, Daisuke
   Okada, Masaki
   Hatakeyama, Tetsuhiro
   Okauchi, Masanobu
   Kawanishi, Masahiko
   Miyake, Keisuke
   Tamiya, Takashi
TI A Rare Case of Postoperative Symptomatic Cyst Formation After Resection
   of a Large Convexity Meningioma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Cyst; Meningioma; Postoperative complication; Valve-like structure
ID TUMOR BED CYSTS; COMPLICATION; IMPLANTATION
AB BACKGROUND: Symptomatic cyst formation after brain tumor resection is a rare complication of the early postoperative phase. We describe a complicated case of postoperative symptomatic cyst formation after gross total removal of a convexity meningioma.
   CASE DESCRIPTION: A 59-year-old woman presented with recent onset motor aphasia. Magnetic resonance imaging revealed a left convexity tumor. We performed gross total resection of the tumor, which was pathologically diagnosed as an atypical meningioma. Tumor resection and decompression of the normal cerebral hemisphere improved aphasia. However, 3 days after surgery, her motor aphasia worsened. Computed tomography scan confirmed that the frontal lobe was being compressed by an enlargement of the postoperative tumor cavity. Conservative therapy did not shrink the cavity, and her motor aphasia persisted. Therefore, 21 days after surgery, a drainage tube was inserted into the enlarged cavity using a neuroendoscope, which promoted shrinkage of the cavity and improved her motor aphasia. We suspected that the enlargement of the postoperative cavity was because of the presence of a valve-like structure.
   CONCLUSIONS: Even though formation of symptomatic cystic lesions after brain tumor resection is rare, neurosurgeons should be aware of such early postoperative complications and their management strategies.
C1 [Fujimori, Takeshi; Shindo, Atsushi; Ogawa, Daisuke; Okada, Masaki; Hatakeyama, Tetsuhiro; Okauchi, Masanobu; Kawanishi, Masahiko; Miyake, Keisuke; Tamiya, Takashi] Kagawa Univ, Fac Med, Dept Neurol Surg, Takamatsu, Kagawa, Japan.
RP Fujimori, T (reprint author), Kagawa Univ, Fac Med, Dept Neurol Surg, Takamatsu, Kagawa, Japan.
EM fujimori@med.kagawa-u.ac.jp
FU JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18K08996,
   18H02913]
FX This work was supported by JSPS KAKENHI (18K08996 and 18H02913).
CR Beez T, 2018, WORLD NEUROSURG, V115, P213, DOI 10.1016/j.wneu.2018.04.087
   Beez T, 2017, WORLD NEUROSURG, V104, P509, DOI 10.1016/j.wneu.2017.05.019
   Della Puppa A, 2010, ACTA NEUROCHIR, V152, P1923, DOI 10.1007/s00701-010-0759-6
   Halani SH, 2013, J NEUROSURG-PEDIATR, V12, P62, DOI 10.3171/2013.4.PEDS12609
   Korinth MC, 2001, ZBL NEUROCHIR, V62, P87, DOI 10.1055/s-2001-21792
   Lonjaret L, 2017, ANAESTH CRIT CARE PA, V36, P213, DOI 10.1016/j.accpm.2016.06.012
   Matsumura H, 2018, NEUROL MED-CHIR, V58, P270, DOI 10.2176/nmc.cr.2017-0218
   McGirt MJ, 2002, J NEUROSURG, V96, P941, DOI 10.3171/jns.2002.96.5.0941
   Ohue S, 2016, JPN J NEUROSURG, V25, P882
   Rao MB, 1999, CLIN NEUROL NEUROSUR, V101, P141, DOI 10.1016/S0303-8467(99)00021-9
   Talacchi A, 2011, BRIT J NEUROSURG, V25, P641, DOI 10.3109/02688697.2010.535929
   Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12183
   Yu JL, 2010, CASE REP MED, DOI 10.1155/2010/634839
NR 13
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 160
EP 164
DI 10.1016/j.wneu.2019.04.022
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300190
PM 30974281
DA 2020-05-12
ER

PT J
AU Liu, HJ
   Zhou, H
   Lu, DL
   Jiao, YB
   Chen, SF
   Cheng, J
   Yao, XJ
   Ren, JY
   Li, SF
   Liu, W
   Gao, JC
   Yue, Y
   Xu, JX
   Zhang, PN
   Feng, YG
AF Liu, Heng-Jian
   Zhou, Han
   Lu, Dong-Lin
   Jiao, Ying-Bin
   Chen, Song-Feng
   Cheng, Jing
   Yao, Xu-Jin
   Ren, Jin-Yang
   Li, Shi-Fang
   Liu, Wei
   Gao, Jing-Chen
   Yue, Yong
   Xu, Jin-Xiang
   Zhang, Pi-Ning
   Feng, Yu-Gong
TI Intracranial Mirror Aneurysm: Epidemiology, Rupture Risk, New Imaging,
   Controversies, and Treatment Strategies
SO WORLD NEUROSURGERY
LA English
DT Review
DE 3D Slicer; Management; Mirror aneurysms; Rupture
ID CEREBRAL-ARTERY ANEURYSMS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ASSISTED
   COIL EMBOLIZATION; HEMODYNAMIC CHARACTERISTICS; CONTRALATERAL APPROACH;
   NONMIRROR MULTIPLE; KEYHOLE APPROACH; NATURAL-HISTORY; POOLED ANALYSIS;
   PARAMETERS
AB There are some controversies about the surgical treatment strategy of mirror aneurysms. Whether to choose 1-stage or 2-stage surgery, bilateral or unilateral craniotomy, or surgical or interventional treatment are the main points in dispute. In this review, the different surgery strategies faced by patients are discussed. Different surgical methods are adopted based on the patient's individual state and the location and size of the aneurysm. A new imaging method is introduced using 3D Slicer, which clearly recognizes the relationship among aneurysm, brain tissue, skull, and nerve. The 3D Slicer can help surgeons undertake adequate preoperative preparation. In addition, we also introduce some ruptured factors (e.g., age, gender, hypertension, morphologic, and hemodynamic) concerning mirror aneurysm. Systematic discussion of the controversies and methods in surgical treatment of mirror aneurysms may provide new perspectives in future research for the prevention and treatment of mirror aneurysms.
C1 [Liu, Heng-Jian; Zhou, Han; Lu, Dong-Lin; Yao, Xu-Jin; Ren, Jin-Yang; Gao, Jing-Chen; Yue, Yong; Xu, Jin-Xiang] Qingdao Univ, Qingdao, Shandong, Peoples R China.
   [Jiao, Ying-Bin; Li, Shi-Fang; Liu, Wei; Feng, Yu-Gong] Qingdao Univ, Affiliated Hosp, Dept Neurosurg, Qingdao, Shandong, Peoples R China.
   [Chen, Song-Feng] Wuhan Univ, Wuhan, Hubei, Peoples R China.
   [Cheng, Jing] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan, Hubei, Peoples R China.
   [Zhang, Pi-Ning] Qingdao Univ, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China.
RP Feng, YG (reprint author), Qingdao Univ, Affiliated Hosp, Dept Neurosurg, Qingdao, Shandong, Peoples R China.
EM fengyugongqdu@163.com
OI Liu, Heng-Jian/0000-0002-5898-6381
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81870914]
FX This work was financed by Grant-in-Aid for Scientific Research from the
   National Natural Science Foundation of China (number 81870914).
CR Acik V, 2017, WORLD NEUROSURG, V108, P774, DOI 10.1016/j.wneu.2017.09.078
   Andrade-Barazarte H, 2015, NEUROSURGERY, V77, P916, DOI 10.1227/NEU.0000000000000930
   Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770
   Bechan RS, 2016, AM J NEURORADIOL, V37, P502, DOI 10.3174/ajnr.A4542
   Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151
   BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103
   Casimiro MV, 2004, SURG NEUROL, V61, P541
   Chung J, 2014, J NEUROSURG, V121, P4, DOI 10.3171/2014.4.JNS131662
   CROMPTON MR, 1966, BRIT MED J, V1, P1138, DOI 10.1136/bmj.1.5496.1138
   de Sousa AA, 2005, SURG NEUROL, V63, P1, DOI 10.1016/j.surneu.2004.09.018
   Dhandapani S, 2018, WORLD NEUROSURG, V112, P73, DOI [10.1016/J.WNEU.2018.01.100, 10.1016/j.wneu.2018.01.100]
   Doddasomayajula R, 2017, AM J NEURORADIOL, V38, P2301, DOI 10.3174/ajnr.A5397
   Fan JX, 2015, WORLD NEUROSURG, V84, P114, DOI 10.1016/j.wneu.2015.02.038
   Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8
   Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1
   He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948
   Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83
   Horikoshi T, 1999, NEUROSURGERY, V44, P705, DOI 10.1097/00006123-199904000-00008
   Huang ZQ, 2016, AM J NEURORADIOL, V37, P1413, DOI 10.3174/ajnr.A4764
   Huang ZQ, 2017, EUR J RADIOL, V96, P80, DOI 10.1016/j.ejrad.2017.09.015
   Inagawa T, 2009, ACTA NEUROCHIR, V151, P1623, DOI 10.1007/s00701-009-0479-y
   Inci S, 2012, NEUROSURG REV, V35, P505, DOI 10.1007/s10143-012-0392-3
   Jeon P, 2014, AM J NEURORADIOL, V35, P1170, DOI 10.3174/ajnr.A3821
   Jiang H, 2016, ACTA NEUROCHIR, V158, P1367, DOI 10.1007/s00701-016-2826-0
   Jiang H, 2015, NEUROL MED-CHIR, V55, P498, DOI 10.2176/nmc.oa.2014-0390
   Jing LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132494
   Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838
   Kakizawa Y, 2000, NEUROSURGERY, V47, P1130, DOI 10.1097/00006123-200011000-00022
   Kang HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142330
   Kim DH, 2005, NEUROSURGERY, V56, P655, DOI 10.1227/01.NEU.0000156787.55281.53
   Lan Q, 2015, WORLD NEUROSURG, V84, P1758, DOI 10.1016/j.wneu.2015.07.046
   Lee JS, 2008, J KOREAN NEUROSURG S, V44, P136, DOI 10.3340/jkns.2008.44.3.136
   Lee YJ, 2015, NEURORADIOLOGY, V57, P35, DOI 10.1007/s00234-014-1437-9
   Li MH, 2013, CAN J NEUROL SCI, V40, P366, DOI 10.1017/S0317167100014323
   Ling AJ, 2006, J CLIN NEUROSCI, V13, P784, DOI 10.1016/j.jocn.2005.09.009
   Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461
   Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   Mariniello G, 2010, J NEUROINTERV SURG, V2, P157, DOI 10.1136/jnis.2009.001503
   Mehrotra A, 2016, WORLD NEUROSURG, V92, P126, DOI 10.1016/j.wneu.2016.04.124
   Meissner I, 2012, J NEUROSURG, V116, P1238, DOI 10.3171/2012.1.JNS11779
   Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260
   Oh Keun, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P184, DOI 10.7461/jcen.2013.15.3.184
   Oshiro EM, 1997, J NEUROSURG, V87, P163, DOI 10.3171/jns.1997.87.2.0163
   Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355
   Reisch R, 2005, NEUROSURGERY, V57, P242, DOI 10.1227/01.NEU.0000178353.42777.2C
   Reisch R, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2012.02.024
   Rodriguez-Hernandez A, 2012, NEUROSURGERY, V71, P123
   Singh Saraj K, 2018, Surg Neurol Int, V9, P80, DOI 10.4103/sni.sni_478_17
   Sosnov A O, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P44, DOI 10.17116/neiro201680544-50
   Steiger HJ, 2001, NEUROSURGERY, V48, P347, DOI 10.1097/00006123-200102000-00021
   TERBERG HWM, 1992, STROKE, V23, P1024, DOI 10.1161/01.STR.23.7.1024
   Tian ZB, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00219
   Wang GX, 2018, J NEUROINTERV SURG, V10, P995, DOI 10.1136/neurintsurg-2017-013553
   Wang R, 2014, NEUROPSYCH DIS TREAT, V10, P2231, DOI 10.2147/NDT.S70515
   Wang WX, 2017, WORLD NEUROSURG, V100, P450, DOI 10.1016/j.wneu.2017.01.049
   Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
   Wong ST, 2014, J NEUROSURG, V121, P1290, DOI 10.3171/2010.10.JNS101680
   Xu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055413
   Xu Y, 2014, TURK NEUROSURG, V24, P598, DOI 10.5137/1019-5149.JTN.9152-13.1
   Zhu Y, 2015, WORLD NEUROSURG, V84, P1726, DOI 10.1016/j.wneu.2015.07.036
   Zouaoui A, 1997, NEUROSURGERY, V41, P125, DOI 10.1097/00006123-199707000-00026
NR 63
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 165
EP 175
DI 10.1016/j.wneu.2019.03.275
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300191
PM 30954748
DA 2020-05-12
ER

PT J
AU Hu, YJ
   Chen, D
   Zhang, LF
   Chen, J
AF Hu, Yan-jia
   Chen, Da
   Zhang, Li-feng
   Chen, Jing
TI Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for
   Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Hypofractionated stereotactic radiotherapy; Radiation necrosis;
   Recurrent malignant glioma
ID RADIATION-THERAPY; CONCURRENT BEVACIZUMAB; SURGICAL RESECTION; SALVAGE
   TREATMENT; DOSE-ESCALATION; GLIOBLASTOMA; REIRRADIATION; RADIOSURGERY;
   SURVIVAL; SURGERY
AB BACKGROUND: The current treatment for patients with relapsed malignant glioma (MG) remains unsatisfactory. Use of hypofractionated stereotactic radiotherapy (HFSRT) for recurrent MG has shown some encouraging results and may be a viable option.
   METHODS: We performed a systematic review and meta-analysis of articles that investigated the use of HFSRT for recurrent MG. Relevant studies were obtained through searching PubMed, Embase, and the Cochrane Library. Data about treatment regimens, median overall survival, and radiation necrosis (RN), as well as other major neurologic complications were extracted. We performed a descriptive analysis of the median overall survival and meta-analysis of the reported rates of RN and other major neurologic complications (MNCs).
   RESULTS: A total of 26 studies were included in our study, comprising 861 patients. Median overall survival ranged from 8.6 to 18 months. A total of 19 studies were included to perform a meta-analysis of the RN rate and the pooled RN rate was 5% (3%-7%). The pooled rate of other MNCs was 2% (1%-4%), calculated from 20 studies.
   CONCLUSIONS: The present evidence suggests that HFSRT is an efficacious and safe treatment approach to treat patients with recurrent MG. However, the retrospective and observational nature of the studies included in our systematic review and meta-analysis restricted formation of more solid conclusions. Thus, well-designed prospective controlled trials are warranted to further define the therapeutic role of HFSRT for recurrent MG.
C1 [Hu, Yan-jia; Chen, Da; Zhang, Li-feng; Chen, Jing] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
RP Chen, J (reprint author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.
EM jchen6811@163.com
CR Barbagallo GMV, 2008, BRIT J NEUROSURG, V22, P452, DOI 10.1080/02688690802182256
   Barker FG, 1998, NEUROSURGERY, V42, P709, DOI 10.1097/00006123-199804000-00013
   Cho KH, 1999, INT J RADIAT ONCOL, V45, P1133, DOI 10.1016/S0360-3016(99)00336-3
   Ciammella P, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-222
   Clark GM, 2014, NEURO-ONCOL PRACT, V1, P172, DOI 10.1093/nop/npu028
   Clarke J, 2017, INT J RADIAT ONCOL, V99, P797, DOI 10.1016/j.ijrobp.2017.06.2466
   Combs SE, 2013, ACTA ONCOL, V52, P147, DOI 10.3109/0284186X.2012.692882
   Cuneo KC, 2012, INT J RADIAT ONCOL, V82, P2018, DOI 10.1016/j.ijrobp.2010.12.074
   Dincoglan F, 2015, TUMORI J, V101, P179, DOI 10.5301/tj.5000236
   Ellingson BM, 2017, J NEURO-ONCOL, V134, P495, DOI 10.1007/s11060-017-2375-2
   Ernst-Stecken A, 2007, J NEURO-ONCOL, V81, P287, DOI 10.1007/s11060-006-9231-0
   Fernandes C, 2017, GLIOBLASTOMA, P197, DOI 10.15586/codon.glioblastoma.2017.ch11
   Fetcko K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008293
   Fogh SE, 2010, J CLIN ONCOL, V28, P3048, DOI 10.1200/JCO.2009.25.6941
   Fokas E, 2009, STRAHLENTHER ONKOL, V185, P235, DOI 10.1007/s00066-009-1753-x
   Grosu AL, 2005, INT J RADIAT ONCOL, V63, P511, DOI 10.1016/j.ijrobp.2005.01.056
   Gutin PH, 2009, INT J RADIAT ONCOL, V75, P156, DOI 10.1016/j.ijrobp.2008.10.043
   HALL WA, 1995, J CLIN ONCOL, V13, P1642, DOI 10.1200/JCO.1995.13.7.1642
   Henke G, 2009, STRAHLENTHER ONKOL, V185, P113, DOI 10.1007/s00066-009-1969-9
   Hudes RS, 1999, INT J RADIAT ONCOL, V43, P293, DOI 10.1016/S0360-3016(98)00416-7
   Jia A, 2016, CUREUS, V8, DOI 10.7759/cureus.536
   Kirkpatrick JP, 2014, SEMIN RADIAT ONCOL, V24, P289, DOI 10.1016/j.semradonc.2014.06.006
   Kong DS, 2008, CANCER-AM CANCER SOC, V112, P2046, DOI 10.1002/cncr.23402
   Lee J, 2018, YONSEI MED J, V59, P194, DOI 10.3349/ymj.2018.59.2.194
   Martinez-Carrillo M, 2014, BIOMED RES INT, DOI 10.1155/2014/657953
   Mayer R, 2008, INT J RADIAT ONCOL, V70, P1350, DOI 10.1016/j.ijrobp.2007.08.015
   McKenzie JT, 2013, J NEURO-ONCOL, V113, P403, DOI 10.1007/s11060-013-1126-2
   Minniti G, 2013, J NEURO-ONCOL, V111, P187, DOI 10.1007/s11060-012-0999-9
   Miwa K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-181
   Montemurro N, 2016, CLIN NEUROL NEUROSUR, V142, P60, DOI 10.1016/j.clineuro.2016.01.010
   Navarria P, 2016, CANCER RES TREAT, V48, P37, DOI 10.4143/crt.2014.259
   Nieder C, 2016, ANTICANCER RES, V36, P4985, DOI 10.21873/anticanres.11067
   Niyazi M, 2012, INT J RADIAT ONCOL, V82, P67, DOI 10.1016/j.ijrobp.2010.09.002
   Park CK, 2013, NEURO-ONCOLOGY, V15, P1096, DOI 10.1093/neuonc/not069
   Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582
   Prabhu VC, 2017, WORLD NEUROSURG, V103, P906, DOI 10.1016/j.wneu.2017.03.076
   Rashed I, 2013, NEURO-ONCOLOGY, V15, P81
   Reynaud T, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818806498
   Romanelli P, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.9.FOCUS09187
   Scoccianti S, 2018, CRIT REV ONCOL HEMAT, V126, P80, DOI 10.1016/j.critrevonc.2018.03.024
   Shapiro LQ, 2013, INT J RADIAT ONCOL, V85, P636, DOI 10.1016/j.ijrobp.2012.05.031
   SHRIEVE DC, 1995, NEUROSURGERY, V36, P275, DOI 10.1227/00006123-199502000-00006
   Vordermark D, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-55
   Wurm RE, 2006, INT J RADIAT ONCOL, V66, pS26, DOI 10.1016/j.ijrobp.2006.04.062
   Wuthrick EJ, 2014, INT J RADIAT ONCOL, V90, P369, DOI 10.1016/j.ijrobp.2014.05.034
   Yazici G, 2014, J NEURO-ONCOL, V120, P117, DOI 10.1007/s11060-014-1524-0
NR 46
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 176
EP 185
DI 10.1016/j.wneu.2019.03.297
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300192
PM 30959254
DA 2020-05-12
ER

PT J
AU Ayandipo, OO
   Adeleye, AO
   Ulasi, IB
   Ogundiran, TO
AF Ayandipo, Omobolaji Oladayo
   Adeleye, Amos Olufemi
   Ulasi, Ikechukwu Bartholomew
   Ogundiran, Temidayo Olusade
TI Outcome of Cerebral Metastasectomy in Select Cases of Brain Metastases
   from Breast Cancer in Ibadan, Nigeria
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain metastasis; Breast cancer; Developing country; Metastasectomy;
   Surgical resection
ID CLINICAL-PRACTICE GUIDELINES; MOLECULAR SUBTYPES; PROGNOSTIC-FACTORS;
   SURGICAL-TREATMENT; SURVIVAL; SURGERY; IRRADIATION; MANAGEMENT;
   CARCINOMA
AB BACKGROUND: Brain metastasis (BM) from breast cancer is increasingly encountered clinically because of the continuing success in the oncological control of the primary disease. Data-driven reports on the surgical treatment of BM from breast cancer are sparse in sub-Saharan Africa.
   METHODS: This is a prospective cohort study of the outcome of surgical excision of BM from breast cancer in an academic surgical practice in Ibadan, Nigeria.
   RESULTS: A total of 12 consecutive cerebral metastasectomies, all in females with primary breast cancer, were recorded over the study period. The median age (range) at breast cancer diagnosis was 41 (27-72) years, and the time interval from primary disease to BM was 19 (12-29) months. The BM was the first site of systemic disease progression in all, and was heralded by headache, seizures, and hemiparesis in more than two-thirds of the patients. The brain lesions were multiple in a quarter: >4 cm large in 42% and were located supratentorial in >80%. They all achieved good recovery and in-hospital outcome after surgical lesionectomy-infra- and supratentorial craniotomies-but only two-thirds could access post-surgical adjuvant whole brain radiation therapy. Median survival after cerebral metastasectomy was 18 (11-55) months, and more than a quarter were alive for >= 3years. These survival statistics were significantly better than those of a contemporary cohort of our patients with breast cancer who also had BMs that were not surgically treated for various clinical and logistic limitations.
   CONCLUSIONS: Surgical resection is feasible for BM from breast cancer even in low-resource clinical practice. It has a salutary effect on the patients' quality of life.
C1 [Ayandipo, Omobolaji Oladayo; Ogundiran, Temidayo Olusade] Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Dept Surg,Div Oncol Surg, Ibadan, Nigeria.
   [Adeleye, Amos Olufemi] Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Dept Surg,Div Neurol Surg, Ibadan, Nigeria.
   [Ulasi, Ikechukwu Bartholomew] Univ Coll Hosp, Dept Surg, Ibadan, Nigeria.
RP Adeleye, AO (reprint author), Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Dept Surg,Div Neurol Surg, Ibadan, Nigeria.
EM femdoy@yahoo.com
OI Adeleye, Amos/0000-0002-5966-1431
CR Adebamowo CA, 2008, BREAST CANCER RES TR, V110, P183, DOI 10.1007/s10549-007-9694-5
   Adeleye Amos Olufemi, 2016, Surg Neurol Int, V7, P54, DOI 10.4103/2152-7806.181905
   Arbit E, 1996, NEUROSURG CLIN N AM, V7, P447
   Benna Mehdi, 2018, CNS Oncol, V7, P35, DOI 10.2217/cns-2017-0020
   BINDAL RK, 1993, J NEUROSURG, V79, P210, DOI 10.3171/jns.1993.79.2.0210
   Bowen RL, 2008, BRIT J CANCER, V98, P277, DOI 10.1038/sj.bjc.6604174
   Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232
   Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492
   Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220
   Clayton AJ, 2004, BRIT J CANCER, V91, P639, DOI 10.1038/sj.bjc.6601970
   ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947
   GLOBOCAN, 2018, AG STAND WORLD INC R
   Gradishar WJ, 2018, J NATL COMPR CANC NE, V16, P310, DOI 10.6004/jnccn.2018.0012
   Hanrahan EO, 2005, CANCER-AM CANCER SOC, V104, P1158, DOI 10.1002/cncr.21305
   HAZRA T, 1972, JOHNS HOPKINS MED J, V130, P377
   Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873
   Khanfir A, 2013, REP PRACT ONCOL RADI, V18, P127, DOI 10.1016/j.rpor.2013.01.001
   KOENDERS PG, 1992, BREAST CANCER RES TR, V21, P173, DOI 10.1007/BF01975000
   Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424
   Muacevic A, 2008, J NEURO-ONCOL, V87, P299, DOI 10.1007/s11060-007-9510-4
   Nathoo Narendra, 2004, Expert Rev Neurother, V4, P633, DOI 10.1586/14737175.4.4.633
   Nwankwo Kenneth Chima, 2013, W AFR J RADIOL, V20, P84, DOI DOI 10.4103/1115-1474.121099
   POSNER JB, 1978, DM-DIS MON, V25, P3
   Pottgen C, 2001, LUNG CANCER-J IASLC, V33, pS153, DOI 10.1016/S0169-5002(01)00317-8
   Roos DE, 2011, CLIN ONCOL-UK, V23, P646, DOI 10.1016/j.clon.2011.04.009
   Singletary SE, 2003, ONCOLOGIST, V8, P241, DOI 10.1634/theoncologist.8-3-241
   Smith-Bindman R, 2006, ANN INTERN MED, V144, P541, DOI 10.7326/0003-4819-144-8-200604180-00004
   Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025
   Tsao MN, 2012, PRACT RADIAT ONCOL, V2, P210, DOI 10.1016/j.prro.2011.12.004
   VICK NA, 1977, ARCH NEUROL-CHICAGO, V34, P523, DOI 10.1001/archneur.1977.00500210025002
   Wronski M, 1999, CANCER, V85, P1677, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1677::AID-CNCR6>3.0.CO;2-C
   Wronski M, 1997, CANCER, V80, P1746, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1746::AID-CNCR8>3.0.CO;2-C
   Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806
   ZIMM S, 1981, CANCER, V48, P384, DOI 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 186
EP 193
DI 10.1016/j.wneu.2019.03.279
PG 8
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300193
PM 30954731
DA 2020-05-12
ER

PT J
AU Ichimura, S
   Takahara, K
   Mochizuki, Y
   Fujii, K
AF Ichimura, Shinya
   Takahara, Kento
   Mochizuki, Yoichi
   Fujii, Koji
TI Intradural Combined Transpetrosal Approach for Primary Pontine
   Hemorrhage
SO WORLD NEUROSURGERY
LA English
DT Article
DE Combined transpetrosal approach; Intradural approach; Primary pontine
   hemorrhage; Subtemporal approach
ID PETROCLIVAL MENINGIOMAS; TRANSTENTORIAL APPROACH; ANTERIOR PETROSECTOMY;
   MICROSURGICAL ANATOMY; SURGERY
AB OBJECTIVE: The standard combined transpetrosal approach (CTPA) is fundamentally an epidural approach that has been quite successfully practiced for many decades. However, it has some disadvantages, such as cosmetic problems, difficulties with custom-tailored petrosectomy, and cerebrospinal fluid leakage, as it is a complicated epidural procedure. We describe here a case of primary pontine hemorrhage via intradural CTPA (iCTPA), which is a modified technique of CTPA and includes intradural anterior petrosectomy and partial posterior petrosectomy without mastoidectomy and skeletonization of the sigmoid sinus.
   METHODS: A 63-year-old woman with primary pontine -montage underwent surgery via iCTPA to improve postoperative functional outcomes. After the temporal craniotomy without mastoidectomy and skeletonization of the sigmoid sinus, Kawase's triangle and Trautmann's triangle were identified from the intradural space. Resection of Kawase's triangle and partial resection of Trautmann's triangle were performed to approach the frontotemporal surface of the pons. The hematoma was irrigated and totally removed after corticotomy on the pons.
   RESULTS: The postoperative symptoms of the patient improved within 2 weeks without surgical complication.
   CONCLUSIONS: The intradural approach allows for petrosectomy and is more straightforward than the epidural route, although it can injure the vein of Labbe. Moreover, it can also reduce cosmetic problems and cerebrospinal fluid leakage. iCTPA could provide enough working space for the frontolateral surface of pontine and petroclival lesions without the need for mastoidectomy and skeletonization of the sigmoid sinus.
C1 [Ichimura, Shinya; Takahara, Kento; Mochizuki, Yoichi; Fujii, Koji] Shizuoka City Shimizu Hosp, Dept Neurosurg, Shizuoka, Japan.
RP Ichimura, S (reprint author), Shizuoka City Shimizu Hosp, Dept Neurosurg, Shizuoka, Japan.
EM shinya3917@gmail.com
OI Ichimura, Shinya/0000-0003-1950-9117
CR al-Mefty O, 1991, Acta Neurochir Suppl (Wien), V53, P166
   Ali MS, 2009, J OTOLARYNGOL-HEAD N, V38, P240, DOI 10.2310/7070.2009.080064
   Alonso F, 2017, WORLD NEUROSURG, V104, P180, DOI 10.1016/j.wneu.2017.04.161
   Cavalcanti DD, 2016, J NEUROSURG, V124, P1359, DOI 10.3171/2015.4.JNS141945
   Caylan R, 2007, EUR ARCH OTO-RHINO-L, V264, P377, DOI 10.1007/s00405-006-0193-9
   de Melo Jose Orlando Junior, 2014, Surg Neurol Int, V5, P131, DOI 10.4103/2152-7806.139819
   Erkmen Kadir, 2005, Neurosurg Focus, V19, pE7
   Gonzalez LF, 2004, BARROW Q, V20, P22
   Gupta SK, 2012, J NEUROSURG, V117, P1007, DOI 10.3171/2012.9.JNS12429
   HAKUBA A, 1988, SURG NEUROL, V30, P108, DOI 10.1016/0090-3019(88)90095-X
   Ichimura S, 2018, WORLD NEUROSURG, V120, pE1289, DOI 10.1016/j.wneu.2018.09.055
   Ichimura S, 2016, NEUROSURG REV, V39, P625, DOI 10.1007/s10143-016-0711-1
   Ichimura S, 2012, NEUROSURG REV, V35, P609, DOI 10.1007/s10143-012-0405-2
   Ichimura S, 2010, NEUROSURG REV, V33, P477, DOI 10.1007/s10143-010-0277-2
   Janjua MB, 2017, J CLIN NEUROSCI, V41, P36, DOI 10.1016/j.jocn.2017.03.015
   KAWASE T, 1994, ACTA NEUROCHIR, V129, P113, DOI 10.1007/BF01406489
   KAWASE T, 1991, NEUROSURGERY, V28, P869, DOI 10.1227/00006123-199106000-00014
   KAWASE T, 1985, J NEUROSURG, V63, P857, DOI 10.3171/jns.1985.63.6.0857
   Kusumi M, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182356269
   Nanda Anil, 2014, Neurosurg Focus, V36, P1, DOI 10.3171/2014.V1.FOCUS13440
   Nitek Stanislaw, 2002, Folia Morphol (Warsz), V61, P305
   Ohata K, 1998, J NEUROSURG, V89, P575, DOI 10.3171/jns.1998.89.4.0575
   Oppel F, 1979, Acta Neurochir Suppl (Wien), V28, P565
   Paparella MM, 1998, 2 INT S MEN DIS, P139
   Russell SM, 2004, SKULL BASE-INTERD AP, V14, P63, DOI 10.1055/s-2004-821366
   Sakata K, 2000, NEUROSURGERY, V47, P153, DOI 10.1097/00006123-200007000-00032
   Sarmiento PB, 2004, OTOLARYNG HEAD NECK, V131, P192, DOI 10.1016/j.otohns.2004.02.009
   Sekhar LN, 1999, NEUROSURGERY, V44, P537, DOI 10.1097/00006123-199903000-00060
   Shibao S, 2015, WORLD NEUROSURG, V84, P574, DOI 10.1016/j.wneu.2015.03.055
   Shibao S, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.09.020
   Sincoff EH, 2007, NEUROSURGERY, V60, P53, DOI 10.1227/01.NEU.0000249232.12860.A5
   Steiger HJ, 2006, J NEUROSURG, V104, P38, DOI 10.3171/jns.2006.104.1.38
   Tahara A, 2009, J CLIN NEUROSCI, V16, P655, DOI 10.1016/j.jocn.2008.08.011
   TEDESCHI H, 1994, SURG NEUROL, V41, P180, DOI 10.1016/0090-3019(94)90123-6
   Tubbs RS, 2012, CLIN ANAT, V25, P992, DOI 10.1002/ca.22038
   Velho Vernon, 2012, Asian J Neurosurg, V7, P116, DOI 10.4103/1793-5482.103710
   Wong Andrew K, 2017, Surg Neurol Int, V8, P129, DOI 10.4103/sni.sni_243_16
NR 37
TC 0
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 194
EP 198
DI 10.1016/j.wneu.2019.03.122
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300194
PM 30928601
DA 2020-05-12
ER

PT J
AU Dogan, SN
   Baltacioglu, F
   Duman, IE
   Kucukyuruk, B
   Batur, S
   Oz, B
   Kizilkilic, O
   Islak, C
   Kocer, N
AF Dogan, Sebahat Nacar
   Baltacioglu, Feyyaz
   Duman, Ikram Eda
   Kucukyuruk, Baris
   Batur, Sebnem
   Oz, Buge
   Kizilkilic, Osman
   Islak, Civan
   Kocer, Naci
TI Cerebral Abscess Following Endovascular Treatment of Aneurysm: Report of
   2 Cases and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Cerebral abscess; Cerebral aneurysm; Coil excision; Endovascular
   embolization; Infection
ID GUGLIELMI DETACHABLE COILS; BRAIN-ABSCESS; SACCULAR ANEURYSM;
   EMBOLIZATION; COMPLICATION; INFLAMMATION; BACTEREMIA; EDEMA; RISK
AB INTRODUCTION: Endovascular treatment is growing in popularity globally as an important treatment option for intracranial aneurysms. Cerebral infection as a complication of endovascular treatment of aneurysms is sufficiently rare that only 6 isolated cerebral abscess cases have been reported thus far.
   CASE REPORT: In this report, we present 2 cerebral abscesses from 3 institutions, which developed after coil embolization of anterior communicating artery and middle cerebral artery aneurysms.
   CONCLUSION: This report was written to discuss the possible mechanisms underlying cerebral abscess after endovascular treatment of aneurysms and to suggest potential treatment and prevention methods.
C1 [Dogan, Sebahat Nacar] Gaziosmanpasa Taksim Training & Res Hosp, Dept Radiol, Istanbul, Turkey.
   [Baltacioglu, Feyyaz; Duman, Ikram Eda] Marmara Univ, Pendik Training & Res Hosp, Dept Radiol, Istanbul, Turkey.
   [Kucukyuruk, Baris] Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey.
   [Batur, Sebnem; Oz, Buge] Istanbul Univ, Cerrahpasa Med Fac, Dept Pathol, Istanbul, Turkey.
   [Kizilkilic, Osman; Islak, Civan; Kocer, Naci] Istanbul Univ, Cerrahpasa Med Fac, Dept Radiol, Div Neuroradiol, Istanbul, Turkey.
RP Kocer, N (reprint author), Istanbul Univ, Cerrahpasa Med Fac, Dept Radiol, Div Neuroradiol, Istanbul, Turkey.
EM nkocer@istanbul.edu.tr
RI Kucukyuruk, Baris/AAD-3536-2020; islak, civan/AAH-3857-2019; Oz,
   Buge/AAH-6542-2019; batur, sebnem/C-5097-2017; Kucukyuruk,
   Baris/C-5037-2018
OI Nacar Dogan, Sebahat/0000-0003-1512-5060; Kucukyuruk,
   Baris/0000-0002-0077-110X
CR Al-Okaili R, 2002, AM J NEURORADIOL, V23, P697
   Bavinzski G, 1999, J NEUROSURG, V91, P284, DOI 10.3171/jns.1999.91.2.0284
   Berge J, 2011, AM J NEURORADIOL, V32, P1930, DOI 10.3174/ajnr.A2710
   Blomstedt G C, 1992, Neurosurg Clin N Am, V3, P375
   Bocher-Schwarz HG, 2002, NEUROSURGERY, V50, P379
   Burkhardt JK, 2020, J NEUROSURG, V132, P797, DOI 10.3171/2018.10.JNS182540
   Chen GZ, 2014, J CLIN NEUROSCI, V21, P163, DOI 10.1016/j.jocn.2012.10.043
   CHEN ST, 1995, STROKE, V26, P696, DOI 10.1161/01.STR.26.4.696
   Cossu G, 2017, ACTA NEUROCHIR, V159, P583, DOI 10.1007/s00701-016-3069-9
   Diaz-Romero R, 2009, SURG INFECT, V10, P359, DOI 10.1089/sur.2008.031
   Jenkinson MD, 2003, ACTA NEUROCHIR, V145, P703, DOI 10.1007/s00701-003-0074-6
   Kelkar PS, 2013, NEUROSURGERY, V72, P327, DOI 10.1227/NEU.0b013e31827d0ff7
   Killer M, 2010, NEUROCHEM RES, V35, P1652, DOI 10.1007/s11064-010-0226-z
   Kirollos RW, 2002, NEUROSURGERY, V51, P234, DOI 10.1097/00006123-200207000-00036
   Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010
   SHAWKER TH, 1974, JAMA-J AM MED ASSOC, V229, P1090, DOI 10.1001/jama.229.8.1090
   Shimizu S, 1999, AM J NEURORADIOL, V20, P546
   Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444
   Stiver SI, 1998, NEUROSURGERY, V43, P1203, DOI 10.1097/00006123-199811000-00106
   Su IC, 2014, NEURORADIOLOGY, V56, P487, DOI 10.1007/s00234-014-1355-x
   Tomokiyo M, 2007, Interv Neuroradiol, V13 Suppl 1, P145
   van Werkum JW, 2008, INT J CARDIOL, V128, P201, DOI 10.1016/j.ijcard.2007.05.037
   Venkatesan AM, 2010, J VASC INTERV RADIOL, V21, P1611, DOI 10.1016/j.jvir.2010.07.018
   Yamanaka K, 2011, J CLIN NEUROSCI, V18, P968, DOI 10.1016/j.jocn.2010.11.013
   Zurin AAR, 1997, J NEUROSURG, V87, P109, DOI 10.3171/jns.1997.87.1.0109
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 199
EP 205
DI 10.1016/j.wneu.2019.02.220
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300195
PM 30928576
DA 2020-05-12
ER

PT J
AU Ricciardi, L
   Sturiale, CL
   Izzo, A
   Pucci, R
   Valentini, V
   Montano, N
   Polli, FM
   Visocchi, M
   Vivas-Buitrago, T
   Chaichana, KL
   Quinones-Hinojosa, A
   Olivi, A
   Chen, S
AF Ricciardi, Luca
   Sturiale, Carmelo Lucio
   Izzo, Alessandro
   Pucci, Resi
   Valentini, Valentino
   Montano, Nicola
   Polli, Filippo Maria
   Visocchi, Massimiliano
   Vivas-Buitrago, Tito
   Chaichana, Kaisorn L.
   Quinones-Hinojosa, Alfredo
   Olivi, Alessandro
   Chen, Selby
TI Submandibular Approach for Single-Stage Craniovertebral Junction Ventral
   Decompression and Stabilization: A Preliminary Cadaveric Study of
   Technical Feasibility
SO WORLD NEUROSURGERY
LA English
DT Article
DE Atlantoaxial; Craniovertebral junction; Extramucosal; Hybrid;
   Instrumentation; Upper cervical spine; Ventral approach
ID ATLANTOAXIAL JOINT DISTRACTION; ENDOSCOPIC ENDONASAL APPROACH; BASILAR
   INVAGINATION; RETROPHARYNGEAL APPROACH; CRANIOCERVICAL JUNCTION;
   ANTERIOR DECOMPRESSION; TRANSNASAL APPROACH; ODONTOID PROCESS; SCREW
   FIXATION; EXPERIENCE
AB BACKGROUND: The craniovertebral junction (CVJ) may be affected by several diseases. It is an anatomically complex region, involving the osteoligamentous, vascular, and nervous structures, which makes surgery challenging. In a case of ventral compression, an anterior approach is preferable, although posterior fixation is often required. Anterior transmucosal approaches are associated with high rates of complications. However, decompression and fixation by the use of retropharyngeal extramucosal approaches may be challenging.
   OBJECTIVE: To investigate the feasibility of a single-stage, anterior, extramucosal submandibular (SM) approach modification to the CVJ for simultaneous decompression and stabilization.
   MATERIALS AND METHODS: This was a preliminary cadaveric feasibility study on 2 injected specimens. A variation of the SM approach with a short "boomerang" incision, microsurgical decompression of the ventral CVJ, and a new hybrid construct for an anterior atlantoaxial stabilization was investigated. The surgical approach, the decompression, and the instrumentation technique have been described. In addition, intraprocedural images and radiographs and also postprocedural computed tomographic images were collected. Furthermore, surgical exposure, working corridors and angles, and decompression grade were measured.
   RESULTS: The SM approach provided wide exposure of the ventral CVJ and the possibility for instrumentation and decompression by removing the anterior arch of C1 and the odontoid process.
   CONCLUSION: A single- stage anterior extramucosal SM approach for decompression and stabilization of the CVJ is feasible and could result in shorter surgical duration, avoiding the complications related to both the transmucosal approach and the prone position, although specific related risks exist. Mechanical investigation of this hybrid system and in vivo studies are needed to confirm our results.
C1 [Ricciardi, Luca; Izzo, Alessandro; Visocchi, Massimiliano; Olivi, Alessandro] Univ Cattolica Sacro Cuore, Ist Neurochirurg, Milan, Italy.
   [Sturiale, Carmelo Lucio; Montano, Nicola; Polli, Filippo Maria] Fdn Policlin Univ A Gemelli, Rome, Italy.
   [Ricciardi, Luca; Izzo, Alessandro; Vivas-Buitrago, Tito; Chaichana, Kaisorn L.; Quinones-Hinojosa, Alfredo; Chen, Selby] Mayo Clin, Coll Med, Dept Neurosurg, Jacksonville, FL 32224 USA.
   [Pucci, Resi; Valentini, Valentino] Univ Roma La Sapienza, Policlin Univ Umberto I, Dipartimento Sci Maxillofacciali, Rome, Italy.
RP Ricciardi, L (reprint author), Univ Cattolica Sacro Cuore, Ist Neurochirurg, Milan, Italy.; Ricciardi, L (reprint author), Mayo Clin, Coll Med, Dept Neurosurg, Jacksonville, FL 32224 USA.
EM ricciardi.lu@gmail.com
RI Sturiale, Carmelo Lucio/K-6412-2016; Ricciardi, Luca/L-5405-2019;
   visocchi, massimiliano/AAA-4267-2019; Montano, Nicola/M-4565-2016
OI Sturiale, Carmelo Lucio/0000-0002-4080-2492; Ricciardi,
   Luca/0000-0001-5110-8386; visocchi, massimiliano/0000-0002-5277-4468;
   Montano, Nicola/0000-0002-4965-1950
CR Alfieri A, 2002, ACTA NEUROCHIR, V144, P219, DOI 10.1007/s007010200029
   Behari S, 2003, NEUROSURGERY, V52, P72, DOI 10.1097/00006123-200301000-00009
   BOHLER J, 1982, J BONE JOINT SURG AM, V64, P18, DOI 10.2106/00004623-198264010-00004
   Cacciola Francesco, 2019, Acta Neurochir Suppl, V125, P273, DOI 10.1007/978-3-319-62515-7_39
   DEANDRADE JR, 1969, J BONE JOINT SURG AM, VA 51, P1621, DOI 10.2106/00004623-196951080-00011
   FANG HSY, 1962, J BONE JOINT SURG AM, V44, P1588, DOI 10.2106/00004623-196244080-00008
   GOEL A, 1994, BRIT J NEUROSURG, V8, P743, DOI 10.3109/02688699409101191
   Goel A, 2008, NEUROL INDIA, V56, P144, DOI 10.4103/0028-3886.41991
   Hwang NH, 2016, J CRANIOFAC SURG, V27, P1170, DOI 10.1097/SCS.0000000000002774
   Ito K, 2017, WORLD NEUROSURG, V105, DOI 10.1016/j.wneu.2017.06.053
   Kassam AB, 2005, NEUROSURGERY, V57, P213, DOI 10.1227/01.NEU.0000163687.64774.E4
   Khanna R, 2015, J CRANIOVERTEBRAL JU, V6, P60, DOI 10.4103/0974-8237.156044
   Lan SB, 2018, WORLD NEUROSURG, V111, pE135, DOI 10.1016/j.wneu.2017.12.013
   Lucioni M, 2007, PRACTICAL GUIDE NECK
   Luna-Ortiz K, 2018, J MAXILLOFAC ORAL SU, V17, P616, DOI 10.1007/s12663-018-1133-0
   MCAFEE PC, 1987, J BONE JOINT SURG AM, V69A, P1371
   Mendes GAC, 2015, J NEUROSURG-SPINE, V22, P470, DOI 10.3171/2014.10.SPINE14374
   Mouchaty H, 2009, EUR SPINE J, V18, pS13, DOI 10.1007/s00586-009-0988-7
   Moulding HD, 2010, NEUROSURGERY, V66, pA113, DOI 10.1227/01.NEU.0000365829.97078.B2
   Nayak JV, 2007, AM J RHINOL, V21, P601, DOI 10.2500/ajr.2007.21.3089
   Pau M, 2016, J CRANIO MAXILL SURG, V44, P1641, DOI 10.1016/j.jcms.2016.07.009
   Polli FM, 2017, ACTA NEUROCHIR SUPPL, V124, P75, DOI 10.1007/978-3-319-39546-3_12
   Polli FM, 2015, SPINE J, V15, P185, DOI 10.1016/j.spinee.2014.09.019
   Reindl R, 2003, SPINE, V28, pE329, DOI 10.1097/01.BRS.0000083328.27907.3B
   Ricciardi L, 2019, WORLD NEUROSURG, V124, P136, DOI 10.1016/j.wneu.2018.12.202
   SAKOU T, 1984, CLIN ORTHOP RELAT R, P134
   Salle H, 2017, WORLD NEUROSURG, V106, P266, DOI [10.1016/J.WNEU.2017.06.162, 10.1016/j.wneu.2017.06.162]
   Shriver MF, 2016, CLIN NEUROL NEUROSUR, V148, P121, DOI 10.1016/j.clineuro.2016.07.019
   SOUTHWICK WO, 1957, J BONE JOINT SURG AM, V39, P631, DOI 10.2106/00004623-195739030-00017
   Traynelis VC, 2010, NEUROSURGERY, V67, P229, DOI 10.1227/01.NEU.0000381666.38707.65
   Visocchi M, 2018, WORLD NEUROSURG, V110, P592, DOI 10.1016/j.wneu.2017.05.125
   Visocchi M, 2017, WORLD NEUROSURG, V101, P122, DOI 10.1016/j.wneu.2017.01.099
   Visocchi M, 2011, EUR SPINE J, V20, P1518, DOI 10.1007/s00586-011-1769-7
   Wolinsky JP, 2007, J NEUROSURG-SPINE, V6, P184, DOI 10.3171/spi.2007.6.2.184
   Yadav YR, 2017, NEUROL INDIA, V65, P341, DOI 10.4103/neuroindia.NI_1276_16
   Youssef AS, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f741f7
   Zenga F, 2016, WORLD NEUROSURG, V89, P394, DOI 10.1016/j.wneu.2016.02.011
NR 37
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 206
EP 212
DI 10.1016/j.wneu.2019.04.038
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300196
PM 30980973
DA 2020-05-12
ER

PT J
AU Werner, JM
   Brunn, A
   Fink, GR
   Galldiks, N
AF Werner, Jan-Michael
   Brunn, Anna
   Fink, Gereon R.
   Galldiks, Norbert
TI Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a
   Isocitrate Dehydrogenase- and B-Raf Proto-Oncogene-Wildtype Epithelioid
   Glioblastoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brain tumors; Chemoradiation; Glioma; Neuroimaging; Temozolomide
ID TEMOZOLOMIDE
AB We here report findings on magnetic resonance imaging from a 60-year-old patient with an epithelioid glioblastoma of the corpus callosum treated with radiotherapy in combination with concomitant and adjuvant temozolomide. Neuropathology revealed a highly aggressive molecular subtype of the epithelioid glioblastoma without an isocitrate dehydrogenase and B-Raf proto-oncogene mutation or a 06-methylguanine-DNA-methyltransferase promoter hypermethylation. This subtype is typically associated with an unfavorable clinical course and poor overall survival. Unexpectedly, the first follow-up magnetic resonance imaging 10 weeks after chemoradiation completion revealed an early and almost complete treatment response.
C1 [Werner, Jan-Michael; Fink, Gereon R.; Galldiks, Norbert] Fac Med, Dept Neurol, Cologne, Germany.
   [Brunn, Anna] Fac Med, Inst Neuropathol, Cologne, Germany.
   [Brunn, Anna] Univ Hosp Cologne, Cologne, Germany.
   [Fink, Gereon R.; Galldiks, Norbert] Forschungszentrum Juelich, Inst Neurosci & Med INM 3, Julich, Germany.
   [Galldiks, Norbert] Univ Cologne, CIO, Cologne, Germany.
RP Galldiks, N (reprint author), Fac Med, Dept Neurol, Cologne, Germany.; Galldiks, N (reprint author), Forschungszentrum Juelich, Inst Neurosci & Med INM 3, Julich, Germany.; Galldiks, N (reprint author), Univ Cologne, CIO, Cologne, Germany.
EM n.galldiks@fz-juelich.de
RI Fink, Gereon R./E-1616-2012; Werner, Jan M./V-7613-2019; Galldiks,
   Norbert/AAG-6896-2019
OI Fink, Gereon R./0000-0002-8230-1856; Werner, Jan M./0000-0001-7147-4594;
   Galldiks, Norbert/0000-0002-2485-1796
CR Burger MC, 2017, ONCOL REP, V38, P3291, DOI 10.3892/or.2017.6013
   Ceccon G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041090
   Ducray F, 2008, J NEURO-ONCOL, V88, P185, DOI 10.1007/s11060-008-9546-0
   Kim SK, 2016, J CLIN NEUROSCI, V34, P145, DOI 10.1016/j.jocn.2016.06.014
   Kleinschmidt-DeMasters BK, 2013, AM J SURG PATHOL, V37, P685, DOI 10.1097/PAS.0b013e31827f9c5e
   Korshunov A, 2018, BRAIN PATHOL, V28, P656, DOI 10.1111/bpa.12566
   Louis DN, 2017, ACTA NEUROPATHOL, V133, P1, DOI 10.1007/s00401-016-1646-x
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Zhang C, 2010, INT J NEUROSCI, V120, P787, DOI 10.3109/00207454.2010.520377
NR 10
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 213
EP 215
DI 10.1016/j.wneu.2019.04.025
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300197
PM 30974270
DA 2020-05-12
ER

PT J
AU Ghorbani, M
   Asaadi, S
   Wipplinger, C
   Griessenauer, CJ
   Zangi-Abadi, F
   Mortazavi, A
AF Ghorbani, Mohammad
   Asaadi, Sina
   Wipplinger, Christoph
   Griessenauer, Christoph J.
   Zangi-Abadi, Fatemeh
   Mortazavi, Abolghasem
TI Dural Arteriovenous Fistulas with Venous Drainage Patterns Inducing
   Ocular Manifestations Mimicking a Carotid Cavernous Fistula: Report of 2
   Cases
SO WORLD NEUROSURGERY
LA English
DT Article
DE Carotid-cavernous fistula; Dural arteriovenous fistula; Ophthalmic
   presentation; Venous drainage pattern
ID ASCENDING PHARYNGEAL-ARTERY; JUGULAR-VEIN FISTULA; TRANSVENOUS
   EMBOLIZATION; TRANSARTERIAL EMBOLIZATION; ENDOVASCULAR TREATMENT;
   CLASSIFICATION
AB BACKGROUND: Cranial dural arteriovenous fistulas (dAVFs) are abnormal connections between arteries supplying the dura mater and the cranial venous system. These present with various signs and symptoms. Progressive ocular manifestations are quite rare and may be confused with carotid cavernous fistulas (CCF).
   CASE DESCRIPTION: Here, we present 2 cases of dAVF manifesting with ocular symptomatology referred to our center erroneously diagnosed as CCF, and discuss the effect of venous drainage pattern on the clinical presentation.
   CONCLUSIONS: Ocular manifestations of cerebrovascular origin are not necessarily associated with CCF or cavernous sinus dAVF. Other vascular malformations such as dAVFs should be considered specifically when accompanied by venous stenosis distal to the site of the fistula.
C1 [Ghorbani, Mohammad; Asaadi, Sina; Zangi-Abadi, Fatemeh; Mortazavi, Abolghasem] Iran Univ Med Sci, Firoozgar Hosp, Div Vasc & Endovasc Neurosurg, Tehran, Iran.
   [Asaadi, Sina] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran.
   [Wipplinger, Christoph] Weill Cornell Med, Dept Neurol Surg, New York, NY USA.
   [Griessenauer, Christoph J.] Geisinger, Dept Neurosurg, Danville, PA USA.
   [Griessenauer, Christoph J.] Paracelsus Med Univ, Res Inst Neurointervent, Salzburg, Austria.
RP Ghorbani, M (reprint author), Iran Univ Med Sci, Firoozgar Hosp, Div Vasc & Endovasc Neurosurg, Tehran, Iran.
EM ghorbani.m@iums.ac.ir
RI Ghorbani, Mohammad/N-8636-2018
OI Ghorbani, Mohammad/0000-0002-7709-3095
CR BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248
   BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166
   Caragine LP, 2003, NEUROSURGERY, V53, P1261, DOI 10.1227/01.NEU.0000093494.54083.29
   Caragine LP, 2003, NEUROSURGERY, V5, P6
   Castro LNG, 2016, STROKE, V47, pE207, DOI 10.1161/STROKEAHA.116.013428
   CHALOUPKA JC, 1992, NEURORADIOLOGY, V34, P524, DOI 10.1007/BF00598966
   Chandra RV, 2014, AM J NEURORADIOL, V35, P1793, DOI 10.3174/ajnr.A3938
   de Keizer R, 2003, Orbit, V22, P121
   Fang B, 2018, WORLD NEUROSURG, V117, pE603, DOI 10.1016/j.wneu.2018.06.098
   FOX AJ, 1978, NEURORADIOLOGY, V15, P149, DOI 10.1007/BF00329058
   Gross BA, 2017, J NEUROINTERV SURG, V9, P97, DOI 10.1136/neurintsurg-2016-012488
   GUGLIELMI G, 1988, J NEUROSURG, V69, P132, DOI 10.3171/jns.1988.69.1.0132
   Hacein-Bey L, 2002, AM J NEURORADIOL, V23, P1246
   HALBACH VV, 1989, AM J NEURORADIOL, V10, P385
   Hanaoka M, 2006, J NEUROSURG, V104, P974, DOI 10.3171/jns.2006.104.6.974
   Harrigan MR, 2013, HDB CEREBROVASCULAR
   Ihn YK, 2012, J KOREAN NEUROSURG S, V52, P480, DOI 10.3340/jkns.2012.52.5.480
   Korkmazer B, 2013, WORLD J RADIOL, V5, P143, DOI 10.4329/wjr.v5.i4.143
   LASJAUNIAS P, 1976, NEURORADIOLOGY, V11, P77, DOI 10.1007/BF00345017
   Li Q, 2013, J CLIN NEUROSCI, V20, P281, DOI 10.1016/j.jocn.2012.03.031
   Liliang PC, 2004, SURG NEUROL, V61, P89, DOI 10.1016/S0090-3019(03)00206-4
   Lv XL, 2011, EUR J RADIOL, V80, pE385, DOI 10.1016/j.ejrad.2010.08.029
   Rivet DJ, 2006, J NEUROSURG, V105, P636, DOI 10.3171/jns.2006.105.4.636
   Satomi J, 2005, NEUROSURGERY, V56, P494, DOI 10.1227/01.NEU.0000153750.95524.62
   Thomas AJ, 2015, NEUROSURGERY, V77, P380, DOI 10.1227/NEU.0000000000000829
   Tomsick SD, 2008, INTERV NEURORADIOL, V14, P191, DOI 10.1177/159101990801400211
   Zanaty M, 2014, NEUROSURG CLIN N AM, V25, P551, DOI 10.1016/j.nec.2014.04.011
NR 27
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 216
EP 219
DI 10.1016/j.wneu.2019.03.136
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300198
PM 30910749
DA 2020-05-12
ER

PT J
AU Cheng, C
   Wang, K
   Zhang, C
   Wu, H
   Jian, FZ
AF Cheng, Cheng
   Wang, Kai
   Zhang, Can
   Wu, Hao
   Jian, Feng-zeng
TI Spondylolisthesis with Uncommon Congenital Deformity of L4-L5 Vertebral
   Fusion Treated by Oblique Lumbar Interbody Fusion
SO WORLD NEUROSURGERY
LA English
DT Article
DE Deformity; Lateral approach; Oblique lumbar interbody fusion;
   Spondylolisthesis
ID COMPLICATIONS; SPINE
AB BACKGROUND: Diagnosis and management of congenital anomalies of the can be a challenge because of their complex presentations. We present an uncommon case of congenital deformity of the spine with L4-L5 vertebral fusion, mimicking a single vertebra, and 13 spondylolisthesis treated by oblique lumbar interbody fusion (OLIF).
   CASE DESCRIPTION: A 69-year-old woman presented with increasing lower -.A pain radiating to the left leg, with aggravation of symptoms for the past 6 months, causing difficulty in walking. She also complained of paresthesia along the 13-15 dermatomes in both legs, with more prominence on the left side. Imaging revealed fusion deformity of the L4-L5 vertebrae, as well as degenerative spondylolisthesis at the 13-14 level. After treatment with OLIF, the patient had an uneventful recovery period. Comparisons were made between the preoperative and 6-month follow-up visual analog scale and the Oswestry Disability Index scores. The patient showed significant improvement in the scores, as well as in her symptoms.
   CONCLUSIONS: OLIF is a promising technique that can be applied in the management of degenerative disk diseases and also for deformities that may be formidable to treat by adopting the traditional posterior approach.
C1 [Cheng, Cheng; Wang, Kai; Zhang, Can; Wu, Hao; Jian, Feng-zeng] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Cheng, Cheng] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 3, Beijing, Peoples R China.
RP Jian, FZ (reprint author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.
EM fengzengjian@hotmail.com
CR Abe K, 2017, SPINE, V42, P55, DOI 10.1097/BRS.0000000000001650
   Blizzard DJ, 2018, SPINE, V43, P440, DOI 10.1097/BRS.0000000000002330
   Chung NS, 2018, J ORTHOP SCI, V23, P918, DOI 10.1016/j.jos.2018.07.010
   Chung NS, 2017, EUR SPINE J, V26, P2797, DOI 10.1007/s00586-017-5176-6
   Davis TT, 2014, J NEUROSURG-SPINE, V21, P785, DOI 10.3171/2014.7.SPINE13564
   DiGiorgio AM, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.5.FOCUS17168
   DiGiorgio AMM, 2018, NEUROSURG CLIN N AM, V29, P419, DOI 10.1016/j.nec.2018.02.003
   Ekiz T, 2014, PM&R, V6, P855, DOI 10.1016/j.pmrj.2014.03.009
   Fujibayashi S, 2017, SPINE, V42, P1478, DOI 10.1097/BRS.0000000000002139
   Gressot LV, 2015, J NEUROSURG-PEDIATR, V15, P207, DOI 10.3171/2014.9.PEDS14151
   Kim KT, 2018, NEUROSURG REV, V41, P355, DOI 10.1007/s10143-017-0927-8
   Louie PK, 2018, SPINE J, V18, P2025, DOI 10.1016/j.spinee.2018.04.008
   Mehren C, 2016, CLIN ORTHOP RELAT R, V474, P2020, DOI 10.1007/s11999-016-4883-3
   Miscusi M, 2018, EUR SPINE J, V27, P222, DOI 10.1007/s00586-018-5596-y
   Naffaa L, 2017, J MED IMAG RADIAT ON, V61, P216, DOI 10.1111/1754-9485.12499
   Ohtori S, 2015, YONSEI MED J, V56, P1051, DOI 10.3349/ymj.2015.56.4.1051
   Orita Sumihisa, 2016, Eur J Orthop Surg Traumatol, V26, P685, DOI 10.1007/s00590-016-1806-7
   Pham MH, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.2.FocusVid.1693
   Quillo-Olvera J, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.01.22
   Samadian M, 2015, ARCH IRAN MED, V18, P861, DOI 0151812/AIM.0013
   Silvestre C, 2012, ASIAN SPINE J, V6, P89, DOI 10.4184/asj.2012.6.2.89
   Woods K, 2017, CUREUS, V9, DOI 10.7759/cureus.1980
   Zeng ZY, 2018, ORTHOP SURG, V10, P98, DOI 10.1111/os.12380
NR 23
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 222
EP 226
DI 10.1016/j.wneu.2019.04.021
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300200
PM 30974268
DA 2020-05-12
ER

PT J
AU Mohole, J
   Ho, AL
   Sussman, ES
   Pendharkar, AV
   Lee, M
AF Mohole, Jyodi
   Ho, Allen L.
   Sussman, Eric S.
   Pendharkar, Arjun V.
   Lee, Marco
TI Focal Intramedullary Spinal Cord Lesion in Human Immunodeficiency
   Virus/Acquired Immunodeficiency Syndrome: Toxoplasmosis Versus Lymphoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Acquired immunodeficiency syndrome (AIDS); Central nervous system
   lymphoma; Human immunodeficiency virus (HIV); Intramedullary lesion;
   Spinal cord lymphoma; Spinal cord toxoplasmosis; Toxoplasmosis
ID CENTRAL-NERVOUS-SYSTEM; PATIENT; DIAGNOSIS; AIDS
AB BACKGROUND: Neurologic complications are common in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). Although both the central nervous system (CNS) and the peripheral nervous system can be affected, 80% of patients with HIV/AIDS have CNS involvement during the course of their illness. The brain is the primary site of HIV/AIDS. associated CNS complications. Spinal cord involvement is rare, particularly focal intramedullary spinal cord lesions without any associated cerebral lesions. Among various opportunistic infections and malignancies, toxoplasmosis and CNS lymphoma are the most common causes of focal neurologic disease in patients with HIV/AIDS. Distinguishing between toxoplasmosis and CNS lymphoma is challenging, as the diseases have similar clinical presentations.
   CASE DESCRIPTION: In a woman with newly diagnosed HIV infection, myelopathy manifested as an isolated, single intramedullary spinal cord lesion.
   CONCLUSIONS: Common methods to distinguish the diagnoses of toxoplasmosis and CNS lymphoma are addressed. There should be a high index of suspicion for toxoplasmosis in patients with HIV/AIDS presenting with a focal intramedullary spinal cord lesion.
C1 [Mohole, Jyodi; Lee, Marco] Santa Clara Valley Med Ctr, Dept Neurosurg, San Jose, CA 95128 USA.
   [Ho, Allen L.; Sussman, Eric S.; Pendharkar, Arjun V.; Lee, Marco] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.
RP Lee, M (reprint author), Santa Clara Valley Med Ctr, Dept Neurosurg, San Jose, CA 95128 USA.; Lee, M (reprint author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.
EM marcolee@stanford.edu
CR Agrawal SR, 2014, J GLOB INFECT DIS, V6, P178, DOI 10.4103/0974-777X.145248
   Basavaraju Anuradha, 2016, Trop Parasitol, V6, P129
   Bastien Patrick, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS205, DOI 10.1016/S0035-9203(02)90078-7
   Collazos J, 2003, CNS DRUGS, V17, P869, DOI 10.2165/00023210-200317120-00002
   Corcoran C, 2008, J CLIN VIROL, V42, P433, DOI 10.1016/j.jcv.2008.03.017
   Dugova M, 2017, EUR C RAD MARCH 1 5
   Garcia-Garcia C, 2015, INFECT DIS-NOR, V47, P277, DOI 10.3109/00365548.2014.993421
   Garcia-Gubern C, 2010, INT J EMERG MED, V3, P439, DOI 10.1007/s12245-010-0207-7
   Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171
   Hussain FS, 2016, CUREUS, V8, DOI 10.7759/cureus.606
   Liu Q, 2015, INT J GRID DISTRIB, V8, P1
   Majmundar N, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.10.FOCUS18472
   Montoya JG, 2002, J INFECT DIS, V185, pS73, DOI 10.1086/338827
   PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306
   RESNICK DK, 1995, J NEUROSURG, V82, P493, DOI 10.3171/jns.1995.82.3.0493
   Rodriguez C, 2013, COLOMB MEDICA, V44, P232
   Sbeih I, 2016, INSIGHTS NEUROSURG, V1, P1
   Sidani C, 2013, NEUROGRAPHICS, V3, P203
   Skiest DJ, 2002, CLIN INFECT DIS, V34, P103, DOI 10.1086/324350
   Taila Aneta K, 2011, J Med Case Rep, V5, P16, DOI 10.1186/1752-1947-5-16
   van Twillert G, 2004, ANN ONCOL, V15, P1143, DOI 10.1093/annonc/mdh258
   Vyas R, 1996, CLIN INFECT DIS, V23, P1061, DOI 10.1093/clinids/23.5.1061
   Zhang K, 2016, CLIN CHIM ACTA, V461, P83, DOI 10.1016/j.cca.2016.07.018
NR 23
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 227
EP 231
DI 10.1016/j.wneu.2019.04.057
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300201
PM 30981796
DA 2020-05-12
ER

PT J
AU Shi, W
   Zhao, BQ
   Yao, JJ
   Zhou, Y
   Tong, MQ
   Jing, LK
   Wang, GH
AF Shi, Wei
   Zhao, Benqi
   Yao, Jingjing
   Zhou, Yang
   Tong, Mengqi
   Jing, Linkai
   Wang, Guihuai
TI Intramedullary Spinal Cord Ganglioglioma Presenting as Hyperhidrosis: A
   Rare Case Report and Literature Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE Fluorescein; Ganglioglioma; Hyperhidrosis; Intramedullary spinal cord
   tumor
AB BACKGROUND: Hyperhidrosis is caused by sympathetic dysfunction of the central or peripheral nervous system. However, intramedullary spinal cord tumors presenting with hyperhidrosis as an initial symptom have been rarely reported in the literature.
   CASE DESCRIPTION: This case involves an 18-year-old man who presented with abnormal enhanced sweating and flushing on the bilateral side of his face and neck that had persisted for 6 years. Magnetic resonance (MR) images revealed that at the C7-T2 levels of the spinal cord, a large intramedullary tumor was involved in the cervicothoracic region. The patient underwent gross total resection of the tumor via the fluorescein-guided technique and intraoperative neurophysiologic monitoring. The histopathologic diagnosis revealed ganglioglioma. The symptoms gradually improved after surgery, and the patient presented with virtually complete remission at the end of an 18-month follow-up.
   CONCLUSIONS: Few cases of intramedullary spinal cord tumors presenting as hyperhidrosis in clinical manifestation have been reported in the literature. Sympathetic irritation by the tumor, particularly in the location around the gray matter of the lateral spinal cord, may account for the hyperhidrosis as the initial symptom in this patient. Therefore, if a patient has autonomic dysfunction, the spine cord should be additionally examined using MR imaging.
C1 [Shi, Wei; Jing, Linkai; Wang, Guihuai] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Neurosurg, Beijing, Peoples R China.
   [Zhao, Benqi] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Radiol, Beijing, Peoples R China.
   [Yao, Jingjing] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Pathol, Beijing, Peoples R China.
   [Zhou, Yang] Gen Navy Hosp PLA, Dept Pathol, Beijing, Peoples R China.
   [Tong, Mengqi] Beijing Jishuitan Hosp, Dept Intens Care Unit, Beijing, Peoples R China.
RP Wang, GH (reprint author), Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Neurosurg, Beijing, Peoples R China.
EM wyvern1230@163.com
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81472817]
FX This work was supported by the Natural Science Foundation of China
   (81472817).
CR Chamoun RB, 2006, ACTA NEUROCHIR, V148, P175, DOI 10.1007/s00701-005-0694-0
   Chatterjee S, 2004, NEUROL INDIA, V52, P390
   DEMIERRE B, 1986, J NEUROSURG, V65, P177, DOI 10.3171/jns.1986.65.2.0177
   Faruqi S, 2004, AGE AGEING, V33, P514, DOI 10.1093/ageing/afh179
   Glaser DA, 2007, CUTIS, V79, P5
   Haddadi K, 2016, INT J SURG CASE REP, V19, P100, DOI 10.1016/j.ijscr.2015.12.034
   Hamburger C, 1997, NEUROSURGERY, V41, P1410, DOI 10.1097/00006123-199712000-00038
   Hornberger J, 2004, J AM ACAD DERMATOL, V51, P274, DOI 10.1016/j.jaad.2003.12.029
   Jacob JT, 2005, NEUROSURG REV, V28, P326, DOI 10.1007/s10143-005-0383-8
   KEWALRAMANI LS, 1980, AM J PHYS MED REHAB, V59, P1
   Kilincer C, 2007, SURG NEUROL, V68, P461, DOI 10.1016/j.surneu.2006.10.067
   MICKLE JP, 1992, PEDIATR NEUROSURG, V18, P310
   Miller DC, 2000, J NEURO-ONCOL, V47, P189, DOI 10.1023/A:1006496204396
   Murakami T, 2013, J NEUROSURG-SPINE, V18, P184, DOI 10.3171/2012.11.SPINE12530
   NATHAN PW, 1987, J NEUROL NEUROSUR PS, V50, P1253, DOI 10.1136/jnnp.50.10.1253
   Oppenheimer DC, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166355
   PICK J, 1946, J ANAT, V80, P12
   Schebesch KM, 2013, ACTA NEUROCHIR, V155, P693, DOI 10.1007/s00701-013-1643-y
   Smith CD, 2001, NEUROLOGY, V56, P1394, DOI 10.1212/WNL.56.10.1394
   SMITH NM, 1992, CHILD NERV SYST, V8, P258, DOI 10.1007/BF00300792
   SUDOU K, 1993, J NEUROL, V240, P75, DOI 10.1007/BF00858720
   VENTUREYRA E, 1986, CHILD NERV SYST, V2, P63
   Walling HW, 2011, J AM ACAD DERMATOL, V64, P690, DOI 10.1016/j.jaad.2010.03.013
NR 23
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 232
EP 236
DI 10.1016/j.wneu.2019.03.115
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300202
PM 30904797
DA 2020-05-12
ER

PT J
AU George, R
   Ahmad, S
   Ngqandu, MD
AF George, Roshan
   Ahmad, Samia
   Ngqandu, Makhosonke Duke
TI Coil Embolization of the Internal Carotid Artery in Patient with
   Retained Transcranial Knife
SO WORLD NEUROSURGERY
LA English
DT Article
DE Carotid artery; Endovascular treatment; Retained knife; Vascular injury
AB BACKGROUND: We describe endovascular coil embolization of the internal carotid artery before removing a retained knife blade partially occluding the lacerum segment of the internal carotid artery.
   CASE DESCRIPTION: A 21-year-old male presented to the emergency department with a retained transcranial knife after sustaining a stab to the left temporal scalp. He was hemodynamically stable and neurologically intact on presentation. Computed tomography angiography followed by digital subtraction angiography revealed narrowing of the lacerum segment of the left internal carotid artery by the tip of the knife blade with adequate blood flow from the contralateral internal carotid artery. Embolization and occlusion of the internal carotid artery proximal and distal to the knife tip were performed. The patient was transferred to the neurosurgical operating room for extraction of the knife. A repeat left carotid artery angiogram post knife extraction showed no displacement of the coils and no extravasation of contrast. Follow-up imaging confirmed a good outcome.
   CONCLUSIONS: A staged approach of digital subtraction angiography and endovascular therapy followed by surgical treatment is a safe and effective management strategy for patients presenting with a retained transcranial knife and suspected vascular injury.
C1 [George, Roshan; Ahmad, Samia] Univ Pretoria, Steve Biko Acad Hosp, Fac Hlth Sci, Dept Radiol, Pretoria, South Africa.
   [Ngqandu, Makhosonke Duke] Univ Pretoria, Steve Biko Acad Hosp, Fac Hlth Sci, Dept Neurosurg, Pretoria, South Africa.
RP George, R (reprint author), Univ Pretoria, Steve Biko Acad Hosp, Fac Hlth Sci, Dept Radiol, Pretoria, South Africa.
EM roshangeorge6@gmail.com
OI George, Roshan/0000-0002-8629-6986
CR Karanja SW, 2017, SA J RADIOL, V21, DOI 10.4102/sajr.v21i1.1197
   Kodadek LM, 2015, OPER NEUROSURG, V11, pE372, DOI 10.1227/NEU.0000000000000691
   Nguyen HS, 2016, WORLD NEUROSURG, V96, pe1
   Riley JP, 2017, WORLD NEUROSURG, V97, DOI 10.1016/j.wneu.2016.09.083
   Senova S, 2017, CLIN NEURORADIOL, V27, P115, DOI 10.1007/s00062-016-0526-z
   Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512
   Zyck S, 2016, WORLD NEUROSURG, V91, P297, DOI 10.1016/j.wneu.2016.04.012
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 237
EP 240
DI 10.1016/j.wneu.2019.04.018
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300203
PM 30965173
DA 2020-05-12
ER

PT J
AU Zavatto, L
   Marrone, F
   Allevi, M
   Ricci, A
   Taddei, G
AF Zavatto, Luca
   Marrone, Federica
   Allevi, Mario
   Ricci, Alessandro
   Taddei, Graziano
TI Bilateral Oculomotor Palsy After Surgical Evacuation of Chronic Subdural
   Hematoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Brainstem hemorrhage; Burr hole evacuation; Chronic subdural hematoma;
   Postoperative hemorrhage; Remote hemorrhage
ID BURR-HOLE EVACUATION; CEREBELLAR HEMORRHAGE; BRAIN; DRAINAGE;
   COMPLICATIONS
AB BACKGROUND: Chronic subdural hematoma is a common neurosurgical disease and the most benign form of intracranial hematoma. Most patients are successfully treated with simple burr hole evacuation and external drainage with good outcome and low rate of complications. Brainstem hemorrhage is a rare cause of severe disability in these patients, and cannot be ignored.
   CASE DESCRIPTION: We report the first case of bilateral oculomotor palsy to a midbrain hemorrhage after evacuation of a unilateral chronic subdural hematoma. The relevant literature is also reviewed to better understand the causes of this rare but disabling occurrence and how it can be prevented during and after surgery.
   CONCLUSIONS: Neurosurgeons must have awareness of remote intracerebral hemorrhage after burr hole evacuation of chronic subdural hematoma, and take measures to avoid it during surgery. Our experience and the review of the relevant literature demonstrate that preoperative computed tomography can provide information to identify the patients at major risk.
C1 [Zavatto, Luca; Marrone, Federica; Allevi, Mario; Ricci, Alessandro; Taddei, Graziano] San Salvatore Hosp, Dept Neurosurg, Laquila, Italy.
   [Zavatto, Luca; Marrone, Federica; Allevi, Mario] Univ LAquila, Dept Life Hlth & Environm Sci MESVA, Laquila, Italy.
RP Taddei, G (reprint author), San Salvatore Hosp, Dept Neurosurg, Laquila, Italy.
EM gr.taddei@gmail.com
OI Taddei, Graziano/0000-0002-8395-244X
CR Akhaddar A, 2008, NEUROCHIRURGIE, V54, P728, DOI 10.1016/j.neuchi.2008.09.001
   BROWDER J, 1951, ANN SURG, V134, P369, DOI 10.1097/00000658-195113430-00008
   Cohen-Gadol AA, 2013, INT J SURG CASE REP, V4, P834, DOI 10.1016/j.ijscr.2013.06.014
   DAVELLA D, 1986, J NEUROSURG, V65, P710, DOI 10.3171/jns.1986.65.5.0710
   Dinc C, 2008, ACTA NEUROCHIR, V150, P497, DOI 10.1007/s00701-008-1512-2
   Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015
   Hyam JA, 2007, J CLIN NEUROSCI, V14, P83, DOI 10.1016/j.jocn.2005.12.048
   Kim CH, 2017, INT J NUMBER THEORY, V13, P1443, DOI 10.1142/S1793042117500804
   KLINTWOR.GK, 1965, AM J PATHOL, V47, P525
   Liang CL, 2001, INJURY, V32, P499, DOI 10.1016/S0020-1383(01)00031-6
   MCKISSOCK W, 1960, LANCET, V1, P1365
   Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371
   Ogasawara K, 2000, SURG NEUROL, V54, P155, DOI 10.1016/S0090-3019(00)00281-0
   Ogasawara K, 1999, NEUROSURGERY, V45, P484, DOI 10.1097/00006123-199909000-00014
   Okuchi K, 1999, NEUROL MED-CHIR, V39, P367, DOI 10.2176/nmc.39.367
   Panourias IG, 2006, CLIN NEUROL NEUROSUR, V108, P396, DOI 10.1016/j.clineuro.2004.12.014
   Park KJ, 2009, NEUROL MED-CHIR, V49, P594, DOI 10.2176/nmc.49.594
   ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263
   Rusconi A, 2015, J KOREAN NEUROSURG S, V57, P379, DOI 10.3340/jkns.2015.57.5.379
   Sacchetti DC, 2017, J CLIN NEUROSCI, V39, P4, DOI 10.1016/j.jocn.2017.02.054
   Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845
   Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6
   Sturiale CL, 2016, NEUROSURG REV, V39, P565, DOI 10.1007/s10143-015-0691-6
   TANAKA A, 1990, NEUROSURGERY, V27, P554, DOI 10.1227/00006123-199010000-00009
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 241
EP 244
DI 10.1016/j.wneu.2019.04.043
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300204
PM 30980981
DA 2020-05-12
ER

PT J
AU Ghorbani, M
   Wipplinger, C
   Griessenauer, CJ
   Hejazian, SE
   Abadi, FZ
   Asaadi, S
AF Ghorbani, Mohammad
   Wipplinger, Christoph
   Griessenauer, Christoph J.
   Hejazian, Seyed Ebrahim
   Abadi, Fatemeh Zangi
   Asaadi, Sina
TI Pial Arteriovenous Fistula with Multiple Venous Aneurysms Resembling a
   Vein of Galen Aneurysmal Malformation; Case Report and Review of
   Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE Aneurysmal malformations; Pial arteriovenous fistula; Vein of Galen
AB BACKGROUND: Pial arteriovenous fistulas are abnormal vascular connections between arteries and the cranial venous system on the surface of the brain in the pia mater. In contrast to vein of Galen aneurysmal malformations, they lack a true vascular nidus and may only indirectly involve the vein of Galen.
   CASE DESCRIPTION: An 18-month-old boy was referred to us with a history of seizures, drowsiness, bulging cephalic veins, and cranial nerves palsy identified as vein of Galen aneurysmal malformation according to initial magnetic resonance imaging. Digital subtraction angiography showed a vertebrobasilar junction pial high-flow fistula between the basilar artery and anterior pontomesencephalic vein, causing retrograde flow, dilation, and tortuosity of the lateral and posterior mesencephalic vein as well as the vein of Galen. Endovascular treatment, including coil embolization of fistula site, was done successfully without complication resulting in recovery from previous symptoms and signs.
   CONCLUSIONS: If cerebral venous dilations are encountered, one must keep in mind that the location of the fistula may not be in close proximity to the dilated veins, especially when there is a suspicion for vein of Galen aneurysmal malformation. Other pathologies, such as pial arteriovenous fistula, in a region away from the site of the vein of Galen must be considered.
C1 [Ghorbani, Mohammad; Hejazian, Seyed Ebrahim; Abadi, Fatemeh Zangi; Asaadi, Sina] Iran Univ Med Sci, Firoozgar Hosp, Div Vasc & Endovasc Neurosurg, Tehran, Iran.
   [Wipplinger, Christoph] Weill Cornell Med, Dept Neurol Surg, New York, NY USA.
   [Griessenauer, Christoph J.] Geisinger Med Ctr, Dept Neurosurg, Danville, PA 17822 USA.
   [Griessenauer, Christoph J.] Paracelsus Med Univ, Res Inst Neurointervent, Salzburg, Austria.
   [Asaadi, Sina] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran.
RP Asaadi, S (reprint author), Iran Univ Med Sci, Firoozgar Hosp, Div Vasc & Endovasc Neurosurg, Tehran, Iran.; Asaadi, S (reprint author), Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran.
EM s.asaadi90@gmail.com
OI Griessenauer, Christoph/0000-0002-2952-3812
CR Alvarez H, 2007, NEUROIMAG CLIN N AM, V17, P189, DOI 10.1016/j.nic.2007.02.005
   Chotai S, 2016, PEDIAT VASCULAR NE 1, P1
   du Toit J, 2009, SA J RADIOL, V13, pa534
   Garg M, 2018, WORLD NEUROSURG, V116, pE624, DOI 10.1016/j.wneu.2018.05.056
   Geibprasert S, 2010, RADIOGRAPHICS, V30, P483, DOI 10.1148/rg.302095728
   Han L, 2013, ACTA NEUROCHIR, V155, P1571, DOI 10.1007/s00701-013-1731-z
   Hetts SW, 2012, AM J NEURORADIOL, V33, P1710, DOI 10.3174/ajnr.A3194
   Hoh BL, 2001, NEUROSURGERY, V49, P1351, DOI 10.1097/00006123-200112000-00011
   Howarth RA, 2015, J NEUROSURG-PEDIATR, V15, P197, DOI 10.3171/2014.10.PEDS14244
   Iizuka Y, 2007, NEURORADIOL J, V20, P551, DOI 10.1177/197140090702000513
   Iizuka Y, 2008, NEURORADIOL J, V21, P57, DOI 10.1177/197140090802100107
   Kakino S, 2008, SURG NEUROL, V69, P187, DOI 10.1016/j.surneu.2006.11.069
   Komiyama M, 2001, INTERV NEURORADIOL, V7, P99, DOI 10.1177/15910199010070S114
   Koroglu Mert, 2006, Diagn Interv Radiol, V12, P64
   LASJAUNIAS P, 1987, AM J NEURORADIOL, V8, P185
   Lasjaunias P., 1997, VASCULAR DIS NEONATE, P67
   Mortazavi MM, 2013, J NEUROSURG-PEDIATR, V12, P293, DOI 10.3171/2013.5.PEDS12587
   Tawk RG, 2002, ACTA NEUROCHIR, V144, P1225, DOI 10.1007/s00701-002-1007-5
   Wagner MW, 2015, NEURORADIOL J, V28, P72, DOI 10.15274/NRJ-2014-10106
   Weon YC, 2005, ACTA NEUROCHIR, V147, P17, DOI 10.1007/s00701-004-0341-1
NR 20
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 245
EP 248
DI 10.1016/j.wneu.2019.04.061
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300205
PM 30981801
DA 2020-05-12
ER

PT J
AU Park, HY
   Kim, YH
   Ha, KY
   Kim, SI
   Rhyu, KW
   Oh, JH
   Jung, CK
AF Park, Hyung-Youl
   Kim, Young-Hoon
   Ha, Kee-Yong
   Kim, Sang-Il
   Rhyu, Kee-Won
   Oh, Joon-Hyuck
   Jung, Chan-Kwon
TI Extrusion of Biocompatible Osteoconductive Polymer (BOP) Causing
   Cervical Myelopathy
SO WORLD NEUROSURGERY
LA English
DT Article
DE Polymethylmethacrylate-N-vinylpyrrolidone; Reoperation; Spinal cord
   compression; Spinal fusion
ID GRAFT; COMPLICATION; SURGERY
AB BACKGROUND: As the prevalence of spinal fusion surgery has increased, reliable and safe bone graft substitutes have been developed in response. Biocompatible osteoconductive polymer (BOP) has been used as a bone graft alternative for spine surgery. We present a case of cervical myelopathy due to extrusion of BOP 23 years after surgery and discuss the pathophysiology in terms of spinal fusion.
   CASE DESCRIPTION: A 65-year-old man presented with a 3-month history of cervical myelopathic symptoms. Twenty-three years earlier, the patient had undergone cervical surgery for a C6-7 herniated disc with the use of BOP. Imaging studies of the cervical spine showed cord compression due to extruded BOP at C6-7. He underwent corpectomy of the C7 vertebral body and removal of the BOP for the neural decompression, combined with interbody fusion by use of an iliac bone graft and plate fixation. During the operation, crumbly fibers of the BOP were easily removed. His myelopathic symptoms improved immediately after surgery. Postoperative magnetic resonance imaging also showed successful decompression of the spinal cord. Histologically, a foreign body reaction and bony degeneration were found around the synthetic fibers of the BOP.
   CONCLUSIONS: Spine surgeons should recognize the pathophysiology of the BOP used for spine fusion surgery. Although BOP is not currently used for spinal surgery, patients undergoing previous surgery with the BOP can present with related complications. Revision surgery is recommended to remove the unincorporated BOP and achieve solid spine fusion.
C1 [Park, Hyung-Youl] Eunpyeong St Marys Hosp, Dept Orthoped Surg, Seoul, South Korea.
   [Kim, Young-Hoon; Ha, Kee-Yong; Kim, Sang-Il] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Jung, Chan-Kwon] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hosp Pathol, Seoul, South Korea.
   [Rhyu, Kee-Won; Oh, Joon-Hyuck] Catholic Univ Korea, St Vincent Hosp, Dept Orthoped Surg, Coll Med, Suwon, South Korea.
RP Kim, YH (reprint author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
EM boscoa@catholic.ac.kr
OI Kim, Young-Hoon/0000-0003-1237-4600; Park,
   Hyung-Youl/0000-0002-0084-8867
FU Small Grant for Exploratory Research (SGER) through the Ministry of
   Education of the Republic of Korea; Catholic University of Korea Songeui
   [NRF2018R1D1A1A02049202]
FX This work was supported by Small Grant for Exploratory Research (SGER)
   through the Ministry of Education of the Republic of Korea and The
   Catholic University of Korea Songeui (NRF2018R1D1A1A02049202).
CR AbouMadawi A, 1996, SPINE, V21, P2123, DOI 10.1097/00007632-199609150-00013
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037
   Buron F., 1994, Clinical Materials, V16, P217, DOI 10.1016/0267-6605(94)90120-1
   Dimar JR, 2009, SPINE J, V9, P880, DOI 10.1016/j.spinee.2009.03.013
   Dorward NL, 1997, BRIT J NEUROSURG, V11, P65
   Fischer CR, 2013, EUR SPINE J, V22, P1423, DOI 10.1007/s00586-013-2718-4
   Hafez RF, 1997, BRIT J NEUROSURG, V11, P57
   Hynes JE, 1997, AM J NEURORADIOL, V18, P792
   Ibanez J, 1998, ACTA NEUROCHIR, V140, P126, DOI 10.1007/s007010050073
   Kaliya-Perumal AK, 2018, CLIN ORTHOP SURG, V10, P210, DOI 10.4055/cios.2018.10.2.210
   Kim YH, 2017, CLIN ORTHOP SURG, V9, P1, DOI 10.4055/cios.2017.9.1.1
   Lin TJ, 2003, J CLIN NEUROSCI, V10, P629, DOI 10.1016/S0967-5868(03)00162-0
   LOZES G, 1990, ACTA NEUROCHIR, V102, P42, DOI 10.1007/BF01402185
   LOZES G, 1989, ACTA NEUROCHIR, V96, P88, DOI 10.1007/BF01456164
   LUSSIER B, 1994, CAN J VET RES, V58, P173
   Madawi A A, 1996, SPINE, V21, P2129
   McLorinan GC, 2001, BRIT J NEUROSURG, V15, P363
   ORTOLANI E, 1991, J INT MED RES, V19, P237, DOI 10.1177/030006059101900310
   SKONDIA V, 1987, J INT MED RES, V15, P293
   TREVOR PB, 1992, J AM VET MED ASSOC, V200, P1651
   Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe
NR 21
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 249
EP 252
DI 10.1016/j.wneu.2019.04.033
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300206
PM 30980972
DA 2020-05-12
ER

PT J
AU Sorenson, TJ
   Brinjikji, W
   Lanzino, G
AF Sorenson, Thomas J.
   Brinjikji, Waleed
   Lanzino, Giuseppe
TI Interval Thrombosis of Arteriovenous Malformation Draining Vein After
   Stereotactic Radiosurgery
SO WORLD NEUROSURGERY
LA English
DT Article
DE Arteriovenous malformation; Catheter angiography; Gamma knife;
   Stereotactic radiosurgery; Venous thrombosis
AB Arteriovenous malformations (AVMs) are high-pressure vascular lesions that can present formidable therapeutic challenges. One treatment option for these lesions is stereotactic radiosurgery, which may be used to provoke progressive thrombosis of the draining veins and subsequent obliteration of the AVM nidus. In this clinical image, we successfully demonstrate this therapeutic modality with the case of a 26-year-old man with a large frontal AVM, treated with stereotactic radiosurgery.
C1 [Sorenson, Thomas J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.
   [Sorenson, Thomas J.; Lanzino, Giuseppe] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.
   [Brinjikji, Waleed; Lanzino, Giuseppe] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA.
RP Lanzino, G (reprint author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.; Lanzino, G (reprint author), Mayo Clin, Dept Radiol, Rochester, MN 55905 USA.
EM Lanzino.giuspeppe@mayo.edu
CR Pollock BE, 2000, NEUROSURGERY, V47, P1178, DOI 10.1097/00006123-200011000-00033
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 253
EP 254
DI 10.1016/j.wneu.2019.03.017
PG 2
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300207
PM 30862599
DA 2020-05-12
ER

PT J
AU Luzzi, S
   Elia, A
   Del Maestro, M
   Elbabaa, SK
   Carnevale, S
   Guerrini, F
   Caulo, M
   Morbini, P
   Galzio, R
AF Luzzi, Sabino
   Elia, Angela
   Del Maestro, Mattia
   Elbabaa, Samer K.
   Carnevale, Sergio
   Guerrini, Francesco
   Caulo, Massimo
   Morbini, Patrizia
   Galzio, Renato
TI Dysembryoplastic Neuroepithelial Tumors: What You Need to Know
SO WORLD NEUROSURGERY
LA English
DT Review
DE BRAF; Brain neoplasm; Diffusion-weighted MRI; DNET; Drug-resistant
   epilepsy; MR spectroscopy; Neuroepithelial tumor
ID PROTON MR SPECTROSCOPY; MALIGNANT-TRANSFORMATION; GENETIC ALTERATIONS;
   BRAIN-TUMORS; EPILEPSY; CHILDREN; FEATURES; SURGERY; DIFFUSION; SEIZURES
AB OBJECTIVE: An updated and comprehensive review on dysembryoplastic neuroepithelial tumor (DNET) focusing on differential diagnosis, atypical presentation, seizure outcome, and risk of malignant transformation.
   METHODS: A PubMed/MEDLINE-based literature search has been performed using "dysembryoplastic neuroepithelial tumor" as a keyword. Two treated cases characterized by an atypical presentation have been reviewed.
   RESULTS: Of 1162 articles, 200 relevant studies have been selected. DNET is a benign mixed neuronal-glial tumor causing drug-resistant epilepsy primarily in children and young adults. The typical radiological pattern is a magnetic resonance imaging (MRI) T1-hypointense, T2-, and fluid-attenuated inversion-recovery hyperintense multicystic lesion involving the cerebral cortex with no edema. Contrast enhancement may be present and a focal cortical dysplasia is commonly associated with it. MRI diffusion, perfusion, and spectroscopy have a paramount role in the differential diagnosis. The "specific glioneuronal elements" are pathognomonic. They are positive for S100 protein, synaptofisin, neuronal nuclei, oligodendrocyte transcription factor, neurite outgrowth inhibitor, and microtubule-associated protein 2, but negative for glial fibrillary acidic protein. As opposed to v-myb avian myeloblastosis viral oncogene homolog, isocitrate dehydrogenase-1/isocitrate dehydrogenase-2 mutation and codeletion 1p-19q, fibroblast growth factor receptor 1 and BRAF V600E mutations are present. The effectiveness of surgery on seizure outcome has been established. Rare malignant transformations have been reported, especially in extra-temporal and complex forms.
   CONCLUSIONS: Advanced MRI techniques are fundamental in the differential diagnosis for DNET versus other low-grade gliomas. Immuno-phenotype assessment and search for fibroblast growth factor receptor 1 and BRAF V600E mutations limit the risk of misdiagnoses. A gross total tumor removal is generally associated with a seizure-free outcome. Recurrences and malignant transformations may rarely follow, legitimizing MRI surveillance in cases of subtotal tumor resection.
C1 [Luzzi, Sabino; Elia, Angela; Guerrini, Francesco; Galzio, Renato] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Neurosurg Unit, Pavia, Italy.
   [Del Maestro, Mattia] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, PhD Sch Expt Med, Pavia, Italy.
   [Carnevale, Sergio; Morbini, Patrizia] Univ Pavia, Dept Mol Med, Unit Pathol Anat, Pavia, Italy.
   [Luzzi, Sabino; Del Maestro, Mattia; Galzio, Renato] Fdn IRCCS Policlin San Matteo, Dept Surg Sci, Neurosurg Unit, Pavia, Italy.
   [Luzzi, Sabino] Univ Bari Aldo Moro, DEOT, Bari, Italy.
   [Caulo, Massimo] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.
   [Elbabaa, Samer K.] Arnold Palmer Hosp Children, Pediat Neurosurg Dept, Pediat Neurosci Ctr Excellence, Orlando, FL USA.
RP Luzzi, S (reprint author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Neurosurg Unit, Pavia, Italy.; Luzzi, S (reprint author), Fdn IRCCS Policlin San Matteo, Dept Surg Sci, Neurosurg Unit, Pavia, Italy.; Luzzi, S (reprint author), Univ Bari Aldo Moro, DEOT, Bari, Italy.
EM sabino.luzzi@unipv.it
RI morbini, patrizia/AAC-2658-2019
OI morbini, patrizia/0000-0001-5012-5790; Carnevale,
   Sergio/0000-0002-9679-4540; Luzzi, Sabino/0000-0002-1381-8528
CR Abdel-Aal AK, 2012, J RADIOL CASE REP, V6, P8, DOI 10.3941/jrcr.v6i8.999
   Aggarwal A, 2014, NEUROL INDIA, V62, P323, DOI 10.4103/0028-3886.137011
   Aoki T, 2002, INT J ONCOL, V21, P629
   Aronica E, 2005, NEUROPATH APPL NEURO, V31, P280, DOI 10.1111/j.1365-2990.2004.00636.x
   Auguste P, 2001, CANCER RES, V61, P1717
   Baisden BL, 2001, AM J SURG PATHOL, V25, P494, DOI 10.1097/00000478-200104000-00009
   Bilginer B, 2009, CHILD NERV SYST, V25, P485, DOI 10.1007/s00381-008-0762-x
   Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x
   Blumcke I, 2014, ACTA NEUROPATHOL, V128, P39, DOI 10.1007/s00401-014-1288-9
   Bonney PA, 2016, J NEURO-ONCOL, V126, P1, DOI 10.1007/s11060-015-1961-4
   Braoudaki M, 2016, MED ONCOL, V33, DOI 10.1007/s12032-015-0719-3
   Bulakbasi N, 2003, AM J NEURORADIOL, V24, P225
   Bulakbasi N, 2007, NEURORADIOLOGY, V49, P805, DOI 10.1007/s00234-007-0263-8
   Burneo JG, 2008, SEIZURE-EUR J EPILEP, V17, P498, DOI 10.1016/j.seizure.2008.01.006
   Campos AR, 2009, NEURORADIOLOGY, V51, P433, DOI 10.1007/s00234-009-0511-1
   Cataltepe O, 2009, J NEUROSURG-PEDIATR, V3, P456, DOI 10.3171/2009.1.PEDS0823
   CerveraPierot P, 1997, NEUROSURGERY, V40, P1065, DOI 10.1097/00006123-199705000-00035
   Chan CH, 2006, J NEUROSURG, V104, P62, DOI 10.3171/jns.2006.104.1.62
   Chang EF, 2010, J NEUROSURG-PEDIATR, V5, P123, DOI 10.3171/2009.8.PEDS09368
   Chappe C, 2013, BRAIN PATHOL, V23, P574, DOI 10.1111/bpa.12048
   Chassoux F, 2013, EPILEPSIA, V54, P129, DOI 10.1111/epi.12457
   Chuang NA, 2014, J PEDIAT HEMATOL ONC, V36, pE536, DOI 10.1097/MPH.0000000000000063
   Cosson RS, 2001, J NEURORADIOLOGY, V28, P230
   Daghistani R, 2013, NEURORADIOLOGY, V55, P217, DOI 10.1007/s00234-013-1135-z
   DAUMASDUPORT C, 1988, NEUROSURGERY, V23, P545, DOI 10.1227/00006123-198811000-00002
   De Tommasi A, 2008, NEUROSURGERY, V63, P976, DOI 10.1227/01.NEU.0000327699.93146.CD
   De Tommasi Antonio, 2007, World J Surg Oncol, V5, P72, DOI 10.1186/1477-7819-5-72
   Degen R, 2002, EPILEPSIA, V43, P1379, DOI 10.1046/j.1528-1157.2002.15201.x
   Dehcordi SR, 2017, WORLD NEUROSURG, V105, P895, DOI 10.1016/j.wneu.2017.05.099
   Devaux B, 2017, NEUROCHIRURGIE, V63, P227, DOI 10.1016/j.neuchi.2016.10.009
   Dozza DC, 2012, ARQ NEURO-PSIQUIAT, V70, P710, DOI 10.1590/S0004-282X2012000900012
   Engel Jr J., 1993, SURG TREATMENT EPILE, P609
   Eye PG, 2017, J NEUROL SCI, V373, P280, DOI 10.1016/j.jns.2016.11.003
   Fernandez C, 2003, AM J NEURORADIOL, V24, P829
   Fujimoto K, 2000, J NEUROSURG, V93, P487, DOI 10.3171/jns.2000.93.3.0487
   Gonzales M, 2007, NEUROPATHOLOGY, V27, P324, DOI 10.1111/j.1440-1789.2007.00783.x
   Guesmi H, 1999, NEUROCHIRURGIE, V45, P190
   Nguyen HS, 2017, WORLD NEUROSURG, V103, P380, DOI 10.1016/j.wneu.2017.04.093
   Hammond RR, 2000, J NEUROSURG, V92, P722, DOI 10.3171/jns.2000.92.4.0722
   Harter DH, 2006, PEDIATR NEUROSURG, V42, P105, DOI 10.1159/000090464
   Heiland DH, 2016, J NEUROPATH EXP NEUR, V75, P358, DOI 10.1093/jnen/nlw007
   Honavar M, 1999, HISTOPATHOLOGY, V34, P342
   Jensen RL, 2006, J NEURO-ONCOL, V78, P59, DOI 10.1007/s11060-005-9054-4
   Kakkar A, 2016, EPILEPSY RES, V127, P141, DOI 10.1016/j.eplepsyres.2016.08.028
   Krossnes BK, 2005, NEUROPATH APPL NEURO, V31, P556, DOI 10.1111/j.1365-2990.2005.00680.x
   KUCHELMEISTER K, 1995, ACTA NEUROPATHOL, V89, P385
   KUROIWA T, 1995, RADIOLOGY, V197, P233, DOI 10.1148/radiology.197.1.7568829
   Kurtkaya-Yapicier Ozlem, 2002, Brain Tumor Pathol, V19, P97, DOI 10.1007/BF02478934
   Lee J, 2009, BRAIN DEV-JPN, V31, P671, DOI 10.1016/j.braindev.2008.10.002
   LELLOUCHTUBIANA A, 1995, ACTA NEUROPATHOL, V90, P319
   Liao JM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010755
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   MCCLELLAND GA, 1991, PHARMACEUT RES, V8, P873, DOI 10.1023/A:1015899328105
   Moazzam AA, 2014, NEUROREPORT, V25, P894, DOI 10.1097/WNR.0000000000000184
   Nadi M, 2016, PEDIATR NEUROSURG, V51, P191, DOI 10.1159/000443405
   Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048
   Nolan MA, 2004, NEUROLOGY, V62, P2270, DOI 10.1212/01.WNL.0000130495.69512.6F
   Ostertun B, 1996, AM J NEURORADIOL, V17, P419
   Palumbo P., 2018, INT J MOL SCI, V19
   Parmar HA, 2007, J COMPUT ASSIST TOMO, V31, P348, DOI 10.1097/01.rct.0000243453.33610.9d
   Pasquier B, 2002, EPILEPTIC DISORD, V4, P99
   Paudel K, 2013, J RADIOL CASE REP, V7, P7, DOI 10.3941/jrcr.v7i11.1559
   Pekmezci M, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0551-z
   Piao YS, 2010, BRAIN PATHOL, V20, P902, DOI 10.1111/j.1750-3639.2010.00386.x
   Prabowo AS, 2015, NEUROPATH APPL NEURO, V41, P743, DOI 10.1111/nan.12235
   Prabowo AS, 2014, BRAIN PATHOL, V24, P52, DOI 10.1111/bpa.12081
   Qaddoumi I, 2016, ACTA NEUROPATHOL, V131, P833, DOI 10.1007/s00401-016-1539-z
   Ranger A, 2015, CHILD NERV SYST, V31, P847, DOI 10.1007/s00381-015-2675-9
   Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003
   Ray WZ, 2009, J NEURO-ONCOL, V94, P283, DOI 10.1007/s11060-009-9849-9
   RAYMOND AA, 1994, BRAIN, V117, P461, DOI 10.1093/brain/117.3.461
   Rivera B, 2016, ACTA NEUROPATHOL, V131, P847, DOI 10.1007/s00401-016-1549-x
   Rosemberg S, 1998, ARQ NEURO-PSIQUIAT, V56, P232, DOI 10.1590/S0004-282X1998000200011
   Rushing Elisabeth J, 2003, Ann Diagn Pathol, V7, P240, DOI 10.1016/S1092-9134(03)00070-4
   Sakuta R, 2005, J CHILD NEUROL, V20, P377, DOI 10.1177/08830738050200041801
   Sandberg David I, 2005, Neurosurg Focus, V18, pE5
   Schittenhelm J, 2007, NEUROPATHOLOGY, V27, P383, DOI 10.1111/j.1440-1789.2007.00780.x
   Sontowska I, 2017, FOLIA NEUROPATHOL, V55, P1, DOI 10.5114/fn.2017.66708
   Soria JC, 2014, ANN ONCOL, V25, P2244, DOI 10.1093/annonc/mdu390
   Stark J, 2018, EPILEPSIA, V59, pE14, DOI 10.1111/epi.13970
   Suh YL, 2015, J PATHOL TRANSL MED, V49, P438, DOI 10.4132/jptm.2015.10.05
   Sukheeja Deepti, 2016, Asian J Neurosurg, V11, P174, DOI 10.4103/1793-5482.175643
   Thom M, 2011, J NEUROPATH EXP NEUR, V70, P859, DOI 10.1097/NEN.0b013e3182302475
   Tonetti Daniel A, 2017, Surg Neurol Int, V8, P140, DOI 10.4103/2152-7806.210257
   Tsuboi Y, 2007, BRAIN TUMOR PATHOL, V24, P63, DOI 10.1007/s10014-007-0217-1
   Urbach H, 2005, EUR RADIOL, V15, P494, DOI 10.1007/s00330-004-2629-1
   Vogt VL, 2018, EPILEPSY BEHAV, V88, P25, DOI 10.1016/j.yebeh.2018.08.028
   Whittle IR, 1999, BRIT J NEUROSURG, V13, P508, DOI 10.1080/0268869998540629
   Yamada S M, 1998, No To Shinkei, V50, P1101
   Yasha TC, 1998, CLIN NEUROPATHOL, V17, P305
   Yin Xiao-lu, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P147
   Zhang JG, 2014, J CHILD NEUROL, V29, P1441, DOI 10.1177/0883073813490831
NR 92
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 255
EP 265
DI 10.1016/j.wneu.2019.04.056
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300208
PM 30981794
DA 2020-05-12
ER

PT J
AU Chanchotisatien, A
   Pan, JW
   Du, ZG
   Qiu, TM
   Yu, JT
   Chu, SG
AF Chanchotisatien, Apisara
   Pan, Jiawei
   Du, Zunguo
   Qiu, Tianming
   Yu, Jintai
   Chu, Shuguang
TI Slow-Growing Thalamic Glioma with Histone H3 Lysine 27-to-Methionine
   Mutation: 3-Year Follow-Up Before Surgical Intervention
SO WORLD NEUROSURGERY
LA English
DT Article
DE Delayed surgical intervention; Diffuse intrinsic pontine glioma; Diffuse
   midline glioma; H3 K27M-mutant; H3 K27M mutation; Slow-growing tumor;
   Thalamic glioma
AB BACKGROUND: The 2016 World Health Organization Classification of Tu-mours of the Central Nervous System was revised to include a new diagnostic entity, diffuse midline glioma, H3 K27M-mutant (DMG-K27M), a highly agressive tumor with a mean survival time of 1 year after diagnosis. DMG-K27M is classified as a World Health Organization grade IV tumor regardless of hist& pathologic features, and there is currently no effective treatment for it despite ongoing research.
   CASE DESCRIPTION: We present a case of a 39-year-old man with a slow-growing thalamic glioma with histone H3 lysine 27-to-methionine mutation. This patient received surgical intervention 3 years after the initial discovery of the tumor. Because the patient did not receive any preoperative treatment for DMG-K27M, this case reflects 1 possible natural course of progression for this type of malignancy.
   CONCLUSIONS: There are currently no effective therapeutic options for treatment of DUIG-K27M. The slow tumor growth and prolonged survival time (>= 3 years) in the absence of intervention in this case serve as a reminder that much is still not known about histone H3 lysine 27-to-methionine mutation and how it impacts the pathophysiology, diagnosis, treatment, and prognosis of the disease. Careful evaluation is warranted to determine if early intervention is the best approach when treating DMG-K27M.
C1 [Chanchotisatien, Apisara] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China.
   [Pan, Jiawei; Chu, Shuguang] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai, Peoples R China.
   [Du, Zunguo] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai, Peoples R China.
   [Qiu, Tianming] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
   [Yu, Jintai] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China.
RP Chu, SG (reprint author), Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai, Peoples R China.
EM chushu1018@hotmail.com
RI Qiu, Tianming/AAF-7597-2020
OI Chanchotisatien, Apisara/0000-0003-3687-2137
CR Aboian MS, 2017, AM J NEURORADIOL, V38, P795, DOI 10.3174/ajnr.A5076
   Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0
   Ebrahimi A, 2019, J CANCER RES CLIN, V145, P839, DOI 10.1007/s00432-018-02836-5
   Feng J, 2015, HUM PATHOL, V46, P1626, DOI 10.1016/j.humpath.2015.07.002
   Himes BT, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00031
   Kleinschmidt-DeMasters BK, 2018, CLIN NEUROPATHOL, V37, P53, DOI 10.5414/NP301085
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Mella D, 2018, NEUROLOGY, V90
   Meyronet D, 2017, NEURO-ONCOLOGY, V19, P1127, DOI 10.1093/neuonc/now274
   Solomon DA, 2016, BRAIN PATHOL, V26, P569, DOI 10.1111/bpa.12336
NR 10
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 266
EP 268
DI 10.1016/J.WNEU.2019.04.054
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300209
PM 30981797
DA 2020-05-12
ER

PT J
AU McCormack, E
   Mathkour, M
   Riffle, J
   Amenta, PS
AF McCormack, Erin
   Mathkour, Mansour
   Riffle, Jonathan
   Amenta, Peter S.
TI Lymphoma of the Optic Apparatus in an Immunocompetent Patient: A Case
   Report and Review of the Literature
SO WORLD NEUROSURGERY
LA English
DT Review
DE CNS lymphoma; Diffuse; Infiltrative; Optic apparatus; Primary; Visual
   acuity
ID CENTRAL-NERVOUS-SYSTEM; PRIMARY CNS LYMPHOMA; HIGH-DOSE METHOTREXATE;
   RADIOTHERAPY; INVOLVEMENT
AB BACKGROUND: Primary optic apparatus involvement by lymphoma is an exceedingly rare entity, with only 3 cases previously reported in the literature. Whether this represents a distinct pathology, metastatic disease from an unidentified systemic lymphoma, or the first manifestation of evolving primary central nervous system lymphoma is not currently understood.
   CASE DESCRIPTION: We present a case of a young immunocompetent male with rapidly progressive visual loss who was found to have isolated lymphomatous involvement of the optic apparatus. We discuss the classification of the lesion, the clinical presentation, the diagnostic workup, and the visual and overall prognosis. Special consideration is given to the operative approach and selecting an appropriate site for biopsy based on the visual exam at the time of presentation.
   CONCLUSIONS: Primary optic nerve lymphoma is a rare disease that requires a systemic workup and a multidisciplinary approach to treatment.
C1 [McCormack, Erin; Mathkour, Mansour; Riffle, Jonathan; Amenta, Peter S.] Tulane Univ Med Ctr Hosp & Clin, Dept Neurosurg, New Orleans, LA 70112 USA.
   [McCormack, Erin; Mathkour, Mansour; Riffle, Jonathan] Ochsner Med Ctr, Dept Neurosurg, New Orleans, LA USA.
RP Amenta, PS (reprint author), Tulane Univ Med Ctr Hosp & Clin, Dept Neurosurg, New Orleans, LA 70112 USA.
EM peter.amenta@gmail.com
RI Mathkour, Mansour/N-7878-2015
OI Mathkour, Mansour/0000-0002-1913-3677
CR Ahle G, 2017, JAMA NEUROL, V74, P1368, DOI 10.1001/jamaneurol.2017.2545
   [Anonymous], 2013, DEVITA HELLMAN ROSEN
   Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036
   Behbehani RS, 2005, AM J OPHTHALMOL, V139, P1128, DOI 10.1016/j.ajo.2004.12.006
   CHRISTMAS NJ, 1991, SURV OPHTHALMOL, V36, P196, DOI 10.1016/0039-6257(91)90002-W
   Corn BW, 1997, CANCER, V79, P2409
   Dayan MR, 2000, ARCH OPHTHALMOL-CHIC, V118, P1455
   EBY NL, 1988, CANCER, V62, P2461, DOI 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M
   Ferreri AJM, 2009, LANCET, V374, P1512, DOI 10.1016/S0140-6736(09)61416-1
   FERRY AP, 1974, ARCH OPHTHALMOL-CHIC, V92, P276, DOI 10.1001/archopht.1974.01010010286003
   Ghesquieres H, 2013, HEMATOL ONCOL, V31, P317, DOI 10.1002/hon.2021
   Herrlinger U, 2002, ANN NEUROL, V51, P247, DOI 10.1002/ana.10102
   Hoang-Xuan K, 2015, LANCET ONCOL, V16, pE322, DOI 10.1016/S1470-2045(15)00076-5
   Jelicic J, 2016, BRIT J NEUROSURG, V30, P80, DOI 10.3109/02688697.2015.1071328
   Kim JL, 2015, SURV OPHTHALMOL, V60, P153, DOI 10.1016/j.survophthal.2014.11.004
   KLINE LB, 1984, ARCH OPHTHALMOL-CHIC, V102, P1655
   Lee AG, 2001, J NEURO-OPHTHALMOL, V21, P95, DOI 10.1097/00041327-200106000-00007
   MACKINTOSH FR, 1982, CANCER, V49, P586, DOI 10.1002/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C
   National Cancer Institute, SEER CANC STAT REV 1
   Niederhuber J.E., 2014, ABELOFFS CLIN ONCOLO
   Olsen Tine Gadegaard, 2019, Surv Ophthalmol, V64, P45, DOI 10.1016/j.survophthal.2018.08.002
   STROMINGER MB, 1993, AM J OPHTHALMOL, V116, P774, DOI 10.1016/S0002-9394(14)73486-5
   Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569
   Thiel E, 2010, LANCET ONCOL, V11, P1036, DOI 10.1016/S1470-2045(10)70229-1
   Weller M, 2012, NEURO-ONCOLOGY, V14, P1481, DOI 10.1093/neuonc/nos159
   West H, 2015, JAMA ONCOL, V1, P998, DOI 10.1001/jamaoncol.2015.3113
   Yun J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00478
   ZAMAN AG, 1993, BRIT J OPHTHALMOL, V77, P184, DOI 10.1136/bjo.77.3.184
NR 28
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 269
EP 274
DI 10.1016/j.wneu.2019.03.224
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300210
PM 30930323
DA 2020-05-12
ER

PT J
AU Gan, CW
   Chen, SY
   Chang, CS
   Liu, JD
AF Gan, Cheat-wei
   Chen, Se-Yi
   Chang, Cheng-Shiu
   Liu, Jung-dung
TI Spontaneous Spinal Subdural Hematoma: Case Report of 2 Years' Clinical
   and Radiologic Findings
SO WORLD NEUROSURGERY
LA English
DT Article
DE Conservative treatment; Decompression; Magnetic resonance imaging;
   Spinal subdural hematoma
ID RESOLUTION
AB BACKGROUND: Spontaneous spinal subdural hematoma (SDH) is rare but leads to severe nerve compression. According to the symptoms, surgery decompression and conservative treatment are justified options. We present a spontaneous spinal SDH case treated by decompression surgery for the lumbar region and conservative observation for the thoracic region. A series of images of the disease course is available.
   CASE DESCRIPTION: A 55-year-old woman without malignancy or coagulopathy history presented with progressive low back pain for the past 2 weeks. Progressive bilateral leg weakness happened 1 week ago. On the day she called for help, she presented with bilateral leg grade 2 muscle power and generalized back pain. There was no headache or meningeal sign. An absent bilateral knee reflex was found. Magnetic resonance imaging showed a space-occupying lesion at the T2-T6 and T12-L1 levels in the ventral and dorsal spinal canal, leading to cord compression. Due to rapid neurologic function deterioration, emergent T12-L1 laminectomy was performed. We found a T12-L1 tense dura sac with subdural hematoma ventral to the cord. Removal of the SDH was performed. T2-T6 levels were treated conservatively. She returned ambulant 1 week after operation. Magnetic resonance images at 3 months and 1 year later showed the SDH being absorbed and replaced by adhesive arachnoid cysts along the whole T and L spine. However, these lesions are asymptomatic for at least 2 years.
   CONCLUSIONS: Surgical intervention is recommended in patients presenting with severe neurologic deficits. Conservative treatment is a reasonable option for asymptomatic patients.
C1 [Gan, Cheat-wei; Chen, Se-Yi; Chang, Cheng-Shiu; Liu, Jung-dung] Chung Shan Med Univ, Coll Med, Dept Neurosurg, Taichung, Taiwan.
   [Gan, Cheat-wei; Chen, Se-Yi; Chang, Cheng-Shiu; Liu, Jung-dung] Chung Shan Med Univ, Coll Med, Sch Med, Taichung, Taiwan.
RP Chen, SY (reprint author), Chung Shan Med Univ, Coll Med, Dept Neurosurg, Taichung, Taiwan.; Chen, SY (reprint author), Chung Shan Med Univ, Coll Med, Sch Med, Taichung, Taiwan.
EM sychen0102@gmail.com
CR Domenicucci M, 1999, J NEUROSURG, V91, P65, DOI 10.3171/spi.1999.91.1.0065
   Kakitsubata Y, 2010, EMERG RADIOL, V17, P69, DOI 10.1007/s10140-008-0792-4
   Kang HS, 2000, SPINAL CORD, V38, P192, DOI 10.1038/sj.sc.3100967
   Lee JL, 1996, J TRAUMA, V40, P654, DOI 10.1097/00005373-199604000-00026
   Longatti P L, 1994, J Neurosurg Sci, V38, P197
   Matsumoto H, 2016, WORLD NEUROSURG, V90, DOI 10.1016/j.wneu.2016.03.020
   Pierce JL, 2018, RADIOGRAPHICS, V38, P1516, DOI 10.1148/rg.2018180099
   RADER JP, 1955, NEW ENGL J MED, V253, P374, DOI 10.1056/NEJM195509012530906
   Satyarthee GD, 2018, J PEDIATR NEUROSCI, V13, P24, DOI [10.4103/jpn.JPN_121_17, 10.4103/JPN.JPN_121_17]
   Wong ST, 2009, SURG NEUROL, V71, P99, DOI 10.1016/j.surneu.2007.06.079
   Yamada K, 2003, ACTA NEUROCHIR, V145, P151, DOI 10.1007/s00701-002-1045-z
   Yamaguchi S, 2005, NEUROL MED-CHIR, V45, P645, DOI 10.2176/nmc.45.645
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 275
EP 278
DI 10.1016/j.wneu.2019.04.063
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300211
PM 30986583
DA 2020-05-12
ER

PT J
AU Sasagasako, T
   Funaki, T
   Tanji, M
   Arakawa, Y
   Suzuki, H
   Miyakoshi, A
   Miyamoto, S
AF Sasagasako, Tomoki
   Funaki, Takeshi
   Tanji, Masahiro
   Arakawa, Yoshiki
   Suzuki, Hime
   Miyakoshi, Akinori
   Miyamoto, Susumu
TI Intractable Medial Anastomotic Branches from the Lenticulostriate Artery
   Causing Recurrent Hemorrhages in Moyamoya Disease
SO WORLD NEUROSURGERY
LA English
DT Article
DE Direct bypass; Intracranial hemorrhage; Moyamoya disease;
   Periventricular anastomosis
ID ANEURYSMS
AB BACKGROUND: Although superficial temporal artery (STA) to middle cerebral artery (MCA) anastomosis is a beneficial treatment for hemorrhagic moyamoya disease, indeterminate mechanisms can cause rebleeding even after successful bypass surgery. We describe a case with a prominent collateral from the lenticulostriate artery (ISA) causing multiple recurrent hemorrhages after successful STA-MCA anastomosis.
   CASE DESCRIPTION: A 49-year-old Japanese woman with moyamoya disease was referred to our institution after suffering intracranial hemorrhage on 2 occasions. Angiography revealed multiple anastomotic vessels branching from a prominent LSA to connect medullary arteries in the periventricular area corresponding to the location of the hemorrhage. She underwent STA-MCA anastomoses and the bypass widely perfused the MCA territory; however, intracranial hemorrhage recurred in the same hemisphere. Angiography revealed sustained dilatation of the medial anastomotic branches from the LSA with de novo pseudoaneurysm, whereas the lateral branches showed shrinkage. Subsequent surgical treatment included direct bypass targeting the medial hemispheric surface in which the medial branches were distributed; marked shrinkage of the branches and disappearance of the aneurysm were obtained without infarct.
   CONCLUSIONS: Lenticulostriate anastomotic branches distributed medially to the anterior cerebral artery territory should be given more attention as an intractable cause of hemorrhage after successful STA-MCA anastomosis. Although challenging, direct bypass targeting the area reached by collateral vessels could be considered an alternative treatment strategy for this pathologic condition.
C1 [Sasagasako, Tomoki; Funaki, Takeshi; Tanji, Masahiro; Arakawa, Yoshiki; Miyakoshi, Akinori; Miyamoto, Susumu] Kyoto Univ, Dept Neurosurg, Grad Sch Med, Kyoto, Japan.
   [Suzuki, Hime] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido, Japan.
RP Funaki, T (reprint author), Kyoto Univ, Dept Neurosurg, Grad Sch Med, Kyoto, Japan.
EM tfunaki@kuhp.kyoto-u.ac.jp
CR Akashi T, 2017, AM J ROENTGENOL, V209, pW160, DOI 10.2214/AJR.16.17231
   Ding JY, 2018, WORLD NEUROSURG, V117, pE557, DOI 10.1016/j.wneu.2018.06.076
   Funaki T, 2018, J NEUROSURG, V128, P777, DOI 10.3171/2016.11.JNS161650
   Funaki T, 2016, J NEUROSURG, V124, P1766, DOI 10.3171/2015.6.JNS15845
   Funaki T, 2015, NEUROL MED-CHIR, V55, P204, DOI 10.2176/nmc.oa.2014-0360
   Han DH, 2000, ACTA NEUROCHIR, V142, P1263, DOI 10.1007/s007010070024
   Jeon JP, 2018, J NEUROSURG, V128, P793, DOI 10.3171/2016.11.JNS161688
   Kim SH, 2009, NEUROSURGERY, V65, P1000, DOI 10.1227/01.NEU.0000345648.46096.CE
   Kobayashi E, 2000, J NEUROSURG, V93, P976, DOI 10.3171/jns.2000.93.6.0976
   Miyakoshi A, 2019, ACTA NEUROCHIR, V161, P947, DOI 10.1007/s00701-019-03866-9
   Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386
   Takahashi JC, 2016, STROKE, V47, P37, DOI 10.1161/STROKEAHA.115.010819
   Yang S, 2010, INTERV NEURORADIOL, V16, P433, DOI 10.1177/159101991001600410
NR 13
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 279
EP 283
DI 10.1016/j.wneu.2019.04.066
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300212
PM 30995561
DA 2020-05-12
ER

PT J
AU Qian, H
   Shi, XE
   Wang, L
AF Qian, Hai
   Shi, Xiang'en
   Wang, Long
TI Distal Outflow-Related Anterior Inferior Cerebellar Artery Aneurysm in
   Hemangioblastoma
SO WORLD NEUROSURGERY
LA English
DT Article
DE Anterior inferior cerebellar artery aneurysm; Cerebellar
   hemangioblastoma
AB Anterior inferior cerebellar artery (AICA) aneurysm is a rare cerebral entity, and its presentation in association with a hypervascularized tumor is even more exceptional. In this study, we describe a patient with rare coexistent pathologic conditions in combination with a cerebellar hypervascularized tumor with an outflow-related AICA aneurysm. A 1-stage procedure to remove both lesions was carried out after meticulous discussion with patient. Postoperative imaging demonstrated no residual aneurysm and total resection of the tumor, which was pathologically diagnosed as hemangioblastoma (HB). She made an excellent neurologic outcome and was discharged in unremarkable condition. At her 3-month follow-up visit, her condition remained stable for vasculopathologic states and neurologic functions. To our knowledge, this is the first published clinical experience regarding cerebellar HB coexistent with an AICA aneurysm that involved the efferent segment of the tumor's feeding vessel. Patients with coexistent vascular pathologic conditions should be aggressively treated, not by the wait-and-see practice, in case of unexpected rupture in the future.
C1 [Qian, Hai; Shi, Xiang'en; Wang, Long] Capital Med Univ, SanBo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China.
   [Wang, Long] Sapporo Teishinkai Hosp, Dept Neurosurg, Stroke Ctr, Sapporo, Hokkaido, Japan.
RP Wang, L (reprint author), Capital Med Univ, SanBo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China.; Wang, L (reprint author), Sapporo Teishinkai Hosp, Dept Neurosurg, Stroke Ctr, Sapporo, Hokkaido, Japan.
EM wanglong@mail.ccmu.edu.cn
RI WANG, LONG/AAI-5029-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 284
EP 288
DI 10.1016/j.wneu.2019.04.023
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300213
PM 30986586
DA 2020-05-12
ER

PT J
AU Zhang, YJ
   Liu, H
   He, F
   Chen, A
   Yang, HL
   Pi, B
AF Zhang, Yijian
   Liu, Hao
   He, Fan
   Chen, Angela
   Yang, Huilin
   Pi, Bin
TI Does Tranexamic Acid Improve Bleeding, Transfusion, and Hemoglobin Level
   in Patients Undergoing Multilevel Spine Surgery? A Systematic Review and
   Meta-Analysis
SO WORLD NEUROSURGERY
LA English
DT Review
DE Blood loss; Blood transfusion; Hemoglobin; Multiple-level spine surgery;
   Platelets; Tranexamic acid
ID REDUCE BLOOD-LOSS; EFFICACY; SAFETY; PLACEBO; TRIAL
AB OBJECTIVE: To investigate the influence of tranexamic acid (TXA) on blood loss and blood transfusion in multiple-level spine surgery and evaluate whether hemoglobin and platelet levels are altered as a result.
   METHOD: This meta-analysis conducted an exhaustive search of literature from Pubmed, Embase, Cochrane Library, Web of Science, and CNKI databases. Stata 11.0 was used to analyze the pooled data. Mean differences (MD) of blood loss, transfusion volume, hemoglobin and platelet levels, and odds ratio (OR) of proportion of transfusion were extracted and compared between the TXA group and controls. Publication bias and sensitivity analysis were also performed.
   RESULT: A total of 11 studies (6 RCTs and 5 retrospective studies) were enrolled in this meta-analysis according to the inclusion criteria. The data showed that administration of TXA can decrease intraoperative blood loss and perioperative blood transfusion compared to controls (standard mean difference = - 0.50; 95% confidence interval [CI]: -0.84, - 0.16; I-2 = 52.9%; P = 0.004) (OR = 0.48; 95% CI: 0.29, 0.78; I-2 = 0%; P = 0.003). Moreover, TXA can maintain a superior hemoglobin level after surgery in contrast to the control group (standard mean difference = -027; 95% CI: 0.07, 0.47; I-2 = 0%; P = 0.009). The above results were also observed and verified after accounting for publication bias and sensitivity analysis.
   CONCLUSION: The application of TXA can effectively reduce intraoperative blood loss and perioperative blood transfusion in patients undergoing multiple-level spine surgery, and it can restore hemoglobin levels after surgery.
C1 [Zhang, Yijian; Liu, Hao; He, Fan; Yang, Huilin; Pi, Bin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Peoples R China.
   [Zhang, Yijian; Liu, Hao; He, Fan; Yang, Huilin; Pi, Bin] Soochow Univ, Inst Orthoped, Suzhou, Peoples R China.
   [Chen, Angela] Univ Waterloo, Waterloo, ON, Canada.
RP Pi, B (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Peoples R China.; Pi, B (reprint author), Soochow Univ, Inst Orthoped, Suzhou, Peoples R China.
EM bpi@suda.edu.cn
RI Chen, Angela/W-8271-2019
OI Chen, Angela/0000-0003-4025-3021
FU Jiangsu Provincial Clinical Orthopedics Center project
FX This study was supported by the Jiangsu Provincial Clinical Orthopedics
   Center project.
CR Baldus CR, 2010, SPINE, V35, P235, DOI 10.1097/BRS.0b013e3181c86cb9
   Bible JE, 2018, J AM ACAD ORTHOP SUR, V26, P35, DOI 10.5435/JAAOS-D-16-00184
   Carabini LM, 2018, WORLD NEUROSURG, V110, pE572, DOI 10.1016/j.wneu.2017.11.070
   Choi HY, 2017, J KOREAN NEUROSURG S, V60, P75, DOI 10.3340/jkns.2016.0505.004
   Colomina MJ, 2017, BRIT J ANAESTH, V118, P380, DOI 10.1093/bja/aew434
   Endres S, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-29
   Farrokhi MR, 2011, J NEUROSURG ANESTH, V23, P290, DOI 10.1097/ANA.0b013e31822914a1
   Fletcher ND, 2018, SPINE DEFORM, V6, P424
   Huerfano E, 2018, J ARTHROPLASTY, DOI [10.1016/j.art.2018.10.018, DOI 10.1016/J.ART.2018.10.018]
   Hui SY, 2018, SPINE J, V18, P1325, DOI 10.1016/j.spinee.2017.11.017
   Jordan M, 2019, ARCH ORTHOP TRAUM SU, V139, P597, DOI 10.1007/s00402-018-3089-4
   Khurana A, 2012, EUR SPINE J, V21, P1121, DOI 10.1007/s00586-012-2205-3
   Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001
   Kutteruf R, 2018, J NEUROSURG ANESTH, V30, P156, DOI 10.1097/ANA.0000000000000448
   Lan T, 2017, EUR SPINE J, V26, P1796, DOI 10.1007/s00586-017-5045-3
   Liang JQ, 2016, CLIN NEUROL NEUROSUR, V147, P110, DOI 10.1016/j.clineuro.2016.06.001
   Lin JD, 2018, SPINE DEFORM, V6, P189, DOI DOI 10.1016/J.JSPD.2017.08.007
   Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45
   Nagabhushan RM, 2018, SPINE, V43, pE267, DOI 10.1097/BRS.0000000000002315
   Ohashi N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173622
   Peters A, 2015, SPINE, V40, pE443, DOI 10.1097/BRS.0000000000000799
   Pong RP, 2018, J BONE JOINT SURG AM, V100, P758, DOI 10.2106/JBJS.17.00860
   Puvanesarajah V, 2018, J NEUROSURG-SPINE, V28, P429, DOI 10.3171/2017.10.SPINE17884
   Raksakietisak M, 2015, SPINE, V40, pE1257, DOI 10.1097/BRS.0000000000001063
   Ren ZN, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008233
   Sabry MM, 2018, ANN CARD ANAESTH, V21, P409, DOI 10.4103/aca.ACA_231_17
   Tabrizi R, 2018, INT J ORAL MAX SURG, V47, P1504, DOI 10.1016/j.ijom.2018.06.017
   Tawara S, 2016, THROMB RES, V147, P72, DOI 10.1016/j.thromres.2016.09.011
   Wang Q, 2013, EUR SPINE J, V22, P2035, DOI 10.1007/s00586-013-2836-z
   Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214
   Willner D, 2016, ANESTH ANALG, V123, P1307, DOI 10.1213/ANE.0000000000001485
   Xie JW, 2019, THROMB RES, V173, P96, DOI 10.1016/j.thromres.2018.11.025
   Xu DR, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0672-2
   Xu H, 2015, SPINE J, V15, P290, DOI 10.1016/j.spinee.2014.09.014
   Xue P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013643
   Yu CC, 2018, SPINE, DOI [10.1097/BRS, DOI 10.1097/BRS]
NR 36
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 289
EP 301
DI 10.1016/j.wneu.2019.02.170
PG 13
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300214
PM 30862591
DA 2020-05-12
ER

PT J
AU Do, ASS
   Bannykh, SI
   Black, KL
   Perry, TG
AF Do, Angelique Sao-Mai S.
   Bannykh, Serguei I.
   Black, Keith L.
   Perry, Tiffany G.
TI Unusual Exophytic Appearance of Spinal Cord Subependymoma
SO WORLD NEUROSURGERY
LA English
DT Review
DE Exophytic subependymoma; Spinal cord neoplasms; Spinal cord
   subependymoma
AB BACKGROUND: Subependymomas are rare in the spinal cord. They are expansile, intramedullary spinal cord masses, eccentrically located with minimal gadolinium enhancement.
   CASE DESCRIPTION: We present a case of subependymoma originating from cervical cord with an unusual exophytic appearance. Hallmarks of subependymoma and treatment are reviewed.
   CONCLUSIONS: This is the first case, to our knowledge, where imaging .ales a mass appearing to be completely extramedullary with a primary exophytic component. Therefore, subependymomas should remain on the differential for masses in the spinal cord that appear extramedullary and exophytic.
C1 [Do, Angelique Sao-Mai S.; Black, Keith L.; Perry, Tiffany G.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.
   [Bannykh, Serguei I.] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA.
RP Perry, TG (reprint author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.
EM tiffany.perry@csmns.org
OI Do, Angelique Sao-Mai/0000-0002-6604-8897
CR D'Amico RS, 2017, WORLD NEUROSURG, V107, P451, DOI 10.1016/j.wneu.2017.08.009
   Ecker RD, 2004, STEREOT FUNCT NEUROS, V82, P58, DOI 10.1159/000076662
   FURIE DM, 1995, J COMPUT ASSIST TOMO, V19, P518, DOI 10.1097/00004728-199507000-00002
   HOEFFEL C, 1995, AM J NEURORADIOL, V16, P2121
   Jain A, 2012, NEUROL RES, V34, P677, DOI 10.1179/1743132812Y.0000000064
   Jallo GI, 1996, NEUROSURGERY, V38, P251, DOI 10.1097/00006123-199602000-00004
   Limaiem F, 2008, PATHOLOGICA, V100, P401
   Liu Y, 2016, MATEC WEB CONF, V77, DOI 10.1051/matecconf/20167701039
   LOMBARDI D, 1991, J NEUROSURG, V75, P583, DOI 10.3171/jns.1991.75.4.0583
   Maiuri F, 1997, CLIN NEUROL NEUROSUR, V99, P17, DOI 10.1016/S0303-8467(96)00554-9
   Ragel BT, 2006, NEUROSURGERY, V58, P881, DOI 10.1227/01.NEU.0000209928.04532.09
   Romoli S, 2007, J Neurosurg Sci, V51, P81
   SCHEINKER IM, 1945, J NEUROSURG, V2, P232, DOI 10.3171/jns.1945.2.3.0232
   Wu L, 2014, J NEURO-ONCOL, V116, P99, DOI 10.1007/s11060-013-1256-6
   Yuh WT, 2018, J KOREAN NEUROSURG S, V61, P233, DOI 10.3340/jkns.2017.0405.001
NR 15
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 302
EP 306
DI 10.1016/j.wneu.2019.03.270
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300215
PM 30954744
DA 2020-05-12
ER

PT J
AU Eljazzar, R
   Loewenstern, J
   Dai, JB
   Shrivastava, RK
   Iloreta, AM
AF Eljazzar, Rachelle
   Loewenstern, Joshua
   Dai, Jennifer B.
   Shrivastava, Raj K.
   Iloreta, Alfred M., Jr.
TI Detection of Cerebrospinal Fluid Leaks: Is There a Radiologic Standard
   of Care? A Systematic Review
SO WORLD NEUROSURGERY
LA English
DT Review
DE CSF leak; CSF rhinorrhea; HRCT; MRI; Radionuclide cisternography
ID ENHANCED MR CISTERNOGRAPHY; HIGH-RESOLUTION CT; MAGNETIC-RESONANCE
   CISTERNOGRAPHY; INTRATHECAL GADOLINIUM; CSF RHINORRHEA;
   COMPUTERIZED-TOMOGRAPHY; DIAGNOSIS; MANAGEMENT; BASE; LOCALIZATION
AB INTRODUCTION: Diagnosis of cerebrospinal fluid (CSF) leaks traditionally involves laboratory testing of markers and appropriate imaging. Surgical localization can be difficult, and the inability to accurately localize skull base defects leads to increased rates of repair failure and complications. Many imaging techniques localizing and identifying CSF leaks have been proposed. Comparisons of current and investigational imaging techniques used to localize CSF leaks are reviewed.
   METHODS: A comprehensive and systematic search through PubMed, Scopus, and reference lists from relevant articles was completed to identify literature on sensitivities of different imaging methods for localization and detection of CSF leaks. Prospective, retrospective, and case series published since 1995 that addressed imaging techniques for CSF leaks confined to the skull base were included. Sensitivities of each major imaging technique proposed were recorded and analyzed.
   RESULTS: In total, 133 studies initially were screened from 2125 studies on preliminary search. Of these, 38 studies were included based on inclusion criteria. Studies were segregated by imaging modality. A total of 1000 patients with CSF leaks subsequently were evaluated.
   CONCLUSIONS: Although radionuclide cisternography has been the historical standard, recent imaging techniques have emerged considering the low sensitivity. Computed tomography cisternography with contrast also has low sensitivity, even in active leaks. Although high-resolution computed tomography is commonly the initial study of choice, magnetic resonance imaging methods, particularly 3-dimensional imaging, may prove to be a more sensitive study of choice. Computed tomography/magnetic resonance imaging combination methods may show promise in localizing CSF leaks. Stratifying by status and etiology may be an important determinant. Further studies investigating various imaging techniques for localizing CSF leaks are needed.
C1 [Eljazzar, Rachelle] Mercer Univ, Sch Med, Macon, GA 31207 USA.
   [Loewenstern, Joshua; Dai, Jennifer B.] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA.
   [Shrivastava, Raj K.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.
   [Iloreta, Alfred M., Jr.] Icahn Sch Med Mt Sinai, Dept Otolaryngol, New York, NY 10029 USA.
RP Iloreta, AM (reprint author), Icahn Sch Med Mt Sinai, Dept Otolaryngol, New York, NY 10029 USA.
EM alfred-marc.iloreta@mountsinai.org
OI ELJAZZAR, RACHELLE/0000-0002-0594-011X
CR Algin O, 2013, AM J NEURORADIOL, V34, P14, DOI 10.3174/ajnr.A2899
   APPELBAUM E, 1960, JAMA-J AM MED ASSOC, V173, P1818, DOI 10.1001/jama.1960.03020340036010
   Arbelaez A, 2007, AM J ROENTGENOL, V188, pW560, DOI 10.2214/AJR.05.1280
   Aydin K, 2008, NEUROSURGERY, V62, P584, DOI 10.1227/01.neu.0000317306.39203.24
   Bachmann G, 2002, NEUROSURGERY, V50, P571, DOI 10.1097/00006123-200203000-00027
   Bathla G, 2016, SEMIN ULTRASOUND CT, V37, P143, DOI 10.1053/j.sult.2015.12.002
   Bleier BS, 2013, ADV OTO-RHINO-LARYNG, V74, P1
   CHOW JM, 1989, OTOLARYNG HEAD NECK, V100, P99, DOI 10.1177/019459988910000204
   Chung SB, 2012, ACTA NEUROCHIR, V154, P1499, DOI 10.1007/s00701-012-1404-3
   Deenadayal DS, 2013, INDIAN J OTOLARYNGOL, V65, pS271, DOI 10.1007/s12070-011-0431-3
   DelGaudio JM, 2015, INT FORUM ALLERGY RH, V5, P333, DOI 10.1002/alr.21475
   Eberhardt KEW, 1997, EUR RADIOL, V7, P1485, DOI 10.1007/s003300050321
   Ecin G, 2013, ACTA RADIOL, V54, P698, DOI 10.1177/0284185113478008
   El Gammal T, 1998, AM J NEURORADIOL, V19, P627
   ELJAMEL M S, 1990, British Journal of Neurosurgery, V4, P381, DOI 10.3109/02688699008992759
   ELJAMEL MS, 1995, J NEUROSURG, V83, P795, DOI 10.3171/jns.1995.83.5.0795
   Goel G, 2007, J NEUROTRAUM, V24, P1570, DOI 10.1089/neu.2007.0326
   Gupta V, 1997, ACTA RADIOL, V38, P603
   Jayakumar PN, 2001, ACTA RADIOL, V42, P582, DOI 10.1080/028418501127347412
   Jinkins JR, 2002, RADIOLOGY, V222, P555, DOI 10.1148/radiol.2222010249
   Johnson DBS, 1996, CLIN RADIOL, V51, P837
   La Fata V, 2008, AM J NEURORADIOL, V29, P536, DOI 10.3174/ajnr.A0885
   LEVY LM, 1995, AM J OTOL, V16, P591
   Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362
   Mathias T, 2016, OCHSNER J, V16, P136
   Meco C, 2003, OTOLARYNG HEAD NECK, V129, P508, DOI 10.1016/S0194-5998(03)01448-7
   Mostafa BE, 2004, SKULL BASE-INTERD AP, V14, P157, DOI 10.1055/s-2004-832259
   Munoz A, 2007, AM J NEURORADIOL, V28, P889
   Nelson RF, 2015, OTOL NEUROTOL, V36, P476, DOI 10.1097/MAO.0000000000000535
   Phang SY, 2016, BRIT J NEUROSURG, V30, P596, DOI 10.1080/02688697.2016.1229746
   Ponto JA, 2013, J AM PHARM ASSOC, V53, P58, DOI 10.1331/JAPhA.2013.12064
   Prosser JD, 2011, OTOLARYNG CLIN N AM, V44, P857, DOI 10.1016/j.otc.2011.06.007
   Ragheb AS, 2014, EGYPT J RADIOL NUC M, V45, P841, DOI 10.1016/j.ejrnm.2014.05.010
   Reddy M, 2017, RADIOL CLIN N AM, V55, P167, DOI 10.1016/j.rcl.2016.08.005
   Reiche W, 2002, EUR RADIOL, V12, P2943, DOI 10.1007/s00330-002-1606-9
   Schlosser RJ, 2004, LARYNGOSCOPE, V114, P255, DOI 10.1097/00005537-200402000-00015
   Schuknecht B, 2008, AM J NEURORADIOL, V29, P542, DOI 10.3174/ajnr.A0840
   Selcuk H, 2010, AM J NEURORADIOL, V31, P71, DOI 10.3174/ajnr.A1788
   Semirgin SU, 2012, CLIN NUCL MED, V37, P289, DOI 10.1097/RLU.0b013e31823926ac
   Servadei F, 1998, ACTA NEUROCHIR, V140, P1183, DOI 10.1007/s007010050235
   Shetty PG, 1998, AM J NEURORADIOL, V19, P633
   Sillers MJ, 1997, AM J RHINOL, V11, P387, DOI 10.2500/105065897781286052
   Stone JA, 1999, AM J NEURORADIOL, V20, P706
   Tumturk A, 2016, TURK NEUROSURG, V26, P699, DOI 10.5137/1019-5149.JTN.13424-14.1
   Tuntiyatorn Lojana, 2004, Journal of the Medical Association of Thailand, V87, P1471
   Vimala LR, 2016, POL J RADIOL, V81, P80, DOI 10.12659/PJR.895698
   Warnecke A, 2004, ARCH OTOLARYNGOL, V130, P1178, DOI 10.1001/archotol.130.10.1178
   Wax MK, 1997, OTOLARYNG HEAD NECK, V116, P442, DOI 10.1016/S0194-5998(97)70292-4
   Wise SK, 2009, AM J RHINOL ALLERGY, V23, P185, DOI 10.2500/ajra.2009.23.3293
   Xie T, 2016, ACTA NEUROCHIR, V158, P2333, DOI 10.1007/s00701-016-2988-9
   Yi HJ, 2013, ACTA OTO-LARYNGOL, V133, P130, DOI 10.3109/00016489.2012.727468
   Zhang GX, 2013, CLIN IMAG, V37, P847, DOI 10.1016/j.clinimag.2013.05.014
   Zhang YY, 2016, BRIT J NEUROSURG, V30, P643, DOI 10.1080/02688697.2016.1199787
   ZLAB M K, 1992, Ear Nose and Throat Journal, V71, P314
   Zuckerman JD, 2008, AM J RHINOL, V22, P151, DOI 10.2500/ajr.2008.22.3150
NR 55
TC 4
Z9 4
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 307
EP 315
DI 10.1016/j.wneu.2019.01.299
PG 9
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300216
PM 30797912
DA 2020-05-12
ER

PT J
AU Figueroa-Sanchez, JA
   Ferrigno, AS
   Moreno-Cuevas, J
   Gonzalez-Garza, MT
   Jamall, S
   Martinez, HR
AF Figueroa-Sanchez, Jose A.
   Ferrigno, Ana S.
   Moreno-Cuevas, Jorge
   Gonzalez-Garza, Maria T.
   Jamall, Selene
   Martinez, Hector R.
TI Spontaneous Bone Regeneration After Large Craniectomy in Pediatric
   Patient
SO WORLD NEUROSURGERY
LA English
DT Article
DE Calvarial stem cells; Craniectomy; Cranioplasty; Spontaneous bone
   regeneration
ID CALVARIAL DEFECTS; CRANIOPLASTY; DURA; GROWTH; IMMATURE; CHILDREN
AB BACKGROUND: In children, decompressive craniectomy is commonly per-formed in cases of increased intracranial pressure that is not medically managed. Currently, it is standard practice to perform cranioplasty after decompressive craniectomy, although optimal timing for the procedure remains controversial. To date, few studies have reported spontaneous cranial bone regeneration in children without intervention.
   CASE DESCRIPTION: A 7-year-old female presented with frontotemporal bone .._matures accompanied by dura mater lacerations and brain edema after a motor vehicle accident. She underwent a large decompressive craniectomy and repair of the lacerated dura with a collagen dural substitute. The patient was discharged from the hospital and did not present for follow-up until 10 months after surgery. At that time, computed tomography imaging revealed remarkable spontaneous bone regeneration. With conservative management, she developed enough bone regeneration in the calvarial defect area that cranioplasty surgery was deemed unnecessary. To this date, the patient has no aesthetic deformation of the skull bone and does not exhibit any residual cognitive impairment or motor deficits.
   CONCLUSIONS: This case report shows that cranial bone regeneration is possible in children older than 6 years old, bypassing the need for cranioplasty after decompressive craniectomy. On the basis of this observation, we recommend that more studies should be performed to identify the factors involved in spontaneous skull bone regeneration in the pediatric population.
C1 [Figueroa-Sanchez, Jose A.; Ferrigno, Ana S.; Martinez, Hector R.] Hosp Zambrano Hellion, Inst Neurol & Neurosurg, San Pedro Garza Garcia, Nuevo Leon, Mexico.
   [Moreno-Cuevas, Jorge; Gonzalez-Garza, Maria T.] Tecnol Monterrey, Sch Med & Hlth Sci, Cell Therapy Dept, San Pedro Garza Garcia, Nuevo Leon, Mexico.
   [Jamall, Selene] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA.
RP Martinez, HR (reprint author), Hosp Zambrano Hellion, Inst Neurol & Neurosurg, San Pedro Garza Garcia, Nuevo Leon, Mexico.
EM hector.ram.martinez@gmail.com
OI Ferrigno, Ana/0000-0003-1855-1196; Figueroa-Sanchez, Jose
   Antonio/0000-0003-1427-9471
CR Albee FH, 1920, ANN SURG, V71, P32
   Brey EM, 2007, PLAST RECONSTR SURG, V119, P1216, DOI 10.1097/01.prs.0000254361.74614.bb
   BUSHE K A, 1961, Zentralbl Neurochir, V21, P337
   Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9
   Doro DH, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00956
   Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8
   Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51
   Greenwald JA, 2000, PLAST RECONSTR SURG, V105, P1382, DOI 10.1097/00006534-200004040-00018
   GRUBER R, 1988, Z KINDERCHIR, V43, P375
   HOBAR PC, 1993, PLAST RECONSTR SURG, V92, P405
   Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2
   Levine JP, 1998, PLAST RECONSTR SURG, V101, P1441, DOI 10.1097/00006534-199805000-00002
   Lin CY, 2012, BIOMATERIALS, V33, P3682, DOI 10.1016/j.biomaterials.2012.02.007
   Mathew J, 2008, TURK NEUROSURG, V18, P407
   PROLO DJ, 1991, CLIN ORTHOP RELAT R, P270
   Springer ING, 2007, J CRANIO MAXILL SURG, V35, P177, DOI 10.1016/j.jcms.2007.04.003
   Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201
   Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0
   Williams L, 2016, J CRANIO MAXILL SURG, V44, P789, DOI 10.1016/j.jcms.2016.03.010
   Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4
NR 20
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1878-8750
EI 1878-8769
J9 WORLD NEUROSURG
JI World Neurosurg.
PD JUL
PY 2019
VL 127
BP 316
EP 318
DI 10.1016/j.wneu.2019.04.085
PG 3
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF5NH
UT WOS:000473128300217
PM 31003030
DA 2020-05-12
ER

EF